{
    "55046d5ff8aee20f27000007": [
        {
            "text": "amphiregulin",
            "probability": 0.17960751001408767,
            "start_logit": 6.7130632400512695,
            "end_logit": 6.653562068939209,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor (EGF), amphiregulin",
            "probability": 0.13851363490273172,
            "start_logit": 6.453258037567139,
            "end_logit": 6.653562068939209,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG) EGFR ligands epidermal growth factor",
            "probability": 0.13117778516045098,
            "start_logit": 6.563972473144531,
            "end_logit": 6.48843240737915,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor",
            "probability": 0.11742961187052316,
            "start_logit": 6.453258037567139,
            "end_logit": 6.48843240737915,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor (EGF) and amphiregulin",
            "probability": 0.09862020654167125,
            "start_logit": 6.326173305511475,
            "end_logit": 6.440954208374023,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "transforming growth factor alpha",
            "probability": 0.08840506890061832,
            "start_logit": 6.725744724273682,
            "end_logit": 5.93203592300415,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG) and transforming growth factor alpha",
            "probability": 0.08729104011322554,
            "start_logit": 6.7130632400512695,
            "end_logit": 5.93203592300415,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor (EGF), amphiregulin (AREG) and transforming growth factor alpha",
            "probability": 0.06731900720395635,
            "start_logit": 6.453258037567139,
            "end_logit": 5.93203592300415,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor receptor (EGFR) ligands, such as epidermal growth factor",
            "probability": 0.028752551402876827,
            "start_logit": 5.289140701293945,
            "end_logit": 6.245437145233154,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG) EGFR ligands epidermal growth factor (EGF)",
            "probability": 0.00966161968219007,
            "start_logit": 6.563972473144531,
            "end_logit": 3.880040168762207,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG)",
            "probability": 0.009229894700306027,
            "start_logit": 6.7130632400512695,
            "end_logit": 3.6852357387542725,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor (EGF)",
            "probability": 0.008649027332885993,
            "start_logit": 6.453258037567139,
            "end_logit": 3.880040168762207,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor (EGF), amphiregulin (AREG)",
            "probability": 0.007118111400846044,
            "start_logit": 6.453258037567139,
            "end_logit": 3.6852357387542725,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "Betacellulin",
            "probability": 0.004982428685738271,
            "start_logit": 5.11470365524292,
            "end_logit": 4.667065143585205,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor (EGF",
            "probability": 0.004838502762430092,
            "start_logit": 6.326173305511475,
            "end_logit": 3.426283359527588,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "EGF) and amphiregulin (AREG) EGFR ligands epidermal growth factor",
            "probability": 0.004513150398110967,
            "start_logit": 3.1944143772125244,
            "end_logit": 6.48843240737915,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "EGF) and amphiregulin",
            "probability": 0.004303881314332994,
            "start_logit": 3.1944143772125244,
            "end_logit": 6.440954208374023,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor (EGF) and amphiregulin (AREG)",
            "probability": 0.0036551960732364597,
            "start_logit": 6.326173305511475,
            "end_logit": 3.1458277702331543,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "transforming growth factor alpha (TGF\u03b1) EGFR and its ligand EGF",
            "probability": 0.003454158849280108,
            "start_logit": 6.725744724273682,
            "end_logit": 2.689685583114624,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "transforming growth factor alpha (TGF\u03b1)",
            "probability": 0.002477612690501264,
            "start_logit": 6.725744724273682,
            "end_logit": 2.3574020862579346,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        }
    ],
    "553fa78b1d53b76422000007": [
        {
            "text": "miR-200a",
            "probability": 0.07913284712304493,
            "start_logit": 4.1839280128479,
            "end_logit": 3.778188467025757,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-100, miR-141, miR-200b",
            "probability": 0.06712562232729048,
            "start_logit": 4.050765514373779,
            "end_logit": 3.746788740158081,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200a levels may serve as novel biomarkers for the early detection of EOC, and miR-200a",
            "probability": 0.06375297900628453,
            "start_logit": 4.1839280128479,
            "end_logit": 3.5620763301849365,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-100",
            "probability": 0.06318115487644212,
            "start_logit": 4.050765514373779,
            "end_logit": 3.6862289905548096,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-141, miR-200b",
            "probability": 0.06187698266082511,
            "start_logit": 3.9693479537963867,
            "end_logit": 3.746788740158081,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-100, miR-141",
            "probability": 0.05656943285604593,
            "start_logit": 4.050765514373779,
            "end_logit": 3.5756916999816895,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-100, miR-141, miR-200b, and miR-200c",
            "probability": 0.05438093366778526,
            "start_logit": 4.050765514373779,
            "end_logit": 3.536236524581909,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200a, miR-100, miR-141, miR-200b",
            "probability": 0.05430060741675191,
            "start_logit": 3.8387351036071777,
            "end_logit": 3.746788740158081,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200b",
            "probability": 0.05370613015333929,
            "start_logit": 3.8277268409729004,
            "end_logit": 3.746788740158081,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-141",
            "probability": 0.052146195366343275,
            "start_logit": 3.9693479537963867,
            "end_logit": 3.5756916999816895,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200a, miR-100",
            "probability": 0.051109769535617,
            "start_logit": 3.8387351036071777,
            "end_logit": 3.6862289905548096,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200c",
            "probability": 0.05030277626696955,
            "start_logit": 3.9728121757507324,
            "end_logit": 3.536236524581909,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-141, miR-200b, and miR-200c",
            "probability": 0.05012881777444599,
            "start_logit": 3.9693479537963867,
            "end_logit": 3.536236524581909,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200a, miR-100, miR-141",
            "probability": 0.04576128248505801,
            "start_logit": 3.8387351036071777,
            "end_logit": 3.5756916999816895,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200a, miR-100, miR-141, miR-200b, and miR-200c",
            "probability": 0.04399091774006987,
            "start_logit": 3.8387351036071777,
            "end_logit": 3.536236524581909,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200b, and miR-200c",
            "probability": 0.04350930986057757,
            "start_logit": 3.8277268409729004,
            "end_logit": 3.536236524581909,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200c) were reported with the consistent direction in four or more studies. MiR-200a",
            "probability": 0.03253813487125059,
            "start_logit": 3.9728121757507324,
            "end_logit": 3.1005890369415283,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200c) were reported with the consistent direction in four or more studies. MiR-200a, miR-200b",
            "probability": 0.03160697832033779,
            "start_logit": 3.9728121757507324,
            "end_logit": 3.071554183959961,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miR-200b, and miR-200c) were reported with the consistent direction in four or more studies. MiR-200a",
            "probability": 0.028143810291602307,
            "start_logit": 3.8277268409729004,
            "end_logit": 3.1005890369415283,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MiR-200a, miR-200b, miR-200c",
            "probability": 0.01673531739991839,
            "start_logit": 3.262996196746826,
            "end_logit": 3.1455135345458984,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        }
    ],
    "5149199dd24251bc05000040": [
        {
            "text": "pyridostigmine",
            "probability": 0.6478647232722591,
            "start_logit": 6.651474475860596,
            "end_logit": 6.50208044052124,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "pyridostigmine bromide",
            "probability": 0.3067743169076985,
            "start_logit": 6.651474475860596,
            "end_logit": 5.754510879516602,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "Pyridostigmine",
            "probability": 0.042888104383660454,
            "start_logit": 4.685450553894043,
            "end_logit": 5.753016948699951,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "pyridostig",
            "probability": 0.0005137522429022765,
            "start_logit": 6.651474475860596,
            "end_logit": -0.6376156210899353,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitor pyridostigmine",
            "probability": 0.00033391967180891895,
            "start_logit": -0.9190622568130493,
            "end_logit": 6.50208044052124,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "inhibitor pyridostigmine",
            "probability": 0.0002758039233374552,
            "start_logit": -1.1102725267410278,
            "end_logit": 6.50208044052124,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "bromide",
            "probability": 0.00017711496998493252,
            "start_logit": -0.8055940866470337,
            "end_logit": 5.754510879516602,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitor pyridostigmine bromide",
            "probability": 0.00015811630968858194,
            "start_logit": -0.9190622568130493,
            "end_logit": 5.754510879516602,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "p",
            "probability": 0.00015612570052670605,
            "start_logit": 6.651474475860596,
            "end_logit": -1.828695297241211,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "yridostigmine",
            "probability": 0.00014114474985857874,
            "start_logit": -1.7801767587661743,
            "end_logit": 6.50208044052124,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "inhibitor pyridostigmine bromide",
            "probability": 0.0001305975725224889,
            "start_logit": -1.1102725267410278,
            "end_logit": 5.754510879516602,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "pyridostigmine bromide has been the drug of choice",
            "probability": 0.00012271658695297912,
            "start_logit": 6.651474475860596,
            "end_logit": -2.06947922706604,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "mine",
            "probability": 0.00010807139551096084,
            "start_logit": -2.047170639038086,
            "end_logit": 6.50208044052124,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "the acetylcholinesterase inhibitor pyridostigmine",
            "probability": 8.122965145058577e-05,
            "start_logit": -2.3326823711395264,
            "end_logit": 6.50208044052124,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "yridostigmine bromide",
            "probability": 6.683429837678818e-05,
            "start_logit": -1.7801767587661743,
            "end_logit": 5.754510879516602,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "pyridost",
            "probability": 5.4668417154215636e-05,
            "start_logit": 6.651474475860596,
            "end_logit": -2.878070592880249,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "mine bromide",
            "probability": 5.1173535684554115e-05,
            "start_logit": -2.047170639038086,
            "end_logit": 5.754510879516602,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "the acetylcholinesterase inhibitor pyridostigmine bromide",
            "probability": 3.8463540213366174e-05,
            "start_logit": -2.3326823711395264,
            "end_logit": 5.754510879516602,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "de",
            "probability": 3.303449393767087e-05,
            "start_logit": -2.4848408699035645,
            "end_logit": 5.754510879516602,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "pyridostigmine bromide has been the drug of choice in the symptomatic therapy",
            "probability": 3.0088376471097857e-05,
            "start_logit": 6.651474475860596,
            "end_logit": -3.475217819213867,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        }
    ],
    "5709e4b2cf1c32585100001c": [
        {
            "text": "DVL-3",
            "probability": 0.41082463813129666,
            "start_logit": 4.505287170410156,
            "end_logit": 3.460824728012085,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL-1 and DVL-3",
            "probability": 0.23693294352250835,
            "start_logit": 4.088350772857666,
            "end_logit": 3.327371835708618,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL-1",
            "probability": 0.1727255199614815,
            "start_logit": 4.088350772857666,
            "end_logit": 3.011298418045044,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL",
            "probability": 0.07871825104735103,
            "start_logit": 4.505287170410156,
            "end_logit": 1.8085333108901978,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dvl-1",
            "probability": 0.05345019990385063,
            "start_logit": 3.7528445720672607,
            "end_logit": 2.173851251602173,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL-1 and DVL",
            "probability": 0.023335547287244802,
            "start_logit": 4.088350772857666,
            "end_logit": 1.0095725059509277,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dvl",
            "probability": 0.006804965317670829,
            "start_logit": 3.7528445720672607,
            "end_logit": 0.11275341361761093,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dvl-1)",
            "probability": 0.004643972786280821,
            "start_logit": 3.7528445720672607,
            "end_logit": -0.26932892203330994,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "dsh-homologous genes, designated as DVL-1 and DVL-3",
            "probability": 0.003300529812329079,
            "start_logit": -0.18534338474273682,
            "end_logit": 3.327371835708618,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dvl-1) shares 50% identity (65% similarity) with dsh",
            "probability": 0.0026340426008825287,
            "start_logit": 3.7528445720672607,
            "end_logit": -0.83637934923172,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "dsh-homologous genes, designated as DVL-1",
            "probability": 0.0024061057930880496,
            "start_logit": -0.18534338474273682,
            "end_logit": 3.011298418045044,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL-3.",
            "probability": 0.0010919058209327645,
            "start_logit": 4.505287170410156,
            "end_logit": -2.469417095184326,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "(Dvl-1",
            "probability": 0.0006884436137261957,
            "start_logit": -0.5992276668548584,
            "end_logit": 2.173851251602173,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "D",
            "probability": 0.00042692821405988064,
            "start_logit": 4.505287170410156,
            "end_logit": -3.4084811210632324,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL-1 and DVL-3.",
            "probability": 0.00039795290188079924,
            "start_logit": 4.088350772857666,
            "end_logit": -3.0618269443511963,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "3",
            "probability": 0.00035707359161708975,
            "start_logit": -2.5426926612854004,
            "end_logit": 3.460824728012085,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "dsh-homologous genes, designated as DVL-1 and DVL",
            "probability": 0.00032506948321962516,
            "start_logit": -0.18534338474273682,
            "end_logit": 1.0095725059509277,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "mouse dishevelled gene (Dvl-1",
            "probability": 0.00031333992931540934,
            "start_logit": -1.386372447013855,
            "end_logit": 2.173851251602173,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "1 and DVL-3",
            "probability": 0.0003130568839091955,
            "start_logit": -2.6742496490478516,
            "end_logit": 3.460824728012085,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "cDNA clones from two different human dsh-homologous genes, designated as DVL-1",
            "probability": 0.00030951339735476875,
            "start_logit": -2.2361068725585938,
            "end_logit": 3.011298418045044,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        }
    ],
    "54d4e03a3706e89528000001": [
        {
            "text": "verapamil",
            "probability": 0.14187815318015412,
            "start_logit": 1.2514761686325073,
            "end_logit": 0.5708928108215332,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "verapamil and diltiazem",
            "probability": 0.110774792891346,
            "start_logit": 1.2514761686325073,
            "end_logit": 0.32342344522476196,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class IV antiarrhythmic drugs are the calcium channel blockers verapamil",
            "probability": 0.09530171116953826,
            "start_logit": 0.8535553216934204,
            "end_logit": 0.5708928108215332,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "amiodarone.Class IV antiarrhythmic drugs are the calcium channel blockers verapamil",
            "probability": 0.07480089631572057,
            "start_logit": 0.611337423324585,
            "end_logit": 0.5708928108215332,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class IV antiarrhythmic drugs are the calcium channel blockers verapamil and diltiazem",
            "probability": 0.07440911148308624,
            "start_logit": 0.8535553216934204,
            "end_logit": 0.32342344522476196,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "diltiazem",
            "probability": 0.06905994548180061,
            "start_logit": 0.7789518237113953,
            "end_logit": 0.32342344522476196,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "diltiazem. Other agents which do not fall neatly into the Vaughan Williams classification include digoxin",
            "probability": 0.06862709428430161,
            "start_logit": 0.7789518237113953,
            "end_logit": 0.3171359598636627,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "amiodarone",
            "probability": 0.05106520215810855,
            "start_logit": 0.611337423324585,
            "end_logit": 0.18916623294353485,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "digoxin",
            "probability": 0.04473680808111516,
            "start_logit": 0.35106101632118225,
            "end_logit": 0.3171359598636627,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class IV",
            "probability": 0.044647576716896065,
            "start_logit": 0.8535553216934204,
            "end_logit": -0.1873549222946167,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "calcium channel blockers verapamil",
            "probability": 0.03724479793755152,
            "start_logit": -0.08598016202449799,
            "end_logit": 0.5708928108215332,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "amiodarone.Class IV",
            "probability": 0.03504321922203008,
            "start_logit": 0.611337423324585,
            "end_logit": -0.1873549222946167,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "sotalol and amiodarone.Class IV antiarrhythmic drugs are the calcium channel blockers verapamil",
            "probability": 0.032250954801269494,
            "start_logit": -0.22994479537010193,
            "end_logit": 0.5708928108215332,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "calcium channel blockers verapamil and diltiazem",
            "probability": 0.029079775041711026,
            "start_logit": -0.08598016202449799,
            "end_logit": 0.32342344522476196,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "sotalol and amiodarone",
            "probability": 0.022017136262212494,
            "start_logit": -0.22994479537010193,
            "end_logit": 0.18916623294353485,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "digoxin and perhexiline",
            "probability": 0.01590142066178854,
            "start_logit": 0.35106101632118225,
            "end_logit": -0.7172521948814392,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "sotalol and amiodarone.Class IV",
            "probability": 0.015109140864441036,
            "start_logit": -0.22994479537010193,
            "end_logit": -0.1873549222946167,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class IV antiarrhythmic drugs",
            "probability": 0.01389674364219599,
            "start_logit": 0.8535553216934204,
            "end_logit": -1.354500412940979,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "perhexiline",
            "probability": 0.013248172312757218,
            "start_logit": 0.16851216554641724,
            "end_logit": -0.7172521948814392,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "amiodarone.Class IV antiarrhythmic drugs",
            "probability": 0.010907347491975656,
            "start_logit": 0.611337423324585,
            "end_logit": -1.354500412940979,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        }
    ],
    "55072c803b8a5dc045000001": [
        {
            "text": "Notch",
            "probability": 0.33390996439196385,
            "start_logit": 2.3022477626800537,
            "end_logit": 0.8255905508995056,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "Notch1-3",
            "probability": 0.29600348905583596,
            "start_logit": 1.8935328722000122,
            "end_logit": 1.1138052940368652,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "Notch1",
            "probability": 0.2397931429051426,
            "start_logit": 1.8935328722000122,
            "end_logit": 0.9032106995582581,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "Notch1-4",
            "probability": 0.06914026294622681,
            "start_logit": 2.3022477626800537,
            "end_logit": -0.7491436004638672,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "Notch-1 to -4",
            "probability": 0.00949115183408829,
            "start_logit": 0.8531808853149414,
            "end_logit": -1.2858539819717407,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "Notch-1",
            "probability": 0.008823898124144263,
            "start_logit": 0.8531808853149414,
            "end_logit": -1.3587502241134644,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3",
            "probability": 0.007119483825610343,
            "start_logit": -0.0887986347079277,
            "end_logit": -0.6313992142677307,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "Notch1-3 demonstrate overlapping and distinct expression patterns in mouse somites. Notch1 and Notch2",
            "probability": 0.0055210842422652616,
            "start_logit": 1.8935328722000122,
            "end_logit": -2.8679916858673096,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3, and NOTCH4",
            "probability": 0.003587099163149864,
            "start_logit": -0.0887986347079277,
            "end_logit": -1.3168905973434448,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "3",
            "probability": 0.0034796190425627183,
            "start_logit": -2.5499155521392822,
            "end_logit": 1.1138052940368652,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3, and NOTCH4.We conclude that CADASIL mutants of NOTCH3",
            "probability": 0.003452541692791,
            "start_logit": -0.0887986347079277,
            "end_logit": -1.35512375831604,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH1, 3, and 4, slow NOTCH3 clearance, and that overexpressed wild type and mutant NOTCH3",
            "probability": 0.0027719103238112225,
            "start_logit": -0.47897347807884216,
            "end_logit": -1.1845228672027588,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH4",
            "probability": 0.0025136352400190404,
            "start_logit": -0.4444124698638916,
            "end_logit": -1.3168905973434448,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3, and NOTCH4.We conclude that CADASIL mutants of NOTCH3 complex with NOTCH1",
            "probability": 0.0024416753774723545,
            "start_logit": -0.0887986347079277,
            "end_logit": -1.701550006866455,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH4.We conclude that CADASIL mutants of NOTCH3",
            "probability": 0.002419345011642734,
            "start_logit": -0.4444124698638916,
            "end_logit": -1.35512375831604,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3, and NOTCH4.We conclude that CADASIL mutants of NOTCH3 complex with NOTCH",
            "probability": 0.0020957361054241225,
            "start_logit": -0.0887986347079277,
            "end_logit": -1.8543295860290527,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "1-3",
            "probability": 0.0020672964161523983,
            "start_logit": -3.070596694946289,
            "end_logit": 1.1138052940368652,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH1, NOTCH3",
            "probability": 0.0019829551264426027,
            "start_logit": -1.3670456409454346,
            "end_logit": -0.6313992142677307,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH4.We conclude that CADASIL mutants of NOTCH3 complex with NOTCH1",
            "probability": 0.0017109873450255905,
            "start_logit": -0.4444124698638916,
            "end_logit": -1.701550006866455,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "1",
            "probability": 0.001674721830228871,
            "start_logit": -3.070596694946289,
            "end_logit": 0.9032106995582581,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        }
    ],
    "53061af558348c0f52000002": [
        {
            "text": "arrested cell-cycle progression",
            "probability": 0.23768298009255645,
            "start_logit": 6.188290119171143,
            "end_logit": 5.885156154632568,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "arrested cell-cycle progression and the development of aberrant gene expression with proinflammatory behavior",
            "probability": 0.19457446360295572,
            "start_logit": 6.188290119171143,
            "end_logit": 5.685033321380615,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "arrested cell-cycle progression and the development of aberrant gene expression",
            "probability": 0.13538157969342482,
            "start_logit": 6.188290119171143,
            "end_logit": 5.322315692901611,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "proinflammatory behavior",
            "probability": 0.09363747326289244,
            "start_logit": 5.456905841827393,
            "end_logit": 5.685033321380615,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "aberrant gene expression with proinflammatory behavior",
            "probability": 0.08444645708215301,
            "start_logit": 5.353592872619629,
            "end_logit": 5.685033321380615,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "aberrant gene expression",
            "probability": 0.058756398694865576,
            "start_logit": 5.353592872619629,
            "end_logit": 5.322315692901611,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "development of aberrant gene expression with proinflammatory behavior",
            "probability": 0.04961641422703274,
            "start_logit": 4.821796894073486,
            "end_logit": 5.685033321380615,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "development of aberrant gene expression",
            "probability": 0.03452225133965098,
            "start_logit": 4.821796894073486,
            "end_logit": 5.322315692901611,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "the development of aberrant gene expression with proinflammatory behavior",
            "probability": 0.019386709013750617,
            "start_logit": 3.8820629119873047,
            "end_logit": 5.685033321380615,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "arrested cell-cycle progression and the development of aberrant gene expression with proinflammatory",
            "probability": 0.014635366523475647,
            "start_logit": 6.188290119171143,
            "end_logit": 3.0976593494415283,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "the development of aberrant gene expression",
            "probability": 0.013488940134991316,
            "start_logit": 3.8820629119873047,
            "end_logit": 5.322315692901611,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell-cycle progression",
            "probability": 0.01205663921996297,
            "start_logit": 3.206967830657959,
            "end_logit": 5.885156154632568,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell-cycle progression and the development of aberrant gene expression with proinflammatory behavior",
            "probability": 0.009869928878227326,
            "start_logit": 3.206967830657959,
            "end_logit": 5.685033321380615,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "proinflammatory",
            "probability": 0.007043158265264591,
            "start_logit": 5.456905841827393,
            "end_logit": 3.0976593494415283,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "slower proliferation and altered morphology",
            "probability": 0.006982973368130045,
            "start_logit": 4.329972743988037,
            "end_logit": 4.216010570526123,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell-cycle progression and the development of aberrant gene expression",
            "probability": 0.0068673274912518885,
            "start_logit": 3.206967830657959,
            "end_logit": 5.322315692901611,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "altered morphology",
            "probability": 0.006535318921376319,
            "start_logit": 4.263719081878662,
            "end_logit": 4.216010570526123,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "aberrant gene expression with proinflammatory",
            "probability": 0.0063518348097735215,
            "start_logit": 5.353592872619629,
            "end_logit": 3.0976593494415283,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "gene expression with proinflammatory behavior",
            "probability": 0.00443177248023554,
            "start_logit": 2.4062747955322266,
            "end_logit": 5.685033321380615,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "development of aberrant gene expression with proinflammatory",
            "probability": 0.003732012898028542,
            "start_logit": 4.821796894073486,
            "end_logit": 3.0976593494415283,
            "question_text": "Which are the major characteristics of cellular senescence?"
        }
    ],
    "53137541e3eabad021000010": [
        {
            "text": "c-Myc",
            "probability": 0.07023974111470853,
            "start_logit": 5.625553607940674,
            "end_logit": 5.4064507484436035,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Sox2, Klf4, and c-Myc",
            "probability": 0.05676311814171514,
            "start_logit": 5.4125261306762695,
            "end_logit": 5.4064507484436035,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc)Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc",
            "probability": 0.05607407341268072,
            "start_logit": 5.400312900543213,
            "end_logit": 5.4064507484436035,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Oct4, Sox2, Klf4, and c-Myc",
            "probability": 0.05490974371353887,
            "start_logit": 5.379330158233643,
            "end_logit": 5.4064507484436035,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Klf4, and c-Myc",
            "probability": 0.05435297627330426,
            "start_logit": 5.369138717651367,
            "end_logit": 5.4064507484436035,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Sox2, Klf4",
            "probability": 0.054106878073846496,
            "start_logit": 5.4125261306762695,
            "end_logit": 5.358525276184082,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc)Yamanaka factors (Oct4, Sox2, Klf4",
            "probability": 0.05345007731374354,
            "start_logit": 5.400312900543213,
            "end_logit": 5.358525276184082,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Oct4, Sox2, Klf4",
            "probability": 0.052340232627059065,
            "start_logit": 5.379330158233643,
            "end_logit": 5.358525276184082,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Klf4",
            "probability": 0.051809519216829344,
            "start_logit": 5.369138717651367,
            "end_logit": 5.358525276184082,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc) Yamanaka factors (c-myc, KLF4",
            "probability": 0.05169703745594639,
            "start_logit": 5.625553607940674,
            "end_logit": 5.0999369621276855,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc) Yamanaka factors (c-myc",
            "probability": 0.04863518310607131,
            "start_logit": 5.625553607940674,
            "end_logit": 5.038883686065674,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Klf4 and c-Myc)Yamanaka factors (Oct4, Sox2, Klf4",
            "probability": 0.04544400350516521,
            "start_logit": 5.238045692443848,
            "end_logit": 5.358525276184082,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-myc, KLF4",
            "probability": 0.045234187936858676,
            "start_logit": 5.492006301879883,
            "end_logit": 5.0999369621276855,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc) Yamanaka factors (c-myc, KLF4, Oct3/4 and SOX2",
            "probability": 0.0450934301772595,
            "start_logit": 5.625553607940674,
            "end_logit": 4.963273048400879,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc)Yamanaka factors (Oct4",
            "probability": 0.04485609186076832,
            "start_logit": 5.400312900543213,
            "end_logit": 5.183236598968506,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Oct4",
            "probability": 0.04392469385876199,
            "start_logit": 5.379330158233643,
            "end_logit": 5.183236598968506,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "KLF4Yamanaka factors' (Oct4, Sox2, Klf4",
            "probability": 0.043350401233003155,
            "start_logit": 5.365978717803955,
            "end_logit": 5.183427333831787,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Sox2",
            "probability": 0.04284177861512338,
            "start_logit": 5.4125261306762695,
            "end_logit": 5.125077724456787,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-myc",
            "probability": 0.04255510801442482,
            "start_logit": 5.492006301879883,
            "end_logit": 5.038883686065674,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc)Yamanaka factors (Oct4, Sox2",
            "probability": 0.04232172434919121,
            "start_logit": 5.400312900543213,
            "end_logit": 5.125077724456787,
            "question_text": "Which are the Yamanaka factors?"
        }
    ],
    "5718bbb37de986d80d00000b": [
        {
            "text": "Alpers syndrome",
            "probability": 0.1362033386833303,
            "start_logit": 4.32871675491333,
            "end_logit": 4.18690824508667,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy syndrome",
            "probability": 0.13172660258762817,
            "start_logit": 4.817965030670166,
            "end_logit": 3.6642396450042725,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy syndromes",
            "probability": 0.12034813686291579,
            "start_logit": 4.817965030670166,
            "end_logit": 3.573899745941162,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia",
            "probability": 0.10890848993946453,
            "start_logit": 4.192023277282715,
            "end_logit": 4.099960803985596,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia-neuropathy syndrome",
            "probability": 0.0704417994245763,
            "start_logit": 4.192023277282715,
            "end_logit": 3.6642396450042725,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia",
            "probability": 0.06905479605206763,
            "start_logit": 4.817965030670166,
            "end_logit": 3.01841139793396,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia",
            "probability": 0.06700765748222742,
            "start_logit": 4.32871675491333,
            "end_logit": 3.4775662422180176,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia-neuropathy syndromes",
            "probability": 0.06435707861196434,
            "start_logit": 4.192023277282715,
            "end_logit": 3.573899745941162,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy syndrome",
            "probability": 0.056342206928314396,
            "start_logit": 4.32871675491333,
            "end_logit": 3.3042032718658447,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy syndromes",
            "probability": 0.03746410904724824,
            "start_logit": 4.32871675491333,
            "end_logit": 2.8961427211761475,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia",
            "probability": 0.03692757573071753,
            "start_logit": 4.192023277282715,
            "end_logit": 3.01841139793396,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy",
            "probability": 0.03149016958824095,
            "start_logit": 4.817965030670166,
            "end_logit": 2.2331864833831787,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia",
            "probability": 0.02228059222208285,
            "start_logit": 4.32871675491333,
            "end_logit": 2.3764753341674805,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia-neuropathy",
            "probability": 0.016839606931372403,
            "start_logit": 4.192023277282715,
            "end_logit": 2.2331864833831787,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "autosomal recessive Progressive External Ophthalmoplegia",
            "probability": 0.0065555878116008584,
            "start_logit": 2.929483652114868,
            "end_logit": 2.5523102283477783,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Myocerebrohepatopathy Spectrum disorders (MCHS), 2) Alpers syndrome",
            "probability": 0.006045326600530875,
            "start_logit": 1.9350104331970215,
            "end_logit": 3.4657511711120605,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, 3) Ataxia Neuropathy Spectrum (ANS) disorders, 4) Myoclonus Epilepsy",
            "probability": 0.0058252539803601506,
            "start_logit": 3.7950427532196045,
            "end_logit": 1.5686359405517578,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy",
            "probability": 0.004564406672957778,
            "start_logit": 4.32871675491333,
            "end_logit": 0.7910478711128235,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia,",
            "probability": 0.004302749019953342,
            "start_logit": 4.192023277282715,
            "end_logit": 0.8687069416046143,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy syndromes.",
            "probability": 0.0033145158224463615,
            "start_logit": 4.817965030670166,
            "end_logit": -0.01817738078534603,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        }
    ],
    "54f9d3eedd3fc62544000004": [
        {
            "text": "calsequestrin",
            "probability": 0.10824679149889799,
            "start_logit": 4.557760715484619,
            "end_logit": 4.455170154571533,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "junctin",
            "probability": 0.10427902348497266,
            "start_logit": 4.8295512199401855,
            "end_logit": 4.146036148071289,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "Junctin",
            "probability": 0.07841973537984612,
            "start_logit": 4.6520562171936035,
            "end_logit": 4.038536548614502,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "triadin, calsequestrin",
            "probability": 0.07145845404217029,
            "start_logit": 4.142463207244873,
            "end_logit": 4.455170154571533,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "ryanodine receptor (RyR), and junctin",
            "probability": 0.06600852278436954,
            "start_logit": 4.372264862060547,
            "end_logit": 4.146036148071289,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "triadin (TRN), the ryanodine receptor (RyR), and junctin",
            "probability": 0.05583743607484125,
            "start_logit": 4.204925537109375,
            "end_logit": 4.146036148071289,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "Triadin (TrD) and Junctin",
            "probability": 0.050757019847584135,
            "start_logit": 4.2170305252075195,
            "end_logit": 4.038536548614502,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "ryanodine receptor",
            "probability": 0.05030768612761027,
            "start_logit": 4.372264862060547,
            "end_logit": 3.8744101524353027,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "calsequestrin and the ryanodine receptor",
            "probability": 0.04808758530512481,
            "start_logit": 4.557760715484619,
            "end_logit": 3.643780469894409,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "triadin",
            "probability": 0.04778290985406251,
            "start_logit": 4.142463207244873,
            "end_logit": 4.052721977233887,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "ryanodine receptor (RyR) at the junctional SR membrane. In cardiac muscle, junctin",
            "probability": 0.042912910864553656,
            "start_logit": 3.973475456237793,
            "end_logit": 4.1142144203186035,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "triadin (TRN), the ryanodine receptor",
            "probability": 0.042555901718933545,
            "start_logit": 4.204925537109375,
            "end_logit": 3.8744101524353027,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "junctin forms a quaternary protein complex with the ryanodine receptor (RyR), calsequestrin",
            "probability": 0.038077913886133304,
            "start_logit": 4.2101006507873535,
            "end_logit": 3.7580509185791016,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "Triadin",
            "probability": 0.03806973505223981,
            "start_logit": 4.2170305252075195,
            "end_logit": 3.750906229019165,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "Triadin and junctin",
            "probability": 0.03796006727778104,
            "start_logit": 4.024200916290283,
            "end_logit": 3.9408509731292725,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "triadin, calsequestrin and the ryanodine receptor",
            "probability": 0.03174472385687466,
            "start_logit": 4.142463207244873,
            "end_logit": 3.643780469894409,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "RyR2, a macromolecular complex devoted to control of calcium release from the sarcoplasmic reticulum.Triadin",
            "probability": 0.026888982516669886,
            "start_logit": 3.8563666343688965,
            "end_logit": 3.763867139816284,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "junctin forms a quaternary protein complex with the ryanodine receptor",
            "probability": 0.022494188490159363,
            "start_logit": 4.2101006507873535,
            "end_logit": 3.2316734790802,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "Junctin (JnC), two proteins that form, with CASQ2 and RyR2",
            "probability": 0.019714126436312932,
            "start_logit": 4.6520562171936035,
            "end_logit": 2.6577963829040527,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "CASQ2 is associated with a reduction in the levels of Triadin (TrD) and Junctin",
            "probability": 0.018396285500862267,
            "start_logit": 3.202129364013672,
            "end_logit": 4.038536548614502,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        }
    ],
    "515deafd298dcd4e51000025": [
        {
            "text": "achalasia",
            "probability": 0.7746618932956515,
            "start_logit": 4.59210729598999,
            "end_logit": 4.3996171951293945,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "esophageal achalasia",
            "probability": 0.2075180116274349,
            "start_logit": 3.8072350025177,
            "end_logit": 3.867280960083008,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "autistic spectrum disorder",
            "probability": 0.005238708238351394,
            "start_logit": 2.0661935806274414,
            "end_logit": 1.9291791915893555,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "chalasia",
            "probability": 0.004261929531500729,
            "start_logit": -0.6105973720550537,
            "end_logit": 4.3996171951293945,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "achalasia.Intestinal mucosal pathology",
            "probability": 0.0014775678290735344,
            "start_logit": 4.59210729598999,
            "end_logit": -1.8624120950698853,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "esophageal",
            "probability": 0.0012694557698008637,
            "start_logit": 3.8072350025177,
            "end_logit": -1.22934889793396,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "achalasia.Intestinal mucosal pathology,",
            "probability": 0.0011836327934222845,
            "start_logit": 4.59210729598999,
            "end_logit": -2.084221124649048,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "a",
            "probability": 0.0007327761258503584,
            "start_logit": 4.59210729598999,
            "end_logit": -2.5637245178222656,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "barium swallow and endoscopy that confirmed achalasia",
            "probability": 0.0006804997652529558,
            "start_logit": -2.445247173309326,
            "end_logit": 4.3996171951293945,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "achalasia.Intestinal mucosal pathology, characterized by ileo-colonic",
            "probability": 0.0006237336255022362,
            "start_logit": 4.59210729598999,
            "end_logit": -2.724841356277466,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "es",
            "probability": 0.00048160779243780445,
            "start_logit": 3.8072350025177,
            "end_logit": -2.1985623836517334,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "confirmed achalasia",
            "probability": 0.0004806648614195703,
            "start_logit": -2.7929043769836426,
            "end_logit": 4.3996171951293945,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "endoscopy that confirmed achalasia",
            "probability": 0.00035880599347806795,
            "start_logit": -3.0852928161621094,
            "end_logit": 4.3996171951293945,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "lymphoid nodular hyperplasia",
            "probability": 0.00029949136485435076,
            "start_logit": 0.18696653842926025,
            "end_logit": 0.9466615915298462,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "hageal achalasia",
            "probability": 0.0002234134499350213,
            "start_logit": -3.026714324951172,
            "end_logit": 3.867280960083008,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "achalasia in childhood: a possible correlation?In the last case, a 15-year-old male underwent barium swallow",
            "probability": 0.00020588942701869016,
            "start_logit": 3.004574775695801,
            "end_logit": -2.2456929683685303,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "ileo-colonic lymphoid nodular hyperplasia",
            "probability": 0.00012176149246094987,
            "start_logit": -0.713054895401001,
            "end_logit": 0.9466615915298462,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "autistic spectrum disorder (ASD",
            "probability": 7.490330105891139e-05,
            "start_logit": 2.0661935806274414,
            "end_logit": -2.318453073501587,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "autistic spectrum disorder (ASD)Ileo-colonic LNH is a characteristic pathological finding in children with ASD",
            "probability": 5.325760769342077e-05,
            "start_logit": 2.0661935806274414,
            "end_logit": -2.659510374069214,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "autistic spectrum disorder (ASD)",
            "probability": 5.199610780266402e-05,
            "start_logit": 2.0661935806274414,
            "end_logit": -2.6834821701049805,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        }
    ],
    "52bf202003868f1b06000018": [
        {
            "text": "refractory partial-onset seizures",
            "probability": 0.46597192215321037,
            "start_logit": 5.3308515548706055,
            "end_logit": 5.280665874481201,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "partial-onset seizures",
            "probability": 0.2509648321565134,
            "start_logit": 4.712038993835449,
            "end_logit": 5.280665874481201,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy",
            "probability": 0.22195439593138813,
            "start_logit": 5.080093860626221,
            "end_logit": 4.789770126342773,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "seizures",
            "probability": 0.05315276884220063,
            "start_logit": 3.1598963737487793,
            "end_logit": 5.280665874481201,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "refractory partial-onset seizure",
            "probability": 0.002701327630860231,
            "start_logit": 5.3308515548706055,
            "end_logit": 0.13028386235237122,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "partial-onset seizure",
            "probability": 0.0014548907417981408,
            "start_logit": 4.712038993835449,
            "end_logit": 0.13028386235237122,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "onset seizures",
            "probability": 0.0005664838839111007,
            "start_logit": -1.3815804719924927,
            "end_logit": 5.280665874481201,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "refractory",
            "probability": 0.00045667833055433225,
            "start_logit": 5.3308515548706055,
            "end_logit": -1.6472355127334595,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "refractory partial-onset",
            "probability": 0.00044696119089730724,
            "start_logit": 5.3308515548706055,
            "end_logit": -1.6687430143356323,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "pilepsy",
            "probability": 0.00041177103759729167,
            "start_logit": -1.2096658945083618,
            "end_logit": 4.789770126342773,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "seizure",
            "probability": 0.00030813668443085637,
            "start_logit": 3.1598963737487793,
            "end_logit": 0.13028386235237122,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epile",
            "probability": 0.0002759519294702441,
            "start_logit": 5.080093860626221,
            "end_logit": -1.9002304077148438,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "partial-onset",
            "probability": 0.00024072596420763806,
            "start_logit": 4.712038993835449,
            "end_logit": -1.6687430143356323,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "refractory epilepsy",
            "probability": 0.00021896414926530396,
            "start_logit": 0.14729885756969452,
            "end_logit": 2.801245927810669,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "y partial-onset seizures",
            "probability": 0.00019737642251801122,
            "start_logit": -2.4359164237976074,
            "end_logit": 5.280665874481201,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "s",
            "probability": 0.0001746953012915444,
            "start_logit": -2.557985782623291,
            "end_logit": 5.280665874481201,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "refractory partial",
            "probability": 0.00014784143317732578,
            "start_logit": 5.3308515548706055,
            "end_logit": -2.7750744819641113,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "e",
            "probability": 0.00012347888133846033,
            "start_logit": 5.080093860626221,
            "end_logit": -2.7043869495391846,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "re",
            "probability": 0.0001226561756925869,
            "start_logit": 5.3308515548706055,
            "end_logit": -2.961829662322998,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "psy",
            "probability": 0.00010814115967712944,
            "start_logit": -2.5466959476470947,
            "end_logit": 4.789770126342773,
            "question_text": "What are the main indications of lacosamide?"
        }
    ],
    "56be0da3ef6e394741000007": [
        {
            "text": "thrombocytopenia",
            "probability": 0.4007043248824504,
            "start_logit": 4.834799289703369,
            "end_logit": 4.831836223602295,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and acute kidney injury",
            "probability": 0.22275994121851186,
            "start_logit": 4.834799289703369,
            "end_logit": 4.244707107543945,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombotic microangiopathy, thrombocytopenia",
            "probability": 0.13275864525150838,
            "start_logit": 3.7301082611083984,
            "end_logit": 4.831836223602295,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "acute kidney injury",
            "probability": 0.07699310031048874,
            "start_logit": 3.7724204063415527,
            "end_logit": 4.244707107543945,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombotic microangiopathy, thrombocytopenia, and acute kidney injury",
            "probability": 0.0738033162510807,
            "start_logit": 3.7301082611083984,
            "end_logit": 4.244707107543945,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombotic microangiopathy",
            "probability": 0.031164041623002577,
            "start_logit": 3.7301082611083984,
            "end_logit": 3.382568359375,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and acute renal failure",
            "probability": 0.01614179371707211,
            "start_logit": 3.757469892501831,
            "end_logit": 2.6973536014556885,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.010452032090654605,
            "start_logit": 2.042025566101074,
            "end_logit": 3.978182554244995,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and renal failure",
            "probability": 0.006307188210836332,
            "start_logit": 3.2786030769348145,
            "end_logit": 2.2364985942840576,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury",
            "probability": 0.005032993129819129,
            "start_logit": 2.042025566101074,
            "end_logit": 3.247400999069214,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia,",
            "probability": 0.0046050827506099535,
            "start_logit": 4.834799289703369,
            "end_logit": 0.3657730519771576,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "renal failure",
            "probability": 0.004143497200429831,
            "start_logit": 2.3975982666015625,
            "end_logit": 2.6973536014556885,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "kidney injury",
            "probability": 0.003918772981793517,
            "start_logit": 0.7944831848144531,
            "end_logit": 4.244707107543945,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "acute renal failure",
            "probability": 0.002747914740475175,
            "start_logit": 1.9869004487991333,
            "end_logit": 2.6973536014556885,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathy, thrombocytopenia",
            "probability": 0.002682130524220616,
            "start_logit": -0.17181307077407837,
            "end_logit": 4.831836223602295,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombotic microangiopathy, thrombocytopenia,",
            "probability": 0.0015257248531605331,
            "start_logit": 3.7301082611083984,
            "end_logit": 0.3657730519771576,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathy, thrombocytopenia, and acute kidney injury",
            "probability": 0.001491052631116556,
            "start_logit": -0.17181307077407837,
            "end_logit": 4.244707107543945,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombotic microangiopathy,",
            "probability": 0.0009453952005727926,
            "start_logit": 3.7301082611083984,
            "end_logit": -0.11284879595041275,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia",
            "probability": 0.0009370319105625898,
            "start_logit": 2.042025566101074,
            "end_logit": 1.5663481950759888,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure",
            "probability": 0.0008860205216336365,
            "start_logit": 0.8550429344177246,
            "end_logit": 2.6973536014556885,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        }
    ],
    "515a7ffdd24251bc050000a5": [
        {
            "text": "inhibited cell migration",
            "probability": 0.3937973451478478,
            "start_logit": 4.566410541534424,
            "end_logit": 5.0698370933532715,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "cell migration",
            "probability": 0.12669510255209207,
            "start_logit": 3.4323575496673584,
            "end_logit": 5.0698370933532715,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "migration",
            "probability": 0.1238122449695225,
            "start_logit": 3.4093403816223145,
            "end_logit": 5.0698370933532715,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "decreased RhoA activation",
            "probability": 0.06312741223894118,
            "start_logit": 3.511256217956543,
            "end_logit": 4.294310092926025,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "transactivation of the c-Jun promoter.knockdown (KD) of km23-1 decreased RhoA activation",
            "probability": 0.05940329996619051,
            "start_logit": 3.450450897216797,
            "end_logit": 4.294310092926025,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "RhoA activation",
            "probability": 0.05160054000262642,
            "start_logit": 3.309633255004883,
            "end_logit": 4.294310092926025,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "phosphorylation of c-Jun, and transactivation of the c-Jun promoter",
            "probability": 0.029542990983788653,
            "start_logit": 3.656872272491455,
            "end_logit": 3.389385461807251,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "transactivation of the c-Jun promoter",
            "probability": 0.024032934216769844,
            "start_logit": 3.450450897216797,
            "end_logit": 3.389385461807251,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "inhibited cell migration of human colon carcinoma cells",
            "probability": 0.017680739634100915,
            "start_logit": 4.566410541534424,
            "end_logit": 1.966476559638977,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "inhibited cell migration of human colon carcinoma cells (HCCCs) in wound-healing assays",
            "probability": 0.01574434977749591,
            "start_logit": 4.566410541534424,
            "end_logit": 1.8504822254180908,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "decreased RhoA activation in Mv1Lu epithelial cells",
            "probability": 0.01499998508041704,
            "start_logit": 3.511256217956543,
            "end_logit": 2.8572041988372803,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "inhibited cell migration of human colon carcinoma cells (HCCCs) in wound-healing",
            "probability": 0.013276581091015293,
            "start_logit": 4.566410541534424,
            "end_logit": 1.6800023317337036,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "RhoA activation in Mv1Lu epithelial cells",
            "probability": 0.012261033720995771,
            "start_logit": 3.309633255004883,
            "end_logit": 2.8572041988372803,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "phosphorylation of c-Jun",
            "probability": 0.010723541226198277,
            "start_logit": 3.656872272491455,
            "end_logit": 2.3759803771972656,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK, phosphorylation of c-Jun",
            "probability": 0.009355263942901107,
            "start_logit": 3.5203700065612793,
            "end_logit": 2.3759803771972656,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "phosphorylation of c-Jun, and transactivation",
            "probability": 0.007720824364897526,
            "start_logit": 3.656872272491455,
            "end_logit": 2.0474600791931152,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK,",
            "probability": 0.0073918429437176735,
            "start_logit": 3.5203700065612793,
            "end_logit": 2.140418291091919,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "reduction in both total intracellular Smad2 levels",
            "probability": 0.00662252746652443,
            "start_logit": 3.1229453086853027,
            "end_logit": 2.427942991256714,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "transactivation",
            "probability": 0.006280815106454066,
            "start_logit": 3.450450897216797,
            "end_logit": 2.0474600791931152,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK",
            "probability": 0.005930625567503272,
            "start_logit": 3.5203700065612793,
            "end_logit": 1.9201709032058716,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        }
    ],
    "56a92be0a17756b72f000009": [
        {
            "text": "SoxB1",
            "probability": 0.19094639387534582,
            "start_logit": 5.069221496582031,
            "end_logit": 4.548830509185791,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1 and SoxB1",
            "probability": 0.17456202254232214,
            "start_logit": 4.979508876800537,
            "end_logit": 4.548830509185791,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 and SoxB1",
            "probability": 0.16109743065903123,
            "start_logit": 4.899238109588623,
            "end_logit": 4.548830509185791,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1",
            "probability": 0.1542837731693881,
            "start_logit": 4.979508876800537,
            "end_logit": 4.425343990325928,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1",
            "probability": 0.14238331504175392,
            "start_logit": 4.899238109588623,
            "end_logit": 4.425343990325928,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog",
            "probability": 0.10049456365080624,
            "start_logit": 4.899238109588623,
            "end_logit": 4.076924800872803,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "SoxB1 regulate zygotic gene activation in zebrafish.Here we show that Nanog, Pou5f1",
            "probability": 0.011421254970332926,
            "start_logit": 3.801330089569092,
            "end_logit": 3.0002052783966064,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 (also called Oct4) and SoxB1",
            "probability": 0.010644424936939121,
            "start_logit": 3.5620031356811523,
            "end_logit": 3.1690924167633057,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1 (also called Oct4) and SoxB1",
            "probability": 0.0092794966890451,
            "start_logit": 3.424774169921875,
            "end_logit": 3.1690924167633057,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "SoxB1 regulate zygotic gene activation in zebrafish.Here we show that Nanog",
            "probability": 0.009063420131944902,
            "start_logit": 3.801330089569092,
            "end_logit": 2.7689757347106934,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog,",
            "probability": 0.006721650827580627,
            "start_logit": 4.899238109588623,
            "end_logit": 1.372154951095581,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "SoxB",
            "probability": 0.004708756963476861,
            "start_logit": 5.069221496582031,
            "end_logit": 0.846261739730835,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1 and SoxB",
            "probability": 0.0043047167454828466,
            "start_logit": 4.979508876800537,
            "end_logit": 0.846261739730835,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430",
            "probability": 0.003985749060663354,
            "start_logit": 4.1989922523498535,
            "end_logit": 1.5497922897338867,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 and SoxB",
            "probability": 0.0039726785775758364,
            "start_logit": 4.899238109588623,
            "end_logit": 0.846261739730835,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "miR-430 expression.Here we show that Nanog, Pou5f1",
            "probability": 0.0037944121519700256,
            "start_logit": 2.742619514465332,
            "end_logit": 2.9569692611694336,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Oct4) and SoxB1",
            "probability": 0.0026607839393755087,
            "start_logit": 2.1755876541137695,
            "end_logit": 3.1690924167633057,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "miR-430 expression.Here we show that Nanog",
            "probability": 0.0024630774380575747,
            "start_logit": 2.742619514465332,
            "end_logit": 2.5248513221740723,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Oct4) and SoxB1 regulate zygotic gene activation in zebrafish.Here we show that Nanog",
            "probability": 0.0017711183652535328,
            "start_logit": 2.1686947345733643,
            "end_logit": 2.7689757347106934,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 (also called Oct4)",
            "probability": 0.0014409602636545477,
            "start_logit": 3.5653152465820312,
            "end_logit": 1.1660537719726562,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        }
    ],
    "56c3327c50c68dd41600000c": [
        {
            "text": "C9orf72 (GGGGCC)\u00b7(GGCCCC) repeats",
            "probability": 0.2503224706187269,
            "start_logit": 0.5086648464202881,
            "end_logit": -2.036705255508423,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C9orf72 (GGGGCC)\u00b7(GGCCCC)",
            "probability": 0.2236244776680165,
            "start_logit": 0.5086648464202881,
            "end_logit": -2.149487018585205,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C9orf72",
            "probability": 0.17634453091559502,
            "start_logit": 0.5086648464202881,
            "end_logit": -2.3870155811309814,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C9orf72 (GGGGCC)\u00b7(GGCCCC) repeats,",
            "probability": 0.15788012974553975,
            "start_logit": 0.5086648464202881,
            "end_logit": -2.497619152069092,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C9orf72 (GGGGCC)",
            "probability": 0.08243705700361002,
            "start_logit": 0.5086648464202881,
            "end_logit": -3.1474201679229736,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C",
            "probability": 0.019348665024393488,
            "start_logit": 0.5086648464202881,
            "end_logit": -4.596831798553467,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "(GGGGCC)\u00b7(GGCCCC) repeats",
            "probability": 0.014384988663787108,
            "start_logit": -2.347899913787842,
            "end_logit": -2.036705255508423,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "(GGGGCC)\u00b7(GGCCCC)",
            "probability": 0.012850766326525206,
            "start_logit": -2.347899913787842,
            "end_logit": -2.149487018585205,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "(GGGGCC)\u00b7(GGCCCC) repeats,",
            "probability": 0.009072712773301158,
            "start_logit": -2.347899913787842,
            "end_logit": -2.497619152069092,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "repeat tracts (CTG)n, (CAG)n",
            "probability": 0.006047703616131759,
            "start_logit": -2.421900749206543,
            "end_logit": -2.8292109966278076,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "expanded C9orf72 (GGGGCC)\u00b7(GGCCCC) repeats",
            "probability": 0.005889891256785766,
            "start_logit": -3.240847587585449,
            "end_logit": -2.036705255508423,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "GGCCCC) repeats",
            "probability": 0.00541272401611932,
            "start_logit": -3.3253326416015625,
            "end_logit": -2.036705255508423,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "expanded C9orf72 (GGGGCC)\u00b7(GGCCCC)",
            "probability": 0.005261708437778572,
            "start_logit": -3.240847587585449,
            "end_logit": -2.149487018585205,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "GGCCCC)",
            "probability": 0.004835433182941983,
            "start_logit": -3.3253326416015625,
            "end_logit": -2.149487018585205,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "(GGGGCC)",
            "probability": 0.004737313943657548,
            "start_logit": -2.347899913787842,
            "end_logit": -3.1474201679229736,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "repeat tracts (CTG)n, (CAG)n, (CGG)n, (CCG)n",
            "probability": 0.004717743601389561,
            "start_logit": -2.421900749206543,
            "end_logit": -3.077558994293213,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "(GGCCCC) repeats",
            "probability": 0.00429639533262342,
            "start_logit": -3.5563087463378906,
            "end_logit": -2.036705255508423,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "repeats",
            "probability": 0.004214075110291681,
            "start_logit": -3.575654983520508,
            "end_logit": -2.036705255508423,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "(CGG)n, (CCG)n",
            "probability": 0.004171964362294211,
            "start_logit": -2.544844388961792,
            "end_logit": -3.077558994293213,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "expanded C9orf72",
            "probability": 0.004149248400491169,
            "start_logit": -3.240847587585449,
            "end_logit": -2.3870155811309814,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        }
    ],
    "5314a7a4dae131f847000003": [
        {
            "text": "TNNC1-A31S",
            "probability": 0.4933049884445109,
            "start_logit": 4.601562976837158,
            "end_logit": 4.42634916305542,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V",
            "probability": 0.2090686992959798,
            "start_logit": 4.239312648773193,
            "end_logit": 3.9301347732543945,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A31S",
            "probability": 0.10975340538692181,
            "start_logit": 3.0986714363098145,
            "end_logit": 4.42634916305542,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V mutation",
            "probability": 0.04046623474468749,
            "start_logit": 4.239312648773193,
            "end_logit": 2.2879397869110107,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "TNNC1",
            "probability": 0.039103833982353876,
            "start_logit": 4.601562976837158,
            "end_logit": 1.891442060470581,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "TNNC1 mutation, A31S",
            "probability": 0.03119786522805517,
            "start_logit": 2.8771347999572754,
            "end_logit": 3.3899993896484375,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "TNNC1-A31",
            "probability": 0.026046533473510557,
            "start_logit": 4.601562976837158,
            "end_logit": 1.4851062297821045,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "TNNC1-A31S,",
            "probability": 0.017402061800904287,
            "start_logit": 4.601562976837158,
            "end_logit": 1.0818102359771729,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V). A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S",
            "probability": 0.013083360714667236,
            "start_logit": 0.9717766046524048,
            "end_logit": 4.42634916305542,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A31",
            "probability": 0.0057949864976153415,
            "start_logit": 3.0986714363098145,
            "end_logit": 1.4851062297821045,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A31S,",
            "probability": 0.004069269562567721,
            "start_logit": 3.705888509750366,
            "end_logit": 0.5243595242500305,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "TNNC1-encoded cardiac troponin C, TNNC1-A31S",
            "probability": 0.003597032603436985,
            "start_logit": -0.31945541501045227,
            "end_logit": 4.42634916305542,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "TNNC1 mutation, A31S,",
            "probability": 0.0017766148871619198,
            "start_logit": 2.8771347999572754,
            "end_logit": 0.5243595242500305,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8",
            "probability": 0.0010693587090992132,
            "start_logit": 4.239312648773193,
            "end_logit": -1.3454689979553223,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V). A mutation in TNNC1-encoded cardiac troponin C, TNNC1",
            "probability": 0.0010371060039972542,
            "start_logit": 0.9717766046524048,
            "end_logit": 1.891442060470581,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "TNNC",
            "probability": 0.0009232512049834891,
            "start_logit": 4.601562976837158,
            "end_logit": -1.8546323776245117,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "TNNC1 mutation, A31",
            "probability": 0.0008679268746445087,
            "start_logit": 2.8771347999572754,
            "end_logit": -0.19199809432029724,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V). A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31",
            "probability": 0.0006908022436082159,
            "start_logit": 0.9717766046524048,
            "end_logit": 1.4851062297821045,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V). A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S,",
            "probability": 0.00046153486596207954,
            "start_logit": 0.9717766046524048,
            "end_logit": 1.0818102359771729,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "TNNC1-encoded cardiac troponin C, TNNC1",
            "probability": 0.0002851334753322403,
            "start_logit": -0.31945541501045227,
            "end_logit": 1.891442060470581,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        }
    ],
    "56c6dd275795f9a73e000008": [
        {
            "text": "H3K9me3",
            "probability": 0.1332054369035705,
            "start_logit": 5.194775581359863,
            "end_logit": 4.892960548400879,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K79me3",
            "probability": 0.13083341515064345,
            "start_logit": 5.221993446350098,
            "end_logit": 4.847774982452393,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3, and H3K79me3",
            "probability": 0.12732043371698945,
            "start_logit": 5.194775581359863,
            "end_logit": 4.847774982452393,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3, H3K9me3",
            "probability": 0.10914488382908294,
            "start_logit": 4.995559215545654,
            "end_logit": 4.892960548400879,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3, H3K9me3, and H3K79me3",
            "probability": 0.10432287352631914,
            "start_logit": 4.995559215545654,
            "end_logit": 4.847774982452393,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3",
            "probability": 0.0912118378027295,
            "start_logit": 4.995559215545654,
            "end_logit": 4.7134690284729,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K79me3.This result indicates that H3K36me3",
            "probability": 0.0889536080115781,
            "start_logit": 5.221993446350098,
            "end_logit": 4.461965084075928,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3, and H3K79me3.This result indicates that H3K36me3",
            "probability": 0.08656513276585132,
            "start_logit": 5.194775581359863,
            "end_logit": 4.461965084075928,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K36me3",
            "probability": 0.05599788913006195,
            "start_logit": 4.75919246673584,
            "end_logit": 4.461965084075928,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K27me1",
            "probability": 0.011890903720953971,
            "start_logit": 4.0559234619140625,
            "end_logit": 3.6156938076019287,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K27me1 and H3K27me2",
            "probability": 0.01186228191811886,
            "start_logit": 4.0559234619140625,
            "end_logit": 3.61328387260437,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K27me2",
            "probability": 0.011572059395227647,
            "start_logit": 4.031153202056885,
            "end_logit": 3.61328387260437,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2, H3K27me1",
            "probability": 0.011317654461862973,
            "start_logit": 4.006513595581055,
            "end_logit": 3.6156938076019287,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2, H3K27me1 and H3K27me2",
            "probability": 0.01129041248916139,
            "start_logit": 4.006513595581055,
            "end_logit": 3.61328387260437,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2",
            "probability": 0.007903074207620082,
            "start_logit": 4.006513595581055,
            "end_logit": 3.2565817832946777,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "methylation marks usually found in constitutive heterochromatin, such as H4K20me3",
            "probability": 0.005637006108546868,
            "start_logit": 2.2117276191711426,
            "end_logit": 4.7134690284729,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3,",
            "probability": 0.00035451660368547957,
            "start_logit": 4.995559215545654,
            "end_logit": -0.8367157578468323,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3,",
            "probability": 0.00023956725652609772,
            "start_logit": 5.194775581359863,
            "end_logit": -1.4278531074523926,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3, H3K9me3,",
            "probability": 0.0001962948434433773,
            "start_logit": 4.995559215545654,
            "end_logit": -1.4278531074523926,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "4K20me3, H3K9me3",
            "probability": 0.00018071815802690394,
            "start_logit": -1.4079335927963257,
            "end_logit": 4.892960548400879,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        }
    ],
    "5322d9339b2d7acc7e000011": [
        {
            "text": "apoptosis",
            "probability": 0.2444265505666581,
            "start_logit": 5.591395378112793,
            "end_logit": 5.954451084136963,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth inhibition and apoptosis",
            "probability": 0.19395708329195785,
            "start_logit": 5.360117435455322,
            "end_logit": 5.954451084136963,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth inhibition",
            "probability": 0.13370396156716238,
            "start_logit": 5.360117435455322,
            "end_logit": 5.582442283630371,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis.Silencing PRKAR1A expression induced growth inhibition and apoptosis",
            "probability": 0.11278211897576447,
            "start_logit": 4.817938327789307,
            "end_logit": 5.954451084136963,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis.Silencing PRKAR1A expression induced growth inhibition",
            "probability": 0.0777461479883163,
            "start_logit": 4.817938327789307,
            "end_logit": 5.582442283630371,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "enhance apoptosis.Silencing PRKAR1A expression induced growth inhibition and apoptosis",
            "probability": 0.0727250985086206,
            "start_logit": 4.379167079925537,
            "end_logit": 5.954451084136963,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "enhance apoptosis.Silencing PRKAR1A expression induced growth inhibition",
            "probability": 0.05013291399792813,
            "start_logit": 4.379167079925537,
            "end_logit": 5.582442283630371,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "enhance apoptosis",
            "probability": 0.03631692420691437,
            "start_logit": 4.379167079925537,
            "end_logit": 5.2600483894348145,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "inhibit cholangiocarcinoma (CCA) cell growth and enhance apoptosis",
            "probability": 0.016144441619402164,
            "start_logit": 3.5684590339660645,
            "end_logit": 5.2600483894348145,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells",
            "probability": 0.013137573200496928,
            "start_logit": 5.591395378112793,
            "end_logit": 3.031012535095215,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth inhibition and apoptosis of CCA cells",
            "probability": 0.010424912406592554,
            "start_logit": 5.360117435455322,
            "end_logit": 3.031012535095215,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "induced growth inhibition and apoptosis",
            "probability": 0.006909845628934562,
            "start_logit": 2.02542781829834,
            "end_logit": 5.954451084136963,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "inhibit cholangiocarcinoma (CCA) cell growth",
            "probability": 0.006868359740033633,
            "start_logit": 3.5684590339660645,
            "end_logit": 4.405397891998291,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis.Silencing PRKAR1A expression induced growth inhibition and apoptosis of CCA cells",
            "probability": 0.006061875603596453,
            "start_logit": 4.817938327789307,
            "end_logit": 3.031012535095215,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "induced growth inhibition",
            "probability": 0.004763289479948571,
            "start_logit": 2.02542781829834,
            "end_logit": 5.582442283630371,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "enhance apoptosis.Silencing PRKAR1A expression induced growth inhibition and apoptosis of CCA cells",
            "probability": 0.003908868749959287,
            "start_logit": 4.379167079925537,
            "end_logit": 3.031012535095215,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells, with an associated decrease in mitogen-activated protein kinases, PI3K/Akt",
            "probability": 0.002859947657196717,
            "start_logit": 5.591395378112793,
            "end_logit": 1.5063395500183105,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells, with an associated decrease",
            "probability": 0.002699004781107052,
            "start_logit": 5.591395378112793,
            "end_logit": 1.4484193325042725,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells, with an associated decrease in mitogen-activated protein kinases",
            "probability": 0.0022759870385561996,
            "start_logit": 5.591395378112793,
            "end_logit": 1.2779500484466553,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells,",
            "probability": 0.002155094990853576,
            "start_logit": 5.591395378112793,
            "end_logit": 1.2233710289001465,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        }
    ],
    "56c1f005ef6e39474100003a": [
        {
            "text": "interleukin-13",
            "probability": 0.38898101113033434,
            "start_logit": 5.5679426193237305,
            "end_logit": 5.227656841278076,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13",
            "probability": 0.31976511014185105,
            "start_logit": 5.3719987869262695,
            "end_logit": 5.227656841278076,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4",
            "probability": 0.2637629592622355,
            "start_logit": 5.3719987869262695,
            "end_logit": 5.035120964050293,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13,",
            "probability": 0.00919771557883117,
            "start_logit": 5.5679426193237305,
            "end_logit": 1.4830814599990845,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13,",
            "probability": 0.007561059411542591,
            "start_logit": 5.3719987869262695,
            "end_logit": 1.4830814599990845,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "Dupilumab, a fully human monoclonal antibody that blocks interleukin-4 and interleukin-13",
            "probability": 0.001953870038324782,
            "start_logit": 0.2742241322994232,
            "end_logit": 5.227656841278076,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "Dupilumab, a fully human monoclonal antibody that blocks interleukin-4",
            "probability": 0.001611678469529536,
            "start_logit": 0.2742241322994232,
            "end_logit": 5.035120964050293,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "ukin-4 and interleukin-13",
            "probability": 0.0014754754946691246,
            "start_logit": -0.006607601419091225,
            "end_logit": 5.227656841278076,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "ukin-4",
            "probability": 0.0012170676864033001,
            "start_logit": -0.006607601419091225,
            "end_logit": 5.035120964050293,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "n-4 and interleukin-13",
            "probability": 0.0007403602676205569,
            "start_logit": -0.696206271648407,
            "end_logit": 5.227656841278076,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "n-4",
            "probability": 0.0006106970676730513,
            "start_logit": -0.696206271648407,
            "end_logit": 5.035120964050293,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "ukin-13",
            "probability": 0.0005976998525029643,
            "start_logit": -0.9102544784545898,
            "end_logit": 5.227656841278076,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "13",
            "probability": 0.0005893422660431414,
            "start_logit": -0.9243360757827759,
            "end_logit": 5.227656841278076,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "4 and interleukin-13",
            "probability": 0.0004846007234919496,
            "start_logit": -1.1200178861618042,
            "end_logit": 5.227656841278076,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "4",
            "probability": 0.00039973004194283364,
            "start_logit": -1.1200178861618042,
            "end_logit": 5.035120964050293,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4",
            "probability": 0.0002723411303811516,
            "start_logit": 1.8181902170181274,
            "end_logit": 1.7131788730621338,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor \u03b1, markedly improved disease activity, but the effect of IL-4/IL-13",
            "probability": 0.00020598385278300946,
            "start_logit": 1.7971603870391846,
            "end_logit": 1.4549510478973389,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor complex. BACKGROUND: Dupilumab, a fully human monoclonal antibody that blocks interleukin-4",
            "probability": 0.0002013088342690727,
            "start_logit": -1.805967092514038,
            "end_logit": 5.035120964050293,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "-13",
            "probability": 0.00018919481266238458,
            "start_logit": -2.060565948486328,
            "end_logit": 5.227656841278076,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-13",
            "probability": 0.00018279393690840334,
            "start_logit": 1.9082926511764526,
            "end_logit": 1.2243804931640625,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        }
    ],
    "513ce3c8bee46bd34c000008": [
        {
            "text": "FGFR2",
            "probability": 0.21029245191676413,
            "start_logit": 5.341903209686279,
            "end_logit": 5.001479625701904,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR2, FGFR3",
            "probability": 0.20922762658112926,
            "start_logit": 5.341903209686279,
            "end_logit": 4.996403217315674,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR3",
            "probability": 0.20790808984161824,
            "start_logit": 5.33557653427124,
            "end_logit": 4.996403217315674,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "MSX2",
            "probability": 0.18913699370950607,
            "start_logit": 5.487839221954346,
            "end_logit": 4.749516010284424,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR3)Syndromic craniosynostosis due to complex chromosome 5 rearrangement and MSX2",
            "probability": 0.16242378871783103,
            "start_logit": 5.33557653427124,
            "end_logit": 4.749516010284424,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "(FGFR2",
            "probability": 0.005227169246690497,
            "start_logit": 1.6472738981246948,
            "end_logit": 5.001479625701904,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "(FGFR2, FGFR3",
            "probability": 0.005200701238938462,
            "start_logit": 1.6472738981246948,
            "end_logit": 4.996403217315674,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "deltaN377craniosynostosis genes (FGFR2",
            "probability": 0.0024618010656384834,
            "start_logit": 0.8942972421646118,
            "end_logit": 5.001479625701904,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "deltaN377craniosynostosis genes (FGFR2, FGFR3",
            "probability": 0.0024493356246676284,
            "start_logit": 0.8942972421646118,
            "end_logit": 4.996403217315674,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "MSX",
            "probability": 0.000885687916149476,
            "start_logit": 5.487839221954346,
            "end_logit": -0.6143462061882019,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR3)Syndromic craniosynostosis due to complex chromosome 5 rearrangement and MSX",
            "probability": 0.0007605957149955917,
            "start_logit": 5.33557653427124,
            "end_logit": -0.6143462061882019,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR2,",
            "probability": 0.0006922155646657526,
            "start_logit": 5.341903209686279,
            "end_logit": -0.7148774266242981,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR2, FGFR3)Syndromic craniosynostosis due to complex chromosome 5",
            "probability": 0.0006790976433199704,
            "start_logit": 5.341903209686279,
            "end_logit": -0.7340099215507507,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR3)Syndromic craniosynostosis due to complex chromosome 5",
            "probability": 0.0006748147753989476,
            "start_logit": 5.33557653427124,
            "end_logit": -0.7340099215507507,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR3 P250R mutation was the single largest contributor (24%) to the genetic groupFGFR3",
            "probability": 0.0005637209479309458,
            "start_logit": 2.596620559692383,
            "end_logit": 1.825067162513733,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR2, FGFR",
            "probability": 0.0003356145812568491,
            "start_logit": 5.341903209686279,
            "end_logit": -1.4388114213943481,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR",
            "probability": 0.00033349795938659,
            "start_logit": 5.33557653427124,
            "end_logit": -1.4388114213943481,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR2, FGFR3)",
            "probability": 0.0002882468415510132,
            "start_logit": 5.341903209686279,
            "end_logit": -1.5909576416015625,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR3)",
            "probability": 0.000286428954001029,
            "start_logit": 5.33557653427124,
            "end_logit": -1.5909576416015625,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "MSX2 gene",
            "probability": 0.00017212115856000168,
            "start_logit": 5.487839221954346,
            "end_logit": -2.252512216567993,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        }
    ],
    "56d06e043975bb303a000011": [
        {
            "text": "advanced, oestrogen receptor-positive, HER2-negative breast cancer",
            "probability": 0.26813369510614543,
            "start_logit": 1.2398020029067993,
            "end_logit": 0.8677669763565063,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "breast cancer",
            "probability": 0.16890220620706575,
            "start_logit": 0.7776361703872681,
            "end_logit": 0.8677669763565063,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced, oestrogen receptor-positive, HER2-negative",
            "probability": 0.15969708375063574,
            "start_logit": 1.2398020029067993,
            "end_logit": 0.34956005215644836,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced",
            "probability": 0.14396298557697795,
            "start_logit": 1.2398020029067993,
            "end_logit": 0.2458374798297882,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced, oestrogen receptor-positive",
            "probability": 0.0752944819152681,
            "start_logit": 1.2398020029067993,
            "end_logit": -0.40231189131736755,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "oestrogen receptor-positive, HER2-negative breast cancer",
            "probability": 0.032846023464648995,
            "start_logit": -0.8598530292510986,
            "end_logit": 0.8677669763565063,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "HER2-negative breast cancer",
            "probability": 0.021385737168566468,
            "start_logit": -1.2889595031738281,
            "end_logit": 0.8677669763565063,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "oestrogen receptor-positive, HER2-negative",
            "probability": 0.019562681810776923,
            "start_logit": -0.8598530292510986,
            "end_logit": 0.34956005215644836,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "hormone receptor-positive, human epidermal growth factor receptor 2- negative",
            "probability": 0.013626571022038585,
            "start_logit": -0.8200441002845764,
            "end_logit": -0.051851000636816025,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "HER2-negative",
            "probability": 0.012737078263608979,
            "start_logit": -1.2889595031738281,
            "end_logit": 0.34956005215644836,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "negative breast cancer",
            "probability": 0.012447245769115269,
            "start_logit": -1.8301843404769897,
            "end_logit": 0.8677669763565063,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "patients with advanced, oestrogen receptor-positive, HER2-negative breast cancer",
            "probability": 0.011337751490258096,
            "start_logit": -1.9235457181930542,
            "end_logit": 0.8677669763565063,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "oestrogen receptor-positive",
            "probability": 0.00922347457587699,
            "start_logit": -0.8598530292510986,
            "end_logit": -0.40231189131736755,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "first-line treatment of patients with advanced, oestrogen receptor-positive, HER2-negative breast cancer",
            "probability": 0.008394957990024507,
            "start_logit": -2.2240524291992188,
            "end_logit": 0.8677669763565063,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "letrozole as first-line treatment of patients with advanced, oestrogen receptor-positive, HER2-negative breast cancer",
            "probability": 0.008037526014314714,
            "start_logit": -2.2675623893737793,
            "end_logit": 0.8677669763565063,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "negative",
            "probability": 0.007413424296667549,
            "start_logit": -1.8301843404769897,
            "end_logit": 0.34956005215644836,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced, oestrogen receptor-positive, HER2-negative breast",
            "probability": 0.007112737708415714,
            "start_logit": 1.2398020029067993,
            "end_logit": -2.761831521987915,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "hormone receptor-positive, human epidermal growth factor receptor 2- negative breast cancer",
            "probability": 0.0069651744753494015,
            "start_logit": -0.8200441002845764,
            "end_logit": -0.7229499816894531,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "patients with advanced, oestrogen receptor-positive, HER2-negative",
            "probability": 0.006752623345480255,
            "start_logit": -1.9235457181930542,
            "end_logit": 0.34956005215644836,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "in combination with letrozole as first-line treatment of patients with advanced, oestrogen receptor-positive, HER2-negative breast cancer",
            "probability": 0.006166540048764301,
            "start_logit": -2.532545804977417,
            "end_logit": 0.8677669763565063,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        }
    ],
    "571e1e11bb137a4b0c000004": [
        {
            "text": "urinary tract and genital infections",
            "probability": 0.2950970213803632,
            "start_logit": 3.9726476669311523,
            "end_logit": 3.7108986377716064,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "urinary tract and genital infections and decrease in blood pressure",
            "probability": 0.1859839709799387,
            "start_logit": 3.9726476669311523,
            "end_logit": 3.2492549419403076,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "decrease in blood pressure",
            "probability": 0.16908919162783137,
            "start_logit": 3.877413511276245,
            "end_logit": 3.2492549419403076,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "genital infections",
            "probability": 0.12776470512047863,
            "start_logit": 3.1355338096618652,
            "end_logit": 3.7108986377716064,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "genital infections and decrease in blood pressure",
            "probability": 0.0805233041602254,
            "start_logit": 3.1355338096618652,
            "end_logit": 3.2492549419403076,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "urinary tract",
            "probability": 0.054449484127225854,
            "start_logit": 3.9726476669311523,
            "end_logit": 2.0208678245544434,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "blood pressure",
            "probability": 0.0331456077655133,
            "start_logit": 2.2478973865509033,
            "end_logit": 3.2492549419403076,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "infections",
            "probability": 0.02167945770008521,
            "start_logit": 1.361708641052246,
            "end_logit": 3.7108986377716064,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "infections and decrease in blood pressure",
            "probability": 0.013663410131667844,
            "start_logit": 1.361708641052246,
            "end_logit": 3.2492549419403076,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "urinary tract and genital",
            "probability": 0.004080908388141947,
            "start_logit": 3.9726476669311523,
            "end_logit": -0.5700859427452087,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "urogenital",
            "probability": 0.0036435298265520373,
            "start_logit": 2.0497400760650635,
            "end_logit": 1.239454984664917,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "decrease in blood pressure, proper patient selection for drug initiation and close monitoring will be important. Urogenital",
            "probability": 0.00282613086408751,
            "start_logit": 3.877413511276245,
            "end_logit": -0.8422628045082092,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "urinary loss of glucose",
            "probability": 0.0018086212430015519,
            "start_logit": 1.8301403522491455,
            "end_logit": 0.7586665749549866,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "genital",
            "probability": 0.001766863163835849,
            "start_logit": 3.1355338096618652,
            "end_logit": -0.5700859427452087,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "genital infections and decrease in blood pressure, proper patient selection for drug initiation and close monitoring will be important. Urogenital",
            "probability": 0.0013458541789377284,
            "start_logit": 3.1355338096618652,
            "end_logit": -0.8422628045082092,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "u",
            "probability": 0.0009468330495693882,
            "start_logit": 3.9726476669311523,
            "end_logit": -2.0310380458831787,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "urogenital side-effects, both of which are evaluated in this review. Promotion of urinary loss of glucose",
            "probability": 0.0005641338003921137,
            "start_logit": 0.9052349328994751,
            "end_logit": 0.5185433626174927,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "urinary tract and genital infections and decrease",
            "probability": 0.0005588750362831309,
            "start_logit": 3.9726476669311523,
            "end_logit": -2.558234930038452,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "blood pressure, proper patient selection for drug initiation and close monitoring will be important. Urogenital",
            "probability": 0.0005539906141442423,
            "start_logit": 2.2478973865509033,
            "end_logit": -0.8422628045082092,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "decrease",
            "probability": 0.0005081068417249937,
            "start_logit": 3.877413511276245,
            "end_logit": -2.558234930038452,
            "question_text": "List side effects of SGLT2 inhibitors?"
        }
    ],
    "56a3a386496b62f23f000007": [
        {
            "text": "JASPAR 2014",
            "probability": 0.475502619618252,
            "start_logit": 2.2902064323425293,
            "end_logit": 1.7118399143218994,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR",
            "probability": 0.19103655131500766,
            "start_logit": 2.2902064323425293,
            "end_logit": 0.7999323010444641,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles.JASPAR 2014",
            "probability": 0.10388630529593096,
            "start_logit": 0.7691311240196228,
            "end_logit": 1.7118399143218994,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "2014",
            "probability": 0.06814273995261731,
            "start_logit": 0.34743866324424744,
            "end_logit": 1.7118399143218994,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles.JASPAR",
            "probability": 0.04173706026798696,
            "start_logit": 0.7691311240196228,
            "end_logit": 0.7999323010444641,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR for promoter sequence analysisJASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles.JASPAR 2014",
            "probability": 0.038069168191839836,
            "start_logit": -0.23476123809814453,
            "end_logit": 1.7118399143218994,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR 2010",
            "probability": 0.02018072821704759,
            "start_logit": 0.7691311240196228,
            "end_logit": 0.07327093183994293,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR for promoter sequence analysisJASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles.JASPAR",
            "probability": 0.015294558437214782,
            "start_logit": -0.23476123809814453,
            "end_logit": 0.7999323010444641,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR for promoter sequence analysisJASPAR 2010",
            "probability": 0.007395233996820987,
            "start_logit": -0.23476123809814453,
            "end_logit": 0.07327093183994293,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR CORE",
            "probability": 0.005623587385845583,
            "start_logit": 1.062196135520935,
            "end_logit": -1.4975523948669434,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR CORE, enhancing the overall breadth of JASPAR for promoter sequence analysisJASPAR 2010",
            "probability": 0.004860564611617576,
            "start_logit": -0.6544423699378967,
            "end_logit": 0.07327093183994293,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR CORE subcollection",
            "probability": 0.0045643371486555045,
            "start_logit": 1.062196135520935,
            "end_logit": -1.7062488794326782,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "2014: an extensively expanded and updated open-access database of transcription factor binding profiles.The fifth major release greatly expands the heart of JASPAR",
            "probability": 0.004088062238707376,
            "start_logit": 0.34743866324424744,
            "end_logit": -1.1016936302185059,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR CORE subcollection,",
            "probability": 0.0035537310313701925,
            "start_logit": 1.062196135520935,
            "end_logit": -1.956524133682251,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles.",
            "probability": 0.003459822619813809,
            "start_logit": 2.2902064323425293,
            "end_logit": -3.211315155029297,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "2010: the greatly expanded open-access database of transcription factor binding profiles.JASPAR 2014",
            "probability": 0.003301270103503056,
            "start_logit": -2.679858684539795,
            "end_logit": 1.7118399143218994,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR-the JASPAR CORE",
            "probability": 0.002986281821344014,
            "start_logit": 0.4292554259300232,
            "end_logit": -1.4975523948669434,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR-the JASPAR CORE subcollection",
            "probability": 0.002423790388288878,
            "start_logit": 0.4292554259300232,
            "end_logit": -1.7062488794326782,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR-the JASPAR",
            "probability": 0.0020064570178768342,
            "start_logit": 0.4292554259300232,
            "end_logit": -1.8952109813690186,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR-the JASPAR CORE subcollection,",
            "probability": 0.0018871303402589867,
            "start_logit": 0.4292554259300232,
            "end_logit": -1.956524133682251,
            "question_text": "List the releases of JASPAR database"
        }
    ],
    "56c1f038ef6e394741000051": [
        {
            "text": "photophobia",
            "probability": 0.2414467491614748,
            "start_logit": 5.215970993041992,
            "end_logit": 5.426092624664307,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "atrichia, and photophobia",
            "probability": 0.21330697437524992,
            "start_logit": 5.09205436706543,
            "end_logit": 5.426092624664307,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "atrichia",
            "probability": 0.12530501113952966,
            "start_logit": 5.09205436706543,
            "end_logit": 4.894111156463623,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis, atrichia, and photophobia",
            "probability": 0.0798426420881304,
            "start_logit": 4.109379768371582,
            "end_logit": 5.426092624664307,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "follicular ichthyosis, atrichia, and photophobia",
            "probability": 0.06879948885704132,
            "start_logit": 3.9605183601379395,
            "end_logit": 5.426092624664307,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis, atrichia",
            "probability": 0.04690274748664525,
            "start_logit": 4.109379768371582,
            "end_logit": 4.894111156463623,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "atrichia and photophobia",
            "probability": 0.0412694192833701,
            "start_logit": 4.229708671569824,
            "end_logit": 4.645827770233154,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "follicular ichthyosis, atrichia",
            "probability": 0.04041555951405308,
            "start_logit": 3.9605183601379395,
            "end_logit": 4.894111156463623,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis, atrichia and photophobia",
            "probability": 0.033007663981104836,
            "start_logit": 4.006326675415039,
            "end_logit": 4.645827770233154,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis",
            "probability": 0.02945024598284943,
            "start_logit": 4.109379768371582,
            "end_logit": 4.428737163543701,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "follicular ichthyosis",
            "probability": 0.0253769391561178,
            "start_logit": 3.9605183601379395,
            "end_logit": 4.428737163543701,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis follicularis; atrichia and photophobia",
            "probability": 0.01696252398144419,
            "start_logit": 3.3494553565979004,
            "end_logit": 4.636965751647949,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "photophobia (IFAP) syndrome have in common and in addition those that characterize IFAP syndrome (photophobia",
            "probability": 0.01066829334625866,
            "start_logit": 3.8721771240234375,
            "end_logit": 3.6505136489868164,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis follicularis; atrichia",
            "probability": 0.009009153768376459,
            "start_logit": 3.3494553565979004,
            "end_logit": 4.004200458526611,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "alopecia-photophobia",
            "probability": 0.005243438919956368,
            "start_logit": 2.79213285446167,
            "end_logit": 4.020259380340576,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "atrichia,",
            "probability": 0.0038355101358770113,
            "start_logit": 5.09205436706543,
            "end_logit": 1.4076627492904663,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "alopecia-photophobia (IFAP) syndrome have in common and in addition those that characterize IFAP syndrome (photophobia",
            "probability": 0.0036227443058043335,
            "start_logit": 2.79213285446167,
            "end_logit": 3.6505136489868164,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis follicularis",
            "probability": 0.0021584482081810643,
            "start_logit": 3.3494553565979004,
            "end_logit": 2.5753488540649414,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "atrichia, photophobia",
            "probability": 0.0019407817509128782,
            "start_logit": 2.8390934467315674,
            "end_logit": 2.979412078857422,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis, atrichia,",
            "probability": 0.0014356645576224412,
            "start_logit": 4.109379768371582,
            "end_logit": 1.4076627492904663,
            "question_text": "List symptoms of the IFAP syndrome."
        }
    ],
    "571529efcb4ef8864c000001": [
        {
            "text": "colchicine",
            "probability": 0.25674025197483147,
            "start_logit": 3.364593029022217,
            "end_logit": 2.80656361579895,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "colchicine, which inhibits Closterium cell elongation after divisionThe antibiotics bacitracin",
            "probability": 0.1574567204591902,
            "start_logit": 3.364593029022217,
            "end_logit": 2.3176493644714355,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "bacitracin and vancomycin",
            "probability": 0.1464290435504323,
            "start_logit": 2.953805446624756,
            "end_logit": 2.655827283859253,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vancomycin",
            "probability": 0.13440993378189472,
            "start_logit": 2.8681588172912598,
            "end_logit": 2.655827283859253,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "bacitracin",
            "probability": 0.10441392495728713,
            "start_logit": 2.953805446624756,
            "end_logit": 2.3176493644714355,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "bacitracin and vancomycin showed no obvious effect.cells treated with ampicillin",
            "probability": 0.06200698432326438,
            "start_logit": 2.953805446624756,
            "end_logit": 1.7965333461761475,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vancomycin showed no obvious effect.cells treated with ampicillin",
            "probability": 0.05691736048275476,
            "start_logit": 2.8681588172912598,
            "end_logit": 1.7965333461761475,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "ampicillin",
            "probability": 0.025958707234865746,
            "start_logit": 2.0830655097961426,
            "end_logit": 1.7965333461761475,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "bacitracin and vancomycin showed no obvious effect.cells treated with ampicillin, D-cycloserine",
            "probability": 0.011781626821132587,
            "start_logit": 2.953805446624756,
            "end_logit": 0.13582758605480194,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "ampicillin, D-cycloserine, or fosfomycin",
            "probability": 0.01176362620732542,
            "start_logit": 2.0830655097961426,
            "end_logit": 1.0050384998321533,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vancomycin showed no obvious effect.cells treated with ampicillin, D-cycloserine",
            "probability": 0.010814573683437481,
            "start_logit": 2.8681588172912598,
            "end_logit": 0.13582758605480194,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "fosfomycin",
            "probability": 0.008557187759066026,
            "start_logit": 1.7648248672485352,
            "end_logit": 1.0050384998321533,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "ampicillin, D-cycloserine",
            "probability": 0.004932279883275607,
            "start_logit": 2.0830655097961426,
            "end_logit": 0.13582758605480194,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "colchicine,",
            "probability": 0.003027418919224415,
            "start_logit": 3.364593029022217,
            "end_logit": -1.6337908506393433,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "D-cycloserine, or fosfomycin",
            "probability": 0.0028011962996035695,
            "start_logit": 0.6480998396873474,
            "end_logit": 1.0050384998321533,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "D-cycloserine",
            "probability": 0.0011744919393169011,
            "start_logit": 0.6480998396873474,
            "end_logit": 0.13582758605480194,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "antibiotics bacitracin and vancomycin",
            "probability": 0.00032575180269831433,
            "start_logit": -3.154355049133301,
            "end_logit": 2.655827283859253,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "antibiotics bacitracin",
            "probability": 0.0002322833193261159,
            "start_logit": -3.154355049133301,
            "end_logit": 2.3176493644714355,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "antibiotics bacitracin and vancomycin showed no obvious effect.cells treated with ampicillin",
            "probability": 0.00013794317324918333,
            "start_logit": -3.154355049133301,
            "end_logit": 1.7965333461761475,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "colchicine, which inhibits Closterium cell elongation after divisionThe antibiotics b",
            "probability": 0.00011869342782366279,
            "start_logit": 3.364593029022217,
            "end_logit": -4.8727126121521,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        }
    ],
    "53358cd2d6d3ac6a3400004e": [
        {
            "text": "ichthyosis",
            "probability": 0.1887519567755458,
            "start_logit": 4.589294910430908,
            "end_logit": 5.222802639007568,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "congenital ichthyosis",
            "probability": 0.1655527223798004,
            "start_logit": 4.458150863647461,
            "end_logit": 5.222802639007568,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "ichthyosis and abnormal brittle hair",
            "probability": 0.14459429446256558,
            "start_logit": 4.589294910430908,
            "end_logit": 4.956300735473633,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "congenital ichthyosis and abnormal brittle hair",
            "probability": 0.1268224155012605,
            "start_logit": 4.458150863647461,
            "end_logit": 4.956300735473633,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "ichthyosis and abnormal brittle hair (trichothiodystrophy",
            "probability": 0.06358706648620172,
            "start_logit": 4.589294910430908,
            "end_logit": 4.13477897644043,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "abnormal brittle hair",
            "probability": 0.0629459754576514,
            "start_logit": 3.7576398849487305,
            "end_logit": 4.956300735473633,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "trichothiodystrophy",
            "probability": 0.055870554921431614,
            "start_logit": 4.4599223136901855,
            "end_logit": 4.13477897644043,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "congenital ichthyosis and abnormal brittle hair (trichothiodystrophy",
            "probability": 0.05577167063467453,
            "start_logit": 4.458150863647461,
            "end_logit": 4.13477897644043,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "brittle hair",
            "probability": 0.028167845052275535,
            "start_logit": 2.9535441398620605,
            "end_logit": 4.956300735473633,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "abnormal brittle hair (trichothiodystrophy",
            "probability": 0.027681243864713715,
            "start_logit": 3.7576398849487305,
            "end_logit": 4.13477897644043,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "trichothiodystrophy is accompanied by congenital ichthyosis",
            "probability": 0.014228246142603667,
            "start_logit": 3.5667994022369385,
            "end_logit": 3.6600935459136963,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "ichthyosis and abnormal brittle hair (trichothiodystrophy)",
            "probability": 0.012438839302287502,
            "start_logit": 4.589294910430908,
            "end_logit": 2.503192663192749,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "brittle hair (trichothiodystrophy",
            "probability": 0.012387145998874652,
            "start_logit": 2.9535441398620605,
            "end_logit": 4.13477897644043,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "trichothiodystrophy)",
            "probability": 0.01092934291202319,
            "start_logit": 4.4599223136901855,
            "end_logit": 2.503192663192749,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "congenital ichthyosis and abnormal brittle hair (trichothiodystrophy)",
            "probability": 0.010909999265265093,
            "start_logit": 4.458150863647461,
            "end_logit": 2.503192663192749,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "abnormal brittle hair (trichothiodystrophy)",
            "probability": 0.005414977654226637,
            "start_logit": 3.7576398849487305,
            "end_logit": 2.503192663192749,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "ichthyosis and abnormal brittle hair (trichothiodystrophy). Other features include photosensitivity",
            "probability": 0.004181290860773247,
            "start_logit": 4.589294910430908,
            "end_logit": 1.4129889011383057,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "trichothiodystrophy). Other features include photosensitivity",
            "probability": 0.003673876679466019,
            "start_logit": 4.4599223136901855,
            "end_logit": 1.4129889011383057,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "congenital ichthyosis and abnormal brittle hair (trichothiodystrophy). Other features include photosensitivity",
            "probability": 0.0036673743514402213,
            "start_logit": 4.458150863647461,
            "end_logit": 1.4129889011383057,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "brittle hair (trichothiodystrophy)",
            "probability": 0.00242316129691894,
            "start_logit": 2.9535441398620605,
            "end_logit": 2.503192663192749,
            "question_text": "List two common features of Tay syndrome."
        }
    ],
    "52b2d405f828ad283c000009": [
        {
            "text": "synovial fibroblasts",
            "probability": 0.5552587229391578,
            "start_logit": 4.342864513397217,
            "end_logit": 3.8624279499053955,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synovial fibroblasts (SFs)",
            "probability": 0.1500274816136387,
            "start_logit": 4.342864513397217,
            "end_logit": 2.553812265396118,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synovial fibroblast",
            "probability": 0.10784654840467427,
            "start_logit": 4.342864513397217,
            "end_logit": 2.223703145980835,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "activated synovial fibroblasts",
            "probability": 0.07710135950765415,
            "start_logit": 2.368551254272461,
            "end_logit": 3.8624279499053955,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "fibroblasts",
            "probability": 0.02538778909943725,
            "start_logit": 1.257698655128479,
            "end_logit": 3.8624279499053955,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "activated synovial fibroblasts (SFs)",
            "probability": 0.02083231170992088,
            "start_logit": 2.368551254272461,
            "end_logit": 2.553812265396118,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "activated synovial fibroblast",
            "probability": 0.014975209135290865,
            "start_logit": 2.368551254272461,
            "end_logit": 2.223703145980835,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synovial fibroblasts (SFs",
            "probability": 0.01001872884371728,
            "start_logit": 4.342864513397217,
            "end_logit": -0.15254999697208405,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "immune cellIn rheumatoid arthritis (RA), activated synovial fibroblasts",
            "probability": 0.007182715833974035,
            "start_logit": -0.004892097786068916,
            "end_logit": 3.8624279499053955,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "fibroblasts (SFs)",
            "probability": 0.006859624000439367,
            "start_logit": 1.257698655128479,
            "end_logit": 2.553812265396118,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "fibroblast",
            "probability": 0.004931008398224002,
            "start_logit": 1.257698655128479,
            "end_logit": 2.223703145980835,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "regulatory T cells and CD4 memory T cells",
            "probability": 0.0046009180177094,
            "start_logit": 2.1069488525390625,
            "end_logit": 1.3051652908325195,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "regulatory T cells",
            "probability": 0.004367644548119435,
            "start_logit": 2.1069488525390625,
            "end_logit": 1.2531332969665527,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "CD4 memory T cells",
            "probability": 0.0020978620656179905,
            "start_logit": 1.321611762046814,
            "end_logit": 1.3051652908325195,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synovial fibroblasts (SFs) have the ability to invade joint cartilage,",
            "probability": 0.0020878414245591847,
            "start_logit": 4.342864513397217,
            "end_logit": -1.7208755016326904,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "immune cellIn rheumatoid arthritis (RA), activated synovial fibroblasts (SFs)",
            "probability": 0.0019407255090265535,
            "start_logit": -0.004892097786068916,
            "end_logit": 2.553812265396118,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "immune cellIn rheumatoid arthritis (RA), activated synovial fibroblast",
            "probability": 0.001395081389744472,
            "start_logit": -0.004892097786068916,
            "end_logit": 2.223703145980835,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "activated synovial fibroblasts (SFs",
            "probability": 0.0013911670046357686,
            "start_logit": 2.368551254272461,
            "end_logit": -0.15254999697208405,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synovial",
            "probability": 0.0012391797275920348,
            "start_logit": 4.342864513397217,
            "end_logit": -2.242556571960449,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "fibroblasts (SFs",
            "probability": 0.00045808082686638643,
            "start_logit": 1.257698655128479,
            "end_logit": -0.15254999697208405,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        }
    ],
    "518cb4b5310faafe08000006": [
        {
            "text": "lithium carbonate",
            "probability": 0.9203066682600827,
            "start_logit": 6.127367973327637,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "steroids in an isolated form or in combination.the addition of lithium carbonate",
            "probability": 0.03244809040982553,
            "start_logit": 2.7823026180267334,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "lithium",
            "probability": 0.019244514815942936,
            "start_logit": 6.127367973327637,
            "end_logit": 1.360026240348816,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "anti-thyroid drugs and steroids in an isolated form or in combination.the addition of lithium carbonate",
            "probability": 0.017207575226019976,
            "start_logit": 2.148010730743408,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "steroids",
            "probability": 0.00360626740365147,
            "start_logit": 2.7823026180267334,
            "end_logit": 3.03053879737854,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "anti-thyroid drugs and steroids",
            "probability": 0.0019124428232820032,
            "start_logit": 2.148010730743408,
            "end_logit": 3.03053879737854,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "anti-thyroid drugs",
            "probability": 0.0009069034592300336,
            "start_logit": 2.148010730743408,
            "end_logit": 2.284438133239746,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "lit",
            "probability": 0.0008377794779958949,
            "start_logit": 6.127367973327637,
            "end_logit": -1.774200201034546,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "lithium carbonate to the two other drugs",
            "probability": 0.0007286182029932622,
            "start_logit": 6.127367973327637,
            "end_logit": -1.9138052463531494,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "steroids in an isolated form or in combination.the addition of lithium",
            "probability": 0.0006785213865955295,
            "start_logit": 2.7823026180267334,
            "end_logit": 1.360026240348816,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "addition of lithium carbonate",
            "probability": 0.0005618765031278534,
            "start_logit": -1.273812174797058,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "anti-thyroid drugs and steroids in an isolated form or in combination.the addition of lithium",
            "probability": 0.0003598272704137456,
            "start_logit": 2.148010730743408,
            "end_logit": 1.360026240348816,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "the addition of lithium carbonate",
            "probability": 0.0003182283363204044,
            "start_logit": -1.8423250913619995,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "high dose of anti-thyroid drugs and steroids in an isolated form or in combination.the addition of lithium carbonate",
            "probability": 0.00019324913493031572,
            "start_logit": -2.341114044189453,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "carbonate",
            "probability": 0.00017847091615336649,
            "start_logit": -2.420668601989746,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "lithium carbonate to the two other drugs resulted in a successful and safety therapy in controlling amiodarone-induced thyrotoxicosis",
            "probability": 0.00013137760536026567,
            "start_logit": 6.127367973327637,
            "end_logit": -3.6268794536590576,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "drugs and steroids in an isolated form or in combination.the addition of lithium carbonate",
            "probability": 0.00011956125045381599,
            "start_logit": -2.821265459060669,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "hium carbonate",
            "probability": 9.683152346456397e-05,
            "start_logit": -3.0321216583251953,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "steroid",
            "probability": 9.304120244458874e-05,
            "start_logit": 1.6302357912063599,
            "end_logit": 0.5252195000648499,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "ate",
            "probability": 7.015479171186805e-05,
            "start_logit": -3.3543901443481445,
            "end_logit": 5.2275071144104,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        }
    ],
    "552faa43bc4f83e828000004": [
        {
            "text": "BCL11B",
            "probability": 0.5278890988018526,
            "start_logit": 5.641804218292236,
            "end_logit": 5.229844093322754,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "NR0B1",
            "probability": 0.2632349071052377,
            "start_logit": 5.419893741607666,
            "end_logit": 4.75591516494751,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "NR0B1, encodes a corepressor protein, and likely plays a transcriptional role in tumorigenesisGSTM4",
            "probability": 0.19261634446712197,
            "start_logit": 5.419893741607666,
            "end_logit": 4.443568706512451,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "NR0B1,",
            "probability": 0.012422083681156174,
            "start_logit": 5.419893741607666,
            "end_logit": 1.7023441791534424,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "NR0B",
            "probability": 0.0018222881932393447,
            "start_logit": 5.419893741607666,
            "end_logit": -0.21703869104385376,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma",
            "probability": 0.00037007347629968866,
            "start_logit": 4.910762786865234,
            "end_logit": -1.3020544052124023,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "NR0B1, encodes a corepressor protein",
            "probability": 0.0003079169374110619,
            "start_logit": 5.419893741607666,
            "end_logit": -1.9950568675994873,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "CL11B",
            "probability": 0.00028091687803497825,
            "start_logit": -1.8967784643173218,
            "end_logit": 5.229844093322754,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "NR0B1, encodes a corepressor protein, and likely plays a transcriptional role in tumorigenesisGSTM",
            "probability": 0.00020804899351773942,
            "start_logit": 5.419893741607666,
            "end_logit": -2.387113332748413,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "N",
            "probability": 0.00015598281397541044,
            "start_logit": 5.419893741607666,
            "end_logit": -2.6751410961151123,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "Ewing's sarcoma. One of these regulated genes, NR0B1",
            "probability": 0.00012572505526796006,
            "start_logit": -2.226810932159424,
            "end_logit": 4.75591516494751,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11",
            "probability": 9.159751254441701e-05,
            "start_logit": 4.910762786865234,
            "end_logit": -2.6983518600463867,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B,",
            "probability": 8.776435388723727e-05,
            "start_logit": 3.204911470413208,
            "end_logit": -1.0352492332458496,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "One of these regulated genes, NR0B1",
            "probability": 6.649713404876381e-05,
            "start_logit": -2.8637495040893555,
            "end_logit": 4.75591516494751,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "corepressor protein, and likely plays a transcriptional role in tumorigenesisGSTM4",
            "probability": 6.088646930162429e-05,
            "start_logit": -2.6395509243011475,
            "end_logit": 4.443568706512451,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "B1",
            "probability": 5.603225908036141e-05,
            "start_logit": -3.0349807739257812,
            "end_logit": 4.75591516494751,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "M4",
            "probability": 5.465881987529953e-05,
            "start_logit": -2.7474513053894043,
            "end_logit": 4.443568706512451,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "TM4",
            "probability": 5.2028632067840874e-05,
            "start_logit": -2.7967677116394043,
            "end_logit": 4.443568706512451,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B, a zinc finger transcription factor, acts as a transcriptional repressor in Ewing's sarcoma",
            "probability": 4.9221599363323006e-05,
            "start_logit": 3.204911470413208,
            "end_logit": -1.613572120666504,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": ", NR0B1",
            "probability": 4.792681671629438e-05,
            "start_logit": -3.1912331581115723,
            "end_logit": 4.75591516494751,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        }
    ],
    "533c3af6c45e13371400000d": [
        {
            "text": "familial cylindromatosis",
            "probability": 0.519519230011053,
            "start_logit": 4.268357753753662,
            "end_logit": 4.155761241912842,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromatosis",
            "probability": 0.4589846485904841,
            "start_logit": 4.144470691680908,
            "end_logit": 4.155761241912842,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromatosis,",
            "probability": 0.004996900215738974,
            "start_logit": 3.999819755554199,
            "end_logit": -0.21978682279586792,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial cylindromatosis,",
            "probability": 0.004111265165540711,
            "start_logit": 3.8047327995300293,
            "end_logit": -0.21978682279586792,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromas predominantly (approximately 90%) on the head and neckphenotype of familial cylindromatosis",
            "probability": 0.002661990833986919,
            "start_logit": 0.04464498162269592,
            "end_logit": 3.105644464492798,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "trichoepithelioma (MFT) and familial cylindromatosis",
            "probability": 0.002378334440586269,
            "start_logit": 0.49920111894607544,
            "end_logit": 2.538414478302002,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "MFTfamilial trichoepithelioma (MFT) and familial cylindromatosis",
            "probability": 0.0019230185834183484,
            "start_logit": 0.28669682145118713,
            "end_logit": 2.538414478302002,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "trichoepithelioma",
            "probability": 0.0015860617667180891,
            "start_logit": 0.49920111894607544,
            "end_logit": 2.133268117904663,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "MFTfamilial trichoepithelioma",
            "probability": 0.0012824210925930076,
            "start_logit": 0.28669682145118713,
            "end_logit": 2.133268117904663,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromatosis patients developed cylindromas",
            "probability": 0.00030416986425473074,
            "start_logit": 2.1928224563598633,
            "end_logit": -1.2117762565612793,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromatosis.Previously, a candidate MTF locus has been mapped to 9p21 while disease gene for familial",
            "probability": 0.0002905541364393803,
            "start_logit": 4.144470691680908,
            "end_logit": -3.2092208862304688,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial cylindromatosis are two clinically distinct cancer syndromes. MFT patients developed mostly trichoepithelioma",
            "probability": 0.0002870531879190381,
            "start_logit": 2.402155637741089,
            "end_logit": -1.4790282249450684,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial trichoepithelioma (MFT) and familial cylindromatosis",
            "probability": 0.0002736001959422647,
            "start_logit": -1.6632866859436035,
            "end_logit": 2.538414478302002,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "trichoepithelioma in the face while cylindromatosis",
            "probability": 0.0002678216657873798,
            "start_logit": -1.5970757007598877,
            "end_logit": 2.450856924057007,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial",
            "probability": 0.00022725871424199032,
            "start_logit": 4.268357753753662,
            "end_logit": -3.5788087844848633,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromatosis are two clinically distinct cancer syndromes. MFT patients developed mostly trichoepithelioma",
            "probability": 0.0001979414517232284,
            "start_logit": 2.030459403991699,
            "end_logit": -1.4790282249450684,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "trichoepithelioma (MFT)",
            "probability": 0.00019724087745851413,
            "start_logit": 0.49920111894607544,
            "end_logit": 0.04868448153138161,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial trichoepithelioma",
            "probability": 0.00018245827951918908,
            "start_logit": -1.6632866859436035,
            "end_logit": 2.133268117904663,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial cylindromatosis are two clinically distinct cancer syndromes",
            "probability": 0.00016855046569336704,
            "start_logit": 2.402155637741089,
            "end_logit": -2.011460542678833,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "MFTfamilial trichoepithelioma (MFT)",
            "probability": 0.00015948046090143885,
            "start_logit": 0.28669682145118713,
            "end_logit": 0.04868448153138161,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        }
    ],
    "571f3b320fd6f91b68000007": [
        {
            "text": "hirsutism",
            "probability": 0.1017163951200981,
            "start_logit": 5.010934352874756,
            "end_logit": 5.067713260650635,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hirsutism, obesity",
            "probability": 0.08824876417990028,
            "start_logit": 5.010934352874756,
            "end_logit": 4.925684452056885,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hirsutism, obesity, striae, acne",
            "probability": 0.07029802141735664,
            "start_logit": 5.010934352874756,
            "end_logit": 4.698268413543701,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hirsutism, obesity, striae, acne and hypertension",
            "probability": 0.06276041859625066,
            "start_logit": 5.010934352874756,
            "end_logit": 4.5848493576049805,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "weight gain, growth retardation, hirsutism",
            "probability": 0.05857380816554806,
            "start_logit": 4.459033489227295,
            "end_logit": 5.067713260650635,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "growth retardation, hirsutism",
            "probability": 0.05801169099909892,
            "start_logit": 4.449390411376953,
            "end_logit": 5.067713260650635,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "obesity",
            "probability": 0.05269956342388298,
            "start_logit": 4.495381832122803,
            "end_logit": 4.925684452056885,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "weight gain, growth retardation, hirsutism, obesity",
            "probability": 0.050818417009538853,
            "start_logit": 4.459033489227295,
            "end_logit": 4.925684452056885,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "growth retardation, hirsutism, obesity",
            "probability": 0.05033072625717909,
            "start_logit": 4.449390411376953,
            "end_logit": 4.925684452056885,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "obesity, striae, acne",
            "probability": 0.041979908417813905,
            "start_logit": 4.495381832122803,
            "end_logit": 4.698268413543701,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "weight gain, growth retardation, hirsutism, obesity, striae, acne",
            "probability": 0.040481407309569874,
            "start_logit": 4.459033489227295,
            "end_logit": 4.698268413543701,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "growth retardation, hirsutism, obesity, striae, acne",
            "probability": 0.04009291807379379,
            "start_logit": 4.449390411376953,
            "end_logit": 4.698268413543701,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hypertension",
            "probability": 0.03861193882637574,
            "start_logit": 4.525171279907227,
            "end_logit": 4.5848493576049805,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "acne",
            "probability": 0.03766490651054525,
            "start_logit": 4.3869194984436035,
            "end_logit": 4.698268413543701,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "obesity, striae, acne and hypertension",
            "probability": 0.037478673962845904,
            "start_logit": 4.495381832122803,
            "end_logit": 4.5848493576049805,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "weight gain, growth retardation, hirsutism, obesity, striae, acne and hypertension",
            "probability": 0.036140847450461,
            "start_logit": 4.459033489227295,
            "end_logit": 4.5848493576049805,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "growth retardation, hirsutism, obesity, striae, acne and hypertension",
            "probability": 0.035794013406403195,
            "start_logit": 4.449390411376953,
            "end_logit": 4.5848493576049805,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hirsutism, obesity, striae",
            "probability": 0.03429183480738387,
            "start_logit": 5.010934352874756,
            "end_logit": 3.9804320335388184,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "acne and hypertension",
            "probability": 0.03362634184191743,
            "start_logit": 4.3869194984436035,
            "end_logit": 4.5848493576049805,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "weight gain, growth retardation",
            "probability": 0.030379404224036552,
            "start_logit": 4.459033489227295,
            "end_logit": 4.411190509796143,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        }
    ],
    "54d65b6b3706e8952800000c": [
        {
            "text": "PMP22",
            "probability": 0.35461353908312765,
            "start_logit": 4.453502178192139,
            "end_logit": 4.3305277824401855,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22, structural myelin protein PMP22",
            "probability": 0.18109223188972162,
            "start_logit": 4.453502178192139,
            "end_logit": 3.65850567817688,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22, structural myelin protein PMP22Duplication of the gene encoding the peripheral myelin protein of 22 kDa (PMP22",
            "probability": 0.16471150800269094,
            "start_logit": 4.453502178192139,
            "end_logit": 3.563694715499878,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene, which is commonly associated with CMT1Many PMP22",
            "probability": 0.1475291610288978,
            "start_logit": 4.4556355476379395,
            "end_logit": 3.4513916969299316,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22Duplication of the gene encoding the peripheral myelin protein of 22 kDa (PMP22",
            "probability": 0.10211053146210253,
            "start_logit": 3.975362539291382,
            "end_logit": 3.563694715499878,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene",
            "probability": 0.02591545043625469,
            "start_logit": 4.4556355476379395,
            "end_logit": 1.712205171585083,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22Duplication of the gene encoding the peripheral myelin protein of 22 kDa (PMP22)",
            "probability": 0.007894595983840463,
            "start_logit": 3.975362539291382,
            "end_logit": 1.0038173198699951,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22)",
            "probability": 0.006720074927537457,
            "start_logit": 3.8142833709716797,
            "end_logit": 1.0038173198699951,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22,",
            "probability": 0.0037242769059156544,
            "start_logit": 4.453502178192139,
            "end_logit": -0.2256280779838562,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22, structural myelin protein PMP22Duplication of the gene encoding the peripheral myelin protein of 22 kDa",
            "probability": 0.001632890225949681,
            "start_logit": 4.453502178192139,
            "end_logit": -1.0501492023468018,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22Duplication of the gene encoding the peripheral myelin protein of 22 kDa",
            "probability": 0.0010122868208350725,
            "start_logit": 3.975362539291382,
            "end_logit": -1.0501492023468018,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "myelin protein PMP22",
            "probability": 0.0005166191990532837,
            "start_logit": -1.4059535264968872,
            "end_logit": 3.65850567817688,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "myelin protein PMP22Duplication of the gene encoding the peripheral myelin protein of 22 kDa (PMP22",
            "probability": 0.0004698883350834576,
            "start_logit": -1.4059535264968872,
            "end_logit": 3.563694715499878,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "the PMP22",
            "probability": 0.0004183434977052473,
            "start_logit": -2.0220491886138916,
            "end_logit": 4.063598155975342,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "22",
            "probability": 0.00037527329970369434,
            "start_logit": -2.397627115249634,
            "end_logit": 4.3305277824401855,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene,",
            "probability": 0.00029752131969729845,
            "start_logit": 4.4556355476379395,
            "end_logit": -2.754903554916382,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "myelin protein of 22 kDa (PMP22",
            "probability": 0.0002746659029115987,
            "start_logit": -1.942893147468567,
            "end_logit": 3.563694715499878,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PM",
            "probability": 0.0002349928212062085,
            "start_logit": 4.453502178192139,
            "end_logit": -2.988701105117798,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22, structural myelin protein PMP22Duplication of the gene encoding the peripheral myelin protein of 22",
            "probability": 0.00022934254605894478,
            "start_logit": 4.453502178192139,
            "end_logit": -3.0130393505096436,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "the PMP22 gene, which is commonly associated with CMT1Many PMP22",
            "probability": 0.0002268063117066052,
            "start_logit": -2.0220491886138916,
            "end_logit": 3.4513916969299316,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        }
    ],
    "517a8c918ed59a060a000043": [
        {
            "text": "Coxsackie B viruses",
            "probability": 0.31556920577971287,
            "start_logit": 5.354276657104492,
            "end_logit": 5.1778154373168945,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "adenovirus genome was found to be the most frequent virus genome in explanted heart tissues.Coxsackie B viruses",
            "probability": 0.2874736126211788,
            "start_logit": 5.2610297203063965,
            "end_logit": 5.1778154373168945,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "adenovirus",
            "probability": 0.19957135346804275,
            "start_logit": 5.2610297203063965,
            "end_logit": 4.812856197357178,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Coxsackie B",
            "probability": 0.09509936311905713,
            "start_logit": 5.354276657104492,
            "end_logit": 3.9783596992492676,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "adenovirus genome was found to be the most frequent virus genome in explanted heart tissues.Coxsackie B",
            "probability": 0.08663252615622032,
            "start_logit": 5.2610297203063965,
            "end_logit": 3.9783596992492676,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Coxsackie B viruses (types 1 to 5)",
            "probability": 0.007584864032611356,
            "start_logit": 5.354276657104492,
            "end_logit": 1.449592113494873,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enteroviruses",
            "probability": 0.0016113255267749295,
            "start_logit": 2.3079540729522705,
            "end_logit": 2.94681715965271,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Coxsackie",
            "probability": 0.0014692915154326217,
            "start_logit": 5.354276657104492,
            "end_logit": -0.19178225100040436,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "adenovirus genome was found to be the most frequent virus genome in explanted heart tissues.Coxsackie",
            "probability": 0.0013384783185400916,
            "start_logit": 5.2610297203063965,
            "end_logit": -0.19178225100040436,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Coxsackie B viruses (types 1",
            "probability": 0.0006053719680004422,
            "start_logit": 5.354276657104492,
            "end_logit": -1.078474760055542,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Coxsackie B viruses (types 1 to 5",
            "probability": 0.0005757475098147937,
            "start_logit": 5.354276657104492,
            "end_logit": -1.1286486387252808,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "adenovirus genome was found to be the most frequent virus genome in explanted heart tissues.Coxsackie B viruses (types 1",
            "probability": 0.0005514748062653571,
            "start_logit": 5.2610297203063965,
            "end_logit": -1.078474760055542,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Coxsackie B viruses (types 1 to 5) are the most frequent reported cause of acute viral myocarditis.",
            "probability": 0.00036848115427923146,
            "start_logit": 5.354276657104492,
            "end_logit": -1.5749282836914062,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "the adenovirus genome was found to be the most frequent virus genome in explanted heart tissues.Coxsackie B viruses",
            "probability": 0.00034312699461042627,
            "start_logit": -1.469756007194519,
            "end_logit": 5.1778154373168945,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Coxsackie B viruses (types 1 to 5) are the most frequent reported cause of acute viral myocarditis",
            "probability": 0.0003148214490949267,
            "start_logit": 5.354276657104492,
            "end_logit": -1.7323122024536133,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "the adenovirus",
            "probability": 0.00023820731962645404,
            "start_logit": -1.469756007194519,
            "end_logit": 4.812856197357178,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Coxsackie B viruses (types 1 to 5) are the most frequent reported cause of acute viral",
            "probability": 0.00020578724784209047,
            "start_logit": 5.354276657104492,
            "end_logit": -2.157474994659424,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "adenovirus genome was found to be the most frequent virus genome in explanted heart tissues.",
            "probability": 0.0001559750101341299,
            "start_logit": 5.2610297203063965,
            "end_logit": -2.3413751125335693,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "adenovirus genome",
            "probability": 0.00015242529113429352,
            "start_logit": 5.2610297203063965,
            "end_logit": -2.364396333694458,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "viruses",
            "probability": 0.00013856071162734657,
            "start_logit": -2.3765480518341064,
            "end_logit": 5.1778154373168945,
            "question_text": "Which viruses are best known to cause myocarditis?"
        }
    ],
    "571f2b5bbb137a4b0c000010": [
        {
            "text": "PDCD10",
            "probability": 0.17405070897242977,
            "start_logit": 4.121287822723389,
            "end_logit": 3.6989896297454834,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2 (also known as OSM and malcavernin) or PDCD10",
            "probability": 0.0940535104560281,
            "start_logit": 3.505805015563965,
            "end_logit": 3.6989896297454834,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "KRIT1",
            "probability": 0.07435972987017554,
            "start_logit": 3.616750478744507,
            "end_logit": 3.3530948162078857,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM3 genesLoss-of-function mutations in genes encoding KRIT1",
            "probability": 0.06277196727979313,
            "start_logit": 3.4473445415496826,
            "end_logit": 3.3530948162078857,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "KRIT1 (also known as CCM1), CCM2",
            "probability": 0.05515036028590586,
            "start_logit": 3.616750478744507,
            "end_logit": 3.054243564605713,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM1, CCM2, and CCM3 genesLoss-of-function mutations in genes encoding KRIT1",
            "probability": 0.05022120039517797,
            "start_logit": 3.224273204803467,
            "end_logit": 3.3530948162078857,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2, and CCM3 genesLoss-of-function mutations in genes encoding KRIT1",
            "probability": 0.04957160407211234,
            "start_logit": 3.211254119873047,
            "end_logit": 3.3530948162078857,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2",
            "probability": 0.049358886240519595,
            "start_logit": 3.505805015563965,
            "end_logit": 3.054243564605713,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM3 genesLoss-of-function mutations in genes encoding KRIT1 (also known as CCM1), CCM2",
            "probability": 0.04655606761051715,
            "start_logit": 3.4473445415496826,
            "end_logit": 3.054243564605713,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "malcavernin) or PDCD10",
            "probability": 0.04255833906606482,
            "start_logit": 2.7128169536590576,
            "end_logit": 3.6989896297454834,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM3",
            "probability": 0.035001567607930675,
            "start_logit": 3.4473445415496826,
            "end_logit": 2.768979072570801,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 genewe outline a consistent association between PDCD10",
            "probability": 0.03451864876271888,
            "start_logit": 3.6626949310302734,
            "end_logit": 2.5397355556488037,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "KRIT1 (also known as CCM1",
            "probability": 0.033317582629172546,
            "start_logit": 3.616750478744507,
            "end_logit": 2.5502655506134033,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM1), CCM2 (also known as OSM and malcavernin) or PDCD10",
            "probability": 0.03320265571221063,
            "start_logit": 2.464570999145508,
            "end_logit": 3.6989896297454834,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM1",
            "probability": 0.03149648457252316,
            "start_logit": 3.224273204803467,
            "end_logit": 2.886533498764038,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM3 genesLoss-of-function mutations in genes encoding KRIT1 (also known as CCM1",
            "probability": 0.028125575634709948,
            "start_logit": 3.4473445415496826,
            "end_logit": 2.5502655506134033,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM1, CCM2, and CCM3",
            "probability": 0.02800327625782591,
            "start_logit": 3.224273204803467,
            "end_logit": 2.768979072570801,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM2, and CCM3",
            "probability": 0.02764106218990767,
            "start_logit": 3.211254119873047,
            "end_logit": 2.768979072570801,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 (also known as CCM3",
            "probability": 0.02639167520329185,
            "start_logit": 4.121287822723389,
            "end_logit": 1.812691569328308,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CCM1, CCM2",
            "probability": 0.02364909718098432,
            "start_logit": 3.224273204803467,
            "end_logit": 2.599982500076294,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        }
    ],
    "550320cbe9bde6963400002d": [
        {
            "text": "hypodontia",
            "probability": 0.10086354187997819,
            "start_logit": 4.323945045471191,
            "end_logit": 4.484010219573975,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypodontia, and hypogonadotropic hypogonadism",
            "probability": 0.09325835412619655,
            "start_logit": 4.323945045471191,
            "end_logit": 4.405615329742432,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "ataxia, hypomyelination, hypodontia",
            "probability": 0.09132336197580054,
            "start_logit": 4.224583148956299,
            "end_logit": 4.484010219573975,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypogonadotropic hypogonadism",
            "probability": 0.08503611843319502,
            "start_logit": 4.231647491455078,
            "end_logit": 4.405615329742432,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination, hypodontia",
            "probability": 0.07912077239868416,
            "start_logit": 4.081151962280273,
            "end_logit": 4.484010219573975,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination, hypodontia, and hypogonadotropic hypogonadism",
            "probability": 0.0731550059968634,
            "start_logit": 4.081151962280273,
            "end_logit": 4.405615329742432,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "ataxia",
            "probability": 0.06967659684172654,
            "start_logit": 4.224583148956299,
            "end_logit": 4.213468074798584,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "ataxia, hypomyelination",
            "probability": 0.05438786997234134,
            "start_logit": 4.224583148956299,
            "end_logit": 3.965744733810425,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination",
            "probability": 0.04712058544746896,
            "start_logit": 4.081151962280273,
            "end_logit": 3.965744733810425,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypodontia.The 4H syndrome (hypomyelination, hypodontia",
            "probability": 0.04702166921163911,
            "start_logit": 3.915451765060425,
            "end_logit": 4.129343509674072,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypodontia, hypogonadotropic hypogonadism",
            "probability": 0.039294904330257806,
            "start_logit": 3.8994760513305664,
            "end_logit": 3.9658055305480957,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypogonadotropic hypogonadism, and hypodontia",
            "probability": 0.03809504502790831,
            "start_logit": 3.6933932304382324,
            "end_logit": 4.140877723693848,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination, hypodontia, hypogonadotropic hypogonadism",
            "probability": 0.027938211762442988,
            "start_logit": 3.5583765506744385,
            "end_logit": 3.9658055305480957,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "Hypomyelination, hypodontia, hypogonadotropic hypogonadism",
            "probability": 0.026258458355660586,
            "start_logit": 3.623551368713379,
            "end_logit": 3.838623523712158,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "Hypomyelination, hypodontia",
            "probability": 0.02485389691896921,
            "start_logit": 3.623551368713379,
            "end_logit": 3.7836499214172363,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination, hypogonadotropic hypogonadism, and hypodontia",
            "probability": 0.02459439709927622,
            "start_logit": 3.2558276653289795,
            "end_logit": 4.140877723693848,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "Ataxia",
            "probability": 0.020139030597113104,
            "start_logit": 3.705862045288086,
            "end_logit": 3.4909844398498535,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination, hypogonadotropic hypogonadism",
            "probability": 0.019420283978437786,
            "start_logit": 3.2558276653289795,
            "end_logit": 3.904677152633667,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypodontia, hypogonadotropic hypogonadism (4H syndrome); Ataxia",
            "probability": 0.019252962054063093,
            "start_logit": 3.660867214202881,
            "end_logit": 3.4909844398498535,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypodontia.The 4H syndrome (hypomyelination",
            "probability": 0.01918893359197691,
            "start_logit": 3.915451765060425,
            "end_logit": 3.2330687046051025,
            "question_text": "List symptoms of 4H leukodystrophy."
        }
    ],
    "511a4d391159fa8212000003": [
        {
            "text": "MET",
            "probability": 0.40475315592494754,
            "start_logit": 0.7121061682701111,
            "end_logit": 0.162479966878891,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DRM) from tobacco and the progenitor species.The comparative investigation of transcription levels of different genes of cytosine DNA met",
            "probability": 0.06551920675201234,
            "start_logit": -0.3396526873111725,
            "end_logit": -0.6066952347755432,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase family MET",
            "probability": 0.06219619071065944,
            "start_logit": -0.4451218545436859,
            "end_logit": -0.5532756447792053,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "met",
            "probability": 0.05903194543037304,
            "start_logit": -0.36347496509552,
            "end_logit": -0.6871375441551208,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase families (MET",
            "probability": 0.05761765909701311,
            "start_logit": -1.237342119216919,
            "end_logit": 0.162479966878891,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1, CMT3 and DRM",
            "probability": 0.04173613699684887,
            "start_logit": 0.7121061682701111,
            "end_logit": -2.1094300746917725,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1, CMT3",
            "probability": 0.0405362387582789,
            "start_logit": 0.7121061682701111,
            "end_logit": -2.138601064682007,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferases, these plant proteins contain a novel arrangement of the motifs required for DNA met",
            "probability": 0.034979952699718826,
            "start_logit": -0.8867785930633545,
            "end_logit": -0.6871375441551208,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "CMT3 and DRM",
            "probability": 0.0332784096708932,
            "start_logit": 0.48564764857292175,
            "end_logit": -2.1094300746917725,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "CMT3",
            "probability": 0.032321667911359264,
            "start_logit": 0.48564764857292175,
            "end_logit": -2.138601064682007,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1",
            "probability": 0.03173494502126902,
            "start_logit": 0.7121061682701111,
            "end_logit": -2.3833789825439453,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase genes and their expression patterns we examined three major DNA methyltransferase families (MET",
            "probability": 0.02850888579640782,
            "start_logit": -1.940955400466919,
            "end_logit": 0.162479966878891,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase family MET (MET",
            "probability": 0.02585896893317871,
            "start_logit": -0.4451218545436859,
            "end_logit": -1.430911898612976,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferases. Relative to all known eukaryotic met",
            "probability": 0.022348239898333552,
            "start_logit": -0.6446057558059692,
            "end_logit": -1.37733793258667,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DRM",
            "probability": 0.01457938424150561,
            "start_logit": -0.3396526873111725,
            "end_logit": -2.1094300746917725,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase family MET (MET1, MET2a, MET2b, MET",
            "probability": 0.012685454540789246,
            "start_logit": -0.4451218545436859,
            "end_logit": -2.143113374710083,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase family MET (MET1, MET",
            "probability": 0.009828627196177398,
            "start_logit": -0.4451218545436859,
            "end_logit": -2.3982701301574707,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase family MET (MET1, MET2a, MET",
            "probability": 0.009260005463812832,
            "start_logit": -0.4451218545436859,
            "end_logit": -2.457864761352539,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1, MET2a, MET2b, MET",
            "probability": 0.007283677857271809,
            "start_logit": -0.9999419450759888,
            "end_logit": -2.143113374710083,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase families (MET1, CMT3 and DRM",
            "probability": 0.005941247099149437,
            "start_logit": -1.237342119216919,
            "end_logit": -2.1094300746917725,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        }
    ],
    "517137c18ed59a060a000001": [
        {
            "text": "DNA-binding protein 2",
            "probability": 0.6213511305239094,
            "start_logit": 4.076158046722412,
            "end_logit": 3.1314432621002197,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7",
            "probability": 0.06865805875496388,
            "start_logit": 2.9685816764831543,
            "end_logit": 2.036261796951294,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "DNA-binding protein 1 (Chd1",
            "probability": 0.04848746726970291,
            "start_logit": 3.046046733856201,
            "end_logit": 1.6109635829925537,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "DNA binding protein 7",
            "probability": 0.038171576800274866,
            "start_logit": 2.9855363368988037,
            "end_logit": 1.4322597980499268,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7, the gene encoding chromodomain helicase DNA binding protein 7",
            "probability": 0.037529846212800644,
            "start_logit": 2.9685816764831543,
            "end_logit": 1.4322597980499268,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "DNA-binding protein 1",
            "probability": 0.03429829324318057,
            "start_logit": 3.046046733856201,
            "end_logit": 1.264753818511963,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "Chd1",
            "probability": 0.02861134443671222,
            "start_logit": 2.5185446739196777,
            "end_logit": 1.6109635829925537,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "DNA-binding protein",
            "probability": 0.023528459838753644,
            "start_logit": 4.076158046722412,
            "end_logit": -0.14224234223365784,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "DNA",
            "probability": 0.022648439480382282,
            "start_logit": 4.076158046722412,
            "end_logit": -0.18036213517189026,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "DNA-binding protein 1 (Chd1)",
            "probability": 0.020090835610993254,
            "start_logit": 3.046046733856201,
            "end_logit": 0.7299219965934753,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "Chd1)",
            "probability": 0.011855142164677836,
            "start_logit": 2.5185446739196777,
            "end_logit": 0.7299219965934753,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "helicase DNA-binding protein 2",
            "probability": 0.006478711136853769,
            "start_logit": -0.4872167110443115,
            "end_logit": 3.1314432621002197,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "DNA binding protein 7,",
            "probability": 0.006325833066608827,
            "start_logit": 2.9855363368988037,
            "end_logit": -0.36518964171409607,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "DNA-binding protein 1 (Chd1) DNA-binding domain in complex with DNA",
            "probability": 0.00626025585717683,
            "start_logit": 3.046046733856201,
            "end_logit": -0.4361207187175751,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7, the gene encoding chromodomain helicase DNA binding protein 7,",
            "probability": 0.006219484811954869,
            "start_logit": 2.9685816764831543,
            "end_logit": -0.36518964171409607,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7, the gene encoding chromodomain helicase",
            "probability": 0.004781375282971387,
            "start_logit": 2.9685816764831543,
            "end_logit": -0.6281484961509705,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7,",
            "probability": 0.004567795534627231,
            "start_logit": 2.9685816764831543,
            "end_logit": -0.6738460063934326,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "Chd1) DNA-binding domain in complex with DNA",
            "probability": 0.0036940336684393046,
            "start_logit": 2.5185446739196777,
            "end_logit": -0.4361207187175751,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "DNA binding protein",
            "probability": 0.003248262624275895,
            "start_logit": 2.9855363368988037,
            "end_logit": -1.0317111015319824,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7, the gene encoding chromodomain helicase DNA binding protein",
            "probability": 0.003193653680740397,
            "start_logit": 2.9685816764831543,
            "end_logit": -1.0317111015319824,
            "question_text": "In which proteins is the chromodomain present?"
        }
    ],
    "531d7430267d7dd053000008": [
        {
            "text": "clonazepam",
            "probability": 0.23209288129647662,
            "start_logit": 5.689929485321045,
            "end_logit": 5.514645576477051,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "capsaicin, alpha-lipoic acid (ALA), and clonazepam",
            "probability": 0.21290526094467377,
            "start_logit": 5.603639125823975,
            "end_logit": 5.514645576477051,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "capsaicin",
            "probability": 0.1447593444332336,
            "start_logit": 5.603639125823975,
            "end_logit": 5.128870964050293,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "alpha-lipoic acid (ALA), and clonazepam",
            "probability": 0.13400358257707615,
            "start_logit": 5.140658378601074,
            "end_logit": 5.514645576477051,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "capsaicin, alpha-lipoic acid",
            "probability": 0.12599509302412054,
            "start_logit": 5.603639125823975,
            "end_logit": 4.990041255950928,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "alpha-lipoic acid",
            "probability": 0.07930191004886254,
            "start_logit": 5.140658378601074,
            "end_logit": 4.990041255950928,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "Catuama",
            "probability": 0.028261934462616933,
            "start_logit": 4.664280414581299,
            "end_logit": 4.434672832489014,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "capsaicin, alpha-lipoic acid (ALA)",
            "probability": 0.024462905464902856,
            "start_logit": 5.603639125823975,
            "end_logit": 3.3509562015533447,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "alpha-lipoic acid (ALA)",
            "probability": 0.015397068902835515,
            "start_logit": 5.140658378601074,
            "end_logit": 3.3509562015533447,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "capsaicin, alpha-lipoic acid (ALA),",
            "probability": 0.0007045745404534161,
            "start_logit": 5.603639125823975,
            "end_logit": -0.19636285305023193,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "alpha-lipoic acid (ALA),",
            "probability": 0.0004434625626178863,
            "start_logit": 5.140658378601074,
            "end_logit": -0.19636285305023193,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "lipoic acid (ALA), and clonazepam",
            "probability": 0.0003293314640173414,
            "start_logit": -0.86789870262146,
            "end_logit": 5.514645576477051,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "lonazepam",
            "probability": 0.00027713410920353424,
            "start_logit": -1.0404618978500366,
            "end_logit": 5.514645576477051,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "capsaicin, alpha-lipoic",
            "probability": 0.0002594412506264974,
            "start_logit": 5.603639125823975,
            "end_logit": -1.1954267024993896,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "capsaicin,",
            "probability": 0.00023102596504467288,
            "start_logit": 5.603639125823975,
            "end_logit": -1.3114268779754639,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "lipoic acid",
            "probability": 0.00019489489484911102,
            "start_logit": -0.86789870262146,
            "end_logit": 4.990041255950928,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "alpha-lipoic",
            "probability": 0.00016329355553718405,
            "start_logit": 5.140658378601074,
            "end_logit": -1.1954267024993896,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "clonazepam were those that showed more reduction in symptoms of BMS.",
            "probability": 0.00010481664353091315,
            "start_logit": 5.689929485321045,
            "end_logit": -2.188034772872925,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "alpha-lipoic acid (ALA), and clonazepam were those that showed more reduction in symptoms of BMS.",
            "probability": 6.051803772863025e-05,
            "start_logit": 5.140658378601074,
            "end_logit": -2.188034772872925,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "c",
            "probability": 5.15258215924365e-05,
            "start_logit": 5.689929485321045,
            "end_logit": -2.8981642723083496,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        }
    ],
    "5523f1a62c8b63434a000002": [
        {
            "text": "Arg14del",
            "probability": 0.3341314336261163,
            "start_logit": 3.672229051589966,
            "end_logit": 3.932230234146118,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "c.40_42delAGA (p.Arg14del",
            "probability": 0.12803885963835093,
            "start_logit": 2.7130284309387207,
            "end_logit": 3.932230234146118,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "p.Arg14del",
            "probability": 0.09353556939613432,
            "start_logit": 2.399036407470703,
            "end_logit": 3.932230234146118,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Arg14del)",
            "probability": 0.075640196417148,
            "start_logit": 3.672229051589966,
            "end_logit": 2.446683645248413,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "R14del",
            "probability": 0.07413125061228107,
            "start_logit": 3.0125906467437744,
            "end_logit": 3.0861713886260986,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN mutation R14del",
            "probability": 0.06622286870956756,
            "start_logit": 2.8997793197631836,
            "end_logit": 3.0861713886260986,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "40_42delAGA (p.Arg14del",
            "probability": 0.03928879918203764,
            "start_logit": 1.5316340923309326,
            "end_logit": 3.932230234146118,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "c.40_42delAGA (p.Arg14del)",
            "probability": 0.028985254056969754,
            "start_logit": 2.7130284309387207,
            "end_logit": 2.446683645248413,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "c.40_42delAGA",
            "probability": 0.02774399801950651,
            "start_logit": 2.7130284309387207,
            "end_logit": 2.4029159545898438,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "(p.Arg14del",
            "probability": 0.02172232805710095,
            "start_logit": 0.9390352964401245,
            "end_logit": 3.932230234146118,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "p.Arg14del)",
            "probability": 0.02117444852264381,
            "start_logit": 2.399036407470703,
            "end_logit": 2.446683645248413,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN R14del",
            "probability": 0.019821317864962662,
            "start_logit": 2.555387020111084,
            "end_logit": 2.2242958545684814,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Arg14",
            "probability": 0.019570132104272362,
            "start_logit": 3.672229051589966,
            "end_logit": 1.0947003364562988,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "40_42delAGA (p.Arg14del)",
            "probability": 0.008894142208866784,
            "start_logit": 1.5316340923309326,
            "end_logit": 2.446683645248413,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "40_42delAGA",
            "probability": 0.008513262065704543,
            "start_logit": 1.5316340923309326,
            "end_logit": 2.4029159545898438,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Arg(9) to Cys, Arg(9) to Leu",
            "probability": 0.007518490309444334,
            "start_logit": 2.390007257461548,
            "end_logit": 1.4202829599380493,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "c.40_42delAGA (p.Arg14",
            "probability": 0.007499256715866977,
            "start_logit": 2.7130284309387207,
            "end_logit": 1.0947003364562988,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Arg(9) to Leu",
            "probability": 0.007172529485732883,
            "start_logit": 2.342900276184082,
            "end_logit": 1.4202829599380493,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "p.Arg14",
            "probability": 0.005478393426399282,
            "start_logit": 2.399036407470703,
            "end_logit": 1.0947003364562988,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "(p.Arg14del)",
            "probability": 0.004917469580893735,
            "start_logit": 0.9390352964401245,
            "end_logit": 2.446683645248413,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        }
    ],
    "52df8ce798d023950500000d": [
        {
            "text": "Cr",
            "probability": 0.3340551469155953,
            "start_logit": 3.9772844314575195,
            "end_logit": 3.9116809368133545,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "RQ significantly reduces exercise-induced lipid peroxidation without associated changes in inflammation or plasma antioxidant status.Cr",
            "probability": 0.19376276586167693,
            "start_logit": 3.432612895965576,
            "end_logit": 3.9116809368133545,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "Quercetin",
            "probability": 0.1542986445879923,
            "start_logit": 3.672497272491455,
            "end_logit": 3.44405198097229,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "Quercetin and vitamin C",
            "probability": 0.14332648990640934,
            "start_logit": 3.672497272491455,
            "end_logit": 3.3702871799468994,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin C",
            "probability": 0.08074457319187167,
            "start_logit": 3.098662853240967,
            "end_logit": 3.3702871799468994,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "RQ",
            "probability": 0.05078155711945206,
            "start_logit": 3.432612895965576,
            "end_logit": 2.5725796222686768,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "RQ significantly reduces exercise-induced lipid peroxidation without associated changes in inflammation or plasma antioxidant status.",
            "probability": 0.01975271128976742,
            "start_logit": 3.432612895965576,
            "end_logit": 1.6283371448516846,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin C supplementation may not be beneficial in lipid profile improvement, although it may reduce induce muscle damage and body fat percent.Vitamins C",
            "probability": 0.007980917650155553,
            "start_logit": 3.098662853240967,
            "end_logit": 1.0560498237609863,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": ".Cr",
            "probability": 0.006389251736456103,
            "start_logit": 0.020595503970980644,
            "end_logit": 3.9116809368133545,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin supplementation. These data indicate that RQ",
            "probability": 0.0019060573174838635,
            "start_logit": 0.15011653304100037,
            "end_logit": 2.5725796222686768,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "Vitamins C",
            "probability": 0.0012900647438854375,
            "start_logit": 1.2763018608093262,
            "end_logit": 1.0560498237609863,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "r",
            "probability": 0.0008206575344297636,
            "start_logit": -2.0316710472106934,
            "end_logit": 3.9116809368133545,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "C",
            "probability": 0.0007438293439190802,
            "start_logit": 3.9772844314575195,
            "end_logit": -2.195568799972534,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin C supplementation may not be beneficial in lipid profile improvement, although it may reduce induce muscle damage and body fat percent.",
            "probability": 0.0007173498542713204,
            "start_logit": 3.098662853240967,
            "end_logit": -1.3531951904296875,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "etin",
            "probability": 0.000695559937627048,
            "start_logit": -1.7294307947158813,
            "end_logit": 3.44405198097229,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": ".",
            "probability": 0.0006513379613808653,
            "start_logit": 0.020595503970980644,
            "end_logit": 1.6283371448516846,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "etin and vitamin C",
            "probability": 0.0006460987693430716,
            "start_logit": -1.7294307947158813,
            "end_logit": 3.3702871799468994,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "Que",
            "probability": 0.0005912529125482623,
            "start_logit": 3.672497272491455,
            "end_logit": -2.120349407196045,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "RQ significantly reduces exercise-induced lipid peroxidation without associated changes in inflammation or plasma antioxidant status.C",
            "probability": 0.0004314450243847117,
            "start_logit": 3.432612895965576,
            "end_logit": -2.195568799972534,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "Quercetin and vitamin",
            "probability": 0.0004142883413499692,
            "start_logit": 3.672497272491455,
            "end_logit": -2.4760310649871826,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        }
    ],
    "5505b9ff8e1671127b000001": [
        {
            "text": "Atg8",
            "probability": 0.4143151388035795,
            "start_logit": 3.307490825653076,
            "end_logit": 3.8956737518310547,
            "question_text": "List markers for autophagy."
        },
        {
            "text": ". Light chain 3/Atg8",
            "probability": 0.17397042340193763,
            "start_logit": 2.439749240875244,
            "end_logit": 3.8956737518310547,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Light chain 3/Atg8",
            "probability": 0.07038085040882618,
            "start_logit": 1.5347851514816284,
            "end_logit": 3.8956737518310547,
            "question_text": "List markers for autophagy."
        },
        {
            "text": ". Light chain 3",
            "probability": 0.06704808626590812,
            "start_logit": 2.439749240875244,
            "end_logit": 2.9421985149383545,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg8 as an autophagy marker increased conversion of microtubule-associated protein, 1A/1B-light chain 3",
            "probability": 0.05395111827897919,
            "start_logit": 3.307490825653076,
            "end_logit": 1.8571252822875977,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "microtubule-associated protein 1 light chain 3",
            "probability": 0.048928728099449884,
            "start_logit": 2.83050799369812,
            "end_logit": 2.2363944053649902,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3B",
            "probability": 0.032062181211387875,
            "start_logit": 2.7493410110473633,
            "end_logit": 1.894873857498169,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3-IIautophagy marker LC3B",
            "probability": 0.029890818567043637,
            "start_logit": 2.6792151927948,
            "end_logit": 1.894873857498169,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Light chain 3",
            "probability": 0.027124733258690196,
            "start_logit": 1.5347851514816284,
            "end_logit": 2.9421985149383545,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "hepatic microtubule-associated protein 1 light chain 3",
            "probability": 0.02091929396139116,
            "start_logit": 1.9808151721954346,
            "end_logit": 2.2363944053649902,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3-II",
            "probability": 0.0149582264609181,
            "start_logit": 2.6792151927948,
            "end_logit": 1.202583909034729,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg8 as an autophagy marker increased conversion of microtubule-associated protein",
            "probability": 0.011710117206062957,
            "start_logit": 3.307490825653076,
            "end_logit": 0.3295000493526459,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "microtubule-associated protein 1 light chain 3 (LC3)-II",
            "probability": 0.0067177207358171094,
            "start_logit": 2.83050799369812,
            "end_logit": 0.2507786154747009,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "microtubule-associated protein, 1A/1B-light chain 3",
            "probability": 0.005220857318808513,
            "start_logit": 0.972074031829834,
            "end_logit": 1.8571252822875977,
            "question_text": "List markers for autophagy."
        },
        {
            "text": ". Light chain 3/Atg8 as an autophagy marker increased conversion of microtubule-associated protein",
            "probability": 0.004917063987350217,
            "start_logit": 2.439749240875244,
            "end_logit": 0.3295000493526459,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "microtubule-associated protein 1",
            "probability": 0.003895352671306731,
            "start_logit": 2.83050799369812,
            "end_logit": -0.2941860854625702,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg8 as an autophagy marker increased conversion of microtubule-associated protein, 1A/1B-light chain 3,",
            "probability": 0.003786092466885699,
            "start_logit": 3.307490825653076,
            "end_logit": -0.799618661403656,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "3/Atg8",
            "probability": 0.003693487707167154,
            "start_logit": -1.4125648736953735,
            "end_logit": 3.8956737518310547,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "microtubule-associated protein 1 light chain 3 (LC3)-II protein",
            "probability": 0.003379253403686737,
            "start_logit": 2.83050799369812,
            "end_logit": -0.43631550669670105,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "microtubule-associated protein 1 light chain 3 (LC3",
            "probability": 0.0031304557848033402,
            "start_logit": 2.83050799369812,
            "end_logit": -0.5127916932106018,
            "question_text": "List markers for autophagy."
        }
    ],
    "57090784cf1c325851000011": [
        {
            "text": "myelodysplastic syndrome",
            "probability": 0.7074349922278567,
            "start_logit": 5.552211284637451,
            "end_logit": 5.427629470825195,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "myelodysplastic syndrome (MDS)",
            "probability": 0.1538563049572021,
            "start_logit": 5.552211284637451,
            "end_logit": 3.9020028114318848,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia",
            "probability": 0.09394202856437663,
            "start_logit": 5.552211284637451,
            "end_logit": 3.4086616039276123,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "acute myeloid leukaemia",
            "probability": 0.026971344954385947,
            "start_logit": 4.3043084144592285,
            "end_logit": 3.4086616039276123,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome",
            "probability": 0.008380256878237902,
            "start_logit": 3.572636365890503,
            "end_logit": 2.9714372158050537,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "myelodysplastic syndrome (MDS),",
            "probability": 0.003273538770805115,
            "start_logit": 5.552211284637451,
            "end_logit": 0.05185532197356224,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "myelodysplastic",
            "probability": 0.001915388584918747,
            "start_logit": 5.552211284637451,
            "end_logit": -0.4840957522392273,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "myeloid leukaemia",
            "probability": 0.0009297066491000492,
            "start_logit": 0.9366472363471985,
            "end_logit": 3.4086616039276123,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver",
            "probability": 0.000877633141470326,
            "start_logit": 3.572636365890503,
            "end_logit": 0.7150320410728455,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndromes",
            "probability": 0.0004239763311145757,
            "start_logit": 3.572636365890503,
            "end_logit": -0.012519000098109245,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia (AML)",
            "probability": 0.00036472011227805997,
            "start_logit": 5.552211284637451,
            "end_logit": -2.142641305923462,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "syndrome",
            "probability": 0.00030733469310770213,
            "start_logit": -2.1892523765563965,
            "end_logit": 5.427629470825195,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "elodysplastic syndrome",
            "probability": 0.00029730188268222227,
            "start_logit": -2.2224416732788086,
            "end_logit": 5.427629470825195,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "aplastic anemia",
            "probability": 0.00024699627763092636,
            "start_logit": 2.049175262451172,
            "end_logit": 0.9706377387046814,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Sotos and Weaver syndrome",
            "probability": 0.0002035735979653562,
            "start_logit": -0.1449698805809021,
            "end_logit": 2.9714372158050537,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "my",
            "probability": 0.00015891607013724852,
            "start_logit": 5.552211284637451,
            "end_logit": -2.973395347595215,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "(MDS)",
            "probability": 0.0001216193623034992,
            "start_logit": -1.5906668901443481,
            "end_logit": 3.9020028114318848,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Acquired aplastic anemia",
            "probability": 0.00011539481249993906,
            "start_logit": 1.2881613969802856,
            "end_logit": 0.9706377387046814,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "acute myeloid leukaemia (AML)",
            "probability": 0.00010471342923271908,
            "start_logit": 4.3043084144592285,
            "end_logit": -2.142641305923462,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "(MDS), but are rare in acute myeloid leukaemia",
            "probability": 7.425870269453507e-05,
            "start_logit": -1.5906668901443481,
            "end_logit": 3.4086616039276123,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        }
    ],
    "55414a763f2354b713000003": [
        {
            "text": "ExTopoDB",
            "probability": 0.2926961669870251,
            "start_logit": 4.658863067626953,
            "end_logit": 4.638967990875244,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane proteinsExTopoDB",
            "probability": 0.26795284894814614,
            "start_logit": 4.658863067626953,
            "end_logit": 4.5506439208984375,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDBTMPDB",
            "probability": 0.1488211730135875,
            "start_logit": 4.587245941162109,
            "end_logit": 4.034195423126221,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDBTMPDB: a database of experimentally-characterized transmembrane topologiesTMPDB",
            "probability": 0.10637922684296357,
            "start_logit": 4.587245941162109,
            "end_logit": 3.698460340499878,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoD",
            "probability": 0.06612560179216753,
            "start_logit": 4.587245941162109,
            "end_logit": 3.223006010055542,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB",
            "probability": 0.0659141144857141,
            "start_logit": 4.057383060455322,
            "end_logit": 3.7496654987335205,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB/Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.029893874518536156,
            "start_logit": 4.057383060455322,
            "end_logit": 2.9589664936065674,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 0.0038306455038179016,
            "start_logit": 2.002762794494629,
            "end_logit": 2.9589664936065674,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDB: a database",
            "probability": 0.0027517679705301454,
            "start_logit": 4.658863067626953,
            "end_logit": -0.027923503890633583,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane proteinsExTopoDB is a publicly accessible database",
            "probability": 0.0024479849963562803,
            "start_logit": 4.658863067626953,
            "end_logit": -0.14490187168121338,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies. TMPDB",
            "probability": 0.0023078962340366605,
            "start_logit": 2.863314628601074,
            "end_logit": 1.5917177200317383,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDB:",
            "probability": 0.002008745874662935,
            "start_logit": 4.658863067626953,
            "end_logit": -0.34265652298927307,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDB is a publicly accessible database",
            "probability": 0.0015709601492041587,
            "start_logit": 4.215284824371338,
            "end_logit": -0.14490187168121338,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "database of experimentally derived topological models of transmembrane proteinsExTopoDB",
            "probability": 0.0014297544453586348,
            "start_logit": -0.5744452476501465,
            "end_logit": 4.5506439208984375,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane proteinsExTopoDB is",
            "probability": 0.0013098253911755181,
            "start_logit": 4.658863067626953,
            "end_logit": -0.7702732682228088,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDBTMPDB: a database of experimentally-characterized transmembrane topologiesTMPDB is a database",
            "probability": 0.0013085397136233074,
            "start_logit": 4.587245941162109,
            "end_logit": -0.6996381878852844,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDBTMPDB: a database",
            "probability": 0.0012072997756873826,
            "start_logit": 4.587245941162109,
            "end_logit": -0.7801637053489685,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "ExTopoDB is",
            "probability": 0.0008405621337611383,
            "start_logit": 4.215284824371338,
            "end_logit": -0.7702732682228088,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "a database of experimentally derived topological models of transmembrane proteinsExTopoDB",
            "probability": 0.0007243615082578421,
            "start_logit": -1.2544126510620117,
            "end_logit": 4.5506439208984375,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "BTMPDB",
            "probability": 0.00047864971538815897,
            "start_logit": -1.1522856950759888,
            "end_logit": 4.034195423126221,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        }
    ],
    "56ebfa13107309bc2f000004": [
        {
            "text": "gene expression",
            "probability": 0.48312100487813747,
            "start_logit": 4.969875812530518,
            "end_logit": 5.201326370239258,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "establishing sites of gene expression",
            "probability": 0.3014083135723896,
            "start_logit": 4.498074531555176,
            "end_logit": 5.201326370239258,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "sites of gene expression",
            "probability": 0.10343069396886109,
            "start_logit": 3.4285104274749756,
            "end_logit": 5.201326370239258,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "gene expression.Chromatin domains and nuclear compartments: establishing sites of gene expression",
            "probability": 0.061385021649539344,
            "start_logit": 2.9067745208740234,
            "end_logit": 5.201326370239258,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "efficient gene expression.Chromatin domains and nuclear compartments: establishing sites of gene expression",
            "probability": 0.0264306170309456,
            "start_logit": 2.064131736755371,
            "end_logit": 5.201326370239258,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "orchestrating events required for efficient gene expression.Chromatin domains and nuclear compartments: establishing sites of gene expression",
            "probability": 0.006796110199958995,
            "start_logit": 0.7059590816497803,
            "end_logit": 5.201326370239258,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "expression",
            "probability": 0.003521233954906219,
            "start_logit": 0.048420146107673645,
            "end_logit": 5.201326370239258,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "gene expression in eukaryotic nuclei",
            "probability": 0.0024812450251769096,
            "start_logit": 4.969875812530518,
            "end_logit": -0.07018031924962997,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "nuclear compartments: establishing sites of gene expression",
            "probability": 0.002144809803628909,
            "start_logit": -0.4473404586315155,
            "end_logit": 5.201326370239258,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "efficient gene expression",
            "probability": 0.0018708848343346669,
            "start_logit": 2.064131736755371,
            "end_logit": 2.5532147884368896,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "establishing sites of gene expression in eukaryotic nuclei",
            "probability": 0.00154799288593775,
            "start_logit": 4.498074531555176,
            "end_logit": -0.07018031924962997,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "expression.Chromatin domains and nuclear compartments: establishing sites of gene expression",
            "probability": 0.001201485988561542,
            "start_logit": -1.0268322229385376,
            "end_logit": 5.201326370239258,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "gene",
            "probability": 0.0010371914611036097,
            "start_logit": 4.969875812530518,
            "end_logit": -0.9424242377281189,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "establishing",
            "probability": 0.0009073686346323787,
            "start_logit": 4.498074531555176,
            "end_logit": -0.604345977306366,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "establishing sites of gene",
            "probability": 0.0006470803918405009,
            "start_logit": 4.498074531555176,
            "end_logit": -0.9424242377281189,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "sites of gene expression in eukaryotic nuclei",
            "probability": 0.0005312062449563047,
            "start_logit": 3.4285104274749756,
            "end_logit": -0.07018031924962997,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "orchestrating events required for efficient gene expression",
            "probability": 0.0004810610168761365,
            "start_logit": 0.7059590816497803,
            "end_logit": 2.5532147884368896,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "coilin",
            "probability": 0.0003973720577122497,
            "start_logit": 1.8953180313110352,
            "end_logit": 1.1727347373962402,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "gene expression.Chromatin domains",
            "probability": 0.0003440411190284922,
            "start_logit": 2.9067745208740234,
            "end_logit": 0.017166415229439735,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "gene expression.Chromatin domains and nuclear compartments: establishing sites of gene expression in eukaryotic nuclei",
            "probability": 0.0003152652814727346,
            "start_logit": 2.9067745208740234,
            "end_logit": -0.07018031924962997,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        }
    ],
    "533c2230c45e133714000002": [
        {
            "text": "innate immunity",
            "probability": 0.6348129996770278,
            "start_logit": 6.039524555206299,
            "end_logit": 5.5071024894714355,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate and adaptive immunity",
            "probability": 0.17059432600618482,
            "start_logit": 5.356132984161377,
            "end_logit": 4.8764519691467285,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "adaptive immunity",
            "probability": 0.08100861594481584,
            "start_logit": 4.611400127410889,
            "end_logit": 4.8764519691467285,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate immunitySPRY domain is a protein interaction module found in 77 murine and ~100 human proteins, and is implicated in important biological pathways",
            "probability": 0.034901074005142536,
            "start_logit": 6.039524555206299,
            "end_logit": 2.6062896251678467,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "regulate innate and adaptive immunity",
            "probability": 0.02225583762124339,
            "start_logit": 3.319448947906494,
            "end_logit": 4.8764519691467285,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate",
            "probability": 0.016182420250680195,
            "start_logit": 5.356132984161377,
            "end_logit": 2.5210890769958496,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "immunity",
            "probability": 0.013561975427211617,
            "start_logit": 2.8241145610809326,
            "end_logit": 4.8764519691467285,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "involved in innate immunity",
            "probability": 0.007142987035142646,
            "start_logit": 1.5523251295089722,
            "end_logit": 5.5071024894714355,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate and adaptive",
            "probability": 0.004019822252100145,
            "start_logit": 5.356132984161377,
            "end_logit": 1.128401279449463,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "regulate innate",
            "probability": 0.0021111682073458996,
            "start_logit": 3.319448947906494,
            "end_logit": 2.5210890769958496,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "pathways, including those that regulate innate and adaptive immunity",
            "probability": 0.0019362441679099344,
            "start_logit": 0.8775947093963623,
            "end_logit": 4.8764519691467285,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "biological pathways, including those that regulate innate and adaptive immunity",
            "probability": 0.0019228655181118188,
            "start_logit": 0.8706611394882202,
            "end_logit": 4.8764519691467285,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "adaptive",
            "probability": 0.001908857372987888,
            "start_logit": 4.611400127410889,
            "end_logit": 1.128401279449463,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "capture of retroviral capsidsfunction of the SPRY/B30.2 domain proteins involved in innate immunity",
            "probability": 0.0018563209010907843,
            "start_logit": 0.2047906070947647,
            "end_logit": 5.5071024894714355,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "important biological pathways, including those that regulate innate and adaptive immunity",
            "probability": 0.0015976856537623508,
            "start_logit": 0.6854007244110107,
            "end_logit": 4.8764519691467285,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate immunitySPRY domain is a protein interaction module found in 77 murine and ~100 human proteins, and is implicated",
            "probability": 0.0010241652276519616,
            "start_logit": 6.039524555206299,
            "end_logit": -0.9223501086235046,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "implicated in important biological pathways, including those that regulate innate and adaptive immunity",
            "probability": 0.001005618002095676,
            "start_logit": 0.22244688868522644,
            "end_logit": 4.8764519691467285,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "ate immunity",
            "probability": 0.000839402531900982,
            "start_logit": -0.5888708233833313,
            "end_logit": 5.5071024894714355,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "inn",
            "probability": 0.0007071386088983543,
            "start_logit": 6.039524555206299,
            "end_logit": -1.2927565574645996,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate immunitySPRY domain is a protein interaction module found in 77 murine and ~100 human proteins, and is implicated in important biological",
            "probability": 0.0006104755886955711,
            "start_logit": 6.039524555206299,
            "end_logit": -1.4397449493408203,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        }
    ],
    "514241fcd24251bc05000006": [
        {
            "text": "paraspeckle component 1",
            "probability": 0.31569956136560323,
            "start_logit": 5.40192985534668,
            "end_logit": 4.488276481628418,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "paraspeckle component 1 (PSPC1",
            "probability": 0.30551501147151966,
            "start_logit": 5.40192985534668,
            "end_logit": 4.455484390258789,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC1",
            "probability": 0.18091423254858982,
            "start_logit": 4.877954006195068,
            "end_logit": 4.455484390258789,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC1-NONO heterodimer.Crystallization of a paraspeckle protein PSPC1",
            "probability": 0.08541293825128814,
            "start_logit": 4.461909294128418,
            "end_logit": 4.1210036277771,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "paraspeckle component 1 (PSPC1) and non-POU domain-containing octamer-binding protein",
            "probability": 0.0300951375951289,
            "start_logit": 5.40192985534668,
            "end_logit": 2.1378490924835205,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC1) and non-POU domain-containing octamer-binding protein",
            "probability": 0.017821182321754787,
            "start_logit": 4.877954006195068,
            "end_logit": 2.1378490924835205,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ",
            "probability": 0.01289894263778834,
            "start_logit": 3.605489492416382,
            "end_logit": 3.087071180343628,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "paraspeckle component",
            "probability": 0.007819324978221466,
            "start_logit": 5.40192985534668,
            "end_logit": 0.7900837063789368,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "paraspeckle component 1 (PSPC1)",
            "probability": 0.006011733107552459,
            "start_logit": 5.40192985534668,
            "end_logit": 0.5271985530853271,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "paraspeckle protein PSPC1",
            "probability": 0.005721224918812555,
            "start_logit": 1.7585946321487427,
            "end_logit": 4.1210036277771,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "paraspeckle component 1 (PSPC",
            "probability": 0.005206677031585212,
            "start_logit": 5.40192985534668,
            "end_logit": 0.38342732191085815,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC1-NONO heterodimer.Crystallization of a paraspeckle protein",
            "probability": 0.004349122174619733,
            "start_logit": 4.461909294128418,
            "end_logit": 1.1434800624847412,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "(PSPC1",
            "probability": 0.004134308039333322,
            "start_logit": 1.0992509126663208,
            "end_logit": 4.455484390258789,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC1)",
            "probability": 0.0035599169945899362,
            "start_logit": 4.877954006195068,
            "end_logit": 0.5271985530853271,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC",
            "probability": 0.0033614326970746178,
            "start_logit": 4.665269374847412,
            "end_logit": 0.6825132369995117,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC1-NONO heterodimer.Crystallization of a paraspeckle protein PSPC",
            "probability": 0.002742876535844017,
            "start_logit": 4.461909294128418,
            "end_logit": 0.6825132369995117,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC1-NONO",
            "probability": 0.0025070910272998875,
            "start_logit": 4.665269374847412,
            "end_logit": 0.389269083738327,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "NONO (p54) are nuclear proteins that interact with each other and have diverse roles in nucleic acids metabolism. The SFPQ",
            "probability": 0.0021842426987479014,
            "start_logit": 1.8296133279800415,
            "end_logit": 3.087071180343628,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC1-NONO heterodimer.Crystallization of a paraspeckle protein PSPC1-NONO",
            "probability": 0.002045747088136117,
            "start_logit": 4.461909294128418,
            "end_logit": 0.389269083738327,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSPC1) and non-POU domain-containing octamer-binding protein (NONO),",
            "probability": 0.0019992965165097696,
            "start_logit": 4.877954006195068,
            "end_logit": -0.049743298441171646,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        }
    ],
    "56f802ea09dd18d46b000017": [
        {
            "text": "SHMT2",
            "probability": 0.47782266361844106,
            "start_logit": 4.755417823791504,
            "end_logit": 4.345387935638428,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "Orai3",
            "probability": 0.18255420299542996,
            "start_logit": 4.1118268966674805,
            "end_logit": 4.0267863273620605,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "Orai1 and Orai3",
            "probability": 0.1779661008155348,
            "start_logit": 4.0863728523254395,
            "end_logit": 4.0267863273620605,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "Orai1",
            "probability": 0.12570438788713056,
            "start_logit": 4.0863728523254395,
            "end_logit": 3.679126262664795,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "GAC to undergo the dimer-to-tetramer transition necessary for enzyme activation.while SHMT2",
            "probability": 0.011388961905561684,
            "start_logit": 1.0188227891921997,
            "end_logit": 4.345387935638428,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "Orai3 channels",
            "probability": 0.00897503174411253,
            "start_logit": 4.1118268966674805,
            "end_logit": 1.0141856670379639,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "Orai1 and Orai3 channels",
            "probability": 0.008749463874218997,
            "start_logit": 4.0863728523254395,
            "end_logit": 1.0141856670379639,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "SHMT",
            "probability": 0.002298852999651438,
            "start_logit": 4.755417823791504,
            "end_logit": -0.9914414286613464,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "Orai",
            "probability": 0.001784542940030192,
            "start_logit": 4.0863728523254395,
            "end_logit": -0.5756444334983826,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "human Orai1 and Orai3",
            "probability": 0.0004932799759015523,
            "start_logit": -1.8018985986709595,
            "end_logit": 4.0267863273620605,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "Orai1 and Orai",
            "probability": 0.0004854899276745524,
            "start_logit": 4.0863728523254395,
            "end_logit": -1.8774034976959229,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "human Orai1",
            "probability": 0.0003484228577438747,
            "start_logit": -1.8018985986709595,
            "end_logit": 3.679126262664795,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "SHMT2 undergoes a dimer-to-tetramer transition upon PLP binding.AMPARs",
            "probability": 0.0003367332003610138,
            "start_logit": 4.755417823791504,
            "end_logit": -2.912316083908081,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "2",
            "probability": 0.00025789548838163533,
            "start_logit": -2.7690227031707764,
            "end_logit": 4.345387935638428,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "S",
            "probability": 0.0001940152947842326,
            "start_logit": 4.755417823791504,
            "end_logit": -3.463670015335083,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "GAC",
            "probability": 0.0001656048461342635,
            "start_logit": 1.0188227891921997,
            "end_logit": 0.1145925298333168,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AMPA-Rs",
            "probability": 0.00014041167843926742,
            "start_logit": 1.2810860872268677,
            "end_logit": -0.3126966059207916,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "3",
            "probability": 0.00012671490719397415,
            "start_logit": -3.1610357761383057,
            "end_logit": 4.0267863273620605,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "SHMT2 undergoes a dimer-to-tetramer transition upon PLP",
            "probability": 0.00011715288131151538,
            "start_logit": 4.755417823791504,
            "end_logit": -3.9681272506713867,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "SHMT2 undergoes a dimer-to-tetramer transition upon PLP binding",
            "probability": 9.007016196247529e-05,
            "start_logit": 4.755417823791504,
            "end_logit": -4.23101806640625,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        }
    ],
    "531376c8e3eabad021000012": [
        {
            "text": "PLN -42 C>G",
            "probability": 0.47324290955214754,
            "start_logit": 3.297764778137207,
            "end_logit": 1.706136703491211,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN -42 C>G mutation",
            "probability": 0.4072031168037498,
            "start_logit": 3.297764778137207,
            "end_logit": 1.555840015411377,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN -42",
            "probability": 0.03173286526111574,
            "start_logit": 3.297764778137207,
            "end_logit": -0.9961192011833191,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "The PLN -42 C>G",
            "probability": 0.027262992237606806,
            "start_logit": 0.4436861574649811,
            "end_logit": 1.706136703491211,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "The PLN -42 C>G mutation",
            "probability": 0.02345851398609624,
            "start_logit": 0.4436861574649811,
            "end_logit": 1.555840015411377,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN",
            "probability": 0.011863843931772885,
            "start_logit": 3.297764778137207,
            "end_logit": -1.9799766540527344,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "L39X",
            "probability": 0.010936152264362812,
            "start_logit": 1.157598853111267,
            "end_logit": 0.07876784354448318,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "-77A-->G",
            "probability": 0.005123618163260721,
            "start_logit": 0.4618528485298157,
            "end_logit": 0.016300687566399574,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "L39X nonsense mutation",
            "probability": 0.001983689124519952,
            "start_logit": 1.157598853111267,
            "end_logit": -1.6283478736877441,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "The PLN -42",
            "probability": 0.0018280947095637163,
            "start_logit": 0.4436861574649811,
            "end_logit": -0.9961192011833191,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "L39X nonsense",
            "probability": 0.001564960283840672,
            "start_logit": 1.157598853111267,
            "end_logit": -1.8654457330703735,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "The PLN",
            "probability": 0.0006834627175422305,
            "start_logit": 0.4436861574649811,
            "end_logit": -1.9799766540527344,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutation",
            "probability": 0.000657751903881715,
            "start_logit": -3.130474805831909,
            "end_logit": 1.555840015411377,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "G",
            "probability": 0.0005999933934881606,
            "start_logit": -3.3726806640625,
            "end_logit": 1.706136703491211,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "G mutation",
            "probability": 0.0005162659069128974,
            "start_logit": -3.3726806640625,
            "end_logit": 1.555840015411377,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "-77A",
            "probability": 0.0004942133643473221,
            "start_logit": 0.4618528485298157,
            "end_logit": -2.322348117828369,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "one L39X",
            "probability": 0.0003599193329293413,
            "start_logit": -2.256350517272949,
            "end_logit": 0.07876784354448318,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "heterozygous single nucleotide transition",
            "probability": 0.00020701674069976882,
            "start_logit": -1.170546293258667,
            "end_logit": -1.5601166486740112,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "-77A-->G,",
            "probability": 0.0001865194165771572,
            "start_logit": 0.4618528485298157,
            "end_logit": -3.2967801094055176,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutation, -77A-->G",
            "probability": 9.41009055846844e-05,
            "start_logit": -3.535395622253418,
            "end_logit": 0.016300687566399574,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        }
    ],
    "5312280ce3eabad02100000a": [
        {
            "text": "12",
            "probability": 0.1708482922014263,
            "start_logit": 0.49263063073158264,
            "end_logit": -0.06787886470556259,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6",
            "probability": 0.16690189522283894,
            "start_logit": 0.3100924789905548,
            "end_logit": 0.09128949046134949,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6p25.3->p23 and 12",
            "probability": 0.14234274277655395,
            "start_logit": 0.3100924789905548,
            "end_logit": -0.06787886470556259,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "12q24.32->qter in a child with moyamoya.Routine karyotype",
            "probability": 0.05365205180562412,
            "start_logit": 0.49263063073158264,
            "end_logit": -1.2261351346969604,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "12q24.32->qter in a child with moyamoya",
            "probability": 0.04706587243715625,
            "start_logit": 0.49263063073158264,
            "end_logit": -1.3571066856384277,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6p25.3",
            "probability": 0.04691938695602372,
            "start_logit": 0.3100924789905548,
            "end_logit": -1.1776857376098633,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "12q24.32->qter in a child with moyamoya.",
            "probability": 0.04477255840968671,
            "start_logit": 0.49263063073158264,
            "end_logit": -1.4070594310760498,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6p25.3->p23 and 12q24.32->qter in a child with moyamoya",
            "probability": 0.039213066092447034,
            "start_logit": 0.3100924789905548,
            "end_logit": -1.3571066856384277,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6p25.3->p23 and 12q24.32->qter in a child with moyamoya.",
            "probability": 0.037302384958256364,
            "start_logit": 0.3100924789905548,
            "end_logit": -1.4070594310760498,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "Complex chromosome rearrangement of 6",
            "probability": 0.03608563018471183,
            "start_logit": -1.2214189767837524,
            "end_logit": 0.09128949046134949,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "Complex chromosome rearrangement of 6p25.3->p23 and 12",
            "probability": 0.030775729469424272,
            "start_logit": -1.2214189767837524,
            "end_logit": -0.06787886470556259,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "rearrangement of 6",
            "probability": 0.02921484844558181,
            "start_logit": -1.4326366186141968,
            "end_logit": 0.09128949046134949,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "rearrangement of 6p25.3->p23 and 12",
            "probability": 0.02491596426747109,
            "start_logit": -1.4326366186141968,
            "end_logit": -0.06787886470556259,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6p and 12",
            "probability": 0.023805811687392566,
            "start_logit": -0.6929605007171631,
            "end_logit": -0.8531339764595032,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "moyamoya",
            "probability": 0.022179980716882364,
            "start_logit": -0.6104704737663269,
            "end_logit": -1.0063636302947998,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "moyamoya syndrome characterized by the association of a moyamoya",
            "probability": 0.02179228653194298,
            "start_logit": -0.6104704737663269,
            "end_logit": -1.0239976644515991,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "moyamoya syndrome",
            "probability": 0.017292308444259673,
            "start_logit": -0.6104704737663269,
            "end_logit": -1.2552919387817383,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17",
            "probability": 0.01593339523383061,
            "start_logit": -1.0582585334777832,
            "end_logit": -0.8893484473228455,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6p. Single nucleotide polymorphism microarray",
            "probability": 0.015582980714607607,
            "start_logit": -0.6906093955039978,
            "end_logit": -1.2792354822158813,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "X-linked moyamoya",
            "probability": 0.013402813443881821,
            "start_logit": -1.1141959428787231,
            "end_logit": -1.0063636302947998,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        }
    ],
    "54df69af1388e8454a000005": [
        {
            "text": "fluorouracil",
            "probability": 0.207597563988522,
            "start_logit": 6.846651554107666,
            "end_logit": 6.124090671539307,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "fluorouracil 500 mg/m(2), epirubicine",
            "probability": 0.20493531420165623,
            "start_logit": 6.846651554107666,
            "end_logit": 6.1111836433410645,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicine",
            "probability": 0.17017617634187693,
            "start_logit": 6.660791397094727,
            "end_logit": 6.1111836433410645,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicine 75 mg/m(2), and cyclophosphamide",
            "probability": 0.14203315223643603,
            "start_logit": 6.660791397094727,
            "end_logit": 5.930409908294678,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "cyclophosphamide",
            "probability": 0.11958081007403452,
            "start_logit": 6.488723278045654,
            "end_logit": 5.930409908294678,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin, and cyclophosphamide",
            "probability": 0.02428224715113372,
            "start_logit": 5.696641445159912,
            "end_logit": 5.128244876861572,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin",
            "probability": 0.02263216168998021,
            "start_logit": 5.696641445159912,
            "end_logit": 5.057871341705322,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "Fluorouracil",
            "probability": 0.021155612621070755,
            "start_logit": 5.363553524017334,
            "end_logit": 5.323492527008057,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin 75 mg/m(2), and cyclophosphamide",
            "probability": 0.01808581375543122,
            "start_logit": 5.553676128387451,
            "end_logit": 4.976592540740967,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "fluorouracil 500 mg/m(2), epirubicin",
            "probability": 0.01780744849642942,
            "start_logit": 5.465888023376465,
            "end_logit": 5.048869609832764,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "Fluorouracil, epirubicin, and cyclophosphamide",
            "probability": 0.01740326082321194,
            "start_logit": 5.363553524017334,
            "end_logit": 5.128244876861572,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "Fluorouracil, epirubicin",
            "probability": 0.01622063272943176,
            "start_logit": 5.363553524017334,
            "end_logit": 5.057871341705322,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab",
            "probability": 0.004922408825626674,
            "start_logit": 5.350339889526367,
            "end_logit": 3.878598928451538,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel",
            "probability": 0.004061711762940905,
            "start_logit": 5.696641445159912,
            "end_logit": 3.3401038646698,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "cyclophosphamide (FEC-75) followed by paclitaxel",
            "probability": 0.0028728453379767076,
            "start_logit": 5.350339889526367,
            "end_logit": 3.3401038646698,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "fluorouracil/epirubicin",
            "probability": 0.0019026328390337847,
            "start_logit": 4.260717868804932,
            "end_logit": 4.0176615715026855,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "fluorouracil/epirubicin/cyclophosphamide",
            "probability": 0.0013674156410734299,
            "start_logit": 4.260717868804932,
            "end_logit": 3.687345504760742,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin/cyclophosphamide",
            "probability": 0.0011291356390217542,
            "start_logit": 4.069247722625732,
            "end_logit": 3.687345504760742,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "fluorouracil 500 mg/m(2), epirubicine 75 mg/m(2),",
            "probability": 0.0010017843927180204,
            "start_logit": 6.846651554107666,
            "end_logit": 0.790272057056427,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicine 75 mg/m(2),",
            "probability": 0.0008318714523938508,
            "start_logit": 6.660791397094727,
            "end_logit": 0.790272057056427,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        }
    ],
    "5536554abc4f83e828000008": [
        {
            "text": "D22S1 and D22S15",
            "probability": 0.3889912988360079,
            "start_logit": 3.6698427200317383,
            "end_logit": 4.1540608406066895,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S15",
            "probability": 0.3508677839584396,
            "start_logit": 3.566695213317871,
            "end_logit": 4.1540608406066895,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1",
            "probability": 0.21622032720356596,
            "start_logit": 3.6698427200317383,
            "end_logit": 3.5668017864227295,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22S15,",
            "probability": 0.014088217415400022,
            "start_logit": 3.517935037612915,
            "end_logit": 0.9877503514289856,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S15,",
            "probability": 0.01288804879182371,
            "start_logit": 3.42889666557312,
            "end_logit": 0.9877503514289856,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "between two probes, D22S1 and D22S15",
            "probability": 0.004039653431650231,
            "start_logit": -0.8264980316162109,
            "end_logit": 4.083003520965576,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "two probes, D22S1 and D22S15",
            "probability": 0.0029619015966039592,
            "start_logit": -1.2078827619552612,
            "end_logit": 4.1540608406066895,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "between two probes, D22S1",
            "probability": 0.0021762352711951678,
            "start_logit": -0.8264980316162109,
            "end_logit": 3.4644410610198975,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "two probes, D22S1",
            "probability": 0.0016463692999787738,
            "start_logit": -1.2078827619552612,
            "end_logit": 3.5668017864227295,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22",
            "probability": 0.0014726169591119604,
            "start_logit": 3.6698427200317383,
            "end_logit": -1.422455072402954,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22",
            "probability": 0.0013346775177851067,
            "start_logit": 3.517935037612915,
            "end_logit": -1.3688987493515015,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "15",
            "probability": 0.0004832755209580428,
            "start_logit": -3.0208826065063477,
            "end_logit": 4.1540608406066895,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "22S1 and D22S15",
            "probability": 0.0004483549470179259,
            "start_logit": -3.095884323120117,
            "end_logit": 4.1540608406066895,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "localized between two probes, D22S1 and D22S15",
            "probability": 0.00043727257583993915,
            "start_logit": -3.0498554706573486,
            "end_logit": 4.083003520965576,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "22S15",
            "probability": 0.0003680191777225266,
            "start_logit": -3.2222771644592285,
            "end_logit": 4.083003520965576,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids",
            "probability": 0.00036747224613907964,
            "start_logit": 3.517935037612915,
            "end_logit": -2.658695936203003,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S15, by both in situ hybridization and somatic cell hybrids",
            "probability": 0.00033616745811322613,
            "start_logit": 3.42889666557312,
            "end_logit": -2.658695936203003,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22S15, by both in situ hybridization",
            "probability": 0.00030011337693310183,
            "start_logit": 3.517935037612915,
            "end_logit": -2.8611834049224854,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids.",
            "probability": 0.0002976475563812054,
            "start_logit": 3.517935037612915,
            "end_logit": -2.869433641433716,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S15, by both in situ hybridization",
            "probability": 0.00027454685933259155,
            "start_logit": 3.42889666557312,
            "end_logit": -2.8611834049224854,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        }
    ],
    "56f3f0f02ac5ed1459000017": [
        {
            "text": "CPModule",
            "probability": 0.350748142997489,
            "start_logit": 3.279402017593384,
            "end_logit": 2.6007654666900635,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "fuzzy itemset",
            "probability": 0.2871497238087042,
            "start_logit": 3.1302337646484375,
            "end_logit": 2.5498690605163574,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "fuzzy itemset mining",
            "probability": 0.1596044136171194,
            "start_logit": 3.1302337646484375,
            "end_logit": 1.9625636339187622,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CisMiner",
            "probability": 0.06163751900898382,
            "start_logit": 2.8609304428100586,
            "end_logit": 1.2804393768310547,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CisMiner, a novel methodology to detect putative CRMs by means of a fuzzy itemset mining",
            "probability": 0.04263625053447197,
            "start_logit": 2.8609304428100586,
            "end_logit": 0.911873459815979,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "'CPModule",
            "probability": 0.02117385007107984,
            "start_logit": 0.47210052609443665,
            "end_logit": 2.6007654666900635,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "fuzzy",
            "probability": 0.01764324012575634,
            "start_logit": 3.1302337646484375,
            "end_logit": -0.23978199064731598,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CPModule'",
            "probability": 0.010899473403645341,
            "start_logit": 3.279402017593384,
            "end_logit": -0.870588481426239,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "itemset",
            "probability": 0.01053486175757052,
            "start_logit": -0.1750800758600235,
            "end_logit": 2.5498690605163574,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CisMiner: genome-wide in-silico cis-regulatory module prediction by fuzzy itemset",
            "probability": 0.007962649229579418,
            "start_logit": -0.45500823855400085,
            "end_logit": 2.5498690605163574,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CPM",
            "probability": 0.007333883443588564,
            "start_logit": 3.279402017593384,
            "end_logit": -1.2667977809906006,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "itemset mining",
            "probability": 0.005855518198145979,
            "start_logit": -0.1750800758600235,
            "end_logit": 1.9625636339187622,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CisMiner: genome-wide in-silico cis-regulatory module prediction by fuzzy itemset mining",
            "probability": 0.004425823379765715,
            "start_logit": -0.45500823855400085,
            "end_logit": 1.9625636339187622,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CisMiner,",
            "probability": 0.0032694847532962045,
            "start_logit": 2.8609304428100586,
            "end_logit": -1.6561989784240723,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CisMiner, a novel methodology to detect putative CRMs by means of a fuzzy",
            "probability": 0.0022387226226580313,
            "start_logit": 2.8609304428100586,
            "end_logit": -2.034925937652588,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "by fuzzy itemset",
            "probability": 0.0018715779987323181,
            "start_logit": -1.902988076210022,
            "end_logit": 2.5498690605163574,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CisMiner, a novel methodology to detect putative CRMs by means of a fuzzy itemset mining approach",
            "probability": 0.0016451133293082223,
            "start_logit": 2.8609304428100586,
            "end_logit": -2.343022108078003,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "C",
            "probability": 0.001249633349227083,
            "start_logit": 2.8609304428100586,
            "end_logit": -2.617981195449829,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "cis-regulatory module prediction by fuzzy itemset",
            "probability": 0.0010798523205950653,
            "start_logit": -2.4529457092285156,
            "end_logit": 2.5498690605163574,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "by fuzzy itemset mining",
            "probability": 0.0010402660502831342,
            "start_logit": -1.902988076210022,
            "end_logit": 1.9625636339187622,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        }
    ],
    "532ad23ad6d3ac6a34000011": [
        {
            "text": "IMGT",
            "probability": 0.28207043770621804,
            "start_logit": 2.2693700790405273,
            "end_logit": 0.970668613910675,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT standardized labels), and numerotation (IMGT",
            "probability": 0.13339134889831286,
            "start_logit": 1.5205005407333374,
            "end_logit": 0.970668613910675,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "numerotation (IMGT",
            "probability": 0.1126222631259216,
            "start_logit": 1.3512526750564575,
            "end_logit": 0.970668613910675,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation (IMGT",
            "probability": 0.08505114499597859,
            "start_logit": 1.0704660415649414,
            "end_logit": 0.970668613910675,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT unique numbering and IMGT",
            "probability": 0.05683943556220153,
            "start_logit": 2.2693700790405273,
            "end_logit": -0.6312578320503235,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "NUMEROTATION) that are used in IMGT",
            "probability": 0.05143798855747357,
            "start_logit": 0.695823073387146,
            "end_logit": 0.8424357771873474,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT gene and allele nomenclature), description (IMGT",
            "probability": 0.03732539021261035,
            "start_logit": 1.0704660415649414,
            "end_logit": 0.1470896303653717,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT unique numbering (NUMEROTATION) that are used in IMGT",
            "probability": 0.03290602283107842,
            "start_logit": 0.24910180270671844,
            "end_logit": 0.8424357771873474,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT standardized labels), and numerotation",
            "probability": 0.029385419829522186,
            "start_logit": 1.5205005407333374,
            "end_logit": -0.5421200394630432,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT standardized labels), and numerotation (IMGT unique numbering and IMGT",
            "probability": 0.02687941721903336,
            "start_logit": 1.5205005407333374,
            "end_logit": -0.6312578320503235,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "numerotation",
            "probability": 0.02481009834175221,
            "start_logit": 1.3512526750564575,
            "end_logit": -0.5421200394630432,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "numerotation (IMGT unique numbering and IMGT",
            "probability": 0.02269428132870236,
            "start_logit": 1.3512526750564575,
            "end_logit": -0.6312578320503235,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT gene and allele nomenclature), description (IMGT standardized labels), and numerotation",
            "probability": 0.018736324531762848,
            "start_logit": 1.0704660415649414,
            "end_logit": -0.5421200394630432,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT unique numbering",
            "probability": 0.018469926486916307,
            "start_logit": 2.2693700790405273,
            "end_logit": -1.7553443908691406,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "NUMEROTATION",
            "probability": 0.015640120416733194,
            "start_logit": 0.695823073387146,
            "end_logit": -0.34810176491737366,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT unique numbering and IMGT Colliers de Perles). Kabat",
            "probability": 0.013605362492467217,
            "start_logit": 2.2693700790405273,
            "end_logit": -2.0610241889953613,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT Colliers de Perles). Kabat",
            "probability": 0.012020753942791703,
            "start_logit": 2.145540714263916,
            "end_logit": -2.0610241889953613,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT unique numbering (NUMEROTATION",
            "probability": 0.010005332128001003,
            "start_logit": 0.24910180270671844,
            "end_logit": -0.34810176491737366,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "IMGT standardized labels), and numerotation (IMGT unique numbering",
            "probability": 0.008734443879257084,
            "start_logit": 1.5205005407333374,
            "end_logit": -1.7553443908691406,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "numerotation (IMGT unique numbering",
            "probability": 0.007374487513265777,
            "start_logit": 1.3512526750564575,
            "end_logit": -1.7553443908691406,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        }
    ],
    "5156be75d24251bc05000088": [
        {
            "text": "osteosarcoma",
            "probability": 0.5951549786688208,
            "start_logit": 3.4519529342651367,
            "end_logit": 2.763209581375122,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "osteosarcoma were examined in plasma of 40 osteosarcoma",
            "probability": 0.34105349981347705,
            "start_logit": 3.4519529342651367,
            "end_logit": 2.2064270973205566,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "epilepsy",
            "probability": 0.05708392329834733,
            "start_logit": 2.231884002685547,
            "end_logit": 1.638979196548462,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "stromal keratitis",
            "probability": 0.0035885513035495667,
            "start_logit": 0.6855252981185913,
            "end_logit": 0.41856396198272705,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "keratitis",
            "probability": 0.00047137394222368815,
            "start_logit": -1.3443268537521362,
            "end_logit": 0.41856396198272705,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "o",
            "probability": 0.00046625062859156945,
            "start_logit": 3.4519529342651367,
            "end_logit": -4.388644218444824,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "oma",
            "probability": 0.00040180084808184857,
            "start_logit": -3.848667621612549,
            "end_logit": 2.763209581375122,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "stromal keratitis (SK)",
            "probability": 0.0002665996829810383,
            "start_logit": 0.6855252981185913,
            "end_logit": -2.1811916828155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "osarcoma",
            "probability": 0.00024404781918941555,
            "start_logit": -4.347259998321533,
            "end_logit": 2.763209581375122,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "oma were examined in plasma of 40 osteosarcoma",
            "probability": 0.00023025193500497002,
            "start_logit": -3.848667621612549,
            "end_logit": 2.2064270973205566,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "osteosarcoma were examined in plasma of 40 o",
            "probability": 0.0002260252166733355,
            "start_logit": 3.4519529342651367,
            "end_logit": -5.112720966339111,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "steosarcoma",
            "probability": 0.00020988988409582955,
            "start_logit": -4.498041152954102,
            "end_logit": 2.763209581375122,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "osarcoma were examined in plasma of 40 osteosarcoma",
            "probability": 0.00013985157789079462,
            "start_logit": -4.347259998321533,
            "end_logit": 2.2064270973205566,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "steosarcoma were examined in plasma of 40 osteosarcoma",
            "probability": 0.00012027737666991958,
            "start_logit": -4.498041152954102,
            "end_logit": 2.2064270973205566,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "epilepsy.Inflammation, stress signalling and neuronal excitation are among the pathways most impacted.Herpes simplex virus",
            "probability": 0.00010121185505333349,
            "start_logit": 1.6457041501998901,
            "end_logit": -4.109902858734131,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "miR-140, and miR-132) that were previously demonstrated to be regulated in osteosarcoma",
            "probability": 8.726741296271711e-05,
            "start_logit": -5.375647068023682,
            "end_logit": 2.763209581375122,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "e",
            "probability": 6.138455870903091e-05,
            "start_logit": 2.231884002685547,
            "end_logit": -5.196140289306641,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "keratitis (SK)",
            "probability": 3.5019185440669213e-05,
            "start_logit": -1.3443268537521362,
            "end_logit": -2.1811916828155518,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "stromal keratitis (SK). miR-132",
            "probability": 2.939532930473404e-05,
            "start_logit": 0.6855252981185913,
            "end_logit": -4.386104106903076,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "psy",
            "probability": 2.8399662932129297e-05,
            "start_logit": -5.0559234619140625,
            "end_logit": 1.3208861351013184,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        }
    ],
    "57169b63cb4ef8864c00000b": [
        {
            "text": "glutamate transporter-1 (GLT-1",
            "probability": 0.13425005161669581,
            "start_logit": 4.458102226257324,
            "end_logit": 3.5778510570526123,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "glutamate transporter-1",
            "probability": 0.11772975046922281,
            "start_logit": 4.458102226257324,
            "end_logit": 3.4465386867523193,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLAST) and glutamate transporter-1 (GLT-1",
            "probability": 0.09774288210335043,
            "start_logit": 4.140738487243652,
            "end_logit": 3.5778510570526123,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLT-1",
            "probability": 0.09041885726980847,
            "start_logit": 4.0628509521484375,
            "end_logit": 3.5778510570526123,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLAST) and glutamate transporter-1",
            "probability": 0.08571501449418456,
            "start_logit": 4.140738487243652,
            "end_logit": 3.4465386867523193,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLAST",
            "probability": 0.08045924347577782,
            "start_logit": 4.140738487243652,
            "end_logit": 3.3832614421844482,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Glutamate/aspartate transporter (GLAST) and glutamate transporter-1 (GLT-1",
            "probability": 0.04789265670000259,
            "start_logit": 3.4273602962493896,
            "end_logit": 3.5778510570526123,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "glutamate transporter-1 (GLT-1)",
            "probability": 0.04647380328151945,
            "start_logit": 4.458102226257324,
            "end_logit": 2.517035722732544,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Glutamate/aspartate transporter (GLAST) and glutamate transporter-1",
            "probability": 0.0419991683779602,
            "start_logit": 3.4273602962493896,
            "end_logit": 3.4465386867523193,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Glutamate/aspartate transporter (GLAST",
            "probability": 0.03942391346771288,
            "start_logit": 3.4273602962493896,
            "end_logit": 3.3832614421844482,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLAST) and glutamate transporter-1 (GLT-1)",
            "probability": 0.03383599052914581,
            "start_logit": 4.140738487243652,
            "end_logit": 2.517035722732544,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLT-1)",
            "probability": 0.031300607598234054,
            "start_logit": 4.0628509521484375,
            "end_logit": 2.517035722732544,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "aspartate transporter (GLAST) and glutamate transporter-1 (GLT-1",
            "probability": 0.030504551595931368,
            "start_logit": 2.976274013519287,
            "end_logit": 3.5778510570526123,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "aspartate transporter (GLAST) and glutamate transporter-1",
            "probability": 0.026750777406166045,
            "start_logit": 2.976274013519287,
            "end_logit": 3.4465386867523193,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "aspartate transporter (GLAST",
            "probability": 0.025110505145339246,
            "start_logit": 2.976274013519287,
            "end_logit": 3.3832614421844482,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLAST)",
            "probability": 0.019591826371006385,
            "start_logit": 4.140738487243652,
            "end_logit": 1.9706231355667114,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Glutamate/aspartate transporter (GLAST) and glutamate transporter-1 (GLT-1)",
            "probability": 0.01657916611056604,
            "start_logit": 3.4273602962493896,
            "end_logit": 2.517035722732544,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Glutamate/aspartate transporter",
            "probability": 0.014061644961497614,
            "start_logit": 3.4273602962493896,
            "end_logit": 2.352339744567871,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "aspartate transporter (GLAST) and glutamate transporter-1 (GLT-1)",
            "probability": 0.010559865810017825,
            "start_logit": 2.976274013519287,
            "end_logit": 2.517035722732544,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Glutamate/aspartate transporter (GLAST)",
            "probability": 0.00959972321586068,
            "start_logit": 3.4273602962493896,
            "end_logit": 1.9706231355667114,
            "question_text": "Which are the human glutamate transporters?"
        }
    ],
    "55184d46622b194345000001": [
        {
            "text": "colloidal Coomassie Blue",
            "probability": 0.48991846669924605,
            "start_logit": 4.016854286193848,
            "end_logit": 4.498800754547119,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue",
            "probability": 0.27157189453904895,
            "start_logit": 3.7998251914978027,
            "end_logit": 4.125817775726318,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue staining",
            "probability": 0.09414441443027777,
            "start_logit": 3.7998251914978027,
            "end_logit": 3.066420793533325,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue stain",
            "probability": 0.07888674570176336,
            "start_logit": 3.7998251914978027,
            "end_logit": 2.889604091644287,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "SDS-PAGE utilizing Coomassie Blue",
            "probability": 0.016474330332702777,
            "start_logit": 0.9974017143249512,
            "end_logit": 4.125817775726318,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue staining (CBS)",
            "probability": 0.01525679928786926,
            "start_logit": 3.7998251914978027,
            "end_logit": 1.2466161251068115,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Sypro Ruby.Several new fast staining protocols for the visualization of proteins separated by SDS-PAGE utilizing Coomassie Blue",
            "probability": 0.007484112212930917,
            "start_logit": 0.20838068425655365,
            "end_logit": 4.125817775726318,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "SDS-PAGE utilizing Coomassie Blue staining",
            "probability": 0.005711070304001045,
            "start_logit": 0.9974017143249512,
            "end_logit": 3.066420793533325,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "SDS-PAGE utilizing Coomassie Blue stain",
            "probability": 0.004785496340733822,
            "start_logit": 0.9974017143249512,
            "end_logit": 2.889604091644287,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "colloidal Coomassie",
            "probability": 0.003143656080622411,
            "start_logit": 4.016854286193848,
            "end_logit": -0.550051748752594,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "SDS-PAGE",
            "probability": 0.0022266324717279957,
            "start_logit": 1.6528321504592896,
            "end_logit": 1.4690742492675781,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "colloidal Coomassie Blue,",
            "probability": 0.002052833956605632,
            "start_logit": 4.016854286193848,
            "end_logit": -0.9762169718742371,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie",
            "probability": 0.0015396073220051534,
            "start_logit": 3.302995204925537,
            "end_logit": -0.550051748752594,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "utilizing Coomassie Blue",
            "probability": 0.001473298764313963,
            "start_logit": -1.4168977737426758,
            "end_logit": 4.125817775726318,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue staining (CBS",
            "probability": 0.0013015602206821817,
            "start_logit": 3.7998251914978027,
            "end_logit": -1.2148454189300537,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue,",
            "probability": 0.0010053765772702092,
            "start_logit": 3.302995204925537,
            "end_logit": -0.9762169718742371,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "SDS-PAGE utilizing Coomassie Blue staining (CBS)",
            "probability": 0.0009255212205030371,
            "start_logit": 0.9974017143249512,
            "end_logit": 1.2466161251068115,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "SDS",
            "probability": 0.0008727350371992003,
            "start_logit": 1.6528321504592896,
            "end_logit": 0.532460629940033,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Blue",
            "probability": 0.0006253923879274406,
            "start_logit": -2.273777723312378,
            "end_logit": 4.125817775726318,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Sypro Ruby.Several new fast staining protocols for the visualization of proteins separated by SDS-PAGE",
            "probability": 0.0006000561125687375,
            "start_logit": 0.20838068425655365,
            "end_logit": 1.6023032665252686,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        }
    ],
    "54cf43abf693c3b16b000008": [
        {
            "text": "sagittal",
            "probability": 0.25888428741988795,
            "start_logit": 2.8759169578552246,
            "end_logit": 3.3814728260040283,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "posterior sagittal",
            "probability": 0.18341331026977883,
            "start_logit": 2.531277894973755,
            "end_logit": 3.3814728260040283,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "Bilambdoid and posterior sagittal",
            "probability": 0.16883464591687897,
            "start_logit": 2.448455572128296,
            "end_logit": 3.3814728260040283,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "Bilambdoid",
            "probability": 0.11476168389475376,
            "start_logit": 2.448455572128296,
            "end_logit": 2.995410680770874,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagittal synostosis",
            "probability": 0.06082066865202296,
            "start_logit": 2.8759169578552246,
            "end_logit": 1.9330213069915771,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "lambdoid",
            "probability": 0.051878489588235634,
            "start_logit": 2.24273419380188,
            "end_logit": 2.4071786403656006,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "lambdoid and sagittal",
            "probability": 0.049230034516071546,
            "start_logit": 2.24273419380188,
            "end_logit": 2.354778289794922,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "posterior sagittal synostosis",
            "probability": 0.04308998541960924,
            "start_logit": 2.531277894973755,
            "end_logit": 1.9330213069915771,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "Bilambdoid and posterior sagittal synostosis",
            "probability": 0.0396649644465957,
            "start_logit": 2.448455572128296,
            "end_logit": 1.9330213069915771,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "lambdoid and sagittal synostosis",
            "probability": 0.006350115564130797,
            "start_logit": 2.24273419380188,
            "end_logit": 0.3067474067211151,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "posterior",
            "probability": 0.005316499798868524,
            "start_logit": 2.531277894973755,
            "end_logit": -0.15945415198802948,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "Bilambdoid and posterior",
            "probability": 0.0048939161489362495,
            "start_logit": 2.448455572128296,
            "end_logit": -0.15945415198802948,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagittal and bilateral lambdoid",
            "probability": 0.0035154644843905835,
            "start_logit": 0.7570186257362366,
            "end_logit": 1.2011616230010986,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "lambdoid sutures",
            "probability": 0.0017200706634987073,
            "start_logit": 1.2516671419143677,
            "end_logit": -0.008293179795145988,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "craniosynostosis that includes bilateral lambdoid",
            "probability": 0.0015284053581202666,
            "start_logit": -1.2819451093673706,
            "end_logit": 2.4071786403656006,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "craniosynostosis that includes bilateral lambdoid and sagittal",
            "probability": 0.0014503785505712219,
            "start_logit": -1.2819451093673706,
            "end_logit": 2.354778289794922,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagittal synostosis (BLSS)",
            "probability": 0.0014178473620239322,
            "start_logit": 2.9156265258789062,
            "end_logit": -1.8654781579971313,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagittal synostosis: the Mercedes Benz syndrome.A consistent pattern of craniosynostosis",
            "probability": 0.0012214404908724268,
            "start_logit": 2.8759169578552246,
            "end_logit": -1.9748774766921997,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagittal and bilateral lambdoid sutures",
            "probability": 0.0010488736322938137,
            "start_logit": 0.7570186257362366,
            "end_logit": -0.008293179795145988,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "bilateral lambdoid",
            "probability": 0.0009589178224587358,
            "start_logit": -1.7481199502944946,
            "end_logit": 2.4071786403656006,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        }
    ],
    "55391ce8bc4f83e828000018": [
        {
            "text": "Myc",
            "probability": 0.1928457170630502,
            "start_logit": 4.649294853210449,
            "end_logit": 4.030651569366455,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Wnt, Myc",
            "probability": 0.1470345227030939,
            "start_logit": 4.3780717849731445,
            "end_logit": 4.030651569366455,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hedgehog",
            "probability": 0.13606179104741672,
            "start_logit": 4.536869525909424,
            "end_logit": 3.7942955493927,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "RBMultiple signaling pathways have been associated with medulloblastoma formation and growth. These include the developmental pathways Hedgehog",
            "probability": 0.126546503002371,
            "start_logit": 4.464370250701904,
            "end_logit": 3.7942955493927,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hedgehog, (Hh) Notch, and Wnt",
            "probability": 0.09347662885681796,
            "start_logit": 4.536869525909424,
            "end_logit": 3.418897867202759,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hedgehog, (Hh) Notch",
            "probability": 0.0770800984600934,
            "start_logit": 4.536869525909424,
            "end_logit": 3.226031541824341,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Wnt",
            "probability": 0.07638618874299888,
            "start_logit": 4.3780717849731445,
            "end_logit": 3.375786066055298,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Wnt as well as the receptor tyrosine kinases (RTK) c-Met",
            "probability": 0.021893620540608436,
            "start_logit": 3.62418794631958,
            "end_logit": 2.88006329536438,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Myc, and RB",
            "probability": 0.01893301427210487,
            "start_logit": 4.649294853210449,
            "end_logit": 1.7096682786941528,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "c-Met",
            "probability": 0.017406526199631657,
            "start_logit": 3.3948378562927246,
            "end_logit": 2.88006329536438,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "RB",
            "probability": 0.015736495715352877,
            "start_logit": 4.464370250701904,
            "end_logit": 1.7096682786941528,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Wnt, Myc, and RB",
            "probability": 0.014435408570259559,
            "start_logit": 4.3780717849731445,
            "end_logit": 1.7096682786941528,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "c-Met, erbB2, IGF-R and TrkC",
            "probability": 0.012829058789133055,
            "start_logit": 3.3948378562927246,
            "end_logit": 2.5749309062957764,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "TrkC",
            "probability": 0.011809832587240126,
            "start_logit": 3.3120574951171875,
            "end_logit": 2.5749309062957764,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Wnt as well as the receptor tyrosine kinases (RTK) c-Met, erbB2",
            "probability": 0.00779902350891162,
            "start_logit": 3.62418794631958,
            "end_logit": 1.8478665351867676,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Notch, and Wnt",
            "probability": 0.007199075364668831,
            "start_logit": 1.9731106758117676,
            "end_logit": 3.418897867202759,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "c-Met, erbB2",
            "probability": 0.006200614776693333,
            "start_logit": 3.3948378562927246,
            "end_logit": 1.8478665351867676,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Notch",
            "probability": 0.0059363013484394905,
            "start_logit": 1.9731106758117676,
            "end_logit": 3.226031541824341,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "erbB2, IGF-R and TrkC",
            "probability": 0.00564442521661734,
            "start_logit": 2.573793411254883,
            "end_logit": 2.5749309062957764,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "c-Met, erbB2, IGF-R",
            "probability": 0.0047451532344971814,
            "start_logit": 3.3948378562927246,
            "end_logit": 1.5803418159484863,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        }
    ],
    "51542dc3d24251bc0500007e": [
        {
            "text": "fever",
            "probability": 0.1884214178003642,
            "start_logit": 5.377359867095947,
            "end_logit": 5.559939384460449,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "gastrointestinal disorders",
            "probability": 0.14646836292815021,
            "start_logit": 5.642436504364014,
            "end_logit": 5.0429911613464355,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever, skin rash",
            "probability": 0.1279504761806831,
            "start_logit": 5.377359867095947,
            "end_logit": 5.172901630401611,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever, skin rash and gastrointestinal disorders",
            "probability": 0.11236278801461715,
            "start_logit": 5.377359867095947,
            "end_logit": 5.0429911613464355,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "skin rash",
            "probability": 0.10585512635293494,
            "start_logit": 5.187788009643555,
            "end_logit": 5.172901630401611,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "rash, fever",
            "probability": 0.09512612441818168,
            "start_logit": 4.9404377937316895,
            "end_logit": 5.313384056091309,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "skin rash and gastrointestinal disorders",
            "probability": 0.0929592251447285,
            "start_logit": 5.187788009643555,
            "end_logit": 5.0429911613464355,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "rash",
            "probability": 0.0671744678305248,
            "start_logit": 4.9404377937316895,
            "end_logit": 4.965473651885986,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "enanthema",
            "probability": 0.017166373654204713,
            "start_logit": 4.407533645629883,
            "end_logit": 4.134037017822266,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "enanthema and fever without skin rash",
            "probability": 0.013181124664995979,
            "start_logit": 4.407533645629883,
            "end_logit": 3.86987042427063,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "enanthema and fever",
            "probability": 0.012361412596786808,
            "start_logit": 4.407533645629883,
            "end_logit": 3.805664300918579,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever without skin rash",
            "probability": 0.005246066361319464,
            "start_logit": 3.4862263202667236,
            "end_logit": 3.86987042427063,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "gastrointestinal disorders.",
            "probability": 0.0028156353000603758,
            "start_logit": 5.642436504364014,
            "end_logit": 1.09136962890625,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "gastrointestinal",
            "probability": 0.0025201108683087525,
            "start_logit": 5.642436504364014,
            "end_logit": 0.9804846048355103,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever, skin rash and gastrointestinal disorders.",
            "probability": 0.0021600066118193247,
            "start_logit": 5.377359867095947,
            "end_logit": 1.09136962890625,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever, skin rash and gastrointestinal",
            "probability": 0.0019332958845728072,
            "start_logit": 5.377359867095947,
            "end_logit": 0.9804846048355103,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "skin rash and gastrointestinal disorders.",
            "probability": 0.0017870021249036107,
            "start_logit": 5.187788009643555,
            "end_logit": 1.09136962890625,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever,",
            "probability": 0.0016263766223770766,
            "start_logit": 5.377359867095947,
            "end_logit": 0.807612955570221,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "skin rash and gastrointestinal",
            "probability": 0.0015994413326768054,
            "start_logit": 5.187788009643555,
            "end_logit": 0.9804846048355103,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "nausea",
            "probability": 0.0012851653077894023,
            "start_logit": 2.8618531227111816,
            "end_logit": 3.0876524448394775,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        }
    ],
    "51595fb0d24251bc0500009c": [
        {
            "text": "Mage-A4",
            "probability": 0.1585497475813866,
            "start_logit": 3.398449420928955,
            "end_logit": 2.293419122695923,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "mucin 1 (MUC1",
            "probability": 0.1070295537413513,
            "start_logit": 3.672421932220459,
            "end_logit": 1.6264832019805908,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "mucin 1",
            "probability": 0.10306002666281122,
            "start_logit": 3.672421932220459,
            "end_logit": 1.5886898040771484,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "RAB25, S100A14",
            "probability": 0.10206760456395128,
            "start_logit": 2.6319408416748047,
            "end_logit": 2.619494676589966,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "S100A14",
            "probability": 0.0997461984602705,
            "start_logit": 2.6089344024658203,
            "end_logit": 2.619494676589966,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "MUC1",
            "probability": 0.05068517332840088,
            "start_logit": 2.924950361251831,
            "end_logit": 1.6264832019805908,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "RAB25",
            "probability": 0.05049810419093676,
            "start_logit": 2.6319408416748047,
            "end_logit": 1.915795087814331,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "mucin 1 (MUC1)",
            "probability": 0.043879763684768903,
            "start_logit": 3.672421932220459,
            "end_logit": 0.7348314523696899,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "RAB25, S100A14 and mucin 1 (MUC1",
            "probability": 0.037811901553040685,
            "start_logit": 2.6319408416748047,
            "end_logit": 1.6264832019805908,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "S100A14 and mucin 1 (MUC1",
            "probability": 0.036951914886046766,
            "start_logit": 2.6089344024658203,
            "end_logit": 1.6264832019805908,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "RAB25, S100A14 and mucin 1",
            "probability": 0.03640952845272291,
            "start_logit": 2.6319408416748047,
            "end_logit": 1.5886898040771484,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "S100A14 and mucin 1",
            "probability": 0.03558143709167473,
            "start_logit": 2.6089344024658203,
            "end_logit": 1.5886898040771484,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "mucin",
            "probability": 0.02949078773705457,
            "start_logit": 3.672421932220459,
            "end_logit": 0.3374561369419098,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Mage-A4,",
            "probability": 0.026456759415021222,
            "start_logit": 3.398449420928955,
            "end_logit": 0.5028623938560486,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "MUC1)",
            "probability": 0.0207798066069345,
            "start_logit": 2.924950361251831,
            "end_logit": 0.7348314523696899,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "RAB25, S100A14 and mucin 1 (MUC1)",
            "probability": 0.015502048234534887,
            "start_logit": 2.6319408416748047,
            "end_logit": 0.7348314523696899,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "S100A14 and mucin 1 (MUC1)",
            "probability": 0.015149472610320493,
            "start_logit": 2.6089344024658203,
            "end_logit": 0.7348314523696899,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "RAB25, S100A14 and mucin",
            "probability": 0.010418643483554977,
            "start_logit": 2.6319408416748047,
            "end_logit": 0.3374561369419098,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "S100A14 and mucin",
            "probability": 0.010181683846086021,
            "start_logit": 2.6089344024658203,
            "end_logit": 0.3374561369419098,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 0.009749843869130944,
            "start_logit": 0.28355672955513,
            "end_logit": 2.619494676589966,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        }
    ],
    "5547d700f35db75526000007": [
        {
            "text": "ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic dysarthria",
            "probability": 0.14869836736724507,
            "start_logit": 5.968442916870117,
            "end_logit": 5.6630425453186035,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic dysarthria",
            "probability": 0.13113195961023022,
            "start_logit": 5.904079914093018,
            "end_logit": 5.60168981552124,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "ataxic dysarthria",
            "probability": 0.12605841237191054,
            "start_logit": 5.968442916870117,
            "end_logit": 5.497868061065674,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "hyperkinetic dysarthria and hypokinetic dysarthria",
            "probability": 0.11903960659250079,
            "start_logit": 5.726566314697266,
            "end_logit": 5.682455539703369,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "hyperkinetic dysarthria",
            "probability": 0.11675097782165937,
            "start_logit": 5.726566314697266,
            "end_logit": 5.6630425453186035,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid dysarthria associated with lower motor neuron impairment, spastic dysarthria",
            "probability": 0.10991230715690617,
            "start_logit": 5.727558612823486,
            "end_logit": 5.60168981552124,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "hypokinetic dysarthria",
            "probability": 0.10844231681523121,
            "start_logit": 5.633328437805176,
            "end_logit": 5.682455539703369,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid dysarthria",
            "probability": 0.10347465464421626,
            "start_logit": 5.727558612823486,
            "end_logit": 5.5413336753845215,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "ataxic",
            "probability": 0.006639886737217494,
            "start_logit": 5.968442916870117,
            "end_logit": 2.554217576980591,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic dysarthria associated with damaged upper motor neurons linked to the motor areas of the cerebral cortex, ataxic",
            "probability": 0.006225986495187931,
            "start_logit": 5.904079914093018,
            "end_logit": 2.554217576980591,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic",
            "probability": 0.004522952270475386,
            "start_logit": 5.904079914093018,
            "end_logit": 2.2346506118774414,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid dysarthria associated with lower motor neuron impairment, spastic",
            "probability": 0.0037910523162023534,
            "start_logit": 5.727558612823486,
            "end_logit": 2.2346506118774414,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "hyperkinetic dysarthria and hypokinetic dysarthria,",
            "probability": 0.00284640455060733,
            "start_logit": 5.726566314697266,
            "end_logit": 1.9490559101104736,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "hypokinetic dysarthria,",
            "probability": 0.002593008435569892,
            "start_logit": 5.633328437805176,
            "end_logit": 1.9490559101104736,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic",
            "probability": 0.00212044561330817,
            "start_logit": 5.968442916870117,
            "end_logit": 1.41274893283844,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "hyperkinetic",
            "probability": 0.001664874357093378,
            "start_logit": 5.726566314697266,
            "end_logit": 1.41274893283844,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "hyperkinetic dysarthria and hypokinetic",
            "probability": 0.0016122369694101329,
            "start_logit": 5.726566314697266,
            "end_logit": 1.3806219100952148,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "ataxic dysarthriaataxic dysarthria",
            "probability": 0.0015142210461477471,
            "start_logit": 3.886976718902588,
            "end_logit": 3.1574900150299072,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "mixed dysarthria",
            "probability": 0.001491618395247195,
            "start_logit": 3.0399656295776367,
            "end_logit": 3.989461660385132,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "hypokinetic",
            "probability": 0.0014687104336332376,
            "start_logit": 5.633328437805176,
            "end_logit": 1.3806219100952148,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        }
    ],
    "531b1e3cb166e2b80600003b": [
        {
            "text": "H3K27me3",
            "probability": 0.49758998482402983,
            "start_logit": 2.2672715187072754,
            "end_logit": 1.6763043403625488,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "trimethylation of the lysine 27 residue of histone H3 (H3K27me3",
            "probability": 0.19275940272709655,
            "start_logit": 1.31893789768219,
            "end_logit": 1.6763043403625488,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3)",
            "probability": 0.12169198641896727,
            "start_logit": 2.2672715187072754,
            "end_logit": 0.2680210769176483,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "trimethylation of the lysine 27 residue of histone H3 (H3K27me3)",
            "probability": 0.04714177401920503,
            "start_logit": 1.31893789768219,
            "end_logit": 0.2680210769176483,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "trimethylation of the lysine 27 residue of histone H3",
            "probability": 0.042078569707850746,
            "start_logit": 1.31893789768219,
            "end_logit": 0.15440012514591217,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "(H3K27me3",
            "probability": 0.016264751563241846,
            "start_logit": -1.1535046100616455,
            "end_logit": 1.6763043403625488,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "histone H3 (H3K27me3",
            "probability": 0.01570037961074964,
            "start_logit": -1.1888200044631958,
            "end_logit": 1.6763043403625488,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3),",
            "probability": 0.009987808006756044,
            "start_logit": 2.2672715187072754,
            "end_logit": -2.232106924057007,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "K27me3",
            "probability": 0.008817325742863622,
            "start_logit": 0.20252494513988495,
            "end_logit": -0.29200688004493713,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K36me",
            "probability": 0.007041408750322735,
            "start_logit": 0.17907994985580444,
            "end_logit": -0.49347224831581116,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3), a modification associated with heterochromatin",
            "probability": 0.0061449006844140844,
            "start_logit": 2.2672715187072754,
            "end_logit": -2.7178494930267334,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K36me)",
            "probability": 0.004685462642326988,
            "start_logit": 0.17907994985580444,
            "end_logit": -0.9008158445358276,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3 (H3K27me3",
            "probability": 0.004283267780267112,
            "start_logit": -2.487788677215576,
            "end_logit": 1.6763043403625488,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "methylated histone H3 Lys36 (H3K36me",
            "probability": 0.00410526155065038,
            "start_logit": -0.3604588508605957,
            "end_logit": -0.49347224831581116,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "(H3K27me3)",
            "probability": 0.003977752741630982,
            "start_logit": -1.1535046100616455,
            "end_logit": 0.2680210769176483,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "trimethylation of the lysine 27 residue of histone H3 (H3K27me3),",
            "probability": 0.0038691371704678915,
            "start_logit": 1.31893789768219,
            "end_logit": -2.232106924057007,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "histone H3 (H3K27me3)",
            "probability": 0.0038397283720243143,
            "start_logit": -1.1888200044631958,
            "end_logit": 0.2680210769176483,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "histone H3",
            "probability": 0.003427327064433669,
            "start_logit": -1.1888200044631958,
            "end_logit": 0.15440012514591217,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "lysine 27 residue of histone H3 (H3K27me3",
            "probability": 0.0033652649983052737,
            "start_logit": -2.7289981842041016,
            "end_logit": 1.6763043403625488,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "trimethylation of the lysine 27",
            "probability": 0.0032285056243958983,
            "start_logit": 1.31893789768219,
            "end_logit": -2.413119077682495,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        }
    ],
    "52d832dd98d0239505000003": [
        {
            "text": "pS-X-X-S",
            "probability": 0.6016975957072378,
            "start_logit": 4.4429850578308105,
            "end_logit": 4.153263092041016,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "K/R-X-K/R-X-X-S/T",
            "probability": 0.23931457429081288,
            "start_logit": 4.270470142364502,
            "end_logit": 3.403801918029785,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "K/R-X-K/R-X-X-S",
            "probability": 0.03651981380237981,
            "start_logit": 4.270470142364502,
            "end_logit": 1.5238779783248901,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "serine that are close to other phosphoserine in a consensus motif of pS-X-X-S",
            "probability": 0.01945922612921353,
            "start_logit": 1.0115513801574707,
            "end_logit": 4.153263092041016,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "K/R-X-K/R-X-X-S/T)",
            "probability": 0.019232776061466363,
            "start_logit": 4.270470142364502,
            "end_logit": 0.8826389312744141,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "phosphoserine in a consensus motif of pS-X-X-S",
            "probability": 0.017037152393042463,
            "start_logit": 0.8786264657974243,
            "end_logit": 4.153263092041016,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "pS-X-X-S,",
            "probability": 0.01387977783308137,
            "start_logit": 4.4429850578308105,
            "end_logit": 0.38394105434417725,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "(K/R-X-K/R-X-X-S/T",
            "probability": 0.011151353474379065,
            "start_logit": 1.2042521238327026,
            "end_logit": 3.403801918029785,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "pS-X-X-S,a novel consensus phosphorylation motif (K/R-X",
            "probability": 0.007724553909458166,
            "start_logit": 4.4429850578308105,
            "end_logit": -0.20208781957626343,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "K/R-X",
            "probability": 0.006500565410190447,
            "start_logit": 4.270470142364502,
            "end_logit": -0.20208781957626343,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "pS-X-X-S,a novel consensus phosphorylation motif (K",
            "probability": 0.004219438067026714,
            "start_logit": 4.4429850578308105,
            "end_logit": -0.8067899346351624,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "pS-X-X-S,a novel consensus phosphorylation motif (K/R-X-K/R-X",
            "probability": 0.003645820819594968,
            "start_logit": 4.4429850578308105,
            "end_logit": -0.9529103636741638,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "K",
            "probability": 0.003550850116453996,
            "start_logit": 4.270470142364502,
            "end_logit": -0.8067899346351624,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "K/R-X-K/R-X-X",
            "probability": 0.0031749004700580407,
            "start_logit": 4.270470142364502,
            "end_logit": -0.9187006950378418,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "K/R-X-K/R-X",
            "probability": 0.00306812496739681,
            "start_logit": 4.270470142364502,
            "end_logit": -0.9529103636741638,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "pS",
            "probability": 0.0024386239847536415,
            "start_logit": 4.4429850578308105,
            "end_logit": -1.355057954788208,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "pS-X-X-S,a novel consensus phosphorylation motif (K/R-X-K",
            "probability": 0.00201199391707114,
            "start_logit": 4.4429850578308105,
            "end_logit": -1.547365665435791,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "R-X-K/R-X-X-S/T",
            "probability": 0.0018866849249874705,
            "start_logit": -0.572487473487854,
            "end_logit": 3.403801918029785,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "pS-X-X",
            "probability": 0.001746317297601278,
            "start_logit": 4.4429850578308105,
            "end_logit": -1.6889827251434326,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "consensus motif of pS-X-X-S",
            "probability": 0.0017398564237937082,
            "start_logit": -1.4029673337936401,
            "end_logit": 4.153263092041016,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        }
    ],
    "56bb616dac7ad10019000008": [
        {
            "text": "Rivaroxaban",
            "probability": 0.7752047105478076,
            "start_logit": 5.359976291656494,
            "end_logit": 5.39609432220459,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban to be noninferior to warfarin",
            "probability": 0.06408770364869622,
            "start_logit": 4.215317726135254,
            "end_logit": 4.047878265380859,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfarin",
            "probability": 0.05408524586412709,
            "start_logit": 4.045626640319824,
            "end_logit": 4.047878265380859,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban",
            "probability": 0.046338071792090096,
            "start_logit": 4.215317726135254,
            "end_logit": 3.7235896587371826,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfarin). This review focuses on the direct Factor Xa inhibitor rivaroxaban",
            "probability": 0.0131544799535778,
            "start_logit": 3.631589412689209,
            "end_logit": 3.048116445541382,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban or warfarin",
            "probability": 0.012001038203942582,
            "start_logit": 3.403907299041748,
            "end_logit": 3.1840293407440186,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism",
            "probability": 0.01115208417355152,
            "start_logit": 5.359976291656494,
            "end_logit": 1.154593586921692,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban, summarizing the properties that make rivaroxaban",
            "probability": 0.011051591921149935,
            "start_logit": 3.2939751148223877,
            "end_logit": 3.211542844772339,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban or warfarin). This review focuses on the direct Factor Xa inhibitor rivaroxaban",
            "probability": 0.010475930242567334,
            "start_logit": 3.403907299041748,
            "end_logit": 3.048116445541382,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial",
            "probability": 0.000836228440585438,
            "start_logit": 5.359976291656494,
            "end_logit": -1.435886263847351,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "ban",
            "probability": 0.00040393844905660273,
            "start_logit": -2.199643611907959,
            "end_logit": 5.39609432220459,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke",
            "probability": 0.0003468329263866286,
            "start_logit": 5.359976291656494,
            "end_logit": -2.3159449100494385,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban versus warfarin",
            "probability": 0.00017094608419963197,
            "start_logit": 1.1947487592697144,
            "end_logit": 1.1417876482009888,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "R",
            "probability": 0.0001419464883738874,
            "start_logit": 5.359976291656494,
            "end_logit": -3.2093379497528076,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfarin). This review focuses on the direct Factor Xa inhibitor rivaroxaban,",
            "probability": 0.0001222878553290058,
            "start_logit": 3.631589412689209,
            "end_logit": -1.63002347946167,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Vitamin K Antagonism",
            "probability": 0.00011777310481041768,
            "start_logit": 0.8093545436859131,
            "end_logit": 1.154593586921692,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition",
            "probability": 0.0001047655400529269,
            "start_logit": 5.359976291656494,
            "end_logit": -3.5130631923675537,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban or warfarin). This review focuses on the direct Factor Xa inhibitor rivaroxaban,",
            "probability": 9.738728147830718e-05,
            "start_logit": 3.403907299041748,
            "end_logit": -1.63002347946167,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban,",
            "probability": 8.724876773466955e-05,
            "start_logit": 3.2939751148223877,
            "end_logit": -1.63002347946167,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "ban to be noninferior to warfarin",
            "probability": 1.9788714482412966e-05,
            "start_logit": -3.8675782680511475,
            "end_logit": 4.047878265380859,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        }
    ],
    "56b3a3ce8525abca1e000005": [
        {
            "text": "perilipin",
            "probability": 0.15377997152734957,
            "start_logit": 2.126375675201416,
            "end_logit": 1.704638123512268,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin, adipophilin",
            "probability": 0.11737427400401089,
            "start_logit": 2.126375675201416,
            "end_logit": 1.4344830513000488,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "adipophilin",
            "probability": 0.11070963295632613,
            "start_logit": 2.0679187774658203,
            "end_logit": 1.4344830513000488,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin family of lipid droplet coat proteins [perilipin",
            "probability": 0.07668256432244418,
            "start_logit": 1.4305272102355957,
            "end_logit": 1.704638123512268,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "lipid storage droplet protein 5 (LSDP5",
            "probability": 0.059777489856738954,
            "start_logit": 2.153099536895752,
            "end_logit": 0.7330206036567688,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "lipid storage droplet protein 5",
            "probability": 0.05975489391766152,
            "start_logit": 2.153099536895752,
            "end_logit": 0.7326425313949585,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin family of lipid droplet coat proteins [perilipin, adipophilin",
            "probability": 0.058528820279512235,
            "start_logit": 1.4305272102355957,
            "end_logit": 1.4344830513000488,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipins 2, 3, 4, and 5) between treatments. This study investigated the lipid droplet coat proteins perilipin",
            "probability": 0.04970061510348201,
            "start_logit": 2.161771297454834,
            "end_logit": 0.5397369861602783,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin, adipophilin/adipocyte differentiation-related protein (ADRP",
            "probability": 0.041048532820373906,
            "start_logit": 2.126375675201416,
            "end_logit": 0.383870393037796,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "adipophilin/adipocyte differentiation-related protein (ADRP",
            "probability": 0.0387177517433165,
            "start_logit": 2.0679187774658203,
            "end_logit": 0.383870393037796,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "myocardial lipid droplet protein (MLDP)/oxidative tissues-enriched PAT",
            "probability": 0.031418387290758736,
            "start_logit": 1.0944150686264038,
            "end_logit": 1.1484692096710205,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin, adipophilin/adipocyte differentiation-related protein",
            "probability": 0.030853631426519826,
            "start_logit": 2.126375675201416,
            "end_logit": 0.09836975485086441,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "adipophilin/adipocyte differentiation-related protein",
            "probability": 0.029101728122152684,
            "start_logit": 2.0679187774658203,
            "end_logit": 0.09836975485086441,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "adipocyte differentiation-related protein (ADRP",
            "probability": 0.026221965197838145,
            "start_logit": 1.6782180070877075,
            "end_logit": 0.383870393037796,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin, adipophilin/adipocyte differentiation-related protein (ADRP)",
            "probability": 0.022396588412423906,
            "start_logit": 2.126375675201416,
            "end_logit": -0.22197605669498444,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "adipophilin/adipocyte differentiation-related protein (ADRP)",
            "probability": 0.021124885360557184,
            "start_logit": 2.0679187774658203,
            "end_logit": -0.22197605669498444,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "adipocyte differentiation-related protein",
            "probability": 0.01970942184543975,
            "start_logit": 1.6782180070877075,
            "end_logit": 0.09836975485086441,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 1 (PLIN1) and perilipin",
            "probability": 0.019419197484169856,
            "start_logit": 1.298187017440796,
            "end_logit": 0.4635660946369171,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin A, adipose differentiation-related protein (ADFP), and LSDP5",
            "probability": 0.017117095554276356,
            "start_logit": 1.4200384616851807,
            "end_logit": 0.21553021669387817,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin, adipophilin/adipocyte differentiation-related protein (ADRP), S3-12",
            "probability": 0.016562552774647205,
            "start_logit": 2.126375675201416,
            "end_logit": -0.5237404108047485,
            "question_text": "List proteins of lipids droplets"
        }
    ],
    "535d59349a4572de6f000009": [
        {
            "text": "iron-restricted anemia",
            "probability": 0.1567955742373221,
            "start_logit": 6.136446475982666,
            "end_logit": 5.631988048553467,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "chronic kidney disease",
            "probability": 0.13528345879586043,
            "start_logit": 5.834605693817139,
            "end_logit": 5.786258220672607,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "cancer, or chronic kidney disease",
            "probability": 0.11921367149144607,
            "start_logit": 5.708150863647461,
            "end_logit": 5.786258220672607,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia of inflammation, cancer, or chronic kidney disease",
            "probability": 0.1093345041906147,
            "start_logit": 5.621645450592041,
            "end_logit": 5.786258220672607,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron-restricted anemias such as anemia of inflammation, cancer, or chronic kidney disease",
            "probability": 0.08815294539679132,
            "start_logit": 5.406306743621826,
            "end_logit": 5.786258220672607,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron-restricted anemiashuman anti-hepcidin antibody as a novel therapeutic for iron-restricted anemias",
            "probability": 0.07662476984024118,
            "start_logit": 6.136446475982666,
            "end_logit": 4.915965557098389,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia of inflammation",
            "probability": 0.04397398549325518,
            "start_logit": 5.621645450592041,
            "end_logit": 4.875444412231445,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "cancer",
            "probability": 0.039068587805942856,
            "start_logit": 5.708150863647461,
            "end_logit": 4.67065954208374,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron-restricted anemias",
            "probability": 0.03692100602980714,
            "start_logit": 5.406306743621826,
            "end_logit": 4.915965557098389,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia of inflammation, cancer",
            "probability": 0.03583099676195069,
            "start_logit": 5.621645450592041,
            "end_logit": 4.67065954208374,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron-restricted anemias such as anemia of inflammation",
            "probability": 0.03545483075779998,
            "start_logit": 5.406306743621826,
            "end_logit": 4.875444412231445,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron-restricted anemias such as anemia of inflammation, cancer",
            "probability": 0.028889397033914396,
            "start_logit": 5.406306743621826,
            "end_logit": 4.67065954208374,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "hemodialysis.Anti-hepcidin therapy for iron-restricted anemia",
            "probability": 0.02661450233445838,
            "start_logit": 4.362959861755371,
            "end_logit": 5.631988048553467,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemias such as anemia of inflammation, cancer, or chronic kidney disease",
            "probability": 0.017893864027257216,
            "start_logit": 3.8116912841796875,
            "end_logit": 5.786258220672607,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia",
            "probability": 0.01067561233687144,
            "start_logit": 3.44946551322937,
            "end_logit": 5.631988048553467,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia management in hemodialysis.Anti-hepcidin therapy for iron-restricted anemia",
            "probability": 0.009718332320787207,
            "start_logit": 3.355517625808716,
            "end_logit": 5.631988048553467,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "hemodialysis",
            "probability": 0.007515883583594051,
            "start_logit": 4.362959861755371,
            "end_logit": 4.367550373077393,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemias",
            "probability": 0.007494468377354526,
            "start_logit": 3.8116912841796875,
            "end_logit": 4.915965557098389,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "inflammation, cancer, or chronic kidney disease",
            "probability": 0.007346754696956112,
            "start_logit": 2.921492099761963,
            "end_logit": 5.786258220672607,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemias such as anemia of inflammation",
            "probability": 0.0071968544877750885,
            "start_logit": 3.8116912841796875,
            "end_logit": 4.875444412231445,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        }
    ],
    "56c1d84cef6e394741000031": [
        {
            "text": "brainstem reflexes",
            "probability": 0.15649702911695004,
            "start_logit": 5.031261920928955,
            "end_logit": 4.8437910079956055,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "brainstem reflexes and respiratory pattern",
            "probability": 0.11454345367010393,
            "start_logit": 5.031261920928955,
            "end_logit": 4.531708240509033,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor function",
            "probability": 0.1030945164769046,
            "start_logit": 4.532454013824463,
            "end_logit": 4.92520809173584,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor function, brainstem reflexes",
            "probability": 0.09503346753634061,
            "start_logit": 4.532454013824463,
            "end_logit": 4.8437910079956055,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye reaction, motor function",
            "probability": 0.08985977002616373,
            "start_logit": 4.3950581550598145,
            "end_logit": 4.92520809173584,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye reaction, motor function, brainstem reflexes",
            "probability": 0.08283355729708029,
            "start_logit": 4.3950581550598145,
            "end_logit": 4.8437910079956055,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor function, brainstem reflexes and respiratory pattern",
            "probability": 0.0695569855049674,
            "start_logit": 4.532454013824463,
            "end_logit": 4.531708240509033,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye reaction, motor function, brainstem reflexes and respiratory pattern",
            "probability": 0.060627615655870465,
            "start_logit": 4.3950581550598145,
            "end_logit": 4.531708240509033,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "respiratory pattern",
            "probability": 0.059762970730753304,
            "start_logit": 4.3806939125061035,
            "end_logit": 4.531708240509033,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye reaction",
            "probability": 0.055251317079232615,
            "start_logit": 4.3950581550598145,
            "end_logit": 4.438849925994873,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "brainstem reflexes and respiration",
            "probability": 0.025505535693000257,
            "start_logit": 4.153420925140381,
            "end_logit": 3.9074904918670654,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "brainstem reflexes, and respiration",
            "probability": 0.02436503683656087,
            "start_logit": 4.1711745262146,
            "end_logit": 3.8439905643463135,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "respiration",
            "probability": 0.013587114736879818,
            "start_logit": 3.5236473083496094,
            "end_logit": 3.9074904918670654,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye and motor responses, brainstem reflexes and respiration",
            "probability": 0.010282549642561412,
            "start_logit": 3.244973659515381,
            "end_logit": 3.9074904918670654,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor response, brainstem reflexes, and respiration",
            "probability": 0.007900214106728778,
            "start_logit": 3.044915199279785,
            "end_logit": 3.8439905643463135,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye and motor response, brainstem reflexes, and respiration",
            "probability": 0.007555555916295351,
            "start_logit": 3.0003085136413574,
            "end_logit": 3.8439905643463135,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye and motor responses, brainstem reflexes",
            "probability": 0.007193912833574559,
            "start_logit": 3.244973659515381,
            "end_logit": 3.5502774715423584,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor response, brainstem reflexes",
            "probability": 0.00601473302046402,
            "start_logit": 3.044915199279785,
            "end_logit": 3.571312665939331,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye and motor response, brainstem reflexes",
            "probability": 0.005752331651239398,
            "start_logit": 3.0003085136413574,
            "end_logit": 3.571312665939331,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor responses, brainstem reflexes and respiration",
            "probability": 0.004782332468328272,
            "start_logit": 2.4794538021087646,
            "end_logit": 3.9074904918670654,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        }
    ],
    "5713bf261174fb1755000011": [
        {
            "text": "ear",
            "probability": 0.4289292892735931,
            "start_logit": 2.2026243209838867,
            "end_logit": 2.9898905754089355,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "ear via 3D printing of a cell-seeded hydrogel matrix in the anatomic geometry of a human ear",
            "probability": 0.40639982968689115,
            "start_logit": 2.2026243209838867,
            "end_logit": 2.9359359741210938,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "ear, which subsequently enables readout of inductively-coupled signals from cochlea-shaped electrodes. The printed ear",
            "probability": 0.03352171799722983,
            "start_logit": 1.9845532178878784,
            "end_logit": 0.6588631272315979,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "human ear",
            "probability": 0.032725570090968534,
            "start_logit": -0.3165564239025116,
            "end_logit": 2.9359359741210938,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "meniscus",
            "probability": 0.01755613985473118,
            "start_logit": 1.6963036060333252,
            "end_logit": 0.300322949886322,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "bionic ear",
            "probability": 0.013428042701796566,
            "start_logit": -1.2613224983215332,
            "end_logit": 2.9898905754089355,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "cartilage was prepared to illustrate the potential application in bioengineering.As a proof of concept, we generated a bionic ear",
            "probability": 0.013093840279629652,
            "start_logit": -1.286525845527649,
            "end_logit": 2.9898905754089355,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "meniscus cartilage",
            "probability": 0.012877998456543544,
            "start_logit": 1.6963036060333252,
            "end_logit": -0.00956047885119915,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "bionic ear via 3D printing of a cell-seeded hydrogel matrix in the anatomic geometry of a human ear",
            "probability": 0.012722736365894506,
            "start_logit": -1.2613224983215332,
            "end_logit": 2.9359359741210938,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "cartilage tissue around an inductive coil antenna in the ear",
            "probability": 0.006106769818267003,
            "start_logit": -1.6081575155258179,
            "end_logit": 2.5487782955169678,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "ear, which subsequently enables readout of inductively-coupled signals from cochlea",
            "probability": 0.0028609225686977557,
            "start_logit": 1.9845532178878784,
            "end_logit": -1.8021862506866455,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "head and neck cartilaginous reconstruction for auricular and nasal",
            "probability": 0.00284905302092298,
            "start_logit": 0.36444342136383057,
            "end_logit": -0.18623393774032593,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "ear,",
            "probability": 0.0028159936468089754,
            "start_logit": 2.225553035736084,
            "end_logit": -2.0590150356292725,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "ear via 3D printing of a cell-seeded hydrogel matrix in the anatomic geometry of a human ear,",
            "probability": 0.0027521611270657376,
            "start_logit": 2.2026243209838867,
            "end_logit": -2.0590150356292725,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "auricular scaffolds that supported cartilage regeneration.A prototype meniscus",
            "probability": 0.0022778283576756373,
            "start_logit": -0.34587761759757996,
            "end_logit": 0.300322949886322,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "auricular and nasal",
            "probability": 0.0019976343287379746,
            "start_logit": 0.009420400485396385,
            "end_logit": -0.18623393774032593,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "head and neck",
            "probability": 0.0018687347010360514,
            "start_logit": 0.36444342136383057,
            "end_logit": -0.6079590320587158,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "nasal",
            "probability": 0.0018244813560276184,
            "start_logit": -0.0812474861741066,
            "end_logit": -0.18623393774032593,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "cartilage regeneration.A prototype meniscus",
            "probability": 0.001720395328714957,
            "start_logit": -0.6265460252761841,
            "end_logit": 0.300322949886322,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "auricular scaffolds that supported cartilage regeneration.A prototype meniscus cartilage",
            "probability": 0.0016708610387671772,
            "start_logit": -0.34587761759757996,
            "end_logit": -0.00956047885119915,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        }
    ],
    "5503263fe9bde69634000030": [
        {
            "text": "congenital cataracts",
            "probability": 0.2664698683604024,
            "start_logit": 5.475749492645264,
            "end_logit": 5.321340084075928,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts facial dysmorphism",
            "probability": 0.1658804577121577,
            "start_logit": 5.475749492645264,
            "end_logit": 4.847346305847168,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts facial dysmorphism syndrome",
            "probability": 0.15533232649820883,
            "start_logit": 5.475749492645264,
            "end_logit": 4.781645774841309,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "facial dysmorphism",
            "probability": 0.1190606316699316,
            "start_logit": 5.144114971160889,
            "end_logit": 4.847346305847168,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "facial dysmorphism syndrome",
            "probability": 0.11148971474221667,
            "start_logit": 5.144114971160889,
            "end_logit": 4.781645774841309,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts facial dysmorphism syndrome (CCFDN), limb-girdle muscular dystrophy",
            "probability": 0.03309728407294881,
            "start_logit": 5.475749492645264,
            "end_logit": 3.235530138015747,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts facial dysmorphism neuropathy",
            "probability": 0.028877401918633888,
            "start_logit": 4.438144207000732,
            "end_logit": 4.136743545532227,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "facial dysmorphism syndrome (CCFDN), limb-girdle muscular dystrophy",
            "probability": 0.023755562304525992,
            "start_logit": 5.144114971160889,
            "end_logit": 3.235530138015747,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "facial dysmorphism neuropathy",
            "probability": 0.023035678606847673,
            "start_logit": 4.21212911605835,
            "end_logit": 4.136743545532227,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "hereditary motor and sensory neuropathy type Russe (HMSNR), congenital cataracts",
            "probability": 0.01539048491893779,
            "start_logit": 2.6242377758026123,
            "end_logit": 5.321340084075928,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "hereditary motor and sensory neuropathy type Russe (HMSNR), congenital cataracts facial dysmorphism",
            "probability": 0.00958074809160988,
            "start_logit": 2.6242377758026123,
            "end_logit": 4.847346305847168,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "hereditary motor and sensory neuropathy type Russe (HMSNR), congenital cataracts facial dysmorphism syndrome",
            "probability": 0.008971520281463294,
            "start_logit": 2.6242377758026123,
            "end_logit": 4.781645774841309,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital myasthenic syndrome (CMS) and spinal muscular atrophy (SMA).The congenital cataracts",
            "probability": 0.008154669262311948,
            "start_logit": 3.0692129135131836,
            "end_logit": 4.241206169128418,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "limb-girdle muscular dystrophy",
            "probability": 0.006992279712379588,
            "start_logit": 3.921104907989502,
            "end_logit": 3.235530138015747,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "Congenital cataracts-facial dysmorphism",
            "probability": 0.004367678131835792,
            "start_logit": 3.227303981781006,
            "end_logit": 3.4587559700012207,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "Congenital cataracts",
            "probability": 0.004196048012086058,
            "start_logit": 3.227303981781006,
            "end_logit": 3.4186675548553467,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "spinal muscular atrophy (SMA).The congenital cataracts",
            "probability": 0.004012868837844272,
            "start_logit": 2.36012864112854,
            "end_logit": 4.241206169128418,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "limb-girdle muscular dystrophy 2C (LGMD2C), congenital myasthenic syndrome",
            "probability": 0.0038926388497337004,
            "start_logit": 3.921104907989502,
            "end_logit": 2.649810791015625,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "spinal muscular atrophy (SMA).The congenital cataracts facial dysmorphism",
            "probability": 0.0038273117948148805,
            "start_logit": 2.36012864112854,
            "end_logit": 4.193862438201904,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "spinal muscular atrophy (SMA).The congenital cataracts facial dysmorphism neuropathy",
            "probability": 0.003614826221109191,
            "start_logit": 2.36012864112854,
            "end_logit": 4.136743545532227,
            "question_text": "List three major features of the CCFDN syndrome."
        }
    ],
    "5309f8f5970c65fa6b000001": [
        {
            "text": "Ras",
            "probability": 0.3288559772115066,
            "start_logit": 4.887371063232422,
            "end_logit": 4.684962749481201,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "c-Abl",
            "probability": 0.09533673258948992,
            "start_logit": 4.505672931671143,
            "end_logit": 3.828456163406372,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "c-Abl in cell senescence and spontaneous immortalizationHere, we report an important role for c-Abl",
            "probability": 0.09524231329490712,
            "start_logit": 4.505672931671143,
            "end_logit": 3.827465295791626,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras-induced premature senescenceA role for c-Abl",
            "probability": 0.09271901819539115,
            "start_logit": 4.4778313636779785,
            "end_logit": 3.828456163406372,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4 contribute to oncogenic Ras",
            "probability": 0.0626228776111716,
            "start_logit": 3.144134998321533,
            "end_logit": 4.769709587097168,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1 and Nox4 contribute to oncogenic Ras",
            "probability": 0.058492657381614785,
            "start_logit": 3.0759055614471436,
            "end_logit": 4.769709587097168,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras-induced premature senescence.these findings suggest that Nox1",
            "probability": 0.04307213219958278,
            "start_logit": 4.887371063232422,
            "end_logit": 2.65221905708313,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1- and Nox4-generated ROS play an important role in Ras",
            "probability": 0.041607809014386696,
            "start_logit": 3.1884095668792725,
            "end_logit": 4.316592216491699,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras-induced premature senescence.these findings suggest that Nox1- and Nox4",
            "probability": 0.03954587208922212,
            "start_logit": 4.887371063232422,
            "end_logit": 2.5668041706085205,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4-generated ROS play an important role in Ras",
            "probability": 0.027534594845562883,
            "start_logit": 2.7755649089813232,
            "end_logit": 4.316592216491699,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras-induced premature senescence.these findings suggest that Nox1- and Nox4-generated ROS",
            "probability": 0.02626614048342839,
            "start_logit": 4.887371063232422,
            "end_logit": 2.157623529434204,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "ROS play an important role in Ras",
            "probability": 0.022443936668281393,
            "start_logit": 2.5711421966552734,
            "end_logit": 4.316592216491699,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4-generated ROS play an important role in Ras-induced premature senescenceA role for c-Abl",
            "probability": 0.01689989071532589,
            "start_logit": 2.7755649089813232,
            "end_logit": 3.828456163406372,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "ROS play an important role in Ras-induced premature senescenceA role for c-Abl",
            "probability": 0.01377540069294951,
            "start_logit": 2.5711421966552734,
            "end_logit": 3.828456163406372,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1",
            "probability": 0.007876744680736774,
            "start_logit": 3.1884095668792725,
            "end_logit": 2.65221905708313,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1- and Nox4",
            "probability": 0.007231885716279781,
            "start_logit": 3.1884095668792725,
            "end_logit": 2.5668041706085205,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4",
            "probability": 0.006459997228916258,
            "start_logit": 3.144134998321533,
            "end_logit": 2.4982078075408936,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1 and Nox4",
            "probability": 0.006033935504263235,
            "start_logit": 3.0759055614471436,
            "end_logit": 2.4982078075408936,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1- and Nox4-generated ROS",
            "probability": 0.0048033768418442365,
            "start_logit": 3.1884095668792725,
            "end_logit": 2.157623529434204,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4-generated ROS",
            "probability": 0.003178707035138749,
            "start_logit": 2.7755649089813232,
            "end_logit": 2.157623529434204,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        }
    ],
    "5517f9286487737b43000002": [
        {
            "text": "junctin",
            "probability": 0.20310048386043186,
            "start_logit": 5.131085395812988,
            "end_logit": 4.309201240539551,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctate",
            "probability": 0.17179115260793143,
            "start_logit": 5.203120708465576,
            "end_logit": 4.06974458694458,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin, and the membrane-bound calcium binding protein junctate",
            "probability": 0.15985133025453985,
            "start_logit": 5.131085395812988,
            "end_logit": 4.06974458694458,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin and junctate",
            "probability": 0.15615225000763908,
            "start_logit": 5.040829181671143,
            "end_logit": 4.136588096618652,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "AbetaH), the structural protein of sarcoplasmic reticulum junctin",
            "probability": 0.07834467598544187,
            "start_logit": 4.178502559661865,
            "end_logit": 4.309201240539551,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "AbetaH)",
            "probability": 0.032095446734226096,
            "start_logit": 4.178502559661865,
            "end_logit": 3.416797399520874,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "AbetaH",
            "probability": 0.03155254124579516,
            "start_logit": 4.178502559661865,
            "end_logit": 3.3997373580932617,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "aspartyl beta-hydroxylase, junctin",
            "probability": 0.023998757439181933,
            "start_logit": 2.9827375411987305,
            "end_logit": 4.321850299835205,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "aspartyl beta-hydroxylase, junctin and junctate",
            "probability": 0.019940241033983275,
            "start_logit": 2.9827375411987305,
            "end_logit": 4.136588096618652,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "aspartyl-beta-hydroxylase (AbetaH)",
            "probability": 0.019871193109157543,
            "start_logit": 3.69905948638916,
            "end_logit": 3.416797399520874,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "aspartyl-beta-hydroxylase (AbetaH",
            "probability": 0.019535065063021693,
            "start_logit": 3.69905948638916,
            "end_logit": 3.3997373580932617,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin), and an integral membrane calcium binding protein (junctate",
            "probability": 0.01568287158862387,
            "start_logit": 4.21711540222168,
            "end_logit": 2.6620395183563232,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "aspartyl-beta-hydroxylase",
            "probability": 0.015633965949184103,
            "start_logit": 3.69905948638916,
            "end_logit": 3.1769721508026123,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "AbetaH-J-J, encodes three functionally distinct proteins aspartyl beta-hydroxylase, junctin",
            "probability": 0.01459458614026047,
            "start_logit": 2.4853861331939697,
            "end_logit": 4.321850299835205,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "aspartyl beta-hydroxylase",
            "probability": 0.010895069734906242,
            "start_logit": 2.9827375411987305,
            "end_logit": 3.532158613204956,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "(AbetaH), the structural protein of sarcoplasmic reticulum junctin",
            "probability": 0.007769360691761025,
            "start_logit": 1.8675724267959595,
            "end_logit": 4.309201240539551,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "AbetaH-J-J, encodes three functionally distinct proteins aspartyl beta-hydroxylase",
            "probability": 0.006625719442066839,
            "start_logit": 2.4853861331939697,
            "end_logit": 3.532158613204956,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin,",
            "probability": 0.006253383807477813,
            "start_logit": 5.131085395812988,
            "end_logit": 0.8286231160163879,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "(AbetaH)",
            "probability": 0.0031828723407796417,
            "start_logit": 1.8675724267959595,
            "end_logit": 3.416797399520874,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "(AbetaH",
            "probability": 0.003129032963590304,
            "start_logit": 1.8675724267959595,
            "end_logit": 3.3997373580932617,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        }
    ],
    "56d1d94667f0cb3d66000005": [
        {
            "text": "cancer development",
            "probability": 0.35835786938452585,
            "start_logit": 4.5277228355407715,
            "end_logit": 4.651061534881592,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size control and cancer development",
            "probability": 0.28683546939799465,
            "start_logit": 4.3050994873046875,
            "end_logit": 4.651061534881592,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size control",
            "probability": 0.22974010833349567,
            "start_logit": 4.3050994873046875,
            "end_logit": 4.429101467132568,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size",
            "probability": 0.050816320845891494,
            "start_logit": 4.3050994873046875,
            "end_logit": 2.92037034034729,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cancer",
            "probability": 0.028986315569019386,
            "start_logit": 4.5277228355407715,
            "end_logit": 2.1363532543182373,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size control and cancer",
            "probability": 0.023201118609834814,
            "start_logit": 4.3050994873046875,
            "end_logit": 2.1363532543182373,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cell proliferation",
            "probability": 0.006578274925831529,
            "start_logit": 2.801297664642334,
            "end_logit": 2.3797271251678467,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cell proliferation YAP and TAZ oncoproteins confer malignancy",
            "probability": 0.004203532214537264,
            "start_logit": 2.801297664642334,
            "end_logit": 1.9318797588348389,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cell proliferation YAP and TAZ oncoproteins confer malignancy and drug resistance",
            "probability": 0.0017252038827829921,
            "start_logit": 2.801297664642334,
            "end_logit": 1.041299819946289,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "development",
            "probability": 0.0013376479314332129,
            "start_logit": -1.062896490097046,
            "end_logit": 4.651061534881592,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size, and cancer development",
            "probability": 0.0010915437827175465,
            "start_logit": 1.0548384189605713,
            "end_logit": 2.3300068378448486,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cell proliferation YAP and TAZ oncoproteins confer malignancy and drug resistance to various cancer",
            "probability": 0.0010438104400553815,
            "start_logit": 2.801297664642334,
            "end_logit": 0.5388324856758118,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "Hippo pathway, which plays a critical role in organ size control and cancer development",
            "probability": 0.0009628026353371125,
            "start_logit": -1.3917161226272583,
            "end_logit": 4.651061534881592,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cancer development. The Hippo signaling pathway converges on YAP to regulate growth, differentiation",
            "probability": 0.0009077174807258267,
            "start_logit": 2.1886982917785645,
            "end_logit": 1.0117318630218506,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cancer development. The Hippo signaling pathway converges on YAP to regulate growth, differentiation, and regeneration",
            "probability": 0.0008392308718906623,
            "start_logit": 2.1886982917785645,
            "end_logit": 0.9332845211029053,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "Hippo pathway, which plays a critical role in organ size control",
            "probability": 0.0007711542167722922,
            "start_logit": -1.3917161226272583,
            "end_logit": 4.429101467132568,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "tissue homeostasis, organ size, and cancer development",
            "probability": 0.0007532091397765995,
            "start_logit": 0.6838330626487732,
            "end_logit": 2.3300068378448486,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cell proliferation YAP and TAZ oncoproteins confer malignancy and drug resistance to various cancer types",
            "probability": 0.000747141725916091,
            "start_logit": 2.801297664642334,
            "end_logit": 0.2044541984796524,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "malignancy",
            "probability": 0.0007155796336971046,
            "start_logit": 1.0307101011276245,
            "end_logit": 1.9318797588348389,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "proliferation",
            "probability": 0.0003859489777645663,
            "start_logit": -0.03452497720718384,
            "end_logit": 2.3797271251678467,
            "question_text": "List processes which are under the control of the YAP protein."
        }
    ],
    "56d29d4df22319765a000003": [
        {
            "text": "Proteomics",
            "probability": 0.20812287234738808,
            "start_logit": 3.360973834991455,
            "end_logit": 3.836951494216919,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics",
            "probability": 0.1318223908157374,
            "start_logit": 3.292205333709717,
            "end_logit": 3.4490468502044678,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics and proteomics",
            "probability": 0.12208629150697513,
            "start_logit": 3.21547794342041,
            "end_logit": 3.4490468502044678,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics",
            "probability": 0.12131971354947817,
            "start_logit": 3.21547794342041,
            "end_logit": 3.4427480697631836,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "Metabolomics complements other omics, such as transcriptomics and proteomics",
            "probability": 0.05261882996838003,
            "start_logit": 2.373823881149292,
            "end_logit": 3.4490468502044678,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "Metabolomics complements other omics, such as transcriptomics",
            "probability": 0.0522884371396263,
            "start_logit": 2.373823881149292,
            "end_logit": 3.4427480697631836,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "integrated omics",
            "probability": 0.05112369260747573,
            "start_logit": 2.3404667377471924,
            "end_logit": 3.453577995300293,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics to integrated omics",
            "probability": 0.05032366584857804,
            "start_logit": 2.3246941566467285,
            "end_logit": 3.453577995300293,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, and proteomics provide greater understanding of global system biology.From proteomics to integrated omics",
            "probability": 0.04253205555102897,
            "start_logit": 2.1564767360687256,
            "end_logit": 3.453577995300293,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics provide greater understanding of global system biology.From proteomics to integrated omics",
            "probability": 0.03756521308420403,
            "start_logit": 2.032297134399414,
            "end_logit": 3.453577995300293,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "Metabolomics",
            "probability": 0.03295218771840604,
            "start_logit": 2.373823881149292,
            "end_logit": 2.9810304641723633,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, and proteomics provide greater understanding of global system biology.From proteomics",
            "probability": 0.022368238003096858,
            "start_logit": 2.1564767360687256,
            "end_logit": 2.810961961746216,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics provide greater understanding of global system biology.From proteomics",
            "probability": 0.01975610198045543,
            "start_logit": 2.032297134399414,
            "end_logit": 2.810961961746216,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "Proteomics technology",
            "probability": 0.014190917503175467,
            "start_logit": 3.360973834991455,
            "end_logit": 1.1514250040054321,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, and proteomics",
            "probability": 0.01071562525487622,
            "start_logit": 2.1564767360687256,
            "end_logit": 2.0750229358673096,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics, and proteomics provide greater understanding of global system biology.From proteomics",
            "probability": 0.008869682089412268,
            "start_logit": 1.231473684310913,
            "end_logit": 2.810961961746216,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "metabolomics in system biology is driving the development of tools for comprehensive analysis of high-resolution NMR spectral datasets.Proteomics",
            "probability": 0.008801857951073199,
            "start_logit": 0.19780802726745605,
            "end_logit": 3.836951494216919,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics",
            "probability": 0.005451247506926734,
            "start_logit": 1.231473684310913,
            "end_logit": 2.324167490005493,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics, and proteomics",
            "probability": 0.004249069121442226,
            "start_logit": 1.231473684310913,
            "end_logit": 2.0750229358673096,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "integrated",
            "probability": 0.002841910452263549,
            "start_logit": 2.3404667377471924,
            "end_logit": 0.5638064742088318,
            "question_text": "List omics technologies comprised in system biology."
        }
    ],
    "52ea605098d0239505000028": [
        {
            "text": "MYH7",
            "probability": 0.5372024425084875,
            "start_logit": 4.414862155914307,
            "end_logit": 3.5315535068511963,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "\u03b2-myosin heavy chain gene (MYH7",
            "probability": 0.1964781833948687,
            "start_logit": 3.409038543701172,
            "end_logit": 3.5315535068511963,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "MYH7)",
            "probability": 0.05772913688898038,
            "start_logit": 4.414862155914307,
            "end_logit": 1.3009405136108398,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "myosin heavy chain gene (MYH7",
            "probability": 0.0414753753816348,
            "start_logit": 1.853587031364441,
            "end_logit": 3.5315535068511963,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "\u03b2-myosin heavy chain",
            "probability": 0.026881525342480977,
            "start_logit": 3.409038543701172,
            "end_logit": 1.5424413681030273,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "\u03b2-myosin heavy chain gene",
            "probability": 0.024407863766243328,
            "start_logit": 3.409038543701172,
            "end_logit": 1.445907473564148,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "cardiac \u03b2-myosin heavy chain gene (MYH7",
            "probability": 0.02163588810084337,
            "start_logit": 1.2028405666351318,
            "end_logit": 3.5315535068511963,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "\u03b2-myosin heavy chain gene (MYH7)",
            "probability": 0.02111404388248172,
            "start_logit": 3.409038543701172,
            "end_logit": 1.3009405136108398,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "(MYH7",
            "probability": 0.015333591426717273,
            "start_logit": 0.8585330843925476,
            "end_logit": 3.5315535068511963,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "TPM1",
            "probability": 0.011233287865855071,
            "start_logit": 2.322154998779297,
            "end_logit": 1.7567671537399292,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "MYH7B",
            "probability": 0.009787445928523819,
            "start_logit": 2.9975733757019043,
            "end_logit": 0.9435678124427795,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "myosin heavy chain",
            "probability": 0.0056745300427052175,
            "start_logit": 1.853587031364441,
            "end_logit": 1.5424413681030273,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "TPM1 is associated with DCM and a lethal, early onset form of NCCMMutation in MYH7",
            "probability": 0.005594952125830401,
            "start_logit": 2.322154998779297,
            "end_logit": 1.0597504377365112,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "myosin heavy chain gene",
            "probability": 0.005152354803353617,
            "start_logit": 1.853587031364441,
            "end_logit": 1.445907473564148,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "TPM1 is associated with DCM and a lethal, early onset form of NCCMMutation in MYH7B",
            "probability": 0.004981256457091381,
            "start_logit": 2.322154998779297,
            "end_logit": 0.9435678124427795,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "myosin heavy chain gene (MYH7)",
            "probability": 0.0044570490255922725,
            "start_logit": 1.853587031364441,
            "end_logit": 1.3009405136108398,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "cardiac \u03b2-myosin heavy chain",
            "probability": 0.002960153968448658,
            "start_logit": 1.2028405666351318,
            "end_logit": 1.5424413681030273,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "alpha-tropomyosin",
            "probability": 0.0028881136831393475,
            "start_logit": 1.7488359212875366,
            "end_logit": 0.9718083143234253,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "cardiac \u03b2-myosin heavy chain gene",
            "probability": 0.0026877579999086136,
            "start_logit": 1.2028405666351318,
            "end_logit": 1.445907473564148,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "cardiac \u03b2-myosin heavy chain gene (MYH7)",
            "probability": 0.002325047406813522,
            "start_logit": 1.2028405666351318,
            "end_logit": 1.3009405136108398,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        }
    ],
    "5318367cb166e2b806000012": [
        {
            "text": "PINK1",
            "probability": 0.3634272602706438,
            "start_logit": 3.07429838180542,
            "end_logit": 3.186875581741333,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1 (PINK1",
            "probability": 0.26325541356119697,
            "start_logit": 2.7518439292907715,
            "end_logit": 3.186875581741333,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1",
            "probability": 0.06042433132282372,
            "start_logit": 2.7518439292907715,
            "end_logit": 1.7151427268981934,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "Parkin gene (PARK2",
            "probability": 0.036998723910270356,
            "start_logit": 2.155222177505493,
            "end_logit": 1.8212560415267944,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1)",
            "probability": 0.03437794055050648,
            "start_logit": 3.07429838180542,
            "end_logit": 0.8287115097045898,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PARK7 and PINK1",
            "probability": 0.029723760458078858,
            "start_logit": 1.6386059522628784,
            "end_logit": 2.1189355850219727,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PARK2",
            "probability": 0.028262824487603547,
            "start_logit": 1.8858860731124878,
            "end_logit": 1.8212560415267944,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "Parkin",
            "probability": 0.02758443079314081,
            "start_logit": 2.155222177505493,
            "end_logit": 1.5276241302490234,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1 (PINK1)",
            "probability": 0.024902311814105998,
            "start_logit": 2.7518439292907715,
            "end_logit": 0.8287115097045898,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PARK2, PARK7 and PINK1",
            "probability": 0.023673825031397082,
            "start_logit": 1.4110292196273804,
            "end_logit": 2.1189355850219727,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK",
            "probability": 0.018842673588138212,
            "start_logit": 3.07429838180542,
            "end_logit": 0.22742058336734772,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1) gene",
            "probability": 0.016922768312225916,
            "start_logit": 3.07429838180542,
            "end_logit": 0.1199563667178154,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1 (PINK",
            "probability": 0.013649047196817152,
            "start_logit": 2.7518439292907715,
            "end_logit": 0.22742058336734772,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PARK7",
            "probability": 0.012519506010214298,
            "start_logit": 1.6386059522628784,
            "end_logit": 1.2542767524719238,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1 (PINK1) gene",
            "probability": 0.012258327477464715,
            "start_logit": 2.7518439292907715,
            "end_logit": 0.1199563667178154,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PARK2, PARK7",
            "probability": 0.009971302089563865,
            "start_logit": 1.4110292196273804,
            "end_logit": 1.2542767524719238,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PARK9",
            "probability": 0.006154410011123453,
            "start_logit": 1.130316138267517,
            "end_logit": 1.0524475574493408,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PARK6), or DJ-1 (PARK7",
            "probability": 0.006055393745778993,
            "start_logit": 1.0964053869247437,
            "end_logit": 1.0701388120651245,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "DJ-1 (PARK7",
            "probability": 0.005969338887245699,
            "start_logit": 1.0820921659469604,
            "end_logit": 1.0701388120651245,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PLA2G6 (PARK14",
            "probability": 0.005026410481659763,
            "start_logit": 1.3142086267471313,
            "end_logit": 0.6660922765731812,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        }
    ],
    "56be06cdef6e394741000004": [
        {
            "text": "chorioretinitis",
            "probability": 0.24062805464435816,
            "start_logit": 4.805959224700928,
            "end_logit": 5.15128231048584,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephaly, chorioretinitis",
            "probability": 0.1534422256266447,
            "start_logit": 4.3560309410095215,
            "end_logit": 5.15128231048584,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephaly",
            "probability": 0.11984370993668048,
            "start_logit": 4.3560309410095215,
            "end_logit": 4.904146671295166,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "retinochoroiditis",
            "probability": 0.0635099655189966,
            "start_logit": 4.030601978302002,
            "end_logit": 4.594583988189697,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "chorioretinitis and intracerebral calcifications",
            "probability": 0.052179744530237715,
            "start_logit": 4.805959224700928,
            "end_logit": 3.6227242946624756,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus, retinochoroiditis",
            "probability": 0.0502897127934054,
            "start_logit": 3.797205686569214,
            "end_logit": 4.594583988189697,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus",
            "probability": 0.04737179900912517,
            "start_logit": 3.797205686569214,
            "end_logit": 4.534810543060303,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "retinochoroiditis and encephalitis",
            "probability": 0.040939158626676936,
            "start_logit": 4.030601978302002,
            "end_logit": 4.1554741859436035,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "encephalitis",
            "probability": 0.038207513572495466,
            "start_logit": 3.9615471363067627,
            "end_logit": 4.1554741859436035,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "cerebral calcification and chorioretinitis",
            "probability": 0.036961981538412673,
            "start_logit": 3.835110664367676,
            "end_logit": 4.248768329620361,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephaly, chorioretinitis and intracerebral calcifications",
            "probability": 0.03327366023543232,
            "start_logit": 4.3560309410095215,
            "end_logit": 3.6227242946624756,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus, retinochoroiditis and encephalitis",
            "probability": 0.03241725156854998,
            "start_logit": 3.797205686569214,
            "end_logit": 4.1554741859436035,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus, cerebral calcification and chorioretinitis",
            "probability": 0.029041716034989288,
            "start_logit": 3.6051087379455566,
            "end_logit": 4.237613677978516,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "cerebral calcification",
            "probability": 0.023581870738066047,
            "start_logit": 3.835110664367676,
            "end_logit": 3.799356698989868,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "intracerebral calcifications",
            "probability": 0.018606804616808848,
            "start_logit": 3.774792194366455,
            "end_logit": 3.6227242946624756,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus, cerebral calcification",
            "probability": 0.017708804327981418,
            "start_logit": 3.548694372177124,
            "end_logit": 3.799356698989868,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephaly,",
            "probability": 0.0010209196874839534,
            "start_logit": 4.3560309410095215,
            "end_logit": 0.13866207003593445,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus,",
            "probability": 0.00039336880814398826,
            "start_logit": 3.797205686569214,
            "end_logit": -0.25622421503067017,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "chorioretinitis and intracerebral calcification",
            "probability": 0.0003552222405494928,
            "start_logit": 4.805959224700928,
            "end_logit": -1.3669817447662354,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephaly, chorioretinitis and intracerebral calcification",
            "probability": 0.00022651594496143052,
            "start_logit": 4.3560309410095215,
            "end_logit": -1.3669817447662354,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        }
    ],
    "515d1ff7298dcd4e51000009": [
        {
            "text": "invasion, and growth",
            "probability": 0.1251789923138808,
            "start_logit": 2.2093446254730225,
            "end_logit": 2.1181979179382324,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "invasion",
            "probability": 0.1242043086389638,
            "start_logit": 2.2093446254730225,
            "end_logit": 2.1103811264038086,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "morphology",
            "probability": 0.0991329941548771,
            "start_logit": 1.705371618270874,
            "end_logit": 2.3888885974884033,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "morphology, invasion, and growth",
            "probability": 0.0756238450648702,
            "start_logit": 1.705371618270874,
            "end_logit": 2.1181979179382324,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "morphology, invasion",
            "probability": 0.07503501361754271,
            "start_logit": 1.705371618270874,
            "end_logit": 2.1103811264038086,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell morphology",
            "probability": 0.061961705161604846,
            "start_logit": 1.2354258298873901,
            "end_logit": 2.3888885974884033,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "endoderm formationIn mammalian embryonic stem cells, the acquisition of pluripotency",
            "probability": 0.05947320913321169,
            "start_logit": 1.605308175086975,
            "end_logit": 1.978015661239624,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "invasion, and growth that plays a significant role in carcinogenesisNanog-like regulates endoderm formation",
            "probability": 0.051941094127201805,
            "start_logit": 2.2093446254730225,
            "end_logit": 1.2385635375976562,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell morphology, invasion, and growth",
            "probability": 0.04726763708736265,
            "start_logit": 1.2354258298873901,
            "end_logit": 2.1181979179382324,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell morphology, invasion",
            "probability": 0.046899596145593185,
            "start_logit": 1.2354258298873901,
            "end_logit": 2.1103811264038086,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "pluripotency",
            "probability": 0.04437201293167325,
            "start_logit": 1.3123911619186401,
            "end_logit": 1.978015661239624,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "growth",
            "probability": 0.03723969969733084,
            "start_logit": 0.9969753623008728,
            "end_logit": 2.1181979179382324,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "morphology, invasion, and growth that plays a significant role in carcinogenesisNanog-like regulates endoderm formation",
            "probability": 0.03137894931224642,
            "start_logit": 1.705371618270874,
            "end_logit": 1.2385635375976562,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "endoderm formation",
            "probability": 0.028391046200870372,
            "start_logit": 1.605308175086975,
            "end_logit": 1.2385635375976562,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell morphology, invasion, and growth that plays a significant role in carcinogenesisNanog-like regulates endoderm formation",
            "probability": 0.019612977718888976,
            "start_logit": 1.2354258298873901,
            "end_logit": 1.2385635375976562,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "acquisition of pluripotency",
            "probability": 0.016771165383671616,
            "start_logit": 0.33944329619407654,
            "end_logit": 1.978015661239624,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "growth that plays a significant role in carcinogenesisNanog-like regulates endoderm formation",
            "probability": 0.015452039607394276,
            "start_logit": 0.9969753623008728,
            "end_logit": 1.2385635375976562,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer stem cells.the effect of FAK and Nanog cross-regulation on cancer cell morphology",
            "probability": 0.014756001972978007,
            "start_logit": -0.19944079220294952,
            "end_logit": 2.3888885974884033,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "endoderm formationIn mammalian embryonic stem cells",
            "probability": 0.01405105983008737,
            "start_logit": 1.605308175086975,
            "end_logit": 0.5351875424385071,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer stem cells.the effect of FAK and Nanog cross-regulation on cancer cell morphology, invasion, and growth",
            "probability": 0.01125665189975005,
            "start_logit": -0.19944079220294952,
            "end_logit": 2.1181979179382324,
            "question_text": "Which cellular processes are regulated by Nanog?"
        }
    ],
    "56ed27202ac5ed145900000c": [
        {
            "text": "macrophages",
            "probability": 0.7824875805502278,
            "start_logit": 5.173020839691162,
            "end_logit": 3.944850444793701,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "macrophage",
            "probability": 0.14383675805610027,
            "start_logit": 5.173020839691162,
            "end_logit": 2.251051425933838,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "accessory cells and macrophages",
            "probability": 0.0428528557425687,
            "start_logit": 2.268315076828003,
            "end_logit": 3.944850444793701,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "accessory cells",
            "probability": 0.009328491464351276,
            "start_logit": 2.268315076828003,
            "end_logit": 2.420151472091675,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "accessory cells and macrophage",
            "probability": 0.007877205973189458,
            "start_logit": 2.268315076828003,
            "end_logit": 2.251051425933838,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "peritoneal macrophages",
            "probability": 0.003484786324079491,
            "start_logit": 2.638472080230713,
            "end_logit": 1.0653278827667236,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "both accessory cells and macrophages",
            "probability": 0.003123793195522845,
            "start_logit": -0.3504091799259186,
            "end_logit": 3.944850444793701,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "mac",
            "probability": 0.0024013667056204243,
            "start_logit": 5.173020839691162,
            "end_logit": -1.8415895700454712,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "peritoneal macrophage",
            "probability": 0.0013775147781156676,
            "start_logit": 2.638472080230713,
            "end_logit": 0.13720214366912842,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "both accessory cells",
            "probability": 0.0006800078467556226,
            "start_logit": -0.3504091799259186,
            "end_logit": 2.420151472091675,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "both accessory cells and macrophage",
            "probability": 0.0005742152300561277,
            "start_logit": -0.3504091799259186,
            "end_logit": 2.251051425933838,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "cells and macrophages",
            "probability": 0.0005575761493954008,
            "start_logit": -2.073613405227661,
            "end_logit": 3.944850444793701,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "s",
            "probability": 0.00039547091766944773,
            "start_logit": -2.417135238647461,
            "end_logit": 3.944850444793701,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "macrophages expressing lamins A/C as soon as such cell types could be identified.",
            "probability": 0.0001939545563693282,
            "start_logit": 5.173020839691162,
            "end_logit": -4.35775899887085,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "macrophages expressing lamins A/C",
            "probability": 0.00017428455529101963,
            "start_logit": 5.173020839691162,
            "end_logit": -4.464693546295166,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "hages",
            "probability": 0.00014053894274790898,
            "start_logit": -3.451727867126465,
            "end_logit": 3.944850444793701,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "rophages",
            "probability": 0.00013500023533767884,
            "start_logit": -3.491935968399048,
            "end_logit": 3.944850444793701,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "accessory cells and mac",
            "probability": 0.00013151061253726057,
            "start_logit": 2.268315076828003,
            "end_logit": -1.8415895700454712,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "macrophages expressing lamins A/C as soon as such cell types",
            "probability": 0.000125711320905767,
            "start_logit": 5.173020839691162,
            "end_logit": -4.7913947105407715,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "cells",
            "probability": 0.00012137684315852942,
            "start_logit": -2.073613405227661,
            "end_logit": 2.420151472091675,
            "question_text": "In which cells are A-type lamins expressed?"
        }
    ],
    "55424745ed966d112c000002": [
        {
            "text": "gamma-bases",
            "probability": 0.32306574360128815,
            "start_logit": 4.916123390197754,
            "end_logit": 4.505190372467041,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha-bases (A or T) and gamma-bases",
            "probability": 0.2530374136445521,
            "start_logit": 4.671804904937744,
            "end_logit": 4.505190372467041,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha-bases",
            "probability": 0.1791970555292768,
            "start_logit": 4.671804904937744,
            "end_logit": 4.160139083862305,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "A or T) and gamma-bases",
            "probability": 0.056698125725464205,
            "start_logit": 3.176008701324463,
            "end_logit": 4.505190372467041,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "gamma-bases (G or C)",
            "probability": 0.027670413286636768,
            "start_logit": 4.916123390197754,
            "end_logit": 2.0476982593536377,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha-bases (A or T",
            "probability": 0.023528683730095694,
            "start_logit": 4.671804904937744,
            "end_logit": 2.129873275756836,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha-bases (A or T) and gamma-bases (G or C)",
            "probability": 0.021672523166577234,
            "start_logit": 4.671804904937744,
            "end_logit": 2.0476982593536377,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "gamma-bases (G or C)A/T",
            "probability": 0.014130649414917805,
            "start_logit": 4.916123390197754,
            "end_logit": 1.375680685043335,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "gamma",
            "probability": 0.01332816523259606,
            "start_logit": 4.916123390197754,
            "end_logit": 1.317214012145996,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "(A or T) and gamma-bases",
            "probability": 0.011988725639936224,
            "start_logit": 1.6222342252731323,
            "end_logit": 4.505190372467041,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "gamma-bases (G or C",
            "probability": 0.011274246843036219,
            "start_logit": 4.916123390197754,
            "end_logit": 1.149855613708496,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha-bases (A or T) and gamma-bases (G or C)A/T",
            "probability": 0.011067663631590459,
            "start_logit": 4.671804904937744,
            "end_logit": 1.375680685043335,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "T) and gamma-bases",
            "probability": 0.0109199990453849,
            "start_logit": 1.5288634300231934,
            "end_logit": 4.505190372467041,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha-bases (A or T) and gamma",
            "probability": 0.010439127409452457,
            "start_logit": 4.671804904937744,
            "end_logit": 1.317214012145996,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha-bases (A or T) and gamma-bases (G or C",
            "probability": 0.008830420180583847,
            "start_logit": 4.671804904937744,
            "end_logit": 1.149855613708496,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha-bases (A or T)",
            "probability": 0.00594693301528173,
            "start_logit": 4.671804904937744,
            "end_logit": 0.7545286417007446,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "A or T",
            "probability": 0.005272075180777803,
            "start_logit": 3.176008701324463,
            "end_logit": 2.129873275756836,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "A or T) and gamma-bases (G or C)",
            "probability": 0.004856165045271705,
            "start_logit": 3.176008701324463,
            "end_logit": 2.0476982593536377,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha-bases (A",
            "probability": 0.003910941407058057,
            "start_logit": 4.671804904937744,
            "end_logit": 0.33543112874031067,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "alpha",
            "probability": 0.003164929270221823,
            "start_logit": 4.671804904937744,
            "end_logit": 0.12378372251987457,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        }
    ],
    "530cf4e0c8a0b4a00c000004": [
        {
            "text": "Arg403-->Gln",
            "probability": 0.8262969352656724,
            "start_logit": 3.9389004707336426,
            "end_logit": 2.8987133502960205,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403",
            "probability": 0.04531649391899837,
            "start_logit": 3.9389004707336426,
            "end_logit": -0.004569774027913809,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense mutation in the alpha-myosin heavy chain (403",
            "probability": 0.025143311928805742,
            "start_logit": 3.9389004707336426,
            "end_logit": -0.5936489105224609,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403Gln",
            "probability": 0.02305339929819092,
            "start_logit": 2.6092090606689453,
            "end_logit": 0.6492637991905212,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense mutation in the alpha-myosin heavy chain (403)",
            "probability": 0.011353656860101417,
            "start_logit": 3.9389004707336426,
            "end_logit": -1.3887009620666504,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Gln",
            "probability": 0.010389027599502875,
            "start_logit": -0.4373035132884979,
            "end_logit": 2.8987133502960205,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "R403Q",
            "probability": 0.009750092261028956,
            "start_logit": 2.327463150024414,
            "end_logit": 0.07047322392463684,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense",
            "probability": 0.008958725642407035,
            "start_logit": 3.9389004707336426,
            "end_logit": -1.6256128549575806,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense mutation",
            "probability": 0.00840486819028829,
            "start_logit": 3.9389004707336426,
            "end_logit": -1.689429759979248,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "R403Q missense allele for cardiac alpha-myosin heavy chain (M-alphaMHC",
            "probability": 0.007640838438087716,
            "start_logit": 2.327463150024414,
            "end_logit": -0.17329618334770203,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg",
            "probability": 0.00681541225458945,
            "start_logit": 3.9389004707336426,
            "end_logit": -1.8990542888641357,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "R403Q missense allele for cardiac alpha-myosin heavy chain (M-alphaMHC(R403Q",
            "probability": 0.00520201642728101,
            "start_logit": 2.327463150024414,
            "end_logit": -0.5577571988105774,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "M-alphaMHC",
            "probability": 0.0024309228706515303,
            "start_logit": 1.1822267770767212,
            "end_logit": -0.17329618334770203,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "an Arg403-->Gln",
            "probability": 0.002136241949558852,
            "start_logit": -2.019005537033081,
            "end_logit": 2.8987133502960205,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403Gln alpha-myosin heavy chain (MHC-403",
            "probability": 0.0018045973251373908,
            "start_logit": 2.6092090606689453,
            "end_logit": -1.89821195602417,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "M-alphaMHC(R403Q",
            "probability": 0.001655014800934232,
            "start_logit": 1.1822267770767212,
            "end_logit": -0.5577571988105774,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "M-alphaMHC(R403Q/+) and F-alphaMHC",
            "probability": 0.0010624125457006893,
            "start_logit": 1.1822267770767212,
            "end_logit": -1.001024842262268,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "M-alphaMHC(R403Q/+) and F-alphaMHC(R403Q",
            "probability": 0.000871226905549949,
            "start_logit": 1.1822267770767212,
            "end_logit": -1.1994199752807617,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "M-alphaMHC(R403Q/+)",
            "probability": 0.000863746713119144,
            "start_logit": 1.1822267770767212,
            "end_logit": -1.208042860031128,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Gly203Ser cardiac troponin I (TnI-203) and Arg403Gln",
            "probability": 0.000851058804394136,
            "start_logit": -0.6898782253265381,
            "end_logit": 0.6492637991905212,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        }
    ],
    "530cf4e0c8a0b4a00c000005": [
        {
            "text": "mitral valve prolapse",
            "probability": 0.294585266129694,
            "start_logit": 6.013062477111816,
            "end_logit": 5.690063953399658,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic root dilation and mitral valve prolapse",
            "probability": 0.1969138845949572,
            "start_logit": 5.610260486602783,
            "end_logit": 5.690063953399658,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic root dilation",
            "probability": 0.1309921615703072,
            "start_logit": 5.610260486602783,
            "end_logit": 5.282434940338135,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "mitral valve prolapse (MVP)",
            "probability": 0.07700620904558164,
            "start_logit": 6.013062477111816,
            "end_logit": 4.348381519317627,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "mitral valve prolapse and mitral valve regurgitation",
            "probability": 0.052766662395573365,
            "start_logit": 5.153000354766846,
            "end_logit": 4.830437183380127,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic root dilation and mitral valve prolapse (MVP)",
            "probability": 0.05147437263349382,
            "start_logit": 5.610260486602783,
            "end_logit": 4.348381519317627,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic regurgitation",
            "probability": 0.0507189077644677,
            "start_logit": 5.042120933532715,
            "end_logit": 4.901735782623291,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "mitral valve regurgitation",
            "probability": 0.04754598528226091,
            "start_logit": 5.048818111419678,
            "end_logit": 4.830437183380127,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic regurgitation with progressive dilatation of the aortic root",
            "probability": 0.025865827394631506,
            "start_logit": 5.042120933532715,
            "end_logit": 4.228359699249268,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "dissection and rupture of the ascending aorta, mitral valve prolapse",
            "probability": 0.013474535229240716,
            "start_logit": 3.766167163848877,
            "end_logit": 4.852192401885986,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "dissection and rupture of the ascending aorta, mitral valve prolapse and mitral valve regurgitation",
            "probability": 0.013184559451056406,
            "start_logit": 3.766167163848877,
            "end_logit": 4.830437183380127,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic regurgitation with progressive dilatation of the aortic root, which may cause dissection",
            "probability": 0.012392588394462159,
            "start_logit": 5.042120933532715,
            "end_logit": 3.4925355911254883,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "dissection and rupture of the ascending aorta",
            "probability": 0.0071885193769722815,
            "start_logit": 3.766167163848877,
            "end_logit": 4.223875999450684,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "rupture of the ascending aorta, mitral valve prolapse",
            "probability": 0.005946060081184262,
            "start_logit": 2.948094367980957,
            "end_logit": 4.852192401885986,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "rupture of the ascending aorta, mitral valve prolapse and mitral valve regurgitation",
            "probability": 0.005818099200171433,
            "start_logit": 2.948094367980957,
            "end_logit": 4.830437183380127,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "dissection",
            "probability": 0.003459571765119161,
            "start_logit": 3.766167163848877,
            "end_logit": 3.4925355911254883,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic root, which may cause dissection and rupture of the ascending aorta, mitral valve prolapse",
            "probability": 0.0032853754528919072,
            "start_logit": 2.354846477508545,
            "end_logit": 4.852192401885986,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "rupture of the ascending aorta",
            "probability": 0.003172158993467786,
            "start_logit": 2.948094367980957,
            "end_logit": 4.223875999450684,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic regurgitation with progressive dilatation of the aortic root,",
            "probability": 0.002448666554802827,
            "start_logit": 5.042120933532715,
            "end_logit": 1.8709806203842163,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic root",
            "probability": 0.0017605886896637647,
            "start_logit": 2.354846477508545,
            "end_logit": 4.228359699249268,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        }
    ],
    "52e0141498d023950500000e": [
        {
            "text": "growth retardation",
            "probability": 0.4937163051507159,
            "start_logit": 5.115536212921143,
            "end_logit": 5.21819543838501,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "altered metabolite profiles and growth retardation",
            "probability": 0.19395049598962616,
            "start_logit": 4.181178092956543,
            "end_logit": 5.21819543838501,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "growth retardation without an accumulation of oxidative damage",
            "probability": 0.11809779068656444,
            "start_logit": 5.115536212921143,
            "end_logit": 3.787747383117676,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "post-embryonic growth retardation",
            "probability": 0.055915381559745875,
            "start_logit": 4.086790561676025,
            "end_logit": 4.068819522857666,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "altered metabolite profiles and growth retardation without an accumulation of oxidative damage",
            "probability": 0.04639329274723066,
            "start_logit": 4.181178092956543,
            "end_logit": 3.787747383117676,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "growth retardation and impaired seedling establishment",
            "probability": 0.020335531238863273,
            "start_logit": 3.860440731048584,
            "end_logit": 3.2836995124816895,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "impaired seedling establishment",
            "probability": 0.017012026063876366,
            "start_logit": 3.6819915771484375,
            "end_logit": 3.2836995124816895,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "post-embryonic growth retardation phenotype",
            "probability": 0.009522397380892448,
            "start_logit": 4.086790561676025,
            "end_logit": 2.298626661300659,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "growth rate deficit",
            "probability": 0.008250331362591089,
            "start_logit": 2.9365484714508057,
            "end_logit": 3.3054754734039307,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "embryonic growth retardation",
            "probability": 0.006448393014268602,
            "start_logit": 1.9267820119857788,
            "end_logit": 4.068819522857666,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "lowered activity of specific mitochondrial enzymes associated with respiratory metabolism",
            "probability": 0.005173692582899591,
            "start_logit": 2.9462063312530518,
            "end_logit": 2.829150915145874,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "growth rate deficit in both roots and shoots and lowered activity of specific mitochondrial enzymes associated with respiratory metabolism",
            "probability": 0.005123966296539697,
            "start_logit": 2.9365484714508057,
            "end_logit": 2.829150915145874,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "oxidative damage",
            "probability": 0.004970249293453815,
            "start_logit": 1.9474931955337524,
            "end_logit": 3.787747383117676,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "altered metabolite profiles",
            "probability": 0.003558222606698693,
            "start_logit": 4.181178092956543,
            "end_logit": 1.2198536396026611,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "changes the mitochondrial proteome leading to altered metabolite profiles and growth retardation",
            "probability": 0.0034887540996499096,
            "start_logit": 0.1631198227405548,
            "end_logit": 5.21819543838501,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "growth retardation phenotype",
            "probability": 0.002199221889325126,
            "start_logit": 2.6212475299835205,
            "end_logit": 2.298626661300659,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "significant growth rate deficit",
            "probability": 0.0021488033079408637,
            "start_logit": 1.5912061929702759,
            "end_logit": 3.3054754734039307,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "significant growth rate deficit in both roots and shoots and lowered activity of specific mitochondrial enzymes associated with respiratory metabolism",
            "probability": 0.0013345398195405438,
            "start_logit": 1.5912061929702759,
            "end_logit": 2.829150915145874,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "mitochondrial proteome leading to altered metabolite profiles and growth retardation",
            "probability": 0.0012624426680402962,
            "start_logit": -0.8533763885498047,
            "end_logit": 5.21819543838501,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "embryonic growth retardation phenotype",
            "probability": 0.0010981622415368092,
            "start_logit": 1.9267820119857788,
            "end_logit": 2.298626661300659,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        }
    ],
    "5518e817622b194345000006": [
        {
            "text": "N-Ras",
            "probability": 0.14867802883058015,
            "start_logit": 5.072134494781494,
            "end_logit": 4.251789093017578,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K-Ras",
            "probability": 0.14422735628764688,
            "start_logit": 4.902093887329102,
            "end_logit": 4.391437530517578,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N-Ras, and H-Ras",
            "probability": 0.12809906380105365,
            "start_logit": 5.072134494781494,
            "end_logit": 4.102809906005859,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K-Ras, N-Ras",
            "probability": 0.12542932845636362,
            "start_logit": 4.902093887329102,
            "end_logit": 4.251789093017578,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K-Ras, N-Ras, and H-Ras",
            "probability": 0.10806828470105663,
            "start_logit": 4.902093887329102,
            "end_logit": 4.102809906005859,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "H-Ras",
            "probability": 0.08921715350537265,
            "start_logit": 4.710403919219971,
            "end_logit": 4.102809906005859,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K, H, and N) Mutations in Ras isoforms such as K-Ras",
            "probability": 0.06096225840177932,
            "start_logit": 4.040957927703857,
            "end_logit": 4.391437530517578,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K, H, and N) Mutations in Ras isoforms such as K-Ras, N-Ras",
            "probability": 0.053016676789584986,
            "start_logit": 4.040957927703857,
            "end_logit": 4.251789093017578,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N) Mutations in Ras isoforms such as K-Ras",
            "probability": 0.021726182655928638,
            "start_logit": 3.009221076965332,
            "end_logit": 4.391437530517578,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N) Mutations in Ras isoforms such as K-Ras, N-Ras",
            "probability": 0.018894477237858302,
            "start_logit": 3.009221076965332,
            "end_logit": 4.251789093017578,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N) Mutations in Ras isoforms such as K-Ras, N-Ras, and H-Ras",
            "probability": 0.016279236846339903,
            "start_logit": 3.009221076965332,
            "end_logit": 4.102809906005859,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "H, and N) Mutations in Ras isoforms such as K-Ras",
            "probability": 0.016084722280445333,
            "start_logit": 2.7085728645324707,
            "end_logit": 4.391437530517578,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K",
            "probability": 0.014878802321305869,
            "start_logit": 4.040957927703857,
            "end_logit": 2.9811201095581055,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "H, and N) Mutations in Ras isoforms such as K-Ras, N-Ras",
            "probability": 0.01398830267691849,
            "start_logit": 2.7085728645324707,
            "end_logit": 4.251789093017578,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "H, and N) Mutations in Ras isoforms such as K-Ras, N-Ras, and H-Ras",
            "probability": 0.012052140394737834,
            "start_logit": 2.7085728645324707,
            "end_logit": 4.102809906005859,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K, H, and N",
            "probability": 0.009995013396703433,
            "start_logit": 4.040957927703857,
            "end_logit": 2.583268880844116,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K, H",
            "probability": 0.009656007164387326,
            "start_logit": 4.040957927703857,
            "end_logit": 2.548762798309326,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N",
            "probability": 0.0035620971466321914,
            "start_logit": 3.009221076965332,
            "end_logit": 2.583268880844116,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "H, and N",
            "probability": 0.002637156478287768,
            "start_logit": 2.7085728645324707,
            "end_logit": 2.583268880844116,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "H",
            "probability": 0.002547710627016852,
            "start_logit": 2.7085728645324707,
            "end_logit": 2.548762798309326,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        }
    ],
    "530cefaaad0bf1360c000003": [
        {
            "text": "Alemtuzumab",
            "probability": 0.5501078045585873,
            "start_logit": 6.917863845825195,
            "end_logit": 7.150869846343994,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alemtuzumab",
            "probability": 0.4408597867373458,
            "start_logit": 6.9889607429504395,
            "end_logit": 6.8583855628967285,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "Alemtuzumab,",
            "probability": 0.007021923596317889,
            "start_logit": 6.745566368103027,
            "end_logit": 2.962090253829956,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "Alemtuzumab, an anti-CD52 monoclonal antibody,",
            "probability": 0.0009985288512953231,
            "start_logit": 6.745566368103027,
            "end_logit": 1.0115808248519897,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "Alemtuzumab (anti-CD52 mAb)",
            "probability": 0.00031695980327929634,
            "start_logit": 6.917863845825195,
            "end_logit": -0.30822473764419556,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alemtuzuma",
            "probability": 0.00015894490713193137,
            "start_logit": 6.9889607429504395,
            "end_logit": -1.069538950920105,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alemtuzumab (anti-CD52 monoclonal antibody)",
            "probability": 0.00010798505040249197,
            "start_logit": 6.9889607429504395,
            "end_logit": -1.456103801727295,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "b",
            "probability": 9.784816738863632e-05,
            "start_logit": -1.7165887355804443,
            "end_logit": 7.150869846343994,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "Alemtuzuma",
            "probability": 8.790527846779698e-05,
            "start_logit": 6.917863845825195,
            "end_logit": -1.5907398462295532,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "Alemtuzumab (anti-CD52 mAb",
            "probability": 8.02608205879653e-05,
            "start_logit": 6.917863845825195,
            "end_logit": -1.681718111038208,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "Ale",
            "probability": 8.008425888660887e-05,
            "start_logit": 6.917863845825195,
            "end_logit": -1.6839203834533691,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "Alem",
            "probability": 6.987711654905769e-05,
            "start_logit": 6.917863845825195,
            "end_logit": -1.8202614784240723,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": ".Alemtuzumab",
            "probability": 1.0656801506474054e-05,
            "start_logit": -3.3935670852661133,
            "end_logit": 6.610629558563232,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "b,",
            "probability": 7.870537203324581e-07,
            "start_logit": -2.350684881210327,
            "end_logit": 2.962090253829956,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": ".Alemtuzumab,",
            "probability": 2.7738718269234125e-07,
            "start_logit": -3.3935670852661133,
            "end_logit": 2.962090253829956,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "b, an anti-CD52 monoclonal antibody,",
            "probability": 1.1192030737608467e-07,
            "start_logit": -2.350684881210327,
            "end_logit": 1.0115808248519897,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "anti-CD52 mAb)",
            "probability": 9.894324738724815e-08,
            "start_logit": -1.1541199684143066,
            "end_logit": -0.30822473764419556,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "anti-CD52 monoclonal antibody,",
            "probability": 6.292496767350871e-08,
            "start_logit": -2.9265289306640625,
            "end_logit": 1.0115808248519897,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "b (anti-CD52 mAb)",
            "probability": 5.637792379918652e-08,
            "start_logit": -1.7165887355804443,
            "end_logit": -0.30822473764419556,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": ".Alemtuzumab, an anti-CD52 monoclonal antibody,",
            "probability": 3.9444904391023273e-08,
            "start_logit": -3.3935670852661133,
            "end_logit": 1.0115808248519897,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        }
    ],
    "530cefaaad0bf1360c000002": [
        {
            "text": "nucleus accumbens",
            "probability": 0.2743258791684727,
            "start_logit": 3.692514419555664,
            "end_logit": 3.760483503341675,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "caudate nucleus and the nucleus accumbens",
            "probability": 0.12603366848817316,
            "start_logit": 2.9147467613220215,
            "end_logit": 3.760483503341675,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "ventral striatum, including the head of the caudate nucleus and the nucleus accumbens",
            "probability": 0.08908686472708544,
            "start_logit": 2.567809581756592,
            "end_logit": 3.760483503341675,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "nucleus accumbens, the lateral habenula",
            "probability": 0.07133538122849044,
            "start_logit": 3.2248148918151855,
            "end_logit": 2.881258726119995,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "caudate nucleus",
            "probability": 0.06147415589901538,
            "start_logit": 2.9147467613220215,
            "end_logit": 3.042551279067993,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "ventral striatum",
            "probability": 0.05617855865255914,
            "start_logit": 2.567809581756592,
            "end_logit": 3.2994067668914795,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "habenula",
            "probability": 0.05393046293858448,
            "start_logit": 2.945117950439453,
            "end_logit": 2.881258726119995,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "The ventral striatum, including the head of the caudate nucleus and the nucleus accumbens",
            "probability": 0.04504546441245911,
            "start_logit": 1.8858699798583984,
            "end_logit": 3.760483503341675,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "ventral striatum, including the head of the caudate nucleus",
            "probability": 0.043452990589584045,
            "start_logit": 2.567809581756592,
            "end_logit": 3.042551279067993,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "The ventral striatum",
            "probability": 0.028405862887637513,
            "start_logit": 1.8858699798583984,
            "end_logit": 3.2994067668914795,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "lateral habenula",
            "probability": 0.024405779403249003,
            "start_logit": 2.152242422103882,
            "end_logit": 2.881258726119995,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "the nucleus accumbens",
            "probability": 0.022829522330848846,
            "start_logit": 1.2062522172927856,
            "end_logit": 3.760483503341675,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "The ventral striatum, including the head of the caudate nucleus",
            "probability": 0.02197136634243819,
            "start_logit": 1.8858699798583984,
            "end_logit": 3.042551279067993,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "head of the caudate nucleus and the nucleus accumbens",
            "probability": 0.020771173895915807,
            "start_logit": 1.111763834953308,
            "end_logit": 3.760483503341675,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "habenula) are about to be assessed in clinical trials. Deep brain stimulation (DBS) to the nucleus accumbens",
            "probability": 0.01632479227132012,
            "start_logit": 1.5647765398025513,
            "end_logit": 3.066589593887329,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "the head of the caudate nucleus and the nucleus accumbens",
            "probability": 0.014589265638548376,
            "start_logit": 0.7584837079048157,
            "end_logit": 3.760483503341675,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "head of the caudate nucleus",
            "probability": 0.010131343454490568,
            "start_logit": 1.111763834953308,
            "end_logit": 3.042551279067993,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "striatum, including the head of the caudate nucleus and the nucleus accumbens",
            "probability": 0.007721928989934368,
            "start_logit": 0.1222618818283081,
            "end_logit": 3.760483503341675,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "the head of the caudate nucleus",
            "probability": 0.007116057170076197,
            "start_logit": 0.7584837079048157,
            "end_logit": 3.042551279067993,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "striatum",
            "probability": 0.004869481511117011,
            "start_logit": 0.1222618818283081,
            "end_logit": 3.2994067668914795,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        }
    ],
    "52ecf2dd98d023950500002e": [
        {
            "text": "Ala92",
            "probability": 0.3403615026170374,
            "start_logit": 2.9118316173553467,
            "end_logit": 2.3722565174102783,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Ala92 allele of the type 2",
            "probability": 0.1963467950854011,
            "start_logit": 2.9219861030578613,
            "end_logit": 1.8119761943817139,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "type 2 iodothyronine deiodinase increases risk for the development of hypertension. Ala92",
            "probability": 0.10098965012112292,
            "start_logit": 1.6968413591384888,
            "end_logit": 2.3722565174102783,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Ala92 type 2",
            "probability": 0.08325391161873616,
            "start_logit": 2.9118316173553467,
            "end_logit": 0.9641433358192444,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "type 2",
            "probability": 0.057670034999141334,
            "start_logit": 1.6968413591384888,
            "end_logit": 1.8119761943817139,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "iodothyronine deiodinase increases risk for the development of hypertension. Ala92",
            "probability": 0.04270523631153526,
            "start_logit": 0.8361448645591736,
            "end_logit": 2.3722565174102783,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Ala92 type 2 deiodinase allele",
            "probability": 0.032053362635926334,
            "start_logit": 2.9118316173553467,
            "end_logit": 0.009650317952036858,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "type 2 iodothyronine deiodinase increases risk for the development of hypertension. Ala92 type 2",
            "probability": 0.02470250995175324,
            "start_logit": 1.6968413591384888,
            "end_logit": 0.9641433358192444,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Ala92 type 2 deiodinase",
            "probability": 0.024664975763448494,
            "start_logit": 2.9118316173553467,
            "end_logit": -0.2523675262928009,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Ala92 allele",
            "probability": 0.022916838277099966,
            "start_logit": 2.9219861030578613,
            "end_logit": -0.3360343277454376,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Ala92 allele of the type 2 iodothyronine deiodinase",
            "probability": 0.019687453195940376,
            "start_logit": 2.9219861030578613,
            "end_logit": -0.487924724817276,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "iodothyronine deiodinase increases risk for the development of hypertension. Ala92 type 2",
            "probability": 0.010445887511368119,
            "start_logit": 0.8361448645591736,
            "end_logit": 0.9641433358192444,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "common Ala92 allele of the type 2",
            "probability": 0.008457664681710577,
            "start_logit": -0.22282326221466064,
            "end_logit": 1.8119761943817139,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Ala92 allele of the type 2 iodothyronine",
            "probability": 0.007725319949813993,
            "start_logit": 2.9219861030578613,
            "end_logit": -1.423403024673462,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "type 2 iodothyronine deiodinase",
            "probability": 0.005782503933206581,
            "start_logit": 1.6968413591384888,
            "end_logit": -0.487924724817276,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "type 2 deiodinase allele",
            "probability": 0.005286628975745743,
            "start_logit": 1.1096103191375732,
            "end_logit": 0.009650317952036858,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "common Ala92",
            "probability": 0.005218383153641922,
            "start_logit": -0.22282326221466064,
            "end_logit": 1.3290907144546509,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "the common Ala92 allele of the type 2",
            "probability": 0.004114958592605281,
            "start_logit": -0.9432675838470459,
            "end_logit": 1.8119761943817139,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "type 2 deiodinase",
            "probability": 0.004068046683219541,
            "start_logit": 1.1096103191375732,
            "end_logit": -0.2523675262928009,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "type 2 iodothyronine deiodinase increases risk for the development of hypertension.",
            "probability": 0.003548335941545462,
            "start_logit": 1.6968413591384888,
            "end_logit": -0.9762827754020691,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        }
    ],
    "5319abe4b166e2b80600002e": [
        {
            "text": "Slug",
            "probability": 0.18820631020825115,
            "start_logit": 4.420808792114258,
            "end_logit": 4.0162177085876465,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Slug/Snail2",
            "probability": 0.08816821797685774,
            "start_logit": 4.420808792114258,
            "end_logit": 3.257925510406494,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail2",
            "probability": 0.06275651385841743,
            "start_logit": 4.204005718231201,
            "end_logit": 3.13474440574646,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "slug",
            "probability": 0.06159097116744417,
            "start_logit": 3.6696979999542236,
            "end_logit": 3.6503050327301025,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail2 (Slug",
            "probability": 0.05865192554266459,
            "start_logit": 4.204005718231201,
            "end_logit": 3.0671024322509766,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail2 zinc fingers in E-cadherin repression and epithelial to mesenchymal transitionnail1",
            "probability": 0.0473585896767432,
            "start_logit": 3.9148426055908203,
            "end_logit": 3.1423933506011963,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "nail1",
            "probability": 0.04702925890703748,
            "start_logit": 3.9078643321990967,
            "end_logit": 3.1423933506011963,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "nail1 (Snail) and Snail2",
            "probability": 0.046670906953418266,
            "start_logit": 3.9078643321990967,
            "end_logit": 3.13474440574646,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "nail1 (Snail) and Snail2 (Slug",
            "probability": 0.04361839737969064,
            "start_logit": 3.9078643321990967,
            "end_logit": 3.0671024322509766,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail1 and Snail2 zinc fingers in E-cadherin repression and epithelial to mesenchymal transitionnail1",
            "probability": 0.04341498182782864,
            "start_logit": 3.8278989791870117,
            "end_logit": 3.1423933506011963,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail2-mediated EMT properties of E-cadherin repression and vimentin induction, compared with wild-type Slug",
            "probability": 0.04277944287609992,
            "start_logit": 3.831333875656128,
            "end_logit": 3.124211549758911,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail1",
            "probability": 0.04028292974404487,
            "start_logit": 3.8278989791870117,
            "end_logit": 3.067516565322876,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "snail-2 (SLUG",
            "probability": 0.03912773979464856,
            "start_logit": 3.779280424118042,
            "end_logit": 3.087038993835449,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "snail-2",
            "probability": 0.03151751253812986,
            "start_logit": 3.779280424118042,
            "end_logit": 2.870750665664673,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail1 and Snail2",
            "probability": 0.03139178572134013,
            "start_logit": 3.8278989791870117,
            "end_logit": 2.8181350231170654,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail2 zinc fingers in E-cadherin repression and epithelial to mesenchymal transitionnail1 (Snail",
            "probability": 0.026299427354601654,
            "start_logit": 3.9148426055908203,
            "end_logit": 2.554192304611206,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "nail1 (Snail",
            "probability": 0.026116541615971562,
            "start_logit": 3.9078643321990967,
            "end_logit": 2.554192304611206,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "vimentin induction, compared with wild-type Slug",
            "probability": 0.02551218516141364,
            "start_logit": 3.314432382583618,
            "end_logit": 3.124211549758911,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail",
            "probability": 0.02539691991353885,
            "start_logit": 3.8278989791870117,
            "end_logit": 2.6062166690826416,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail1 and Snail2 zinc fingers in E-cadherin repression and epithelial to mesenchymal transitionnail1 (Snail",
            "probability": 0.024109441781857758,
            "start_logit": 3.8278989791870117,
            "end_logit": 2.554192304611206,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        }
    ],
    "54ff30dc6ad7dcbc1200000f": [
        {
            "text": "Prader Willi Syndrome",
            "probability": 0.23474007985765355,
            "start_logit": 4.48213529586792,
            "end_logit": 4.405128002166748,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi syndrome",
            "probability": 0.10136478145810762,
            "start_logit": 4.011475086212158,
            "end_logit": 4.036035060882568,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi syndrome (PWS), Angelman syndrome",
            "probability": 0.09708385062776963,
            "start_logit": 4.011475086212158,
            "end_logit": 3.992884397506714,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Angelman syndrome",
            "probability": 0.07938112306722182,
            "start_logit": 3.8101606369018555,
            "end_logit": 3.992884397506714,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Beckwith-Wiedemann syndrome (BWS), Prader-Willi syndrome",
            "probability": 0.05755126593866129,
            "start_logit": 3.445425510406494,
            "end_logit": 4.036035060882568,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Beckwith-Wiedemann syndrome (BWS), Prader-Willi syndrome (PWS), Angelman syndrome",
            "probability": 0.055120707857858664,
            "start_logit": 3.445425510406494,
            "end_logit": 3.992884397506714,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Hydatidiform mole.In the neurodevelopmental Rett syndrome",
            "probability": 0.05100617407602695,
            "start_logit": 3.8654422760009766,
            "end_logit": 3.495288848876953,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi syndrome (PWS), Angelman syndrome and Hydatidiform mole",
            "probability": 0.05063918593665031,
            "start_logit": 4.011475086212158,
            "end_logit": 3.3420350551605225,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Angelman syndrome and Hydatidiform mole.In the neurodevelopmental Rett syndrome",
            "probability": 0.048262991557122485,
            "start_logit": 3.8101606369018555,
            "end_logit": 3.495288848876953,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Hydatidiform mole",
            "probability": 0.043758806850908306,
            "start_logit": 3.8654422760009766,
            "end_logit": 3.3420350551605225,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Angelman syndrome and Hydatidiform mole",
            "probability": 0.041405397755323016,
            "start_logit": 3.8101606369018555,
            "end_logit": 3.3420350551605225,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Beckwith-Wiedemann syndrome",
            "probability": 0.038081540731522236,
            "start_logit": 3.445425510406494,
            "end_logit": 3.6230885982513428,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Rett syndrome",
            "probability": 0.0214319680227802,
            "start_logit": 2.9983792304992676,
            "end_logit": 3.495288848876953,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi syndrome and Angelman syndrome",
            "probability": 0.020193013792504787,
            "start_logit": 3.414340019226074,
            "end_logit": 3.0197811126708984,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Beckwith-Wiedemann and Silver-Russell syndrome",
            "probability": 0.018206620741611376,
            "start_logit": 3.3121237754821777,
            "end_logit": 3.0184459686279297,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader Willi Syndrome (PWS)",
            "probability": 0.014149288402714358,
            "start_logit": 4.48213529586792,
            "end_logit": 1.5963134765625,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Silver-Russell syndrome",
            "probability": 0.009537917600247896,
            "start_logit": 2.6656136512756348,
            "end_logit": 3.0184459686279297,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader Willi Syndrome (PWS),",
            "probability": 0.006705408206092888,
            "start_logit": 4.48213529586792,
            "end_logit": 0.8495635390281677,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi syndrome (PWS)",
            "probability": 0.005738138503401504,
            "start_logit": 4.011475086212158,
            "end_logit": 1.1644442081451416,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Beckwith-Wiedemann",
            "probability": 0.005641739015821008,
            "start_logit": 3.3121237754821777,
            "end_logit": 1.8468530178070068,
            "question_text": "List human diseases involving genomic imprinting."
        }
    ],
    "530cefaaad0bf1360c000011": [
        {
            "text": "headache, muscle and joint pain",
            "probability": 0.1165725622786001,
            "start_logit": 3.116887092590332,
            "end_logit": 3.5183589458465576,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "headache",
            "probability": 0.10627944465911848,
            "start_logit": 3.116887092590332,
            "end_logit": 3.425916910171509,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "skin rash, headache, muscle and joint pain",
            "probability": 0.09262649147603788,
            "start_logit": 2.886948347091675,
            "end_logit": 3.5183589458465576,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "joint pain",
            "probability": 0.08697388362554642,
            "start_logit": 2.8239810466766357,
            "end_logit": 3.5183589458465576,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "skin rash, headache",
            "probability": 0.0844477626842303,
            "start_logit": 2.886948347091675,
            "end_logit": 3.425916910171509,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "dysmnesia",
            "probability": 0.07008806518059349,
            "start_logit": 2.8623459339141846,
            "end_logit": 3.264138698577881,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "muscle and joint pain",
            "probability": 0.05519147327501968,
            "start_logit": 2.3691816329956055,
            "end_logit": 3.5183589458465576,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "headache, muscle and joint pain, and loss of memory",
            "probability": 0.04783780438486835,
            "start_logit": 3.116887092590332,
            "end_logit": 2.6276612281799316,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "fatigue, skin rash, headache, muscle and joint pain",
            "probability": 0.046500430417865446,
            "start_logit": 2.1978347301483154,
            "end_logit": 3.5183589458465576,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "fatigue, skin rash, headache",
            "probability": 0.04239453799951311,
            "start_logit": 2.1978347301483154,
            "end_logit": 3.425916910171509,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "skin rash, headache, muscle and joint pain, and loss of memory",
            "probability": 0.038011071331669685,
            "start_logit": 2.886948347091675,
            "end_logit": 2.6276612281799316,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "joint pain, and loss of memory",
            "probability": 0.035691414430160356,
            "start_logit": 2.8239810466766357,
            "end_logit": 2.6276612281799316,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "loss of memory",
            "probability": 0.033027906061631966,
            "start_logit": 2.7464237213134766,
            "end_logit": 2.6276612281799316,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "skin rash",
            "probability": 0.03243925188049079,
            "start_logit": 2.886948347091675,
            "end_logit": 2.4691529273986816,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "dysmnesia, disturbance of orientation, cognitive impairment, and double vision",
            "probability": 0.024087529850953072,
            "start_logit": 2.8623459339141846,
            "end_logit": 2.196080446243286,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "muscle and joint pain, and loss of memory",
            "probability": 0.02264888795987085,
            "start_logit": 2.3691816329956055,
            "end_logit": 2.6276612281799316,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "fatigue, skin rash, headache, muscle and joint pain, and loss of memory",
            "probability": 0.019082350517660274,
            "start_logit": 2.1978347301483154,
            "end_logit": 2.6276612281799316,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "fatigue",
            "probability": 0.017791168233818683,
            "start_logit": 2.1978347301483154,
            "end_logit": 2.5575995445251465,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "fatigue, skin rash",
            "probability": 0.016285180954593324,
            "start_logit": 2.1978347301483154,
            "end_logit": 2.4691529273986816,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "dysmnesia, disturbance of orientation",
            "probability": 0.012022782797757741,
            "start_logit": 2.8623459339141846,
            "end_logit": 1.5011895895004272,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        }
    ],
    "55031628e9bde69634000024": [
        {
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 0.12325320370306768,
            "start_logit": 4.182330131530762,
            "end_logit": 4.298306941986084,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "pheochromocytoma",
            "probability": 0.1206592589073986,
            "start_logit": 4.161059856414795,
            "end_logit": 4.298306941986084,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 0.11797000987184933,
            "start_logit": 4.138519763946533,
            "end_logit": 4.298306941986084,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "pheochromocytoma, and paraganglioma",
            "probability": 0.09987123533331113,
            "start_logit": 4.161059856414795,
            "end_logit": 4.109218120574951,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "paraganglioma",
            "probability": 0.0984195976966983,
            "start_logit": 4.14641809463501,
            "end_logit": 4.109218120574951,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "medullary thyroid carcinoma",
            "probability": 0.09781232596864897,
            "start_logit": 4.182330131530762,
            "end_logit": 4.067116737365723,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma",
            "probability": 0.09764530898724146,
            "start_logit": 4.138519763946533,
            "end_logit": 4.109218120574951,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors",
            "probability": 0.08040230725076386,
            "start_logit": 4.182330131530762,
            "end_logit": 3.8711090087890625,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "gastroenteropancreatic tumors",
            "probability": 0.07695589806284281,
            "start_logit": 4.138519763946533,
            "end_logit": 3.8711090087890625,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 0.018789585488951793,
            "start_logit": 2.301392078399658,
            "end_logit": 4.298306941986084,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma",
            "probability": 0.015552383888107958,
            "start_logit": 2.301392078399658,
            "end_logit": 4.109218120574951,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "thyroid carcinoma",
            "probability": 0.014911199104315102,
            "start_logit": 2.301392078399658,
            "end_logit": 4.067116737365723,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "thyroid carcinoma, gastroenteropancreatic tumors",
            "probability": 0.012257093367217647,
            "start_logit": 2.301392078399658,
            "end_logit": 3.8711090087890625,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "medullary thyroid carcinoma, gastroenteropancreatic",
            "probability": 0.006973974386758833,
            "start_logit": 4.182330131530762,
            "end_logit": 1.4262514114379883,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "gastroenteropancreatic",
            "probability": 0.006675038072308437,
            "start_logit": 4.138519763946533,
            "end_logit": 1.4262514114379883,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "paragangliomas",
            "probability": 0.004267404552612787,
            "start_logit": 3.382405996322632,
            "end_logit": 1.7349960803985596,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "pheochromocytoma-paraganglioma",
            "probability": 0.002566981099177471,
            "start_logit": 2.596014976501465,
            "end_logit": 2.0131118297576904,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "paragangliomas (PGLs)",
            "probability": 0.002472519490947831,
            "start_logit": 3.382405996322632,
            "end_logit": 1.1892279386520386,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "pheochromocytoma-paraganglioma syndrome, and familial nonmedullary thyroid carcinoma",
            "probability": 0.001481513048645929,
            "start_logit": 2.596014976501465,
            "end_logit": 1.4634451866149902,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "thyroid carcinoma, gastroenteropancreatic",
            "probability": 0.0010631617191343143,
            "start_logit": 2.301392078399658,
            "end_logit": 1.4262514114379883,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        }
    ],
    "530cefaaad0bf1360c00000c": [
        {
            "text": "pentostatin",
            "probability": 0.6762153406139946,
            "start_logit": 5.627413272857666,
            "end_logit": 5.446784496307373,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "2-deoxycoformicin",
            "probability": 0.1554608618335518,
            "start_logit": 4.691974639892578,
            "end_logit": 4.912105560302734,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "alemtuzumab",
            "probability": 0.11427442294357919,
            "start_logit": 4.626773834228516,
            "end_logit": 4.669515132904053,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "alemtuzumab has resulted in significantly higher response rates and increased survival.Nelarabine",
            "probability": 0.017448884405639385,
            "start_logit": 4.263020038604736,
            "end_logit": 3.1539418697357178,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "fludarabine",
            "probability": 0.011326270776693168,
            "start_logit": 3.631472110748291,
            "end_logit": 3.3533389568328857,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "Nelarabine is an effective regimen against indolent leukemias, and combining it with fludarabine",
            "probability": 0.007094967782387351,
            "start_logit": 3.1637330055236816,
            "end_logit": 3.3533389568328857,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "Nelarabine",
            "probability": 0.00581237161318186,
            "start_logit": 3.1637330055236816,
            "end_logit": 3.1539418697357178,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "pentostat",
            "probability": 0.0032732495555778387,
            "start_logit": 5.627413272857666,
            "end_logit": 0.1160561591386795,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "deoxycoformicin",
            "probability": 0.002652238924254279,
            "start_logit": 0.6209847927093506,
            "end_logit": 4.912105560302734,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "purine analogues and alemtuzumab",
            "probability": 0.001834771629044841,
            "start_logit": 0.4950910806655884,
            "end_logit": 4.669515132904053,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "alemtuzumab has resulted in significantly higher response rates and improved survival. Treatment with purine analogs",
            "probability": 0.0015068553029272808,
            "start_logit": 4.626773834228516,
            "end_logit": 0.3409372568130493,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "coformicin",
            "probability": 0.0009644418951486401,
            "start_logit": -0.3906250596046448,
            "end_logit": 4.912105560302734,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "analogue pentostatin",
            "probability": 0.00050328129404363,
            "start_logit": -1.5757043361663818,
            "end_logit": 5.446784496307373,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "monoclonal antibody alemtuzumab",
            "probability": 0.00041796145914391425,
            "start_logit": -0.61637282371521,
            "end_logit": 4.301692962646484,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "2-deoxy",
            "probability": 0.0002927440505422196,
            "start_logit": 4.691974639892578,
            "end_logit": -1.3627450466156006,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "analogues and alemtuzumab",
            "probability": 0.00020117015626359915,
            "start_logit": -1.715433120727539,
            "end_logit": 4.669515132904053,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "alemtuzumab has resulted in significantly higher response rates and increased survival.",
            "probability": 0.00020048065368974977,
            "start_logit": 4.263020038604736,
            "end_logit": -1.3123713731765747,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "pen",
            "probability": 0.0001863876754789948,
            "start_logit": 5.627413272857666,
            "end_logit": -2.7496535778045654,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "2",
            "probability": 0.00017018079375641414,
            "start_logit": 4.691974639892578,
            "end_logit": -1.9051823616027832,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "Treatment with purine analogues and alemtuzumab",
            "probability": 0.00016311664110126153,
            "start_logit": -1.9251186847686768,
            "end_logit": 4.669515132904053,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        }
    ],
    "54d670163706e8952800000f": [
        {
            "text": "HSPG2",
            "probability": 0.24588343696217402,
            "start_logit": 3.554067611694336,
            "end_logit": 3.7762539386749268,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "Robo3",
            "probability": 0.14787626092080441,
            "start_logit": 3.634584903717041,
            "end_logit": 3.1872549057006836,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "DSCAM gene encoding an axon guidance protein in the same structural class with Chl1 and Robo3",
            "probability": 0.10571467963352095,
            "start_logit": 3.29895281791687,
            "end_logit": 3.1872549057006836,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "DSCAM",
            "probability": 0.09239208541733702,
            "start_logit": 3.29895281791687,
            "end_logit": 3.0525524616241455,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "Chl1 and Robo3",
            "probability": 0.07836392642897971,
            "start_logit": 2.99957275390625,
            "end_logit": 3.1872549057006836,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "DSCAM gene encoding an axon guidance protein in the same structural class with Chl1",
            "probability": 0.05319927932986718,
            "start_logit": 3.29895281791687,
            "end_logit": 2.500555992126465,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "Chl1",
            "probability": 0.03943543532395608,
            "start_logit": 2.99957275390625,
            "end_logit": 2.500555992126465,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "Robo3. Mutations in the Robo3",
            "probability": 0.03603421456074304,
            "start_logit": 2.680495262145996,
            "end_logit": 2.7294375896453857,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "HL1 is of interest, as it encodes an axon guidance protein related to Robo3. Mutations in the Robo3",
            "probability": 0.03554455581863029,
            "start_logit": 2.666813373565674,
            "end_logit": 2.7294375896453857,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "SNPs in the DSCAM gene encoding an axon guidance protein in the same structural class with Chl1 and Robo3",
            "probability": 0.034089294972867855,
            "start_logit": 2.1671924591064453,
            "end_logit": 3.1872549057006836,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "SNPs in the DSCAM",
            "probability": 0.02979322326727562,
            "start_logit": 2.1671924591064453,
            "end_logit": 3.0525524616241455,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "HSPG2 Variant Associated with Familial Idiopathic Scoliosis.Overall, these findings demonstrate a novel role for kif6",
            "probability": 0.02353324672215419,
            "start_logit": 3.554067611694336,
            "end_logit": 1.4298105239868164,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "HL1",
            "probability": 0.02284449844199646,
            "start_logit": 2.666813373565674,
            "end_logit": 2.287360906600952,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "HL1 is of interest, as it encodes an axon guidance protein related to Robo3",
            "probability": 0.019878454787561523,
            "start_logit": 2.666813373565674,
            "end_logit": 2.148287057876587,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "SNPs in the DSCAM gene encoding an axon guidance protein in the same structural class with Chl1",
            "probability": 0.0171549110464767,
            "start_logit": 2.1671924591064453,
            "end_logit": 2.500555992126465,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "DSCAM gene",
            "probability": 0.006078084194747597,
            "start_logit": 3.29895281791687,
            "end_logit": 0.3312006890773773,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "kif6 in spinal development and identify a new candidate gene for human idiopathic scoliosis.HL1",
            "probability": 0.006074319258239248,
            "start_logit": 1.3421729803085327,
            "end_logit": 2.287360906600952,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "kif6",
            "probability": 0.0025767258537548513,
            "start_logit": 1.3421729803085327,
            "end_logit": 1.4298105239868164,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "SNPs in the DSCAM gene",
            "probability": 0.0019599700410857296,
            "start_logit": 2.1671924591064453,
            "end_logit": 0.3312006890773773,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "Exome Sequencing Identifies a Rare HSPG2",
            "probability": 0.0015733970178276248,
            "start_logit": -1.4975529909133911,
            "end_logit": 3.7762539386749268,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        }
    ],
    "5324cf139b2d7acc7e00001f": [
        {
            "text": "fibromyalgia syndrome",
            "probability": 0.4289612132214499,
            "start_logit": 3.428640365600586,
            "end_logit": 2.3400230407714844,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "fibromyalgia",
            "probability": 0.35169918569725805,
            "start_logit": 3.428640365600586,
            "end_logit": 2.141432762145996,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake inhibitors",
            "probability": 0.13042943961517148,
            "start_logit": 2.1290581226348877,
            "end_logit": 2.449071168899536,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "dapoxetine (SSRI)Drug therapy of fibromyalgia syndrome",
            "probability": 0.03235039083914949,
            "start_logit": 0.8438999652862549,
            "end_logit": 2.3400230407714844,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "dapoxetine (SSRI)Drug therapy of fibromyalgia",
            "probability": 0.026523624431384802,
            "start_logit": 0.8438999652862549,
            "end_logit": 2.141432762145996,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "myalgia syndrome",
            "probability": 0.005464139254861544,
            "start_logit": -0.9345195293426514,
            "end_logit": 2.3400230407714844,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "dapoxetine",
            "probability": 0.004662081694908063,
            "start_logit": 0.8438999652862549,
            "end_logit": 0.40285900235176086,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "myalgia",
            "probability": 0.00447996990692755,
            "start_logit": -0.9345195293426514,
            "end_logit": 2.141432762145996,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "serotonin reuptake inhibitors",
            "probability": 0.0028817845992522824,
            "start_logit": -1.6833645105361938,
            "end_logit": 2.449071168899536,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "fi",
            "probability": 0.0022012638852414263,
            "start_logit": 3.428640365600586,
            "end_logit": -2.932311773300171,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "syndrome",
            "probability": 0.0017862127923641462,
            "start_logit": -2.052628517150879,
            "end_logit": 2.3400230407714844,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake inhibitor",
            "probability": 0.0014815873320044657,
            "start_logit": 2.1290581226348877,
            "end_logit": -2.0286471843719482,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "inhibitors",
            "probability": 0.0013913795623621454,
            "start_logit": -2.4114785194396973,
            "end_logit": 2.449071168899536,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "gia syndrome",
            "probability": 0.001231074194841083,
            "start_logit": -2.4248390197753906,
            "end_logit": 2.3400230407714844,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "gia",
            "probability": 0.001009340188608144,
            "start_logit": -2.4248390197753906,
            "end_logit": 2.141432762145996,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "fibromyalgia syndrome.",
            "probability": 0.0008492441391747265,
            "start_logit": 3.428640365600586,
            "end_logit": -3.884752035140991,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "reports on the off-label use of selective serotonin reuptake inhibitors",
            "probability": 0.0007604716831994459,
            "start_logit": -3.0155906677246094,
            "end_logit": 2.449071168899536,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "Drug therapy of fibromyalgia syndrome",
            "probability": 0.0006666996793703223,
            "start_logit": -3.0381417274475098,
            "end_logit": 2.3400230407714844,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake",
            "probability": 0.0005885958323028387,
            "start_logit": 2.1290581226348877,
            "end_logit": -2.9517767429351807,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective",
            "probability": 0.0005823014501684231,
            "start_logit": 2.1290581226348877,
            "end_logit": -2.9625282287597656,
            "question_text": "List the off-label use of SSRIs"
        }
    ],
    "54cf705ff693c3b16b000014": [
        {
            "text": "\u03b1v\u03b25",
            "probability": 0.3428944319829507,
            "start_logit": 3.9335532188415527,
            "end_logit": 4.380614757537842,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v\u03b23 and \u03b1v\u03b25",
            "probability": 0.26541086290435045,
            "start_logit": 3.7917470932006836,
            "end_logit": 4.266277313232422,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v\u03b23",
            "probability": 0.17645357428459477,
            "start_logit": 3.7917470932006836,
            "end_logit": 3.85805606842041,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v heterodimer with high specificity for \u03b1v\u03b23 and \u03b1v\u03b25",
            "probability": 0.06598280960687475,
            "start_logit": 2.399862289428711,
            "end_logit": 4.266277313232422,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v heterodimer with high specificity for \u03b1v\u03b23",
            "probability": 0.04386746823045012,
            "start_logit": 2.399862289428711,
            "end_logit": 3.85805606842041,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "integrin \u03b1v heterodimer with high specificity for \u03b1v\u03b23 and \u03b1v\u03b25",
            "probability": 0.02179022167990513,
            "start_logit": 1.2919293642044067,
            "end_logit": 4.266277313232422,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "integrin \u03b1v heterodimer with high specificity for \u03b1v\u03b23",
            "probability": 0.014486831691054733,
            "start_logit": 1.2919293642044067,
            "end_logit": 3.85805606842041,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v\u03b25 integrins",
            "probability": 0.013958692743879323,
            "start_logit": 3.9335532188415527,
            "end_logit": 1.1792945861816406,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v\u03b23 and \u03b1v\u03b25 integrins",
            "probability": 0.010776339727773818,
            "start_logit": 3.6748037338256836,
            "end_logit": 1.1792945861816406,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v\u03b25 integrin",
            "probability": 0.009595417253160396,
            "start_logit": 3.9335532188415527,
            "end_logit": 0.8044777512550354,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "integrins \u03b1v\u03b23 and \u03b1v\u03b25",
            "probability": 0.008182858623306512,
            "start_logit": 0.5875073075294495,
            "end_logit": 3.9912796020507812,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v\u03b23 and \u03b1v\u03b25 integrin",
            "probability": 0.00740781948905205,
            "start_logit": 3.6748037338256836,
            "end_logit": 0.8044777512550354,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v",
            "probability": 0.005615715585136061,
            "start_logit": 2.399862289428711,
            "end_logit": 1.8024520874023438,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "integrins \u03b1v\u03b23",
            "probability": 0.004925936661203347,
            "start_logit": 0.5875073075294495,
            "end_logit": 3.483752489089966,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "integrin \u03b1v",
            "probability": 0.0018545389052160555,
            "start_logit": 1.2919293642044067,
            "end_logit": 1.8024520874023438,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v\u03b25.",
            "probability": 0.0018316516933457381,
            "start_logit": 3.8957629203796387,
            "end_logit": -0.8137994408607483,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v\u03b23 and \u03b1v\u03b25.",
            "probability": 0.0016507047159018743,
            "start_logit": 3.7917470932006836,
            "end_logit": -0.8137994408607483,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "high specificity for \u03b1v\u03b23 and \u03b1v\u03b25",
            "probability": 0.0013412450256927958,
            "start_logit": -1.4959336519241333,
            "end_logit": 4.266277313232422,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v heterodimer",
            "probability": 0.0010652979733230456,
            "start_logit": 2.399862289428711,
            "end_logit": 0.14013761281967163,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1v\u03b23 and \u03b1v",
            "probability": 0.0009075812228285543,
            "start_logit": 3.7917470932006836,
            "end_logit": -1.4119739532470703,
            "question_text": "List receptors of the drug Cilengitide"
        }
    ],
    "5171a1498ed59a060a000012": [
        {
            "text": "MYD88",
            "probability": 0.12334474832028385,
            "start_logit": 4.9748945236206055,
            "end_logit": 4.264004707336426,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "ATM in 9%, MYD88",
            "probability": 0.10822084058291388,
            "start_logit": 4.844085216522217,
            "end_logit": 4.264004707336426,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "TP53 in 15% of patients, ATM in 9%, MYD88",
            "probability": 0.09290854598499908,
            "start_logit": 4.691526889801025,
            "end_logit": 4.264004707336426,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "TP53",
            "probability": 0.08472834206044719,
            "start_logit": 4.691526889801025,
            "end_logit": 4.171839237213135,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "MYD88 in 10%, and NOTCH1",
            "probability": 0.08262830651506843,
            "start_logit": 4.9748945236206055,
            "end_logit": 3.8633737564086914,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "ATM in 9%, MYD88 in 10%, and NOTCH1",
            "probability": 0.07249684245804934,
            "start_logit": 4.844085216522217,
            "end_logit": 3.8633737564086914,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "ATM",
            "probability": 0.06630121894227417,
            "start_logit": 4.844085216522217,
            "end_logit": 3.7740390300750732,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "NOTCH1",
            "probability": 0.0656562555196422,
            "start_logit": 4.7449750900268555,
            "end_logit": 3.8633737564086914,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "TP53 in 15% of patients, ATM in 9%, MYD88 in 10%, and NOTCH1",
            "probability": 0.062239178563027506,
            "start_logit": 4.691526889801025,
            "end_logit": 3.8633737564086914,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "TP53 in 15% of patients, ATM",
            "probability": 0.05692018113868094,
            "start_logit": 4.691526889801025,
            "end_logit": 3.7740390300750732,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "MYD88 in 10%, and NOTCH1 in 4%) and five with unestablished roles (SF3B1",
            "probability": 0.03521531721567518,
            "start_logit": 4.9748945236206055,
            "end_logit": 3.010502576828003,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "NOTCH1 in 4%) and five with unestablished roles (SF3B1, ZMYM3, MAPK1",
            "probability": 0.029681092276149956,
            "start_logit": 4.7449750900268555,
            "end_logit": 3.069451093673706,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "NOTCH1 in 4%) and five with unestablished roles (SF3B1",
            "probability": 0.027982007169612994,
            "start_logit": 4.7449750900268555,
            "end_logit": 3.010502576828003,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "NOTCH1 in 4%) and five with unestablished roles (SF3B1, ZMYM3",
            "probability": 0.023510183012165432,
            "start_logit": 4.7449750900268555,
            "end_logit": 2.836374521255493,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "kelch-like 6 (KLHL6",
            "probability": 0.014301187732657154,
            "start_logit": 3.8870038986206055,
            "end_logit": 3.1972546577453613,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "XPO1), myeloid differentiation primary response gene 88 (MYD88",
            "probability": 0.012837394289753395,
            "start_logit": 3.5293827056884766,
            "end_logit": 3.4468955993652344,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "MYD88) and kelch-like 6 (KLHL6",
            "probability": 0.012173024727061001,
            "start_logit": 3.725883722305298,
            "end_logit": 3.1972546577453613,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "notch 1 (NOTCH1), exportin 1 (XPO1), myeloid differentiation primary response gene 88 (MYD88",
            "probability": 0.010350739495891256,
            "start_logit": 3.3140783309936523,
            "end_logit": 3.4468955993652344,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "myeloid differentiation primary response gene 88 (MYD88",
            "probability": 0.010067673495989408,
            "start_logit": 3.2863500118255615,
            "end_logit": 3.4468955993652344,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "KLHL6",
            "probability": 0.00843692049965782,
            "start_logit": 3.359278678894043,
            "end_logit": 3.1972546577453613,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        }
    ],
    "54d77bdf3706e89528000019": [
        {
            "text": "22",
            "probability": 0.3411381726352128,
            "start_logit": 1.444567322731018,
            "end_logit": 1.4292514324188232,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3) ) and 22",
            "probability": 0.22097335449890312,
            "start_logit": 1.010321855545044,
            "end_logit": 1.4292514324188232,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "1",
            "probability": 0.13943791266516253,
            "start_logit": 1.010321855545044,
            "end_logit": 0.9688287377357483,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "Chromosomes 1 (LOD = 3.07, p = 3 \u00d7 10(-3) ) and 22",
            "probability": 0.0776695500236012,
            "start_logit": -0.03525698184967041,
            "end_logit": 1.4292514324188232,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "6",
            "probability": 0.06520065634627861,
            "start_logit": 1.07984459400177,
            "end_logit": 0.13915610313415527,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "Chromosomes 1",
            "probability": 0.049010795702009106,
            "start_logit": -0.03525698184967041,
            "end_logit": 0.9688287377357483,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "22 (LOD = 3.45, p = 6 \u00d7 10(-5) )",
            "probability": 0.017285505901107643,
            "start_logit": 1.444567322731018,
            "end_logit": -1.5531678199768066,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "(LOD = 3.07, p = 3 \u00d7 10(-3) ) and 22",
            "probability": 0.01589326840256115,
            "start_logit": -1.6218246221542358,
            "end_logit": 1.4292514324188232,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "6p",
            "probability": 0.012908431256051893,
            "start_logit": 1.07984459400177,
            "end_logit": -1.4804327487945557,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "6p trisomy. Of particular interest were two regions (Chr8, Max LOD\u200a=\u200a3.04; Chr12,",
            "probability": 0.00955840679829491,
            "start_logit": 1.07984459400177,
            "end_logit": -1.7808923721313477,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "22 (",
            "probability": 0.00822951706209091,
            "start_logit": 1.444567322731018,
            "end_logit": -2.295308828353882,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "3.07, p = 3 \u00d7 10(-3) ) and 22",
            "probability": 0.007194777791093779,
            "start_logit": -2.414364814758301,
            "end_logit": 1.4292514324188232,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "6p trisomy. Of particular interest were two regions (Chr8",
            "probability": 0.007031938291023349,
            "start_logit": 1.07984459400177,
            "end_logit": -2.087851047515869,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5",
            "probability": 0.0055338218226371645,
            "start_logit": -0.45295289158821106,
            "end_logit": -0.7946372628211975,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3) ) and 22 (",
            "probability": 0.005330696289625601,
            "start_logit": 1.010321855545044,
            "end_logit": -2.295308828353882,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "6p trisomy",
            "probability": 0.005207100971857564,
            "start_logit": 1.07984459400177,
            "end_logit": -2.3882901668548584,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "1 (",
            "probability": 0.00421163476067972,
            "start_logit": 1.010321855545044,
            "end_logit": -2.530939817428589,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3) )",
            "probability": 0.004087911684289841,
            "start_logit": 1.010321855545044,
            "end_logit": -2.5607564449310303,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q35.1). CGH microarray showed a approximately 520.7 kb microdeletion on 16",
            "probability": 0.002188906228172956,
            "start_logit": -0.45295289158821106,
            "end_logit": -1.7221139669418335,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5 (5",
            "probability": 0.001907640869346145,
            "start_logit": -1.517964243888855,
            "end_logit": -0.7946372628211975,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        }
    ],
    "56be0a18ef6e394741000006": [
        {
            "text": "pleural effusion",
            "probability": 0.38855919520493404,
            "start_logit": 4.396334171295166,
            "end_logit": 4.676707744598389,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites and pleural effusion",
            "probability": 0.26952235720221024,
            "start_logit": 4.0305399894714355,
            "end_logit": 4.676707744598389,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites",
            "probability": 0.22248311865050616,
            "start_logit": 4.0305399894714355,
            "end_logit": 4.484907627105713,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites, and pleural effusion",
            "probability": 0.06336775501161661,
            "start_logit": 3.4958889484405518,
            "end_logit": 3.763662576675415,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "pleural effusion.Although postmenopausal women with ovarian tumor, ascites",
            "probability": 0.01005050437320598,
            "start_logit": 4.396334171295166,
            "end_logit": 1.0218850374221802,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ovarian tumor, ascites",
            "probability": 0.007658658555638848,
            "start_logit": 1.2290617227554321,
            "end_logit": 3.9173715114593506,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites and pleural effusion.Although postmenopausal women with ovarian tumor, ascites",
            "probability": 0.006971487647612876,
            "start_logit": 4.0305399894714355,
            "end_logit": 1.0218850374221802,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ovarian tumor, ascites, and pleural effusion",
            "probability": 0.006567464980675388,
            "start_logit": 1.2290617227554321,
            "end_logit": 3.763662576675415,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "pleural effusion.Although postmenopausal women with ovarian tumor, ascites, pleural effusion",
            "probability": 0.0048581387702670556,
            "start_logit": 4.396334171295166,
            "end_logit": 0.29491761326789856,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "benign solid ovarian tumor, ascites",
            "probability": 0.003764542960287929,
            "start_logit": 0.5188513398170471,
            "end_logit": 3.9173715114593506,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "solid ovarian tumor, ascites",
            "probability": 0.003635736547495583,
            "start_logit": 0.4840365946292877,
            "end_logit": 3.9173715114593506,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "benign solid ovarian tumor, ascites, and pleural effusion",
            "probability": 0.0032281768250049265,
            "start_logit": 0.5188513398170471,
            "end_logit": 3.763662576675415,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "solid ovarian tumor, ascites, and pleural effusion",
            "probability": 0.003117722546471081,
            "start_logit": 0.4840365946292877,
            "end_logit": 3.763662576675415,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "pleural effusion and ascites",
            "probability": 0.0014890148258083612,
            "start_logit": 2.042130470275879,
            "end_logit": 1.4665806293487549,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ovarian tumor",
            "probability": 0.0012524386359815665,
            "start_logit": 1.2290617227554321,
            "end_logit": 2.1066272258758545,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "pleural effusion.",
            "probability": 0.0008038989380772701,
            "start_logit": 4.396334171295166,
            "end_logit": -1.5040194988250732,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites and hydrothorax",
            "probability": 0.000768618480280785,
            "start_logit": 1.617721438407898,
            "end_logit": 1.2297143936157227,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "hydrothorax",
            "probability": 0.0006909845477305962,
            "start_logit": 1.5112441778182983,
            "end_logit": 1.2297143936157227,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "benign solid ovarian tumor",
            "probability": 0.0006156246575068435,
            "start_logit": 0.5188513398170471,
            "end_logit": 2.1066272258758545,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "solid ovarian tumor",
            "probability": 0.0005945606386879673,
            "start_logit": 0.4840365946292877,
            "end_logit": 2.1066272258758545,
            "question_text": "List symptoms of Meigs' Syndrome."
        }
    ],
    "5311b99ae3eabad021000004": [
        {
            "text": "blood urea nitrogen",
            "probability": 0.28195116804442694,
            "start_logit": 5.2938971519470215,
            "end_logit": 5.350654125213623,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "creatinine (SCr) and blood urea nitrogen",
            "probability": 0.2030270056899503,
            "start_logit": 4.9655022621154785,
            "end_logit": 5.350654125213623,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "creatinine",
            "probability": 0.13902556266508623,
            "start_logit": 4.9655022621154785,
            "end_logit": 4.971972942352295,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "serum creatinine (SCr) and blood urea nitrogen",
            "probability": 0.09249192224600647,
            "start_logit": 4.179284572601318,
            "end_logit": 5.350654125213623,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "serum creatinine",
            "probability": 0.06333512868659202,
            "start_logit": 4.179284572601318,
            "end_logit": 4.971972942352295,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "urea nitrogen",
            "probability": 0.03666536719717961,
            "start_logit": 3.253995895385742,
            "end_logit": 5.350654125213623,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "blood urea nitrogen (BUN)",
            "probability": 0.03481302560823685,
            "start_logit": 5.2938971519470215,
            "end_logit": 3.2589118480682373,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "creatinine (SCr)",
            "probability": 0.03368647054431427,
            "start_logit": 4.9655022621154785,
            "end_logit": 3.5544114112854004,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "creatinine (SCr) and blood urea nitrogen (BUN)",
            "probability": 0.02506811515366444,
            "start_logit": 4.9655022621154785,
            "end_logit": 3.2589118480682373,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "blood urea nitrogen (BUN) concentrations",
            "probability": 0.021255336001975468,
            "start_logit": 5.2938971519470215,
            "end_logit": 2.7655282020568848,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "serum creatinine (SCr)",
            "probability": 0.015346364409694528,
            "start_logit": 4.179284572601318,
            "end_logit": 3.5544114112854004,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "creatinine (SCr) and blood urea nitrogen (BUN) concentrations",
            "probability": 0.015305512842333401,
            "start_logit": 4.9655022621154785,
            "end_logit": 2.7655282020568848,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "serum creatinine (SCr) and blood urea nitrogen (BUN)",
            "probability": 0.011420146545368852,
            "start_logit": 4.179284572601318,
            "end_logit": 3.2589118480682373,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "serum creatinine (SCr) and blood urea nitrogen (BUN) concentrations",
            "probability": 0.006972650258706087,
            "start_logit": 4.179284572601318,
            "end_logit": 2.7655282020568848,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "urea nitrogen (BUN)",
            "probability": 0.004527139844902837,
            "start_logit": 3.253995895385742,
            "end_logit": 3.2589118480682373,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "decreased glomerular filtration rate (GFR) are diagnosed by the evaluation of changes in the serum creatinine",
            "probability": 0.0042554904048208815,
            "start_logit": 1.4790544509887695,
            "end_logit": 4.971972942352295,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "changes in the serum creatinine (SCr) and blood urea nitrogen",
            "probability": 0.003570668912985354,
            "start_logit": 0.9249162077903748,
            "end_logit": 5.350654125213623,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "urea nitrogen (BUN) concentrations",
            "probability": 0.0027640768606039703,
            "start_logit": 3.253995895385742,
            "end_logit": 2.7655282020568848,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "changes in the serum creatinine",
            "probability": 0.0024450651430904333,
            "start_logit": 0.9249162077903748,
            "end_logit": 4.971972942352295,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "(SCr) and blood urea nitrogen",
            "probability": 0.0020737829400611805,
            "start_logit": 0.38153770565986633,
            "end_logit": 5.350654125213623,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        }
    ],
    "5131fa145274a5fb07000009": [
        {
            "text": "cystic fibrosis",
            "probability": 0.43420387684616596,
            "start_logit": 3.749323844909668,
            "end_logit": 3.620734453201294,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cytomegalovirus",
            "probability": 0.22082236917609285,
            "start_logit": 3.3646676540374756,
            "end_logit": 3.329235076904297,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cytomegalovirus, none had cystic fibrosis",
            "probability": 0.08880301431625888,
            "start_logit": 3.0931828022003174,
            "end_logit": 2.689781904220581,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "congenital cytomegalovirus",
            "probability": 0.08479806898126022,
            "start_logit": 2.8851318359375,
            "end_logit": 2.851685047149658,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "congenital cytomegalovirus, none had cystic fibrosis",
            "probability": 0.0721227571878254,
            "start_logit": 2.8851318359375,
            "end_logit": 2.689781904220581,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "anorectal malformation and cystic fibrosis",
            "probability": 0.060172123373476015,
            "start_logit": 2.2693896293640137,
            "end_logit": 3.124363660812378,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic fibrosis (CF)",
            "probability": 0.022155308762344242,
            "start_logit": 3.749323844909668,
            "end_logit": 0.6452974081039429,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "anorectal malformation",
            "probability": 0.010133818886963901,
            "start_logit": 2.2693896293640137,
            "end_logit": 1.343032717704773,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "fibrosis",
            "probability": 0.0018596563070779144,
            "start_logit": -1.7037986516952515,
            "end_logit": 3.620734453201294,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic fibrosis,",
            "probability": 0.0014296357510059528,
            "start_logit": 3.7204976081848145,
            "end_logit": -2.0665338039398193,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic fibrosis, were detected postnatallySix had chromosomal/genetic abnormalities,",
            "probability": 0.0007360832769924817,
            "start_logit": 3.7204976081848145,
            "end_logit": -2.730365514755249,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "malformation and cystic fibrosis",
            "probability": 0.00048438314506553664,
            "start_logit": -2.5526986122131348,
            "end_logit": 3.124363660812378,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "serology for cytomegalovirus",
            "probability": 0.0004760840645706458,
            "start_logit": -2.7748517990112305,
            "end_logit": 3.329235076904297,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "anorectal malformation and cystic fibrosis,",
            "probability": 0.00033497871497229767,
            "start_logit": 2.2693896293640137,
            "end_logit": -2.0665338039398193,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cytomegalovir",
            "probability": 0.00032572424215179135,
            "start_logit": 3.3646676540374756,
            "end_logit": -3.1898276805877686,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "omegalovirus",
            "probability": 0.000315952302142532,
            "start_logit": -3.1848549842834473,
            "end_logit": 3.329235076904297,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cytomegalovirus (CMV)",
            "probability": 0.00025663619609871433,
            "start_logit": 3.3646676540374756,
            "end_logit": -3.4282193183898926,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "sis",
            "probability": 0.0001947663477661362,
            "start_logit": -3.9601449966430664,
            "end_logit": 3.620734453201294,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic fibrosis, were detected postnatallySix had chromosomal/genetic abnormalities, two had congenital c",
            "probability": 0.00019452516975927985,
            "start_logit": 3.7204976081848145,
            "end_logit": -4.061147212982178,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "ovirus",
            "probability": 0.00018023695200946203,
            "start_logit": -3.746173858642578,
            "end_logit": 3.329235076904297,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        }
    ],
    "51630226298dcd4e5100004d": [
        {
            "text": "selective detection of PTMs to automatically screen for acetylation, phosphorylation, and methylation",
            "probability": 0.16092915697287924,
            "start_logit": 1.5578038692474365,
            "end_logit": 0.8957672715187073,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "automatically screen for acetylation, phosphorylation, and methylation",
            "probability": 0.0835945415456532,
            "start_logit": 0.9028178453445435,
            "end_logit": 0.8957672715187073,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "methylation",
            "probability": 0.07009881755769898,
            "start_logit": 0.7267455458641052,
            "end_logit": 0.8957672715187073,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "selective detection",
            "probability": 0.06911871592188425,
            "start_logit": 1.5578038692474365,
            "end_logit": 0.05062856897711754,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "enable selective detection of PTMs to automatically screen for acetylation, phosphorylation, and methylation",
            "probability": 0.06254207335714168,
            "start_logit": 0.612679123878479,
            "end_logit": 0.8957672715187073,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "detection of PTMs to automatically screen for acetylation, phosphorylation, and methylation",
            "probability": 0.06181171924070048,
            "start_logit": 0.6009325981140137,
            "end_logit": 0.8957672715187073,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "screen for acetylation, phosphorylation, and methylation",
            "probability": 0.060526859700702665,
            "start_logit": 0.5799268484115601,
            "end_logit": 0.8957672715187073,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "selective",
            "probability": 0.05024175710841632,
            "start_logit": 1.5578038692474365,
            "end_logit": -0.2683504819869995,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "selective detection of PTMs to automatically screen",
            "probability": 0.044533138895763484,
            "start_logit": 1.5578038692474365,
            "end_logit": -0.38896337151527405,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "selective detection of PTMs to automatically screen for acetylation, phosphorylation",
            "probability": 0.0438287040612211,
            "start_logit": 1.5578038692474365,
            "end_logit": -0.40490803122520447,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "selective detection of PTMs to automatically screen for acetylation",
            "probability": 0.040978497852612206,
            "start_logit": 1.5578038692474365,
            "end_logit": -0.47214949131011963,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "methylation.our UHPLC-MS approach for histone profiling offers a sensitive",
            "probability": 0.03775161352065301,
            "start_logit": 0.7267455458641052,
            "end_logit": 0.2768895626068115,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "sensitive",
            "probability": 0.036444514902206716,
            "start_logit": 0.6915082931518555,
            "end_logit": 0.2768895626068115,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "acetylation, phosphorylation, and methylation",
            "probability": 0.033004887874888776,
            "start_logit": -0.02650471217930317,
            "end_logit": 0.8957672715187073,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "enable selective detection",
            "probability": 0.026861681766383892,
            "start_logit": 0.612679123878479,
            "end_logit": 0.05062856897711754,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "detection",
            "probability": 0.026547996293556957,
            "start_logit": 0.6009325981140137,
            "end_logit": 0.05062856897711754,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "phosphorylation, and methylation",
            "probability": 0.0239995710337504,
            "start_logit": -0.34512442350387573,
            "end_logit": 0.8957672715187073,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "automatically screen",
            "probability": 0.023132708824216492,
            "start_logit": 0.9028178453445435,
            "end_logit": -0.38896337151527405,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "automatically screen for acetylation, phosphorylation",
            "probability": 0.022766790626731113,
            "start_logit": 0.9028178453445435,
            "end_logit": -0.40490803122520447,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "automatically screen for acetylation",
            "probability": 0.021286252942939052,
            "start_logit": 0.9028178453445435,
            "end_logit": -0.47214949131011963,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        }
    ],
    "5505eed08e1671127b000006": [
        {
            "text": "trypsin",
            "probability": 0.31537011278395444,
            "start_logit": 5.242842197418213,
            "end_logit": 4.693035125732422,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "LysC and trypsin",
            "probability": 0.1813022761930097,
            "start_logit": 4.689260959625244,
            "end_logit": 4.693035125732422,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "LysC",
            "probability": 0.11744035369233291,
            "start_logit": 4.689260959625244,
            "end_logit": 4.258800029754639,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin Asp-N to trypsin",
            "probability": 0.09762904221276132,
            "start_logit": 5.242842197418213,
            "end_logit": 3.520463228225708,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "endoproteinases LysC and trypsin",
            "probability": 0.08047969705867823,
            "start_logit": 3.8771002292633057,
            "end_logit": 4.693035125732422,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "LysC and trypsin Asp-N to trypsin",
            "probability": 0.05612569757947471,
            "start_logit": 4.689260959625244,
            "end_logit": 3.520463228225708,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "endoproteinases LysC",
            "probability": 0.052131524689525054,
            "start_logit": 3.8771002292633057,
            "end_logit": 4.258800029754639,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin tryptic digestiontryptic digestenzymatic digestion is most commonly performed using trypsin",
            "probability": 0.02665052747282786,
            "start_logit": 4.062652111053467,
            "end_logit": 3.402287244796753,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "endoproteinases LysC and trypsin Asp-N to trypsin",
            "probability": 0.024914078484014487,
            "start_logit": 3.8771002292633057,
            "end_logit": 3.520463228225708,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin Asp-N to trypsin tryptic digestion",
            "probability": 0.01767787785935512,
            "start_logit": 5.242842197418213,
            "end_logit": 1.811602234840393,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "LysC and trypsin Asp-N to trypsin tryptic digestion",
            "probability": 0.010162787671508742,
            "start_logit": 4.689260959625244,
            "end_logit": 1.811602234840393,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "endoproteinases",
            "probability": 0.005888402079460699,
            "start_logit": 3.8771002292633057,
            "end_logit": 2.078014850616455,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin tryptic digestion",
            "probability": 0.00543100355192043,
            "start_logit": 4.062652111053467,
            "end_logit": 1.811602234840393,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "endoproteinases LysC and trypsin Asp-N to trypsin tryptic digestion",
            "probability": 0.004511239959304098,
            "start_logit": 3.8771002292633057,
            "end_logit": 1.811602234840393,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin Asp-N to trypsin tryptic",
            "probability": 0.0011248986367394151,
            "start_logit": 5.242842197418213,
            "end_logit": -0.9430188536643982,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin Asp-N to trypsin tryptic digest",
            "probability": 0.0008887218078239766,
            "start_logit": 5.242842197418213,
            "end_logit": -1.178682804107666,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "LysC and trypsin Asp-N to trypsin tryptic",
            "probability": 0.0006466899527254316,
            "start_logit": 4.689260959625244,
            "end_logit": -0.9430188536643982,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin Asp-N to trypsin tryptic digestiontryptic digestenzymatic digestion",
            "probability": 0.0005923633260803538,
            "start_logit": 5.242842197418213,
            "end_logit": -1.584346890449524,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "tryps",
            "probability": 0.0005217900979367139,
            "start_logit": 5.242842197418213,
            "end_logit": -1.7112016677856445,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "LysC and trypsin Asp-N to trypsin tryptic digest",
            "probability": 0.000510914890566166,
            "start_logit": 4.689260959625244,
            "end_logit": -1.178682804107666,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        }
    ],
    "55451e53bf90a13052000003": [
        {
            "text": "Mfd",
            "probability": 0.678970265544817,
            "start_logit": 5.79472017288208,
            "end_logit": 5.329409122467041,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "NusA",
            "probability": 0.09788310828495365,
            "start_logit": 4.368405342102051,
            "end_logit": 4.818920612335205,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "CSB",
            "probability": 0.059003010175763676,
            "start_logit": 4.464576721191406,
            "end_logit": 4.216563701629639,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd, promotes direct restart of the fork following the collision by facilitating displacement of the RNAP",
            "probability": 0.04767816258611494,
            "start_logit": 5.673278331756592,
            "end_logit": 2.7947471141815186,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd,",
            "probability": 0.041760658717604086,
            "start_logit": 5.673278331756592,
            "end_logit": 2.6622283458709717,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "RNAP.We report observations suggesting that the transcription elongation factor NusA",
            "probability": 0.04094703746549921,
            "start_logit": 3.496910810470581,
            "end_logit": 4.818920612335205,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd) is a transcription repair coupling factor, involved in repair of template strand during transcription.the transcription-repair coupling factor, Mfd",
            "probability": 0.02558286418825339,
            "start_logit": 2.6779422760009766,
            "end_logit": 5.167532444000244,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "RNAP",
            "probability": 0.005409225730253996,
            "start_logit": 3.496910810470581,
            "end_logit": 2.7947471141815186,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "CSB,",
            "probability": 0.0011008041496627981,
            "start_logit": 4.464576721191406,
            "end_logit": 0.23501619696617126,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "transcription elongation factor NusA",
            "probability": 0.0006768917038978947,
            "start_logit": -0.6056126356124878,
            "end_logit": 4.818920612335205,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "RNAP.We report observations suggesting that the transcription elongation factor",
            "probability": 0.00019097090337898083,
            "start_logit": 3.496910810470581,
            "end_logit": -0.5489930510520935,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "M",
            "probability": 0.0001657859197951744,
            "start_logit": 5.79472017288208,
            "end_logit": -2.9882261753082275,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd)",
            "probability": 0.0001361382247765888,
            "start_logit": 2.6779422760009766,
            "end_logit": -0.06847486644983292,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "d",
            "probability": 9.839343121168624e-05,
            "start_logit": -3.0446383953094482,
            "end_logit": 5.329409122467041,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "fd",
            "probability": 9.238741530659622e-05,
            "start_logit": -3.107621669769287,
            "end_logit": 5.329409122467041,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "TCR coupling factor, CSB",
            "probability": 7.678019437664489e-05,
            "start_logit": -2.1798202991485596,
            "end_logit": 4.216563701629639,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": ", Mfd",
            "probability": 7.15806451020123e-05,
            "start_logit": -3.200911045074463,
            "end_logit": 5.167532444000244,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "usA",
            "probability": 6.923167674468612e-05,
            "start_logit": -2.8856654167175293,
            "end_logit": 4.818920612335205,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "NAP.We report observations suggesting that the transcription elongation factor NusA",
            "probability": 5.854596113702528e-05,
            "start_logit": -3.053311824798584,
            "end_logit": 4.818920612335205,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "B",
            "probability": 2.8157081349941243e-05,
            "start_logit": -3.1829681396484375,
            "end_logit": 4.216563701629639,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        }
    ],
    "52eea509c8da89891000000d": [
        {
            "text": "KCNH2",
            "probability": 0.1691599232294287,
            "start_logit": 2.2244982719421387,
            "end_logit": 0.7566338181495667,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1",
            "probability": 0.11426881152900879,
            "start_logit": 1.9016594886779785,
            "end_logit": 0.6871817111968994,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNH2 (locus name LQT2) and SCN5A",
            "probability": 0.10043081789050666,
            "start_logit": 2.0813541412353516,
            "end_logit": 0.3784025013446808,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1 (locus name LQT1), KCNH2",
            "probability": 0.0972642407354136,
            "start_logit": 1.9016594886779785,
            "end_logit": 0.5260594487190247,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1 and KCNH2",
            "probability": 0.0884135072200712,
            "start_logit": 1.5756784677505493,
            "end_logit": 0.7566338181495667,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "SCN5A",
            "probability": 0.07060581864568197,
            "start_logit": 1.7289975881576538,
            "end_logit": 0.3784025013446808,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNE1",
            "probability": 0.05848404549884243,
            "start_logit": 1.8511253595352173,
            "end_logit": 0.06791616231203079,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "SCN5A (locus name LQT3) are the most common. Other, less frequently involved genes are KCNE1",
            "probability": 0.05176044353103433,
            "start_logit": 1.7289975881576538,
            "end_logit": 0.06791616231203079,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNE1 (locus name LQT5), KCNE2",
            "probability": 0.03421988060576799,
            "start_logit": 1.8511253595352173,
            "end_logit": -0.46803104877471924,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNJ5",
            "probability": 0.03389959799624924,
            "start_logit": 1.4635162353515625,
            "end_logit": -0.08982554823160172,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNE2",
            "probability": 0.02715407610389726,
            "start_logit": 1.6198457479476929,
            "end_logit": -0.46803104877471924,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "SCN4B",
            "probability": 0.024071007929277626,
            "start_logit": 1.3159486055374146,
            "end_logit": -0.2846529483795166,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1; MIM 607542).Mutations in a cardiac voltage-gated potassium channel, KCNQ1",
            "probability": 0.02368464798973864,
            "start_logit": 1.5190333127975464,
            "end_logit": -0.5039187073707581,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "CAV3 (locus name LQT9), SCN4B",
            "probability": 0.020920889233627768,
            "start_logit": 1.175688624382019,
            "end_logit": -0.2846529483795166,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNE2 (locus name LQT6), CAV3",
            "probability": 0.018571507662115884,
            "start_logit": 1.6198457479476929,
            "end_logit": -0.8479296565055847,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KQT-like, voltage-gated potassium channel-1 gene (KCNQ1",
            "probability": 0.014618822787571881,
            "start_logit": 0.5055689811706543,
            "end_logit": 0.027028480544686317,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "SNTA1",
            "probability": 0.014418676059259734,
            "start_logit": 0.5373104214668274,
            "end_logit": -0.018498575314879417,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "SNTA1 (locus name LQT12) and KCNJ5",
            "probability": 0.013426056609466476,
            "start_logit": 0.5373104214668274,
            "end_logit": -0.08982554823160172,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNE1 (locus name LQT5), KCNE2 (locus name LQT6)",
            "probability": 0.012658001847309957,
            "start_logit": 1.8511253595352173,
            "end_logit": -1.4625482559204102,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNE2 (locus name LQT6), CAV3 (locus name LQT9)",
            "probability": 0.011969226895729566,
            "start_logit": 1.6198457479476929,
            "end_logit": -1.2872192859649658,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        }
    ],
    "54e1252fae9738404b000003": [
        {
            "text": "dystrophic scarring and joint hypermobility",
            "probability": 0.2026501185777983,
            "start_logit": 5.5843071937561035,
            "end_logit": 5.3805718421936035,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "dystrophic scarring",
            "probability": 0.18863892247055875,
            "start_logit": 5.5843071937561035,
            "end_logit": 5.308925628662109,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility",
            "probability": 0.17358926578222714,
            "start_logit": 5.392569065093994,
            "end_logit": 5.417520999908447,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility, dystrophic scarring and joint hypermobility",
            "probability": 0.16729233809563776,
            "start_logit": 5.392569065093994,
            "end_logit": 5.3805718421936035,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility, dystrophic scarring",
            "probability": 0.15572577315727704,
            "start_logit": 5.392569065093994,
            "end_logit": 5.308925628662109,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "joint hypermobility",
            "probability": 0.1077617742475758,
            "start_logit": 4.952749252319336,
            "end_logit": 5.3805718421936035,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility,",
            "probability": 0.0009699628931164289,
            "start_logit": 5.392569065093994,
            "end_logit": 0.23033156991004944,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hyperextensibility",
            "probability": 0.00043350904818351854,
            "start_logit": -0.599965512752533,
            "end_logit": 5.417520999908447,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hyperextensibility, dystrophic scarring and joint hypermobility",
            "probability": 0.00041778356472350783,
            "start_logit": -0.599965512752533,
            "end_logit": 5.3805718421936035,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hyperextensibility, dystrophic scarring",
            "probability": 0.0003888980772794162,
            "start_logit": -0.599965512752533,
            "end_logit": 5.308925628662109,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "dystrophic scarring and joint hypermobilityAll type V collagen defects",
            "probability": 0.0003292174388113762,
            "start_logit": 5.5843071937561035,
            "end_logit": -1.0419459342956543,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "dystrophic",
            "probability": 0.0003275471905396473,
            "start_logit": 5.5843071937561035,
            "end_logit": -1.0470322370529175,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility, dystrophic scarring and joint hypermobilityAll type V collagen defects",
            "probability": 0.0002717765746555383,
            "start_logit": 5.392569065093994,
            "end_logit": -1.0419459342956543,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility, dystrophic",
            "probability": 0.00027039774625643,
            "start_logit": 5.392569065093994,
            "end_logit": -1.0470322370529175,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "scarring and joint hypermobility",
            "probability": 0.00021174922436573826,
            "start_logit": -1.2795263528823853,
            "end_logit": 5.3805718421936035,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "scarring",
            "probability": 0.00019710891757013558,
            "start_logit": -1.2795263528823853,
            "end_logit": 5.308925628662109,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hypermobility",
            "probability": 0.00018238345998503844,
            "start_logit": -1.428817629814148,
            "end_logit": 5.3805718421936035,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "joint hypermobilityAll type V collagen defects",
            "probability": 0.00017506555421005994,
            "start_logit": 4.952749252319336,
            "end_logit": -1.0419459342956543,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "dystrophic scar",
            "probability": 9.115633016587799e-05,
            "start_logit": 5.5843071937561035,
            "end_logit": -2.3260884284973145,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility, dystrophic scar",
            "probability": 7.525164906238728e-05,
            "start_logit": 5.392569065093994,
            "end_logit": -2.3260884284973145,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        }
    ],
    "517a8bef8ed59a060a000041": [
        {
            "text": "D3",
            "probability": 0.2763737627734132,
            "start_logit": 1.6687618494033813,
            "end_logit": 1.254202127456665,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D2, and D3",
            "probability": 0.17279823399936123,
            "start_logit": 1.1991323232650757,
            "end_logit": 1.254202127456665,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D2, and D3",
            "probability": 0.15338128959688663,
            "start_logit": 1.0799345970153809,
            "end_logit": 1.254202127456665,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1",
            "probability": 0.12732870971947208,
            "start_logit": 1.1991323232650757,
            "end_logit": 0.9488494992256165,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D2",
            "probability": 0.08802122489756396,
            "start_logit": 1.1991323232650757,
            "end_logit": 0.5796554684638977,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D2",
            "probability": 0.07813048012247541,
            "start_logit": 1.0799345970153809,
            "end_logit": 0.5796554684638977,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinases D1, D2, and D3",
            "probability": 0.041745183530169296,
            "start_logit": -0.22140823304653168,
            "end_logit": 1.254202127456665,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinases D1",
            "probability": 0.03076050161437797,
            "start_logit": -0.22140823304653168,
            "end_logit": 0.9488494992256165,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinases D1, D2",
            "probability": 0.021264466093517474,
            "start_logit": -0.22140823304653168,
            "end_logit": 0.5796554684638977,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D",
            "probability": 0.002686603899801374,
            "start_logit": 1.1991323232650757,
            "end_logit": -2.909644603729248,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D2, and D",
            "probability": 0.0012261262374541248,
            "start_logit": 1.1991323232650757,
            "end_logit": -3.6940627098083496,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D2, and D",
            "probability": 0.0010883492218444043,
            "start_logit": 1.0799345970153809,
            "end_logit": -3.6940627098083496,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D",
            "probability": 0.0009237311009771648,
            "start_logit": 1.1991323232650757,
            "end_logit": -3.9772567749023438,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "deiodinases D1, D2, and D3",
            "probability": 0.0007988063877048205,
            "start_logit": -4.177628993988037,
            "end_logit": 1.254202127456665,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1,",
            "probability": 0.0006770679370604919,
            "start_logit": 1.1991323232650757,
            "end_logit": -4.287906169891357,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinases D",
            "probability": 0.0006490388835252306,
            "start_logit": -0.22140823304653168,
            "end_logit": -2.909644603729248,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine",
            "probability": 0.0006127635603473318,
            "start_logit": -0.22140823304653168,
            "end_logit": -2.967158079147339,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "deiodinases D1",
            "probability": 0.0005886112624420869,
            "start_logit": -4.177628993988037,
            "end_logit": 0.9488494992256165,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D2,",
            "probability": 0.0005006532119722866,
            "start_logit": 1.1991323232650757,
            "end_logit": -4.58976411819458,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D2,",
            "probability": 0.0004443959496334703,
            "start_logit": 1.0799345970153809,
            "end_logit": -4.58976411819458,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        }
    ],
    "5148885ad24251bc05000032": [
        {
            "text": "VKORC1",
            "probability": 0.3507940862223839,
            "start_logit": 4.556870460510254,
            "end_logit": 3.8910152912139893,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP4F2",
            "probability": 0.1527142027579185,
            "start_logit": 4.140284061431885,
            "end_logit": 3.475970506668091,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 gene has also been associated with bleeding risk with warfarin. The CYP4F2",
            "probability": 0.12204256500736632,
            "start_logit": 3.916085720062256,
            "end_logit": 3.475970506668091,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9",
            "probability": 0.10177214123692699,
            "start_logit": 3.916085720062256,
            "end_logit": 3.294337034225464,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1",
            "probability": 0.09902833352249231,
            "start_logit": 3.4424328804016113,
            "end_logit": 3.740659475326538,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1",
            "probability": 0.049180186831598235,
            "start_logit": 3.2834722995758057,
            "end_logit": 3.199704885482788,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1)",
            "probability": 0.029078685225935538,
            "start_logit": 4.396729946136475,
            "end_logit": 1.5609618425369263,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 gene",
            "probability": 0.018834676249844123,
            "start_logit": 3.916085720062256,
            "end_logit": 1.6073002815246582,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9) and vitamin K epoxide reductase complex subunit 1",
            "probability": 0.012420588845367377,
            "start_logit": 3.4424328804016113,
            "end_logit": 1.6646089553833008,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1)",
            "probability": 0.011197699703549164,
            "start_logit": 3.4424328804016113,
            "end_logit": 1.5609618425369263,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP4F2 gene",
            "probability": 0.009643911616112876,
            "start_logit": 4.140284061431885,
            "end_logit": 0.7137290835380554,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "vitamin K epoxide reductase complex subunit 1 (VKORC1",
            "probability": 0.008667068299961703,
            "start_logit": 1.0065574645996094,
            "end_logit": 3.740659475326538,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 gene has also been associated with bleeding risk with warfarin. The CYP4F2 gene",
            "probability": 0.007706995741584508,
            "start_logit": 3.916085720062256,
            "end_logit": 0.7137290835380554,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC",
            "probability": 0.0054699327665193205,
            "start_logit": 4.396729946136475,
            "end_logit": -0.10977727174758911,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9)",
            "probability": 0.004229861539724707,
            "start_logit": 3.4424328804016113,
            "end_logit": 0.5874227285385132,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "The CYP2C9 gene has also been associated with bleeding risk with warfarin. The CYP4F2",
            "probability": 0.004149592931363346,
            "start_logit": 0.534726083278656,
            "end_logit": 3.475970506668091,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "(CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1",
            "probability": 0.004046158075881554,
            "start_logit": 0.24479468166828156,
            "end_logit": 3.740659475326538,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "The CYP2C9",
            "probability": 0.003460374319902029,
            "start_logit": 0.534726083278656,
            "end_logit": 3.294337034225464,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "cytochrome P450 (CYP) 2C9 (CYP2C9",
            "probability": 0.0028876537059974203,
            "start_logit": 1.166633129119873,
            "end_logit": 2.4814975261688232,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genotype",
            "probability": 0.002675285399570019,
            "start_logit": 4.556870460510254,
            "end_logit": -0.9851280450820923,
            "question_text": "Which genes are involved in patient response to warfarin?"
        }
    ],
    "571e189dbb137a4b0c000003": [
        {
            "text": "empagliflozin",
            "probability": 0.47310033003879454,
            "start_logit": 5.7199625968933105,
            "end_logit": 5.567079544067383,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "dapagliflozin have been approved for the treatment of type 2 diabetes mellitusTo review available studies of empagliflozin",
            "probability": 0.19336936818787084,
            "start_logit": 4.861135005950928,
            "end_logit": 5.5312018394470215,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "dapagliflozin",
            "probability": 0.09028438275355007,
            "start_logit": 4.861135005950928,
            "end_logit": 4.769564151763916,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "canagliflozin and dapagliflozin",
            "probability": 0.08826951818797166,
            "start_logit": 4.838565349578857,
            "end_logit": 4.769564151763916,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "canagliflozin",
            "probability": 0.08009275391873275,
            "start_logit": 4.838565349578857,
            "end_logit": 4.672354698181152,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "dapagliflozin has also been approved.To review available studies of empagliflozin",
            "probability": 0.046998952451353035,
            "start_logit": 3.410780429840088,
            "end_logit": 5.567079544067383,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Empagliflozin",
            "probability": 0.02317565025263173,
            "start_logit": 4.200943470001221,
            "end_logit": 4.0698933601379395,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflozin,",
            "probability": 0.0023375814638195215,
            "start_logit": 5.60959529876709,
            "end_logit": 0.36725619435310364,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Canagliflozin",
            "probability": 0.0017845685275286254,
            "start_logit": 2.855421543121338,
            "end_logit": 2.851489782333374,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "dapagliflozin has also been approved.To review available studies of empagliflozin,",
            "probability": 0.00015307262052895415,
            "start_logit": 3.410780429840088,
            "end_logit": -0.1598885953426361,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "em",
            "probability": 9.105379025238343e-05,
            "start_logit": 5.7199625968933105,
            "end_logit": -2.988532781600952,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "type 2 diabetes mellitusTo review available studies of empagliflozin",
            "probability": 7.350505106314486e-05,
            "start_logit": -3.0138683319091797,
            "end_logit": 5.5312018394470215,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "zin",
            "probability": 5.506458006195437e-05,
            "start_logit": -3.30271577835083,
            "end_logit": 5.5312018394470215,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "zin have been approved for the treatment of type 2 diabetes mellitusTo review available studies of empagliflozin",
            "probability": 5.23622574462099e-05,
            "start_logit": -3.353036403656006,
            "end_logit": 5.5312018394470215,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "zin and dapagliflozin",
            "probability": 3.325986851024513e-05,
            "start_logit": -3.0452332496643066,
            "end_logit": 4.769564151763916,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "dapagliflozin have been approved for the treatment of type 2 diabetes mellitusTo review available studies of em",
            "probability": 3.15922249046055e-05,
            "start_logit": 4.861135005950928,
            "end_logit": -3.188244581222534,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor approved in 2014",
            "probability": 2.9488425240930955e-05,
            "start_logit": 5.7199625968933105,
            "end_logit": -4.11598539352417,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflo",
            "probability": 2.722065236771989e-05,
            "start_logit": 5.7199625968933105,
            "end_logit": -4.196007251739502,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "zin has also been approved.To review available studies of empagliflozin",
            "probability": 2.477380379729546e-05,
            "start_logit": -4.137313365936279,
            "end_logit": 5.567079544067383,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor",
            "probability": 1.5500943573906767e-05,
            "start_logit": 5.60959529876709,
            "end_logit": -4.648715019226074,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        }
    ],
    "52bf1f4503868f1b06000016": [
        {
            "text": "schizophrenia",
            "probability": 0.9260872750570323,
            "start_logit": 4.3037872314453125,
            "end_logit": 4.195999622344971,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenic disorder",
            "probability": 0.06066168069868346,
            "start_logit": 3.3774924278259277,
            "end_logit": 2.3966381549835205,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizoaffective disorder",
            "probability": 0.0024867126280409984,
            "start_logit": 1.5768285989761353,
            "end_logit": 1.0029513835906982,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenia, schizoaffective disorder",
            "probability": 0.0019992126233596215,
            "start_logit": 1.3586204051971436,
            "end_logit": 1.0029513835906982,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizoaffective disorder, or delusional disorder",
            "probability": 0.0012176470459444545,
            "start_logit": 1.5768285989761353,
            "end_logit": 0.2889101207256317,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenia, schizoaffective disorder, or delusional disorder",
            "probability": 0.0009789371387744334,
            "start_logit": 1.3586204051971436,
            "end_logit": 0.2889101207256317,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenic",
            "probability": 0.0009006215108071868,
            "start_logit": 3.3774924278259277,
            "end_logit": -1.8133442401885986,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "delusional disorder",
            "probability": 0.0008170318509719789,
            "start_logit": 1.1778310537338257,
            "end_logit": 0.2889101207256317,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenia.",
            "probability": 0.000778277231911667,
            "start_logit": 4.3037872314453125,
            "end_logit": -2.88564133644104,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenia. Reviewed here is the use of atypical neuroleptics in children and adolescents with a schizo",
            "probability": 0.0007147475894574957,
            "start_logit": 4.3037872314453125,
            "end_logit": -2.970794677734375,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenic disorder.",
            "probability": 0.0006165956207976178,
            "start_logit": 3.3774924278259277,
            "end_logit": -2.192215919494629,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "zophrenia",
            "probability": 0.000597664580023363,
            "start_logit": -3.0419068336486816,
            "end_logit": 4.195999622344971,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "chizophrenia",
            "probability": 0.000462483770471956,
            "start_logit": -3.2983250617980957,
            "end_logit": 4.195999622344971,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schi",
            "probability": 0.0004266233464063446,
            "start_logit": 4.3037872314453125,
            "end_logit": -3.4868226051330566,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenia. Reviewed here is the use of atypical neuroleptics in children and adolescents with a schi",
            "probability": 0.0003696294807614051,
            "start_logit": 4.3037872314453125,
            "end_logit": -3.630223035812378,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizo",
            "probability": 0.0002830531403233846,
            "start_logit": 3.3774924278259277,
            "end_logit": -2.970794677734375,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "s",
            "probability": 0.0002559024892761788,
            "start_logit": 4.3037872314453125,
            "end_logit": -3.997927665710449,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "childhood and adolescent schizophrenia",
            "probability": 0.0001815883252931186,
            "start_logit": -4.233194351196289,
            "end_logit": 4.195999622344971,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "zophrenia. Reviewed here is the use of atypical neuroleptics in children and adolescents with a schizophrenic disorder",
            "probability": 9.885639349228761e-05,
            "start_logit": -3.0419068336486816,
            "end_logit": 2.3966381549835205,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "chizophrenic disorder",
            "probability": 6.545947817069945e-05,
            "start_logit": -3.454143762588501,
            "end_logit": 2.3966381549835205,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        }
    ],
    "52eeddfcc8da898910000010": [
        {
            "text": "periodic paralysis",
            "probability": 0.11711940243488766,
            "start_logit": 6.247344493865967,
            "end_logit": 6.429173946380615,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "cardiodysrhythmic periodic paralysis",
            "probability": 0.09468386911294711,
            "start_logit": 6.03322172164917,
            "end_logit": 6.4306464195251465,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "ventricular arrhythmia, periodic paralysis",
            "probability": 0.07239293035498477,
            "start_logit": 5.863609790802002,
            "end_logit": 6.331823348999023,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, cardiac arrhythmia",
            "probability": 0.06933151548100779,
            "start_logit": 6.247344493865967,
            "end_logit": 5.904879570007324,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, and dysmorphic features.Andersen cardiodysrhythmic periodic paralysis",
            "probability": 0.06326752154127299,
            "start_logit": 6.019924640655518,
            "end_logit": 6.040771961212158,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "scoliosis, which, together with cardiodysrhythmic periodic paralysis",
            "probability": 0.06172650576681336,
            "start_logit": 5.605391502380371,
            "end_logit": 6.4306464195251465,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis or Andersen-Tawil syndrome includes the distinct clinical features of periodic paralysis",
            "probability": 0.05525569088656385,
            "start_logit": 5.496121883392334,
            "end_logit": 6.429173946380615,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "cleft palate, and scoliosis, which, together with cardiodysrhythmic periodic paralysis",
            "probability": 0.048469446263016754,
            "start_logit": 5.363611698150635,
            "end_logit": 6.4306464195251465,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, cardiac arrhythmia, and facial and skeletal dysmorphisms",
            "probability": 0.04812297002515836,
            "start_logit": 6.247344493865967,
            "end_logit": 5.539739608764648,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "scoliosis",
            "probability": 0.046057762437514124,
            "start_logit": 5.605391502380371,
            "end_logit": 6.137829303741455,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "ventricular arrhythmia",
            "probability": 0.03928367871819054,
            "start_logit": 5.863609790802002,
            "end_logit": 5.720523834228516,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "cardiac arrhythmia",
            "probability": 0.03803650401919554,
            "start_logit": 5.64699125289917,
            "end_logit": 5.904879570007324,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "cleft palate, and scoliosis",
            "probability": 0.036165893625880685,
            "start_logit": 5.363611698150635,
            "end_logit": 6.137829303741455,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "dysmorphic features.Andersen cardiodysrhythmic periodic paralysis",
            "probability": 0.03510380113051494,
            "start_logit": 5.430861949920654,
            "end_logit": 6.040771961212158,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, and dysmorphic features",
            "probability": 0.03399892492960379,
            "start_logit": 6.019924640655518,
            "end_logit": 5.419728755950928,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis or Andersen-Tawil syndrome includes the distinct clinical features of periodic paralysis, cardiac arrhythmia",
            "probability": 0.03270987307372405,
            "start_logit": 5.496121883392334,
            "end_logit": 5.904879570007324,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "ventricular arrhythmia, periodic paralysis, and dysmorphic features",
            "probability": 0.029078935746141808,
            "start_logit": 5.863609790802002,
            "end_logit": 5.419728755950928,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "clinodactyly, cleft palate, and scoliosis",
            "probability": 0.02730491660210229,
            "start_logit": 5.08256196975708,
            "end_logit": 6.137829303741455,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "cardiac arrhythmia, and facial and skeletal dysmorphisms",
            "probability": 0.026401118309305936,
            "start_logit": 5.64699125289917,
            "end_logit": 5.539739608764648,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "facial and skeletal dysmorphisms",
            "probability": 0.025488739541173654,
            "start_logit": 5.61182165145874,
            "end_logit": 5.539739608764648,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        }
    ],
    "56f56a8609dd18d46b00000b": [
        {
            "text": "SPINK5",
            "probability": 0.2767105185506102,
            "start_logit": 5.8717942237854,
            "end_logit": 5.492416858673096,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene",
            "probability": 0.14673920367009555,
            "start_logit": 5.8717942237854,
            "end_logit": 4.858101844787598,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI, encoded by the SPINK5",
            "probability": 0.12312984675365239,
            "start_logit": 5.458903789520264,
            "end_logit": 5.095574855804443,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI, encoded by the SPINK5 gene",
            "probability": 0.08258233839748912,
            "start_logit": 5.458903789520264,
            "end_logit": 4.696131229400635,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI",
            "probability": 0.08231217341392483,
            "start_logit": 5.458903789520264,
            "end_logit": 4.692854404449463,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI).Loss-of-function mutations in the Kazal-type serine protease inhibitor, LEKTI",
            "probability": 0.04438065397166062,
            "start_logit": 4.841188430786133,
            "end_logit": 4.692854404449463,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene encoding the lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.041461179683567294,
            "start_logit": 5.8717942237854,
            "end_logit": 3.5942025184631348,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI in the skin and all stratified epithelial tissues.Recently, we identified SPINK5",
            "probability": 0.040610690965589225,
            "start_logit": 4.379245758056641,
            "end_logit": 5.0660247802734375,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 0.03271495899812698,
            "start_logit": 5.3637518882751465,
            "end_logit": 3.8653197288513184,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKT",
            "probability": 0.019548398506854886,
            "start_logit": 5.458903789520264,
            "end_logit": 3.2552287578582764,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI,",
            "probability": 0.015806996146751788,
            "start_logit": 5.458903789520264,
            "end_logit": 3.042788028717041,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5, which encodes the serine protease inhibitor Kazal-type 5",
            "probability": 0.011924344092846095,
            "start_logit": 5.258591175079346,
            "end_logit": 2.9612300395965576,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5, which encodes the serine protease inhibitor Kazal-type 5 protein",
            "probability": 0.011605386109903627,
            "start_logit": 5.258591175079346,
            "end_logit": 2.934117317199707,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene encoding the lymphoepithelial Kazal-type-related inhibitor (LEKT",
            "probability": 0.011557553259885256,
            "start_logit": 5.8717942237854,
            "end_logit": 2.316784143447876,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene encoding lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.01143687798841635,
            "start_logit": 5.542837142944336,
            "end_logit": 2.6352450847625732,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI).Loss-of-function mutations in the Kazal-type serine protease inhibitor, LEKT",
            "probability": 0.010540004884454746,
            "start_logit": 4.841188430786133,
            "end_logit": 3.2552287578582764,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5,",
            "probability": 0.010393892357410478,
            "start_logit": 5.258591175079346,
            "end_logit": 2.823866367340088,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "Kazal-type serine protease inhibitor, LEKTI, encoded by the SPINK5",
            "probability": 0.009889199843132513,
            "start_logit": 2.937107563018799,
            "end_logit": 5.095574855804443,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI).Loss-of-function mutations in the Kazal-type serine protease inhibitor, LEKTI,",
            "probability": 0.008522734818246048,
            "start_logit": 4.841188430786133,
            "end_logit": 3.042788028717041,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "Kazal-type-related inhibitor (LEKTI",
            "probability": 0.008133047587382376,
            "start_logit": 4.242972373962402,
            "end_logit": 3.5942025184631348,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        }
    ],
    "54fb6fb5d176fff445000004": [
        {
            "text": "CSL",
            "probability": 0.2797828102482926,
            "start_logit": 5.061615467071533,
            "end_logit": 4.518148422241211,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "CSL and a transcriptional co-activator of the Mastermind family (MAML",
            "probability": 0.1891880618281845,
            "start_logit": 5.061615467071533,
            "end_logit": 4.126876354217529,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "MAML",
            "probability": 0.11154019334158168,
            "start_logit": 4.53325891494751,
            "end_logit": 4.126876354217529,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "Mastermind-like 1 and the DNA binding protein CSL",
            "probability": 0.10492030635648623,
            "start_logit": 4.302917003631592,
            "end_logit": 4.296034336090088,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "NICD) forms a transcriptional activation complex with the DNA-binding factor CSL",
            "probability": 0.0574941611593683,
            "start_logit": 3.47928524017334,
            "end_logit": 4.518148422241211,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "CSL and a transcriptional co-activator of the Mastermind family (MAML)",
            "probability": 0.05637310419155498,
            "start_logit": 5.061615467071533,
            "end_logit": 2.9161269664764404,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "Mastermind-like 1",
            "probability": 0.049624987925454535,
            "start_logit": 4.302917003631592,
            "end_logit": 3.547327756881714,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "MAML)",
            "probability": 0.03323606616627661,
            "start_logit": 4.53325891494751,
            "end_logit": 2.9161269664764404,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "DNA binding protein CSL",
            "probability": 0.02508150563211255,
            "start_logit": 2.8718466758728027,
            "end_logit": 4.296034336090088,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "CSL, ICN",
            "probability": 0.014221651795014284,
            "start_logit": 3.869419813156128,
            "end_logit": 2.731096029281616,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "NICD",
            "probability": 0.012887808367861405,
            "start_logit": 3.47928524017334,
            "end_logit": 3.0227468013763428,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "DNA-binding factor CSL",
            "probability": 0.011296028498658633,
            "start_logit": 1.8520530462265015,
            "end_logit": 4.518148422241211,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "Mastermind",
            "probability": 0.008956913565731165,
            "start_logit": 4.302917003631592,
            "end_logit": 1.835258960723877,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "MAML). The \"RAM\" region of NICD recruits Notch to CSL",
            "probability": 0.00877721925099543,
            "start_logit": 4.53325891494751,
            "end_logit": 1.584650993347168,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "ICN",
            "probability": 0.007763403281662022,
            "start_logit": 3.2640750408172607,
            "end_logit": 2.731096029281616,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "DNA-binding factor CSL and a transcriptional co-activator of the Mastermind family (MAML",
            "probability": 0.007638331090178925,
            "start_logit": 1.8520530462265015,
            "end_logit": 4.126876354217529,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "CSL and a transcriptional co-activator of the Mastermind",
            "probability": 0.005923247833541974,
            "start_logit": 5.061615467071533,
            "end_logit": 0.6630197167396545,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "Mastermind family (MAML",
            "probability": 0.005462287202515706,
            "start_logit": 1.5167415142059326,
            "end_logit": 4.126876354217529,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "CSL (for CBF-1",
            "probability": 0.005346136915933247,
            "start_logit": 4.9466552734375,
            "end_logit": 0.6754692196846008,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "CSL and a transcriptional co-activator of the Mastermind family",
            "probability": 0.004485775348595269,
            "start_logit": 5.061615467071533,
            "end_logit": 0.3850461542606354,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        }
    ],
    "532c0c21d6d3ac6a3400001b": [
        {
            "text": "Cat-Scramble methodology",
            "probability": 0.2944441357824709,
            "start_logit": 2.6086082458496094,
            "end_logit": 0.9532134532928467,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "decoy set and Cat-Scramble methodology",
            "probability": 0.22103073924225727,
            "start_logit": 2.3218207359313965,
            "end_logit": 0.9532134532928467,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "test set, decoy set and Cat-Scramble methodology",
            "probability": 0.12486214025590506,
            "start_logit": 1.7507292032241821,
            "end_logit": 0.9532134532928467,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "decoy set",
            "probability": 0.06874927187024099,
            "start_logit": 2.3218207359313965,
            "end_logit": -0.21462218463420868,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Cat",
            "probability": 0.056672162317601325,
            "start_logit": 2.6086082458496094,
            "end_logit": -0.6945927143096924,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Cat-Scramble",
            "probability": 0.046528105148107915,
            "start_logit": 2.6086082458496094,
            "end_logit": -0.8918192982673645,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "decoy set and Cat",
            "probability": 0.04254216134489694,
            "start_logit": 2.3218207359313965,
            "end_logit": -0.6945927143096924,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "test set, decoy set",
            "probability": 0.0388370470830522,
            "start_logit": 1.7507292032241821,
            "end_logit": -0.21462218463420868,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "decoy set and Cat-Scramble",
            "probability": 0.03492730955261909,
            "start_logit": 2.3218207359313965,
            "end_logit": -0.8918192982673645,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "test set, decoy set and Cat",
            "probability": 0.02403242795480059,
            "start_logit": 1.7507292032241821,
            "end_logit": -0.6945927143096924,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "test set, decoy set and Cat-Scramble",
            "probability": 0.019730733558017122,
            "start_logit": 1.7507292032241821,
            "end_logit": -0.8918192982673645,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "test set",
            "probability": 0.0066470900243828,
            "start_logit": 1.7507292032241821,
            "end_logit": -1.9798176288604736,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "test",
            "probability": 0.004748367299917924,
            "start_logit": 1.7507292032241821,
            "end_logit": -2.3161959648132324,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "methodology",
            "probability": 0.004505824612507022,
            "start_logit": -1.5711101293563843,
            "end_logit": 0.9532134532928467,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "de",
            "probability": 0.003626903072122613,
            "start_logit": 2.3218207359313965,
            "end_logit": -3.1567091941833496,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "validated by various methods such as test set, decoy set and Cat-Scramble methodology",
            "probability": 0.0026806693570456666,
            "start_logit": -2.090414524078369,
            "end_logit": 0.9532134532928467,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "test set, de",
            "probability": 0.002048868323195505,
            "start_logit": 1.7507292032241821,
            "end_logit": -3.1567091941833496,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "pharmacophore mapping",
            "probability": 0.0013547122620069815,
            "start_logit": -0.48379990458488464,
            "end_logit": -1.335878610610962,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "methods such as test set, decoy set and Cat-Scramble methodology",
            "probability": 0.0011975371097512591,
            "start_logit": -2.896214008331299,
            "end_logit": 0.9532134532928467,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "validated by various methods such as test set, decoy set",
            "probability": 0.0008337938291006845,
            "start_logit": -2.090414524078369,
            "end_logit": -0.21462218463420868,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        }
    ],
    "5166f41a298dcd4e5100005b": [
        {
            "text": "BIX-01294",
            "probability": 0.800287938626269,
            "start_logit": 4.45371675491333,
            "end_logit": 4.19732141494751,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "BIX-01294 and TM2-115",
            "probability": 0.10733526119259275,
            "start_logit": 3.893843173980713,
            "end_logit": 2.748180627822876,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "TM2-115",
            "probability": 0.06801186885084141,
            "start_logit": 3.437568187713623,
            "end_logit": 2.748180627822876,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "BIX",
            "probability": 0.009754548304539265,
            "start_logit": 4.45371675491333,
            "end_logit": -0.20991650223731995,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "BIX-01294 and its derivative TM2-115",
            "probability": 0.006553947126723907,
            "start_logit": 2.7396888732910156,
            "end_logit": 1.1064451932907104,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "BIX-01294)",
            "probability": 0.0032704792658926093,
            "start_logit": 4.45371675491333,
            "end_logit": -1.3027136325836182,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(BIX-01294",
            "probability": 0.001712141446537787,
            "start_logit": -1.6935099363327026,
            "end_logit": 4.19732141494751,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "BIX-01",
            "probability": 0.0005738096391461389,
            "start_logit": 4.45371675491333,
            "end_logit": -3.043107748031616,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "BIX-01294) of the human G9a histone methyltransferase. Two compounds, BIX",
            "probability": 0.0005449772093054215,
            "start_logit": 4.45371675491333,
            "end_logit": -3.0946614742279053,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "BIX-01294 and TM2",
            "probability": 0.00045322198625550306,
            "start_logit": 3.893843173980713,
            "end_logit": -2.7191498279571533,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "TM2",
            "probability": 0.0002871793849201006,
            "start_logit": 3.437568187713623,
            "end_logit": -2.7191498279571533,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "adenosine-containing inhibitors of histone methyltransferase DOT1L",
            "probability": 0.00025438875738200724,
            "start_logit": 1.5558632612228394,
            "end_logit": -0.9586883187294006,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "BIX-01294 and its derivative TM2-115,",
            "probability": 0.00021838492935326125,
            "start_logit": 2.7396888732910156,
            "end_logit": -2.2951183319091797,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "compound library based upon a known specific inhibitor (BIX-01294",
            "probability": 0.0001589770855712499,
            "start_logit": -4.070250034332275,
            "end_logit": 4.19732141494751,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "adenosine",
            "probability": 0.00013437161046751822,
            "start_logit": 1.5558632612228394,
            "end_logit": -1.5969427824020386,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "4",
            "probability": 0.00012993670764026833,
            "start_logit": -4.271962642669678,
            "end_logit": 4.19732141494751,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "TM2-115,",
            "probability": 0.00010944136776653464,
            "start_logit": 2.048818588256836,
            "end_logit": -2.2951183319091797,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "115",
            "probability": 9.656575781613835e-05,
            "start_logit": -3.119645118713379,
            "end_logit": 2.748180627822876,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "ad",
            "probability": 6.114307912526738e-05,
            "start_logit": 1.5558632612228394,
            "end_logit": -2.3843352794647217,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "DOT1L",
            "probability": 5.141767185408614e-05,
            "start_logit": -0.04301845282316208,
            "end_logit": -0.9586883187294006,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        }
    ],
    "517539af8ed59a060a000026": [
        {
            "text": "calsequestrin",
            "probability": 0.42506552012315507,
            "start_logit": 6.1486334800720215,
            "end_logit": 5.423159122467041,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "calsequestrin gene (casq2",
            "probability": 0.21360778510533657,
            "start_logit": 6.1486334800720215,
            "end_logit": 4.735057353973389,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "calsequestrin gene",
            "probability": 0.12555402005320532,
            "start_logit": 6.1486334800720215,
            "end_logit": 4.2036519050598145,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "casq2",
            "probability": 0.09436509092034051,
            "start_logit": 5.331663131713867,
            "end_logit": 4.735057353973389,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "calsequestrin gene (casq2)",
            "probability": 0.05889794675545692,
            "start_logit": 6.1486334800720215,
            "end_logit": 3.4467220306396484,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "casq2)",
            "probability": 0.0260192300475345,
            "start_logit": 5.331663131713867,
            "end_logit": 3.4467220306396484,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "cTnT",
            "probability": 0.01234893913738553,
            "start_logit": 4.248101711273193,
            "end_logit": 3.785017728805542,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "COX-2",
            "probability": 0.008034772692162025,
            "start_logit": 4.040437698364258,
            "end_logit": 3.5628902912139893,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "(casq2",
            "probability": 0.0072476944836068246,
            "start_logit": 2.7651753425598145,
            "end_logit": 4.735057353973389,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "COX-2, ANF",
            "probability": 0.006857424406488331,
            "start_logit": 4.040437698364258,
            "end_logit": 3.4044435024261475,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "ANF",
            "probability": 0.004972836520132032,
            "start_logit": 3.7190961837768555,
            "end_logit": 3.4044435024261475,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "estrogen receptor (ER)alpha gene, which we show to be a direct MEF2 target genecardiac calsequestrin",
            "probability": 0.003399285256798309,
            "start_logit": 1.3199553489685059,
            "end_logit": 5.423159122467041,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "casq2 gene",
            "probability": 0.0033644638120110012,
            "start_logit": 4.511958599090576,
            "end_logit": 2.2208592891693115,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "calsequestrin gene (casq",
            "probability": 0.0033248785657576073,
            "start_logit": 6.1486334800720215,
            "end_logit": 0.572348952293396,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "(casq2)",
            "probability": 0.001998402462648019,
            "start_logit": 2.7651753425598145,
            "end_logit": 3.4467220306396484,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "casq",
            "probability": 0.001468825061792982,
            "start_logit": 5.331663131713867,
            "end_logit": 0.572348952293396,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "the estrogen receptor (ER)alpha gene, which we show to be a direct MEF2 target genecardiac calsequestrin",
            "probability": 0.0012829994308347346,
            "start_logit": 0.3455908000469208,
            "end_logit": 5.423159122467041,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "estrogen receptor (ER)alpha gene, which we show to be a direct MEF2 target genecardiac calsequestrin gene",
            "probability": 0.0010040662182502222,
            "start_logit": 1.3199553489685059,
            "end_logit": 4.2036519050598145,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "cTnT promoter",
            "probability": 0.0007347215104027067,
            "start_logit": 4.248101711273193,
            "end_logit": 0.9631838202476501,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MEF2 target genecardiac calsequestrin",
            "probability": 0.0004510974367005619,
            "start_logit": -0.6996817588806152,
            "end_logit": 5.423159122467041,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        }
    ],
    "52d2818403868f1b06000033": [
        {
            "text": "ZFN",
            "probability": 0.2679066837755462,
            "start_logit": 4.070703983306885,
            "end_logit": 3.26949143409729,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "TALEN",
            "probability": 0.2538183961336529,
            "start_logit": 3.785801649093628,
            "end_logit": 3.5003740787506104,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "TALEN) and zinc finger nuclease (ZFN",
            "probability": 0.2014893226789335,
            "start_logit": 3.785801649093628,
            "end_logit": 3.26949143409729,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "TALENs",
            "probability": 0.09401624712917732,
            "start_logit": 3.4823427200317383,
            "end_logit": 2.8106815814971924,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "zinc finger nuclease (ZFN",
            "probability": 0.04340007503080928,
            "start_logit": 2.2505264282226562,
            "end_logit": 3.26949143409729,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "TALEN) and zinc finger nuclease",
            "probability": 0.03401295876460149,
            "start_logit": 3.785801649093628,
            "end_logit": 1.4904966354370117,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(TALEN",
            "probability": 0.024766532547085822,
            "start_logit": 1.4586758613586426,
            "end_logit": 3.5003740787506104,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(ZFN",
            "probability": 0.0207603422647366,
            "start_logit": 1.513109803199768,
            "end_logit": 3.26949143409729,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(TALEN) and zinc finger nuclease (ZFN",
            "probability": 0.019660481446704924,
            "start_logit": 1.4586758613586426,
            "end_logit": 3.26949143409729,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "ZFN)",
            "probability": 0.008563845111330954,
            "start_logit": 4.070703983306885,
            "end_logit": -0.1735980063676834,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "TALEN)",
            "probability": 0.007890315259130557,
            "start_logit": 3.785801649093628,
            "end_logit": 0.029391134157776833,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "zinc finger nuclease",
            "probability": 0.007326268919746912,
            "start_logit": 2.2505264282226562,
            "end_logit": 1.4904966354370117,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "TALEN) and zinc finger nuclease (ZFN)",
            "probability": 0.006440762606934522,
            "start_logit": 3.785801649093628,
            "end_logit": -0.1735980063676834,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(TALEN) and zinc finger nuclease",
            "probability": 0.003318841593430517,
            "start_logit": 1.4586758613586426,
            "end_logit": 1.4904966354370117,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "TALE-TFs), while fused to restriction endonucleases (TALENs",
            "probability": 0.0014392103328972473,
            "start_logit": -0.6970303058624268,
            "end_logit": 2.8106815814971924,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "zinc finger nuclease (ZFN)",
            "probability": 0.0013873170879729944,
            "start_logit": 2.2505264282226562,
            "end_logit": -0.1735980063676834,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "TALEN) and zinc finger",
            "probability": 0.0012047453040506747,
            "start_logit": 3.785801649093628,
            "end_logit": -1.8499767780303955,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "TALEN) and zinc",
            "probability": 0.0011641297496075692,
            "start_logit": 3.785801649093628,
            "end_logit": -1.8842711448669434,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(TALEN)",
            "probability": 0.0007699038077962047,
            "start_logit": 1.4586758613586426,
            "end_logit": 0.029391134157776833,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(ZFN)",
            "probability": 0.0006636204558538526,
            "start_logit": 1.513109803199768,
            "end_logit": -0.1735980063676834,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        }
    ],
    "571cd9537de986d80d00000e": [
        {
            "text": "CASPASE-1",
            "probability": 0.3747293899417525,
            "start_logit": 3.8020944595336914,
            "end_logit": 2.893723964691162,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspases-4 and -5",
            "probability": 0.22355413460585552,
            "start_logit": 3.189542055130005,
            "end_logit": 2.9897258281707764,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspases-4",
            "probability": 0.12149673048597427,
            "start_logit": 3.189542055130005,
            "end_logit": 2.3799595832824707,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "CASPASE-1 (CASP1",
            "probability": 0.09989922340085446,
            "start_logit": 3.8020944595336914,
            "end_logit": 1.5716817378997803,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "CASPASE-1 (CASP1)",
            "probability": 0.0815267196996385,
            "start_logit": 3.8020944595336914,
            "end_logit": 1.36845064163208,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-1. ctivation of inflammatory caspase proteases. One such caspase, CASPASE-1",
            "probability": 0.05084337016811069,
            "start_logit": 1.8046400547027588,
            "end_logit": 2.893723964691162,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "CASP1",
            "probability": 0.012180325117041183,
            "start_logit": 1.6977545022964478,
            "end_logit": 1.5716817378997803,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "CASP1)",
            "probability": 0.009940236949419461,
            "start_logit": 1.6977545022964478,
            "end_logit": 1.36845064163208,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-1",
            "probability": 0.007092269226782796,
            "start_logit": 1.8046400547027588,
            "end_logit": 0.9239795804023743,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "CASPASE-1 (CASP1),",
            "probability": 0.006554545872811948,
            "start_logit": 3.8020944595336914,
            "end_logit": -1.1523213386535645,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "4 and -5",
            "probability": 0.003146897963889019,
            "start_logit": -1.0736943483352661,
            "end_logit": 2.9897258281707764,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "5",
            "probability": 0.0019238376405056837,
            "start_logit": -1.5657895803451538,
            "end_logit": 2.9897258281707764,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "4",
            "probability": 0.0017102694810792862,
            "start_logit": -1.0736943483352661,
            "end_logit": 2.3799595832824707,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "CA",
            "probability": 0.0014277540841277244,
            "start_logit": 3.8020944595336914,
            "end_logit": -2.676377534866333,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "5, during intestinal homeostasis and disease has not yet been established. This study demonstrates that caspases-4 and -5",
            "probability": 0.0008377401429246231,
            "start_logit": -2.3971588611602783,
            "end_logit": 2.9897258281707764,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase, CASPASE-1",
            "probability": 0.0008069057442110785,
            "start_logit": -2.338658094406128,
            "end_logit": 2.893723964691162,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "CASP1),",
            "probability": 0.000799170373978374,
            "start_logit": 1.6977545022964478,
            "end_logit": -1.1523213386535645,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "1",
            "probability": 0.000590972224277153,
            "start_logit": -2.6500959396362305,
            "end_logit": 2.893723964691162,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspases-4 and -5,",
            "probability": 0.00048421362736269266,
            "start_logit": 2.7568726539611816,
            "end_logit": -2.7124874591827393,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "5, during intestinal homeostasis and disease has not yet been established. This study demonstrates that caspases-4",
            "probability": 0.0004552932494030845,
            "start_logit": -2.3971588611602783,
            "end_logit": 2.3799595832824707,
            "question_text": "List inflammatory caspase proteins?"
        }
    ],
    "553c994af32186855800000b": [
        {
            "text": "Drosophila melanogaster",
            "probability": 0.5410782252610525,
            "start_logit": 1.8124375343322754,
            "end_logit": 1.329176902770996,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "tunicates",
            "probability": 0.29573315820726875,
            "start_logit": 1.4515944719314575,
            "end_logit": 1.0859136581420898,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Diptera",
            "probability": 0.06505936951425204,
            "start_logit": 0.7448841333389282,
            "end_logit": 0.27846667170524597,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Diptera species",
            "probability": 0.05053482018457642,
            "start_logit": 0.7448841333389282,
            "end_logit": 0.025829048827290535,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Olfactores",
            "probability": 0.0171423484469499,
            "start_logit": 0.43551236391067505,
            "end_logit": -0.7459098696708679,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Drosophila melanogaster homothorax",
            "probability": 0.007512803771408992,
            "start_logit": 1.8124375343322754,
            "end_logit": -2.9477782249450684,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Drosophila",
            "probability": 0.005679463184175259,
            "start_logit": 1.8124375343322754,
            "end_logit": -3.2275302410125732,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "species we described an ultraconserved element found at an internal exon-intron junction of the Drosophila melanogaster",
            "probability": 0.0038770679830214994,
            "start_logit": -3.126047134399414,
            "end_logit": 1.329176902770996,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Drosophila melanogaster homothorax (hth) gene",
            "probability": 0.003279727607773323,
            "start_logit": 1.8124375343322754,
            "end_logit": -3.7766265869140625,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "tunic",
            "probability": 0.002257097961179193,
            "start_logit": 1.4515944719314575,
            "end_logit": -3.789463996887207,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Diptera species we described an ultraconserved element found at an internal exon-intron junction of the Drosophila",
            "probability": 0.0019528763117371028,
            "start_logit": 0.7448841333389282,
            "end_logit": -3.2275302410125732,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "vertebrates are present in non-syntenic loci of tunicates",
            "probability": 0.0012743757560349188,
            "start_logit": -3.9954066276550293,
            "end_logit": 1.0859136581420898,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "species",
            "probability": 0.0010530927801208846,
            "start_logit": -3.126047134399414,
            "end_logit": 0.025829048827290535,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Dip",
            "probability": 0.0009684583945792373,
            "start_logit": 0.7448841333389282,
            "end_logit": -3.9288833141326904,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "study that identified highly evolutionary conserved sequences in three genomes of Diptera",
            "probability": 0.0008053161708912694,
            "start_logit": -3.6469364166259766,
            "end_logit": 0.27846667170524597,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "study that identified highly evolutionary conserved sequences in three genomes of Diptera species",
            "probability": 0.0006255287776621761,
            "start_logit": -3.6469364166259766,
            "end_logit": 0.025829048827290535,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "three genomes of Diptera",
            "probability": 0.0004398485413027146,
            "start_logit": -4.2517409324646,
            "end_logit": 0.27846667170524597,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "three genomes of Diptera species",
            "probability": 0.00034165204964538856,
            "start_logit": -4.2517409324646,
            "end_logit": 0.025829048827290535,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "vertebrate (Olfactores",
            "probability": 0.0001997272067331705,
            "start_logit": -4.016842365264893,
            "end_logit": -0.7459098696708679,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "tunicate and vertebrate (Olfactores",
            "probability": 0.00018504188963518696,
            "start_logit": -4.093212604522705,
            "end_logit": -0.7459098696708679,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        }
    ],
    "54e061ee1388e8454a00000c": [
        {
            "text": "everolimus",
            "probability": 0.5606355975771279,
            "start_logit": 4.776336193084717,
            "end_logit": 4.956785678863525,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus",
            "probability": 0.22807808940302501,
            "start_logit": 4.478075981140137,
            "end_logit": 4.355662822723389,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus showed efficacy in reducing angiomyolipoma lesion volume in patients with SEGA associated with TSC.Everolimus",
            "probability": 0.21041055086247942,
            "start_logit": 4.478075981140137,
            "end_logit": 4.275035381317139,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "everolimus,",
            "probability": 0.0001905237000853246,
            "start_logit": 4.776336193084717,
            "end_logit": -3.030264139175415,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "mus",
            "probability": 0.00018814234387041397,
            "start_logit": -3.2232913970947266,
            "end_logit": 4.956785678863525,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "everolimus, an mTOR inhibitor,",
            "probability": 8.444025231636066e-05,
            "start_logit": 4.776336193084717,
            "end_logit": -3.843996524810791,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "ever",
            "probability": 7.969267207810463e-05,
            "start_logit": 4.776336193084717,
            "end_logit": -3.9018630981445312,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "olimus",
            "probability": 7.085008951093729e-05,
            "start_logit": -3.6717681884765625,
            "end_logit": 4.4286298751831055,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Ever",
            "probability": 5.7387793489488076e-05,
            "start_logit": 4.478075981140137,
            "end_logit": -3.9319489002227783,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "everolimus, an mTOR inhibitor, in the treatment of angiomyolipoma",
            "probability": 4.9612792281576146e-05,
            "start_logit": 4.776336193084717,
            "end_logit": -4.375792026519775,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "mus showed efficacy in reducing angiomyolipoma lesion volume in patients with SEGA associated with TSC.Everolimus",
            "probability": 4.5909062394624735e-05,
            "start_logit": -3.9520773887634277,
            "end_logit": 4.275035381317139,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus showed efficacy in reducing angiomyolipoma lesion volume in patients with SEGA associated with TSC.Ever",
            "probability": 2.9649727332596142e-05,
            "start_logit": 4.478075981140137,
            "end_logit": -4.59232759475708,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "exemestane in advanced hormone-receptor (HR)-positive, HER2-negative breast cancer.The effect of everolimus",
            "probability": 2.2475247519461762e-05,
            "start_logit": -4.2964043617248535,
            "end_logit": 3.9051144123077393,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus showed efficacy in reducing angiomyolipoma",
            "probability": 2.196542064117747e-05,
            "start_logit": 4.478075981140137,
            "end_logit": -4.892311096191406,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "angiomyolipoma lesion volume in patients with SEGA associated with TSC.Everolimus",
            "probability": 1.330509651342678e-05,
            "start_logit": -5.1905927658081055,
            "end_logit": 4.275035381317139,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "olimus showed efficacy in reducing angiomyolipoma lesion volume in patients with SEGA associated with TSC.Everolimus",
            "probability": 1.1256960487272393e-05,
            "start_logit": -5.357753276824951,
            "end_logit": 4.275035381317139,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "everolimus on renal angiomyolipoma",
            "probability": 1.0442074922349438e-05,
            "start_logit": 3.894437789916992,
            "end_logit": -5.0522990226745605,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "mus,",
            "probability": 6.393738758621263e-08,
            "start_logit": -3.2232913970947266,
            "end_logit": -3.030264139175415,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "mus, an mTOR inhibitor,",
            "probability": 2.8337099992341578e-08,
            "start_logit": -3.2232913970947266,
            "end_logit": -3.843996524810791,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "mus, an mTOR inhibitor, in the treatment of angiomyolipoma",
            "probability": 1.664943693577642e-08,
            "start_logit": -3.2232913970947266,
            "end_logit": -4.375792026519775,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        }
    ],
    "553d061cf321868558000013": [
        {
            "text": "TFCONES",
            "probability": 0.31633613731194016,
            "start_logit": 2.643252372741699,
            "end_logit": 2.1620798110961914,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "TFCONES (Transcription Factor Genes & Associated COnserved Noncoding ElementS) (http://tfcones",
            "probability": 0.16299751146592192,
            "start_logit": 2.643252372741699,
            "end_logit": 1.499009370803833,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora",
            "probability": 0.15881678502775112,
            "start_logit": 1.9690271615982056,
            "end_logit": 2.1472508907318115,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora: a web resource for exploring highly conserved noncoding elements and their association with developmental regulatory genes We describe Ancora",
            "probability": 0.10142467580463849,
            "start_logit": 1.9690271615982056,
            "end_logit": 1.6988160610198975,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "tfcones",
            "probability": 0.08453938725924927,
            "start_logit": 1.9867349863052368,
            "end_logit": 1.499009370803833,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http://ancora",
            "probability": 0.06251270717453108,
            "start_logit": 1.8717337846755981,
            "end_logit": 1.3121628761291504,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora",
            "probability": 0.03959569610844195,
            "start_logit": 1.4150843620300293,
            "end_logit": 1.3121628761291504,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "TFCONES (Transcription Factor Genes & Associated COnserved Noncoding ElementS)",
            "probability": 0.016943924588727986,
            "start_logit": 2.643252372741699,
            "end_logit": -0.7648162245750427,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "TFCONES (Transcription Factor Genes & Associated COnserved Noncoding ElementS) (http://tfcones.fugu",
            "probability": 0.009811137974640664,
            "start_logit": 2.643252372741699,
            "end_logit": -1.3112072944641113,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "TFCONES (Transcription Factor Genes",
            "probability": 0.007102526765791411,
            "start_logit": 2.643252372741699,
            "end_logit": -1.634274959564209,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "tfcones.fugu",
            "probability": 0.005088590526521523,
            "start_logit": 1.9867349863052368,
            "end_logit": -1.3112072944641113,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "tfcones.fugu-sg.org",
            "probability": 0.005068116369073017,
            "start_logit": 1.9867349863052368,
            "end_logit": -1.3152389526367188,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Transcription Factor Genes & Associated COnserved Noncoding ElementS) (http://tfcones",
            "probability": 0.004861716895188891,
            "start_logit": -0.8690909147262573,
            "end_logit": 1.499009370803833,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http://ancora.genereg.net,",
            "probability": 0.004604122516853964,
            "start_logit": 1.8717337846755981,
            "end_logit": -1.2962548732757568,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "a database named TFCONES",
            "probability": 0.0045413478010364735,
            "start_logit": -1.6003291606903076,
            "end_logit": 2.1620798110961914,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http://ancora.genereg.net",
            "probability": 0.004231163193161078,
            "start_logit": 1.8717337846755981,
            "end_logit": -1.3807300329208374,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "TFCONES (Transcription Factor Genes & Associated COnserved Noncoding ElementS",
            "probability": 0.003078913456869637,
            "start_logit": 2.643252372741699,
            "end_logit": -2.470148801803589,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora.genereg.net,",
            "probability": 0.002916262057159132,
            "start_logit": 1.4150843620300293,
            "end_logit": -1.2962548732757568,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "database named TFCONES",
            "probability": 0.0028492489602836243,
            "start_logit": -2.066497564315796,
            "end_logit": 2.1620798110961914,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora.genereg.net",
            "probability": 0.002680028742218483,
            "start_logit": 1.4150843620300293,
            "end_logit": -1.3807300329208374,
            "question_text": "List available databases containing information about conserved noncoding elements."
        }
    ],
    "56c1f043ef6e394741000057": [
        {
            "text": "MT2",
            "probability": 0.28957388409160956,
            "start_logit": 5.324018955230713,
            "end_logit": 4.735065460205078,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1 and MT2",
            "probability": 0.18547898266211696,
            "start_logit": 4.878550052642822,
            "end_logit": 4.735065460205078,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1",
            "probability": 0.13481438304968502,
            "start_logit": 4.878550052642822,
            "end_logit": 4.416022777557373,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin MT1 and MT2",
            "probability": 0.10154031562316888,
            "start_logit": 4.276064395904541,
            "end_logit": 4.735065460205078,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2 receptors",
            "probability": 0.08924176592428991,
            "start_logit": 5.324018955230713,
            "end_logit": 3.558004140853882,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin MT1",
            "probability": 0.07380402247700989,
            "start_logit": 4.276064395904541,
            "end_logit": 4.416022777557373,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1 and MT2 receptors",
            "probability": 0.057161480589083546,
            "start_logit": 4.878550052642822,
            "end_logit": 3.558004140853882,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin MT1 and MT2 receptors",
            "probability": 0.03129300526236204,
            "start_logit": 4.276064395904541,
            "end_logit": 3.558004140853882,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2 receptor",
            "probability": 0.020651670376515927,
            "start_logit": 4.949282169342041,
            "end_logit": 2.4691879749298096,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin",
            "probability": 0.008220093843636077,
            "start_logit": 4.276064395904541,
            "end_logit": 2.221191167831421,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1 receptor",
            "probability": 0.0036908824765081887,
            "start_logit": 3.9424264430999756,
            "end_logit": 1.7541130781173706,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "the melatonin MT1 and MT2",
            "probability": 0.0014286342996746382,
            "start_logit": 0.01232743076980114,
            "end_logit": 4.735065460205078,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "the melatonin MT1",
            "probability": 0.0010383950189392145,
            "start_logit": 0.01232743076980114,
            "end_logit": 4.416022777557373,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "the MT2",
            "probability": 0.0005199258060427312,
            "start_logit": -0.40855351090431213,
            "end_logit": 4.145158290863037,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "the melatonin MT1 and MT2 receptors",
            "probability": 0.0004402808912237471,
            "start_logit": 0.01232743076980114,
            "end_logit": 3.558004140853882,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "1 and MT2",
            "probability": 0.0002578348462439976,
            "start_logit": -1.6998275518417358,
            "end_logit": 4.735065460205078,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT2,",
            "probability": 0.000254630850265876,
            "start_logit": 3.9044437408447266,
            "end_logit": -0.8817102313041687,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1 and MT2,",
            "probability": 0.00025266845313351834,
            "start_logit": 3.896707057952881,
            "end_logit": -0.8817102313041687,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "1",
            "probability": 0.00018740584634549239,
            "start_logit": -1.6998275518417358,
            "end_logit": 4.416022777557373,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "2",
            "probability": 0.0001497376121448756,
            "start_logit": -2.24326229095459,
            "end_logit": 4.735065460205078,
            "question_text": "Which receptors are bound by Tasimelteon?"
        }
    ],
    "5318380bb166e2b806000013": [
        {
            "text": "PICK1",
            "probability": 0.2931244591822681,
            "start_logit": 4.158535480499268,
            "end_logit": 3.5739521980285645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "CDC37",
            "probability": 0.08820680404017361,
            "start_logit": 3.3663949966430664,
            "end_logit": 3.165179491043091,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP90, CDC37",
            "probability": 0.08568255537803965,
            "start_logit": 3.337360143661499,
            "end_logit": 3.165179491043091,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "PICK1 via a PDZ-mediated interaction, which predominantly promotes PICK1",
            "probability": 0.08074704843638672,
            "start_logit": 4.158535480499268,
            "end_logit": 2.2846763134002686,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "TUFM).We find that parkin binds PICK1",
            "probability": 0.08024101462644494,
            "start_logit": 2.8629729747772217,
            "end_logit": 3.5739521980285645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "LRPPRC, and TUFM).We find that parkin binds PICK1",
            "probability": 0.06030435503427171,
            "start_logit": 2.5773425102233887,
            "end_logit": 3.5739521980285645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP60, LRPPRC, and TUFM).We find that parkin binds PICK1",
            "probability": 0.057189755729885806,
            "start_logit": 2.524312973022461,
            "end_logit": 3.5739521980285645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "GRP75, HSP60, LRPPRC, and TUFM).We find that parkin binds PICK1",
            "probability": 0.052264328128502784,
            "start_logit": 2.4342522621154785,
            "end_logit": 3.5739521980285645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP90",
            "probability": 0.04343096868499648,
            "start_logit": 3.337360143661499,
            "end_logit": 2.4857029914855957,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "TUFM).We find that parkin binds PICK1 via a PDZ-mediated interaction, which predominantly promotes PICK1",
            "probability": 0.022104006989732337,
            "start_logit": 2.8629729747772217,
            "end_logit": 2.2846763134002686,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "CDC37), 12 proteins were identified using the TAP assay; four of which are mitochondrially localized (GRP75",
            "probability": 0.020345913395828998,
            "start_logit": 3.3663949966430664,
            "end_logit": 1.6983754634857178,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP60",
            "probability": 0.015560326487138369,
            "start_logit": 2.524312973022461,
            "end_logit": 2.2723019123077393,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "LRPPRC",
            "probability": 0.015416826688177575,
            "start_logit": 2.5773425102233887,
            "end_logit": 2.210007429122925,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP60, LRPPRC",
            "probability": 0.014620578429630623,
            "start_logit": 2.524312973022461,
            "end_logit": 2.210007429122925,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "GRP75, HSP60",
            "probability": 0.014220204281891182,
            "start_logit": 2.4342522621154785,
            "end_logit": 2.2723019123077393,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "TUFM",
            "probability": 0.013859086021966893,
            "start_logit": 2.8629729747772217,
            "end_logit": 1.8178584575653076,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "GRP75, HSP60, LRPPRC",
            "probability": 0.013361391366730544,
            "start_logit": 2.4342522621154785,
            "end_logit": 2.210007429122925,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "LRPPRC, and TUFM",
            "probability": 0.010415661464526924,
            "start_logit": 2.5773425102233887,
            "end_logit": 1.8178584575653076,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP60, LRPPRC, and TUFM",
            "probability": 0.009877713385425533,
            "start_logit": 2.524312973022461,
            "end_logit": 1.8178584575653076,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "GRP75, HSP60, LRPPRC, and TUFM",
            "probability": 0.009027002247981364,
            "start_logit": 2.4342522621154785,
            "end_logit": 1.8178584575653076,
            "question_text": "List Parkin binding partners"
        }
    ],
    "5173b5ea8ed59a060a00001f": [
        {
            "text": "H3K36me3",
            "probability": 0.20286289525489365,
            "start_logit": 3.8304648399353027,
            "end_logit": 3.334556818008423,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K27me2, and H3K27me3",
            "probability": 0.05254680693284589,
            "start_logit": 3.216759204864502,
            "end_logit": 2.5974364280700684,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K27me1, H3K27me2, and H3K27me3",
            "probability": 0.052142782339398744,
            "start_logit": 3.209040641784668,
            "end_logit": 2.5974364280700684,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K27me1",
            "probability": 0.051282503762656195,
            "start_logit": 3.209040641784668,
            "end_logit": 2.5808002948760986,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K79me1, H2BK5me1, H3K27me1",
            "probability": 0.050353118190376175,
            "start_logit": 3.190751552581787,
            "end_logit": 2.5808002948760986,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K79me1",
            "probability": 0.04863442160269326,
            "start_logit": 3.190751552581787,
            "end_logit": 2.5460712909698486,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K79me1, H2BK5me1",
            "probability": 0.04805459010800668,
            "start_logit": 3.190751552581787,
            "end_logit": 2.5340774059295654,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K36me3, H3K79me1, H2BK5me1, H3K27me1",
            "probability": 0.047256126934863536,
            "start_logit": 3.1272733211517334,
            "end_logit": 2.5808002948760986,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K27me3",
            "probability": 0.04693273395819021,
            "start_logit": 3.1037702560424805,
            "end_logit": 2.5974364280700684,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K36me3, H3K79me1",
            "probability": 0.04564313955634636,
            "start_logit": 3.1272733211517334,
            "end_logit": 2.5460712909698486,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K36me3, H3K79me1, H2BK5me1",
            "probability": 0.04509897085938217,
            "start_logit": 3.1272733211517334,
            "end_logit": 2.5340774059295654,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K27me2",
            "probability": 0.04272411195553216,
            "start_logit": 3.216759204864502,
            "end_logit": 2.390495538711548,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K27me1, H3K27me2",
            "probability": 0.042395612604747925,
            "start_logit": 3.209040641784668,
            "end_logit": 2.390495538711548,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K79me1, H2BK5me1, H3K27me1, H3K27me2",
            "probability": 0.04162728290569143,
            "start_logit": 3.190751552581787,
            "end_logit": 2.390495538711548,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H2BK5me1, H3K27me1, H3K27me2, and H3K27me3",
            "probability": 0.03848318630977717,
            "start_logit": 2.905276298522949,
            "end_logit": 2.5974364280700684,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H2BK5me1, H3K27me1",
            "probability": 0.03784827080926545,
            "start_logit": 2.905276298522949,
            "end_logit": 2.5808002948760986,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H2BK5me1",
            "probability": 0.03612056622113432,
            "start_logit": 2.905276298522949,
            "end_logit": 2.5340774059295654,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K36me3 and H3K79me1",
            "probability": 0.0341632389507204,
            "start_logit": 2.9779229164123535,
            "end_logit": 2.4057185649871826,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H2BK5me1, H3K27me1, H3K27me2",
            "probability": 0.031289436147961126,
            "start_logit": 2.905276298522949,
            "end_logit": 2.390495538711548,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K9me2 and H3K27me3",
            "probability": 0.0045402045955172735,
            "start_logit": 1.7135034799575806,
            "end_logit": 1.6519598960876465,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        }
    ],
    "5324cca79b2d7acc7e00001d": [
        {
            "text": "dermatology",
            "probability": 0.5073797356156706,
            "start_logit": 6.469209671020508,
            "end_logit": 5.398275852203369,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "physical activity promotionMobile applications (apps) offer a novel way to engage children in behavior change,Mobile applications in dermatology",
            "probability": 0.11722560107301402,
            "start_logit": 5.004050254821777,
            "end_logit": 5.398275852203369,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "healthy eating, and physical activity promotionMobile applications (apps) offer a novel way to engage children in behavior change,Mobile applications in dermatology",
            "probability": 0.06831383112419766,
            "start_logit": 4.464062213897705,
            "end_logit": 5.398275852203369,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "behavior change,Mobile applications in dermatology",
            "probability": 0.03782740090680444,
            "start_logit": 3.872983694076538,
            "end_logit": 5.398275852203369,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "physical activity",
            "probability": 0.03388800159056866,
            "start_logit": 5.004050254821777,
            "end_logit": 4.157236576080322,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "physical activity promotion",
            "probability": 0.02735138205039571,
            "start_logit": 5.004050254821777,
            "end_logit": 3.9429426193237305,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "healthy eating",
            "probability": 0.02363764537317503,
            "start_logit": 4.464062213897705,
            "end_logit": 4.3370041847229,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "physical activity promotionMobile applications (apps) offer a novel way to engage children in behavior change",
            "probability": 0.021060193995246286,
            "start_logit": 5.004050254821777,
            "end_logit": 3.6815602779388428,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "healthy eating, and physical activity",
            "probability": 0.019748409874671816,
            "start_logit": 4.464062213897705,
            "end_logit": 4.157236576080322,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "obesity prevention and treatment, healthy eating",
            "probability": 0.019255133834185992,
            "start_logit": 4.258999347686768,
            "end_logit": 4.3370041847229,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "obesity prevention and treatment",
            "probability": 0.01718994001136643,
            "start_logit": 4.258999347686768,
            "end_logit": 4.223550796508789,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "obesity prevention and treatment, healthy eating, and physical activity",
            "probability": 0.01608697774866775,
            "start_logit": 4.258999347686768,
            "end_logit": 4.157236576080322,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "healthy eating, and physical activity promotion",
            "probability": 0.01593916070637472,
            "start_logit": 4.464062213897705,
            "end_logit": 3.9429426193237305,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "obesity prevention",
            "probability": 0.014493524752082718,
            "start_logit": 4.258999347686768,
            "end_logit": 4.052928447723389,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "obesity prevention and treatment, healthy eating, and physical activity promotion",
            "probability": 0.01298397821612717,
            "start_logit": 4.258999347686768,
            "end_logit": 3.9429426193237305,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "healthy eating, and physical activity promotionMobile applications (apps) offer a novel way to engage children in behavior change",
            "probability": 0.012272938017506941,
            "start_logit": 4.464062213897705,
            "end_logit": 3.6815602779388428,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "obesity",
            "probability": 0.010251761448526317,
            "start_logit": 4.258999347686768,
            "end_logit": 3.7066760063171387,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "obesity prevention and treatment, healthy eating, and physical activity promotionMobile applications (apps) offer a novel way to engage children in behavior change",
            "probability": 0.009997487496531602,
            "start_logit": 4.258999347686768,
            "end_logit": 3.6815602779388428,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "weight-loss mobile appsWeight-loss mobile applications (apps) have the potential to be a helpful toolMobile apps for pediatric obesity prevention",
            "probability": 0.008301005214947314,
            "start_logit": 3.701673984527588,
            "end_logit": 4.052928447723389,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "behavior change",
            "probability": 0.00679589094993901,
            "start_logit": 3.872983694076538,
            "end_logit": 3.6815602779388428,
            "question_text": "What are the mobile applications fields of use for patients ?"
        }
    ],
    "54f431d664850a5854000006": [
        {
            "text": "TINF2",
            "probability": 0.12906758410187302,
            "start_logit": 4.936313629150391,
            "end_logit": 4.06749963760376,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1",
            "probability": 0.10916213439077274,
            "start_logit": 4.662010669708252,
            "end_logit": 4.174300670623779,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NOP10",
            "probability": 0.07965653201021815,
            "start_logit": 4.670891284942627,
            "end_logit": 3.8503098487854004,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 (codes for dyskerin), TERC and TERT (code for telomerase) and NOP10",
            "probability": 0.07895226479014851,
            "start_logit": 4.662010669708252,
            "end_logit": 3.8503098487854004,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 (codes for dyskerin), TERC",
            "probability": 0.06641379835165927,
            "start_logit": 4.662010669708252,
            "end_logit": 3.6773712635040283,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 (codes for dyskerin",
            "probability": 0.06422113781856012,
            "start_logit": 4.662010669708252,
            "end_logit": 3.643798828125,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 (codes for dyskerin), TERC and TERT",
            "probability": 0.061234816464358105,
            "start_logit": 4.662010669708252,
            "end_logit": 3.596182346343994,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "TERC and TERT (code for telomerase) and NOP10",
            "probability": 0.05141916154526053,
            "start_logit": 4.23317813873291,
            "end_logit": 3.8503098487854004,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "dyskerin), TERC and TERT (code for telomerase) and NOP10",
            "probability": 0.047745878942870607,
            "start_logit": 4.159060001373291,
            "end_logit": 3.8503098487854004,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "TERC",
            "probability": 0.04325324720392866,
            "start_logit": 4.23317813873291,
            "end_logit": 3.6773712635040283,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "dyskerin), TERC",
            "probability": 0.04016332127599982,
            "start_logit": 4.159060001373291,
            "end_logit": 3.6773712635040283,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "TERC and TERT",
            "probability": 0.03988033691426278,
            "start_logit": 4.23317813873291,
            "end_logit": 3.596182346343994,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "TERT (code for telomerase) and NOP10",
            "probability": 0.03916291302431559,
            "start_logit": 3.960897445678711,
            "end_logit": 3.8503098487854004,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "dyskerin",
            "probability": 0.038837323793160995,
            "start_logit": 4.159060001373291,
            "end_logit": 3.643798828125,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "dyskerin), TERC and TERT",
            "probability": 0.03703136498702386,
            "start_logit": 4.159060001373291,
            "end_logit": 3.596182346343994,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "TERT",
            "probability": 0.030374477510274275,
            "start_logit": 3.960897445678711,
            "end_logit": 3.596182346343994,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 (codes for dyskerin), TERC and TERT (code for telomerase)",
            "probability": 0.011758812243529912,
            "start_logit": 4.662010669708252,
            "end_logit": 1.946069359779358,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1, TERC",
            "probability": 0.011748506819755535,
            "start_logit": 3.894578456878662,
            "end_logit": 2.7126247882843018,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "telomerase) and NOP10",
            "probability": 0.0114391875900763,
            "start_logit": 2.7302122116088867,
            "end_logit": 3.8503098487854004,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1, TERC, TERT, NOP10",
            "probability": 0.008477200221951395,
            "start_logit": 3.894578456878662,
            "end_logit": 2.3862788677215576,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        }
    ],
    "5354f289288f4dae47000008": [
        {
            "text": "MITIE",
            "probability": 0.6939558239568929,
            "start_logit": 5.049174785614014,
            "end_logit": 5.557881832122803,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "MITIE (Mixed Integer Transcript IdEntification) for simultaneous transcript reconstruction and quantification.Montebello",
            "probability": 0.165404578023416,
            "start_logit": 5.049174785614014,
            "end_logit": 4.123867988586426,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "MITIE (Mixed Integer Transcript IdEntification",
            "probability": 0.029769111149215988,
            "start_logit": 5.049174785614014,
            "end_logit": 2.408944845199585,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "SpankiORMAN",
            "probability": 0.029032403578614783,
            "start_logit": 3.583636999130249,
            "end_logit": 3.849423885345459,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Montebello",
            "probability": 0.025166464702250382,
            "start_logit": 3.166292667388916,
            "end_logit": 4.123867988586426,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Mixed Integer Transcript IdEntification) for simultaneous transcript reconstruction and quantification.Montebello",
            "probability": 0.018718428576567536,
            "start_logit": 2.870288848876953,
            "end_logit": 4.123867988586426,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "MITIE (Mixed Integer Transcript IdEntification)",
            "probability": 0.01371036639527213,
            "start_logit": 5.049174785614014,
            "end_logit": 1.6336257457733154,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "MITIE (Mixed Integer Transcript IdEntification) for simultaneous transcript reconstruction and quantification.Montebello,",
            "probability": 0.009330198565764648,
            "start_logit": 5.049174785614014,
            "end_logit": 1.2487298250198364,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Mixed Integer Transcript IdEntification",
            "probability": 0.00336889696460284,
            "start_logit": 2.870288848876953,
            "end_logit": 2.408944845199585,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Splicing Analysis Kit (SpankiORMAN",
            "probability": 0.002317966037256865,
            "start_logit": 1.0559145212173462,
            "end_logit": 3.849423885345459,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "MITIE (Mixed Integer Transcript IdEntification) for simultaneous transcript reconstruction and quantification.",
            "probability": 0.0020329193869168777,
            "start_logit": 5.049174785614014,
            "end_logit": -0.27505359053611755,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Mixed Integer Transcript IdEntification)",
            "probability": 0.0015515683858045423,
            "start_logit": 2.870288848876953,
            "end_logit": 1.6336257457733154,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Montebello,",
            "probability": 0.0014195986330986672,
            "start_logit": 3.166292667388916,
            "end_logit": 1.2487298250198364,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "MITIE (Mixed Integer Transcript IdEntification) for simultaneous transcript reconstruction and quantification",
            "probability": 0.0011037450015802903,
            "start_logit": 5.049174785614014,
            "end_logit": -0.8858175277709961,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Mixed Integer Transcript IdEntification) for simultaneous transcript reconstruction and quantification.Montebello,",
            "probability": 0.0010558755842521726,
            "start_logit": 2.870288848876953,
            "end_logit": 1.2487298250198364,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "(Mixed Integer Transcript IdEntification) for simultaneous transcript reconstruction and quantification.Montebello",
            "probability": 0.0006991018518723787,
            "start_logit": -0.41717851161956787,
            "end_logit": 4.123867988586426,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "MITIE (Mixed",
            "probability": 0.0005249257209341844,
            "start_logit": 5.049174785614014,
            "end_logit": -1.6290249824523926,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Transcript IdEntification) for simultaneous transcript reconstruction and quantification.Montebello",
            "probability": 0.0003225327513430155,
            "start_logit": -1.1907702684402466,
            "end_logit": 4.123867988586426,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Splicing Analysis Kit",
            "probability": 0.00025845077300837174,
            "start_logit": 1.0559145212173462,
            "end_logit": 1.6556837558746338,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": ".Montebello",
            "probability": 0.00025704396133522343,
            "start_logit": -1.4177278280258179,
            "end_logit": 4.123867988586426,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        }
    ],
    "570a5343cf1c325851000022": [
        {
            "text": "R160W",
            "probability": 0.12956960224758723,
            "start_logit": 3.9978082180023193,
            "end_logit": 3.8834121227264404,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R151C, R160W",
            "probability": 0.12428018649228509,
            "start_logit": 3.9561285972595215,
            "end_logit": 3.8834121227264404,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R151C",
            "probability": 0.07462892034166847,
            "start_logit": 3.9561285972595215,
            "end_logit": 3.373401641845703,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R163Q",
            "probability": 0.07195642953238433,
            "start_logit": 4.040534496307373,
            "end_logit": 3.252528429031372,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R160W; NRHC: V60L, R163Q",
            "probability": 0.06894675307710725,
            "start_logit": 3.9978082180023193,
            "end_logit": 3.252528429031372,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R151C, R160W; NRHC: V60L, R163Q",
            "probability": 0.06613214196711778,
            "start_logit": 3.9561285972595215,
            "end_logit": 3.252528429031372,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R160W; NRHC: V60L",
            "probability": 0.05255519577590414,
            "start_logit": 3.9978082180023193,
            "end_logit": 2.98105788230896,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R151C, R160W; NRHC: V60L",
            "probability": 0.05040973668875755,
            "start_logit": 3.9561285972595215,
            "end_logit": 2.98105788230896,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "V60L, R163Q",
            "probability": 0.04845117327456313,
            "start_logit": 3.6450302600860596,
            "end_logit": 3.252528429031372,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R163Q and the synonymous polymorphism T314T",
            "probability": 0.045618993473614027,
            "start_logit": 4.040534496307373,
            "end_logit": 2.7967917919158936,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R160W; NRHC: V60L, R163Q and the synonymous polymorphism T314T",
            "probability": 0.0437109164405647,
            "start_logit": 3.9978082180023193,
            "end_logit": 2.7967917919158936,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "V60L",
            "probability": 0.036932281556017195,
            "start_logit": 3.6450302600860596,
            "end_logit": 2.98105788230896,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "D84E, R151C, R160W",
            "probability": 0.03682593435237917,
            "start_logit": 2.7397923469543457,
            "end_logit": 3.8834121227264404,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "RHC: D84E, R151C, R160W",
            "probability": 0.031213790609299328,
            "start_logit": 2.5744500160217285,
            "end_logit": 3.8834121227264404,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "V60L, R163Q and the synonymous polymorphism T314T",
            "probability": 0.03071711272731347,
            "start_logit": 3.6450302600860596,
            "end_logit": 2.7967917919158936,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "D84E, R151C",
            "probability": 0.02211357899323576,
            "start_logit": 2.7397923469543457,
            "end_logit": 3.373401641845703,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "D84E, R151C, R160W; NRHC: V60L, R163Q",
            "probability": 0.019595866303390844,
            "start_logit": 2.7397923469543457,
            "end_logit": 3.252528429031372,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "RHC: D84E, R151C",
            "probability": 0.018743546808947888,
            "start_logit": 2.5744500160217285,
            "end_logit": 3.373401641845703,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "D84E, R151C, R160W; NRHC: V60L",
            "probability": 0.014937100646659747,
            "start_logit": 2.7397923469543457,
            "end_logit": 2.98105788230896,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "RHC: D84E, R151C, R160W; NRHC: V60L",
            "probability": 0.012660738691202949,
            "start_logit": 2.5744500160217285,
            "end_logit": 2.98105788230896,
            "question_text": "List variants of the MC1R gene."
        }
    ],
    "5713b29f1174fb175500000f": [
        {
            "text": "Silver syndrome/spastic paraplegia 17",
            "probability": 0.14361092830041278,
            "start_logit": 4.495296955108643,
            "end_logit": 4.32201623916626,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "Silver syndrome",
            "probability": 0.13062905212173395,
            "start_logit": 4.495296955108643,
            "end_logit": 4.227270126342773,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "distal hereditary motor neuropathy type V",
            "probability": 0.11150919120698727,
            "start_logit": 4.517312526702881,
            "end_logit": 4.046999931335449,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "Silver syndrome/spastic paraplegia 17, distal hereditary motor neuropathy type V",
            "probability": 0.10908107883717007,
            "start_logit": 4.495296955108643,
            "end_logit": 4.046999931335449,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "spastic paraplegia 17",
            "probability": 0.09128061200519776,
            "start_logit": 4.04212760925293,
            "end_logit": 4.32201623916626,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "distal hereditary motor neuropathy type V (OMIM #182960) and Silver syndrome",
            "probability": 0.0784545881694302,
            "start_logit": 3.9459564685821533,
            "end_logit": 4.266768932342529,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "spastic paraplegia 17, distal hereditary motor neuropathy type V",
            "probability": 0.06933307758874427,
            "start_logit": 4.04212760925293,
            "end_logit": 4.046999931335449,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "distal hereditary motor neuropathy type V, and Charcot-Marie-Tooth disease type 2",
            "probability": 0.044196663679228386,
            "start_logit": 4.475305080413818,
            "end_logit": 3.1635496616363525,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "spastic paraplegia 17, distal hereditary motor neuropathy type V, and Charcot-Marie-Tooth disease type 2",
            "probability": 0.03989528158481541,
            "start_logit": 3.899158239364624,
            "end_logit": 3.63730525970459,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "distal hereditary motor neuropathy type V, and Charcot-Marie-Tooth disease type 2 (CMT2)",
            "probability": 0.0389686648111613,
            "start_logit": 4.475305080413818,
            "end_logit": 3.037658214569092,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "Silver syndrome/spastic paraplegia 17, distal hereditary motor neuropathy",
            "probability": 0.02115710850946621,
            "start_logit": 4.327549457550049,
            "end_logit": 2.574631929397583,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "distal hereditary motor neuropathy",
            "probability": 0.01858886640017715,
            "start_logit": 4.475305080413818,
            "end_logit": 2.2974631786346436,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "Charcot-Marie-Tooth disease type 2",
            "probability": 0.017872766232315953,
            "start_logit": 3.5699338912963867,
            "end_logit": 3.1635496616363525,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "Silver syndrome/spastic paraplegia",
            "probability": 0.016296386032497428,
            "start_logit": 4.495296955108643,
            "end_logit": 2.1458518505096436,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "Charcot-Marie-Tooth disease type 2 (CMT2)",
            "probability": 0.015758606613618536,
            "start_logit": 3.5699338912963867,
            "end_logit": 3.037658214569092,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "spastic paraplegia 17, distal hereditary motor neuropathy",
            "probability": 0.01378505081299032,
            "start_logit": 3.899158239364624,
            "end_logit": 2.574631929397583,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "Silver syndrome/spastic paraplegia 17, distal hereditary motor neuropathy type V, and Charcot-Marie-Tooth disease",
            "probability": 0.013761834037360999,
            "start_logit": 4.327549457550049,
            "end_logit": 2.14455509185791,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "spastic paraplegia",
            "probability": 0.01035815385447269,
            "start_logit": 4.04212760925293,
            "end_logit": 2.1458518505096436,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "spastic paraplegia 17, distal hereditary motor neuropathy type V, and Charcot-Marie-Tooth disease",
            "probability": 0.00896661192620349,
            "start_logit": 3.899158239364624,
            "end_logit": 2.14455509185791,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "Silver syndrome (OMIM #270685)",
            "probability": 0.0064954772760160194,
            "start_logit": 4.3969645500183105,
            "end_logit": 1.3243470191955566,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        }
    ],
    "5141bcd423fec9037500000d": [
        {
            "text": "SCH-527123",
            "probability": 0.8448497462078985,
            "start_logit": 5.106359004974365,
            "end_logit": 5.236072063446045,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "AZ1039776",
            "probability": 0.07503076287352764,
            "start_logit": 4.524244785308838,
            "end_logit": 3.396925687789917,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "G31P",
            "probability": 0.03423936159479121,
            "start_logit": 3.6970417499542236,
            "end_logit": 3.4396064281463623,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "SCH-527123,",
            "probability": 0.012900427378351415,
            "start_logit": 5.106359004974365,
            "end_logit": 1.0541737079620361,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "SB225002)G31P",
            "probability": 0.009043707483188473,
            "start_logit": 2.3657350540161133,
            "end_logit": 3.4396064281463623,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "SB225002",
            "probability": 0.006141387955488267,
            "start_logit": 2.3657350540161133,
            "end_logit": 3.0525879859924316,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "(SB225002)G31P",
            "probability": 0.004260046477368029,
            "start_logit": 1.6129459142684937,
            "end_logit": 3.4396064281463623,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "SCH",
            "probability": 0.00331388931223965,
            "start_logit": 5.106359004974365,
            "end_logit": -0.30496421456336975,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "(SB225002",
            "probability": 0.0028929062748394288,
            "start_logit": 1.6129459142684937,
            "end_logit": 3.0525879859924316,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "prostate cancer cells in nude mice.The CXCR2 antagonist, SCH-527123",
            "probability": 0.0015865299496756748,
            "start_logit": -1.171250581741333,
            "end_logit": 5.236072063446045,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "G31P,",
            "probability": 0.0012703815837159247,
            "start_logit": 3.6970417499542236,
            "end_logit": 0.14554783701896667,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "SCH-527123, shows antitumor activityretreatment with the CXCR2 antagonist AZ103977",
            "probability": 0.0008067152077888005,
            "start_logit": 5.106359004974365,
            "end_logit": -1.7178713083267212,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "SCH-52712",
            "probability": 0.0007674845372870647,
            "start_logit": 5.106359004974365,
            "end_logit": -1.7677236795425415,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "CXCR2 small-molecule antagonist (SB225002)G31P",
            "probability": 0.0006322005254714737,
            "start_logit": -0.29488280415534973,
            "end_logit": 3.4396064281463623,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "527123",
            "probability": 0.0006085881121100196,
            "start_logit": -2.129413366317749,
            "end_logit": 5.236072063446045,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "AZ103977",
            "probability": 0.000450724588273351,
            "start_logit": 4.524244785308838,
            "end_logit": -1.7178713083267212,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "CXCR2 small-molecule antagonist (SB225002",
            "probability": 0.0004293138295108817,
            "start_logit": -0.29488280415534973,
            "end_logit": 3.0525879859924316,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "SB225002)G31P,",
            "probability": 0.0003355482958801526,
            "start_logit": 2.3657350540161133,
            "end_logit": 0.14554783701896667,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "G31P, an antagonist against CXC chemokine receptors 1 and 2,",
            "probability": 0.00023279668151115742,
            "start_logit": 3.6970417499542236,
            "end_logit": -1.5513592958450317,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer",
            "probability": 0.00020748113108317535,
            "start_logit": 3.6970417499542236,
            "end_logit": -1.6664843559265137,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        }
    ],
    "52bf1af803868f1b06000008": [
        {
            "text": "CPVT",
            "probability": 0.7763239071944228,
            "start_logit": 3.512113094329834,
            "end_logit": 3.506579637527466,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "autosomal recessive form of CPVT",
            "probability": 0.08785642339304808,
            "start_logit": 1.1351685523986816,
            "end_logit": 3.704658269882202,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "polymorphic ventricular tachycardia",
            "probability": 0.05229176079109923,
            "start_logit": 1.8462748527526855,
            "end_logit": 2.474686861038208,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "Catecholaminergic polymorphic ventricular tachycardia",
            "probability": 0.031747623974848524,
            "start_logit": 1.3472539186477661,
            "end_logit": 2.474686861038208,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "The autosomal recessive form of CPVT",
            "probability": 0.02415068012224023,
            "start_logit": -0.15622283518314362,
            "end_logit": 3.704658269882202,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ventricular tachycardia",
            "probability": 0.007156193347781244,
            "start_logit": -0.14258578419685364,
            "end_logit": 2.474686861038208,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "autosomal recessive",
            "probability": 0.005670040538714292,
            "start_logit": 1.1351685523986816,
            "end_logit": 0.964150607585907,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "Recessively inherited CPVT",
            "probability": 0.004174405118791434,
            "start_logit": -1.7134848833084106,
            "end_logit": 3.506579637527466,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "autosomal recessive form",
            "probability": 0.00317050566639097,
            "start_logit": 1.1351685523986816,
            "end_logit": 0.3828454315662384,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "The autosomal recessive",
            "probability": 0.0015586263364945833,
            "start_logit": -0.15622283518314362,
            "end_logit": 0.964150607585907,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "form of CPVT",
            "probability": 0.001277209675080844,
            "start_logit": -3.095857620239258,
            "end_logit": 3.704658269882202,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "The autosomal recessive form",
            "probability": 0.0008715340918466895,
            "start_logit": -0.15622283518314362,
            "end_logit": 0.3828454315662384,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CPVT is",
            "probability": 0.0007847463685884787,
            "start_logit": 3.512113094329834,
            "end_logit": -3.3903849124908447,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "C",
            "probability": 0.0006688922469161634,
            "start_logit": 3.512113094329834,
            "end_logit": -3.5501224994659424,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "T",
            "probability": 0.0005637715991830034,
            "start_logit": -3.7155628204345703,
            "end_logit": 3.506579637527466,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CPVT is caused by mutations in the CASQ2",
            "probability": 0.00040485392712228844,
            "start_logit": 3.261467933654785,
            "end_logit": -3.8015739917755127,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CPVT is caused by mutations in the CASQ2 gene",
            "probability": 0.0003857619000776548,
            "start_logit": 3.261467933654785,
            "end_logit": -3.8498799800872803,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "polymorphic ventricular tachycardia is a familial cardiac arrhythmia",
            "probability": 0.0003373518125959025,
            "start_logit": 1.8462748527526855,
            "end_logit": -2.5687808990478516,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ive form of CPVT",
            "probability": 0.0003142065782883567,
            "start_logit": -4.498239994049072,
            "end_logit": 3.704658269882202,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CPVT is caused",
            "probability": 0.00029150531646923787,
            "start_logit": 3.261467933654785,
            "end_logit": -4.13004207611084,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        }
    ],
    "550303a5e9bde6963400000c": [
        {
            "text": "chronic obstructive pulmonary disease",
            "probability": 0.8963944096718894,
            "start_logit": 4.977752208709717,
            "end_logit": 4.687062740325928,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic obstructive pulmonary",
            "probability": 0.04210008379972818,
            "start_logit": 4.977752208709717,
            "end_logit": 1.6287319660186768,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic obstructive pulmonary disease (COPD)",
            "probability": 0.021386455507882873,
            "start_logit": 4.977752208709717,
            "end_logit": 0.9514400362968445,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory Illness ProjectThis project supported community-based patients suffering from chronic obstructive pulmonary disease",
            "probability": 0.01802095582999025,
            "start_logit": 1.0709069967269897,
            "end_logit": 4.687062740325928,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "obstructive pulmonary disease",
            "probability": 0.01546543320928755,
            "start_logit": 0.9179791212081909,
            "end_logit": 4.687062740325928,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "pulmonary disease",
            "probability": 0.0016852798946978516,
            "start_logit": -1.2986966371536255,
            "end_logit": 4.687062740325928,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory Illness ProjectThis project supported community-based patients suffering from chronic obstructive pulmonary",
            "probability": 0.0008463726931000087,
            "start_logit": 1.0709069967269897,
            "end_logit": 1.6287319660186768,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic obstructive",
            "probability": 0.0007890768067283112,
            "start_logit": 4.977752208709717,
            "end_logit": -2.3482093811035156,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "obstructive pulmonary",
            "probability": 0.0007263499494027724,
            "start_logit": 0.9179791212081909,
            "end_logit": 1.6287319660186768,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "disease",
            "probability": 0.00044892010708616313,
            "start_logit": -2.6215386390686035,
            "end_logit": 4.687062740325928,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory Illness ProjectThis project supported community-based patients suffering from chronic obstructive pulmonary disease (COPD)",
            "probability": 0.0004299495466606936,
            "start_logit": 1.0709069967269897,
            "end_logit": 0.9514400362968445,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic",
            "probability": 0.00038167005665140684,
            "start_logit": 4.977752208709717,
            "end_logit": -3.074516534805298,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "obstructive pulmonary disease (COPD)",
            "probability": 0.0003689790963350925,
            "start_logit": 0.9179791212081909,
            "end_logit": 0.9514400362968445,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic obstructive pulmonary disease (COPD",
            "probability": 0.00022412588408501157,
            "start_logit": 4.977752208709717,
            "end_logit": -3.606865167617798,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory Illness",
            "probability": 0.00017414729102293707,
            "start_logit": 1.0709069967269897,
            "end_logit": 0.04767360910773277,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "tructive pulmonary disease",
            "probability": 0.00015246014034816905,
            "start_logit": -3.7014803886413574,
            "end_logit": 4.687062740325928,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory",
            "probability": 0.00011411085669974408,
            "start_logit": 1.0709069967269897,
            "end_logit": -0.3750574290752411,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Parkinson's disease",
            "probability": 0.00010679474849824838,
            "start_logit": 0.1983250379562378,
            "end_logit": 0.43126288056373596,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Illness ProjectThis project supported community-based patients suffering from chronic obstructive pulmonary disease",
            "probability": 9.960815188034355e-05,
            "start_logit": -4.127139568328857,
            "end_logit": 4.687062740325928,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic o",
            "probability": 8.481675802499628e-05,
            "start_logit": 4.977752208709717,
            "end_logit": -4.578579902648926,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        }
    ],
    "51bdf045047fa84d1d000003": [
        {
            "text": "GABARAPL1",
            "probability": 0.19189435298631755,
            "start_logit": 6.022641658782959,
            "end_logit": 4.62261438369751,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP",
            "probability": 0.16452271469703866,
            "start_logit": 5.538198947906494,
            "end_logit": 4.953160762786865,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP subfamily.GABARAPL1 belongs to the small family of GABARAP",
            "probability": 0.09579289026318777,
            "start_logit": 5.538198947906494,
            "end_logit": 4.4123005867004395,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP subfamily.GABARAPL1",
            "probability": 0.08341570079542923,
            "start_logit": 5.538198947906494,
            "end_logit": 4.273948669433594,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP subfamily.GABARAPL1 belongs to the small family of GABARAP proteins (including GABARAP",
            "probability": 0.07142881760708221,
            "start_logit": 5.538198947906494,
            "end_logit": 4.118813514709473,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAPL",
            "probability": 0.06991193179666537,
            "start_logit": 6.022641658782959,
            "end_logit": 3.612905740737915,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAPL1 belongs to the small family of GABARAP",
            "probability": 0.05365009444726339,
            "start_logit": 4.958493709564209,
            "end_logit": 4.4123005867004395,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAPL1 belongs to the small family of GABARAP proteins (including GABARAP",
            "probability": 0.040004668408559034,
            "start_logit": 4.958493709564209,
            "end_logit": 4.118813514709473,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP proteins (including GABARAP",
            "probability": 0.03311181508729885,
            "start_logit": 4.769387722015381,
            "end_logit": 4.118813514709473,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAPL1Stbd1 has been reported to interact with a known autophagy protein, GABARAPL1",
            "probability": 0.028426771693763137,
            "start_logit": 4.113028049468994,
            "end_logit": 4.62261438369751,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAPL1 belongs to the small family of GABARAP proteins (including GABARAP, GABARAPL1",
            "probability": 0.02709649716533327,
            "start_logit": 4.958493709564209,
            "end_logit": 3.729221820831299,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP subfamily.GABARAPL1 belongs to the small family of GABARAP proteins (including GABARAP, GABARAPL",
            "probability": 0.025320942921363245,
            "start_logit": 5.538198947906494,
            "end_logit": 3.0817439556121826,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP proteins (including GABARAP, GABARAPL1",
            "probability": 0.022427737545252915,
            "start_logit": 4.769387722015381,
            "end_logit": 3.729221820831299,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP proteins (including GABARAP, GABARAPL1 and GABARAPL",
            "probability": 0.018551540130208665,
            "start_logit": 4.769387722015381,
            "end_logit": 3.539476156234741,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP subfamily.GABARAPL",
            "probability": 0.015301759473264318,
            "start_logit": 5.538198947906494,
            "end_logit": 2.57807993888855,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAPL1 belongs to the small family of GABARAP proteins (including GABARAP, GABARAPL",
            "probability": 0.014181334079100752,
            "start_logit": 4.958493709564209,
            "end_logit": 3.0817439556121826,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP proteins (including GABARAP, GABARAPL",
            "probability": 0.011737872863306343,
            "start_logit": 4.769387722015381,
            "end_logit": 3.0817439556121826,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAPL1 and GABARAPL",
            "probability": 0.011377051126865713,
            "start_logit": 4.280433177947998,
            "end_logit": 3.539476156234741,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP proteins (including GABARAP, GABARAPL1 and GABARAPL2",
            "probability": 0.011144030925985772,
            "start_logit": 4.769387722015381,
            "end_logit": 3.029827356338501,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "GABARAP, GABARAPL1",
            "probability": 0.010701475986713697,
            "start_logit": 4.029470920562744,
            "end_logit": 3.729221820831299,
            "question_text": "Which are the Atg8 homologs in human?"
        }
    ],
    "515db020298dcd4e51000011": [
        {
            "text": "2009-016278-34",
            "probability": 0.17053989975554093,
            "start_logit": 0.6732239127159119,
            "end_logit": 0.15262480080127716,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "2009-016278-34 and the Clinical Trials Registry, India as CTRI/2010/091/000250",
            "probability": 0.14632432487798228,
            "start_logit": 0.6732239127159119,
            "end_logit": -0.0005189233925193548,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "EudraCT: 2009-016278-34",
            "probability": 0.08675847177194598,
            "start_logit": -0.002617301419377327,
            "end_logit": 0.15262480080127716,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "Clinical Trials Registry, India as CTRI/2010/091/000250",
            "probability": 0.07832335908176205,
            "start_logit": 0.04824423789978027,
            "end_logit": -0.0005189233925193548,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "2009-016278-34 and the Clinical Trials Registry",
            "probability": 0.07296451067476958,
            "start_logit": 0.6732239127159119,
            "end_logit": -0.69637131690979,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "Polycap",
            "probability": 0.05604579138447192,
            "start_logit": 0.49605974555015564,
            "end_logit": -0.783011257648468,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "phase II, double-blind, randomised trial",
            "probability": 0.053929432171161425,
            "start_logit": 0.04793053865432739,
            "end_logit": -0.37337473034858704,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "European Clinical Trials database, as EudraCT: 2009-016278-34",
            "probability": 0.04271083983483572,
            "start_logit": -0.7112926244735718,
            "end_logit": 0.15262480080127716,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "Clinical Trials Registry",
            "probability": 0.03905588202488239,
            "start_logit": 0.04824423789978027,
            "end_logit": -0.69637131690979,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "EudraCT: 2009-016278-34 and the Clinical Trials Registry",
            "probability": 0.03711911082863864,
            "start_logit": -0.002617301419377327,
            "end_logit": -0.69637131690979,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "2009-016278-34 and the Clinical Trials Registry, India as CTRI/2010/091/000250.",
            "probability": 0.029626042337414348,
            "start_logit": 0.6732239127159119,
            "end_logit": -1.5976907014846802,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "double-blind, randomised trial",
            "probability": 0.028625298817119227,
            "start_logit": -0.5854549407958984,
            "end_logit": -0.37337473034858704,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "CTRI/2010/091/000250",
            "probability": 0.025639366020661414,
            "start_logit": -1.0684727430343628,
            "end_logit": -0.0005189233925193548,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "2009-016278",
            "probability": 0.02388219121331395,
            "start_logit": 0.6732239127159119,
            "end_logit": -1.813211441040039,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "ACTRN12606000067572",
            "probability": 0.02354443817891463,
            "start_logit": -1.1576792001724243,
            "end_logit": 0.0034482500050216913,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind",
            "probability": 0.020843645152440114,
            "start_logit": 0.49605974555015564,
            "end_logit": -1.7721312046051025,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "European Clinical Trials database, as EudraCT: 2009-016278-34 and the Clinical Trials Registry",
            "probability": 0.018273586026052488,
            "start_logit": -0.7112926244735718,
            "end_logit": -0.69637131690979,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "Clinical Trials Registry, India as CTRI/2010/091/000250.",
            "probability": 0.015858000056379867,
            "start_logit": 0.04824423789978027,
            "end_logit": -1.5976907014846802,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "Clinical Trial Registry (ACTRN12606000067572",
            "probability": 0.01511798737976036,
            "start_logit": -1.600683569908142,
            "end_logit": 0.0034482500050216913,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "Zealand Clinical Trial Registry (ACTRN12606000067572",
            "probability": 0.014817822411952772,
            "start_logit": -1.62073814868927,
            "end_logit": 0.0034482500050216913,
            "question_text": "List all clinical trials of the polypill."
        }
    ],
    "533c2a55c45e133714000003": [
        {
            "text": "YAPYAP1",
            "probability": 0.24060225034312518,
            "start_logit": 5.885071754455566,
            "end_logit": 5.175394535064697,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "Yap1human ortholog of Yorkie, YAPYAP1",
            "probability": 0.1357098353240257,
            "start_logit": 5.312445640563965,
            "end_logit": 5.175394535064697,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYorkie ortholog, Yap1human ortholog of Yorkie, YAPYAP1",
            "probability": 0.10941953025574203,
            "start_logit": 5.097115993499756,
            "end_logit": 5.175394535064697,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "Yap1",
            "probability": 0.09656833646113931,
            "start_logit": 5.312445640563965,
            "end_logit": 4.8351263999938965,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYorkie ortholog, Yap1",
            "probability": 0.07786069438465858,
            "start_logit": 5.097115993499756,
            "end_logit": 4.8351263999938965,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYAP",
            "probability": 0.05728107068060178,
            "start_logit": 5.885071754455566,
            "end_logit": 3.7402195930480957,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "Yap1human ortholog of Yorkie, YAPYAP",
            "probability": 0.03230894415227759,
            "start_logit": 5.312445640563965,
            "end_logit": 3.7402195930480957,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYAP1, the ortholog of Drosophila YorkieYorkie",
            "probability": 0.02980433805234679,
            "start_logit": 5.885071754455566,
            "end_logit": 3.0869033336639404,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "Yorkie, YAPYAP1",
            "probability": 0.027294998685638713,
            "start_logit": 3.708630084991455,
            "end_logit": 5.175394535064697,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYorkie ortholog, Yap1human ortholog of Yorkie, YAPYAP",
            "probability": 0.02604991365408687,
            "start_logit": 5.097115993499756,
            "end_logit": 3.7402195930480957,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "Yap1human ortholog of Yorkie",
            "probability": 0.022396730987116226,
            "start_logit": 5.312445640563965,
            "end_logit": 3.3737905025482178,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYAP1, the ortholog of Drosophila YorkieYorkie ortholog YAP",
            "probability": 0.022372858807587458,
            "start_logit": 5.885071754455566,
            "end_logit": 2.800097942352295,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYAP1, the ortholog of Drosophila Yorkie",
            "probability": 0.021827456823348346,
            "start_logit": 5.885071754455566,
            "end_logit": 2.7754180431365967,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "Yap",
            "probability": 0.020284902417070615,
            "start_logit": 5.312445640563965,
            "end_logit": 3.274752378463745,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYorkie",
            "probability": 0.018786974817764892,
            "start_logit": 5.097115993499756,
            "end_logit": 3.4133689403533936,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYorkie ortholog, Yap1human ortholog of Yorkie",
            "probability": 0.018057937938125435,
            "start_logit": 5.097115993499756,
            "end_logit": 3.3737905025482178,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAPYorkie ortholog, Yap",
            "probability": 0.016355222069645285,
            "start_logit": 5.097115993499756,
            "end_logit": 3.274752378463745,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAP",
            "probability": 0.016015180898131597,
            "start_logit": 5.550760269165039,
            "end_logit": 2.800097942352295,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "Yorkie, YAPYAP",
            "probability": 0.0064982216363699856,
            "start_logit": 3.708630084991455,
            "end_logit": 3.7402195930480957,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "Yorkie",
            "probability": 0.004504601611197409,
            "start_logit": 3.708630084991455,
            "end_logit": 3.3737905025482178,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        }
    ],
    "5548da00f35db7552600000b": [
        {
            "text": "myosins-Ibeta, -VI, and -VIIa",
            "probability": 0.43929582922818455,
            "start_logit": 5.132395267486572,
            "end_logit": 4.459312915802002,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "myosins-Ibeta",
            "probability": 0.3441974713428947,
            "start_logit": 5.132395267486572,
            "end_logit": 4.215355396270752,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "myosins-Ibeta, -VI",
            "probability": 0.1378863663526988,
            "start_logit": 5.132395267486572,
            "end_logit": 3.300569772720337,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "-Ibeta, -VI, and -VIIa",
            "probability": 0.013208734347082614,
            "start_logit": 1.6281005144119263,
            "end_logit": 4.459312915802002,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "-VI, and -VIIa",
            "probability": 0.012578813608905046,
            "start_logit": 1.5792361497879028,
            "end_logit": 4.459312915802002,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "-Ibeta",
            "probability": 0.010349319659814758,
            "start_logit": 1.6281005144119263,
            "end_logit": 4.215355396270752,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "Ibeta, -VI, and -VIIa",
            "probability": 0.009646670348003128,
            "start_logit": 1.3138350248336792,
            "end_logit": 4.459312915802002,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "Ibeta",
            "probability": 0.00755836800566676,
            "start_logit": 1.3138350248336792,
            "end_logit": 4.215355396270752,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "-VIIa",
            "probability": 0.004222020363670698,
            "start_logit": 0.4875359833240509,
            "end_logit": 4.459312915802002,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "-Ibeta, -VI",
            "probability": 0.004145963294113736,
            "start_logit": 1.6281005144119263,
            "end_logit": 3.300569772720337,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "-VI",
            "probability": 0.003948243498252896,
            "start_logit": 1.5792361497879028,
            "end_logit": 3.300569772720337,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "Ibeta, -VI",
            "probability": 0.0030279010934965087,
            "start_logit": 1.3138350248336792,
            "end_logit": 3.300569772720337,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "VI, and -VIIa",
            "probability": 0.0027276513030904475,
            "start_logit": 0.05066312104463577,
            "end_logit": 4.459312915802002,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "VIIa",
            "probability": 0.0023229025815147183,
            "start_logit": -0.10996027290821075,
            "end_logit": 4.459312915802002,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "myosins-I",
            "probability": 0.002160895329976044,
            "start_logit": 5.132395267486572,
            "end_logit": -0.8553375005722046,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "VI",
            "probability": 0.0008561563799072265,
            "start_logit": 0.05066312104463577,
            "end_logit": 3.300569772720337,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "myosins-Ibeta,",
            "probability": 0.00057829665857803,
            "start_logit": 5.132395267486572,
            "end_logit": -2.1735284328460693,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "myosins-Ibeta, -VI,",
            "probability": 0.0004664197038764837,
            "start_logit": 5.132395267486572,
            "end_logit": -2.3885295391082764,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "my",
            "probability": 0.00045707041856683106,
            "start_logit": 5.132395267486572,
            "end_logit": -2.408777952194214,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "myosins-Ibeta, -VI, and -V",
            "probability": 0.0003649064817059439,
            "start_logit": 5.132395267486572,
            "end_logit": -2.633974313735962,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        }
    ],
    "530db83b38c1322806000002": [
        {
            "text": "I\u03baBs",
            "probability": 0.443311019061138,
            "start_logit": 4.8457207679748535,
            "end_logit": 4.309025287628174,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs, Sef",
            "probability": 0.18288533690088904,
            "start_logit": 4.352610111236572,
            "end_logit": 3.9167237281799316,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Sef",
            "probability": 0.141991756134808,
            "start_logit": 4.099519729614258,
            "end_logit": 3.9167237281799316,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs.The inhibitor of NF-kappaB (IkappaB",
            "probability": 0.11954775343085983,
            "start_logit": 4.8457207679748535,
            "end_logit": 2.998469591140747,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "IkappaB",
            "probability": 0.03687944211718832,
            "start_logit": 3.66965913772583,
            "end_logit": 2.998469591140747,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baB proteins and translocates into the nucleus upon their ligand-induced degradation.Like I\u03baBs",
            "probability": 0.01964819896114068,
            "start_logit": 1.98711097240448,
            "end_logit": 4.05134916305542,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baB proteins and translocates into the nucleus upon their ligand-induced degradation.Like I\u03baBs, Sef",
            "probability": 0.017173375411306566,
            "start_logit": 1.98711097240448,
            "end_logit": 3.9167237281799316,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs.The inhibitor of NF-kappaB (IkappaB)",
            "probability": 0.013822365038101582,
            "start_logit": 4.8457207679748535,
            "end_logit": 0.841041624546051,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs.The inhibitor of NF-kappaB",
            "probability": 0.006170851037271859,
            "start_logit": 4.8457207679748535,
            "end_logit": 0.034590449184179306,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "IkappaB)",
            "probability": 0.004264079388494189,
            "start_logit": 3.66965913772583,
            "end_logit": 0.841041624546051,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "The inhibitor of NF-kappaB (IkappaB",
            "probability": 0.0028921028910177298,
            "start_logit": 1.1239887475967407,
            "end_logit": 2.998469591140747,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "inhibitor of NF-kappaB (IkappaB",
            "probability": 0.0026004964329055845,
            "start_logit": 1.0177072286605835,
            "end_logit": 2.998469591140747,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baB",
            "probability": 0.002247750158060906,
            "start_logit": 1.98711097240448,
            "end_logit": 1.8832932710647583,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs.The inhibitor",
            "probability": 0.0019647729888912415,
            "start_logit": 4.8457207679748535,
            "end_logit": -1.1098695993423462,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "(IkappaB",
            "probability": 0.0014520363827272768,
            "start_logit": 0.4349718391895294,
            "end_logit": 2.998469591140747,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs.The inhibitor of NF-kappaB (IkappaB) family",
            "probability": 0.001331138726093525,
            "start_logit": 4.8457207679748535,
            "end_logit": -1.4992115497589111,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs.The inhibitor of NF-kappaB (IkappaB) family of proteins",
            "probability": 0.000570853588177602,
            "start_logit": 4.8457207679748535,
            "end_logit": -2.3458688259124756,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs.",
            "probability": 0.0004282972205578654,
            "start_logit": 4.8457207679748535,
            "end_logit": -2.6331841945648193,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "IkappaB) family",
            "probability": 0.0004106447188679793,
            "start_logit": 3.66965913772583,
            "end_logit": -1.4992115497589111,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "inhibitors, I\u03baBs",
            "probability": 0.00040772941150231563,
            "start_logit": -2.145702362060547,
            "end_logit": 4.309025287628174,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        }
    ],
    "56c1f007ef6e39474100003b": [
        {
            "text": "glioblastoma",
            "probability": 0.5367960773826842,
            "start_logit": 4.903748989105225,
            "end_logit": 4.7450103759765625,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "non-small cell lung cancer",
            "probability": 0.3741359263633592,
            "start_logit": 4.943442344665527,
            "end_logit": 4.34431791305542,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "non-small cell lung",
            "probability": 0.08166459277689232,
            "start_logit": 4.943442344665527,
            "end_logit": 2.822319269180298,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "glioblastomas",
            "probability": 0.003419553076313332,
            "start_logit": 4.903748989105225,
            "end_logit": -0.31109803915023804,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "lung cancer",
            "probability": 0.0018364265967274228,
            "start_logit": -0.3733552098274231,
            "end_logit": 4.34431791305542,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "lung",
            "probability": 0.00040084637592581267,
            "start_logit": -0.3733552098274231,
            "end_logit": 2.822319269180298,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "small cell lung cancer",
            "probability": 0.0003850973251030167,
            "start_logit": -1.9354360103607178,
            "end_logit": 4.34431791305542,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "non-small cell",
            "probability": 0.00026165621850107295,
            "start_logit": 4.943442344665527,
            "end_logit": -2.921025037765503,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "non",
            "probability": 0.00018321932603603542,
            "start_logit": 4.943442344665527,
            "end_logit": -3.2773725986480713,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer",
            "probability": 0.00017325661647378177,
            "start_logit": -2.7341582775115967,
            "end_logit": 4.34431791305542,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "glioblast",
            "probability": 0.0001681605691352006,
            "start_logit": 4.903748989105225,
            "end_logit": -3.32344388961792,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "g",
            "probability": 0.00013510048697146947,
            "start_logit": 4.903748989105225,
            "end_logit": -3.542344331741333,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "small cell lung",
            "probability": 8.405719423872012e-05,
            "start_logit": -1.9354360103607178,
            "end_logit": 2.822319269180298,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "oma",
            "probability": 8.028308563650946e-05,
            "start_logit": -3.9040656089782715,
            "end_logit": 4.7450103759765625,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 6.9417657698295e-05,
            "start_logit": -3.6487908363342285,
            "end_logit": 4.34431791305542,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "lioblastoma",
            "probability": 6.219215543391376e-05,
            "start_logit": -4.159395694732666,
            "end_logit": 4.7450103759765625,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "blastoma",
            "probability": 3.910183983512079e-05,
            "start_logit": -4.623455047607422,
            "end_logit": 4.7450103759765625,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 3.875217418032514e-05,
            "start_logit": -4.23174524307251,
            "end_logit": 4.34431791305542,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cell lung cancer",
            "probability": 3.55137159422897e-05,
            "start_logit": -4.3190131187438965,
            "end_logit": 4.34431791305542,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "non-small cell lung cancer both in vitro and in vivo.",
            "probability": 3.076906291184698e-05,
            "start_logit": 4.943442344665527,
            "end_logit": -5.061546802520752,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        }
    ],
    "56e46ad951531f7e3300001a": [
        {
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3",
            "probability": 0.18027261278228943,
            "start_logit": 5.667608261108398,
            "end_logit": 5.114830493927002,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "tissue inhibitor of metalloproteinases-1",
            "probability": 0.16859258930733087,
            "start_logit": 5.667608261108398,
            "end_logit": 5.047845363616943,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "thrombospondin 3",
            "probability": 0.14829442894101724,
            "start_logit": 5.47233772277832,
            "end_logit": 5.114830493927002,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "neurotensin (Nts) (angiocrine factors)vascular endothelial growth factor",
            "probability": 0.0553990486851946,
            "start_logit": 5.094379901885986,
            "end_logit": 4.508151054382324,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1)",
            "probability": 0.05414511738013514,
            "start_logit": 5.667608261108398,
            "end_logit": 3.9120280742645264,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "vascular endothelial growth factor",
            "probability": 0.05357991533962517,
            "start_logit": 5.0609917640686035,
            "end_logit": 4.508151054382324,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "tissue inhibitor of metalloproteinases",
            "probability": 0.04974521547518845,
            "start_logit": 5.667608261108398,
            "end_logit": 3.8272745609283447,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "neurotensin",
            "probability": 0.04854901452901522,
            "start_logit": 5.094379901885986,
            "end_logit": 4.376162528991699,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1",
            "probability": 0.036087803606594276,
            "start_logit": 5.667608261108398,
            "end_logit": 3.506315231323242,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Timp-1) and thrombospondin 3",
            "probability": 0.03425809763817917,
            "start_logit": 4.007061004638672,
            "end_logit": 5.114830493927002,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "neurotensin (Nts) (angiocrine factors)vascular endothelial growth factor (VEGF)-A",
            "probability": 0.030951375667251525,
            "start_logit": 5.094379901885986,
            "end_logit": 3.9260060787200928,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "vascular endothelial growth factor (VEGF)-A",
            "probability": 0.02993502825869772,
            "start_logit": 5.0609917640686035,
            "end_logit": 3.9260060787200928,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS3",
            "probability": 0.02764913481011097,
            "start_logit": 5.667608261108398,
            "end_logit": 3.239954710006714,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "thrombospondin 3 (THBS3",
            "probability": 0.022744512292226703,
            "start_logit": 5.47233772277832,
            "end_logit": 3.239954710006714,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Ccl4 and neurotensin (Nts) (angiocrine factors)vascular endothelial growth factor",
            "probability": 0.012486802958612984,
            "start_logit": 3.604489803314209,
            "end_logit": 4.508151054382324,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Ccl4 and neurotensin",
            "probability": 0.010942822894008733,
            "start_logit": 3.604489803314209,
            "end_logit": 4.376162528991699,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS3)",
            "probability": 0.01054479484564621,
            "start_logit": 5.667608261108398,
            "end_logit": 2.2759926319122314,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Timp-1)",
            "probability": 0.010289464878835848,
            "start_logit": 4.007061004638672,
            "end_logit": 3.9120280742645264,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "thrombospondin 3 (THBS3)",
            "probability": 0.008674275619579376,
            "start_logit": 5.47233772277832,
            "end_logit": 2.2759926319122314,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Timp-1",
            "probability": 0.006857944090460307,
            "start_logit": 4.007061004638672,
            "end_logit": 3.506315231323242,
            "question_text": "List angiocrine factors"
        }
    ],
    "530cf22aa177c6630c000005": [
        {
            "text": "Mrc1 and Ctf4",
            "probability": 0.3822572918961323,
            "start_logit": 4.802700519561768,
            "end_logit": 4.138700485229492,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "Ctf4",
            "probability": 0.3241175818134417,
            "start_logit": 4.6377129554748535,
            "end_logit": 4.138700485229492,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "Mrc1",
            "probability": 0.19463716291832764,
            "start_logit": 4.802700519561768,
            "end_logit": 3.4637436866760254,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "SCF",
            "probability": 0.029521430638513507,
            "start_logit": 3.7092902660369873,
            "end_logit": 2.671133279800415,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "SCF(Dia2)",
            "probability": 0.015430180852916881,
            "start_logit": 3.7092902660369873,
            "end_logit": 2.0223422050476074,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "GINS and Ctf4",
            "probability": 0.009552788299958438,
            "start_logit": 1.9350756406784058,
            "end_logit": 3.3170645236968994,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM",
            "probability": 0.007946439674745148,
            "start_logit": 3.537777900695801,
            "end_logit": 1.5302531719207764,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM2-7",
            "probability": 0.00731899858156945,
            "start_logit": 3.537777900695801,
            "end_logit": 1.4480026960372925,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "Mrc1 and Ctf4,",
            "probability": 0.007069061100534398,
            "start_logit": 4.802700519561768,
            "end_logit": 0.14833423495292664,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "Ctf4,",
            "probability": 0.005993886939949461,
            "start_logit": 4.6377129554748535,
            "end_logit": 0.14833423495292664,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM2-7 helicase",
            "probability": 0.004815489910691081,
            "start_logit": 3.537777900695801,
            "end_logit": 1.0293669700622559,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "SCF(Dia2) associates with the replisome progression complex (RPC) that assembles around the MCM",
            "probability": 0.0029256028084686213,
            "start_logit": 3.7092902660369873,
            "end_logit": 0.359517365694046,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM2-7 helicase at DNA replication forksWe found previously that many regulatory proteins assemble around the MCM",
            "probability": 0.0026932548295547525,
            "start_logit": 2.4558043479919434,
            "end_logit": 1.5302531719207764,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "SCF(Dia2",
            "probability": 0.0022037420292283843,
            "start_logit": 3.7092902660369873,
            "end_logit": 0.07617365568876266,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM2",
            "probability": 0.0014976219065072612,
            "start_logit": 3.537777900695801,
            "end_logit": -0.13859236240386963,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "GINS",
            "probability": 0.0009825377570515169,
            "start_logit": 1.9350756406784058,
            "end_logit": 1.0426149368286133,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM2-7 helicase at DNA replication forksWe found previously that many regulatory proteins assemble around the MCM2",
            "probability": 0.0005075829676737633,
            "start_logit": 2.4558043479919434,
            "end_logit": -0.13859236240386963,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "Dia2Here we show that SCF",
            "probability": 0.0002963981832591773,
            "start_logit": -0.8918777108192444,
            "end_logit": 2.671133279800415,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "Dia2Here we show that SCF(Dia2)",
            "probability": 0.0001549205940649289,
            "start_logit": -0.8918777108192444,
            "end_logit": 2.0223422050476074,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "the GINS and Ctf4",
            "probability": 7.80262974112657e-05,
            "start_logit": -2.872466802597046,
            "end_logit": 3.3170645236968994,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        }
    ],
    "56bf487def6e394741000011": [
        {
            "text": "Aip1, Ede1",
            "probability": 0.24302998429241324,
            "start_logit": 4.31934928894043,
            "end_logit": 3.497584342956543,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Ede1",
            "probability": 0.22310449333682697,
            "start_logit": 4.233804702758789,
            "end_logit": 3.497584342956543,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1",
            "probability": 0.19853508169248138,
            "start_logit": 4.31934928894043,
            "end_logit": 3.295365333557129,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ede1 and Inn1",
            "probability": 0.12392888505246688,
            "start_logit": 4.31934928894043,
            "end_logit": 2.8241074085235596,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Ede1 and Inn1",
            "probability": 0.11376822983357131,
            "start_logit": 4.233804702758789,
            "end_logit": 2.8241074085235596,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Inn1",
            "probability": 0.08458694382339703,
            "start_logit": 3.9374213218688965,
            "end_logit": 2.8241074085235596,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip",
            "probability": 0.0035246157724942557,
            "start_logit": 4.31934928894043,
            "end_logit": -0.7358290553092957,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ede",
            "probability": 0.0026928795865095658,
            "start_logit": 4.31934928894043,
            "end_logit": -1.0049893856048584,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Ede",
            "probability": 0.0024720963444676324,
            "start_logit": 4.233804702758789,
            "end_logit": -1.0049893856048584,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ede1 and Inn",
            "probability": 0.001057964519112298,
            "start_logit": 4.31934928894043,
            "end_logit": -1.9392536878585815,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Ede1 and Inn",
            "probability": 0.0009712243478602634,
            "start_logit": 4.233804702758789,
            "end_logit": -1.9392536878585815,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Inn",
            "probability": 0.0007221075644101251,
            "start_logit": 3.9374213218688965,
            "end_logit": -1.9392536878585815,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1,",
            "probability": 0.00061784758555822,
            "start_logit": 4.31934928894043,
            "end_logit": -2.477113962173462,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "ip1, Ede1",
            "probability": 0.0001927615232383324,
            "start_logit": -2.8201370239257812,
            "end_logit": 3.497584342956543,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "A",
            "probability": 0.00018406769296022346,
            "start_logit": 4.31934928894043,
            "end_logit": -3.688052177429199,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "ip1",
            "probability": 0.00015746997175971158,
            "start_logit": -2.8201370239257812,
            "end_logit": 3.295365333557129,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ed",
            "probability": 0.00011655307201754391,
            "start_logit": 4.31934928894043,
            "end_logit": -4.1450090408325195,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "1, Ede1",
            "probability": 0.00011390321600012338,
            "start_logit": -3.3462417125701904,
            "end_logit": 3.497584342956543,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ede1 and Inn1 as cytokinetic regulators. Our",
            "probability": 0.00011241755510298222,
            "start_logit": 4.31934928894043,
            "end_logit": -4.181135654449463,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ede1 and Inn1 as cytokinetic regulators",
            "probability": 0.00011047321735178435,
            "start_logit": 4.31934928894043,
            "end_logit": -4.198582649230957,
            "question_text": "Which CDK targets control cytokinesis?"
        }
    ],
    "5543a1b2ee40ea110c000001": [
        {
            "text": "etioplasts",
            "probability": 0.42645294771149134,
            "start_logit": 5.228779315948486,
            "end_logit": 4.552796840667725,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "etioplasts also had an average diameter of appr. 1\u03bcmetioplasts",
            "probability": 0.30679424668478217,
            "start_logit": 5.228779315948486,
            "end_logit": 4.2234721183776855,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "etioplast",
            "probability": 0.0741303195468781,
            "start_logit": 5.228779315948486,
            "end_logit": 2.803119421005249,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "etioplasts also had an average diameter of appr. 1\u03bcmetioplast",
            "probability": 0.03645357000856693,
            "start_logit": 5.228779315948486,
            "end_logit": 2.093334197998047,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "PLBs of wheat leaf etioplasts",
            "probability": 0.033776747794732595,
            "start_logit": 2.693049907684326,
            "end_logit": 4.552796840667725,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "PLBs of wheat leaf etioplasts also had an average diameter of appr. 1\u03bcmetioplasts",
            "probability": 0.024299308870430004,
            "start_logit": 2.693049907684326,
            "end_logit": 4.2234721183776855,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "etioplasts transformed into regular chloroplastsPOR",
            "probability": 0.015727533745325508,
            "start_logit": 4.538158416748047,
            "end_logit": 1.943328619003296,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "wheat leaf etioplasts",
            "probability": 0.01522304274928292,
            "start_logit": 1.8960875272750854,
            "end_logit": 4.552796840667725,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "wheat leaf etioplasts also had an average diameter of appr. 1\u03bcmetioplasts",
            "probability": 0.0109515996022054,
            "start_logit": 1.8960875272750854,
            "end_logit": 4.2234721183776855,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "chloroplastsPOR",
            "probability": 0.010517700832102973,
            "start_logit": 4.135805130004883,
            "end_logit": 1.943328619003296,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "leaf etioplasts",
            "probability": 0.010368580696664773,
            "start_logit": 1.5120574235916138,
            "end_logit": 4.552796840667725,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "leaf etioplasts also had an average diameter of appr. 1\u03bcmetioplasts",
            "probability": 0.007459254112544445,
            "start_logit": 1.5120574235916138,
            "end_logit": 4.2234721183776855,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "PLBs of wheat leaf etioplast",
            "probability": 0.005871412357950896,
            "start_logit": 2.693049907684326,
            "end_logit": 2.803119421005249,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "chloroplast",
            "probability": 0.005629614879180474,
            "start_logit": 3.4923744201660156,
            "end_logit": 1.9617407321929932,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "etioplasts transformed into regular chloroplastsPOR complex",
            "probability": 0.004145341571505196,
            "start_logit": 4.538158416748047,
            "end_logit": 0.6099008917808533,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "PLBs of wheat leaf etioplasts also had an average diameter of appr. 1\u03bcmetioplast",
            "probability": 0.0028872658683789768,
            "start_logit": 2.693049907684326,
            "end_logit": 2.093334197998047,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "chloroplastsPOR complex",
            "probability": 0.0027721741502497008,
            "start_logit": 4.135805130004883,
            "end_logit": 0.6099008917808533,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "wheat leaf etioplast",
            "probability": 0.002646221651265467,
            "start_logit": 1.8960875272750854,
            "end_logit": 2.803119421005249,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "PLBs",
            "probability": 0.0020907466953093423,
            "start_logit": 2.693049907684326,
            "end_logit": 1.770545482635498,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "leaf etioplast",
            "probability": 0.001802370471153012,
            "start_logit": 1.5120574235916138,
            "end_logit": 2.803119421005249,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        }
    ],
    "56cf2be73975bb303a000005": [
        {
            "text": "monoclonal anti-IL-5 antibodies",
            "probability": 0.4640398959799053,
            "start_logit": 4.129557132720947,
            "end_logit": 4.863196849822998,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antagonist therapies in current development include two monoclonal anti-IL-5 antibodies",
            "probability": 0.14872284659776197,
            "start_logit": 2.991671085357666,
            "end_logit": 4.863196849822998,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 antibodies",
            "probability": 0.10967533898067174,
            "start_logit": 2.5595405101776123,
            "end_logit": 4.990767478942871,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal anti-IL-5",
            "probability": 0.10028460459795857,
            "start_logit": 4.129557132720947,
            "end_logit": 3.3312385082244873,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antagonist therapies in current development include two monoclonal anti-IL-5",
            "probability": 0.03214079650251725,
            "start_logit": 2.991671085357666,
            "end_logit": 3.3312385082244873,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antagonist therapies",
            "probability": 0.025651124521812806,
            "start_logit": 2.991671085357666,
            "end_logit": 3.1056997776031494,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 monoclonal antibody",
            "probability": 0.021678502802801907,
            "start_logit": 2.807988166809082,
            "end_logit": 3.1211163997650146,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antibodies",
            "probability": 0.01696673986887978,
            "start_logit": 0.6932709217071533,
            "end_logit": 4.990767478942871,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "two monoclonal anti-IL-5 antibodies",
            "probability": 0.013551641029805717,
            "start_logit": 0.5960942506790161,
            "end_logit": 4.863196849822998,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 monoclonal antibody",
            "probability": 0.012093217727675467,
            "start_logit": 2.2243118286132812,
            "end_logit": 3.1211163997650146,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal antibody",
            "probability": 0.012076679204628632,
            "start_logit": 2.2229433059692383,
            "end_logit": 3.1211163997650146,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5",
            "probability": 0.008312480215631137,
            "start_logit": 2.991671085357666,
            "end_logit": 1.9788703918457031,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "an anti-IL-5 monoclonal antibody",
            "probability": 0.006927759760361561,
            "start_logit": 1.6672035455703735,
            "end_logit": 3.1211163997650146,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antagonist",
            "probability": 0.0064503401858521416,
            "start_logit": 2.991671085357666,
            "end_logit": 1.7252452373504639,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "antagonist therapies in current development include two monoclonal anti-IL-5 antibodies",
            "probability": 0.005261052440445108,
            "start_logit": -0.35008230805397034,
            "end_logit": 4.863196849822998,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5",
            "probability": 0.005061480506375259,
            "start_logit": 2.807988166809082,
            "end_logit": 1.6664543151855469,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "hypereosinophilic syndrome have received mepolizumab, an anti-IL-5 monoclonal antibody",
            "probability": 0.0034731966507412283,
            "start_logit": 0.9767424464225769,
            "end_logit": 3.1211163997650146,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "two monoclonal anti-IL-5",
            "probability": 0.002928672672546218,
            "start_logit": 0.5960942506790161,
            "end_logit": 3.3312385082244873,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 monoclonal antibody,",
            "probability": 0.0024699099909653776,
            "start_logit": 2.807988166809082,
            "end_logit": 0.948976993560791,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "antibodies",
            "probability": 0.0022337197626629973,
            "start_logit": -1.3343157768249512,
            "end_logit": 4.990767478942871,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        }
    ],
    "5713bc991174fb1755000010": [
        {
            "text": "GDAP1",
            "probability": 0.6230087838341941,
            "start_logit": 4.967084884643555,
            "end_logit": 4.279786586761475,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "LRSAM1",
            "probability": 0.07312160485624106,
            "start_logit": 3.879354476928711,
            "end_logit": 3.2250802516937256,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GDAP1 gene",
            "probability": 0.036123890596949614,
            "start_logit": 4.967084884643555,
            "end_logit": 1.432180404663086,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "MFN2 are associated with autosomal DI-CMT. Moreover, GDAP1",
            "probability": 0.02784982417367511,
            "start_logit": 3.324639081954956,
            "end_logit": 2.8144984245300293,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "MFN2",
            "probability": 0.024993960337279953,
            "start_logit": 3.324639081954956,
            "end_logit": 2.706305980682373,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GDAP",
            "probability": 0.023690617370473083,
            "start_logit": 4.967084884643555,
            "end_logit": 1.0103050470352173,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GDAP1, KARS, and PLEKHG5",
            "probability": 0.023245112145803725,
            "start_logit": 3.4704065322875977,
            "end_logit": 2.487999200820923,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GNB4, NEFL, and MFN2",
            "probability": 0.019567576461891986,
            "start_logit": 3.079878807067871,
            "end_logit": 2.706305980682373,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "NEFL, and MFN2 are associated with autosomal DI-CMT. Moreover, GDAP1",
            "probability": 0.015486532335584828,
            "start_logit": 2.737783193588257,
            "end_logit": 2.8144984245300293,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GNB4",
            "probability": 0.01468106846198625,
            "start_logit": 3.079878807067871,
            "end_logit": 2.4189908504486084,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "MPZ, INF2, DNM2, YARS, GNB4, NEFL, and MFN2",
            "probability": 0.014211854189290015,
            "start_logit": 2.7600812911987305,
            "end_logit": 2.706305980682373,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "NEFL, and MFN2",
            "probability": 0.01389846386619152,
            "start_logit": 2.737783193588257,
            "end_logit": 2.706305980682373,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "YARS, GNB4, NEFL, and MFN2",
            "probability": 0.0134475082094021,
            "start_logit": 2.704798698425293,
            "end_logit": 2.706305980682373,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GDAP1, KARS",
            "probability": 0.012785449133442409,
            "start_logit": 3.4704065322875977,
            "end_logit": 1.890212059020996,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GNB4, NEFL",
            "probability": 0.012080570863389015,
            "start_logit": 3.079878807067871,
            "end_logit": 2.2240304946899414,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "PLEKHG5",
            "probability": 0.011107163176915359,
            "start_logit": 2.7319018840789795,
            "end_logit": 2.487999200820923,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "MFN2 are associated with autosomal DI-CMT. Moreover, GDAP1, KARS",
            "probability": 0.011051214014684634,
            "start_logit": 3.324639081954956,
            "end_logit": 1.890212059020996,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "MPZ, INF2, DNM2, YARS, GNB4",
            "probability": 0.010662802556620693,
            "start_logit": 2.7600812911987305,
            "end_logit": 2.4189908504486084,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "YARS, GNB4",
            "probability": 0.010089332679999424,
            "start_logit": 2.704798698425293,
            "end_logit": 2.4189908504486084,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "KARS, and PLEKHG5",
            "probability": 0.008896670735985024,
            "start_logit": 2.509988784790039,
            "end_logit": 2.487999200820923,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        }
    ],
    "54fb4b34d176fff445000001": [
        {
            "text": "c-Jun",
            "probability": 0.1446969489568848,
            "start_logit": 5.045760154724121,
            "end_logit": 4.869873523712158,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF-2/c-Jun",
            "probability": 0.1120469602879744,
            "start_logit": 4.790036678314209,
            "end_logit": 4.869873523712158,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "c-Jun, IRF-3/IRF-7, NF-kappaB",
            "probability": 0.07983139857834101,
            "start_logit": 5.045760154724121,
            "end_logit": 4.275148868560791,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "c-Jun, IRF-3",
            "probability": 0.06662251245479496,
            "start_logit": 5.045760154724121,
            "end_logit": 4.094274520874023,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF-2/c-Jun, IRF-3/IRF-7, NF-kappaB",
            "probability": 0.06181792781896268,
            "start_logit": 4.790036678314209,
            "end_logit": 4.275148868560791,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF-3/IRF-7, NF-kappaB",
            "probability": 0.058411552725096294,
            "start_logit": 4.733356952667236,
            "end_logit": 4.275148868560791,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF-2 and c-Jun",
            "probability": 0.05805368660939759,
            "start_logit": 4.5217766761779785,
            "end_logit": 4.480583667755127,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF-2",
            "probability": 0.05289294948927613,
            "start_logit": 4.790036678314209,
            "end_logit": 4.11922550201416,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF-2/c-Jun, IRF-3",
            "probability": 0.05158954671208571,
            "start_logit": 4.790036678314209,
            "end_logit": 4.094274520874023,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF-3",
            "probability": 0.048746789712230426,
            "start_logit": 4.733356952667236,
            "end_logit": 4.094274520874023,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "c-Jun, IRF-3/IRF-7",
            "probability": 0.04792338646690976,
            "start_logit": 5.045760154724121,
            "end_logit": 3.7648355960845947,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF-7, NF-kappaB",
            "probability": 0.04636380033356133,
            "start_logit": 4.502362251281738,
            "end_logit": 4.275148868560791,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "NF-kappaB",
            "probability": 0.04080751862303064,
            "start_logit": 4.374709606170654,
            "end_logit": 4.275148868560791,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF-2/c-Jun, IRF-3/IRF-7",
            "probability": 0.03710976505747251,
            "start_logit": 4.790036678314209,
            "end_logit": 3.7648355960845947,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF-3/IRF-7",
            "probability": 0.035064892576447175,
            "start_logit": 4.733356952667236,
            "end_logit": 3.7648355960845947,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF-7",
            "probability": 0.027832536583703594,
            "start_logit": 4.502362251281738,
            "end_logit": 3.7648355960845947,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "c-Jun, IRF-3/IRF-7, NF-kappaB and HMGI(Y)",
            "probability": 0.010691144122220657,
            "start_logit": 5.045760154724121,
            "end_logit": 2.2646477222442627,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF-3/IRF-7, NF-kappaB and HMGI(Y)",
            "probability": 0.00782256530272193,
            "start_logit": 4.733356952667236,
            "end_logit": 2.2646477222442627,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF-7, NF-kappaB and HMGI(Y)",
            "probability": 0.00620911170601049,
            "start_logit": 4.502362251281738,
            "end_logit": 2.2646477222442627,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "NF-kappaB and HMGI(Y)",
            "probability": 0.005465005882878149,
            "start_logit": 4.374709606170654,
            "end_logit": 2.2646477222442627,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        }
    ],
    "56a39a32496b62f23f000005": [
        {
            "text": "ddgraph",
            "probability": 0.40729172271240827,
            "start_logit": 3.6477584838867188,
            "end_logit": 3.296438455581665,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "MMDiff",
            "probability": 0.25028786602773045,
            "start_logit": 3.6508469581604004,
            "end_logit": 2.806432008743286,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "ddgraph, available as part of BioconductorHere, we present MMDiff",
            "probability": 0.24951605087162362,
            "start_logit": 3.6477584838867188,
            "end_logit": 2.806432008743286,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "cosmo",
            "probability": 0.04727433856250619,
            "start_logit": 2.4559144973754883,
            "end_logit": 2.3347203731536865,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "MMDiff,",
            "probability": 0.01697829886989593,
            "start_logit": 3.6508469581604004,
            "end_logit": 0.11575628072023392,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "ddgraph, available as part of BioconductorHere, we present MMDiff,",
            "probability": 0.016925942722549794,
            "start_logit": 3.6477584838867188,
            "end_logit": 0.11575628072023392,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "ddgraph,",
            "probability": 0.005655804985659804,
            "start_logit": 3.6477584838867188,
            "end_logit": -0.980408787727356,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "R package ddgraph",
            "probability": 0.001308248081041206,
            "start_logit": -1.0881153345108032,
            "end_logit": 2.291471481323242,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "MM",
            "probability": 0.0008351963612992263,
            "start_logit": 3.6508469581604004,
            "end_logit": -2.896268129348755,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "ddgraph, available as part of BioconductorHere, we present MM",
            "probability": 0.000832620858058871,
            "start_logit": 3.6477584838867188,
            "end_logit": -2.896268129348755,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "MMDiff, a robust, broadly applicable method for detecting differences between sequence count data sets",
            "probability": 0.0007334271380271767,
            "start_logit": 3.6508469581604004,
            "end_logit": -3.0262067317962646,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "discriminative pattern analysis",
            "probability": 0.0005531727498127151,
            "start_logit": 0.43275782465934753,
            "end_logit": -0.09017551690340042,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "R package ddgraph, available as part of BioconductorHere, we present MMDiff",
            "probability": 0.00039320342270602617,
            "start_logit": -1.0881153345108032,
            "end_logit": 1.089354395866394,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "cosmo,",
            "probability": 0.0003131277838422417,
            "start_logit": 2.4559144973754883,
            "end_logit": -2.6823911666870117,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "BioconductorHere, we present MMDiff",
            "probability": 0.000251323999343388,
            "start_logit": -3.252777099609375,
            "end_logit": 2.806432008743286,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "PC (NCPC)",
            "probability": 0.00024193591041701552,
            "start_logit": -0.32602736353874207,
            "end_logit": -0.15838780999183655,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "discriminative pattern",
            "probability": 0.00016246861316098317,
            "start_logit": 0.43275782465934753,
            "end_logit": -1.3153610229492188,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "pattern analysis",
            "probability": 0.0001579763221291493,
            "start_logit": -0.8204673528671265,
            "end_logit": -0.09017551690340042,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "PC (NCPC) algorithms",
            "probability": 0.0001543993568311406,
            "start_logit": -0.32602736353874207,
            "end_logit": -0.607518196105957,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "the R package ddgraph",
            "probability": 0.000132874650956442,
            "start_logit": -3.3751533031463623,
            "end_logit": 2.291471481323242,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        }
    ],
    "515de993298dcd4e51000024": [
        {
            "text": "Mindfulness-based therapy",
            "probability": 0.28953664439737575,
            "start_logit": 1.6893293857574463,
            "end_logit": 4.243398189544678,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "psychotropic medicationMindfulness-based therapy",
            "probability": 0.15863016421372256,
            "start_logit": 1.0876230001449585,
            "end_logit": 4.243398189544678,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "MBT)",
            "probability": 0.1396410644732012,
            "start_logit": 2.212843418121338,
            "end_logit": 2.99067759513855,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Social Skills Intervention",
            "probability": 0.08515306928254343,
            "start_logit": 2.1237735748291016,
            "end_logit": 2.585122585296631,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Mindfulness-based therapy (MBT)",
            "probability": 0.08272826100255089,
            "start_logit": 1.6893293857574463,
            "end_logit": 2.99067759513855,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "psychotropic medicationMindfulness-based therapy (MBT)",
            "probability": 0.04532482461853554,
            "start_logit": 1.0876230001449585,
            "end_logit": 2.99067759513855,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Multimodal Anxiety and Social Skills Intervention",
            "probability": 0.03635375701007903,
            "start_logit": 1.272620677947998,
            "end_logit": 2.585122585296631,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "fulness-based therapy",
            "probability": 0.03528862937038842,
            "start_logit": -0.4153916835784912,
            "end_logit": 4.243398189544678,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Social Skills",
            "probability": 0.029651341452533113,
            "start_logit": 2.1237735748291016,
            "end_logit": 1.530179500579834,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "(MBT)",
            "probability": 0.026434387710522183,
            "start_logit": 0.5484338402748108,
            "end_logit": 2.99067759513855,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Multimodal Anxiety and Social Skills",
            "probability": 0.012658823355052596,
            "start_logit": 1.272620677947998,
            "end_logit": 1.530179500579834,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "fulness-based therapy (MBT)",
            "probability": 0.010082892778742988,
            "start_logit": -0.4153916835784912,
            "end_logit": 2.99067759513855,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "depression, or anxiety was associated with a high rate of use, with 80% receiving \u2265 1 psychotropic medicationMindfulness-based therapy",
            "probability": 0.01001007215755467,
            "start_logit": -1.6753606796264648,
            "end_logit": 4.243398189544678,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "therapy",
            "probability": 0.009989626887086381,
            "start_logit": -1.6774052381515503,
            "end_logit": 4.243398189544678,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Mindfulness-based",
            "probability": 0.0068676351288433045,
            "start_logit": 1.6893293857574463,
            "end_logit": 0.501936137676239,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Social Skills Intervention (MASSI)",
            "probability": 0.0059616389019433195,
            "start_logit": 2.1237735748291016,
            "end_logit": -0.07398243993520737,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "MBT",
            "probability": 0.005466510017206397,
            "start_logit": 2.212843418121338,
            "end_logit": -0.249757319688797,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "psychotropic medicationMindfulness-based",
            "probability": 0.0037626121229517753,
            "start_logit": 1.0876230001449585,
            "end_logit": 0.501936137676239,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Mindfulness-based therapy (MBT",
            "probability": 0.003238552134950956,
            "start_logit": 1.6893293857574463,
            "end_logit": -0.249757319688797,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Mindfulness",
            "probability": 0.0032194929842156443,
            "start_logit": 1.6893293857574463,
            "end_logit": -0.2556597888469696,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        }
    ],
    "54fc9b236ad7dcbc12000005": [
        {
            "text": "istradefylline",
            "probability": 0.806298010214066,
            "start_logit": 6.456905841827393,
            "end_logit": 6.228395938873291,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Istradefylline",
            "probability": 0.12751697141975857,
            "start_logit": 5.3662943840026855,
            "end_logit": 5.474803447723389,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefylline), AMPA receptor antagonists (eg, talampanel",
            "probability": 0.05549944099683995,
            "start_logit": 6.456905841827393,
            "end_logit": 3.5523154735565186,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "fipamezole), adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 0.006412159879303521,
            "start_logit": 1.6226485967636108,
            "end_logit": 6.228395938873291,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "talampanel",
            "probability": 0.0019256157956616701,
            "start_logit": 3.095778703689575,
            "end_logit": 3.5523154735565186,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Istradefylline (KW-6002)",
            "probability": 0.0007290327582531158,
            "start_logit": 5.3662943840026855,
            "end_logit": 0.3105173707008362,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefyllin",
            "probability": 0.0006489167007590899,
            "start_logit": 6.456905841827393,
            "end_logit": -0.8965083956718445,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "is",
            "probability": 0.00019987124762814345,
            "start_logit": 6.456905841827393,
            "end_logit": -2.074139356613159,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "(eg, istradefylline",
            "probability": 0.00016611263188872532,
            "start_logit": -2.030636787414551,
            "end_logit": 6.228395938873291,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefylline and preladenant",
            "probability": 0.0001600805442307583,
            "start_logit": 2.9147024154663086,
            "end_logit": 1.246067762374878,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "e",
            "probability": 9.50501974220594e-05,
            "start_logit": -2.588897705078125,
            "end_logit": 6.228395938873291,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefylline,",
            "probability": 7.168485045282837e-05,
            "start_logit": 5.437996864318848,
            "end_logit": -2.0806243419647217,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "preladenant",
            "probability": 6.598362247667795e-05,
            "start_logit": 2.0284318923950195,
            "end_logit": 1.246067762374878,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Istradefyllin",
            "probability": 6.486594033086863e-05,
            "start_logit": 5.3662943840026855,
            "end_logit": -2.1088786125183105,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Istradefylline (KW-6002",
            "probability": 5.831742738041235e-05,
            "start_logit": 5.3662943840026855,
            "end_logit": -2.2153003215789795,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "e reduces OFF time and dyskinesia associated with standard 'dopamine replacement' treatments. Istradefylline",
            "probability": 3.246892351438055e-05,
            "start_logit": -2.9094269275665283,
            "end_logit": 5.474803447723389,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "fipamezole",
            "probability": 2.0777501029465103e-05,
            "start_logit": 1.6226485967636108,
            "end_logit": 0.49631521105766296,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "talampanel), neuronal synchronization modulators (eg, levetiracetam",
            "probability": 1.4971966498046029e-05,
            "start_logit": 3.095778703689575,
            "end_logit": -1.3045060634613037,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "(eg, istradefylline), AMPA receptor antagonists (eg, talampanel",
            "probability": 1.1433933974226834e-05,
            "start_logit": -2.030636787414551,
            "end_logit": 3.5523154735565186,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "quetiapine",
            "probability": 8.233448531440102e-06,
            "start_logit": 1.104500412940979,
            "end_logit": 0.08879762142896652,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        }
    ],
    "54fe09036ad7dcbc12000009": [
        {
            "text": "AFP",
            "probability": 0.23044065844921185,
            "start_logit": 1.5124162435531616,
            "end_logit": -0.189669668674469,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP IIItype III anti-freeze proteins wild type III",
            "probability": 0.12525249799965857,
            "start_logit": 1.5124162435531616,
            "end_logit": -0.7993313670158386,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP IIItype III anti-freeze proteins wild type III thermal hysteresis protein",
            "probability": 0.1138262070409295,
            "start_logit": 1.5124162435531616,
            "end_logit": -0.8949902653694153,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP IIItype III",
            "probability": 0.07565726122935654,
            "start_logit": 1.5124162435531616,
            "end_logit": -1.3034496307373047,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP IIItype III anti-freeze proteins wild type III thermal hysteresis",
            "probability": 0.07382307313703504,
            "start_logit": 1.5124162435531616,
            "end_logit": -1.3279917240142822,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP I or AFP",
            "probability": 0.04116414369144745,
            "start_logit": -0.21000955998897552,
            "end_logit": -0.189669668674469,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "III anti-freeze protein (AFP)AFP I or AFP",
            "probability": 0.04077428052795828,
            "start_logit": -0.21952563524246216,
            "end_logit": -0.189669668674469,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "anti-freeze protein (AFP)AFP I or AFP",
            "probability": 0.031958373792130505,
            "start_logit": -0.46314290165901184,
            "end_logit": -0.189669668674469,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "notothenoids, pe III anti-freeze protein (AFP)AFP I or AFP",
            "probability": 0.029227433332592385,
            "start_logit": -0.5524693727493286,
            "end_logit": -0.189669668674469,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP I",
            "probability": 0.028537858969012824,
            "start_logit": -0.21000955998897552,
            "end_logit": -0.5560056567192078,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "III anti-freeze protein (AFP)AFP I",
            "probability": 0.028267578599274958,
            "start_logit": -0.21952563524246216,
            "end_logit": -0.5560056567192078,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP I or AFP IIItype III anti-freeze proteins wild type III",
            "probability": 0.022374141178332994,
            "start_logit": -0.21000955998897552,
            "end_logit": -0.7993313670158386,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "anti-freeze protein (AFP)AFP I",
            "probability": 0.022155776420251502,
            "start_logit": -0.46314290165901184,
            "end_logit": -0.5560056567192078,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "III",
            "probability": 0.021836209693725607,
            "start_logit": -0.21952563524246216,
            "end_logit": -0.8141515851020813,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "III anti-freeze protein (AFP",
            "probability": 0.020659860255825876,
            "start_logit": -0.21952563524246216,
            "end_logit": -0.8695284724235535,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP I or AFP IIItype III anti-freeze proteins wild type III thermal hysteresis protein",
            "probability": 0.020333036600474506,
            "start_logit": -0.21000955998897552,
            "end_logit": -0.8949902653694153,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "notothenoids, pe III anti-freeze protein (AFP)AFP I",
            "probability": 0.020262497787486882,
            "start_logit": -0.5524693727493286,
            "end_logit": -0.5560056567192078,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP IIItype III anti-freeze proteins wild type",
            "probability": 0.018699961313292778,
            "start_logit": 1.5124162435531616,
            "end_logit": -2.701141595840454,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP IIItype",
            "probability": 0.01737866433763204,
            "start_logit": 1.5124162435531616,
            "end_logit": -2.7744197845458984,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "anti-freeze protein (AFP)AFP I or AFP IIItype III anti-freeze proteins wild type III",
            "probability": 0.017370485644369837,
            "start_logit": -0.46314290165901184,
            "end_logit": -0.7993313670158386,
            "question_text": "List fish anti-freeze proteins."
        }
    ],
    "517295c18ed59a060a000016": [
        {
            "text": "microRNAs and snoRNAs",
            "probability": 0.3659581917784813,
            "start_logit": 5.424641132354736,
            "end_logit": 5.609180927276611,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "microRNAs",
            "probability": 0.342573002079069,
            "start_logit": 5.424641132354736,
            "end_logit": 5.54314661026001,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "snoRNAs",
            "probability": 0.27216979278012476,
            "start_logit": 5.1285481452941895,
            "end_logit": 5.609180927276611,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "microRNAs and snoRNAs,",
            "probability": 0.007143866132901013,
            "start_logit": 5.424641132354736,
            "end_logit": 1.6729159355163574,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "snoRNAs,",
            "probability": 0.0053130237516791365,
            "start_logit": 5.1285481452941895,
            "end_logit": 1.6729159355163574,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "microRNAs and snoRNAs, undergo maturation processes that lead to the production of shorter RNAs.",
            "probability": 0.0013984285367834603,
            "start_logit": 5.424641132354736,
            "end_logit": 0.04201096296310425,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "snoRNAs, undergo maturation processes that lead to the production of shorter RNAs.",
            "probability": 0.0010400368501781074,
            "start_logit": 5.1285481452941895,
            "end_logit": 0.04201096296310425,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "microRNA",
            "probability": 0.0008073579639241579,
            "start_logit": 5.424641132354736,
            "end_logit": -0.5073263049125671,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "RNA classes, in particular microRNAs and snoRNAs",
            "probability": 0.0007016442975198643,
            "start_logit": -0.832206666469574,
            "end_logit": 5.609180927276611,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "RNA classes, in particular microRNAs",
            "probability": 0.0006568083425730081,
            "start_logit": -0.832206666469574,
            "end_logit": 5.54314661026001,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "microRNAs and s",
            "probability": 0.0004369745198177818,
            "start_logit": 5.424641132354736,
            "end_logit": -1.1212185621261597,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "microRNAs and snoR",
            "probability": 0.0003574278637696629,
            "start_logit": 5.424641132354736,
            "end_logit": -1.3221598863601685,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "s",
            "probability": 0.0003249859333139088,
            "start_logit": 5.1285481452941895,
            "end_logit": -1.1212185621261597,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "snoR",
            "probability": 0.0002658256320025681,
            "start_logit": 5.1285481452941895,
            "end_logit": -1.3221598863601685,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "micro",
            "probability": 0.0002195887651390494,
            "start_logit": 5.424641132354736,
            "end_logit": -1.8093369007110596,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "in particular microRNAs and snoRNAs",
            "probability": 0.00020550472578859122,
            "start_logit": -2.060164213180542,
            "end_logit": 5.609180927276611,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "in particular microRNAs",
            "probability": 0.00019237271479756273,
            "start_logit": -2.060164213180542,
            "end_logit": 5.54314661026001,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "microRNAs and snoRNAs, undergo maturation processes that lead to the production of shorter RNAs",
            "probability": 8.967540337434391e-05,
            "start_logit": 5.424641132354736,
            "end_logit": -2.704896926879883,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "RNAs and snoRNAs",
            "probability": 7.514695701481129e-05,
            "start_logit": -3.066187620162964,
            "end_logit": 5.609180927276611,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "RNAs",
            "probability": 7.034497174817549e-05,
            "start_logit": -3.066187620162964,
            "end_logit": 5.54314661026001,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        }
    ],
    "5505c9008e1671127b000002": [
        {
            "text": "Rictor",
            "probability": 0.388638895499529,
            "start_logit": 4.935710430145264,
            "end_logit": 4.7165350914001465,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 Rictor, an mTORC2-specific componentf Rictor",
            "probability": 0.21579315959434334,
            "start_logit": 4.3473801612854,
            "end_logit": 4.7165350914001465,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 Rictor",
            "probability": 0.10844957768162655,
            "start_logit": 4.3473801612854,
            "end_logit": 4.028500080108643,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor, an mTORC2-specific componentf Rictor",
            "probability": 0.09374020610007608,
            "start_logit": 3.51358699798584,
            "end_logit": 4.7165350914001465,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin-insensitive companion of mTOR), Rictor",
            "probability": 0.06597763900693314,
            "start_logit": 3.9521632194519043,
            "end_logit": 3.9267475605010986,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin-insensitive companion of mTOR",
            "probability": 0.03269612641871045,
            "start_logit": 4.935710430145264,
            "end_logit": 2.2411410808563232,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2), which contains the regulatory protein Rictor",
            "probability": 0.020709430774570704,
            "start_logit": 2.816741466522217,
            "end_logit": 3.903442621231079,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2-specific componentf Rictor",
            "probability": 0.015963528842723996,
            "start_logit": 1.7433664798736572,
            "end_logit": 4.7165350914001465,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 component, The mammalian target of rapamycin",
            "probability": 0.008334562330495605,
            "start_logit": 4.106185436248779,
            "end_logit": 1.7038204669952393,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mammalian target of rapamycin (mTOR) complex 2 (mTORC2), which contains the regulatory protein Rictor",
            "probability": 0.008200900459257891,
            "start_logit": 1.890396237373352,
            "end_logit": 3.903442621231079,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor, an mTORC2-specific componentf Rictor (rapamycin-insensitive companion of mTOR",
            "probability": 0.00788634813616532,
            "start_logit": 3.51358699798584,
            "end_logit": 2.2411410808563232,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor, a key component of mTORC2",
            "probability": 0.00610155385989556,
            "start_logit": 4.61932897567749,
            "end_logit": 0.87880939245224,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin-insensitive companion of mTOR), an mTORC2",
            "probability": 0.005291916922541503,
            "start_logit": 4.935710430145264,
            "end_logit": 0.4200650155544281,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTOR complex 1 (mTORC1) and mTORC2 Rictor",
            "probability": 0.004436983807493732,
            "start_logit": 1.1510696411132812,
            "end_logit": 4.028500080108643,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTOR) complex 2 (mTORC2), which contains the regulatory protein Rictor",
            "probability": 0.003968268918323253,
            "start_logit": 1.1644822359085083,
            "end_logit": 3.903442621231079,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC1) and mTORC2 Rictor, an mTORC2-specific componentf Rictor",
            "probability": 0.0033766514393753187,
            "start_logit": 0.189944326877594,
            "end_logit": 4.7165350914001465,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin-insensitive companion of mTOR), Rictor, a key component of mTORC2",
            "probability": 0.0031310791254443708,
            "start_logit": 3.9521632194519043,
            "end_logit": 0.87880939245224,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 Rictor, an mTORC2",
            "probability": 0.0025273326589196647,
            "start_logit": 4.3473801612854,
            "end_logit": 0.269379198551178,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin-insensitive companion of mTOR)",
            "probability": 0.0024672054718927225,
            "start_logit": 4.935710430145264,
            "end_logit": -0.3430294096469879,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2",
            "probability": 0.002308632951681791,
            "start_logit": 4.106185436248779,
            "end_logit": 0.4200650155544281,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        }
    ],
    "5326c6fed6d3ac6a3400000c": [
        {
            "text": "Type 2 diabetes mellitus",
            "probability": 0.1611310876796543,
            "start_logit": 5.885513782501221,
            "end_logit": 5.507256984710693,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "coronary heart disease",
            "probability": 0.12309799242591539,
            "start_logit": 5.718760013580322,
            "end_logit": 5.404773235321045,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "Type 2 diabetes",
            "probability": 0.11305871137878527,
            "start_logit": 5.885513782501221,
            "end_logit": 5.1529459953308105,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "coronary heart disease (CHD) and Type 2 diabetes mellitus",
            "probability": 0.10224797065303853,
            "start_logit": 5.718760013580322,
            "end_logit": 5.219193458557129,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "obesity",
            "probability": 0.0867219166100093,
            "start_logit": 5.495262622833252,
            "end_logit": 5.27799654006958,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "obesity and insulin resistance",
            "probability": 0.07709585008138232,
            "start_logit": 5.495262622833252,
            "end_logit": 5.16033935546875,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "insulin resistance",
            "probability": 0.06996572385323283,
            "start_logit": 5.398218631744385,
            "end_logit": 5.16033935546875,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "coronary heart disease (CHD) and Type 2 diabetes",
            "probability": 0.06211383738718496,
            "start_logit": 5.718760013580322,
            "end_logit": 4.720761299133301,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "dyslipidemia",
            "probability": 0.03306442666528071,
            "start_logit": 4.982914447784424,
            "end_logit": 4.826096057891846,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "ronary heart disease",
            "probability": 0.0320021999730408,
            "start_logit": 4.371583938598633,
            "end_logit": 5.404773235321045,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "dyslipidemia, prothrombotic status, and increased blood pressure",
            "probability": 0.03138943235342418,
            "start_logit": 4.982914447784424,
            "end_logit": 4.774109363555908,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "ronary heart disease (CHD) and Type 2 diabetes mellitus",
            "probability": 0.02658174954108569,
            "start_logit": 4.371583938598633,
            "end_logit": 5.219193458557129,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "ronary heart disease (CHD) and Type 2 diabetes",
            "probability": 0.01614794365029101,
            "start_logit": 4.371583938598633,
            "end_logit": 4.720761299133301,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "increased blood pressure",
            "probability": 0.016013312484611245,
            "start_logit": 4.309863567352295,
            "end_logit": 4.774109363555908,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "prothrombotic status, and increased blood pressure",
            "probability": 0.011623584057973247,
            "start_logit": 3.9894793033599854,
            "end_logit": 4.774109363555908,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "blood pressure",
            "probability": 0.010617029360591574,
            "start_logit": 3.898902416229248,
            "end_logit": 4.774109363555908,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabetes mellitus",
            "probability": 0.00927677405380792,
            "start_logit": 3.0308094024658203,
            "end_logit": 5.507256984710693,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "dyslipidemia, prothrombotic status",
            "probability": 0.007566407845597149,
            "start_logit": 4.982914447784424,
            "end_logit": 3.3513565063476562,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabetes",
            "probability": 0.0065091109070202465,
            "start_logit": 3.0308094024658203,
            "end_logit": 5.1529459953308105,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "obesity and insulin resistance,",
            "probability": 0.0037749390380733064,
            "start_logit": 5.495262622833252,
            "end_logit": 2.14367413520813,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        }
    ],
    "5319a6c9b166e2b806000022": [
        {
            "text": "vatalanib",
            "probability": 0.1493067916638115,
            "start_logit": 5.092923641204834,
            "end_logit": 4.5804829597473145,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "sorafenib",
            "probability": 0.14392886109025393,
            "start_logit": 4.884463787078857,
            "end_logit": 4.752258777618408,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "sorafenib, vatalanib",
            "probability": 0.12121227403580578,
            "start_logit": 4.884463787078857,
            "end_logit": 4.5804829597473145,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "vatalanib, and AG-013736",
            "probability": 0.07084853951992534,
            "start_logit": 5.092923641204834,
            "end_logit": 3.835024118423462,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474, SU11248, AEE 788, sorafenib",
            "probability": 0.06227182758261115,
            "start_logit": 4.046653747558594,
            "end_logit": 4.752258777618408,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "sorafenib, vatalanib, and AG-013736",
            "probability": 0.05751722672242825,
            "start_logit": 4.884463787078857,
            "end_logit": 3.835024118423462,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AEE 788, sorafenib",
            "probability": 0.05663626575322322,
            "start_logit": 3.951794147491455,
            "end_logit": 4.752258777618408,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474, SU11248, AEE 788, sorafenib, vatalanib",
            "probability": 0.05244333744099242,
            "start_logit": 4.046653747558594,
            "end_logit": 4.5804829597473145,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AEE 788, sorafenib, vatalanib",
            "probability": 0.047697247882337854,
            "start_logit": 3.951794147491455,
            "end_logit": 4.5804829597473145,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AG-013736",
            "probability": 0.04163294919297064,
            "start_logit": 4.5612711906433105,
            "end_logit": 3.835024118423462,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248, AEE 788, sorafenib",
            "probability": 0.032718482266686326,
            "start_logit": 3.4030847549438477,
            "end_logit": 4.752258777618408,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248, AEE 788, sorafenib, vatalanib",
            "probability": 0.027554457170743094,
            "start_logit": 3.4030847549438477,
            "end_logit": 4.5804829597473145,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474",
            "probability": 0.026902602491862486,
            "start_logit": 4.046653747558594,
            "end_logit": 3.9129726886749268,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AEE 788, sorafenib, vatalanib, and AG-013736",
            "probability": 0.02263313218324648,
            "start_logit": 3.951794147491455,
            "end_logit": 3.835024118423462,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474, SU11248",
            "probability": 0.021953558141082716,
            "start_logit": 4.046653747558594,
            "end_logit": 3.709678888320923,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474, SU11248, AEE 788",
            "probability": 0.01648217943361118,
            "start_logit": 4.046653747558594,
            "end_logit": 3.4230294227600098,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AEE 788",
            "probability": 0.01499055240278481,
            "start_logit": 3.951794147491455,
            "end_logit": 3.4230294227600098,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248, AEE 788, sorafenib, vatalanib, and AG-013736",
            "probability": 0.013075045187543525,
            "start_logit": 3.4030847549438477,
            "end_logit": 3.835024118423462,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248",
            "probability": 0.011534704064639613,
            "start_logit": 3.4030847549438477,
            "end_logit": 3.709678888320923,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248, AEE 788",
            "probability": 0.008659965773439677,
            "start_logit": 3.4030847549438477,
            "end_logit": 3.4230294227600098,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        }
    ],
    "56a37e33496b62f23f000003": [
        {
            "text": "palindromic sequences",
            "probability": 0.24826480900407968,
            "start_logit": 3.5690369606018066,
            "end_logit": 2.7793307304382324,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic",
            "probability": 0.18494099905784026,
            "start_logit": 3.5690369606018066,
            "end_logit": 2.4848716259002686,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic words in bacterial and archaeal genomes: a close connection with restriction enzymes.Short palindromic sequences",
            "probability": 0.1265335352764098,
            "start_logit": 2.8950483798980713,
            "end_logit": 2.7793307304382324,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic words in bacterial and archaeal genomes: a close connection with restriction enzymes.Short palindromic",
            "probability": 0.09425918446603178,
            "start_logit": 2.8950483798980713,
            "end_logit": 2.4848716259002686,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic sequences (4, 5 and 6 bp palindromes)",
            "probability": 0.07467992450424125,
            "start_logit": 3.5690369606018066,
            "end_logit": 1.5780460834503174,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "Short palindromic sequences",
            "probability": 0.06220120038292017,
            "start_logit": 2.18491530418396,
            "end_logit": 2.7793307304382324,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "Short palindromic",
            "probability": 0.04633581451821927,
            "start_logit": 2.18491530418396,
            "end_logit": 2.4848716259002686,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic words",
            "probability": 0.040360709304994705,
            "start_logit": 2.8950483798980713,
            "end_logit": 1.6366801261901855,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic sequences (4, 5 and 6 bp palindromes",
            "probability": 0.036693903848662515,
            "start_logit": 3.5690369606018066,
            "end_logit": 0.8674454092979431,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "Palindromes",
            "probability": 0.03626855782190593,
            "start_logit": 2.6537580490112305,
            "end_logit": 1.7710648775100708,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "Short palindromic sequences (4, 5 and 6 bp palindromes)",
            "probability": 0.018710589580955582,
            "start_logit": 2.18491530418396,
            "end_logit": 1.5780460834503174,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic words in bacterial and archaeal genomes: a close connection with restriction enzymes.",
            "probability": 0.011068548150127332,
            "start_logit": 2.8950483798980713,
            "end_logit": 0.34293094277381897,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "Short palindromic sequences (4, 5 and 6 bp palindromes",
            "probability": 0.009193428884577665,
            "start_logit": 2.18491530418396,
            "end_logit": 0.8674454092979431,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": ".Short palindromic sequences",
            "probability": 0.003349642181781054,
            "start_logit": -0.7366054654121399,
            "end_logit": 2.7793307304382324,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": ".Short palindromic",
            "probability": 0.002495263722917298,
            "start_logit": -0.7366054654121399,
            "end_logit": 2.4848716259002686,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic words in bacterial and archaeal genomes: a close connection with restriction enzymes.Short",
            "probability": 0.0011123722416342685,
            "start_logit": 2.8950483798980713,
            "end_logit": -1.9546817541122437,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": ".Short palindromic sequences (4, 5 and 6 bp palindromes)",
            "probability": 0.0010075975981256385,
            "start_logit": -0.7366054654121399,
            "end_logit": 1.5780460834503174,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic sequences (4, 5 and 6 bp palindromes) are avoided at a statistically significant level",
            "probability": 0.0009363396838525679,
            "start_logit": 3.5690369606018066,
            "end_logit": -2.8009421825408936,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic sequences (4, 5 and 6 bp palindromes) are avoided",
            "probability": 0.0009103296452421104,
            "start_logit": 3.5690369606018066,
            "end_logit": -2.829113721847534,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "sequences",
            "probability": 0.0006772501254809617,
            "start_logit": -2.3351736068725586,
            "end_logit": 2.7793307304382324,
            "question_text": "List types of avoided words in bacterial genomes"
        }
    ],
    "571ce13f7de986d80d000011": [
        {
            "text": "sebocytes",
            "probability": 0.08475305304568295,
            "start_logit": 4.361025810241699,
            "end_logit": 3.626096725463867,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "inner root sheath and hair shaft",
            "probability": 0.0788539572967254,
            "start_logit": 4.06699800491333,
            "end_logit": 3.847980260848999,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "sebocytes of the sebaceous gland",
            "probability": 0.06465135917138194,
            "start_logit": 4.361025810241699,
            "end_logit": 3.3553640842437744,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "hair shaft",
            "probability": 0.06361250156970445,
            "start_logit": 3.852210521697998,
            "end_logit": 3.847980260848999,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "inner root sheath",
            "probability": 0.06356116885459002,
            "start_logit": 4.06699800491333,
            "end_logit": 3.632385492324829,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "inner root sheath and hair shaft and in the most mature sebocytes",
            "probability": 0.06316270172891435,
            "start_logit": 4.06699800491333,
            "end_logit": 3.626096725463867,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "epidermis",
            "probability": 0.05866963033079916,
            "start_logit": 3.603010892868042,
            "end_logit": 4.016292095184326,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "hair shaft and in the most mature sebocytes",
            "probability": 0.05095416388245353,
            "start_logit": 3.852210521697998,
            "end_logit": 3.626096725463867,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "epidermis, the differentiating inner root sheath and hair shaft",
            "probability": 0.04958113346897088,
            "start_logit": 3.603010892868042,
            "end_logit": 3.847980260848999,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "inner root sheath and hair shaft and in the most mature sebocytes of the sebaceous gland",
            "probability": 0.04818179840093574,
            "start_logit": 4.06699800491333,
            "end_logit": 3.3553640842437744,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "preputial, meibomium, ceruminous gland, and anal glands",
            "probability": 0.04161294746286896,
            "start_logit": 3.7334182262420654,
            "end_logit": 3.5423738956451416,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating inner root sheath and hair shaft",
            "probability": 0.04084076462275959,
            "start_logit": 3.409081220626831,
            "end_logit": 3.847980260848999,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "epidermis, the differentiating inner root sheath",
            "probability": 0.039965461524834524,
            "start_logit": 3.603010892868042,
            "end_logit": 3.632385492324829,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "sebaceous gland and preputial, meibomium, ceruminous gland, and anal glands",
            "probability": 0.03975173887366059,
            "start_logit": 3.6876604557037354,
            "end_logit": 3.5423738956451416,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "epidermis, the differentiating inner root sheath and hair shaft and in the most mature sebocytes",
            "probability": 0.03971491668956671,
            "start_logit": 3.603010892868042,
            "end_logit": 3.626096725463867,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "hair shaft and in the most mature sebocytes of the sebaceous gland",
            "probability": 0.03886887648361548,
            "start_logit": 3.852210521697998,
            "end_logit": 3.3553640842437744,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "upper epidermis",
            "probability": 0.03465833021118527,
            "start_logit": 3.076626777648926,
            "end_logit": 4.016292095184326,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "sebaceous gland",
            "probability": 0.03297150732090696,
            "start_logit": 3.6876604557037354,
            "end_logit": 3.3553640842437744,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating inner root sheath",
            "probability": 0.03292018340397977,
            "start_logit": 3.409081220626831,
            "end_logit": 3.632385492324829,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating inner root sheath and hair shaft and in the most mature sebocytes",
            "probability": 0.03271380565646368,
            "start_logit": 3.409081220626831,
            "end_logit": 3.626096725463867,
            "question_text": "In which cells are gasdermins expressed?"
        }
    ],
    "533c3533c45e133714000004": [
        {
            "text": "miR-146a",
            "probability": 0.23762169329003716,
            "start_logit": 3.1187214851379395,
            "end_logit": 2.9189963340759277,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "microRNA-146 (miR-146",
            "probability": 0.2280520516034246,
            "start_logit": 2.9856393337249756,
            "end_logit": 3.010972499847412,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-146",
            "probability": 0.22322838207430115,
            "start_logit": 2.9642608165740967,
            "end_logit": 3.010972499847412,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "microRNA-146",
            "probability": 0.21873086890816829,
            "start_logit": 2.9856393337249756,
            "end_logit": 2.969240665435791,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "microRNA-146 (miR-146)",
            "probability": 0.02792635746669257,
            "start_logit": 2.9856393337249756,
            "end_logit": 0.9109695553779602,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-146)",
            "probability": 0.02733566986434753,
            "start_logit": 2.9642608165740967,
            "end_logit": 0.9109695553779602,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-146a in RAIn this study we investigated the expression, regulation, and function of miR-155",
            "probability": 0.006854093050017191,
            "start_logit": 1.5150519609451294,
            "end_logit": 0.9768319725990295,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-155",
            "probability": 0.005740309114944999,
            "start_logit": 0.8990904092788696,
            "end_logit": 1.4154605865478516,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "(miR-146",
            "probability": 0.005147708776406323,
            "start_logit": -0.8053828477859497,
            "end_logit": 3.010972499847412,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "146a",
            "probability": 0.0044668546243971045,
            "start_logit": -0.8552739024162292,
            "end_logit": 2.9189963340759277,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-155 and miR-146a in RAIn this study we investigated the expression, regulation, and function of miR-155",
            "probability": 0.00370204158686979,
            "start_logit": 0.8990904092788696,
            "end_logit": 0.9768319725990295,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-146a in RAIn this study we investigated the expression, regulation, and function of miR-155 and miR-146a",
            "probability": 0.0022175541281023304,
            "start_logit": 1.5150519609451294,
            "end_logit": -0.15160918235778809,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-155 and miR-146a",
            "probability": 0.0021500671221212704,
            "start_logit": 0.8990904092788696,
            "end_logit": 0.43344658613204956,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "146 (miR-146",
            "probability": 0.0018825554121145918,
            "start_logit": -1.8113044500350952,
            "end_logit": 3.010972499847412,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "146",
            "probability": 0.0018056096323819085,
            "start_logit": -1.8113044500350952,
            "end_logit": 2.969240665435791,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miRNA miR-155",
            "probability": 0.00104853190834098,
            "start_logit": -0.8010316491127014,
            "end_logit": 1.4154605865478516,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miRNA miR-155 and miR-146a in RAIn this study we investigated the expression, regulation, and function of miR-155",
            "probability": 0.0006762194599820682,
            "start_logit": -0.8010316491127014,
            "end_logit": 0.9768319725990295,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "(miR-146)",
            "probability": 0.0006303681743426807,
            "start_logit": -0.8053828477859497,
            "end_logit": 0.9109695553779602,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miRNA miR-155 and miR-146a",
            "probability": 0.00039273389942531264,
            "start_logit": -0.8010316491127014,
            "end_logit": 0.43344658613204956,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-146a in RAIn this study we investigated the expression, regulation, and function of miR-155 and miR-146",
            "probability": 0.0003903299035818694,
            "start_logit": 1.5150519609451294,
            "end_logit": -1.8887770175933838,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        }
    ],
    "52f112bb2059c6d71c000002": [
        {
            "text": "RNMT",
            "probability": 0.33333763659048365,
            "start_logit": 5.666650295257568,
            "end_logit": 5.192491054534912,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT and RNMT",
            "probability": 0.2590706311981176,
            "start_logit": 5.414595127105713,
            "end_logit": 5.192491054534912,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT",
            "probability": 0.24474198229825164,
            "start_logit": 5.414595127105713,
            "end_logit": 5.135594844818115,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT (RNA guanylyltransferase and 5' phosphatase) and RNMT",
            "probability": 0.11187123636340039,
            "start_logit": 5.213833332061768,
            "end_logit": 4.553500652313232,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "CTD recruits RNGTT and RNMT",
            "probability": 0.008257906337423036,
            "start_logit": 1.9686654806137085,
            "end_logit": 5.192491054534912,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "CTD recruits RNGTT",
            "probability": 0.007801178996274024,
            "start_logit": 1.9686654806137085,
            "end_logit": 5.135594844818115,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNA guanylyltransferase and 5' phosphatase) and RNMT",
            "probability": 0.0071471666832518595,
            "start_logit": 2.463200807571411,
            "end_logit": 4.553500652313232,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNMT,",
            "probability": 0.0038046834702465033,
            "start_logit": 5.666650295257568,
            "end_logit": 0.7195679545402527,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNMT, the enzymes involved in mRNA capping,",
            "probability": 0.003646655933338,
            "start_logit": 5.666650295257568,
            "end_logit": 0.6771457195281982,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT and RNMT,",
            "probability": 0.0029570070701519634,
            "start_logit": 5.414595127105713,
            "end_logit": 0.7195679545402527,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT and RNMT, the enzymes involved in mRNA capping,",
            "probability": 0.002834187774520291,
            "start_logit": 5.414595127105713,
            "end_logit": 0.6771457195281982,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNMT (RNA",
            "probability": 0.0023173210551304547,
            "start_logit": 5.2646484375,
            "end_logit": 0.6257488131523132,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT (RNA guanylyltransferase and 5' phosphatase) and RNMT (RNA",
            "probability": 0.0022025079655661048,
            "start_logit": 5.213833332061768,
            "end_logit": 0.6257488131523132,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT (RNA",
            "probability": 0.0019195587966854915,
            "start_logit": 5.213833332061768,
            "end_logit": 0.48824748396873474,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT (RNA guanylyltransferase and 5' phosphatase",
            "probability": 0.0018024783462243896,
            "start_logit": 5.213833332061768,
            "end_logit": 0.42531469464302063,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "5' phosphatase) and RNMT",
            "probability": 0.001522118465337109,
            "start_logit": 0.9165878891944885,
            "end_logit": 4.553500652313232,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNMT (RNA guanine-7 methyltransferase",
            "probability": 0.0013807926975285764,
            "start_logit": 5.2646484375,
            "end_logit": 0.10799476504325867,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT (RNA guanylyltransferase and 5'-phosphatase) and RNMT",
            "probability": 0.0013153002633233834,
            "start_logit": 2.9879798889160156,
            "end_logit": 2.3360705375671387,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNMT (RNA guanine-7 methyltransferase)",
            "probability": 0.0010930468646278338,
            "start_logit": 5.2646484375,
            "end_logit": -0.1256939023733139,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "RNGTT (RNA guanylyltransferase",
            "probability": 0.0009766028301176563,
            "start_logit": 5.213833332061768,
            "end_logit": -0.18752311170101166,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        }
    ],
    "5358e067f1005d6b5800000b": [
        {
            "text": "CRP1",
            "probability": 0.9371242616447588,
            "start_logit": 5.536990165710449,
            "end_logit": 4.821294784545898,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP1, a protein localized in filopodia of growth cones, is involved in dendritic growthCRP1",
            "probability": 0.025989914616957113,
            "start_logit": 3.822162628173828,
            "end_logit": 2.951014995574951,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP",
            "probability": 0.013418978963727577,
            "start_logit": 5.536990165710449,
            "end_logit": 0.5751489400863647,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP1 increases filopodia formation and neurite branching",
            "probability": 0.010474863596970424,
            "start_logit": 5.536990165710449,
            "end_logit": 0.32745733857154846,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP1 increases filopodia formation",
            "probability": 0.0030369674482001157,
            "start_logit": 5.536990165710449,
            "end_logit": -0.9106616377830505,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "RNA interference results in inhibition of filopodia formation and dendritic growth in neurons.Overexpression of CRP1",
            "probability": 0.0022415068071550497,
            "start_logit": -0.49867740273475647,
            "end_logit": 4.821294784545898,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP1 increases filopodia formation and neurite branching,",
            "probability": 0.0019512508628102732,
            "start_logit": 5.536990165710449,
            "end_logit": -1.3530504703521729,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP1 increases filopodia",
            "probability": 0.0013082042997026068,
            "start_logit": 5.536990165710449,
            "end_logit": -1.7528656721115112,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Overexpression of CRP1",
            "probability": 0.0010324764768368268,
            "start_logit": -1.2738654613494873,
            "end_logit": 4.821294784545898,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP1 increases filopodia formation and neurite branching, which require its actin-bundling activity.",
            "probability": 0.0009956072911513133,
            "start_logit": 5.536990165710449,
            "end_logit": -2.025923490524292,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP1,",
            "probability": 0.0009735228066574777,
            "start_logit": 3.822162628173828,
            "end_logit": -0.3335275948047638,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP family member expressed in the CNS with little known about its function in nerve cells.Here, we report that CRP1",
            "probability": 0.0007472941853491426,
            "start_logit": -0.3740435838699341,
            "end_logit": 3.5982162952423096,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP1, a protein localized in filopodia of growth cones, is involved in dendritic growthCRP1,",
            "probability": 0.00024064949389317745,
            "start_logit": 3.822162628173828,
            "end_logit": -1.7311073541641235,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "1",
            "probability": 0.0001887050883286692,
            "start_logit": -2.973395586013794,
            "end_logit": 4.821294784545898,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "RP1",
            "probability": 9.318385030265856e-05,
            "start_logit": -3.679006576538086,
            "end_logit": 4.821294784545898,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "filopodia formation and dendritic growth in neurons.Overexpression of CRP1",
            "probability": 6.324819003593974e-05,
            "start_logit": -4.066514492034912,
            "end_logit": 4.821294784545898,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "CRP1, which cross-links actin filaments to make actin bundles, is the only CRP",
            "probability": 5.190488863753726e-05,
            "start_logit": 2.8993139266967773,
            "end_logit": -2.3421871662139893,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "RNA interference results in inhibition of filopodia formation and dendritic growth in neurons.Overexpression of CRP",
            "probability": 3.2096845555438085e-05,
            "start_logit": -0.49867740273475647,
            "end_logit": 0.5751489400863647,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "branching",
            "probability": 1.8121325137536965e-05,
            "start_logit": -0.822654128074646,
            "end_logit": 0.32745733857154846,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "filopodia formation and neurite branching",
            "probability": 1.7241317832575264e-05,
            "start_logit": -0.8724348545074463,
            "end_logit": 0.32745733857154846,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        }
    ],
    "56e0447a51531f7e3300000b": [
        {
            "text": "viroids",
            "probability": 0.6032552491319382,
            "start_logit": 3.8990797996520996,
            "end_logit": 2.9955272674560547,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "Viroids",
            "probability": 0.2973338803791413,
            "start_logit": 3.2260708808898926,
            "end_logit": 2.9610514640808105,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "RNAs (satRNAs) and viroids",
            "probability": 0.07436093586785149,
            "start_logit": 1.805670142173767,
            "end_logit": 2.9955272674560547,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "RNAs (satRNAs",
            "probability": 0.007423561077242953,
            "start_logit": 1.805670142173767,
            "end_logit": 0.6912553906440735,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "RNAs",
            "probability": 0.00664150236163601,
            "start_logit": 1.805670142173767,
            "end_logit": 0.5799347162246704,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "satRNAs) and viroids",
            "probability": 0.00431858349762362,
            "start_logit": -1.0403331518173218,
            "end_logit": 2.9955272674560547,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "v",
            "probability": 0.001959138150128487,
            "start_logit": 3.8990797996520996,
            "end_logit": -2.7343084812164307,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "RNAs (satRNAs)",
            "probability": 0.0007537669422846451,
            "start_logit": 1.805670142173767,
            "end_logit": -1.5960755348205566,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "viro",
            "probability": 0.0005062661909336899,
            "start_logit": 3.8990797996520996,
            "end_logit": -4.08750581741333,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "viroid-like RNA (AHVd-like RNA), respectively.We show that viroids",
            "probability": 0.00044336960291406664,
            "start_logit": -0.3456825911998749,
            "end_logit": 0.024597713723778725,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "Viroids are plant subviral pathogens whose genomes are constituted by a single-stranded and covalently closed small RNA",
            "probability": 0.0004419430102292481,
            "start_logit": 3.2260708808898926,
            "end_logit": -3.5503785610198975,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "satRNAs",
            "probability": 0.0004311305121113012,
            "start_logit": -1.0403331518173218,
            "end_logit": 0.6912553906440735,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "Viro",
            "probability": 0.0003948845665845804,
            "start_logit": 3.2260708808898926,
            "end_logit": -3.662966012954712,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "viroids as subviral pathogens of plants ,",
            "probability": 0.000371618413758083,
            "start_logit": 3.8990797996520996,
            "end_logit": -4.396700859069824,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "V",
            "probability": 0.0003373296207115166,
            "start_logit": 3.2260708808898926,
            "end_logit": -3.8204989433288574,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "iroids",
            "probability": 0.00030651255745643897,
            "start_logit": -3.6857571601867676,
            "end_logit": 2.9955272674560547,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "RNAs (satRNAs) and v",
            "probability": 0.00024149536460328945,
            "start_logit": 1.805670142173767,
            "end_logit": -2.7343084812164307,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "satellite RNAs (satRNAs) and viroids",
            "probability": 0.00020251342329692117,
            "start_logit": -4.100209712982178,
            "end_logit": 2.9955272674560547,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "(satRNAs) and viroids",
            "probability": 0.00014816403439474462,
            "start_logit": -4.41269588470459,
            "end_logit": 2.9955272674560547,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "ids",
            "probability": 0.00012815529515937027,
            "start_logit": -4.557773113250732,
            "end_logit": 2.9955272674560547,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        }
    ],
    "52f893f92059c6d71c00003c": [
        {
            "text": "androgen replacement therapy",
            "probability": 0.7132408643219318,
            "start_logit": 1.8786147832870483,
            "end_logit": 2.214717149734497,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "clinical trials with androgen replacement therapy",
            "probability": 0.178073042107507,
            "start_logit": 0.49098941683769226,
            "end_logit": 2.214717149734497,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "several clinical trials with androgen replacement therapy",
            "probability": 0.05185738652973551,
            "start_logit": -0.7427070140838623,
            "end_logit": 2.214717149734497,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "androgen replacement therapy have failed to show clinical benefit",
            "probability": 0.01439498470985782,
            "start_logit": 1.8786147832870483,
            "end_logit": -1.6882221698760986,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "replacement therapy",
            "probability": 0.010075138371042163,
            "start_logit": -2.381133556365967,
            "end_logit": 2.214717149734497,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "trials with androgen replacement therapy",
            "probability": 0.00692847484273157,
            "start_logit": -2.7555646896362305,
            "end_logit": 2.214717149734497,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "with androgen replacement therapy",
            "probability": 0.004497247319306828,
            "start_logit": -3.1877388954162598,
            "end_logit": 2.214717149734497,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "rogen replacement therapy",
            "probability": 0.004214024960883307,
            "start_logit": -3.252786159515381,
            "end_logit": 2.214717149734497,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "clinical trials with androgen replacement therapy have failed to show clinical benefit",
            "probability": 0.0035939594134337498,
            "start_logit": 0.49098941683769226,
            "end_logit": -1.6882221698760986,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "androgen replacement",
            "probability": 0.0018537641090502132,
            "start_logit": 1.8786147832870483,
            "end_logit": -3.7378838062286377,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "clinical trials.gov as NCT00794079",
            "probability": 0.0017259228835807827,
            "start_logit": -0.8530385494232178,
            "end_logit": -1.0776867866516113,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "androgen",
            "probability": 0.0016710150901514727,
            "start_logit": 1.8786147832870483,
            "end_logit": -3.8416707515716553,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "and",
            "probability": 0.0013652446261012362,
            "start_logit": 1.8786147832870483,
            "end_logit": -4.043768405914307,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "clinical trials",
            "probability": 0.0013565465787539145,
            "start_logit": 0.49098941683769226,
            "end_logit": -2.662534475326538,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "resistance training",
            "probability": 0.0011507540534570024,
            "start_logit": -0.8521459102630615,
            "end_logit": -1.4839239120483398,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "several clinical trials with androgen replacement therapy have failed to show clinical benefit",
            "probability": 0.0010466117738478203,
            "start_logit": -0.7427070140838623,
            "end_logit": -1.6882221698760986,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "androgen replacement therapy have failed to show clinical benefit.",
            "probability": 0.0010218064421143728,
            "start_logit": 1.8786147832870483,
            "end_logit": -4.333529949188232,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "androgen replacement therapy have failed to show clinical benefit.Clinical trials are needed to find better interventions for this syndrome.",
            "probability": 0.0009669131378097384,
            "start_logit": 1.8786147832870483,
            "end_logit": -4.388748645782471,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "physical exercise [in particular, resistance training",
            "probability": 0.0005034741335898801,
            "start_logit": -1.678786277770996,
            "end_logit": -1.4839239120483398,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "clinical trials with androgen replacement",
            "probability": 0.00046282459511361634,
            "start_logit": 0.49098941683769226,
            "end_logit": -3.7378838062286377,
            "question_text": "List clinical trials for prevention of sarcopenia"
        }
    ],
    "56bdfa73ef6e394741000003": [
        {
            "text": "urinary incontinence",
            "probability": 0.27003139149163774,
            "start_logit": 4.2984161376953125,
            "end_logit": 4.526221752166748,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "dementia, gait disturbances and urinary incontinence",
            "probability": 0.17976388655473674,
            "start_logit": 3.891522169113159,
            "end_logit": 4.526221752166748,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbances and urinary incontinence",
            "probability": 0.1720549826181348,
            "start_logit": 3.8476920127868652,
            "end_logit": 4.526221752166748,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "dementia, gait disturbances",
            "probability": 0.0836521019377065,
            "start_logit": 3.891522169113159,
            "end_logit": 3.761244058609009,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbances",
            "probability": 0.08006480734649694,
            "start_logit": 3.8476920127868652,
            "end_logit": 3.761244058609009,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "dementia",
            "probability": 0.07719299888427628,
            "start_logit": 3.891522169113159,
            "end_logit": 3.6808862686157227,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "dementia, and urinary incontinence",
            "probability": 0.04980697433671383,
            "start_logit": 3.6726484298706055,
            "end_logit": 3.46160626411438,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "urinary incontinence.Normal pressure hydrocephalus (NPH) is a clinical triad of gait disturbance",
            "probability": 0.03465740948913252,
            "start_logit": 4.2984161376953125,
            "end_logit": 2.4731950759887695,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbance, dementia, and urinary incontinence",
            "probability": 0.01584054547030885,
            "start_logit": 2.527066230773926,
            "end_logit": 3.46160626411438,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbance, dementia",
            "probability": 0.014547993753843916,
            "start_logit": 2.527066230773926,
            "end_logit": 3.3764865398406982,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbance",
            "probability": 0.00589533661372877,
            "start_logit": 2.527066230773926,
            "end_logit": 2.4731950759887695,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "dementia, gait disturbance",
            "probability": 0.003667411710909435,
            "start_logit": 3.891522169113159,
            "end_logit": 0.6340636610984802,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "dementia, and urinary incontinence combined with radiographic findings of ventriculomegaly",
            "probability": 0.0035730235321411474,
            "start_logit": 3.6726484298706055,
            "end_logit": 0.8268634080886841,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "urinary incontinence combined with radiographic findings of ventriculomegaly",
            "probability": 0.0024348121978779104,
            "start_logit": 3.2891058921813965,
            "end_logit": 0.8268634080886841,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "incontinence",
            "probability": 0.0014668924211122159,
            "start_logit": -0.9169759154319763,
            "end_logit": 4.526221752166748,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "urinary incontinence.Normal pressure hydrocephalus",
            "probability": 0.0012056110847653546,
            "start_logit": 4.2984161376953125,
            "end_logit": -0.8853299021720886,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbance, dementia, and urinary incontinence combined with radiographic findings of ventriculomegaly",
            "probability": 0.0011363597665005173,
            "start_logit": 2.527066230773926,
            "end_logit": 0.8268634080886841,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "dementia, gait",
            "probability": 0.0011265898967821614,
            "start_logit": 3.891522169113159,
            "end_logit": -0.546227216720581,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait",
            "probability": 0.001078277783283238,
            "start_logit": 3.8476920127868652,
            "end_logit": -0.546227216720581,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "dementia, gait disturbances and urinary incontinence.Normal pressure hydrocephalus",
            "probability": 0.0008025931099110891,
            "start_logit": 3.891522169113159,
            "end_logit": -0.8853299021720886,
            "question_text": "List symptoms of Hakim Triad."
        }
    ],
    "56f96333cf1c325851000004": [
        {
            "text": "disulfide bonds",
            "probability": 0.26184379479915537,
            "start_logit": 5.178616046905518,
            "end_logit": 5.243424892425537,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulphide bonds",
            "probability": 0.21053438851057882,
            "start_logit": 5.552164554595947,
            "end_logit": 4.651777267456055,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "cystine disulfide bonds",
            "probability": 0.12467404860193282,
            "start_logit": 4.825094699859619,
            "end_logit": 4.85490083694458,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulphide",
            "probability": 0.11687462462731837,
            "start_logit": 5.552164554595947,
            "end_logit": 4.063230037689209,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "cystine disulfide",
            "probability": 0.05072779113885221,
            "start_logit": 4.825094699859619,
            "end_logit": 3.955672025680542,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic interactions in addition to cross-linking through disulphide bonds",
            "probability": 0.050306138783978764,
            "start_logit": 4.12064266204834,
            "end_logit": 4.651777267456055,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide",
            "probability": 0.0461203725786295,
            "start_logit": 5.178616046905518,
            "end_logit": 3.5069315433502197,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "thiols by controlled reduction of cystine disulfide bonds",
            "probability": 0.037757860945719965,
            "start_logit": 3.6305856704711914,
            "end_logit": 4.85490083694458,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic interactions in addition to cross-linking through disulphide",
            "probability": 0.02792660680481597,
            "start_logit": 4.12064266204834,
            "end_logit": 4.063230037689209,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "thiols by controlled reduction of cystine disulfide",
            "probability": 0.015363043916379347,
            "start_logit": 3.6305856704711914,
            "end_logit": 3.955672025680542,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "amide bonds",
            "probability": 0.014362332898310966,
            "start_logit": 3.79602313041687,
            "end_logit": 3.7228786945343018,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "thiols",
            "probability": 0.009201248537550865,
            "start_logit": 3.6305856704711914,
            "end_logit": 3.4430463314056396,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic interactions",
            "probability": 0.008384516202161126,
            "start_logit": 4.12064266204834,
            "end_logit": 2.860036849975586,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulphide bonds.The method involves the generation of thiols by controlled reduction of cystine disulfide",
            "probability": 0.007421445443956023,
            "start_logit": 5.552164554595947,
            "end_logit": 1.306502103805542,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "cross-linking through disulphide bonds",
            "probability": 0.005589308226904012,
            "start_logit": 1.9233710765838623,
            "end_logit": 4.651777267456055,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulphide bonds.The method involves the generation of thiols by controlled reduction of cystine disulfide bonds",
            "probability": 0.003563837013958691,
            "start_logit": 5.552164554595947,
            "end_logit": 0.5729660391807556,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "cross-linking through disulphide",
            "probability": 0.003102810450906289,
            "start_logit": 1.9233710765838623,
            "end_logit": 4.063230037689209,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic",
            "probability": 0.002791991520065632,
            "start_logit": 4.12064266204834,
            "end_logit": 1.7604053020477295,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic interactions in addition to cross-linking",
            "probability": 0.0018450294456854393,
            "start_logit": 4.12064266204834,
            "end_logit": 1.3461453914642334,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "cystine disulfide bonds in keratinossible chemical bonds",
            "probability": 0.0016088095531398812,
            "start_logit": 4.825094699859619,
            "end_logit": 0.5046926140785217,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        }
    ],
    "54c90dabf693c3b16b000004": [
        {
            "text": "SERCA2a",
            "probability": 0.44740231548512555,
            "start_logit": 5.352688789367676,
            "end_logit": 4.588616847991943,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AAV1/SERCA2a",
            "probability": 0.21727863957091315,
            "start_logit": 4.765440464019775,
            "end_logit": 4.453587532043457,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AAV1",
            "probability": 0.12286828636525057,
            "start_logit": 4.765440464019775,
            "end_logit": 3.8835198879241943,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "SERCA",
            "probability": 0.07807682311305866,
            "start_logit": 5.181447505950928,
            "end_logit": 3.0140931606292725,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AAV1/SERCA",
            "probability": 0.05150537709118784,
            "start_logit": 4.765440464019775,
            "end_logit": 3.0140931606292725,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "SERCA2",
            "probability": 0.03378059590635781,
            "start_logit": 5.181447505950928,
            "end_logit": 2.176286458969116,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AAV1/SERCA2",
            "probability": 0.022284235720023717,
            "start_logit": 4.765440464019775,
            "end_logit": 2.176286458969116,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AAV",
            "probability": 0.014904761394664762,
            "start_logit": 4.765440464019775,
            "end_logit": 1.77408766746521,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "YAP",
            "probability": 0.007973821210206827,
            "start_logit": 3.2199976444244385,
            "end_logit": 2.6940135955810547,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "SERCA2a.",
            "probability": 0.0006515970480391786,
            "start_logit": 5.352688789367676,
            "end_logit": -1.9431703090667725,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AV-mediated gene therapy, may be a strategy to improve outcome after MIcalcium up-regulation by AAV1/SERCA2a",
            "probability": 0.0005320885976593271,
            "start_logit": -1.2466853857040405,
            "end_logit": 4.453587532043457,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "SERCA2a gene therapy",
            "probability": 0.0005195601451153749,
            "start_logit": 5.181447505950928,
            "end_logit": -1.9983727931976318,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AV1/SERCA2a",
            "probability": 0.0003883850455618185,
            "start_logit": -1.5614981651306152,
            "end_logit": 4.453587532043457,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AAV1/SERCA2a gene therapy",
            "probability": 0.00034274116349444436,
            "start_logit": 4.765440464019775,
            "end_logit": -1.9983727931976318,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AV-mediated gene therapy, may be a strategy to improve outcome after MIcalcium up-regulation by AAV1",
            "probability": 0.00030088928353932276,
            "start_logit": -1.2466853857040405,
            "end_logit": 3.8835198879241943,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "focusing on SERCA2a",
            "probability": 0.00029825807853498275,
            "start_logit": -1.9605655670166016,
            "end_logit": 4.588616847991943,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "SE",
            "probability": 0.00022920379019540695,
            "start_logit": 5.352688789367676,
            "end_logit": -2.987985134124756,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "SERCA2a gene",
            "probability": 0.00022775582613402838,
            "start_logit": 5.181447505950928,
            "end_logit": -2.8230812549591064,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "AV1",
            "probability": 0.00021962676631402593,
            "start_logit": -1.5614981651306152,
            "end_logit": 3.8835198879241943,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "YAP or its downstream targets, potentially through AAV",
            "probability": 0.00021503839862254404,
            "start_logit": 3.2199976444244385,
            "end_logit": -0.9190889000892639,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        }
    ],
    "52f8995b2059c6d71c00004a": [
        {
            "text": "BTBD9",
            "probability": 0.580897903470394,
            "start_logit": 2.7335829734802246,
            "end_logit": 1.4505484104156494,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 rs9296249",
            "probability": 0.23834087139342416,
            "start_logit": 2.7335829734802246,
            "end_logit": 0.5596752762794495,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "MEIS1",
            "probability": 0.04268909962655132,
            "start_logit": 1.0196603536605835,
            "end_logit": 0.5538396239280701,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "MEIS1 and BTBD9",
            "probability": 0.03731075441660127,
            "start_logit": 1.0196603536605835,
            "end_logit": 0.4191776216030121,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "SKOR1",
            "probability": 0.02932207685543479,
            "start_logit": 0.13245904445648193,
            "end_logit": 1.0654380321502686,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "MAP2K5/SKOR1",
            "probability": 0.01976353504714008,
            "start_logit": -0.2620430886745453,
            "end_logit": 1.0654380321502686,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "L-ferritin",
            "probability": 0.010893526457875991,
            "start_logit": -0.24755489826202393,
            "end_logit": 0.45527997612953186,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "ferritin",
            "probability": 0.005859937992077864,
            "start_logit": -0.8675845861434937,
            "end_logit": 0.45527997612953186,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "rs9296249 was associated with lower serum ferritin. A frequent polymorphism in BTBD9",
            "probability": 0.005678005173799592,
            "start_logit": -1.1885663270950317,
            "end_logit": 0.7447226643562317,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "rs9296249",
            "probability": 0.004718790803960025,
            "start_logit": -1.1885663270950317,
            "end_logit": 0.5596752762794495,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "SKOR1 and BTBD9",
            "probability": 0.004465537887186876,
            "start_logit": 0.13245904445648193,
            "end_logit": -0.8165130019187927,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 rs9296249 was associated with lower serum ferritin",
            "probability": 0.003911986298755523,
            "start_logit": 2.7335829734802246,
            "end_logit": -3.5499813556671143,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "MAP2K5",
            "probability": 0.003063635127378067,
            "start_logit": -0.2620430886745453,
            "end_logit": -0.7987983822822571,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "MAP2K5/SKOR1 and BTBD9",
            "probability": 0.0030098418666886424,
            "start_logit": -0.2620430886745453,
            "end_logit": -0.8165130019187927,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "T-allele of BTBD9",
            "probability": 0.0024319732772998095,
            "start_logit": -2.7422890663146973,
            "end_logit": 1.4505484104156494,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 rs9296249 was associated with lower serum ferritin.",
            "probability": 0.0022028287679600168,
            "start_logit": 2.7335829734802246,
            "end_logit": -4.124284267425537,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "Homozygosity for the T-allele of BTBD9",
            "probability": 0.0020254247278564505,
            "start_logit": -2.9252126216888428,
            "end_logit": 1.4505484104156494,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "ferritin. A frequent polymorphism in BTBD9",
            "probability": 0.0015854122126926866,
            "start_logit": -2.4643218517303467,
            "end_logit": 0.7447226643562317,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "T-allele of BTBD9 rs9296249",
            "probability": 0.0009978321950454415,
            "start_logit": -2.7422890663146973,
            "end_logit": 0.5596752762794495,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "Homozygosity for the T-allele of BTBD9 rs9296249",
            "probability": 0.0008310264018773461,
            "start_logit": -2.9252126216888428,
            "end_logit": 0.5596752762794495,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        }
    ],
    "52bf1dea03868f1b06000012": [
        {
            "text": "nausea, dizziness, and insomnia",
            "probability": 0.1494556836092188,
            "start_logit": 5.885461330413818,
            "end_logit": 5.940597057342529,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "insomnia",
            "probability": 0.1175761228369831,
            "start_logit": 5.645547389984131,
            "end_logit": 5.940597057342529,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "dizziness, and insomnia",
            "probability": 0.11527011061136314,
            "start_logit": 5.625739574432373,
            "end_logit": 5.940597057342529,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "nausea, dizziness",
            "probability": 0.0872840425996814,
            "start_logit": 5.885461330413818,
            "end_logit": 5.402764797210693,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "nausea",
            "probability": 0.08272288592540479,
            "start_logit": 5.885461330413818,
            "end_logit": 5.349093437194824,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "dizziness",
            "probability": 0.0673192280286864,
            "start_logit": 5.625739574432373,
            "end_logit": 5.402764797210693,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fatigue, lightheadedness, nausea",
            "probability": 0.050922334290820985,
            "start_logit": 5.598360061645508,
            "end_logit": 5.151000022888184,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fatigue, lightheadedness",
            "probability": 0.05075218620589933,
            "start_logit": 5.598360061645508,
            "end_logit": 5.147653102874756,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fatigue",
            "probability": 0.049255791981200295,
            "start_logit": 5.598360061645508,
            "end_logit": 5.117725372314453,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "lightheadedness, nausea",
            "probability": 0.04008148790983307,
            "start_logit": 5.358973026275635,
            "end_logit": 5.151000022888184,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "lightheadedness",
            "probability": 0.03994756261941492,
            "start_logit": 5.358973026275635,
            "end_logit": 5.147653102874756,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fatigue, lightheadedness, nausea and vomiting",
            "probability": 0.037901443950623774,
            "start_logit": 5.598360061645508,
            "end_logit": 4.855687618255615,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "vomiting",
            "probability": 0.03501272948409391,
            "start_logit": 5.519082546234131,
            "end_logit": 4.855687618255615,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "nausea and vomiting",
            "probability": 0.030234918083726317,
            "start_logit": 5.372368335723877,
            "end_logit": 4.855687618255615,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "lightheadedness, nausea and vomiting",
            "probability": 0.02983261251921785,
            "start_logit": 5.358973026275635,
            "end_logit": 4.855687618255615,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "nausea, dizziness,",
            "probability": 0.00704785596273206,
            "start_logit": 5.885461330413818,
            "end_logit": 2.8863205909729004,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "dizziness,",
            "probability": 0.0054357727774426955,
            "start_logit": 5.625739574432373,
            "end_logit": 2.8863205909729004,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "nausea,",
            "probability": 0.0016068397130343107,
            "start_logit": 5.885461330413818,
            "end_logit": 1.4078664779663086,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fatigue,",
            "probability": 0.0012181376204538866,
            "start_logit": 5.598360061645508,
            "end_logit": 1.418021559715271,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fatigue, lightheadedness,",
            "probability": 0.0011222532701690463,
            "start_logit": 5.598360061645508,
            "end_logit": 1.3360369205474854,
            "question_text": "What are the side effects of Nalmefene?"
        }
    ],
    "530cf4d5e2bfff940c000004": [
        {
            "text": "Knowledge Network Gene Prioritization (KNGP) algorithm which can incorporate both link and node knowledge In recent years, network-based methods",
            "probability": 0.22821470283369533,
            "start_logit": 3.9901227951049805,
            "end_logit": 3.518937587738037,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Knowledge Network Gene Prioritization",
            "probability": 0.18351006667267883,
            "start_logit": 3.9901227951049805,
            "end_logit": 3.300920248031616,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based methods",
            "probability": 0.11675282565995646,
            "start_logit": 3.319895029067993,
            "end_logit": 3.518937587738037,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Knowledge Network Gene Prioritization (KNGP)",
            "probability": 0.10118063034788888,
            "start_logit": 3.9901227951049805,
            "end_logit": 2.7055580615997314,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Knowledge Network Gene Prioritization (KNGP",
            "probability": 0.06488902163609796,
            "start_logit": 3.9901227951049805,
            "end_logit": 2.261329174041748,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "KNGP) algorithm which can incorporate both link and node knowledge In recent years, network-based methods",
            "probability": 0.06305279412769091,
            "start_logit": 2.703808307647705,
            "end_logit": 3.518937587738037,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Knowledge Network",
            "probability": 0.05329528896720387,
            "start_logit": 3.9901227951049805,
            "end_logit": 2.0644986629486084,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Knowledge Network Gene Prioritization (KNGP) algorithm which can incorporate both link and node knowledge In recent years, network-based",
            "probability": 0.0280152262021542,
            "start_logit": 3.9901227951049805,
            "end_logit": 1.4213988780975342,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "KNGP)",
            "probability": 0.02795490989765223,
            "start_logit": 2.703808307647705,
            "end_logit": 2.7055580615997314,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Knowledge Network Gene Prioritization (KNGP) algorithm which can incorporate both link and node knowledge In recent years, network",
            "probability": 0.02194410575676321,
            "start_logit": 3.9901227951049805,
            "end_logit": 1.1771492958068848,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Knowledge Network Gene Prioritization (KNGP) algorithm",
            "probability": 0.02039835282521501,
            "start_logit": 3.9901227951049805,
            "end_logit": 1.1041048765182495,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "KNGP",
            "probability": 0.017928004074959522,
            "start_logit": 2.703808307647705,
            "end_logit": 2.261329174041748,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based",
            "probability": 0.014332366758104507,
            "start_logit": 3.319895029067993,
            "end_logit": 1.4213988780975342,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network inference algorithm called the Knowledge Network Gene Prioritization",
            "probability": 0.01123720696076559,
            "start_logit": 1.197083592414856,
            "end_logit": 3.300920248031616,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network",
            "probability": 0.011226429856931827,
            "start_logit": 3.319895029067993,
            "end_logit": 1.1771492958068848,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "(KNGP) algorithm which can incorporate both link and node knowledge In recent years, network-based methods",
            "probability": 0.010433363617697453,
            "start_logit": 0.9048446416854858,
            "end_logit": 3.518937587738037,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "KNGP) algorithm which can incorporate both link and node knowledge In recent years, network-based",
            "probability": 0.007740247531081991,
            "start_logit": 2.703808307647705,
            "end_logit": 1.4213988780975342,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network inference algorithm called the Knowledge Network Gene Prioritization (KNGP)",
            "probability": 0.006195778271215805,
            "start_logit": 1.197083592414856,
            "end_logit": 2.7055580615997314,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "KNGP) algorithm which can incorporate both link and node knowledge In recent years, network",
            "probability": 0.006062874851695037,
            "start_logit": 2.703808307647705,
            "end_logit": 1.1771492958068848,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "KNGP) algorithm",
            "probability": 0.0056358031505513665,
            "start_logit": 2.703808307647705,
            "end_logit": 1.1041048765182495,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        }
    ],
    "5537766dbc4f83e82800000d": [
        {
            "text": "dwarfism, microtia",
            "probability": 0.10283853701206559,
            "start_logit": 5.454977512359619,
            "end_logit": 5.894667148590088,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microtia",
            "probability": 0.091154044584751,
            "start_logit": 5.3343682289123535,
            "end_logit": 5.894667148590088,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "dwarfism",
            "probability": 0.08669565926667767,
            "start_logit": 5.454977512359619,
            "end_logit": 5.723910808563232,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "dwarfism, microtia, and patellar aplasia/hypoplasia",
            "probability": 0.08447952307547799,
            "start_logit": 5.454977512359619,
            "end_logit": 5.698016166687012,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "primordial dwarfism, microtia",
            "probability": 0.08389859473200109,
            "start_logit": 5.2514262199401855,
            "end_logit": 5.894667148590088,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microtia, and patellar aplasia/hypoplasia",
            "probability": 0.07488097785771824,
            "start_logit": 5.3343682289123535,
            "end_logit": 5.698016166687012,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "primordial dwarfism",
            "probability": 0.07072877729663989,
            "start_logit": 5.2514262199401855,
            "end_logit": 5.723910808563232,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "primordial dwarfism, microtia, and patellar aplasia/hypoplasia",
            "probability": 0.06892079054791193,
            "start_logit": 5.2514262199401855,
            "end_logit": 5.698016166687012,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "patellar aplasia/hypoplasia",
            "probability": 0.05971979546093856,
            "start_logit": 5.1081318855285645,
            "end_logit": 5.698016166687012,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "dwarfism, microtia, and patellar aplasia",
            "probability": 0.04950541257485723,
            "start_logit": 5.454977512359619,
            "end_logit": 5.163589000701904,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microtia, and patellar aplasia",
            "probability": 0.04388061825991927,
            "start_logit": 5.3343682289123535,
            "end_logit": 5.163589000701904,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "primordial dwarfism, microtia, and patellar aplasia",
            "probability": 0.040387919425294364,
            "start_logit": 5.2514262199401855,
            "end_logit": 5.163589000701904,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "patellar aplasia",
            "probability": 0.03499609142606564,
            "start_logit": 5.1081318855285645,
            "end_logit": 5.163589000701904,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "hypoplasia",
            "probability": 0.02926150180589354,
            "start_logit": 4.394741058349609,
            "end_logit": 5.698016166687012,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microtia, aplasia or hypoplasia of the patellae",
            "probability": 0.02256881495985222,
            "start_logit": 4.8234758377075195,
            "end_logit": 5.009577751159668,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "bilateral microtia",
            "probability": 0.015606781038099303,
            "start_logit": 4.052404880523682,
            "end_logit": 5.411785125732422,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "aplasia or hypoplasia of the patellae",
            "probability": 0.012017070338281172,
            "start_logit": 4.193234920501709,
            "end_logit": 5.009577751159668,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "bilateral microtia, aplasia or hypoplasia of the patellae",
            "probability": 0.010438471118740545,
            "start_logit": 4.052404880523682,
            "end_logit": 5.009577751159668,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "hypoplasia of the patellae",
            "probability": 0.010259569428530534,
            "start_logit": 4.0351176261901855,
            "end_logit": 5.009577751159668,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "aplasia or hypoplasia of the patellae, and severe intrauterine and post-natal growth retardation",
            "probability": 0.007761049790284106,
            "start_logit": 4.193234920501709,
            "end_logit": 4.572367191314697,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        }
    ],
    "55439140ed966d112c00000a": [
        {
            "text": "C-phycocyanin",
            "probability": 0.19892269665106319,
            "start_logit": 4.5559611320495605,
            "end_logit": 4.4518723487854,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycoerythrin",
            "probability": 0.174305999109387,
            "start_logit": 4.6983208656311035,
            "end_logit": 4.177408695220947,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycoerythrin I or phycoerythrin",
            "probability": 0.16733758336584786,
            "start_logit": 4.657521724700928,
            "end_logit": 4.177408695220947,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycocyanin, phycoerythrin I or phycoerythrin",
            "probability": 0.12048570055192497,
            "start_logit": 4.329039573669434,
            "end_logit": 4.177408695220947,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycocyanin",
            "probability": 0.11696432175250109,
            "start_logit": 4.329039573669434,
            "end_logit": 4.147746562957764,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycocyanin, phycoerythrin",
            "probability": 0.10227712245317022,
            "start_logit": 4.329039573669434,
            "end_logit": 4.013563632965088,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-phycocyanin (C-PC)",
            "probability": 0.042853056294834733,
            "start_logit": 4.5559611320495605,
            "end_logit": 2.9167330265045166,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-phycocyanin (C-PC",
            "probability": 0.017199012389828773,
            "start_logit": 4.5559611320495605,
            "end_logit": 2.00380802154541,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Phycocyanin",
            "probability": 0.01671456269820291,
            "start_logit": 2.9947011470794678,
            "end_logit": 3.53649640083313,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-PC)",
            "probability": 0.00969731139088139,
            "start_logit": 3.070032835006714,
            "end_logit": 2.9167330265045166,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycocyanin (C-PC)",
            "probability": 0.007778315958885051,
            "start_logit": 2.8495240211486816,
            "end_logit": 2.9167330265045166,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycocyanin (C-PC)C-Phycocyanin",
            "probability": 0.005879022752780859,
            "start_logit": 1.949811339378357,
            "end_logit": 3.53649640083313,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-PC",
            "probability": 0.003892001952259819,
            "start_logit": 3.070032835006714,
            "end_logit": 2.00380802154541,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-phycocyanin (C-PC)C-Phycocyanin",
            "probability": 0.003780066452403332,
            "start_logit": 1.5081623792648315,
            "end_logit": 3.53649640083313,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-phycocyanin (C-PC),",
            "probability": 0.003632757698972173,
            "start_logit": 4.5559611320495605,
            "end_logit": 0.44894811511039734,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycocyanin (C-PC",
            "probability": 0.0031218159010280877,
            "start_logit": 2.8495240211486816,
            "end_logit": 2.00380802154541,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-Phycocyanin",
            "probability": 0.0018910455839848464,
            "start_logit": 0.815550684928894,
            "end_logit": 3.53649640083313,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycoerythrin I",
            "probability": 0.0014218139295822984,
            "start_logit": 4.657521724700928,
            "end_logit": -0.5906710624694824,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycocyanin, phycoerythrin I",
            "probability": 0.0010237284650255745,
            "start_logit": 4.329039573669434,
            "end_logit": -0.5906710624694824,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-PC),",
            "probability": 0.0008220646474356861,
            "start_logit": 3.070032835006714,
            "end_logit": 0.44894811511039734,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        }
    ],
    "517539ca8ed59a060a000027": [
        {
            "text": "TRalpha1",
            "probability": 0.46144811166746896,
            "start_logit": 5.077454090118408,
            "end_logit": 4.168269634246826,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "ARB1",
            "probability": 0.1288748653916306,
            "start_logit": 4.284672260284424,
            "end_logit": 3.685523748397827,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "ARB2",
            "probability": 0.08781303510152749,
            "start_logit": 4.415128231048584,
            "end_logit": 3.171435832977295,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TAK1",
            "probability": 0.08693747832031778,
            "start_logit": 3.9815688133239746,
            "end_logit": 3.5949745178222656,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "p38",
            "probability": 0.07799543928458344,
            "start_logit": 4.181634426116943,
            "end_logit": 3.286370038986206,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "ARB1 (p<0.05, -37%) and ARB2",
            "probability": 0.07707307381623024,
            "start_logit": 4.284672260284424,
            "end_logit": 3.171435832977295,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TAK1 and p38",
            "probability": 0.06385307502607493,
            "start_logit": 3.9815688133239746,
            "end_logit": 3.286370038986206,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha1-induced myocardial growth and gene expression by diminishing TAK1",
            "probability": 0.004223764863419738,
            "start_logit": 0.9571064710617065,
            "end_logit": 3.5949745178222656,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha1-induced myocardial growth and gene expression by diminishing TAK1 and p38",
            "probability": 0.003102233696297689,
            "start_logit": 0.9571064710617065,
            "end_logit": 3.286370038986206,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TAK",
            "probability": 0.001463381499505439,
            "start_logit": 3.9815688133239746,
            "end_logit": -0.4894648492336273,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha",
            "probability": 0.0010938355025955989,
            "start_logit": 5.077454090118408,
            "end_logit": -1.876409649848938,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "p38 activities, respectively.Selective ablation of TRalpha2",
            "probability": 0.0010462022814696388,
            "start_logit": 4.181634426116943,
            "end_logit": -1.025113582611084,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TAK1 and p38 activities, respectively.Selective ablation of TRalpha2",
            "probability": 0.0008565017824617333,
            "start_logit": 3.9815688133239746,
            "end_logit": -1.025113582611084,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "myocardial growth and gene expression by diminishing TAK1",
            "probability": 0.0007272097468788658,
            "start_logit": -0.8021607398986816,
            "end_logit": 3.5949745178222656,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "ARB2 (p<0.05, -42%)",
            "probability": 0.0006714884618243305,
            "start_logit": 4.415128231048584,
            "end_logit": -1.7020325660705566,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "overexpression of TRalpha1",
            "probability": 0.0006019137747464989,
            "start_logit": -1.56455659866333,
            "end_logit": 4.168269634246826,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "ARB1 (p<0.05, -37%) and ARB2 (p<0.05, -42%)",
            "probability": 0.0005893621570544404,
            "start_logit": 4.284672260284424,
            "end_logit": -1.7020325660705566,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "ARB2 (p<0.05, -42%) was associated with a reduction of the messenger for TRalpha1",
            "probability": 0.0005713688670854126,
            "start_logit": 4.415128231048584,
            "end_logit": -1.8634943962097168,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "myocardial growth and gene expression by diminishing TAK1 and p38",
            "probability": 0.0005341146237996777,
            "start_logit": -0.8021607398986816,
            "end_logit": 3.286370038986206,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "mRNA expression of ARB1",
            "probability": 0.0005235441350275981,
            "start_logit": -1.2213035821914673,
            "end_logit": 3.685523748397827,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        }
    ],
    "554143ad182542114d000004": [
        {
            "text": "MetaTM",
            "probability": 0.24620961968193808,
            "start_logit": 3.094235420227051,
            "end_logit": 2.5535924434661865,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "HMMpTMMetaTM",
            "probability": 0.23667661876857196,
            "start_logit": 2.763153314590454,
            "end_logit": 2.8451859951019287,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "HMMpTMMetaTM - a consensus method for transmembrane protein topology prediction.A novel TM consensus method, named MetaTM",
            "probability": 0.17681450345971553,
            "start_logit": 2.763153314590454,
            "end_logit": 2.5535924434661865,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "HMMpTM",
            "probability": 0.1375174443624595,
            "start_logit": 2.4704675674438477,
            "end_logit": 2.5949277877807617,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "MetaTM, is proposed in this work. MetaTM",
            "probability": 0.12661258907813586,
            "start_logit": 3.094235420227051,
            "end_logit": 1.8885411024093628,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "MetaTM is made available both as downloadable source code and as DAS server at http://MetaTM",
            "probability": 0.031071403635048213,
            "start_logit": 2.711634397506714,
            "end_logit": 0.8662980794906616,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "SVM-based system also has higher accuracy than a previous consensus predictor. MetaTM",
            "probability": 0.013363973950266535,
            "start_logit": 0.4778416156768799,
            "end_logit": 2.2563655376434326,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "MetaTM.sbc.su.seWe present a support vector machine",
            "probability": 0.00484405679072545,
            "start_logit": 2.3414573669433594,
            "end_logit": -0.622060239315033,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "HMMpTM: improving transmembrane protein topology prediction using phosphorylation and glycosylation site prediction",
            "probability": 0.004735576066481744,
            "start_logit": 2.4704675674438477,
            "end_logit": -0.7737196087837219,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "TM consensus method, named MetaTM",
            "probability": 0.004301294771628626,
            "start_logit": -0.9530317783355713,
            "end_logit": 2.5535924434661865,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "MetaTM,",
            "probability": 0.0034203940995367267,
            "start_logit": 3.094235420227051,
            "end_logit": -1.7228350639343262,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "HMMpTMMetaTM - a consensus method for transmembrane protein topology prediction.A novel TM consensus method",
            "probability": 0.0033005289910638096,
            "start_logit": 2.763153314590454,
            "end_logit": -1.4274259805679321,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "HMMpT",
            "probability": 0.002424015800650597,
            "start_logit": 2.763153314590454,
            "end_logit": -1.7360831499099731,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "TM consensus method, named MetaTM, is proposed in this work. MetaTM",
            "probability": 0.0022119284702509985,
            "start_logit": -0.9530317783355713,
            "end_logit": 1.8885411024093628,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "MetaTM, is proposed in this work. MetaTM is based on support vector machine",
            "probability": 0.0012622694455601425,
            "start_logit": 3.094235420227051,
            "end_logit": -2.719679594039917,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "Meta",
            "probability": 0.001206110785540072,
            "start_logit": 3.094235420227051,
            "end_logit": -2.7651898860931396,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "HMMpTMMetaTM - a consensus method for transmembrane protein topology prediction.A novel TM consensus",
            "probability": 0.0011085395807066923,
            "start_logit": 2.763153314590454,
            "end_logit": -2.518465280532837,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "A novel TM consensus method, named MetaTM",
            "probability": 0.00105887397275393,
            "start_logit": -2.3547418117523193,
            "end_logit": 2.5535924434661865,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus method for transmembrane protein topology prediction.A novel TM consensus method, named MetaTM",
            "probability": 0.0009388211931521137,
            "start_logit": -2.4750781059265137,
            "end_logit": 2.5535924434661865,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "SVM",
            "probability": 0.000921437095813265,
            "start_logit": 0.4778416156768799,
            "end_logit": -0.41801780462265015,
            "question_text": "List available methods for transmembrane protein topology prediction."
        }
    ],
    "56b739d976d8bf8d13000005": [
        {
            "text": "Brainbow",
            "probability": 0.5123564938232702,
            "start_logit": 1.6947263479232788,
            "end_logit": 2.4437096118927,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Drosophila Brainbow",
            "probability": 0.4267136577913886,
            "start_logit": 1.425450325012207,
            "end_logit": 2.530078172683716,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Flybow",
            "probability": 0.02830644381739241,
            "start_logit": -0.5164186358451843,
            "end_logit": 1.7589234113693237,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Flybow. Sequences encoding different membrane-tethered fluorescent proteins were arranged in pairs within cassettes flanked by recombination sites. Flybow",
            "probability": 0.009239650137168336,
            "start_logit": 0.3979130685329437,
            "end_logit": -0.27499374747276306,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow: a recombinase",
            "probability": 0.0035478981220490352,
            "start_logit": 1.1206356287002563,
            "end_logit": -1.9548649787902832,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Drosophila Brainbow: a recombinase",
            "probability": 0.0028801866001524805,
            "start_logit": 1.425450325012207,
            "end_logit": -2.468179941177368,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow-2 system, called Flybow",
            "probability": 0.0026911224919380257,
            "start_logit": -1.4212332963943481,
            "end_logit": 0.310606986284256,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Drosophila Brainbow: a recombinase-based fluorescence labeling technique",
            "probability": 0.0019083072364620586,
            "start_logit": 1.425450325012207,
            "end_logit": -2.8798184394836426,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Drosophila Brain",
            "probability": 0.001794421876990782,
            "start_logit": 1.425450325012207,
            "end_logit": -2.941352128982544,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brain",
            "probability": 0.001737723045905851,
            "start_logit": 1.6947263479232788,
            "end_logit": -3.2427353858947754,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Drosophila Brainbow:",
            "probability": 0.0016475682853822342,
            "start_logit": 1.425450325012207,
            "end_logit": -3.0267345905303955,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow: a recombinase-based fluorescence labeling technique",
            "probability": 0.0014902490587946023,
            "start_logit": 1.1206356287002563,
            "end_logit": -2.822277069091797,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow: a recombinase-based fluorescence",
            "probability": 0.0013294062520192947,
            "start_logit": 1.1206356287002563,
            "end_logit": -2.936487913131714,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Flybow.",
            "probability": 0.0012552494338089089,
            "start_logit": 0.3979130685329437,
            "end_logit": -2.2711634635925293,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow:",
            "probability": 0.0010083649729666435,
            "start_logit": 1.1206356287002563,
            "end_logit": -3.212890148162842,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow: a recombinase-based fluorescence labeling",
            "probability": 0.0008112779824539329,
            "start_logit": 1.1206356287002563,
            "end_logit": -3.4303648471832275,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow: a recombinase-based fluorescence labeling technique to subdivide neural expression patterns.We developed",
            "probability": 0.00044526612155005614,
            "start_logit": 1.1206356287002563,
            "end_logit": -4.030303478240967,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Flybow: genetic multicolor cell labeling for neural circuit analysis in Drosophila melanogaster",
            "probability": 0.00030025738843725167,
            "start_logit": -0.5164186358451843,
            "end_logit": -2.7872812747955322,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "mouse Brainbow-2 system, called Flybow",
            "probability": 0.0002821251595019694,
            "start_logit": -3.676596164703369,
            "end_logit": 0.310606986284256,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Flybow:",
            "probability": 0.0002543304023672485,
            "start_logit": -0.5164186358451843,
            "end_logit": -2.953287124633789,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        }
    ],
    "5319abffb166e2b80600002f": [
        {
            "text": "fibroblast growth factors",
            "probability": 0.632154650053673,
            "start_logit": 5.746659278869629,
            "end_logit": 4.374247074127197,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "fibroblast",
            "probability": 0.18115394776045457,
            "start_logit": 5.746659278869629,
            "end_logit": 3.124460220336914,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "fibroblast growth factors (FGFs)",
            "probability": 0.16107372243276616,
            "start_logit": 5.746659278869629,
            "end_logit": 3.0069751739501953,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "fibroblast growth",
            "probability": 0.019629939359611,
            "start_logit": 5.746659278869629,
            "end_logit": 0.9021689295768738,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Fibroblast growth factor receptor 1",
            "probability": 0.0022151955169373736,
            "start_logit": 3.5668272972106934,
            "end_logit": 0.9002856612205505,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF",
            "probability": 0.0007129672258444153,
            "start_logit": 5.746659278869629,
            "end_logit": -2.4132068157196045,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Fibroblast",
            "probability": 0.0006649397921884335,
            "start_logit": 3.5668272972106934,
            "end_logit": -0.30311378836631775,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "cytokines. Among these factors, fibroblast growth factors",
            "probability": 0.0005748145760715661,
            "start_logit": -1.2561825513839722,
            "end_logit": 4.374247074127197,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "FGFR1-4.Fibroblast growth factor receptor 1",
            "probability": 0.00037895859831976676,
            "start_logit": 1.8011583089828491,
            "end_logit": 0.9002856612205505,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Fibroblast growth factor",
            "probability": 0.0002447958211002359,
            "start_logit": 3.5668272972106934,
            "end_logit": -1.3023858070373535,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "growth factors",
            "probability": 0.00024283921286146802,
            "start_logit": -2.117830514907837,
            "end_logit": 4.374247074127197,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "cytokines. Among these factors, fibroblast",
            "probability": 0.00016472223952916458,
            "start_logit": -1.2561825513839722,
            "end_logit": 3.124460220336914,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "cytokines. Among these factors, fibroblast growth factors (FGFs)",
            "probability": 0.00014646340649174762,
            "start_logit": -1.2561825513839722,
            "end_logit": 3.0069751739501953,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "soluble growth factors or cytokines. Among these factors, fibroblast growth factors",
            "probability": 0.000123740557204598,
            "start_logit": -2.7920429706573486,
            "end_logit": 4.374247074127197,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "FGFR1-4.Fibroblast",
            "probability": 0.00011375278149855957,
            "start_logit": 1.8011583089828491,
            "end_logit": -0.30311378836631775,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Fibroblast growth factor receptor",
            "probability": 0.0001014404455731506,
            "start_logit": 3.5668272972106934,
            "end_logit": -2.1833384037017822,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "FGFR1.Fibroblast growth factor receptor 1",
            "probability": 8.275014443964055e-05,
            "start_logit": 0.50496506690979,
            "end_logit": 0.6748777031898499,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "FGF receptor (FGFR) family, including FGFR1-4.Fibroblast growth factor receptor 1",
            "probability": 7.973352433439566e-05,
            "start_logit": 0.2424214780330658,
            "end_logit": 0.9002856612205505,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "growth factors or cytokines. Among these factors, fibroblast growth factors",
            "probability": 7.875084400153025e-05,
            "start_logit": -3.243941068649292,
            "end_logit": 4.374247074127197,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "growth factors (FGFs)",
            "probability": 6.187570709939168e-05,
            "start_logit": -2.117830514907837,
            "end_logit": 3.0069751739501953,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        }
    ],
    "534bb147aeec6fbd07000014": [
        {
            "text": "negative inotropic and chronotropic action was produced, and the resistance to ischemic injury",
            "probability": 0.10945105659412054,
            "start_logit": 4.925517559051514,
            "end_logit": 3.9430229663848877,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative inotropic",
            "probability": 0.07239290510625014,
            "start_logit": 4.925517559051514,
            "end_logit": 3.529653787612915,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative inotropic and chronotropic",
            "probability": 0.06844250857855315,
            "start_logit": 4.925517559051514,
            "end_logit": 3.4735395908355713,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative inotropic and chronotropic action was produced, and the resistance to ischemic injury was increased",
            "probability": 0.06189510307522472,
            "start_logit": 4.925517559051514,
            "end_logit": 3.3729865550994873,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative chronotropy, negative inotropy, hyperglycemia",
            "probability": 0.0611175124332536,
            "start_logit": 4.127111434936523,
            "end_logit": 4.158750057220459,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative inotropic and chronotropic action",
            "probability": 0.055422164382052316,
            "start_logit": 4.925517559051514,
            "end_logit": 3.2625250816345215,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative chronotropy",
            "probability": 0.04946142801880228,
            "start_logit": 4.127111434936523,
            "end_logit": 3.9471447467803955,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "hypothermia, negative chronotropy, negative inotropy, hyperglycemia",
            "probability": 0.04807622181591405,
            "start_logit": 3.8871006965637207,
            "end_logit": 4.158750057220459,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative inotropy, hyperglycemia",
            "probability": 0.045451544674395515,
            "start_logit": 3.8309597969055176,
            "end_logit": 4.158750057220459,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "hyperglycemia",
            "probability": 0.04389478382932426,
            "start_logit": 3.7961084842681885,
            "end_logit": 4.158750057220459,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "hypothermia",
            "probability": 0.043782498628907,
            "start_logit": 3.8871006965637207,
            "end_logit": 4.065196514129639,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative chronotropy, negative inotropy",
            "probability": 0.04110619577060643,
            "start_logit": 4.127111434936523,
            "end_logit": 3.762110471725464,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "metabolic depression",
            "probability": 0.041021694793409266,
            "start_logit": 3.6668906211853027,
            "end_logit": 4.220273494720459,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "reduction of the respiratory quotient, ketonuria",
            "probability": 0.03962069410436789,
            "start_logit": 3.929309844970703,
            "end_logit": 3.923104763031006,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "hypothermia, negative chronotropy",
            "probability": 0.038907319524182665,
            "start_logit": 3.8871006965637207,
            "end_logit": 3.9471447467803955,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "metabolic depression, hypothermia, negative chronotropy, negative inotropy, hyperglycemia",
            "probability": 0.03857396745024933,
            "start_logit": 3.6668906211853027,
            "end_logit": 4.158750057220459,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative inotropy, hyperglycemia, reduction of the respiratory quotient, ketonuria",
            "probability": 0.03590948662906134,
            "start_logit": 3.8309597969055176,
            "end_logit": 3.923104763031006,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "negative inotropic effect as shown by reduced cardiac output",
            "probability": 0.03566446609986568,
            "start_logit": 3.8137598037719727,
            "end_logit": 3.933458089828491,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "metabolic depression, hypothermia",
            "probability": 0.03512889767978817,
            "start_logit": 3.6668906211853027,
            "end_logit": 4.065196514129639,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "hyperglycemia, reduction of the respiratory quotient, ketonuria",
            "probability": 0.034679550811671525,
            "start_logit": 3.7961084842681885,
            "end_logit": 3.923104763031006,
            "question_text": "Which are the cardiac effects of thyronamines?"
        }
    ],
    "55086ea1098a1b487b000001": [
        {
            "text": "non-small cell lung cancer",
            "probability": 0.5985907846181336,
            "start_logit": 4.517712116241455,
            "end_logit": 3.598511219024658,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non-small cell lung",
            "probability": 0.39236564651159866,
            "start_logit": 4.517712116241455,
            "end_logit": 3.1761271953582764,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "lung cancer",
            "probability": 0.002139687766831432,
            "start_logit": -1.116206169128418,
            "end_logit": 3.598511219024658,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "lung",
            "probability": 0.0014025273952410604,
            "start_logit": -1.116206169128418,
            "end_logit": 3.1761271953582764,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non-small cell lung cancer (NSCLC)",
            "probability": 0.0011912143290269146,
            "start_logit": 4.076998233795166,
            "end_logit": -2.180379867553711,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "advanced non-small cell lung cancer",
            "probability": 0.0008725455693691055,
            "start_logit": -2.0132064819335938,
            "end_logit": 3.598511219024658,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "advanced non-small cell lung",
            "probability": 0.0005719381507931899,
            "start_logit": -2.0132064819335938,
            "end_logit": 3.1761271953582764,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer",
            "probability": 0.0004956080531648448,
            "start_logit": -2.578835964202881,
            "end_logit": 3.598511219024658,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non",
            "probability": 0.0004612539176969134,
            "start_logit": 4.517712116241455,
            "end_logit": -3.569873571395874,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "cancer",
            "probability": 0.0004157760289200008,
            "start_logit": -2.754474639892578,
            "end_logit": 3.598511219024658,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung",
            "probability": 0.0003248622918918357,
            "start_logit": -2.578835964202881,
            "end_logit": 3.1761271953582764,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "small cell lung cancer",
            "probability": 0.00028444271875439924,
            "start_logit": -3.134089469909668,
            "end_logit": 3.598511219024658,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "small cell lung",
            "probability": 0.00018644715907343038,
            "start_logit": -3.134089469909668,
            "end_logit": 3.1761271953582764,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non-small cell lung cancer (NSCLC).",
            "probability": 0.00015931454803273234,
            "start_logit": 4.076998233795166,
            "end_logit": -4.192227840423584,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non-small cell lung cancer.",
            "probability": 0.00015732773869872344,
            "start_logit": 4.517712116241455,
            "end_logit": -4.645491123199463,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non-small cell",
            "probability": 0.00014737686335404158,
            "start_logit": 4.517712116241455,
            "end_logit": -4.710829257965088,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer",
            "probability": 0.00013591845903495163,
            "start_logit": -3.8725662231445312,
            "end_logit": 3.598511219024658,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "paclitaxel in patients with EGFR-expressing advanced non-small cell lung",
            "probability": 8.90921401105938e-05,
            "start_logit": -3.8725662231445312,
            "end_logit": 3.1761271953582764,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "lung cancer (NSCLC)",
            "probability": 6.702391446551334e-06,
            "start_logit": -1.1032658815383911,
            "end_logit": -2.180379867553711,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "advanced non-small cell lung cancer (NSCLC)",
            "probability": 1.533348826771473e-06,
            "start_logit": -2.5782761573791504,
            "end_logit": -2.180379867553711,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        }
    ],
    "5171651e8ed59a060a000009": [
        {
            "text": "Human kallikrein-related peptidase 3",
            "probability": 0.49765441463637233,
            "start_logit": 4.986766338348389,
            "end_logit": 4.72302770614624,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase 3 (hK3",
            "probability": 0.21622425730620734,
            "start_logit": 4.986766338348389,
            "end_logit": 3.8894379138946533,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "human kallikrein-related peptidase 3",
            "probability": 0.10804170574917163,
            "start_logit": 4.053018093109131,
            "end_logit": 4.129387378692627,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "kallikrein-related peptidase 3",
            "probability": 0.062473950494099734,
            "start_logit": 2.9116101264953613,
            "end_logit": 4.72302770614624,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3",
            "probability": 0.04615034507304746,
            "start_logit": 3.442354679107666,
            "end_logit": 3.8894379138946533,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "kallikrein-related peptidase 3 (hK3",
            "probability": 0.027144104722635343,
            "start_logit": 2.9116101264953613,
            "end_logit": 3.8894379138946533,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase 3 (hK3),",
            "probability": 0.011941625830930114,
            "start_logit": 4.986766338348389,
            "end_logit": 0.9931520819664001,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase 3 (hK3)",
            "probability": 0.01026461186428289,
            "start_logit": 4.986766338348389,
            "end_logit": 0.8418240547180176,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase 3 (hK3), also known as prostate-specific antigen",
            "probability": 0.0031544741115251142,
            "start_logit": 4.986766338348389,
            "end_logit": -0.33805638551712036,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3),",
            "probability": 0.00254878966724896,
            "start_logit": 3.442354679107666,
            "end_logit": 0.9931520819664001,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3)",
            "probability": 0.002190852152664339,
            "start_logit": 3.442354679107666,
            "end_logit": 0.8418240547180176,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "(hK3",
            "probability": 0.002158506350859318,
            "start_logit": 0.37986671924591064,
            "end_logit": 3.8894379138946533,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein",
            "probability": 0.002138715116933489,
            "start_logit": 4.986766338348389,
            "end_logit": -0.7266729474067688,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "kallikrein-related peptidase 3 (hK3),",
            "probability": 0.0014991136801744435,
            "start_logit": 2.9116101264953613,
            "end_logit": 0.9931520819664001,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase",
            "probability": 0.0014005756536865706,
            "start_logit": 4.986766338348389,
            "end_logit": -1.1499948501586914,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "kallikrein-related peptidase 3 (hK3)",
            "probability": 0.0012885866870465197,
            "start_logit": 2.9116101264953613,
            "end_logit": 0.8418240547180176,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "3, prostate-specific antigen, in the brain.Human kallikrein-related peptidase 3",
            "probability": 0.0012185336314757625,
            "start_logit": -1.0254913568496704,
            "end_logit": 4.72302770614624,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "3",
            "probability": 0.0011544873583200258,
            "start_logit": -1.079483151435852,
            "end_logit": 4.72302770614624,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "human kallikrein",
            "probability": 0.0006790671346674733,
            "start_logit": 4.053018093109131,
            "end_logit": -0.9401652216911316,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3), also known as prostate-specific antigen",
            "probability": 0.0006732827786510313,
            "start_logit": 3.442354679107666,
            "end_logit": -0.33805638551712036,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        }
    ],
    "55414c65472cfd8617000001": [
        {
            "text": "askHERMES",
            "probability": 0.1913979257059095,
            "start_logit": 5.121309757232666,
            "end_logit": 4.723466396331787,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "askHERMES (http://www.askhermes.org/), EAGLi",
            "probability": 0.14601147013359214,
            "start_logit": 5.121309757232666,
            "end_logit": 4.452796936035156,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "EAGLi",
            "probability": 0.12012775321962332,
            "start_logit": 4.926180362701416,
            "end_logit": 4.452796936035156,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "EAGLi (http://eagl.unige.ch/EAGLi/), and HONQA",
            "probability": 0.11710374572256917,
            "start_logit": 4.926180362701416,
            "end_logit": 4.427301406860352,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "HONQA",
            "probability": 0.09167853745083596,
            "start_logit": 4.681408405303955,
            "end_logit": 4.427301406860352,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "askhermes.org/), EAGLi",
            "probability": 0.06941287818446606,
            "start_logit": 4.377696990966797,
            "end_logit": 4.452796936035156,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "askHERMES (http://www.askhermes",
            "probability": 0.06625773294555529,
            "start_logit": 5.121309757232666,
            "end_logit": 3.6626639366149902,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "EAGLi (http://eagl.unige.ch/EAGLi",
            "probability": 0.043757857241899296,
            "start_logit": 4.926180362701416,
            "end_logit": 3.4429123401641846,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "EAGLi/), and HONQA",
            "probability": 0.034407725871368935,
            "start_logit": 3.7014012336730957,
            "end_logit": 4.427301406860352,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "askhermes",
            "probability": 0.03149848393089092,
            "start_logit": 4.377696990966797,
            "end_logit": 3.6626639366149902,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "askhermes.org/), EAGLi (http://eagl.unige.ch/EAGLi",
            "probability": 0.025284405417890128,
            "start_logit": 4.377696990966797,
            "end_logit": 3.4429123401641846,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "INDOC",
            "probability": 0.02508302342917269,
            "start_logit": 3.9696149826049805,
            "end_logit": 3.8429977893829346,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "INDOC: a biomedical question answering systemIn this paper we introduce INDOC",
            "probability": 0.022054775414405814,
            "start_logit": 3.9696149826049805,
            "end_logit": 3.7143356800079346,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "INDOC: a biomedical question answering system.In this paper we introduce INDOC",
            "probability": 0.005986496571832818,
            "start_logit": 3.407622814178467,
            "end_logit": 2.9723050594329834,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "EAGLi (http://eagl.unige.ch/EAGLi/)",
            "probability": 0.0033026191755931075,
            "start_logit": 4.926180362701416,
            "end_logit": 0.8589569926261902,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "askhermes.org/), EAGLi (http://eagl.unige.ch/EAGLi/)",
            "probability": 0.0019083375521559177,
            "start_logit": 4.377696990966797,
            "end_logit": 0.8589569926261902,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "askHERMES (http://www.askhermes.org/), EAGLi (",
            "probability": 0.0013717224180305075,
            "start_logit": 5.121309757232666,
            "end_logit": -0.21482105553150177,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "askHERMES (http://www.askhermes.org/)",
            "probability": 0.0012555707855938234,
            "start_logit": 5.121309757232666,
            "end_logit": -0.3032979667186737,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "EAGLi (",
            "probability": 0.0011285547085323347,
            "start_logit": 4.926180362701416,
            "end_logit": -0.21482105553150177,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "EAGLi/)",
            "probability": 0.000970384120082278,
            "start_logit": 3.7014012336730957,
            "end_logit": 0.8589569926261902,
            "question_text": "List available biomedical question answering systems."
        }
    ],
    "517a8c238ed59a060a000042": [
        {
            "text": "iodothyronine",
            "probability": 0.3832911501023988,
            "start_logit": 2.4262752532958984,
            "end_logit": 0.7395641207695007,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine deiodinase activity in both liver and kidney.Co-expression of the deiodinases",
            "probability": 0.10443730826810453,
            "start_logit": 2.4262752532958984,
            "end_logit": -0.5606437921524048,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine deiodinase",
            "probability": 0.0939501635741135,
            "start_logit": 2.4262752532958984,
            "end_logit": -0.6664662957191467,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinases",
            "probability": 0.0873441658855839,
            "start_logit": 2.247544527053833,
            "end_logit": -0.5606437921524048,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase in vitro activity studies in the chicken showed the presence of type I and type III iodothyronine",
            "probability": 0.07455681019260095,
            "start_logit": 0.7890417575836182,
            "end_logit": 0.7395641207695007,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine deiodinase activity in both liver and kidney.Co-expression of the dei",
            "probability": 0.045285993935964365,
            "start_logit": 2.4262752532958984,
            "end_logit": -1.3962329626083374,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "dei",
            "probability": 0.03787408381382451,
            "start_logit": 2.247544527053833,
            "end_logit": -1.3962329626083374,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase activity in both liver and kidney.Co-expression of the deiodinases",
            "probability": 0.02231617990903252,
            "start_logit": 0.8830002546310425,
            "end_logit": -0.5606437921524048,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase",
            "probability": 0.02007528523638962,
            "start_logit": 0.8830002546310425,
            "end_logit": -0.6664662957191467,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine dei",
            "probability": 0.019050241140173944,
            "start_logit": 2.4262752532958984,
            "end_logit": -2.262151002883911,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "type III iodothyronine",
            "probability": 0.015226890461759698,
            "start_logit": -0.7994566559791565,
            "end_logit": 0.7395641207695007,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "Iodothyronine deiodinase",
            "probability": 0.01367571060014787,
            "start_logit": 0.6137570738792419,
            "end_logit": -0.7810912728309631,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase in vitro activity studies in the chicken showed the presence of type I and type III",
            "probability": 0.013065211224493715,
            "start_logit": 0.7890417575836182,
            "end_logit": -1.0020442008972168,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "type I and type III iodothyronine",
            "probability": 0.011155462535327494,
            "start_logit": -1.1105903387069702,
            "end_logit": 0.7395641207695007,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine deiodinase activity in both liver and kidney.",
            "probability": 0.01114706048041849,
            "start_logit": 2.4262752532958984,
            "end_logit": -2.7980549335479736,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "Iodothyronine deiodinase in vitro activity studies in the chicken showed the presence of type I and type III",
            "probability": 0.010964561413921154,
            "start_logit": 0.6137570738792419,
            "end_logit": -1.0020442008972168,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase activity in both liver and kidney.Co-expression of the dei",
            "probability": 0.009676718069370044,
            "start_logit": 0.8830002546310425,
            "end_logit": -1.3962329626083374,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "Iodothyronine",
            "probability": 0.009462356077952512,
            "start_logit": 0.6137570738792419,
            "end_logit": -1.1493911743164062,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine deiodinase activity in both liver and kidney.Co-expression",
            "probability": 0.008735067098241879,
            "start_logit": 2.4262752532958984,
            "end_logit": -3.0418851375579834,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine deiodinase activity in both liver and kidney.Co-expression of the deiodinas",
            "probability": 0.008709579980180588,
            "start_logit": 2.4262752532958984,
            "end_logit": -3.044807195663452,
            "question_text": "Which dediodinases are present in kidney?"
        }
    ],
    "530e1c985937551c09000004": [
        {
            "text": "osteodystrophy",
            "probability": 0.10860258225514154,
            "start_logit": 4.359799861907959,
            "end_logit": 4.052811145782471,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "osteodystrophy, mental retardation, and seizures",
            "probability": 0.10680430716328815,
            "start_logit": 4.359799861907959,
            "end_logit": 4.03611421585083,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy",
            "probability": 0.08327690621043335,
            "start_logit": 4.0687174797058105,
            "end_logit": 4.078369617462158,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy",
            "probability": 0.08117544522156048,
            "start_logit": 4.0687174797058105,
            "end_logit": 4.052811145782471,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy, mental retardation, and seizures",
            "probability": 0.07983131713380377,
            "start_logit": 4.0687174797058105,
            "end_logit": 4.03611421585083,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "osteodystrophy, mental retardation",
            "probability": 0.07192598086825769,
            "start_logit": 4.359799861907959,
            "end_logit": 3.6407535076141357,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "mental retardation, and seizures",
            "probability": 0.06767015940164842,
            "start_logit": 3.903446912765503,
            "end_logit": 4.03611421585083,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy, mental retardation",
            "probability": 0.053761369193427645,
            "start_logit": 4.0687174797058105,
            "end_logit": 3.6407535076141357,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "seizures",
            "probability": 0.052441980157491595,
            "start_logit": 3.6485090255737305,
            "end_logit": 4.03611421585083,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "mental retardation",
            "probability": 0.04557159462711192,
            "start_logit": 3.903446912765503,
            "end_logit": 3.6407535076141357,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness, onychodystrophy",
            "probability": 0.03373804502703915,
            "start_logit": 3.1651723384857178,
            "end_logit": 4.078369617462158,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "osteodystrophy, intellectual disability, and seizures",
            "probability": 0.03328412711034062,
            "start_logit": 3.847825527191162,
            "end_logit": 3.3821709156036377,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness, onychodystrophy, osteodystrophy",
            "probability": 0.03288667831937108,
            "start_logit": 3.1651723384857178,
            "end_logit": 4.052811145782471,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures",
            "probability": 0.03234213054483858,
            "start_logit": 3.1651723384857178,
            "end_logit": 4.03611421585083,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "osteodystrophy, intellectual disability",
            "probability": 0.023464114199386182,
            "start_logit": 3.847825527191162,
            "end_logit": 3.032562494277954,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy, intellectual disability, and seizures",
            "probability": 0.02230945697089322,
            "start_logit": 3.4477555751800537,
            "end_logit": 3.3821709156036377,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness, onychodystrophy, osteodystrophy, mental retardation",
            "probability": 0.021780389991672085,
            "start_logit": 3.1651723384857178,
            "end_logit": 3.6407535076141357,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness",
            "probability": 0.021041457166596132,
            "start_logit": 3.1651723384857178,
            "end_logit": 3.6062381267547607,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy, intellectual disability",
            "probability": 0.015727365910963003,
            "start_logit": 3.4477555751800537,
            "end_logit": 3.032562494277954,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "deafness, onychodystrophy, osteodystrophy",
            "probability": 0.012364592526735302,
            "start_logit": 2.5567715167999268,
            "end_logit": 3.682981252670288,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        }
    ],
    "516c0ebc298dcd4e5100006e": [
        {
            "text": "GH gene in GH3-PV and ME",
            "probability": 0.22028353175881796,
            "start_logit": 4.160795211791992,
            "end_logit": 3.4936935901641846,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "ME",
            "probability": 0.1998773915633986,
            "start_logit": 4.063583850860596,
            "end_logit": 3.4936935901641846,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "GH",
            "probability": 0.15685601547968434,
            "start_logit": 4.160795211791992,
            "end_logit": 3.154106378555298,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "GH gene",
            "probability": 0.09593130906785052,
            "start_logit": 4.160795211791992,
            "end_logit": 2.6624104976654053,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "GH gene in GH3",
            "probability": 0.06199722682437028,
            "start_logit": 4.160795211791992,
            "end_logit": 2.225867748260498,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "GH3-PV and ME",
            "probability": 0.06172424268171534,
            "start_logit": 2.888556480407715,
            "end_logit": 3.4936935901641846,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "LDLr",
            "probability": 0.039219548275283754,
            "start_logit": 3.4100654125213623,
            "end_logit": 2.5186831951141357,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "GH gene in GH3-PV and ME gene",
            "probability": 0.028952430241963083,
            "start_logit": 4.160795211791992,
            "end_logit": 1.4644322395324707,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "ME gene",
            "probability": 0.02627039883544625,
            "start_logit": 4.063583850860596,
            "end_logit": 1.4644322395324707,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "ChREBP gene expression reciprocally.In contrast treatment with L-T3 produced an increase in S14 and ME",
            "probability": 0.021830324389133914,
            "start_logit": 2.9149701595306396,
            "end_logit": 2.427903175354004,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "ChREBP",
            "probability": 0.017863878388569437,
            "start_logit": 2.9149701595306396,
            "end_logit": 2.227383852005005,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "GH3",
            "probability": 0.017371847289476734,
            "start_logit": 2.888556480407715,
            "end_logit": 2.225867748260498,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "SREBP-1c and ChREBP",
            "probability": 0.013565729501693657,
            "start_logit": 2.6397361755371094,
            "end_logit": 2.227383852005005,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "LDLr gene",
            "probability": 0.009341154680314781,
            "start_logit": 3.4100654125213623,
            "end_logit": 1.0839377641677856,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "GH3-PV and ME gene",
            "probability": 0.008112575716449704,
            "start_logit": 2.888556480407715,
            "end_logit": 1.4644322395324707,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "SREBP-1c",
            "probability": 0.005487912484520619,
            "start_logit": 2.6397361755371094,
            "end_logit": 1.3223850727081299,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "GH gene in GH3-PV",
            "probability": 0.005462200379800522,
            "start_logit": 4.160795211791992,
            "end_logit": -0.20337019860744476,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "ChREBP mRNA",
            "probability": 0.003630853440228167,
            "start_logit": 2.4518227577209473,
            "end_logit": 1.0972182750701904,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "GH gene in GH",
            "probability": 0.0031366014560827884,
            "start_logit": 4.160795211791992,
            "end_logit": -0.7580820322036743,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "S14 and ME",
            "probability": 0.0030848275451995965,
            "start_logit": 0.9581658840179443,
            "end_logit": 2.427903175354004,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        }
    ],
    "5713b0a51174fb175500000e": [
        {
            "text": "Arts syndrome",
            "probability": 0.3285190922068411,
            "start_logit": 3.207801342010498,
            "end_logit": 2.8740198612213135,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Arts syndrome, and non-syndromic sensorineural deafness",
            "probability": 0.13751853357399096,
            "start_logit": 3.207801342010498,
            "end_logit": 2.003183603286743,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "non-syndromic sensorineural deafness",
            "probability": 0.08434525844112237,
            "start_logit": 2.718961238861084,
            "end_logit": 2.003183603286743,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease type 5 (CMTX5), Arts syndrome",
            "probability": 0.07302812430007025,
            "start_logit": 1.7040510177612305,
            "end_logit": 2.8740198612213135,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness",
            "probability": 0.05827606497816038,
            "start_logit": 2.349234104156494,
            "end_logit": 2.003183603286743,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Arts syndrome, and non-syndromic sensorineural deafness (DFN2)",
            "probability": 0.0528592501238997,
            "start_logit": 3.207801342010498,
            "end_logit": 1.0470576286315918,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness type 2 (DFN2), or in syndromic deafness including Arts syndrome",
            "probability": 0.04815764220807357,
            "start_logit": 1.7775994539260864,
            "end_logit": 2.3841066360473633,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "non-syndromic sensorineural deafness (DFN2)",
            "probability": 0.03242055450151685,
            "start_logit": 2.718961238861084,
            "end_logit": 1.0470576286315918,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "syndromic hearing loss",
            "probability": 0.022883854186400928,
            "start_logit": 1.7541019916534424,
            "end_logit": 1.6635558605194092,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness (DFN2)",
            "probability": 0.022400101388950645,
            "start_logit": 2.349234104156494,
            "end_logit": 1.0470576286315918,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "syndromic deafness including Arts syndrome",
            "probability": 0.02082718546419669,
            "start_logit": 0.9393787384033203,
            "end_logit": 2.3841066360473633,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "non-syndromic to syndromic hearing loss",
            "probability": 0.020310541979075416,
            "start_logit": 1.634810447692871,
            "end_logit": 1.6635558605194092,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease type 5",
            "probability": 0.01954363709477713,
            "start_logit": 1.7040510177612305,
            "end_logit": 1.5558249950408936,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness type 2 (DFN2)",
            "probability": 0.013305398895130025,
            "start_logit": 1.7775994539260864,
            "end_logit": 1.0977966785430908,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "deafness including Arts syndrome",
            "probability": 0.012283093613494882,
            "start_logit": 0.41134342551231384,
            "end_logit": 2.3841066360473633,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Arts syndrome and X-linked Charcot-Marie-Tooth disease",
            "probability": 0.012029122299072626,
            "start_logit": 2.9527106285095215,
            "end_logit": -0.17815381288528442,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease",
            "probability": 0.011539003477977193,
            "start_logit": 1.7040510177612305,
            "end_logit": 1.028908133506775,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness type 2",
            "probability": 0.01145962274761478,
            "start_logit": 1.7775994539260864,
            "end_logit": 0.9484565854072571,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness type 2 (DFN2), or in syndromic deafness",
            "probability": 0.010269989782601172,
            "start_logit": 1.7775994539260864,
            "end_logit": 0.8388528227806091,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "hearing loss",
            "probability": 0.008023928737033524,
            "start_logit": 0.7060985565185547,
            "end_logit": 1.6635558605194092,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        }
    ],
    "56c8605b5795f9a73e000014": [
        {
            "text": "JAK1 and JAK2",
            "probability": 0.30361769948846656,
            "start_logit": 4.568570613861084,
            "end_logit": 3.9385454654693604,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK2",
            "probability": 0.2871137002847441,
            "start_logit": 4.512679576873779,
            "end_logit": 3.9385454654693604,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK1",
            "probability": 0.21517874879352347,
            "start_logit": 4.568570613861084,
            "end_logit": 3.594245195388794,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1 and JAK2",
            "probability": 0.05878826358318886,
            "start_logit": 2.926743507385254,
            "end_logit": 3.9385454654693604,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1",
            "probability": 0.0416641882962919,
            "start_logit": 2.926743507385254,
            "end_logit": 3.594245195388794,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK",
            "probability": 0.03312023069259133,
            "start_logit": 4.568570613861084,
            "end_logit": 1.7229204177856445,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAKs) with selectivity for JAK1 and JAK2",
            "probability": 0.012763087805172456,
            "start_logit": 1.3993585109710693,
            "end_logit": 3.9385454654693604,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK1 and JAK",
            "probability": 0.011376766662371442,
            "start_logit": 4.568570613861084,
            "end_logit": 0.6543493866920471,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAKs) with selectivity for JAK1",
            "probability": 0.00904540568381196,
            "start_logit": 1.3993585109710693,
            "end_logit": 3.594245195388794,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK",
            "probability": 0.006412935922946891,
            "start_logit": 2.926743507385254,
            "end_logit": 1.7229204177856445,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK1 and JAK2,",
            "probability": 0.005419565645815386,
            "start_logit": 4.568570613861084,
            "end_logit": -0.08720820397138596,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK2,",
            "probability": 0.005124969819373929,
            "start_logit": 4.512679576873779,
            "end_logit": -0.08720820397138596,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK1/2",
            "probability": 0.003248563417035659,
            "start_logit": 3.1606132984161377,
            "end_logit": 0.8089463114738464,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1 and JAK",
            "probability": 0.002202837181095677,
            "start_logit": 2.926743507385254,
            "end_logit": 0.6543493866920471,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAKs) with selectivity for JAK",
            "probability": 0.0013922653823189534,
            "start_logit": 1.3993585109710693,
            "end_logit": 1.7229204177856445,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1 and JAK2,",
            "probability": 0.0010493685125385547,
            "start_logit": 2.926743507385254,
            "end_logit": -0.08720820397138596,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs)",
            "probability": 0.0008356626542634872,
            "start_logit": 2.926743507385254,
            "end_logit": -0.31492704153060913,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs",
            "probability": 0.0006851491265442855,
            "start_logit": 2.926743507385254,
            "end_logit": -0.5135155320167542,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus",
            "probability": 0.000482349258656842,
            "start_logit": 2.926743507385254,
            "end_logit": -0.8644835948944092,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAKs) with selectivity for JAK1 and JAK",
            "probability": 0.0004782417892482624,
            "start_logit": 1.3993585109710693,
            "end_logit": 0.6543493866920471,
            "question_text": "Which kinases does baricitinib inhibit?"
        }
    ],
    "550b0408c2af5d5b7000000c": [
        {
            "text": "Aptamers",
            "probability": 0.7758565168111737,
            "start_logit": 4.412652492523193,
            "end_logit": 4.007724285125732,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "enzymes coated to magnetic beads Aptamers",
            "probability": 0.0935226766425175,
            "start_logit": 2.296888828277588,
            "end_logit": 4.007724285125732,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "aptamer-based magnetic separation system enzymes coated to magnetic beads Aptamers",
            "probability": 0.054770266577439664,
            "start_logit": 1.761832356452942,
            "end_logit": 4.007724285125732,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "enzymes",
            "probability": 0.019527512931179773,
            "start_logit": 2.296888828277588,
            "end_logit": 2.441344738006592,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "aptamer-based magnetic separation system enzymes",
            "probability": 0.011436018805613244,
            "start_logit": 1.761832356452942,
            "end_logit": 2.441344738006592,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "Aptamers are short, single-stranded (ss) oligonucleotidesable to recognize target molecules with high affinity",
            "probability": 0.009784085257517472,
            "start_logit": 4.412652492523193,
            "end_logit": -0.365486204624176,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "Aptamers are short, single-stranded (ss) oligonucleotide",
            "probability": 0.00704072215483957,
            "start_logit": 4.412652492523193,
            "end_logit": -0.694532573223114,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "magnetic beads Aptamers",
            "probability": 0.003887100918314268,
            "start_logit": -0.8836514949798584,
            "end_logit": 4.007724285125732,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "aptamer",
            "probability": 0.0037531606359749114,
            "start_logit": 1.761832356452942,
            "end_logit": 1.3271751403808594,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "magnetic separation system enzymes coated to magnetic beads Aptamers",
            "probability": 0.0032909645205491463,
            "start_logit": -1.0501344203948975,
            "end_logit": 4.007724285125732,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "coated to magnetic beads Aptamers",
            "probability": 0.002988837446564268,
            "start_logit": -1.1464306116104126,
            "end_logit": 4.007724285125732,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ptamers",
            "probability": 0.002637382596768598,
            "start_logit": -1.2715281248092651,
            "end_logit": 4.007724285125732,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "Aptamers are short, single-stranded (ss) oligonucleotidesable to recognize target molecules with high affinity.",
            "probability": 0.00217873034484641,
            "start_logit": 4.412652492523193,
            "end_logit": -1.8675010204315186,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "Aptamers are short",
            "probability": 0.002001060498551774,
            "start_logit": 4.412652492523193,
            "end_logit": -1.9525660276412964,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "enzymes coated",
            "probability": 0.0018146517882777304,
            "start_logit": 2.296888828277588,
            "end_logit": 0.0654139444231987,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "separation system enzymes coated to magnetic beads Aptamers",
            "probability": 0.0014926205023937653,
            "start_logit": -1.840781807899475,
            "end_logit": 4.007724285125732,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ptamer-based magnetic separation system enzymes coated to magnetic beads Aptamers",
            "probability": 0.00120291402081629,
            "start_logit": -2.056568145751953,
            "end_logit": 4.007724285125732,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "aptamer-based magnetic separation system enzymes coated",
            "probability": 0.001062725808940486,
            "start_logit": 1.761832356452942,
            "end_logit": 0.0654139444231987,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "Aptamers are short, single-stranded (ss) oligonucleotidesable to recognize target molecules",
            "probability": 0.0008861012893520486,
            "start_logit": 4.412652492523193,
            "end_logit": -2.767167329788208,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "Aptamers are short, single-stranded (ss) oligonucleotidesable",
            "probability": 0.0008659504483695412,
            "start_logit": 4.412652492523193,
            "end_logit": -2.790170907974243,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        }
    ],
    "51477de5d24251bc05000020": [
        {
            "text": "pancreatic islets and anterior pituitary glands",
            "probability": 0.15011031097091043,
            "start_logit": 4.589707851409912,
            "end_logit": 4.05526876449585,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid, pancreatic islets and anterior pituitary glands",
            "probability": 0.1346136532909807,
            "start_logit": 4.480746269226074,
            "end_logit": 4.05526876449585,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pituitary glands",
            "probability": 0.13170435722579663,
            "start_logit": 4.458897113800049,
            "end_logit": 4.05526876449585,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid",
            "probability": 0.10950422731596068,
            "start_logit": 4.480746269226074,
            "end_logit": 3.848823070526123,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pancreatic islets",
            "probability": 0.10215948668210291,
            "start_logit": 4.589707851409912,
            "end_logit": 3.670433521270752,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid, pancreatic islets",
            "probability": 0.09161303864911817,
            "start_logit": 4.480746269226074,
            "end_logit": 3.670433521270752,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 0.03698855674191053,
            "start_logit": 3.8340487480163574,
            "end_logit": 3.410166025161743,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pituitary glands and the endocrine pancreas",
            "probability": 0.03553054883126144,
            "start_logit": 3.793833017349243,
            "end_logit": 3.410166025161743,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid and pituitary glands",
            "probability": 0.03130384253040332,
            "start_logit": 3.8340487480163574,
            "end_logit": 3.243298292160034,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "anterior pituitary glands",
            "probability": 0.030491532049140582,
            "start_logit": 2.995786428451538,
            "end_logit": 4.05526876449585,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pancreas",
            "probability": 0.029063497458572805,
            "start_logit": 3.592923164367676,
            "end_logit": 3.410166025161743,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pancreatic islets and anterior pituitary",
            "probability": 0.027379881790786164,
            "start_logit": 4.589707851409912,
            "end_logit": 2.3537068367004395,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid, pancreatic islets and anterior pituitary",
            "probability": 0.024553316095968718,
            "start_logit": 4.480746269226074,
            "end_logit": 2.3537068367004395,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pituitary",
            "probability": 0.024022665124400374,
            "start_logit": 4.458897113800049,
            "end_logit": 2.3537068367004395,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "endocrine pancreas",
            "probability": 0.013287217627296854,
            "start_logit": 2.8102426528930664,
            "end_logit": 3.410166025161743,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid and pituitary",
            "probability": 0.010098929599009408,
            "start_logit": 3.8340487480163574,
            "end_logit": 2.1119868755340576,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "anterior pituitary",
            "probability": 0.0055616069124473505,
            "start_logit": 2.995786428451538,
            "end_logit": 2.3537068367004395,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pancreatic islets and anterior pituitary glands;",
            "probability": 0.004330456827156962,
            "start_logit": 4.589707851409912,
            "end_logit": 0.509571373462677,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid, pancreatic islets and anterior pituitary glands;",
            "probability": 0.003883401547515507,
            "start_logit": 4.480746269226074,
            "end_logit": 0.509571373462677,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pituitary glands;",
            "probability": 0.0037994727292603864,
            "start_logit": 4.458897113800049,
            "end_logit": 0.509571373462677,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        }
    ],
    "5524562387ecba3764000001": [
        {
            "text": "Sonic Hh, Indian Hh, and Desert Hh",
            "probability": 0.219968379803564,
            "start_logit": 5.6375651359558105,
            "end_logit": 5.08103609085083,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Desert Hh",
            "probability": 0.18479119822384912,
            "start_logit": 5.463307857513428,
            "end_logit": 5.08103609085083,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Indian Hh, and Desert Hh",
            "probability": 0.14355050072377443,
            "start_logit": 5.210768222808838,
            "end_logit": 5.08103609085083,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh, Indian Hh",
            "probability": 0.12921609103301754,
            "start_logit": 5.6375651359558105,
            "end_logit": 4.549038410186768,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh",
            "probability": 0.1002889741966602,
            "start_logit": 5.6375651359558105,
            "end_logit": 4.295608043670654,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Indian Hh",
            "probability": 0.08432591350594631,
            "start_logit": 5.210768222808838,
            "end_logit": 4.549038410186768,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh, Indian",
            "probability": 0.0361088679195373,
            "start_logit": 5.6375651359558105,
            "end_logit": 3.2740907669067383,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Indian",
            "probability": 0.023564505385033664,
            "start_logit": 5.210768222808838,
            "end_logit": 3.2740907669067383,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh, and Desert Hh",
            "probability": 0.015432447894247083,
            "start_logit": 2.98055362701416,
            "end_logit": 5.08103609085083,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic",
            "probability": 0.013915451308341452,
            "start_logit": 5.6375651359558105,
            "end_logit": 2.320552110671997,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh",
            "probability": 0.009065487474818513,
            "start_logit": 2.98055362701416,
            "end_logit": 4.549038410186768,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh, Indian Hh, and Desert Hh,",
            "probability": 0.008756498926042359,
            "start_logit": 5.6375651359558105,
            "end_logit": 1.8573484420776367,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh, Indian Hh, and Desert Hh",
            "probability": 0.007757387890362194,
            "start_logit": 2.292726993560791,
            "end_logit": 5.08103609085083,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Desert Hh,",
            "probability": 0.007356166055476842,
            "start_logit": 5.463307857513428,
            "end_logit": 1.8573484420776367,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Indian Hh, and Desert Hh,",
            "probability": 0.005714456807578882,
            "start_logit": 5.210768222808838,
            "end_logit": 1.8573484420776367,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh, Indian Hh",
            "probability": 0.00455692468487795,
            "start_logit": 2.292726993560791,
            "end_logit": 4.549038410186768,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh, Indian Hh, and Desert",
            "probability": 0.0017480547846175421,
            "start_logit": 5.6375651359558105,
            "end_logit": 0.24605590105056763,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Desert",
            "probability": 0.0014685071486132495,
            "start_logit": 5.463307857513428,
            "end_logit": 0.24605590105056763,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh, Indian",
            "probability": 0.00127341254676627,
            "start_logit": 2.292726993560791,
            "end_logit": 3.2740907669067383,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Indian Hh, and Desert",
            "probability": 0.0011407736868750263,
            "start_logit": 5.210768222808838,
            "end_logit": 0.24605590105056763,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        }
    ],
    "51486f7dd24251bc0500002e": [
        {
            "text": "9-item Patient Health Questionnaire (PHQ-9",
            "probability": 0.15519917334717429,
            "start_logit": 0.6674391031265259,
            "end_logit": 0.829008936882019,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "PHQ-9",
            "probability": 0.1267187510995583,
            "start_logit": 0.4646998941898346,
            "end_logit": 0.829008936882019,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "9-item Patient Health Questionnaire",
            "probability": 0.1106336550989868,
            "start_logit": 0.6674391031265259,
            "end_logit": 0.4905239939689636,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "2-item Patient Health Questionnaire (PHQ-2) followed by the 9-item Patient Health Questionnaire (PHQ-9",
            "probability": 0.08307264371103999,
            "start_logit": 0.04244527220726013,
            "end_logit": 0.829008936882019,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "9",
            "probability": 0.07639962319578213,
            "start_logit": 0.6674391031265259,
            "end_logit": 0.12027741968631744,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "2-item Patient Health Questionnaire (PHQ-2) followed by the 9-item Patient Health Questionnaire",
            "probability": 0.0592182935918682,
            "start_logit": 0.04244527220726013,
            "end_logit": 0.4905239939689636,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "PHQ-2) followed by the 9-item Patient Health Questionnaire (PHQ-9",
            "probability": 0.048960243019385875,
            "start_logit": -0.4862615764141083,
            "end_logit": 0.829008936882019,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "2-item Patient Health Questionnaire (PHQ-2) followed by the 9",
            "probability": 0.040894023727842684,
            "start_logit": 0.04244527220726013,
            "end_logit": 0.12027741968631744,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "9-item Patient Health Questionnaire (PHQ-9)",
            "probability": 0.04002828851842291,
            "start_logit": 0.6674391031265259,
            "end_logit": -0.5261139273643494,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "PHQ-2) followed by the 9-item Patient Health Questionnaire",
            "probability": 0.03490128538025447,
            "start_logit": -0.4862615764141083,
            "end_logit": 0.4905239939689636,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "PHQ-9)",
            "probability": 0.0326827432151377,
            "start_logit": 0.4646998941898346,
            "end_logit": -0.5261139273643494,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "(PHQ-9",
            "probability": 0.030449035675648526,
            "start_logit": -0.9612158536911011,
            "end_logit": 0.829008936882019,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "2-item Patient Health Questionnaire",
            "probability": 0.029446964493414225,
            "start_logit": 0.04244527220726013,
            "end_logit": -0.20811568200588226,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "PHQ-2) followed by the 9",
            "probability": 0.024101572434845106,
            "start_logit": -0.4862615764141083,
            "end_logit": 0.12027741968631744,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "PHQ-2 and PHQ-9",
            "probability": 0.019249943929825892,
            "start_logit": -0.36635807156562805,
            "end_logit": -0.2243950217962265,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "2-item Patient Health Questionnaire (PHQ-2",
            "probability": 0.019149441179593597,
            "start_logit": 0.04244527220726013,
            "end_logit": -0.6384329795837402,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "(PHQ-2) followed by the 9-item Patient Health Questionnaire (PHQ-9",
            "probability": 0.018507512425977653,
            "start_logit": -1.459093451499939,
            "end_logit": 0.829008936882019,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Patient Health Questionnaire (PHQ-2) followed by the 9-item Patient Health Questionnaire (PHQ-9",
            "probability": 0.018276313345335478,
            "start_logit": -1.471664309501648,
            "end_logit": 0.829008936882019,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Patient Health Questionnaire (PHQ-9",
            "probability": 0.01632958091695566,
            "start_logit": -1.584291934967041,
            "end_logit": 0.829008936882019,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "2",
            "probability": 0.015780911692950532,
            "start_logit": 0.04244527220726013,
            "end_logit": -0.8319054245948792,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        }
    ],
    "52ef7754c8da898910000014": [
        {
            "text": "DNA",
            "probability": 0.3314151340150399,
            "start_logit": 2.126660108566284,
            "end_logit": 0.8886951804161072,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "HMGs (1 + 2) and the \"primitive\" histone-like DNA",
            "probability": 0.1618462256183394,
            "start_logit": 1.4099349975585938,
            "end_logit": 0.8886951804161072,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "HMGs",
            "probability": 0.15197821313666451,
            "start_logit": 1.4099349975585938,
            "end_logit": 0.8257856965065002,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "H2A",
            "probability": 0.10800453704280731,
            "start_logit": 1.128151535987854,
            "end_logit": 0.7660052180290222,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "H2A and H2B",
            "probability": 0.06819518194538463,
            "start_logit": 1.128151535987854,
            "end_logit": 0.3062058985233307,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "H2B",
            "probability": 0.06141208949356961,
            "start_logit": 1.0233843326568604,
            "end_logit": 0.3062058985233307,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "DNA-packaging proteins",
            "probability": 0.05336699612960023,
            "start_logit": 2.126660108566284,
            "end_logit": -0.937484085559845,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "HMGs (1 + 2) and the \"primitive\" histone-like DNA-packaging proteins",
            "probability": 0.026061715382533976,
            "start_logit": 1.4099349975585938,
            "end_logit": -0.937484085559845,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "HMGs (1 + 2)",
            "probability": 0.012734587280519117,
            "start_logit": 1.4099349975585938,
            "end_logit": -1.6536297798156738,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "histone-like DNA",
            "probability": 0.005103849057509457,
            "start_logit": -2.0467166900634766,
            "end_logit": 0.8886951804161072,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "D",
            "probability": 0.0037158942848103307,
            "start_logit": 2.126660108566284,
            "end_logit": -3.6020572185516357,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "DNA-packaging",
            "probability": 0.0029806433553304914,
            "start_logit": 2.126660108566284,
            "end_logit": -3.822537422180176,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "H2A and H2",
            "probability": 0.0024806053475161837,
            "start_logit": 1.128151535987854,
            "end_logit": -3.0076653957366943,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "H2",
            "probability": 0.002233869802149584,
            "start_logit": 1.0233843326568604,
            "end_logit": -3.0076653957366943,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "HMGs (1 + 2) and the \"primitive\" histone-like D",
            "probability": 0.0018146529927810069,
            "start_logit": 1.4099349975585938,
            "end_logit": -3.6020572185516357,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "histones H2A",
            "probability": 0.001796314548621988,
            "start_logit": -2.9682846069335938,
            "end_logit": 0.7660052180290222,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "HMGs (1 + 2) and the \"primitive\" histone-like DNA-packaging",
            "probability": 0.001455593989116776,
            "start_logit": 1.4099349975585938,
            "end_logit": -3.822537422180176,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "H",
            "probability": 0.0014367137321047907,
            "start_logit": 1.128151535987854,
            "end_logit": -3.553809642791748,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "histones H2A and H2B",
            "probability": 0.0011342115880360226,
            "start_logit": -2.9682846069335938,
            "end_logit": 0.3062058985233307,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "H2A and H",
            "probability": 0.0008329712575643864,
            "start_logit": 1.128151535987854,
            "end_logit": -4.098924160003662,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        }
    ],
    "5319a724b166e2b806000025": [
        {
            "text": "dentatorubral-pallidoluysian atrophy",
            "probability": 0.10599811192252406,
            "start_logit": 3.8217875957489014,
            "end_logit": 3.2385637760162354,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "myotonic dystrophy, Huntington's disease",
            "probability": 0.09737444631507328,
            "start_logit": 3.864778757095337,
            "end_logit": 3.11071515083313,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "myotonic dystrophy",
            "probability": 0.0927656253603995,
            "start_logit": 3.864778757095337,
            "end_logit": 3.062227487564087,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "myotonic dystrophy, Huntington's disease, spinocerebellar ataxia type 1",
            "probability": 0.08614235092820346,
            "start_logit": 3.864778757095337,
            "end_logit": 2.988152503967285,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "spinocerebellar ataxia type 1",
            "probability": 0.07822038867983619,
            "start_logit": 3.76830792427063,
            "end_logit": 2.988152503967285,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy (DRPLA)",
            "probability": 0.07276897867776916,
            "start_logit": 3.8217875957489014,
            "end_logit": 2.8624322414398193,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "myotonic dystrophy, Huntington's disease, spinocerebellar ataxia type 1 (SCA1)",
            "probability": 0.06403352599458446,
            "start_logit": 3.864778757095337,
            "end_logit": 2.6915581226348877,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington's disease",
            "probability": 0.05938954826205616,
            "start_logit": 3.370333194732666,
            "end_logit": 3.11071515083313,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "spinocerebellar ataxia type 1 (SCA1)",
            "probability": 0.05814477127529737,
            "start_logit": 3.76830792427063,
            "end_logit": 2.6915581226348877,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington's disease, spinocerebellar ataxia type 1",
            "probability": 0.052538992533050055,
            "start_logit": 3.370333194732666,
            "end_logit": 2.988152503967285,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "myotonic dystrophy, Huntington's disease, spinocerebellar ataxia",
            "probability": 0.04657110017491033,
            "start_logit": 3.864778757095337,
            "end_logit": 2.373131513595581,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "spinocerebellar ataxia",
            "probability": 0.04228825331183756,
            "start_logit": 3.76830792427063,
            "end_logit": 2.373131513595581,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington's disease, spinocerebellar ataxia type 1 (SCA1)",
            "probability": 0.039054621888579825,
            "start_logit": 3.370333194732666,
            "end_logit": 2.6915581226348877,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington's disease, spinocerebellar ataxia",
            "probability": 0.02840413174217707,
            "start_logit": 3.370333194732666,
            "end_logit": 2.373131513595581,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "X-linked spinal and bulbar muscular atrophy",
            "probability": 0.018015201497433842,
            "start_logit": 2.3473284244537354,
            "end_logit": 2.9408175945281982,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "spinal and bulbar muscular atrophy",
            "probability": 0.015082562141263729,
            "start_logit": 2.169651746749878,
            "end_logit": 2.9408175945281982,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy (DRPLA",
            "probability": 0.012949042063510984,
            "start_logit": 3.8217875957489014,
            "end_logit": 1.1361643075942993,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "bulbar muscular atrophy",
            "probability": 0.012578316811126542,
            "start_logit": 1.9880869388580322,
            "end_logit": 2.9408175945281982,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "muscular atrophy",
            "probability": 0.008962377090057205,
            "start_logit": 1.6491479873657227,
            "end_logit": 2.9408175945281982,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "X-linked spinal and bulbar muscular atrophy (SBMA)",
            "probability": 0.008717653330309206,
            "start_logit": 2.3473284244537354,
            "end_logit": 2.214951753616333,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        }
    ],
    "53188992b166e2b806000019": [
        {
            "text": "BCR-ABL",
            "probability": 0.15030493173793186,
            "start_logit": 5.5328545570373535,
            "end_logit": 4.959479808807373,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "c-kit",
            "probability": 0.14400472795265953,
            "start_logit": 5.677659511566162,
            "end_logit": 4.771854877471924,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "BCR-ABL, platelet-derived growth factor receptor and c-kit",
            "probability": 0.12459159864971459,
            "start_logit": 5.5328545570373535,
            "end_logit": 4.771854877471924,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "BCR-ABL, platelet-derived growth factor receptor",
            "probability": 0.12361388463943286,
            "start_logit": 5.5328545570373535,
            "end_logit": 4.763976573944092,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor and c-kit",
            "probability": 0.10925305733915845,
            "start_logit": 5.401480197906494,
            "end_logit": 4.771854877471924,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor",
            "probability": 0.10839571024686435,
            "start_logit": 5.401480197906494,
            "end_logit": 4.763976573944092,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "c-kit kinases",
            "probability": 0.06742218377389544,
            "start_logit": 5.677659511566162,
            "end_logit": 4.0129828453063965,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "BCR-ABL, platelet-derived growth factor receptor and c-kit kinases",
            "probability": 0.05833306850595901,
            "start_logit": 5.5328545570373535,
            "end_logit": 4.0129828453063965,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor and c-kit kinases",
            "probability": 0.051151651855501724,
            "start_logit": 5.401480197906494,
            "end_logit": 4.0129828453063965,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor (PDGFR), and c-kit",
            "probability": 0.03574085047319941,
            "start_logit": 4.62620210647583,
            "end_logit": 4.429760456085205,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "ABL, platelet-derived growth factor receptor (PDGFR), and c-kit",
            "probability": 0.0076979917260957985,
            "start_logit": 3.090867280960083,
            "end_logit": 4.429760456085205,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor (PDGFR)",
            "probability": 0.0034189468630954705,
            "start_logit": 4.62620210647583,
            "end_logit": 2.082798719406128,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "ABL, platelet-derived growth factor receptor",
            "probability": 0.0029824530743313253,
            "start_logit": 3.090867280960083,
            "end_logit": 3.4815471172332764,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "c-kit kinase",
            "probability": 0.0027247633105003787,
            "start_logit": 5.677659511566162,
            "end_logit": 0.8043903112411499,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "BCR-ABL, platelet-derived growth factor receptor and c-kit kinase",
            "probability": 0.002357440770340076,
            "start_logit": 5.5328545570373535,
            "end_logit": 0.8043903112411499,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "ABL",
            "probability": 0.0022882575221404994,
            "start_logit": 3.090867280960083,
            "end_logit": 3.2165915966033936,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor and c-kit kinase",
            "probability": 0.002067214920162871,
            "start_logit": 5.401480197906494,
            "end_logit": 0.8043903112411499,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor (PDGFR), and c-kit kinases",
            "probability": 0.001765775214867507,
            "start_logit": 4.62620210647583,
            "end_logit": 1.422055959701538,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "PDGFR), and c-kit",
            "probability": 0.000994373951191871,
            "start_logit": 1.044265866279602,
            "end_logit": 4.429760456085205,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor (PDGFR",
            "probability": 0.0008911174729569645,
            "start_logit": 4.62620210647583,
            "end_logit": 0.7381871342658997,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        }
    ],
    "52ebb2c698d0239505000029": [
        {
            "text": "renal angiomyolipomas",
            "probability": 0.5318538648981658,
            "start_logit": 5.0367960929870605,
            "end_logit": 5.429532527923584,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "angiomyolipomas",
            "probability": 0.2671424534607908,
            "start_logit": 4.348209381103516,
            "end_logit": 5.429532527923584,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Rhabdomyoma",
            "probability": 0.08212444292147915,
            "start_logit": 4.285520553588867,
            "end_logit": 4.3126749992370605,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Lymphangioleiomyomatosis",
            "probability": 0.07843299940473676,
            "start_logit": 4.238248348236084,
            "end_logit": 4.313956260681152,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "giant cell astrocytomas",
            "probability": 0.015400106551114255,
            "start_logit": 3.1283321380615234,
            "end_logit": 3.796002149581909,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "ubependymal giant cell astrocytomas",
            "probability": 0.005520953587572003,
            "start_logit": 2.102508306503296,
            "end_logit": 3.796002149581909,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Lymphangioleiomyomatosis (LAM)",
            "probability": 0.004543884068223994,
            "start_logit": 4.238248348236084,
            "end_logit": 1.4654936790466309,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "epilepsy",
            "probability": 0.0033976803132696066,
            "start_logit": 3.1620116233825684,
            "end_logit": 2.2510411739349365,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "astrocytomas",
            "probability": 0.0031324925771803952,
            "start_logit": 1.535786747932434,
            "end_logit": 3.796002149581909,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "renal",
            "probability": 0.0019520848710245285,
            "start_logit": 5.0367960929870605,
            "end_logit": -0.17793826758861542,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "giant cell astrocytomas (SEGAs)",
            "probability": 0.0013456912302831925,
            "start_logit": 3.1283321380615234,
            "end_logit": 1.3585355281829834,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "neurologic sequelae.In contrast to renal angiomyolipomas",
            "probability": 0.0012736740210733618,
            "start_logit": -0.9976670145988464,
            "end_logit": 5.429532527923584,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "cystic lung disease that almost exclusively affects women.Rhabdomyoma",
            "probability": 0.0011064129670634148,
            "start_logit": -0.021591918542981148,
            "end_logit": 4.3126749992370605,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "renal angiomyolipomas,",
            "probability": 0.0006825591237800147,
            "start_logit": 5.0367960929870605,
            "end_logit": -1.2287423610687256,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "ubependymal giant cell astrocytomas (SEGAs)",
            "probability": 0.00048243165077702793,
            "start_logit": 2.102508306503296,
            "end_logit": 1.3585355281829834,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "myolipomas",
            "probability": 0.00045079620666342774,
            "start_logit": -2.0363125801086426,
            "end_logit": 5.429532527923584,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "angiomyolipomas,",
            "probability": 0.00034283951098776637,
            "start_logit": 4.348209381103516,
            "end_logit": -1.2287423610687256,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "giomyolipomas",
            "probability": 0.000291107539623761,
            "start_logit": -2.473635196685791,
            "end_logit": 5.429532527923584,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "astrocytomas (SEGAs)",
            "probability": 0.00027372328730633727,
            "start_logit": 1.535786747932434,
            "end_logit": 1.3585355281829834,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "renal angio",
            "probability": 0.0002498018088842131,
            "start_logit": 5.0367960929870605,
            "end_logit": -2.2339236736297607,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        }
    ],
    "54f0920f94afd61504000018": [
        {
            "text": "cisplatin",
            "probability": 0.08437111072834474,
            "start_logit": 6.122270584106445,
            "end_logit": 5.9459710121154785,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "rituximab, dexamethasone",
            "probability": 0.07934065969103458,
            "start_logit": 6.024322032928467,
            "end_logit": 5.982445240020752,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "rituximab, dexamethasone, aracytine, and cisplatin",
            "probability": 0.07649891072795346,
            "start_logit": 6.024322032928467,
            "end_logit": 5.9459710121154785,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "dexamethasone",
            "probability": 0.07225571988446769,
            "start_logit": 5.930782794952393,
            "end_logit": 5.982445240020752,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "rituximab",
            "probability": 0.07132243993700935,
            "start_logit": 6.024322032928467,
            "end_logit": 5.875905513763428,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "dexamethasone, aracytine, and cisplatin",
            "probability": 0.06966773261718298,
            "start_logit": 5.930782794952393,
            "end_logit": 5.9459710121154785,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "aracytine, and cisplatin",
            "probability": 0.05889420888570898,
            "start_logit": 5.76278829574585,
            "end_logit": 5.9459710121154785,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "rituximab, dexamethasone, aracytine",
            "probability": 0.05739686834903538,
            "start_logit": 6.024322032928467,
            "end_logit": 5.658684253692627,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "dexamethasone, aracytine",
            "probability": 0.05227145902017507,
            "start_logit": 5.930782794952393,
            "end_logit": 5.658684253692627,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "dexamethasone, cytarabine, and cisplatin",
            "probability": 0.04566292600267395,
            "start_logit": 5.796567916870117,
            "end_logit": 5.657735347747803,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cytarabine, and cisplatin",
            "probability": 0.04491342093703226,
            "start_logit": 5.780017852783203,
            "end_logit": 5.657735347747803,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "aracytine",
            "probability": 0.0441881213963275,
            "start_logit": 5.76278829574585,
            "end_logit": 5.658684253692627,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "Rituximab",
            "probability": 0.04045069300508806,
            "start_logit": 5.7612690925598145,
            "end_logit": 5.571831226348877,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "dexamethasone (DHAP) with or without Rituximab",
            "probability": 0.036960366330094876,
            "start_logit": 5.671031475067139,
            "end_logit": 5.571831226348877,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "dexamethasone, cytarabine",
            "probability": 0.036866039477907675,
            "start_logit": 5.796567916870117,
            "end_logit": 5.443739414215088,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cytarabine",
            "probability": 0.03626092531292359,
            "start_logit": 5.780017852783203,
            "end_logit": 5.443739414215088,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cisplatin [ESHAP] 36%, and gemcitabine",
            "probability": 0.02847629602156637,
            "start_logit": 5.4629902839660645,
            "end_logit": 5.519098281860352,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "carboplatin (R-ICE) and rituximab, dexamethasone",
            "probability": 0.023501303740677836,
            "start_logit": 4.807627201080322,
            "end_logit": 5.982445240020752,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "carboplatin (R-ICE) and rituximab",
            "probability": 0.021126246378756968,
            "start_logit": 4.807627201080322,
            "end_logit": 5.875905513763428,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cisplatin [ESHAP] 36%, and gemcitabine, dexamethasone",
            "probability": 0.019574551556038777,
            "start_logit": 5.4629902839660645,
            "end_logit": 5.144256591796875,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        }
    ],
    "57220e400fd6f91b68000015": [
        {
            "text": "fatigability",
            "probability": 0.12468327205253975,
            "start_logit": 5.485905647277832,
            "end_logit": 5.530045986175537,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "fatigability, decreased deep-tendon reflexes",
            "probability": 0.1104684188891183,
            "start_logit": 5.485905647277832,
            "end_logit": 5.408998966217041,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "respiratory failure",
            "probability": 0.09093867360114095,
            "start_logit": 5.131873607635498,
            "end_logit": 5.56848669052124,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "decreased deep-tendon reflexes",
            "probability": 0.07085128090273077,
            "start_logit": 5.041759014129639,
            "end_logit": 5.408998966217041,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "fatigability, decreased deep-tendon reflexes, and autonomic symptoms",
            "probability": 0.06954287581371305,
            "start_logit": 5.485905647277832,
            "end_logit": 4.9462127685546875,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "skeletal muscle weakness and autonomic symptoms.Primary respiratory failure",
            "probability": 0.06687608323916067,
            "start_logit": 4.824529647827148,
            "end_logit": 5.56848669052124,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "proximal limb muscle weakness, fatigability",
            "probability": 0.06660929132209098,
            "start_logit": 4.858973026275635,
            "end_logit": 5.530045986175537,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "proximal limb muscle weakness",
            "probability": 0.06541630059792533,
            "start_logit": 4.858973026275635,
            "end_logit": 5.5119733810424805,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "proximal limb muscle weakness, fatigability, decreased deep-tendon reflexes",
            "probability": 0.05901531917269069,
            "start_logit": 4.858973026275635,
            "end_logit": 5.408998966217041,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "skeletal muscle weakness",
            "probability": 0.04482170615597921,
            "start_logit": 4.824529647827148,
            "end_logit": 5.168337821960449,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "decreased deep-tendon reflexes, and autonomic symptoms",
            "probability": 0.044602809369497176,
            "start_logit": 5.041759014129639,
            "end_logit": 4.9462127685546875,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "autonomic symptoms",
            "probability": 0.040090363932247707,
            "start_logit": 4.935098171234131,
            "end_logit": 4.9462127685546875,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "proximal limb muscle weakness, fatigability, decreased deep-tendon reflexes, and autonomic symptoms",
            "probability": 0.03715174937420365,
            "start_logit": 4.858973026275635,
            "end_logit": 4.9462127685546875,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "autonomic symptoms.Primary respiratory failure",
            "probability": 0.02864541697843467,
            "start_logit": 3.976681709289551,
            "end_logit": 5.56848669052124,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "muscle weakness",
            "probability": 0.02205881843632075,
            "start_logit": 4.406283378601074,
            "end_logit": 4.877604007720947,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "skeletal muscle weakness and autonomic symptoms",
            "probability": 0.01435767080767268,
            "start_logit": 4.824529647827148,
            "end_logit": 4.0299296379089355,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "Primary respiratory failure",
            "probability": 0.013909954294966335,
            "start_logit": 3.2542929649353027,
            "end_logit": 5.56848669052124,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "muscle weakness, fatigability",
            "probability": 0.010425272628789438,
            "start_logit": 3.004361867904663,
            "end_logit": 5.530045986175537,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "deep-tendon reflexes",
            "probability": 0.010298011163647564,
            "start_logit": 3.113126754760742,
            "end_logit": 5.408998966217041,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "muscle weakness, fatigability, decreased deep-tendon reflexes",
            "probability": 0.009236711267130339,
            "start_logit": 3.004361867904663,
            "end_logit": 5.408998966217041,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        }
    ],
    "553babc0f321868558000007": [
        {
            "text": "anaerobic Gram-negative",
            "probability": 0.21483180318418554,
            "start_logit": 4.391127586364746,
            "end_logit": 3.8710386753082275,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "Gram-negative",
            "probability": 0.20934560915104705,
            "start_logit": 4.365258693695068,
            "end_logit": 3.8710386753082275,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "anaerobic",
            "probability": 0.1929862660183584,
            "start_logit": 4.391127586364746,
            "end_logit": 3.7638022899627686,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "anaerobic Gram-negative microflora",
            "probability": 0.06433737413066272,
            "start_logit": 4.391127586364746,
            "end_logit": 2.6653239727020264,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "Gram-negative microflora",
            "probability": 0.06269438034281641,
            "start_logit": 4.365258693695068,
            "end_logit": 2.6653239727020264,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "anaerobic Actinomyces and spirochetes",
            "probability": 0.053688068149077395,
            "start_logit": 3.488035202026367,
            "end_logit": 3.3874664306640625,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "Actinomyces and spirochetes",
            "probability": 0.051519670176886884,
            "start_logit": 3.446808099746704,
            "end_logit": 3.3874664306640625,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "anaerobic Actinomyces",
            "probability": 0.05020067671045626,
            "start_logit": 3.488035202026367,
            "end_logit": 3.3203041553497314,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "Actinomyces",
            "probability": 0.04817313037969086,
            "start_logit": 3.446808099746704,
            "end_logit": 3.3203041553497314,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "spirochetes",
            "probability": 0.039908563193577794,
            "start_logit": 3.1914353370666504,
            "end_logit": 3.3874664306640625,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "P. gingivalis",
            "probability": 0.0028120177742197968,
            "start_logit": 1.6424165964126587,
            "end_logit": 2.283796548843384,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "an anaerobic Gram-negative",
            "probability": 0.0021033806783450387,
            "start_logit": -0.23518192768096924,
            "end_logit": 3.8710386753082275,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "an anaerobic",
            "probability": 0.00188949483788,
            "start_logit": -0.23518192768096924,
            "end_logit": 3.7638022899627686,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. denticola, P. intermedia",
            "probability": 0.001027141946162957,
            "start_logit": 1.9721254110336304,
            "end_logit": 0.9469655752182007,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. forsythensis",
            "probability": 0.000851262636699602,
            "start_logit": 1.6921823024749756,
            "end_logit": 1.0390939712524414,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "P. gingivalis, T. forsythensis",
            "probability": 0.0008099358088282136,
            "start_logit": 1.6424165964126587,
            "end_logit": 1.0390939712524414,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. forsythensis, T. denticola, P. intermedia",
            "probability": 0.0007763413489991321,
            "start_logit": 1.6921823024749756,
            "end_logit": 0.9469655752182007,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "P. gingivalis, T. forsythensis, T. denticola, P. intermedia",
            "probability": 0.0007386517759856621,
            "start_logit": 1.6424165964126587,
            "end_logit": 0.9469655752182007,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. denticola",
            "probability": 0.0006763157584132774,
            "start_logit": 1.9721254110336304,
            "end_logit": 0.5290902256965637,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "an anaerobic Gram-negative microflora",
            "probability": 0.0006299159977066826,
            "start_logit": -0.23518192768096924,
            "end_logit": 2.6653239727020264,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        }
    ],
    "5162c8a8298dcd4e51000047": [
        {
            "text": "CCR4",
            "probability": 0.5131333137267895,
            "start_logit": 3.80273699760437,
            "end_logit": 2.7902228832244873,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4-Not deadenylase complex.The CCR4",
            "probability": 0.2140852796726814,
            "start_logit": 2.9285757541656494,
            "end_logit": 2.7902228832244873,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4, an evolutionarily conserved member of the CCR4",
            "probability": 0.1086909156882603,
            "start_logit": 3.2090954780578613,
            "end_logit": 1.8318369388580322,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4 family",
            "probability": 0.09423869867497714,
            "start_logit": 3.80273699760437,
            "end_logit": 1.0955181121826172,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4-Not deadenylase complex.The CCR4 family",
            "probability": 0.0393174982448401,
            "start_logit": 2.9285757541656494,
            "end_logit": 1.0955181121826172,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "ribonuclease D (RNase D) family of deadenylases and is a component of the CCR4",
            "probability": 0.011248673861578778,
            "start_logit": 0.3635827302932739,
            "end_logit": 2.4090917110443115,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "The CCR4",
            "probability": 0.003521545629370917,
            "start_logit": -1.1788986921310425,
            "end_logit": 2.7902228832244873,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4,",
            "probability": 0.0031045031688580384,
            "start_logit": 3.2090954780578613,
            "end_logit": -1.7238175868988037,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4-associated factor 1 (Caf1), which belongs to the ribonuclease D (RNase D) family",
            "probability": 0.002913924360282109,
            "start_logit": 3.017186164855957,
            "end_logit": -1.5952612161636353,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4-associated factor 1",
            "probability": 0.00233496276053318,
            "start_logit": 3.017186164855957,
            "end_logit": -1.8167660236358643,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4-associated factor 1 (Caf1),",
            "probability": 0.0013882826605223957,
            "start_logit": 3.017186164855957,
            "end_logit": -2.3366944789886475,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4-associated factor 1 (Caf1), which belongs to the ribonuclease D",
            "probability": 0.0013744287239747654,
            "start_logit": 3.017186164855957,
            "end_logit": -2.346723794937134,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4-associated factor 1 (Caf1",
            "probability": 0.0009789288487180483,
            "start_logit": 3.017186164855957,
            "end_logit": -2.686058282852173,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4-associated factor 1 (Caf1), which belongs to the ribonuclease D (RNase D)",
            "probability": 0.0009340843981972793,
            "start_logit": 3.017186164855957,
            "end_logit": -2.732950448989868,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR",
            "probability": 0.0007555230282435025,
            "start_logit": 2.9285757541656494,
            "end_logit": -2.856496572494507,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4, an evolutionarily conserved member of the CCR4-NOT complex,",
            "probability": 0.0007173788265939042,
            "start_logit": 3.2090954780578613,
            "end_logit": -3.1888225078582764,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "The CCR4 family",
            "probability": 0.0006467439719050588,
            "start_logit": -1.1788986921310425,
            "end_logit": 1.0955181121826172,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4-NOT complex,",
            "probability": 0.0003134262006042149,
            "start_logit": 2.3810553550720215,
            "end_logit": -3.1888225078582764,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "ribonuclease D (RNase D) family",
            "probability": 0.00020513177848717422,
            "start_logit": 0.3635827302932739,
            "end_logit": -1.5952612161636353,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "ribonuclease D",
            "probability": 9.675577458211902e-05,
            "start_logit": 0.3635827302932739,
            "end_logit": -2.346723794937134,
            "question_text": "What are the known families of deadenylases?"
        }
    ],
    "56a3bf0f496b62f23f00000a": [
        {
            "text": "GenomicFeatures",
            "probability": 0.29468044687374795,
            "start_logit": 4.316392421722412,
            "end_logit": 3.8231353759765625,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges, and GenomicFeatures",
            "probability": 0.18968170107865556,
            "start_logit": 3.8758482933044434,
            "end_logit": 3.8231353759765625,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges, and GenomicFeatures",
            "probability": 0.1476543265596065,
            "start_logit": 3.6253747940063477,
            "end_logit": 3.8231353759765625,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges",
            "probability": 0.13360505171587414,
            "start_logit": 3.8758482933044434,
            "end_logit": 3.4726760387420654,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges",
            "probability": 0.1251337647682246,
            "start_logit": 3.6253747940063477,
            "end_logit": 3.657644748687744,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges",
            "probability": 0.10400246214519353,
            "start_logit": 3.6253747940063477,
            "end_logit": 3.4726760387420654,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges,",
            "probability": 0.0007748307105940456,
            "start_logit": 3.8758482933044434,
            "end_logit": -1.6773227453231812,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges,",
            "probability": 0.0006031531039624314,
            "start_logit": 3.6253747940063477,
            "end_logit": -1.6773227453231812,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "G",
            "probability": 0.0005280071252800305,
            "start_logit": 4.316392421722412,
            "end_logit": -2.501401662826538,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "I",
            "probability": 0.0005070496354910253,
            "start_logit": 3.6253747940063477,
            "end_logit": -1.8508849143981934,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "Ranges, and GenomicFeatures",
            "probability": 0.0004776407204737718,
            "start_logit": -2.108395576477051,
            "end_logit": 3.8231353759765625,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges, and G",
            "probability": 0.00033987083556879627,
            "start_logit": 3.8758482933044434,
            "end_logit": -2.501401662826538,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "Ranges",
            "probability": 0.00033643315510990335,
            "start_logit": -2.108395576477051,
            "end_logit": 3.4726760387420654,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicFeature",
            "probability": 0.00031069501872698827,
            "start_logit": 4.316392421722412,
            "end_logit": -3.0316996574401855,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges,",
            "probability": 0.0002845573311438849,
            "start_logit": 3.6253747940063477,
            "end_logit": -2.4285590648651123,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges, and G",
            "probability": 0.0002645663712302524,
            "start_logit": 3.6253747940063477,
            "end_logit": -2.501401662826538,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "Genomic",
            "probability": 0.0002346219370324215,
            "start_logit": 4.316392421722412,
            "end_logit": -3.3125360012054443,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, G",
            "probability": 0.00020903140977833294,
            "start_logit": 3.6253747940063477,
            "end_logit": -2.737009286880493,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges, and GenomicFeature",
            "probability": 0.00019999005802393474,
            "start_logit": 3.8758482933044434,
            "end_logit": -3.0316996574401855,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "Features",
            "probability": 0.00017179944628175728,
            "start_logit": -3.1309266090393066,
            "end_logit": 3.8231353759765625,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        }
    ],
    "516281e6298dcd4e51000040": [
        {
            "text": "SIMAC",
            "probability": 0.14579655126991625,
            "start_logit": 4.4765777587890625,
            "end_logit": 4.6559157371521,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "IMAC (SIMAC",
            "probability": 0.10171190142773719,
            "start_logit": 4.116509914398193,
            "end_logit": 4.6559157371521,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "IMAC",
            "probability": 0.08873682413613074,
            "start_logit": 4.116509914398193,
            "end_logit": 4.51944637298584,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "TiSH",
            "probability": 0.0732473053948764,
            "start_logit": 3.801131248474121,
            "end_logit": 4.642991542816162,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "TiO2, SIMAC",
            "probability": 0.06539658817861158,
            "start_logit": 4.143146991729736,
            "end_logit": 4.1876044273376465,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "hydrophilic interaction liquid chromatography (HILIC",
            "probability": 0.05655398608455437,
            "start_logit": 4.649218559265137,
            "end_logit": 3.5362584590911865,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "hydrophilic interaction liquid chromatography",
            "probability": 0.055924118031700346,
            "start_logit": 4.649218559265137,
            "end_logit": 3.5250585079193115,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "TiSH--a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC",
            "probability": 0.04645361766984812,
            "start_logit": 3.801131248474121,
            "end_logit": 4.1876044273376465,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "immobilized metal affinity chromatography (IMAC",
            "probability": 0.0418358962789834,
            "start_logit": 4.009779453277588,
            "end_logit": 3.8742566108703613,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "TiO2",
            "probability": 0.04162754177896329,
            "start_logit": 4.143146991729736,
            "end_logit": 3.735896348953247,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "titanium dioxide",
            "probability": 0.040794254632538204,
            "start_logit": 4.2472028732299805,
            "end_logit": 3.611619710922241,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "immobilized metal affinity chromatography",
            "probability": 0.03503266633837834,
            "start_logit": 4.009779453277588,
            "end_logit": 3.6967828273773193,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "TiO2, SIMAC, and HILIC",
            "probability": 0.03330179435476357,
            "start_logit": 4.143146991729736,
            "end_logit": 3.5127456188201904,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "HILIC) of the mono-phosphorylated peptides (collectively abbreviated \"TiSH",
            "probability": 0.029825348754367386,
            "start_logit": 3.2798571586608887,
            "end_logit": 4.265782833099365,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "TiSH--a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2",
            "probability": 0.029569584043958368,
            "start_logit": 3.801131248474121,
            "end_logit": 3.735896348953247,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "SIMAC, and HILIC",
            "probability": 0.028490388844643107,
            "start_logit": 3.987102508544922,
            "end_logit": 3.5127456188201904,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "sequential elution from IMAC (SIMAC",
            "probability": 0.02349814508594285,
            "start_logit": 2.651287078857422,
            "end_logit": 4.6559157371521,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "SIMAC)",
            "probability": 0.02335327300934963,
            "start_logit": 4.4765777587890625,
            "end_logit": 2.8244407176971436,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "sequential elution from IMAC",
            "probability": 0.02050055832943034,
            "start_logit": 2.651287078857422,
            "end_logit": 4.51944637298584,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "strong cation exchange chromatography combined with immobilized metal affinity chromatography (IMAC",
            "probability": 0.01834965635530659,
            "start_logit": 3.185635566711426,
            "end_logit": 3.8742566108703613,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        }
    ],
    "56c3326750c68dd41600000b": [
        {
            "text": "H3K36me3",
            "probability": 0.7868356460243727,
            "start_logit": 4.613035678863525,
            "end_logit": 4.019516468048096,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K36",
            "probability": 0.137286780951159,
            "start_logit": 3.8312878608703613,
            "end_logit": 3.055316925048828,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K36 trimethylation",
            "probability": 0.023868895448348793,
            "start_logit": 3.8312878608703613,
            "end_logit": 1.3058210611343384,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "K36",
            "probability": 0.008157886856415286,
            "start_logit": 2.2172701358795166,
            "end_logit": 1.8462477922439575,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K36me3,",
            "probability": 0.007959555070550548,
            "start_logit": 4.613035678863525,
            "end_logit": -0.5741298198699951,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3 K4 and K36",
            "probability": 0.006823414899592187,
            "start_logit": 2.038645029067993,
            "end_logit": 1.8462477922439575,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3",
            "probability": 0.005157839588664311,
            "start_logit": 4.613035678863525,
            "end_logit": -1.0079851150512695,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "histone H3 K4 and K36",
            "probability": 0.004886064888555909,
            "start_logit": 1.7046722173690796,
            "end_logit": 1.8462477922439575,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "K36me3",
            "probability": 0.0033597605052957413,
            "start_logit": -0.8431140184402466,
            "end_logit": 4.019516468048096,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "me3",
            "probability": 0.003315122940203974,
            "start_logit": -0.8564890027046204,
            "end_logit": 4.019516468048096,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3 K4",
            "probability": 0.001994965301493745,
            "start_logit": 2.038645029067993,
            "end_logit": 0.6165143847465515,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "K4 and K36",
            "probability": 0.0018662516996100925,
            "start_logit": 0.742216944694519,
            "end_logit": 1.8462477922439575,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B K123 monoubiquitination and histone H3 K4 and K36",
            "probability": 0.0015362816070921398,
            "start_logit": 0.5476499199867249,
            "end_logit": 1.8462477922439575,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "histone H3 K4",
            "probability": 0.0014285412886293222,
            "start_logit": 1.7046722173690796,
            "end_logit": 0.6165143847465515,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K36 trimethylation,",
            "probability": 0.0012304933662413912,
            "start_logit": 3.8312878608703613,
            "end_logit": -1.6593399047851562,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "K36 trimethylation",
            "probability": 0.0010112600488084431,
            "start_logit": 2.2172701358795166,
            "end_logit": -0.24154025316238403,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H",
            "probability": 0.0009495158876546595,
            "start_logit": 4.613035678863525,
            "end_logit": -2.700305938720703,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "K123 monoubiquitination and histone H3 K4 and K36",
            "probability": 0.0008802044642610991,
            "start_logit": -0.009316088631749153,
            "end_logit": 1.8462477922439575,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3 K4 and K36 trimethylation",
            "probability": 0.0008458375319309022,
            "start_logit": 2.038645029067993,
            "end_logit": -0.24154025316238403,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "histone H3 K4 and K36 trimethylation",
            "probability": 0.0006056816311195402,
            "start_logit": 1.7046722173690796,
            "end_logit": -0.24154025316238403,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        }
    ],
    "54d646403706e89528000008": [
        {
            "text": "major depressive disorder",
            "probability": 0.375465848814607,
            "start_logit": 5.213080883026123,
            "end_logit": 4.747562885284424,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "schizophrenia",
            "probability": 0.24456354616325568,
            "start_logit": 4.718785285949707,
            "end_logit": 4.81316614151001,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "schizophrenia and major depressive disorder",
            "probability": 0.22903433376681845,
            "start_logit": 4.718785285949707,
            "end_logit": 4.747562885284424,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major depressive disorder (MDD)",
            "probability": 0.05082954098774296,
            "start_logit": 5.213080883026123,
            "end_logit": 2.747873067855835,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major depressive",
            "probability": 0.03736516749716973,
            "start_logit": 5.213080883026123,
            "end_logit": 2.440134286880493,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "schizophrenia and major depressive disorder (MDD)",
            "probability": 0.031006042473783565,
            "start_logit": 4.718785285949707,
            "end_logit": 2.747873067855835,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "schizophrenia and major depressive",
            "probability": 0.022792768692061444,
            "start_logit": 4.718785285949707,
            "end_logit": 2.440134286880493,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "depressive disorder",
            "probability": 0.004014654236056058,
            "start_logit": 0.6748645901679993,
            "end_logit": 4.747562885284424,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "psychiatric disorders in Caucasian populations. he aim of the study was to replicate the association of rs2535629 with schizophrenia",
            "probability": 0.0018929157270126521,
            "start_logit": -0.14257153868675232,
            "end_logit": 4.81316614151001,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "chizophrenia",
            "probability": 0.0006589497477006209,
            "start_logit": -1.1977978944778442,
            "end_logit": 4.81316614151001,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "chizophrenia and major depressive disorder",
            "probability": 0.0006171079820280266,
            "start_logit": -1.1977978944778442,
            "end_logit": 4.747562885284424,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "depressive disorder (MDD)",
            "probability": 0.0005434929240235297,
            "start_logit": 0.6748645901679993,
            "end_logit": 2.747873067855835,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "depressive",
            "probability": 0.00039952562515885656,
            "start_logit": 0.6748645901679993,
            "end_logit": 2.440134286880493,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "pressive disorder",
            "probability": 0.00026619917519829685,
            "start_logit": -2.0385971069335938,
            "end_logit": 4.747562885284424,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "zophrenia",
            "probability": 0.00012598803791636279,
            "start_logit": -2.8522582054138184,
            "end_logit": 4.81316614151001,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "zophrenia and major depressive disorder",
            "probability": 0.00011798809258146998,
            "start_logit": -2.8522582054138184,
            "end_logit": 4.747562885284424,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "chizophrenia and major depressive disorder (MDD)",
            "probability": 8.354239291106633e-05,
            "start_logit": -1.1977978944778442,
            "end_logit": 2.747873067855835,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major depressive disorder (MDD) in Japanese subjects. In the MDD-bipolar",
            "probability": 7.439118524925603e-05,
            "start_logit": 5.213080883026123,
            "end_logit": -3.779022455215454,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major depressive disorder (MDD) in Japanese subjects.",
            "probability": 7.425530799849453e-05,
            "start_logit": 5.213080883026123,
            "end_logit": -3.780850648880005,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major",
            "probability": 7.374117072652613e-05,
            "start_logit": 5.213080883026123,
            "end_logit": -3.7877986431121826,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        }
    ],
    "5172f8118ed59a060a000019": [
        {
            "text": "Endopterygota",
            "probability": 0.9655462837592679,
            "start_logit": 2.660179853439331,
            "end_logit": 2.010206937789917,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "insects",
            "probability": 0.012736579466028387,
            "start_logit": 0.09330523014068604,
            "end_logit": 0.24886564910411835,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "Endopterygota infraclass",
            "probability": 0.009911608820715755,
            "start_logit": 2.660179853439331,
            "end_logit": -2.5687804222106934,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "End",
            "probability": 0.006324590259446559,
            "start_logit": 2.660179853439331,
            "end_logit": -3.0180418491363525,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "the Endopterygota",
            "probability": 0.0011626005455814548,
            "start_logit": -4.061854839324951,
            "end_logit": 2.010206937789917,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "a",
            "probability": 0.0009059801050646832,
            "start_logit": -4.311252117156982,
            "end_logit": 2.010206937789917,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "insect",
            "probability": 0.0006769506513208553,
            "start_logit": -0.9765498042106628,
            "end_logit": -1.6159143447875977,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "insect species",
            "probability": 0.00046849232901171743,
            "start_logit": -1.0432939529418945,
            "end_logit": -1.9172488451004028,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "metazoan",
            "probability": 0.0004058132336517518,
            "start_logit": -1.6291747093200684,
            "end_logit": -1.4749947786331177,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "Drosophila",
            "probability": 0.0002822796505139105,
            "start_logit": -2.260399341583252,
            "end_logit": -1.2067649364471436,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "insect species, possibly as a consequence of the relaxation in insects",
            "probability": 0.0002662899869772119,
            "start_logit": -0.9765498042106628,
            "end_logit": -2.548926830291748,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "insects may be related to the fundamental differences in antioxidant defense between these animals and other metazoans",
            "probability": 0.0002581646952083144,
            "start_logit": 0.09330523014068604,
            "end_logit": -3.6497700214385986,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "insect species, possibly as a consequence of the relaxation in insects of the selective constraints acting across metazoans",
            "probability": 0.00023703602035034398,
            "start_logit": -0.9765498042106628,
            "end_logit": -2.6653006076812744,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "Drosophila.Selenoproteins have been independently lost in several insect",
            "probability": 0.00018749437401525718,
            "start_logit": -2.260399341583252,
            "end_logit": -1.6159143447875977,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "all metazoan",
            "probability": 0.00010983337047985094,
            "start_logit": -2.936103343963623,
            "end_logit": -1.4749947786331177,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "five insect species",
            "probability": 0.00010724274276771077,
            "start_logit": -2.51771879196167,
            "end_logit": -1.9172488451004028,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "metazoans to maintain selenoproteins. The dispensability of selenoproteins in insects",
            "probability": 0.00010500839593110669,
            "start_logit": -4.704887866973877,
            "end_logit": 0.24886564910411835,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "Drosophila.Selenoproteins have been independently lost in several insect species",
            "probability": 0.00010435426982253804,
            "start_logit": -2.260399341583252,
            "end_logit": -2.201871633529663,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "several insect",
            "probability": 0.00010186671669003649,
            "start_logit": -2.870482921600342,
            "end_logit": -1.6159143447875977,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "five insect",
            "probability": 0.00010153060715472938,
            "start_logit": -2.51771879196167,
            "end_logit": -1.9719834327697754,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        }
    ],
    "534df8c9aeec6fbd07000016": [
        {
            "text": "multiple sclerosis",
            "probability": 0.19616474566410047,
            "start_logit": 4.583646297454834,
            "end_logit": 4.588191032409668,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "multiple sclerosis, Alzheimer disease",
            "probability": 0.1827678063946979,
            "start_logit": 4.583646297454834,
            "end_logit": 4.517452716827393,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "multiple sclerosis, Alzheimer disease and rheumatoid arthritis",
            "probability": 0.1658601365075677,
            "start_logit": 4.583646297454834,
            "end_logit": 4.42038106918335,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "rheumatoid arthritis",
            "probability": 0.15487452550040126,
            "start_logit": 4.5151166915893555,
            "end_logit": 4.42038106918335,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "Alzheimer disease",
            "probability": 0.15007511231243573,
            "start_logit": 4.386565685272217,
            "end_logit": 4.517452716827393,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "Alzheimer disease and rheumatoid arthritis",
            "probability": 0.13619181137828246,
            "start_logit": 4.386565685272217,
            "end_logit": 4.42038106918335,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "prion diseases",
            "probability": 0.004822823719161739,
            "start_logit": 2.5595245361328125,
            "end_logit": 2.906717538833618,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "rheumatoid arthritis (RA)",
            "probability": 0.0018046986847300784,
            "start_logit": 2.829124927520752,
            "end_logit": 1.654151201248169,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "cancer",
            "probability": 0.001675207356332371,
            "start_logit": 2.2545199394226074,
            "end_logit": 2.15429949760437,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases including rheumatoid arthritis",
            "probability": 0.0014866721217224046,
            "start_logit": 1.1235204935073853,
            "end_logit": 3.1659021377563477,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "multiple sclerosis, Alzheimer",
            "probability": 0.0008332989040802733,
            "start_logit": 4.583646297454834,
            "end_logit": -0.8731266856193542,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "inflammatory diseases and cancer",
            "probability": 0.0007612146315146656,
            "start_logit": 1.465743064880371,
            "end_logit": 2.15429949760437,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "Alzheimer",
            "probability": 0.0006842420943084895,
            "start_logit": 4.386565685272217,
            "end_logit": -0.8731266856193542,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "inflammatory diseases",
            "probability": 0.00046878599805109846,
            "start_logit": 1.465743064880371,
            "end_logit": 1.6695305109024048,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "arthritis",
            "probability": 0.00041056174576601425,
            "start_logit": -0.16324859857559204,
            "end_logit": 3.1659021377563477,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases including rheumatoid arthritis (RA)",
            "probability": 0.00032784616497786423,
            "start_logit": 1.1235204935073853,
            "end_logit": 1.654151201248169,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "heimer disease",
            "probability": 0.0002485507817903445,
            "start_logit": -2.0166783332824707,
            "end_logit": 4.517452716827393,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "heimer disease and rheumatoid arthritis",
            "probability": 0.00022555759359381978,
            "start_logit": -2.0166783332824707,
            "end_logit": 4.42038106918335,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases",
            "probability": 0.00017755757967061677,
            "start_logit": 1.1235204935073853,
            "end_logit": 1.0409016609191895,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "multiple",
            "probability": 0.0001388448668144594,
            "start_logit": 4.583646297454834,
            "end_logit": -2.6651618480682373,
            "question_text": "List diseases where protein citrullination plays an important role."
        }
    ],
    "56e30dd551531f7e33000016": [
        {
            "text": "CLOCK",
            "probability": 0.11872570734762042,
            "start_logit": 3.736262321472168,
            "end_logit": 4.0191779136657715,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "BMAL1, Per, and Cry.CLOCK",
            "probability": 0.10162573940371206,
            "start_logit": 3.9838345050811768,
            "end_logit": 3.616086721420288,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, BMAL1, Per, and Cry.CLOCK",
            "probability": 0.07933859132696534,
            "start_logit": 3.736262321472168,
            "end_logit": 3.616086721420288,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "BMAL1",
            "probability": 0.06761262116656343,
            "start_logit": 3.9838345050811768,
            "end_logit": 3.2085845470428467,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "BMAL1, Per, and Cry.CLOCK, RORA",
            "probability": 0.0553170420070402,
            "start_logit": 3.9838345050811768,
            "end_logit": 3.00787091255188,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "BMAL1, Per, and Cry",
            "probability": 0.054853411522556204,
            "start_logit": 3.9838345050811768,
            "end_logit": 2.9994542598724365,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, BMAL1",
            "probability": 0.052784758573505265,
            "start_logit": 3.736262321472168,
            "end_logit": 3.2085845470428467,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "RORA",
            "probability": 0.04822743859514304,
            "start_logit": 3.846681594848633,
            "end_logit": 3.00787091255188,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, BMAL1, Per, and Cry.CLOCK, RORA",
            "probability": 0.04318567535118795,
            "start_logit": 3.736262321472168,
            "end_logit": 3.00787091255188,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, BMAL1, Per, and Cry",
            "probability": 0.04282372187610352,
            "start_logit": 3.736262321472168,
            "end_logit": 2.9994542598724365,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "BMAL1, Per",
            "probability": 0.04155682258064336,
            "start_logit": 3.9838345050811768,
            "end_logit": 2.7218515872955322,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "BMAL1, Per, and Cry.CLOCK, RORA, and NPAS2",
            "probability": 0.03963480817925197,
            "start_logit": 3.9838345050811768,
            "end_logit": 2.674497604370117,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "Bmal1 and Per2. This review will focus on the core circadian clock genes CLOCK",
            "probability": 0.03721274304646384,
            "start_logit": 2.5760977268218994,
            "end_logit": 4.0191779136657715,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "Cry.CLOCK",
            "probability": 0.03703374338021604,
            "start_logit": 2.974367141723633,
            "end_logit": 3.616086721420288,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "RORA, and NPAS2",
            "probability": 0.03455508842016305,
            "start_logit": 3.846681594848633,
            "end_logit": 2.674497604370117,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, BMAL1, Per",
            "probability": 0.0324431564573929,
            "start_logit": 3.736262321472168,
            "end_logit": 2.7218515872955322,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, BMAL1, Per, and Cry.CLOCK, RORA, and NPAS2",
            "probability": 0.030942651604869646,
            "start_logit": 3.736262321472168,
            "end_logit": 2.674497604370117,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "NPAS2",
            "probability": 0.028906736592712715,
            "start_logit": 3.668201446533203,
            "end_logit": 2.674497604370117,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "Per, and Cry.CLOCK",
            "probability": 0.028352083963710535,
            "start_logit": 2.70723819732666,
            "end_logit": 3.616086721420288,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "Bmal1 and Per2. This review will focus on the core circadian clock genes CLOCK, BMAL1, Per, and Cry.CLOCK",
            "probability": 0.024867458604178532,
            "start_logit": 2.5760977268218994,
            "end_logit": 3.616086721420288,
            "question_text": "List core circadian clock genes."
        }
    ],
    "530e0d6e5937551c09000001": [
        {
            "text": "subarachnoid aneurysm trial",
            "probability": 0.4340729049487947,
            "start_logit": 1.8179813623428345,
            "end_logit": 2.227968692779541,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "International subarachnoid aneurysm trial",
            "probability": 0.14521391704027822,
            "start_logit": 0.722976803779602,
            "end_logit": 2.227968692779541,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "Barrow Ruptured Aneurysm Trial",
            "probability": 0.0895169326975227,
            "start_logit": 1.2152029275894165,
            "end_logit": 1.251962423324585,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "Barrow Ruptured Aneurysm Trial (BRAT)",
            "probability": 0.07263818520904386,
            "start_logit": 1.2152029275894165,
            "end_logit": 1.0430253744125366,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "subarachnoid aneurysmal trial",
            "probability": 0.05730461770721978,
            "start_logit": 0.6033264398574829,
            "end_logit": 1.4177923202514648,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "(BRAT)",
            "probability": 0.03955773522710205,
            "start_logit": 0.6074734330177307,
            "end_logit": 1.0430253744125366,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "international subarachnoid aneurysmal trial",
            "probability": 0.03839555939807613,
            "start_logit": 0.20288704335689545,
            "end_logit": 1.4177923202514648,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "subarachnoid aneurysm",
            "probability": 0.022245646506850684,
            "start_logit": 1.8179813623428345,
            "end_logit": -0.7430974841117859,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "the Barrow Ruptured Aneurysm Trial",
            "probability": 0.0193341235351226,
            "start_logit": -0.3173532783985138,
            "end_logit": 1.251962423324585,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "Barrow Ruptured Aneurysm Trial (BRAT",
            "probability": 0.017382574566361744,
            "start_logit": 1.2152029275894165,
            "end_logit": -0.38699713349342346,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "the Barrow Ruptured Aneurysm Trial (BRAT)",
            "probability": 0.015688603305301085,
            "start_logit": -0.3173532783985138,
            "end_logit": 1.0430253744125366,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "(BRAT",
            "probability": 0.00946630591448042,
            "start_logit": 0.6074734330177307,
            "end_logit": -0.38699713349342346,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "subarachnoid aneurysm trial (ISAT)",
            "probability": 0.00768463282288478,
            "start_logit": 1.8179813623428345,
            "end_logit": -1.8060212135314941,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "International subarachnoid aneurysm",
            "probability": 0.00744201591374205,
            "start_logit": 0.722976803779602,
            "end_logit": -0.7430974841117859,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "BRAT)",
            "probability": 0.007165869987241404,
            "start_logit": -1.1009583473205566,
            "end_logit": 1.0430253744125366,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "FIAT study",
            "probability": 0.0044400249281246916,
            "start_logit": -0.537077784538269,
            "end_logit": 0.00047532678581774235,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "the Barrow Ruptured Aneurysm Trial (BRAT",
            "probability": 0.0037543382452582485,
            "start_logit": -0.3173532783985138,
            "end_logit": -0.38699713349342346,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "trial",
            "probability": 0.003716403127524019,
            "start_logit": -2.942474842071533,
            "end_logit": 2.227968692779541,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "International subarachnoid aneurysm trial (ISAT)",
            "probability": 0.0025708023249205758,
            "start_logit": 0.722976803779602,
            "end_logit": -1.8060212135314941,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling",
            "probability": 0.0024088065941505012,
            "start_logit": 1.8179813623428345,
            "end_logit": -2.9661123752593994,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        }
    ],
    "5311bf53e3eabad021000006": [
        {
            "text": "flutemetamol",
            "probability": 0.5642805711924815,
            "start_logit": 6.179457187652588,
            "end_logit": 5.7412028312683105,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "amyloid \u03b2 positron emission tomography (PET) imaging agent [(18)F]flutemetamol",
            "probability": 0.16140019369637648,
            "start_logit": 4.927792549133301,
            "end_logit": 5.7412028312683105,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flutemetamol (Pittsburgh Compound B",
            "probability": 0.0885316105332951,
            "start_logit": 6.179457187652588,
            "end_logit": 3.8890109062194824,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "[(18)F]flutemetamol",
            "probability": 0.05288206068596652,
            "start_logit": 3.811969757080078,
            "end_logit": 5.7412028312683105,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "fluro-deoxyglucose",
            "probability": 0.039369845924018314,
            "start_logit": 5.222772598266602,
            "end_logit": 4.035336017608643,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "amyloid \u03b2",
            "probability": 0.02312262412232994,
            "start_logit": 4.927792549133301,
            "end_logit": 3.7981274127960205,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "fibrillar amyloid \u03b2 positron emission tomography (PET) imaging agent [(18)F]flutemetamol",
            "probability": 0.015080055454406634,
            "start_logit": 2.557278633117676,
            "end_logit": 5.7412028312683105,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flutemetamol (Pittsburgh",
            "probability": 0.01472820137778933,
            "start_logit": 6.179457187652588,
            "end_logit": 2.0954153537750244,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "[(18)F]fluro-deoxyglucose",
            "probability": 0.008833971587912557,
            "start_logit": 3.728377103805542,
            "end_logit": 4.035336017608643,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "[(18)F]flutemetamol (Pittsburgh Compound B",
            "probability": 0.008296819419024583,
            "start_logit": 3.811969757080078,
            "end_logit": 3.8890109062194824,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "amyloid \u03b2 positron emission tomography",
            "probability": 0.005555282028220526,
            "start_logit": 4.927792549133301,
            "end_logit": 2.3720650672912598,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "Pittsburgh Compound B",
            "probability": 0.004663601957754755,
            "start_logit": 3.2358856201171875,
            "end_logit": 3.8890109062194824,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "positron emission tomography (PET) imaging agent [(18)F]flutemetamol",
            "probability": 0.003036345960753989,
            "start_logit": 0.954560399055481,
            "end_logit": 5.7412028312683105,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flute",
            "probability": 0.002953658212363104,
            "start_logit": 6.179457187652588,
            "end_logit": 0.4886957108974457,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "fibrillar amyloid \u03b2",
            "probability": 0.0021604091422101203,
            "start_logit": 2.557278633117676,
            "end_logit": 3.7981274127960205,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "[(18)F]flutemetamol (Pittsburgh",
            "probability": 0.0013802666241182976,
            "start_logit": 3.811969757080078,
            "end_logit": 2.0954153537750244,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "compound B",
            "probability": 0.001361897885763371,
            "start_logit": 3.0483713150024414,
            "end_logit": 2.845616340637207,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "amyloid \u03b2 positron emission tomography (PET) imaging agent [(18)F]flute",
            "probability": 0.000844829738831614,
            "start_logit": 4.927792549133301,
            "end_logit": 0.4886957108974457,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "Pittsburgh",
            "probability": 0.0007758411754390583,
            "start_logit": 3.2358856201171875,
            "end_logit": 2.0954153537750244,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flutemetamol (Pittsburgh Compound",
            "probability": 0.0007419132809440031,
            "start_logit": 6.179457187652588,
            "end_logit": -0.8928716778755188,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        }
    ],
    "515bd543298dcd4e51000001": [
        {
            "text": "GC-rich",
            "probability": 0.2928076327308516,
            "start_logit": 0.8509243726730347,
            "end_logit": -0.4890620708465576,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich (H)",
            "probability": 0.13468366955398856,
            "start_logit": 0.8509243726730347,
            "end_logit": -1.2656490802764893,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich (H) than in AT-rich (L) isochores",
            "probability": 0.11627800979309841,
            "start_logit": 0.8509243726730347,
            "end_logit": -1.412593960762024,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich (H",
            "probability": 0.08178827754924042,
            "start_logit": 0.8509243726730347,
            "end_logit": -1.7644439935684204,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich (H) than in AT-rich",
            "probability": 0.07755708669147904,
            "start_logit": 0.8509243726730347,
            "end_logit": -1.8175636529922485,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich (H) than in AT-rich (L)",
            "probability": 0.06764540467809707,
            "start_logit": 0.8509243726730347,
            "end_logit": -1.954298496246338,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich isochores",
            "probability": 0.038298227087546974,
            "start_logit": 0.3368578851222992,
            "end_logit": -2.009107828140259,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich isochoresAlu sequences being unstable in the GC-poor isochores",
            "probability": 0.031195921427801167,
            "start_logit": 0.12870419025421143,
            "end_logit": -2.006070375442505,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich isochoresAlu sequences being unstable in the GC-poor",
            "probability": 0.020824813271546238,
            "start_logit": 0.12870419025421143,
            "end_logit": -2.410212516784668,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-poor isochores",
            "probability": 0.017080281007315696,
            "start_logit": -0.4736585319042206,
            "end_logit": -2.006070375442505,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-poor isochores but stable in the compositionally matching GC-rich isochores",
            "probability": 0.017028479174327794,
            "start_logit": -0.4736585319042206,
            "end_logit": -2.009107828140259,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich (H) than in AT-rich (L",
            "probability": 0.01583931737597077,
            "start_logit": 0.8509243726730347,
            "end_logit": -3.4060826301574707,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "AT-rich (L) isochores",
            "probability": 0.01448901472767384,
            "start_logit": -1.2316688299179077,
            "end_logit": -1.412593960762024,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "H)",
            "probability": 0.01336921779925341,
            "start_logit": -1.4590495824813843,
            "end_logit": -1.2656490802764893,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-rich (H) than in AT",
            "probability": 0.011958701255774404,
            "start_logit": 0.8509243726730347,
            "end_logit": -3.6871187686920166,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "H) than in AT-rich (L) isochores",
            "probability": 0.0115422013918659,
            "start_logit": -1.4590495824813843,
            "end_logit": -1.412593960762024,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "GC-poor",
            "probability": 0.011401928403560479,
            "start_logit": -0.4736585319042206,
            "end_logit": -2.410212516784668,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "AT-rich",
            "probability": 0.009664129729325777,
            "start_logit": -1.2316688299179077,
            "end_logit": -1.8175636529922485,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "AT-rich (L)",
            "probability": 0.008429068113432565,
            "start_logit": -1.2316688299179077,
            "end_logit": -1.954298496246338,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "H",
            "probability": 0.008118618237850065,
            "start_logit": -1.4590495824813843,
            "end_logit": -1.7644439935684204,
            "question_text": "In which isochores are Alu elements enriched?"
        }
    ],
    "52e6c92598d0239505000019": [
        {
            "text": "codon 12, 13 and 61",
            "probability": 0.11328445325879476,
            "start_logit": 2.0847902297973633,
            "end_logit": 3.0604212284088135,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "codon 12",
            "probability": 0.09117122500803261,
            "start_logit": 2.0847902297973633,
            "end_logit": 2.8432586193084717,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "61",
            "probability": 0.08975491073396753,
            "start_logit": 1.8519710302352905,
            "end_logit": 3.0604212284088135,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "codon 12, 13",
            "probability": 0.0846721833583474,
            "start_logit": 2.0847902297973633,
            "end_logit": 2.7693064212799072,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "codons 15, 16, 18",
            "probability": 0.07613950473494796,
            "start_logit": 1.9253288507461548,
            "end_logit": 2.8225479125976562,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "codons 15",
            "probability": 0.06481786758032353,
            "start_logit": 1.9253288507461548,
            "end_logit": 2.661561965942383,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "codons 15, 16",
            "probability": 0.06157122931392452,
            "start_logit": 1.9253288507461548,
            "end_logit": 2.610175371170044,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "codon 12, 13 and 61 of the H- and K-ras oncogene.mutation in the codon 12, 13 and 61",
            "probability": 0.05829769974924814,
            "start_logit": 2.0847902297973633,
            "end_logit": 2.3960819244384766,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "61 of the H- and K-ras oncogene.mutation in the codon 12, 13 and 61",
            "probability": 0.046189081435878195,
            "start_logit": 1.8519710302352905,
            "end_logit": 2.3960819244384766,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "codon 12, 13 and 61 of the H- and K-ras oncogene.mutation in the codon 12",
            "probability": 0.042569087623559654,
            "start_logit": 2.0847902297973633,
            "end_logit": 2.0816476345062256,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "61 of the H- and K-ras oncogene.mutation in the codon 12",
            "probability": 0.03372735225150954,
            "start_logit": 1.8519710302352905,
            "end_logit": 2.0816476345062256,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "13 and 61",
            "probability": 0.033148831561934766,
            "start_logit": 0.8558957576751709,
            "end_logit": 3.0604212284088135,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "18",
            "probability": 0.030683967872665373,
            "start_logit": 1.0165019035339355,
            "end_logit": 2.8225479125976562,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "15, 16, 18",
            "probability": 0.028118325618506596,
            "start_logit": 0.9291831254959106,
            "end_logit": 2.8225479125976562,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "codon 12, 13 and 61 of the H- and K-ras oncogene.mutation in the codon 12, 13",
            "probability": 0.02606878865403375,
            "start_logit": 2.0847902297973633,
            "end_logit": 1.5912580490112305,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "16, 18",
            "probability": 0.025051520931979997,
            "start_logit": 0.8136961460113525,
            "end_logit": 2.8225479125976562,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "13",
            "probability": 0.024776426626830293,
            "start_logit": 0.8558957576751709,
            "end_logit": 2.7693064212799072,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "15",
            "probability": 0.023937244047822406,
            "start_logit": 0.9291831254959106,
            "end_logit": 2.661561965942383,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "12, 13 and 61",
            "probability": 0.02328203937966409,
            "start_logit": 0.5025705099105835,
            "end_logit": 3.0604212284088135,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "15, 16",
            "probability": 0.022738260258028872,
            "start_logit": 0.9291831254959106,
            "end_logit": 2.610175371170044,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        }
    ],
    "531778ddb166e2b80600000f": [
        {
            "text": "adrenocortical cancer",
            "probability": 0.891769158094173,
            "start_logit": 1.0340713262557983,
            "end_logit": -0.0015403272118419409,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age and family history, is at high risk for a TP53",
            "probability": 0.019288994285540585,
            "start_logit": 1.0340713262557983,
            "end_logit": -3.8352129459381104,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC),",
            "probability": 0.019088812789774843,
            "start_logit": 1.0340713262557983,
            "end_logit": -3.8456451892852783,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "LFS, any patient with adrenocortical cancer",
            "probability": 0.013384022342243963,
            "start_logit": -3.165074348449707,
            "end_logit": -0.0015403272118419409,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC)",
            "probability": 0.010128794276070024,
            "start_logit": 1.0340713262557983,
            "end_logit": -4.479365348815918,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age and family history",
            "probability": 0.009618266501525996,
            "start_logit": 1.0340713262557983,
            "end_logit": -4.531083583831787,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "ad",
            "probability": 0.00835099769215253,
            "start_logit": 1.0340713262557983,
            "end_logit": -4.672366619110107,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "cancer",
            "probability": 0.008133886375316342,
            "start_logit": -3.6630971431732178,
            "end_logit": -0.0015403272118419409,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age and family history,",
            "probability": 0.007580424831247096,
            "start_logit": 1.0340713262557983,
            "end_logit": -4.76917839050293,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age",
            "probability": 0.004102502106216101,
            "start_logit": 1.0340713262557983,
            "end_logit": -5.383150577545166,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "any patient with adrenocortical cancer",
            "probability": 0.0029347192041483776,
            "start_logit": -4.68252420425415,
            "end_logit": -0.0015403272118419409,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age and family history, is at high risk",
            "probability": 0.0011401812539407162,
            "start_logit": 1.0340713262557983,
            "end_logit": -6.663560390472412,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "patient with adrenocortical cancer",
            "probability": 0.0008961328866623275,
            "start_logit": -5.868802547454834,
            "end_logit": -0.0015403272118419409,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "LFS",
            "probability": 0.0007415397104969073,
            "start_logit": -3.165074348449707,
            "end_logit": -2.8946285247802734,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "According to the Chompret criteria for LFS, any patient with adrenocortical cancer",
            "probability": 0.000650455714300721,
            "start_logit": -6.189218044281006,
            "end_logit": -0.0015403272118419409,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "criteria for LFS, any patient with adrenocortical cancer",
            "probability": 0.0006121448790051165,
            "start_logit": -6.249922275543213,
            "end_logit": -0.0015403272118419409,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "the Chompret criteria for LFS, any patient with adrenocortical cancer",
            "probability": 0.0004922361393260019,
            "start_logit": -6.46793270111084,
            "end_logit": -0.0015403272118419409,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "LFS,",
            "probability": 0.0004580380404954159,
            "start_logit": -3.165074348449707,
            "end_logit": -3.3764050006866455,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "cancer (ACC), irrespective of age and family history, is at high risk for a TP53 germline mutation",
            "probability": 0.0003288506904471187,
            "start_logit": -3.6630971431732178,
            "end_logit": -3.209730625152588,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": ", any patient with adrenocortical cancer",
            "probability": 0.0002998421869167487,
            "start_logit": -6.963634967803955,
            "end_logit": -0.0015403272118419409,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        }
    ],
    "52fb42752059c6d71c00005e": [
        {
            "text": "TRIAC",
            "probability": 0.29956435255041636,
            "start_logit": 4.0102925300598145,
            "end_logit": 3.3517160415649414,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "3, 3?, 5-triiodo-thyroacetic acid (TRIAC",
            "probability": 0.1732789217239642,
            "start_logit": 3.4628658294677734,
            "end_logit": 3.3517160415649414,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "3, 3?, 5-triiodo-thyroacetic acid",
            "probability": 0.1533026118727253,
            "start_logit": 3.4628658294677734,
            "end_logit": 3.229227304458618,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "3,5,3',5'-tetraiodothyroacetic acid (tetrac",
            "probability": 0.05796056228110795,
            "start_logit": 3.1765027046203613,
            "end_logit": 2.5429394245147705,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "3,5,3',5'-tetraiodothyroacetic acid",
            "probability": 0.05421416369578931,
            "start_logit": 3.1765027046203613,
            "end_logit": 2.476118803024292,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "tetrac",
            "probability": 0.0447058338871881,
            "start_logit": 2.916843891143799,
            "end_logit": 2.5429394245147705,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "triiodo-thyroacetic acid (TRIAC",
            "probability": 0.02993456938339527,
            "start_logit": 1.7069772481918335,
            "end_logit": 3.3517160415649414,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "TRIAC)",
            "probability": 0.027678930219706552,
            "start_logit": 4.0102925300598145,
            "end_logit": 0.970058262348175,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "tetraiodothyroacetic acid (tetrac",
            "probability": 0.027246259502436566,
            "start_logit": 2.4216561317443848,
            "end_logit": 2.5429394245147705,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "triiodo-thyroacetic acid",
            "probability": 0.026483588575592763,
            "start_logit": 1.7069772481918335,
            "end_logit": 3.229227304458618,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "tetraiodothyroacetic acid",
            "probability": 0.02548514221789248,
            "start_logit": 2.4216561317443848,
            "end_logit": 2.476118803024292,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "thyroacetic acid (TRIAC",
            "probability": 0.018090053214443454,
            "start_logit": 1.2033255100250244,
            "end_logit": 3.3517160415649414,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "3, 3?, 5-triiodo-thyroacetic acid (TRIAC)",
            "probability": 0.01601050038868162,
            "start_logit": 3.4628658294677734,
            "end_logit": 0.970058262348175,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "thyroacetic acid",
            "probability": 0.016004557156170454,
            "start_logit": 1.2033255100250244,
            "end_logit": 3.229227304458618,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "(TRIAC",
            "probability": 0.013347168771462246,
            "start_logit": 0.8992675542831421,
            "end_logit": 3.3517160415649414,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "3, 3?, 5-triiodo-thyroacetic",
            "probability": 0.0037314017879964195,
            "start_logit": 3.4628658294677734,
            "end_logit": -0.4864025413990021,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "3,5,3',5'-tetraiodothyroacetic acid (tetrac)",
            "probability": 0.003689419261284537,
            "start_logit": 3.1765027046203613,
            "end_logit": -0.2113543301820755,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "(tetrac",
            "probability": 0.003660387512639243,
            "start_logit": 0.41430890560150146,
            "end_logit": 2.5429394245147705,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "tetrac)",
            "probability": 0.0028457033221180447,
            "start_logit": 2.916843891143799,
            "end_logit": -0.2113543301820755,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "triiodo-thyroacetic acid (TRIAC)",
            "probability": 0.0027658726749889796,
            "start_logit": 1.7069772481918335,
            "end_logit": 0.970058262348175,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        }
    ],
    "5509b6d22e93f0133a000005": [
        {
            "text": "surgical resection",
            "probability": 0.8569845840422505,
            "start_logit": 5.8289618492126465,
            "end_logit": 5.317953586578369,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Resection",
            "probability": 0.12873041727186021,
            "start_logit": 4.127130508422852,
            "end_logit": 5.124085426330566,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgical resectionExtra luminal colonic gastrointestinal stromal tumors are very rare and can present as mass abdomen",
            "probability": 0.004738990190681318,
            "start_logit": 5.8289618492126465,
            "end_logit": 0.12035772949457169,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "resection",
            "probability": 0.0033832966597855283,
            "start_logit": 0.29439249634742737,
            "end_logit": 5.317953586578369,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgical",
            "probability": 0.0015744681888923157,
            "start_logit": 5.8289618492126465,
            "end_logit": -0.9815487861633301,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgical re",
            "probability": 0.0013427490399891737,
            "start_logit": 5.8289618492126465,
            "end_logit": -1.140747308731079,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "mass abdomen. Resection",
            "probability": 0.0009878710530167203,
            "start_logit": -0.7427930235862732,
            "end_logit": 5.124085426330566,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgical resectionExtra luminal colonic gastrointestinal stromal tumors are very rare and can present as mass abdomen.",
            "probability": 0.0006395921109956562,
            "start_logit": 5.8289618492126465,
            "end_logit": -1.8823909759521484,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "urgery aiming at an R0 resection remains the mainstay of treatment.The treatment of choice for GIST is surgical resection",
            "probability": 0.00028449150345993785,
            "start_logit": -2.1815099716186523,
            "end_logit": 5.317953586578369,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Resection is the treatment of choice",
            "probability": 0.00025175626433016627,
            "start_logit": 4.127130508422852,
            "end_logit": -1.112928867340088,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "treatment of choice for GIST is surgical resection",
            "probability": 0.00022808703168415825,
            "start_logit": -2.4024860858917236,
            "end_logit": 5.317953586578369,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Re",
            "probability": 0.0001565540299811144,
            "start_logit": 4.127130508422852,
            "end_logit": -1.587989091873169,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "section",
            "probability": 0.00013008680120032347,
            "start_logit": -2.7701432704925537,
            "end_logit": 5.124085426330566,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Resection is the treatment of choice.",
            "probability": 0.00010692268313347743,
            "start_logit": 4.127130508422852,
            "end_logit": -1.9692842960357666,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "sectionExtra luminal colonic gastrointestinal stromal tumors are very rare and can present as mass abdomen. Resection",
            "probability": 9.899840103287687e-05,
            "start_logit": -3.043241500854492,
            "end_logit": 5.124085426330566,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "toolSurgery aiming at an R0 resection remains the mainstay of treatment.The treatment of choice for GIST is surgical resection",
            "probability": 8.496342624421778e-05,
            "start_logit": -3.3899924755096436,
            "end_logit": 5.317953586578369,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "is surgical resection",
            "probability": 8.119761136243445e-05,
            "start_logit": -3.4353275299072266,
            "end_logit": 5.317953586578369,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "colonic gastrointestinal stromal tumors are very rare and can present as mass abdomen. Resection",
            "probability": 7.730294283947683e-05,
            "start_logit": -3.2906131744384766,
            "end_logit": 5.124085426330566,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "abdomen. Resection",
            "probability": 6.905890243411203e-05,
            "start_logit": -3.4033854007720947,
            "end_logit": 5.124085426330566,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "resection remains the mainstay of treatment.The treatment of choice for GIST is surgical resection",
            "probability": 4.8611844826579996e-05,
            "start_logit": -3.9483461380004883,
            "end_logit": 5.317953586578369,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        }
    ],
    "56be0e4aef6e394741000008": [
        {
            "text": "bronchiectasis and sinusitis",
            "probability": 0.16430907436277864,
            "start_logit": 3.5667312145233154,
            "end_logit": 4.072092056274414,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis",
            "probability": 0.16309541372582298,
            "start_logit": 3.5593173503875732,
            "end_logit": 4.072092056274414,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus, bronchiectasis and sinusitis",
            "probability": 0.15522655696806592,
            "start_logit": 3.5098676681518555,
            "end_logit": 4.072092056274414,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis",
            "probability": 0.12277209468294767,
            "start_logit": 3.5667312145233154,
            "end_logit": 3.780672550201416,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus, bronchiectasis",
            "probability": 0.11598561809991247,
            "start_logit": 3.5098676681518555,
            "end_logit": 3.780672550201416,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus",
            "probability": 0.08243456123678493,
            "start_logit": 3.5098676681518555,
            "end_logit": 3.439211130142212,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus, chronic rhinosinusitis",
            "probability": 0.04103252634652123,
            "start_logit": 3.015716314315796,
            "end_logit": 3.235722780227661,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus, chronic rhinosinusitis, and bronchiectasis",
            "probability": 0.03686205031064994,
            "start_logit": 3.015716314315796,
            "end_logit": 3.128540277481079,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic rhinosinusitis",
            "probability": 0.029075343821067173,
            "start_logit": 2.6712417602539062,
            "end_logit": 3.235722780227661,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic rhinosinusitis, and bronchiectasis",
            "probability": 0.026120175435468622,
            "start_logit": 2.6712417602539062,
            "end_logit": 3.128540277481079,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis, and situs inversus",
            "probability": 0.014793373865300856,
            "start_logit": 2.624826431274414,
            "end_logit": 2.606426954269409,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "rhinosinusitis",
            "probability": 0.010702016810431942,
            "start_logit": 1.671783447265625,
            "end_logit": 3.235722780227661,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "rhinosinusitis, and bronchiectasis",
            "probability": 0.009614282063941439,
            "start_logit": 1.671783447265625,
            "end_logit": 3.128540277481079,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis, and situs inversus",
            "probability": 0.005242275390018432,
            "start_logit": 1.5874027013778687,
            "end_logit": 2.606426954269409,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis",
            "probability": 0.0049490832009421535,
            "start_logit": 1.5874027013778687,
            "end_logit": 2.5488736629486084,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis, and situs inversus",
            "probability": 0.00411271908458384,
            "start_logit": 1.3447314500808716,
            "end_logit": 2.606426954269409,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis",
            "probability": 0.003882701196977083,
            "start_logit": 1.3447314500808716,
            "end_logit": 2.5488736629486084,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus and bronchiectasis",
            "probability": 0.0033943385559966088,
            "start_logit": 1.609325647354126,
            "end_logit": 2.14985728263855,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0033761565213609934,
            "start_logit": 1.6039546728134155,
            "end_logit": 2.14985728263855,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, situs inversus",
            "probability": 0.003019638320427239,
            "start_logit": 1.6039546728134155,
            "end_logit": 2.0382564067840576,
            "question_text": "List Kartagener Syndrome Triad."
        }
    ],
    "54dfc6501388e8454a000009": [
        {
            "text": "host-mediated defense",
            "probability": 0.3207852824707697,
            "start_logit": 4.243526935577393,
            "end_logit": 3.3244378566741943,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "host-mediated defense against exogenous viruses",
            "probability": 0.24686185667963906,
            "start_logit": 4.243526935577393,
            "end_logit": 3.0624947547912598,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "defense",
            "probability": 0.1502196875467277,
            "start_logit": 3.484853744506836,
            "end_logit": 3.3244378566741943,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "defense against exogenous viruses",
            "probability": 0.11560228291021907,
            "start_logit": 3.484853744506836,
            "end_logit": 3.0624947547912598,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "restrict the replication of retroviruses",
            "probability": 0.02671720294179818,
            "start_logit": 2.7751593589782715,
            "end_logit": 2.3073410987854004,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cytidine deaminases play a critical role in host-mediated defense",
            "probability": 0.018722040469645283,
            "start_logit": 1.4024564027786255,
            "end_logit": 3.3244378566741943,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "restrict the replication",
            "probability": 0.01632363017191545,
            "start_logit": 2.7751593589782715,
            "end_logit": 1.8146471977233887,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "replication of retroviruses",
            "probability": 0.014602954721056572,
            "start_logit": 2.1710755825042725,
            "end_logit": 2.3073410987854004,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cytidine deaminases play a critical role in host-mediated defense against exogenous viruses",
            "probability": 0.014407636271745463,
            "start_logit": 1.4024564027786255,
            "end_logit": 3.0624947547912598,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cytidine deaminases that potently restrict the replication of retroviruses",
            "probability": 0.010136110147701162,
            "start_logit": 1.8059560060501099,
            "end_logit": 2.3073410987854004,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "replication",
            "probability": 0.008922087869865569,
            "start_logit": 2.1710755825042725,
            "end_logit": 1.8146471977233887,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "host-mediated defense against exogenous viruses,",
            "probability": 0.008669221027461068,
            "start_logit": 4.243526935577393,
            "end_logit": -0.2865552008152008,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "restrict the replication of retroviruses by hypermutating viral cDNA and/or inhibiting reverse transcription",
            "probability": 0.008178757342316347,
            "start_logit": 2.7751593589782715,
            "end_logit": 1.123573660850525,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cellular cytidine deaminases that potently restrict the replication of retroviruses",
            "probability": 0.007340963417590832,
            "start_logit": 1.4833217859268188,
            "end_logit": 2.3073410987854004,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "critical role in host-mediated defense",
            "probability": 0.006520532981644382,
            "start_logit": 0.34771105647087097,
            "end_logit": 3.3244378566741943,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cytidine deaminases that potently restrict the replication",
            "probability": 0.006192942943664934,
            "start_logit": 1.8059560060501099,
            "end_logit": 1.8146471977233887,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cytidine deaminases",
            "probability": 0.005809207359470972,
            "start_logit": 1.4024564027786255,
            "end_logit": 2.1541805267333984,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "critical role in host-mediated defense against exogenous viruses",
            "probability": 0.005017907511190853,
            "start_logit": 0.34771105647087097,
            "end_logit": 3.0624947547912598,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cellular cytidine deaminases that potently restrict the replication",
            "probability": 0.00448516905738068,
            "start_logit": 1.4833217859268188,
            "end_logit": 1.8146471977233887,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "host",
            "probability": 0.0044845261581965565,
            "start_logit": 4.243526935577393,
            "end_logit": -0.9457013010978699,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        }
    ],
    "52e0c9a298d0239505000010": [
        {
            "text": "H4K20me3, H3K9me3",
            "probability": 0.17582218783288164,
            "start_logit": 4.951760768890381,
            "end_logit": 4.258970260620117,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3",
            "probability": 0.17388221434512283,
            "start_logit": 4.9406657218933105,
            "end_logit": 4.258970260620117,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3",
            "probability": 0.16566556096559168,
            "start_logit": 4.951760768890381,
            "end_logit": 4.19946813583374,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3, H3K9me3, and H3K79me3",
            "probability": 0.15702800380647577,
            "start_logit": 4.951760768890381,
            "end_logit": 4.145921230316162,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3, and H3K79me3",
            "probability": 0.15529540015744256,
            "start_logit": 4.9406657218933105,
            "end_logit": 4.145921230316162,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K79me3",
            "probability": 0.14840509414555444,
            "start_logit": 4.89528226852417,
            "end_logit": 4.145921230316162,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "methylation marks usually found in constitutive heterochromatin, such as H4K20me3",
            "probability": 0.017652430299789922,
            "start_logit": 2.712663173675537,
            "end_logit": 4.19946813583374,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "trimethylation at lysine 36",
            "probability": 0.0012839504371273528,
            "start_logit": 2.015166997909546,
            "end_logit": 2.2760324478149414,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3,",
            "probability": 0.001125872045677243,
            "start_logit": 4.951760768890381,
            "end_logit": -0.7919450402259827,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3, H3K9me3,",
            "probability": 0.0006401617406756489,
            "start_logit": 4.951760768890381,
            "end_logit": -1.3565373420715332,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3,",
            "probability": 0.0006330983727350297,
            "start_logit": 4.9406657218933105,
            "end_logit": -1.3565373420715332,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H4K20",
            "probability": 0.0005245321714863109,
            "start_logit": 4.951760768890381,
            "end_logit": -1.5557514429092407,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3 trimethylation at lysine 36",
            "probability": 0.0002830704272801094,
            "start_logit": 0.5031658411026001,
            "end_logit": 2.2760324478149414,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H",
            "probability": 0.0002738501161627223,
            "start_logit": 4.951760768890381,
            "end_logit": -2.2056772708892822,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "4K20me3, H3K9me3",
            "probability": 0.0002699079334100804,
            "start_logit": -1.5273867845535278,
            "end_logit": 4.258970260620117,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "4K20me3",
            "probability": 0.00025431630528875834,
            "start_logit": -1.5273867845535278,
            "end_logit": 4.19946813583374,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "4K20me3, H3K9me3, and H3K79me3",
            "probability": 0.00024105662952619554,
            "start_logit": -1.5273867845535278,
            "end_logit": 4.145921230316162,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H4K20me3, H3K9me3, and H3K79me",
            "probability": 0.00024100505358428236,
            "start_logit": 4.951760768890381,
            "end_logit": -2.3334403038024902,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "lysine 36",
            "probability": 0.00023994134383884414,
            "start_logit": 0.33786460757255554,
            "end_logit": 2.2760324478149414,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3, and H3K79me",
            "probability": 0.00023834587034846796,
            "start_logit": 4.9406657218933105,
            "end_logit": -2.3334403038024902,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        }
    ],
    "51487ef9d24251bc05000031": [
        {
            "text": "entacapone",
            "probability": 0.5072197634428426,
            "start_logit": 6.276045322418213,
            "end_logit": 5.933628559112549,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Entacapone",
            "probability": 0.47044787169389335,
            "start_logit": 6.01079797744751,
            "end_logit": 6.123616695404053,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "ropinirole, a new non-ergot agonist, in December 2006 and entacapone",
            "probability": 0.009152630273837734,
            "start_logit": 3.5047574043273926,
            "end_logit": 4.690013408660889,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone,",
            "probability": 0.004431707086085347,
            "start_logit": 6.039124011993408,
            "end_logit": 1.4303903579711914,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone. It is available in fixed-dose combinations of levodopa/carbidopa/entacapone",
            "probability": 0.00441887215316562,
            "start_logit": 5.472543239593506,
            "end_logit": 1.9940707683563232,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "ropinirole",
            "probability": 0.0025264215485246294,
            "start_logit": 3.5047574043273926,
            "end_logit": 3.402776002883911,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "carbidopa and the catechol-O-methyl transferase inhibitor entacapone",
            "probability": 0.0006314494528757522,
            "start_logit": -0.4126364290714264,
            "end_logit": 5.933628559112549,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone, at doses of 200 mg and 400 mg,",
            "probability": 0.0005642448844846049,
            "start_logit": 6.039124011993408,
            "end_logit": -0.6306614279747009,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacap",
            "probability": 0.00011963112736456926,
            "start_logit": 6.276045322418213,
            "end_logit": -2.4186580181121826,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "carbidopa, and the COMT inhibitor entacapone",
            "probability": 0.00011569179133691382,
            "start_logit": -0.6686731576919556,
            "end_logit": 4.492577075958252,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "en",
            "probability": 5.829874561407562e-05,
            "start_logit": 6.276045322418213,
            "end_logit": -3.1374905109405518,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "En",
            "probability": 5.180447813716957e-05,
            "start_logit": 6.01079797744751,
            "end_logit": -2.990347146987915,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Stalevo is a combination tablet comprised of levodopa, carbidopa, and the COMT inhibitor entacapone",
            "probability": 5.082996079598573e-05,
            "start_logit": -1.4911168813705444,
            "end_logit": 4.492577075958252,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "one",
            "probability": 4.978155236076379e-05,
            "start_logit": -3.142997980117798,
            "end_logit": 6.123616695404053,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Entacap",
            "probability": 4.3911520148980725e-05,
            "start_logit": 6.01079797744751,
            "end_logit": -3.155647039413452,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone. It is available in fixed-dose combinations of levodopa/carbidopa",
            "probability": 3.958870208564543e-05,
            "start_logit": 5.472543239593506,
            "end_logit": -2.721025228500366,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "ropinirole, a new non-ergot agonist, in December 2006 and entacapone,",
            "probability": 3.2879249706969134e-05,
            "start_logit": 3.5047574043273926,
            "end_logit": -0.9389414191246033,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone in a single tablet.We investigated whether administration of the catechol-O-methyl transferase (COMT) inhibitor",
            "probability": 2.0720768021253784e-05,
            "start_logit": 6.276045322418213,
            "end_logit": -4.171934604644775,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "carbidopa/entacapone",
            "probability": 1.2350540533260345e-05,
            "start_logit": -0.40739670395851135,
            "end_logit": 1.9940707683563232,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone, at doses of 200 mg and 400 mg, alters the pharmacokinetics of apomorphine",
            "probability": 1.1551028184836138e-05,
            "start_logit": 6.039124011993408,
            "end_logit": -4.519375324249268,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        }
    ],
    "5505db6a8e1671127b000003": [
        {
            "text": "intermediate filaments",
            "probability": 0.30646450658864116,
            "start_logit": 4.151243686676025,
            "end_logit": 3.7638344764709473,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "intermediate filaments of the cytoskeleton",
            "probability": 0.1874284186940524,
            "start_logit": 4.151243686676025,
            "end_logit": 3.272129535675049,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "intermediate filaments of the cytoskeleton and provide scaffold structures within cells.keratin intermediate filaments",
            "probability": 0.14426244105005473,
            "start_logit": 4.151243686676025,
            "end_logit": 3.010366678237915,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "keratin intermediate filamentskeratin intermediate filaments",
            "probability": 0.043890870260670616,
            "start_logit": 2.9019775390625,
            "end_logit": 3.069705009460449,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "keratin intermediate filaments",
            "probability": 0.041362223999524876,
            "start_logit": 2.9019775390625,
            "end_logit": 3.010366678237915,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "keratin intermediate filamentskeratin",
            "probability": 0.03333758682542422,
            "start_logit": 2.9019775390625,
            "end_logit": 2.7946841716766357,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "intermediate filamentskeratin intermediate filaments",
            "probability": 0.03191512157114036,
            "start_logit": 2.5833511352539062,
            "end_logit": 3.069705009460449,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "keratin intermediate filamentskeratin intermediate filamentskeratin intermediate filament",
            "probability": 0.02862098758202904,
            "start_logit": 2.9019775390625,
            "end_logit": 2.642138957977295,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "keratin intermediate filamentskeratin intermediate filamentskeratin",
            "probability": 0.02575664750934753,
            "start_logit": 2.9019775390625,
            "end_logit": 2.536691427230835,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "intermediate filamentskeratin",
            "probability": 0.024241331513885647,
            "start_logit": 2.5833511352539062,
            "end_logit": 2.7946841716766357,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "intermediate filamentskeratin intermediate filament",
            "probability": 0.024015122986665877,
            "start_logit": 2.7265210151672363,
            "end_logit": 2.642138957977295,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "intermediate filamentskeratin intermediate filamentskeratin intermediate filament",
            "probability": 0.02081166977873905,
            "start_logit": 2.5833511352539062,
            "end_logit": 2.642138957977295,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "intermediate filamentskeratin intermediate filamentskeratin",
            "probability": 0.018728873035411896,
            "start_logit": 2.5833511352539062,
            "end_logit": 2.536691427230835,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "intermediate filament",
            "probability": 0.01871545958055765,
            "start_logit": 2.477187156677246,
            "end_logit": 2.642138957977295,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "scaffold structures within cells.keratin intermediate filamentskeratin intermediate filaments",
            "probability": 0.010225916202023079,
            "start_logit": 1.445196509361267,
            "end_logit": 3.069705009460449,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "scaffold structures within cells.keratin intermediate filaments",
            "probability": 0.009636779449494256,
            "start_logit": 1.445196509361267,
            "end_logit": 3.010366678237915,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "keratin intermediate filamentskeratin intermediate filamentskeratin intermediate filament protein",
            "probability": 0.008781932358135814,
            "start_logit": 2.9019775390625,
            "end_logit": 1.4606951475143433,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "scaffold structures within cells.keratin intermediate filamentskeratin",
            "probability": 0.0077671590294242625,
            "start_logit": 1.445196509361267,
            "end_logit": 2.7946841716766357,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "intermediate filamentskeratin intermediate filament protein",
            "probability": 0.007368690022898954,
            "start_logit": 2.7265210151672363,
            "end_logit": 1.4606951475143433,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "scaffold structures within cells.keratin intermediate filamentskeratin intermediate filamentskeratin intermediate filament",
            "probability": 0.006668261961878453,
            "start_logit": 1.445196509361267,
            "end_logit": 2.642138957977295,
            "question_text": "What are the structures formed when keratin molecules come together?"
        }
    ],
    "56c9f9d95795f9a73e00001e": [
        {
            "text": "aggregate, be recruited to stress granules and alter paraspeckle integrity",
            "probability": 0.21922575554296497,
            "start_logit": 4.53052282333374,
            "end_logit": 5.322868824005127,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "alter paraspeckle integrity",
            "probability": 0.15051518432026784,
            "start_logit": 4.154484748840332,
            "end_logit": 5.322868824005127,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "aggregate, be recruited to stress granules",
            "probability": 0.12841193549101032,
            "start_logit": 4.53052282333374,
            "end_logit": 4.788010120391846,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "aggregate",
            "probability": 0.1120856924680418,
            "start_logit": 4.53052282333374,
            "end_logit": 4.6520304679870605,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "ability to aggregate, be recruited to stress granules and alter paraspeckle integrity",
            "probability": 0.1060219722077147,
            "start_logit": 3.8040671348571777,
            "end_logit": 5.322868824005127,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "ability to aggregate, be recruited to stress granules",
            "probability": 0.062102587453956845,
            "start_logit": 3.8040671348571777,
            "end_logit": 4.788010120391846,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "ability to aggregate",
            "probability": 0.0542068888862841,
            "start_logit": 3.8040671348571777,
            "end_logit": 4.6520304679870605,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "recruited to stress granules and alter paraspeckle integrity",
            "probability": 0.041303969442069925,
            "start_logit": 2.861379384994507,
            "end_logit": 5.322868824005127,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "paraspeckle integrity",
            "probability": 0.029615254640319288,
            "start_logit": 2.52871036529541,
            "end_logit": 5.322868824005127,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "recruited to stress granules",
            "probability": 0.024193884730292353,
            "start_logit": 2.861379384994507,
            "end_logit": 4.788010120391846,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "be recruited to stress granules and alter paraspeckle integrity",
            "probability": 0.019675666149703695,
            "start_logit": 2.1198034286499023,
            "end_logit": 5.322868824005127,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "stress granules and alter paraspeckle integrity",
            "probability": 0.013721984573100398,
            "start_logit": 1.7594200372695923,
            "end_logit": 5.322868824005127,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "be recruited to stress granules",
            "probability": 0.011525061761564927,
            "start_logit": 2.1198034286499023,
            "end_logit": 4.788010120391846,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "stress granules",
            "probability": 0.00803768057929794,
            "start_logit": 1.7594200372695923,
            "end_logit": 4.788010120391846,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "the ability to aggregate, be recruited to stress granules and alter paraspeckle integrity",
            "probability": 0.005782197993150683,
            "start_logit": 0.8952046632766724,
            "end_logit": 5.322868824005127,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "the ability to aggregate, be recruited to stress granules",
            "probability": 0.003386934321899031,
            "start_logit": 0.8952046632766724,
            "end_logit": 4.788010120391846,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "the ability to aggregate",
            "probability": 0.002956320823000187,
            "start_logit": 0.8952046632766724,
            "end_logit": 4.6520304679870605,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "alter paraspeckle integrity.Similar to several proteins implicated in ALS, CREST contains a prion-like domain",
            "probability": 0.0027866034268031977,
            "start_logit": 4.154484748840332,
            "end_logit": 1.3336282968521118,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "to aggregate, be recruited to stress granules and alter paraspeckle integrity",
            "probability": 0.002331189106083929,
            "start_logit": -0.013200739398598671,
            "end_logit": 5.322868824005127,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "aggregate, be recruited",
            "probability": 0.002113236082473914,
            "start_logit": 4.53052282333374,
            "end_logit": 0.6809872388839722,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        }
    ],
    "54c225bcf693c3b16b000002": [
        {
            "text": "CASQ2",
            "probability": 0.13826273081334037,
            "start_logit": 3.4641151428222656,
            "end_logit": 2.7599761486053467,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2, CASQ2",
            "probability": 0.1295515837609552,
            "start_logit": 3.3948655128479004,
            "end_logit": 2.7641491889953613,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2",
            "probability": 0.10598181337952237,
            "start_logit": 3.3948655128479004,
            "end_logit": 2.563337564468384,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2, CASQ2, TRDN",
            "probability": 0.06714292004313191,
            "start_logit": 3.3948655128479004,
            "end_logit": 2.106893539428711,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "CASQ2, TRDN",
            "probability": 0.06537192892861958,
            "start_logit": 3.3681349754333496,
            "end_logit": 2.106893539428711,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin 2",
            "probability": 0.06268196810512112,
            "start_logit": 3.2136592864990234,
            "end_logit": 2.2193500995635986,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin 2 (CASQ2) and inward rectifier potassium channel 2 (KCNJ2",
            "probability": 0.052097267349449944,
            "start_logit": 3.2136592864990234,
            "end_logit": 2.034388780593872,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2, CASQ2, TRDN, and CALM1",
            "probability": 0.04879434879900611,
            "start_logit": 3.3948655128479004,
            "end_logit": 1.7876845598220825,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "CASQ2, TRDN, and CALM1",
            "probability": 0.047507327649107596,
            "start_logit": 3.3681349754333496,
            "end_logit": 1.7876845598220825,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "TRDN",
            "probability": 0.039422578582610536,
            "start_logit": 2.8623807430267334,
            "end_logit": 2.106893539428711,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor 2 (RYR2), calsequestrin 2",
            "probability": 0.03686678992697913,
            "start_logit": 2.682896614074707,
            "end_logit": 2.2193500995635986,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin 2 (CASQ2",
            "probability": 0.030402941129424092,
            "start_logit": 3.2136592864990234,
            "end_logit": 1.495815634727478,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor 2",
            "probability": 0.029434718051803987,
            "start_logit": 2.682896614074707,
            "end_logit": 1.9942138195037842,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "KCNJ2)point mutations in RYR2",
            "probability": 0.028679975445292962,
            "start_logit": 2.0921010971069336,
            "end_logit": 2.5590336322784424,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "TRDN, and CALM1",
            "probability": 0.028649320712897604,
            "start_logit": 2.8623807430267334,
            "end_logit": 1.7876845598220825,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2, the gene encoding for the cardiac isoform of the RyR (RyR2",
            "probability": 0.020494516272164965,
            "start_logit": 3.2106523513793945,
            "end_logit": 1.1044405698776245,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor 2 (RYR2), calsequestrin 2 (CASQ2",
            "probability": 0.017881679176075797,
            "start_logit": 2.682896614074707,
            "end_logit": 1.495815634727478,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "CASQ2 gene",
            "probability": 0.016996495421057783,
            "start_logit": 3.4641151428222656,
            "end_logit": 0.6638275980949402,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "KCNJ2",
            "probability": 0.016971819767567935,
            "start_logit": 2.0921010971069336,
            "end_logit": 2.034388780593872,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin 2 (CASQ2) and inward rectifier potassium channel 2",
            "probability": 0.01680727668587093,
            "start_logit": 3.2136592864990234,
            "end_logit": 0.9030882120132446,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        }
    ],
    "532c0d7fd6d3ac6a3400001c": [
        {
            "text": "LigandScout",
            "probability": 0.7271506435882278,
            "start_logit": 4.560986042022705,
            "end_logit": 4.275897979736328,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "LigandScout program",
            "probability": 0.1479703724538794,
            "start_logit": 4.560986042022705,
            "end_logit": 2.683776378631592,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "LigandS",
            "probability": 0.07957502843796622,
            "start_logit": 4.560986042022705,
            "end_logit": 2.063464641571045,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "PharmaGist",
            "probability": 0.014645232593287151,
            "start_logit": 2.0326218605041504,
            "end_logit": 2.8992433547973633,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "the LigandScout",
            "probability": 0.013149472873952269,
            "start_logit": 0.5482340455055237,
            "end_logit": 4.275897979736328,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "program CatalystThe PharmaGist",
            "probability": 0.007527281797153513,
            "start_logit": 1.367040991783142,
            "end_logit": 2.8992433547973633,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "the LigandScout program",
            "probability": 0.0026758312268409874,
            "start_logit": 0.5482340455055237,
            "end_logit": 2.683776378631592,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "the LigandS",
            "probability": 0.001438999864904964,
            "start_logit": 0.5482340455055237,
            "end_logit": 2.063464641571045,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "thermolysin binding modes and activity profiles were generated using the LigandScout",
            "probability": 0.0011307282686085682,
            "start_logit": -1.9052857160568237,
            "end_logit": 4.275897979736328,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Pharmacophore models based on thermolysin binding modes and activity profiles were generated using the LigandScout",
            "probability": 0.000998847601508248,
            "start_logit": -2.0293006896972656,
            "end_logit": 4.275897979736328,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Discovery Studio program A pharmacophore-based screening was then carried out using the program CatalystThe PharmaGist",
            "probability": 0.0004955840997793638,
            "start_logit": -1.3535112142562866,
            "end_logit": 2.8992433547973633,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "L",
            "probability": 0.0004691229611055435,
            "start_logit": 4.560986042022705,
            "end_logit": -3.0701260566711426,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "using the LigandScout",
            "probability": 0.00046240100047546096,
            "start_logit": -2.7994704246520996,
            "end_logit": 4.275897979736328,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "LigandSco",
            "probability": 0.0004615380372453865,
            "start_logit": 4.560986042022705,
            "end_logit": -3.0864264965057373,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "generated using the LigandScout",
            "probability": 0.0003849162011245747,
            "start_logit": -2.982877254486084,
            "end_logit": 4.275897979736328,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "ut",
            "probability": 0.0003571068018271515,
            "start_logit": -3.057868003845215,
            "end_logit": 4.275897979736328,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "LigandScout programIn this study,",
            "probability": 0.0003438273697130637,
            "start_logit": 4.560986042022705,
            "end_logit": -3.3808512687683105,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "the program CatalystThe PharmaGist",
            "probability": 0.0003297101421172319,
            "start_logit": -1.761034369468689,
            "end_logit": 2.8992433547973633,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "thermolysin binding modes and activity profiles were generated using the LigandScout program",
            "probability": 0.0002300957642346351,
            "start_logit": -1.9052857160568237,
            "end_logit": 2.683776378631592,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Pharmacophore models based on thermolysin binding modes and activity profiles were generated using the LigandScout program",
            "probability": 0.00020325891604867493,
            "start_logit": -2.0293006896972656,
            "end_logit": 2.683776378631592,
            "question_text": "List programs suitable for pharmacophore modelling"
        }
    ],
    "530c844e970c65fa6b000014": [
        {
            "text": "Leber's hereditary optic neuropathy plus dystonia",
            "probability": 0.25628145053142876,
            "start_logit": 3.2001287937164307,
            "end_logit": 3.4241738319396973,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "optic neuropathy plus dystonia",
            "probability": 0.2138856924573117,
            "start_logit": 3.019294261932373,
            "end_logit": 3.4241738319396973,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Leber's hereditary optic neuropathy",
            "probability": 0.17189001132525,
            "start_logit": 3.2001287937164307,
            "end_logit": 3.024752378463745,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "dystonia",
            "probability": 0.17120958884447546,
            "start_logit": 2.796741008758545,
            "end_logit": 3.4241738319396973,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "optic neuropathy",
            "probability": 0.14345483850883559,
            "start_logit": 3.019294261932373,
            "end_logit": 3.024752378463745,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Leber's hereditary",
            "probability": 0.01437819751217544,
            "start_logit": 3.2001287937164307,
            "end_logit": 0.5436105728149414,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Leigh's syndrome",
            "probability": 0.005425014290969015,
            "start_logit": 1.7103029489517212,
            "end_logit": 1.058743953704834,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Leigh syndrome",
            "probability": 0.0048496461649195745,
            "start_logit": 1.4249322414398193,
            "end_logit": 1.2319998741149902,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Leber's hereditary optic neuropathy and/or dystonia",
            "probability": 0.004090725451864034,
            "start_logit": 0.5531604290008545,
            "end_logit": 1.9335882663726807,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "optic neuropathy and/or dystonia",
            "probability": 0.0033203555037549606,
            "start_logit": 0.34450995922088623,
            "end_logit": 1.9335882663726807,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "hereditary optic neuropathy plus dystonia",
            "probability": 0.0031371930695441586,
            "start_logit": -1.2028189897537231,
            "end_logit": 3.4241738319396973,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Leber's",
            "probability": 0.002588996289599371,
            "start_logit": 3.2001287937164307,
            "end_logit": -1.1708321571350098,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "hereditary optic neuropathy",
            "probability": 0.0021041403938335786,
            "start_logit": -1.2028189897537231,
            "end_logit": 3.024752378463745,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Leigh's-like and Leigh's syndrome",
            "probability": 0.0018750386125589867,
            "start_logit": 0.6479116678237915,
            "end_logit": 1.058743953704834,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "neuropathy plus dystonia",
            "probability": 0.0005061739476204388,
            "start_logit": -3.027022361755371,
            "end_logit": 3.4241738319396973,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "neuropathy",
            "probability": 0.00033949490065943654,
            "start_logit": -3.027022361755371,
            "end_logit": 3.024752378463745,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Leber's hereditary op",
            "probability": 0.00018001706372357073,
            "start_logit": 3.2001287937164307,
            "end_logit": -3.836806058883667,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "hereditary",
            "probability": 0.00017600642377432692,
            "start_logit": -1.2028189897537231,
            "end_logit": 0.5436105728149414,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "ia",
            "probability": 0.00015718124709405856,
            "start_logit": -4.196503162384033,
            "end_logit": 3.4241738319396973,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "op",
            "probability": 0.00015023746060749784,
            "start_logit": 3.019294261932373,
            "end_logit": -3.836806058883667,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        }
    ],
    "571653aecb4ef8864c000005": [
        {
            "text": "nanoplasmonics",
            "probability": 0.41201018056254235,
            "start_logit": 4.127963066101074,
            "end_logit": 3.527221202850342,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "deep sequencing",
            "probability": 0.2691269934055685,
            "start_logit": 3.8034894466400146,
            "end_logit": 3.425830125808716,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "deep sequencing (CAPP-Seq",
            "probability": 0.09799622715955975,
            "start_logit": 3.8034894466400146,
            "end_logit": 2.4155757427215576,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "deep sequencing (CAPP-Seq)",
            "probability": 0.0736420373384727,
            "start_logit": 3.8034894466400146,
            "end_logit": 2.1298627853393555,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "CAPP-Seq",
            "probability": 0.03990348185336659,
            "start_logit": 2.9050240516662598,
            "end_logit": 2.4155757427215576,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "CAPP-Seq)",
            "probability": 0.029986600359583594,
            "start_logit": 2.9050240516662598,
            "end_logit": 2.1298627853393555,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "liquid biopsy",
            "probability": 0.02763631446144458,
            "start_logit": 2.545745372772217,
            "end_logit": 2.4075214862823486,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "personalized profiling by deep sequencing",
            "probability": 0.008805154379440128,
            "start_logit": 0.38364335894584656,
            "end_logit": 3.425830125808716,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "nanoplasmonics has emerged as a platform for one-step dual detection",
            "probability": 0.006686911292765675,
            "start_logit": 4.127963066101074,
            "end_logit": -0.5936747789382935,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "deep sequencing (CAPP-Seq),",
            "probability": 0.004969510595899708,
            "start_logit": 3.8034894466400146,
            "end_logit": -0.5660318732261658,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "(CAPP-Seq",
            "probability": 0.004078020924530135,
            "start_logit": 0.6241722702980042,
            "end_logit": 2.4155757427215576,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "profiling by deep sequencing",
            "probability": 0.0032362969659270172,
            "start_logit": -0.6172641515731812,
            "end_logit": 3.425830125808716,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "personalized profiling by deep sequencing (CAPP-Seq",
            "probability": 0.003206188639139137,
            "start_logit": 0.38364335894584656,
            "end_logit": 2.4155757427215576,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "cancer personalized profiling by deep sequencing",
            "probability": 0.0031799918704790756,
            "start_logit": -0.6348152756690979,
            "end_logit": 3.425830125808716,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "(CAPP-Seq)",
            "probability": 0.0030645441961999545,
            "start_logit": 0.6241722702980042,
            "end_logit": 2.1298627853393555,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "personalized profiling",
            "probability": 0.0029987506489825523,
            "start_logit": 0.38364335894584656,
            "end_logit": 2.3486886024475098,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "deep sequencing (CAPP-Seq), an economical and ultrasensitive method for quantifying ctDNA",
            "probability": 0.0025970859788669934,
            "start_logit": 3.8034894466400146,
            "end_logit": -1.2149631977081299,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "genetic mutations.Recently, nanoplasmonics",
            "probability": 0.0024427729986308344,
            "start_logit": -0.9999511241912842,
            "end_logit": 3.527221202850342,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "personalized profiling by deep sequencing (CAPP-Seq)",
            "probability": 0.002409381160085184,
            "start_logit": 0.38364335894584656,
            "end_logit": 2.1298627853393555,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "CAPP-Seq),",
            "probability": 0.0020235552085155176,
            "start_logit": 2.9050240516662598,
            "end_logit": -0.5660318732261658,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        }
    ],
    "517a8bab8ed59a060a000040": [
        {
            "text": "iodothyronine deiodinase (D3",
            "probability": 0.1501164191616205,
            "start_logit": 1.6066678762435913,
            "end_logit": 0.28345179557800293,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type III",
            "probability": 0.14663742902087434,
            "start_logit": 1.2258840799331665,
            "end_logit": 0.6407875418663025,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "iodothyronine deiodinase",
            "probability": 0.11745134280828518,
            "start_logit": 1.6066678762435913,
            "end_logit": 0.03806481882929802,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type III iodothyronine deiodinase (D3",
            "probability": 0.1025783938700663,
            "start_logit": 1.2258840799331665,
            "end_logit": 0.28345179557800293,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "iodothyronine deiodinase (D3)",
            "probability": 0.08152974930358357,
            "start_logit": 1.6066678762435913,
            "end_logit": -0.32699134945869446,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type III iodothyronine deiodinase",
            "probability": 0.08025751060705225,
            "start_logit": 1.2258840799331665,
            "end_logit": 0.03806481882929802,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "iodothyronine",
            "probability": 0.07570646633094366,
            "start_logit": 1.6066678762435913,
            "end_logit": -0.40109574794769287,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type III iodothyronine deiodinase (D3)",
            "probability": 0.055711365771299544,
            "start_logit": 1.2258840799331665,
            "end_logit": -0.32699134945869446,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type III iodothyronine",
            "probability": 0.05173216737501229,
            "start_logit": 1.2258840799331665,
            "end_logit": -0.40109574794769287,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "D3",
            "probability": 0.03824337397939941,
            "start_logit": 0.2392270714044571,
            "end_logit": 0.28345179557800293,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "5'-deiodinase",
            "probability": 0.03081971486190281,
            "start_logit": 1.1439766883850098,
            "end_logit": -0.8371135592460632,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "D3)",
            "probability": 0.020770364164540242,
            "start_logit": 0.2392270714044571,
            "end_logit": -0.32699134945869446,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "(D3",
            "probability": 0.01222191608976482,
            "start_logit": -0.9015125036239624,
            "end_logit": 0.28345179557800293,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "5D (type-III) together with our previous report of 5'-deiodinase",
            "probability": 0.0073480789140683315,
            "start_logit": -0.2897389829158783,
            "end_logit": -0.8371135592460632,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "(D3)",
            "probability": 0.006637846548518773,
            "start_logit": -0.9015125036239624,
            "end_logit": -0.32699134945869446,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "5",
            "probability": 0.004983925886854831,
            "start_logit": 1.1439766883850098,
            "end_logit": -2.659050226211548,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "5'-deiodinase (type-I in euthyroidism and type-II in hypothyroidism",
            "probability": 0.004668181647492111,
            "start_logit": 1.1439766883850098,
            "end_logit": -2.7244985103607178,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "5'-deiodinase (type-I",
            "probability": 0.004337936149770237,
            "start_logit": 1.1439766883850098,
            "end_logit": -2.7978694438934326,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase (D3",
            "probability": 0.004336754686264147,
            "start_logit": -1.9376169443130493,
            "end_logit": 0.28345179557800293,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "5'-deiodinase (type-I in euthyroidism and type-II",
            "probability": 0.0039110628226867086,
            "start_logit": 1.1439766883850098,
            "end_logit": -2.901458978652954,
            "question_text": "Which deiodinases are best known to be present in brain?"
        }
    ],
    "5149a61ed24251bc05000044": [
        {
            "text": "BETAWARE",
            "probability": 0.9657033271338878,
            "start_logit": 2.7192087173461914,
            "end_logit": 3.2695584297180176,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "BOCTOPUS",
            "probability": 0.020215638539975562,
            "start_logit": 0.8512135148048401,
            "end_logit": 1.271153450012207,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "BETA",
            "probability": 0.004711411807135667,
            "start_logit": 2.7192087173461914,
            "end_logit": -2.0533106327056885,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "BETAWARE: a machine-learning",
            "probability": 0.0025577799107401856,
            "start_logit": 2.7192087173461914,
            "end_logit": -2.664158582687378,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel proteins in prokaryotesRecently,",
            "probability": 0.0017056663709047563,
            "start_logit": 2.7192087173461914,
            "end_logit": -3.0693423748016357,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "WARE",
            "probability": 0.0013222793289131808,
            "start_logit": -3.874290943145752,
            "end_logit": 3.2695584297180176,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "BETAWARE: a machine-learning tool",
            "probability": 0.0011673877055483526,
            "start_logit": 2.7192087173461914,
            "end_logit": -3.4485297203063965,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "BETAWARE:",
            "probability": 0.0011081753481908688,
            "start_logit": 2.7192087173461914,
            "end_logit": -3.5005834102630615,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "BETAWARE: a machine",
            "probability": 0.0008821143100918576,
            "start_logit": 2.7192087173461914,
            "end_logit": -3.728731870651245,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel proteins in prokaryotesRecently",
            "probability": 0.0003651309718829717,
            "start_logit": 2.7192087173461914,
            "end_logit": -4.61079740524292,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "machine-learning",
            "probability": 7.47180841062709e-05,
            "start_logit": -0.9962171912193298,
            "end_logit": -2.481905460357666,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "BOCTOPUS: improved topology",
            "probability": 7.338154222453024e-05,
            "start_logit": 0.8512135148048401,
            "end_logit": -4.347385883331299,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "machine-learning tool to detect and predict transmembrane beta-barrel proteins in prokaryotesRecently,",
            "probability": 3.286357698588192e-05,
            "start_logit": -1.2301374673843384,
            "end_logit": -3.0693423748016357,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "machine-learning tool",
            "probability": 2.249240319682811e-05,
            "start_logit": -1.2301374673843384,
            "end_logit": -3.4485297203063965,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "machine-learning approaches",
            "probability": 2.22236325893923e-05,
            "start_logit": -0.9962171912193298,
            "end_logit": -3.6944713592529297,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "machine",
            "probability": 1.915076701105776e-05,
            "start_logit": -0.9962171912193298,
            "end_logit": -3.843284845352173,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "machine-learning tool to detect and predict transmembrane beta-barrel proteins in prokaryotesRecently",
            "probability": 7.035086115956479e-06,
            "start_logit": -1.2301374673843384,
            "end_logit": -4.61079740524292,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "WARE: a machine-learning",
            "probability": 3.502213784350195e-06,
            "start_logit": -3.874290943145752,
            "end_logit": -2.664158582687378,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "extreme learning machines",
            "probability": 3.0598370743697417e-06,
            "start_logit": -3.072399616241455,
            "end_logit": -3.601083517074585,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "N-to-1 extreme learning machines",
            "probability": 2.661429640054704e-06,
            "start_logit": -3.211897850036621,
            "end_logit": -3.601083517074585,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        }
    ],
    "56c33e5695c1e7cc5b000001": [
        {
            "text": "pericentromeric heterochromatin",
            "probability": 0.2557004354310072,
            "start_logit": 4.7141194343566895,
            "end_logit": 3.9186291694641113,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar heterochromatin, and pericentromeric heterochromatin",
            "probability": 0.20014707594257775,
            "start_logit": 4.469165325164795,
            "end_logit": 3.9186291694641113,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar heterochromatin",
            "probability": 0.19838967146395714,
            "start_logit": 4.469165325164795,
            "end_logit": 3.9098098278045654,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "pericentromeric",
            "probability": 0.12549020478802345,
            "start_logit": 4.7141194343566895,
            "end_logit": 3.206850290298462,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar heterochromatin, and pericentromeric",
            "probability": 0.09822626037152397,
            "start_logit": 4.469165325164795,
            "end_logit": 3.206850290298462,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar",
            "probability": 0.0711818794687552,
            "start_logit": 4.469165325164795,
            "end_logit": 2.884814977645874,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin, perinucleolar heterochromatin, and pericentromeric heterochromatin",
            "probability": 0.011290025952258234,
            "start_logit": 1.5940325260162354,
            "end_logit": 3.9186291694641113,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin, perinucleolar heterochromatin",
            "probability": 0.011190893141654825,
            "start_logit": 1.5940325260162354,
            "end_logit": 3.9098098278045654,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin",
            "probability": 0.007023669095963635,
            "start_logit": 1.5940325260162354,
            "end_logit": 3.443995237350464,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin, perinucleolar heterochromatin, and pericentromeric",
            "probability": 0.0055408105442716835,
            "start_logit": 1.5940325260162354,
            "end_logit": 3.206850290298462,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin, perinucleolar",
            "probability": 0.00401527358192997,
            "start_logit": 1.5940325260162354,
            "end_logit": 2.884814977645874,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar heterochromatin,",
            "probability": 0.002590136355647143,
            "start_logit": 4.469165325164795,
            "end_logit": -0.42871278524398804,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the peripheral heterochromatin, perinucleolar heterochromatin, and pericentromeric heterochromatin",
            "probability": 0.0021802758849258095,
            "start_logit": -0.05043572932481766,
            "end_logit": 3.9186291694641113,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the peripheral heterochromatin, perinucleolar heterochromatin",
            "probability": 0.0021611318300514006,
            "start_logit": -0.05043572932481766,
            "end_logit": 3.9098098278045654,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the peripheral heterochromatin",
            "probability": 0.0013563774271542002,
            "start_logit": -0.05043572932481766,
            "end_logit": 3.443995237350464,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the peripheral heterochromatin, perinucleolar heterochromatin, and pericentromeric",
            "probability": 0.001070014866547039,
            "start_logit": -0.05043572932481766,
            "end_logit": 3.206850290298462,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the peripheral heterochromatin, perinucleolar",
            "probability": 0.0007754104551292489,
            "start_logit": -0.05043572932481766,
            "end_logit": 2.884814977645874,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "heterochromatin",
            "probability": 0.0006877699730861068,
            "start_logit": -1.2041879892349243,
            "end_logit": 3.9186291694641113,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral",
            "probability": 0.0006477292960340021,
            "start_logit": 1.5940325260162354,
            "end_logit": 1.0604270696640015,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "per",
            "probability": 0.00033495412950218474,
            "start_logit": 4.7141194343566895,
            "end_logit": -2.7191390991210938,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        }
    ],
    "5547a7e9f35db75526000006": [
        {
            "text": "UvrC",
            "probability": 0.15355223644196112,
            "start_logit": 4.87477445602417,
            "end_logit": 4.096238613128662,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrC nuclease",
            "probability": 0.08903979568507817,
            "start_logit": 4.87477445602417,
            "end_logit": 3.551281213760376,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrB, UvrC",
            "probability": 0.07574503605426706,
            "start_logit": 4.364211559295654,
            "end_logit": 3.9001336097717285,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrA, UvrB, UvrC",
            "probability": 0.06506062681641041,
            "start_logit": 4.212158203125,
            "end_logit": 3.9001336097717285,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "DNA polymerase I, and ligase.During nucleotide excision repair (NER) in bacteria the UvrC",
            "probability": 0.06404233517161495,
            "start_logit": 4.000277996063232,
            "end_logit": 4.096238613128662,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrD",
            "probability": 0.06178463606422503,
            "start_logit": 4.477949142456055,
            "end_logit": 3.5826778411865234,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrC, the UvrD",
            "probability": 0.06120956527638425,
            "start_logit": 4.468597888946533,
            "end_logit": 3.5826778411865234,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrB, UvrC, the UvrD",
            "probability": 0.05514230144962362,
            "start_logit": 4.364211559295654,
            "end_logit": 3.5826778411865234,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrB",
            "probability": 0.05209282025131515,
            "start_logit": 4.364211559295654,
            "end_logit": 3.525787830352783,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrA",
            "probability": 0.05020369870207933,
            "start_logit": 4.212158203125,
            "end_logit": 3.6409027576446533,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrA, UvrB, UvrC, the UvrD",
            "probability": 0.047364063485845605,
            "start_logit": 4.212158203125,
            "end_logit": 3.5826778411865234,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrA, UvrB",
            "probability": 0.0447447346352439,
            "start_logit": 4.212158203125,
            "end_logit": 3.525787830352783,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrD helicase, DNA polymerase I, and ligase",
            "probability": 0.02550030718351862,
            "start_logit": 4.477949142456055,
            "end_logit": 2.697713613510132,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrC, the UvrD helicase, DNA polymerase I, and ligase",
            "probability": 0.025262958828387673,
            "start_logit": 4.468597888946533,
            "end_logit": 2.697713613510132,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrD helicase",
            "probability": 0.023822654901571535,
            "start_logit": 4.477949142456055,
            "end_logit": 2.629660129547119,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrC, the UvrD helicase",
            "probability": 0.02360092157439834,
            "start_logit": 4.468597888946533,
            "end_logit": 2.629660129547119,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrB, UvrC, the UvrD helicase, DNA polymerase I, and ligase",
            "probability": 0.022758823476922322,
            "start_logit": 4.364211559295654,
            "end_logit": 2.697713613510132,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrB, UvrC, the UvrD helicase",
            "probability": 0.02126153201820739,
            "start_logit": 4.364211559295654,
            "end_logit": 2.629660129547119,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase I, and ligase",
            "probability": 0.01954851958815839,
            "start_logit": 4.212158203125,
            "end_logit": 2.697713613510132,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrA, UvrB, UvrC, the UvrD helicase",
            "probability": 0.018262432394786948,
            "start_logit": 4.212158203125,
            "end_logit": 2.629660129547119,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        }
    ],
    "570921e4cf1c325851000017": [
        {
            "text": "genes",
            "probability": 0.3066164676226175,
            "start_logit": 0.9065439701080322,
            "end_logit": 0.5791142582893372,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genes which are involved in metabolism, transport, and signaling processes",
            "probability": 0.21607336259966778,
            "start_logit": 0.9065439701080322,
            "end_logit": 0.22913457453250885,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genes which are involved in metabolism",
            "probability": 0.163656577280182,
            "start_logit": 0.9065439701080322,
            "end_logit": -0.04871322587132454,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "metabolism, transport, and signaling processes",
            "probability": 0.08797053371922853,
            "start_logit": 0.007927892729640007,
            "end_logit": 0.22913457453250885,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "metabolism",
            "probability": 0.0666299458516499,
            "start_logit": 0.007927892729640007,
            "end_logit": -0.04871322587132454,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genes which are involved in metabolism, transport",
            "probability": 0.04514568910994489,
            "start_logit": 0.9065439701080322,
            "end_logit": -1.3365886211395264,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "metabolism, transport",
            "probability": 0.018380286761596042,
            "start_logit": 0.007927892729640007,
            "end_logit": -1.3365886211395264,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genes which are involved in metabolism, transport, and signaling",
            "probability": 0.015115192801356071,
            "start_logit": 0.9065439701080322,
            "end_logit": -2.4307830333709717,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "transport, and signaling processes",
            "probability": 0.011838379418867432,
            "start_logit": -1.9977272748947144,
            "end_logit": 0.22913457453250885,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "signaling processes",
            "probability": 0.009822035696905006,
            "start_logit": -2.18444561958313,
            "end_logit": 0.22913457453250885,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genes which are involved in metabolism, transport, and signaling processes. In contrast, they are significantly fewer in genes",
            "probability": 0.009199304554299405,
            "start_logit": 0.9065439701080322,
            "end_logit": -2.9273555278778076,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "in genes",
            "probability": 0.007872525131580084,
            "start_logit": -2.7556748390197754,
            "end_logit": 0.5791142582893372,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "involved in metabolism, transport, and signaling processes",
            "probability": 0.006198345604674318,
            "start_logit": -2.644791603088379,
            "end_logit": 0.22913457453250885,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "metabolism, transport, and signaling",
            "probability": 0.006153889410551428,
            "start_logit": 0.007927892729640007,
            "end_logit": -2.4307830333709717,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "clustered in genes",
            "probability": 0.006063287287239878,
            "start_logit": -3.016801595687866,
            "end_logit": 0.5791142582893372,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "in genes which are involved in metabolism, transport, and signaling processes",
            "probability": 0.005547787405288808,
            "start_logit": -2.7556748390197754,
            "end_logit": 0.22913457453250885,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "involved in metabolism",
            "probability": 0.004694701902427922,
            "start_logit": -2.644791603088379,
            "end_logit": -0.04871322587132454,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genes which are involved in metabolism, transport, and signaling processes.",
            "probability": 0.004546913442830364,
            "start_logit": 0.9065439701080322,
            "end_logit": -3.6320347785949707,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "clustered in genes which are involved in metabolism, transport, and signaling processes",
            "probability": 0.004272813142489865,
            "start_logit": -3.016801595687866,
            "end_logit": 0.22913457453250885,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "in genes which are involved in metabolism",
            "probability": 0.004201961256602687,
            "start_logit": -2.7556748390197754,
            "end_logit": -0.04871322587132454,
            "question_text": "In which genomic regions are Alu enriched?"
        }
    ],
    "56bcdf1ad36b5da378000009": [
        {
            "text": "prostate cancer",
            "probability": 0.2266014165083344,
            "start_logit": 4.2285943031311035,
            "end_logit": 4.112382411956787,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate cancer, human gastric tumor",
            "probability": 0.10948564983357444,
            "start_logit": 4.2285943031311035,
            "end_logit": 3.3849833011627197,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate cancer, human gastric tumor cells and human melanoma",
            "probability": 0.0977334639710722,
            "start_logit": 4.2285943031311035,
            "end_logit": 3.2714338302612305,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric tumor",
            "probability": 0.09297027593738429,
            "start_logit": 4.065080642700195,
            "end_logit": 3.3849833011627197,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric tumor cells and human melanoma",
            "probability": 0.0829908497371006,
            "start_logit": 4.065080642700195,
            "end_logit": 3.2714338302612305,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric tumor cells.Dracorhodin perchlorate suppresses proliferation and induces apoptosis in human prostate cancer",
            "probability": 0.06902640156070347,
            "start_logit": 3.2697386741638184,
            "end_logit": 3.8825345039367676,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "melanoma",
            "probability": 0.058186969361968134,
            "start_logit": 3.7100117206573486,
            "end_logit": 3.2714338302612305,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate cancer, human gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer",
            "probability": 0.04731003613975178,
            "start_logit": 4.2285943031311035,
            "end_logit": 2.545912265777588,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer",
            "probability": 0.0401735489646931,
            "start_logit": 4.065080642700195,
            "end_logit": 2.545912265777588,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate cancer, human gastric",
            "probability": 0.039174184174684316,
            "start_logit": 4.2285943031311035,
            "end_logit": 2.357207775115967,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric",
            "probability": 0.03326495041019944,
            "start_logit": 4.065080642700195,
            "end_logit": 2.357207775115967,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "melanoma, but the cytotoxic effect of DP on human breast cancer",
            "probability": 0.028166684281160263,
            "start_logit": 3.7100117206573486,
            "end_logit": 2.545912265777588,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate",
            "probability": 0.025058490798975333,
            "start_logit": 4.2285943031311035,
            "end_logit": 1.910402536392212,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "breast cancer MCF-7 apoptosis through mitochondrial pathways.It was reported that DP could induce apoptosis in human prostate cancer",
            "probability": 0.022385043893134168,
            "start_logit": 1.913794755935669,
            "end_logit": 4.112382411956787,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric tumor cells.Dracorhodin perchlorate suppresses proliferation and induces apoptosis in human prostate",
            "probability": 0.012231750788409868,
            "start_logit": 3.2697386741638184,
            "end_logit": 2.152080535888672,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "human gastric tumor",
            "probability": 0.0041346052150841904,
            "start_logit": 0.9521926641464233,
            "end_logit": 3.3849833011627197,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "human gastric tumor cells and human melanoma",
            "probability": 0.003690796834446166,
            "start_logit": 0.9521926641464233,
            "end_logit": 3.2714338302612305,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "breast cancer",
            "probability": 0.0027933439354019905,
            "start_logit": 1.6940157413482666,
            "end_logit": 2.2510077953338623,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "breast cancer MCF-7 apoptosis through mitochondrial pathways.It was reported that DP could induce apoptosis in human prostate",
            "probability": 0.0024754276697565576,
            "start_logit": 1.913794755935669,
            "end_logit": 1.910402536392212,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "human melanoma",
            "probability": 0.0021461099841651667,
            "start_logit": 0.41000717878341675,
            "end_logit": 3.2714338302612305,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        }
    ],
    "56bcc455d36b5da378000003": [
        {
            "text": "NBEAL2",
            "probability": 0.5335102305053984,
            "start_logit": 4.379910469055176,
            "end_logit": 4.435067653656006,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "NBEAL2 gene. Mutations in NBEAL2",
            "probability": 0.23792493734087558,
            "start_logit": 4.379910469055176,
            "end_logit": 3.627544641494751,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "NBEAL2 gene",
            "probability": 0.0966301072447523,
            "start_logit": 4.379910469055176,
            "end_logit": 2.7264797687530518,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "GFI1B",
            "probability": 0.06517913848643861,
            "start_logit": 3.7824161052703857,
            "end_logit": 2.930223226547241,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "GFI1B mutation in the gray platelet syndromeWe detected a nonsense mutation in the gene encoding the transcription factor GFI1B",
            "probability": 0.04323835115187985,
            "start_logit": 3.372004508972168,
            "end_logit": 2.930223226547241,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "GFI1B (growth factor independent 1B)",
            "probability": 0.00837611602524127,
            "start_logit": 3.7824161052703857,
            "end_logit": 0.8784680962562561,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "the NBEAL2",
            "probability": 0.003783848370364233,
            "start_logit": -0.5688261985778809,
            "end_logit": 4.435067653656006,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "GFI1B (growth factor independent 1B",
            "probability": 0.0027021228704930613,
            "start_logit": 3.7824161052703857,
            "end_logit": -0.2528785169124603,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "the NBEAL2 gene. Mutations in NBEAL2",
            "probability": 0.0016874500898950895,
            "start_logit": -0.5688261985778809,
            "end_logit": 3.627544641494751,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "biallelic mutations in the NBEAL2",
            "probability": 0.0016617609961430864,
            "start_logit": -1.3916898965835571,
            "end_logit": 4.435067653656006,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "mutations in the NBEAL2",
            "probability": 0.0008087981071347082,
            "start_logit": -2.111773729324341,
            "end_logit": 4.435067653656006,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "biallelic mutations in the NBEAL2 gene. Mutations in NBEAL2",
            "probability": 0.0007410811607273466,
            "start_logit": -1.3916898965835571,
            "end_logit": 3.627544641494751,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "the NBEAL2 gene",
            "probability": 0.0006853358247316259,
            "start_logit": -0.5688261985778809,
            "end_logit": 2.7264797687530518,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "NBEAL2 gene.",
            "probability": 0.0006765741157991658,
            "start_logit": 4.379910469055176,
            "end_logit": -2.235123872756958,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "NBEAL",
            "probability": 0.0006692725199575617,
            "start_logit": 4.379910469055176,
            "end_logit": -2.245974540710449,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "Mutations in NBEAL2",
            "probability": 0.00048487558282857653,
            "start_logit": -1.8159077167510986,
            "end_logit": 3.627544641494751,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "mutations in the NBEAL2 gene. Mutations in NBEAL2",
            "probability": 0.0003606926877093823,
            "start_logit": -2.111773729324341,
            "end_logit": 3.627544641494751,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "biallelic mutations in the NBEAL2 gene",
            "probability": 0.00030098043878247255,
            "start_logit": -1.3916898965835571,
            "end_logit": 2.7264797687530518,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "in biallelic mutations in the NBEAL2",
            "probability": 0.00029678310518127277,
            "start_logit": -3.11432147026062,
            "end_logit": 4.435067653656006,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "GFI1B mutation",
            "probability": 0.00028154337566637744,
            "start_logit": 3.372004508972168,
            "end_logit": -2.103973388671875,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        }
    ],
    "52f89fd32059c6d71c000051": [
        {
            "text": "FOG-1",
            "probability": 0.27003620549186236,
            "start_logit": 5.844295024871826,
            "end_logit": 5.4272847175598145,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "FOG-1 and GATA-1/TAL-1",
            "probability": 0.1560189236367733,
            "start_logit": 5.844295024871826,
            "end_logit": 4.878705978393555,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "TAL-1",
            "probability": 0.11249808014455918,
            "start_logit": 5.517253875732422,
            "end_logit": 4.878705978393555,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "ACF/WCRF complex, in addition to the known GATA-1/FOG-1",
            "probability": 0.07232610672486417,
            "start_logit": 4.526924133300781,
            "end_logit": 5.4272847175598145,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "WCRF complex, in addition to the known GATA-1/FOG-1",
            "probability": 0.04273624221368762,
            "start_logit": 4.000786304473877,
            "end_logit": 5.4272847175598145,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "GATA-1/TAL-1",
            "probability": 0.037152825624296386,
            "start_logit": 4.40935754776001,
            "end_logit": 4.878705978393555,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1/MeCP1",
            "probability": 0.03522110618775095,
            "start_logit": 4.869614124298096,
            "end_logit": 4.365055084228516,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "GATA-1/FOG-1",
            "probability": 0.034621820763738556,
            "start_logit": 3.7902231216430664,
            "end_logit": 5.4272847175598145,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "FOG-1/MeCP1",
            "probability": 0.0329530811117207,
            "start_logit": 4.803053379058838,
            "end_logit": 4.365055084228516,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MeCP1",
            "probability": 0.030785298105430504,
            "start_logit": 4.735005855560303,
            "end_logit": 4.365055084228516,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1",
            "probability": 0.02500577196699535,
            "start_logit": 4.869614124298096,
            "end_logit": 4.022516250610352,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "WCRF complex, in addition to the known GATA-1/FOG-1 and GATA-1/TAL-1",
            "probability": 0.02469173531125221,
            "start_logit": 4.000786304473877,
            "end_logit": 4.878705978393555,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "GATA-1/FOG-1 and GATA-1/TAL-1",
            "probability": 0.02000346286922832,
            "start_logit": 3.7902231216430664,
            "end_logit": 4.878705978393555,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "GATA-1/FOG-1/MeCP1",
            "probability": 0.01887058631250962,
            "start_logit": 4.245573043823242,
            "end_logit": 4.365055084228516,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "ACF/WCRF",
            "probability": 0.01821402894832301,
            "start_logit": 4.526924133300781,
            "end_logit": 4.0482916831970215,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "Gfi-1b",
            "probability": 0.017958690753906686,
            "start_logit": 4.869614124298096,
            "end_logit": 3.691483736038208,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MeCP1 complex, and the chromatin remodeling ACF/WCRF",
            "probability": 0.014956954208955816,
            "start_logit": 4.32990837097168,
            "end_logit": 4.0482916831970215,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "GATA-1/Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1/MeCP1",
            "probability": 0.013674312180944469,
            "start_logit": 3.923487663269043,
            "end_logit": 4.365055084228516,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "Gfi-1b, the repressive MeCP1",
            "probability": 0.011512413597946157,
            "start_logit": 4.3388991355896,
            "end_logit": 3.777550458908081,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "WCRF",
            "probability": 0.01076235384525479,
            "start_logit": 4.000786304473877,
            "end_logit": 4.0482916831970215,
            "question_text": "List interaction partners for the protein GATA1."
        }
    ],
    "533675ced6d3ac6a34000056": [
        {
            "text": "H2AX",
            "probability": 0.32718801188749047,
            "start_logit": 5.198645114898682,
            "end_logit": 3.807685136795044,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2AX and H2A.Z",
            "probability": 0.31585894770288214,
            "start_logit": 5.198645114898682,
            "end_logit": 3.7724459171295166,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2A.Z",
            "probability": 0.24293572211771158,
            "start_logit": 4.936146259307861,
            "end_logit": 3.7724459171295166,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2AX and H2A",
            "probability": 0.0428720385152376,
            "start_logit": 5.198645114898682,
            "end_logit": 1.7753700017929077,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2A",
            "probability": 0.0329740528520812,
            "start_logit": 4.936146259307861,
            "end_logit": 1.7753700017929077,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2A.X and H2A.Z",
            "probability": 0.014706690250991195,
            "start_logit": 3.4735453128814697,
            "end_logit": 2.4305524826049805,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2A.X",
            "probability": 0.008731145488033054,
            "start_logit": 3.4735453128814697,
            "end_logit": 1.9091465473175049,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "(H2AX",
            "probability": 0.004975733343156098,
            "start_logit": 1.0126829147338867,
            "end_logit": 3.807685136795044,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "(H2AX and H2A.Z",
            "probability": 0.004803445849843247,
            "start_logit": 1.0126829147338867,
            "end_logit": 3.7724459171295166,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H",
            "probability": 0.0007991348862241538,
            "start_logit": 5.198645114898682,
            "end_logit": -2.207075357437134,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "(H2AX and H2A",
            "probability": 0.0006519793628707095,
            "start_logit": 1.0126829147338867,
            "end_logit": 1.7753700017929077,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2AX and H2A.",
            "probability": 0.0006066440385267332,
            "start_logit": 5.198645114898682,
            "end_logit": -2.4826629161834717,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2A.X and H2A",
            "probability": 0.0005621115294130039,
            "start_logit": 3.4735453128814697,
            "end_logit": -0.8338050246238708,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2A.",
            "probability": 0.00046658645778345313,
            "start_logit": 4.936146259307861,
            "end_logit": -2.4826629161834717,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "(H2A.X and H2A.Z",
            "probability": 0.00044308641143696396,
            "start_logit": -0.028747664764523506,
            "end_logit": 2.4305524826049805,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2A (H2A.X and H2A.Z",
            "probability": 0.00033742816613047745,
            "start_logit": -0.3011598289012909,
            "end_logit": 2.4305524826049805,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2AFX (H2AFX)))the specialization imparted by histone H2A (H2A.X",
            "probability": 0.00033207116261706323,
            "start_logit": 0.2042427510023117,
            "end_logit": 1.9091465473175049,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "(H2A.X",
            "probability": 0.00026305387928911257,
            "start_logit": -0.028747664764523506,
            "end_logit": 1.9091465473175049,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2A.Z)",
            "probability": 0.0002580692082446666,
            "start_logit": 3.966766834259033,
            "end_logit": -2.105499029159546,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "2AX",
            "probability": 0.00023404689003726922,
            "start_logit": -2.044123649597168,
            "end_logit": 3.807685136795044,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        }
    ],
    "52f895602059c6d71c000040": [
        {
            "text": "blood pressure",
            "probability": 0.3943676843823513,
            "start_logit": 1.3113702535629272,
            "end_logit": 1.7934354543685913,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "body weight and blood pressure",
            "probability": 0.14095124554611124,
            "start_logit": 0.28250062465667725,
            "end_logit": 1.7934354543685913,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "blood pressure, in parallel with the data automatically transmitted by implantable cardioverter-defibrillators",
            "probability": 0.13198789912038977,
            "start_logit": 1.3113702535629272,
            "end_logit": 0.6988620162010193,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "body weight and blood pressure, in parallel with the data automatically transmitted by implantable cardioverter-defibrillators",
            "probability": 0.04717389257481965,
            "start_logit": 0.28250062465667725,
            "end_logit": 0.6988620162010193,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "self-measured body weight and blood pressure",
            "probability": 0.043540046805567126,
            "start_logit": -0.8922322988510132,
            "end_logit": 1.7934354543685913,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "vital signs",
            "probability": 0.037201325379347235,
            "start_logit": 0.33974605798721313,
            "end_logit": 0.4041203558444977,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "body weight",
            "probability": 0.03482152967557607,
            "start_logit": 0.28250062465667725,
            "end_logit": 0.39525726437568665,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "vital signs with a set of wireless sensors",
            "probability": 0.030280863067439392,
            "start_logit": 0.33974605798721313,
            "end_logit": 0.19829189777374268,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "Sleepbox\u00ae technologies was associated with low HPSG failure rate In this study, we monitored remotely self-measured body weight and blood pressure",
            "probability": 0.01938315579232964,
            "start_logit": -1.7015089988708496,
            "end_logit": 1.7934354543685913,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "Home-polysomnography",
            "probability": 0.01646116939059003,
            "start_logit": -0.04251202940940857,
            "end_logit": -0.028961708769202232,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "blood pressure, in parallel with the data automatically transmitted by implantable cardioverter-defibrillators.Body weight",
            "probability": 0.0154861004323325,
            "start_logit": 1.3113702535629272,
            "end_logit": -1.4439053535461426,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "remotely self-measured body weight and blood pressure",
            "probability": 0.015033384359964526,
            "start_logit": -1.9556400775909424,
            "end_logit": 1.7934354543685913,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "self-measured body weight and blood pressure, in parallel with the data automatically transmitted by implantable cardioverter-defibrillators",
            "probability": 0.014572084714473174,
            "start_logit": -0.8922322988510132,
            "end_logit": 0.6988620162010193,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "blood pressure, in parallel with the data automatically transmitted by implantable cardioverter-defibrillators.Body weight, patient activity",
            "probability": 0.011045070079975919,
            "start_logit": 1.3113702535629272,
            "end_logit": -1.781864047050476,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "self-measured body weight",
            "probability": 0.010756421669363926,
            "start_logit": -0.8922322988510132,
            "end_logit": 0.39525726437568665,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "cardioverter-defibrillators",
            "probability": 0.007852330401364611,
            "start_logit": -1.510529637336731,
            "end_logit": 0.6988620162010193,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "implantable cardioverter-defibrillators",
            "probability": 0.007584797853965711,
            "start_logit": -1.5451940298080444,
            "end_logit": 0.6988620162010193,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "vital signs with a set of wireless sensorsthis terminal is very helpful in special circumstances such as disaster relief, dangerous outdoor sports and adventure monitoring",
            "probability": 0.007432890647999838,
            "start_logit": 0.33974605798721313,
            "end_logit": -1.206309199333191,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "wireless sensors",
            "probability": 0.0070881105725788054,
            "start_logit": -1.1123510599136353,
            "end_logit": 0.19829189777374268,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "blood pressure,",
            "probability": 0.006979997533459573,
            "start_logit": 1.3113702535629272,
            "end_logit": -2.24079966545105,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        }
    ],
    "551829a76487737b43000009": [
        {
            "text": "asthma",
            "probability": 0.45287386665013935,
            "start_logit": 3.413700819015503,
            "end_logit": 3.2743303775787354,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "sepsis",
            "probability": 0.3377340991467329,
            "start_logit": 3.208019256591797,
            "end_logit": 3.186657190322876,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "cancer",
            "probability": 0.20236381150293575,
            "start_logit": 2.9851274490356445,
            "end_logit": 2.897357225418091,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "psis",
            "probability": 0.001749662509292481,
            "start_logit": -2.054816722869873,
            "end_logit": 3.186657190322876,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "cancer.",
            "probability": 0.0011491820533902823,
            "start_logit": 2.9851274490356445,
            "end_logit": -2.2736594676971436,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "cancer.Point of care monitoring of hemodialysis patients with a breath ammonia",
            "probability": 0.0006579614367094874,
            "start_logit": 2.9851274490356445,
            "end_logit": -2.8313188552856445,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "asth",
            "probability": 0.0005502809400930756,
            "start_logit": 3.413700819015503,
            "end_logit": -3.4386096000671387,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "sepsis in real time,",
            "probability": 0.0005238348369160122,
            "start_logit": 3.208019256591797,
            "end_logit": -3.2821805477142334,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "thma",
            "probability": 0.0003985748621749443,
            "start_logit": -3.6217727661132812,
            "end_logit": 3.2743303775787354,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "se",
            "probability": 0.0003764431015378523,
            "start_logit": 3.208019256591797,
            "end_logit": -3.6125900745391846,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "as",
            "probability": 0.00034805535417170233,
            "start_logit": 3.413700819015503,
            "end_logit": -3.896677017211914,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "cancer.Point of care monitoring of hemodialysis",
            "probability": 0.00021939630827057756,
            "start_logit": 2.9851274490356445,
            "end_logit": -3.9295854568481445,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "cancer.Point of care monitoring",
            "probability": 0.00021730677748202308,
            "start_logit": 2.9851274490356445,
            "end_logit": -3.939155101776123,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "nitric oxide (FeNO) has emerged as an important biomarker for the assessment and management of asthma",
            "probability": 0.00020496526840550026,
            "start_logit": -4.286827564239502,
            "end_logit": 3.2743303775787354,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "ma",
            "probability": 0.0001954723792800868,
            "start_logit": -4.334249019622803,
            "end_logit": 3.2743303775787354,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "cancer.Point of care monitoring of hemodialysis patients",
            "probability": 0.0001921378596510412,
            "start_logit": 2.9851274490356445,
            "end_logit": -4.062252044677734,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "cancer.Point of care monitoring of hemodialysis patients with a breath ammonia measurement",
            "probability": 0.00017484176975048163,
            "start_logit": 2.9851274490356445,
            "end_logit": -4.156583786010742,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "ammonia measurement device based on printed polyaniline nanoparticle sensors.",
            "probability": 2.8255701857308945e-05,
            "start_logit": -0.7520368695259094,
            "end_logit": -2.2420055866241455,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "kidney dysfunction",
            "probability": 2.5049650020227508e-05,
            "start_logit": -1.8459283113479614,
            "end_logit": -1.2685495615005493,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "ammonia systems as a noninvasive means of monitoring kidney dysfunction",
            "probability": 1.680189118892206e-05,
            "start_logit": -2.2452967166900635,
            "end_logit": -1.2685495615005493,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        }
    ],
    "52bf209303868f1b0600001a": [
        {
            "text": "ischemic stroke",
            "probability": 0.8812042390386057,
            "start_logit": 5.955077648162842,
            "end_logit": 6.022327899932861,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "central venous catheter (CVC) occlusions",
            "probability": 0.08186547124073473,
            "start_logit": 4.9349188804626465,
            "end_logit": 4.666274547576904,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "stroke",
            "probability": 0.016415884781284775,
            "start_logit": 1.972037672996521,
            "end_logit": 6.022327899932861,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "thrombus-related venous catheter occlusion",
            "probability": 0.00919886454755317,
            "start_logit": 3.6045703887939453,
            "end_logit": 3.8106257915496826,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "venous catheter occlusion",
            "probability": 0.003245070203950287,
            "start_logit": 2.5626273155212402,
            "end_logit": 3.8106257915496826,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "occlusions",
            "probability": 0.0026451969001204815,
            "start_logit": 1.502587080001831,
            "end_logit": 4.666274547576904,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "central venous catheter (CVC) occlusion",
            "probability": 0.001631815974767109,
            "start_logit": 4.9349188804626465,
            "end_logit": 0.7508907318115234,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "central venous catheter",
            "probability": 0.0007948571940274764,
            "start_logit": 4.9349188804626465,
            "end_logit": 0.03160443156957626,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "chemic stroke",
            "probability": 0.0006482139829087201,
            "start_logit": -1.2597461938858032,
            "end_logit": 6.022327899932861,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "thrombus-related venous catheter occlusion in pediatric patients",
            "probability": 0.00047099593345044887,
            "start_logit": 3.6045703887939453,
            "end_logit": 0.8386399149894714,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "catheter (CVC) occlusions",
            "probability": 0.0003371876099511468,
            "start_logit": -0.5572742223739624,
            "end_logit": 4.666274547576904,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "treatment of thrombus-related venous catheter occlusion",
            "probability": 0.0003038248584411131,
            "start_logit": 0.19418646395206451,
            "end_logit": 3.8106257915496826,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ischemic",
            "probability": 0.00024330240247390886,
            "start_logit": 5.955077648162842,
            "end_logit": -2.1724116802215576,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "venous catheter occlusion in pediatric patients; however, data regarding its use in occluded dialysis catheters",
            "probability": 0.00017749817262428187,
            "start_logit": 2.5626273155212402,
            "end_logit": 0.9046938419342041,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "venous catheter occlusion in pediatric patients",
            "probability": 0.00016615255740757168,
            "start_logit": 2.5626273155212402,
            "end_logit": 0.8386399149894714,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "central venous catheter (CVC)",
            "probability": 0.00015911956260226923,
            "start_logit": 4.9349188804626465,
            "end_logit": -1.576902151107788,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "thrombus",
            "probability": 0.00015660642999318412,
            "start_logit": 3.6045703887939453,
            "end_logit": -0.2624737024307251,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "CVC) occlusions",
            "probability": 0.0001273781486288718,
            "start_logit": -1.530753493309021,
            "end_logit": 4.666274547576904,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "thrombolysis",
            "probability": 0.00012445186918916132,
            "start_logit": 1.2363356351852417,
            "end_logit": 1.8759442567825317,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "Intravenous thrombolysis",
            "probability": 8.38685912858693e-05,
            "start_logit": 0.8416677713394165,
            "end_logit": 1.8759442567825317,
            "question_text": "What are the indications for alteplase?"
        }
    ],
    "55152bd246478f2f2c000002": [
        {
            "text": "caveolin-1 and IQGAP1",
            "probability": 0.2613684107394731,
            "start_logit": 4.708156108856201,
            "end_logit": 4.269558906555176,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "IQGAP1",
            "probability": 0.25161660542094433,
            "start_logit": 4.670131683349609,
            "end_logit": 4.269558906555176,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "caveolin-1",
            "probability": 0.23957583824295908,
            "start_logit": 4.708156108856201,
            "end_logit": 4.182497978210449,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "MP1",
            "probability": 0.06535804146261923,
            "start_logit": 4.165492534637451,
            "end_logit": 3.4261720180511475,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "KSR",
            "probability": 0.03552784151762393,
            "start_logit": 3.507309913635254,
            "end_logit": 3.4747908115386963,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "KSR and MP1",
            "probability": 0.033841838542637795,
            "start_logit": 3.507309913635254,
            "end_logit": 3.4261720180511475,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "caveolin-1 and IQGAP",
            "probability": 0.032753488792756615,
            "start_logit": 4.708156108856201,
            "end_logit": 2.1926374435424805,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "IQGAP",
            "probability": 0.03153143733938509,
            "start_logit": 4.670131683349609,
            "end_logit": 2.1926374435424805,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "caveolin",
            "probability": 0.012084765493778979,
            "start_logit": 4.708156108856201,
            "end_logit": 1.1955735683441162,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "hDlg",
            "probability": 0.01106387653831198,
            "start_logit": 3.378450870513916,
            "end_logit": 2.437018632888794,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "caveolin-1 and IQGAP1,",
            "probability": 0.006930248053086342,
            "start_logit": 4.708156108856201,
            "end_logit": 0.6395235657691956,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "IQGAP1,",
            "probability": 0.00667167652322317,
            "start_logit": 4.670131683349609,
            "end_logit": 0.6395235657691956,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "MP1,",
            "probability": 0.003113722739163279,
            "start_logit": 4.165492534637451,
            "end_logit": 0.3821105659008026,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "hDlg acts as a MEK2",
            "probability": 0.002886841179176914,
            "start_logit": 3.378450870513916,
            "end_logit": 1.0934960842132568,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "IQGAP1, are required for phosphorylation of the actin associated pool of extracellular signal regulated kinase 1 and 2",
            "probability": 0.0017300040711857516,
            "start_logit": 4.670131683349609,
            "end_logit": -0.7102238535881042,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "KSR and MP1,",
            "probability": 0.0016122591780166958,
            "start_logit": 3.507309913635254,
            "end_logit": 0.3821105659008026,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "MEK2",
            "probability": 0.0007980068903237082,
            "start_logit": 2.0926499366760254,
            "end_logit": 1.0934960842132568,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "cave",
            "probability": 0.0005957889577452093,
            "start_logit": 4.708156108856201,
            "end_logit": -1.81424081325531,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "Human disc-large homolog (hDlg",
            "probability": 0.0004728667346817716,
            "start_logit": 1.1403239965438843,
            "end_logit": 1.5225183963775635,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "IQGAP1, are required for phosphorylation of the actin associated pool of extracellular signal regulated kinase 1",
            "probability": 0.0004664415829072715,
            "start_logit": 4.670131683349609,
            "end_logit": -2.020970106124878,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        }
    ],
    "516c3960298dcd4e51000073": [
        {
            "text": "Dnmt3",
            "probability": 0.2864018847476954,
            "start_logit": 4.1639909744262695,
            "end_logit": 3.7715542316436768,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methyltransferase 3B (Dnmt3",
            "probability": 0.18231902415818924,
            "start_logit": 3.712352991104126,
            "end_logit": 3.7715542316436768,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methyltransferase 3B",
            "probability": 0.10738475674158869,
            "start_logit": 3.712352991104126,
            "end_logit": 3.2422144412994385,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "Dnmt3b",
            "probability": 0.09125421315998877,
            "start_logit": 4.1639909744262695,
            "end_logit": 2.627807378768921,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methyltransferase 3B (Dnmt3b",
            "probability": 0.058091025163152045,
            "start_logit": 3.712352991104126,
            "end_logit": 2.627807378768921,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "Dnmt3b)",
            "probability": 0.0507841404042029,
            "start_logit": 4.1639909744262695,
            "end_logit": 2.0417423248291016,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3a are most highly expressed in postmitotic neurons.DNA methyltransferase 3B",
            "probability": 0.039831525772233006,
            "start_logit": 2.7205934524536133,
            "end_logit": 3.2422144412994385,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methyltransferase 3B (Dnmt3b)",
            "probability": 0.03232840080421729,
            "start_logit": 3.712352991104126,
            "end_logit": 2.0417423248291016,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3",
            "probability": 0.02966241021804328,
            "start_logit": 3.199463367462158,
            "end_logit": 2.468566417694092,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methyltransferase 3",
            "probability": 0.024829187044523027,
            "start_logit": 3.712352991104126,
            "end_logit": 1.7778160572052002,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methyltransferase 3B (Dnmt3",
            "probability": 0.017198117552372792,
            "start_logit": 1.3513948917388916,
            "end_logit": 3.7715542316436768,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "(Dnmt3",
            "probability": 0.016102955759228706,
            "start_logit": 1.285597801208496,
            "end_logit": 3.7715542316436768,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3B",
            "probability": 0.01607422931557979,
            "start_logit": 3.199463367462158,
            "end_logit": 1.855903148651123,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methyltransferase 3B",
            "probability": 0.010129582901740456,
            "start_logit": 1.3513948917388916,
            "end_logit": 3.2422144412994385,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3a are most highly expressed in postmitotic neurons.DNA methyltransferase 3",
            "probability": 0.009209728025434844,
            "start_logit": 2.7205934524536133,
            "end_logit": 1.7778160572052002,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1",
            "probability": 0.0062427793094697185,
            "start_logit": 2.3076834678649902,
            "end_logit": 1.8018912076950073,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3 family proteins.The DNMT3",
            "probability": 0.006134936390729618,
            "start_logit": 1.6235824823379517,
            "end_logit": 2.468566417694092,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methyltransferase 3B (Dnmt3b",
            "probability": 0.005479714934338957,
            "start_logit": 1.3513948917388916,
            "end_logit": 2.627807378768921,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3",
            "probability": 0.005410616343258526,
            "start_logit": 2.3076834678649902,
            "end_logit": 1.6588287353515625,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "(Dnmt3b",
            "probability": 0.0051307712540126695,
            "start_logit": 1.285597801208496,
            "end_logit": 2.627807378768921,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        }
    ],
    "54e0ac041388e8454a00000f": [
        {
            "text": "Ty3/gypsy-like",
            "probability": 0.140473400098899,
            "start_logit": 3.469757080078125,
            "end_logit": 2.6844351291656494,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Ty1/copia-like and Ty3/gypsy-like",
            "probability": 0.11815660408964973,
            "start_logit": 3.2967498302459717,
            "end_logit": 2.6844351291656494,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "gypsy-like",
            "probability": 0.08460657475265812,
            "start_logit": 2.9627509117126465,
            "end_logit": 2.6844351291656494,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Ty1/copia",
            "probability": 0.06652818761151542,
            "start_logit": 3.2967498302459717,
            "end_logit": 2.1100499629974365,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Ty1/copia-like",
            "probability": 0.06353537765892957,
            "start_logit": 3.2967498302459717,
            "end_logit": 2.064021110534668,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Ty3/gypsy",
            "probability": 0.05692577017659658,
            "start_logit": 3.469757080078125,
            "end_logit": 1.7811651229858398,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR retrotransposons, which includes the Long INterspersed Element-1",
            "probability": 0.05085489554172888,
            "start_logit": 2.9617905616760254,
            "end_logit": 2.1763598918914795,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR retrotransposons",
            "probability": 0.04989151411377232,
            "start_logit": 2.9617905616760254,
            "end_logit": 2.1572344303131104,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Ty3",
            "probability": 0.049065757659808876,
            "start_logit": 3.469757080078125,
            "end_logit": 1.6325783729553223,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Ty1/copia-like and Ty3/gypsy",
            "probability": 0.047882059411383404,
            "start_logit": 3.2967498302459717,
            "end_logit": 1.7811651229858398,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "copia-like and Ty3/gypsy-like",
            "probability": 0.042595694771557883,
            "start_logit": 2.276492118835449,
            "end_logit": 2.6844351291656494,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Ty1/copia-like and Ty3",
            "probability": 0.04127075516138358,
            "start_logit": 3.2967498302459717,
            "end_logit": 1.6325783729553223,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "gypsy",
            "probability": 0.03428616682167576,
            "start_logit": 2.9627509117126465,
            "end_logit": 1.7811651229858398,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Ty1",
            "probability": 0.0336364824919463,
            "start_logit": 3.2967498302459717,
            "end_logit": 1.4280354976654053,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Long INterspersed Element-1",
            "probability": 0.02838237369449859,
            "start_logit": 2.37858247756958,
            "end_logit": 2.1763598918914795,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "copia",
            "probability": 0.02398354620157271,
            "start_logit": 2.276492118835449,
            "end_logit": 2.1100499629974365,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "copia-like",
            "probability": 0.0229046321600613,
            "start_logit": 2.276492118835449,
            "end_logit": 2.064021110534668,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "copia-like and Ty3/gypsy",
            "probability": 0.01726157926960555,
            "start_logit": 2.276492118835449,
            "end_logit": 1.7811651229858398,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "copia-like and Ty3",
            "probability": 0.014878190714690534,
            "start_logit": 2.276492118835449,
            "end_logit": 1.6325783729553223,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "LTR-retrotransposons, Ty1/copia-like and Ty3/gypsy-like",
            "probability": 0.012880437598066103,
            "start_logit": 1.0804486274719238,
            "end_logit": 2.6844351291656494,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        }
    ],
    "553a7a59f321868558000002": [
        {
            "text": "FOG-1",
            "probability": 0.14276650596662568,
            "start_logit": 5.4175190925598145,
            "end_logit": 4.724481582641602,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "FOG-1/MeCP1",
            "probability": 0.10037787099101686,
            "start_logit": 5.255655765533447,
            "end_logit": 4.53407621383667,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "FOG-1 and GATA-1/TAL-1",
            "probability": 0.07892455103686458,
            "start_logit": 5.4175190925598145,
            "end_logit": 4.131763458251953,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1/MeCP1",
            "probability": 0.06738061792358697,
            "start_logit": 4.857071399688721,
            "end_logit": 4.53407621383667,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "MeCP1",
            "probability": 0.06601493916619276,
            "start_logit": 4.836595058441162,
            "end_logit": 4.53407621383667,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1",
            "probability": 0.058823296389745754,
            "start_logit": 4.857071399688721,
            "end_logit": 4.398256778717041,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "ACF/WCRF complex, in addition to the known GATA-1/FOG-1",
            "probability": 0.05849321813725483,
            "start_logit": 4.577487468719482,
            "end_logit": 4.672213554382324,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "Gfi-1b",
            "probability": 0.05173414960714306,
            "start_logit": 4.857071399688721,
            "end_logit": 4.269836902618408,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "GATA-1/FOG-1/MeCP1",
            "probability": 0.044343036788107124,
            "start_logit": 4.438669681549072,
            "end_logit": 4.53407621383667,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "GATA-1/FOG-1",
            "probability": 0.03871148226580953,
            "start_logit": 4.438669681549072,
            "end_logit": 4.398256778717041,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "TAL-1",
            "probability": 0.0369123080157239,
            "start_logit": 4.658529758453369,
            "end_logit": 4.130805492401123,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "WCRF complex, in addition to the known GATA-1/FOG-1",
            "probability": 0.03481314916600314,
            "start_logit": 4.058571815490723,
            "end_logit": 4.672213554382324,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "GATA-1/Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1/MeCP1",
            "probability": 0.03148419020096432,
            "start_logit": 4.0961995124816895,
            "end_logit": 4.53407621383667,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "Gfi-1b, the repressive MeCP1",
            "probability": 0.029179814955820237,
            "start_logit": 4.660166263580322,
            "end_logit": 3.894101142883301,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "GATA-1/TAL-1",
            "probability": 0.02895321903922125,
            "start_logit": 4.414708137512207,
            "end_logit": 4.131763458251953,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "GATA-1/Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1",
            "probability": 0.02748570596195361,
            "start_logit": 4.0961995124816895,
            "end_logit": 4.398256778717041,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "ACF/WCRF",
            "probability": 0.027247328062493775,
            "start_logit": 4.577487468719482,
            "end_logit": 3.9082581996917725,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "MeCP1 complex, and the chromatin remodeling ACF/WCRF",
            "probability": 0.026292337678129007,
            "start_logit": 4.541809558868408,
            "end_logit": 3.9082581996917725,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "Gfi-1b, the repressive MeCP1 complex",
            "probability": 0.025889039275101812,
            "start_logit": 4.660166263580322,
            "end_logit": 3.7744436264038086,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "GATA-1/Gfi-1b",
            "probability": 0.024173239372241816,
            "start_logit": 4.0961995124816895,
            "end_logit": 4.269836902618408,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        }
    ],
    "52f129d92059c6d71c000009": [
        {
            "text": "Friedreich ataxia",
            "probability": 0.23346423139935518,
            "start_logit": 4.2547783851623535,
            "end_logit": 4.027714252471924,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Menkes disease",
            "probability": 0.2261196088314059,
            "start_logit": 4.158640384674072,
            "end_logit": 4.091887474060059,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "spinocerebellar ataxia type 10",
            "probability": 0.14924374854155958,
            "start_logit": 4.275430202484131,
            "end_logit": 3.559614419937134,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Friedreich ataxia and spinocerebellar ataxia type 10",
            "probability": 0.14619320199538083,
            "start_logit": 4.2547783851623535,
            "end_logit": 3.559614419937134,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "spinocerebellar ataxia",
            "probability": 0.11228855275231696,
            "start_logit": 4.275430202484131,
            "end_logit": 3.2751054763793945,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Friedreich ataxia and spinocerebellar ataxia",
            "probability": 0.10999337147925611,
            "start_logit": 4.2547783851623535,
            "end_logit": 3.2751054763793945,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "ataxia",
            "probability": 0.00661852801687795,
            "start_logit": 0.6916224956512451,
            "end_logit": 4.027714252471924,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "ataxia and spinocerebellar ataxia type 10",
            "probability": 0.004144462719123825,
            "start_logit": 0.6916224956512451,
            "end_logit": 3.559614419937134,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "ataxia and spinocerebellar ataxia",
            "probability": 0.0031182258902908385,
            "start_logit": 0.6916224956512451,
            "end_logit": 3.2751054763793945,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "ataxia type 10",
            "probability": 0.0025028262768421873,
            "start_logit": 0.18726994097232819,
            "end_logit": 3.559614419937134,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Menkes",
            "probability": 0.0020193655325083056,
            "start_logit": 4.158640384674072,
            "end_logit": -0.6263932585716248,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "optic atrophy",
            "probability": 0.0009787429843597776,
            "start_logit": 1.3121839761734009,
            "end_logit": 1.4957935810089111,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "spinocerebellar ataxia type 10.",
            "probability": 0.0005571945539635791,
            "start_logit": 4.275430202484131,
            "end_logit": -2.0308072566986084,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Friedreich ataxia and spinocerebellar ataxia type 10.",
            "probability": 0.000545805481129685,
            "start_logit": 4.2547783851623535,
            "end_logit": -2.0308072566986084,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "spinocerebellar",
            "probability": 0.0005235324441811656,
            "start_logit": 4.275430202484131,
            "end_logit": -2.093122720718384,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Friedreich ataxia and spinocerebellar",
            "probability": 0.0005128314258469563,
            "start_logit": 4.2547783851623535,
            "end_logit": -2.093122720718384,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Autosomal dominant optic atrophy",
            "probability": 0.0004945591664679687,
            "start_logit": 0.6295816898345947,
            "end_logit": 1.4957935810089111,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Friedreich",
            "probability": 0.0003666480374897125,
            "start_logit": 4.2547783851623535,
            "end_logit": -2.4286675453186035,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "optic atrophy (ADOA)",
            "probability": 0.000185044369171888,
            "start_logit": 1.3121839761734009,
            "end_logit": -0.16987986862659454,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "disorders: Friedreich ataxia",
            "probability": 0.00012951810247155385,
            "start_logit": -3.242185115814209,
            "end_logit": 4.027714252471924,
            "question_text": "Which diseases are associated with Alu element insertion?"
        }
    ],
    "55192f20622b194345000014": [
        {
            "text": "c-Rel",
            "probability": 0.08003884542941544,
            "start_logit": 5.033877372741699,
            "end_logit": 4.451435565948486,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Rel-B, NF-kappaB/p50",
            "probability": 0.07160923270253731,
            "start_logit": 5.038370609283447,
            "end_logit": 4.335654258728027,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "NF-kappaB/p50",
            "probability": 0.07143329028064367,
            "start_logit": 5.035910606384277,
            "end_logit": 4.335654258728027,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "c-Rel, Rel-B, NF-kappaB/p50",
            "probability": 0.07128819726562975,
            "start_logit": 5.033877372741699,
            "end_logit": 4.335654258728027,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Rel-B",
            "probability": 0.06810520162605592,
            "start_logit": 5.038370609283447,
            "end_logit": 4.2854838371276855,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "c-Rel, Rel-B",
            "probability": 0.0677998753107954,
            "start_logit": 5.033877372741699,
            "end_logit": 4.2854838371276855,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Rel-A, c-Rel",
            "probability": 0.06257670362784229,
            "start_logit": 4.7877583503723145,
            "end_logit": 4.451435565948486,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Rel-A, c-Rel, Rel-B, NF-kappaB/p50",
            "probability": 0.055735191687497715,
            "start_logit": 4.7877583503723145,
            "end_logit": 4.335654258728027,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Rel-B, NF-kappaB",
            "probability": 0.05434928267828914,
            "start_logit": 5.038370609283447,
            "end_logit": 4.059861660003662,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "NF-kappaB",
            "probability": 0.054215747601013255,
            "start_logit": 5.035910606384277,
            "end_logit": 4.059861660003662,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "c-Rel, Rel-B, NF-kappaB",
            "probability": 0.054105626308129214,
            "start_logit": 5.033877372741699,
            "end_logit": 4.059861660003662,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Rel-A, c-Rel, Rel-B",
            "probability": 0.053007919848991905,
            "start_logit": 4.7877583503723145,
            "end_logit": 4.2854838371276855,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "p50",
            "probability": 0.048864256792442655,
            "start_logit": 4.656192779541016,
            "end_logit": 4.335654258728027,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Rel-A, c-Rel, Rel-B, NF-kappaB",
            "probability": 0.042301356596509264,
            "start_logit": 4.7877583503723145,
            "end_logit": 4.059861660003662,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Rel-B, NF-kappaB/p50 and NF-kappaB2/p52",
            "probability": 0.03037430737813799,
            "start_logit": 5.038370609283447,
            "end_logit": 3.47802734375,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "NF-kappaB/p50 and NF-kappaB2/p52",
            "probability": 0.030299678325406053,
            "start_logit": 5.035910606384277,
            "end_logit": 3.47802734375,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "NF-kappaB2/p52",
            "probability": 0.024882665632658413,
            "start_logit": 4.838944911956787,
            "end_logit": 3.47802734375,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "p50 and NF-kappaB2/p52",
            "probability": 0.02072662839138801,
            "start_logit": 4.656192779541016,
            "end_logit": 3.47802734375,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Rel-A",
            "probability": 0.01936234155343076,
            "start_logit": 4.7877583503723145,
            "end_logit": 3.2783725261688232,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "RelB, c-Rel",
            "probability": 0.018923650963185695,
            "start_logit": 4.301008701324463,
            "end_logit": 3.7422046661376953,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        }
    ],
    "571e417bbb137a4b0c00000a": [
        {
            "text": "coproporphyrinuria",
            "probability": 0.32291951994126655,
            "start_logit": 6.021246433258057,
            "end_logit": 6.11749792098999,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "conjugated hyperbilirubinemia, coproporphyrinuria",
            "probability": 0.24862901780239344,
            "start_logit": 5.759805202484131,
            "end_logit": 6.11749792098999,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "conjugated hyperbilirubinemia",
            "probability": 0.1968012601252643,
            "start_logit": 5.759805202484131,
            "end_logit": 5.883730411529541,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "coproporphyrinuria, and near-absent hepatic uptake of anionic diagnostics",
            "probability": 0.1414479389393403,
            "start_logit": 6.021246433258057,
            "end_logit": 5.292026519775391,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "near-absent hepatic uptake of anionic diagnostics",
            "probability": 0.05607837903728796,
            "start_logit": 5.096065044403076,
            "end_logit": 5.292026519775391,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "coproporphyrinuria,",
            "probability": 0.006847155988427144,
            "start_logit": 6.021246433258057,
            "end_logit": 2.263928174972534,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "conjugated hyperbilirubinemia, coproporphyrinuria,",
            "probability": 0.0052719069706658,
            "start_logit": 5.759805202484131,
            "end_logit": 2.263928174972534,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "hyperbilirubinemia, coproporphyrinuria",
            "probability": 0.0037235618889811624,
            "start_logit": 1.5585240125656128,
            "end_logit": 6.11749792098999,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "hyperbilirubinemia",
            "probability": 0.0029473698540221148,
            "start_logit": 1.5585240125656128,
            "end_logit": 5.883730411529541,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "coproporphyrinuria, and near-absent hepatic uptake",
            "probability": 0.002934751365944338,
            "start_logit": 6.021246433258057,
            "end_logit": 1.416717529296875,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "conjugated hyperbilirubinemia,",
            "probability": 0.0024430290305348726,
            "start_logit": 5.759805202484131,
            "end_logit": 1.4947746992111206,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "conjugated hyperbilirubinemia, coproporphyrinuria, and near-absent hepatic uptake",
            "probability": 0.002259585762240965,
            "start_logit": 5.759805202484131,
            "end_logit": 1.416717529296875,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "hyperbilirubinemia, coproporphyrinuria, and near-absent hepatic uptake of anionic diagnostics",
            "probability": 0.0016310260674401408,
            "start_logit": 1.5585240125656128,
            "end_logit": 5.292026519775391,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "absent hepatic uptake of anionic diagnostics",
            "probability": 0.0012775445751442298,
            "start_logit": 1.314254641532898,
            "end_logit": 5.292026519775391,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "near-absent hepatic uptake",
            "probability": 0.001163510056871195,
            "start_logit": 5.096065044403076,
            "end_logit": 1.416717529296875,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "coproporphyrinuria, and near-absent hepatic uptake of anionic diagnostics,",
            "probability": 0.0011610495022325326,
            "start_logit": 6.021246433258057,
            "end_logit": 0.4894191324710846,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "hepatic uptake of anionic diagnostics",
            "probability": 0.0009971984718857164,
            "start_logit": 1.0665092468261719,
            "end_logit": 5.292026519775391,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "anionic diagnostics",
            "probability": 0.0007422586256388618,
            "start_logit": 0.7712571620941162,
            "end_logit": 5.292026519775391,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "near-absent hepatic uptake of anionic diagnostics,",
            "probability": 0.00046030910422224455,
            "start_logit": 5.096065044403076,
            "end_logit": 0.4894191324710846,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "coproporphyrinuria, and near-absent hepatic uptake of anionic diagnostic",
            "probability": 0.00026362689019591783,
            "start_logit": 6.021246433258057,
            "end_logit": -0.9931256771087646,
            "question_text": "What are the symptoms of Rotor syndrome?"
        }
    ],
    "52fa73e82059c6d71c000059": [
        {
            "text": "Agrobacterium-mediated",
            "probability": 0.3171440640077564,
            "start_logit": 3.7725913524627686,
            "end_logit": 2.8303167819976807,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "Agrobacterium-mediated as well as direct delivery methods",
            "probability": 0.19391717406481962,
            "start_logit": 3.7725913524627686,
            "end_logit": 2.3383917808532715,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "Agrobacterium-mediated as well as direct delivery",
            "probability": 0.14889305505256142,
            "start_logit": 3.7725913524627686,
            "end_logit": 2.0741889476776123,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "direct delivery methods",
            "probability": 0.08202937557421389,
            "start_logit": 2.9122376441955566,
            "end_logit": 2.3383917808532715,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "direct delivery",
            "probability": 0.06298361345352574,
            "start_logit": 2.9122376441955566,
            "end_logit": 2.0741889476776123,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "Agrobacterium",
            "probability": 0.03512458037281036,
            "start_logit": 3.7725913524627686,
            "end_logit": 0.6298618316650391,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "plant artificial chromosomes",
            "probability": 0.02281465585730102,
            "start_logit": 2.1162667274475098,
            "end_logit": 1.8546884059906006,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "plant artificial chromosomes. Existing methods for site-directed plasmid mutagenesis",
            "probability": 0.019241313866072758,
            "start_logit": 2.1162667274475098,
            "end_logit": 1.684345006942749,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "minichromosomes or plant artificial chromosomes",
            "probability": 0.0172002671710793,
            "start_logit": 1.833788514137268,
            "end_logit": 1.8546884059906006,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "minichromosomes or plant artificial chromosomes. Existing methods for site-directed plasmid mutagenesis",
            "probability": 0.014506277950852084,
            "start_logit": 1.833788514137268,
            "end_logit": 1.684345006942749,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "genetic transformation, Agrobacterium-mediated",
            "probability": 0.012193985232205188,
            "start_logit": 0.5141780376434326,
            "end_logit": 2.8303167819976807,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "site-directed plasmid mutagenesis",
            "probability": 0.011408732728236299,
            "start_logit": 1.5935860872268677,
            "end_logit": 1.684345006942749,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "plant artificial chromosome",
            "probability": 0.011095345779347926,
            "start_logit": 2.1162667274475098,
            "end_logit": 1.1338109970092773,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "minichromosomes",
            "probability": 0.010919085464694837,
            "start_logit": 1.833788514137268,
            "end_logit": 1.400275707244873,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "minichromosomes or plant artificial chromosome",
            "probability": 0.008364926166493933,
            "start_logit": 1.833788514137268,
            "end_logit": 1.1338109970092773,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "genetic transformation, Agrobacterium-mediated as well as direct delivery methods",
            "probability": 0.007455990589688418,
            "start_logit": 0.5141780376434326,
            "end_logit": 2.3383917808532715,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "Agrobacterium-mediated as well as direct delivery methods have been used",
            "probability": 0.007214789230180864,
            "start_logit": 3.7725913524627686,
            "end_logit": -0.9529063701629639,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "transformation, Agrobacterium-mediated",
            "probability": 0.006893097951343127,
            "start_logit": -0.05624416470527649,
            "end_logit": 2.8303167819976807,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "genetic transformation, Agrobacterium-mediated as well as direct delivery",
            "probability": 0.005724842179119089,
            "start_logit": 0.5141780376434326,
            "end_logit": 2.0741889476776123,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "efficient genetic transformation, Agrobacterium-mediated",
            "probability": 0.004874827307697917,
            "start_logit": -0.40268009901046753,
            "end_logit": 2.8303167819976807,
            "question_text": "List the existing methods for genetic manipulation of cells."
        }
    ],
    "554397f6ed966d112c00000c": [
        {
            "text": "Fcy21p",
            "probability": 0.2271492339957555,
            "start_logit": 3.7323391437530518,
            "end_logit": 2.243077278137207,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "AzgA",
            "probability": 0.2234492840706778,
            "start_logit": 3.4203457832336426,
            "end_logit": 2.5386478900909424,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "Fcy21",
            "probability": 0.2108429562824401,
            "start_logit": 3.7323391437530518,
            "end_logit": 2.168583631515503,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "AzgA and Fcy21p",
            "probability": 0.16627014737985524,
            "start_logit": 3.4203457832336426,
            "end_logit": 2.243077278137207,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "AzgA and Fcy21",
            "probability": 0.1543341740511472,
            "start_logit": 3.4203457832336426,
            "end_logit": 2.168583631515503,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "Fcy",
            "probability": 0.006637725450864946,
            "start_logit": 3.7323391437530518,
            "end_logit": -1.2897605895996094,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "AzgA and Fcy",
            "probability": 0.0048587246787851965,
            "start_logit": 3.4203457832336426,
            "end_logit": -1.2897605895996094,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "Fcy21p, a herein characterized protein of Candida albicans, and the second was AzgA",
            "probability": 0.0016522048122878938,
            "start_logit": 0.48728153109550476,
            "end_logit": 0.5646383166313171,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "AzgA, a transporter of Aspergillus nidulansThe azgA",
            "probability": 0.0015509016952695413,
            "start_logit": 1.280236840248108,
            "end_logit": -0.2915911376476288,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "azgA",
            "probability": 0.0007364072866061026,
            "start_logit": 0.5354284048080444,
            "end_logit": -0.2915911376476288,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "Fcy21p,",
            "probability": 0.0005540208100074207,
            "start_logit": 3.7323391437530518,
            "end_logit": -3.773082971572876,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "A",
            "probability": 0.00041799200228491743,
            "start_logit": 3.4203457832336426,
            "end_logit": -3.7428295612335205,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "AzgA and Fcy21p,",
            "probability": 0.00040553569171693503,
            "start_logit": 3.4203457832336426,
            "end_logit": -3.773082971572876,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "F",
            "probability": 0.0003449980209835669,
            "start_logit": 3.7323391437530518,
            "end_logit": -4.24674654006958,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "AzgA and F",
            "probability": 0.00025253385532335955,
            "start_logit": 3.4203457832336426,
            "end_logit": -4.24674654006958,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "analysis of AzgA",
            "probability": 0.00013728852428274203,
            "start_logit": -3.9745092391967773,
            "end_logit": 2.5386478900909424,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "21p",
            "probability": 0.00010833357824183618,
            "start_logit": -3.9158082008361816,
            "end_logit": 2.243077278137207,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "analysis of AzgA and Fcy21p",
            "probability": 0.00010215733409481006,
            "start_logit": -3.9745092391967773,
            "end_logit": 2.243077278137207,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "21",
            "probability": 0.00010055667588819859,
            "start_logit": -3.9158082008361816,
            "end_logit": 2.168583631515503,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "analysis of AzgA and Fcy21",
            "probability": 9.482380348632452e-05,
            "start_logit": -3.9745092391967773,
            "end_logit": 2.168583631515503,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        }
    ],
    "551910d3622b194345000008": [
        {
            "text": "persephin and GDNF",
            "probability": 0.10488297840045487,
            "start_logit": 5.619997024536133,
            "end_logit": 5.03010892868042,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF",
            "probability": 0.09767022038527437,
            "start_logit": 5.534561634063721,
            "end_logit": 5.044295787811279,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "persephin",
            "probability": 0.08951618342027191,
            "start_logit": 5.619997024536133,
            "end_logit": 4.871683120727539,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF, NRTN, ARTN, and PSPN",
            "probability": 0.05905003926711012,
            "start_logit": 5.534561634063721,
            "end_logit": 4.541084289550781,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN, and PSPN) are also good candidates for the disease.Indeed, the RET ligands persephin",
            "probability": 0.05830197752106263,
            "start_logit": 5.191213607788086,
            "end_logit": 4.871683120727539,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "PSPN) are also good candidates for the disease.Indeed, the RET ligands persephin and GDNF",
            "probability": 0.05668433261456953,
            "start_logit": 5.004649639129639,
            "end_logit": 5.03010892868042,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF, NRTN, ARTN",
            "probability": 0.055454262071534026,
            "start_logit": 5.534561634063721,
            "end_logit": 4.478257656097412,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF, NRTN",
            "probability": 0.05292300224538304,
            "start_logit": 5.534561634063721,
            "end_logit": 4.43153715133667,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "PSPN) are also good candidates for the disease.Indeed, the RET ligands persephin",
            "probability": 0.048379300366621754,
            "start_logit": 5.004649639129639,
            "end_logit": 4.871683120727539,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN, and PSPN",
            "probability": 0.041889583045321546,
            "start_logit": 5.191213607788086,
            "end_logit": 4.541084289550781,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN",
            "probability": 0.039338770051528096,
            "start_logit": 5.191213607788086,
            "end_logit": 4.478257656097412,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF, NTN, ARTN, PSPN",
            "probability": 0.03847460908315381,
            "start_logit": 5.14159631729126,
            "end_logit": 4.50566291809082,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "NRTN, ARTN, and PSPN",
            "probability": 0.03526344912618185,
            "start_logit": 5.019023418426514,
            "end_logit": 4.541084289550781,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF, NTN, ARTN",
            "probability": 0.03525785020139558,
            "start_logit": 5.14159631729126,
            "end_logit": 4.4183526039123535,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "PSPN",
            "probability": 0.035234774532511656,
            "start_logit": 5.05363130569458,
            "end_logit": 4.50566291809082,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN, PSPN",
            "probability": 0.0332650533237749,
            "start_logit": 4.996105194091797,
            "end_logit": 4.50566291809082,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "NRTN, ARTN",
            "probability": 0.0331161261475855,
            "start_logit": 5.019023418426514,
            "end_logit": 4.478257656097412,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "NRTN",
            "probability": 0.03160451069038224,
            "start_logit": 5.019023418426514,
            "end_logit": 4.43153715133667,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF, NTN",
            "probability": 0.030904383790387454,
            "start_logit": 5.14159631729126,
            "end_logit": 4.286562442779541,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "NTN, ARTN, PSPN",
            "probability": 0.02278859371549488,
            "start_logit": 4.617857933044434,
            "end_logit": 4.50566291809082,
            "question_text": "Which proteins have been identified as RET ligands?"
        }
    ],
    "5314b20bdae131f847000005": [
        {
            "text": "fava beans",
            "probability": 0.8915638049183287,
            "start_logit": 4.174919605255127,
            "end_logit": 3.775243043899536,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "beans",
            "probability": 0.09523144638707658,
            "start_logit": 1.9382528066635132,
            "end_logit": 3.775243043899536,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "fava beans cultivation",
            "probability": 0.008488012867487729,
            "start_logit": 4.174919605255127,
            "end_logit": -0.8790790438652039,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "fava beans cultivation.",
            "probability": 0.0013138089746140434,
            "start_logit": 4.174919605255127,
            "end_logit": -2.7448034286499023,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "ava beans",
            "probability": 0.0009708055563278359,
            "start_logit": -2.64768648147583,
            "end_logit": 3.775243043899536,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "beans cultivation",
            "probability": 0.0009066381316332376,
            "start_logit": 1.9382528066635132,
            "end_logit": -0.8790790438652039,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "f",
            "probability": 0.0008558650226677267,
            "start_logit": 4.174919605255127,
            "end_logit": -3.1733765602111816,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "high rate of fava beans",
            "probability": 0.00033780540424469186,
            "start_logit": -3.7033426761627197,
            "end_logit": 3.775243043899536,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "beans cultivation.",
            "probability": 0.0001403331183237957,
            "start_logit": 1.9382528066635132,
            "end_logit": -2.7448034286499023,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "liver function of favism patients in an endemic area of the disease with a high rate of fava beans",
            "probability": 7.680190861950368e-05,
            "start_logit": -5.1845831871032715,
            "end_logit": 3.775243043899536,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "kidney and liver function of favism patients in an endemic area of the disease with a high rate of fava beans",
            "probability": 5.5585742907194655e-05,
            "start_logit": -5.507885932922363,
            "end_logit": 3.775243043899536,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "favism patients in an endemic area of the disease with a high rate of fava beans",
            "probability": 3.552962701805995e-05,
            "start_logit": -5.955445766448975,
            "end_logit": 3.775243043899536,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "ava beans cultivation",
            "probability": 9.242423266267629e-06,
            "start_logit": -2.64768648147583,
            "end_logit": -0.8790790438652039,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "cultivation",
            "probability": 3.8644528417356e-06,
            "start_logit": -3.5196704864501953,
            "end_logit": -0.8790790438652039,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "favism",
            "probability": 3.559021917823329e-06,
            "start_logit": -2.4580631256103516,
            "end_logit": -2.0230207443237305,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "high rate of fava beans cultivation",
            "probability": 3.2160307564285834e-06,
            "start_logit": -3.7033426761627197,
            "end_logit": -0.8790790438652039,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "ava beans cultivation.",
            "probability": 1.430579668524708e-06,
            "start_logit": -2.64768648147583,
            "end_logit": -2.7448034286499023,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "favism.G6PD deficiency is the most common enzymopathy of red blood cells. The clinical symptoms of favism",
            "probability": 8.411806953148206e-07,
            "start_logit": -2.4580631256103516,
            "end_logit": -3.4654552936553955,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "liver function of favism patients in an endemic area of the disease with a high rate of fava beans cultivation",
            "probability": 7.311822048111079e-07,
            "start_logit": -5.1845831871032715,
            "end_logit": -0.8790790438652039,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "haemolytic anaemia",
            "probability": 6.774694005046667e-07,
            "start_logit": -2.699279308319092,
            "end_logit": -3.440681219100952,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        }
    ],
    "52fb78d82059c6d71c000068": [
        {
            "text": "c.664C>T; p.Arg222X",
            "probability": 0.2722931508253672,
            "start_logit": 3.7762579917907715,
            "end_logit": 4.138004779815674,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "c.664C>T",
            "probability": 0.1888021311749252,
            "start_logit": 3.7762579917907715,
            "end_logit": 3.771825075149536,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "p.Arg222X",
            "probability": 0.18146766312757048,
            "start_logit": 3.3704562187194824,
            "end_logit": 4.138004779815674,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "Arg222X",
            "probability": 0.15515654258577333,
            "start_logit": 3.213813304901123,
            "end_logit": 4.138004779815674,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "664C>T; p.Arg222X",
            "probability": 0.047551748684756964,
            "start_logit": 2.0311973094940186,
            "end_logit": 4.138004779815674,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "664C>T",
            "probability": 0.032971345278289564,
            "start_logit": 2.0311973094940186,
            "end_logit": 3.771825075149536,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "I137M",
            "probability": 0.017721625503980706,
            "start_logit": 3.0891966819763184,
            "end_logit": 2.09297251701355,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "(c.664C>T; p.Arg222X",
            "probability": 0.009848775375835133,
            "start_logit": 0.4567258656024933,
            "end_logit": 4.138004779815674,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "R27H, E901K, G1743R",
            "probability": 0.009798062017777182,
            "start_logit": 2.3272321224212646,
            "end_logit": 2.262336015701294,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "E1152X",
            "probability": 0.009711848884464747,
            "start_logit": 2.630361795425415,
            "end_logit": 1.9503684043884277,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "V728I, N1443S",
            "probability": 0.009586029019075279,
            "start_logit": 2.5798068046569824,
            "end_logit": 1.987883448600769,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "V728I, N1443S and E1152X",
            "probability": 0.009233070733961572,
            "start_logit": 2.5798068046569824,
            "end_logit": 1.9503684043884277,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "E901K, G1743R",
            "probability": 0.007901068606066534,
            "start_logit": 2.1120455265045166,
            "end_logit": 2.262336015701294,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "R27H, E901K, G1743R (detected in three families), V728I, N1443S",
            "probability": 0.007446410064608427,
            "start_logit": 2.3272321224212646,
            "end_logit": 1.987883448600769,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "G1743R",
            "probability": 0.007203654063970225,
            "start_logit": 2.0196359157562256,
            "end_logit": 2.262336015701294,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "c.664C>T; p.Arg222X)",
            "probability": 0.007114103195311371,
            "start_logit": 3.7762579917907715,
            "end_logit": 0.4932047128677368,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "(c.664C>T",
            "probability": 0.006828926011485878,
            "start_logit": 0.4567258656024933,
            "end_logit": 3.771825075149536,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "V728I",
            "probability": 0.006649013899722594,
            "start_logit": 2.5798068046569824,
            "end_logit": 1.6220452785491943,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "N1443S",
            "probability": 0.006476650851030277,
            "start_logit": 2.1877036094665527,
            "end_logit": 1.987883448600769,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "N1443S and E1152X",
            "probability": 0.006238180096027243,
            "start_logit": 2.1877036094665527,
            "end_logit": 1.9503684043884277,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        }
    ],
    "535d5bac7d100faa09000001": [
        {
            "text": "Cardiovascular events",
            "probability": 0.258395997486033,
            "start_logit": -0.4604014456272125,
            "end_logit": -0.21602389216423035,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Cardiovascular events associated with smoking cessation pharmacotherapies",
            "probability": 0.1488956396688497,
            "start_logit": -0.4604014456272125,
            "end_logit": -0.7672715187072754,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.Pharmacological interventions",
            "probability": 0.12236275460707334,
            "start_logit": -0.4604014456272125,
            "end_logit": -0.9635271430015564,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "smoking cessation pharmacotherapies",
            "probability": 0.07156636548253391,
            "start_logit": -1.1930218935012817,
            "end_logit": -0.7672715187072754,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Pharmacological interventions",
            "probability": 0.06080217962327071,
            "start_logit": -1.1597658395767212,
            "end_logit": -0.9635271430015564,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "smoking cessation pharmacotherapies: a network meta-analysis.Pharmacological interventions",
            "probability": 0.05881339196456991,
            "start_logit": -1.1930218935012817,
            "end_logit": -0.9635271430015564,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "pharmacotherapies",
            "probability": 0.04163398819423072,
            "start_logit": -1.7347302436828613,
            "end_logit": -0.7672715187072754,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "pharmacotherapies: a network meta-analysis.Pharmacological interventions",
            "probability": 0.034214900396376396,
            "start_logit": -1.7347302436828613,
            "end_logit": -0.9635271430015564,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis",
            "probability": 0.032596178497416736,
            "start_logit": -0.4604014456272125,
            "end_logit": -2.2863221168518066,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.",
            "probability": 0.025346945034990322,
            "start_logit": -0.4604014456272125,
            "end_logit": -2.5378589630126953,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Cardiovascular events associated with smoking cessation",
            "probability": 0.021476226303745842,
            "start_logit": -0.4604014456272125,
            "end_logit": -2.703570604324341,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Pharmacological interventions for smoking cessation: an overview",
            "probability": 0.01735228736984852,
            "start_logit": -1.1597658395767212,
            "end_logit": -2.21742844581604,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "network meta-analysis.Pharmacological interventions",
            "probability": 0.016519970681458995,
            "start_logit": -2.4628214836120605,
            "end_logit": -0.9635271430015564,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "smoking cessation pharmacotherapies: a network meta-analysis",
            "probability": 0.015667282325179336,
            "start_logit": -1.1930218935012817,
            "end_logit": -2.2863221168518066,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Cardiovascular events associated with smoking cessation pharmacotherapies: a network",
            "probability": 0.015476820736553971,
            "start_logit": -0.4604014456272125,
            "end_logit": -3.0311737060546875,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Cardiovascular events associated with smoking",
            "probability": 0.01418896701369831,
            "start_logit": -0.4604014456272125,
            "end_logit": -3.1180524826049805,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "smoking cessation pharmacotherapies: a network meta-analysis.",
            "probability": 0.012182954022523458,
            "start_logit": -1.1930218935012817,
            "end_logit": -2.5378589630126953,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "Pharmacological interventions for smoking cessation",
            "probability": 0.011276751030514464,
            "start_logit": -1.1597658395767212,
            "end_logit": -2.648409605026245,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "smoking cessation pharmacotherapies: a network meta-analysis.Pharmacological interventions for smoking cessation",
            "probability": 0.010907898081184583,
            "start_logit": -1.1930218935012817,
            "end_logit": -2.648409605026245,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "smoking cessation",
            "probability": 0.010322501479947854,
            "start_logit": -1.1930218935012817,
            "end_logit": -2.703570604324341,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        }
    ],
    "55031270e9bde6963400001a": [
        {
            "text": "Shwachman-Diamond syndrome",
            "probability": 0.1351161014239428,
            "start_logit": 5.3814826011657715,
            "end_logit": 4.910759449005127,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Diamond-Blackfan anemia (DBA), and Shwachman-Diamond syndrome",
            "probability": 0.12323738777371589,
            "start_logit": 5.2894606590271,
            "end_logit": 4.910759449005127,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita",
            "probability": 0.11024295374040564,
            "start_logit": 5.299750804901123,
            "end_logit": 4.789043426513672,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia (FA), dyskeratosis congenita",
            "probability": 0.09665281407159851,
            "start_logit": 5.168189525604248,
            "end_logit": 4.789043426513672,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita (DC), Diamond-Blackfan anemia",
            "probability": 0.08880732033275174,
            "start_logit": 5.299750804901123,
            "end_logit": 4.572825908660889,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Diamond-Blackfan anemia",
            "probability": 0.087898165740831,
            "start_logit": 5.2894606590271,
            "end_logit": 4.572825908660889,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia (FA), dyskeratosis congenita (DC), Diamond-Blackfan anemia",
            "probability": 0.07785964661769013,
            "start_logit": 5.168189525604248,
            "end_logit": 4.572825908660889,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia",
            "probability": 0.06992511567275339,
            "start_logit": 5.168189525604248,
            "end_logit": 4.465342998504639,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia and dyskeratosis congenita",
            "probability": 0.05531299830641137,
            "start_logit": 4.9757609367370605,
            "end_logit": 4.423354625701904,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita (DC), Diamond-Blackfan anemia (DBA)",
            "probability": 0.02663934388349047,
            "start_logit": 5.299750804901123,
            "end_logit": 3.368746042251587,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Diamond-Blackfan anemia (DBA)",
            "probability": 0.026366626705146567,
            "start_logit": 5.2894606590271,
            "end_logit": 3.368746042251587,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita (DC)",
            "probability": 0.022679721948329196,
            "start_logit": 5.299750804901123,
            "end_logit": 3.2078280448913574,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia (FA), dyskeratosis congenita (DC)",
            "probability": 0.019883891661948386,
            "start_logit": 5.168189525604248,
            "end_logit": 3.2078280448913574,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia (FA)",
            "probability": 0.01644140474166868,
            "start_logit": 5.168189525604248,
            "end_logit": 3.017720937728882,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita, Shwachman-Diamond syndrome",
            "probability": 0.00970547220937675,
            "start_logit": 4.1645684242248535,
            "end_logit": 3.4942290782928467,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome",
            "probability": 0.007432657806926266,
            "start_logit": 3.8977620601654053,
            "end_logit": 3.4942290782928467,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia, dyskeratosis congenita",
            "probability": 0.006590699632448418,
            "start_logit": 3.8977620601654053,
            "end_logit": 3.374005079269409,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita (DC), Diamond-Blackfan",
            "probability": 0.006517431130409822,
            "start_logit": 5.299750804901123,
            "end_logit": 1.9608371257781982,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Diamond-Blackfan",
            "probability": 0.006450709688781612,
            "start_logit": 5.2894606590271,
            "end_logit": 1.9608371257781982,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita, Shwachman-Diamond syndrome, and amegakaryocytic thrombocytopenia",
            "probability": 0.006239536911373311,
            "start_logit": 4.1645684242248535,
            "end_logit": 3.05244517326355,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        }
    ],
    "56d2ac03f22319765a000004": [
        {
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0783951669303362,
            "start_logit": 5.8205132484436035,
            "end_logit": 5.830727577209473,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Pseudomonas aeruginosa",
            "probability": 0.07824932710268945,
            "start_logit": 5.74065637588501,
            "end_logit": 5.908722400665283,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.074122570776396,
            "start_logit": 5.8205132484436035,
            "end_logit": 5.774685382843018,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Klebsiella pneumoniae, Acintobacter baumannii",
            "probability": 0.0664557806154023,
            "start_logit": 5.576833248138428,
            "end_logit": 5.909182071685791,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.06642523983880091,
            "start_logit": 5.576833248138428,
            "end_logit": 5.908722400665283,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Acintobacter baumannii",
            "probability": 0.0653876790310952,
            "start_logit": 5.5606303215026855,
            "end_logit": 5.909182071685791,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Acintobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.0653576291170128,
            "start_logit": 5.5606303215026855,
            "end_logit": 5.908722400665283,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Enterococcus faecium",
            "probability": 0.06528835501540267,
            "start_logit": 5.8205132484436035,
            "end_logit": 5.6477789878845215,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Klebsiella pneumoniae",
            "probability": 0.061441301928304826,
            "start_logit": 5.576833248138428,
            "end_logit": 5.830727577209473,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii",
            "probability": 0.049592131950432564,
            "start_logit": 5.284128665924072,
            "end_logit": 5.909182071685791,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.04585011453057348,
            "start_logit": 5.284128665924072,
            "end_logit": 5.830727577209473,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Staphylococcus aureus",
            "probability": 0.043351248456659414,
            "start_logit": 5.284128665924072,
            "end_logit": 5.774685382843018,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Enterobacter species).'ESKAPE' (Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.0393839430291777,
            "start_logit": 5.1881513595581055,
            "end_logit": 5.774685382843018,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Enterobacter species).'ESKAPE' (Enterococcus faecium",
            "probability": 0.03469001179346804,
            "start_logit": 5.1881513595581055,
            "end_logit": 5.6477789878845215,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.03162369775358957,
            "start_logit": 5.241339206695557,
            "end_logit": 5.50204610824585,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.03134928988754102,
            "start_logit": 5.241339206695557,
            "end_logit": 5.493330955505371,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Acinetobacter baumannii",
            "probability": 0.031255330129949487,
            "start_logit": 5.2296223640441895,
            "end_logit": 5.50204610824585,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.030984118695080876,
            "start_logit": 5.2296223640441895,
            "end_logit": 5.493330955505371,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.027709840135953786,
            "start_logit": 5.109220027923584,
            "end_logit": 5.50204610824585,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Klebsiella species, Acinetobacter baumannii",
            "probability": 0.013087223282133827,
            "start_logit": 4.7468485832214355,
            "end_logit": 5.114266395568848,
            "question_text": "Which ones are the ESKAPE organisms?"
        }
    ],
    "515870cdd24251bc0500008f": [
        {
            "text": "OXA-48",
            "probability": 0.1697926065639634,
            "start_logit": 3.2373104095458984,
            "end_logit": 1.9475759267807007,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA-48, KPC",
            "probability": 0.16460860419327608,
            "start_logit": 3.2373104095458984,
            "end_logit": 1.9165687561035156,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "VIM-1",
            "probability": 0.10238957232810023,
            "start_logit": 3.265779972076416,
            "end_logit": 1.4133135080337524,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA-48, KPC and VIM-1",
            "probability": 0.09951568920197833,
            "start_logit": 3.2373104095458984,
            "end_logit": 1.4133135080337524,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "VIM-1; in P. aeruginosa it was VIM-2",
            "probability": 0.06806865176202848,
            "start_logit": 3.265779972076416,
            "end_logit": 1.0050454139709473,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA-48, KPC and VIM-1; in P. aeruginosa it was VIM-2",
            "probability": 0.06615809246122482,
            "start_logit": 3.2373104095458984,
            "end_logit": 1.0050454139709473,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "VIM",
            "probability": 0.05498057723435504,
            "start_logit": 3.265779972076416,
            "end_logit": 0.7915086150169373,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA-48, KPC and VIM",
            "probability": 0.053437375621285206,
            "start_logit": 3.2373104095458984,
            "end_logit": 0.7915086150169373,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "KPC",
            "probability": 0.05066304485999918,
            "start_logit": 2.058936595916748,
            "end_logit": 1.9165687561035156,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "KPC and VIM-1",
            "probability": 0.030628823147019372,
            "start_logit": 2.058936595916748,
            "end_logit": 1.4133135080337524,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "VIM-2",
            "probability": 0.029636902872786336,
            "start_logit": 2.434283494949341,
            "end_logit": 1.0050454139709473,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "KPC and VIM-1; in P. aeruginosa it was VIM-2",
            "probability": 0.020362060796527425,
            "start_logit": 2.058936595916748,
            "end_logit": 1.0050454139709473,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "VIM-1; in P. aeruginosa it was VIM",
            "probability": 0.01872896478016994,
            "start_logit": 3.265779972076416,
            "end_logit": -0.2854001224040985,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA-48, KPC and VIM-1; in P. aeruginosa it was VIM",
            "probability": 0.018203277890112585,
            "start_logit": 3.2373104095458984,
            "end_logit": -0.2854001224040985,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "KPC and VIM",
            "probability": 0.016446893353903955,
            "start_logit": 2.058936595916748,
            "end_logit": 0.7915086150169373,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA",
            "probability": 0.012097396869477254,
            "start_logit": 3.2373104095458984,
            "end_logit": -0.6940115094184875,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "VIM-2 and in A. baumannii OXA-23",
            "probability": 0.008762898834451645,
            "start_logit": 2.434283494949341,
            "end_logit": -0.21344812214374542,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "VIM-1; in P. aeruginosa it was VIM-2 and in A. baumannii OXA",
            "probability": 0.005837149794519325,
            "start_logit": 3.265779972076416,
            "end_logit": -1.4512287378311157,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "KPC and VIM-1; in P. aeruginosa it was VIM",
            "probability": 0.005602583709797817,
            "start_logit": 2.058936595916748,
            "end_logit": -0.2854001224040985,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA-23",
            "probability": 0.004078833725023786,
            "start_logit": 1.6695678234100342,
            "end_logit": -0.21344812214374542,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        }
    ],
    "52f4f1d62059c6d71c00001c": [
        {
            "text": "sick sinus syndrome",
            "probability": 0.17110761559097695,
            "start_logit": 5.095672130584717,
            "end_logit": 5.0032639503479,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "complete left branch conductive block in 3, serious sick sinus syndrome",
            "probability": 0.11293980652145734,
            "start_logit": 4.680234432220459,
            "end_logit": 5.0032639503479,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "heart failure in 2, complete left branch conductive block in 3, serious sick sinus syndrome",
            "probability": 0.10330452683077682,
            "start_logit": 4.591060638427734,
            "end_logit": 5.0032639503479,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "heart enlargement was evidenced in 3, heart failure in 2, complete left branch conductive block in 3, serious sick sinus syndrome",
            "probability": 0.08201123499263141,
            "start_logit": 4.360235691070557,
            "end_logit": 5.0032639503479,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "complete left branch conductive block",
            "probability": 0.0793432818304589,
            "start_logit": 4.680234432220459,
            "end_logit": 4.650192737579346,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "paroxysmal supraventricular tachycardia",
            "probability": 0.07259029513103277,
            "start_logit": 4.8019537925720215,
            "end_logit": 4.439520835876465,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "heart failure in 2, complete left branch conductive block",
            "probability": 0.07257423612762501,
            "start_logit": 4.591060638427734,
            "end_logit": 4.650192737579346,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "heart enlargement was evidenced in 3, heart failure in 2, complete left branch conductive block",
            "probability": 0.05761512022820828,
            "start_logit": 4.360235691070557,
            "end_logit": 4.650192737579346,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "heart failure",
            "probability": 0.05352858120721471,
            "start_logit": 4.591060638427734,
            "end_logit": 4.345798492431641,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "heart enlargement was evidenced in 3, heart failure",
            "probability": 0.04249518570854315,
            "start_logit": 4.360235691070557,
            "end_logit": 4.345798492431641,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "supraventricular tachycardia",
            "probability": 0.03353271256652049,
            "start_logit": 4.029644012451172,
            "end_logit": 4.439520835876465,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "heart enlargement",
            "probability": 0.027856839853456796,
            "start_logit": 4.360235691070557,
            "end_logit": 3.9234862327575684,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "serious sick sinus syndrome",
            "probability": 0.022390751928813412,
            "start_logit": 3.0620274543762207,
            "end_logit": 5.0032639503479,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "sick sinus syndrome (SSS)",
            "probability": 0.018526299404428084,
            "start_logit": 5.095672130584717,
            "end_logit": 2.7801625728607178,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "complete left branch conductive block in 3, serious sick sinus syndrome (SSS)",
            "probability": 0.01222830826709875,
            "start_logit": 4.680234432220459,
            "end_logit": 2.7801625728607178,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "heart failure in 2, complete left branch conductive block in 3, serious sick sinus syndrome (SSS)",
            "probability": 0.011185069625858714,
            "start_logit": 4.591060638427734,
            "end_logit": 2.7801625728607178,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "left branch conductive block in 3, serious sick sinus syndrome",
            "probability": 0.007709899069322471,
            "start_logit": 1.9958845376968384,
            "end_logit": 5.0032639503479,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "heart failure in 53% of subjects, syncope in 20%o, ventricular arrhythmias",
            "probability": 0.007457072078278089,
            "start_logit": 3.8452024459838867,
            "end_logit": 3.1206037998199463,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "ventricular arrhythmias in 13%o and stroke",
            "probability": 0.006020244181384485,
            "start_logit": 3.555751323699951,
            "end_logit": 3.1960198879241943,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "ventricular arrhythmias",
            "probability": 0.005582918855913417,
            "start_logit": 3.555751323699951,
            "end_logit": 3.1206037998199463,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        }
    ],
    "533c384dc45e133714000006": [
        {
            "text": "promoter region",
            "probability": 0.5201508689895764,
            "start_logit": 1.9334179162979126,
            "end_logit": 1.5769320726394653,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "promoter",
            "probability": 0.31586342543732404,
            "start_logit": 1.9334179162979126,
            "end_logit": 1.0781230926513672,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "the promoter region",
            "probability": 0.05158093115053158,
            "start_logit": -0.3775489330291748,
            "end_logit": 1.5769320726394653,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "the promoter",
            "probability": 0.031322699954539866,
            "start_logit": -0.3775489330291748,
            "end_logit": 1.0781230926513672,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "in the promoter region",
            "probability": 0.02266101894163693,
            "start_logit": -1.2000547647476196,
            "end_logit": 1.5769320726394653,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "in the promoter",
            "probability": 0.013760982617812301,
            "start_logit": -1.2000547647476196,
            "end_logit": 1.0781230926513672,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "mH2A in the promoter region",
            "probability": 0.007445573698347298,
            "start_logit": -2.3130812644958496,
            "end_logit": 1.5769320726394653,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "X chromosome",
            "probability": 0.006388372098281649,
            "start_logit": -0.9330019950866699,
            "end_logit": 0.0437125600874424,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "inactive X chromosome",
            "probability": 0.005257830870242333,
            "start_logit": -1.1277629137039185,
            "end_logit": 0.0437125600874424,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "enrichment of mH2A in the promoter region",
            "probability": 0.00453422313109637,
            "start_logit": -2.809047222137451,
            "end_logit": 1.5769320726394653,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "mH2A in the promoter",
            "probability": 0.004521350540612384,
            "start_logit": -2.3130812644958496,
            "end_logit": 1.0781230926513672,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "L41gene, with enrichment of mH2A in the promoter region",
            "probability": 0.003283314287898792,
            "start_logit": -3.131847620010376,
            "end_logit": 1.5769320726394653,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "enrichment of mH2A in the promoter",
            "probability": 0.0027534227764866985,
            "start_logit": -2.809047222137451,
            "end_logit": 1.0781230926513672,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "region",
            "probability": 0.002659605724346677,
            "start_logit": -3.3425230979919434,
            "end_logit": 1.5769320726394653,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "L41gene, with enrichment of mH2A in the promoter",
            "probability": 0.001993804028007504,
            "start_logit": -3.131847620010376,
            "end_logit": 1.0781230926513672,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "chromosome",
            "probability": 0.0015243950549922484,
            "start_logit": -2.3658838272094727,
            "end_logit": 0.0437125600874424,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "with enrichment of mH2A in the promoter region",
            "probability": 0.0011863157838661656,
            "start_logit": -4.149848461151123,
            "end_logit": 1.5769320726394653,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "X chromosome,",
            "probability": 0.0011173202309637535,
            "start_logit": -0.9330019950866699,
            "end_logit": -1.6998337507247925,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "promoter region.",
            "probability": 0.0010749550427699194,
            "start_logit": 1.9334179162979126,
            "end_logit": -4.604907989501953,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "inactive X chromosome,",
            "probability": 0.0009195896406672513,
            "start_logit": -1.1277629137039185,
            "end_logit": -1.6998337507247925,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        }
    ],
    "54e071e11388e8454a00000d": [
        {
            "text": "fludarabine, cytarabine",
            "probability": 0.1394174760209606,
            "start_logit": 5.906495571136475,
            "end_logit": 5.534609317779541,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabine",
            "probability": 0.11803591911006187,
            "start_logit": 5.906495571136475,
            "end_logit": 5.3681254386901855,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabine, cytarabine, and amsacrine",
            "probability": 0.10844494410638235,
            "start_logit": 5.906495571136475,
            "end_logit": 5.283379077911377,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "cytarabine",
            "probability": 0.10237578649523352,
            "start_logit": 5.597672939300537,
            "end_logit": 5.534609317779541,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "amsacrine",
            "probability": 0.0827641632898786,
            "start_logit": 5.6362481117248535,
            "end_logit": 5.283379077911377,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabine, Ara-C and amsacrine",
            "probability": 0.0797761299738915,
            "start_logit": 5.5420002937316895,
            "end_logit": 5.340856075286865,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "cytarabine, and amsacrine",
            "probability": 0.07963231555456786,
            "start_logit": 5.597672939300537,
            "end_logit": 5.283379077911377,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabine, amsacrine",
            "probability": 0.04495241536901354,
            "start_logit": 5.465043544769287,
            "end_logit": 4.844192981719971,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabine, high-dose AraC, amsacrine",
            "probability": 0.03928196218860484,
            "start_logit": 5.395203113555908,
            "end_logit": 4.779194355010986,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabine, amsacrine, and cytarabine",
            "probability": 0.035913264033479594,
            "start_logit": 5.465043544769287,
            "end_logit": 4.61969518661499,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "amsacrine, and cytarabine",
            "probability": 0.03354374207777948,
            "start_logit": 5.396787166595459,
            "end_logit": 4.61969518661499,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "Ara-C and amsacrine",
            "probability": 0.025378067694753238,
            "start_logit": 4.396661281585693,
            "end_logit": 5.340856075286865,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "cyclophosphamide (fludarabine",
            "probability": 0.02151544225328286,
            "start_logit": 4.64126443862915,
            "end_logit": 4.931138515472412,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabine, Ara-C",
            "probability": 0.02107789713273811,
            "start_logit": 5.5420002937316895,
            "end_logit": 4.009856700897217,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "cyclophosphamide (fludarabine, amsacrine",
            "probability": 0.019723787367432195,
            "start_logit": 4.64126443862915,
            "end_logit": 4.844192981719971,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "cyclophosphamide (fludarabine, amsacrine, and cytarabine",
            "probability": 0.0157576757033411,
            "start_logit": 4.64126443862915,
            "end_logit": 4.61969518661499,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabine (4 \u00d7 30 mg/m(2)), amsacrine",
            "probability": 0.012968723413029912,
            "start_logit": 4.482681751251221,
            "end_logit": 4.58349084854126,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "cyclophosphamide",
            "probability": 0.01056908341718884,
            "start_logit": 4.64126443862915,
            "end_logit": 4.220300674438477,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "Ara-C",
            "probability": 0.006705217468843576,
            "start_logit": 4.396661281585693,
            "end_logit": 4.009856700897217,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "high-dose AraC, amsacrine",
            "probability": 0.0021659873295366036,
            "start_logit": 2.497313976287842,
            "end_logit": 4.779194355010986,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        }
    ],
    "5506e2ff8e1671127b00000d": [
        {
            "text": "IKK\u03b2",
            "probability": 0.31108506594433405,
            "start_logit": 3.2518458366394043,
            "end_logit": 1.15696382522583,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b2) and a regulatory subunit NEMO/IKK\u03b3",
            "probability": 0.19002863836641512,
            "start_logit": 3.2518458366394043,
            "end_logit": 0.6640722155570984,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b1 and IKK\u03b2",
            "probability": 0.12475823432258777,
            "start_logit": 2.3381571769714355,
            "end_logit": 1.15696382522583,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b1 and IKK\u03b2) and a regulatory subunit NEMO/IKK\u03b3",
            "probability": 0.07620950019362802,
            "start_logit": 2.3381571769714355,
            "end_logit": 0.6640722155570984,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b1",
            "probability": 0.07369711422218718,
            "start_logit": 2.3381571769714355,
            "end_logit": 0.6305497288703918,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b2) and a regulatory subunit NEMO",
            "probability": 0.04584945298023845,
            "start_logit": 3.2518458366394043,
            "end_logit": -0.7577393054962158,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b3",
            "probability": 0.03976595340881198,
            "start_logit": 1.6876821517944336,
            "end_logit": 0.6640722155570984,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b3/NEMO",
            "probability": 0.033163937809702795,
            "start_logit": 1.8059953451156616,
            "end_logit": 0.36421099305152893,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b2, IKK\u03b3/NEMO",
            "probability": 0.029110478059774843,
            "start_logit": 1.6756304502487183,
            "end_logit": 0.36421099305152893,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b1 and IKK\u03b2) and a regulatory subunit NEMO",
            "probability": 0.018387564768199513,
            "start_logit": 2.3381571769714355,
            "end_logit": -0.7577393054962158,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "NEMO/IKK\u03b3",
            "probability": 0.016552970503876774,
            "start_logit": 0.8112366199493408,
            "end_logit": 0.6640722155570984,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b2, IKK\u03b3",
            "probability": 0.016409426852146587,
            "start_logit": 1.6756304502487183,
            "end_logit": -0.20903120934963226,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "NEMO",
            "probability": 0.007243283773855398,
            "start_logit": 0.28460693359375,
            "end_logit": 0.36421099305152893,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b1, IKK\u03b2",
            "probability": 0.0041747759289904665,
            "start_logit": -1.0199354887008667,
            "end_logit": 1.1177394390106201,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b2 and NEMO subunits, with IKK\u03b2",
            "probability": 0.0026096544971409715,
            "start_logit": 0.3848762512207031,
            "end_logit": -0.7569151520729065,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b3 that regulates the canonical NF-\u03baB pathway, whereas IKK\u03b1",
            "probability": 0.002540187085268402,
            "start_logit": 1.6876821517944336,
            "end_logit": -2.0867011547088623,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b2 and NEMO",
            "probability": 0.0023168581836756517,
            "start_logit": 0.3848762512207031,
            "end_logit": -0.8759209513664246,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b2)",
            "probability": 0.0021193627013633537,
            "start_logit": 3.2518458366394043,
            "end_logit": -3.831987142562866,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "NEMO subunits, with IKK\u03b2",
            "probability": 0.002012461804328259,
            "start_logit": 0.1250171661376953,
            "end_logit": -0.7569151520729065,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKK\u03b1, IKK\u03b2, IKK\u03b3/NEMO",
            "probability": 0.0019650785934746213,
            "start_logit": -1.0199354887008667,
            "end_logit": 0.36421099305152893,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        }
    ],
    "53189b05b166e2b80600001e": [
        {
            "text": "salivary",
            "probability": 0.20406173836182254,
            "start_logit": 5.422124862670898,
            "end_logit": 4.253391742706299,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lacrimal",
            "probability": 0.12947891259971903,
            "start_logit": 4.847434997558594,
            "end_logit": 4.3731770515441895,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary and lacrimal",
            "probability": 0.12423391944258119,
            "start_logit": 4.8060832023620605,
            "end_logit": 4.3731770515441895,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lachrymal and salivary",
            "probability": 0.11884639060271912,
            "start_logit": 4.881534099578857,
            "end_logit": 4.253391742706299,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary glands.Sj\u00f6gren's syndrome is an autoimmune disease in which immune cells chronically attack the lachrymal",
            "probability": 0.09313097774533159,
            "start_logit": 5.099478721618652,
            "end_logit": 3.7916221618652344,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lacrimal and/or salivary",
            "probability": 0.08657771374020543,
            "start_logit": 4.890434265136719,
            "end_logit": 3.9277021884918213,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lachrymal",
            "probability": 0.07489313592656832,
            "start_logit": 4.881534099578857,
            "end_logit": 3.7916221618652344,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary glands",
            "probability": 0.062276250767307646,
            "start_logit": 5.422124862670898,
            "end_logit": 3.066549301147461,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lachrymal and salivary glands",
            "probability": 0.03626994302499299,
            "start_logit": 4.881534099578857,
            "end_logit": 3.066549301147461,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lacrimal and/or salivary glands",
            "probability": 0.027515900951568403,
            "start_logit": 4.890434265136719,
            "end_logit": 2.781423807144165,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lacrimal glands",
            "probability": 0.019811703383434957,
            "start_logit": 4.847434997558594,
            "end_logit": 2.49593186378479,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary and lacrimal glands",
            "probability": 0.019009161513172244,
            "start_logit": 4.8060832023620605,
            "end_logit": 2.49593186378479,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "saliva",
            "probability": 0.0008216515022541169,
            "start_logit": 4.8060832023620605,
            "end_logit": -0.6454281210899353,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary glands.",
            "probability": 0.0007348567561312373,
            "start_logit": 5.099478721618652,
            "end_logit": -1.050464391708374,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lacrimal and/or salivary glands.",
            "probability": 0.0005962327638049662,
            "start_logit": 4.890434265136719,
            "end_logit": -1.050464391708374,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "the lachrymal and salivary",
            "probability": 0.0005499968370598212,
            "start_logit": -0.49414047598838806,
            "end_logit": 4.253391742706299,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lachrymal and saliva",
            "probability": 0.0003776497008909138,
            "start_logit": 4.881534099578857,
            "end_logit": -1.4982283115386963,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "the lachrymal",
            "probability": 0.0003465901460549818,
            "start_logit": -0.49414047598838806,
            "end_logit": 3.7916221618652344,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lachrymal and salivary glands.",
            "probability": 0.0002393924007615773,
            "start_logit": 4.881534099578857,
            "end_logit": -1.9540913105010986,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lacrimal and/or saliva",
            "probability": 0.00022788183361905823,
            "start_logit": 4.890434265136719,
            "end_logit": -2.012268304824829,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        }
    ],
    "51716a438ed59a060a00000a": [
        {
            "text": "GeneMark",
            "probability": 0.25147818183432435,
            "start_logit": 2.8631415367126465,
            "end_logit": 2.233597993850708,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GeneMark.hmm",
            "probability": 0.12475576267501093,
            "start_logit": 2.8631415367126465,
            "end_logit": 1.532599687576294,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GeneMark.hmm-E",
            "probability": 0.117011470325696,
            "start_logit": 2.8631415367126465,
            "end_logit": 1.4685137271881104,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GeneMark.hmm-E and GeneMark-ES",
            "probability": 0.08228539639421119,
            "start_logit": 2.8631415367126465,
            "end_logit": 1.1164354085922241,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GeneMark.hmm-E and GeneMark",
            "probability": 0.07970725382205554,
            "start_logit": 2.8631415367126465,
            "end_logit": 1.0846023559570312,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GeneMark-ES",
            "probability": 0.05816772321598059,
            "start_logit": 2.5162785053253174,
            "end_logit": 1.1164354085922241,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GeneMark, Pombe",
            "probability": 0.03388353751639933,
            "start_logit": 1.9544970989227295,
            "end_logit": 1.1378154754638672,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "hmm",
            "probability": 0.033053790468050424,
            "start_logit": 1.5349198579788208,
            "end_logit": 1.532599687576294,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "hmm-E",
            "probability": 0.03100195565778675,
            "start_logit": 1.5349198579788208,
            "end_logit": 1.4685137271881104,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GenScan, HMMGene, GeneMark, Pombe",
            "probability": 0.023590172975605173,
            "start_logit": 1.5923980474472046,
            "end_logit": 1.1378154754638672,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "hmm-E and GeneMark-ES",
            "probability": 0.0218013516384003,
            "start_logit": 1.5349198579788208,
            "end_logit": 1.1164354085922241,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "HMMGene, GeneMark, Pombe",
            "probability": 0.02120150622510222,
            "start_logit": 1.485640048980713,
            "end_logit": 1.1378154754638672,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "hmm-E and GeneMark",
            "probability": 0.02111827790657771,
            "start_logit": 1.5349198579788208,
            "end_logit": 1.0846023559570312,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GenScan, HMMGene",
            "probability": 0.019247060099023446,
            "start_logit": 1.5923980474472046,
            "end_logit": 0.9343435764312744,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "HMMGene",
            "probability": 0.01729816330411599,
            "start_logit": 1.485640048980713,
            "end_logit": 0.9343435764312744,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GenScan, HMMGene, GeneMark",
            "probability": 0.014624143658937697,
            "start_logit": 1.5923980474472046,
            "end_logit": 0.6596590876579285,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Pombe",
            "probability": 0.013710080508534934,
            "start_logit": 1.0496991872787476,
            "end_logit": 1.1378154754638672,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "HMMGene, GeneMark",
            "probability": 0.013143348848793372,
            "start_logit": 1.485640048980713,
            "end_logit": 0.6596590876579285,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GenScan",
            "probability": 0.012661568013507176,
            "start_logit": 1.5923980474472046,
            "end_logit": 0.5155565142631531,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "GeneMark, Pombe and FFG",
            "probability": 0.010259254911886851,
            "start_logit": 1.9544970989227295,
            "end_logit": -0.05693358555436134,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        }
    ],
    "514168ab23fec9037500000a": [
        {
            "text": "c-Myc",
            "probability": 0.3262445841876743,
            "start_logit": 5.268708229064941,
            "end_logit": 4.942562580108643,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "c-Myc protein was able to induce liver glucose utilization and accumulation, and suggested that c-Myc",
            "probability": 0.2271027940690259,
            "start_logit": 4.906463623046875,
            "end_logit": 4.942562580108643,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "myc",
            "probability": 0.1520603981340632,
            "start_logit": 4.504258155822754,
            "end_logit": 4.943643093109131,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "myc regulates hepatic glycolysisincrease in c-Myc",
            "probability": 0.10936770123348463,
            "start_logit": 4.504258155822754,
            "end_logit": 4.614080905914307,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Myc",
            "probability": 0.08042713537462617,
            "start_logit": 3.868412494659424,
            "end_logit": 4.942562580108643,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Myc protein was able to induce liver glucose utilization and accumulation, and suggested that c-Myc",
            "probability": 0.049226895967548416,
            "start_logit": 3.3775010108947754,
            "end_logit": 4.942562580108643,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF1 alpha",
            "probability": 0.022312663492049804,
            "start_logit": 4.393227577209473,
            "end_logit": 3.1355502605438232,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF1 alpha-mediated switches in the energy production of tumor cells from OXPHOS to glycolysisNF-\u03baB",
            "probability": 0.015665739969615282,
            "start_logit": 4.393227577209473,
            "end_logit": 2.781872034072876,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "c-Myc transcription factor is involved in the control in vivo of liver carbohydrate metabolismSTAT3",
            "probability": 0.003848627615671323,
            "start_logit": 5.268708229064941,
            "end_logit": 0.5026318430900574,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "c-Myc transcription factor",
            "probability": 0.0023496984997810467,
            "start_logit": 5.268708229064941,
            "end_logit": 0.009202243760228157,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "c-Myc protein",
            "probability": 0.0022425864059084236,
            "start_logit": 4.906463623046875,
            "end_logit": 0.3247896730899811,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF1",
            "probability": 0.0017212722402819465,
            "start_logit": 4.393227577209473,
            "end_logit": 0.5734595656394958,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "c-Myc protein was able to induce liver glucose utilization and accumulation, and suggested that c-Myc transcription factor",
            "probability": 0.0016356534955170442,
            "start_logit": 4.906463623046875,
            "end_logit": 0.009202243760228157,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "myc regulates hepatic glycolysisincrease in c-Myc protein",
            "probability": 0.0014999389061527892,
            "start_logit": 4.504258155822754,
            "end_logit": 0.3247896730899811,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "NF-\u03baB",
            "probability": 0.0014484137120509832,
            "start_logit": 2.5295567512512207,
            "end_logit": 2.264535665512085,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Myc transcription factor is involved in the control in vivo of liver carbohydrate metabolismSTAT3",
            "probability": 0.0009487792572031196,
            "start_logit": 3.868412494659424,
            "end_logit": 0.5026318430900574,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Myc transcription factor",
            "probability": 0.000579257184611943,
            "start_logit": 3.868412494659424,
            "end_logit": 0.009202243760228157,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Myc protein",
            "probability": 0.0004861039607832324,
            "start_logit": 3.3775010108947754,
            "end_logit": 0.3247896730899811,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "c-Myc protein was able to induce liver glucose utilization and accumulation,",
            "probability": 0.00042584705796550233,
            "start_logit": 4.906463623046875,
            "end_logit": -1.336515188217163,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF",
            "probability": 0.0004059092359850268,
            "start_logit": 4.393227577209473,
            "end_logit": -0.8712298274040222,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        }
    ],
    "53215fca9b2d7acc7e000005": [
        {
            "text": "MINOS",
            "probability": 0.3846679630108516,
            "start_logit": 4.655727863311768,
            "end_logit": 3.8844728469848633,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS protein complex APOOL physically interacts with several subunits of the MINOS",
            "probability": 0.14394722923277037,
            "start_logit": 4.655727863311768,
            "end_logit": 2.9015390872955322,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS protein complex APOOL physically interacts with several subunits of the MINOS complex",
            "probability": 0.1141197722204008,
            "start_logit": 4.655727863311768,
            "end_logit": 2.6693408489227295,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS complex, namely Mitofilin, MINOS1, and SAMM50. Mitofilin/MINOS",
            "probability": 0.10512025549348308,
            "start_logit": 4.203729152679443,
            "end_logit": 3.039196014404297,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS complex",
            "probability": 0.07262068653523465,
            "start_logit": 4.203729152679443,
            "end_logit": 2.6693408489227295,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS complex, namely Mitofilin, MINOS1, and SAMM50. Mitofilin/MINOS protein complex MINOS",
            "probability": 0.04822676736785303,
            "start_logit": 4.203729152679443,
            "end_logit": 2.260005235671997,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS protein complex MINOS",
            "probability": 0.04551139600052774,
            "start_logit": 4.145777702331543,
            "end_logit": 2.260005235671997,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS protein complex APOOL physically interacts with several subunits of the MINOS complex, namely Mitofilin, MINOS",
            "probability": 0.017860437638177403,
            "start_logit": 4.655727863311768,
            "end_logit": 0.8146803975105286,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS complex, namely Mitofilin, MINOS",
            "probability": 0.011365578618569317,
            "start_logit": 4.203729152679443,
            "end_logit": 0.8146803975105286,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS protein complex",
            "probability": 0.010944737683760891,
            "start_logit": 4.655727863311768,
            "end_logit": 0.32495108246803284,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS1, and SAMM50. Mitofilin/MINOS",
            "probability": 0.010923768530191587,
            "start_logit": 1.9395651817321777,
            "end_logit": 3.039196014404297,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MIB) complex (Mitofilin, Sam50, and ChChd3), Mitofilin/MINOS",
            "probability": 0.01043227176132178,
            "start_logit": 1.0482513904571533,
            "end_logit": 3.8844728469848633,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS1, and SAMM50. Mitofilin/MINOS protein complex MINOS",
            "probability": 0.005011574992970631,
            "start_logit": 1.9395651817321777,
            "end_logit": 2.260005235671997,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS protein complex MINOS subunits (mitofilin, MINOS",
            "probability": 0.004342082251241436,
            "start_logit": 4.145777702331543,
            "end_logit": -0.08960350602865219,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "Mitofilin/MINOS",
            "probability": 0.0034068985197214766,
            "start_logit": -0.07085031270980835,
            "end_logit": 3.8844728469848633,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS complex, namely Mitofilin, MINOS1, and SAMM50. Mitofilin/MINOS protein complex",
            "probability": 0.003391400573255871,
            "start_logit": 4.203729152679443,
            "end_logit": -0.39466598629951477,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS protein complex APOOL physically interacts with several subunits of the MINOS complex, namely Mitofilin, MINOS1",
            "probability": 0.0030054407232724205,
            "start_logit": 4.655727863311768,
            "end_logit": -0.9674834609031677,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS complex, namely Mitofilin, MINOS1",
            "probability": 0.0019125272020651496,
            "start_logit": 4.203729152679443,
            "end_logit": -0.9674834609031677,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MINOS complex, namely Mitofilin, MINOS1, and SAMM50",
            "probability": 0.0016409242219222468,
            "start_logit": 4.203729152679443,
            "end_logit": -1.1206493377685547,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "the MINOS complex, namely Mitofilin, MINOS1, and SAMM50. Mitofilin/MINOS",
            "probability": 0.0015482874224082878,
            "start_logit": -0.014226401224732399,
            "end_logit": 3.039196014404297,
            "question_text": "Which protein complexes contain mitofilin?"
        }
    ],
    "515c4f05298dcd4e51000006": [
        {
            "text": "KCNE1",
            "probability": 0.3024379675698869,
            "start_logit": 4.6268839836120605,
            "end_logit": 3.706624746322632,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "nucleotide-gated potassium channel 2 mRNA",
            "probability": 0.23010044665574658,
            "start_logit": 4.236520290374756,
            "end_logit": 3.8236281871795654,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "nucleotide-gated potassium channel 2 mRNA in the heartKCNE1",
            "probability": 0.20314830323697336,
            "start_logit": 4.236520290374756,
            "end_logit": 3.6990485191345215,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "nucleotide-gated potassium channel 2",
            "probability": 0.1792401810832081,
            "start_logit": 4.236520290374756,
            "end_logit": 3.573838949203491,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "TRalpha1-dependent repression of KCNE1",
            "probability": 0.013385131483886353,
            "start_logit": 1.5091522932052612,
            "end_logit": 3.706624746322632,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "2 mRNA",
            "probability": 0.012775815038110967,
            "start_logit": 1.3455582857131958,
            "end_logit": 3.8236281871795654,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "2 mRNA in the heartKCNE1",
            "probability": 0.011279357277148655,
            "start_logit": 1.3455582857131958,
            "end_logit": 3.6990485191345215,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "2",
            "probability": 0.009951912020155974,
            "start_logit": 1.3455582857131958,
            "end_logit": 3.573838949203491,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "potassium channel 2 mRNA",
            "probability": 0.007208587688018207,
            "start_logit": 0.7732774019241333,
            "end_logit": 3.8236281871795654,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCNE",
            "probability": 0.006709540360949537,
            "start_logit": 4.6268839836120605,
            "end_logit": -0.10172099620103836,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "potassium channel 2 mRNA in the heartKCNE1",
            "probability": 0.006364230834139769,
            "start_logit": 0.7732774019241333,
            "end_logit": 3.6990485191345215,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "potassium channel 2",
            "probability": 0.005615237090294016,
            "start_logit": 0.7732774019241333,
            "end_logit": 3.573838949203491,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "nucleotide-gated potassium channel 2 mRNA in the heartKCNE",
            "probability": 0.0031085617761458504,
            "start_logit": 4.236520290374756,
            "end_logit": -0.48072758316993713,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "nucleotide-gated potassium channel",
            "probability": 0.002430005243929985,
            "start_logit": 4.236520290374756,
            "end_logit": -0.7269943356513977,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "CNE1",
            "probability": 0.0014853604302386353,
            "start_logit": -0.6817585229873657,
            "end_logit": 3.6990485191345215,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "mRNA",
            "probability": 0.00134660819262822,
            "start_logit": -0.9044066667556763,
            "end_logit": 3.8236281871795654,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "mRNA in the heartKCNE1",
            "probability": 0.0011888771770474018,
            "start_logit": -0.9044066667556763,
            "end_logit": 3.6990485191345215,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "nucleotide-gated potassium channel 2 m",
            "probability": 0.0008039012439332691,
            "start_logit": 4.236520290374756,
            "end_logit": -1.8331665992736816,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "TRalpha1",
            "probability": 0.0007425719440499155,
            "start_logit": 1.5091522932052612,
            "end_logit": 0.8148447275161743,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCNE1 expression",
            "probability": 0.0006774036535082383,
            "start_logit": 4.6268839836120605,
            "end_logit": -2.3947393894195557,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        }
    ],
    "56ae40110a360a5e45000009": [
        {
            "text": "DEEP",
            "probability": 0.8013682887658398,
            "start_logit": 2.621407985687256,
            "end_logit": 3.2177064418792725,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP: a general computational framework for predicting enhancersWe report the first computational enhancer prediction results on FANTOM5 data where DEEP",
            "probability": 0.0893033330291909,
            "start_logit": 2.621407985687256,
            "end_logit": 1.0234246253967285,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel ensemble prediction framework. DEEP",
            "probability": 0.033858683089564384,
            "start_logit": 1.9414693117141724,
            "end_logit": 0.733519971370697,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP: a general computational framework",
            "probability": 0.030180131251022105,
            "start_logit": 2.621407985687256,
            "end_logit": -0.06143038347363472,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP-VISTA",
            "probability": 0.008051056618497168,
            "start_logit": 1.0866390466690063,
            "end_logit": 0.15195809304714203,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel ensemble prediction framework",
            "probability": 0.007739124093823306,
            "start_logit": 1.9414693117141724,
            "end_logit": -0.7423869967460632,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP: a general computational",
            "probability": 0.006041820801781196,
            "start_logit": 2.621407985687256,
            "end_logit": -1.6699087619781494,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP,",
            "probability": 0.0041825023593155776,
            "start_logit": 1.9414693117141724,
            "end_logit": -1.357765793800354,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP: a general",
            "probability": 0.004031632264142462,
            "start_logit": 2.621407985687256,
            "end_logit": -2.0744428634643555,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP: a general computational framework for predicting enhancersWe report the first computational enhancer prediction",
            "probability": 0.003985786354804129,
            "start_logit": 2.621407985687256,
            "end_logit": -2.0858795642852783,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "general computational framework for predicting enhancersWe report the first computational enhancer prediction results on FANTOM5 data where DEEP",
            "probability": 0.0021973412345167244,
            "start_logit": -1.0833827257156372,
            "end_logit": 1.0234246253967285,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel ensemble prediction",
            "probability": 0.0020016886500833207,
            "start_logit": 1.9414693117141724,
            "end_logit": -2.094684362411499,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP uses features derived from histone modification marks or attributes coming from sequence characteristics. Experimental results indicate that DEEP",
            "probability": 0.0019360249322128446,
            "start_logit": -0.38717249035835266,
            "end_logit": 0.2006031572818756,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel ensemble",
            "probability": 0.0011742173252157352,
            "start_logit": 1.9414693117141724,
            "end_logit": -2.6280736923217773,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "computational enhancer prediction results on FANTOM5 data where DEEP",
            "probability": 0.0007770370266894825,
            "start_logit": -2.1228981018066406,
            "end_logit": 1.0234246253967285,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "general computational framework",
            "probability": 0.0007425931889834473,
            "start_logit": -1.0833827257156372,
            "end_logit": -0.06143038347363472,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "computational framework for predicting enhancersWe report the first computational enhancer prediction results on FANTOM5 data where DEEP",
            "probability": 0.0007006116792511825,
            "start_logit": -2.2264323234558105,
            "end_logit": 1.0234246253967285,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "enhancer prediction results on FANTOM5 data where DEEP",
            "probability": 0.0006786602330276427,
            "start_logit": -2.258265495300293,
            "end_logit": 1.0234246253967285,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "ensemble prediction framework. DEEP",
            "probability": 0.000595470738821287,
            "start_logit": -2.0991291999816895,
            "end_logit": 0.733519971370697,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "a general computational framework for predicting enhancersWe report the first computational enhancer prediction results on FANTOM5 data where DEEP",
            "probability": 0.0004539963632171031,
            "start_logit": -2.66029691696167,
            "end_logit": 1.0234246253967285,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        }
    ],
    "5311d130e3eabad021000009": [
        {
            "text": "tau",
            "probability": 0.134368172117917,
            "start_logit": 4.477457523345947,
            "end_logit": 4.467624664306641,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau (t-tau) and phosphorylated tau",
            "probability": 0.11458207338916938,
            "start_logit": 4.318165302276611,
            "end_logit": 4.467624664306641,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "total tau (t-tau) and phosphorylated tau",
            "probability": 0.09171960981144961,
            "start_logit": 4.09561014175415,
            "end_logit": 4.467624664306641,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "total tau",
            "probability": 0.0871534433735818,
            "start_logit": 4.09561014175415,
            "end_logit": 4.416558742523193,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "phosphorylated tau",
            "probability": 0.07320954015252877,
            "start_logit": 3.870199680328369,
            "end_logit": 4.467624664306641,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "amyloid (A\u03b2 1-42) and elevated total tau (t-tau) and phosphorylated tau",
            "probability": 0.06553796972088549,
            "start_logit": 3.7595036029815674,
            "end_logit": 4.467624664306641,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "amyloid (A\u03b2 1-42) and elevated total tau",
            "probability": 0.06227522930625993,
            "start_logit": 3.7595036029815674,
            "end_logit": 4.416558742523193,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau (t-tau",
            "probability": 0.046715165054199495,
            "start_logit": 4.318165302276611,
            "end_logit": 3.570402145385742,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "Abeta 1-42, tau",
            "probability": 0.045288568127726525,
            "start_logit": 3.882866382598877,
            "end_logit": 3.974686861038208,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau (p-tau",
            "probability": 0.04192544209223268,
            "start_logit": 4.477457523345947,
            "end_logit": 3.302933931350708,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "total tau (t-tau",
            "probability": 0.03739412793217656,
            "start_logit": 4.09561014175415,
            "end_logit": 3.570402145385742,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau (t-tau) and phosphorylated tau (p-tau",
            "probability": 0.03575180049684558,
            "start_logit": 4.318165302276611,
            "end_logit": 3.302933931350708,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "total tau (t-tau) and phosphorylated tau (p-tau",
            "probability": 0.02861827417357085,
            "start_logit": 4.09561014175415,
            "end_logit": 3.302933931350708,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "amyloid (A\u03b2 1-42) and elevated total tau (t-tau",
            "probability": 0.02671986098933419,
            "start_logit": 3.7595036029815674,
            "end_logit": 3.570402145385742,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "phosphorylated tau (p-tau",
            "probability": 0.022842778076718022,
            "start_logit": 3.870199680328369,
            "end_logit": 3.302933931350708,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "Abeta 1-42",
            "probability": 0.02198578278131125,
            "start_logit": 3.882866382598877,
            "end_logit": 3.252028226852417,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "t-tau) and phosphorylated tau",
            "probability": 0.021754315022145986,
            "start_logit": 2.6566860675811768,
            "end_logit": 4.467624664306641,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau) and phosphorylated tau",
            "probability": 0.018863183704021853,
            "start_logit": 2.5140860080718994,
            "end_logit": 4.467624664306641,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "FDG-PET",
            "probability": 0.01226806826702854,
            "start_logit": 3.816687822341919,
            "end_logit": 2.7348105907440186,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau (t-tau)",
            "probability": 0.011026595410896458,
            "start_logit": 4.318165302276611,
            "end_logit": 2.126643419265747,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        }
    ],
    "52f509232059c6d71c00001f": [
        {
            "text": "KCNJ2",
            "probability": 0.9765644027351739,
            "start_logit": 4.0610246658325195,
            "end_logit": 3.859666347503662,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "CACNA2D1",
            "probability": 0.013110338021596515,
            "start_logit": 2.565971851348877,
            "end_logit": 1.0440795421600342,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "Kir2.1 currents.In this study, we identified a novel KCNJ2",
            "probability": 0.0027288935223563743,
            "start_logit": -0.8470126390457153,
            "end_logit": 2.887559175491333,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1",
            "probability": 0.0024673823656455587,
            "start_logit": 4.0610246658325195,
            "end_logit": -2.1212165355682373,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "CACNA2D1 gene",
            "probability": 0.001011579632261536,
            "start_logit": 2.565971851348877,
            "end_logit": -1.517808437347412,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "2",
            "probability": 0.000619532020376896,
            "start_logit": -3.301806926727295,
            "end_logit": 3.859666347503662,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2 gain-of-function mutation, M301K,",
            "probability": 0.0005703013769121426,
            "start_logit": 3.259129047393799,
            "end_logit": -2.784069061279297,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents",
            "probability": 0.0004961552713659897,
            "start_logit": 4.0610246658325195,
            "end_logit": -3.725240707397461,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2 mutation",
            "probability": 0.0003967237276458728,
            "start_logit": 4.0610246658325195,
            "end_logit": -3.9488894939422607,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "J2",
            "probability": 0.0003025017088985449,
            "start_logit": -4.018684387207031,
            "end_logit": 3.859666347503662,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "CACNA2",
            "probability": 0.00025877248047206144,
            "start_logit": 2.565971851348877,
            "end_logit": -2.8811275959014893,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2 mutation associated with short-QT syndrome impairs inward rectification",
            "probability": 0.00023539610015838367,
            "start_logit": 4.0610246658325195,
            "end_logit": -4.470860004425049,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "gain-of-function KCNJ2",
            "probability": 0.0002227758983011039,
            "start_logit": -4.3246049880981445,
            "end_logit": 3.859666347503662,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.",
            "probability": 0.00022222525752256845,
            "start_logit": 4.0610246658325195,
            "end_logit": -4.528438091278076,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "CNJ2",
            "probability": 0.00020945539487927462,
            "start_logit": -4.386260509490967,
            "end_logit": 3.859666347503662,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "A novel gain-of-function KCNJ2",
            "probability": 0.00020437071416045627,
            "start_logit": -4.4108357429504395,
            "end_logit": 3.859666347503662,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2 gain-of-function mutation, M301K",
            "probability": 0.00016777122265011147,
            "start_logit": 3.259129047393799,
            "end_logit": -4.007632732391357,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "inward rectification of Kir2.1 currents.In this study, we identified a novel KCNJ2",
            "probability": 8.985241394093168e-05,
            "start_logit": -4.260495662689209,
            "end_logit": 2.887559175491333,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2 gain-of-function mutation, M301K, associated with SQTS.",
            "probability": 8.613088143205411e-05,
            "start_logit": 3.259129047393799,
            "end_logit": -4.674365997314453,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "the CACNA2D1",
            "probability": 3.543925425008126e-05,
            "start_logit": -3.3473644256591797,
            "end_logit": 1.0440795421600342,
            "question_text": "Which genes are implicated in short QT syndrome?"
        }
    ],
    "56be1723ef6e39474100000c": [
        {
            "text": "facial pain",
            "probability": 0.13264101871959483,
            "start_logit": 4.281376838684082,
            "end_logit": 4.549039840698242,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otorrhea, facial pain",
            "probability": 0.10665799031876212,
            "start_logit": 4.063357830047607,
            "end_logit": 4.549039840698242,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "facial pain with trigeminal nerve involvement and abducens nerve palsy",
            "probability": 0.10335724616759862,
            "start_logit": 4.281376838684082,
            "end_logit": 4.299584865570068,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otorrhea",
            "probability": 0.09210004965560914,
            "start_logit": 4.063357830047607,
            "end_logit": 4.40228796005249,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media",
            "probability": 0.08532386747031451,
            "start_logit": 4.1420817375183105,
            "end_logit": 4.247142791748047,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otorrhea, facial pain with trigeminal nerve involvement and abducens nerve palsy",
            "probability": 0.08311061138954527,
            "start_logit": 4.063357830047607,
            "end_logit": 4.299584865570068,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media, deep facial pain",
            "probability": 0.08285665338507522,
            "start_logit": 4.1420817375183105,
            "end_logit": 4.217800617218018,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "abducens nerve palsy",
            "probability": 0.06781537520604712,
            "start_logit": 3.8599743843078613,
            "end_logit": 4.299584865570068,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "deep facial pain",
            "probability": 0.04380410928935684,
            "start_logit": 3.504697322845459,
            "end_logit": 4.217800617218018,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "suppurative otitis media",
            "probability": 0.03539800883060165,
            "start_logit": 3.0857841968536377,
            "end_logit": 4.423641681671143,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "facial pain with trigeminal nerve involvement",
            "probability": 0.028111941492929025,
            "start_logit": 4.281376838684082,
            "end_logit": 2.9975879192352295,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media, deep facial pain and ipsilateral abducens nerve paralysis",
            "probability": 0.027282012957615613,
            "start_logit": 4.1420817375183105,
            "end_logit": 3.1069161891937256,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otorrhea, facial pain with trigeminal nerve involvement",
            "probability": 0.022605097672937946,
            "start_logit": 4.063357830047607,
            "end_logit": 2.9975879192352295,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "deep facial pain and ipsilateral abducens nerve paralysis",
            "probability": 0.014423274757127808,
            "start_logit": 3.504697322845459,
            "end_logit": 3.1069161891937256,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "abducens nerve paralysis",
            "probability": 0.013810893967517866,
            "start_logit": 3.4613118171691895,
            "end_logit": 3.1069161891937256,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "trigeminal nerve involvement and abducens nerve palsy",
            "probability": 0.013611812844002464,
            "start_logit": 2.2541234493255615,
            "end_logit": 4.299584865570068,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "abducens nerve palsy.Gradenigo's syndrome is a rare but life threatening complication of acute otitis media",
            "probability": 0.01315266406321987,
            "start_logit": 3.8599743843078613,
            "end_logit": 2.6594202518463135,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media (AOM), which includes a classic triad of otitis media",
            "probability": 0.011591944342956673,
            "start_logit": 2.145937919616699,
            "end_logit": 4.247142791748047,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media (AOM), which includes a classic triad of otitis media, deep facial pain",
            "probability": 0.011256753156642915,
            "start_logit": 2.145937919616699,
            "end_logit": 4.217800617218018,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "diplopia and facial pain",
            "probability": 0.011088674312544735,
            "start_logit": 3.069169521331787,
            "end_logit": 3.2795250415802,
            "question_text": "List symptoms of Gradenigo's syndrome."
        }
    ],
    "550e9d2cb305b40c5c000001": [
        {
            "text": "Age",
            "probability": 0.802622728162901,
            "start_logit": 2.594949722290039,
            "end_logit": 3.191601514816284,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and NIH Stroke Scale: SPAN-100.METHODS: We created the Stroke Prognostication using Age",
            "probability": 0.1416524467896292,
            "start_logit": 2.594949722290039,
            "end_logit": 1.4570932388305664,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "age",
            "probability": 0.015270379670793031,
            "start_logit": 0.6364890933036804,
            "end_logit": 1.1880923509597778,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and NIH Stroke Scale (SPAN) index by combining age",
            "probability": 0.010916127284226874,
            "start_logit": 1.0670881271362305,
            "end_logit": 0.4218195974826813,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and the NIH Stroke Scale index, created by combining age",
            "probability": 0.010211742375023744,
            "start_logit": 0.7354580760002136,
            "end_logit": 0.6867466568946838,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "age in years plus NIH Stroke Scale (NIHSS) \u2265100. The SPAN-100 index is considered positive if the sum of the age",
            "probability": 0.008946688285970504,
            "start_logit": 0.10185755044221878,
            "end_logit": 1.1880923509597778,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and NIH Stroke Scale",
            "probability": 0.007520726419320671,
            "start_logit": 2.594949722290039,
            "end_logit": -1.4786205291748047,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and NIH Stroke Scale: SPAN-100.METHODS: We created the Stroke Prognostication using Age and NIH Stroke Scale",
            "probability": 0.0008730922260154908,
            "start_logit": 2.594949722290039,
            "end_logit": -3.6319973468780518,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Stroke Prognostication using Age",
            "probability": 0.0006920748962409192,
            "start_logit": -4.460996150970459,
            "end_logit": 3.191601514816284,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and NIH Stroke",
            "probability": 0.0002671537819993986,
            "start_logit": 2.594949722290039,
            "end_logit": -4.816214084625244,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "NIH Stroke Scale: SPAN-100.METHODS: We created the Stroke Prognostication using Age",
            "probability": 0.0001737975965667086,
            "start_logit": -4.108290672302246,
            "end_logit": 1.4570932388305664,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and NIHSS-100",
            "probability": 0.00016917142224416796,
            "start_logit": 1.9315367937088013,
            "end_logit": -4.609713077545166,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100.METHODS: We created the Stroke Prognostication using Age",
            "probability": 0.0001221421957967628,
            "start_logit": -4.460996150970459,
            "end_logit": 1.4570932388305664,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Stroke Scale: SPAN-100.METHODS: We created the Stroke Prognostication using Age",
            "probability": 0.0001129190657030874,
            "start_logit": -4.539510726928711,
            "end_logit": 1.4570932388305664,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "age and the NIH Stroke Scale",
            "probability": 0.00010602684182805464,
            "start_logit": 0.6364890933036804,
            "end_logit": -3.7818856239318848,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and NIH Stroke Scale (SPAN) index by combining age in years plus NIH Stroke Scale (NIHSS) \u2265100",
            "probability": 7.864312788805962e-05,
            "start_logit": 1.0670881271362305,
            "end_logit": -4.511256694793701,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "42, with higher scores indicating more severe strokes) score is greater than or equal to 100The Stroke Prognostication using Age",
            "probability": 6.857898101841527e-05,
            "start_logit": -4.7866387367248535,
            "end_logit": 1.2055360078811646,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and the NIH Stroke Scale index, created by combining age in years plus a National Institutes of Health (NIH) Stroke Scale score of 100",
            "probability": 6.80332950538438e-05,
            "start_logit": 0.7354580760002136,
            "end_logit": -4.324549674987793,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "age and the NIH Stroke Scale (a 15-item neurological examination scale with scores ranging from 0 to 42",
            "probability": 6.658551718961157e-05,
            "start_logit": 0.6364890933036804,
            "end_logit": -4.247090816497803,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "Age and the NIH Stroke Scale index",
            "probability": 6.094206459047865e-05,
            "start_logit": 0.7354580760002136,
            "end_logit": -4.4346232414245605,
            "question_text": "Which variables are included in the SPAN-100 score?"
        }
    ],
    "516c0ed3298dcd4e5100006f": [
        {
            "text": "pyruvate kinase mRNA",
            "probability": 0.2766601440749689,
            "start_logit": 5.560889720916748,
            "end_logit": 5.103880405426025,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "phosphoenolpyruvate-carboxykinase was up-regulated and pyruvate kinase mRNA",
            "probability": 0.26649341556411665,
            "start_logit": 5.523449420928955,
            "end_logit": 5.103880405426025,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "phosphoenolpyruvate-carboxykinase",
            "probability": 0.24792797253643337,
            "start_logit": 5.523449420928955,
            "end_logit": 5.0316691398620605,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "pyruvate kinase",
            "probability": 0.08353797257325263,
            "start_logit": 5.560889720916748,
            "end_logit": 3.9063918590545654,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "phosphoenolpyruvate-carboxykinase was up-regulated and pyruvate kinase",
            "probability": 0.08046811265418478,
            "start_logit": 5.523449420928955,
            "end_logit": 3.9063918590545654,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "mRNA",
            "probability": 0.012161903433174318,
            "start_logit": 2.436408281326294,
            "end_logit": 5.103880405426025,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "pyruvate kinase mRNA down-regulated",
            "probability": 0.006080077531290308,
            "start_logit": 5.560889720916748,
            "end_logit": 1.2861080169677734,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "hepatic phosphoenolpyruvate-carboxykinase was up-regulated and pyruvate kinase mRNA",
            "probability": 0.005920474573030659,
            "start_logit": 1.7165164947509766,
            "end_logit": 5.103880405426025,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "phosphoenolpyruvate-carboxykinase was up-regulated and pyruvate kinase mRNA down-regulated",
            "probability": 0.005856646368871729,
            "start_logit": 5.523449420928955,
            "end_logit": 1.2861080169677734,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "hepatic phosphoenolpyruvate-carboxykinase",
            "probability": 0.005508020730035041,
            "start_logit": 1.7165164947509766,
            "end_logit": 5.0316691398620605,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "phosphoenolpyruvate-carboxykinase was up-regulated",
            "probability": 0.002326319353852847,
            "start_logit": 5.523449420928955,
            "end_logit": 0.3628182113170624,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "pyruvate kinase mRNA down-regulated,",
            "probability": 0.00208058869952881,
            "start_logit": 5.560889720916748,
            "end_logit": 0.2137414515018463,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "hepatic phosphoenolpyruvate-carboxykinase was up-regulated and pyruvate kinase",
            "probability": 0.0017876967575367597,
            "start_logit": 1.7165164947509766,
            "end_logit": 3.9063918590545654,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "carboxykinase was up-regulated and pyruvate kinase mRNA",
            "probability": 0.0008988052920016651,
            "start_logit": -0.16858896613121033,
            "end_logit": 5.103880405426025,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "carboxykinase",
            "probability": 0.0008361894168352394,
            "start_logit": -0.16858896613121033,
            "end_logit": 5.0316691398620605,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "up-regulated and pyruvate kinase mRNA",
            "probability": 0.0004508085452286962,
            "start_logit": -0.8586126565933228,
            "end_logit": 5.103880405426025,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "phosphoenolpyruvate",
            "probability": 0.00033005531393460547,
            "start_logit": 5.523449420928955,
            "end_logit": -1.5899641513824463,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "carboxykinase was up-regulated and pyruvate kinase",
            "probability": 0.00027139569410324305,
            "start_logit": -0.16858896613121033,
            "end_logit": 3.9063918590545654,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "mRNA down-regulated",
            "probability": 0.00026727852704988125,
            "start_logit": 2.436408281326294,
            "end_logit": 1.2861080169677734,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "up-regulated and pyruvate kinase",
            "probability": 0.00013612236056993377,
            "start_logit": -0.8586126565933228,
            "end_logit": 3.9063918590545654,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        }
    ],
    "516ec97f298dcd4e51000087": [
        {
            "text": "bootstrap and jackknife",
            "probability": 0.23365959969015843,
            "start_logit": 3.885957717895508,
            "end_logit": 3.3953135013580322,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "jackknife",
            "probability": 0.19421828622341006,
            "start_logit": 3.7010750770568848,
            "end_logit": 3.3953135013580322,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "bootstrap",
            "probability": 0.1752326281114923,
            "start_logit": 3.885957717895508,
            "end_logit": 3.10756254196167,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "SuperTRI",
            "probability": 0.10535695760420416,
            "start_logit": 3.199328899383545,
            "end_logit": 3.285431146621704,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "bootstrap method for perturbing the phylogenetic tree.SuperTRI",
            "probability": 0.05509890412010982,
            "start_logit": 2.5511045455932617,
            "end_logit": 3.285431146621704,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "supertree Bootstrap",
            "probability": 0.051393372155224507,
            "start_logit": 2.7584445476531982,
            "end_logit": 3.0084705352783203,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "Bootstrap",
            "probability": 0.04827257258567597,
            "start_logit": 2.695798873901367,
            "end_logit": 3.0084705352783203,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "jackknife techniques to input data.An alignment confidence score capturing robustness to guide tree uncertainty.We build on the widely used bootstrap",
            "probability": 0.04617236375899603,
            "start_logit": 3.7010750770568848,
            "end_logit": 1.9587122201919556,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "jackknife techniques to input data.An alignment confidence score capturing robustness to guide tree uncertainty.We build on the widely used bootstrap method",
            "probability": 0.01614214169130163,
            "start_logit": 3.7010750770568848,
            "end_logit": 0.9077641367912292,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "supertree Bootstrap percentage",
            "probability": 0.014553940110131813,
            "start_logit": 2.7584445476531982,
            "end_logit": 1.7468230724334717,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "Bootstrap percentage",
            "probability": 0.013670169924868398,
            "start_logit": 2.695798873901367,
            "end_logit": 1.7468230724334717,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "bootstrap and jackknife techniques",
            "probability": 0.0075228224550405575,
            "start_logit": 3.885957717895508,
            "end_logit": -0.040610458701848984,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "jackknife techniques",
            "probability": 0.006252983770914602,
            "start_logit": 3.7010750770568848,
            "end_logit": -0.040610458701848984,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "the supertree Bootstrap",
            "probability": 0.006161625020049665,
            "start_logit": 0.6372758746147156,
            "end_logit": 3.0084705352783203,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "bootstrap method",
            "probability": 0.005111346217665315,
            "start_logit": 2.5511045455932617,
            "end_logit": 0.9077641367912292,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "reproducibility index",
            "probability": 0.00496708000507107,
            "start_logit": 2.2425129413604736,
            "end_logit": 1.1877250671386719,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "supertree Bootstrap percentage and two other values calculated from the separate analyses: the mean branch support (mean Bootstrap",
            "probability": 0.004236554271538288,
            "start_logit": 2.7584445476531982,
            "end_logit": 0.5127115845680237,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "supertree Bootstrap percentage and two other values calculated from the separate analyses: the mean branch support",
            "probability": 0.004123887808372298,
            "start_logit": 2.7584445476531982,
            "end_logit": 0.4857576787471771,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "Bootstrap percentage and two other values calculated from the separate analyses: the mean branch support (mean Bootstrap",
            "probability": 0.003979294702988229,
            "start_logit": 2.695798873901367,
            "end_logit": 0.5127115845680237,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "Bootstrap percentage and two other values calculated from the separate analyses: the mean branch support",
            "probability": 0.0038734697727866264,
            "start_logit": 2.695798873901367,
            "end_logit": 0.4857576787471771,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        }
    ],
    "5324d0169b2d7acc7e000022": [
        {
            "text": "finasteride",
            "probability": 0.19869199263584633,
            "start_logit": 5.729376316070557,
            "end_logit": 5.908900737762451,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "minoxidil and finasteride",
            "probability": 0.14150176158344394,
            "start_logit": 5.6727142333984375,
            "end_logit": 5.626119136810303,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "monoxidil and oral finasteride",
            "probability": 0.12237335125584253,
            "start_logit": 5.244697093963623,
            "end_logit": 5.908900737762451,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "minoxidil",
            "probability": 0.10485515882647645,
            "start_logit": 5.6727142333984375,
            "end_logit": 5.32638692855835,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "monoxidil",
            "probability": 0.08440359464017655,
            "start_logit": 5.244697093963623,
            "end_logit": 5.537434101104736,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "Topical monoxidil and oral finasteride",
            "probability": 0.0583494431780787,
            "start_logit": 4.504070281982422,
            "end_logit": 5.908900737762451,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "finasteride tablets for men. Topical monoxidil and oral finasteride",
            "probability": 0.05569439507437253,
            "start_logit": 4.457499980926514,
            "end_logit": 5.908900737762451,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "oral finasteride",
            "probability": 0.04804450201342929,
            "start_logit": 4.30974817276001,
            "end_logit": 5.908900737762451,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "Topical monoxidil",
            "probability": 0.040244895632434,
            "start_logit": 4.504070281982422,
            "end_logit": 5.537434101104736,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "finasteride tablets for men. Topical monoxidil",
            "probability": 0.03841365049944034,
            "start_logit": 4.457499980926514,
            "end_logit": 5.537434101104736,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "minoxidil solution for men and women and prescription oral finasteride tablets for men. Topical monoxidil and oral finasteride",
            "probability": 0.026909841818546366,
            "start_logit": 3.7301125526428223,
            "end_logit": 5.908900737762451,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "minoxidil solution for men and women and prescription oral finasteride tablets for men. Topical monoxidil",
            "probability": 0.018560310372928678,
            "start_logit": 3.7301125526428223,
            "end_logit": 5.537434101104736,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "finasteride are commonly in use and have FDA approval for the treatment of male androgenetic alopecia; dutasteride",
            "probability": 0.015951488793018033,
            "start_logit": 5.729376316070557,
            "end_logit": 3.3866970539093018,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "finasteride), a novel device was FDA-approved for the treatment of hair loss, the laser hair comb",
            "probability": 0.012047707233087183,
            "start_logit": 5.71146821975708,
            "end_logit": 3.123927354812622,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "minoxidil and finasteride), a novel device was FDA-approved for the treatment of hair loss, the laser hair comb",
            "probability": 0.01158974185891397,
            "start_logit": 5.6727142333984375,
            "end_logit": 3.123927354812622,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "topical minoxidil solution for men and women and prescription oral finasteride tablets for men. Topical monoxidil",
            "probability": 0.008008071682054118,
            "start_logit": 2.8895370960235596,
            "end_logit": 5.537434101104736,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "minoxidil solution for men and women and prescription oral finasteride",
            "probability": 0.004403829488966761,
            "start_logit": 3.7301125526428223,
            "end_logit": 4.098883152008057,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "oral finasteride are commonly in use and have FDA approval for the treatment of male androgenetic alopecia; dutasteride",
            "probability": 0.0038571324655137886,
            "start_logit": 4.30974817276001,
            "end_logit": 3.3866970539093018,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "oral finasteride tablets for men. Topical monoxidil and oral finasteride",
            "probability": 0.003609546947079002,
            "start_logit": 1.7212027311325073,
            "end_logit": 5.908900737762451,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "oral finasteride tablets for men. Topical monoxidil",
            "probability": 0.0024895840003515256,
            "start_logit": 1.7212027311325073,
            "end_logit": 5.537434101104736,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        }
    ],
    "54fc9ca16ad7dcbc12000006": [
        {
            "text": "orexin",
            "probability": 0.5344810599493918,
            "start_logit": 5.044187068939209,
            "end_logit": 3.8461437225341797,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptors, for the treatment of primary insomnia, and demonstrate promising results.METHODS: We evaluated suvorexant, an orexin",
            "probability": 0.34617035944925134,
            "start_logit": 4.609821796417236,
            "end_logit": 3.8461437225341797,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptors",
            "probability": 0.04707547121272527,
            "start_logit": 4.609821796417236,
            "end_logit": 1.8509647846221924,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor",
            "probability": 0.041122695329832135,
            "start_logit": 5.044187068939209,
            "end_logit": 1.2814075946807861,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptors,",
            "probability": 0.014286580842058007,
            "start_logit": 4.609821796417236,
            "end_logit": 0.6585333943367004,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist,",
            "probability": 0.008062782403555388,
            "start_logit": 5.044187068939209,
            "end_logit": -0.3478938639163971,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist",
            "probability": 0.00571913147442016,
            "start_logit": 5.044187068939209,
            "end_logit": -0.6913356184959412,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "ore",
            "probability": 0.0009530010322474883,
            "start_logit": 5.044187068939209,
            "end_logit": -2.4832918643951416,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptors, for the treatment of primary insomnia, and demonstrate promising results.METHODS: We evaluated suvorexant, an ore",
            "probability": 0.0006172355479160624,
            "start_logit": 4.609821796417236,
            "end_logit": -2.4832918643951416,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptors, for the treatment of primary insomnia,",
            "probability": 0.0005747663205411984,
            "start_logit": 4.609821796417236,
            "end_logit": -2.554579019546509,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist being developed for the treatment of insomnia.",
            "probability": 0.0005504228342099433,
            "start_logit": 4.656126022338867,
            "end_logit": -2.644160032272339,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "an orexin",
            "probability": 0.00013021877373552382,
            "start_logit": -3.275648593902588,
            "end_logit": 3.8461437225341797,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonists, suvorexant and almorexant. Suvorexant (MK-4305) is an ore",
            "probability": 7.572664082571839e-05,
            "start_logit": 2.6950254440307617,
            "end_logit": -2.666616201400757,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "xin",
            "probability": 5.903793826733872e-05,
            "start_logit": -4.066684246063232,
            "end_logit": 3.8461437225341797,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "xin receptors, for the treatment of primary insomnia, and demonstrate promising results.METHODS: We evaluated suvorexant, an orexin",
            "probability": 3.934038687224995e-05,
            "start_logit": -4.4726128578186035,
            "end_logit": 3.8461437225341797,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "receptors, for the treatment of primary insomnia, and demonstrate promising results.METHODS: We evaluated suvorexant, an orexin",
            "probability": 2.6644206589785858e-05,
            "start_logit": -4.862292766571045,
            "end_logit": 3.8461437225341797,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "MK-4305) is an orexin",
            "probability": 2.2813966763175614e-05,
            "start_logit": -4.956701755523682,
            "end_logit": 3.785353899002075,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "non-selective (dual) antagonist for orexin",
            "probability": 1.638966692292702e-05,
            "start_logit": -4.847357273101807,
            "end_logit": 3.345287561416626,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "an orexin receptor",
            "probability": 1.00189648610885e-05,
            "start_logit": -3.275648593902588,
            "end_logit": 1.2814075946807861,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "receptor",
            "probability": 6.303059013593409e-06,
            "start_logit": -3.73909330368042,
            "end_logit": 1.2814075946807861,
            "question_text": "Which receptors are targeted by suvorexant?"
        }
    ],
    "515d7693298dcd4e5100000c": [
        {
            "text": "keratin contaminants",
            "probability": 0.330495405031006,
            "start_logit": 0.652310311794281,
            "end_logit": -0.3971812129020691,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratin",
            "probability": 0.29263640921217227,
            "start_logit": 0.652310311794281,
            "end_logit": -0.5188430547714233,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratin contaminants.Most of the interfering masses originate from trypsin autolysis and human keratins",
            "probability": 0.06758903049215514,
            "start_logit": 0.652310311794281,
            "end_logit": -1.984328269958496,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis or keratin contaminants",
            "probability": 0.060845829469853376,
            "start_logit": -1.0399391651153564,
            "end_logit": -0.3971812129020691,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis or keratin",
            "probability": 0.053875802145943875,
            "start_logit": -1.0399391651153564,
            "end_logit": -0.5188430547714233,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratin contaminants.Most of the interfering masses originate from trypsin autolysis and human keratin",
            "probability": 0.03380537808713459,
            "start_logit": 0.652310311794281,
            "end_logit": -2.677154064178467,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratin contaminants.",
            "probability": 0.03372972464202334,
            "start_logit": 0.652310311794281,
            "end_logit": -2.679394483566284,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratin contaminants.Most of the interfering masses originate from trypsin autolysis",
            "probability": 0.026695605546333316,
            "start_logit": 0.652310311794281,
            "end_logit": -2.9132750034332275,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratin contaminants.Most of the interfering masses originate from trypsin autolysis and human keratins.",
            "probability": 0.02415921100691879,
            "start_logit": 0.652310311794281,
            "end_logit": -3.013108253479004,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratin contaminants.Most of the interfering masses originate from trypsin",
            "probability": 0.023033794172422975,
            "start_logit": 0.652310311794281,
            "end_logit": -3.0608115196228027,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis",
            "probability": 0.010276255954548062,
            "start_logit": -1.0399391651153564,
            "end_logit": -2.1756885051727295,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratins",
            "probability": 0.009509192782459933,
            "start_logit": -1.308876395225525,
            "end_logit": -1.984328269958496,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis or keratin contaminants.",
            "probability": 0.006209808192162677,
            "start_logit": -1.0399391651153564,
            "end_logit": -2.679394483566284,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratins.5-15% FBS. Contamination by bovine proteins",
            "probability": 0.005461309278228327,
            "start_logit": -1.308876395225525,
            "end_logit": -2.5388987064361572,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis or keratin contaminants.Most of the interfering masses originate from trypsin autolysis",
            "probability": 0.004914792272268599,
            "start_logit": -1.0399391651153564,
            "end_logit": -2.9132750034332275,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis or keratin contaminants.Most of the interfering masses originate from trypsin",
            "probability": 0.0042406347892415186,
            "start_logit": -1.0399391651153564,
            "end_logit": -3.0608115196228027,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "trypsin autolysis and human keratins",
            "probability": 0.003954854566264602,
            "start_logit": -2.1861915588378906,
            "end_logit": -1.984328269958496,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratins.",
            "probability": 0.0033989923107949197,
            "start_logit": -1.308876395225525,
            "end_logit": -3.013108253479004,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "antigenMaConDa",
            "probability": 0.002896622265885196,
            "start_logit": -2.230557680130005,
            "end_logit": -2.2513606548309326,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "trypsin autolysis and human keratins.5-15% FBS. Contamination by bovine proteins",
            "probability": 0.0022713477821823245,
            "start_logit": -2.1861915588378906,
            "end_logit": -2.5388987064361572,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        }
    ],
    "56c1f030ef6e39474100004d": [
        {
            "text": "epilepsy",
            "probability": 0.20206280621605915,
            "start_logit": 4.748279094696045,
            "end_logit": 5.172863483428955,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes",
            "probability": 0.18247899637574552,
            "start_logit": 4.851511001586914,
            "end_logit": 4.967688083648682,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy",
            "probability": 0.17638792747753404,
            "start_logit": 4.612386226654053,
            "end_logit": 5.172863483428955,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy, neonatal diabetes",
            "probability": 0.16458105281814792,
            "start_logit": 4.748279094696045,
            "end_logit": 4.967688083648682,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy, neonatal diabetes",
            "probability": 0.1436687500896267,
            "start_logit": 4.612386226654053,
            "end_logit": 4.967688083648682,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay",
            "probability": 0.08840739393858743,
            "start_logit": 4.612386226654053,
            "end_logit": 4.482133388519287,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "diabetes",
            "probability": 0.03499763636330477,
            "start_logit": 3.2001564502716064,
            "end_logit": 4.967688083648682,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "mental retardation and motor problems (iDEND syndrome) and epilepsy",
            "probability": 0.0029600089241515535,
            "start_logit": 1.7469098567962646,
            "end_logit": 3.9508464336395264,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay,",
            "probability": 0.0010062588900163296,
            "start_logit": 4.612386226654053,
            "end_logit": 0.006417165044695139,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "motor problems (iDEND syndrome) and epilepsy",
            "probability": 0.0009612057483214333,
            "start_logit": 0.6221507787704468,
            "end_logit": 3.9508464336395264,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "pilepsy",
            "probability": 0.00041865916706179305,
            "start_logit": -1.430997610092163,
            "end_logit": 5.172863483428955,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "pilepsy, neonatal diabetes",
            "probability": 0.0003409997504108829,
            "start_logit": -1.430997610092163,
            "end_logit": 4.967688083648682,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy,",
            "probability": 0.00024461863619729964,
            "start_logit": 4.748279094696045,
            "end_logit": -1.5437699556350708,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal",
            "probability": 0.0002395966588846938,
            "start_logit": 4.851511001586914,
            "end_logit": -1.6677453517913818,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neurologic symptoms such as mental retardation and motor problems (iDEND syndrome) and epilepsy",
            "probability": 0.0002199148521190563,
            "start_logit": -0.852797269821167,
            "end_logit": 3.9508464336395264,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy, neonatal",
            "probability": 0.00021609648865974842,
            "start_logit": 4.748279094696045,
            "end_logit": -1.6677453517913818,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy,",
            "probability": 0.00021353644972685407,
            "start_logit": 4.612386226654053,
            "end_logit": -1.5437699556350708,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "mental retardation and motor problems",
            "probability": 0.0002039551354528938,
            "start_logit": 1.7469098567962646,
            "end_logit": 1.2757989168167114,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "mental retardation",
            "probability": 0.00020194758383613643,
            "start_logit": 1.7469098567962646,
            "end_logit": 1.2659070491790771,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy, neonatal",
            "probability": 0.00018863843615587718,
            "start_logit": 4.612386226654053,
            "end_logit": -1.6677453517913818,
            "question_text": "List features of the DEND syndrome."
        }
    ],
    "550312b4e9bde6963400001c": [
        {
            "text": "RPL11",
            "probability": 0.06452301702992506,
            "start_logit": 4.158520221710205,
            "end_logit": 3.800565719604492,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS19, RPS26, RPL5",
            "probability": 0.06185848913129044,
            "start_logit": 4.088932514190674,
            "end_logit": 3.8279807567596436,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS19",
            "probability": 0.06149003014468194,
            "start_logit": 4.088932514190674,
            "end_logit": 3.8220064640045166,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS19, RPS26, RPL5, RPL11",
            "probability": 0.06018567130546916,
            "start_logit": 4.088932514190674,
            "end_logit": 3.800565719604492,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL5",
            "probability": 0.05972885059834613,
            "start_logit": 4.053898334503174,
            "end_logit": 3.8279807567596436,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19, RPS26, RPL5",
            "probability": 0.05907207232574698,
            "start_logit": 4.04284143447876,
            "end_logit": 3.8279807567596436,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19",
            "probability": 0.058720210581115415,
            "start_logit": 4.04284143447876,
            "end_logit": 3.8220064640045166,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL5, RPL11",
            "probability": 0.058113623854209755,
            "start_logit": 4.053898334503174,
            "end_logit": 3.800565719604492,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19, RPS26, RPL5, RPL11",
            "probability": 0.05747460661033028,
            "start_logit": 4.04284143447876,
            "end_logit": 3.800565719604492,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17",
            "probability": 0.056833563758852755,
            "start_logit": 4.04284143447876,
            "end_logit": 3.7893495559692383,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS26, RPL5",
            "probability": 0.05626277548734646,
            "start_logit": 3.9941163063049316,
            "end_logit": 3.8279807567596436,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS26, RPL5, RPL11",
            "probability": 0.05474128061918607,
            "start_logit": 3.9941163063049316,
            "end_logit": 3.800565719604492,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS19, RPS26",
            "probability": 0.04361893133907412,
            "start_logit": 4.088932514190674,
            "end_logit": 3.4786226749420166,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19, RPS26",
            "probability": 0.041654115757091825,
            "start_logit": 4.04284143447876,
            "end_logit": 3.4786226749420166,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS26",
            "probability": 0.039673166535309334,
            "start_logit": 3.9941163063049316,
            "end_logit": 3.4786226749420166,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL35A",
            "probability": 0.036119952787577216,
            "start_logit": 4.193225860595703,
            "end_logit": 3.185683488845825,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL11, and RPL35A",
            "probability": 0.03488789017354347,
            "start_logit": 4.158520221710205,
            "end_logit": 3.185683488845825,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS19, RPS26, RPL5, RPL11, and RPL35A",
            "probability": 0.03254266751897781,
            "start_logit": 4.088932514190674,
            "end_logit": 3.185683488845825,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL5, RPL11, and RPL35A",
            "probability": 0.031422301992976735,
            "start_logit": 4.053898334503174,
            "end_logit": 3.185683488845825,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19, RPS26, RPL5, RPL11, and RPL35A",
            "probability": 0.031076782448949087,
            "start_logit": 4.04284143447876,
            "end_logit": 3.185683488845825,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        }
    ],
    "51492168d24251bc05000041": [
        {
            "text": "Hamilton",
            "probability": 0.37791172231795295,
            "start_logit": 4.67592716217041,
            "end_logit": 3.8169503211975098,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Hamilton Depression Rating Scale",
            "probability": 0.35145970729177173,
            "start_logit": 4.67592716217041,
            "end_logit": 3.744384765625,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Hamilton Depression",
            "probability": 0.07392971521076705,
            "start_logit": 4.67592716217041,
            "end_logit": 2.1854045391082764,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Hamilton Depression Rating Scale (HDRS)",
            "probability": 0.04813928095550907,
            "start_logit": 4.67592716217041,
            "end_logit": 1.7563881874084473,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Hamilton Depression Rating Scale (HDRS",
            "probability": 0.03863007943831006,
            "start_logit": 4.67592716217041,
            "end_logit": 1.5363209247589111,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "the Hamilton",
            "probability": 0.027401195594148248,
            "start_logit": 2.0518531799316406,
            "end_logit": 3.8169503211975098,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "the Hamilton Depression Rating Scale",
            "probability": 0.025483242816324855,
            "start_logit": 2.0518531799316406,
            "end_logit": 3.744384765625,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Depression Scale",
            "probability": 0.016876738839757925,
            "start_logit": 2.731180191040039,
            "end_logit": 2.652972936630249,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Depression Scale (CESD)",
            "probability": 0.00572715733895385,
            "start_logit": 2.731180191040039,
            "end_logit": 1.5722559690475464,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "the Hamilton Depression",
            "probability": 0.005360412146743481,
            "start_logit": 2.0518531799316406,
            "end_logit": 2.1854045391082764,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "HDRS)",
            "probability": 0.004275551082403968,
            "start_logit": 2.254741668701172,
            "end_logit": 1.7563881874084473,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Montgomery-Asberg Depression Rating Scale",
            "probability": 0.003827049494478015,
            "start_logit": 2.430824041366577,
            "end_logit": 1.469486951828003,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "the Hamilton Depression Rating Scale (HDRS)",
            "probability": 0.003490428518948581,
            "start_logit": 2.0518531799316406,
            "end_logit": 1.7563881874084473,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "HDRS",
            "probability": 0.0034309793307562135,
            "start_logit": 2.254741668701172,
            "end_logit": 1.5363209247589111,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Depression Rating Scale",
            "probability": 0.0030756788784611845,
            "start_logit": -0.06264226138591766,
            "end_logit": 3.744384765625,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "the Hamilton Depression Rating Scale (HDRS",
            "probability": 0.0028009460940088262,
            "start_logit": 2.0518531799316406,
            "end_logit": 1.5363209247589111,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Montgomery-Asberg Depression Rating Scale (MADRS",
            "probability": 0.002743684862459634,
            "start_logit": 2.430824041366577,
            "end_logit": 1.1366946697235107,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "HAMD), and Montgomery-Asberg Depression Rating Scale",
            "probability": 0.0019244686992940733,
            "start_logit": 1.743379831314087,
            "end_logit": 1.469486951828003,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Hamilton Rating Scale",
            "probability": 0.0018216037153511123,
            "start_logit": 2.6366055011749268,
            "end_logit": 0.5213286280632019,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Depression",
            "probability": 0.0016903573735990518,
            "start_logit": 2.731180191040039,
            "end_logit": 0.3519766330718994,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        }
    ],
    "56d8b47a51531f7e33000004": [
        {
            "text": "congenital sensorineural deafness, goiter",
            "probability": 0.1522257576520472,
            "start_logit": 5.678133487701416,
            "end_logit": 6.253622531890869,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "goiter",
            "probability": 0.13094109217569172,
            "start_logit": 5.5275163650512695,
            "end_logit": 6.253622531890869,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "congenital sensorineural deafness",
            "probability": 0.09678494319590056,
            "start_logit": 5.678133487701416,
            "end_logit": 5.8007493019104,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "congenital sensorineural hearing loss and goiter",
            "probability": 0.09515339605035224,
            "start_logit": 5.371160984039307,
            "end_logit": 6.0907206535339355,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "congenital sensorineural deafness, goiter, and impaired iodide organification",
            "probability": 0.08681308037069592,
            "start_logit": 5.678133487701416,
            "end_logit": 5.692015171051025,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "goiter, and impaired iodide organification",
            "probability": 0.07467461311546411,
            "start_logit": 5.5275163650512695,
            "end_logit": 5.692015171051025,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "congenital sensorineural hearing loss",
            "probability": 0.06332262823351258,
            "start_logit": 5.371160984039307,
            "end_logit": 5.683473110198975,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "sensorineural deafness, goiter",
            "probability": 0.057832846735745215,
            "start_logit": 4.710325717926025,
            "end_logit": 6.253622531890869,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "sensorineural hearing loss and goiter",
            "probability": 0.04526767723367916,
            "start_logit": 4.6282639503479,
            "end_logit": 6.0907206535339355,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "impaired iodide organification",
            "probability": 0.044335195044835664,
            "start_logit": 5.006155014038086,
            "end_logit": 5.692015171051025,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "sensorineural deafness",
            "probability": 0.036770050433715465,
            "start_logit": 4.710325717926025,
            "end_logit": 5.8007493019104,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "sensorineural deafness, goiter, and impaired iodide organification",
            "probability": 0.03298159029835427,
            "start_logit": 4.710325717926025,
            "end_logit": 5.692015171051025,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "sensorineural hearing loss",
            "probability": 0.03012470826523165,
            "start_logit": 4.6282639503479,
            "end_logit": 5.683473110198975,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "hearing loss and goiter",
            "probability": 0.01832074667015907,
            "start_logit": 3.7237048149108887,
            "end_logit": 6.0907206535339355,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "hearing loss",
            "probability": 0.0121920801412169,
            "start_logit": 3.7237048149108887,
            "end_logit": 5.683473110198975,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "deafness, goiter",
            "probability": 0.005759700725016522,
            "start_logit": 2.4036543369293213,
            "end_logit": 6.253622531890869,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "iodide organification",
            "probability": 0.004547224733356849,
            "start_logit": 2.728893280029297,
            "end_logit": 5.692015171051025,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "congenital sensorineural hearing loss and goiter, with a positive finding in the perchlorate discharge test",
            "probability": 0.004258280511322182,
            "start_logit": 5.371160984039307,
            "end_logit": 2.984095811843872,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "goiter, with a positive finding in the perchlorate discharge test",
            "probability": 0.004032378014842781,
            "start_logit": 5.316651821136475,
            "end_logit": 2.984095811843872,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "deafness",
            "probability": 0.003662010398859818,
            "start_logit": 2.4036543369293213,
            "end_logit": 5.8007493019104,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        }
    ],
    "54edaee3445c3b5a5f000003": [
        {
            "text": "B. afzelii (serotype 2), B. garinii",
            "probability": 0.1560707708147682,
            "start_logit": 5.911357402801514,
            "end_logit": 6.022379398345947,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. afzelii",
            "probability": 0.15313494461596125,
            "start_logit": 5.911357402801514,
            "end_logit": 6.003389358520508,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. garinii",
            "probability": 0.14363029798875934,
            "start_logit": 5.8282904624938965,
            "end_logit": 6.022379398345947,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. garinii (serotypes, 3, 5 and 6) and B. bavariensis",
            "probability": 0.13208947060341691,
            "start_logit": 5.8282904624938965,
            "end_logit": 5.9386162757873535,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. bavariensis",
            "probability": 0.12792152245366156,
            "start_logit": 5.796227931976318,
            "end_logit": 5.9386162757873535,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. burgdorferi (serotype 1), B. afzelii",
            "probability": 0.07772529805775781,
            "start_logit": 5.233218669891357,
            "end_logit": 6.003389358520508,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. bavariensis (serotype 4), while only B. burgdorferi",
            "probability": 0.07025924674478211,
            "start_logit": 5.796227931976318,
            "end_logit": 5.339391231536865,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. burgdorferi",
            "probability": 0.04852529598760924,
            "start_logit": 5.233218669891357,
            "end_logit": 5.532293796539307,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. burgdorferi is present in the US. Borrelia afzelii",
            "probability": 0.029863367939303193,
            "start_logit": 5.155620098114014,
            "end_logit": 5.124439716339111,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia afzelii",
            "probability": 0.02062909193555497,
            "start_logit": 4.785689830780029,
            "end_logit": 5.124439716339111,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. afzelii (serotype 2)",
            "probability": 0.00877388779930867,
            "start_logit": 5.911357402801514,
            "end_logit": 3.1438498497009277,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "bavariensis",
            "probability": 0.005373717229717559,
            "start_logit": 2.626330852508545,
            "end_logit": 5.9386162757873535,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. burgdorferi (serotype 1), B. afzelii (serotype 2)",
            "probability": 0.004453281685880541,
            "start_logit": 5.233218669891357,
            "end_logit": 3.1438498497009277,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "afzelii (serotype 2), B. garinii",
            "probability": 0.0039680368855712096,
            "start_logit": 2.239319324493408,
            "end_logit": 6.022379398345947,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "afzelii",
            "probability": 0.003893394679438208,
            "start_logit": 2.239319324493408,
            "end_logit": 6.003389358520508,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. bavariensis (serotype 4)",
            "probability": 0.003617673423018311,
            "start_logit": 5.796227931976318,
            "end_logit": 2.373030424118042,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "bavariensis (serotype 4), while only B. burgdorferi",
            "probability": 0.0029514448979152696,
            "start_logit": 2.626330852508545,
            "end_logit": 5.339391231536865,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "garinii",
            "probability": 0.0026275058048545728,
            "start_logit": 1.827082872390747,
            "end_logit": 6.022379398345947,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "garinii (serotypes, 3, 5 and 6) and B. bavariensis",
            "probability": 0.0024163832814564448,
            "start_logit": 1.827082872390747,
            "end_logit": 5.9386162757873535,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "burgdorferi (serotype 1), B. afzelii (serotype 2), B. garinii",
            "probability": 0.0020753671712646967,
            "start_logit": 1.5911859273910522,
            "end_logit": 6.022379398345947,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        }
    ],
    "5506eca18e1671127b00000f": [
        {
            "text": "p65 and p50",
            "probability": 0.15996808345362676,
            "start_logit": 5.345174312591553,
            "end_logit": 5.2307844161987305,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65",
            "probability": 0.146283687202498,
            "start_logit": 5.345174312591553,
            "end_logit": 5.141357898712158,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50",
            "probability": 0.13337769541664887,
            "start_logit": 5.163384914398193,
            "end_logit": 5.2307844161987305,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50 subunits, and the non-canonical, mediated by the subunits RelB, p52",
            "probability": 0.06567359428352103,
            "start_logit": 5.345174312591553,
            "end_logit": 4.3405070304870605,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50 subunits, and the non-canonical, mediated by the subunits RelB",
            "probability": 0.06519397067931465,
            "start_logit": 5.345174312591553,
            "end_logit": 4.333177089691162,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50 subunits, and the non-canonical, mediated by the subunits RelB, p52",
            "probability": 0.054757126960287096,
            "start_logit": 5.163384914398193,
            "end_logit": 4.3405070304870605,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50 subunits, and the non-canonical, mediated by the subunits RelB",
            "probability": 0.05435722787032257,
            "start_logit": 5.163384914398193,
            "end_logit": 4.333177089691162,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50 subunits, and the non-canonical, mediated by the subunits RelB, p52 and p50",
            "probability": 0.05321626383041242,
            "start_logit": 5.345174312591553,
            "end_logit": 4.130174160003662,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50 subunits, and the non-canonical, mediated by the subunits RelB, p52 and p50",
            "probability": 0.044370492382890744,
            "start_logit": 5.163384914398193,
            "end_logit": 4.130174160003662,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "RelB, p52",
            "probability": 0.04113124471763698,
            "start_logit": 4.8772454261779785,
            "end_logit": 4.3405070304870605,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "RelB",
            "probability": 0.04083085738461237,
            "start_logit": 4.8772454261779785,
            "end_logit": 4.333177089691162,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p52",
            "probability": 0.03904344559711002,
            "start_logit": 4.825152397155762,
            "end_logit": 4.3405070304870605,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "RelB, p52 and p50",
            "probability": 0.03332924281740216,
            "start_logit": 4.8772454261779785,
            "end_logit": 4.130174160003662,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p52 and p50",
            "probability": 0.031637468976865694,
            "start_logit": 4.825152397155762,
            "end_logit": 4.130174160003662,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "the p65 and p50",
            "probability": 0.007685751584186849,
            "start_logit": 2.309568166732788,
            "end_logit": 5.2307844161987305,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50 subunits",
            "probability": 0.007496560906962203,
            "start_logit": 5.345174312591553,
            "end_logit": 2.1702544689178467,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "the p65",
            "probability": 0.00702827749376154,
            "start_logit": 2.309568166732788,
            "end_logit": 5.141357898712158,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50 subunits",
            "probability": 0.0062504594399983284,
            "start_logit": 5.163384914398193,
            "end_logit": 2.1702544689178467,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50 subunit",
            "probability": 0.004563558917683806,
            "start_logit": 5.345174312591553,
            "end_logit": 1.6739128828048706,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50 subunit",
            "probability": 0.0038049900842577282,
            "start_logit": 5.163384914398193,
            "end_logit": 1.6739128828048706,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        }
    ],
    "5335d4e8d6d3ac6a34000053": [
        {
            "text": "endothelin receptor antagonist",
            "probability": 0.5080822440739096,
            "start_logit": 4.551546573638916,
            "end_logit": 4.378795623779297,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin receptors",
            "probability": 0.15506539101726213,
            "start_logit": 4.449030876159668,
            "end_logit": 3.2945148944854736,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin-1",
            "probability": 0.10953431316029227,
            "start_logit": 4.807312488555908,
            "end_logit": 2.5886242389678955,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin-1 receptor antagonist,",
            "probability": 0.08105765851086752,
            "start_logit": 4.807312488555908,
            "end_logit": 2.2875471115112305,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin-1 receptor antagonist",
            "probability": 0.0466607155097627,
            "start_logit": 4.807312488555908,
            "end_logit": 1.7352889776229858,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin receptors with tissue-targeting properties,",
            "probability": 0.027947608258905427,
            "start_logit": 4.449030876159668,
            "end_logit": 1.5809996128082275,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin",
            "probability": 0.02701395002058546,
            "start_logit": 4.449030876159668,
            "end_logit": 1.5470213890075684,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin-1 receptor",
            "probability": 0.025205414388619497,
            "start_logit": 4.807312488555908,
            "end_logit": 1.1194452047348022,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "antagonist",
            "probability": 0.0051222072685322365,
            "start_logit": -0.04551130533218384,
            "end_logit": 4.378795623779297,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin receptor",
            "probability": 0.005022901882204201,
            "start_logit": 4.551546573638916,
            "end_logit": -0.23783987760543823,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin receptor antagonist,",
            "probability": 0.004388489678216473,
            "start_logit": 2.7831368446350098,
            "end_logit": 1.3955471515655518,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin receptor antagonist, in healthy subjects.Macitentan is a potent, orally active, non-peptide antagonist",
            "probability": 0.0016437281572601898,
            "start_logit": 2.7831368446350098,
            "end_logit": 0.4135289490222931,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "non-selective endothelin-1",
            "probability": 0.0005884428175697095,
            "start_logit": -0.4192008972167969,
            "end_logit": 2.5886242389678955,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "antagonist of endothelin receptors",
            "probability": 0.0005491834523470662,
            "start_logit": -1.194138765335083,
            "end_logit": 3.2945148944854736,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "dual endothelin receptor antagonist",
            "probability": 0.0004490754441715194,
            "start_logit": -0.1530245840549469,
            "end_logit": 2.052159070968628,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "non-selective endothelin-1 receptor antagonist,",
            "probability": 0.00043545986260887384,
            "start_logit": -0.4192008972167969,
            "end_logit": 2.2875471115112305,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "non-peptide antagonist of endothelin receptors",
            "probability": 0.0003947131396618185,
            "start_logit": -1.5244120359420776,
            "end_logit": 3.2945148944854736,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "1",
            "probability": 0.00031327103009765614,
            "start_logit": -1.0496119260787964,
            "end_logit": 2.5886242389678955,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "Macitentan is a potent, orally active, non-peptide antagonist of endothelin receptors",
            "probability": 0.00027456053203050426,
            "start_logit": -1.8873995542526245,
            "end_logit": 3.2945148944854736,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "non-selective endothelin-1 receptor antagonist",
            "probability": 0.000250671795094955,
            "start_logit": -0.4192008972167969,
            "end_logit": 1.7352889776229858,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        }
    ],
    "518ba4b5310faafe08000005": [
        {
            "text": "fluticasone",
            "probability": 0.8561754471605173,
            "start_logit": 5.735096454620361,
            "end_logit": 5.576476573944092,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "proton-pump inhibitors",
            "probability": 0.07114771189536746,
            "start_logit": 4.437526702880859,
            "end_logit": 4.386329174041748,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "immunosuppressive drugs, elimination diets, and esophageal dilatation.Aerosolized, swallowed fluticasone",
            "probability": 0.03821294094875852,
            "start_logit": 2.625795364379883,
            "end_logit": 5.576476573944092,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "fluticasone leads to a histologic but not a symptomatic response in adults with EoEOVB",
            "probability": 0.011811921899371977,
            "start_logit": 5.735096454620361,
            "end_logit": 1.2931106090545654,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "proton-pump inhibitors, immunosuppressive drugs",
            "probability": 0.011615882251824364,
            "start_logit": 4.437526702880859,
            "end_logit": 2.573944330215454,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "esophageal dilatation.Aerosolized, swallowed fluticasone",
            "probability": 0.0024598339531752425,
            "start_logit": -0.11728501319885254,
            "end_logit": 5.576476573944092,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "immunosuppressive drugs",
            "probability": 0.0018976987783165112,
            "start_logit": 2.625795364379883,
            "end_logit": 2.573944330215454,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "proton-pump inhibitor",
            "probability": 0.00137362680135687,
            "start_logit": 4.437526702880859,
            "end_logit": 0.43902555108070374,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "fluticason",
            "probability": 0.0012354823738265702,
            "start_logit": 5.735096454620361,
            "end_logit": -0.9645372629165649,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "elimination diets, and esophageal dilatation.Aerosolized, swallowed fluticasone",
            "probability": 0.000994324573985075,
            "start_logit": -1.0230704545974731,
            "end_logit": 5.576476573944092,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "Aerosolized, swallowed fluticasone",
            "probability": 0.0005287646385822133,
            "start_logit": -1.6545907258987427,
            "end_logit": 5.576476573944092,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "proton-pump inhibitors, immunosuppressive drugs, elimination diets, and esophageal dilatation",
            "probability": 0.0004953505923244836,
            "start_logit": 4.437526702880859,
            "end_logit": -0.5809184908866882,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "proton-pump inhibitors, immunosuppressive drugs, elimination diets",
            "probability": 0.0003963757113675133,
            "start_logit": 4.437526702880859,
            "end_logit": -0.8038217425346375,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "proton-pump inhibitors, immunosuppressive",
            "probability": 0.0003764797621734969,
            "start_logit": 4.437526702880859,
            "end_logit": -0.8553199768066406,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "Proton pump inhibitor",
            "probability": 0.00026212328645361854,
            "start_logit": 1.4547393321990967,
            "end_logit": 1.7654180526733398,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "flu",
            "probability": 0.0002588797172779558,
            "start_logit": 5.735096454620361,
            "end_logit": -2.527390480041504,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "sone",
            "probability": 0.00024418163792640885,
            "start_logit": -2.4272217750549316,
            "end_logit": 5.576476573944092,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "e",
            "probability": 0.00019234940628134033,
            "start_logit": -2.665820598602295,
            "end_logit": 5.576476573944092,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "inhibitors",
            "probability": 0.00017619405904874814,
            "start_logit": -1.5634007453918457,
            "end_logit": 4.386329174041748,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "flutica",
            "probability": 0.0001444305520643335,
            "start_logit": 5.735096454620361,
            "end_logit": -3.110955238342285,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        }
    ],
    "54db7c4ac0bb8dce23000001": [
        {
            "text": "protein kinase A",
            "probability": 0.8919263503412211,
            "start_logit": 4.995812892913818,
            "end_logit": 3.9568629264831543,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein kinase A (PKA)",
            "probability": 0.03959898896248494,
            "start_logit": 4.995812892913818,
            "end_logit": 0.8422829508781433,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein kinase A (PKA) or calcium-calmodulin-dependent protein kinases",
            "probability": 0.023832362664556392,
            "start_logit": 4.199343204498291,
            "end_logit": 1.1309934854507446,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "CAMKII) relieves these inhibitory effects. We have found that phosphorylation of PLN by protein kinase A",
            "probability": 0.021103019792864962,
            "start_logit": 1.2518454790115356,
            "end_logit": 3.9568629264831543,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein kinase A (PKA) or calcium-calmodulin-dependent protein kinases (CAMKII",
            "probability": 0.00579282632467983,
            "start_logit": 4.199343204498291,
            "end_logit": -0.28343063592910767,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "A",
            "probability": 0.003893134307835064,
            "start_logit": -0.43835610151290894,
            "end_logit": 3.9568629264831543,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein kinase A (PKA), Ca(2+)-calmodulin-dependent protein kinase II (CaMKII",
            "probability": 0.0025599607971286435,
            "start_logit": 3.5007834434509277,
            "end_logit": -0.4014992415904999,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "calcium-calmodulin-dependent protein kinases",
            "probability": 0.0023141178598069054,
            "start_logit": 1.867327332496643,
            "end_logit": 1.1309934854507446,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein kinase A (PKA) or calcium-calmodulin-dependent protein kinases (CAMKII)",
            "probability": 0.0022246396830921684,
            "start_logit": 4.199343204498291,
            "end_logit": -1.240455985069275,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein kinase A (PKA), Ca(2+)-calmodulin-dependent protein kinase II",
            "probability": 0.0021506668763347113,
            "start_logit": 3.5007834434509277,
            "end_logit": -0.5757132172584534,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein",
            "probability": 0.0014024548095679407,
            "start_logit": 4.995812892913818,
            "end_logit": -2.4982964992523193,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "phosphorylation of PLN by protein kinase A",
            "probability": 0.0008858847542443428,
            "start_logit": -1.9187390804290771,
            "end_logit": 3.9568629264831543,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "calcium-calmodulin-dependent protein kinases (CAMKII",
            "probability": 0.0005624823289819096,
            "start_logit": 1.867327332496643,
            "end_logit": -0.28343063592910767,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein kinase A (PKA) or calcium",
            "probability": 0.00045721604813142,
            "start_logit": 4.199343204498291,
            "end_logit": -2.822650194168091,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "CAMKII",
            "probability": 0.00030395445313173027,
            "start_logit": 1.2518454790115356,
            "end_logit": -0.28343063592910767,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "A (PKA) or calcium-calmodulin-dependent protein kinases",
            "probability": 0.00027751198886890054,
            "start_logit": -0.2535923719406128,
            "end_logit": 1.1309934854507446,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "calcium-calmodulin-dependent protein kinases (CAMKII)",
            "probability": 0.00021601208804761132,
            "start_logit": 1.867327332496643,
            "end_logit": -1.240455985069275,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "A (PKA)",
            "probability": 0.0001728440721887565,
            "start_logit": -0.43835610151290894,
            "end_logit": 0.8422829508781433,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "kinase A",
            "probability": 0.0001644875768048532,
            "start_logit": -3.6024909019470215,
            "end_logit": 3.9568629264831543,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "phosphorylation by protein kinase A",
            "probability": 0.00016108427002783237,
            "start_logit": -3.430870532989502,
            "end_logit": 3.7643351554870605,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        }
    ],
    "56f8077a8b98c98849000002": [
        {
            "text": "limbic encephalitis",
            "probability": 0.1460897825833553,
            "start_logit": 3.6907074451446533,
            "end_logit": 3.6290762424468994,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cerebellar ataxia and limbic encephalitis",
            "probability": 0.1263622141089039,
            "start_logit": 3.5456385612487793,
            "end_logit": 3.6290762424468994,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cerebellar ataxia",
            "probability": 0.11274577306954088,
            "start_logit": 3.5456385612487793,
            "end_logit": 3.515059232711792,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "stiff-person syndrome, cerebellar ataxia and limbic encephalitis",
            "probability": 0.10341973205604871,
            "start_logit": 3.3452818393707275,
            "end_logit": 3.6290762424468994,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "stiff-person syndrome",
            "probability": 0.10069397644804932,
            "start_logit": 3.3452818393707275,
            "end_logit": 3.6023664474487305,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "stiff-person syndrome, cerebellar ataxia",
            "probability": 0.09227550912692009,
            "start_logit": 3.3452818393707275,
            "end_logit": 3.515059232711792,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "type 1 diabetes and a number of neurological disorders, including stiff-person syndrome",
            "probability": 0.08881105663826078,
            "start_logit": 3.2197070121765137,
            "end_logit": 3.6023664474487305,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "type 1 diabetes and a number of neurological disorders, including stiff-person syndrome, cerebellar ataxia",
            "probability": 0.08138605462287321,
            "start_logit": 3.2197070121765137,
            "end_logit": 3.515059232711792,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "type 1 diabetes",
            "probability": 0.073450009623356,
            "start_logit": 3.2197070121765137,
            "end_logit": 3.4124603271484375,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "type 1 diabetes mellitus",
            "probability": 0.012831054458451523,
            "start_logit": 3.152595043182373,
            "end_logit": 1.7348356246948242,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "diabetes and a number of neurological disorders, including stiff-person syndrome",
            "probability": 0.011239653996406642,
            "start_logit": 1.1526439189910889,
            "end_logit": 3.6023664474487305,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "diabetes and a number of neurological disorders, including stiff-person syndrome, cerebellar ataxia",
            "probability": 0.010299968593095886,
            "start_logit": 1.1526439189910889,
            "end_logit": 3.515059232711792,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "diabetes",
            "probability": 0.009295607162538841,
            "start_logit": 1.1526439189910889,
            "end_logit": 3.4124603271484375,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "type 1 diabetes. 100% (39/39) selected type 1 diabetes",
            "probability": 0.009078334023558158,
            "start_logit": 1.8926583528518677,
            "end_logit": 2.648794651031494,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological disorders, including stiff-person syndrome, cerebellar ataxia and limbic encephalitis",
            "probability": 0.005234646203780466,
            "start_logit": 0.36178532242774963,
            "end_logit": 3.6290762424468994,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological disorders, including stiff-person syndrome",
            "probability": 0.005096680595456181,
            "start_logit": 0.36178532242774963,
            "end_logit": 3.6023664474487305,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological disorders, including stiff-person syndrome, cerebellar ataxia",
            "probability": 0.004670575275628855,
            "start_logit": 0.36178532242774963,
            "end_logit": 3.515059232711792,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "type 1 diabetes. 100% (39/39) selected type 1 diabetes mellitus",
            "probability": 0.003639810689295133,
            "start_logit": 1.8926583528518677,
            "end_logit": 1.7348356246948242,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "type 1 diabetes and a number of neurological disorders",
            "probability": 0.0021756066509033005,
            "start_logit": 3.2197070121765137,
            "end_logit": -0.10683716088533401,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "diabetes. 100% (39/39) selected type 1 diabetes",
            "probability": 0.0012039540735766974,
            "start_logit": -0.1276211440563202,
            "end_logit": 2.648794651031494,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        }
    ],
    "5503145ee9bde69634000022": [
        {
            "text": "follicular thyroid carcinoma",
            "probability": 0.22232095207885832,
            "start_logit": 4.877431392669678,
            "end_logit": 4.526647567749023,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "papillary and follicular thyroid carcinoma",
            "probability": 0.1201464890041859,
            "start_logit": 4.262021064758301,
            "end_logit": 4.526647567749023,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "follicular",
            "probability": 0.10967491659674532,
            "start_logit": 4.877431392669678,
            "end_logit": 3.8200461864471436,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary-type",
            "probability": 0.10271654665007257,
            "start_logit": 4.649599552154541,
            "end_logit": 3.982330560684204,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "papillary and follicular",
            "probability": 0.05927041980394139,
            "start_logit": 4.262021064758301,
            "end_logit": 3.8200461864471436,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "papillary-type, of undifferentiated anaplastic, and of medullary-type",
            "probability": 0.04867129110077632,
            "start_logit": 3.9027156829833984,
            "end_logit": 3.982330560684204,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "undifferentiated anaplastic, and of medullary-type",
            "probability": 0.04317656380052041,
            "start_logit": 3.782924175262451,
            "end_logit": 3.982330560684204,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "papillary-type",
            "probability": 0.037892318467045244,
            "start_logit": 3.9027156829833984,
            "end_logit": 3.731989622116089,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "papillary",
            "probability": 0.0369290230909837,
            "start_logit": 4.262021064758301,
            "end_logit": 3.346933603286743,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic, and of medullary-type",
            "probability": 0.03572590126171721,
            "start_logit": 3.5935022830963135,
            "end_logit": 3.982330560684204,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "papillary-type, of undifferentiated anaplastic",
            "probability": 0.02918958343448042,
            "start_logit": 3.9027156829833984,
            "end_logit": 3.471053123474121,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "undifferentiated anaplastic",
            "probability": 0.02589423627287658,
            "start_logit": 3.782924175262451,
            "end_logit": 3.471053123474121,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic",
            "probability": 0.021425858079081657,
            "start_logit": 3.5935022830963135,
            "end_logit": 3.471053123474121,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid carcinoma",
            "probability": 0.019965473199871693,
            "start_logit": 3.6556901931762695,
            "end_logit": 3.338271141052246,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary",
            "probability": 0.019225091773045447,
            "start_logit": 4.649599552154541,
            "end_logit": 2.3065736293792725,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary-type thyroid cancer",
            "probability": 0.017323196532852206,
            "start_logit": 4.649599552154541,
            "end_logit": 2.2024037837982178,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary (15%), and H\u00fcrthle cell carcinoma",
            "probability": 0.015400489157808669,
            "start_logit": 3.446596145629883,
            "end_logit": 3.287760019302368,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "follicular (22%), anaplastic (19%), medullary",
            "probability": 0.013064066145944932,
            "start_logit": 3.511151075363159,
            "end_logit": 3.058671236038208,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "follicular (22%), anaplastic",
            "probability": 0.011478975455046525,
            "start_logit": 3.511151075363159,
            "end_logit": 2.9293229579925537,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic (19%), medullary (15%), and H\u00fcrthle cell carcinoma",
            "probability": 0.01050860809414562,
            "start_logit": 3.064391613006592,
            "end_logit": 3.287760019302368,
            "question_text": "List the different subtypes of thyroid cancer."
        }
    ],
    "55391825bc4f83e828000016": [
        {
            "text": "deafness",
            "probability": 0.4037046664321259,
            "start_logit": 6.29974889755249,
            "end_logit": 5.65412712097168,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "albinism, black lock",
            "probability": 0.12067386504556894,
            "start_logit": 5.212381839752197,
            "end_logit": 5.533902168273926,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "albinism",
            "probability": 0.09911921252320163,
            "start_logit": 5.212381839752197,
            "end_logit": 5.337133884429932,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "black lock",
            "probability": 0.09198941184799923,
            "start_logit": 4.9409637451171875,
            "end_logit": 5.533902168273926,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "cell migration disorder of the neurocytes of the gut (Hirschsprung disease [HSCR]), and deafness",
            "probability": 0.07685610906902235,
            "start_logit": 4.641000270843506,
            "end_logit": 5.65412712097168,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "deafness. This phenotype clearly overlaps with the features of the Shah-Waardenburg syndrome",
            "probability": 0.05814060752792056,
            "start_logit": 6.29974889755249,
            "end_logit": 3.7163078784942627,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "intestinal neuronal dysplasiaABCD syndrome is an autosomal recessive syndrome characterized by albinism",
            "probability": 0.027491003023635188,
            "start_logit": 3.929917335510254,
            "end_logit": 5.337133884429932,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "deafness. This phenotype clearly overlaps with the features of the Shah-Waardenburg syndrome, comprising sensorineural deafness",
            "probability": 0.027019489015529124,
            "start_logit": 6.29974889755249,
            "end_logit": 2.9500019550323486,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "albinism, black lock, cell migration disorder of the neurocytes of the gut",
            "probability": 0.016640272195172015,
            "start_logit": 5.212381839752197,
            "end_logit": 3.5526363849639893,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "black lock, cell migration disorder of the neurocytes of the gut",
            "probability": 0.012684841507698903,
            "start_logit": 4.9409637451171875,
            "end_logit": 3.5526363849639893,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "albinism, black lock, cell migration disorder",
            "probability": 0.012019121904718615,
            "start_logit": 5.212381839752197,
            "end_logit": 3.227309465408325,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "intestinal neuronal dysplasia",
            "probability": 0.010603386510594932,
            "start_logit": 3.929917335510254,
            "end_logit": 4.384448528289795,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "cell migration disorder of the neurocytes of the gut",
            "probability": 0.009397504959788673,
            "start_logit": 4.641000270843506,
            "end_logit": 3.5526363849639893,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "black lock, cell migration disorder",
            "probability": 0.009162149190522408,
            "start_logit": 4.9409637451171875,
            "end_logit": 3.227309465408325,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "cell migration disorder",
            "probability": 0.006787734983365774,
            "start_logit": 4.641000270843506,
            "end_logit": 3.227309465408325,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "long-segment HSCR",
            "probability": 0.00444600679003324,
            "start_logit": 3.8708276748657227,
            "end_logit": 3.574371099472046,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "albinism, black lock, cell migration disorder of the neurocytes",
            "probability": 0.003987856440862003,
            "start_logit": 5.212381839752197,
            "end_logit": 2.1240644454956055,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "deaf",
            "probability": 0.003290676176643531,
            "start_logit": 6.29974889755249,
            "end_logit": 0.8445366024971008,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "black lock, cell migration disorder of the neurocytes",
            "probability": 0.0030399338613263495,
            "start_logit": 4.9409637451171875,
            "end_logit": 2.1240644454956055,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "albinism, black lock,",
            "probability": 0.0029461509942706582,
            "start_logit": 5.212381839752197,
            "end_logit": 1.8213101625442505,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        }
    ],
    "56be15ffef6e39474100000b": [
        {
            "text": "atrial septal defect",
            "probability": 0.6578407795045301,
            "start_logit": 0.9968857169151306,
            "end_logit": 0.021110335364937782,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "Tetralogy of Fallot (TOF) with an atrial septal defect",
            "probability": 0.13977261206339112,
            "start_logit": -0.5520603060722351,
            "end_logit": 0.021110335364937782,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "right ventricular hypertrophy (tetralogy of Fallot), and an atrial septal defect",
            "probability": 0.03058606468846754,
            "start_logit": -1.1686903238296509,
            "end_logit": -0.8817320466041565,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "right ventricular hypertrophy",
            "probability": 0.028160983948292043,
            "start_logit": -1.1686903238296509,
            "end_logit": -0.9643390774726868,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "patent foramen ovale",
            "probability": 0.025479644286199605,
            "start_logit": -1.4177950620651245,
            "end_logit": -0.8152919411659241,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "ventricular septal defect, obstruction of the pulmonary outflow, right ventricular hypertrophy",
            "probability": 0.017315475595774878,
            "start_logit": -1.655027151107788,
            "end_logit": -0.9643390774726868,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "ventricular septal defect",
            "probability": 0.016137836546285554,
            "start_logit": -1.655027151107788,
            "end_logit": -1.0347731113433838,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal defect (ASD)",
            "probability": 0.011873955055894286,
            "start_logit": 0.9968857169151306,
            "end_logit": -3.9935052394866943,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "right ventricular hypertrophy and a patent foramen ovale",
            "probability": 0.011853682808199038,
            "start_logit": -2.1830363273620605,
            "end_logit": -0.8152919411659241,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal defect (ASD).Additionally, an atrial septal defect",
            "probability": 0.00982818225932305,
            "start_logit": 0.9968857169151306,
            "end_logit": -4.18259859085083,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "ventricular septal defect, an overriding aorta, a right ventricular hypertrophy",
            "probability": 0.008439190130729543,
            "start_logit": -1.6458429098129272,
            "end_logit": -1.6922376155853271,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "ventricular septal defect, an overriding aorta",
            "probability": 0.0076524438776403554,
            "start_logit": -1.6458429098129272,
            "end_logit": -1.7900989055633545,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "Tetralogy of Fallot with an atrial septal defect",
            "probability": 0.00745454689285617,
            "start_logit": -2.2636451721191406,
            "end_logit": -1.1984975337982178,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "biventricular origin of the aorta above a large ventricular septal defect",
            "probability": 0.005701242250725268,
            "start_logit": -2.695509672164917,
            "end_logit": -1.0347731113433838,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "tetralogy of Fallot), and an atrial septal defect",
            "probability": 0.005542824155658538,
            "start_logit": -2.8767306804656982,
            "end_logit": -0.8817320466041565,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "patent foramen ovale.Additionally, an atrial septal defect",
            "probability": 0.004061735367135459,
            "start_logit": -1.4177950620651245,
            "end_logit": -2.6515614986419678,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "aorta, a right ventricular hypertrophy and a patent foramen ovale",
            "probability": 0.0036257300318040856,
            "start_logit": -3.367619276046753,
            "end_logit": -0.8152919411659241,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "cyanotic congenital heart disease characterized by biventricular origin of the aorta above a large ventricular septal defect",
            "probability": 0.003474639896679524,
            "start_logit": -3.1907029151916504,
            "end_logit": -1.0347731113433838,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "pulmonic stenosis, a ventricular septal defect",
            "probability": 0.0026755500811763504,
            "start_logit": -3.0093374252319336,
            "end_logit": -1.4774744510650635,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "Tetralogy of Fallot (TOF) with an atrial septal defect (ASD)",
            "probability": 0.002522880559237548,
            "start_logit": -0.5520603060722351,
            "end_logit": -3.9935052394866943,
            "question_text": "List Pentalogy of Fallot."
        }
    ],
    "5333f728d6d3ac6a34000041": [
        {
            "text": "na\u00efve Bayes classifier non-interacting proteins (NIPs",
            "probability": 0.16831306024908796,
            "start_logit": 1.4916826486587524,
            "end_logit": 0.4096520245075226,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "NIPs",
            "probability": 0.12503360996798576,
            "start_logit": 1.1944395303726196,
            "end_logit": 0.4096520245075226,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "non-interacting proteins (NIPs",
            "probability": 0.11324812107555848,
            "start_logit": 1.0954381227493286,
            "end_logit": 0.4096520245075226,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "supervised-learning",
            "probability": 0.06506871425864921,
            "start_logit": 1.1086132526397705,
            "end_logit": -0.15766042470932007,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "na\u00efve Bayes classifier",
            "probability": 0.06293392331108874,
            "start_logit": 1.4916826486587524,
            "end_logit": -0.5740883350372314,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "classifier non-interacting proteins (NIPs",
            "probability": 0.05448717060898461,
            "start_logit": 0.36382222175598145,
            "end_logit": 0.4096520245075226,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "na\u00efve Bayes classifier non-interacting proteins (NIPs) is important for training the algorithms to predict protein-protein interactions",
            "probability": 0.04165182431317496,
            "start_logit": 1.4916826486587524,
            "end_logit": -0.9868285059928894,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "na\u00efve Bayes classifier non-interacting proteins",
            "probability": 0.039668550992864204,
            "start_logit": 1.4916826486587524,
            "end_logit": -1.0356149673461914,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "supervised",
            "probability": 0.034213760139900774,
            "start_logit": 1.1086132526397705,
            "end_logit": -0.8004763722419739,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "na\u00efve Bayes classifier non-interacting proteins (NIPs) is important for training the algorithms to predict protein-protein interactions (PPIs)",
            "probability": 0.03267935313919709,
            "start_logit": 1.4916826486587524,
            "end_logit": -1.2294301986694336,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "na\u00efve Bayes classifier non-interacting proteins (NIPs) is important for training the algorithms to predict protein-protein interactions (PPIs",
            "probability": 0.0322170424679099,
            "start_logit": 1.4916826486587524,
            "end_logit": -1.243678092956543,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "NIPs) is important for training the algorithms to predict protein-protein interactions",
            "probability": 0.03094161527288138,
            "start_logit": 1.1944395303726196,
            "end_logit": -0.9868285059928894,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "na\u00efve Bayes classifier non-interacting proteins (NIPs)",
            "probability": 0.030382927367163817,
            "start_logit": 1.4916826486587524,
            "end_logit": -1.302292823791504,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "non-interacting proteins (NIPs) is important for training the algorithms to predict protein-protein interactions",
            "probability": 0.028025102959066947,
            "start_logit": 1.0954381227493286,
            "end_logit": -0.9868285059928894,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "non-interacting proteins",
            "probability": 0.026690673077202243,
            "start_logit": 1.0954381227493286,
            "end_logit": -1.0356149673461914,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "NIPs) is important for training the algorithms to predict protein-protein interactions (PPIs)",
            "probability": 0.02427629494921848,
            "start_logit": 1.1944395303726196,
            "end_logit": -1.2294301986694336,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "NIPs) is important for training the algorithms to predict protein-protein interactions (PPIs",
            "probability": 0.0239328612782234,
            "start_logit": 1.1944395303726196,
            "end_logit": -1.243678092956543,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "NIPs)",
            "probability": 0.022570364322825543,
            "start_logit": 1.1944395303726196,
            "end_logit": -1.302292823791504,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "non-interacting proteins (NIPs) is important for training the algorithms to predict protein-protein interactions (PPIs)",
            "probability": 0.021988046177175834,
            "start_logit": 1.0954381227493286,
            "end_logit": -1.2294301986694336,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "non-interacting proteins (NIPs) is important for training the algorithms to predict protein-protein interactions (PPIs",
            "probability": 0.021676984071840853,
            "start_logit": 1.0954381227493286,
            "end_logit": -1.243678092956543,
            "question_text": "List algorithms suitable for predicting protein complexes"
        }
    ],
    "51434c74d24251bc0500000c": [
        {
            "text": "TMBETAPRED-RBF",
            "probability": 0.4897129887766881,
            "start_logit": 4.999865531921387,
            "end_logit": 4.738140106201172,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "TMBETAPRED",
            "probability": 0.2862700658007896,
            "start_logit": 4.999865531921387,
            "end_logit": 4.201256275177002,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "TMBETADISC-RBF",
            "probability": 0.12229346701188987,
            "start_logit": 4.281869411468506,
            "end_logit": 4.068740367889404,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "tmrbf.html.We have developed a prediction server, TMBETADISC-RBF",
            "probability": 0.032920773371500824,
            "start_logit": 2.9695496559143066,
            "end_logit": 4.068740367889404,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "TMBETADISC",
            "probability": 0.031165410475184133,
            "start_logit": 4.281869411468506,
            "end_logit": 2.7016255855560303,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "tmrbf.html.We have developed a prediction server, TMBETADISC",
            "probability": 0.008389568472889757,
            "start_logit": 2.9695496559143066,
            "end_logit": 2.7016255855560303,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "RBF",
            "probability": 0.00725597791259294,
            "start_logit": 0.7878717184066772,
            "end_logit": 4.738140106201172,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "tmrbf",
            "probability": 0.006639394886251129,
            "start_logit": 2.9695496559143066,
            "end_logit": 2.4676573276519775,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "TMB",
            "probability": 0.006251308557530691,
            "start_logit": 2.7117786407470703,
            "end_logit": 2.66519832611084,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "TMBETADISC-RBF,",
            "probability": 0.0031839737039903605,
            "start_logit": 4.281869411468506,
            "end_logit": 0.4204467535018921,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "web server, TMBETAPRED-RBF",
            "probability": 0.0013502280405098502,
            "start_logit": -0.8936804533004761,
            "end_logit": 4.738140106201172,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "tmrbf.html.We have developed a prediction server, TMBETADISC-RBF,",
            "probability": 0.0008571093721604425,
            "start_logit": 2.9695496559143066,
            "end_logit": 0.4204467535018921,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "web server, TMBETAPRED",
            "probability": 0.0007892987910498038,
            "start_logit": -0.8936804533004761,
            "end_logit": 4.201256275177002,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "OMP.html.TMB",
            "probability": 0.0007724378044867401,
            "start_logit": 0.6207840442657471,
            "end_logit": 2.66519832611084,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "sachen/tmrbf.html.We have developed a prediction server, TMBETADISC-RBF",
            "probability": 0.0005914773657254723,
            "start_logit": -1.049686074256897,
            "end_logit": 4.068740367889404,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "T",
            "probability": 0.0004559839475758692,
            "start_logit": 4.999865531921387,
            "end_logit": -2.2409770488739014,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "prediction server, TMBETADISC-RBF",
            "probability": 0.00031987437628954254,
            "start_logit": -1.6643811464309692,
            "end_logit": 4.068740367889404,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "TMBE",
            "probability": 0.00029546801413150663,
            "start_logit": 4.999865531921387,
            "end_logit": -2.6748740673065186,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "a web server, TMBETAPRED-RBF",
            "probability": 0.0002706891421220924,
            "start_logit": -2.5007381439208984,
            "end_logit": 4.738140106201172,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "sachen/OMP.html.TMB",
            "probability": 0.0002145041766411854,
            "start_logit": -0.6604382395744324,
            "end_logit": 2.66519832611084,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        }
    ],
    "5150f401d24251bc05000075": [
        {
            "text": "sildenafil",
            "probability": 0.42505225103873817,
            "start_logit": 6.739047050476074,
            "end_logit": 5.946552276611328,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Elonza",
            "probability": 0.2762027234928725,
            "start_logit": 6.282410144805908,
            "end_logit": 5.97211217880249,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Elonza (generic sildenafil",
            "probability": 0.26923246789433053,
            "start_logit": 6.282410144805908,
            "end_logit": 5.946552276611328,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "sildenafil)",
            "probability": 0.014440773996844574,
            "start_logit": 6.739047050476074,
            "end_logit": 2.5643959045410156,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Elonza (generic sildenafil)",
            "probability": 0.009146934787366657,
            "start_logit": 6.282410144805908,
            "end_logit": 2.5643959045410156,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "sildenafil) in PAH patients.",
            "probability": 0.0027867749203343856,
            "start_logit": 6.739047050476074,
            "end_logit": 0.9192251563072205,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Elonza (generic sildenafil) in PAH patients.",
            "probability": 0.0017651718992996782,
            "start_logit": 6.282410144805908,
            "end_logit": 0.9192251563072205,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "(generic sildenafil",
            "probability": 0.0003300927664082604,
            "start_logit": -0.42154660820961,
            "end_logit": 5.946552276611328,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "fil",
            "probability": 0.00018080505635857398,
            "start_logit": -1.023500919342041,
            "end_logit": 5.946552276611328,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "sildenafi",
            "probability": 0.00013821528599329528,
            "start_logit": 6.739047050476074,
            "end_logit": -2.0846025943756104,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "si",
            "probability": 0.0001233935589398296,
            "start_logit": 6.739047050476074,
            "end_logit": -2.1980361938476562,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Elonza (",
            "probability": 9.186667177329559e-05,
            "start_logit": 6.282410144805908,
            "end_logit": -2.036439895629883,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Elonza (generic sildenafi",
            "probability": 8.754698383024015e-05,
            "start_logit": 6.282410144805908,
            "end_logit": -2.0846025943756104,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "silde",
            "probability": 8.218554418185623e-05,
            "start_logit": 6.739047050476074,
            "end_logit": -2.604435682296753,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Elonza (generic si",
            "probability": 7.815874945832748e-05,
            "start_logit": 6.282410144805908,
            "end_logit": -2.1980361938476562,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "l",
            "probability": 6.980052136297138e-05,
            "start_logit": -1.9752788543701172,
            "end_logit": 5.946552276611328,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "El",
            "probability": 6.835268939112571e-05,
            "start_logit": 6.282410144805908,
            "end_logit": -2.332097291946411,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Elonza (generic silde",
            "probability": 5.205716904509016e-05,
            "start_logit": 6.282410144805908,
            "end_logit": -2.604435682296753,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "za",
            "probability": 3.566348887467638e-05,
            "start_logit": -2.6723527908325195,
            "end_logit": 5.97211217880249,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "za (generic sildenafil",
            "probability": 3.476348459575888e-05,
            "start_logit": -2.6723527908325195,
            "end_logit": 5.946552276611328,
            "question_text": "What are the generic versions of Viagra?"
        }
    ],
    "51601071298dcd4e51000038": [
        {
            "text": "Neisseria meningitidis",
            "probability": 0.21218701383762317,
            "start_logit": 4.338512897491455,
            "end_logit": 4.7643046379089355,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "serogroup B meningococcusThe Neisseria meningitidis",
            "probability": 0.14578143672535113,
            "start_logit": 3.96315336227417,
            "end_logit": 4.7643046379089355,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "serogroup B meningococcus",
            "probability": 0.11640591083049835,
            "start_logit": 3.96315336227417,
            "end_logit": 4.539279460906982,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "meningococcusThe Neisseria meningitidis",
            "probability": 0.09142740473886064,
            "start_logit": 3.4965901374816895,
            "end_logit": 4.7643046379089355,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "meningococcus",
            "probability": 0.07300442746730695,
            "start_logit": 3.4965901374816895,
            "end_logit": 4.539279460906982,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Neisseria meningitidis serogroup B",
            "probability": 0.06315830324910231,
            "start_logit": 4.338512897491455,
            "end_logit": 3.552480936050415,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Neisseria meningitidisThis process, first applied to serogroup B Neisseria meningitidis",
            "probability": 0.047449489628849,
            "start_logit": 3.281209945678711,
            "end_logit": 4.323805332183838,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "serogroup B",
            "probability": 0.04472111195721808,
            "start_logit": 3.96315336227417,
            "end_logit": 3.582641839981079,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "serogroup B meningococcusThe Neisseria meningitidis serogroup B",
            "probability": 0.04339242078139368,
            "start_logit": 3.96315336227417,
            "end_logit": 3.552480936050415,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "serogroup B Neisseria meningitidis",
            "probability": 0.04072556993523469,
            "start_logit": 3.1284003257751465,
            "end_logit": 4.323805332183838,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "serogroup B Neisseria meningitidisThis process, first applied to serogroup B Neisseria meningitidis",
            "probability": 0.027411746756451538,
            "start_logit": 2.732515811920166,
            "end_logit": 4.323805332183838,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "meningococcusThe Neisseria meningitidis serogroup B",
            "probability": 0.027213728349060294,
            "start_logit": 3.4965901374816895,
            "end_logit": 3.552480936050415,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Neisseria meningitidis serogroup B project",
            "probability": 0.012887381861806664,
            "start_logit": 4.338512897491455,
            "end_logit": 1.9630852937698364,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Neisseria",
            "probability": 0.010793432615655024,
            "start_logit": 4.338512897491455,
            "end_logit": 1.7857744693756104,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Neisseria meningitidisThis process, first applied to serogroup B",
            "probability": 0.01075441661630112,
            "start_logit": 3.281209945678711,
            "end_logit": 2.839456081390381,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "serogroup B meningococcusThe Neisseria meningitidis serogroup B project",
            "probability": 0.008854175425081004,
            "start_logit": 3.96315336227417,
            "end_logit": 1.9630852937698364,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "serogroup B meningococcusThe Neisseria",
            "probability": 0.007415543889564167,
            "start_logit": 3.96315336227417,
            "end_logit": 1.7857744693756104,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "serogroup B Neisseria meningitidisThis process, first applied to serogroup B",
            "probability": 0.006212866505105374,
            "start_logit": 2.732515811920166,
            "end_logit": 2.839456081390381,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "meningococcusThe Neisseria meningitidis serogroup B project",
            "probability": 0.005552931144058216,
            "start_logit": 3.4965901374816895,
            "end_logit": 1.9630852937698364,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "meningococcusThe Neisseria",
            "probability": 0.004650687685478599,
            "start_logit": 3.4965901374816895,
            "end_logit": 1.7857744693756104,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        }
    ],
    "515993f3d24251bc050000a0": [
        {
            "text": "GC-1",
            "probability": 0.32356653883032765,
            "start_logit": 4.1243062019348145,
            "end_logit": 3.276041269302368,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "CO23Diiodothyropropionic acid (DITPA) and GC-1",
            "probability": 0.12752388663515915,
            "start_logit": 3.1932051181793213,
            "end_logit": 3.276041269302368,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "GC-24",
            "probability": 0.10065842536254505,
            "start_logit": 3.0916547775268555,
            "end_logit": 3.1410207748413086,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "CO23",
            "probability": 0.09691312956009991,
            "start_logit": 3.7814130783081055,
            "end_logit": 2.413344621658325,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "GC-1, a noniodinated thyroid hormone analog,analogs DITPA and GC-1",
            "probability": 0.09566966822521422,
            "start_logit": 4.1243062019348145,
            "end_logit": 2.057537794113159,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "CO23Diiodothyropropionic acid",
            "probability": 0.05526375585792822,
            "start_logit": 3.1932051181793213,
            "end_logit": 2.439854860305786,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "GC-24 and CO23",
            "probability": 0.04862105681702124,
            "start_logit": 3.0916547775268555,
            "end_logit": 2.413344621658325,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "GC-1, a noniodinated thyroid hormone analog,analogs DITPA",
            "probability": 0.036597241242622404,
            "start_logit": 4.1243062019348145,
            "end_logit": 1.096609354019165,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "CO23two thyroid hormone agonists, the TR\u03b2-selective GC-24",
            "probability": 0.020928172714534444,
            "start_logit": 3.7814130783081055,
            "end_logit": 0.88062584400177,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "CO23Diiodothyropropionic acid (DITPA",
            "probability": 0.01809479445134297,
            "start_logit": 3.1932051181793213,
            "end_logit": 1.323361873626709,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "DITPA) and GC-1",
            "probability": 0.015779341435784838,
            "start_logit": 1.1036030054092407,
            "end_logit": 3.276041269302368,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "GC-24 and CO23two thyroid hormone agonists, the TR\u03b2-selective GC-24",
            "probability": 0.010499608043291876,
            "start_logit": 3.0916547775268555,
            "end_logit": 0.88062584400177,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "iodothyronine, 3,5-diiodo-L-thyronine",
            "probability": 0.010227457358958561,
            "start_logit": 2.7085320949554443,
            "end_logit": 1.2374866008758545,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "3,5-diiodo-L-thyronine",
            "probability": 0.009002521071659646,
            "start_logit": 2.580960750579834,
            "end_logit": 1.2374866008758545,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "DITPA and GC-1",
            "probability": 0.007458098492143044,
            "start_logit": 1.5727053880691528,
            "end_logit": 2.057537794113159,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "CO23two thyroid hormone agonists, the TR\u03b2-selective GC-24 and the TR\u03b1-selective CO23",
            "probability": 0.0072084755163131144,
            "start_logit": 3.7814130783081055,
            "end_logit": -0.1852128952741623,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "DITPA) and GC-1, a noniodinated thyroid hormone analog,analogs DITPA and GC-1",
            "probability": 0.004665514442349428,
            "start_logit": 1.1036030054092407,
            "end_logit": 2.057537794113159,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "GC-24 and the TR\u03b1-selective CO23Diiodothyropropionic acid",
            "probability": 0.004454710461671237,
            "start_logit": 0.675049901008606,
            "end_logit": 2.439854860305786,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "CO23Diiodothyropropionic acid (DITPA)",
            "probability": 0.003730906978443272,
            "start_logit": 3.1932051181793213,
            "end_logit": -0.2556110620498657,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "iodothyronine",
            "probability": 0.0031366965025901397,
            "start_logit": 2.7085320949554443,
            "end_logit": 0.05558077618479729,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        }
    ],
    "53357c98d6d3ac6a3400004a": [
        {
            "text": "BRCA)2",
            "probability": 0.2164967751891576,
            "start_logit": 4.945244312286377,
            "end_logit": 3.8104043006896973,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "p53",
            "probability": 0.15114263855858812,
            "start_logit": 4.097650527954102,
            "end_logit": 4.298646450042725,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "BRCA1",
            "probability": 0.14884047664424432,
            "start_logit": 4.468006610870361,
            "end_logit": 3.9129414558410645,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "p53, a negative regulator and breast cancer early-onset (BRCA)2",
            "probability": 0.09275687918049894,
            "start_logit": 4.097650527954102,
            "end_logit": 3.8104043006896973,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "p53 and BRCA1",
            "probability": 0.08692208039859813,
            "start_logit": 3.9301435947418213,
            "end_logit": 3.9129414558410645,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "(BRCA)2",
            "probability": 0.05085709830552199,
            "start_logit": 3.4966883659362793,
            "end_logit": 3.8104043006896973,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "F-ara-A",
            "probability": 0.03649192399772008,
            "start_logit": 4.064674377441406,
            "end_logit": 2.910489559173584,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "breast cancer early-onset (BRCA)2",
            "probability": 0.035287373760320546,
            "start_logit": 3.1311938762664795,
            "end_logit": 3.8104043006896973,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "BRCA",
            "probability": 0.031046085918030944,
            "start_logit": 4.945244312286377,
            "end_logit": 1.8683013916015625,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "2CdA and F-ara-A",
            "probability": 0.029707332953917892,
            "start_logit": 3.8589773178100586,
            "end_logit": 2.910489559173584,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "early-onset (BRCA)2",
            "probability": 0.023979193223910903,
            "start_logit": 2.7448551654815674,
            "end_logit": 3.8104043006896973,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "BRCA)2, a positive regulator. Both the players not only interact with each other but also directly interact with human RAD51",
            "probability": 0.02334640692615461,
            "start_logit": 4.945244312286377,
            "end_logit": 1.5832717418670654,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "BRCA)2,",
            "probability": 0.014365000104096661,
            "start_logit": 4.945244312286377,
            "end_logit": 1.097623348236084,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "p53, a negative regulator and breast cancer early-onset (BRCA",
            "probability": 0.013301528570160457,
            "start_logit": 4.097650527954102,
            "end_logit": 1.8683013916015625,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "2CdA",
            "probability": 0.01205808777636994,
            "start_logit": 3.8589773178100586,
            "end_logit": 2.008831262588501,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "(BRCA",
            "probability": 0.007293013219968071,
            "start_logit": 3.4966883659362793,
            "end_logit": 1.8683013916015625,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "p53,",
            "probability": 0.007276915907016308,
            "start_logit": 4.097650527954102,
            "end_logit": 1.265129566192627,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "NRF2",
            "probability": 0.0071922950265085024,
            "start_logit": 2.9833154678344727,
            "end_logit": 2.367767810821533,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "p53, a negative regulator and breast cancer early-onset (BRCA)2,",
            "probability": 0.006154607050933475,
            "start_logit": 4.097650527954102,
            "end_logit": 1.097623348236084,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "(BRCA)2, a positive regulator. Both the players not only interact with each other but also directly interact with human RAD51",
            "probability": 0.005484287288283023,
            "start_logit": 3.4966883659362793,
            "end_logit": 1.5832717418670654,
            "question_text": "What genes are related to breast cancer?"
        }
    ],
    "5523e47f7b523f2123000004": [
        {
            "text": "mCherry",
            "probability": 0.3253107496455122,
            "start_logit": 3.4296486377716064,
            "end_logit": 3.4348175525665283,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs)mCherry",
            "probability": 0.2572369657147166,
            "start_logit": 3.1948654651641846,
            "end_logit": 3.4348175525665283,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs",
            "probability": 0.135706338170645,
            "start_logit": 3.1948654651641846,
            "end_logit": 2.7953131198883057,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "Flavin-based fluorescent proteins (FbFPs)mCherry",
            "probability": 0.11360937741347546,
            "start_logit": 2.377633810043335,
            "end_logit": 3.4348175525665283,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "Flavin-based fluorescent proteins (FbFPs",
            "probability": 0.05993505850837947,
            "start_logit": 2.377633810043335,
            "end_logit": 2.7953131198883057,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "(FbFPs)mCherry",
            "probability": 0.019964879481019184,
            "start_logit": 0.6388424634933472,
            "end_logit": 3.4348175525665283,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs)",
            "probability": 0.018688251930731137,
            "start_logit": 3.1948654651641846,
            "end_logit": 0.8127149343490601,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein",
            "probability": 0.012229718787938467,
            "start_logit": 2.0823934078216553,
            "end_logit": 1.5011608600616455,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "(FbFPs",
            "probability": 0.01053254799075854,
            "start_logit": 0.6388424634933472,
            "end_logit": 2.7953131198883057,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "flavin-based fluorescent proteins: an emerging class of fluorescent reporters.Flavin-based fluorescent proteins (FbFPs",
            "probability": 0.009379003801987806,
            "start_logit": 0.5228457450866699,
            "end_logit": 2.7953131198883057,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "Flavin-based fluorescent proteins (FbFPs)",
            "probability": 0.008253715250051554,
            "start_logit": 2.377633810043335,
            "end_logit": 0.8127149343490601,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "Flavin-based fluorescent proteins",
            "probability": 0.00652955502800485,
            "start_logit": 2.377633810043335,
            "end_logit": 0.5783903002738953,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (Gfp)",
            "probability": 0.00416565287814775,
            "start_logit": 2.0823934078216553,
            "end_logit": 0.42416492104530334,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "fluorescent proteins (FbFPs)mCherry",
            "probability": 0.003783035042134722,
            "start_logit": -1.024605631828308,
            "end_logit": 3.4348175525665283,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "dsRed, in which fluorescence shifts over time from green to red as the protein matures.green fluorescent protein",
            "probability": 0.0035300449186972506,
            "start_logit": 0.8398350477218628,
            "end_logit": 1.5011608600616455,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent protein, dsRed, in which fluorescence shifts over time from green to red as the protein matures.green fluorescent protein",
            "probability": 0.003082302151141315,
            "start_logit": 0.7042012214660645,
            "end_logit": 1.5011608600616455,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green",
            "probability": 0.0024157130184643536,
            "start_logit": 2.0823934078216553,
            "end_logit": -0.12071360647678375,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "fluorescent proteins (FbFPs",
            "probability": 0.0019957545032959637,
            "start_logit": -1.024605631828308,
            "end_logit": 2.7953131198883057,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "dsRed",
            "probability": 0.0019492895831391525,
            "start_logit": 0.8398350477218628,
            "end_logit": 0.9073152542114258,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent protein, dsRed",
            "probability": 0.001702046181759213,
            "start_logit": 0.7042012214660645,
            "end_logit": 0.9073152542114258,
            "question_text": "List fluorescent reporter proteins."
        }
    ],
    "54fb5720d176fff445000002": [
        {
            "text": "c-Myc",
            "probability": 0.06741675634049363,
            "start_logit": 5.464842796325684,
            "end_logit": 5.057239532470703,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "KLF4",
            "probability": 0.06028017527310042,
            "start_logit": 5.297499179840088,
            "end_logit": 5.112692832946777,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "MYC, and KLF4",
            "probability": 0.0584800120333714,
            "start_logit": 5.267180919647217,
            "end_logit": 5.112692832946777,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4, and c-Myc",
            "probability": 0.05762782876418451,
            "start_logit": 5.307954788208008,
            "end_logit": 5.057239532470703,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4",
            "probability": 0.05706112942293015,
            "start_logit": 5.307954788208008,
            "end_logit": 5.047357082366943,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "SOX2, MYC, and KLF4",
            "probability": 0.0556910905404856,
            "start_logit": 5.218316078186035,
            "end_logit": 5.112692832946777,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "OCT4, SOX2, MYC, and KLF4",
            "probability": 0.053931217716994655,
            "start_logit": 5.1862053871154785,
            "end_logit": 5.112692832946777,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "MYC",
            "probability": 0.05239747779166547,
            "start_logit": 5.267180919647217,
            "end_logit": 5.002866268157959,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4, and c-Myc",
            "probability": 0.05088616836769652,
            "start_logit": 5.183540344238281,
            "end_logit": 5.057239532470703,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4",
            "probability": 0.05038576502591984,
            "start_logit": 5.183540344238281,
            "end_logit": 5.047357082366943,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "SOX2, MYC",
            "probability": 0.04989863336764599,
            "start_logit": 5.218316078186035,
            "end_logit": 5.002866268157959,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2, Klf4, and c-Myc",
            "probability": 0.04925396090341995,
            "start_logit": 5.150938987731934,
            "end_logit": 5.057239532470703,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2, Klf4",
            "probability": 0.04876960832938226,
            "start_logit": 5.150938987731934,
            "end_logit": 5.047357082366943,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "OCT4, SOX2, MYC",
            "probability": 0.04832180576486777,
            "start_logit": 5.1862053871154785,
            "end_logit": 5.002866268157959,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "SOX2",
            "probability": 0.04345355729101463,
            "start_logit": 5.218316078186035,
            "end_logit": 4.864565372467041,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "OCT4, SOX2",
            "probability": 0.04208039806898664,
            "start_logit": 5.1862053871154785,
            "end_logit": 4.864565372467041,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "OCT4",
            "probability": 0.039426472806360115,
            "start_logit": 5.1862053871154785,
            "end_logit": 4.7994208335876465,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2",
            "probability": 0.038870138635138926,
            "start_logit": 5.183540344238281,
            "end_logit": 4.787874698638916,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4",
            "probability": 0.03814445029437685,
            "start_logit": 5.077089786529541,
            "end_logit": 4.875479221343994,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2",
            "probability": 0.03762335326196442,
            "start_logit": 5.150938987731934,
            "end_logit": 4.787874698638916,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        }
    ],
    "5363bad27d100faa0900000e": [
        {
            "text": "ci-ankrd52",
            "probability": 0.37077472140819895,
            "start_logit": 4.24453592300415,
            "end_logit": 3.5666818618774414,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "MALAT1",
            "probability": 0.2492881274416542,
            "start_logit": 3.929769515991211,
            "end_logit": 3.4844629764556885,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA MALAT1",
            "probability": 0.15934975566506457,
            "start_logit": 3.4822616577148438,
            "end_logit": 3.4844629764556885,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "MALAT",
            "probability": 0.056112687762020996,
            "start_logit": 3.929769515991211,
            "end_logit": 1.993215560913086,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "ankrd52",
            "probability": 0.04665186754646217,
            "start_logit": 2.171654224395752,
            "end_logit": 3.5666818618774414,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA MALAT",
            "probability": 0.03586830699220069,
            "start_logit": 3.4822616577148438,
            "end_logit": 1.993215560913086,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA",
            "probability": 0.032612518909537105,
            "start_logit": 3.4822616577148438,
            "end_logit": 1.8980576992034912,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "MALAT1 (metastasis-associated lung adenocarcinoma transcript 1), also known as MALAT",
            "probability": 0.014346878567935217,
            "start_logit": 3.929769515991211,
            "end_logit": 0.6293860077857971,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA MALAT1 (metastasis-associated lung adenocarcinoma transcript 1), also known as MALAT",
            "probability": 0.009170800141261865,
            "start_logit": 3.4822616577148438,
            "end_logit": 0.6293860077857971,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "ci-ankrd52,",
            "probability": 0.004649398333122782,
            "start_logit": 4.24453592300415,
            "end_logit": -0.8121749758720398,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "ci-ankrd5",
            "probability": 0.004488790009612434,
            "start_logit": 4.24453592300415,
            "end_logit": -0.8473296165466309,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "MALAT1 (metastasis-associated lung adenocarcinoma transcript 1),",
            "probability": 0.0035561112401846697,
            "start_logit": 3.929769515991211,
            "end_logit": -0.765478789806366,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "MALAT1 (metastasis-associated lung adenocarcinoma transcript 1), also known as MALAT-1",
            "probability": 0.0026795035809412597,
            "start_logit": 3.929769515991211,
            "end_logit": -1.0485148429870605,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA MALAT1 (metastasis-associated lung adenocarcinoma transcript 1),",
            "probability": 0.002273134557416276,
            "start_logit": 3.4822616577148438,
            "end_logit": -0.765478789806366,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "MALAT1) and multiple endocrine neoplasia-\u03b2 (MEN\u03b2) RNAs. MALAT1",
            "probability": 0.0021636127181729257,
            "start_logit": 0.9625842571258545,
            "end_logit": 1.7048182487487793,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA, ci-ankrd52",
            "probability": 0.0018521131806501737,
            "start_logit": -1.0547314882278442,
            "end_logit": 3.5666818618774414,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA MALAT1 (metastasis-associated lung adenocarcinoma transcript 1), also known as MALAT-1",
            "probability": 0.0017127901168361472,
            "start_logit": 3.4822616577148438,
            "end_logit": -1.0485148429870605,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA.Many long noncoding RNAs",
            "probability": 0.0010269190734090996,
            "start_logit": 1.1869559288024902,
            "end_logit": 0.7352303266525269,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "MALAT1) and multiple endocrine neoplasia-\u03b2 (MEN\u03b2) RNAs. MALAT",
            "probability": 0.0008369630164370406,
            "start_logit": 0.9625842571258545,
            "end_logit": 0.7550634741783142,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "ankrd52,",
            "probability": 0.0005849997388813077,
            "start_logit": 2.171654224395752,
            "end_logit": -0.8121749758720398,
            "question_text": "Which are the most abundant human lincRNA?"
        }
    ],
    "532b15ecd6d3ac6a34000014": [
        {
            "text": "doxorubicin",
            "probability": 0.12022814148838623,
            "start_logit": 5.309524059295654,
            "end_logit": 5.213063716888428,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "fludarabine",
            "probability": 0.10655148460787972,
            "start_logit": 5.449344158172607,
            "end_logit": 4.952480792999268,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "doxorubicin, etoposide, cisplatin, and fludarabine",
            "probability": 0.09264807663170306,
            "start_logit": 5.309524059295654,
            "end_logit": 4.952480792999268,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "doxorubicin, etoposide, cisplatin",
            "probability": 0.09183796793924405,
            "start_logit": 5.309524059295654,
            "end_logit": 4.943698406219482,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "cisplatin, and fludarabine",
            "probability": 0.07665102965554979,
            "start_logit": 5.119978904724121,
            "end_logit": 4.952480792999268,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "cisplatin",
            "probability": 0.07598079809039018,
            "start_logit": 5.119978904724121,
            "end_logit": 4.943698406219482,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "doxorubicin, etoposide",
            "probability": 0.06606701546385398,
            "start_logit": 5.309524059295654,
            "end_logit": 4.614342212677002,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "etoposide, cisplatin, and fludarabine",
            "probability": 0.06152511097663742,
            "start_logit": 4.900161266326904,
            "end_logit": 4.952480792999268,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "etoposide, cisplatin",
            "probability": 0.06098713945020399,
            "start_logit": 4.900161266326904,
            "end_logit": 4.943698406219482,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "etoposide",
            "probability": 0.043873338833219956,
            "start_logit": 4.900161266326904,
            "end_logit": 4.614342212677002,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "Vincristine, doxorubicin",
            "probability": 0.04199683270908711,
            "start_logit": 4.257727146148682,
            "end_logit": 5.213063716888428,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "Vincristine",
            "probability": 0.03520477128733456,
            "start_logit": 4.257727146148682,
            "end_logit": 5.036651134490967,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "Vincristine, doxorubicin, etoposide, cisplatin, and fludarabine",
            "probability": 0.03236285387889965,
            "start_logit": 4.257727146148682,
            "end_logit": 4.952480792999268,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "Vincristine, doxorubicin, etoposide, cisplatin",
            "probability": 0.03207987521174073,
            "start_logit": 4.257727146148682,
            "end_logit": 4.943698406219482,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "Vincristine, doxorubicin, etoposide",
            "probability": 0.02307783653373838,
            "start_logit": 4.257727146148682,
            "end_logit": 4.614342212677002,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "bortezomib",
            "probability": 0.020065694039254577,
            "start_logit": 4.541297435760498,
            "end_logit": 4.190910816192627,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "Etoposide and cisplatin",
            "probability": 0.009815388003149501,
            "start_logit": 3.582313060760498,
            "end_logit": 4.434834957122803,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "Etoposide",
            "probability": 0.007279763956063792,
            "start_logit": 3.582313060760498,
            "end_logit": 4.135982036590576,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "fludarabine,",
            "probability": 0.0009451015778680099,
            "start_logit": 5.449344158172607,
            "end_logit": 0.2273896336555481,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "doxorubicin, etoposide, cisplatin, and fludarabine,",
            "probability": 0.0008217796657953224,
            "start_logit": 5.309524059295654,
            "end_logit": 0.2273896336555481,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        }
    ],
    "56c830635795f9a73e00000e": [
        {
            "text": "TDP-43",
            "probability": 0.6574453726355766,
            "start_logit": 3.5955986976623535,
            "end_logit": 3.229436159133911,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "TDP-43 in motor neuron degeneration is not yet known, TDP-43",
            "probability": 0.0975211952185469,
            "start_logit": 1.8966792821884155,
            "end_logit": 3.020063638687134,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "TIA-1",
            "probability": 0.0894990353567464,
            "start_logit": 3.2462596893310547,
            "end_logit": 1.5846413373947144,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS mutants, but not wild-type FUS",
            "probability": 0.06488090645425461,
            "start_logit": 2.1268560886383057,
            "end_logit": 2.3823704719543457,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS",
            "probability": 0.06206445435268065,
            "start_logit": 2.0824761390686035,
            "end_logit": 2.3823704719543457,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS.Recently, TDP-43",
            "probability": 0.011196164152542515,
            "start_logit": -0.4771917462348938,
            "end_logit": 3.229436159133911,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "TIA-1 immunoreactive) and processing bodies (P-bodies; XRN-1",
            "probability": 0.007714849578741981,
            "start_logit": 3.2462596893310547,
            "end_logit": -0.8664395213127136,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "ALS-linked FUS mutants, but not wild-type FUS",
            "probability": 0.0015340939894720183,
            "start_logit": -1.6177573204040527,
            "end_logit": 2.3823704719543457,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS mutants",
            "probability": 0.001474808907424656,
            "start_logit": 2.1268560886383057,
            "end_logit": -1.4016544818878174,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "TDP-43 has been shown to accumulate in RNA",
            "probability": 0.0010185633150993142,
            "start_logit": 3.0088226795196533,
            "end_logit": -2.6537563800811768,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "XRN-1",
            "probability": 0.0009122436956094359,
            "start_logit": 1.1112645864486694,
            "end_logit": -0.8664395213127136,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS mutants, but not wild-type FUS,",
            "probability": 0.0006960932096935783,
            "start_logit": 2.1268560886383057,
            "end_logit": -2.1524546146392822,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS mutants,",
            "probability": 0.0006690092235981631,
            "start_logit": 2.1268560886383057,
            "end_logit": -2.1921403408050537,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS,",
            "probability": 0.0006658761043774692,
            "start_logit": 2.0824761390686035,
            "end_logit": -2.1524546146392822,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "TIA-1 immunoreactive",
            "probability": 0.000617375978721668,
            "start_logit": 3.2462596893310547,
            "end_logit": -3.3918635845184326,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "43",
            "probability": 0.0004835525314636025,
            "start_logit": -3.6193583011627197,
            "end_logit": 3.229436159133911,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "TIA-1 immunoreactive) and processing bodies (P-bodies",
            "probability": 0.0004543746051682989,
            "start_logit": 3.2462596893310547,
            "end_logit": -3.6984198093414307,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "wild-type FUS",
            "probability": 0.00042535440257581916,
            "start_logit": -2.9005298614501953,
            "end_logit": 2.3823704719543457,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "TDP-43 has been shown to accumulate in RNA stress granules",
            "probability": 0.0004219587473040956,
            "start_logit": 3.0088226795196533,
            "end_logit": -3.5349972248077393,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "ALS-linked FUS",
            "probability": 0.0003047175404022672,
            "start_logit": -1.6177573204040527,
            "end_logit": 0.766060471534729,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        }
    ],
    "5720a8da0fd6f91b68000010": [
        {
            "text": "sleep apnea",
            "probability": 0.8645636773793365,
            "start_logit": 5.803044319152832,
            "end_logit": 5.495466709136963,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleep apneaA clinically relevant sleep-wake disturbance is found in up to half the patients with dementia",
            "probability": 0.08852613973778976,
            "start_logit": 5.803044319152832,
            "end_logit": 3.2165396213531494,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleep apneaA clinically relevant sleep-wake disturbance",
            "probability": 0.011000041873255723,
            "start_logit": 5.803044319152832,
            "end_logit": 1.1311408281326294,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "dementia",
            "probability": 0.007592386056056055,
            "start_logit": 3.3468923568725586,
            "end_logit": 3.2165396213531494,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "traumatic brain injury",
            "probability": 0.007569617604300784,
            "start_logit": 3.4271416664123535,
            "end_logit": 3.133286952972412,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleep",
            "probability": 0.004332972475266092,
            "start_logit": 5.803044319152832,
            "end_logit": 0.19949553906917572,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleep-wake disturbance is found in up to half the patients with dementia",
            "probability": 0.004131109476160443,
            "start_logit": 2.7382924556732178,
            "end_logit": 3.2165396213531494,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleep apneaA",
            "probability": 0.004011169679312969,
            "start_logit": 5.803044319152832,
            "end_logit": 0.122324638068676,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleep apneaA clinically relevant sleep-wake disturbance is found in up to half the patients with dementia,",
            "probability": 0.0016960976891971522,
            "start_logit": 5.803044319152832,
            "end_logit": -0.7384281158447266,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "dementia, and the sundowning agitation",
            "probability": 0.0016690594203368837,
            "start_logit": 3.3468923568725586,
            "end_logit": 1.7016539573669434,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleep apneaA clinically relevant sleep",
            "probability": 0.0011066893654970516,
            "start_logit": 5.803044319152832,
            "end_logit": -1.1653852462768555,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Sleep-wake disturbances (SWD) are common after traumatic brain injury",
            "probability": 0.0009551529004295504,
            "start_logit": 1.3571152687072754,
            "end_logit": 3.133286952972412,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleep-wake disturbance is found in up to half the patients with dementia, and the sundowning agitation",
            "probability": 0.0009081555043066752,
            "start_logit": 2.7382924556732178,
            "end_logit": 1.7016539573669434,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleep-wake disturbance",
            "probability": 0.0005133215720844324,
            "start_logit": 2.7382924556732178,
            "end_logit": 1.1311408281326294,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "brain injury",
            "probability": 0.00039898766637976464,
            "start_logit": 0.48417434096336365,
            "end_logit": 3.133286952972412,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "apnea",
            "probability": 0.0003988857636991884,
            "start_logit": -1.878260850906372,
            "end_logit": 5.495466709136963,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "traumatic brain injury (TBI)",
            "probability": 0.00019848250963403377,
            "start_logit": 3.4271416664123535,
            "end_logit": -0.507909893989563,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "agitation",
            "probability": 0.00019334239052385156,
            "start_logit": 1.1913394927978516,
            "end_logit": 1.7016539573669434,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "dementia,",
            "probability": 0.00014546470097207096,
            "start_logit": 3.3468923568725586,
            "end_logit": -0.7384281158447266,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Sleep-wake disturbances",
            "probability": 8.92462354611197e-05,
            "start_logit": 1.3571152687072754,
            "end_logit": 0.7628147602081299,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        }
    ],
    "54d8d60d014675820d000007": [
        {
            "text": "vemurafenib or dabrafenib",
            "probability": 0.2541426025023039,
            "start_logit": 5.59605598449707,
            "end_logit": 5.693042755126953,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "vemurafenib",
            "probability": 0.22600914790790635,
            "start_logit": 5.59605598449707,
            "end_logit": 5.575722694396973,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "dabrafenib",
            "probability": 0.2207998661888726,
            "start_logit": 5.455417156219482,
            "end_logit": 5.693042755126953,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "vemurafenib and the MEK inhibitor cobimetinib. METHODS: All patients treated with the BRAF inhibitors vemurafenib",
            "probability": 0.10681145610596356,
            "start_logit": 4.846545696258545,
            "end_logit": 5.575722694396973,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Dabrafenib",
            "probability": 0.053548884679228734,
            "start_logit": 4.934858322143555,
            "end_logit": 4.796939849853516,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "cobimetinib. METHODS: All patients treated with the BRAF inhibitors vemurafenib or dabrafenib",
            "probability": 0.0525222458808726,
            "start_logit": 4.019397258758545,
            "end_logit": 5.693042755126953,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "cobimetinib. METHODS: All patients treated with the BRAF inhibitors vemurafenib",
            "probability": 0.04670806043877648,
            "start_logit": 4.019397258758545,
            "end_logit": 5.575722694396973,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "vemurafenib and the MEK inhibitor cobimetinib",
            "probability": 0.017628181187199474,
            "start_logit": 4.846545696258545,
            "end_logit": 3.774156332015991,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Dabrafenib) and MEK inhibition (Trametinib",
            "probability": 0.009093853827963967,
            "start_logit": 4.934858322143555,
            "end_logit": 3.0239436626434326,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "cobimetinib",
            "probability": 0.0077087063722881335,
            "start_logit": 4.019397258758545,
            "end_logit": 3.774156332015991,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "vemurafenib and MEK inhibition with cobimetinib",
            "probability": 0.0036875841882754966,
            "start_logit": 3.9983417987823486,
            "end_logit": 3.057832956314087,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Trametinib",
            "probability": 0.0010788286343618107,
            "start_logit": 2.803135395050049,
            "end_logit": 3.0239436626434326,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "ib or dabrafenib",
            "probability": 4.410902833288917e-05,
            "start_logit": -3.0629303455352783,
            "end_logit": 5.693042755126953,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "ib",
            "probability": 3.922618172005068e-05,
            "start_logit": -3.0629303455352783,
            "end_logit": 5.575722694396973,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "ve",
            "probability": 3.8305286708017564e-05,
            "start_logit": 5.59605598449707,
            "end_logit": -3.107020139694214,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Dabrafenib)",
            "probability": 3.6457912174440216e-05,
            "start_logit": 4.934858322143555,
            "end_logit": -2.4952518939971924,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "(Dabrafenib",
            "probability": 3.512310266529736e-05,
            "start_logit": -2.3946328163146973,
            "end_logit": 4.796939849853516,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "ib and the MEK inhibitor cobimetinib. METHODS: All patients treated with the BRAF inhibitors vemurafenib",
            "probability": 2.6119251881591182e-05,
            "start_logit": -3.469602108001709,
            "end_logit": 5.575722694396973,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "vemurafenib or da",
            "probability": 2.1079172843582203e-05,
            "start_logit": 5.59605598449707,
            "end_logit": -3.704322576522827,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "b. METHODS: All patients treated with the BRAF inhibitors vemurafenib or dabrafenib",
            "probability": 2.0162149661255263e-05,
            "start_logit": -3.845787763595581,
            "end_logit": 5.693042755126953,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        }
    ],
    "531375a6e3eabad021000011": [
        {
            "text": "J wave",
            "probability": 0.6719330662278551,
            "start_logit": 5.064683437347412,
            "end_logit": 4.6729655265808105,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "J wave is associated with increased risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy.The J wave",
            "probability": 0.20318790969791728,
            "start_logit": 5.064683437347412,
            "end_logit": 3.476938009262085,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "J wave is associated with increased risk of sudden cardiac arrest",
            "probability": 0.0597153195655459,
            "start_logit": 5.064683437347412,
            "end_logit": 2.2523953914642334,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "J",
            "probability": 0.02316693710508856,
            "start_logit": 5.064683437347412,
            "end_logit": 1.3055329322814941,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "J wave is associated with increased risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy.The J",
            "probability": 0.008554016533144974,
            "start_logit": 5.064683437347412,
            "end_logit": 0.3092077374458313,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "J wave is associated with increased risk",
            "probability": 0.006403840376817304,
            "start_logit": 5.064683437347412,
            "end_logit": 0.01970466412603855,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "J wave may be a risk factor for SCA",
            "probability": 0.004862704571351902,
            "start_logit": 3.8036320209503174,
            "end_logit": 1.0054529905319214,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "late gadolinium enhancement (LGE). J wave",
            "probability": 0.004656035276679539,
            "start_logit": 0.09268899261951447,
            "end_logit": 4.6729655265808105,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "J wave is associated with increased risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy.",
            "probability": 0.0046008500420544485,
            "start_logit": 5.064683437347412,
            "end_logit": -0.3109521269798279,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "sudden cardiac arrest in patients with hypertrophic cardiomyopathy.The J wave",
            "probability": 0.003961022622622781,
            "start_logit": 1.1270544528961182,
            "end_logit": 3.476938009262085,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "The J wave",
            "probability": 0.002270724245414824,
            "start_logit": 0.5706510543823242,
            "end_logit": 3.476938009262085,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial replacement fibrosis",
            "probability": 0.0012857561893542086,
            "start_logit": 2.156519651412964,
            "end_logit": 1.3223176002502441,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "arrest in patients with hypertrophic cardiomyopathy.The J wave",
            "probability": 0.0011971284241469287,
            "start_logit": -0.06952206790447235,
            "end_logit": 3.476938009262085,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "sudden cardiac arrest",
            "probability": 0.0011641132194722343,
            "start_logit": 1.1270544528961182,
            "end_logit": 2.2523953914642334,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "gadolinium enhancement (LGE). J wave",
            "probability": 0.000830892101278853,
            "start_logit": -1.6307306289672852,
            "end_logit": 4.6729655265808105,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "J wave may be a risk factor for SCA in patients with HCM.Extreme left ventricular hypertrophy",
            "probability": 0.0007159809898674265,
            "start_logit": 3.8036320209503174,
            "end_logit": -0.9102434515953064,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "late gadolinium enhancement (LGE). J wave is associated with increased risk of sudden cardiac arrest",
            "probability": 0.0004137862064390359,
            "start_logit": 0.09268899261951447,
            "end_logit": 2.2523953914642334,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "SCA",
            "probability": 0.00036971932705515527,
            "start_logit": 1.227026104927063,
            "end_logit": 1.0054529905319214,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "cardiac arrest in patients with hypertrophic cardiomyopathy.The J wave",
            "probability": 0.00035837070260576935,
            "start_logit": -1.2756351232528687,
            "end_logit": 3.476938009262085,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "arrest",
            "probability": 0.00035182657528793395,
            "start_logit": -0.06952206790447235,
            "end_logit": 2.2523953914642334,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        }
    ],
    "56d1e23c67f0cb3d66000009": [
        {
            "text": "TAZ",
            "probability": 0.82461433064159,
            "start_logit": 5.301585674285889,
            "end_logit": 4.6585612297058105,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ;YAP and TAZ",
            "probability": 0.16921217345535505,
            "start_logit": 5.301585674285889,
            "end_logit": 3.074798822402954,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ;",
            "probability": 0.002378963605778453,
            "start_logit": 5.301585674285889,
            "end_logit": -1.1896896362304688,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ;YAP and TAZ are transcription coactivators and effectors of the Hippo",
            "probability": 0.000710139103323348,
            "start_logit": 5.301585674285889,
            "end_logit": -2.398648977279663,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ;YAP and TAZ are transcription coactivators and effectors of the Hippo pathway,",
            "probability": 0.0007097641798915668,
            "start_logit": 5.301585674285889,
            "end_logit": -2.399177074432373,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Taz",
            "probability": 0.0005886022072736213,
            "start_logit": 2.2302517890930176,
            "end_logit": 0.48497462272644043,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ;YAP and TAZ are transcription coactivators and effectors of the Hippo pathway",
            "probability": 0.00027609641640450645,
            "start_logit": 5.301585674285889,
            "end_logit": -3.3433597087860107,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ;YAP",
            "probability": 0.00024004383684469912,
            "start_logit": 5.301585674285889,
            "end_logit": -3.483288288116455,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ-TEAD",
            "probability": 0.00021526381644327794,
            "start_logit": 2.1359524726867676,
            "end_logit": -0.42661231756210327,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ;YAP and TAZ are transcription coactivators",
            "probability": 0.00021110198631870263,
            "start_logit": 5.301585674285889,
            "end_logit": -3.6117684841156006,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TA",
            "probability": 0.00020513145674704538,
            "start_logit": 5.301585674285889,
            "end_logit": -3.640458822250366,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ are transcription coactivators and effectors of the Hippo",
            "probability": 0.0001624173700533357,
            "start_logit": 3.826294183731079,
            "end_logit": -2.398648977279663,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ are transcription coactivators and effectors of the Hippo pathway,",
            "probability": 0.00016233162054668792,
            "start_logit": 3.826294183731079,
            "end_logit": -2.399177074432373,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Z",
            "probability": 9.417143069434773e-05,
            "start_logit": -3.775968551635742,
            "end_logit": 4.6585612297058105,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ are transcription coactivators and effectors of the Hippo pathway",
            "probability": 6.31465773729577e-05,
            "start_logit": 3.826294183731079,
            "end_logit": -3.3433597087860107,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ are transcription coactivators",
            "probability": 4.8281568034294244e-05,
            "start_logit": 3.826294183731079,
            "end_logit": -3.6117684841156006,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Taz, which bind to and activate Teads",
            "probability": 4.1451347726134995e-05,
            "start_logit": 2.2302517890930176,
            "end_logit": -2.168255567550659,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Taz,",
            "probability": 3.076194282559031e-05,
            "start_logit": 2.2302517890930176,
            "end_logit": -2.4664976596832275,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Z;YAP and TAZ",
            "probability": 1.932412750187442e-05,
            "start_logit": -3.775968551635742,
            "end_logit": 3.074798822402954,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Taz, which bind to and activate Teads.TEADs",
            "probability": 1.6503309274690877e-05,
            "start_logit": 2.2302517890930176,
            "end_logit": -3.089215040206909,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        }
    ],
    "531b3ff3b166e2b80600003d": [
        {
            "text": "aPKC",
            "probability": 0.4062512193798215,
            "start_logit": 5.694459915161133,
            "end_logit": 5.032318115234375,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "Par6 and aPKC",
            "probability": 0.3490970335480266,
            "start_logit": 5.542838096618652,
            "end_logit": 5.032318115234375,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "Par6",
            "probability": 0.23751164413229459,
            "start_logit": 5.542838096618652,
            "end_logit": 4.6471848487854,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "Par6Recently, we found that aPKC",
            "probability": 0.0014103671138064801,
            "start_logit": 2.9028966426849365,
            "end_logit": 2.160759687423706,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "polarity proteins Par6 and aPKC",
            "probability": 0.0009303518398237629,
            "start_logit": -0.38470426201820374,
            "end_logit": 5.032318115234375,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "Par6Recently, we found that aPKC can also phosphorylate Par6",
            "probability": 0.0009125349670470569,
            "start_logit": 2.9028966426849365,
            "end_logit": 1.725380778312683,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "polarity proteins Par6",
            "probability": 0.0006329741414650192,
            "start_logit": -0.38470426201820374,
            "end_logit": 4.6471848487854,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "aPKC can also phosphorylate Par6",
            "probability": 0.0006027981524854829,
            "start_logit": 2.488252639770508,
            "end_logit": 1.725380778312683,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "ZEB1",
            "probability": 0.00035486896484348434,
            "start_logit": 2.133577346801758,
            "end_logit": 1.5502222776412964,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "SIRT1",
            "probability": 0.0003482485749788054,
            "start_logit": 2.074129581451416,
            "end_logit": 1.5908379554748535,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "SIRT1 regulates EMT in prostate cancer cells through cooperation with the EMT inducing transcription factor ZEB1",
            "probability": 0.0003343876146079936,
            "start_logit": 2.074129581451416,
            "end_logit": 1.5502222776412964,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "Par",
            "probability": 0.0003329279897406033,
            "start_logit": 5.542838096618652,
            "end_logit": -1.922860860824585,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "aPKC regulate cell polarization",
            "probability": 0.00028608675463401875,
            "start_logit": 5.694459915161133,
            "end_logit": -2.226113796234131,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "Par6 and aPKC regulate cell polarization",
            "probability": 0.0002458381233478674,
            "start_logit": 5.542838096618652,
            "end_logit": -2.226113796234131,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "PKC",
            "probability": 0.00021794805664669166,
            "start_logit": -1.8360103368759155,
            "end_logit": 5.032318115234375,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "conserved polarity proteins Par6 and aPKC",
            "probability": 0.00016175367158776302,
            "start_logit": -2.13419246673584,
            "end_logit": 5.032318115234375,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "conserved polarity proteins Par6",
            "probability": 0.00011005072169414312,
            "start_logit": -2.13419246673584,
            "end_logit": 4.6471848487854,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "ZEB",
            "probability": 8.877949141138456e-05,
            "start_logit": 2.133577346801758,
            "end_logit": 0.16462934017181396,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "aPKC regulate cell polarization processes",
            "probability": 8.653120067012573e-05,
            "start_logit": 5.694459915161133,
            "end_logit": -3.4219038486480713,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "SIRT1 regulates EMT in prostate cancer cells through cooperation with the EMT inducing transcription factor ZEB",
            "probability": 8.365556106676488e-05,
            "start_logit": 2.074129581451416,
            "end_logit": 0.16462934017181396,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        }
    ],
    "5314c7afdae131f84700000a": [
        {
            "text": "hyperhidrosis",
            "probability": 0.22953154974527287,
            "start_logit": 3.817667007446289,
            "end_logit": 4.062869548797607,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "hyperhidrosis and congenital agenesis of the corpus callosum",
            "probability": 0.16527063267957687,
            "start_logit": 3.817667007446289,
            "end_logit": 3.7344133853912354,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "congenital agenesis of the corpus callosum",
            "probability": 0.13262987647869592,
            "start_logit": 3.5976450443267822,
            "end_logit": 3.7344133853912354,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "hypothermia, hyperhidrosis",
            "probability": 0.06326937615751539,
            "start_logit": 2.5290279388427734,
            "end_logit": 4.062869548797607,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "periodic hypothermia and hyperhidrosis",
            "probability": 0.05366790322375855,
            "start_logit": 2.8698201179504395,
            "end_logit": 3.5574910640716553,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "hypothermia, hyperhidrosis and congenital agenesis of the corpus callosum",
            "probability": 0.045556133082354414,
            "start_logit": 2.5290279388427734,
            "end_logit": 3.7344133853912354,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "hyperhidrosis along with agenesis of the corpus callosum",
            "probability": 0.04357459226306403,
            "start_logit": 3.140061140060425,
            "end_logit": 3.078909158706665,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "agenesis of the corpus callosum",
            "probability": 0.0434895790641287,
            "start_logit": 2.4826040267944336,
            "end_logit": 3.7344133853912354,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "recurrent hypothermia, hyperhidrosis",
            "probability": 0.035441868021762815,
            "start_logit": 1.9495203495025635,
            "end_logit": 4.062869548797607,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "hypothermia",
            "probability": 0.03521952220461601,
            "start_logit": 2.5290279388427734,
            "end_logit": 3.4770686626434326,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "periodic hypothermia and hyperhidrosis along with agenesis of the corpus callosum",
            "probability": 0.03325593382634825,
            "start_logit": 2.8698201179504395,
            "end_logit": 3.078909158706665,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "periodic hypothermia",
            "probability": 0.03210083923360513,
            "start_logit": 2.8698201179504395,
            "end_logit": 3.043558120727539,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "recurrent hypothermia, hyperhidrosis and congenital agenesis of the corpus callosum",
            "probability": 0.025519367415082064,
            "start_logit": 1.9495203495025635,
            "end_logit": 3.7344133853912354,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "recurrent hypothermia",
            "probability": 0.019729065364227936,
            "start_logit": 1.9495203495025635,
            "end_logit": 3.4770686626434326,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "hyperhidrosis and congenital agenesis",
            "probability": 0.009774549597713929,
            "start_logit": 3.817667007446289,
            "end_logit": 0.9066110849380493,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "corpus callosum",
            "probability": 0.008985429269945153,
            "start_logit": 0.9056869745254517,
            "end_logit": 3.7344133853912354,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "congenital agenesis",
            "probability": 0.007844087511258653,
            "start_logit": 3.5976450443267822,
            "end_logit": 0.9066110849380493,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "hypothermia and hyperhidrosis",
            "probability": 0.005809593180046253,
            "start_logit": 0.6465155482292175,
            "end_logit": 3.5574910640716553,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "triad of recurrent hypothermia, hyperhidrosis",
            "probability": 0.004976352221781652,
            "start_logit": -0.013676347211003304,
            "end_logit": 4.062869548797607,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "hyperhidrosis along with agenesis",
            "probability": 0.004353749459245307,
            "start_logit": 3.140061140060425,
            "end_logit": 0.7754723429679871,
            "question_text": "List common features of Shapiro syndrome"
        }
    ],
    "52f5417b2059c6d71c000024": [
        {
            "text": "C58/J",
            "probability": 0.41816359343184695,
            "start_logit": 4.565306186676025,
            "end_logit": 4.333348274230957,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J mouse strain, a model of ASD core symptoms. the C58/J",
            "probability": 0.17442864428002977,
            "start_logit": 4.565306186676025,
            "end_logit": 3.458991289138794,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR T+tf/J (BTBR)",
            "probability": 0.07524297997670497,
            "start_logit": 3.6162667274475098,
            "end_logit": 3.567237615585327,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J mouse model of autismBoth C58/J",
            "probability": 0.05638324244696187,
            "start_logit": 3.764038562774658,
            "end_logit": 3.1309151649475098,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR T+tf/J",
            "probability": 0.056129182805968895,
            "start_logit": 3.6162667274475098,
            "end_logit": 3.2741708755493164,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J mouse strain",
            "probability": 0.04984924185300306,
            "start_logit": 4.565306186676025,
            "end_logit": 2.2064788341522217,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR), a model of ASD with cognitive deficits,C58/J",
            "probability": 0.03830179020740249,
            "start_logit": 2.1749300956726074,
            "end_logit": 4.333348274230957,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR",
            "probability": 0.01932441007723736,
            "start_logit": 3.6162667274475098,
            "end_logit": 2.2078840732574463,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR)",
            "probability": 0.017803338184255914,
            "start_logit": 2.1749300956726074,
            "end_logit": 3.567237615585327,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J mouse",
            "probability": 0.016468317138386954,
            "start_logit": 4.565306186676025,
            "end_logit": 1.0989139080047607,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J mouse strain, a model of ASD core symptoms. the C58/J mouse",
            "probability": 0.016071605821175512,
            "start_logit": 4.565306186676025,
            "end_logit": 1.0745296478271484,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR T+tf/J (BTBR",
            "probability": 0.01438370548064697,
            "start_logit": 3.6162667274475098,
            "end_logit": 1.9126110076904297,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J mouse model of autismBoth C58/J and Grin1 knockdown mice",
            "probability": 0.012924355214756973,
            "start_logit": 3.764038562774658,
            "end_logit": 1.6578567028045654,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J mouse strain, a model of ASD core symptoms. the C58/J mouse model",
            "probability": 0.00814804015385883,
            "start_logit": 4.565306186676025,
            "end_logit": 0.3952529728412628,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J and Grin1 knockdown mice",
            "probability": 0.006688950161809983,
            "start_logit": 3.105381965637207,
            "end_logit": 1.6578567028045654,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "tf/J (BTBR), a model of ASD with cognitive deficits,C58/J",
            "probability": 0.005288157413383476,
            "start_logit": 0.19490332901477814,
            "end_logit": 4.333348274230957,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR), a model of ASD with cognitive deficits,C58/J mouse strain",
            "probability": 0.004565952735823174,
            "start_logit": 2.1749300956726074,
            "end_logit": 2.2064788341522217,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J mouse model",
            "probability": 0.0036565124203667833,
            "start_logit": 3.764038562774658,
            "end_logit": 0.3952529728412628,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "C58/J mouse strain,",
            "probability": 0.0033208205717876076,
            "start_logit": 4.565306186676025,
            "end_logit": -0.5023125410079956,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "T+tf/J (BTBR), a model of ASD with cognitive deficits,C58/J",
            "probability": 0.002857159624592636,
            "start_logit": -0.42073854804039,
            "end_logit": 4.333348274230957,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        }
    ],
    "5717ab7ccb4ef8864c00000c": [
        {
            "text": "stress granule formation",
            "probability": 0.8206132169566079,
            "start_logit": 5.495344638824463,
            "end_logit": 5.521958351135254,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "stress granule formationG3BP1, G3BP2 and CAPRIN1 are required for translation of interferon",
            "probability": 0.07075532962252314,
            "start_logit": 5.495344638824463,
            "end_logit": 3.071134328842163,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "stress granule",
            "probability": 0.028461996546687685,
            "start_logit": 5.495344638824463,
            "end_logit": 2.1604762077331543,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "interferon",
            "probability": 0.01907976857879174,
            "start_logit": 4.1847453117370605,
            "end_logit": 3.071134328842163,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "interferon stimulated mRNAs",
            "probability": 0.016377783119444857,
            "start_logit": 4.1847453117370605,
            "end_logit": 2.918431520462036,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "translation of interferon",
            "probability": 0.007927036297009152,
            "start_logit": 3.306396007537842,
            "end_logit": 3.071134328842163,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "stress granule formationG3BP1, G3BP2 and CAPRIN1 are required for translation",
            "probability": 0.0075485775216865515,
            "start_logit": 5.495344638824463,
            "end_logit": 0.8332656025886536,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "translation of interferon stimulated mRNAs",
            "probability": 0.006804447376615124,
            "start_logit": 3.306396007537842,
            "end_logit": 2.918431520462036,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "formation",
            "probability": 0.006709117410724965,
            "start_logit": 0.6887601613998413,
            "end_logit": 5.521958351135254,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "granule formation",
            "probability": 0.005680332082528994,
            "start_logit": 0.5223024487495422,
            "end_logit": 5.521958351135254,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "contribute to stress granule formation",
            "probability": 0.005020029134561286,
            "start_logit": 0.39872848987579346,
            "end_logit": 5.521958351135254,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "to stress granule formation",
            "probability": 0.0011749928089265442,
            "start_logit": -1.0534452199935913,
            "end_logit": 5.521958351135254,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "translation",
            "probability": 0.0008457009291657491,
            "start_logit": 3.306396007537842,
            "end_logit": 0.8332656025886536,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "formationG3BP1, G3BP2 and CAPRIN1 are required for translation of interferon",
            "probability": 0.0005784769292805032,
            "start_logit": 0.6887601613998413,
            "end_logit": 3.071134328842163,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "formationG3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs",
            "probability": 0.0004965557966929224,
            "start_logit": 0.6887601613998413,
            "end_logit": 2.918431520462036,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "granule formationG3BP1, G3BP2 and CAPRIN1 are required for translation of interferon",
            "probability": 0.0004897724781417755,
            "start_logit": 0.5223024487495422,
            "end_logit": 3.071134328842163,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "contribute to stress granule formationG3BP1, G3BP2 and CAPRIN1 are required for translation of interferon",
            "probability": 0.0004328395019615377,
            "start_logit": 0.39872848987579346,
            "end_logit": 3.071134328842163,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "stress granule formationG3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated",
            "probability": 0.00036481790631971364,
            "start_logit": 5.495344638824463,
            "end_logit": -2.1964504718780518,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "stress",
            "probability": 0.0003393993847343743,
            "start_logit": 5.495344638824463,
            "end_logit": -2.2686712741851807,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "G3BP2 contribute to stress granule formation",
            "probability": 0.000299809617595709,
            "start_logit": -2.4193148612976074,
            "end_logit": 5.521958351135254,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        }
    ],
    "56c6dc6f5795f9a73e000007": [
        {
            "text": "H3K79me3",
            "probability": 0.24112139001381588,
            "start_logit": 3.774066925048828,
            "end_logit": 3.4339540004730225,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K9me3, and H3K79me3",
            "probability": 0.203119083622148,
            "start_logit": 3.6025588512420654,
            "end_logit": 3.4339540004730225,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K9me3",
            "probability": 0.18194354526269307,
            "start_logit": 3.6025588512420654,
            "end_logit": 3.3238580226898193,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K36me3",
            "probability": 0.08962527574778344,
            "start_logit": 3.2393369674682617,
            "end_logit": 2.979020833969116,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K79me3. Strikingly, we found that trimethylated histone H3 at lysine 36",
            "probability": 0.0587000222663864,
            "start_logit": 3.774066925048828,
            "end_logit": 2.0210936069488525,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "trimethylated histone H3 at lysine 36 (H3K36me3",
            "probability": 0.045006117134705044,
            "start_logit": 3.1299548149108887,
            "end_logit": 2.399564027786255,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H4K20me3, H3K9me3, and H3K79me3",
            "probability": 0.032338330513657386,
            "start_logit": 2.6810317039489746,
            "end_logit": 2.517941951751709,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "trimethylated histone H3 at lysine 36",
            "probability": 0.030825060015432806,
            "start_logit": 3.1299548149108887,
            "end_logit": 2.0210936069488525,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H4K20me3, H3K9me3",
            "probability": 0.028781129607926385,
            "start_logit": 2.6810317039489746,
            "end_logit": 2.4014086723327637,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K9me2",
            "probability": 0.0210031829995809,
            "start_logit": 2.878359794616699,
            "end_logit": 1.889034628868103,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H4K20me3",
            "probability": 0.019145429066331494,
            "start_logit": 2.6810317039489746,
            "end_logit": 1.9937527179718018,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "trimethylated histone H3 at lysine 36 (H3K36me3)",
            "probability": 0.013272304422937146,
            "start_logit": 3.1299548149108887,
            "end_logit": 1.1784451007843018,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K36me3)",
            "probability": 0.008260549923959793,
            "start_logit": 2.655766487121582,
            "end_logit": 1.1784451007843018,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "trimethylation at lysine 36",
            "probability": 0.007031514379772762,
            "start_logit": 1.5087636709213257,
            "end_logit": 2.1643588542938232,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3 trimethylation at lysine 36",
            "probability": 0.006951497151817727,
            "start_logit": 1.4973186254501343,
            "end_logit": 2.1643588542938232,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K79me3. Strikingly, we found that trimethylated histone H3",
            "probability": 0.003663499500482977,
            "start_logit": 3.774066925048828,
            "end_logit": -0.7529276609420776,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K9me3, and H3K79me3. Strikingly, we found that trimethylated histone H3",
            "probability": 0.003086108044357499,
            "start_logit": 3.6025588512420654,
            "end_logit": -0.7529276609420776,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "histone H3 at lysine 36 (H3K36me3",
            "probability": 0.0021154468076696542,
            "start_logit": 0.07242244482040405,
            "end_logit": 2.399564027786255,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "trimethylation",
            "probability": 0.002016731761408366,
            "start_logit": 1.5087636709213257,
            "end_logit": 0.9154350161552429,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3 trimethylation",
            "probability": 0.001993781757133186,
            "start_logit": 1.4973186254501343,
            "end_logit": 0.9154350161552429,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        }
    ],
    "56f5692f09dd18d46b00000a": [
        {
            "text": "TREX1",
            "probability": 0.08464154448625165,
            "start_logit": 3.42409086227417,
            "end_logit": 3.059924364089966,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2B, RNASEH2C, SAMHD1",
            "probability": 0.07495477320086544,
            "start_logit": 3.6028835773468018,
            "end_logit": 2.7595913410186768,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2B",
            "probability": 0.07009831969726055,
            "start_logit": 3.6028835773468018,
            "end_logit": 2.6926052570343018,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2C, SAMHD1",
            "probability": 0.06709193875449176,
            "start_logit": 3.492062568664551,
            "end_logit": 2.7595913410186768,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1",
            "probability": 0.06340858274989472,
            "start_logit": 3.4355978965759277,
            "end_logit": 2.7595913410186768,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1",
            "probability": 0.06268311998062176,
            "start_logit": 3.42409086227417,
            "end_logit": 2.7595913410186768,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2A, RNASEH2B",
            "probability": 0.05930022752841843,
            "start_logit": 3.4355978965759277,
            "end_logit": 2.6926052570343018,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2A, RNASEH2B",
            "probability": 0.058621768786469096,
            "start_logit": 3.42409086227417,
            "end_logit": 2.6926052570343018,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2B, RNASEH2C",
            "probability": 0.05675311287761558,
            "start_logit": 3.6028835773468018,
            "end_logit": 2.481416940689087,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2A",
            "probability": 0.0547138214518775,
            "start_logit": 3.4355978965759277,
            "end_logit": 2.6121084690093994,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2A",
            "probability": 0.05408783615609272,
            "start_logit": 3.42409086227417,
            "end_logit": 2.6121084690093994,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2C",
            "probability": 0.050799651719415494,
            "start_logit": 3.492062568664551,
            "end_logit": 2.481416940689087,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "SAMHD1",
            "probability": 0.049119355709308414,
            "start_logit": 3.2155585289001465,
            "end_logit": 2.7242846488952637,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2A, RNASEH2B, RNASEH2C",
            "probability": 0.04801074435340767,
            "start_logit": 3.4355978965759277,
            "end_logit": 2.481416940689087,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2A, RNASEH2B, RNASEH2C",
            "probability": 0.04746144950966607,
            "start_logit": 3.42409086227417,
            "end_logit": 2.481416940689087,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2B, RNASEH2C, SAMHD1, and ADAR",
            "probability": 0.0247364055093454,
            "start_logit": 3.6028835773468018,
            "end_logit": 1.6509824991226196,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2C, SAMHD1, and ADAR",
            "probability": 0.022141530586608615,
            "start_logit": 3.492062568664551,
            "end_logit": 1.6509824991226196,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR",
            "probability": 0.020925957730149856,
            "start_logit": 3.4355978965759277,
            "end_logit": 1.6509824991226196,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "ADAR",
            "probability": 0.016395542521824798,
            "start_logit": 3.191617012023926,
            "end_logit": 1.6509824991226196,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "SAMHD1, and ADAR",
            "probability": 0.014054316690414265,
            "start_logit": 3.037537097930908,
            "end_logit": 1.6509824991226196,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        }
    ],
    "530a3e18970c65fa6b000005": [
        {
            "text": "Chromobacterium) and the Firmicutes dominated the biostimulated aquifer community.Shewanella oneidensis",
            "probability": 0.12246700088357648,
            "start_logit": 1.2278631925582886,
            "end_logit": 2.2790801525115967,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Shewanella oneidensis",
            "probability": 0.10814332691220724,
            "start_logit": 1.103479027748108,
            "end_logit": 2.2790801525115967,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Rhodoferax, Polaromonas, Delftia, Chromobacterium) and the Firmicutes",
            "probability": 0.08582318386678463,
            "start_logit": 1.2987033128738403,
            "end_logit": 1.8526875972747803,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Chromobacterium) and the Firmicutes",
            "probability": 0.07995380720061941,
            "start_logit": 1.2278631925582886,
            "end_logit": 1.8526875972747803,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Firmicutes dominated the biostimulated aquifer community.Shewanella oneidensis",
            "probability": 0.07236852270600269,
            "start_logit": 0.7017930150032043,
            "end_logit": 2.2790801525115967,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Delftia, Chromobacterium) and the Firmicutes",
            "probability": 0.0499147316895797,
            "start_logit": 0.756730318069458,
            "end_logit": 1.8526875972747803,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Firmicutes",
            "probability": 0.04724651432698995,
            "start_logit": 0.7017930150032043,
            "end_logit": 1.8526875972747803,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Dechloromonas, Ralstonia",
            "probability": 0.04720784523359585,
            "start_logit": 0.9721179008483887,
            "end_logit": 1.5815439224243164,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Ralstonia",
            "probability": 0.04504644872268152,
            "start_logit": 0.9252519607543945,
            "end_logit": 1.5815439224243164,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Rhodoferax, Polaromonas",
            "probability": 0.04265378289190735,
            "start_logit": 1.2987033128738403,
            "end_logit": 1.1535143852233887,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Rhodoferax, Polaromonas, Delftia",
            "probability": 0.03976493045692894,
            "start_logit": 1.2987033128738403,
            "end_logit": 1.0833837985992432,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Bacillus. Members of the genera Paenibacillus",
            "probability": 0.03535137381673742,
            "start_logit": 1.3847192525863647,
            "end_logit": 0.8797197341918945,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Dechloromonas, Ralstonia, Rhodoferax, Polaromonas",
            "probability": 0.03076970352697153,
            "start_logit": 0.9721179008483887,
            "end_logit": 1.1535143852233887,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Ralstonia, Rhodoferax, Polaromonas",
            "probability": 0.029360922221322455,
            "start_logit": 0.9252519607543945,
            "end_logit": 1.1535143852233887,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Polaromonas, Delftia, Chromobacterium) and the Firmicutes",
            "probability": 0.02910776430649111,
            "start_logit": 0.2174190878868103,
            "end_logit": 1.8526875972747803,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Dechloromonas, Ralstonia, Rhodoferax, Polaromonas, Delftia",
            "probability": 0.028685735190969144,
            "start_logit": 0.9721179008483887,
            "end_logit": 1.0833837985992432,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Ralstonia, Rhodoferax, Polaromonas, Delftia",
            "probability": 0.02737236772740507,
            "start_logit": 0.9252519607543945,
            "end_logit": 1.0833837985992432,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Bacillus",
            "probability": 0.026659665291430493,
            "start_logit": 1.3847192525863647,
            "end_logit": 0.5975342392921448,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Bacillus. Members of the genera Paenibacillus, Lysinibacillus",
            "probability": 0.026319313547792184,
            "start_logit": 1.3847192525863647,
            "end_logit": 0.5846855044364929,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Dechloromonas",
            "probability": 0.025783059480006802,
            "start_logit": 0.9721179008483887,
            "end_logit": 0.9767014980316162,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        }
    ],
    "570a922dcf1c325851000028": [
        {
            "text": "necroptosis",
            "probability": 0.20381081123112452,
            "start_logit": 4.951850891113281,
            "end_logit": 4.791582107543945,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis",
            "probability": 0.19247604581040445,
            "start_logit": 4.951850891113281,
            "end_logit": 4.73436164855957,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis",
            "probability": 0.1803678459648101,
            "start_logit": 4.886877536773682,
            "end_logit": 4.73436164855957,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis, and pro-survival",
            "probability": 0.05409842110325139,
            "start_logit": 4.951850891113281,
            "end_logit": 3.4651949405670166,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis, and pro-survival",
            "probability": 0.05069522102559332,
            "start_logit": 4.886877536773682,
            "end_logit": 3.4651949405670166,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pro-survival/inflammation NF-\u03baB activation. receptor-interacting protein-1 (RIP1)-mediated necroptosis",
            "probability": 0.04231303118953523,
            "start_logit": 3.880281686782837,
            "end_logit": 4.2910542488098145,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis, and pro-survival/inflammation",
            "probability": 0.03888026471702868,
            "start_logit": 4.951850891113281,
            "end_logit": 3.1348767280578613,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis, and pro-survival/inflammation",
            "probability": 0.03643440183959239,
            "start_logit": 4.886877536773682,
            "end_logit": 3.1348767280578613,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis, and pro-survival/inflammation NF-\u03baB activation",
            "probability": 0.029953784300057767,
            "start_logit": 4.951850891113281,
            "end_logit": 2.8740456104278564,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis, and pro-survival/inflammation NF-\u03baB activation",
            "probability": 0.028069464592065715,
            "start_logit": 4.886877536773682,
            "end_logit": 2.8740456104278564,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "NF-\u03baB activation. receptor-interacting protein-1 (RIP1)-mediated necroptosis",
            "probability": 0.02577459357478973,
            "start_logit": 3.384575843811035,
            "end_logit": 4.2910542488098145,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis, and pro-survival/inflammation NF-\u03baB",
            "probability": 0.023963586713901565,
            "start_logit": 4.951850891113281,
            "end_logit": 2.650925397872925,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis, and pro-survival/inflammation NF-\u03baB",
            "probability": 0.022456095764950113,
            "start_logit": 4.886877536773682,
            "end_logit": 2.650925397872925,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pro-survival",
            "probability": 0.01852712355225888,
            "start_logit": 3.880281686782837,
            "end_logit": 3.4651949405670166,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pro-survival/inflammation",
            "probability": 0.013315351048454695,
            "start_logit": 3.880281686782837,
            "end_logit": 3.1348767280578613,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pro-survival/inflammation NF-\u03baB activation",
            "probability": 0.010258293149178966,
            "start_logit": 3.880281686782837,
            "end_logit": 2.8740456104278564,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "inflammation NF-\u03baB activation. receptor-interacting protein-1 (RIP1)-mediated necroptosis",
            "probability": 0.009150980926294816,
            "start_logit": 2.3490476608276367,
            "end_logit": 4.2910542488098145,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pro-survival/inflammation NF-\u03baB",
            "probability": 0.008206826054245787,
            "start_logit": 3.880281686782837,
            "end_logit": 2.650925397872925,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "NF-\u03baB activation",
            "probability": 0.0062487448726322725,
            "start_logit": 3.384575843811035,
            "end_logit": 2.8740456104278564,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "NF-\u03baB",
            "probability": 0.004999112569829198,
            "start_logit": 3.384575843811035,
            "end_logit": 2.650925397872925,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        }
    ],
    "5173eb428ed59a060a000021": [
        {
            "text": "T-cell leukemia",
            "probability": 0.18317773622674885,
            "start_logit": 6.031962871551514,
            "end_logit": 5.946617603302002,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Multiple Sclerosis",
            "probability": 0.13391802160807656,
            "start_logit": 6.249958515167236,
            "end_logit": 5.415392875671387,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Multiple Sclerosis, CADASIL, Alagille Syndrome",
            "probability": 0.11166707300520008,
            "start_logit": 6.249958515167236,
            "end_logit": 5.233686923980713,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "T-cell leukemia and other cancers, Multiple Sclerosis",
            "probability": 0.10768735739919526,
            "start_logit": 6.031962871551514,
            "end_logit": 5.415392875671387,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "T-cell leukemia and other cancers, Multiple Sclerosis, CADASIL, Alagille Syndrome",
            "probability": 0.0897947255793971,
            "start_logit": 6.031962871551514,
            "end_logit": 5.233686923980713,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille Syndrome",
            "probability": 0.07035644838948422,
            "start_logit": 5.788011074066162,
            "end_logit": 5.233686923980713,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Multiple Sclerosis, CADASIL, Alagille Syndrome, Spondylocostal Dysostosis",
            "probability": 0.057750081274914156,
            "start_logit": 6.249958515167236,
            "end_logit": 4.574289798736572,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Multiple Sclerosis, CADASIL",
            "probability": 0.05547429470138151,
            "start_logit": 6.249958515167236,
            "end_logit": 4.534084796905518,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "T-cell leukemia and other cancers, Multiple Sclerosis, CADASIL",
            "probability": 0.04460848605917331,
            "start_logit": 6.031962871551514,
            "end_logit": 4.534084796905518,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille Syndrome, Spondylocostal Dysostosis",
            "probability": 0.03638575368155131,
            "start_logit": 5.788011074066162,
            "end_logit": 4.574289798736572,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "CADASIL, Alagille Syndrome",
            "probability": 0.033011651460611205,
            "start_logit": 5.031297206878662,
            "end_logit": 5.233686923980713,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Spondylocostal Dysostosis",
            "probability": 0.019386700333884475,
            "start_logit": 5.158421039581299,
            "end_logit": 4.574289798736572,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "CADASIL, Alagille Syndrome, Spondylocostal Dysostosis",
            "probability": 0.017072405531580986,
            "start_logit": 5.031297206878662,
            "end_logit": 4.574289798736572,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "CADASIL",
            "probability": 0.016399624637962507,
            "start_logit": 5.031297206878662,
            "end_logit": 4.534084796905518,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Multiple Sclerosis, CADASIL,",
            "probability": 0.005329628312534604,
            "start_logit": 6.249958515167236,
            "end_logit": 2.191446542739868,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "T-cell leukemia and other cancers, Multiple Sclerosis, CADASIL,",
            "probability": 0.0042857083908874735,
            "start_logit": 6.031962871551514,
            "end_logit": 2.191446542739868,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Multiple Sclerosis,",
            "probability": 0.003950791193769891,
            "start_logit": 6.249958515167236,
            "end_logit": 1.8920809030532837,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Multiple Sclerosis, CADASIL, Alagille Syndrome,",
            "probability": 0.0036397435333843566,
            "start_logit": 6.249958515167236,
            "end_logit": 1.8100782632827759,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "T-cell leukemia and other cancers, Multiple Sclerosis,",
            "probability": 0.003176945553588082,
            "start_logit": 6.031962871551514,
            "end_logit": 1.8920809030532837,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "T-cell leukemia and other cancers, Multiple Sclerosis, CADASIL, Alagille Syndrome,",
            "probability": 0.0029268231266741792,
            "start_logit": 6.031962871551514,
            "end_logit": 1.8100782632827759,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        }
    ],
    "51bdb644047fa84d1d000001": [
        {
            "text": "NDC1NDC1",
            "probability": 0.46224618176099536,
            "start_logit": 5.952773571014404,
            "end_logit": 5.2839155197143555,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "NDC1",
            "probability": 0.24463271068704276,
            "start_logit": 5.952773571014404,
            "end_logit": 4.647575855255127,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "Pom121",
            "probability": 0.09328995336313005,
            "start_logit": 5.114503383636475,
            "end_logit": 4.521800518035889,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "Pom121the transmembrane nucleoporin POM121",
            "probability": 0.0922174704430501,
            "start_logit": 5.114503383636475,
            "end_logit": 4.510237693786621,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "POM121",
            "probability": 0.07543979137224473,
            "start_logit": 4.913688659667969,
            "end_logit": 4.510237693786621,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "nucleoporin NDC1NDC1",
            "probability": 0.009285148098441713,
            "start_logit": 2.0450921058654785,
            "end_logit": 5.2839155197143555,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "Pom12",
            "probability": 0.005503647951415419,
            "start_logit": 5.114503383636475,
            "end_logit": 1.6914992332458496,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "nucleoporin NDC1",
            "probability": 0.004913942046636292,
            "start_logit": 2.0450921058654785,
            "end_logit": 4.647575855255127,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "NDC",
            "probability": 0.003753337095922774,
            "start_logit": 5.952773571014404,
            "end_logit": 0.47046324610710144,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "Pom",
            "probability": 0.0027508992087027675,
            "start_logit": 5.114503383636475,
            "end_logit": 0.9980159401893616,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "NDC1NDC",
            "probability": 0.0017270847636855408,
            "start_logit": 5.952773571014404,
            "end_logit": -0.30574721097946167,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "Pom121the transmembrane nucleoporin POM",
            "probability": 0.0014214820689260083,
            "start_logit": 5.114503383636475,
            "end_logit": 0.3377881348133087,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "POM",
            "probability": 0.0011628632861426166,
            "start_logit": 4.913688659667969,
            "end_logit": 0.3377881348133087,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "nucleoporin POM121",
            "probability": 0.0004814812548931036,
            "start_logit": -0.1405341923236847,
            "end_logit": 4.510237693786621,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "Pom121the transmembrane nucleoporin POM12",
            "probability": 0.0003896936908724389,
            "start_logit": 5.114503383636475,
            "end_logit": -0.9563061594963074,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "POM12",
            "probability": 0.0003187943737477827,
            "start_logit": 4.913688659667969,
            "end_logit": -0.9563061594963074,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "NDC1NDC1 is a transmembrane nucleoporin that is required for NPC",
            "probability": 0.0001948696442430971,
            "start_logit": 5.952773571014404,
            "end_logit": -2.4876065254211426,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "POM121 is critical for the incorporation of the Nup107/160",
            "probability": 0.00010539454437728425,
            "start_logit": 4.913688659667969,
            "end_logit": -2.0631415843963623,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "1NDC1",
            "probability": 8.986098983780135e-05,
            "start_logit": -2.592815399169922,
            "end_logit": 5.2839155197143555,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "nucleoporin NDC",
            "probability": 7.539335569252455e-05,
            "start_logit": 2.0450921058654785,
            "end_logit": 0.47046324610710144,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        }
    ],
    "534ab91eaeec6fbd07000012": [
        {
            "text": "hepaCAM",
            "probability": 0.314098561566987,
            "start_logit": 4.875833034515381,
            "end_logit": 4.172106742858887,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "APC",
            "probability": 0.1257537505314267,
            "start_logit": 4.346321105957031,
            "end_logit": 3.7862374782562256,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RAR\u03b2(2) and APC",
            "probability": 0.09834922471145821,
            "start_logit": 4.100520133972168,
            "end_logit": 3.7862374782562256,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hepaCAM gene expression when bladder cancer occurs.Methylated RAR\u03b2(2) and APC",
            "probability": 0.08855694216580554,
            "start_logit": 3.9956412315368652,
            "end_logit": 3.7862374782562256,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "APC.Thus, methylated RAR\u03b2(2) and APC",
            "probability": 0.0728898800571231,
            "start_logit": 4.0892205238342285,
            "end_logit": 3.497962236404419,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hepaCAM promoter is involved in absence of hepaCAM",
            "probability": 0.04971399882249399,
            "start_logit": 4.041296482086182,
            "end_logit": 3.1632230281829834,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RAR\u03b2(2)",
            "probability": 0.04455828344942793,
            "start_logit": 4.100520133972168,
            "end_logit": 2.9945108890533447,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hepaCAM promoter is involved in absence of hepaCAM gene expression when bladder cancer occurs.Methylated RAR\u03b2(2)",
            "probability": 0.041996001894367106,
            "start_logit": 4.041296482086182,
            "end_logit": 2.9945108890533447,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hepaCAM gene expression when bladder cancer occurs.Methylated RAR\u03b2(2)",
            "probability": 0.04012177362877407,
            "start_logit": 3.9956412315368652,
            "end_logit": 2.9945108890533447,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hepaCAM gene",
            "probability": 0.0400413487702332,
            "start_logit": 4.875833034515381,
            "end_logit": 2.1123125553131104,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RAR\u03b2(2) and 86 (67.2%) showed methylated APC",
            "probability": 0.039198568119549436,
            "start_logit": 3.492915630340576,
            "end_logit": 3.4739575386047363,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "APC.Thus, methylated RAR\u03b2(2)",
            "probability": 0.023997015855085072,
            "start_logit": 4.0892205238342285,
            "end_logit": 2.386941909790039,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RAR",
            "probability": 0.004160504386787409,
            "start_logit": 4.100520133972168,
            "end_logit": 0.623349130153656,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hepaCAM promoter is involved in absence of hepaCAM gene expression when bladder cancer occurs.Methylated RAR",
            "probability": 0.0039212585535830366,
            "start_logit": 4.041296482086182,
            "end_logit": 0.623349130153656,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hepaCAM gene expression when bladder cancer occurs.Methylated RAR",
            "probability": 0.003746257760976406,
            "start_logit": 3.9956412315368652,
            "end_logit": 0.623349130153656,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RAR\u03b2",
            "probability": 0.002099426202581964,
            "start_logit": 4.100520133972168,
            "end_logit": -0.06062311306595802,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hepaCAM promoter is involved in absence of hepaCAM gene expression when bladder cancer occurs.Methylated RAR\u03b2",
            "probability": 0.001978700702884641,
            "start_logit": 4.041296482086182,
            "end_logit": -0.06062311306595802,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hepaCAM gene expression when bladder cancer occurs.Methylated RAR\u03b2",
            "probability": 0.0018903938017700223,
            "start_logit": 3.9956412315368652,
            "end_logit": -0.06062311306595802,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "methylated RAR\u03b2(2) and APC",
            "probability": 0.0017153836928319975,
            "start_logit": 0.3399074971675873,
            "end_logit": 3.497962236404419,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "APC.Thus, methylated RAR",
            "probability": 0.0012127253258527766,
            "start_logit": 4.0892205238342285,
            "end_logit": -0.5981174111366272,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        }
    ],
    "51740da48ed59a060a000024": [
        {
            "text": "SCGPred",
            "probability": 0.5840593215505113,
            "start_logit": 3.583221912384033,
            "end_logit": 3.6106202602386475,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "WPSS method poses efficient results compared with the performance of many methods proposed in the literature.SCGPred",
            "probability": 0.33629160917972256,
            "start_logit": 3.031198024749756,
            "end_logit": 3.6106202602386475,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "WPSS",
            "probability": 0.06168041203907093,
            "start_logit": 3.031198024749756,
            "end_logit": 1.9146080017089844,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SCGPred, to improve the accuracy of prediction by combining multiple sources of evidence.Therefore, SCG-Pred",
            "probability": 0.0069617192098146525,
            "start_logit": 1.9850915670394897,
            "end_logit": 0.7791745066642761,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SCG-Pred",
            "probability": 0.003966111042048317,
            "start_logit": 1.422451138496399,
            "end_logit": 0.7791745066642761,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SCGPred: a score-based method for gene structure prediction",
            "probability": 0.0019626586395984063,
            "start_logit": 3.583221912384033,
            "end_logit": -2.0850822925567627,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SCGPred: a score-based method for gene structure prediction by combining multiple sources of evidence",
            "probability": 0.0008163551010504966,
            "start_logit": 3.583221912384033,
            "end_logit": -2.9622881412506104,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SCGPred: a score",
            "probability": 0.0006494853412649517,
            "start_logit": 3.583221912384033,
            "end_logit": -3.1909573078155518,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "WPSS method",
            "probability": 0.0005058986894507197,
            "start_logit": 3.031198024749756,
            "end_logit": -2.888777256011963,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SCGPred: a score-based method",
            "probability": 0.00047652528492925017,
            "start_logit": 3.583221912384033,
            "end_logit": -3.5006167888641357,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "S",
            "probability": 0.00043355537552457516,
            "start_logit": 3.583221912384033,
            "end_logit": -3.5951180458068848,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SCGPred,",
            "probability": 0.00038281854206651466,
            "start_logit": 1.9850915670394897,
            "end_logit": -2.121446132659912,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "WPSS method poses efficient results compared with the performance of many methods proposed in the literature.SCGPred: a score",
            "probability": 0.00037396281934649775,
            "start_logit": 3.031198024749756,
            "end_logit": -3.1909573078155518,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "WPSS method poses efficient results compared with the performance of many methods proposed in the literature.SCGPred: a score-based method",
            "probability": 0.00027437530567659004,
            "start_logit": 3.031198024749756,
            "end_logit": -3.5006167888641357,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "WPSS method poses efficient results compared with the performance of many methods proposed in the literature.S",
            "probability": 0.00024963394902527707,
            "start_logit": 3.031198024749756,
            "end_logit": -3.5951180458068848,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "red",
            "probability": 0.0002296527648687274,
            "start_logit": -4.257967472076416,
            "end_logit": 3.6106202602386475,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SCG",
            "probability": 0.0001947285226234122,
            "start_logit": 3.583221912384033,
            "end_logit": -4.395531177520752,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "CGPred",
            "probability": 0.00018754780531448723,
            "start_logit": -4.4605021476745605,
            "end_logit": 3.6106202602386475,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SC",
            "probability": 0.00016526103496742936,
            "start_logit": 3.583221912384033,
            "end_logit": -4.5596113204956055,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "W",
            "probability": 0.00013836780312491284,
            "start_logit": 3.031198024749756,
            "end_logit": -4.1851983070373535,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        }
    ],
    "51766e438ed59a060a000031": [
        {
            "text": "SECp43",
            "probability": 0.35102264868979277,
            "start_logit": 4.570175647735596,
            "end_logit": 4.3734450340271,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "tRNASec",
            "probability": 0.107020437680047,
            "start_logit": 4.1547698974609375,
            "end_logit": 3.601019859313965,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SECp43 and SLA",
            "probability": 0.10598358655683253,
            "start_logit": 4.570175647735596,
            "end_logit": 3.1758785247802734,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SBP2)Taken together, these data establish the role of SECp43",
            "probability": 0.09859241134736031,
            "start_logit": 3.300319194793701,
            "end_logit": 4.3734450340271,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "tRNASec, and protein factors including the SECIS binding protein 2 (SBP2",
            "probability": 0.08482061217405766,
            "start_logit": 4.1547698974609375,
            "end_logit": 3.3685386180877686,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SECIS binding protein 2 (SBP2)Taken together, these data establish the role of SECp43",
            "probability": 0.03838540687744514,
            "start_logit": 2.3570022583007812,
            "end_logit": 4.3734450340271,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SBP2",
            "probability": 0.03609260074018499,
            "start_logit": 3.300319194793701,
            "end_logit": 3.3685386180877686,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SLA",
            "probability": 0.035368078048504795,
            "start_logit": 3.472701072692871,
            "end_logit": 3.1758785247802734,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "tRNASec, and protein factors including the SECIS binding protein 2",
            "probability": 0.032044562049562256,
            "start_logit": 4.1547698974609375,
            "end_logit": 2.395127534866333,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SBP2)Taken together, these data establish the role of SECp43 and SLA",
            "probability": 0.029767815270273314,
            "start_logit": 3.300319194793701,
            "end_logit": 3.1758785247802734,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SECIS binding protein 2 (SBP2",
            "probability": 0.014052087232109997,
            "start_logit": 2.3570022583007812,
            "end_logit": 3.3685386180877686,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SPS1",
            "probability": 0.013848152499212498,
            "start_logit": 2.96004319190979,
            "end_logit": 2.7508785724639893,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SECIS binding protein 2 (SBP2)Taken together, these data establish the role of SECp43 and SLA",
            "probability": 0.011589631345725868,
            "start_logit": 2.3570022583007812,
            "end_logit": 3.1758785247802734,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "tRNASec, and protein factors including the SECIS binding protein 2 (SBP2)",
            "probability": 0.007926775047222964,
            "start_logit": 4.1547698974609375,
            "end_logit": 0.9982463121414185,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SPS1 (selenophosphate synthetase 1) and a second one, SPS2",
            "probability": 0.006887902359187366,
            "start_logit": 2.96004319190979,
            "end_logit": 2.0524933338165283,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SPS2, was identified as a selenoprotein in mammals.These in vivo studies indicate that SPS2",
            "probability": 0.00583782733235278,
            "start_logit": 2.700554609298706,
            "end_logit": 2.146574020385742,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "Sec insertion sequence (SECIS) element, tRNASec",
            "probability": 0.005655055039082995,
            "start_logit": 1.2142999172210693,
            "end_logit": 3.601019859313965,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SPS2",
            "probability": 0.005313644832509944,
            "start_logit": 2.700554609298706,
            "end_logit": 2.0524933338165283,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "SECIS binding protein 2",
            "probability": 0.005308768348796853,
            "start_logit": 2.3570022583007812,
            "end_logit": 2.395127534866333,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "Sec insertion sequence (SECIS) element, tRNASec, and protein factors including the SECIS binding protein 2 (SBP2",
            "probability": 0.004481996529737969,
            "start_logit": 1.2142999172210693,
            "end_logit": 3.3685386180877686,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        }
    ],
    "552435602c8b63434a000009": [
        {
            "text": "p16INK4A (P16",
            "probability": 0.23457441413035002,
            "start_logit": 5.816192150115967,
            "end_logit": 6.228377819061279,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "P16",
            "probability": 0.19815201792706902,
            "start_logit": 5.647453784942627,
            "end_logit": 6.228377819061279,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p16",
            "probability": 0.15732173918257744,
            "start_logit": 5.816192150115967,
            "end_logit": 5.828897953033447,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p16INK4A",
            "probability": 0.0963311368921933,
            "start_logit": 5.816192150115967,
            "end_logit": 5.3383965492248535,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p16INK4A (P16) and gankyrin",
            "probability": 0.07735885801296881,
            "start_logit": 5.816192150115967,
            "end_logit": 5.119060039520264,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "P16) and gankyrin",
            "probability": 0.06534733925109734,
            "start_logit": 5.647453784942627,
            "end_logit": 5.119060039520264,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "gankyrin bind to cyclin-dependent kinase 4 (CDK4) in similar fashion, only P16",
            "probability": 0.053930326838922786,
            "start_logit": 4.742552280426025,
            "end_logit": 5.831937789916992,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p16INK4A (P16)",
            "probability": 0.034378123236204025,
            "start_logit": 5.816192150115967,
            "end_logit": 4.308025360107422,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "P16)",
            "probability": 0.02904022809586511,
            "start_logit": 5.647453784942627,
            "end_logit": 4.308025360107422,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "gankyrin",
            "probability": 0.026438339735918234,
            "start_logit": 4.742552280426025,
            "end_logit": 5.119060039520264,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "(P16",
            "probability": 0.010306200339968976,
            "start_logit": 2.691164970397949,
            "end_logit": 6.228377819061279,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p18",
            "probability": 0.006047370963997971,
            "start_logit": 4.147583484649658,
            "end_logit": 4.238837242126465,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "(P16) and gankyrin",
            "probability": 0.0033988186295110393,
            "start_logit": 2.691164970397949,
            "end_logit": 5.119060039520264,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p18(Ink4c",
            "probability": 0.0020642040313811785,
            "start_logit": 4.147583484649658,
            "end_logit": 3.1639583110809326,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "(P16)",
            "probability": 0.001510428265154174,
            "start_logit": 2.691164970397949,
            "end_logit": 4.308025360107422,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p21",
            "probability": 0.001216823652168974,
            "start_logit": 3.477681875228882,
            "end_logit": 3.305359125137329,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p18(Ink4c)",
            "probability": 0.0010942197320695053,
            "start_logit": 4.147583484649658,
            "end_logit": 2.5292551517486572,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "only P16",
            "probability": 0.0005936240729919906,
            "start_logit": 0.23335027694702148,
            "end_logit": 5.831937789916992,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "P16 inhibits the kinase activity of CDK4.Recent biological studies of Cyclin D1",
            "probability": 0.0004481321450834117,
            "start_logit": 5.486384868621826,
            "end_logit": 0.29774510860443115,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p21 C-terminal domain (p21",
            "probability": 0.00044765486450712265,
            "start_logit": 3.477681875228882,
            "end_logit": 2.305382490158081,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        }
    ],
    "54f21b69c409818c32000007": [
        {
            "text": "Juvenile hemochromatosis",
            "probability": 0.6242969992003392,
            "start_logit": 6.041021823883057,
            "end_logit": 6.315083026885986,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hemochromatosis",
            "probability": 0.16913254987934875,
            "start_logit": 4.73507833480835,
            "end_logit": 6.315083026885986,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Juvenile hemochromatosis (JH)",
            "probability": 0.13780914529006807,
            "start_logit": 6.041021823883057,
            "end_logit": 4.80432653427124,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hemochromatosis (JH)",
            "probability": 0.03733481366954838,
            "start_logit": 4.73507833480835,
            "end_logit": 4.80432653427124,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Juvenile hemochromatosis (JH",
            "probability": 0.019710849955043047,
            "start_logit": 6.041021823883057,
            "end_logit": 2.859626054763794,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hemochromatosis (JH",
            "probability": 0.005340000540537382,
            "start_logit": 4.73507833480835,
            "end_logit": 2.859626054763794,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "JH)",
            "probability": 0.0027151055107180674,
            "start_logit": 2.113982915878296,
            "end_logit": 4.80432653427124,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "juvenile hemochromatosis",
            "probability": 0.0021218682361348272,
            "start_logit": 2.1046302318573,
            "end_logit": 4.567145347595215,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Juvenile",
            "probability": 0.0004415327007059548,
            "start_logit": 6.041021823883057,
            "end_logit": -0.9390463829040527,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "JH",
            "probability": 0.0003883416969260554,
            "start_logit": 2.113982915878296,
            "end_logit": 2.859626054763794,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "tosis",
            "probability": 0.00014804002852482576,
            "start_logit": -2.3058769702911377,
            "end_logit": 6.315083026885986,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "(JH)",
            "probability": 0.000141680508281444,
            "start_logit": -0.8390285968780518,
            "end_logit": 4.80432653427124,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Juvenile hemochromatosis (JH) is the most severe form,",
            "probability": 0.0001131124561479814,
            "start_logit": 6.041021823883057,
            "end_logit": -2.3009159564971924,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Juvenile hem",
            "probability": 0.00010787986814874967,
            "start_logit": 6.041021823883057,
            "end_logit": -2.348280191421509,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "romatosis",
            "probability": 4.0200590061585084e-05,
            "start_logit": -3.609477996826172,
            "end_logit": 6.315083026885986,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Juvenile hemochromatosis (JH) is",
            "probability": 3.328741270802885e-05,
            "start_logit": 6.041021823883057,
            "end_logit": -3.5241191387176514,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "tosis (JH)",
            "probability": 3.267878882303692e-05,
            "start_logit": -2.3058769702911377,
            "end_logit": 4.80432653427124,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Juvenile hemochromatosis (JH) is the most severe form",
            "probability": 3.20431329812438e-05,
            "start_logit": 6.041021823883057,
            "end_logit": -3.562215566635132,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hemochromatosis (JH) is the most severe form,",
            "probability": 3.06440654943544e-05,
            "start_logit": 4.73507833480835,
            "end_logit": -2.3009159564971924,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hem",
            "probability": 2.9226469459275363e-05,
            "start_logit": 4.73507833480835,
            "end_logit": -2.348280191421509,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        }
    ],
    "52e203bc98d0239505000011": [
        {
            "text": "TGC",
            "probability": 0.22602605681064894,
            "start_logit": 3.7542848587036133,
            "end_logit": 3.821772336959839,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "GCA.TGC",
            "probability": 0.18952192833964976,
            "start_logit": 3.578139305114746,
            "end_logit": 3.821772336959839,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CpG",
            "probability": 0.15294041710384237,
            "start_logit": 3.927138328552246,
            "end_logit": 3.258316993713379,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CG",
            "probability": 0.14245937890243396,
            "start_logit": 3.9765686988830566,
            "end_logit": 3.137895107269287,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CTA.TAG",
            "probability": 0.06752049874506126,
            "start_logit": 4.081697940826416,
            "end_logit": 2.286140203475952,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TGC tends to be under-represented in phage, human viral, and eukaryotic sequences, and CTA.TAG",
            "probability": 0.048667826004400186,
            "start_logit": 3.7542848587036133,
            "end_logit": 2.286140203475952,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CG is strongly under-represented in vertebrates and in mitochondrial genomesFor trinucleotides, GCA",
            "probability": 0.04184760565518845,
            "start_logit": 3.9765686988830566,
            "end_logit": 1.9128727912902832,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CTA",
            "probability": 0.0354146509563321,
            "start_logit": 4.081697940826416,
            "end_logit": 1.6408345699310303,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "GCA",
            "probability": 0.028095381095133484,
            "start_logit": 3.578139305114746,
            "end_logit": 1.9128727912902832,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TGC tends to be under-represented in phage, human viral, and eukaryotic sequences, and CTA",
            "probability": 0.025526382399173306,
            "start_logit": 3.7542848587036133,
            "end_logit": 1.6408345699310303,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "GCA.TGC tends to be under-represented in phage, human viral, and eukaryotic sequences, and CTA",
            "probability": 0.02140376770754111,
            "start_logit": 3.578139305114746,
            "end_logit": 1.6408345699310303,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CG is strongly under-represented in vertebrates and in mitochondrial genomesFor trinucleotides, GCA.",
            "probability": 0.007539045755350998,
            "start_logit": 3.9765686988830566,
            "end_logit": 0.19893382489681244,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "GCA.",
            "probability": 0.005061516908171623,
            "start_logit": 3.578139305114746,
            "end_logit": 0.19893382489681244,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CTA.",
            "probability": 0.0022155249113334835,
            "start_logit": 4.081697940826416,
            "end_logit": -1.1308016777038574,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TGC tends to be under-represented in phage, human viral, and eukaryotic sequences, and CTA.",
            "probability": 0.0015969192007942456,
            "start_logit": 3.7542848587036133,
            "end_logit": -1.1308016777038574,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "GCA.TGC tends to be under-represented in phage, human viral, and eukaryotic sequences, and CTA.",
            "probability": 0.0013390102477905048,
            "start_logit": 3.578139305114746,
            "end_logit": -1.1308016777038574,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TAG is strongly under-represented in many prokaryotic, eukaryotic, and viral sequencesThe dinucleotide CpG",
            "probability": 0.001273989292660315,
            "start_logit": -0.8607569336891174,
            "end_logit": 3.258316993713379,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CpG is significantly under-represented in vertebrate DNA",
            "probability": 0.0006152689470829541,
            "start_logit": 3.927138328552246,
            "end_logit": -2.257427215576172,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TAG",
            "probability": 0.0004818975990393842,
            "start_logit": -0.8607569336891174,
            "end_logit": 2.286140203475952,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TA is almost universally under-represented, with the exception of vertebrate mitochondrial genomes, and CG",
            "probability": 0.000452933418371818,
            "start_logit": -1.7744983434677124,
            "end_logit": 3.137895107269287,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        }
    ],
    "515df86a298dcd4e5100002e": [
        {
            "text": "breast cancer",
            "probability": 0.9446954256738543,
            "start_logit": 5.078934669494629,
            "end_logit": 4.878868103027344,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "breast cancer, and autoantibodies against amphiphysin",
            "probability": 0.02504122405465661,
            "start_logit": 5.078934669494629,
            "end_logit": 1.2485289573669434,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "breast cancer,",
            "probability": 0.005871871004935268,
            "start_logit": 5.078934669494629,
            "end_logit": -0.20182114839553833,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "breast cancer, and autoantibodies",
            "probability": 0.0055503323662799715,
            "start_logit": 5.078934669494629,
            "end_logit": -0.25813665986061096,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "insulin-dependent diabetes mellitus",
            "probability": 0.004986254340792722,
            "start_logit": 2.275578260421753,
            "end_logit": 2.438046932220459,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "insulin-dependent diabetes",
            "probability": 0.0039403076628319895,
            "start_logit": 2.275578260421753,
            "end_logit": 2.2026207447052,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "Graves' disease",
            "probability": 0.002659228698153002,
            "start_logit": 1.8338388204574585,
            "end_logit": 2.2511374950408936,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "diabetes mellitus",
            "probability": 0.0014330905158398024,
            "start_logit": 1.028726577758789,
            "end_logit": 2.438046932220459,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "autoantibodies against amphiphysin",
            "probability": 0.0011820624106020344,
            "start_logit": 2.02567195892334,
            "end_logit": 1.2485289573669434,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "diabetes",
            "probability": 0.001132476836349604,
            "start_logit": 1.028726577758789,
            "end_logit": 2.2026207447052,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "breast",
            "probability": 0.0007994610104766194,
            "start_logit": 5.078934669494629,
            "end_logit": -2.1958119869232178,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "cancer",
            "probability": 0.0007013948517562001,
            "start_logit": -2.1266121864318848,
            "end_logit": 4.878868103027344,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "amphiphysin",
            "probability": 0.0005446652959730393,
            "start_logit": 1.250827431678772,
            "end_logit": 1.2485289573669434,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "encephalomyelitis",
            "probability": 0.00047390162152302943,
            "start_logit": 0.88551926612854,
            "end_logit": 1.4746654033660889,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "stiff-man syndrome, breast cancer",
            "probability": 0.00041790961746407385,
            "start_logit": -2.6444180011749268,
            "end_logit": 4.878868103027344,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "autoantibodies",
            "probability": 0.0002620015396295038,
            "start_logit": 2.02567195892334,
            "end_logit": -0.25813665986061096,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "triad of stiff-man syndrome, breast cancer",
            "probability": 0.00010233639290337501,
            "start_logit": -4.051417827606201,
            "end_logit": 4.878868103027344,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "progressive encephalomyelitis",
            "probability": 7.659545404540133e-05,
            "start_logit": -0.9369427561759949,
            "end_logit": 1.4746654033660889,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "insulin",
            "probability": 6.726809743026128e-05,
            "start_logit": 2.275578260421753,
            "end_logit": -1.8677072525024414,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "autoimmune conditions, Graves' disease",
            "probability": 6.219255450327735e-05,
            "start_logit": -1.9217172861099243,
            "end_logit": 2.2511374950408936,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        }
    ],
    "56be2570ef6e39474100000d": [
        {
            "text": "conscientiousness",
            "probability": 0.0944115953438572,
            "start_logit": 4.833034038543701,
            "end_logit": 4.437406063079834,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "extraversion, agreeableness, conscientiousness",
            "probability": 0.0667158796278401,
            "start_logit": 4.485813140869141,
            "end_logit": 4.437406063079834,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "conscientiousness, emotional stability",
            "probability": 0.06611363392745168,
            "start_logit": 4.833034038543701,
            "end_logit": 4.081117153167725,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "neuroticism",
            "probability": 0.06386557296142185,
            "start_logit": 4.701083660125732,
            "end_logit": 4.178472995758057,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "agreeableness, conscientiousness",
            "probability": 0.0634090701613671,
            "start_logit": 4.434977054595947,
            "end_logit": 4.437406063079834,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "extraversion, agreeableness",
            "probability": 0.05993987859075369,
            "start_logit": 4.485813140869141,
            "end_logit": 4.330305099487305,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "extraversion",
            "probability": 0.05943424333713557,
            "start_logit": 4.485813140869141,
            "end_logit": 4.321833610534668,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "agreeableness",
            "probability": 0.056968925362694406,
            "start_logit": 4.434977054595947,
            "end_logit": 4.330305099487305,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "extraversion, agreeableness, conscientiousness, emotional stability",
            "probability": 0.04671914743944572,
            "start_logit": 4.485813140869141,
            "end_logit": 4.081117153167725,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "extroversion, conscientiousness, agreeableness and neuroticism",
            "probability": 0.04543446859901405,
            "start_logit": 4.360574245452881,
            "end_logit": 4.178472995758057,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "conscientiousness, agreeableness and neuroticism",
            "probability": 0.044537418778816694,
            "start_logit": 4.340632915496826,
            "end_logit": 4.178472995758057,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "agreeableness, conscientiousness, emotional stability",
            "probability": 0.044403487061735004,
            "start_logit": 4.434977054595947,
            "end_logit": 4.081117153167725,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "emotional stability",
            "probability": 0.042757490423503505,
            "start_logit": 4.39720344543457,
            "end_logit": 4.081117153167725,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "agreeableness and neuroticism",
            "probability": 0.0398556176772543,
            "start_logit": 4.22956657409668,
            "end_logit": 4.178472995758057,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "conscientiousness, emotional stability, openness to experience",
            "probability": 0.038218140267945656,
            "start_logit": 4.833034038543701,
            "end_logit": 3.533052444458008,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "openness, extroversion, conscientiousness, agreeableness and neuroticism",
            "probability": 0.03658440225760664,
            "start_logit": 4.143925189971924,
            "end_logit": 4.178472995758057,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "extroversion, conscientiousness",
            "probability": 0.03413496699149927,
            "start_logit": 4.360574245452881,
            "end_logit": 3.892524242401123,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "extroversion, conscientiousness, agreeableness",
            "probability": 0.033307928088424886,
            "start_logit": 4.360574245452881,
            "end_logit": 3.867997407913208,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "conscientiousness, agreeableness",
            "probability": 0.0326503024613582,
            "start_logit": 4.340632915496826,
            "end_logit": 3.867997407913208,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "conscientiousness, emotional stability, openness",
            "probability": 0.03053783064087473,
            "start_logit": 4.833034038543701,
            "end_logit": 3.308708429336548,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        }
    ],
    "5322d3cb9b2d7acc7e000010": [
        {
            "text": "HDAC6",
            "probability": 0.8676233743589703,
            "start_logit": 4.383944988250732,
            "end_logit": 4.141153335571289,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC",
            "probability": 0.06789411983607682,
            "start_logit": 4.383944988250732,
            "end_logit": 1.593345046043396,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6 as well as its depletion enhance microtubule acetylation, only pharmacological inhibition of HDAC",
            "probability": 0.031572877429360616,
            "start_logit": 4.383944988250732,
            "end_logit": 0.8276940584182739,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6 deacetylase",
            "probability": 0.02608234016743388,
            "start_logit": 4.162317752838135,
            "end_logit": 0.8582813143730164,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6,",
            "probability": 0.0016775633508284396,
            "start_logit": 2.0379769802093506,
            "end_logit": 0.23870597779750824,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6, the tubulin deacetylase",
            "probability": 0.001312263873141534,
            "start_logit": 2.0379769802093506,
            "end_logit": -0.0068825832568109035,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "deacetylase function, HDAC6",
            "probability": 0.0009278241069729643,
            "start_logit": -1.268150806427002,
            "end_logit": 2.95257830619812,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cellsHDAC",
            "probability": 0.0005212579789769013,
            "start_logit": 0.2298930287361145,
            "end_logit": 0.877937376499176,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "deacetylase",
            "probability": 0.0005111121400393629,
            "start_logit": 0.2298930287361145,
            "end_logit": 0.8582813143730164,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "6",
            "probability": 0.00032243586297233437,
            "start_logit": -3.5136637687683105,
            "end_logit": 4.141153335571289,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6, the tubulin deacetylase,",
            "probability": 0.0003115392197872706,
            "start_logit": 2.0379769802093506,
            "end_logit": -1.444866418838501,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "DAC6",
            "probability": 0.0003014173709278987,
            "start_logit": -3.2292256355285645,
            "end_logit": 3.789306879043579,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "H",
            "probability": 0.0002971271870443716,
            "start_logit": 4.162317752838135,
            "end_logit": -3.616572141647339,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "acetylated microtubules in cells.We found that whereas both pharmacological inhibition of HDAC6",
            "probability": 0.0001662082065920724,
            "start_logit": -4.176326751708984,
            "end_logit": 4.141153335571289,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "6 as well as its depletion enhance microtubule acetylation, only pharmacological inhibition of HDAC6",
            "probability": 0.00012718489765872203,
            "start_logit": -3.5136637687683105,
            "end_logit": 3.210891008377075,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "C6",
            "probability": 0.00010754000801888172,
            "start_logit": -4.25985860824585,
            "end_logit": 3.789306879043579,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "tubulin deacetylase",
            "probability": 7.903779715295201e-05,
            "start_logit": -0.771605908870697,
            "end_logit": -0.0068825832568109035,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "deacetylase function, HDAC",
            "probability": 6.48185998518434e-05,
            "start_logit": -1.268150806427002,
            "end_logit": 0.2913287281990051,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "deacetylase,",
            "probability": 5.001530167167299e-05,
            "start_logit": 0.20878073573112488,
            "end_logit": -1.444866418838501,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "DAC6 as well as its depletion enhance microtubule acetylation, only pharmacological inhibition of HDAC6",
            "probability": 4.9942306521078265e-05,
            "start_logit": -4.448437213897705,
            "end_logit": 3.210891008377075,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        }
    ],
    "515de748298dcd4e51000023": [
        {
            "text": "gastrointestinal stromal tumors",
            "probability": 0.24805515180257895,
            "start_logit": 4.742323398590088,
            "end_logit": 4.547395706176758,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "chronic myelogenous leukemia and metastatic gastrointestinal stromal tumors",
            "probability": 0.20736005063715396,
            "start_logit": 4.56312894821167,
            "end_logit": 4.547395706176758,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "chronic myelogenous leukemia",
            "probability": 0.1378011224872551,
            "start_logit": 4.56312894821167,
            "end_logit": 4.1387505531311035,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "metastatic gastrointestinal stromal tumors",
            "probability": 0.13603148364130507,
            "start_logit": 4.141558647155762,
            "end_logit": 4.547395706176758,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "gastrointestinal stromal tumors (GIST)",
            "probability": 0.05491380082005419,
            "start_logit": 4.742323398590088,
            "end_logit": 3.0395092964172363,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "chronic myelogenous leukemia and metastatic gastrointestinal stromal tumors (GIST)",
            "probability": 0.0459048257453149,
            "start_logit": 4.56312894821167,
            "end_logit": 3.0395092964172363,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "metastatic gastrointestinal stromal tumors (GIST)",
            "probability": 0.03011429411423909,
            "start_logit": 4.141558647155762,
            "end_logit": 3.0395092964172363,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "treatment of chronic myelogenous leukemia and metastatic gastrointestinal stromal tumors",
            "probability": 0.029419264290736453,
            "start_logit": 2.6103219985961914,
            "end_logit": 4.547395706176758,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "gastrointestinal stromal tumors (GIST",
            "probability": 0.020824886996563916,
            "start_logit": 4.742323398590088,
            "end_logit": 2.0698933601379395,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "treatment of chronic myelogenous leukemia",
            "probability": 0.01955057220306409,
            "start_logit": 2.6103219985961914,
            "end_logit": 4.1387505531311035,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "chronic myelogenous leukemia and metastatic gastrointestinal stromal tumors (GIST",
            "probability": 0.017408425468047897,
            "start_logit": 4.56312894821167,
            "end_logit": 2.0698933601379395,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "gastrointestinal stromal tumors (GIST). Treatment with adjuvant imatinib",
            "probability": 0.01199702632076961,
            "start_logit": 4.742323398590088,
            "end_logit": 1.51840341091156,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "metastatic gastrointestinal stromal tumors (GIST",
            "probability": 0.011420203346793216,
            "start_logit": 4.141558647155762,
            "end_logit": 2.0698933601379395,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "metastatic gastrointestinal stromal tumors (GIST). Treatment with adjuvant imatinib",
            "probability": 0.006579074362450353,
            "start_logit": 4.141558647155762,
            "end_logit": 1.51840341091156,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "treatment of chronic myelogenous leukemia and metastatic gastrointestinal stromal tumors (GIST)",
            "probability": 0.00651275979472416,
            "start_logit": 2.6103219985961914,
            "end_logit": 3.0395092964172363,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "gastrointestinal stromal tumors (GIST).",
            "probability": 0.00475250084307979,
            "start_logit": 4.742323398590088,
            "end_logit": 0.5924155712127686,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "chronic myelogenous leukemia and metastatic gastrointestinal stromal tumors (GIST).",
            "probability": 0.003972821400050826,
            "start_logit": 4.56312894821167,
            "end_logit": 0.5924155712127686,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "metastatic gastrointestinal stromal tumors (GIST).",
            "probability": 0.002606233879815657,
            "start_logit": 4.141558647155762,
            "end_logit": 0.5924155712127686,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "treatment of chronic myelogenous leukemia and metastatic gastrointestinal stromal tumors (GIST",
            "probability": 0.0024698251575287987,
            "start_logit": 2.6103219985961914,
            "end_logit": 2.0698933601379395,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "chronic myelogenous leukemia and metastatic",
            "probability": 0.0023056766884741917,
            "start_logit": 4.56312894821167,
            "end_logit": 0.04831325635313988,
            "question_text": "List all approved indications for Glivec"
        }
    ],
    "54dfbed11388e8454a000008": [
        {
            "text": "APOBEC3",
            "probability": 0.4628547566131111,
            "start_logit": 3.899958610534668,
            "end_logit": 3.647233009338379,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "APOBEC3G",
            "probability": 0.34105009872784614,
            "start_logit": 3.899958610534668,
            "end_logit": 3.3418490886688232,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "APOBEC3 (hA3",
            "probability": 0.038925210109786,
            "start_logit": 3.7287697792053223,
            "end_logit": 1.3426506519317627,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "SAMHD1Here, we demonstrate that the Aicardi-Gouti\u00e8res syndrome gene product SAMHD1",
            "probability": 0.0353478076122446,
            "start_logit": 2.9851608276367188,
            "end_logit": 1.989853858947754,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "APOBEC3 (hA3)",
            "probability": 0.03156574213612303,
            "start_logit": 3.7287697792053223,
            "end_logit": 1.1330809593200684,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "APOBEC3 (hA3) proteins",
            "probability": 0.017244549684815355,
            "start_logit": 3.7287697792053223,
            "end_logit": 0.5285046696662903,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "SAMHD1",
            "probability": 0.016909222856328673,
            "start_logit": 2.247783660888672,
            "end_logit": 1.989853858947754,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "APOBEC",
            "probability": 0.013164121451728019,
            "start_logit": 3.899958610534668,
            "end_logit": 0.08731476217508316,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "human APOBEC3",
            "probability": 0.009167165103494402,
            "start_logit": -0.0009871515212580562,
            "end_logit": 3.6263935565948486,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "hA3",
            "probability": 0.009152973735665816,
            "start_logit": 1.8149703741073608,
            "end_logit": 1.8088867664337158,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "Vpx",
            "probability": 0.006933699716061754,
            "start_logit": 1.949507713317871,
            "end_logit": 1.3966641426086426,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "hA3)",
            "probability": 0.004679608634271491,
            "start_logit": 1.8199118375778198,
            "end_logit": 1.1330809593200684,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "APOBEC3G oligomerization",
            "probability": 0.0030663980088478336,
            "start_logit": 3.899958610534668,
            "end_logit": -1.3696767091751099,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "hA3) proteins",
            "probability": 0.0025564975868835097,
            "start_logit": 1.8199118375778198,
            "end_logit": 0.5285046696662903,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "antiretroviral restriction factors, human APOBEC3",
            "probability": 0.002179781311389378,
            "start_logit": -1.437390685081482,
            "end_logit": 3.6263935565948486,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "APOBEC3 (hA3) proteins (A-H),",
            "probability": 0.002178467385333937,
            "start_logit": 3.7287697792053223,
            "end_logit": -1.5403698682785034,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "human APOBEC3 (hA3",
            "probability": 0.000934153212422216,
            "start_logit": -0.0009871515212580562,
            "end_logit": 1.3426506519317627,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "human APOBEC3 (hA3)",
            "probability": 0.0007575357804308266,
            "start_logit": -0.0009871515212580562,
            "end_logit": 1.1330809593200684,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "SAMHD",
            "probability": 0.0007551270961735813,
            "start_logit": 2.9851608276367188,
            "end_logit": -1.8562517166137695,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "Aicardi-Gouti\u00e8res syndrome gene product SAMHD1",
            "probability": 0.0005770832370424291,
            "start_logit": -1.129844307899475,
            "end_logit": 1.989853858947754,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        }
    ],
    "5149aafcd24251bc05000045": [
        {
            "text": "PPIs",
            "probability": 0.6072815747675074,
            "start_logit": 3.959362268447876,
            "end_logit": 3.835681676864624,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "bui/PPIs",
            "probability": 0.2347107793985949,
            "start_logit": 3.008723735809326,
            "end_logit": 3.835681676864624,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "bui",
            "probability": 0.0442643250117751,
            "start_logit": 3.008723735809326,
            "end_logit": 2.167506694793701,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPIs.zip",
            "probability": 0.04204985726171423,
            "start_logit": 3.959362268447876,
            "end_logit": 1.165545105934143,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPIs.zipWe",
            "probability": 0.03238919182509908,
            "start_logit": 3.959362268447876,
            "end_logit": 0.9045138955116272,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "bui/PPIs.zip",
            "probability": 0.01625202407182383,
            "start_logit": 3.008723735809326,
            "end_logit": 1.165545105934143,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "bui/PPIs.zipWe",
            "probability": 0.012518233342202088,
            "start_logit": 3.008723735809326,
            "end_logit": 0.9045138955116272,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPIs.",
            "probability": 0.0019173234944333264,
            "start_logit": 3.959362268447876,
            "end_logit": -1.9223806858062744,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "zip",
            "probability": 0.001418792254990368,
            "start_logit": 0.5703122615814209,
            "end_logit": 1.165545105934143,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PP",
            "probability": 0.0012641483285522636,
            "start_logit": 3.959362268447876,
            "end_logit": -2.33891224861145,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "zipWe",
            "probability": 0.0010928344945581518,
            "start_logit": 0.5703122615814209,
            "end_logit": 0.9045138955116272,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "bui/PPIs.",
            "probability": 0.0007410343248269445,
            "start_logit": 3.008723735809326,
            "end_logit": -1.9223806858062744,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPIs.zipWe describe a system",
            "probability": 0.0006590773153672652,
            "start_logit": 3.959362268447876,
            "end_logit": -2.990225315093994,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPIs.zipWe describe a system for the detection of mentions of protein-protein interactions in the biomedical scientific literature.",
            "probability": 0.0006544282566577368,
            "start_logit": 3.959362268447876,
            "end_logit": -2.9973042011260986,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "~bui/PPIs",
            "probability": 0.0006261269830273256,
            "start_logit": -2.917832374572754,
            "end_logit": 3.835681676864624,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPIs.zipWe describe",
            "probability": 0.00061681745496099,
            "start_logit": 3.959362268447876,
            "end_logit": -3.056493043899536,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "bui/PP",
            "probability": 0.0004885859406874404,
            "start_logit": 3.008723735809326,
            "end_logit": -2.33891224861145,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPIs.zipWe describe a system for the detection of mentions of protein-protein interactions in the biomedical scientific literature",
            "probability": 0.0004639451772230025,
            "start_logit": 3.959362268447876,
            "end_logit": -3.3412997722625732,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "staff.science.uva.nl/~bui/PPIs",
            "probability": 0.0003361707655774426,
            "start_logit": -3.539766311645508,
            "end_logit": 3.835681676864624,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "bui/PPIs.zipWe describe a system",
            "probability": 0.00025472953042088764,
            "start_logit": 3.008723735809326,
            "end_logit": -2.990225315093994,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        }
    ],
    "51600ab3298dcd4e51000036": [
        {
            "text": "frontotemporal dementia",
            "probability": 0.2879436079196524,
            "start_logit": 5.215164661407471,
            "end_logit": 4.962710857391357,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "Amyotrophic lateral sclerosis",
            "probability": 0.23090375341377284,
            "start_logit": 4.921459197998047,
            "end_logit": 5.0356526374816895,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia",
            "probability": 0.2146608179991518,
            "start_logit": 4.921459197998047,
            "end_logit": 4.962710857391357,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "frontotemporal dementia (FTD)",
            "probability": 0.08240958764842322,
            "start_logit": 5.215164661407471,
            "end_logit": 3.7116479873657227,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)",
            "probability": 0.06143602083543929,
            "start_logit": 4.921459197998047,
            "end_logit": 3.7116479873657227,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "Amyotrophic lateral sclerosis (ALS)",
            "probability": 0.03898800865521502,
            "start_logit": 4.921459197998047,
            "end_logit": 3.2569057941436768,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "fibrosis",
            "probability": 0.023048946838671414,
            "start_logit": 3.6121039390563965,
            "end_logit": 4.0406270027160645,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "heart failure",
            "probability": 0.011751036407003023,
            "start_logit": 3.9623944759368896,
            "end_logit": 3.016657829284668,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "dementia",
            "probability": 0.008483070549424316,
            "start_logit": 1.6904724836349487,
            "end_logit": 4.962710857391357,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "fibrosis is a key pathological change in a variety of heart diseases contributing to the development of heart failure",
            "probability": 0.008278409865057299,
            "start_logit": 3.6121039390563965,
            "end_logit": 3.016657829284668,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "heart failure, arrhythmias",
            "probability": 0.005307255675215543,
            "start_logit": 3.9623944759368896,
            "end_logit": 2.2217912673950195,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "heart failure, arrhythmias, and sudden death. Recent studies have shown that relaxin prevents and reverses cardiac fibrosis",
            "probability": 0.005076924469845602,
            "start_logit": 3.9623944759368896,
            "end_logit": 2.177422046661377,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "Myocardial fibrosis",
            "probability": 0.004752479935746557,
            "start_logit": 2.0331504344940186,
            "end_logit": 4.0406270027160645,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "heart failure, arrhythmias, and sudden death",
            "probability": 0.0038303298676072976,
            "start_logit": 3.9623944759368896,
            "end_logit": 1.895667314529419,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "fibrosis is a key pathological change in a variety of heart diseases contributing to the development of heart failure, arrhythmias",
            "probability": 0.003738873424977414,
            "start_logit": 3.6121039390563965,
            "end_logit": 2.2217912673950195,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "dementia (FTD)",
            "probability": 0.0024278585345975574,
            "start_logit": 1.6904724836349487,
            "end_logit": 3.7116479873657227,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "lateral sclerosis",
            "probability": 0.0022916984133793364,
            "start_logit": 0.3087514340877533,
            "end_logit": 5.0356526374816895,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "lateral sclerosis (ALS) and frontotemporal dementia",
            "probability": 0.0021304887804999353,
            "start_logit": 0.3087514340877533,
            "end_logit": 4.962710857391357,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "Myocardial fibrosis is a key pathological change in a variety of heart diseases contributing to the development of heart failure",
            "probability": 0.0017069316467666848,
            "start_logit": 2.0331504344940186,
            "end_logit": 3.016657829284668,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "yotrophic lateral sclerosis",
            "probability": 0.000833899119553518,
            "start_logit": -0.7021846175193787,
            "end_logit": 5.0356526374816895,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        }
    ],
    "56c1f000ef6e394741000037": [
        {
            "text": "trifluridine",
            "probability": 0.2972407778985221,
            "start_logit": 5.9564738273620605,
            "end_logit": 5.897494792938232,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine",
            "probability": 0.16405288322189981,
            "start_logit": 5.532741546630859,
            "end_logit": 5.726873397827148,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine and tipiracil",
            "probability": 0.1534092658722587,
            "start_logit": 5.9564738273620605,
            "end_logit": 5.2360615730285645,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "tipiracil",
            "probability": 0.13655228998527583,
            "start_logit": 5.840072154998779,
            "end_logit": 5.2360615730285645,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine and tipiracil hydrochloride",
            "probability": 0.06260506390526388,
            "start_logit": 5.9564738273620605,
            "end_logit": 4.339798450469971,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "tipiracil hydrochloride",
            "probability": 0.05572587022257712,
            "start_logit": 5.840072154998779,
            "end_logit": 4.339798450469971,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine and the thymidine phosphorylase inhibitor TPI",
            "probability": 0.03265949369600575,
            "start_logit": 5.532741546630859,
            "end_logit": 4.112820148468018,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine and the thymidine phosphorylase inhibitor",
            "probability": 0.024073443232550683,
            "start_logit": 5.532741546630859,
            "end_logit": 3.8077938556671143,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "Trifluridine",
            "probability": 0.01822916653964651,
            "start_logit": 4.569883346557617,
            "end_logit": 4.492565631866455,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase inhibitor TPI",
            "probability": 0.013541179884432306,
            "start_logit": 4.652341365814209,
            "end_logit": 4.112820148468018,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase inhibitor",
            "probability": 0.011687381855898493,
            "start_logit": 4.826650142669678,
            "end_logit": 3.791285753250122,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "\u03b1,\u03b1,\u03b1-trifluorothymidine",
            "probability": 0.007785086812642159,
            "start_logit": 3.7535743713378906,
            "end_logit": 4.458061695098877,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "TPI",
            "probability": 0.0063281986878976305,
            "start_logit": 3.8916215896606445,
            "end_logit": 4.112820148468018,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase inhibitor).TAS-102, a combination of trifluorothymidine",
            "probability": 0.004174498210305589,
            "start_logit": 1.8615468740463257,
            "end_logit": 5.726873397827148,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "\u03b1,\u03b1,\u03b1-trifluorothymidine (FTD) and thymidine phosphorylase inhibitor",
            "probability": 0.003996560094070894,
            "start_logit": 3.7535743713378906,
            "end_logit": 3.791285753250122,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine with a thymidine phosphorylase inhibitor",
            "probability": 0.0027957371888986332,
            "start_logit": 4.259948253631592,
            "end_logit": 2.9275736808776855,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase inhibitor (TPI)",
            "probability": 0.0016191155638801708,
            "start_logit": 4.826650142669678,
            "end_logit": 1.8146560192108154,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine and the thymidine",
            "probability": 0.00147124359180284,
            "start_logit": 5.532741546630859,
            "end_logit": 1.0127925872802734,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "TFT and tipiracil",
            "probability": 0.001168637699611417,
            "start_logit": 1.840520977973938,
            "end_logit": 4.474743843078613,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "Trifluridine (TFT",
            "probability": 0.000884105836559164,
            "start_logit": 4.569883346557617,
            "end_logit": 1.4663642644882202,
            "question_text": "Which drugs are included in TAS-102?"
        }
    ],
    "515db20e298dcd4e51000014": [
        {
            "text": "cognitive-behavioural therapy",
            "probability": 0.6155473805248792,
            "start_logit": 4.717029571533203,
            "end_logit": 4.094222545623779,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "manualised cognitive-behavioural therapy",
            "probability": 0.3648611705106679,
            "start_logit": 4.194034576416016,
            "end_logit": 4.094222545623779,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "cognitive-behavioral",
            "probability": 0.0047269924820413116,
            "start_logit": 2.9196085929870605,
            "end_logit": 1.0224207639694214,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "cognitive-behavioural",
            "probability": 0.0032563414969397574,
            "start_logit": 4.717029571533203,
            "end_logit": -1.1476850509643555,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "cognitive-behavioral treatment",
            "probability": 0.0028566882336240997,
            "start_logit": 2.9196085929870605,
            "end_logit": 0.518794596195221,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "manualised cognitive-behavioural",
            "probability": 0.0019301724087312222,
            "start_logit": 4.194034576416016,
            "end_logit": -1.1476850509643555,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "cognitive",
            "probability": 0.001647299677058572,
            "start_logit": 4.717029571533203,
            "end_logit": -1.82915198802948,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "cognitive-behavioural therapy (FRIENDS)",
            "probability": 0.0011133912483733883,
            "start_logit": 4.717029571533203,
            "end_logit": -2.220878839492798,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "manualised cognitive",
            "probability": 0.0009764247357220995,
            "start_logit": 4.194034576416016,
            "end_logit": -1.82915198802948,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "manual",
            "probability": 0.0006890352264561616,
            "start_logit": 4.194034576416016,
            "end_logit": -2.1777572631835938,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "manualised cognitive-behavioural therapy (FRIENDS)",
            "probability": 0.0006599544518757464,
            "start_logit": 4.194034576416016,
            "end_logit": -2.220878839492798,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "therapy",
            "probability": 0.0004465682802657235,
            "start_logit": -2.5116453170776367,
            "end_logit": 4.094222545623779,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "cognitive-behavioral treatment (CBT)",
            "probability": 0.00027919170239092415,
            "start_logit": 2.9196085929870605,
            "end_logit": -1.806725025177002,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "group format in the delivery of manualised cognitive-behavioural therapy",
            "probability": 0.00023553296706743204,
            "start_logit": -3.1513867378234863,
            "end_logit": 4.094222545623779,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "group cognitive-behavioral",
            "probability": 0.0001743321699168842,
            "start_logit": -0.3804733455181122,
            "end_logit": 1.0224207639694214,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "Social Phobia",
            "probability": 0.00017060085579559186,
            "start_logit": 0.6242660284042358,
            "end_logit": -0.0039544603787362576,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "individual versus a group format in the delivery of manualised cognitive-behavioural therapy",
            "probability": 0.0001525633672117725,
            "start_logit": -3.5856575965881348,
            "end_logit": 4.094222545623779,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "Social Phobia (n = 22) or Specific Phobia",
            "probability": 0.00012771501563804485,
            "start_logit": 0.6242660284042358,
            "end_logit": -0.2934797704219818,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "group cognitive-behavioral treatment",
            "probability": 0.0001053550773426781,
            "start_logit": -0.3804733455181122,
            "end_logit": 0.518794596195221,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "al therapy",
            "probability": 4.32895680012173e-05,
            "start_logit": -4.845325946807861,
            "end_logit": 4.094222545623779,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        }
    ],
    "54cf6d40f693c3b16b00000e": [
        {
            "text": "icatibant",
            "probability": 0.9178808098881479,
            "start_logit": 5.145908832550049,
            "end_logit": 5.231918811798096,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant and ecallantide",
            "probability": 0.04107688542180919,
            "start_logit": 4.141439914703369,
            "end_logit": 3.129765748977661,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ecallantide",
            "probability": 0.017640461223300204,
            "start_logit": 3.296189546585083,
            "end_logit": 3.129765748977661,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant,",
            "probability": 0.012815369834536421,
            "start_logit": 5.145908832550049,
            "end_logit": 0.9604964852333069,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant, a specific bradykinin B2 receptor antagonist",
            "probability": 0.00873670369690808,
            "start_logit": 5.145908832550049,
            "end_logit": 0.5773842334747314,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant, a specific bradykinin B2",
            "probability": 0.0006011582789456879,
            "start_logit": 5.145908832550049,
            "end_logit": -2.099045753479004,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant, a specific bradykinin",
            "probability": 0.0003444434282696864,
            "start_logit": 5.145908832550049,
            "end_logit": -2.6559741497039795,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant, a specific bradykinin B2 receptor",
            "probability": 0.0002820362009027527,
            "start_logit": 5.145908832550049,
            "end_logit": -2.8558685779571533,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant, a specific bradykinin B",
            "probability": 0.0001614458536670591,
            "start_logit": 5.145908832550049,
            "end_logit": -3.413734197616577,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatiba",
            "probability": 0.00011708041001131129,
            "start_logit": 5.145908832550049,
            "end_logit": -3.7350430488586426,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant, a specific bradykinin B2 receptor antagonist approved for the treatment of hereditary angioedema.",
            "probability": 9.812977003227813e-05,
            "start_logit": 4.983739376068115,
            "end_logit": -3.749443769454956,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "nt",
            "probability": 8.565140456463362e-05,
            "start_logit": -4.1336283683776855,
            "end_logit": 5.231918811798096,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant and ecallantide,",
            "probability": 8.244089965641395e-05,
            "start_logit": 4.141439914703369,
            "end_logit": -3.0813534259796143,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ecallantide,",
            "probability": 3.540422986477975e-05,
            "start_logit": 3.296189546585083,
            "end_logit": -3.0813534259796143,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "bradykinin B2 receptor antagonist",
            "probability": 2.0129062612374517e-05,
            "start_logit": -0.889710545539856,
            "end_logit": 0.5398800373077393,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "nt and ecallantide",
            "probability": 9.483782121841218e-06,
            "start_logit": -4.232177734375,
            "end_logit": 3.129765748977661,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ide",
            "probability": 4.333647792273575e-06,
            "start_logit": -5.015351295471191,
            "end_logit": 3.129765748977661,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "antagonist",
            "probability": 3.4515366909204023e-06,
            "start_logit": -2.6905598640441895,
            "end_logit": 0.5773842334747314,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "B2 receptor antagonist",
            "probability": 3.385572910538013e-06,
            "start_logit": -2.7098562717437744,
            "end_logit": 0.5773842334747314,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "nt,",
            "probability": 1.1958572556681295e-06,
            "start_logit": -4.1336283683776855,
            "end_logit": 0.9604964852333069,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        }
    ],
    "515bf6d6298dcd4e51000004": [
        {
            "text": "colitis",
            "probability": 0.8780007759650845,
            "start_logit": 4.881909370422363,
            "end_logit": 5.049177169799805,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "skin carcinogenesis",
            "probability": 0.021348790437335667,
            "start_logit": 3.278635025024414,
            "end_logit": 2.9357991218566895,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "colitis-associated tumorigenesisTpl2 ablation promotes intestinal inflammation and tumorigenesis",
            "probability": 0.021333231048230688,
            "start_logit": 4.881909370422363,
            "end_logit": 1.3317956924438477,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "tumorigenesis.Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis",
            "probability": 0.018625050597257584,
            "start_logit": 1.0287693738937378,
            "end_logit": 5.049177169799805,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "intestinal myofibroblast HGF release to suppress colitis",
            "probability": 0.014316338432555047,
            "start_logit": 0.7656633257865906,
            "end_logit": 5.049177169799805,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "colitis-associated tumorigenes",
            "probability": 0.010528484717058492,
            "start_logit": 4.881909370422363,
            "end_logit": 0.6256141066551208,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "carcinogenesis",
            "probability": 0.008330288279624835,
            "start_logit": 2.337538003921509,
            "end_logit": 2.9357991218566895,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "colitis-associated",
            "probability": 0.006677711480961277,
            "start_logit": 4.881909370422363,
            "end_logit": 0.1703050285577774,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "skin",
            "probability": 0.004062707928947235,
            "start_logit": 3.278635025024414,
            "end_logit": 1.27665376663208,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "tumorigenesis and inflammation in two-stage skin carcinogenesis",
            "probability": 0.0033139812437590526,
            "start_logit": 1.4157902002334595,
            "end_logit": 2.9357991218566895,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "two-stage skin carcinogenesis",
            "probability": 0.002368206432397773,
            "start_logit": 1.0797728300094604,
            "end_logit": 2.9357991218566895,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "colitis-associated tumorigenesisTpl2 ablation promotes intestinal inflammation",
            "probability": 0.002292753097474706,
            "start_logit": 4.881909370422363,
            "end_logit": -0.8987169861793518,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "skin carcinogenesis Previously identified as an oncogene, its mutation or overexpression is reported in a variety of human cancer",
            "probability": 0.0018692647763673778,
            "start_logit": 3.278635025024414,
            "end_logit": 0.500349223613739,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis",
            "probability": 0.0018083264145429365,
            "start_logit": 0.8100417256355286,
            "end_logit": 2.9357991218566895,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "colitis-associated tumor",
            "probability": 0.001458184083788426,
            "start_logit": 4.881909370422363,
            "end_logit": -1.3512784242630005,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "skin carcin",
            "probability": 0.0008940970762451654,
            "start_logit": 3.278635025024414,
            "end_logit": -0.23713688552379608,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "skin car",
            "probability": 0.0007594196148947205,
            "start_logit": 3.278635025024414,
            "end_logit": -0.40039676427841187,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "carcinogenesis Previously identified as an oncogene, its mutation or overexpression is reported in a variety of human cancer",
            "probability": 0.000729386262130176,
            "start_logit": 2.337538003921509,
            "end_logit": 0.500349223613739,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "inflammation in two-stage skin carcinogenesis",
            "probability": 0.0006498562495793271,
            "start_logit": -0.2133641541004181,
            "end_logit": 2.9357991218566895,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "skin carcinogenesis Previously identified as an oncogene, its mutation or overexpression is reported in a variety of human cancers",
            "probability": 0.0006331458617646026,
            "start_logit": 3.278635025024414,
            "end_logit": -0.5822504162788391,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        }
    ],
    "530cf4fe960c95ad0c000007": [
        {
            "text": "hypertension",
            "probability": 0.9772393805513365,
            "start_logit": 5.327560901641846,
            "end_logit": 4.391916751861572,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "diuretic",
            "probability": 0.010288108897655716,
            "start_logit": 2.8551080226898193,
            "end_logit": 2.310626745223999,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "ypertension",
            "probability": 0.004058110372450256,
            "start_logit": -0.15645329654216766,
            "end_logit": 4.391916751861572,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "h",
            "probability": 0.001521906317112982,
            "start_logit": 5.327560901641846,
            "end_logit": -2.0728511810302734,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "tension",
            "probability": 0.0011896249542926217,
            "start_logit": -1.3835326433181763,
            "end_logit": 4.391916751861572,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "diuretic in combination is again hydrochlorothiazide, which is combined with reninangiotensin system blockers",
            "probability": 0.0009863360715957356,
            "start_logit": 2.8551080226898193,
            "end_logit": -0.03412014618515968,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertens",
            "probability": 0.0008429155065069466,
            "start_logit": 5.327560901641846,
            "end_logit": -2.663703441619873,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertension and the appropriate indication for using a fixed combination of telmisartan",
            "probability": 0.0007658081007738455,
            "start_logit": 5.327560901641846,
            "end_logit": -2.759638547897339,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "blood pressure reduction",
            "probability": 0.0005659538236049241,
            "start_logit": 1.280946969985962,
            "end_logit": 0.984556257724762,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "amiloridearticle gives an overview of the risk factors for hypertension",
            "probability": 0.0005128392023272172,
            "start_logit": -2.224963665008545,
            "end_logit": 4.391916751861572,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertension and the appropriate indication for using a fixed combination of telmisartan and hydrochlorothiazide",
            "probability": 0.0004990460971307945,
            "start_logit": 5.327560901641846,
            "end_logit": -3.1878716945648193,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "ion",
            "probability": 0.00044676082039507705,
            "start_logit": -2.3629026412963867,
            "end_logit": 4.391916751861572,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hyper",
            "probability": 0.00035424134230501597,
            "start_logit": 5.327560901641846,
            "end_logit": -3.5305917263031006,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hydrochlorothiazide + amiloridearticle gives an overview of the risk factors for hypertension",
            "probability": 0.0002848364295985731,
            "start_logit": -2.8130109310150146,
            "end_logit": 4.391916751861572,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "blood pressure reduction in patients with severe renal disease",
            "probability": 9.929080114889353e-05,
            "start_logit": 1.280946969985962,
            "end_logit": -0.7559033036231995,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "blood pressure",
            "probability": 9.534040548778624e-05,
            "start_logit": 1.280946969985962,
            "end_logit": -0.7965025305747986,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "antihypertensive",
            "probability": 9.317658325201834e-05,
            "start_logit": 1.7791980504989624,
            "end_logit": -1.3177108764648438,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "reninangiotensin system blockers",
            "probability": 8.799041898744488e-05,
            "start_logit": 0.4383388161659241,
            "end_logit": -0.03412014618515968,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "long-term blood pressure reduction",
            "probability": 5.5186121633406895e-05,
            "start_logit": -1.046854019165039,
            "end_logit": 0.984556257724762,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "reduction",
            "probability": 1.3147182404553528e-05,
            "start_logit": -2.481358051300049,
            "end_logit": 0.984556257724762,
            "question_text": "What are the indications for hydrochlorothiazide?"
        }
    ],
    "52bf1cb303868f1b0600000b": [
        {
            "text": "craniosynostosis with symmetrical syndactyly",
            "probability": 0.11514385843801914,
            "start_logit": 4.4504714012146,
            "end_logit": 4.594789981842041,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "craniosynostosis",
            "probability": 0.08616038153597895,
            "start_logit": 4.4504714012146,
            "end_logit": 4.304818153381348,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "symphalangism",
            "probability": 0.07074441419487593,
            "start_logit": 4.138870716094971,
            "end_logit": 4.419281959533691,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "symmetrical syndactyly",
            "probability": 0.06672611588433089,
            "start_logit": 3.9048855304718018,
            "end_logit": 4.594789981842041,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "short thumb with radial clinodactyly",
            "probability": 0.06443729974664393,
            "start_logit": 3.9070916175842285,
            "end_logit": 4.557680130004883,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly",
            "probability": 0.061293883951405476,
            "start_logit": 3.8199691772460938,
            "end_logit": 4.594789981842041,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly with a bony fusion involving the index, long and ring fingers, symphalangism",
            "probability": 0.05310037705272444,
            "start_logit": 3.8519811630249023,
            "end_logit": 4.419281959533691,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "short thumb with radial clinodactyly, complex syndactyly",
            "probability": 0.05266901081948419,
            "start_logit": 3.9070916175842285,
            "end_logit": 4.356014728546143,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "radial clinodactyly",
            "probability": 0.05149763053184947,
            "start_logit": 3.6829347610473633,
            "end_logit": 4.557680130004883,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "radial clinodactyly, complex syndactyly",
            "probability": 0.04209253445324647,
            "start_logit": 3.6829347610473633,
            "end_logit": 4.356014728546143,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndromic craniosynostosis with symmetrical syndactyly",
            "probability": 0.041397250853690504,
            "start_logit": 3.4275035858154297,
            "end_logit": 4.594789981842041,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "short thumb",
            "probability": 0.03920229738989973,
            "start_logit": 3.9070916175842285,
            "end_logit": 4.060722827911377,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "symphalangism and simple syndactyly",
            "probability": 0.038785522558492616,
            "start_logit": 4.138870716094971,
            "end_logit": 3.8182554244995117,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "complex syndactyly with a bony fusion involving the index, long and ring fingers, symphalangism",
            "probability": 0.035814677046830605,
            "start_logit": 3.4581549167633057,
            "end_logit": 4.419281959533691,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "complex syndactyly",
            "probability": 0.03361897204379327,
            "start_logit": 3.4581549167633057,
            "end_logit": 4.356014728546143,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "a short thumb with radial clinodactyly",
            "probability": 0.0316048721649393,
            "start_logit": 3.1947102546691895,
            "end_logit": 4.557680130004883,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndromic craniosynostosis",
            "probability": 0.030976927267159286,
            "start_logit": 3.4275035858154297,
            "end_logit": 4.304818153381348,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "short thumb with radial clinodactyly, complex syndactyly with a bony fusion involving the index, long and ring fingers",
            "probability": 0.029596364407451357,
            "start_logit": 3.9070916175842285,
            "end_logit": 3.7796390056610107,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly with a bony fusion involving the index, long and ring fingers",
            "probability": 0.02800942540546496,
            "start_logit": 3.8519811630249023,
            "end_logit": 3.7796390056610107,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "craniosynostosis with symmetrical syndactyly) and two had polydactyly",
            "probability": 0.0271281842537194,
            "start_logit": 4.4504714012146,
            "end_logit": 3.1491808891296387,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        }
    ],
    "5539029cbc4f83e828000012": [
        {
            "text": "Myt1L, Nfia",
            "probability": 0.07225071575710786,
            "start_logit": 4.2303853034973145,
            "end_logit": 3.469835042953491,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Myt1L, Nfia, Nfib",
            "probability": 0.0703718220106391,
            "start_logit": 4.2303853034973145,
            "end_logit": 3.443485736846924,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Myt1L, Nfia, Nfib, Tead1 and Tgif2",
            "probability": 0.06777915081050588,
            "start_logit": 4.2303853034973145,
            "end_logit": 3.40594744682312,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Myt1L, Nfia, Nfib, Tead1",
            "probability": 0.05619301978320345,
            "start_logit": 4.2303853034973145,
            "end_logit": 3.2184853553771973,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Tgif2",
            "probability": 0.05357516941823078,
            "start_logit": 3.9952163696289062,
            "end_logit": 3.40594744682312,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "CREBBP",
            "probability": 0.051992343172857475,
            "start_logit": 4.055923938751221,
            "end_logit": 3.3152506351470947,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Tead1 and Tgif2",
            "probability": 0.05164797662210478,
            "start_logit": 3.9585816860198975,
            "end_logit": 3.40594744682312,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Nfib",
            "probability": 0.05072507562258274,
            "start_logit": 3.903012752532959,
            "end_logit": 3.443485736846924,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "PTEN, CREBBP",
            "probability": 0.05042525286868096,
            "start_logit": 4.025319576263428,
            "end_logit": 3.3152506351470947,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Nfib, Tead1 and Tgif2",
            "probability": 0.04885623893577127,
            "start_logit": 3.903012752532959,
            "end_logit": 3.40594744682312,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Myt1L",
            "probability": 0.046269591781577316,
            "start_logit": 4.2303853034973145,
            "end_logit": 3.0241777896881104,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "PTEN",
            "probability": 0.046021147172802854,
            "start_logit": 4.025319576263428,
            "end_logit": 3.2238595485687256,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Nfia",
            "probability": 0.04403756094099835,
            "start_logit": 3.735285997390747,
            "end_logit": 3.469835042953491,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Nfia, Nfib",
            "probability": 0.04289235570677008,
            "start_logit": 3.735285997390747,
            "end_logit": 3.443485736846924,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Tead1",
            "probability": 0.042819299701797216,
            "start_logit": 3.9585816860198975,
            "end_logit": 3.2184853553771973,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Crebbp, Myt1L, Nfia",
            "probability": 0.04192295677171004,
            "start_logit": 3.6860766410827637,
            "end_logit": 3.469835042953491,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Nfia, Nfib, Tead1 and Tgif2",
            "probability": 0.04131209570824398,
            "start_logit": 3.735285997390747,
            "end_logit": 3.40594744682312,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Crebbp, Myt1L, Nfia, Nfib",
            "probability": 0.04083274222523204,
            "start_logit": 3.6860766410827637,
            "end_logit": 3.443485736846924,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Nfib, Tead1",
            "probability": 0.040504780131077875,
            "start_logit": 3.903012752532959,
            "end_logit": 3.2184853553771973,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "CREBBP) or associated with poor outcome (PTEN",
            "probability": 0.03957070485810577,
            "start_logit": 4.055923938751221,
            "end_logit": 3.042243242263794,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        }
    ],
    "5300aad02059c6d71c000080": [
        {
            "text": "baseball/softball and football",
            "probability": 0.09116392186925944,
            "start_logit": 4.233429908752441,
            "end_logit": 4.350976467132568,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseball/softball and football predominant in the United States (55% of events) and soccer, cricket, and hockey",
            "probability": 0.08798613126909166,
            "start_logit": 4.233429908752441,
            "end_logit": 4.315496444702148,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football",
            "probability": 0.07406038481389558,
            "start_logit": 4.025651454925537,
            "end_logit": 4.350976467132568,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "soccer, cricket, and hockey",
            "probability": 0.07190247369217564,
            "start_logit": 4.031561374664307,
            "end_logit": 4.315496444702148,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football predominant in the United States (55% of events) and soccer, cricket, and hockey",
            "probability": 0.07147878904793101,
            "start_logit": 4.025651454925537,
            "end_logit": 4.315496444702148,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseball/softball",
            "probability": 0.06627037100520271,
            "start_logit": 4.233429908752441,
            "end_logit": 4.032060146331787,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseball/softball and football predominant in the United States (55% of events) and soccer",
            "probability": 0.059389662994863535,
            "start_logit": 4.233429908752441,
            "end_logit": 3.9224374294281006,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "hockey",
            "probability": 0.05877211103278787,
            "start_logit": 3.829918146133423,
            "end_logit": 4.315496444702148,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseball/softball and football predominant in the United States (55% of events) and soccer, cricket",
            "probability": 0.05267908619902875,
            "start_logit": 4.233429908752441,
            "end_logit": 3.8025357723236084,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseball",
            "probability": 0.05153569749868691,
            "start_logit": 4.233429908752441,
            "end_logit": 3.7805919647216797,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "cricket, and hockey",
            "probability": 0.05143344779309204,
            "start_logit": 3.6965394020080566,
            "end_logit": 4.315496444702148,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "soccer",
            "probability": 0.0485333724699797,
            "start_logit": 4.031561374664307,
            "end_logit": 3.9224374294281006,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football predominant in the United States (55% of events) and soccer",
            "probability": 0.048247390033033674,
            "start_logit": 4.025651454925537,
            "end_logit": 3.9224374294281006,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "soccer, cricket",
            "probability": 0.043049473308120166,
            "start_logit": 4.031561374664307,
            "end_logit": 3.8025357723236084,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football predominant in the United States (55% of events) and soccer, cricket",
            "probability": 0.04279580469497126,
            "start_logit": 4.025651454925537,
            "end_logit": 3.8025357723236084,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "cricket",
            "probability": 0.0307942512157861,
            "start_logit": 3.6965394020080566,
            "end_logit": 3.8025357723236084,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "softball and football",
            "probability": 0.014926590591335802,
            "start_logit": 2.423914909362793,
            "end_logit": 4.350976467132568,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "softball and football predominant in the United States (55% of events) and soccer, cricket, and hockey",
            "probability": 0.014406279723822604,
            "start_logit": 2.423914909362793,
            "end_logit": 4.315496444702148,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "softball",
            "probability": 0.010850681673713157,
            "start_logit": 2.423914909362793,
            "end_logit": 4.032060146331787,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "softball and football predominant in the United States (55% of events) and soccer",
            "probability": 0.009724079073222251,
            "start_logit": 2.423914909362793,
            "end_logit": 3.9224374294281006,
            "question_text": "Which sports have a risk for commotio cordis?"
        }
    ],
    "553e1aa5a3cf796f71000003": [
        {
            "text": "deletion mutations",
            "probability": 0.15886559756257207,
            "start_logit": 4.670650959014893,
            "end_logit": 4.100234031677246,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "deletion",
            "probability": 0.13239222868309214,
            "start_logit": 4.670650959014893,
            "end_logit": 3.9179444313049316,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "substitution and deletion mutations",
            "probability": 0.1279525322821857,
            "start_logit": 4.454251766204834,
            "end_logit": 4.100234031677246,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "substitution and deletion",
            "probability": 0.10663051771049277,
            "start_logit": 4.454251766204834,
            "end_logit": 3.9179444313049316,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "transversion",
            "probability": 0.07147240875758838,
            "start_logit": 4.1868672370910645,
            "end_logit": 3.7852706909179688,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G:C-->T:A mutations.a G:C-->T:A transversion",
            "probability": 0.06790444912707501,
            "start_logit": 3.790621280670166,
            "end_logit": 4.130306720733643,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G:C-->T:A mutations",
            "probability": 0.045284755628398864,
            "start_logit": 3.790621280670166,
            "end_logit": 3.725175619125366,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "transversion mutations",
            "probability": 0.03613184862066768,
            "start_logit": 4.1868672370910645,
            "end_logit": 3.1031339168548584,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G:C-->T:A transversion",
            "probability": 0.03581491504116712,
            "start_logit": 3.1508841514587402,
            "end_logit": 4.130306720733643,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "transition and transversion",
            "probability": 0.025636122648928727,
            "start_logit": 3.161558151245117,
            "end_logit": 3.7852706909179688,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "transversion mutations, including A:T-->G:C, A:T-->C:G",
            "probability": 0.023783721986230542,
            "start_logit": 4.1868672370910645,
            "end_logit": 2.6849606037139893,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "substitution",
            "probability": 0.023346146235974665,
            "start_logit": 4.454251766204834,
            "end_logit": 2.3990066051483154,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "A:T-->C:G and G:C-->T:A mutations",
            "probability": 0.02262677647944602,
            "start_logit": 3.096784830093384,
            "end_logit": 3.725175619125366,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "a G:C-->T:A transversion",
            "probability": 0.020890580249922734,
            "start_logit": 2.6118180751800537,
            "end_logit": 4.130306720733643,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "transversion mutations, including A:T-->G:C",
            "probability": 0.019493213212940404,
            "start_logit": 4.1868672370910645,
            "end_logit": 2.48602557182312,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "deletion mutations. Of the substitutions, a G.C-->A.T transition",
            "probability": 0.01833385367451342,
            "start_logit": 4.670650959014893,
            "end_logit": 1.9409247636795044,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "deletion mutations. Of the substitutions",
            "probability": 0.01705844960252844,
            "start_logit": 4.670650959014893,
            "end_logit": 1.868821144104004,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G:C-->T:A",
            "probability": 0.016931330015564103,
            "start_logit": 3.790621280670166,
            "end_logit": 2.741370916366577,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "substitution and deletion mutations. Of the substitutions, a G.C-->A.T transition",
            "probability": 0.014766337332543551,
            "start_logit": 4.454251766204834,
            "end_logit": 1.9409247636795044,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "A:T-->G:C, A:T-->C:G and G:C-->T:A mutations",
            "probability": 0.014684215148167985,
            "start_logit": 2.664423942565918,
            "end_logit": 3.725175619125366,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        }
    ],
    "56c08702ef6e394741000024": [
        {
            "text": "Erythropoietic Protoporphyria",
            "probability": 0.36554342142012497,
            "start_logit": 5.387274265289307,
            "end_logit": 5.289072513580322,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphyria",
            "probability": 0.31577017708194566,
            "start_logit": 5.238089084625244,
            "end_logit": 5.291887283325195,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "vitiligo",
            "probability": 0.2097517354383998,
            "start_logit": 5.12551736831665,
            "end_logit": 4.995368957519531,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "photodermatoses such as erythropoietic protoporphyria",
            "probability": 0.07875519287338224,
            "start_logit": 4.0067667961120605,
            "end_logit": 5.1345391273498535,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "photodermatoses",
            "probability": 0.01160250464551889,
            "start_logit": 4.0067667961120605,
            "end_logit": 3.2194159030914307,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphyria (EPP)",
            "probability": 0.007647666629873108,
            "start_logit": 4.990643501281738,
            "end_logit": 1.8187187910079956,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "photodermatoses such as erythropoietic protoporphyria (EPP)",
            "probability": 0.002859148577796528,
            "start_logit": 4.0067667961120605,
            "end_logit": 1.8187187910079956,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "Protoporphyria",
            "probability": 0.0018808782648837572,
            "start_logit": 0.11762802302837372,
            "end_logit": 5.289072513580322,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "protoporphyria",
            "probability": 0.0013945323693474892,
            "start_logit": -0.02701828069984913,
            "end_logit": 5.1345391273498535,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "Erythropoietic",
            "probability": 0.0010802399477515454,
            "start_logit": 5.387274265289307,
            "end_logit": -0.5351293683052063,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "photodermatose",
            "probability": 0.0010193907615865688,
            "start_logit": 4.0067667961120605,
            "end_logit": 0.7874000668525696,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "protoporphyria.Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo",
            "probability": 0.001012426391367512,
            "start_logit": -0.2080574333667755,
            "end_logit": 4.995368957519531,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic",
            "probability": 0.0006092359694839322,
            "start_logit": 4.990643501281738,
            "end_logit": -0.7112314105033875,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "Erythropoietic Protoporphy",
            "probability": 0.00023629344568673263,
            "start_logit": 5.387274265289307,
            "end_logit": -2.0549933910369873,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "photodermatoses such as erythropoietic",
            "probability": 0.00022776831679460584,
            "start_logit": 4.0067667961120605,
            "end_logit": -0.7112314105033875,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "Erythropoietic Protoporphyria.",
            "probability": 0.00014710048935354583,
            "start_logit": 5.387274265289307,
            "end_logit": -2.52895188331604,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "er",
            "probability": 0.00013081928596629674,
            "start_logit": 5.238089084625244,
            "end_logit": -2.497065782546997,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "Er",
            "probability": 0.00012284401471261415,
            "start_logit": 5.387274265289307,
            "end_logit": -2.7091524600982666,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphyria.",
            "probability": 0.00010517884696113559,
            "start_logit": 5.238089084625244,
            "end_logit": -2.7152204513549805,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphy",
            "probability": 0.00010344522906319297,
            "start_logit": 5.238089084625244,
            "end_logit": -2.7318403720855713,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        }
    ],
    "56c1f034ef6e394741000050": [
        {
            "text": "parkinsonism",
            "probability": 0.1233376364697682,
            "start_logit": 4.333652019500732,
            "end_logit": 4.493513107299805,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, and hypoventilation",
            "probability": 0.10132602508895827,
            "start_logit": 4.333652019500732,
            "end_logit": 4.29693078994751,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation",
            "probability": 0.07235207585852146,
            "start_logit": 3.9968528747558594,
            "end_logit": 4.29693078994751,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, depression",
            "probability": 0.07171283405771485,
            "start_logit": 4.118065357208252,
            "end_logit": 4.166843891143799,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Parkinsonism",
            "probability": 0.06611289080099952,
            "start_logit": 3.8649768829345703,
            "end_logit": 4.338626384735107,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Depression, parkinsonism",
            "probability": 0.05792027081557625,
            "start_logit": 3.577793836593628,
            "end_logit": 4.493513107299805,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "depression",
            "probability": 0.05584535102674371,
            "start_logit": 3.8679819107055664,
            "end_logit": 4.166843891143799,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, depression, severe weight loss, and hypoventilation",
            "probability": 0.05100610135483543,
            "start_logit": 4.118065357208252,
            "end_logit": 3.8261194229125977,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Depression, parkinsonism, and hypoventilation",
            "probability": 0.047583454505850456,
            "start_logit": 3.577793836593628,
            "end_logit": 4.29693078994751,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, central hypoventilation",
            "probability": 0.04475014596327314,
            "start_logit": 3.9941935539245605,
            "end_logit": 3.819140672683716,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "central hypoventilation, and psychiatric disturbances. OBJECTIVES: Perry syndrome consists of autosomal dominant Parkinsonism",
            "probability": 0.0407631654769591,
            "start_logit": 3.381392002105713,
            "end_logit": 4.338626384735107,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "depression, severe weight loss, and hypoventilation",
            "probability": 0.039720277020065926,
            "start_logit": 3.8679819107055664,
            "end_logit": 3.8261194229125977,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Parkinsonism, depression, weight loss, and central hypoventilation",
            "probability": 0.03909527025530595,
            "start_logit": 3.8649768829345703,
            "end_logit": 3.8132641315460205,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "autosomal dominant parkinsonism",
            "probability": 0.03487338368420531,
            "start_logit": 2.9864654541015625,
            "end_logit": 4.577497959136963,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Parkinsonism, depression",
            "probability": 0.03411072196440028,
            "start_logit": 3.8649768829345703,
            "end_logit": 3.6768743991851807,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "depression, weight loss, and central hypoventilation",
            "probability": 0.025799317217996307,
            "start_logit": 3.4493234157562256,
            "end_logit": 3.8132641315460205,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "central hypoventilation",
            "probability": 0.024247006213425737,
            "start_logit": 3.381392002105713,
            "end_logit": 3.819140672683716,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "psychiatric disturbances. OBJECTIVES: Perry syndrome consists of autosomal dominant Parkinsonism",
            "probability": 0.02323638721027947,
            "start_logit": 2.8193325996398926,
            "end_logit": 4.338626384735107,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "autosomal dominant parkinsonism, depression",
            "probability": 0.023128597181636547,
            "start_logit": 2.9864654541015625,
            "end_logit": 4.166843891143799,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, depression, severe weight loss",
            "probability": 0.023079087833483995,
            "start_logit": 4.118065357208252,
            "end_logit": 3.0331010818481445,
            "question_text": "List features of the Perry syndrome."
        }
    ],
    "571f5d3e0fd6f91b6800000a": [
        {
            "text": "Huntington's disease",
            "probability": 0.34431228010188,
            "start_logit": 4.970322132110596,
            "end_logit": 4.531158447265625,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia (FRDA) and Huntington's disease",
            "probability": 0.2880588306967345,
            "start_logit": 4.791937828063965,
            "end_logit": 4.531158447265625,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia",
            "probability": 0.2367852627561712,
            "start_logit": 4.791937828063965,
            "end_logit": 4.335147380828857,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia (FRDA)",
            "probability": 0.07547398629688339,
            "start_logit": 4.791937828063965,
            "end_logit": 3.191781759262085,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Huntington's disease (HD)",
            "probability": 0.008702981342135851,
            "start_logit": 3.783874988555908,
            "end_logit": 2.039722204208374,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia (FRDA) and Huntington's disease (HD)",
            "probability": 0.008615023415611768,
            "start_logit": 3.773716926574707,
            "end_logit": 2.039722204208374,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases Friedreich's ataxia (FRDA) and Huntington's disease",
            "probability": 0.008472022739953,
            "start_logit": 1.2655423879623413,
            "end_logit": 4.531158447265625,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia and Huntington's disease",
            "probability": 0.007268415139301013,
            "start_logit": 3.0816283226013184,
            "end_logit": 2.5618414878845215,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases Friedreich's ataxia",
            "probability": 0.006964029277297105,
            "start_logit": 1.2655423879623413,
            "end_logit": 4.335147380828857,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Huntington's",
            "probability": 0.0062061258513570385,
            "start_logit": 4.970322132110596,
            "end_logit": 0.5151462554931641,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia (FRDA) and Huntington's",
            "probability": 0.005192174253470442,
            "start_logit": 4.791937828063965,
            "end_logit": 0.5151462554931641,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases Friedreich's ataxia (FRDA)",
            "probability": 0.002219745621529893,
            "start_logit": 1.2655423879623413,
            "end_logit": 3.191781759262085,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "(FRDA) and Huntington's disease",
            "probability": 0.00041787989567444196,
            "start_logit": -1.7437881231307983,
            "end_logit": 4.531158447265625,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases Friedreich's ataxia (FRDA) and Huntington's disease (HD)",
            "probability": 0.00035337032919086216,
            "start_logit": 0.57997065782547,
            "end_logit": 2.039722204208374,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "ataxia (FRDA) and Huntington's disease",
            "probability": 0.0002312401796630792,
            "start_logit": -2.3355252742767334,
            "end_logit": 4.531158447265625,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases",
            "probability": 0.00019595784984310642,
            "start_logit": 1.2655423879623413,
            "end_logit": 0.7645334601402283,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "ataxia",
            "probability": 0.00019008015331059647,
            "start_logit": -2.3355252742767334,
            "end_logit": 4.335147380828857,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases Friedreich's ataxia (FRDA) and Huntington's",
            "probability": 0.00015270567556913551,
            "start_logit": 1.2655423879623413,
            "end_logit": 0.5151462554931641,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "(FRDA)",
            "probability": 0.00010948826475338956,
            "start_logit": -1.7437881231307983,
            "end_logit": 3.191781759262085,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "diseases Friedreich's ataxia (FRDA) and Huntington's disease",
            "probability": 7.840015967014704e-05,
            "start_logit": -2.2896206378936768,
            "end_logit": 3.40362286567688,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        }
    ],
    "52fc94db2059c6d71c000074": [
        {
            "text": "bapineuzumab",
            "probability": 0.9961088003247359,
            "start_logit": 4.377394199371338,
            "end_logit": 4.342309474945068,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "bapineuzumab,",
            "probability": 0.00290317836116001,
            "start_logit": 4.377394199371338,
            "end_logit": -1.4957408905029297,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "b",
            "probability": 0.00030901578326391715,
            "start_logit": -3.7008252143859863,
            "end_logit": 4.342309474945068,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "bapineuz",
            "probability": 0.00020351258103189356,
            "start_logit": 4.38065767288208,
            "end_logit": -4.1568379402160645,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "bapineuzuma",
            "probability": 0.00011130457642464508,
            "start_logit": 4.377394199371338,
            "end_logit": -4.7570319175720215,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "bapineuzumab failed to improve cognitive and functional performances in AD patients,",
            "probability": 8.75421090333614e-05,
            "start_logit": 4.38065767288208,
            "end_logit": -5.00044584274292,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "passive immunotherapy trial with bapineuzumab",
            "probability": 4.700200583590251e-05,
            "start_logit": -5.584027290344238,
            "end_logit": 4.342309474945068,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "meningoencephalitis.The first passive immunotherapy trial with bapineuzumab",
            "probability": 4.317601490825233e-05,
            "start_logit": -5.6689324378967285,
            "end_logit": 4.342309474945068,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "bap",
            "probability": 3.934958652021996e-05,
            "start_logit": 4.38065767288208,
            "end_logit": -5.800080299377441,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "uzumab",
            "probability": 3.6463236439200155e-05,
            "start_logit": -5.795130252838135,
            "end_logit": 4.299526691436768,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "first passive immunotherapy trial with bapineuzumab",
            "probability": 3.186992849618886e-05,
            "start_logit": -5.972554683685303,
            "end_logit": 4.342309474945068,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "The first passive immunotherapy trial with bapineuzumab",
            "probability": 2.984782821811853e-05,
            "start_logit": -6.038105487823486,
            "end_logit": 4.342309474945068,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "trials showed that bapineuzumab",
            "probability": 2.4190671509563924e-05,
            "start_logit": -6.205467700958252,
            "end_logit": 4.299526691436768,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "AN1792",
            "probability": 2.2415329590858533e-05,
            "start_logit": -1.3867350816726685,
            "end_logit": -0.595427930355072,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "b,",
            "probability": 9.006324760269642e-07,
            "start_logit": -3.7008252143859863,
            "end_logit": -1.4957408905029297,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "2",
            "probability": 4.3290718046564585e-07,
            "start_logit": -5.333712100982666,
            "end_logit": -0.595427930355072,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "AN1792 in AD patients was halted when a subset of patients developed meningoencephalitis.",
            "probability": 2.630091321509296e-07,
            "start_logit": -1.3867350816726685,
            "end_logit": -5.0407395362854,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": ",",
            "probability": 2.5473665697029547e-07,
            "start_logit": -4.9636921882629395,
            "end_logit": -1.4957408905029297,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "The first active immunization clinical trial with AN1792",
            "probability": 2.510664925154175e-07,
            "start_logit": -5.8785176277160645,
            "end_logit": -0.595427930355072,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "1792",
            "probability": 2.2931089435349315e-07,
            "start_logit": -5.969156742095947,
            "end_logit": -0.595427930355072,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        }
    ],
    "516e5f25298dcd4e5100007d": [
        {
            "text": "Etoposide",
            "probability": 0.9971533830957382,
            "start_logit": 3.826387405395508,
            "end_logit": 4.00290060043335,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "oside",
            "probability": 0.0011765864931146438,
            "start_logit": -2.9158997535705566,
            "end_logit": 4.00290060043335,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "ide",
            "probability": 0.0006244716936977033,
            "start_logit": -3.5493664741516113,
            "end_logit": 4.00290060043335,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Et",
            "probability": 0.00038532923608645226,
            "start_logit": 3.826387405395508,
            "end_logit": -3.855661153793335,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "oposide",
            "probability": 0.00023096168329332078,
            "start_logit": -4.544020652770996,
            "end_logit": 4.00290060043335,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "14512",
            "probability": 0.0001488258478851633,
            "start_logit": -0.9048178791999817,
            "end_logit": -0.07577718049287796,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Etoposide is effective as an anti-tumour drug",
            "probability": 9.223277074641529e-05,
            "start_logit": 3.826387405395508,
            "end_logit": -5.2854437828063965,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Etopos",
            "probability": 6.18205756372189e-05,
            "start_logit": 3.826387405395508,
            "end_logit": -5.68552303314209,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Etoposide is effective as an anti-tumour drug by inhibiting eukaryotic DNA",
            "probability": 4.207133679811237e-05,
            "start_logit": 3.826387405395508,
            "end_logit": -6.070392608642578,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Etoposide is",
            "probability": 3.1452121660591455e-05,
            "start_logit": 3.826387405395508,
            "end_logit": -6.361292839050293,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F14512",
            "probability": 2.8704509853802632e-05,
            "start_logit": -2.5505404472351074,
            "end_logit": -0.07577718049287796,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "14512, a polyamine-containing inhibitor of DNA topoisomerase IIF14512",
            "probability": 1.2454629784994672e-05,
            "start_logit": -0.9048178791999817,
            "end_logit": -2.5564615726470947,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "14512,",
            "probability": 5.8759845460039935e-06,
            "start_logit": -0.9048178791999817,
            "end_logit": -3.307680368423462,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F14512, a polyamine-containing inhibitor of DNA topoisomerase IIF14512",
            "probability": 2.402163659532448e-06,
            "start_logit": -2.5505404472351074,
            "end_logit": -2.5564615726470947,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F14512,",
            "probability": 1.1333196396885997e-06,
            "start_logit": -2.5505404472351074,
            "end_logit": -3.307680368423462,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "2",
            "probability": 9.083936786611618e-07,
            "start_logit": -6.003672122955322,
            "end_logit": -0.07577718049287796,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "14512, a polyamine-containing inhibitor of DNA topoisomerase IIF14512,",
            "probability": 4.3396378145832435e-07,
            "start_logit": -0.9048178791999817,
            "end_logit": -5.913348197937012,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "14512, a polyamine-containing inhibitor",
            "probability": 3.603090592726205e-07,
            "start_logit": -0.9048178791999817,
            "end_logit": -6.099347114562988,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "14",
            "probability": 3.3897764370685583e-07,
            "start_logit": -0.9048178791999817,
            "end_logit": -6.160375118255615,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "14512, a polyamine-containing inhibitor of DNA",
            "probability": 2.5289369489207164e-07,
            "start_logit": -0.9048178791999817,
            "end_logit": -6.45334005355835,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        }
    ],
    "52fc8b772059c6d71c00006e": [
        {
            "text": "1,7-naphtyridine-3-carbonitrile",
            "probability": 0.5771542961919349,
            "start_logit": 4.442953109741211,
            "end_logit": 4.287175178527832,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphtyridine-3-carbonitrile",
            "probability": 0.23230826314512945,
            "start_logit": 3.5329086780548096,
            "end_logit": 4.287175178527832,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "Honokiol",
            "probability": 0.10712208850185118,
            "start_logit": 3.697930335998535,
            "end_logit": 3.348057508468628,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "luteolin",
            "probability": 0.048834741166767004,
            "start_logit": 3.3340911865234375,
            "end_logit": 2.9263694286346436,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1,7-naphtyridine",
            "probability": 0.01864382597749024,
            "start_logit": 4.442953109741211,
            "end_logit": 0.8545805811882019,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphtyridine",
            "probability": 0.007504258150355125,
            "start_logit": 3.5329086780548096,
            "end_logit": 0.8545805811882019,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1,7-naphtyridine-3",
            "probability": 0.0016683896326299102,
            "start_logit": 4.442953109741211,
            "end_logit": -1.5590755939483643,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1,7-naphtyridine-3-carbonitrile,",
            "probability": 0.0012386246177839002,
            "start_logit": 4.442953109741211,
            "end_logit": -1.8569328784942627,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1,",
            "probability": 0.0009085798771887531,
            "start_logit": 4.442953109741211,
            "end_logit": -2.166806936264038,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphtyridine-3",
            "probability": 0.0006715374040578979,
            "start_logit": 3.5329086780548096,
            "end_logit": -1.5590755939483643,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "7-naphtyridine-3-carbonitrile",
            "probability": 0.0005780408175189793,
            "start_logit": -2.4632673263549805,
            "end_logit": 4.287175178527832,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1",
            "probability": 0.0005277935488897922,
            "start_logit": 4.442953109741211,
            "end_logit": -2.709984540939331,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphtyridine-3-carbonitrile,",
            "probability": 0.0004985542610437188,
            "start_logit": 3.5329086780548096,
            "end_logit": -1.8569328784942627,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "3-carbonitrile",
            "probability": 0.000486304689569756,
            "start_logit": -2.6360764503479004,
            "end_logit": 4.287175178527832,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "carbonitrile",
            "probability": 0.00045306972119951944,
            "start_logit": -2.7068657875061035,
            "end_logit": 4.287175178527832,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1,7-nap",
            "probability": 0.00044700494259309893,
            "start_logit": 4.442953109741211,
            "end_logit": -2.876120090484619,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1,7-naphtyrid",
            "probability": 0.00038247989415464195,
            "start_logit": 4.442953109741211,
            "end_logit": -3.0320136547088623,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1,7-naphtyridine-3-carbonitril",
            "probability": 0.00021503653799535372,
            "start_logit": 4.442953109741211,
            "end_logit": -3.607881784439087,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "nap",
            "probability": 0.00017992232322664323,
            "start_logit": 3.5329086780548096,
            "end_logit": -2.876120090484619,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "-naphtyridine-3-carbonitrile",
            "probability": 0.00017718859861995786,
            "start_logit": -3.6456971168518066,
            "end_logit": 4.287175178527832,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        }
    ],
    "5324d0429b2d7acc7e000023": [
        {
            "text": "central serous chorioretinopathy",
            "probability": 0.5563849085050061,
            "start_logit": 5.610983848571777,
            "end_logit": 6.455184459686279,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "Hypertrichosis",
            "probability": 0.12317632209029053,
            "start_logit": 4.719502925872803,
            "end_logit": 5.838821887969971,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "chorioretinopathy",
            "probability": 0.10576913917829411,
            "start_logit": 3.950782299041748,
            "end_logit": 6.455184459686279,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "pruritus",
            "probability": 0.07306928869305396,
            "start_logit": 4.930871963500977,
            "end_logit": 5.105244159698486,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "pruritus or local irritation",
            "probability": 0.036819398200422675,
            "start_logit": 4.930871963500977,
            "end_logit": 4.41986083984375,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "hair growth",
            "probability": 0.027869033670026976,
            "start_logit": 4.554795265197754,
            "end_logit": 4.517428874969482,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "local irritation",
            "probability": 0.017927911984945553,
            "start_logit": 4.211205959320068,
            "end_logit": 4.41986083984375,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "serous chorioretinopathy",
            "probability": 0.015299213351092673,
            "start_logit": 2.017324924468994,
            "end_logit": 6.455184459686279,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "a case of central serous chorioretinopathy",
            "probability": 0.014326504056647885,
            "start_logit": 1.9516347646713257,
            "end_logit": 6.455184459686279,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "hair growth on areas other than the scalp",
            "probability": 0.009597169979885918,
            "start_logit": 4.554795265197754,
            "end_logit": 3.451380968093872,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "additional hair growth",
            "probability": 0.005833798826461852,
            "start_logit": 2.9909474849700928,
            "end_logit": 4.517428874969482,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "scalp) with minoxidil (5%) twice daily. a case of central serous chorioretinopathy",
            "probability": 0.0057953180857860135,
            "start_logit": 1.0465738773345947,
            "end_logit": 6.455184459686279,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "additional hair growth on areas other than the scalp",
            "probability": 0.0020089666412161323,
            "start_logit": 2.9909474849700928,
            "end_logit": 3.451380968093872,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "case of central serous chorioretinopathy",
            "probability": 0.001875114470962004,
            "start_logit": -0.08180677890777588,
            "end_logit": 6.455184459686279,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "retinopathy",
            "probability": 0.0012407319903080941,
            "start_logit": -0.4947749674320221,
            "end_logit": 6.455184459686279,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "irritation",
            "probability": 0.0009542892236015418,
            "start_logit": 1.278058648109436,
            "end_logit": 4.41986083984375,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "orioretinopathy",
            "probability": 0.0007118230560555612,
            "start_logit": -1.0504024028778076,
            "end_logit": 6.455184459686279,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "ritus",
            "probability": 0.0004862468277418446,
            "start_logit": -0.08157509565353394,
            "end_logit": 5.105244159698486,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "central serous",
            "probability": 0.00044027342717490887,
            "start_logit": 5.610983848571777,
            "end_logit": -0.6866351962089539,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "Hypertrichosis is a well-recognized adverse effect of therapy with either oral or topical minoxidil.reported increase of adverse events",
            "probability": 0.00041454774102561823,
            "start_logit": 4.719502925872803,
            "end_logit": 0.14463791251182556,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        }
    ],
    "553fca6054168f6c79000002": [
        {
            "text": "MutY, MutM, and MutT",
            "probability": 0.1947927145965907,
            "start_logit": 4.941739559173584,
            "end_logit": 4.941816806793213,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutM, and MutT",
            "probability": 0.18554291503805714,
            "start_logit": 4.893089771270752,
            "end_logit": 4.941816806793213,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutT",
            "probability": 0.17251112463942742,
            "start_logit": 4.820265293121338,
            "end_logit": 4.941816806793213,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY, MutM",
            "probability": 0.1525118404005126,
            "start_logit": 4.941739559173584,
            "end_logit": 4.697123050689697,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutM",
            "probability": 0.14526976280572512,
            "start_logit": 4.893089771270752,
            "end_logit": 4.697123050689697,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY",
            "probability": 0.1420436451552728,
            "start_logit": 4.941739559173584,
            "end_logit": 4.6260151863098145,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "Mut",
            "probability": 0.0014569013038673358,
            "start_logit": 4.941739559173584,
            "end_logit": 0.04619260132312775,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY, Mut",
            "probability": 0.0007750701338220394,
            "start_logit": 4.941739559173584,
            "end_logit": -0.5849209427833557,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY, MutM,",
            "probability": 0.0007374316383292485,
            "start_logit": 4.941739559173584,
            "end_logit": -0.6347010731697083,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutM,",
            "probability": 0.00070241444142436,
            "start_logit": 4.893089771270752,
            "end_logit": -0.6347010731697083,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "GO repair enzymes MutY, MutM, and MutT",
            "probability": 0.0005211688854355062,
            "start_logit": -0.9818775653839111,
            "end_logit": 4.941816806793213,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY, MutM, and MutT are involved in the prevention of base substitution mutations",
            "probability": 0.00041255708553137633,
            "start_logit": 4.941739559173584,
            "end_logit": -1.2154998779296875,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "GO repair enzymes MutY, MutM",
            "probability": 0.00040804619434490954,
            "start_logit": -0.9818775653839111,
            "end_logit": 4.697123050689697,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutM, and MutT are involved in the prevention of base substitution mutations",
            "probability": 0.0003929666693522037,
            "start_logit": 4.893089771270752,
            "end_logit": -1.2154998779296875,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "GO repair enzymes MutY",
            "probability": 0.00038003848543350873,
            "start_logit": -0.9818775653839111,
            "end_logit": 4.6260151863098145,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutT are involved in the prevention of base substitution mutations",
            "probability": 0.0003653662661376958,
            "start_logit": 4.820265293121338,
            "end_logit": -1.2154998779296875,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "repair enzymes MutY, MutM, and MutT",
            "probability": 0.00030880594153473673,
            "start_logit": -1.505238652229309,
            "end_logit": 4.941816806793213,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "base substitution mutations in carbon-starved P. putida.Our results demonstrated that the GO repair enzymes MutY",
            "probability": 0.0002991343106528471,
            "start_logit": -0.3356136977672577,
            "end_logit": 3.7403714656829834,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "base substitution mutations in carbon-starved P. putida.Our results demonstrated that the GO repair enzymes MutY, MutM",
            "probability": 0.00028984037595553247,
            "start_logit": -0.3356136977672577,
            "end_logit": 3.7088091373443604,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutT are involved in the prevention of base substitution mutations in carbon-starved P. putida.Our results demonstrated that the GO repair",
            "probability": 0.00027825563259325684,
            "start_logit": 4.820265293121338,
            "end_logit": -1.4878599643707275,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        }
    ],
    "52ee065d98d0239505000033": [
        {
            "text": "prostate, and colon cancer",
            "probability": 0.21292416770015093,
            "start_logit": 1.9086096286773682,
            "end_logit": 1.5197620391845703,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "colon cancer",
            "probability": 0.16726631109489074,
            "start_logit": 1.667260766029358,
            "end_logit": 1.5197620391845703,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "leukemia, prostate, and colon cancer",
            "probability": 0.10869460534933989,
            "start_logit": 1.2362157106399536,
            "end_logit": 1.5197620391845703,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "leukemia",
            "probability": 0.08133096556074793,
            "start_logit": 1.2362157106399536,
            "end_logit": 1.229746699333191,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "support vector machine",
            "probability": 0.046240904490955664,
            "start_logit": 0.806891143321991,
            "end_logit": 1.0944092273712158,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "microarray classification models such as support vector machine",
            "probability": 0.04047993968621141,
            "start_logit": 0.673832893371582,
            "end_logit": 1.0944092273712158,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "decision trees",
            "probability": 0.038609887697710434,
            "start_logit": 1.0072838068008423,
            "end_logit": 0.7136601805686951,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "support vector machine, artificial neural network",
            "probability": 0.036603572805821286,
            "start_logit": 0.806891143321991,
            "end_logit": 0.8606902956962585,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "microarray classification models such as support vector machine, artificial neural network",
            "probability": 0.03204328366391069,
            "start_logit": 0.673832893371582,
            "end_logit": 0.8606902956962585,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "support vector machine, artificial neural network, decision trees",
            "probability": 0.03159869234220566,
            "start_logit": 0.806891143321991,
            "end_logit": 0.7136601805686951,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "artificial neural network",
            "probability": 0.031110919480846284,
            "start_logit": 0.6443041563034058,
            "end_logit": 0.8606902956962585,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "microarray classification models such as support vector machine, artificial neural network, decision trees",
            "probability": 0.02766194074827882,
            "start_logit": 0.673832893371582,
            "end_logit": 0.7136601805686951,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "artificial neural network, decision trees",
            "probability": 0.02685706060371384,
            "start_logit": 0.6443041563034058,
            "end_logit": 0.7136601805686951,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "decision trees, k nearest neighbors",
            "probability": 0.0203272782307027,
            "start_logit": 1.0072838068008423,
            "end_logit": 0.07211551815271378,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prostate",
            "probability": 0.019053410437916533,
            "start_logit": 1.9086096286773682,
            "end_logit": -0.8939279317855835,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prostate, and colon cancer datasets show that fuzzy support vector machine",
            "probability": 0.017357443019778936,
            "start_logit": 1.9086096286773682,
            "end_logit": -0.987152636051178,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "support vector machine, artificial neural network, decision trees, k nearest neighbors",
            "probability": 0.016636034168120064,
            "start_logit": 0.806891143321991,
            "end_logit": 0.07211551815271378,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "decision trees, k nearest neighbors, and diagonal linear discriminant analysis",
            "probability": 0.016500497377018954,
            "start_logit": 1.0072838068008423,
            "end_logit": -0.13645769655704498,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "microarray classification models such as support vector machine, artificial neural network, decision trees, k nearest neighbors",
            "probability": 0.014563418842184822,
            "start_logit": 0.673832893371582,
            "end_logit": 0.07211551815271378,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "artificial neural network, decision trees, k nearest neighbors",
            "probability": 0.014139666699494421,
            "start_logit": 0.6443041563034058,
            "end_logit": 0.07211551815271378,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        }
    ],
    "56d094f33975bb303a000012": [
        {
            "text": "cell division",
            "probability": 0.7970249907984178,
            "start_logit": 5.363815784454346,
            "end_logit": 5.079594135284424,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division protein in Escherichia coli",
            "probability": 0.049796879072484965,
            "start_logit": 5.363815784454346,
            "end_logit": 2.3066604137420654,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "essential cell division",
            "probability": 0.04708182247753977,
            "start_logit": 2.5348167419433594,
            "end_logit": 5.079594135284424,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division protein",
            "probability": 0.022099106765445964,
            "start_logit": 5.363815784454346,
            "end_logit": 1.4942452907562256,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "bacterial division",
            "probability": 0.014592756961244225,
            "start_logit": 2.890758752822876,
            "end_logit": 3.552290439605713,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "bacterial division FtsZ proteinThe GTPase-dependent polymerization/depolymerization dynamics of FtsZ regulate bacterial cell division",
            "probability": 0.013784121021511619,
            "start_logit": 2.890758752822876,
            "end_logit": 3.4952824115753174,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division protein in Escherichia coli,",
            "probability": 0.008495198308567034,
            "start_logit": 5.363815784454346,
            "end_logit": 0.5382091999053955,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division protein in Escherichia coli, and its localization, filamentation, and bundling at the mid-cell",
            "probability": 0.008239412003922548,
            "start_logit": 5.363815784454346,
            "end_logit": 0.507637083530426,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division protein in Escherichia coli, and its localization, filamentation",
            "probability": 0.00808565931257548,
            "start_logit": 5.363815784454346,
            "end_logit": 0.48880013823509216,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division requires FtsZ plus the essential Z ring-associated proteins FtsA and ZipA.FtsZ is an essential cell division",
            "probability": 0.00795731441495197,
            "start_logit": 0.7570213079452515,
            "end_logit": 5.079594135284424,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division",
            "probability": 0.006952627054390436,
            "start_logit": 0.6220493316650391,
            "end_logit": 5.079594135284424,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "an essential cell division",
            "probability": 0.0032254715224328124,
            "start_logit": -0.14599110186100006,
            "end_logit": 5.079594135284424,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "essential cell division protein in Escherichia coli",
            "probability": 0.0029415988802027745,
            "start_logit": 2.5348167419433594,
            "end_logit": 2.3066604137420654,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "FtsZ is an essential cell division",
            "probability": 0.0022621202610898818,
            "start_logit": -0.500767707824707,
            "end_logit": 5.079594135284424,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "GTPase-dependent polymerization/depolymerization dynamics of FtsZ regulate bacterial cell division",
            "probability": 0.0019808188259573,
            "start_logit": 0.950751781463623,
            "end_logit": 3.4952824115753174,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "bacterial cell division",
            "probability": 0.0014451319957563007,
            "start_logit": 0.6354421377182007,
            "end_logit": 3.4952824115753174,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division FtsZ proteinThe GTPase-dependent polymerization/depolymerization dynamics of FtsZ regulate bacterial cell division",
            "probability": 0.0014208580707477233,
            "start_logit": 0.6185024380683899,
            "end_logit": 3.4952824115753174,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "essential cell division protein",
            "probability": 0.0013054373873529867,
            "start_logit": 2.5348167419433594,
            "end_logit": 1.4942452907562256,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division in vivo",
            "probability": 0.0006673456217530178,
            "start_logit": 2.904428005218506,
            "end_logit": 0.4536486864089966,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "filamentation, and bundling at the mid-cell are required for Z-ring stability",
            "probability": 0.0006413292436552077,
            "start_logit": -0.4091695547103882,
            "end_logit": 3.7274811267852783,
            "question_text": "List functional roles of the FtsZ protein."
        }
    ],
    "550e866271445a662f000005": [
        {
            "text": "prostate cancer",
            "probability": 0.9271518198043446,
            "start_logit": 5.1458001136779785,
            "end_logit": 4.6954216957092285,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "prostate",
            "probability": 0.061298577636658476,
            "start_logit": 5.1458001136779785,
            "end_logit": 1.9790610074996948,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "prostate cancer (CRPC)",
            "probability": 0.007975043169394765,
            "start_logit": 5.1458001136779785,
            "end_logit": -0.06037857010960579,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "cancer",
            "probability": 0.0005979388899953396,
            "start_logit": -2.2005839347839355,
            "end_logit": 4.6954216957092285,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "castration-resistant prostate cancer",
            "probability": 0.0004711294615285108,
            "start_logit": -2.4389395713806152,
            "end_logit": 4.6954216957092285,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "pro",
            "probability": 0.00045397100104479853,
            "start_logit": 5.1458001136779785,
            "end_logit": -2.926417589187622,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "antiangiogenic, antitumor properties which has shown potential therapeutic effect in castration-resistant prostate cancer",
            "probability": 0.0003394980045429434,
            "start_logit": -2.766604423522949,
            "end_logit": 4.6954216957092285,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "antitumor properties which has shown potential therapeutic effect in castration-resistant prostate cancer",
            "probability": 0.00032831064395234284,
            "start_logit": -2.800112247467041,
            "end_logit": 4.6954216957092285,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer",
            "probability": 0.00019148007980837188,
            "start_logit": -3.0366268157958984,
            "end_logit": 4.392759799957275,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "prostate cancer.",
            "probability": 0.00018809223018643694,
            "start_logit": 4.803083896636963,
            "end_logit": -3.4648022651672363,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "prostate cancer (CRPC) patients",
            "probability": 0.00017735517866877912,
            "start_logit": 5.1458001136779785,
            "end_logit": -3.8662965297698975,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "prostate cancer.BACKGROUND: Intetumumab is a fully human mAb with antiangiogenic, antitumor properties",
            "probability": 0.000167360551913437,
            "start_logit": 4.803083896636963,
            "end_logit": -3.5815842151641846,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "state cancer",
            "probability": 0.0001463697030511081,
            "start_logit": -3.6079368591308594,
            "end_logit": 4.6954216957092285,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "prostate cancer.BACKGROUND: Intetumumab is a fully human mAb with antiangiogenic",
            "probability": 0.00014045304666868846,
            "start_logit": 4.803083896636963,
            "end_logit": -3.756861448287964,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "prostate cancer.BACKGROUND: Intetumumab is a fully human mAb with antiangiogenic, antitumor",
            "probability": 0.00012557285794994002,
            "start_logit": 4.803083896636963,
            "end_logit": -3.8688485622406006,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "prostate cancer.BACKGROUND: Intetumumab",
            "probability": 9.230483903881182e-05,
            "start_logit": 4.803083896636963,
            "end_logit": -4.176638126373291,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "metastatic castration-resistant prostate cancer",
            "probability": 7.942208786966413e-05,
            "start_logit": -3.9166340827941895,
            "end_logit": 4.392759799957275,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "castration-resistant prostate",
            "probability": 3.114869135511909e-05,
            "start_logit": -2.4389395713806152,
            "end_logit": 1.9790610074996948,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "antiangiogenic, antitumor properties which has shown potential therapeutic effect in castration-resistant prostate",
            "probability": 2.2445886794848663e-05,
            "start_logit": -2.766604423522949,
            "end_logit": 1.9790610074996948,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "antitumor properties which has shown potential therapeutic effect in castration-resistant prostate",
            "probability": 2.170623523286722e-05,
            "start_logit": -2.800112247467041,
            "end_logit": 1.9790610074996948,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        }
    ],
    "56acc7ca0a360a5e45000002": [
        {
            "text": "Insyght",
            "probability": 0.8646502673261826,
            "start_logit": 3.2848548889160156,
            "end_logit": 3.455989122390747,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genomicus",
            "probability": 0.06321357087849344,
            "start_logit": 2.1639232635498047,
            "end_logit": 1.9611146450042725,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "eukaryotaGenomicus (http://www.dyogen.ens.fr/genomicus",
            "probability": 0.015431052730807806,
            "start_logit": 0.7537861466407776,
            "end_logit": 1.9611146450042725,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "five genome browsers",
            "probability": 0.008344801306655351,
            "start_logit": 0.3386196196079254,
            "end_logit": 1.761538028717041,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome browsers",
            "probability": 0.008142025291606254,
            "start_logit": 0.3140198290348053,
            "end_logit": 1.761538028717041,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "eukaryotaGenomicus",
            "probability": 0.006816966930715081,
            "start_logit": 0.7537861466407776,
            "end_logit": 1.1441473960876465,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "dyogen.ens.fr/genomicus",
            "probability": 0.004726537127442722,
            "start_logit": -0.4294029176235199,
            "end_logit": 1.9611146450042725,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "five genome browsers for comparative genomics in eukaryotaGenomicus",
            "probability": 0.004500768294585894,
            "start_logit": 0.3386196196079254,
            "end_logit": 1.1441473960876465,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome browsers for comparative genomics in eukaryotaGenomicus",
            "probability": 0.0043914010579199254,
            "start_logit": 0.3140198290348053,
            "end_logit": 1.1441473960876465,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Insyght is a comparative genomic visualization tool that combines three complementary displays: (i) a table",
            "probability": 0.0029727667884524513,
            "start_logit": 3.2848548889160156,
            "end_logit": -2.2168428897857666,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Insyght is a comparative genomic visualization tool",
            "probability": 0.0025485371257056907,
            "start_logit": 3.2848548889160156,
            "end_logit": -2.370816469192505,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "eukaryotaGenomicus (http://www.dyogen",
            "probability": 0.0021535375540501314,
            "start_logit": 0.7537861466407776,
            "end_logit": -0.008155381307005882,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "(http://www.dyogen.ens.fr/genomicus",
            "probability": 0.0020262010450484594,
            "start_logit": -1.2764331102371216,
            "end_logit": 1.9611146450042725,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "comparative genomics in eukaryotaGenomicus",
            "probability": 0.0017315750681714023,
            "start_logit": -0.616597056388855,
            "end_logit": 1.1441473960876465,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "five genome browser",
            "probability": 0.0016739973939698407,
            "start_logit": 0.3386196196079254,
            "end_logit": 0.15511369705200195,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome browser",
            "probability": 0.0016333197902405514,
            "start_logit": 0.3140198290348053,
            "end_logit": 0.15511369705200195,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "five genome browsers for comparative genomics in eukaryotaGenomicus (http://www.dyogen",
            "probability": 0.0014218307999701804,
            "start_logit": 0.3386196196079254,
            "end_logit": -0.008155381307005882,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome browsers for comparative genomics in eukaryotaGenomicus (http://www.dyogen",
            "probability": 0.0013872807641937643,
            "start_logit": 0.3140198290348053,
            "end_logit": -0.008155381307005882,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "five genome browsers for comparative genomics",
            "probability": 0.0011305169640483058,
            "start_logit": 0.3386196196079254,
            "end_logit": -0.23742569983005524,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "genome browsers for comparative genomics",
            "probability": 0.0011030457617403143,
            "start_logit": 0.3140198290348053,
            "end_logit": -0.23742569983005524,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        }
    ],
    "515ffc2b298dcd4e51000035": [
        {
            "text": "Aspergillus terreus",
            "probability": 0.37238663796765376,
            "start_logit": 4.093249320983887,
            "end_logit": 3.303023099899292,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreusA potent itaconic acid producing strain, Aspergillus terreus",
            "probability": 0.3360944329382799,
            "start_logit": 3.990708827972412,
            "end_logit": 3.303023099899292,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreusA",
            "probability": 0.18547312399579385,
            "start_logit": 3.990708827972412,
            "end_logit": 2.708540916442871,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus",
            "probability": 0.05586121119964186,
            "start_logit": 3.990708827972412,
            "end_logit": 1.5085011720657349,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreusA potent itaconic acid producing strain, Aspergillus",
            "probability": 0.038481405656586525,
            "start_logit": 3.990708827972412,
            "end_logit": 1.1358060836791992,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreus SKR10,",
            "probability": 0.0029561598976256117,
            "start_logit": 4.093249320983887,
            "end_logit": -1.5330184698104858,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreusA potent itaconic acid producing strain, Aspergillus terreus SKR10,",
            "probability": 0.002668057290910812,
            "start_logit": 3.990708827972412,
            "end_logit": -1.5330184698104858,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreus SKR10",
            "probability": 0.000946835430186626,
            "start_logit": 4.093249320983887,
            "end_logit": -2.671539545059204,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreusA potent itaconic acid producing strain, Aspergillus terreus SKR10",
            "probability": 0.0008545583663560135,
            "start_logit": 3.990708827972412,
            "end_logit": -2.671539545059204,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergill",
            "probability": 0.0007150668086060208,
            "start_logit": 4.093249320983887,
            "end_logit": -2.952288866043091,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "As",
            "probability": 0.0006701006298871743,
            "start_logit": 4.093249320983887,
            "end_logit": -3.0172369480133057,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreusA potent itaconic acid producing strain, Aspergill",
            "probability": 0.0006453775432519725,
            "start_logit": 3.990708827972412,
            "end_logit": -2.952288866043091,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreusA potent itaconic acid producing strain, As",
            "probability": 0.0006047936962579114,
            "start_logit": 3.990708827972412,
            "end_logit": -3.0172369480133057,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreusA potent itaconic acid producing strain",
            "probability": 0.000586171196535112,
            "start_logit": 3.990708827972412,
            "end_logit": -3.0485124588012695,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "pergillus terreusA potent itaconic acid producing strain, Aspergillus terreus",
            "probability": 0.00026899669909385585,
            "start_logit": -3.139739513397217,
            "end_logit": 3.303023099899292,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "gillus terreusA potent itaconic acid producing strain, Aspergillus terreus",
            "probability": 0.00019008644190265838,
            "start_logit": -3.48695969581604,
            "end_logit": 3.303023099899292,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terreusA potent",
            "probability": 0.00018988976367698786,
            "start_logit": 3.990708827972412,
            "end_logit": -4.175680637359619,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "pergillus terreusA",
            "probability": 0.00014844535712573386,
            "start_logit": -3.139739513397217,
            "end_logit": 2.708540916442871,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "gillus terreus",
            "probability": 0.00014147666782309432,
            "start_logit": -3.782303810119629,
            "end_logit": 3.303023099899292,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "pergillus terreus",
            "probability": 0.00011717245280453778,
            "start_logit": -3.970791816711426,
            "end_logit": 3.303023099899292,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        }
    ],
    "5321badd9b2d7acc7e00000a": [
        {
            "text": "melanoma",
            "probability": 0.559732411579675,
            "start_logit": 2.876370429992676,
            "end_logit": 3.7527265548706055,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate cancer",
            "probability": 0.1990608955709077,
            "start_logit": 2.6413211822509766,
            "end_logit": 2.953927755355835,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "epithelioid subtype of melanoma",
            "probability": 0.13991717260258837,
            "start_logit": 1.4899622201919556,
            "end_logit": 3.7527265548706055,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate adenocarcinoma",
            "probability": 0.061011609772727855,
            "start_logit": 2.629275321960449,
            "end_logit": 1.7834270000457764,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate adenocarcinomas",
            "probability": 0.014611722569592044,
            "start_logit": 2.629275321960449,
            "end_logit": 0.3541869521141052,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "adenocarcinoma",
            "probability": 0.013262813353935575,
            "start_logit": 1.1031752824783325,
            "end_logit": 1.7834270000457764,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "adenocarcinomas",
            "probability": 0.003176322505534222,
            "start_logit": 1.1031752824783325,
            "end_logit": 0.3541869521141052,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "epithelioid",
            "probability": 0.002736134462199731,
            "start_logit": 1.4899622201919556,
            "end_logit": -0.1817779242992401,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate",
            "probability": 0.0018610625855758204,
            "start_logit": 2.6413211822509766,
            "end_logit": -1.7185354232788086,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma has the highest incidence of NY-ESO-1 expression. These findin Immunotherapy",
            "probability": 0.0014310670382092143,
            "start_logit": 2.876370429992676,
            "end_logit": -2.2163119316101074,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "cancer",
            "probability": 0.0008601098967746278,
            "start_logit": -2.8029847145080566,
            "end_logit": 2.953927755355835,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "oma",
            "probability": 0.0006278026162457468,
            "start_logit": -3.9166178703308105,
            "end_logit": 3.7527265548706055,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "pro",
            "probability": 0.00030962708052473904,
            "start_logit": 2.629275321960449,
            "end_logit": -3.50002384185791,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "the epithelioid subtype of melanoma",
            "probability": 0.00027205600109248343,
            "start_logit": -4.752835750579834,
            "end_logit": 3.7527265548706055,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate ad",
            "probability": 0.00025486073074104643,
            "start_logit": 2.629275321960449,
            "end_logit": -3.6946752071380615,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate adenocar",
            "probability": 0.0002289389981150041,
            "start_logit": 2.629275321960449,
            "end_logit": -3.8019368648529053,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma has the highest incidence of NY-ESO-1 expression. These findin Im",
            "probability": 0.00022147377742241106,
            "start_logit": 2.876370429992676,
            "end_logit": -4.082183361053467,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate adenocarcin",
            "probability": 0.00016810589197658622,
            "start_logit": 2.629275321960449,
            "end_logit": -4.110798358917236,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "me",
            "probability": 0.0001444485854631565,
            "start_logit": 2.876370429992676,
            "end_logit": -4.50956392288208,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "carcinoma",
            "probability": 0.00011136438069859926,
            "start_logit": -3.67673659324646,
            "end_logit": 1.7834270000457764,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        }
    ],
    "5540eda30083d1bf0e000006": [
        {
            "text": "MutSL",
            "probability": 0.42673607761647053,
            "start_logit": 5.663083076477051,
            "end_logit": 4.872807502746582,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutY and MutSL",
            "probability": 0.1367210290797845,
            "start_logit": 4.52485990524292,
            "end_logit": 4.872807502746582,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutY",
            "probability": 0.12059871022190642,
            "start_logit": 4.52485990524292,
            "end_logit": 4.747333526611328,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutS1 and MutL",
            "probability": 0.04390342076389504,
            "start_logit": 4.465949535369873,
            "end_logit": 3.7957675457000732,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutS1 and MutL, which constitute a conserved core involved in mismatch recognition.the mutS",
            "probability": 0.043343768096784065,
            "start_logit": 4.465949535369873,
            "end_logit": 3.782938241958618,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutL",
            "probability": 0.04295258488237822,
            "start_logit": 4.444054126739502,
            "end_logit": 3.7957675457000732,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutL, which constitute a conserved core involved in mismatch recognition.the mutS",
            "probability": 0.042405052861627296,
            "start_logit": 4.444054126739502,
            "end_logit": 3.782938241958618,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "mutS",
            "probability": 0.03196188501437441,
            "start_logit": 4.161330699920654,
            "end_logit": 3.782938241958618,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutS1",
            "probability": 0.027724049165111227,
            "start_logit": 4.465949535369873,
            "end_logit": 3.3360755443573,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "mutS, mutL",
            "probability": 0.024695863384942725,
            "start_logit": 4.106533527374268,
            "end_logit": 3.579827070236206,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "mutL",
            "probability": 0.024189764243836037,
            "start_logit": 4.085827350616455,
            "end_logit": 3.579827070236206,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutS",
            "probability": 0.01035594195598512,
            "start_logit": 4.465949535369873,
            "end_logit": 2.3513357639312744,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "mutS, mutL and uvrD",
            "probability": 0.006242161561086789,
            "start_logit": 4.106533527374268,
            "end_logit": 2.2045178413391113,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "mutL and uvrD",
            "probability": 0.006114239222212766,
            "start_logit": 4.085827350616455,
            "end_logit": 2.2045178413391113,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "uvrD",
            "probability": 0.003613473293652598,
            "start_logit": 3.5598764419555664,
            "end_logit": 2.2045178413391113,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "DNA Mismatch Repair (MMR) protein MutS",
            "probability": 0.0025372495030754716,
            "start_logit": 2.9669127464294434,
            "end_logit": 2.44389271736145,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutY and MutS",
            "probability": 0.0018545463665247822,
            "start_logit": 4.52485990524292,
            "end_logit": 0.5725050568580627,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutS1 and MutL, which constitute a conserved core involved in mismatch recognition.the mutS/L",
            "probability": 0.0014313967647129938,
            "start_logit": 4.465949535369873,
            "end_logit": 0.37242603302001953,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutL, which constitute a conserved core involved in mismatch recognition.the mutS/L",
            "probability": 0.0014003963692792178,
            "start_logit": 4.444054126739502,
            "end_logit": 0.37242603302001953,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutSL (mismatch repair system [MMR])Escherichia coli DNA Mismatch Repair",
            "probability": 0.001218389632359561,
            "start_logit": 5.663083076477051,
            "end_logit": -0.9858282208442688,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        }
    ],
    "56cdf3745795f9a73e000039": [
        {
            "text": "mLST8",
            "probability": 0.14852211493264733,
            "start_logit": 5.016509532928467,
            "end_logit": 4.683262348175049,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "raptor and mLST8",
            "probability": 0.12024200884522881,
            "start_logit": 4.805282115936279,
            "end_logit": 4.683262348175049,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "raptor",
            "probability": 0.09894069059588756,
            "start_logit": 4.805282115936279,
            "end_logit": 4.488276481628418,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR",
            "probability": 0.07877267699206614,
            "start_logit": 4.814955711364746,
            "end_logit": 4.250648498535156,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "raptor, mTOR",
            "probability": 0.0705189400115125,
            "start_logit": 4.704270839691162,
            "end_logit": 4.250648498535156,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR) is part of two distinct complexes, mTORC1, containing raptor and mLST8",
            "probability": 0.047555841829093705,
            "start_logit": 3.8776803016662598,
            "end_logit": 4.683262348175049,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR, and GbetaL",
            "probability": 0.04534011010607274,
            "start_logit": 4.814955711364746,
            "end_logit": 3.6982743740081787,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "raptor, mTOR, and GbetaL",
            "probability": 0.0405894102723911,
            "start_logit": 4.704270839691162,
            "end_logit": 3.6982743740081787,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR) is part of two distinct complexes, mTORC1, containing raptor",
            "probability": 0.039131147904354305,
            "start_logit": 3.8776803016662598,
            "end_logit": 4.488276481628418,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mLST8, and mTORC2, containing rictor",
            "probability": 0.03736753132420858,
            "start_logit": 5.016509532928467,
            "end_logit": 3.303330659866333,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mLST8, and mTORC2, containing rictor, mLST8",
            "probability": 0.0349630900180512,
            "start_logit": 5.016509532928467,
            "end_logit": 3.236821413040161,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "raptor and mLST8, and mTORC2, containing rictor",
            "probability": 0.03025237712274317,
            "start_logit": 4.805282115936279,
            "end_logit": 3.303330659866333,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR-Raptor",
            "probability": 0.029553441670599593,
            "start_logit": 4.144791603088379,
            "end_logit": 3.940446615219116,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "raptor and mLST8, and mTORC2, containing rictor, mLST8",
            "probability": 0.02830576565054647,
            "start_logit": 4.805282115936279,
            "end_logit": 3.236821413040161,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR, and GbetaL)The mammalian target of rapamycin (mTOR",
            "probability": 0.027282411971056825,
            "start_logit": 4.814955711364746,
            "end_logit": 3.190324544906616,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTORC1, containing raptor and mLST8",
            "probability": 0.026231103307451438,
            "start_logit": 3.282721519470215,
            "end_logit": 4.683262348175049,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Raptor",
            "probability": 0.02596975298034512,
            "start_logit": 4.015523910522461,
            "end_logit": 3.940446615219116,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "raptor, mTOR, and GbetaL)The mammalian target of rapamycin (mTOR",
            "probability": 0.024423783050436406,
            "start_logit": 4.704270839691162,
            "end_logit": 3.190324544906616,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR-Raptor (regulatory associated protein of mTOR)-mLST8",
            "probability": 0.024194516355426625,
            "start_logit": 4.144791603088379,
            "end_logit": 3.7403724193573,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mLST8, and mTORC2, containing rictor, mLST8 and sin1",
            "probability": 0.02184328505988037,
            "start_logit": 5.016509532928467,
            "end_logit": 2.7664220333099365,
            "question_text": "Which are the main components of mTORC1?"
        }
    ],
    "5508685b4b2a315d4100000a": [
        {
            "text": "Crohn's disease",
            "probability": 0.37667648829943035,
            "start_logit": 5.66289758682251,
            "end_logit": 5.120765209197998,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative colitis (UC) and Crohn's disease",
            "probability": 0.2056040599254062,
            "start_logit": 5.0574631690979,
            "end_logit": 5.120765209197998,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative colitis",
            "probability": 0.1857104155487311,
            "start_logit": 5.0574631690979,
            "end_logit": 5.019001483917236,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's disease.NCLUSIONS: Vedolizumab-treated patients with active Crohn's disease",
            "probability": 0.16029396777911062,
            "start_logit": 5.02440071105957,
            "end_logit": 4.9048848152160645,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's",
            "probability": 0.027380938745589497,
            "start_logit": 5.66289758682251,
            "end_logit": 2.499225616455078,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's disease.NCLUSIONS: Vedolizumab-treated patients with active Crohn's",
            "probability": 0.02102806834992666,
            "start_logit": 5.02440071105957,
            "end_logit": 2.8737335205078125,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative colitis (UC) and Crohn's",
            "probability": 0.01494553640997872,
            "start_logit": 5.0574631690979,
            "end_logit": 2.499225616455078,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's disease (CD)",
            "probability": 0.003624333870448829,
            "start_logit": 5.66289758682251,
            "end_logit": 0.4770490229129791,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative colitis (UC) and Crohn's disease (CD)",
            "probability": 0.0019782964465174645,
            "start_logit": 5.0574631690979,
            "end_logit": 0.4770490229129791,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "colitis (UC) and Crohn's disease",
            "probability": 0.0006777839927041664,
            "start_logit": -0.6574157476425171,
            "end_logit": 5.120765209197998,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "colitis",
            "probability": 0.0006122036062081434,
            "start_logit": -0.6574157476425171,
            "end_logit": 5.019001483917236,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative colitis (UC)",
            "probability": 0.00031521870643857824,
            "start_logit": 5.0574631690979,
            "end_logit": -1.359675645828247,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative",
            "probability": 0.0002668901272280549,
            "start_logit": 5.0574631690979,
            "end_logit": -1.526105284690857,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "inflammatory bowel disease",
            "probability": 0.0002254985018330214,
            "start_logit": 1.7487772703170776,
            "end_logit": 1.6140570640563965,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's disease.",
            "probability": 0.00013941978281368088,
            "start_logit": 5.02440071105957,
            "end_logit": -2.142390489578247,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn",
            "probability": 0.00012757746912794353,
            "start_logit": 5.02440071105957,
            "end_logit": -2.23115611076355,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "C",
            "probability": 0.0001266010120757161,
            "start_logit": 5.66289758682251,
            "end_logit": -2.877336263656616,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "hn's disease",
            "probability": 0.0001036920308185913,
            "start_logit": -2.5348191261291504,
            "end_logit": 5.120765209197998,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ul",
            "probability": 8.165424811328957e-05,
            "start_logit": 5.0574631690979,
            "end_logit": -2.7104485034942627,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "disease",
            "probability": 8.135514749951564e-05,
            "start_logit": -2.826547861099243,
            "end_logit": 5.16989278793335,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        }
    ],
    "553fac39c6a5098552000001": [
        {
            "text": "polC",
            "probability": 0.3528009121498243,
            "start_logit": 5.537635803222656,
            "end_logit": 5.612164497375488,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "polC and dnaEBacterial DNA polymerase III, the primary complex of DNA replication, consists of PolC",
            "probability": 0.0835736979805329,
            "start_logit": 5.537635803222656,
            "end_logit": 4.171989440917969,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "dnaEBacterial DNA polymerase III, the primary complex of DNA replication, consists of PolC and DnaE",
            "probability": 0.08132083601520865,
            "start_logit": 5.387831211090088,
            "end_logit": 4.294467449188232,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "dnaEBacterial DNA polymerase III, the primary complex of DNA replication, consists of PolC",
            "probability": 0.0719466060305132,
            "start_logit": 5.387831211090088,
            "end_logit": 4.171989440917969,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PAS is a characteristic of organisms with a heterodimeric DNA polymerase III alpha-subunit constituted by polC",
            "probability": 0.0544281790527262,
            "start_logit": 3.668613910675049,
            "end_logit": 5.612164497375488,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "polC and dnaE",
            "probability": 0.04588806540986652,
            "start_logit": 5.537635803222656,
            "end_logit": 3.572465658187866,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DnaE",
            "probability": 0.04514417415313597,
            "start_logit": 4.603516101837158,
            "end_logit": 4.490241527557373,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "dnaE",
            "probability": 0.03950394254799057,
            "start_logit": 5.387831211090088,
            "end_logit": 3.572465658187866,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DnaE and PolC",
            "probability": 0.02991326816975641,
            "start_logit": 4.603516101837158,
            "end_logit": 4.0786824226379395,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PolC",
            "probability": 0.028225847877960227,
            "start_logit": 4.545452117919922,
            "end_logit": 4.0786824226379395,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PolC and DnaE",
            "probability": 0.02518115082843676,
            "start_logit": 4.215524673461914,
            "end_logit": 4.294467449188232,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DnaE. PolC is conserved in Gram-positive bacteria, especially in the Firmicutes with low GC content, whereas DnaE",
            "probability": 0.021507277759722245,
            "start_logit": 4.600783348083496,
            "end_logit": 3.751504421234131,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "polC are all features associated with a group of low-GC, gram-positive bacteria (Firmicutes)PAS",
            "probability": 0.018665925456376676,
            "start_logit": 3.9326539039611816,
            "end_logit": 4.277942180633545,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DnaE and PolC, rather than a single one.SGD, PAS",
            "probability": 0.016025847361104323,
            "start_logit": 4.603516101837158,
            "end_logit": 3.454583168029785,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DnaE. PolC",
            "probability": 0.015577350292931344,
            "start_logit": 4.600783348083496,
            "end_logit": 3.4289309978485107,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DnaE and PolC, rather than a single one.SGD, PAS, and polC",
            "probability": 0.015560824649841355,
            "start_logit": 4.603516101837158,
            "end_logit": 3.4251368045806885,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PolC, rather than a single one.SGD, PAS",
            "probability": 0.01512182243554648,
            "start_logit": 4.545452117919922,
            "end_logit": 3.454583168029785,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PolC, rather than a single one.SGD, PAS, and polC",
            "probability": 0.01468303185494467,
            "start_logit": 4.545452117919922,
            "end_logit": 3.4251368045806885,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PAS",
            "probability": 0.014334363553934875,
            "start_logit": 3.668613910675049,
            "end_logit": 4.277942180633545,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PolC and DnaE. PolC",
            "probability": 0.010596876419646415,
            "start_logit": 4.215524673461914,
            "end_logit": 3.4289309978485107,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        }
    ],
    "56cf4b623975bb303a00000a": [
        {
            "text": "serotonin",
            "probability": 0.2888759014860231,
            "start_logit": 4.738110065460205,
            "end_logit": 4.494451999664307,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopamine",
            "probability": 0.25342301532078104,
            "start_logit": 4.7638373374938965,
            "end_logit": 4.337787628173828,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "serotonin and dopamine",
            "probability": 0.24698628722466137,
            "start_logit": 4.738110065460205,
            "end_logit": 4.337787628173828,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "5-hydroxytryptamine (5-HT, serotonin",
            "probability": 0.029150114982001676,
            "start_logit": 3.5804643630981445,
            "end_logit": 3.3585593700408936,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "5-hydroxytryptamine",
            "probability": 0.025716301007351176,
            "start_logit": 3.5804643630981445,
            "end_logit": 3.2332255840301514,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopamine, 5-hydroxytryptamine (5-HT, serotonin",
            "probability": 0.023070230223149017,
            "start_logit": 3.346548557281494,
            "end_logit": 3.3585593700408936,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopamine, 5-hydroxytryptamine",
            "probability": 0.020352612162720576,
            "start_logit": 3.346548557281494,
            "end_logit": 3.2332255840301514,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "serotonin), and norepinephrine",
            "probability": 0.019943877989729755,
            "start_logit": 3.6097030639648438,
            "end_logit": 2.94978404045105,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "5-hydroxytryptamine (5-HT, serotonin), and norepinephrine",
            "probability": 0.019369187450851144,
            "start_logit": 3.5804643630981445,
            "end_logit": 2.94978404045105,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "norepinephrine",
            "probability": 0.018575361652578157,
            "start_logit": 3.538616895675659,
            "end_logit": 2.94978404045105,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopamine, 5-hydroxytryptamine (5-HT, serotonin), and norepinephrine",
            "probability": 0.015329325939275603,
            "start_logit": 3.346548557281494,
            "end_logit": 2.94978404045105,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "norepinephrine. These traits are controlled by neurotransmitters like dopamine, serotonin",
            "probability": 0.006949288810306388,
            "start_logit": 3.538616895675659,
            "end_logit": 1.9665873050689697,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "Monoamine oxidase A (MAOA) modulates metabolism of serotonin",
            "probability": 0.006444812667654698,
            "start_logit": 0.935388445854187,
            "end_logit": 4.494451999664307,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "serotonin), and norepinephrine. These traits are controlled by neurotransmitters like dopamine",
            "probability": 0.005794066806017501,
            "start_logit": 3.6097030639648438,
            "end_logit": 1.7136962413787842,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "Monoamine oxidase A (MAOA) modulates metabolism of serotonin and dopamine",
            "probability": 0.005510256634264509,
            "start_logit": 0.935388445854187,
            "end_logit": 4.337787628173828,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "norepinephrine. These traits are controlled by neurotransmitters like dopamine",
            "probability": 0.005396487404124552,
            "start_logit": 3.538616895675659,
            "end_logit": 1.7136962413787842,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "serotonin)",
            "probability": 0.0024680749902603314,
            "start_logit": 3.6097030639648438,
            "end_logit": 0.8603003025054932,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "5-hydroxytryptamine (5-HT, serotonin)",
            "probability": 0.0023969564572009164,
            "start_logit": 3.5804643630981445,
            "end_logit": 0.8603003025054932,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "monoamine",
            "probability": 0.00235082126516895,
            "start_logit": 2.633509397506714,
            "end_logit": 1.7878202199935913,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopamine, 5-hydroxytryptamine (5-HT, serotonin)",
            "probability": 0.0018970195258794674,
            "start_logit": 3.346548557281494,
            "end_logit": 0.8603003025054932,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        }
    ],
    "52bf1d6003868f1b0600000e": [
        {
            "text": "Type 2",
            "probability": 0.28081843648439136,
            "start_logit": 2.303013801574707,
            "end_logit": 3.3725531101226807,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type II",
            "probability": 0.10396465404807702,
            "start_logit": 2.2988123893737793,
            "end_logit": 2.3830971717834473,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type 2, in which clover leaf skull deformity and multiple congenital anomalies are present at birth; and type 3",
            "probability": 0.08442248975853471,
            "start_logit": 2.39949107170105,
            "end_logit": 2.0742013454437256,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type 1",
            "probability": 0.07873603494946838,
            "start_logit": 2.2056543827056885,
            "end_logit": 2.198305130004883,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type 2",
            "probability": 0.0723457514802475,
            "start_logit": 2.39949107170105,
            "end_logit": 1.919824242591858,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type 3",
            "probability": 0.07046163956198967,
            "start_logit": 2.2187256813049316,
            "end_logit": 2.0742013454437256,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type 3, which is similar to type 2",
            "probability": 0.06448148711491464,
            "start_logit": 2.2187256813049316,
            "end_logit": 1.985511064529419,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type 1, characterized by mild expression; type 2",
            "probability": 0.059597882242270334,
            "start_logit": 2.2056543827056885,
            "end_logit": 1.919824242591858,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "Type 1",
            "probability": 0.03605552174595809,
            "start_logit": 1.722333312034607,
            "end_logit": 1.9005852937698364,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type I (61 percent), seven were classified as type II",
            "probability": 0.02860670961604401,
            "start_logit": 1.008402705192566,
            "end_logit": 2.3830971717834473,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type III (14 percent). Pfeiffer syndrome is divided into three clinical subtypes. Type 1",
            "probability": 0.02381469646347101,
            "start_logit": 1.3075761795043945,
            "end_logit": 1.9005852937698364,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type 2 but without a cloverleaf skull. Recently, based on clinical findings, the disorder has been divided into three subtypes: type 1",
            "probability": 0.01956738867930082,
            "start_logit": 0.8134177923202515,
            "end_logit": 2.198305130004883,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type II (25 percent), and four were classified as type III",
            "probability": 0.017702996142021112,
            "start_logit": 2.2988123893737793,
            "end_logit": 0.6127800941467285,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type I",
            "probability": 0.014041391696510303,
            "start_logit": 1.008402705192566,
            "end_logit": 1.6714653968811035,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type II (25 percent)",
            "probability": 0.011909776986508098,
            "start_logit": 2.2988123893737793,
            "end_logit": 0.21640585362911224,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type I. Type 2",
            "probability": 0.009918913504984622,
            "start_logit": -1.0402511358261108,
            "end_logit": 3.3725531101226807,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type II (25 percent), and four were classified as type III (14 percent)",
            "probability": 0.006678034044843691,
            "start_logit": 2.2988123893737793,
            "end_logit": -0.36213016510009766,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type III",
            "probability": 0.006569893937727632,
            "start_logit": 1.3075761795043945,
            "end_logit": 0.6127800941467285,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "Type 3 is similar to type 2",
            "probability": 0.005435179961987514,
            "start_logit": 0.8208833336830139,
            "end_logit": 0.9098678827285767,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type I (61 percent), seven were classified as type II (25 percent), and four were classified as type III",
            "probability": 0.004871121580749514,
            "start_logit": 1.008402705192566,
            "end_logit": 0.6127800941467285,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        }
    ],
    "515c4f1f298dcd4e51000007": [
        {
            "text": "HCN4",
            "probability": 0.557671697700184,
            "start_logit": 5.7869744300842285,
            "end_logit": 5.508898735046387,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "\u03b2-MHC",
            "probability": 0.17910657853743012,
            "start_logit": 5.03347635269165,
            "end_logit": 5.126607418060303,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "MHC",
            "probability": 0.04782690899730725,
            "start_logit": 3.7130837440490723,
            "end_logit": 5.126607418060303,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2/3 transcription.he TRbeta1 aporeceptor suppressed KCND3",
            "probability": 0.037490425318454305,
            "start_logit": 4.61459493637085,
            "end_logit": 3.981593370437622,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2/3",
            "probability": 0.0338307396020642,
            "start_logit": 4.61459493637085,
            "end_logit": 3.878877639770508,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND3",
            "probability": 0.028863699707297664,
            "start_logit": 4.353094100952148,
            "end_logit": 3.981593370437622,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "HCN4 transcription",
            "probability": 0.02406783746647924,
            "start_logit": 5.7869744300842285,
            "end_logit": 2.366004705429077,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2",
            "probability": 0.02186620928140984,
            "start_logit": 4.61459493637085,
            "end_logit": 3.4424502849578857,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND",
            "probability": 0.01351220699400692,
            "start_logit": 4.61459493637085,
            "end_logit": 2.9611012935638428,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "SERCA",
            "probability": 0.01183452193228707,
            "start_logit": 3.7524890899658203,
            "end_logit": 3.6906344890594482,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "\u03b2-MHC transcription",
            "probability": 0.01109985214457812,
            "start_logit": 5.03347635269165,
            "end_logit": 2.3455581665039062,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "\u03b2-MHC transcription, as a target of miR-27aHCN2",
            "probability": 0.008106639882696767,
            "start_logit": 5.03347635269165,
            "end_logit": 2.0313098430633545,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "\u03b2-MHC transcription,",
            "probability": 0.005233559678019192,
            "start_logit": 5.03347635269165,
            "end_logit": 1.5937180519104004,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "HCN4 transcription.",
            "probability": 0.004134720513988741,
            "start_logit": 5.7869744300842285,
            "end_logit": 0.6045480370521545,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "TRbeta1-mediated reduction of KCND2/3 transcription.he TRbeta1 aporeceptor suppressed KCND3",
            "probability": 0.0033569810616835877,
            "start_logit": 2.2015514373779297,
            "end_logit": 3.981593370437622,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "TRbeta1-mediated reduction of KCND2/3",
            "probability": 0.0030292841754178536,
            "start_logit": 2.2015514373779297,
            "end_logit": 3.878877639770508,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "MHC transcription",
            "probability": 0.002963998434548627,
            "start_logit": 3.7130837440490723,
            "end_logit": 2.3455581665039062,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "MHC transcription, as a target of miR-27aHCN2",
            "probability": 0.002164719638495323,
            "start_logit": 3.7130837440490723,
            "end_logit": 2.0313098430633545,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "TRbeta1-mediated reduction of KCND2",
            "probability": 0.001957951925724622,
            "start_logit": 2.2015514373779297,
            "end_logit": 3.4424502849578857,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2/3 transcription.he TRbeta1 aporeceptor suppressed KCND3 expression",
            "probability": 0.0018814670079266077,
            "start_logit": 4.61459493637085,
            "end_logit": 0.9895595908164978,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        }
    ],
    "553f96191d53b76422000004": [
        {
            "text": "in situ end labeling",
            "probability": 0.4422611626697182,
            "start_logit": 4.708614349365234,
            "end_logit": 3.2011537551879883,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "in situ end labeling (ISEL",
            "probability": 0.2007195137073653,
            "start_logit": 4.708614349365234,
            "end_logit": 2.4111616611480713,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "in situ end labeling (ISEL)",
            "probability": 0.11855463651714626,
            "start_logit": 4.708614349365234,
            "end_logit": 1.884627103805542,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling",
            "probability": 0.09434433996257267,
            "start_logit": 4.1669487953186035,
            "end_logit": 2.1978700160980225,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "terminal deoxynucleotidyl transferase",
            "probability": 0.04387699612143807,
            "start_logit": 4.1669487953186035,
            "end_logit": 1.4323089122772217,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "(TUNEL) and in situ end labeling",
            "probability": 0.015451361319445231,
            "start_logit": 1.3544108867645264,
            "end_logit": 3.2011537551879883,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "dUTP-biotin nick end labeling of DNA fragments (TUNEL) and in situ end labeling",
            "probability": 0.014640361577703076,
            "start_logit": 1.300495982170105,
            "end_logit": 3.2011537551879883,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling of DNA fragments",
            "probability": 0.011516481624024315,
            "start_logit": 4.1669487953186035,
            "end_logit": 0.09469792991876602,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "in situ end labeling (ISEL) techniques",
            "probability": 0.007807023487704019,
            "start_logit": 4.708614349365234,
            "end_logit": -0.8357230424880981,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "(TUNEL) and in situ end labeling (ISEL",
            "probability": 0.0070125753557790165,
            "start_logit": 1.3544108867645264,
            "end_logit": 2.4111616611480713,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "dUTP-biotin nick end labeling of DNA fragments (TUNEL) and in situ end labeling (ISEL",
            "probability": 0.006644504434071494,
            "start_logit": 1.300495982170105,
            "end_logit": 2.4111616611480713,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "dUTP-biotin nick end labeling",
            "probability": 0.005368231190778166,
            "start_logit": 1.300495982170105,
            "end_logit": 2.1978700160980225,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "terminal",
            "probability": 0.004890830360218509,
            "start_logit": 4.1669487953186035,
            "end_logit": -0.7617191672325134,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL) and in situ end labeling",
            "probability": 0.004785113253211315,
            "start_logit": 0.18222346901893616,
            "end_logit": 3.2011537551879883,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "(TUNEL) and in situ end labeling (ISEL)",
            "probability": 0.0041419656066204,
            "start_logit": 1.3544108867645264,
            "end_logit": 1.884627103805542,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "dUTP-biotin nick end labeling of DNA fragments (TUNEL) and in situ end labeling (ISEL)",
            "probability": 0.00392456514799242,
            "start_logit": 1.300495982170105,
            "end_logit": 1.884627103805542,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "(ISEL",
            "probability": 0.003910189412844732,
            "start_logit": 0.7702916860580444,
            "end_logit": 2.4111616611480713,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "ISEL",
            "probability": 0.0038086735349595704,
            "start_logit": 0.7439868450164795,
            "end_logit": 2.4111616611480713,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "(TUNEL",
            "probability": 0.0032561916602860297,
            "start_logit": 1.3544108867645264,
            "end_logit": 1.6440149545669556,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "dUTP-biotin nick end labeling of DNA fragments (TUNEL",
            "probability": 0.003085283056121064,
            "start_logit": 1.300495982170105,
            "end_logit": 1.6440149545669556,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        }
    ],
    "54de15f91388e8454a000002": [
        {
            "text": "APOBEC3F",
            "probability": 0.2615225337882943,
            "start_logit": 4.292639255523682,
            "end_logit": 3.465242862701416,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G) and APOBEC3F",
            "probability": 0.21357298468885408,
            "start_logit": 4.090097427368164,
            "end_logit": 3.465242862701416,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3D, APOBEC3F",
            "probability": 0.16261409516247305,
            "start_logit": 3.7643837928771973,
            "end_logit": 3.518357753753662,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G",
            "probability": 0.07910031118162869,
            "start_logit": 4.090097427368164,
            "end_logit": 2.4719810485839844,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F, APOBEC3G",
            "probability": 0.073955457089313,
            "start_logit": 4.187500476837158,
            "end_logit": 2.307324171066284,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3D",
            "probability": 0.0561707214967273,
            "start_logit": 3.7643837928771973,
            "end_logit": 2.455373525619507,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3D, APOBEC3F, APOBEC3G",
            "probability": 0.04844098712524542,
            "start_logit": 3.7643837928771973,
            "end_logit": 2.307324171066284,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F, APOBEC3G, and APOBEC3H",
            "probability": 0.024227637769502555,
            "start_logit": 4.187500476837158,
            "end_logit": 1.1913552284240723,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G, and APOBEC3H",
            "probability": 0.019571643397987032,
            "start_logit": 3.974088191986084,
            "end_logit": 1.1913552284240723,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H",
            "probability": 0.015869156049569958,
            "start_logit": 3.7643837928771973,
            "end_logit": 1.1913552284240723,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F (A3F)",
            "probability": 0.014103224094923197,
            "start_logit": 4.292639255523682,
            "end_logit": 0.5451258420944214,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G) and APOBEC3F (A3F)",
            "probability": 0.011517430716417023,
            "start_logit": 4.090097427368164,
            "end_logit": 0.5451258420944214,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3H",
            "probability": 0.010777046158198023,
            "start_logit": 3.377424955368042,
            "end_logit": 1.1913552284240723,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G)",
            "probability": 0.003163415803581119,
            "start_logit": 4.090097427368164,
            "end_logit": -0.7470833659172058,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G, we find that three other human APOBEC3 proteins, APOBEC3D",
            "probability": 0.001897046920534367,
            "start_logit": 2.1114742755889893,
            "end_logit": 0.7201858162879944,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F (A3F",
            "probability": 0.0008378820192499227,
            "start_logit": 4.292639255523682,
            "end_logit": -2.278155565261841,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G",
            "probability": 0.0007114899251881197,
            "start_logit": 4.090097427368164,
            "end_logit": -2.2391297817230225,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G) and APOBEC3F (A3F",
            "probability": 0.0006842582972723537,
            "start_logit": 4.090097427368164,
            "end_logit": -2.278155565261841,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F, APOBEC3G, and APOBEC3",
            "probability": 0.0006555622892196702,
            "start_logit": 4.187500476837158,
            "end_logit": -2.418400764465332,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F (A3F),",
            "probability": 0.0006071160258207441,
            "start_logit": 4.292639255523682,
            "end_logit": -2.6003129482269287,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        }
    ],
    "5306158358348c0f52000001": [
        {
            "text": "SNRPN",
            "probability": 0.40058091520862216,
            "start_logit": 0.6862063407897949,
            "end_logit": -1.4246001243591309,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "absence of function of PWS genes",
            "probability": 0.1876739252188892,
            "start_logit": -0.8327685594558716,
            "end_logit": -0.6638349890708923,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "SNRPN gene",
            "probability": 0.15632676440801951,
            "start_logit": 0.6862063407897949,
            "end_logit": -2.365567445755005,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "PWS genes",
            "probability": 0.10187425055090207,
            "start_logit": -1.4437353610992432,
            "end_logit": -0.6638349890708923,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "absence of function of PWS genes that are normally expressed only from the paternal chromosome 15",
            "probability": 0.029778948603540484,
            "start_logit": -0.8327685594558716,
            "end_logit": -2.504739284515381,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15q11-q13 or maternal UPD of chromosome 15. The basic defect seemed to be an absence of function of PWS genes",
            "probability": 0.02902704353410135,
            "start_logit": -2.699246644973755,
            "end_logit": -0.6638349890708923,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "PWS genes that are normally expressed only from the paternal chromosome 15",
            "probability": 0.01616478190905435,
            "start_logit": -1.4437353610992432,
            "end_logit": -2.504739284515381,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15",
            "probability": 0.011352243359559533,
            "start_logit": -1.9752719402313232,
            "end_logit": -2.326622247695923,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "microdeletions of 15q11-q13 or maternal UPD of chromosome 15",
            "probability": 0.008749244889020154,
            "start_logit": -2.226327896118164,
            "end_logit": -2.3360142707824707,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "maternal UPD of chromosome 15. The basic defect seemed to be an absence of function of PWS genes",
            "probability": 0.00849796317748659,
            "start_logit": -3.9276480674743652,
            "end_logit": -0.6638349890708923,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15. The basic defect seemed to be an absence of function of PWS genes",
            "probability": 0.008165719171745495,
            "start_logit": -3.967529773712158,
            "end_logit": -0.6638349890708923,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15q11-13",
            "probability": 0.007301716820858002,
            "start_logit": -1.9752719402313232,
            "end_logit": -2.767928123474121,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15q11-q13 or maternal UPD of chromosome 15",
            "probability": 0.005452360582985918,
            "start_logit": -2.699246644973755,
            "end_logit": -2.3360142707824707,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "genetic defects in certain regions of chromosome 15",
            "probability": 0.005127531703721869,
            "start_logit": -2.7700629234313965,
            "end_logit": -2.326622247695923,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "absence of function",
            "probability": 0.005014909351365025,
            "start_logit": -0.8327685594558716,
            "end_logit": -4.286125659942627,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "microdeletions of 15",
            "probability": 0.004041471031143388,
            "start_logit": -2.226327896118164,
            "end_logit": -3.108372926712036,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "imprinting genes on the proximal long arm of chromosome 15 and SNRPN",
            "probability": 0.004034732685913846,
            "start_logit": -3.911769390106201,
            "end_logit": -1.4246001243591309,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "absence of function of PWS",
            "probability": 0.0037765403517618697,
            "start_logit": -0.8327685594558716,
            "end_logit": -4.569732666015625,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "an absence of function of PWS genes",
            "probability": 0.0037609298753399625,
            "start_logit": -4.7428083419799805,
            "end_logit": -0.6638349890708923,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "genetic defects in certain regions of chromosome 15q11-13",
            "probability": 0.0032980075659689986,
            "start_logit": -2.7700629234313965,
            "end_logit": -2.767928123474121,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        }
    ],
    "5149af96d24251bc05000046": [
        {
            "text": "MosaicFinder",
            "probability": 0.7639335012623786,
            "start_logit": 4.826461315155029,
            "end_logit": 4.874783515930176,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "FusedTriplets.We implemented this method in the C++ program MosaicFinder",
            "probability": 0.1537192246259956,
            "start_logit": 3.2231082916259766,
            "end_logit": 4.874783515930176,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "rosetta-stone method",
            "probability": 0.021381510351760214,
            "start_logit": 3.216175079345703,
            "end_logit": 2.9091155529022217,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "FusedTriplets",
            "probability": 0.019981828773524758,
            "start_logit": 3.2231082916259766,
            "end_logit": 2.8344790935516357,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "MosaicFinder,",
            "probability": 0.01588683237761994,
            "start_logit": 4.826461315155029,
            "end_logit": 1.001793384552002,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "rosetta-stone",
            "probability": 0.00832170565752406,
            "start_logit": 3.216175079345703,
            "end_logit": 1.965456247329712,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "the rosetta-stone method",
            "probability": 0.005721190008861911,
            "start_logit": 1.8978253602981567,
            "end_logit": 2.9091155529022217,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "FusedTriplets.We implemented this method in the C++ program MosaicFinder,",
            "probability": 0.003196759339412892,
            "start_logit": 3.2231082916259766,
            "end_logit": 1.001793384552002,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "the rosetta-stone",
            "probability": 0.002226692992274834,
            "start_logit": 1.8978253602981567,
            "end_logit": 1.965456247329712,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "Mosaic",
            "probability": 0.0014543996743597836,
            "start_logit": 4.826461315155029,
            "end_logit": -1.3891040086746216,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "MosaicFinder: Identification of fused gene families in sequence similarity networks",
            "probability": 0.0009150592213507236,
            "start_logit": 3.9624125957489014,
            "end_logit": -0.988415002822876,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "C++ program MosaicFinder",
            "probability": 0.0006616849830703683,
            "start_logit": -2.224985122680664,
            "end_logit": 4.874783515930176,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "fused gene identification, which we implemented in the Python program FusedTriplets.We implemented this method in the C++ program MosaicFinder",
            "probability": 0.0006394340155168524,
            "start_logit": -2.2591912746429443,
            "end_logit": 4.874783515930176,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "Finder",
            "probability": 0.00039202201245485535,
            "start_logit": -2.7484567165374756,
            "end_logit": 4.874783515930176,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "Python program FusedTriplets.We implemented this method in the C++ program MosaicFinder",
            "probability": 0.00034691997660172007,
            "start_logit": -2.870680570602417,
            "end_logit": 4.874783515930176,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "FusedTriplets.We implemented this method in the C++ program Mosaic",
            "probability": 0.0002926553029412176,
            "start_logit": 3.2231082916259766,
            "end_logit": -1.3891040086746216,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "MosaicFinder: Identification of fused gene families in sequence similarity networksThis leads to an efficient formulation of previous methods of fused gene identification",
            "probability": 0.0002702026143921297,
            "start_logit": 3.9624125957489014,
            "end_logit": -2.2082316875457764,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "program MosaicFinder",
            "probability": 0.00023412739003134518,
            "start_logit": -3.263909339904785,
            "end_logit": 4.874783515930176,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "MosaicFinder:",
            "probability": 0.00021342160027635644,
            "start_logit": 3.9624125957489014,
            "end_logit": -2.44413423538208,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "MosaicFinder: Identification of fused gene families in sequence similarity networksThis",
            "probability": 0.00021082781965195858,
            "start_logit": 3.9624125957489014,
            "end_logit": -2.456362009048462,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        }
    ],
    "56e460d051531f7e33000019": [
        {
            "text": "heightened sensitivity to light",
            "probability": 0.5163309083515665,
            "start_logit": 4.077735900878906,
            "end_logit": 4.276534080505371,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "sensitivity to light",
            "probability": 0.10493230508266402,
            "start_logit": 2.4843034744262695,
            "end_logit": 4.276534080505371,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "potentiated resetting responses to light.We now demonstrate that the mutation results in a heightened sensitivity to light",
            "probability": 0.06653572416528795,
            "start_logit": 2.0287270545959473,
            "end_logit": 4.276534080505371,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "heightened sensitivity to light, suggesting that CK1epsilon also regulates the photic entrainment",
            "probability": 0.05879972014529507,
            "start_logit": 4.077735900878906,
            "end_logit": 2.1039233207702637,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "light",
            "probability": 0.0532761829213034,
            "start_logit": 1.806477427482605,
            "end_logit": 4.276534080505371,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "heightened sensitivity to light, suggesting that CK1epsilon also regulates the photic entrainment pathway",
            "probability": 0.03582031447214437,
            "start_logit": 4.077735900878906,
            "end_logit": 1.6083014011383057,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "heightened sensitivity",
            "probability": 0.029377308681772362,
            "start_logit": 4.077735900878906,
            "end_logit": 1.4100087881088257,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "a heightened sensitivity to light",
            "probability": 0.022526737652630035,
            "start_logit": 0.9456909894943237,
            "end_logit": 4.276534080505371,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "breast cancer",
            "probability": 0.013156154052773372,
            "start_logit": 2.4807519912719727,
            "end_logit": 2.203659772872925,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "photic entrainment",
            "probability": 0.013029720888781262,
            "start_logit": 2.570831775665283,
            "end_logit": 2.1039233207702637,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "heightened sensitivity to light,",
            "probability": 0.012413936504870018,
            "start_logit": 4.077735900878906,
            "end_logit": 0.5486059784889221,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "resetting responses to light.We now demonstrate that the mutation results in a heightened sensitivity to light",
            "probability": 0.01212017093081846,
            "start_logit": 0.3258591294288635,
            "end_logit": 4.276534080505371,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "sensitivity to light, suggesting that CK1epsilon also regulates the photic entrainment",
            "probability": 0.01194968202225124,
            "start_logit": 2.4843034744262695,
            "end_logit": 2.1039233207702637,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "breast cancer development",
            "probability": 0.009841310775300609,
            "start_logit": 2.4807519912719727,
            "end_logit": 1.9133590459823608,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "photic entrainment pathway",
            "probability": 0.00793760069889991,
            "start_logit": 2.570831775665283,
            "end_logit": 1.6083014011383057,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "sensitivity to light, suggesting that CK1epsilon also regulates the photic entrainment pathway",
            "probability": 0.007279649746996624,
            "start_logit": 2.4843034744262695,
            "end_logit": 1.6083014011383057,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "potentiated resetting responses to light",
            "probability": 0.0068436885895513866,
            "start_logit": 2.0287270545959473,
            "end_logit": 2.002121925354004,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "light, suggesting that CK1epsilon also regulates the photic entrainment",
            "probability": 0.006067087202242799,
            "start_logit": 1.806477427482605,
            "end_logit": 2.1039233207702637,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "sensitivity",
            "probability": 0.005970257962950359,
            "start_logit": 2.4843034744262695,
            "end_logit": 1.4100087881088257,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "light.We now demonstrate that the mutation results in a heightened sensitivity to light",
            "probability": 0.005791539151900461,
            "start_logit": -0.4126138687133789,
            "end_logit": 4.276534080505371,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        }
    ],
    "514a11add24251bc05000054": [
        {
            "text": "breast cancer",
            "probability": 0.7678988143157097,
            "start_logit": 3.276371479034424,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancers",
            "probability": 0.22692898537262077,
            "start_logit": 3.276371479034424,
            "end_logit": 2.393404245376587,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "cancer",
            "probability": 0.0014248080401248202,
            "start_logit": -3.013249397277832,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast",
            "probability": 0.0006122657529374906,
            "start_logit": 3.276371479034424,
            "end_logit": -3.5218217372894287,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "rpoor-prognosis ER-positive breast cancer",
            "probability": 0.0005243885790012535,
            "start_logit": -4.012808799743652,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "cancers",
            "probability": 0.0004210583958049264,
            "start_logit": -3.013249397277832,
            "end_logit": 2.393404245376587,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "ER-positive breast cancer",
            "probability": 0.0004002256161256591,
            "start_logit": -4.283013343811035,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "high score on the Oncotype DX gene expression profile rpoor-prognosis ER-positive breast cancer",
            "probability": 0.00037472037377474026,
            "start_logit": -4.3488616943359375,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "gene expression profile rpoor-prognosis ER-positive breast cancer",
            "probability": 0.00021492703053107372,
            "start_logit": -4.904743194580078,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancers in need of more aggressive therapy",
            "probability": 0.00020872342438524322,
            "start_logit": 3.276371479034424,
            "end_logit": -4.597978115081787,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "rpoor-prognosis ER-positive breast cancers",
            "probability": 0.00015496699038373597,
            "start_logit": -4.012808799743652,
            "end_logit": 2.393404245376587,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "positive breast cancer",
            "probability": 0.00014812868649318584,
            "start_logit": -5.276960372924805,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "s",
            "probability": 0.00011920905730843658,
            "start_logit": -4.275142192840576,
            "end_logit": 2.393404245376587,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "ER-positive breast cancers",
            "probability": 0.00011827442795111213,
            "start_logit": -4.283013343811035,
            "end_logit": 2.393404245376587,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "high score on the Oncotype DX gene expression profile rpoor-prognosis ER-positive breast cancers",
            "probability": 0.00011073713441650171,
            "start_logit": -4.3488616943359375,
            "end_logit": 2.393404245376587,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "profile rpoor-prognosis ER-positive breast cancer",
            "probability": 9.166734942450821e-05,
            "start_logit": -5.756875514984131,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "expression profile rpoor-prognosis ER-positive breast cancer",
            "probability": 7.946736035614394e-05,
            "start_logit": -5.89969539642334,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "gene expression profile rpoor-prognosis ER-positive breast cancers",
            "probability": 6.351510388908416e-05,
            "start_logit": -4.904743194580078,
            "end_logit": 2.393404245376587,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "score on the Oncotype DX gene expression profile rpoor-prognosis ER-positive breast cancer",
            "probability": 6.134209042403138e-05,
            "start_logit": -6.158575534820557,
            "end_logit": 3.6124250888824463,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "positive breast cancers",
            "probability": 4.377489833791765e-05,
            "start_logit": -5.276960372924805,
            "end_logit": 2.393404245376587,
            "question_text": "Which diseases can Oncotype DX be used for?"
        }
    ],
    "5165932e298dcd4e51000059": [
        {
            "text": "5-azacytosine",
            "probability": 0.7553983809808994,
            "start_logit": 6.200109481811523,
            "end_logit": 5.77230978012085,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-Aza-CdR",
            "probability": 0.10236214757880507,
            "start_logit": 5.315933704376221,
            "end_logit": 4.65775728225708,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "procainamide",
            "probability": 0.0834408824773624,
            "start_logit": 4.968174934387207,
            "end_logit": 4.801137447357178,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-Aza-2'-deoxycytidine",
            "probability": 0.039376153573284695,
            "start_logit": 4.557685375213623,
            "end_logit": 4.460649013519287,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-Aza-2'-deoxycytidine (5-Aza-CdR",
            "probability": 0.009316811199547642,
            "start_logit": 4.557685375213623,
            "end_logit": 3.0193090438842773,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-Aza-2'-deoxycytidine (5-Aza-CdR)",
            "probability": 0.004617665092037333,
            "start_logit": 4.557685375213623,
            "end_logit": 2.317377805709839,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-Aza-CdR)",
            "probability": 0.001800932952060551,
            "start_logit": 3.616101026535034,
            "end_logit": 2.317377805709839,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "azacytosine",
            "probability": 0.0009731728304106896,
            "start_logit": -0.5138281583786011,
            "end_logit": 5.831808567047119,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5",
            "probability": 0.0006825349142072608,
            "start_logit": 6.200109481811523,
            "end_logit": -1.2368770837783813,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-Aza-2'-deoxycytidine (5-Aza-CdR),",
            "probability": 0.0004815138507754907,
            "start_logit": 4.557685375213623,
            "end_logit": 0.05666833743453026,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "CdR",
            "probability": 0.0003393200823696989,
            "start_logit": -0.39339470863342285,
            "end_logit": 4.65775728225708,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-azacytosine has remained unclear,",
            "probability": 0.00028334428001779806,
            "start_logit": 6.063027381896973,
            "end_logit": -1.9789459705352783,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-Aza-CdR),",
            "probability": 0.00018779494472877576,
            "start_logit": 3.616101026535034,
            "end_logit": 0.05666833743453026,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "ine",
            "probability": 0.00018400596725705483,
            "start_logit": -2.1199228763580322,
            "end_logit": 5.77230978012085,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "deoxycytidine",
            "probability": 0.00016176299518181906,
            "start_logit": -0.9370980262756348,
            "end_logit": 4.460649013519287,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "Aza-CdR",
            "probability": 0.00013304045247601495,
            "start_logit": -1.3296853303909302,
            "end_logit": 4.65775728225708,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-azac",
            "probability": 0.00010965413372667137,
            "start_logit": 6.063027381896973,
            "end_logit": -2.9282774925231934,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-Aza",
            "probability": 6.612895790972532e-05,
            "start_logit": 5.315933704376221,
            "end_logit": -2.68690824508667,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "de",
            "probability": 4.2653351919375585e-05,
            "start_logit": -2.6106128692626953,
            "end_logit": 4.801137447357178,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-Aza-2'-deoxycytidine (5",
            "probability": 4.209938502287275e-05,
            "start_logit": 4.557685375213623,
            "end_logit": -2.3802335262298584,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        }
    ],
    "5131bef65274a5fb07000008": [
        {
            "text": "H3K4me2 as a mark for active enhancersHyperacetylation of histones H3 and H4",
            "probability": 0.2228146470780302,
            "start_logit": 3.7197861671447754,
            "end_logit": 3.0794670581817627,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3K4me2 as a mark for active enhancersHyperacetylation of histones H3",
            "probability": 0.2064318811048086,
            "start_logit": 3.7197861671447754,
            "end_logit": 3.0030972957611084,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3K4me2",
            "probability": 0.20556379752723106,
            "start_logit": 3.7197861671447754,
            "end_logit": 2.9988832473754883,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3 and H4",
            "probability": 0.11754183694375858,
            "start_logit": 3.080240249633789,
            "end_logit": 3.0794670581817627,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3",
            "probability": 0.10889940507509513,
            "start_logit": 3.080240249633789,
            "end_logit": 3.0030972957611084,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H4",
            "probability": 0.08288391512393922,
            "start_logit": 2.730886936187744,
            "end_logit": 3.0794670581817627,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histones H3 and H4",
            "probability": 0.01941211675872085,
            "start_logit": 1.2793433666229248,
            "end_logit": 3.0794670581817627,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histones H3",
            "probability": 0.01798481307795518,
            "start_logit": 1.2793433666229248,
            "end_logit": 3.0030972957611084,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3K4me2 as a mark for active enhancersHyperacetylation",
            "probability": 0.004698938552696835,
            "start_logit": 3.7197861671447754,
            "end_logit": -0.7795365452766418,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3K4",
            "probability": 0.004694806970690174,
            "start_logit": 3.7197861671447754,
            "end_logit": -0.7804161906242371,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3K4me2 as a mark for active enhancersHyperacetylation of histones H3 and H4,",
            "probability": 0.0012846012405147663,
            "start_logit": 3.7197861671447754,
            "end_logit": -2.0764248371124268,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "K4",
            "probability": 0.001283597058415519,
            "start_logit": 0.7071933746337891,
            "end_logit": 0.9353859424591064,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "K9",
            "probability": 0.0012396409991391009,
            "start_logit": 0.8181954026222229,
            "end_logit": 0.7895393967628479,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "K4 and K9",
            "probability": 0.0011094005150369866,
            "start_logit": 0.7071933746337891,
            "end_logit": 0.7895393967628479,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "mono-methylation at K4",
            "probability": 0.0009753587153421152,
            "start_logit": 0.43257707357406616,
            "end_logit": 0.9353859424591064,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "mono-methylation at K4 and K9",
            "probability": 0.0008429930982251258,
            "start_logit": 0.43257707357406616,
            "end_logit": 0.7895393967628479,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3 and H4,",
            "probability": 0.0006776681494258234,
            "start_logit": 3.080240249633789,
            "end_logit": -2.0764248371124268,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "methylation at K4",
            "probability": 0.0006143056107980701,
            "start_logit": -0.02973570115864277,
            "end_logit": 0.9353859424591064,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "methylation at K4 and K9",
            "probability": 0.0005309383942113044,
            "start_logit": -0.02973570115864277,
            "end_logit": 0.7895393967628479,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "me2 as a mark for active enhancersHyperacetylation of histones H3 and H4",
            "probability": 0.000515338005965304,
            "start_logit": -2.3494863510131836,
            "end_logit": 3.0794670581817627,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        }
    ],
    "5516757c46478f2f2c000008": [
        {
            "text": "Nmd2p",
            "probability": 0.1564221645024392,
            "start_logit": 5.709957599639893,
            "end_logit": 4.603963375091553,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Nmd2p, and Upf3",
            "probability": 0.1187393132205766,
            "start_logit": 5.709957599639893,
            "end_logit": 4.328335285186768,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1p, Nmd2p",
            "probability": 0.11502661696518536,
            "start_logit": 5.402562618255615,
            "end_logit": 4.603963375091553,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf3",
            "probability": 0.0958665767826172,
            "start_logit": 5.4959845542907715,
            "end_logit": 4.328335285186768,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1p",
            "probability": 0.09244199808696549,
            "start_logit": 5.402562618255615,
            "end_logit": 4.38538122177124,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1p, Nmd2p, and Upf3",
            "probability": 0.08731615205541701,
            "start_logit": 5.402562618255615,
            "end_logit": 4.328335285186768,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Nmd2",
            "probability": 0.0405475525391113,
            "start_logit": 5.709957599639893,
            "end_logit": 3.253880262374878,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Nmd2p, and Upf3pOur results indicate that Upf1p, Nmd2p",
            "probability": 0.038588846124857426,
            "start_logit": 5.709957599639893,
            "end_logit": 3.2043681144714355,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Nmd2p, and Upf3pOur results indicate that Upf1p, Nmd2p, and Upf3p",
            "probability": 0.03147957073362931,
            "start_logit": 5.709957599639893,
            "end_logit": 3.0007436275482178,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf3pOur results indicate that Upf1p, Nmd2p",
            "probability": 0.031155482372624766,
            "start_logit": 5.4959845542907715,
            "end_logit": 3.2043681144714355,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Nmd2p, and Upf3pOur results indicate that Upf1p",
            "probability": 0.030415537596161706,
            "start_logit": 5.709957599639893,
            "end_logit": 2.9663584232330322,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1p, Nmd2",
            "probability": 0.029817051884097626,
            "start_logit": 5.402562618255615,
            "end_logit": 3.253880262374878,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1p, Nmd2p, and Upf3pOur results indicate that Upf1p, Nmd2p",
            "probability": 0.02837669735904489,
            "start_logit": 5.402562618255615,
            "end_logit": 3.2043681144714355,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf3pOur results indicate that Upf1p, Nmd2p, and Upf3p",
            "probability": 0.025415665654164622,
            "start_logit": 5.4959845542907715,
            "end_logit": 3.0007436275482178,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf3pOur results indicate that Upf1p",
            "probability": 0.024556597063437668,
            "start_logit": 5.4959845542907715,
            "end_logit": 2.9663584232330322,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1p, Nmd2p, and Upf3pOur results indicate that Upf1p",
            "probability": 0.02236637246385458,
            "start_logit": 5.402562618255615,
            "end_logit": 2.9663584232330322,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Xrn1p, and the three nonsense-mediated mRNA decay (NMD) factors, Upf1p, Nmd2p",
            "probability": 0.009285855911470025,
            "start_logit": 2.8858914375305176,
            "end_logit": 4.603963375091553,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Xrn1p, and the three nonsense-mediated mRNA decay (NMD) factors, Upf1p",
            "probability": 0.0074626473163490374,
            "start_logit": 2.8858914375305176,
            "end_logit": 4.38538122177124,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1",
            "probability": 0.0074267569022432095,
            "start_logit": 5.402562618255615,
            "end_logit": 1.8638890981674194,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1p, Upf2p/Nmd2p",
            "probability": 0.007292544465752746,
            "start_logit": 4.131896495819092,
            "end_logit": 3.116318464279175,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        }
    ],
    "5160412d298dcd4e5100003c": [
        {
            "text": "H4-K20",
            "probability": 0.2978532201045248,
            "start_logit": 1.3937275409698486,
            "end_logit": 0.5041906833648682,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 lysine 20",
            "probability": 0.1108774356728955,
            "start_logit": 0.10151521861553192,
            "end_logit": 0.8082275986671448,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20 methylationthe H4-K20",
            "probability": 0.10503105164619819,
            "start_logit": 0.3513827621936798,
            "end_logit": 0.5041906833648682,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20",
            "probability": 0.08578412907623363,
            "start_logit": 0.3513827621936798,
            "end_logit": 0.3017686605453491,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "methylationthe H4-K20",
            "probability": 0.0614916481123616,
            "start_logit": -0.18397191166877747,
            "end_logit": 0.5041906833648682,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4-K20 met",
            "probability": 0.045655288449132206,
            "start_logit": 1.3937275409698486,
            "end_logit": -1.371290683746338,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "met",
            "probability": 0.04160377049553322,
            "start_logit": 1.3007988929748535,
            "end_logit": -1.371290683746338,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "lysine 20",
            "probability": 0.03971208725250115,
            "start_logit": -0.9252545833587646,
            "end_logit": 0.8082275986671448,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "K20",
            "probability": 0.03318592630744223,
            "start_logit": -0.8007473945617676,
            "end_logit": 0.5041906833648682,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "histone H4 lysine 20",
            "probability": 0.025073257447221796,
            "start_logit": -1.3851083517074585,
            "end_logit": 0.8082275986671448,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20 methylation",
            "probability": 0.023163724909425237,
            "start_logit": 0.3513827621936798,
            "end_logit": -1.007477879524231,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "mitotic chromosomes and subsequent increase in H4 Lys 20 methylationthe H4-K20",
            "probability": 0.020545264439687943,
            "start_logit": -1.2802428007125854,
            "end_logit": 0.5041906833648682,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4-K20 methyltransferase PR-Set7",
            "probability": 0.01951340493657128,
            "start_logit": 1.3937275409698486,
            "end_logit": -2.221308469772339,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "methyltransferase PR-Set7",
            "probability": 0.01778175646556335,
            "start_logit": 1.3007988929748535,
            "end_logit": -2.221308469772339,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "mitotic chromosomes and subsequent increase in H4 Lys 20",
            "probability": 0.016780348182520926,
            "start_logit": -1.2802428007125854,
            "end_logit": 0.3017686605453491,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20 methylationthe H4-K20 met",
            "probability": 0.016099281912547753,
            "start_logit": 0.3513827621936798,
            "end_logit": -1.371290683746338,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "methylation",
            "probability": 0.013561471572235556,
            "start_logit": -0.18397191166877747,
            "end_logit": -1.007477879524231,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "methylationthe H4-K20 met",
            "probability": 0.009425511434112431,
            "start_logit": -0.18397191166877747,
            "end_logit": -1.371290683746338,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "20",
            "probability": 0.008636162895550541,
            "start_logit": -2.4509518146514893,
            "end_logit": 0.8082275986671448,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4",
            "probability": 0.008225258687740778,
            "start_logit": 0.10151521861553192,
            "end_logit": -1.7929880619049072,
            "question_text": "Which histone marks are deposited by Set7?"
        }
    ],
    "54df6ed91388e8454a000007": [
        {
            "text": "radiotherapy",
            "probability": 0.40429175997659417,
            "start_logit": 4.663247585296631,
            "end_logit": 4.984825611114502,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiochemotherapy",
            "probability": 0.20543890092500236,
            "start_logit": 4.425958156585693,
            "end_logit": 4.545126914978027,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiotherapy. The standard treatment today is maximal surgical resection followed by concomitant chemo-radiation therapy",
            "probability": 0.1045496778334523,
            "start_logit": 4.645345211029053,
            "end_logit": 3.6502535343170166,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiotherapy and concomitant/adjuvant temozolomide",
            "probability": 0.08276730512128243,
            "start_logit": 4.663247585296631,
            "end_logit": 3.398721933364868,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiotherapy. The standard treatment today is maximal surgical resection followed by concomitant chemo-radiation",
            "probability": 0.04654030763532143,
            "start_logit": 4.645345211029053,
            "end_logit": 2.840909957885742,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "post-operative radiotherapy",
            "probability": 0.03109308174337861,
            "start_logit": 2.0980961322784424,
            "end_logit": 4.984825611114502,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "chemo-radiation therapy",
            "probability": 0.02888271818618541,
            "start_logit": 3.358926296234131,
            "end_logit": 3.6502535343170166,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "surgical resection with post-operative radiotherapy",
            "probability": 0.02458464793433306,
            "start_logit": 1.863232970237732,
            "end_logit": 4.984825611114502,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiation therapy",
            "probability": 0.022234026968376848,
            "start_logit": 3.097306728363037,
            "end_logit": 3.6502535343170166,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "chemo-radiation",
            "probability": 0.012857147124553459,
            "start_logit": 3.358926296234131,
            "end_logit": 2.840909957885742,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiation",
            "probability": 0.009897481049426993,
            "start_logit": 3.097306728363037,
            "end_logit": 2.840909957885742,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "temozolomide",
            "probability": 0.009365940036905204,
            "start_logit": 2.4842941761016846,
            "end_logit": 3.398721933364868,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "post-operative radiotherapy and concomitant/adjuvant temozolomide",
            "probability": 0.006365429223598775,
            "start_logit": 2.0980961322784424,
            "end_logit": 3.398721933364868,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "surgical resection with post-operative radiotherapy and concomitant/adjuvant temozolomide",
            "probability": 0.005033011449449407,
            "start_logit": 1.863232970237732,
            "end_logit": 3.398721933364868,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "Fluorescence-guided surgery (FGS) followed by concomitant radiochemotherapy",
            "probability": 0.0014302342925728625,
            "start_logit": -0.38565871119499207,
            "end_logit": 4.38943338394165,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "surgery (FGS) followed by concomitant radiochemotherapy",
            "probability": 0.0013005150776012923,
            "start_logit": -0.4807365834712982,
            "end_logit": 4.38943338394165,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radio",
            "probability": 0.0011610599024736927,
            "start_logit": 4.180445194244385,
            "end_logit": -0.385175496339798,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiotherapy. The standard treatment today is maximal surgical resection",
            "probability": 0.0011391214837706515,
            "start_logit": 4.645345211029053,
            "end_logit": -0.8691514730453491,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "surgical resection",
            "probability": 0.0005950181312737653,
            "start_logit": 1.863232970237732,
            "end_logit": 1.2635400295257568,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "chemo-radiation therapy followed by adjuvant TMZ",
            "probability": 0.00047261590444722324,
            "start_logit": 3.358926296234131,
            "end_logit": -0.4624621570110321,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        }
    ],
    "54e22b62ae9738404b000011": [
        {
            "text": "COL5A1 and COL5A2",
            "probability": 0.35907927451959376,
            "start_logit": 3.9579992294311523,
            "end_logit": 3.8314316272735596,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2",
            "probability": 0.32208768933338283,
            "start_logit": 3.8492798805236816,
            "end_logit": 3.8314316272735596,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1",
            "probability": 0.2571022671727852,
            "start_logit": 3.9579992294311523,
            "end_logit": 3.4973623752593994,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1 and the COL5A2",
            "probability": 0.028452648823300137,
            "start_logit": 2.5645909309387207,
            "end_logit": 2.68953800201416,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1 and COL5A2 genes",
            "probability": 0.008272156384361977,
            "start_logit": 3.9579992294311523,
            "end_logit": 0.060783665627241135,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2 genes",
            "probability": 0.007419976380447306,
            "start_logit": 3.8492798805236816,
            "end_logit": 0.060783665627241135,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1 and COL5A2 genes, which encode type V collagen,",
            "probability": 0.005310605975029183,
            "start_logit": 3.9579992294311523,
            "end_logit": -0.3824056088924408,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2 genes, which encode type V collagen,",
            "probability": 0.004763518612277554,
            "start_logit": 3.8492798805236816,
            "end_logit": -0.3824056088924408,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1 and COL5A2 genes, which encode type V collagen",
            "probability": 0.0017457733213175378,
            "start_logit": 3.9579992294311523,
            "end_logit": -1.494913935661316,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2 genes, which encode type V collagen",
            "probability": 0.0015659274568695517,
            "start_logit": 3.8492798805236816,
            "end_logit": -1.494913935661316,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1 and COL5A2 genes,",
            "probability": 0.000825490883464756,
            "start_logit": 3.9579992294311523,
            "end_logit": -2.2438886165618896,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2 genes,",
            "probability": 0.0007404505636719166,
            "start_logit": 3.8492798805236816,
            "end_logit": -2.2438886165618896,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "the COL5A1 and COL5A2",
            "probability": 0.0006216833118954808,
            "start_logit": -2.4008684158325195,
            "end_logit": 3.8314316272735596,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "the COL5A1",
            "probability": 0.00044512785976204305,
            "start_logit": -2.4008684158325195,
            "end_logit": 3.4973623752593994,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2 gene",
            "probability": 0.0003375971210214458,
            "start_logit": 3.2654218673706055,
            "end_logit": -2.4454362392425537,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "Mutations in the COL5A1 and COL5A2",
            "probability": 0.00033296642085345476,
            "start_logit": -3.0252575874328613,
            "end_logit": 3.8314316272735596,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "Mutations in the COL5A1",
            "probability": 0.00023840535438410474,
            "start_logit": -3.0252575874328613,
            "end_logit": 3.4973623752593994,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1 or COL5A2",
            "probability": 0.00023535477722865764,
            "start_logit": 0.7677820324897766,
            "end_logit": -0.30855557322502136,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1 and COL5A2 genes, which encode type V",
            "probability": 0.0002230309519670439,
            "start_logit": 3.9579992294311523,
            "end_logit": -3.552556276321411,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2 genes, which encode type V",
            "probability": 0.0002000547763860708,
            "start_logit": 3.8492798805236816,
            "end_logit": -3.552556276321411,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        }
    ],
    "551adceb622b194345000018": [
        {
            "text": "blood pressure",
            "probability": 0.12644626628048056,
            "start_logit": 3.91737961769104,
            "end_logit": 3.7961294651031494,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "blood pressure, clinical features, duration of symptoms and diabetes",
            "probability": 0.09372890492826498,
            "start_logit": 3.91737961769104,
            "end_logit": 3.496718645095825,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "duration of symptoms and diabetes",
            "probability": 0.0752934520534032,
            "start_logit": 3.698366165161133,
            "end_logit": 3.496718645095825,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "blood pressure, clinical features, duration of symptoms",
            "probability": 0.06309441535536775,
            "start_logit": 3.91737961769104,
            "end_logit": 3.1009442806243896,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "clinical features, duration of symptoms and diabetes",
            "probability": 0.06031333768723201,
            "start_logit": 3.4765262603759766,
            "end_logit": 3.496718645095825,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "blood pressure, clinical features",
            "probability": 0.05693470507402658,
            "start_logit": 3.91737961769104,
            "end_logit": 2.9982171058654785,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "age, blood pressure",
            "probability": 0.0557353604998275,
            "start_logit": 3.098176956176758,
            "end_logit": 3.7961294651031494,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "duration of symptoms",
            "probability": 0.050684432310744876,
            "start_logit": 3.698366165161133,
            "end_logit": 3.1009442806243896,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "diabetes",
            "probability": 0.04995966311137833,
            "start_logit": 3.288188934326172,
            "end_logit": 3.496718645095825,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "blood pressure, clinical features and duration of symptoms",
            "probability": 0.04769360277783712,
            "start_logit": 3.5464444160461426,
            "end_logit": 3.192044496536255,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes",
            "probability": 0.041314104869202735,
            "start_logit": 3.098176956176758,
            "end_logit": 3.496718645095825,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "clinical features, duration of symptoms",
            "probability": 0.040600439986141365,
            "start_logit": 3.4765262603759766,
            "end_logit": 3.1009442806243896,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "age",
            "probability": 0.03802267002920043,
            "start_logit": 3.098176956176758,
            "end_logit": 3.4136972427368164,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "clinical features",
            "probability": 0.0366367461124278,
            "start_logit": 3.4765262603759766,
            "end_logit": 2.9982171058654785,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "clinical features and duration of symptoms",
            "probability": 0.03156019981977256,
            "start_logit": 3.1335439682006836,
            "end_logit": 3.192044496536255,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 0.02936082324765821,
            "start_logit": 3.5464444160461426,
            "end_logit": 2.7069084644317627,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "age, blood pressure, clinical features, duration of symptoms",
            "probability": 0.02781094364270784,
            "start_logit": 3.098176956176758,
            "end_logit": 3.1009442806243896,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 0.026781741373592596,
            "start_logit": 3.4545035362243652,
            "end_logit": 2.7069084644317627,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "age, blood pressure, clinical features",
            "probability": 0.02509584826501189,
            "start_logit": 3.098176956176758,
            "end_logit": 2.9982171058654785,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Blood pressure",
            "probability": 0.022932342575721593,
            "start_logit": 2.9262373447418213,
            "end_logit": 3.080002546310425,
            "question_text": "Which factors are considered in the ABCD2 score?"
        }
    ],
    "532f0b2cd6d3ac6a3400002c": [
        {
            "text": "dural ectasia, protrusio acetabuli, and ligamentous laxity",
            "probability": 0.0775338765752814,
            "start_logit": 5.6824774742126465,
            "end_logit": 5.769796848297119,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "protrusio acetabuli, and ligamentous laxity",
            "probability": 0.07280154424391373,
            "start_logit": 5.619499683380127,
            "end_logit": 5.769796848297119,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "dural ectasia",
            "probability": 0.06865544893660787,
            "start_logit": 5.6824774742126465,
            "end_logit": 5.648182392120361,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "ligamentous laxity",
            "probability": 0.06833331737158721,
            "start_logit": 5.556159973144531,
            "end_logit": 5.769796848297119,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "scoliosis, dural ectasia, protrusio acetabuli, and ligamentous laxity",
            "probability": 0.06736883109940886,
            "start_logit": 5.541944980621338,
            "end_logit": 5.769796848297119,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "dural ectasia, protrusio acetabuli",
            "probability": 0.061132817170376066,
            "start_logit": 5.6824774742126465,
            "end_logit": 5.532130718231201,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "scoliosis",
            "probability": 0.0601001531564206,
            "start_logit": 5.541944980621338,
            "end_logit": 5.6556267738342285,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "scoliosis, dural ectasia",
            "probability": 0.05965440589022475,
            "start_logit": 5.541944980621338,
            "end_logit": 5.648182392120361,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "protrusio acetabuli",
            "probability": 0.05740153453649328,
            "start_logit": 5.619499683380127,
            "end_logit": 5.532130718231201,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "dural ectasia, protrusio acetabuli, and ligamentous laxity.Scoliosis",
            "probability": 0.05332165189739923,
            "start_logit": 5.6824774742126465,
            "end_logit": 5.3954243659973145,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "scoliosis, dural ectasia, protrusio acetabuli",
            "probability": 0.053118025519893974,
            "start_logit": 5.541944980621338,
            "end_logit": 5.532130718231201,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "protrusio acetabuli, and ligamentous laxity.Scoliosis",
            "probability": 0.05006712899229221,
            "start_logit": 5.619499683380127,
            "end_logit": 5.3954243659973145,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "ligamentous laxity.Scoliosis",
            "probability": 0.04699423687843707,
            "start_logit": 5.556159973144531,
            "end_logit": 5.3954243659973145,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "ligamentous laxity.Scoliosis, pectus excavatum and carinatum",
            "probability": 0.03546032570323669,
            "start_logit": 5.556159973144531,
            "end_logit": 5.113813877105713,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "protrusio acetabuli, and ligamentous laxity.Scoliosis, pectus excavatum",
            "probability": 0.032447459863972794,
            "start_logit": 5.619499683380127,
            "end_logit": 4.961681842803955,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "ligamentous laxity.Scoliosis, pectus excavatum",
            "probability": 0.03045598271044991,
            "start_logit": 5.556159973144531,
            "end_logit": 4.961681842803955,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "arachnodactyly",
            "probability": 0.028521119926624938,
            "start_logit": 5.155337810516357,
            "end_logit": 5.296866416931152,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "pectus excavatum and carinatum, arachnodactyly",
            "probability": 0.027105787463478095,
            "start_logit": 5.104440212249756,
            "end_logit": 5.296866416931152,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "arachnodactyly, and acetabular protrusion",
            "probability": 0.0251164002752516,
            "start_logit": 5.155337810516357,
            "end_logit": 5.169742584228516,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "Scoliosis",
            "probability": 0.02440995178864962,
            "start_logit": 4.901125907897949,
            "end_logit": 5.3954243659973145,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        }
    ],
    "5512c1ee6a8cde6b72000009": [
        {
            "text": "p38\u03b3, and p38\u03b4",
            "probability": 0.13506126045218167,
            "start_logit": 6.354101657867432,
            "end_logit": 6.285740375518799,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2, p38\u03b3, and p38\u03b4",
            "probability": 0.12506536961516376,
            "start_logit": 6.277209758758545,
            "end_logit": 6.285740375518799,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b4",
            "probability": 0.12099408674955792,
            "start_logit": 6.244114875793457,
            "end_logit": 6.285740375518799,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b3",
            "probability": 0.11756302416365243,
            "start_logit": 6.354101657867432,
            "end_logit": 6.146986484527588,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2, p38\u03b3",
            "probability": 0.10886217869489843,
            "start_logit": 6.277209758758545,
            "end_logit": 6.146986484527588,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2, p38\u03b3, and p38\u03b4",
            "probability": 0.09552051778398025,
            "start_logit": 6.00771427154541,
            "end_logit": 6.285740375518799,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2",
            "probability": 0.09470276711046287,
            "start_logit": 6.277209758758545,
            "end_logit": 6.0076470375061035,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2, p38\u03b3",
            "probability": 0.0831450921068408,
            "start_logit": 6.00771427154541,
            "end_logit": 6.146986484527588,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2",
            "probability": 0.07233063299458961,
            "start_logit": 6.00771427154541,
            "end_logit": 6.0076470375061035,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1",
            "probability": 0.029856625261872355,
            "start_logit": 6.00771427154541,
            "end_logit": 5.122806072235107,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38",
            "probability": 0.0027944210907675723,
            "start_logit": 6.277209758758545,
            "end_logit": 2.4845287799835205,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b3, and p38",
            "probability": 0.0026177756645876806,
            "start_logit": 6.354101657867432,
            "end_logit": 2.342336893081665,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2, p38\u03b3, and p38",
            "probability": 0.002424033952927253,
            "start_logit": 6.277209758758545,
            "end_logit": 2.342336893081665,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2, p38",
            "probability": 0.0021912582448372878,
            "start_logit": 6.277209758758545,
            "end_logit": 2.241379737854004,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38",
            "probability": 0.0021342802593391098,
            "start_logit": 6.00771427154541,
            "end_logit": 2.4845287799835205,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2, p38\u03b3, and p38",
            "probability": 0.0018513916284103441,
            "start_logit": 6.00771427154541,
            "end_logit": 2.342336893081665,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2, p38",
            "probability": 0.001673605753449877,
            "start_logit": 6.00771427154541,
            "end_logit": 2.241379737854004,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b3,",
            "probability": 0.00044585417566884766,
            "start_logit": 6.354101657867432,
            "end_logit": 0.5722485780715942,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2, p38\u03b3,",
            "probability": 0.00041285648518163133,
            "start_logit": 6.277209758758545,
            "end_logit": 0.5722485780715942,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2,",
            "probability": 0.0003529678116300491,
            "start_logit": 6.277209758758545,
            "end_logit": 0.4155254065990448,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        }
    ],
    "515db70c298dcd4e51000017": [
        {
            "text": "insomnia",
            "probability": 0.9774446395375223,
            "start_logit": 3.447557210922241,
            "end_logit": 3.5576963424682617,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "overactive bladder",
            "probability": 0.017399915635184483,
            "start_logit": 2.0689849853515625,
            "end_logit": 0.9077922701835632,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "nia",
            "probability": 0.0020324824316957485,
            "start_logit": -2.7281265258789062,
            "end_logit": 3.5576963424682617,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "insomnia in children. We identified 23 children,Adverse effects were noted in 6",
            "probability": 0.0006017832427739145,
            "start_logit": 3.447557210922241,
            "end_logit": -3.8351032733917236,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "ins",
            "probability": 0.0005585247911066029,
            "start_logit": 3.447557210922241,
            "end_logit": -3.9097015857696533,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "insomnia in children.",
            "probability": 0.00039587826001739575,
            "start_logit": 3.447557210922241,
            "end_logit": -4.253893852233887,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "insomnia in children. We identified 23 children,",
            "probability": 0.0003620914145670778,
            "start_logit": 3.447557210922241,
            "end_logit": -4.343103885650635,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "omnia",
            "probability": 0.00026695032140863106,
            "start_logit": -4.758077144622803,
            "end_logit": 3.5576963424682617,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "bladder",
            "probability": 0.0002316408165818431,
            "start_logit": -2.2500476837158203,
            "end_logit": 0.9077922701835632,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "insomnia in children. We identified 23",
            "probability": 0.00017367587615923827,
            "start_logit": 3.447557210922241,
            "end_logit": -5.077809810638428,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "insomnia in children. We identified 23 children,Adverse effects",
            "probability": 0.0001660601328264567,
            "start_logit": 3.447557210922241,
            "end_logit": -5.122650623321533,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "gabapentin to treat insomnia",
            "probability": 0.00010176488957728238,
            "start_logit": -5.722474575042725,
            "end_logit": 3.5576963424682617,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "insom",
            "probability": 8.640074319808987e-05,
            "start_logit": 3.447557210922241,
            "end_logit": -5.776004314422607,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "insomnia in children. We identified 23 children,Adverse effects were noted in 6 children",
            "probability": 7.185917153191662e-05,
            "start_logit": 3.447557210922241,
            "end_logit": -5.960292339324951,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "over",
            "probability": 4.461517236396046e-05,
            "start_logit": 2.0689849853515625,
            "end_logit": -5.058354377746582,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "6 children.To determine the effectiveness of gabapentin as an add-on therapy in children presenting with overactive bladder",
            "probability": 3.2700627095603264e-05,
            "start_logit": -4.207841396331787,
            "end_logit": 0.9077922701835632,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "anticholinergics",
            "probability": 1.851352815380925e-05,
            "start_logit": -1.4871422052383423,
            "end_logit": -2.3817994594573975,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "anticholinergic",
            "probability": 4.2751908582176585e-06,
            "start_logit": -1.4871422052383423,
            "end_logit": -3.8474724292755127,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "Adverse effects were noted in 6 children.To determine the effectiveness of gabapentin as an add-on therapy in children presenting with overactive bladder",
            "probability": 3.909553877033854e-06,
            "start_logit": -6.331812381744385,
            "end_logit": 0.9077922701835632,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "noted in 6 children.To determine the effectiveness of gabapentin as an add-on therapy in children presenting with overactive bladder",
            "probability": 2.3186635004086194e-06,
            "start_logit": -6.854244709014893,
            "end_logit": 0.9077922701835632,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        }
    ],
    "54fb5c69d176fff445000003": [
        {
            "text": "Mef2c",
            "probability": 0.13997273670074636,
            "start_logit": 5.474328517913818,
            "end_logit": 4.977097034454346,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2c",
            "probability": 0.13383507838459874,
            "start_logit": 5.4294891357421875,
            "end_logit": 4.977097034454346,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2c, and Tbx5",
            "probability": 0.1293724721550494,
            "start_logit": 5.474328517913818,
            "end_logit": 4.898344993591309,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4",
            "probability": 0.12727979763647965,
            "start_logit": 5.4294891357421875,
            "end_logit": 4.926876544952393,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2c, and Tbx5",
            "probability": 0.12369962436826479,
            "start_logit": 5.4294891357421875,
            "end_logit": 4.898344993591309,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5",
            "probability": 0.10356373232473966,
            "start_logit": 5.251820087432861,
            "end_logit": 4.898344993591309,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2c and Tbx5",
            "probability": 0.08892203707835902,
            "start_logit": 5.343099117279053,
            "end_logit": 4.654638767242432,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2c and Tbx5",
            "probability": 0.08891898423489956,
            "start_logit": 5.343064785003662,
            "end_logit": 4.654638767242432,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand2, Nkx2.5, Gata4",
            "probability": 0.010031982063499026,
            "start_logit": 3.7490832805633545,
            "end_logit": 4.0666728019714355,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Nkx2.5, Gata4",
            "probability": 0.008936297408175468,
            "start_logit": 3.6334264278411865,
            "end_logit": 4.0666728019714355,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand2, Nkx2.5, Gata4, Mef2c",
            "probability": 0.0077071797983160615,
            "start_logit": 3.7490832805633545,
            "end_logit": 3.803046941757202,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand2, Nkx2.5, Gata4, Mef2c, and Tbx5",
            "probability": 0.007425440941202935,
            "start_logit": 3.7490832805633545,
            "end_logit": 3.7658066749572754,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Nkx2.5, Gata4, Mef2c",
            "probability": 0.006865408093843014,
            "start_logit": 3.6334264278411865,
            "end_logit": 3.803046941757202,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Nkx2.5, Gata4, Mef2c, and Tbx5",
            "probability": 0.006614440518077214,
            "start_logit": 3.6334264278411865,
            "end_logit": 3.7658066749572754,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand2, Nkx2.5",
            "probability": 0.0037306184628306508,
            "start_logit": 3.7490832805633545,
            "end_logit": 3.0774686336517334,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Nkx2.5",
            "probability": 0.0033231634475886676,
            "start_logit": 3.6334264278411865,
            "end_logit": 3.0774686336517334,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand2",
            "probability": 0.003023005839768418,
            "start_logit": 3.7490832805633545,
            "end_logit": 2.8671462535858154,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2c, and Tbx5, collectively termed GMT",
            "probability": 0.002458773391953302,
            "start_logit": 5.474328517913818,
            "end_logit": 0.9353119730949402,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2c, and Tbx5, collectively termed GMT",
            "probability": 0.0023509587466705663,
            "start_logit": 5.4294891357421875,
            "end_logit": 0.9353119730949402,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5, collectively termed GMT",
            "probability": 0.0019682684049375284,
            "start_logit": 5.251820087432861,
            "end_logit": 0.9353119730949402,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        }
    ],
    "5357b9bcf1005d6b58000008": [
        {
            "text": "S19",
            "probability": 0.2147613965654914,
            "start_logit": 1.3053373098373413,
            "end_logit": 1.8333220481872559,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S19, S33/35",
            "probability": 0.15249911416469142,
            "start_logit": 1.3053373098373413,
            "end_logit": 1.4909532070159912,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S33/35",
            "probability": 0.11114785870983265,
            "start_logit": 0.9890398979187012,
            "end_logit": 1.4909532070159912,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68",
            "probability": 0.06721133997130226,
            "start_logit": 1.506455421447754,
            "end_logit": 0.4705182909965515,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68A",
            "probability": 0.06449848098302367,
            "start_logit": 1.492051124572754,
            "end_logit": 0.44372227787971497,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S19, S33",
            "probability": 0.05581231042761134,
            "start_logit": 1.3053373098373413,
            "end_logit": 0.48578888177871704,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68A, T68D",
            "probability": 0.05402330120408497,
            "start_logit": 1.492051124572754,
            "end_logit": 0.26649606227874756,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "(S19",
            "probability": 0.04538535411280691,
            "start_logit": -0.24900086224079132,
            "end_logit": 1.8333220481872559,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68D",
            "probability": 0.04347447789410322,
            "start_logit": 1.274809718132019,
            "end_logit": 0.26649606227874756,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S33",
            "probability": 0.0406783923149749,
            "start_logit": 0.9890398979187012,
            "end_logit": 0.48578888177871704,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68A, T68",
            "probability": 0.0338355998177544,
            "start_logit": 1.492051124572754,
            "end_logit": -0.20140589773654938,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "(S19, S33/35",
            "probability": 0.03222751578700628,
            "start_logit": -0.24900086224079132,
            "end_logit": 1.4909532070159912,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68A, T68D and Q69E",
            "probability": 0.02284590369749316,
            "start_logit": 1.492051124572754,
            "end_logit": -0.5941475629806519,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68D and Q69E",
            "probability": 0.018384913789614463,
            "start_logit": 1.274809718132019,
            "end_logit": -0.5941475629806519,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "(S19, S33",
            "probability": 0.011794770909112571,
            "start_logit": -0.24900086224079132,
            "end_logit": 0.48578888177871704,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "Q69E",
            "probability": 0.008139479942286245,
            "start_logit": 0.46000558137893677,
            "end_logit": -0.5941475629806519,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S19, S33/35, T432, in Chk2 wildtype and Chk2 mutants (T68A",
            "probability": 0.0075278141646059555,
            "start_logit": -0.6559858322143555,
            "end_logit": 0.44372227787971497,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T432, in Chk2 wildtype and Chk2 mutants (T68A",
            "probability": 0.00591217473603144,
            "start_logit": -0.8975768089294434,
            "end_logit": 0.44372227787971497,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T432, in Chk2 wildtype and Chk2 mutants (T68A, T68D",
            "probability": 0.004951980134537967,
            "start_logit": -0.8975768089294434,
            "end_logit": 0.26649606227874756,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S33/35, T432, in Chk2 wildtype and Chk2 mutants (T68A",
            "probability": 0.004887820673634898,
            "start_logit": -1.0878440141677856,
            "end_logit": 0.44372227787971497,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        }
    ],
    "5542644fed966d112c000004": [
        {
            "text": "correlation",
            "probability": 0.31687162026674043,
            "start_logit": 0.30331578850746155,
            "end_logit": -0.4506298005580902,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "GC skew",
            "probability": 0.11625490458642057,
            "start_logit": 1.1411486864089966,
            "end_logit": -2.2911741733551025,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "comparative genomics",
            "probability": 0.0961311449798209,
            "start_logit": -0.5417381525039673,
            "end_logit": -0.798359215259552,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "GC skew measure",
            "probability": 0.08881080994393915,
            "start_logit": 1.1411486864089966,
            "end_logit": -2.560451030731201,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "correlation measure",
            "probability": 0.07498251383460418,
            "start_logit": 0.30331578850746155,
            "end_logit": -1.8918715715408325,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "Z-curve theory, we have developed a web-based system Ori-Finder",
            "probability": 0.0397442415517514,
            "start_logit": 0.15264487266540527,
            "end_logit": -2.375990629196167,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "Z-curve theory",
            "probability": 0.03908131725476471,
            "start_logit": 0.15264487266540527,
            "end_logit": -2.3928110599517822,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "Z-curve",
            "probability": 0.037953400414577405,
            "start_logit": 0.15264487266540527,
            "end_logit": -2.4220964908599854,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "Ori-Finder to predict oriCs in bacterial genomes with high accuracy and reliability by taking advantage of comparative genomics",
            "probability": 0.02652088014168939,
            "start_logit": -1.8295191526412964,
            "end_logit": -0.798359215259552,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "comparative genomicswe have applied a combination of multiple in silico approaches - Z curve",
            "probability": 0.023468670419956636,
            "start_logit": -0.5417381525039673,
            "end_logit": -2.2084062099456787,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "correlation based method is able to correctly predict the origin of replication whereas the generally used GC skew",
            "probability": 0.022816522719576474,
            "start_logit": -0.4871515929698944,
            "end_logit": -2.2911741733551025,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "Z curve",
            "probability": 0.0219220597945286,
            "start_logit": -0.6099110841751099,
            "end_logit": -2.2084062099456787,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "G",
            "probability": 0.020621983304588,
            "start_logit": 1.1411486864089966,
            "end_logit": -4.020601749420166,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "correlation based method is able to correctly predict the origin of replication whereas the generally used GC skew measure",
            "probability": 0.01743026558783627,
            "start_logit": -0.4871515929698944,
            "end_logit": -2.560451030731201,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "a correlation",
            "probability": 0.01580484294331498,
            "start_logit": -2.694864511489868,
            "end_logit": -0.4506298005580902,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "Z",
            "probability": 0.01509345461964315,
            "start_logit": 0.15264487266540527,
            "end_logit": -3.3441944122314453,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "Z-curve theory,",
            "probability": 0.00886675843299065,
            "start_logit": 0.15264487266540527,
            "end_logit": -3.8761463165283203,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "comparative",
            "probability": 0.0066269727233424745,
            "start_logit": -0.5417381525039673,
            "end_logit": -3.4729244709014893,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "comparative genomicswe have applied a combination of multiple in silico approaches - Z",
            "probability": 0.00552204151780618,
            "start_logit": -0.5417381525039673,
            "end_logit": -3.655324935913086,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "Ori-Finder",
            "probability": 0.005475594962108805,
            "start_logit": -1.8295191526412964,
            "end_logit": -2.375990629196167,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        }
    ],
    "55242d512c8b63434a000006": [
        {
            "text": "5-hydroxytryptamine type 2a",
            "probability": 0.4933337984704476,
            "start_logit": 4.444063663482666,
            "end_logit": 4.131520748138428,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR",
            "probability": 0.14554867292461876,
            "start_logit": 4.444063663482666,
            "end_logit": 2.9108452796936035,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "serotonin 2A",
            "probability": 0.0998820905320874,
            "start_logit": 3.6377785205841064,
            "end_logit": 3.3406102657318115,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT2AR",
            "probability": 0.04428974699180538,
            "start_logit": 3.2543063163757324,
            "end_logit": 2.9108452796936035,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor",
            "probability": 0.04428720222576607,
            "start_logit": 4.444063663482666,
            "end_logit": 1.7210304737091064,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "serotonin 2A (5-HT2A",
            "probability": 0.027157894280614433,
            "start_logit": 3.6377785205841064,
            "end_logit": 2.03828763961792,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-hydroxytryptamine",
            "probability": 0.02556994723236867,
            "start_logit": 4.444063663482666,
            "end_logit": 1.1717524528503418,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "serotonin 2A (5-HT2A )",
            "probability": 0.022983842141109222,
            "start_logit": 3.6377785205841064,
            "end_logit": 1.8714113235473633,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "type 2a",
            "probability": 0.021263794597597925,
            "start_logit": 1.299883484840393,
            "end_logit": 4.131520748138428,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2AR)",
            "probability": 0.016244257721391573,
            "start_logit": 4.444063663482666,
            "end_logit": 0.7180742025375366,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT2AR availability in albino rats.Imaging the cerebral serotonin 2A",
            "probability": 0.010603538601039674,
            "start_logit": 1.3949759006500244,
            "end_logit": 3.3406102657318115,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "serotonin 2A (5-HT2A ) receptors",
            "probability": 0.010361353444025409,
            "start_logit": 3.6377785205841064,
            "end_logit": 1.0747027397155762,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "type 2a receptor (5-HT2AR",
            "probability": 0.006273474662830042,
            "start_logit": 1.299883484840393,
            "end_logit": 2.9108452796936035,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "2a",
            "probability": 0.005578585992539547,
            "start_logit": -0.038187019526958466,
            "end_logit": 4.131520748138428,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT2A",
            "probability": 0.005171415053003716,
            "start_logit": 1.9792571067810059,
            "end_logit": 2.03828763961792,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT2AR)",
            "probability": 0.004943047917192119,
            "start_logit": 3.2543063163757324,
            "end_logit": 0.7180742025375366,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "(5-HT2AR",
            "probability": 0.004376832256154312,
            "start_logit": 0.9398783445358276,
            "end_logit": 2.9108452796936035,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT2A )",
            "probability": 0.004376590688374396,
            "start_logit": 1.9792571067810059,
            "end_logit": 1.8714113235473633,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5",
            "probability": 0.003905753795643931,
            "start_logit": 4.444063663482666,
            "end_logit": -0.7072144746780396,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-hydroxytryptamine type 2a receptor (5-HT2",
            "probability": 0.003848160471389749,
            "start_logit": 4.444063663482666,
            "end_logit": -0.722070038318634,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        }
    ],
    "550316a6e9bde69634000029": [
        {
            "text": "type 1 diabetes",
            "probability": 0.17585543615106672,
            "start_logit": 5.423545837402344,
            "end_logit": 5.651121616363525,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "type 1 diabetes, seropositive rheumatoid arthritis",
            "probability": 0.10222147152877425,
            "start_logit": 5.423545837402344,
            "end_logit": 5.108601093292236,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus erythematosus",
            "probability": 0.09967079621055912,
            "start_logit": 5.423545837402344,
            "end_logit": 5.083332061767578,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.0816268729896385,
            "start_logit": 5.223831653594971,
            "end_logit": 5.083332061767578,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "systemic lupus erythematosus, and Hashimoto thyroiditis",
            "probability": 0.0795621937210903,
            "start_logit": 5.223831653594971,
            "end_logit": 5.057712554931641,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis",
            "probability": 0.07538693744332431,
            "start_logit": 5.119038105010986,
            "end_logit": 5.108601093292236,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis, systemic lupus erythematosus",
            "probability": 0.07350584927489201,
            "start_logit": 5.119038105010986,
            "end_logit": 5.083332061767578,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis",
            "probability": 0.07164658408983264,
            "start_logit": 5.119038105010986,
            "end_logit": 5.057712554931641,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "Hashimoto thyroiditis",
            "probability": 0.05515213142538535,
            "start_logit": 4.857388019561768,
            "end_logit": 5.057712554931641,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "seropositive rheumatoid arthritis",
            "probability": 0.0522279701454106,
            "start_logit": 4.7520222663879395,
            "end_logit": 5.108601093292236,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "seropositive rheumatoid arthritis, systemic lupus erythematosus",
            "probability": 0.05092475476044251,
            "start_logit": 4.7520222663879395,
            "end_logit": 5.083332061767578,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "seropositive rheumatoid arthritis, systemic lupus erythematosus, and Hashimoto thyroiditis",
            "probability": 0.04963665830937383,
            "start_logit": 4.7520222663879395,
            "end_logit": 5.057712554931641,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "Wegener's granulomatosis",
            "probability": 0.015119756418278939,
            "start_logit": 4.0302324295043945,
            "end_logit": 4.590775012969971,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "type 1 diabetes, seropositive rheumatoid arthritis, systemic lupus",
            "probability": 0.0030458824621989733,
            "start_logit": 5.423545837402344,
            "end_logit": 1.5952500104904175,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "type 1 diabetes,",
            "probability": 0.0028050626351459823,
            "start_logit": 5.423545837402344,
            "end_logit": 1.5128852128982544,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "thyroiditis",
            "probability": 0.0025217861572897795,
            "start_logit": 1.772260069847107,
            "end_logit": 5.057712554931641,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "type 1 diabetes, seropositive rheumatoid arthritis,",
            "probability": 0.002503092569577199,
            "start_logit": 5.423545837402344,
            "end_logit": 1.3989863395690918,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "systemic lupus",
            "probability": 0.0024944705002461253,
            "start_logit": 5.223831653594971,
            "end_logit": 1.5952500104904175,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis, systemic lupus",
            "probability": 0.0022462966654992547,
            "start_logit": 5.119038105010986,
            "end_logit": 1.5952500104904175,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis,",
            "probability": 0.001845996541973562,
            "start_logit": 5.119038105010986,
            "end_logit": 1.3989863395690918,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        }
    ],
    "513f45abbee46bd34c000013": [
        {
            "text": "adipose tissues",
            "probability": 0.25834254716300675,
            "start_logit": 4.799709796905518,
            "end_logit": 4.056580543518066,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "adipose tissues,These fibrocytes infiltrate orbital connective tissues",
            "probability": 0.14607919493737828,
            "start_logit": 4.799709796905518,
            "end_logit": 3.486443042755127,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "adipose tissues.TSH worked as a lipolytic factor in white adipose tissues",
            "probability": 0.10722388749832995,
            "start_logit": 3.920342445373535,
            "end_logit": 4.056580543518066,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "orbital connective tissues",
            "probability": 0.07439342641098383,
            "start_logit": 4.1249284744262695,
            "end_logit": 3.486443042755127,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "fibrocytes infiltrate orbital connective tissues",
            "probability": 0.05808537399331595,
            "start_logit": 3.877474784851074,
            "end_logit": 3.486443042755127,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "white adipose tissues",
            "probability": 0.04657814199934319,
            "start_logit": 3.086554765701294,
            "end_logit": 4.056580543518066,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "adipose",
            "probability": 0.04622976305544388,
            "start_logit": 4.799709796905518,
            "end_logit": 2.3359179496765137,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "adipose tissues,These fibrocytes infiltrate orbital connective tissues in thyroid-associated ophthalmopathy",
            "probability": 0.03899310520694018,
            "start_logit": 4.799709796905518,
            "end_logit": 2.1656789779663086,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "connective tissues",
            "probability": 0.02744436584436682,
            "start_logit": 3.1277217864990234,
            "end_logit": 3.486443042755127,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "ophthalmopathy",
            "probability": 0.02696474624546042,
            "start_logit": 4.4308552742004395,
            "end_logit": 2.1656789779663086,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "white adipose tissues,These fibrocytes infiltrate orbital connective tissues",
            "probability": 0.026337502512312646,
            "start_logit": 3.086554765701294,
            "end_logit": 3.486443042755127,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "adipose tissues,These fibrocytes infiltrate orbital",
            "probability": 0.0248397024488131,
            "start_logit": 4.799709796905518,
            "end_logit": 1.7147374153137207,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "adipose tissues,These fibrocytes",
            "probability": 0.022845247257647246,
            "start_logit": 4.799709796905518,
            "end_logit": 1.6310372352600098,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "orbital connective tissues in thyroid-associated ophthalmopathy",
            "probability": 0.019857931884083788,
            "start_logit": 4.1249284744262695,
            "end_logit": 2.1656789779663086,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "adipose tissues.TSH worked as a lipolytic factor in white adipose",
            "probability": 0.019187450798817438,
            "start_logit": 3.920342445373535,
            "end_logit": 2.3359179496765137,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "fibrocytes infiltrate orbital connective tissues in thyroid-associated ophthalmopathy",
            "probability": 0.015504802720721274,
            "start_logit": 3.877474784851074,
            "end_logit": 2.1656789779663086,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "orbital",
            "probability": 0.012650059969105669,
            "start_logit": 4.1249284744262695,
            "end_logit": 1.7147374153137207,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "fibrocytes infiltrate orbital",
            "probability": 0.009876994511371107,
            "start_logit": 3.877474784851074,
            "end_logit": 1.7147374153137207,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "adipose tissues.TSH worked as a lipolytic factor in white adipose tissues,These fibrocytes",
            "probability": 0.009481814934184648,
            "start_logit": 3.920342445373535,
            "end_logit": 1.6310372352600098,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "fibrocytes",
            "probability": 0.00908394060837389,
            "start_logit": 3.877474784851074,
            "end_logit": 1.6310372352600098,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        }
    ],
    "56ddbbaf51531f7e33000009": [
        {
            "text": "H3K27me3",
            "probability": 0.2568387768412227,
            "start_logit": 3.7424330711364746,
            "end_logit": 3.0640389919281006,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac enrichment, and H3K27me3",
            "probability": 0.20484565670871158,
            "start_logit": 3.5162413120269775,
            "end_logit": 3.0640389919281006,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac",
            "probability": 0.1752122714195744,
            "start_logit": 3.442610740661621,
            "end_logit": 2.9814109802246094,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27me3 depletion",
            "probability": 0.09598958906299976,
            "start_logit": 3.7424330711364746,
            "end_logit": 2.0798301696777344,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac enrichment, and H3K27me3 depletion",
            "probability": 0.07655795067489053,
            "start_logit": 3.5162413120269775,
            "end_logit": 2.0798301696777344,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac enrichment",
            "probability": 0.04584639814936818,
            "start_logit": 3.5162413120269775,
            "end_logit": 1.5670788288116455,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27me3We also find that some developmental enhancers exhibit components of this signature, including hypersensitivity",
            "probability": 0.024461072938543486,
            "start_logit": 3.3952174186706543,
            "end_logit": 1.0598890781402588,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "hypersensitivity, H3K27ac enrichment, and H3K27me3",
            "probability": 0.022980541685341638,
            "start_logit": 1.3286323547363281,
            "end_logit": 3.0640389919281006,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "hypersensitivity to sonication, and strong depletion of H3K27me3",
            "probability": 0.017008373486950088,
            "start_logit": 1.0849717855453491,
            "end_logit": 3.0067574977874756,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "hypersensitivity, H3K27ac",
            "probability": 0.016796452533605604,
            "start_logit": 1.3286323547363281,
            "end_logit": 2.750558853149414,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac marking, nucleosome displacement",
            "probability": 0.01411397463783448,
            "start_logit": 3.442610740661621,
            "end_logit": 0.4625781774520874,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac marking",
            "probability": 0.011661109931876874,
            "start_logit": 3.442610740661621,
            "end_logit": 0.2716721296310425,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "hypersensitivity, H3K27ac enrichment, and H3K27me3 depletion",
            "probability": 0.008588628165694619,
            "start_logit": 1.3286323547363281,
            "end_logit": 2.0798301696777344,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "nucleosome displacement, hypersensitivity to sonication, and strong depletion of H3K27me3",
            "probability": 0.006438179001965991,
            "start_logit": 0.11351174116134644,
            "end_logit": 3.0067574977874756,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac marking, nucleosome displacement, hypersensitivity to sonication",
            "probability": 0.006023214548990724,
            "start_logit": 3.442610740661621,
            "end_logit": -0.3889661431312561,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "hypersensitivity, H3K27ac enrichment",
            "probability": 0.00514326288739672,
            "start_logit": 1.3286323547363281,
            "end_logit": 1.5670788288116455,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "strong depletion of H3K27me3",
            "probability": 0.0035956067908244757,
            "start_logit": -0.4690212309360504,
            "end_logit": 3.0067574977874756,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "high levels of H3K27ac",
            "probability": 0.00313439472442761,
            "start_logit": -0.5809513926506042,
            "end_logit": 2.9814109802246094,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "hypersensitivity",
            "probability": 0.0030971983053939157,
            "start_logit": 1.3286323547363281,
            "end_logit": 1.0598890781402588,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac marking, nucleosome displacement, hypersensitivity",
            "probability": 0.001667347504386773,
            "start_logit": 3.442610740661621,
            "end_logit": -1.6733531951904297,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        }
    ],
    "517843638ed59a060a000036": [
        {
            "text": "Alu, L1, and SVA",
            "probability": 0.17668389760364178,
            "start_logit": 5.467834949493408,
            "end_logit": 4.825634479522705,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "SVA",
            "probability": 0.1134653868455202,
            "start_logit": 5.024970531463623,
            "end_logit": 4.825634479522705,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "L1, and SVA",
            "probability": 0.10657851645931664,
            "start_logit": 4.96235466003418,
            "end_logit": 4.825634479522705,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu",
            "probability": 0.10310127257210815,
            "start_logit": 5.467834949493408,
            "end_logit": 4.286983966827393,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "SVA elements).Since certain types of retrotransposons, particularly members of the Alu, L1, and SVA",
            "probability": 0.07663757949524481,
            "start_logit": 4.6325602531433105,
            "end_logit": 4.825634479522705,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu, L1",
            "probability": 0.0655859251688657,
            "start_logit": 5.467834949493408,
            "end_logit": 3.8346333503723145,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu, and SVA elements).Since certain types of retrotransposons, particularly members of the Alu",
            "probability": 0.053332142547897816,
            "start_logit": 4.808662414550781,
            "end_logit": 4.286983966827393,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "SVA elements).Since certain types of retrotransposons, particularly members of the Alu",
            "probability": 0.044720724864986114,
            "start_logit": 4.6325602531433105,
            "end_logit": 4.286983966827393,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "L1",
            "probability": 0.03956246550996046,
            "start_logit": 4.96235466003418,
            "end_logit": 3.8346333503723145,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu, and SVA elements).Since certain types of retrotransposons, particularly members of the Alu, L1",
            "probability": 0.03392623410923805,
            "start_logit": 4.808662414550781,
            "end_logit": 3.8346333503723145,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu, and SVA",
            "probability": 0.03388709956964626,
            "start_logit": 4.808662414550781,
            "end_logit": 3.833479166030884,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1), Alu, and SVA",
            "probability": 0.030570957186804127,
            "start_logit": 4.705678462982178,
            "end_logit": 3.833479166030884,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1), Alu",
            "probability": 0.030064223410828372,
            "start_logit": 4.705678462982178,
            "end_logit": 3.8167645931243896,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "SVA elements).Since certain types of retrotransposons, particularly members of the Alu, L1",
            "probability": 0.028448243569845953,
            "start_logit": 4.6325602531433105,
            "end_logit": 3.8346333503723145,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1",
            "probability": 0.017768600580975544,
            "start_logit": 4.705678462982178,
            "end_logit": 3.2908616065979004,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu, and SVA elements",
            "probability": 0.011490345547511582,
            "start_logit": 4.808662414550781,
            "end_logit": 2.7519519329071045,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1), Alu, and SVA elements",
            "probability": 0.010365917008406538,
            "start_logit": 4.705678462982178,
            "end_logit": 2.7519519329071045,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "SVA elements",
            "probability": 0.009635026032797893,
            "start_logit": 4.6325602531433105,
            "end_logit": 2.7519519329071045,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu, L1, and SVA families",
            "probability": 0.008632012768182993,
            "start_logit": 5.467834949493408,
            "end_logit": 1.806749939918518,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "SVA families",
            "probability": 0.005543429148221171,
            "start_logit": 5.024970531463623,
            "end_logit": 1.806749939918518,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        }
    ],
    "55031286e9bde6963400001b": [
        {
            "text": "reticulocytopenia",
            "probability": 0.17481384137548478,
            "start_logit": 5.5288405418396,
            "end_logit": 6.138118743896484,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "macrocytic anemia and reticulocytopenia",
            "probability": 0.16187701780897604,
            "start_logit": 5.451955795288086,
            "end_logit": 6.138118743896484,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "hypoplastic anemia",
            "probability": 0.14789294299787498,
            "start_logit": 5.690603733062744,
            "end_logit": 5.809122562408447,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "reticulocytopenia.Diamond Blackfan anemia is characterized by a severe hypoplastic anemia",
            "probability": 0.12580404055991526,
            "start_logit": 5.5288405418396,
            "end_logit": 5.809122562408447,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "macrocytic anemia and reticulocytopenia.Diamond Blackfan anemia is characterized by a severe hypoplastic anemia",
            "probability": 0.11649411027137593,
            "start_logit": 5.451955795288086,
            "end_logit": 5.809122562408447,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "macrocytic anemia",
            "probability": 0.06542968121565883,
            "start_logit": 5.451955795288086,
            "end_logit": 5.232257843017578,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "hypoplastic anemia that presents in infancy with macrocytic anemia and reticulocytopenia",
            "probability": 0.060569924358226064,
            "start_logit": 4.468917369842529,
            "end_logit": 6.138118743896484,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "severe hypoplastic anemia",
            "probability": 0.04949540664260403,
            "start_logit": 4.59599494934082,
            "end_logit": 5.809122562408447,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "hypoplastic anemia that presents in infancy with macrocytic anemia",
            "probability": 0.024481985742361188,
            "start_logit": 4.468917369842529,
            "end_logit": 5.232257843017578,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "anemia and malformations",
            "probability": 0.015742851083767127,
            "start_logit": 4.552780628204346,
            "end_logit": 4.706843376159668,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "malformations",
            "probability": 0.012081910271411476,
            "start_logit": 4.2881035804748535,
            "end_logit": 4.706843376159668,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital anomalies",
            "probability": 0.006322799506875492,
            "start_logit": 4.239010334014893,
            "end_logit": 4.108389377593994,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "hypoplastic",
            "probability": 0.006197657433996365,
            "start_logit": 5.690603733062744,
            "end_logit": 2.636805295944214,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "red cell aplasia",
            "probability": 0.006116373988811945,
            "start_logit": 4.1982502937316895,
            "end_logit": 4.115956783294678,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "red cell aplasia, congenital anomalies",
            "probability": 0.006070263593500524,
            "start_logit": 4.1982502937316895,
            "end_logit": 4.108389377593994,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "reticulocytopenia.Diamond Blackfan anemia is characterized by a severe hypoplastic",
            "probability": 0.005271991559557661,
            "start_logit": 5.5288405418396,
            "end_logit": 2.636805295944214,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "macrocytic anemia and reticulocytopenia.Diamond Blackfan anemia is characterized by a severe hypoplastic",
            "probability": 0.004881846110470325,
            "start_logit": 5.451955795288086,
            "end_logit": 2.636805295944214,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "a severe hypoplastic anemia",
            "probability": 0.004293351109233567,
            "start_logit": 2.1511826515197754,
            "end_logit": 5.809122562408447,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "anemia",
            "probability": 0.003123545668728846,
            "start_logit": 4.552780628204346,
            "end_logit": 3.089425802230835,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "congenital anomalies, and a predisposition to cancer",
            "probability": 0.0030384587011695174,
            "start_logit": 4.239010334014893,
            "end_logit": 3.375577688217163,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        }
    ],
    "533ec7abc45e133714000015": [
        {
            "text": "NELF",
            "probability": 0.25109508822717674,
            "start_logit": 5.227044582366943,
            "end_logit": 4.936774730682373,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF (negative elongation factor) and DSIF",
            "probability": 0.24161745589072925,
            "start_logit": 5.227044582366943,
            "end_logit": 4.898298740386963,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DSIF",
            "probability": 0.23203527466081095,
            "start_logit": 5.186578273773193,
            "end_logit": 4.898298740386963,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF) complexNA polymerase II (Pol II) and the pausing complex, NELF and DSIF",
            "probability": 0.03976561984222163,
            "start_logit": 4.373445987701416,
            "end_logit": 3.9475443363189697,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF) complexNA polymerase II (Pol II) and the pausing complex, NELF",
            "probability": 0.035410782661651576,
            "start_logit": 4.373445987701416,
            "end_logit": 3.8315579891204834,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF and DSIF",
            "probability": 0.032594187156615835,
            "start_logit": 4.174577236175537,
            "end_logit": 3.9475443363189697,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF (negative elongation factor) and DSIF (DRB sensitivity-inducing factor)BMP",
            "probability": 0.02634117199002389,
            "start_logit": 5.227044582366943,
            "end_logit": 2.6820762157440186,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DSIF (DRB sensitivity-inducing factor)BMP",
            "probability": 0.02529652112700426,
            "start_logit": 5.186578273773193,
            "end_logit": 2.6820762157440186,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF (negative elongation factor) and DSIF (DRB sensitivity-inducing factor)",
            "probability": 0.021549000464088565,
            "start_logit": 5.227044582366943,
            "end_logit": 2.4812724590301514,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DSIF (DRB sensitivity-inducing factor)",
            "probability": 0.020694399843412075,
            "start_logit": 5.186578273773193,
            "end_logit": 2.4812724590301514,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF (negative elongation factor)",
            "probability": 0.01538839257976113,
            "start_logit": 5.227044582366943,
            "end_logit": 2.1445565223693848,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF (negative elongation factor) and DSIF (DRB sensitivity-inducing factor",
            "probability": 0.010662719135147958,
            "start_logit": 5.227044582366943,
            "end_logit": 1.7776964902877808,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DSIF (DRB sensitivity-inducing factor",
            "probability": 0.01023985189329225,
            "start_logit": 5.186578273773193,
            "end_logit": 1.7776964902877808,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "negative elongation factor) and DSIF",
            "probability": 0.010170999721065407,
            "start_logit": 2.0592293739318848,
            "end_logit": 4.898298740386963,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DRB sensitivity-inducing factor)BMP target gene expression requires the pause-inducing negative elongation factor (NELF",
            "probability": 0.008976419330435796,
            "start_logit": 2.730008125305176,
            "end_logit": 4.102580547332764,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF (negative elongation factor",
            "probability": 0.005589684431783942,
            "start_logit": 5.227044582366943,
            "end_logit": 1.1318658590316772,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DSIF (DRB sensitivity-inducing factor)BMP target gene expression requires the pause-inducing negative elongation factor",
            "probability": 0.004450886948332408,
            "start_logit": 5.186578273773193,
            "end_logit": 0.9445127248764038,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "(NELF",
            "probability": 0.0030353750686715713,
            "start_logit": 1.6457420587539673,
            "end_logit": 4.102580547332764,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "(NELF) complexNA polymerase II (Pol II) and the pausing complex, NELF and DSIF",
            "probability": 0.002599447147844905,
            "start_logit": 1.6457420587539673,
            "end_logit": 3.9475443363189697,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF)",
            "probability": 0.002486721879930021,
            "start_logit": 4.373445987701416,
            "end_logit": 1.1755069494247437,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        }
    ],
    "54ecb640445c3b5a5f000001": [
        {
            "text": "pancytopenia",
            "probability": 0.505647213516964,
            "start_logit": 5.527295112609863,
            "end_logit": 5.890206813812256,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "progressive pancytopenia",
            "probability": 0.11494042312007093,
            "start_logit": 4.045869827270508,
            "end_logit": 5.890206813812256,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "pancytopenia and predisposition to both hematologic malignancies",
            "probability": 0.09049688094440607,
            "start_logit": 5.527295112609863,
            "end_logit": 4.16968297958374,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "congenital malformations, progressive pancytopenia",
            "probability": 0.05736422867214386,
            "start_logit": 3.350876808166504,
            "end_logit": 5.890206813812256,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "pancytopenia and predisposition to both hematologic malignancies and solid tumors",
            "probability": 0.03444546311910157,
            "start_logit": 5.527295112609863,
            "end_logit": 3.203744888305664,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "short stature, skeletal or skin abnormalities",
            "probability": 0.03294153649312174,
            "start_logit": 4.569840431213379,
            "end_logit": 4.116556644439697,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "short stature, skeletal or skin abnormalities, progressive bone marrow (BM) failure",
            "probability": 0.030149937420552254,
            "start_logit": 4.569840431213379,
            "end_logit": 4.028005123138428,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "short stature",
            "probability": 0.030142893704332166,
            "start_logit": 4.569840431213379,
            "end_logit": 4.027771472930908,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "progressive pancytopenia and predisposition to both hematologic malignancies",
            "probability": 0.02057116010676434,
            "start_logit": 4.045869827270508,
            "end_logit": 4.16968297958374,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "hematologic malignancies",
            "probability": 0.013942602076379372,
            "start_logit": 3.656928777694702,
            "end_logit": 4.16968297958374,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "diverse congenital malformations, progressive pancytopenia",
            "probability": 0.012861704539157793,
            "start_logit": 1.8557101488113403,
            "end_logit": 5.890206813812256,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "congenital malformations, progressive pancytopenia and predisposition to both hematologic malignancies",
            "probability": 0.01026661204459802,
            "start_logit": 3.350876808166504,
            "end_logit": 4.16968297958374,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "progressive pancytopenia and predisposition to both hematologic malignancies and solid tumors",
            "probability": 0.007829917775950539,
            "start_logit": 4.045869827270508,
            "end_logit": 3.203744888305664,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "bone marrow (BM) failure",
            "probability": 0.007094292489598783,
            "start_logit": 3.122948169708252,
            "end_logit": 4.028005123138428,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "progressive bone marrow (BM) failure",
            "probability": 0.006463644844715552,
            "start_logit": 3.029850959777832,
            "end_logit": 4.028005123138428,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "congenital malformations",
            "probability": 0.005886929092517997,
            "start_logit": 3.350876808166504,
            "end_logit": 3.613520383834839,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "hematologic malignancies and solid tumors",
            "probability": 0.005306916443907796,
            "start_logit": 3.656928777694702,
            "end_logit": 3.203744888305664,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "skeletal or skin abnormalities",
            "probability": 0.005063794839396887,
            "start_logit": 2.6972222328186035,
            "end_logit": 4.116556644439697,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "skeletal or skin abnormalities, progressive bone marrow (BM) failure",
            "probability": 0.004634668378331716,
            "start_logit": 2.6972222328186035,
            "end_logit": 4.028005123138428,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia",
            "probability": 0.003949180377988854,
            "start_logit": 3.227919578552246,
            "end_logit": 3.3372511863708496,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        }
    ],
    "513f3d1fbee46bd34c000010": [
        {
            "text": "raloxifene",
            "probability": 0.2813033095399107,
            "start_logit": 5.011496067047119,
            "end_logit": 4.852175235748291,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "raloxifene and proton-pump inhibitors",
            "probability": 0.12628504380948563,
            "start_logit": 5.011496067047119,
            "end_logit": 4.051283359527588,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene",
            "probability": 0.08141395697144989,
            "start_logit": 3.771609306335449,
            "end_logit": 4.852175235748291,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "sevelamer",
            "probability": 0.07360955317496838,
            "start_logit": 4.363709449768066,
            "end_logit": 4.159303188323975,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene",
            "probability": 0.05756568461860116,
            "start_logit": 3.4249892234802246,
            "end_logit": 4.852175235748291,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "proton-pump inhibitors",
            "probability": 0.055980159369888045,
            "start_logit": 4.197951793670654,
            "end_logit": 4.051283359527588,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "phosphate binders, raloxifene",
            "probability": 0.055400411534873954,
            "start_logit": 3.3866496086120605,
            "end_logit": 4.852175235748291,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "sevelamer hydrochloride or chromium picolinate",
            "probability": 0.04970895054686566,
            "start_logit": 4.363709449768066,
            "end_logit": 3.7667133808135986,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "sevelamer hydrochloride",
            "probability": 0.04365609759603881,
            "start_logit": 4.363709449768066,
            "end_logit": 3.636871337890625,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "chromium picolinate",
            "probability": 0.036192219237703264,
            "start_logit": 4.046368598937988,
            "end_logit": 3.7667133808135986,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene and proton-pump inhibitors",
            "probability": 0.025842870515363322,
            "start_logit": 3.4249892234802246,
            "end_logit": 4.051283359527588,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "phosphate binders, raloxifene and proton-pump inhibitors",
            "probability": 0.024870817940918957,
            "start_logit": 3.3866496086120605,
            "end_logit": 4.051283359527588,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "sucralfate",
            "probability": 0.015007618029416758,
            "start_logit": 3.771609306335449,
            "end_logit": 3.161186456680298,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "sucralfate, calcium carbonate, aluminium-containing antacids",
            "probability": 0.013154456875806261,
            "start_logit": 3.771609306335449,
            "end_logit": 3.0293891429901123,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders",
            "probability": 0.012889705969525489,
            "start_logit": 3.771609306335449,
            "end_logit": 3.0090575218200684,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "ferrous sulphate, sucralfate",
            "probability": 0.010493542623149294,
            "start_logit": 3.413811445236206,
            "end_logit": 3.161186456680298,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "calcium carbonate, aluminium-containing antacids",
            "probability": 0.009301173214160345,
            "start_logit": 3.4249892234802246,
            "end_logit": 3.0293891429901123,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "ferrous sulphate, sucralfate, calcium carbonate, aluminium-containing antacids",
            "probability": 0.009197785660594725,
            "start_logit": 3.413811445236206,
            "end_logit": 3.0293891429901123,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "calcium carbonate, aluminium-containing antacids, phosphate binders",
            "probability": 0.009113974756544631,
            "start_logit": 3.4249892234802246,
            "end_logit": 3.0090575218200684,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "ferrous sulphate, sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders",
            "probability": 0.00901266801473453,
            "start_logit": 3.413811445236206,
            "end_logit": 3.0090575218200684,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        }
    ],
    "553f7a71ab98a37113000009": [
        {
            "text": "illegitimate recombinationTranscription-coupled repair",
            "probability": 0.283711062158928,
            "start_logit": 5.254271984100342,
            "end_logit": 4.984294414520264,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "illegitimate recombinationTranscription-coupled repair (TCR) is a subpathway of nucleotide excision repair",
            "probability": 0.2151506175626782,
            "start_logit": 5.254271984100342,
            "end_logit": 4.707676410675049,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide excision repair",
            "probability": 0.15051121072783305,
            "start_logit": 4.896971225738525,
            "end_logit": 4.707676410675049,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "illegitimate recombination",
            "probability": 0.09761517409405028,
            "start_logit": 5.254271984100342,
            "end_logit": 3.9173710346221924,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "illegitimate recombinationTranscription-coupled repair (TCR)",
            "probability": 0.09449958005875128,
            "start_logit": 5.254271984100342,
            "end_logit": 3.8849334716796875,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide excision repair (NER)",
            "probability": 0.040755285442917726,
            "start_logit": 4.896971225738525,
            "end_logit": 3.401224374771118,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "recombinationTranscription-coupled repair",
            "probability": 0.02649253672599447,
            "start_logit": 2.8831787109375,
            "end_logit": 4.984294414520264,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "recombinationTranscription-coupled repair (TCR) is a subpathway of nucleotide excision repair",
            "probability": 0.02009045961770326,
            "start_logit": 2.8831787109375,
            "end_logit": 4.707676410675049,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "illegitimate recombinationTranscription-coupled",
            "probability": 0.017574899680940198,
            "start_logit": 5.254271984100342,
            "end_logit": 2.2028098106384277,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "recombination",
            "probability": 0.009115166553683109,
            "start_logit": 2.8831787109375,
            "end_logit": 3.9173710346221924,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "recombinationTranscription-coupled repair (TCR)",
            "probability": 0.008824236800097363,
            "start_logit": 2.8831787109375,
            "end_logit": 3.8849334716796875,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "illegitimate recombinationTranscription-coupled repair (TCR",
            "probability": 0.008461390368582553,
            "start_logit": 5.254271984100342,
            "end_logit": 1.4718515872955322,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "illegitimate recombinationTranscription-coupled repair (TCR) is a subpathway of nucleotide excision",
            "probability": 0.006791095726896477,
            "start_logit": 5.254271984100342,
            "end_logit": 1.2519503831863403,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "TCR) is a subpathway of nucleotide excision repair",
            "probability": 0.0049609104595778,
            "start_logit": 1.4845229387283325,
            "end_logit": 4.707676410675049,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide excision",
            "probability": 0.0047507929635667015,
            "start_logit": 4.896971225738525,
            "end_logit": 1.2519503831863403,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "excision repair",
            "probability": 0.002709543361194805,
            "start_logit": 0.879713773727417,
            "end_logit": 4.707676410675049,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "TCR)",
            "probability": 0.0021789570508790003,
            "start_logit": 1.4845229387283325,
            "end_logit": 3.8849334716796875,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "Transcription-coupled repair",
            "probability": 0.0021756992125169716,
            "start_logit": 0.3836657404899597,
            "end_logit": 4.984294414520264,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "illegitimate",
            "probability": 0.001981452714738821,
            "start_logit": 5.254271984100342,
            "end_logit": 0.020168351009488106,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "Transcription-coupled repair (TCR) is a subpathway of nucleotide excision repair",
            "probability": 0.001649928718470058,
            "start_logit": 0.3836657404899597,
            "end_logit": 4.707676410675049,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        }
    ],
    "53355befd6d3ac6a34000046": [
        {
            "text": "HADDOCK",
            "probability": 0.2334833560591829,
            "start_logit": 4.041390895843506,
            "end_logit": 3.5124623775482178,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HADDOCK (High Ambiguity Driven Biomolecular Dock",
            "probability": 0.1505659295610919,
            "start_logit": 4.041390895843506,
            "end_logit": 3.0737526416778564,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK",
            "probability": 0.11465178631539893,
            "start_logit": 3.5321569442749023,
            "end_logit": 3.3104851245880127,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking program, HADDOCK",
            "probability": 0.07048381536001373,
            "start_logit": 2.843663215637207,
            "end_logit": 3.5124623775482178,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK program for rigid-body protein-protein dock",
            "probability": 0.06300351278529388,
            "start_logit": 3.5321569442749023,
            "end_logit": 2.7117760181427,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK program for rigid-body protein-protein dockingGalaxyDock protein-ligand dock",
            "probability": 0.05516290531006481,
            "start_logit": 3.5321569442749023,
            "end_logit": 2.578876256942749,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "dock",
            "probability": 0.05051500381626371,
            "start_logit": 2.843663215637207,
            "end_logit": 3.179349660873413,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HADDOCK (High Ambiguity Driven Biomolecular Docking). We report the performance of our approaches for protein-protein dock",
            "probability": 0.04990722425642845,
            "start_logit": 4.041390895843506,
            "end_logit": 1.9695173501968384,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking program, HADDOCK (High Ambiguity Driven Biomolecular Dock",
            "probability": 0.04545275242661326,
            "start_logit": 2.843663215637207,
            "end_logit": 3.0737526416778564,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK program for rigid-body protein-protein dockingGalaxyDock",
            "probability": 0.031287228714012086,
            "start_logit": 3.5321569442749023,
            "end_logit": 2.0117955207824707,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK program",
            "probability": 0.023102687305486088,
            "start_logit": 3.5321569442749023,
            "end_logit": 1.7085344791412354,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "Dock",
            "probability": 0.021807824214561167,
            "start_logit": 2.1092586517333984,
            "end_logit": 3.0737526416778564,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking and interface analysis in CAPRI rounds 20-26. At the core of our pipeline was the ZDOCK",
            "probability": 0.017793091548967792,
            "start_logit": 1.669067621231079,
            "end_logit": 3.3104851245880127,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK program for rigid-body protein-protein dockingGalaxyDock protein-ligand docking program is introduced. GalaxyDock",
            "probability": 0.015675315527525893,
            "start_logit": 3.5321569442749023,
            "end_logit": 1.3206727504730225,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "dockingGalaxyDock protein-ligand dock",
            "probability": 0.0150616584941693,
            "start_logit": 2.234018564224243,
            "end_logit": 2.578876256942749,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK program for rigid-body protein-protein docking",
            "probability": 0.013664678087780045,
            "start_logit": 3.5321569442749023,
            "end_logit": 1.1833997964859009,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "dockingGalaxyDock",
            "probability": 0.008542652919940344,
            "start_logit": 2.234018564224243,
            "end_logit": 2.0117955207824707,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HADDOCK (High Ambiguity Driven Biomolecular Docking",
            "probability": 0.0077173424105355815,
            "start_logit": 4.041390895843506,
            "end_logit": 0.10282164067029953,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "Docking). We report the performance of our approaches for protein-protein dock",
            "probability": 0.0072285142913375445,
            "start_logit": 2.1092586517333984,
            "end_logit": 1.9695173501968384,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "Biomolecular Dock",
            "probability": 0.0048927205953326605,
            "start_logit": 0.6147383451461792,
            "end_logit": 3.0737526416778564,
            "question_text": "List programs suitable for protein docking"
        }
    ],
    "52f89f4f2059c6d71c00004e": [
        {
            "text": "NBEAL2",
            "probability": 0.5943682399053942,
            "start_logit": 5.274794101715088,
            "end_logit": 4.950979232788086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene.Here we show that mutations in NBEAL2",
            "probability": 0.17278043252832323,
            "start_logit": 5.274794101715088,
            "end_logit": 3.7155017852783203,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene",
            "probability": 0.12249265574544335,
            "start_logit": 5.274794101715088,
            "end_logit": 3.3715312480926514,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "GFI1B",
            "probability": 0.05613743665137238,
            "start_logit": 4.49031400680542,
            "end_logit": 3.375763177871704,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene.Here we show that mutations in NBEAL2 (neurobeachin-like 2)",
            "probability": 0.01111160043177784,
            "start_logit": 5.274794101715088,
            "end_logit": 0.9714698195457458,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene.Here we show that mutations in NBEAL2 (neurobeachin-like 2),",
            "probability": 0.00952561491251849,
            "start_logit": 5.274794101715088,
            "end_logit": 0.8174646496772766,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene.Here we show that mutations in NBEAL2 (neurobeachin-like 2",
            "probability": 0.007234188593031846,
            "start_logit": 5.274794101715088,
            "end_logit": 0.5422983765602112,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "the NBEAL2",
            "probability": 0.00533144101370269,
            "start_logit": 0.5609166026115417,
            "end_logit": 4.950979232788086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "GATA1",
            "probability": 0.0036631968895258207,
            "start_logit": 3.116304874420166,
            "end_logit": 2.020305633544922,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "GFI1B (growth factor independent 1B)",
            "probability": 0.0036182278533893513,
            "start_logit": 4.49031400680542,
            "end_logit": 0.6339446306228638,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 (neurobeachin-like 2)",
            "probability": 0.0026692870909057337,
            "start_logit": 3.848615884780884,
            "end_logit": 0.9714698195457458,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 (neurobeachin-like 2),",
            "probability": 0.002288293308874546,
            "start_logit": 3.848615884780884,
            "end_logit": 0.8174646496772766,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 (neurobeachin-like 2",
            "probability": 0.0017378348279454665,
            "start_logit": 3.848615884780884,
            "end_logit": 0.5422983765602112,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL",
            "probability": 0.0017029027474993377,
            "start_logit": 5.274794101715088,
            "end_logit": -0.9041855335235596,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "the NBEAL2 gene.Here we show that mutations in NBEAL2",
            "probability": 0.0015498282419892013,
            "start_logit": 0.5609166026115417,
            "end_logit": 3.7155017852783203,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "GFI1B (growth factor independent 1B",
            "probability": 0.0012818727123395594,
            "start_logit": 4.49031400680542,
            "end_logit": -0.40371766686439514,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "the NBEAL2 gene",
            "probability": 0.001098750446057766,
            "start_logit": 0.5609166026115417,
            "end_logit": 3.3715312480926514,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene.Here we show that mutations in NBEAL",
            "probability": 0.0006565897951902945,
            "start_logit": 5.274794101715088,
            "end_logit": -1.8572156429290771,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "biallelic mutations in the NBEAL2",
            "probability": 0.0003942003178282883,
            "start_logit": -2.0436010360717773,
            "end_logit": 4.950979232788086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "GATA1 gene. Sequencing of GATA1",
            "probability": 0.00035740598689050745,
            "start_logit": 3.116304874420166,
            "end_logit": -0.3069135248661041,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        }
    ],
    "550712739d0faaa527000008": [
        {
            "text": "RYR2-S4153R",
            "probability": 0.34497560540612754,
            "start_logit": 4.177867889404297,
            "end_logit": 4.247426509857178,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "G230C",
            "probability": 0.2776351269420744,
            "start_logit": 4.327184200286865,
            "end_logit": 3.88094425201416,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RyR2-V2475F",
            "probability": 0.22681663518648337,
            "start_logit": 4.007107734680176,
            "end_logit": 3.998854875564575,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "S4153R",
            "probability": 0.07175361342994978,
            "start_logit": 3.6427550315856934,
            "end_logit": 3.212303876876831,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "V2475F",
            "probability": 0.030707288021380674,
            "start_logit": 2.0074658393859863,
            "end_logit": 3.998854875564575,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "S4153R mutation",
            "probability": 0.020851368681108814,
            "start_logit": 3.6427550315856934,
            "end_logit": 1.976485252380371,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2-S4153R mutation",
            "probability": 0.005662769406008654,
            "start_logit": 4.177867889404297,
            "end_logit": 0.13786587119102478,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "the S4153R",
            "probability": 0.004704902254025935,
            "start_logit": 0.9181218147277832,
            "end_logit": 3.212303876876831,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "G230C,",
            "probability": 0.004323192561958532,
            "start_logit": 4.327184200286865,
            "end_logit": -0.2813693583011627,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RyR2-V2475F mutation",
            "probability": 0.0030813088922108482,
            "start_logit": 4.007107734680176,
            "end_logit": -0.2999325692653656,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "-V2475F",
            "probability": 0.0027820611692530445,
            "start_logit": -0.39384210109710693,
            "end_logit": 3.998854875564575,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "the S4153R mutation",
            "probability": 0.0013672294232686885,
            "start_logit": 0.9181218147277832,
            "end_logit": 1.976485252380371,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "-S4153R",
            "probability": 0.00126727163221754,
            "start_logit": -1.4287395477294922,
            "end_logit": 4.247426509857178,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RyR2",
            "probability": 0.0010833905939743912,
            "start_logit": 4.007107734680176,
            "end_logit": -1.345191478729248,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "G230C has an intrinsic structural impact on the N-terminal domains of RyR2.The novel RYR2-S4153R",
            "probability": 0.0008468721902534671,
            "start_logit": -1.8318113088607788,
            "end_logit": 4.247426509857178,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "mutation RyR2-V2475F",
            "probability": 0.0007741152917394002,
            "start_logit": -1.3971997499465942,
            "end_logit": 3.7229859828948975,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "G",
            "probability": 0.0004796455911151396,
            "start_logit": 4.327184200286865,
            "end_logit": -2.4800713062286377,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "V2475F mutation",
            "probability": 0.000417159171584424,
            "start_logit": 2.0074658393859863,
            "end_logit": -0.2999325692653656,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2",
            "probability": 0.0002564422638317757,
            "start_logit": 4.177867889404297,
            "end_logit": -2.9568989276885986,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "novel RyR2-V2475F",
            "probability": 0.00021400189143358674,
            "start_logit": -2.9588046073913574,
            "end_logit": 3.998854875564575,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        }
    ],
    "511a20f3df1ebcce7d00000c": [
        {
            "text": "psoriatic arthritis",
            "probability": 0.3040345312365199,
            "start_logit": 5.334329128265381,
            "end_logit": 5.163269996643066,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "alopeciaPsoriasis and psoriatic arthritis",
            "probability": 0.20230094432626466,
            "start_logit": 4.926944255828857,
            "end_logit": 5.163269996643066,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "alopeciaPsoriasis",
            "probability": 0.14901032201734524,
            "start_logit": 4.926944255828857,
            "end_logit": 4.857529163360596,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "alopecia is a less well-known side effect of this class of drugs.3 patients who developed scalp alopeciaPsoriasis",
            "probability": 0.059777379883051575,
            "start_logit": 4.013556003570557,
            "end_logit": 4.857529163360596,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "myelosuppression",
            "probability": 0.05835408746585472,
            "start_logit": 4.570374011993408,
            "end_logit": 4.276613235473633,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "myelosuppression and liver toxicity",
            "probability": 0.05422731236087334,
            "start_logit": 4.570374011993408,
            "end_logit": 4.203268527984619,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "alopecia",
            "probability": 0.028908878136940337,
            "start_logit": 4.013556003570557,
            "end_logit": 4.1310505867004395,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "liver toxicity",
            "probability": 0.02885315161333416,
            "start_logit": 3.939408540725708,
            "end_logit": 4.203268527984619,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psoriasisAnti-TNF drug-induced alopecia",
            "probability": 0.026533211604549686,
            "start_logit": 3.927804470062256,
            "end_logit": 4.1310505867004395,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "scalp alopeciaPsoriasis and psoriatic arthritis",
            "probability": 0.023598654300554033,
            "start_logit": 2.7783775329589844,
            "end_logit": 5.163269996643066,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psoriasis",
            "probability": 0.019792617580306017,
            "start_logit": 3.927804470062256,
            "end_logit": 3.8379623889923096,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "scalp alopeciaPsoriasis",
            "probability": 0.01738223757784519,
            "start_logit": 2.7783775329589844,
            "end_logit": 4.857529163360596,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "alopecia is a less well-known side effect of this class of drugs.3 patients who developed scalp alopecia",
            "probability": 0.009436968182054067,
            "start_logit": 4.013556003570557,
            "end_logit": 3.0115365982055664,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Psoriasis and psoriatic arthritis",
            "probability": 0.004764017466018625,
            "start_logit": 1.178279161453247,
            "end_logit": 5.163269996643066,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Psoriasis",
            "probability": 0.0035090680326375916,
            "start_logit": 1.178279161453247,
            "end_logit": 4.857529163360596,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "myelosuppression and liver",
            "probability": 0.002768764081417033,
            "start_logit": 4.570374011993408,
            "end_logit": 1.228484869003296,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "scalp alopecia",
            "probability": 0.0027441086122534774,
            "start_logit": 2.7783775329589844,
            "end_logit": 3.0115365982055664,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "liver",
            "probability": 0.0014731980314835011,
            "start_logit": 3.939408540725708,
            "end_logit": 1.228484869003296,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psoriatic arthritis induced in a patient treated with infliximab",
            "probability": 0.0014628978946213415,
            "start_logit": 5.334329128265381,
            "end_logit": -0.1734519600868225,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psoriatic",
            "probability": 0.0010676495960752882,
            "start_logit": 5.334329128265381,
            "end_logit": -0.48841169476509094,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        }
    ],
    "518cca6f310faafe0800000a": [
        {
            "text": "miR-221",
            "probability": 0.1691872718041528,
            "start_logit": 4.126185417175293,
            "end_logit": 3.7113022804260254,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-21 and miR-221",
            "probability": 0.15615624005561057,
            "start_logit": 4.046036243438721,
            "end_logit": 3.7113022804260254,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-146a and miR-222",
            "probability": 0.1299830685749742,
            "start_logit": 3.894634246826172,
            "end_logit": 3.6792514324188232,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-222",
            "probability": 0.12737770665680517,
            "start_logit": 3.874386787414551,
            "end_logit": 3.6792514324188232,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-146a",
            "probability": 0.12002956201251234,
            "start_logit": 3.894634246826172,
            "end_logit": 3.5995852947235107,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-21",
            "probability": 0.10923366363827999,
            "start_logit": 4.046036243438721,
            "end_logit": 3.3539345264434814,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-221), (3) c-miRNA responsive only to sustained training (miR-20a",
            "probability": 0.07062278362925342,
            "start_logit": 4.126185417175293,
            "end_logit": 2.837648868560791,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-20a",
            "probability": 0.03789324088093745,
            "start_logit": 3.503605365753174,
            "end_logit": 2.837648868560791,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-133",
            "probability": 0.012000002877792293,
            "start_logit": 2.814937114715576,
            "end_logit": 2.376451253890991,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "(miR-21 and miR-221",
            "probability": 0.011561452650704587,
            "start_logit": 1.442855715751648,
            "end_logit": 3.7113022804260254,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "(miR-146a and miR-222",
            "probability": 0.008678316987933685,
            "start_logit": 1.1880576610565186,
            "end_logit": 3.6792514324188232,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "(miR-21",
            "probability": 0.008087411873948937,
            "start_logit": 1.442855715751648,
            "end_logit": 3.3539345264434814,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "(miR-146a",
            "probability": 0.008013771320274683,
            "start_logit": 1.1880576610565186,
            "end_logit": 3.5995852947235107,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-208a",
            "probability": 0.007400016471309594,
            "start_logit": 2.8489723205566406,
            "end_logit": 1.8589913845062256,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-133 and miR-208a",
            "probability": 0.007152393244563676,
            "start_logit": 2.814937114715576,
            "end_logit": 1.8589913845062256,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-1, miR-133",
            "probability": 0.006079773130174714,
            "start_logit": 2.134997606277466,
            "end_logit": 2.376451253890991,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-1, miR-133 and miR-208a",
            "probability": 0.0036237431530301047,
            "start_logit": 2.134997606277466,
            "end_logit": 1.8589913845062256,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-1",
            "probability": 0.0024508327078142556,
            "start_logit": 2.134997606277466,
            "end_logit": 1.467911720275879,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "(miR-20a",
            "probability": 0.0022346536412583295,
            "start_logit": 0.6729188561439514,
            "end_logit": 2.837648868560791,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-133a",
            "probability": 0.0022340946886692083,
            "start_logit": 1.8123083114624023,
            "end_logit": 1.6980092525482178,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        }
    ],
    "5717cdd2070aa3d072000001": [
        {
            "text": "Cyclosporine A",
            "probability": 0.26472960737305,
            "start_logit": 6.562777042388916,
            "end_logit": 5.918325424194336,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "Cyclosporine A). treatment with the MPTP inhibitor atractyloside cyclosporine A",
            "probability": 0.21599946238773673,
            "start_logit": 6.562777042388916,
            "end_logit": 5.714892387390137,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "Cyclosporine A). treatment with the MPTP inhibitor atractyloside",
            "probability": 0.09740506708261266,
            "start_logit": 6.562777042388916,
            "end_logit": 4.918494701385498,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "atractyloside cyclosporine A",
            "probability": 0.09417052124683581,
            "start_logit": 5.732608318328857,
            "end_logit": 5.714892387390137,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "atractyloside cyclosporine A, an MPTP inhibitor,NIM-811",
            "probability": 0.07429086501299587,
            "start_logit": 5.732608318328857,
            "end_logit": 5.477773189544678,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "NIM-811",
            "probability": 0.04473191115941508,
            "start_logit": 5.225307464599609,
            "end_logit": 5.477773189544678,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclosporine A",
            "probability": 0.042722685462673604,
            "start_logit": 4.942231178283691,
            "end_logit": 5.714892387390137,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "atractyloside",
            "probability": 0.042466244303825715,
            "start_logit": 5.732608318328857,
            "end_logit": 4.918494701385498,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclosporine A, an MPTP inhibitor,NIM-811",
            "probability": 0.03370380896990958,
            "start_logit": 4.942231178283691,
            "end_logit": 5.477773189544678,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "NIM-811 (N-metyl-4-isoleucine-cyclosporine",
            "probability": 0.0202262873067621,
            "start_logit": 5.225307464599609,
            "end_logit": 4.6840691566467285,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "Cyclosporine",
            "probability": 0.018257960296258965,
            "start_logit": 6.562777042388916,
            "end_logit": 3.24421763420105,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclosporine",
            "probability": 0.017915575818675363,
            "start_logit": 5.103994846343994,
            "end_logit": 4.6840691566467285,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "Cyclosporine A). treatment with the MPTP inhibitor atractyloside cyclosporine",
            "probability": 0.00800562925129437,
            "start_logit": 6.562777042388916,
            "end_logit": 2.4197614192962646,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "(Cyclosporine A",
            "probability": 0.0075260975758964874,
            "start_logit": 3.0024447441101074,
            "end_logit": 5.918325424194336,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "(Cyclosporine A). treatment with the MPTP inhibitor atractyloside cyclosporine A",
            "probability": 0.006140729956134036,
            "start_logit": 3.0024447441101074,
            "end_logit": 5.714892387390137,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "atractyloside cyclosporine",
            "probability": 0.0034902599810642332,
            "start_logit": 5.732608318328857,
            "end_logit": 2.4197614192962646,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "(Cyclosporine A). treatment with the MPTP inhibitor atractyloside",
            "probability": 0.0027691652872715846,
            "start_logit": 3.0024447441101074,
            "end_logit": 4.918494701385498,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "N-metyl-4-isoleucine-cyclosporine",
            "probability": 0.002265731413446791,
            "start_logit": 3.036221981048584,
            "end_logit": 4.6840691566467285,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "Cyclosporine A)",
            "probability": 0.0018893090225299324,
            "start_logit": 6.562777042388916,
            "end_logit": 0.9758276343345642,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "Cyclosporine A). treatment with the MPTP inhibitor atractyloside cyclosporine A,",
            "probability": 0.0012930810916109987,
            "start_logit": 6.562777042388916,
            "end_logit": 0.5966442823410034,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        }
    ],
    "56d1fd67f22319765a000002": [
        {
            "text": "Treponema denticola",
            "probability": 0.24125728823302112,
            "start_logit": 4.144814968109131,
            "end_logit": 4.338839054107666,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Clostridium perfringens, C. ghonii, C. sordellii",
            "probability": 0.10809122609613099,
            "start_logit": 3.5725698471069336,
            "end_logit": 4.108195781707764,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Clostridium perfringens",
            "probability": 0.0877243332577303,
            "start_logit": 3.5725698471069336,
            "end_logit": 3.8994195461273193,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "C. ghonii, C. sordellii",
            "probability": 0.08257685663690317,
            "start_logit": 3.303323745727539,
            "end_logit": 4.108195781707764,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "C. sordellii",
            "probability": 0.07503899952424094,
            "start_logit": 3.2076022624969482,
            "end_logit": 4.108195781707764,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Clostridium perfringens, C. ghonii",
            "probability": 0.07150426215072728,
            "start_logit": 3.5725698471069336,
            "end_logit": 3.694977283477783,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "C. ghonii",
            "probability": 0.054626054470849394,
            "start_logit": 3.303323745727539,
            "end_logit": 3.694977283477783,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Bacteroides sp",
            "probability": 0.04397550530575487,
            "start_logit": 4.162006378173828,
            "end_logit": 2.6194164752960205,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Clostridium perfringens, C. ghonii, C. sordellii, Eubacterium tenue",
            "probability": 0.029392336963083212,
            "start_logit": 3.5725698471069336,
            "end_logit": 2.8059542179107666,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Eubacterium tenue",
            "probability": 0.023761208792331973,
            "start_logit": 3.3598902225494385,
            "end_logit": 2.8059542179107666,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "C. ghonii, C. sordellii, Eubacterium tenue",
            "probability": 0.022454429312010075,
            "start_logit": 3.303323745727539,
            "end_logit": 2.8059542179107666,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "C. sordellii, Eubacterium tenue",
            "probability": 0.020404723297593127,
            "start_logit": 3.2076022624969482,
            "end_logit": 2.8059542179107666,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Eubacterium tenue, and Bacteroides sp",
            "probability": 0.019717698347093738,
            "start_logit": 3.3598902225494385,
            "end_logit": 2.6194164752960205,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Vibrio. while the untreated skin still bears the remains of large numbers of bacteria belonging to the genera Sphingomonas",
            "probability": 0.019385710375151795,
            "start_logit": 2.9296555519104004,
            "end_logit": 3.032670736312866,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Bacteroides",
            "probability": 0.019232896066564982,
            "start_logit": 4.162006378173828,
            "end_logit": 1.7924058437347412,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "C. ghonii, C. sordellii, Eubacterium tenue, and Bacteroides sp",
            "probability": 0.018633297135675814,
            "start_logit": 3.303323745727539,
            "end_logit": 2.6194164752960205,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "spirochete Treponema denticola",
            "probability": 0.01771119055636303,
            "start_logit": 1.5331476926803589,
            "end_logit": 4.338839054107666,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "C. sordellii, Eubacterium tenue, and Bacteroides sp",
            "probability": 0.0169323952478249,
            "start_logit": 3.2076022624969482,
            "end_logit": 2.6194164752960205,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Vibrio",
            "probability": 0.016257222797968932,
            "start_logit": 2.9296555519104004,
            "end_logit": 2.8566718101501465,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Curtobacterium, Microbacterium, Agromyces",
            "probability": 0.011322365432980286,
            "start_logit": 2.450028657913208,
            "end_logit": 2.974541425704956,
            "question_text": "List bacterial species identified in the iceman tissues."
        }
    ],
    "56df03c751531f7e3300000a": [
        {
            "text": "stability",
            "probability": 0.8609747374263029,
            "start_logit": 5.283638954162598,
            "end_logit": 5.838075160980225,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "mRNA stability",
            "probability": 0.05396761725177521,
            "start_logit": 2.513957977294922,
            "end_logit": 5.838075160980225,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "stability, including that of key na\u00efve pluripotency-promoting transcripts",
            "probability": 0.03988784231692645,
            "start_logit": 5.283638954162598,
            "end_logit": 2.7660815715789795,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "stability, including that of key na\u00efve pluripotency",
            "probability": 0.010437798111404144,
            "start_logit": 5.283638954162598,
            "end_logit": 1.4254436492919922,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "fate.m(6)A predominantly and directly reduces mRNA stability",
            "probability": 0.007760842677949085,
            "start_logit": 0.5746647119522095,
            "end_logit": 5.838075160980225,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "reduces mRNA stability",
            "probability": 0.0073392430178343075,
            "start_logit": 0.5188094973564148,
            "end_logit": 5.838075160980225,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "stability,",
            "probability": 0.006127190903245282,
            "start_logit": 5.283638954162598,
            "end_logit": 0.8927463889122009,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "pluripotency-promoting transcripts",
            "probability": 0.004722648534094926,
            "start_logit": 3.149937152862549,
            "end_logit": 2.7660815715789795,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "mRNA stability, including that of key na\u00efve pluripotency-promoting transcripts",
            "probability": 0.0025002496746814365,
            "start_logit": 2.513957977294922,
            "end_logit": 2.7660815715789795,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "stability, including that of key na\u00efve pluripotency-promoting",
            "probability": 0.0015590874882864376,
            "start_logit": 5.283638954162598,
            "end_logit": -0.47588929533958435,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "pluripotency",
            "probability": 0.0012358164565117022,
            "start_logit": 3.149937152862549,
            "end_logit": 1.4254436492919922,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "mRNA fate.m(6)A predominantly and directly reduces mRNA stability",
            "probability": 0.00066869378420515,
            "start_logit": -1.8768552541732788,
            "end_logit": 5.838075160980225,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "mRNA stability, including that of key na\u00efve pluripotency",
            "probability": 0.0006542620461913126,
            "start_logit": 2.513957977294922,
            "end_logit": 1.4254436492919922,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "na\u00efve pluripotency-promoting transcripts",
            "probability": 0.00039215619576218267,
            "start_logit": 0.6614723205566406,
            "end_logit": 2.7660815715789795,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "mRNA stability,",
            "probability": 0.00038406457137565506,
            "start_logit": 2.513957977294922,
            "end_logit": 0.8927463889122009,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "fate.m(6)A predominantly and directly reduces mRNA stability, including that of key na\u00efve pluripotency-promoting transcripts",
            "probability": 0.00035954977019404604,
            "start_logit": 0.5746647119522095,
            "end_logit": 2.7660815715789795,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "reduces mRNA stability, including that of key na\u00efve pluripotency-promoting transcripts",
            "probability": 0.00034001760504156093,
            "start_logit": 0.5188094973564148,
            "end_logit": 2.7660815715789795,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "directly reduces mRNA stability",
            "probability": 0.0002562371341217714,
            "start_logit": -2.83607816696167,
            "end_logit": 5.838075160980225,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "key na\u00efve pluripotency-promoting transcripts",
            "probability": 0.0002473518895845491,
            "start_logit": 0.20062407851219177,
            "end_logit": 2.7660815715789795,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "pluripotency-promoting",
            "probability": 0.0001845931445120354,
            "start_logit": 3.149937152862549,
            "end_logit": -0.47588929533958435,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        }
    ],
    "517775c78ed59a060a000033": [
        {
            "text": "Memantine",
            "probability": 0.9761325283408506,
            "start_logit": 6.374044895172119,
            "end_logit": 5.939076900482178,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "reversal by Memantine",
            "probability": 0.012306705426939527,
            "start_logit": 2.0005908012390137,
            "end_logit": 5.939076900482178,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "by Memantine",
            "probability": 0.004498206831480915,
            "start_logit": 0.9941253662109375,
            "end_logit": 5.939076900482178,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Memantine.",
            "probability": 0.00433380211960015,
            "start_logit": 6.374044895172119,
            "end_logit": 0.5219237804412842,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "7-nitroindazole",
            "probability": 0.0015669040396959625,
            "start_logit": 2.7116270065307617,
            "end_logit": 3.1669981479644775,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Me",
            "probability": 0.00022514886733428154,
            "start_logit": 6.374044895172119,
            "end_logit": -2.4355149269104004,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "tine",
            "probability": 0.00016871316003826448,
            "start_logit": -2.2891087532043457,
            "end_logit": 5.939076900482178,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "mantine",
            "probability": 0.0001617996699752181,
            "start_logit": -2.3309497833251953,
            "end_logit": 5.939076900482178,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine",
            "probability": 0.00015858289363396662,
            "start_logit": -2.3510313034057617,
            "end_logit": 5.939076900482178,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Meman",
            "probability": 7.147369563174813e-05,
            "start_logit": 6.374044895172119,
            "end_logit": -3.582947254180908,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "reversal by Memantine.",
            "probability": 5.4638918913212864e-05,
            "start_logit": 2.0005908012390137,
            "end_logit": 0.5219237804412842,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "neuronal nitric oxide synthase inhibitor 7-nitroindazole",
            "probability": 5.0338083077810586e-05,
            "start_logit": -0.7264680862426758,
            "end_logit": 3.1669981479644775,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "nitric oxide synthase inhibitor 7-nitroindazole",
            "probability": 4.2994854439262584e-05,
            "start_logit": -0.8841495513916016,
            "end_logit": 3.1669981479644775,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "reversal",
            "probability": 4.072596127148178e-05,
            "start_logit": 2.0005908012390137,
            "end_logit": 0.2280431091785431,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "reversal with the neuronal nitric oxide synthase inhibitor 7-nitroindazole",
            "probability": 3.770456097261292e-05,
            "start_logit": -1.0154489278793335,
            "end_logit": 3.1669981479644775,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "le.Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine",
            "probability": 3.6965976243918376e-05,
            "start_logit": -3.8073108196258545,
            "end_logit": 5.939076900482178,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Memantine.Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression",
            "probability": 3.57472611060671e-05,
            "start_logit": 6.374044895172119,
            "end_logit": -4.275803089141846,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Memantine.Full reversal of Alzheimer's disease",
            "probability": 2.989163445524853e-05,
            "start_logit": 6.374044895172119,
            "end_logit": -4.454698085784912,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "the neuronal nitric oxide synthase inhibitor 7-nitroindazole",
            "probability": 2.715670887082794e-05,
            "start_logit": -1.343605875968933,
            "end_logit": 3.1669981479644775,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "by Memantine.",
            "probability": 1.9970995469034037e-05,
            "start_logit": 0.9941253662109375,
            "end_logit": 0.5219237804412842,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        }
    ],
    "54e0dfa91388e8454a000018": [
        {
            "text": "Med70",
            "probability": 0.3616729443075557,
            "start_logit": 4.354653358459473,
            "end_logit": 4.130123615264893,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med220 and the Med70",
            "probability": 0.34730685564941816,
            "start_logit": 4.314121723175049,
            "end_logit": 4.130123615264893,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med220",
            "probability": 0.14612200679511425,
            "start_logit": 4.314121723175049,
            "end_logit": 3.264356851577759,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med",
            "probability": 0.055448132459583785,
            "start_logit": 4.314121723175049,
            "end_logit": 2.295362949371338,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med220 and the Med",
            "probability": 0.03756524399231946,
            "start_logit": 4.314121723175049,
            "end_logit": 1.905994176864624,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med70 subunits",
            "probability": 0.009711209712104648,
            "start_logit": 4.354653358459473,
            "end_logit": 0.5126641392707825,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med2) that specifically lacks both the Med220 and the Med70",
            "probability": 0.009673025839403172,
            "start_logit": 0.7332541942596436,
            "end_logit": 4.130123615264893,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med220 and the Med70 subunits",
            "probability": 0.009325468666506211,
            "start_logit": 4.314121723175049,
            "end_logit": 0.5126641392707825,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med2) that specifically lacks both the Med220",
            "probability": 0.004069720837475654,
            "start_logit": 0.7332541942596436,
            "end_logit": 3.264356851577759,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP/Med2) that specifically lacks both the Med220 and the Med70",
            "probability": 0.003953934545016468,
            "start_logit": -0.16137580573558807,
            "end_logit": 4.130123615264893,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med70 subunit",
            "probability": 0.002847796748010173,
            "start_logit": 4.354653358459473,
            "end_logit": -0.7140710949897766,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med220 and the Med70 subunit",
            "probability": 0.0027346788020698215,
            "start_logit": 4.314121723175049,
            "end_logit": -0.7140710949897766,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "both the Med220 and the Med70",
            "probability": 0.0018898748506295737,
            "start_logit": -0.8995763659477234,
            "end_logit": 4.130123615264893,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP/Med2) that specifically lacks both the Med220",
            "probability": 0.0016635342523659772,
            "start_logit": -0.16137580573558807,
            "end_logit": 3.264356851577759,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med2) that specifically lacks both the Med",
            "probability": 0.0015443150899664719,
            "start_logit": 0.7332541942596436,
            "end_logit": 2.295362949371338,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "the Med220 and the Med70",
            "probability": 0.0011015360504387447,
            "start_logit": -1.4393813610076904,
            "end_logit": 4.130123615264893,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Med2) that specifically lacks both the Med220 and the Med",
            "probability": 0.0010462493610203507,
            "start_logit": 0.7332541942596436,
            "end_logit": 1.905994176864624,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "(CRSP/Med2) that specifically lacks both the Med220 and the Med70",
            "probability": 0.0008139245432551674,
            "start_logit": -1.7419745922088623,
            "end_logit": 4.130123615264893,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "both the Med220",
            "probability": 0.0007951248334826031,
            "start_logit": -0.8995763659477234,
            "end_logit": 3.264356851577759,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "lacks both the Med220 and the Med70",
            "probability": 0.0007144226642635383,
            "start_logit": -1.87236750125885,
            "end_logit": 4.130123615264893,
            "question_text": "List components of the CRSP/Med complex."
        }
    ],
    "517539e68ed59a060a000028": [
        {
            "text": "NADH dehydrogenase subunit 3",
            "probability": 0.40924554636538313,
            "start_logit": 4.5300493240356445,
            "end_logit": 3.294011354446411,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "NADH dehydrogenase subunit 3 (ND3",
            "probability": 0.1785174560373695,
            "start_logit": 4.5300493240356445,
            "end_logit": 2.4643824100494385,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "NADH dehydrogenase subunit 3 (ND3)",
            "probability": 0.14717132451497328,
            "start_logit": 4.5300493240356445,
            "end_logit": 2.2712934017181396,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "NADH dehydrogenase subunit 3 (ND3) gene",
            "probability": 0.04406689724758283,
            "start_logit": 4.5300493240356445,
            "end_logit": 1.0654048919677734,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "NADH dehydrogenase",
            "probability": 0.040160521939952,
            "start_logit": 4.5300493240356445,
            "end_logit": 0.9725804924964905,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "ND3",
            "probability": 0.034541118828636336,
            "start_logit": 2.8875133991241455,
            "end_logit": 2.4643824100494385,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "ND3)",
            "probability": 0.028475995127195623,
            "start_logit": 2.8875133991241455,
            "end_logit": 2.2712934017181396,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "mitochondrial NADH dehydrogenase subunit 3",
            "probability": 0.022090406171906454,
            "start_logit": 1.6108773946762085,
            "end_logit": 3.294011354446411,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "NADH",
            "probability": 0.021101588486237735,
            "start_logit": 4.5300493240356445,
            "end_logit": 0.3290443420410156,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "subunit 6 of ATP synthase",
            "probability": 0.013292907859946718,
            "start_logit": 2.685274600982666,
            "end_logit": 1.7117013931274414,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "subunit 6",
            "probability": 0.01110974284095745,
            "start_logit": 2.685274600982666,
            "end_logit": 1.5322932004928589,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "mitochondrial NADH dehydrogenase subunit 3 (ND3",
            "probability": 0.009636080704272552,
            "start_logit": 1.6108773946762085,
            "end_logit": 2.4643824100494385,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "ATP synthase",
            "probability": 0.009484836015359831,
            "start_logit": 2.347738265991211,
            "end_logit": 1.7117013931274414,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "ND3) gene",
            "probability": 0.008526448718378762,
            "start_logit": 2.8875133991241455,
            "end_logit": 1.0654048919677734,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "mitochondrial NADH dehydrogenase subunit 3 (ND3)",
            "probability": 0.007944067722341406,
            "start_logit": 1.6108773946762085,
            "end_logit": 2.2712934017181396,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "subunit 3",
            "probability": 0.0037376917423530233,
            "start_logit": -0.16579777002334595,
            "end_logit": 3.294011354446411,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "(ND3",
            "probability": 0.0033413537617586865,
            "start_logit": 0.551738977432251,
            "end_logit": 2.4643824100494385,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "(ND3)",
            "probability": 0.0027546407489034285,
            "start_logit": 0.551738977432251,
            "end_logit": 2.2712934017181396,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "subunit 6 of ATP",
            "probability": 0.002422716027545687,
            "start_logit": 2.685274600982666,
            "end_logit": 0.009359980002045631,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "mitochondrial NADH dehydrogenase subunit 3 (ND3) gene",
            "probability": 0.0023786591389455204,
            "start_logit": 1.6108773946762085,
            "end_logit": 1.0654048919677734,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        }
    ],
    "518cb5ab310faafe08000008": [
        {
            "text": "quadruple therapy",
            "probability": 0.2629484295070982,
            "start_logit": 5.55233907699585,
            "end_logit": 5.878794193267822,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "equential therapy and quadruple therapy",
            "probability": 0.2044484162224822,
            "start_logit": 5.300696849822998,
            "end_logit": 5.878794193267822,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "equential therapy",
            "probability": 0.12954463002918584,
            "start_logit": 5.300696849822998,
            "end_logit": 5.42250394821167,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy (either bismuth-based",
            "probability": 0.06787352075636797,
            "start_logit": 5.55233907699585,
            "end_logit": 4.524482250213623,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "equential therapy and quadruple therapy (either bismuth-based",
            "probability": 0.052773214307060966,
            "start_logit": 5.300696849822998,
            "end_logit": 4.524482250213623,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "bismuth-based",
            "probability": 0.042617291323075075,
            "start_logit": 5.086953163146973,
            "end_logit": 4.524482250213623,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy (either bismuth-based or non-bismuth-based",
            "probability": 0.03904578536254991,
            "start_logit": 5.55233907699585,
            "end_logit": 3.971571207046509,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "equential therapy and quadruple therapy (either bismuth-based or non-bismuth-based",
            "probability": 0.03035899089604874,
            "start_logit": 5.300696849822998,
            "end_logit": 3.971571207046509,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "bismuth-based or non-bismuth-based",
            "probability": 0.024516565387952556,
            "start_logit": 5.086953163146973,
            "end_logit": 3.971571207046509,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy (either bismuth",
            "probability": 0.02267857132759837,
            "start_logit": 5.55233907699585,
            "end_logit": 3.4282567501068115,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "bismuth-based or non-bismuth-based) are the best current options to replace initial treatment with triple therapy",
            "probability": 0.01802074261657547,
            "start_logit": 5.086953163146973,
            "end_logit": 3.663745641708374,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "equential therapy and quadruple therapy (either bismuth",
            "probability": 0.017633107749711503,
            "start_logit": 5.300696849822998,
            "end_logit": 3.4282567501068115,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy (either bismuth-based or non-bismuth-based)",
            "probability": 0.01730257702350058,
            "start_logit": 5.55233907699585,
            "end_logit": 3.157691717147827,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "bismuth",
            "probability": 0.014239710424462093,
            "start_logit": 5.086953163146973,
            "end_logit": 3.4282567501068115,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "equential therapy and quadruple therapy (either bismuth-based or non-bismuth-based)",
            "probability": 0.013453149256883892,
            "start_logit": 5.300696849822998,
            "end_logit": 3.157691717147827,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin",
            "probability": 0.011806902254489823,
            "start_logit": 3.995272397994995,
            "end_logit": 4.332587242126465,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "bismuth-based or non-bismuth-based)",
            "probability": 0.010864162598803847,
            "start_logit": 5.086953163146973,
            "end_logit": 3.157691717147827,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy (either bismuth-based or non-bismuth",
            "probability": 0.007506578988307808,
            "start_logit": 5.55233907699585,
            "end_logit": 2.3226161003112793,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "Triple therapy",
            "probability": 0.006460264782608143,
            "start_logit": 3.5694210529327393,
            "end_logit": 4.15542459487915,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "fluoroquinolone resistance in gastric biopsies without necessitating culture. In regions of high clarithromycin",
            "probability": 0.005907389185236959,
            "start_logit": 3.3027920722961426,
            "end_logit": 4.332587242126465,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        }
    ],
    "570a6d03cf1c325851000025": [
        {
            "text": "gremlin-1",
            "probability": 0.0764081678978471,
            "start_logit": 4.251208782196045,
            "end_logit": 3.9327614307403564,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A, midkine",
            "probability": 0.07183507059124007,
            "start_logit": 4.251208782196045,
            "end_logit": 3.871044635772705,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A, midkine",
            "probability": 0.06991457568397708,
            "start_logit": 4.224110126495361,
            "end_logit": 3.871044635772705,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "annexin A1 and A2, and collagen \u03b11",
            "probability": 0.06438495748300938,
            "start_logit": 4.36641263961792,
            "end_logit": 3.646347999572754,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "annexin A1 and A2",
            "probability": 0.060364929852076435,
            "start_logit": 4.36641263961792,
            "end_logit": 3.581876277923584,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A, midkine, annexin A1 and A2, and collagen \u03b11",
            "probability": 0.057378872975768144,
            "start_logit": 4.251208782196045,
            "end_logit": 3.646347999572754,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A, midkine, annexin A1 and A2, and collagen \u03b11",
            "probability": 0.05584486135125822,
            "start_logit": 4.224110126495361,
            "end_logit": 3.646347999572754,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "collagen \u03b11",
            "probability": 0.05505887415389365,
            "start_logit": 4.209935665130615,
            "end_logit": 3.646347999572754,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A, midkine, annexin A1 and A2",
            "probability": 0.05379628685920125,
            "start_logit": 4.251208782196045,
            "end_logit": 3.581876277923584,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A, midkine, annexin A1 and A2",
            "probability": 0.052358054891272286,
            "start_logit": 4.224110126495361,
            "end_logit": 3.581876277923584,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "annexin A1",
            "probability": 0.04805530759549731,
            "start_logit": 4.36641263961792,
            "end_logit": 3.353820562362671,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A",
            "probability": 0.04610005357806639,
            "start_logit": 4.251208782196045,
            "end_logit": 3.427485942840576,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A",
            "probability": 0.04486757872431406,
            "start_logit": 4.224110126495361,
            "end_logit": 3.427485942840576,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A, midkine, annexin A1",
            "probability": 0.042826142908631244,
            "start_logit": 4.251208782196045,
            "end_logit": 3.353820562362671,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A, midkine, annexin A1",
            "probability": 0.04168119534086519,
            "start_logit": 4.224110126495361,
            "end_logit": 3.353820562362671,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "midkine",
            "probability": 0.03961201378303969,
            "start_logit": 3.655968427658081,
            "end_logit": 3.871044635772705,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "midkine, annexin A1 and A2, and collagen \u03b11",
            "probability": 0.03164043256955579,
            "start_logit": 3.655968427658081,
            "end_logit": 3.646347999572754,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "alkaline phosphatase, carbonic anhydrase, gremlin-1",
            "probability": 0.030001682124293542,
            "start_logit": 3.3163726329803467,
            "end_logit": 3.9327614307403564,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "midkine, annexin A1 and A2",
            "probability": 0.029664887067054675,
            "start_logit": 3.655968427658081,
            "end_logit": 3.581876277923584,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "alkaline phosphatase, carbonic anhydrase, gremlin-1, fetuin A, midkine",
            "probability": 0.028206054569138498,
            "start_logit": 3.3163726329803467,
            "end_logit": 3.871044635772705,
            "question_text": "List sclerostin interaction partners."
        }
    ],
    "56cd765b5795f9a73e000038": [
        {
            "text": "energy starvation",
            "probability": 0.7901117755624477,
            "start_logit": 6.347768306732178,
            "end_logit": 6.668592929840088,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "energy starvation conditions",
            "probability": 0.15752431369436987,
            "start_logit": 6.347768306732178,
            "end_logit": 5.0559983253479,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "Under energy starvation",
            "probability": 0.02635382245631409,
            "start_logit": 2.94720721244812,
            "end_logit": 6.668592929840088,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "energy starvation conditions,",
            "probability": 0.008080863439007064,
            "start_logit": 6.347768306732178,
            "end_logit": 2.0859172344207764,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "Under energy starvation conditions",
            "probability": 0.005254152544048549,
            "start_logit": 2.94720721244812,
            "end_logit": 5.0559983253479,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "starvation",
            "probability": 0.0052535957539215005,
            "start_logit": 1.334506630897522,
            "end_logit": 6.668592929840088,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "energy depletion",
            "probability": 0.0023915980957917447,
            "start_logit": 3.625642776489258,
            "end_logit": 3.590505838394165,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "energy levels and plays an essential role in the cellular energy response pathway. Under energy starvation",
            "probability": 0.0017397166100130842,
            "start_logit": 0.2293161153793335,
            "end_logit": 6.668592929840088,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "starvation conditions",
            "probability": 0.0010474075835346563,
            "start_logit": 1.334506630897522,
            "end_logit": 5.0559983253479,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "hypoxia",
            "probability": 0.00042648742146194127,
            "start_logit": 3.107290267944336,
            "end_logit": 2.3847241401672363,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "nutrient deprivation",
            "probability": 0.00038666354783775566,
            "start_logit": 2.8008508682250977,
            "end_logit": 2.5931355953216553,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "energy levels and plays an essential role in the cellular energy response pathway. Under energy starvation conditions",
            "probability": 0.0003468467038349399,
            "start_logit": 0.2293161153793335,
            "end_logit": 5.0559983253479,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "nutrient deprivation or hypoxia",
            "probability": 0.00031392166313106676,
            "start_logit": 2.8008508682250977,
            "end_logit": 2.3847241401672363,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "energy",
            "probability": 0.0003082778508208769,
            "start_logit": 6.347768306732178,
            "end_logit": -1.180335283279419,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "Under energy starvation conditions,",
            "probability": 0.0002695335608860067,
            "start_logit": 2.94720721244812,
            "end_logit": 2.0859172344207764,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates TSC2",
            "probability": 6.054336054267892e-05,
            "start_logit": 6.347768306732178,
            "end_logit": -2.8079769611358643,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "starvation conditions,",
            "probability": 5.373111901916163e-05,
            "start_logit": 1.334506630897522,
            "end_logit": 2.0859172344207764,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "conditions",
            "probability": 4.544282218569313e-05,
            "start_logit": -1.8031119108200073,
            "end_logit": 5.0559983253479,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "energy levels and plays an essential role in the cellular energy response pathway. Under energy starvation conditions,",
            "probability": 1.779294117984818e-05,
            "start_logit": 0.2293161153793335,
            "end_logit": 2.0859172344207764,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "low intracellular ATP following stresses such as nutrient deprivation",
            "probability": 1.3513269651837503e-05,
            "start_logit": -0.5530319213867188,
            "end_logit": 2.5931355953216553,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        }
    ],
    "5326300fd6d3ac6a34000005": [
        {
            "text": "contrast-enhanced MR cisternography",
            "probability": 0.5263319209536191,
            "start_logit": 4.427311420440674,
            "end_logit": 5.01181697845459,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "3D-CISS and contrast-enhanced MR cisternography",
            "probability": 0.21622852149673935,
            "start_logit": 3.537715196609497,
            "end_logit": 5.01181697845459,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "CT cisternography",
            "probability": 0.06287568314413752,
            "start_logit": 3.103022575378418,
            "end_logit": 4.211333274841309,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "CTC",
            "probability": 0.05722173727072541,
            "start_logit": 3.7199325561523438,
            "end_logit": 3.500197649002075,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "CT cisternography in the investigation of cerebrospinal fluid rhinorrhoea.CTC",
            "probability": 0.0308773797109774,
            "start_logit": 3.103022575378418,
            "end_logit": 3.500197649002075,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "contrast-enhanced",
            "probability": 0.02306972228697471,
            "start_logit": 4.427311420440674,
            "end_logit": 1.8844059705734253,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "3D-CISS",
            "probability": 0.017969924342537278,
            "start_logit": 3.537715196609497,
            "end_logit": 2.5241806507110596,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "MR cisternography",
            "probability": 0.016056012159441836,
            "start_logit": 0.9374627470970154,
            "end_logit": 5.01181697845459,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "intrathecal sodium-fluorescein",
            "probability": 0.009911128488307757,
            "start_logit": 2.4557642936706543,
            "end_logit": 3.0110902786254883,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "3D-CISS and contrast-enhanced",
            "probability": 0.009477540203936242,
            "start_logit": 3.537715196609497,
            "end_logit": 1.8844059705734253,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "qualitative determination of beta-2-transferrin.surgery the use of intrathecal sodium-fluorescein",
            "probability": 0.00629253950487502,
            "start_logit": 2.0014708042144775,
            "end_logit": 3.0110902786254883,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "intrathecal sodium-fluorescein improves visualisation of the site of leakageThe contribution of 3D-CISS",
            "probability": 0.006090612111791807,
            "start_logit": 2.4557642936706543,
            "end_logit": 2.5241806507110596,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "cisternography",
            "probability": 0.0038383934245584186,
            "start_logit": -0.49356672167778015,
            "end_logit": 5.01181697845459,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "sodium-fluorescein",
            "probability": 0.002983314532678476,
            "start_logit": 1.255141019821167,
            "end_logit": 3.0110902786254883,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "qualitative determination of beta-2-transferrin",
            "probability": 0.0029069939994755523,
            "start_logit": 2.0014708042144775,
            "end_logit": 2.238845109939575,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "CISS and contrast-enhanced MR cisternography",
            "probability": 0.0020151938246226954,
            "start_logit": -1.137905240058899,
            "end_logit": 5.01181697845459,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "sodium-fluorescein improves visualisation of the site of leakageThe contribution of 3D-CISS",
            "probability": 0.0018333141021682439,
            "start_logit": 1.255141019821167,
            "end_logit": 2.5241806507110596,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "cisternography in the investigation of cerebrospinal fluid rhinorrhoea.CTC",
            "probability": 0.0015318497704789442,
            "start_logit": 0.0994747132062912,
            "end_logit": 3.500197649002075,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "fluorescein",
            "probability": 0.0013252630716276406,
            "start_logit": 0.4437170624732971,
            "end_logit": 3.0110902786254883,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "contrast",
            "probability": 0.0011629556003266406,
            "start_logit": 4.427311420440674,
            "end_logit": -1.1031503677368164,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        }
    ],
    "51be411b047fa84d1d000006": [
        {
            "text": "LaTcOm",
            "probability": 0.4418135043012125,
            "start_logit": 4.615688800811768,
            "end_logit": 4.514716148376465,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm: a web server for visualizing rare codon clusters in coding sequencesWe present LaTcOm",
            "probability": 0.334028301629452,
            "start_logit": 4.615688800811768,
            "end_logit": 4.235054016113281,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "Sherlocc, detects statistically relevant conserved rare codon clusters and produces a user-friendly HTML output.LaTcOm",
            "probability": 0.14748532949832435,
            "start_logit": 3.5185296535491943,
            "end_logit": 4.514716148376465,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "Sherlocc",
            "probability": 0.051543299616582064,
            "start_logit": 3.5185296535491943,
            "end_logit": 3.463409662246704,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm: a web server for visualizing rare codon clusters in coding sequencesWe present LaTcOm,",
            "probability": 0.007429992552963489,
            "start_logit": 4.615688800811768,
            "end_logit": 0.42935314774513245,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm,",
            "probability": 0.006265344894744025,
            "start_logit": 4.445197582244873,
            "end_logit": 0.42935314774513245,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm: a web server",
            "probability": 0.0024095734440234256,
            "start_logit": 4.615688800811768,
            "end_logit": -0.6967219710350037,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "web server for visualizing rare codon clusters in coding sequencesWe present LaTcOm",
            "probability": 0.001902571345282946,
            "start_logit": -0.5523306131362915,
            "end_logit": 4.235054016113281,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "visualizing rare codon clusters in coding sequencesWe present LaTcOm",
            "probability": 0.0011581954821173396,
            "start_logit": -1.0486737489700317,
            "end_logit": 4.235054016113281,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "Our program Sherlocc, detects statistically relevant conserved rare codon clusters and produces a user-friendly HTML output.LaTcOm",
            "probability": 0.0008883134077775411,
            "start_logit": -1.5936297178268433,
            "end_logit": 4.514716148376465,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "a web server for visualizing rare codon clusters in coding sequencesWe present LaTcOm",
            "probability": 0.0006429625519920481,
            "start_logit": -1.637205719947815,
            "end_logit": 4.235054016113281,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm: a web server for visualizing rare codon clusters in coding sequencesWe present LaTcOm, a new web tool,",
            "probability": 0.0006309424030976354,
            "start_logit": 4.615688800811768,
            "end_logit": -2.036712408065796,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "%MinMax",
            "probability": 0.0005421985587691859,
            "start_logit": 1.6593114137649536,
            "end_logit": 0.7680826783180237,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm: a web server for visualizing rare codon clusters in coding sequences",
            "probability": 0.0005337864723379035,
            "start_logit": 4.615688800811768,
            "end_logit": -2.2039310932159424,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm, a new web tool,",
            "probability": 0.0005320424934408037,
            "start_logit": 4.445197582244873,
            "end_logit": -2.036712408065796,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm: a web server for visualizing rare codon clusters in coding sequencesWe present LaTcOm, a new web tool",
            "probability": 0.000517315485194448,
            "start_logit": 4.615688800811768,
            "end_logit": -2.235274076461792,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm: a web",
            "probability": 0.0004825169691891805,
            "start_logit": 4.615688800811768,
            "end_logit": -2.304910898208618,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm, a new web tool",
            "probability": 0.00043622653872544073,
            "start_logit": 4.445197582244873,
            "end_logit": -2.235274076461792,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "LaTcOm:",
            "probability": 0.00040124860536709347,
            "start_logit": 4.615688800811768,
            "end_logit": -2.4893457889556885,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "%MinMax algorithm",
            "probability": 0.0003563337494069192,
            "start_logit": 1.6593114137649536,
            "end_logit": 0.3483181893825531,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        }
    ],
    "54db7217c4c6ce8e1d000003": [
        {
            "text": "RyR3",
            "probability": 0.23935627167071857,
            "start_logit": 3.496619701385498,
            "end_logit": 3.6560914516448975,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1-RyR3",
            "probability": 0.22350973805264168,
            "start_logit": 3.428121566772461,
            "end_logit": 3.6560914516448975,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1",
            "probability": 0.09597374625595817,
            "start_logit": 3.428121566772461,
            "end_logit": 2.810711145401001,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three",
            "probability": 0.056795955194727216,
            "start_logit": 2.493509292602539,
            "end_logit": 3.2207138538360596,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three ryanodine receptor isoforms (RyR1-RyR3",
            "probability": 0.05155151998406677,
            "start_logit": 1.9612482786178589,
            "end_logit": 3.6560914516448975,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three mammalian isoforms (RyR 1-3",
            "probability": 0.041746055834277075,
            "start_logit": 2.518836259841919,
            "end_logit": 2.887526750564575,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR3, expressed in various cells at lower levels than the other isoforms. Generally, three",
            "probability": 0.03802065763541314,
            "start_logit": 2.6474459171295166,
            "end_logit": 2.6654417514801025,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2",
            "probability": 0.03171516317260946,
            "start_logit": 3.052962303161621,
            "end_logit": 2.0785906314849854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2, expressed in cardiac muscle; and RyR3",
            "probability": 0.027271132702923834,
            "start_logit": 2.445675849914551,
            "end_logit": 2.5349109172821045,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "3",
            "probability": 0.02680776122507117,
            "start_logit": 2.075922727584839,
            "end_logit": 2.887526750564575,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR 1-3",
            "probability": 0.02540227271492634,
            "start_logit": 2.0220699310302734,
            "end_logit": 2.887526750564575,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three ryanodine receptor isoforms (RyR1",
            "probability": 0.022135914708532784,
            "start_logit": 1.9612482786178589,
            "end_logit": 2.810711145401001,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1) and cardiac muscle (RyR2",
            "probability": 0.020970185910447747,
            "start_logit": 2.6392691135406494,
            "end_logit": 2.0785906314849854,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1, expressed in skeletal muscle; RyR2, expressed in cardiac muscle; and RyR3",
            "probability": 0.020951325597299737,
            "start_logit": 2.182049036026001,
            "end_logit": 2.5349109172821045,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three RyR isoforms, RyR3",
            "probability": 0.01830281846359629,
            "start_logit": 2.493509292602539,
            "end_logit": 2.088303804397583,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three mammalian isoforms (RyR 1",
            "probability": 0.015249503595250135,
            "start_logit": 2.518836259841919,
            "end_logit": 1.880468726158142,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three isoforms: RyR1, expressed in skeletal muscle; RyR2, expressed in cardiac muscle; and RyR3",
            "probability": 0.014957618091251809,
            "start_logit": 1.8450678586959839,
            "end_logit": 2.5349109172821045,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "(RyR1-RyR3",
            "probability": 0.012038908554412633,
            "start_logit": 0.5068103671073914,
            "end_logit": 3.6560914516448975,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR 1",
            "probability": 0.009279249053648997,
            "start_logit": 2.0220699310302734,
            "end_logit": 1.880468726158142,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three isoforms: RyR1",
            "probability": 0.007964201582226781,
            "start_logit": 1.8450678586959839,
            "end_logit": 1.904646873474121,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        }
    ],
    "5506a7a48e1671127b000008": [
        {
            "text": "protein phosphatase 2B",
            "probability": 0.43484230649907774,
            "start_logit": 4.357230186462402,
            "end_logit": 3.3511085510253906,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 1",
            "probability": 0.35657601030504554,
            "start_logit": 4.341245651245117,
            "end_logit": 3.168657064437866,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 2C",
            "probability": 0.08037047165680822,
            "start_logit": 3.525132179260254,
            "end_logit": 2.4948699474334717,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase (protein phosphatase 2B",
            "probability": 0.052069946313397265,
            "start_logit": 2.234834671020508,
            "end_logit": 3.3511085510253906,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "Protein phosphatase 2A (PP2A) and protein phosphatase 2C",
            "probability": 0.02532919713275938,
            "start_logit": 2.370443105697632,
            "end_logit": 2.4948699474334717,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "Protein phosphatase 2A",
            "probability": 0.011508956744354369,
            "start_logit": 2.370443105697632,
            "end_logit": 1.7060377597808838,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "(protein phosphatase 2B",
            "probability": 0.011285001958617098,
            "start_logit": 0.7057213187217712,
            "end_logit": 3.3511085510253906,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 1 (PP1)",
            "probability": 0.009977458886321223,
            "start_logit": 4.148147106170654,
            "end_logit": -0.21446338295936584,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 2B)",
            "probability": 0.006537898109404427,
            "start_logit": 4.357230186462402,
            "end_logit": -0.8462591767311096,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 2C (PP2C)",
            "probability": 0.0031131571639340444,
            "start_logit": 3.525132179260254,
            "end_logit": -0.7561395168304443,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "2B",
            "probability": 0.0019708642167702776,
            "start_logit": -1.0392811298370361,
            "end_logit": 3.3511085510253906,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase",
            "probability": 0.0014651540140317508,
            "start_logit": 2.234834671020508,
            "end_logit": -0.2195190191268921,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "Protein phosphatase 2A (PP2A) and protein phosphatase 2C (PP2C)",
            "probability": 0.000981128639474244,
            "start_logit": 2.370443105697632,
            "end_logit": -0.7561395168304443,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "calcium/calmodulin-stimulated protein phosphatase (protein phosphatase 2B",
            "probability": 0.0008832592907907733,
            "start_logit": -1.84188973903656,
            "end_logit": 3.3511085510253906,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 2",
            "probability": 0.000801131529279674,
            "start_logit": 4.357230186462402,
            "end_logit": -2.9456050395965576,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase (protein phosphatase 2B)",
            "probability": 0.0007828769153119925,
            "start_logit": 2.234834671020508,
            "end_logit": -0.8462591767311096,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "1",
            "probability": 0.0007396233629573812,
            "start_logit": -1.8369159698486328,
            "end_logit": 3.168657064437866,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein",
            "probability": 0.000367770205893825,
            "start_logit": 4.341245651245117,
            "end_logit": -3.7081873416900635,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "2C (PP2C) accounted for the remainder of the activity.These results are consistent with the views that protein phosphatase 1",
            "probability": 0.00022353320302005676,
            "start_logit": -3.0334970951080322,
            "end_logit": 3.168657064437866,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "phosphatase 1",
            "probability": 0.0001742538527505608,
            "start_logit": -3.282543897628784,
            "end_logit": 3.168657064437866,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        }
    ],
    "532c0ac4d6d3ac6a3400001a": [
        {
            "text": "pharmacokinetic properties",
            "probability": 0.35631654803885926,
            "start_logit": 1.024972677230835,
            "end_logit": 1.0480046272277832,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "improved pharmacokinetic properties",
            "probability": 0.23822002698969552,
            "start_logit": 0.622347891330719,
            "end_logit": 1.0480046272277832,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "pharmacokinetic",
            "probability": 0.1520240789211408,
            "start_logit": 1.024972677230835,
            "end_logit": 0.19622403383255005,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "improved pharmacokinetic",
            "probability": 0.10163766006098654,
            "start_logit": 0.622347891330719,
            "end_logit": 0.19622403383255005,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "pharmacokinetic properties in rodents",
            "probability": 0.03680467904900922,
            "start_logit": 1.024972677230835,
            "end_logit": -1.2221899032592773,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "improved pharmacokinetic properties in rodents",
            "probability": 0.02460624319768016,
            "start_logit": 0.622347891330719,
            "end_logit": -1.2221899032592773,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "pharmacokinetic properties in rodents, which are well suited as tool compounds for further in vivo validation studies",
            "probability": 0.018220080387298585,
            "start_logit": 1.024972677230835,
            "end_logit": -1.925290584564209,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "improved pharmacokinetic properties in rodents, which are well suited as tool compounds for further in vivo validation studies",
            "probability": 0.012181269900334055,
            "start_logit": 0.622347891330719,
            "end_logit": -1.925290584564209,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "improved",
            "probability": 0.011816967650008113,
            "start_logit": 0.622347891330719,
            "end_logit": -1.9556536674499512,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "potent and selective tankyrase inhibitors 22 and 49 with improved pharmacokinetic properties",
            "probability": 0.0072501260335675255,
            "start_logit": -2.86982798576355,
            "end_logit": 1.0480046272277832,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "kinetic properties",
            "probability": 0.005957968407468001,
            "start_logit": -3.066117286682129,
            "end_logit": 1.0480046272277832,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "optimization of compound 8 leading to the identification of more potent and selective tankyrase inhibitors 22 and 49 with improved pharmacokinetic properties",
            "probability": 0.005570564894406253,
            "start_logit": -3.133350372314453,
            "end_logit": 1.0480046272277832,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "improved in vitro potency",
            "probability": 0.00505044590982723,
            "start_logit": -0.3813219964504242,
            "end_logit": -1.8020436763763428,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "pharmacokinetic properties in rodents,",
            "probability": 0.00457895413715479,
            "start_logit": 1.024972677230835,
            "end_logit": -3.3063442707061768,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "pharmacokin",
            "probability": 0.003909132236044363,
            "start_logit": 1.024972677230835,
            "end_logit": -3.4644994735717773,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "dock",
            "probability": 0.003854431195465226,
            "start_logit": -1.4479776620864868,
            "end_logit": -1.0056411027908325,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "pharmacokinetic properties in rodents, which are well suited as tool compounds for further in vivo validation",
            "probability": 0.0032327039844428627,
            "start_logit": 1.024972677230835,
            "end_logit": -3.65449595451355,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "potent and selective tankyrase inhibitors 22 and 49 with improved pharmacokinetic",
            "probability": 0.0030932993103510976,
            "start_logit": -2.86982798576355,
            "end_logit": 0.19622403383255005,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "improved pharmacokinetic properties in rodents,",
            "probability": 0.003061318886650842,
            "start_logit": 0.622347891330719,
            "end_logit": -3.3063442707061768,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "improved pharmacokin",
            "probability": 0.002613500809609376,
            "start_logit": 0.622347891330719,
            "end_logit": -3.4644994735717773,
            "question_text": "What are the main benefits of pharmacophore models?"
        }
    ],
    "52e7b7cb98d023950500001c": [
        {
            "text": "enistein",
            "probability": 0.7251804700272417,
            "start_logit": 3.492658853530884,
            "end_logit": 4.016391277313232,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "ACE inhibitor drugs",
            "probability": 0.1427221995410655,
            "start_logit": 3.1284356117248535,
            "end_logit": 2.755094051361084,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "ACE inhibitor",
            "probability": 0.10057018377684285,
            "start_logit": 3.1284356117248535,
            "end_logit": 2.4050498008728027,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "enistein treatment",
            "probability": 0.012402458737769295,
            "start_logit": 3.492658853530884,
            "end_logit": -0.05213453248143196,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "ACE",
            "probability": 0.0066169809150284885,
            "start_logit": 3.1284356117248535,
            "end_logit": -0.31616681814193726,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "ACE inhibitor drugs,",
            "probability": 0.004654736578904663,
            "start_logit": 3.1284356117248535,
            "end_logit": -0.667920708656311,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "istein",
            "probability": 0.0022107406209136374,
            "start_logit": -2.300434112548828,
            "end_logit": 4.016391277313232,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "inhibitor drugs",
            "probability": 0.0012618418614022005,
            "start_logit": -1.599892020225525,
            "end_logit": 2.755094051361084,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "ein",
            "probability": 0.001165711939252824,
            "start_logit": -2.9404296875,
            "end_logit": 4.016391277313232,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "inhibitor",
            "probability": 0.0008891655839568164,
            "start_logit": -1.599892020225525,
            "end_logit": 2.4050498008728027,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "drugs",
            "probability": 0.00038154008948391023,
            "start_logit": -2.796003818511963,
            "end_logit": 2.755094051361084,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "GSEA approach may be useful in proposing putative targets related to insulin resistance.he positive effects of ACE inhibitor drugs",
            "probability": 0.0003813012868853254,
            "start_logit": -2.7966299057006836,
            "end_logit": 2.755094051361084,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "enistein treatment could help reduce insulin resistance",
            "probability": 0.0003294648826077316,
            "start_logit": 3.492658853530884,
            "end_logit": -3.680314779281616,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "GSEA approach may be useful in proposing putative targets related to insulin resistance.he positive effects of ACE inhibitor",
            "probability": 0.0002686865856868335,
            "start_logit": -2.7966299057006836,
            "end_logit": 2.4050498008728027,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "ACE inhibitor drugs, particularly on hypertriglyceridemia and insulin resistance,",
            "probability": 0.0002644908421064887,
            "start_logit": 3.1284356117248535,
            "end_logit": -3.535754680633545,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "enistein treatment could help reduce insulin resistance through the amelioration of OVX-induced metabolic dysfunction,",
            "probability": 0.00018015026452477233,
            "start_logit": 3.492658853530884,
            "end_logit": -4.283993244171143,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "enistein treatment could help reduce insulin resistance through the amelioration of OVX-induced metabolic dysfunction",
            "probability": 0.0001611193842059899,
            "start_logit": 3.492658853530884,
            "end_logit": -4.395638942718506,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "ACE inhibitor drugs, particularly on hypertriglyceridemia",
            "probability": 0.00013056175765292495,
            "start_logit": 3.1284356117248535,
            "end_logit": -4.241714954376221,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "en",
            "probability": 0.00012571886542435659,
            "start_logit": 3.492658853530884,
            "end_logit": -4.643736362457275,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "ACE inhibitor drugs, particularly on hypertriglyceridemia and insulin resistance",
            "probability": 0.0001024764590436376,
            "start_logit": 3.1284356117248535,
            "end_logit": -4.483928203582764,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        }
    ],
    "5895f9cf78275d0c4a000002": [
        {
            "text": "lymphoedema",
            "probability": 0.171914304437748,
            "start_logit": 3.223285675048828,
            "end_logit": 3.874044179916382,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "intrahepatic cholestasis",
            "probability": 0.15723687493744112,
            "start_logit": 2.8990273475646973,
            "end_logit": 4.109059810638428,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema",
            "probability": 0.12430494682100224,
            "start_logit": 2.8990273475646973,
            "end_logit": 3.874044179916382,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "neonatal intrahepatic cholestasis",
            "probability": 0.0949546742138735,
            "start_logit": 2.3946735858917236,
            "end_logit": 4.109059810638428,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "chronic lymphoedema",
            "probability": 0.08811101063329252,
            "start_logit": 2.554887056350708,
            "end_logit": 3.874044179916382,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema",
            "probability": 0.07506722410539678,
            "start_logit": 2.3946735858917236,
            "end_logit": 3.874044179916382,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "lymphedema and sporadic cholestasis",
            "probability": 0.06594890704363915,
            "start_logit": 2.826907157897949,
            "end_logit": 3.3123068809509277,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "cholestasis",
            "probability": 0.06262861436817983,
            "start_logit": 1.9784961938858032,
            "end_logit": 4.109059810638428,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "lymphedema",
            "probability": 0.05888580207257218,
            "start_logit": 2.826907157897949,
            "end_logit": 3.199026584625244,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema",
            "probability": 0.049511582964282645,
            "start_logit": 1.9784961938858032,
            "end_logit": 3.874044179916382,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "severe chronic lymphoedema",
            "probability": 0.021213763010641602,
            "start_logit": 1.1309397220611572,
            "end_logit": 3.874044179916382,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "sporadic cholestasis",
            "probability": 0.010929425422217748,
            "start_logit": 1.0294855833053589,
            "end_logit": 3.3123068809509277,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 0.005112648994114097,
            "start_logit": 1.206917405128479,
            "end_logit": 2.375133991241455,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "chronic lymphedema",
            "probability": 0.0041866208418866405,
            "start_logit": 1.0070936679840088,
            "end_logit": 2.375133991241455,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis",
            "probability": 0.0027040737239530112,
            "start_logit": -1.1639666557312012,
            "end_logit": 4.109059810638428,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "severe chronic lymphedema",
            "probability": 0.0021142602375776283,
            "start_logit": 0.32390472292900085,
            "end_logit": 2.375133991241455,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "lymphedema and sporadic cholestasis.BACKGROUND: Lymphedema",
            "probability": 0.0018512493627527962,
            "start_logit": 2.826907157897949,
            "end_logit": -0.2607126832008362,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "lymphedema and sporadic cholestasis.BACKGROUND: Lymphedema-cholestasis",
            "probability": 0.0013601799277979895,
            "start_logit": 2.826907157897949,
            "end_logit": -0.5689564347267151,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "lymphedema cholestasis",
            "probability": 0.0010652544471949142,
            "start_logit": 1.1758692264556885,
            "end_logit": 0.8376781940460205,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "lymphoedema cholestasis",
            "probability": 0.000898582434435722,
            "start_logit": 0.8045783042907715,
            "end_logit": 1.038818597793579,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        }
    ],
    "58a2fac960087bc10a000009": [
        {
            "text": "hepatotoxicity",
            "probability": 0.9833061422736904,
            "start_logit": 6.07103157043457,
            "end_logit": 5.057179927825928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "patotoxicity",
            "probability": 0.012410359277317679,
            "start_logit": 1.698642611503601,
            "end_logit": 5.057179927825928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxicity.",
            "probability": 0.0015957986203295532,
            "start_logit": 6.07103157043457,
            "end_logit": -1.3663662672042847,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "he",
            "probability": 0.0014400880244629657,
            "start_logit": 6.07103157043457,
            "end_logit": -1.469036340713501,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepa",
            "probability": 0.0006307554707844237,
            "start_logit": 6.07103157043457,
            "end_logit": -2.2945775985717773,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepato",
            "probability": 0.00017985596329912236,
            "start_logit": 6.07103157043457,
            "end_logit": -3.549339532852173,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxi",
            "probability": 0.00010773365255260302,
            "start_logit": 6.07103157043457,
            "end_logit": -4.06183385848999,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "city",
            "probability": 9.52065860229533e-05,
            "start_logit": -3.1715950965881348,
            "end_logit": 5.057179927825928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "totoxicity",
            "probability": 6.592629470132022e-05,
            "start_logit": -3.539106845855713,
            "end_logit": 5.057179927825928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "toxicity",
            "probability": 4.206237498995384e-05,
            "start_logit": -3.988490581512451,
            "end_logit": 5.057179927825928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "xicity",
            "probability": 2.693255257820525e-05,
            "start_logit": -4.4343085289001465,
            "end_logit": 5.057179927825928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxicity.Tacrine and its analogues impair mitochondrial function",
            "probability": 2.3893493159166427e-05,
            "start_logit": 6.07103157043457,
            "end_logit": -5.56788969039917,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "patotoxicity.",
            "probability": 2.0140659517028945e-05,
            "start_logit": 1.698642611503601,
            "end_logit": -1.3663662672042847,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxicity.Tacrine and its analogues impair mitochondrial function and bioenergetics",
            "probability": 1.960440941814531e-05,
            "start_logit": 6.07103157043457,
            "end_logit": -5.765741348266602,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "associated with significant adverse effects including hepatotoxicity",
            "probability": 1.148527249085218e-05,
            "start_logit": -5.28657865524292,
            "end_logit": 5.057179927825928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "pa",
            "probability": 7.960798445200354e-06,
            "start_logit": 1.698642611503601,
            "end_logit": -2.2945775985717773,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "significant adverse effects including hepatotoxicity",
            "probability": 7.439745673328314e-06,
            "start_logit": -5.7208075523376465,
            "end_logit": 5.057179927825928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "was associated with significant adverse effects including hepatotoxicity",
            "probability": 4.984846683563597e-06,
            "start_logit": -6.121241569519043,
            "end_logit": 5.057179927825928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "pato",
            "probability": 2.26997170743687e-06,
            "start_logit": 1.698642611503601,
            "end_logit": -3.549339532852173,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "patotoxi",
            "probability": 1.359712176051247e-06,
            "start_logit": 1.698642611503601,
            "end_logit": -4.06183385848999,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        }
    ],
    "589c215778275d0c4a00003c": [
        {
            "text": "tyrosine hydroxylase",
            "probability": 0.22393946399669076,
            "start_logit": 5.092227458953857,
            "end_logit": 4.157864093780518,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase",
            "probability": 0.12568797740920482,
            "start_logit": 5.092227458953857,
            "end_logit": 3.5802907943725586,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "tyrosine hydroxylase, dopamine-\u00df-hydroxylase",
            "probability": 0.10708721472074273,
            "start_logit": 4.625646114349365,
            "end_logit": 3.8867132663726807,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "dopamine-\u00df-hydroxylase",
            "probability": 0.10703085582438644,
            "start_logit": 4.625119686126709,
            "end_logit": 3.8867132663726807,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "dopamine-\u03b2-hydroxylase",
            "probability": 0.09692434683271893,
            "start_logit": 4.707015514373779,
            "end_logit": 3.7056310176849365,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "dopamine-\u03b2-hydroxylase (DBH) and phenylethanolamine N-methyltransferase",
            "probability": 0.06898908026383722,
            "start_logit": 4.707015514373779,
            "end_logit": 3.3656485080718994,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "aromatic L-amino acid decarboxylase (AAAD), dopamine-\u03b2-hydroxylase",
            "probability": 0.06702327735827993,
            "start_logit": 4.338124752044678,
            "end_logit": 3.7056310176849365,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "aromatic L-amino acid decarboxylase",
            "probability": 0.05912771462036795,
            "start_logit": 4.338124752044678,
            "end_logit": 3.5802907943725586,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "phenylethanolamine N-methyltransferase",
            "probability": 0.05141553976668476,
            "start_logit": 4.413007736206055,
            "end_logit": 3.3656485080718994,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "dopamine-\u00df-hydroxylase and phenylethanolamine N-methyltransferase",
            "probability": 0.05135163958939204,
            "start_logit": 4.625119686126709,
            "end_logit": 3.1522929668426514,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "dopamine \u03b2-hydroxylase",
            "probability": 0.014884692876105136,
            "start_logit": 3.6343929767608643,
            "end_logit": 2.904656171798706,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "tyrosine hydroxylase, dopamine \u03b2-hydroxylase",
            "probability": 0.014877501222106888,
            "start_logit": 3.6339097023010254,
            "end_logit": 2.904656171798706,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "tyrosine hydroxylase, dopamine",
            "probability": 0.0018440713055758833,
            "start_logit": 4.625646114349365,
            "end_logit": -0.17495453357696533,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "dopamine",
            "probability": 0.0018431007898718791,
            "start_logit": 4.625119686126709,
            "end_logit": -0.17495453357696533,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "dopamine \u03b2-hydroxylase and phenyl-ethanolamine-N-methyltransferase",
            "probability": 0.0018168461438401759,
            "start_logit": 3.6343929767608643,
            "end_logit": 0.8014249205589294,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "dopamine-\u03b2-hydroxylase (DBH)",
            "probability": 0.0015813056312976106,
            "start_logit": 4.707015514373779,
            "end_logit": -0.41004887223243713,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (AAAD)",
            "probability": 0.0015370095249825698,
            "start_logit": 5.092227458953857,
            "end_logit": -0.8236730098724365,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "tyrosine hydroxylase (TH), dopamine-beta-hydroxylase",
            "probability": 0.0013226787510690374,
            "start_logit": 2.870797872543335,
            "end_logit": 1.2475769519805908,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "tyrosine hydroxylase, dopamine-\u00df-hydroxylase and phenylethanolamine",
            "probability": 0.0008580674824544999,
            "start_logit": 4.625646114349365,
            "end_logit": -0.9400028586387634,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "dopamine-\u00df-hydroxylase and phenylethanolamine",
            "probability": 0.0008576158903906251,
            "start_logit": 4.625119686126709,
            "end_logit": -0.9400028586387634,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        }
    ],
    "5896deff78275d0c4a000013": [
        {
            "text": "ledipasvir",
            "probability": 0.17101464434872435,
            "start_logit": 5.996246337890625,
            "end_logit": 6.066434383392334,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir and 90 mg ledipasvir",
            "probability": 0.13167384433564028,
            "start_logit": 5.734825134277344,
            "end_logit": 6.066434383392334,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "ledipasvir to four healthy volunteers.After the introductions of sofosbuvir (Sovaldi) and ledipasvir",
            "probability": 0.10673100936666216,
            "start_logit": 5.996246337890625,
            "end_logit": 5.594996929168701,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "ledipasvir to four healthy volunteers.After the introductions of sofosbuvir",
            "probability": 0.10504629025938199,
            "start_logit": 5.996246337890625,
            "end_logit": 5.5790863037109375,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir",
            "probability": 0.09552436016951991,
            "start_logit": 5.734825134277344,
            "end_logit": 5.745487689971924,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir and 90 mg ledipasvir to four healthy volunteers.After the introductions of sofosbuvir",
            "probability": 0.08088107848498137,
            "start_logit": 5.734825134277344,
            "end_logit": 5.5790863037109375,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir (Sovaldi) and ledipasvir",
            "probability": 0.06637436281695826,
            "start_logit": 5.52124547958374,
            "end_logit": 5.594996929168701,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "ledipasvir plus sofosbuvir",
            "probability": 0.06592167618732905,
            "start_logit": 5.564924716949463,
            "end_logit": 5.544474124908447,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir (Sovaldi) and ledipasvir plus sofosbuvir",
            "probability": 0.06310424714926205,
            "start_logit": 5.52124547958374,
            "end_logit": 5.544474124908447,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "Ledipasvir",
            "probability": 0.027710726944397426,
            "start_logit": 5.20762300491333,
            "end_logit": 5.035128116607666,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "Sofosbuvir/Ledipasvir",
            "probability": 0.022585022588229392,
            "start_logit": 5.0030903816223145,
            "end_logit": 5.035128116607666,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "Ledipasvir/Sofosbuvir",
            "probability": 0.022466151807764602,
            "start_logit": 5.08052921295166,
            "end_logit": 4.952412128448486,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "Sofosbuvir",
            "probability": 0.021267066680811252,
            "start_logit": 5.0030903816223145,
            "end_logit": 4.975000858306885,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir; Harvoni(\u00ae)) was recently approved in the US and the EU. Ledipasvir",
            "probability": 0.0052402640097063595,
            "start_logit": 3.7693443298339844,
            "end_logit": 4.807959079742432,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir (ledipasvir/sofosbuvir",
            "probability": 0.004610739749926085,
            "start_logit": 4.417840480804443,
            "end_logit": 4.031479358673096,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir (ledipasvir",
            "probability": 0.004336065599182374,
            "start_logit": 4.417840480804443,
            "end_logit": 3.9700584411621094,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "ledipasvir/sofosbuvir",
            "probability": 0.0027221700319209844,
            "start_logit": 3.8908815383911133,
            "end_logit": 4.031479358673096,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "ledipasvir and the HCV NS5B polymerase inhibitor sofosbuvir",
            "probability": 0.0016444426703761312,
            "start_logit": 2.851492404937744,
            "end_logit": 4.566840648651123,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "ledipasvir and the HCV NS5B polymerase inhibitor sofosbuvir (ledipasvir",
            "probability": 0.0009053979729014919,
            "start_logit": 2.851492404937744,
            "end_logit": 3.9700584411621094,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "400 mg sofosbuvir and 90 mg ledipasvir",
            "probability": 0.0002404388263245435,
            "start_logit": -0.5707924365997314,
            "end_logit": 6.066434383392334,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        }
    ],
    "58a7fb2860087bc10a000034": [
        {
            "text": "SLITRK1",
            "probability": 0.8248668522957211,
            "start_logit": 4.576208114624023,
            "end_logit": 3.7383577823638916,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "SLITRK1 gene",
            "probability": 0.10765234615485685,
            "start_logit": 4.576208114624023,
            "end_logit": 1.702042818069458,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "The SLITRK1",
            "probability": 0.036730208244467516,
            "start_logit": 1.4645856618881226,
            "end_logit": 3.7383577823638916,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histidine decarboxylase (Hdc)",
            "probability": 0.006079132491489523,
            "start_logit": 2.240453004837036,
            "end_logit": 1.1637529134750366,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histidine-decarboxylase",
            "probability": 0.0060487961358461585,
            "start_logit": 1.9864977598190308,
            "end_logit": 1.412705421447754,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histidine decarboxylase",
            "probability": 0.005554803944801074,
            "start_logit": 2.240453004837036,
            "end_logit": 1.0735540390014648,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "The SLITRK1 gene",
            "probability": 0.004793613758715838,
            "start_logit": 1.4645856618881226,
            "end_logit": 1.702042818069458,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "L-histidine-decarboxylase",
            "probability": 0.0026390497551453044,
            "start_logit": 1.1570574045181274,
            "end_logit": 1.412705421447754,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "Hdc)",
            "probability": 0.001703806980678498,
            "start_logit": 0.9684561491012573,
            "end_logit": 1.1637529134750366,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "SLITRK",
            "probability": 0.0009180324399169943,
            "start_logit": 4.576208114624023,
            "end_logit": -3.0623867511749268,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histidine decarboxylase (Hdc",
            "probability": 0.0005542819260585415,
            "start_logit": 2.240453004837036,
            "end_logit": -1.2311909198760986,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histamine (HA), has been implicated as a rare genetic cause.Histidine decarboxylase",
            "probability": 0.000519367392008934,
            "start_logit": 0.9376564025878906,
            "end_logit": 0.006543750409036875,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "SLIT",
            "probability": 0.0004942727906858417,
            "start_logit": 4.576208114624023,
            "end_logit": -3.6815319061279297,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "Histidine decarboxylase",
            "probability": 0.00036860800839383893,
            "start_logit": 0.5947786569595337,
            "end_logit": 0.006543750409036875,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histidine decarboxylase (Hdc), the key enzyme for the biosynthesis of histamine (HA),",
            "probability": 0.0002732319448446431,
            "start_logit": 2.240453004837036,
            "end_logit": -1.9385433197021484,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histidine decarboxylase (Hdc),",
            "probability": 0.00025273746438517187,
            "start_logit": 2.240453004837036,
            "end_logit": -2.0165131092071533,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "Hdc",
            "probability": 0.00015534937200407516,
            "start_logit": 0.9684561491012573,
            "end_logit": -1.2311909198760986,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "1",
            "probability": 0.00014971661054692418,
            "start_logit": -4.03802490234375,
            "end_logit": 3.7383577823638916,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histidine decarboxylase (Hdc), the key enzyme for the biosynthesis of histamine (HA)",
            "probability": 0.00012752259278598943,
            "start_logit": 2.240453004837036,
            "end_logit": -2.700570821762085,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histidine decarboxylase (Hdc), the key enzyme for the biosynthesis of histamine",
            "probability": 0.00011826969664704341,
            "start_logit": 2.240453004837036,
            "end_logit": -2.7758967876434326,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        }
    ],
    "588fd8f3621ea6ff7e000001": [
        {
            "text": "BLUEPRINT",
            "probability": 0.19560808365076193,
            "start_logit": 0.6527416706085205,
            "end_logit": -0.34587255120277405,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "BLUEPRINT and DEEP",
            "probability": 0.16307241626869465,
            "start_logit": 0.6527416706085205,
            "end_logit": -0.5277912616729736,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE, ROADMAP",
            "probability": 0.10417026788898964,
            "start_logit": -0.05460891127586365,
            "end_logit": -0.26860830187797546,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE, ROADMAP, BLUEPRINT",
            "probability": 0.09642471055437343,
            "start_logit": -0.05460891127586365,
            "end_logit": -0.34587255120277405,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ROADMAP",
            "probability": 0.0931273825805761,
            "start_logit": -0.1666674017906189,
            "end_logit": -0.26860830187797546,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ROADMAP, BLUEPRINT",
            "probability": 0.08620291655185013,
            "start_logit": -0.1666674017906189,
            "end_logit": -0.34587255120277405,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE, ROADMAP, BLUEPRINT and DEEP",
            "probability": 0.08038630226644998,
            "start_logit": -0.05460891127586365,
            "end_logit": -0.5277912616729736,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ROADMAP, BLUEPRINT and DEEP",
            "probability": 0.07186470839628871,
            "start_logit": -0.1666674017906189,
            "end_logit": -0.5277912616729736,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE",
            "probability": 0.04406811182003663,
            "start_logit": -0.05460891127586365,
            "end_logit": -1.1288986206054688,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "DEEP",
            "probability": 0.03361927644431472,
            "start_logit": -0.9263530969619751,
            "end_logit": -0.5277912616729736,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "BLUEPRINT and DEEP.",
            "probability": 0.012403026094823692,
            "start_logit": 0.6527416706085205,
            "end_logit": -3.1040451526641846,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE, ROADMAP, BLUEPRINT and DEEP.",
            "probability": 0.006114053053793908,
            "start_logit": -0.05460891127586365,
            "end_logit": -3.1040451526641846,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ROADMAP, BLUEPRINT and DEEP.",
            "probability": 0.005465914309305394,
            "start_logit": -0.1666674017906189,
            "end_logit": -3.1040451526641846,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "DEEP.",
            "probability": 0.0025570281753896813,
            "start_logit": -0.9263530969619751,
            "end_logit": -3.1040451526641846,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "It contains data from four major epigenome projects, namely ENCODE, ROADMAP",
            "probability": 0.0010751779185263492,
            "start_logit": -4.628149509429932,
            "end_logit": -0.26860830187797546,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "It contains data from four major epigenome projects, namely ENCODE, ROADMAP, BLUEPRINT",
            "probability": 0.0009952333011069734,
            "start_logit": -4.628149509429932,
            "end_logit": -0.34587255120277405,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "It contains data from four major epigenome projects, namely ENCODE, ROADMAP, BLUEPRINT and DEEP",
            "probability": 0.0008296952566252051,
            "start_logit": -4.628149509429932,
            "end_logit": -0.5277912616729736,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "EN",
            "probability": 0.000783592554433441,
            "start_logit": -0.05460891127586365,
            "end_logit": -5.158501148223877,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "data from four major epigenome projects, namely ENCODE, ROADMAP",
            "probability": 0.0006398390008500743,
            "start_logit": -5.14717435836792,
            "end_logit": -0.26860830187797546,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "data from four major epigenome projects, namely ENCODE, ROADMAP, BLUEPRINT",
            "probability": 0.0005922639128097023,
            "start_logit": -5.14717435836792,
            "end_logit": -0.34587255120277405,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        }
    ],
    "58846be0e56acf5176000005": [
        {
            "text": "essential tremor",
            "probability": 0.4562256245277844,
            "start_logit": 4.750925064086914,
            "end_logit": 4.625091552734375,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Parkinson Disease",
            "probability": 0.16598709987737345,
            "start_logit": 4.151786804199219,
            "end_logit": 4.2131524085998535,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Idiopathic Parkinson Disease",
            "probability": 0.1490868064478176,
            "start_logit": 4.044405460357666,
            "end_logit": 4.2131524085998535,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Tremor-Dominant, Idiopathic Parkinson Disease",
            "probability": 0.09108625674436088,
            "start_logit": 3.5516836643218994,
            "end_logit": 4.2131524085998535,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Parkinson",
            "probability": 0.050197850237261164,
            "start_logit": 4.151786804199219,
            "end_logit": 3.01721453666687,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Idiopathic Parkinson",
            "probability": 0.04508686029184158,
            "start_logit": 4.044405460357666,
            "end_logit": 3.01721453666687,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Tremor-Dominant, Idiopathic Parkinson",
            "probability": 0.027546323046212982,
            "start_logit": 3.5516836643218994,
            "end_logit": 3.01721453666687,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Tremor",
            "probability": 0.007510269283350643,
            "start_logit": 3.5516836643218994,
            "end_logit": 1.7176167964935303,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Tremor-Dominant",
            "probability": 0.00200437409612216,
            "start_logit": 3.5516836643218994,
            "end_logit": 0.39667731523513794,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Idiopathic",
            "probability": 0.001335442875823987,
            "start_logit": 4.044405460357666,
            "end_logit": -0.5021133422851562,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "tremor",
            "probability": 0.0012442398518123165,
            "start_logit": -1.153537631034851,
            "end_logit": 4.625091552734375,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Tremor-Dominant, Idiopathic",
            "probability": 0.0008159038049910013,
            "start_logit": 3.5516836643218994,
            "end_logit": -0.5021133422851562,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "essential",
            "probability": 0.0005728710650390626,
            "start_logit": 4.750925064086914,
            "end_logit": -2.054990530014038,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "essential tremor.",
            "probability": 0.0002485205879374962,
            "start_logit": 4.750925064086914,
            "end_logit": -2.8901255130767822,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "thalamotomy for essential tremor",
            "probability": 0.00020381363398741265,
            "start_logit": -2.962611675262451,
            "end_logit": 4.625091552734375,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Park",
            "probability": 0.00018818126052339338,
            "start_logit": 4.151786804199219,
            "end_logit": -2.5691072940826416,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "or",
            "probability": 0.00018813411236069086,
            "start_logit": -3.0426626205444336,
            "end_logit": 4.625091552734375,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "essential tremor,",
            "probability": 0.0001819158561561466,
            "start_logit": 3.656644344329834,
            "end_logit": -2.1078262329101562,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Idiopathic Park",
            "probability": 0.00016902122626085992,
            "start_logit": 4.044405460357666,
            "end_logit": -2.5691072940826416,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Disease",
            "probability": 0.00012049117298288382,
            "start_logit": -3.0763020515441895,
            "end_logit": 4.2131524085998535,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        }
    ],
    "58839d892305cd7e21000006": [
        {
            "text": "microRNA genes related to reproduction",
            "probability": 0.1746183619858694,
            "start_logit": 2.879157066345215,
            "end_logit": 2.4381353855133057,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA genes related to reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding and microRNA genes related to reproduction",
            "probability": 0.12421942027485838,
            "start_logit": 2.879157066345215,
            "end_logit": 2.0975821018218994,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA genes related to reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding and microRNA",
            "probability": 0.12069568741734214,
            "start_logit": 2.879157066345215,
            "end_logit": 2.068804979324341,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA",
            "probability": 0.12056425228348491,
            "start_logit": 2.8780674934387207,
            "end_logit": 2.068804979324341,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and microRNA genes related to reproduction",
            "probability": 0.08720869678260128,
            "start_logit": 2.1848583221435547,
            "end_logit": 2.4381353855133057,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and microRNA genes related to reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding and microRNA",
            "probability": 0.06027838932424749,
            "start_logit": 2.1848583221435547,
            "end_logit": 2.068804979324341,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "reproduction",
            "probability": 0.059843353778290684,
            "start_logit": 1.8082846403121948,
            "end_logit": 2.4381353855133057,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and microRNA",
            "probability": 0.053044552883529196,
            "start_logit": 2.0570168495178223,
            "end_logit": 2.068804979324341,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding and microRNA genes related to reproduction",
            "probability": 0.04257116278667234,
            "start_logit": 1.8082846403121948,
            "end_logit": 2.0975821018218994,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding and microRNA",
            "probability": 0.04136354641910159,
            "start_logit": 1.8082846403121948,
            "end_logit": 2.068804979324341,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA genes related to reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding",
            "probability": 0.028494012447190263,
            "start_logit": 2.879157066345215,
            "end_logit": 0.6252265572547913,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding",
            "probability": 0.022030298100511058,
            "start_logit": 2.1848583221435547,
            "end_logit": 1.062250018119812,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and microRNA genes related to reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding",
            "probability": 0.014230609332068805,
            "start_logit": 2.1848583221435547,
            "end_logit": 0.6252265572547913,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA genes",
            "probability": 0.01302764049604993,
            "start_logit": 2.879157066345215,
            "end_logit": -0.15739412605762482,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding",
            "probability": 0.009765165862558102,
            "start_logit": 1.8082846403121948,
            "end_logit": 0.6252265572547913,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA genes related to reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding and microRNA genes",
            "probability": 0.008729909320230447,
            "start_logit": 2.879157066345215,
            "end_logit": -0.5577124357223511,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and microRNA genes",
            "probability": 0.006506323486785964,
            "start_logit": 2.1848583221435547,
            "end_logit": -0.15739412605762482,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "both protein-coding and microRNA genes related to reproduction",
            "probability": 0.004637528423092384,
            "start_logit": -0.7492641806602478,
            "end_logit": 2.4381353855133057,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and microRNA genes related to reproduction exhibited evidence of rapid sequence evolution.In addition, both protein-coding and microRNA genes",
            "probability": 0.004359931030100891,
            "start_logit": 2.1848583221435547,
            "end_logit": -0.5577124357223511,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA genes related to reproduction exhibited evidence of rapid sequence evolution.In addition, both protein",
            "probability": 0.0038111575654147982,
            "start_logit": 2.879157066345215,
            "end_logit": -1.3865344524383545,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        }
    ],
    "58919aad621ea6ff7e00000d": [
        {
            "text": "Fulvestrant",
            "probability": 0.49540655650508497,
            "start_logit": 5.1226959228515625,
            "end_logit": 5.199974536895752,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "fulvestrant",
            "probability": 0.33647027118434725,
            "start_logit": 5.171756267547607,
            "end_logit": 4.764045238494873,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "RAD1901",
            "probability": 0.09175638951480514,
            "start_logit": 4.400361061096191,
            "end_logit": 4.236067771911621,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "RAD1901, and evaluate its therapeutic potential for the treatment of breast cancer.Identification of GDC-0810",
            "probability": 0.03654934666698046,
            "start_logit": 4.112394332885742,
            "end_logit": 3.60356068611145,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "GDC-0810",
            "probability": 0.027167268950475925,
            "start_logit": 3.815743923187256,
            "end_logit": 3.60356068611145,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts.Fulvestrant",
            "probability": 0.008243995608132345,
            "start_logit": 1.0268023014068604,
            "end_logit": 5.199974536895752,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "GDC-0810 (ARN-810",
            "probability": 0.0019535217838896617,
            "start_logit": 3.815743923187256,
            "end_logit": 0.9711815714836121,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "exemestane, and the selective estrogen receptor degrader fulvestrant",
            "probability": 0.0003903072804574296,
            "start_logit": -1.5875744819641113,
            "end_logit": 4.764045238494873,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "RAD1901,",
            "probability": 0.00035923441874368203,
            "start_logit": 4.112394332885742,
            "end_logit": -1.0188827514648438,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "letrozole, and exemestane, and the selective estrogen receptor degrader fulvestrant",
            "probability": 0.0003175501055341479,
            "start_logit": -1.7938731908798218,
            "end_logit": 4.764045238494873,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "GDC-0810 (ARN-810)",
            "probability": 0.00027219932337505675,
            "start_logit": 3.815743923187256,
            "end_logit": -0.9996728897094727,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "(SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts.Fulvestrant",
            "probability": 0.00019687763752091207,
            "start_logit": -2.707855701446533,
            "end_logit": 5.199974536895752,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "Fulvestrant is a steroid-based, selective estrogen receptor degrader (SERD",
            "probability": 0.00018853401469126092,
            "start_logit": 5.1226959228515625,
            "end_logit": -2.6738810539245605,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "f",
            "probability": 0.0001728269329248902,
            "start_logit": 5.1226959228515625,
            "end_logit": -2.760868787765503,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "RAD1901, and evaluate its therapeutic potential for the treatment of breast cancer.Identification of GDC",
            "probability": 0.00015123064232379157,
            "start_logit": 4.112394332885742,
            "end_logit": -1.88405179977417,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "GDC-0810 (ARN-810),",
            "probability": 0.00012830324785561854,
            "start_logit": 3.815743923187256,
            "end_logit": -1.751810908317566,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "GDC",
            "probability": 0.00011241031395166934,
            "start_logit": 3.815743923187256,
            "end_logit": -1.88405179977417,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "nt",
            "probability": 7.684939082444698e-05,
            "start_logit": -3.648590564727783,
            "end_logit": 5.199974536895752,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "SERD",
            "probability": 5.078704634662078e-05,
            "start_logit": 1.0268023014068604,
            "end_logit": 0.11037545651197433,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "RAD1901, and evaluate its therapeutic potential for the treatment of breast cancer.Identification of G",
            "probability": 3.553943173441887e-05,
            "start_logit": 4.112394332885742,
            "end_logit": -3.3322150707244873,
            "question_text": "List selective estrogen receptor degraders."
        }
    ],
    "587d2700fe8a08052f000001": [
        {
            "text": "dbSUPER",
            "probability": 0.4871432451203778,
            "start_logit": -0.023876087740063667,
            "end_logit": -0.5069423317909241,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER: a database of super-enhancers in mouse and human genomeWe developed dbSUPER",
            "probability": 0.11487298716009915,
            "start_logit": -0.4755825996398926,
            "end_logit": -1.4999669790267944,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER also provides an overlap analysis tool to annotate user-defined regions. We believe dbSUPER",
            "probability": 0.04364402446780022,
            "start_logit": -1.5032247304916382,
            "end_logit": -1.440085530281067,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER lists genes associated with super-enhancers and also links to external databases such as GeneCards, UniProt",
            "probability": 0.04084754298247876,
            "start_logit": -0.023876087740063667,
            "end_logit": -2.985653877258301,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER lists genes associated with super-enhancers",
            "probability": 0.030958324226976558,
            "start_logit": -0.023876087740063667,
            "end_logit": -3.2628586292266846,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER (http://bioinfo.au.tsinghua.edu.cn/dbsuper",
            "probability": 0.030813362054408728,
            "start_logit": -1.0655628442764282,
            "end_logit": -2.225865364074707,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "sea",
            "probability": 0.0304073757786439,
            "start_logit": -1.5090876817703247,
            "end_logit": -1.7956037521362305,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER lists genes associated with super-enhancers and also links to external databases",
            "probability": 0.029695759598320576,
            "start_logit": -0.023876087740063667,
            "end_logit": -3.3044962882995605,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER lists genes associated with super-enhancers and also links to external databases such as GeneCards",
            "probability": 0.028382288022722246,
            "start_logit": -0.023876087740063667,
            "end_logit": -3.3497352600097656,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "Super-Enhancer Archive (SEA",
            "probability": 0.023652724956148605,
            "start_logit": -1.7825888395309448,
            "end_logit": -1.7733094692230225,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "Super-Enhancer Archive (SEA, http://sea",
            "probability": 0.0231312390905697,
            "start_logit": -1.7825888395309448,
            "end_logit": -1.7956037521362305,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "sea.edbc.org). SEA",
            "probability": 0.01748074365251199,
            "start_logit": -1.5090876817703247,
            "end_logit": -2.349189043045044,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "SEA",
            "probability": 0.01723952578821203,
            "start_logit": -2.098862409591675,
            "end_logit": -1.7733094692230225,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "SEA, http://sea",
            "probability": 0.01685943558530716,
            "start_logit": -2.098862409591675,
            "end_logit": -1.7956037521362305,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "GeneCards, UniProt and Entrez. dbSUPER",
            "probability": 0.016163150493916662,
            "start_logit": -2.886029005050659,
            "end_logit": -1.0506136417388916,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "Super-Enhancer Archive (SEA, http://sea.edbc.org). SEA",
            "probability": 0.013297801949459991,
            "start_logit": -1.7825888395309448,
            "end_logit": -2.349189043045044,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "sea.edbc.org).",
            "probability": 0.010511063721981002,
            "start_logit": -1.5090876817703247,
            "end_logit": -2.857860565185547,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "SEA, http://sea.edbc.org). SEA",
            "probability": 0.009692236309316149,
            "start_logit": -2.098862409591675,
            "end_logit": -2.349189043045044,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "Super-Enhancer Archive (SEA, http://sea.edbc.org).",
            "probability": 0.007995886584205565,
            "start_logit": -1.7825888395309448,
            "end_logit": -2.857860565185547,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "Entrez. dbSUPER",
            "probability": 0.007211282456543067,
            "start_logit": -3.6931161880493164,
            "end_logit": -1.0506136417388916,
            "question_text": "List all the available databases of super enhancers"
        }
    ],
    "58a2efec60087bc10a000008": [
        {
            "text": "neuronal loss",
            "probability": 0.2322309118331656,
            "start_logit": 5.127709865570068,
            "end_logit": 4.918707370758057,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "dendritic and axonal instability, synaptic degeneration, and neuronal loss",
            "probability": 0.0830256118353015,
            "start_logit": 4.191817283630371,
            "end_logit": 4.826016902923584,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "synaptic degeneration, and neuronal loss",
            "probability": 0.07818409390248401,
            "start_logit": 4.131734371185303,
            "end_logit": 4.826016902923584,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "neurofibrillary tangles",
            "probability": 0.07037148995734879,
            "start_logit": 4.404416561126709,
            "end_logit": 4.448056697845459,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "dendritic and axonal instability",
            "probability": 0.0648764757802055,
            "start_logit": 4.191817283630371,
            "end_logit": 4.579352855682373,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "neurofibrillary tangles. Neurofibrillary tangles",
            "probability": 0.06476968157255118,
            "start_logit": 4.404416561126709,
            "end_logit": 4.365106105804443,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "dendritic and axonal instability, synaptic degeneration",
            "probability": 0.05703122166849125,
            "start_logit": 4.191817283630371,
            "end_logit": 4.450466632843018,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "synaptic degeneration",
            "probability": 0.05370552883305361,
            "start_logit": 4.131734371185303,
            "end_logit": 4.450466632843018,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "axonal instability, synaptic degeneration, and neuronal loss",
            "probability": 0.051969765262332615,
            "start_logit": 3.72333025932312,
            "end_logit": 4.826016902923584,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "Neurofibrillary tangles",
            "probability": 0.04914394627645686,
            "start_logit": 4.128332614898682,
            "end_logit": 4.365106105804443,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "neuronal loss is evident",
            "probability": 0.0440036946873796,
            "start_logit": 5.127709865570068,
            "end_logit": 3.255248785018921,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "axonal instability",
            "probability": 0.040609339007738776,
            "start_logit": 3.72333025932312,
            "end_logit": 4.579352855682373,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "axonal instability, synaptic degeneration",
            "probability": 0.03569861320161128,
            "start_logit": 3.72333025932312,
            "end_logit": 4.450466632843018,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "neurofibrillary tangles. Neurofibrillary tangles (NFTs), a marker of neuronal alterations",
            "probability": 0.01737506677898041,
            "start_logit": 4.404416561126709,
            "end_logit": 3.049304723739624,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "Neurofibrillary tangles (NFTs), a marker of neuronal alterations",
            "probability": 0.01318331860840783,
            "start_logit": 4.128332614898682,
            "end_logit": 3.049304723739624,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "tau inclusions propagate to the dentate gyrus, and neuronal loss",
            "probability": 0.012604008728365396,
            "start_logit": 2.2139925956726074,
            "end_logit": 4.918707370758057,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "inclusions propagate to the dentate gyrus, and neuronal loss",
            "probability": 0.010252404263710775,
            "start_logit": 2.0074899196624756,
            "end_logit": 4.918707370758057,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "neurofibrillary tangles. Neurofibrillary tangles (NFTs)",
            "probability": 0.007814136032580979,
            "start_logit": 4.404416561126709,
            "end_logit": 2.2502028942108154,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "dentate gyrus, and neuronal loss",
            "probability": 0.007221722041119838,
            "start_logit": 1.6570711135864258,
            "end_logit": 4.918707370758057,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "Neurofibrillary tangles (NFTs)",
            "probability": 0.00592896972871376,
            "start_logit": 4.128332614898682,
            "end_logit": 2.2502028942108154,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        }
    ],
    "58a45d6060087bc10a00001d": [
        {
            "text": "Stevens-Johnson syndrome",
            "probability": 0.20727849280221392,
            "start_logit": 4.8062214851379395,
            "end_logit": 4.970210075378418,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "toxic epidermal necrolysis",
            "probability": 0.16183212094310095,
            "start_logit": 4.822547435760498,
            "end_logit": 4.706380367279053,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens-Johnson syndrome/toxic epidermal necrolysis",
            "probability": 0.1592115079339297,
            "start_logit": 4.8062214851379395,
            "end_logit": 4.706380367279053,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens-Johnson Syndrome",
            "probability": 0.07639346689149785,
            "start_logit": 4.043632507324219,
            "end_logit": 4.734632968902588,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis",
            "probability": 0.06601528492080473,
            "start_logit": 4.043632507324219,
            "end_logit": 4.588622093200684,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "toxic epidermal necrolysis (SJS/TEN), acute generalized exanthematous pustulosis",
            "probability": 0.04281583082445894,
            "start_logit": 4.822547435760498,
            "end_logit": 3.3767287731170654,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome",
            "probability": 0.0409849169108301,
            "start_logit": 3.9954137802124023,
            "end_logit": 4.160158634185791,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens Johnson Syndrome",
            "probability": 0.039466584485740815,
            "start_logit": 4.075289249420166,
            "end_logit": 4.0425333976745605,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Toxic epidermal necrolysis (TEN) and Stevens Johnson Syndrome",
            "probability": 0.038806107884838285,
            "start_logit": 4.058412551879883,
            "end_logit": 4.0425333976745605,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Toxic epidermal necrolysis",
            "probability": 0.038555467309658954,
            "start_logit": 4.058412551879883,
            "end_logit": 4.036053657531738,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Johnson syndrome",
            "probability": 0.035238651620792386,
            "start_logit": 3.0343017578125,
            "end_logit": 4.970210075378418,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Johnson syndrome/toxic epidermal necrolysis",
            "probability": 0.02706696090972757,
            "start_logit": 3.0343017578125,
            "end_logit": 4.706380367279053,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "toxic epidermal necrolysis (TEN)",
            "probability": 0.01340920641499063,
            "start_logit": 4.911401748657227,
            "end_logit": 2.12690806388855,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "acute generalized exanthematous pustulosis",
            "probability": 0.011863142549944071,
            "start_logit": 3.5390758514404297,
            "end_logit": 3.3767287731170654,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens-Johnson Syndrome (SJS)",
            "probability": 0.009358874138655427,
            "start_logit": 4.043632507324219,
            "end_logit": 2.6350607872009277,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Johnson Syndrome",
            "probability": 0.00857037789531458,
            "start_logit": 1.8560471534729004,
            "end_logit": 4.734632968902588,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Johnson Syndrome (SJS) and toxic epidermal necrolysis",
            "probability": 0.0074060775307099765,
            "start_logit": 1.8560471534729004,
            "end_logit": 4.588622093200684,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN)",
            "probability": 0.005630353763488698,
            "start_logit": 4.043632507324219,
            "end_logit": 2.12690806388855,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens Johnson Syndrome (SJS)",
            "probability": 0.005090885331111524,
            "start_logit": 4.075289249420166,
            "end_logit": 1.9945307970046997,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Toxic epidermal necrolysis (TEN) and Stevens Johnson Syndrome (SJS)",
            "probability": 0.005005688938191029,
            "start_logit": 4.058412551879883,
            "end_logit": 1.9945307970046997,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        }
    ],
    "58a0da5278275d0c4a000054": [
        {
            "text": "Polyneuropathy",
            "probability": 0.16865604155672909,
            "start_logit": 3.3083906173706055,
            "end_logit": 3.073772430419922,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Polyneuropathy, organomegaly",
            "probability": 0.15914709036978766,
            "start_logit": 3.3083906173706055,
            "end_logit": 3.015739917755127,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.1197177420106723,
            "start_logit": 3.3083906173706055,
            "end_logit": 2.7310478687286377,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "organomegaly",
            "probability": 0.1022108550718877,
            "start_logit": 2.8655996322631836,
            "end_logit": 3.015739917755127,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "endocrinopathy",
            "probability": 0.09586040669949257,
            "start_logit": 3.086146831512451,
            "end_logit": 2.7310478687286377,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes",
            "probability": 0.08527405816808172,
            "start_logit": 3.3083906173706055,
            "end_logit": 2.3917813301086426,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "organomegaly, endocrinopathy",
            "probability": 0.0768876939550346,
            "start_logit": 2.8655996322631836,
            "end_logit": 2.7310478687286377,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "endocrinopathy, M-protein and skin changes",
            "probability": 0.06828065547861559,
            "start_logit": 3.086146831512451,
            "end_logit": 2.3917813301086426,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "organomegaly, endocrinopathy, M-protein and skin changes",
            "probability": 0.05476653315217723,
            "start_logit": 2.8655996322631836,
            "end_logit": 2.3917813301086426,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "skin changes",
            "probability": 0.03748467735950451,
            "start_logit": 2.486452579498291,
            "end_logit": 2.3917813301086426,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS) syndrome",
            "probability": 0.006104045079700648,
            "start_logit": 3.3083906173706055,
            "end_logit": -0.2451372742652893,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "endocrinopathy, M-protein and skin changes (POEMS) syndrome",
            "probability": 0.004887631808157377,
            "start_logit": 3.086146831512451,
            "end_logit": -0.2451372742652893,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "organomegaly, endocrinopathy, M-protein and skin changes (POEMS) syndrome",
            "probability": 0.003920270647385914,
            "start_logit": 2.8655996322631836,
            "end_logit": -0.2451372742652893,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 0.003545748284645279,
            "start_logit": 3.3083906173706055,
            "end_logit": -0.7883397340774536,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "endocrinopathy,",
            "probability": 0.0028391520497423376,
            "start_logit": 3.086146831512451,
            "end_logit": -0.7883397340774536,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "skin changes (POEMS) syndrome",
            "probability": 0.002683209469748131,
            "start_logit": 2.486452579498291,
            "end_logit": -0.2451372742652893,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "organomegaly, endocrinopathy,",
            "probability": 0.0022772264525928987,
            "start_logit": 2.8655996322631836,
            "end_logit": -0.7883397340774536,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "endocrinopathy, M-protein and skin changes (POEMS) syndrome is a fatal systemic disorder associated with plasma cell dyscrasia",
            "probability": 0.0021077883202832246,
            "start_logit": 3.086146831512451,
            "end_logit": -1.0862059593200684,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Polyneuropathy, organomegaly,",
            "probability": 0.0020393920177445104,
            "start_logit": 3.3083906173706055,
            "end_logit": -1.3414372205734253,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "organomegaly,",
            "probability": 0.0013097820480167596,
            "start_logit": 2.8655996322631836,
            "end_logit": -1.3414372205734253,
            "question_text": "For what indications is thalidomide currently marketed?"
        }
    ],
    "58932cd87d9090f353000001": [
        {
            "text": "Velocardiofacial syndrome",
            "probability": 0.20472541321723214,
            "start_logit": 4.284450531005859,
            "end_logit": 3.685533046722412,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Smith Magenis syndrome",
            "probability": 0.15988134577477792,
            "start_logit": 3.8425374031066895,
            "end_logit": 3.8802084922790527,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Smith Magenis syndrome and Velocardiofacial syndrome",
            "probability": 0.1315986164655803,
            "start_logit": 3.8425374031066895,
            "end_logit": 3.685533046722412,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Williams syndrome, Smith Magenis syndrome",
            "probability": 0.12519465952001163,
            "start_logit": 3.597975254058838,
            "end_logit": 3.8802084922790527,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Williams syndrome, Smith Magenis syndrome and Velocardiofacial syndrome",
            "probability": 0.10304794409800375,
            "start_logit": 3.597975254058838,
            "end_logit": 3.685533046722412,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Williams syndrome",
            "probability": 0.08578871097842235,
            "start_logit": 3.597975254058838,
            "end_logit": 3.5022261142730713,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Prader Willi/Angelman regions, Williams syndrome, Smith Magenis syndrome",
            "probability": 0.054280536234092014,
            "start_logit": 2.7622711658477783,
            "end_logit": 3.8802084922790527,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Prader Willi/Angelman regions, Williams syndrome, Smith Magenis syndrome and Velocardiofacial syndrome",
            "probability": 0.04467840469318336,
            "start_logit": 2.7622711658477783,
            "end_logit": 3.685533046722412,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Prader Willi/Angelman regions, Williams syndrome",
            "probability": 0.037195334470285155,
            "start_logit": 2.7622711658477783,
            "end_logit": 3.5022261142730713,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Velocardiofacial",
            "probability": 0.011433978298327272,
            "start_logit": 4.284450531005859,
            "end_logit": 0.8004528880119324,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Smith Magenis syndrome and Velocardiofacial",
            "probability": 0.007349823849962004,
            "start_logit": 3.8425374031066895,
            "end_logit": 0.8004528880119324,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Williams syndrome, Smith Magenis syndrome and Velocardiofacial",
            "probability": 0.005755259877060741,
            "start_logit": 3.597975254058838,
            "end_logit": 0.8004528880119324,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Smith Magenis",
            "probability": 0.005279716097077256,
            "start_logit": 3.8425374031066895,
            "end_logit": 0.4696488678455353,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Williams",
            "probability": 0.00436123748864417,
            "start_logit": 3.597975254058838,
            "end_logit": 0.5230945348739624,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Angelman regions, Williams syndrome, Smith Magenis syndrome",
            "probability": 0.00434890479870324,
            "start_logit": 0.23802949488162994,
            "end_logit": 3.8802084922790527,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Williams syndrome, Smith Magenis",
            "probability": 0.00413426754655318,
            "start_logit": 3.597975254058838,
            "end_logit": 0.4696488678455353,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Angelman regions, Williams syndrome, Smith Magenis syndrome and Velocardiofacial syndrome",
            "probability": 0.003579591176672182,
            "start_logit": 0.23802949488162994,
            "end_logit": 3.685533046722412,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Angelman regions, Williams syndrome",
            "probability": 0.0029800547266074914,
            "start_logit": 0.23802949488162994,
            "end_logit": 3.5022261142730713,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Prader Willi/Angelman regions, Williams syndrome, Smith Magenis syndrome and Velocardiofacial",
            "probability": 0.0024953028626870178,
            "start_logit": 2.7622711658477783,
            "end_logit": 0.8004528880119324,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "Prader Willi/Angelman regions, Williams",
            "probability": 0.0018908978261168593,
            "start_logit": 2.7622711658477783,
            "end_logit": 0.5230945348739624,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        }
    ],
    "589a246378275d0c4a00002c": [
        {
            "text": "epilepsy",
            "probability": 0.08165899922460057,
            "start_logit": 4.7483391761779785,
            "end_logit": 4.844964504241943,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "sensorineural deafness",
            "probability": 0.0811162236343785,
            "start_logit": 4.766664028167725,
            "end_logit": 4.819970607757568,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "ataxia, sensorineural deafness",
            "probability": 0.07675928089843281,
            "start_logit": 4.711455345153809,
            "end_logit": 4.819970607757568,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "sensorineural deafness, and tubulopathy",
            "probability": 0.07567579472860002,
            "start_logit": 4.766664028167725,
            "end_logit": 4.750545978546143,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "epilepsy, ataxia, sensorineural deafness",
            "probability": 0.073327352571416,
            "start_logit": 4.665714740753174,
            "end_logit": 4.819970607757568,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "epilepsy, ataxia",
            "probability": 0.07240549939725724,
            "start_logit": 4.7483391761779785,
            "end_logit": 4.724694728851318,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "ataxia, sensorineural deafness, and tubulopathy",
            "probability": 0.07161107019684862,
            "start_logit": 4.711455345153809,
            "end_logit": 4.750545978546143,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "ataxia",
            "probability": 0.07160444602031628,
            "start_logit": 4.711455345153809,
            "end_logit": 4.750453472137451,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "tubulopathy",
            "probability": 0.0708264719205287,
            "start_logit": 4.700438499450684,
            "end_logit": 4.750545978546143,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "epilepsy, ataxia, sensorineural deafness, and tubulopathy",
            "probability": 0.06840931977058098,
            "start_logit": 4.665714740753174,
            "end_logit": 4.750545978546143,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "sensorineural deafness and tubulopathy",
            "probability": 0.05195368098542249,
            "start_logit": 4.750338554382324,
            "end_logit": 4.39076566696167,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "epilepsy, ataxia, sensorineural deafness and tubulopathy",
            "probability": 0.05184990970161517,
            "start_logit": 4.7483391761779785,
            "end_logit": 4.39076566696167,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "ataxia, sensorineural deafness and tubulopathy",
            "probability": 0.05106080392803039,
            "start_logit": 4.73300313949585,
            "end_logit": 4.39076566696167,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Tubulopathy, hence the acronym EAST syndrome. Generation and validation of a zebrafish model of EAST (epilepsy",
            "probability": 0.024713842409268855,
            "start_logit": 3.5531506538391113,
            "end_logit": 4.844964504241943,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Ataxia",
            "probability": 0.016559394283080196,
            "start_logit": 3.9603536128997803,
            "end_logit": 4.037351608276367,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Epilepsy, Ataxia",
            "probability": 0.014484131111742746,
            "start_logit": 3.826453685760498,
            "end_logit": 4.037351608276367,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Epilepsy",
            "probability": 0.014215345497663151,
            "start_logit": 3.826453685760498,
            "end_logit": 4.018620014190674,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Ataxia, Sensorineural deafness",
            "probability": 0.011074277535279073,
            "start_logit": 3.9603536128997803,
            "end_logit": 3.6350231170654297,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "ataxia, epilepsy",
            "probability": 0.011007733780424146,
            "start_logit": 3.736631155014038,
            "end_logit": 3.8527185916900635,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Epilepsy, Ataxia, Sensorineural deafness",
            "probability": 0.009686422404514021,
            "start_logit": 3.826453685760498,
            "end_logit": 3.6350231170654297,
            "question_text": "List symptoms of EAST syndrome."
        }
    ],
    "589c42b178275d0c4a00003f": [
        {
            "text": "fibrates and statins",
            "probability": 0.36107072342430224,
            "start_logit": 5.967746257781982,
            "end_logit": 5.841584205627441,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "fibrates",
            "probability": 0.28176790989797224,
            "start_logit": 5.967746257781982,
            "end_logit": 5.593594074249268,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "statins",
            "probability": 0.24481552573173904,
            "start_logit": 5.579177379608154,
            "end_logit": 5.841584205627441,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "bezafibrate",
            "probability": 0.040874833083459385,
            "start_logit": 5.016744136810303,
            "end_logit": 4.61402702331543,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "bezafibrate and pravastatin",
            "probability": 0.03981767516256299,
            "start_logit": 5.016744136810303,
            "end_logit": 4.587823390960693,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "pravastatin",
            "probability": 0.029051401177047197,
            "start_logit": 4.701499938964844,
            "end_logit": 4.587823390960693,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "fibrates and statins)",
            "probability": 0.0006769152706674494,
            "start_logit": 5.967746257781982,
            "end_logit": -0.4376988112926483,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "statins)",
            "probability": 0.0004589665046577413,
            "start_logit": 5.579177379608154,
            "end_logit": -0.4376988112926483,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "fibrates and stat",
            "probability": 0.00042685395398291923,
            "start_logit": 5.967746257781982,
            "end_logit": -0.8988029956817627,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "stat",
            "probability": 0.00028941830055880517,
            "start_logit": 5.579177379608154,
            "end_logit": -0.8988029956817627,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "(fibrates and statins",
            "probability": 0.00015864961603222997,
            "start_logit": -1.7623847723007202,
            "end_logit": 5.841584205627441,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "(fibrates",
            "probability": 0.00012380502714695734,
            "start_logit": -1.7623847723007202,
            "end_logit": 5.593594074249268,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "fibra",
            "probability": 0.0001137887785247063,
            "start_logit": 5.967746257781982,
            "end_logit": -2.2209010124206543,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "fi",
            "probability": 9.685251923666229e-05,
            "start_logit": 5.967746257781982,
            "end_logit": -2.3820555210113525,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "bezafibrate and pra",
            "probability": 4.9220877015969246e-05,
            "start_logit": 5.016744136810303,
            "end_logit": -2.1079249382019043,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "brates and statins",
            "probability": 4.70635579465286e-05,
            "start_logit": -2.977583885192871,
            "end_logit": 5.841584205627441,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "bezafibrate and pravastat",
            "probability": 4.704929843654225e-05,
            "start_logit": 5.016744136810303,
            "end_logit": -2.1530468463897705,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "tes and statins",
            "probability": 4.070886315372327e-05,
            "start_logit": -3.1226370334625244,
            "end_logit": 5.841584205627441,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "brates",
            "probability": 3.67268778514955e-05,
            "start_logit": -2.977583885192871,
            "end_logit": 5.593594074249268,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "pra",
            "probability": 3.5912077705166104e-05,
            "start_logit": 4.701499938964844,
            "end_logit": -2.1079249382019043,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        }
    ],
    "58a326da60087bc10a00000e": [
        {
            "text": "sibutramine",
            "probability": 0.2567473344938954,
            "start_logit": 4.990628719329834,
            "end_logit": 4.941199779510498,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Sibutramine",
            "probability": 0.18422107985431743,
            "start_logit": 4.910672664642334,
            "end_logit": 4.689199924468994,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn from sale globally due to the increased incidence of serious, non-fatal cardiovascular eventsDiclofenac",
            "probability": 0.13044096642862346,
            "start_logit": 4.990628719329834,
            "end_logit": 4.264028072357178,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "rofecoxib",
            "probability": 0.09463446660911262,
            "start_logit": 4.390713691711426,
            "end_logit": 4.543044090270996,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.Sibutramine",
            "probability": 0.09178810502884507,
            "start_logit": 4.016239166259766,
            "end_logit": 4.886979579925537,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine",
            "probability": 0.09138571148979163,
            "start_logit": 4.209625244140625,
            "end_logit": 4.689199924468994,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "clobutinol",
            "probability": 0.0568367525885212,
            "start_logit": 4.322674751281738,
            "end_logit": 4.1012444496154785,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdecoxib",
            "probability": 0.05348246098394024,
            "start_logit": 4.390713691711426,
            "end_logit": 3.9723761081695557,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "valdecoxib",
            "probability": 0.03426094179402307,
            "start_logit": 3.9453659057617188,
            "end_logit": 3.9723761081695557,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Diclofenac has a risk very similar to rofecoxib",
            "probability": 0.0026963364716621947,
            "start_logit": 1.042251706123352,
            "end_logit": 4.333378314971924,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Diclofenac",
            "probability": 0.0025156815142816165,
            "start_logit": 1.042251706123352,
            "end_logit": 4.264028072357178,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "clobutinol,",
            "probability": 0.0002301108632543694,
            "start_logit": 4.322674751281738,
            "end_logit": -1.408132791519165,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Sibutramine Cardiovascular Outcomes (SCOUT) trial",
            "probability": 0.00020675043895420635,
            "start_logit": 4.910672664642334,
            "end_logit": -2.103179454803467,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005",
            "probability": 0.00010725340111183735,
            "start_logit": 4.390713691711426,
            "end_logit": -2.2395386695861816,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial",
            "probability": 0.00010256174798018956,
            "start_logit": 4.209625244140625,
            "end_logit": -2.103179454803467,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Sibutramine Cardiovascular Outcomes",
            "probability": 9.772234073144765e-05,
            "start_logit": 4.910672664642334,
            "end_logit": -2.8525617122650146,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Sibutramine Cardiovascular Outcomes (SCOUT) trial and it was withdrawn from the market in 2010",
            "probability": 8.87504628827606e-05,
            "start_logit": 4.910672664642334,
            "end_logit": -2.9488632678985596,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Si",
            "probability": 6.18236773072741e-05,
            "start_logit": 4.910672664642334,
            "end_logit": -3.3104054927825928,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes",
            "probability": 4.8476676193915465e-05,
            "start_logit": 4.209625244140625,
            "end_logit": -2.8525617122650146,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "si",
            "probability": 4.67131345699302e-05,
            "start_logit": 4.990628719329834,
            "end_logit": -3.6706225872039795,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        }
    ],
    "589aec4778275d0c4a000037": [
        {
            "text": "cryptococcal",
            "probability": 0.3871374890069551,
            "start_logit": 4.486069202423096,
            "end_logit": 3.875976324081421,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "tuberculous or cryptococcal",
            "probability": 0.31177849003967895,
            "start_logit": 4.269582271575928,
            "end_logit": 3.875976324081421,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "tuberculous",
            "probability": 0.1766984773737155,
            "start_logit": 4.269582271575928,
            "end_logit": 3.3081281185150146,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial, tuberculous or cryptococcal",
            "probability": 0.05984026165384536,
            "start_logit": 2.6189680099487305,
            "end_logit": 3.875976324081421,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial, tuberculous",
            "probability": 0.03391408791072641,
            "start_logit": 2.6189680099487305,
            "end_logit": 3.3081281185150146,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "bacterial",
            "probability": 0.008393456887349375,
            "start_logit": 2.6189680099487305,
            "end_logit": 1.911750078201294,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "cryptococcal), 39 (21 %) had normal CSF and 14 (8 %) had aseptic",
            "probability": 0.006750781027117474,
            "start_logit": 4.486069202423096,
            "end_logit": -0.1731453686952591,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "herpesvirus",
            "probability": 0.004069036462465845,
            "start_logit": 2.406031370162964,
            "end_logit": 1.4006404876708984,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "cryptococcal), 39 (21 %) had normal CSF and 14 (8 %) had aseptic meningitis",
            "probability": 0.002131790818151449,
            "start_logit": 4.486069202423096,
            "end_logit": -1.3258411884307861,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "(bacterial, tuberculous or cryptococcal",
            "probability": 0.0017711497213624857,
            "start_logit": -0.9010818004608154,
            "end_logit": 3.875976324081421,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Aseptic meningitis",
            "probability": 0.00149395540460348,
            "start_logit": 0.9569710493087769,
            "end_logit": 1.847721815109253,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "herpesvirus infection in patients with aseptic meningitis, and that VZV",
            "probability": 0.001435403109614904,
            "start_logit": 2.406031370162964,
            "end_logit": 0.35867998003959656,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "(bacterial, tuberculous",
            "probability": 0.0010037878460627686,
            "start_logit": -0.9010818004608154,
            "end_logit": 3.3081281185150146,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "tube",
            "probability": 0.0009520032235333367,
            "start_logit": 4.269582271575928,
            "end_logit": -1.9155035018920898,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "cry",
            "probability": 0.0006549847670619114,
            "start_logit": 4.486069202423096,
            "end_logit": -2.5059468746185303,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "tuberculous or cry",
            "probability": 0.0005274874365625822,
            "start_logit": 4.269582271575928,
            "end_logit": -2.5059468746185303,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "VZV",
            "probability": 0.00041416033626756756,
            "start_logit": 1.163083553314209,
            "end_logit": 0.35867998003959656,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Aseptic",
            "probability": 0.0003625981908011791,
            "start_logit": 0.9569710493087769,
            "end_logit": 0.4318346083164215,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "herpesvirus infection in patients with aseptic",
            "probability": 0.0003500181083814197,
            "start_logit": 2.406031370162964,
            "end_logit": -1.052536129951477,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "herpesvirus infection in patients with aseptic meningitis",
            "probability": 0.0003205806757427656,
            "start_logit": 2.406031370162964,
            "end_logit": -1.1403870582580566,
            "question_text": "Which are the types of viral meningitis?"
        }
    ],
    "58a0c09778275d0c4a000052": [
        {
            "text": "Sulphonylurea",
            "probability": 0.5805774161168765,
            "start_logit": 4.145933628082275,
            "end_logit": 4.096274375915527,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Sulphonylurea (SU) drugs",
            "probability": 0.09214204451250141,
            "start_logit": 4.145933628082275,
            "end_logit": 2.255582571029663,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "exenatide and lixisenatide. Sulphonylurea",
            "probability": 0.07672622163871384,
            "start_logit": 2.1221539974212646,
            "end_logit": 4.096274375915527,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "lixisenatide. Sulphonylurea",
            "probability": 0.06960083587969979,
            "start_logit": 2.0246870517730713,
            "end_logit": 4.096274375915527,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "sulfonylureas",
            "probability": 0.035846501993574115,
            "start_logit": 3.054206609725952,
            "end_logit": 2.403224229812622,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "sulfonylurea",
            "probability": 0.025675701906581316,
            "start_logit": 3.054206609725952,
            "end_logit": 2.069523334503174,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Sulphonylurea (SU)",
            "probability": 0.024117069413697036,
            "start_logit": 4.145933628082275,
            "end_logit": 0.9151710867881775,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "exenatide and lixisenatide. Sulphonylurea (SU) drugs",
            "probability": 0.012177033989360705,
            "start_logit": 2.1221539974212646,
            "end_logit": 2.255582571029663,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "lixisenatide. Sulphonylurea (SU) drugs",
            "probability": 0.011046181163277564,
            "start_logit": 2.0246870517730713,
            "end_logit": 2.255582571029663,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "metformin once glycaemic control with metformin monotherapy deteriorates;In 2013, sulfonylureas",
            "probability": 0.010104351496066836,
            "start_logit": 1.7879267930984497,
            "end_logit": 2.403224229812622,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "sulfonylureas were the most common second-line treatment after metformin",
            "probability": 0.009439299888823216,
            "start_logit": 3.054206609725952,
            "end_logit": 1.0688600540161133,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "glucagon-like peptide-1 receptor agonists exenatide and lixisenatide. Sulphonylurea",
            "probability": 0.009051978359919435,
            "start_logit": -0.015106188133358955,
            "end_logit": 4.096274375915527,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "exenatide and lixisenatide",
            "probability": 0.0073860807982197565,
            "start_logit": 2.1221539974212646,
            "end_logit": 1.7556281089782715,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "metformin once glycaemic control with metformin monotherapy deteriorates;In 2013, sulfonylurea",
            "probability": 0.007237423529326176,
            "start_logit": 1.7879267930984497,
            "end_logit": 2.069523334503174,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "lixisenatide",
            "probability": 0.006700152652528201,
            "start_logit": 2.0246870517730713,
            "end_logit": 1.7556281089782715,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "metformin",
            "probability": 0.006381939565799042,
            "start_logit": 1.7879267930984497,
            "end_logit": 1.943730115890503,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "metformin monotherapy deteriorates;In 2013, sulfonylureas",
            "probability": 0.0048485947653992036,
            "start_logit": 1.0536495447158813,
            "end_logit": 2.403224229812622,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "exenatide",
            "probability": 0.00428108724888292,
            "start_logit": 2.1221539974212646,
            "end_logit": 1.2102378606796265,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "metformin monotherapy deteriorates;In 2013, sulfonylurea",
            "probability": 0.0034728932235707946,
            "start_logit": 1.0536495447158813,
            "end_logit": 2.069523334503174,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "exenatide and lixisenatide. Sulphonylurea (SU)",
            "probability": 0.003187191857182156,
            "start_logit": 2.1221539974212646,
            "end_logit": 0.9151710867881775,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        }
    ],
    "5883bce3e56acf5176000003": [
        {
            "text": "Q-nexus",
            "probability": 0.7482382680653551,
            "start_logit": 4.379264831542969,
            "end_logit": 4.399806499481201,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "MACE and MACS2 to the available ChIP-nexus data.Q-nexus",
            "probability": 0.12487090344948437,
            "start_logit": 2.5040221214294434,
            "end_logit": 4.484608173370361,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "MACS2 to the available ChIP-nexus data.Q-nexus",
            "probability": 0.0736365624254441,
            "start_logit": 1.9758833646774292,
            "end_logit": 4.484608173370361,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "PeakXus",
            "probability": 0.025497511316809156,
            "start_logit": 2.1865227222442627,
            "end_logit": 3.2134079933166504,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "Q",
            "probability": 0.00846762407513977,
            "start_logit": 4.379264831542969,
            "end_logit": -0.08166500926017761,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "MACE and MACS2",
            "probability": 0.005937362019079993,
            "start_logit": 2.5040221214294434,
            "end_logit": 1.4385926723480225,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "MACE",
            "probability": 0.003850227670441641,
            "start_logit": 2.5040221214294434,
            "end_logit": 1.0054600238800049,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "MACS2",
            "probability": 0.0035012714482146245,
            "start_logit": 1.9758833646774292,
            "end_logit": 1.4385926723480225,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "MACE and MACS2 to the available ChIP-nexus data.Q",
            "probability": 0.0012777439196686635,
            "start_logit": 2.5040221214294434,
            "end_logit": -0.09757629781961441,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "peak calling method as well as the two other methods MACE and MACS2",
            "probability": 0.000983909131071885,
            "start_logit": 0.7065354585647583,
            "end_logit": 1.4385926723480225,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "MACS2 to the available ChIP-nexus data.Q",
            "probability": 0.0007534875403738555,
            "start_logit": 1.9758833646774292,
            "end_logit": -0.09757629781961441,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "peak calling method as well as the two other methods MACE",
            "probability": 0.0006380399493039778,
            "start_logit": 0.7065354585647583,
            "end_logit": 1.0054600238800049,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "Q-nexus: a comprehensive and efficient analysis pipeline designed for ChIP-nexus",
            "probability": 0.0005766530173455473,
            "start_logit": 4.379264831542969,
            "end_logit": -2.7684295177459717,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "Q-nexus: a comprehensive and efficient analysis pipeline",
            "probability": 0.0004621933365863959,
            "start_logit": 4.379264831542969,
            "end_logit": -2.989686965942383,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "methods MACE and MACS2 to the available ChIP-nexus data.Q-nexus",
            "probability": 0.00036762338601416006,
            "start_logit": -3.3239545822143555,
            "end_logit": 4.484608173370361,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "peak calling",
            "probability": 0.0003568920064694611,
            "start_logit": 0.7065354585647583,
            "end_logit": 0.42449235916137695,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "peak calling method as well as the two other methods MACE and MACS2 to the available ChIP-nexus data.Q",
            "probability": 0.00021174115805867302,
            "start_logit": 0.7065354585647583,
            "end_logit": -0.09757629781961441,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "us",
            "probability": 0.00014600786817110667,
            "start_logit": -4.2473530769348145,
            "end_logit": 4.484608173370361,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "PeakXus: comprehensive transcription factor binding site discovery from ChIP-Nexus and ChIP-Exo experiments.We describe a peak caller",
            "probability": 0.0001171325771878749,
            "start_logit": 2.1865227222442627,
            "end_logit": -2.169621706008911,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "calling method as well as the two other methods MACE and MACS2 to the available ChIP-nexus data.Q-nexus",
            "probability": 0.00010884563977992132,
            "start_logit": -4.541082859039307,
            "end_logit": 4.484608173370361,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        }
    ],
    "5884fe4ce56acf5176000010": [
        {
            "text": "cervical cancer",
            "probability": 0.33294881306683266,
            "start_logit": 5.710729598999023,
            "end_logit": 5.180816650390625,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "lung cancer",
            "probability": 0.25066791965284124,
            "start_logit": 5.408909797668457,
            "end_logit": 5.198776721954346,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "lung cancer and cervical cancer",
            "probability": 0.24620609317338688,
            "start_logit": 5.408909797668457,
            "end_logit": 5.180816650390625,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical",
            "probability": 0.07351994711525388,
            "start_logit": 5.710729598999023,
            "end_logit": 3.670384645462036,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "lung cancer and cervical",
            "probability": 0.054365891209611425,
            "start_logit": 5.408909797668457,
            "end_logit": 3.670384645462036,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "prostate cancer",
            "probability": 0.026369778109111862,
            "start_logit": 4.444691181182861,
            "end_logit": 3.9110848903656006,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "prostate",
            "probability": 0.004861721759287829,
            "start_logit": 4.444691181182861,
            "end_logit": 2.220258951187134,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "lung",
            "probability": 0.004446561561970083,
            "start_logit": 5.408909797668457,
            "end_logit": 1.166778802871704,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical cancer progression",
            "probability": 0.0015902704537602383,
            "start_logit": 5.710729598999023,
            "end_logit": -0.16326801478862762,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "vical cancer",
            "probability": 0.0015774064750294428,
            "start_logit": 0.35852286219596863,
            "end_logit": 5.180816650390625,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "lung cancer and cervical cancer progression",
            "probability": 0.0011759593671558908,
            "start_logit": 5.408909797668457,
            "end_logit": -0.16326801478862762,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "prostate cancer (PCa). Sperm-associated antigen 5 (SPAG5) attracted our attention.",
            "probability": 0.0004109626314405781,
            "start_logit": 4.444691181182861,
            "end_logit": -0.25038668513298035,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "vical",
            "probability": 0.00034831432361990405,
            "start_logit": 0.35852286219596863,
            "end_logit": 3.670384645462036,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "SPAG5 was recently identified as an oncogene participating in lung cancer",
            "probability": 0.0002648990544059311,
            "start_logit": -1.4436256885528564,
            "end_logit": 5.198776721954346,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "prostate cancer (PCa)",
            "probability": 0.0002609781372770049,
            "start_logit": 4.444691181182861,
            "end_logit": -0.7044523358345032,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "SPAG5 was recently identified as an oncogene participating in lung cancer and cervical cancer",
            "probability": 0.0002601839172756286,
            "start_logit": -1.4436256885528564,
            "end_logit": 5.180816650390625,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical cancer progression.",
            "probability": 0.000210158304070443,
            "start_logit": 5.710729598999023,
            "end_logit": -2.1870663166046143,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer",
            "probability": 0.00020441255224716318,
            "start_logit": -1.684874176979065,
            "end_logit": 5.180816650390625,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "lung cancer and cervical cancer progression.",
            "probability": 0.00015540603528970163,
            "start_logit": 5.408909797668457,
            "end_logit": -2.1870663166046143,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer and cervical cancer",
            "probability": 0.0001543231001324323,
            "start_logit": -1.965965986251831,
            "end_logit": 5.180816650390625,
            "question_text": "SPAG5 was implicated in which cancers?"
        }
    ],
    "58a3275960087bc10a00000f": [
        {
            "text": "conjunctivitis",
            "probability": 0.1381030947979007,
            "start_logit": 4.744129180908203,
            "end_logit": 4.608726501464844,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "arthralgia and conjunctivitis",
            "probability": 0.11848416697533216,
            "start_logit": 4.590908050537109,
            "end_logit": 4.608726501464844,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "arthralgia",
            "probability": 0.08702289844242408,
            "start_logit": 4.590908050537109,
            "end_logit": 4.300118446350098,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "maculopapular rash, arthralgia and conjunctivitis",
            "probability": 0.08083239983875122,
            "start_logit": 4.2085065841674805,
            "end_logit": 4.608726501464844,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "maculopapular rash, arthralgia",
            "probability": 0.05936885831749625,
            "start_logit": 4.2085065841674805,
            "end_logit": 4.300118446350098,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "maculopapular rash",
            "probability": 0.049088126023074406,
            "start_logit": 4.2085065841674805,
            "end_logit": 4.109965801239014,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "conjunctivitis, there have been reports of more severe reactions that are associated with neurological complications",
            "probability": 0.04661703040186841,
            "start_logit": 4.744129180908203,
            "end_logit": 3.5226919651031494,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "conjunctivitis (1).* Zika virus infection during pregnancy is a cause of microcephaly and other severe brain defects",
            "probability": 0.04074904035800044,
            "start_logit": 4.148686408996582,
            "end_logit": 3.9836010932922363,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "arthralgia and conjunctivitis, there have been reports of more severe reactions that are associated with neurological complications",
            "probability": 0.03999461432860717,
            "start_logit": 4.590908050537109,
            "end_logit": 3.5226919651031494,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "arthralgia, and conjunctivitis",
            "probability": 0.0380869648621194,
            "start_logit": 4.0559515953063965,
            "end_logit": 4.00877571105957,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "conjunctivitis (1).* Zika virus infection during pregnancy is a cause of microcephaly",
            "probability": 0.03802270096577964,
            "start_logit": 4.148686408996582,
            "end_logit": 3.9143521785736084,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "fever, maculopapular rash, arthralgia and conjunctivitis",
            "probability": 0.037636705159206967,
            "start_logit": 3.444108486175537,
            "end_logit": 4.608726501464844,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "Guillain-Barr\u00e9 syndrome",
            "probability": 0.03516760586013844,
            "start_logit": 3.760063648223877,
            "end_logit": 4.224916934967041,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "arthralgia, and conjunctivitis (1).* Zika virus infection during pregnancy is a cause of microcephaly",
            "probability": 0.03465522685701264,
            "start_logit": 4.0559515953063965,
            "end_logit": 3.9143521785736084,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "microcephaly and other severe brain defects (2). Infection has also been associated with Guillain-Barr\u00e9 syndrome",
            "probability": 0.03313301650689418,
            "start_logit": 3.7004685401916504,
            "end_logit": 4.224916934967041,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "fever, maculopapular rash, arthralgia",
            "probability": 0.027642977575721307,
            "start_logit": 3.444108486175537,
            "end_logit": 4.300118446350098,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "microcephaly and other severe brain defects",
            "probability": 0.026029081211911293,
            "start_logit": 3.7004685401916504,
            "end_logit": 3.9836010932922363,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "microcephaly",
            "probability": 0.02428758966197801,
            "start_logit": 3.7004685401916504,
            "end_logit": 3.9143521785736084,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "fever, maculopapular rash",
            "probability": 0.022856123653806747,
            "start_logit": 3.444108486175537,
            "end_logit": 4.109965801239014,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "brain defects (2). Infection has also been associated with Guillain-Barr\u00e9 syndrome",
            "probability": 0.022221778201976367,
            "start_logit": 3.301011085510254,
            "end_logit": 4.224916934967041,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        }
    ],
    "58a80bc838c171fb5b000001": [
        {
            "text": "Cdk1",
            "probability": 0.6023296416797342,
            "start_logit": 5.8621368408203125,
            "end_logit": 5.767376899719238,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Plk1, albeit at distinctive sites.Likewise, we find that phosphorylation of Bora by Cdk1",
            "probability": 0.20072552152552972,
            "start_logit": 4.763270378112793,
            "end_logit": 5.767376899719238,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Plk1",
            "probability": 0.052052644586791166,
            "start_logit": 4.763270378112793,
            "end_logit": 4.417694091796875,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Aurora A and Plk1",
            "probability": 0.043443712369686624,
            "start_logit": 4.5824809074401855,
            "end_logit": 4.417694091796875,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Aurora A suggesting that this mechanism is conserved in humans. we show that the master mitotic kinase Cdk1",
            "probability": 0.021333269484136996,
            "start_logit": 3.4617724418640137,
            "end_logit": 4.82720422744751,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 contributes to Plk1",
            "probability": 0.019397251828664436,
            "start_logit": 5.10624885559082,
            "end_logit": 3.0875914096832275,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 promotes phosphorylation of human Plk1 by Aurora A",
            "probability": 0.016985489638143766,
            "start_logit": 5.8621368408203125,
            "end_logit": 2.1989314556121826,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Aurora A",
            "probability": 0.010891300633604295,
            "start_logit": 4.5824809074401855,
            "end_logit": 3.0341923236846924,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 promotes phosphorylation of human Plk1 by Aurora",
            "probability": 0.006203300340032915,
            "start_logit": 5.8621368408203125,
            "end_logit": 1.1916534900665283,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 contributes to Plk1 activation through SPAT-1",
            "probability": 0.0054159243485176235,
            "start_logit": 5.10624885559082,
            "end_logit": 1.8118035793304443,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "SPAT-1/Bora phosphorylationthe potential role of Bora phosphorylation by Cdk1",
            "probability": 0.00450851616578363,
            "start_logit": 0.99451744556427,
            "end_logit": 5.740159511566162,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 promotes phosphorylation of human Plk1",
            "probability": 0.0040546359854351935,
            "start_logit": 5.8621368408203125,
            "end_logit": 0.7664329409599304,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Aurora A suggesting that this mechanism is conserved in humans. we show that the master mitotic kinase Cdk1 contributes to Plk1",
            "probability": 0.0037458740614840086,
            "start_logit": 3.4617724418640137,
            "end_logit": 3.0875914096832275,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Aurora",
            "probability": 0.0015698297725473087,
            "start_logit": 4.5824809074401855,
            "end_logit": 1.0971951484680176,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Plk1 activation through SPAT-1",
            "probability": 0.0014381343619298574,
            "start_logit": 3.780251979827881,
            "end_logit": 1.8118035793304443,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "mitotic kinase Cdk1",
            "probability": 0.001260687118783767,
            "start_logit": 0.6331615447998047,
            "end_logit": 4.82720422744751,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 in this processphosphorylation of Bora on the Cdk consensus site T52",
            "probability": 0.0012418421892502745,
            "start_logit": 5.883384704589844,
            "end_logit": -0.43807992339134216,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk",
            "probability": 0.0011992518818271104,
            "start_logit": 5.8621368408203125,
            "end_logit": -0.45173004269599915,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 in this processphosphorylation of Bora on the Cdk",
            "probability": 0.0011896626516960604,
            "start_logit": 5.883384704589844,
            "end_logit": -0.48100605607032776,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Plk1,",
            "probability": 0.0010135093764212122,
            "start_logit": 4.763270378112793,
            "end_logit": 0.4788574278354645,
            "question_text": "List kinases that phosphorylates the protein Bora."
        }
    ],
    "58a94483ee23e0236b000003": [
        {
            "text": "IV",
            "probability": 0.3858716186477642,
            "start_logit": 1.3171517848968506,
            "end_logit": 0.8915653824806213,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "Ib, and IV",
            "probability": 0.14182385430647154,
            "start_logit": 0.3162328898906708,
            "end_logit": 0.8915653824806213,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "Ib",
            "probability": 0.10075048066625043,
            "start_logit": 0.3162328898906708,
            "end_logit": 0.5496265292167664,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "II, Ib, and IV",
            "probability": 0.07040865845878391,
            "start_logit": -0.38403668999671936,
            "end_logit": 0.8915653824806213,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "IV to be associated with disease (periodontitis",
            "probability": 0.0660883654833816,
            "start_logit": 1.3171517848968506,
            "end_logit": -0.8729466199874878,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "II, Ib",
            "probability": 0.05001772245915226,
            "start_logit": -0.38403668999671936,
            "end_logit": 0.5496265292167664,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "IV to be associated with disease (periodontitis and cardiovascular disease",
            "probability": 0.031035028990514402,
            "start_logit": 1.3171517848968506,
            "end_logit": -1.6288228034973145,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "II",
            "probability": 0.02704219033340339,
            "start_logit": -0.38403668999671936,
            "end_logit": -0.06535261124372482,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "genotypes II, Ib, and IV",
            "probability": 0.02523244742060899,
            "start_logit": -1.4102221727371216,
            "end_logit": 0.8915653824806213,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "Ib, and IV to be associated with disease (periodontitis",
            "probability": 0.024290220541521194,
            "start_logit": 0.3162328898906708,
            "end_logit": -0.8729466199874878,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "genotypes II, Ib",
            "probability": 0.017924919742476956,
            "start_logit": -1.4102221727371216,
            "end_logit": 0.5496265292167664,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "II, Ib, and IV to be associated with disease (periodontitis",
            "probability": 0.012058915267531714,
            "start_logit": -0.38403668999671936,
            "end_logit": -0.8729466199874878,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "Ib, and IV to be associated with disease (periodontitis and cardiovascular disease",
            "probability": 0.011406662779118955,
            "start_logit": 0.3162328898906708,
            "end_logit": -1.6288228034973145,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "genotypes II",
            "probability": 0.009691146808671733,
            "start_logit": -1.4102221727371216,
            "end_logit": -0.06535261124372482,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "periodontitis",
            "probability": 0.0067111428655036295,
            "start_logit": -0.9700716733932495,
            "end_logit": -0.8729466199874878,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "II, Ib, and IV to be associated with disease (periodontitis and cardiovascular disease",
            "probability": 0.005662854304001679,
            "start_logit": -0.38403668999671936,
            "end_logit": -1.6288228034973145,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "genotypes II, Ib, and IV to be associated with disease (periodontitis",
            "probability": 0.004321569990084261,
            "start_logit": -1.4102221727371216,
            "end_logit": -0.8729466199874878,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "V",
            "probability": 0.0034552734725946783,
            "start_logit": -3.398451328277588,
            "end_logit": 0.8915653824806213,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "periodontitis and cardiovascular disease",
            "probability": 0.003151545841192921,
            "start_logit": -0.9700716733932495,
            "end_logit": -1.6288228034973145,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "IV to be associated with disease (periodontitis and cardiovascular disease)",
            "probability": 0.003055381620971234,
            "start_logit": 1.3171517848968506,
            "end_logit": -3.9470348358154297,
            "question_text": "Which fimA genotypes are associated with disease?"
        }
    ],
    "58bd645702b8c60953000010": [
        {
            "text": "Gordon syndrome",
            "probability": 0.22241859714218715,
            "start_logit": 6.557749271392822,
            "end_logit": 6.742490768432617,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome, Marden-Walker syndrome",
            "probability": 0.2042250529692053,
            "start_logit": 6.557749271392822,
            "end_logit": 6.65715217590332,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5",
            "probability": 0.1424946519845713,
            "start_logit": 6.557749271392822,
            "end_logit": 6.297234058380127,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Marden-Walker syndrome",
            "probability": 0.11495067893917861,
            "start_logit": 5.983029842376709,
            "end_logit": 6.65715217590332,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type 5",
            "probability": 0.10782270371782,
            "start_logit": 6.278933048248291,
            "end_logit": 6.297234058380127,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Marden-Walker syndrome, and distal arthrogryposis type 5",
            "probability": 0.08020493447147416,
            "start_logit": 5.983029842376709,
            "end_logit": 6.297234058380127,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Marden-Walker syndrome.Mutations in PIEZO2 cause Gordon syndrome",
            "probability": 0.030316577133035715,
            "start_logit": 4.564882755279541,
            "end_logit": 6.742490768432617,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Marden-Walker syndrome.Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome",
            "probability": 0.027836721615869166,
            "start_logit": 4.564882755279541,
            "end_logit": 6.65715217590332,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type 5 and Marden-Walker syndrome.Mutations in PIEZO2 cause Gordon syndrome",
            "probability": 0.022430086326942746,
            "start_logit": 4.263591289520264,
            "end_logit": 6.742490768432617,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis",
            "probability": 0.013976304106058393,
            "start_logit": 6.557749271392822,
            "end_logit": 3.975292921066284,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis",
            "probability": 0.010575575123063934,
            "start_logit": 6.278933048248291,
            "end_logit": 3.975292921066284,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Marden-Walker syndrome, and distal arthrogryposis",
            "probability": 0.007866741238128586,
            "start_logit": 5.983029842376709,
            "end_logit": 3.975292921066284,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type 5 and Marden-Walker syndrome",
            "probability": 0.003718826026812403,
            "start_logit": 4.263591289520264,
            "end_logit": 4.94549560546875,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome, Marden-Walker syndrome,",
            "probability": 0.002389215099818342,
            "start_logit": 6.557749271392822,
            "end_logit": 2.2088944911956787,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5.",
            "probability": 0.002332640700468868,
            "start_logit": 6.557749271392822,
            "end_logit": 2.1849305629730225,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type 5.",
            "probability": 0.0017650601171615582,
            "start_logit": 6.278933048248291,
            "end_logit": 2.1849305629730225,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Marden-Walker syndrome,",
            "probability": 0.0013448002282916219,
            "start_logit": 5.983029842376709,
            "end_logit": 2.2088944911956787,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Marden-Walker syndrome, and distal arthrogryposis type 5.",
            "probability": 0.001312956605184427,
            "start_logit": 5.983029842376709,
            "end_logit": 2.1849305629730225,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome, Marden-Walker",
            "probability": 0.0010300768591108708,
            "start_logit": 6.557749271392822,
            "end_logit": 1.367563009262085,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome,",
            "probability": 0.0009877995956170606,
            "start_logit": 6.557749271392822,
            "end_logit": 1.325654149055481,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        }
    ],
    "58bc666702b8c60953000004": [
        {
            "text": "Parkinson's disease",
            "probability": 0.22077911809771694,
            "start_logit": 4.6164870262146,
            "end_logit": 4.398967266082764,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's disease (PD), and Alzheimer's disease",
            "probability": 0.21805666417109162,
            "start_logit": 4.6164870262146,
            "end_logit": 4.38655948638916,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Alzheimer's disease",
            "probability": 0.21227301687784159,
            "start_logit": 4.589605331420898,
            "end_logit": 4.38655948638916,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS), Parkinson's disease",
            "probability": 0.11727931243382035,
            "start_logit": 3.9838826656341553,
            "end_logit": 4.398967266082764,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis",
            "probability": 0.1003420591999094,
            "start_logit": 3.9838826656341553,
            "end_logit": 4.2429938316345215,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's-Linked \u03b1-Synuclein",
            "probability": 0.03758526210457492,
            "start_logit": 3.9282968044281006,
            "end_logit": 3.3166067600250244,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Alzheimer's disease (AD).Human Hsp70 Disaggregase Reverses Parkinson's",
            "probability": 0.030219088381603258,
            "start_logit": 4.589605331420898,
            "end_logit": 2.437160015106201,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's",
            "probability": 0.015598351932696916,
            "start_logit": 3.9282968044281006,
            "end_logit": 2.437160015106201,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 0.010188173743859708,
            "start_logit": 4.6164870262146,
            "end_logit": 1.3230321407318115,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS)",
            "probability": 0.009439761218641485,
            "start_logit": 3.9838826656341553,
            "end_logit": 1.879339575767517,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD)",
            "probability": 0.005412024569766247,
            "start_logit": 3.9838826656341553,
            "end_logit": 1.3230321407318115,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's disease (PD), and Alzheimer's",
            "probability": 0.00440445546299874,
            "start_logit": 4.6164870262146,
            "end_logit": 0.48442116379737854,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Alzheimer's",
            "probability": 0.004287633457059835,
            "start_logit": 4.589605331420898,
            "end_logit": 0.48442116379737854,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "\u03b1-Synuclein",
            "probability": 0.004017173112451939,
            "start_logit": 1.6922632455825806,
            "end_logit": 3.3166067600250244,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS), Parkinson's",
            "probability": 0.002452845563806203,
            "start_logit": 3.9838826656341553,
            "end_logit": 0.5316576957702637,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Alzheimer's",
            "probability": 0.0023396755671306296,
            "start_logit": 3.9838826656341553,
            "end_logit": 0.48442116379737854,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's disease (PD), and Alzheimer's disease (AD)",
            "probability": 0.0017666727346494348,
            "start_logit": 4.6164870262146,
            "end_logit": -0.4290975034236908,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Alzheimer's disease (AD)",
            "probability": 0.001719814217306453,
            "start_logit": 4.589605331420898,
            "end_logit": -0.4290975034236908,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's-Linked \u03b1-Synuclein Amyloid Fibrils",
            "probability": 0.0014069495617000962,
            "start_logit": 3.9282968044281006,
            "end_logit": 0.031418681144714355,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Alzheimer's disease (AD).Human Hsp70 Disaggregase",
            "probability": 0.0004319475913745679,
            "start_logit": 4.589605331420898,
            "end_logit": -1.8107647895812988,
            "question_text": "List diseases that could be targeted by disaggregases?"
        }
    ],
    "58bbb71f22d3005309000016": [
        {
            "text": "RMBase",
            "probability": 0.5914156105818668,
            "start_logit": 3.3636369705200195,
            "end_logit": 3.513329267501831,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase (RNA Modification Base, http://mirlab.sysu.edu.cn/rmbase",
            "probability": 0.18473883322358675,
            "start_logit": 3.3636369705200195,
            "end_logit": 2.3497533798217773,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "MODOMICS databaseMODOMICS",
            "probability": 0.11915163607166811,
            "start_logit": 2.6676690578460693,
            "end_logit": 2.60717511177063,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "MODOMICS",
            "probability": 0.03787790418833401,
            "start_logit": 2.6676690578460693,
            "end_logit": 1.4611461162567139,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "rmbase",
            "probability": 0.029292488968935253,
            "start_logit": 1.5220249891281128,
            "end_logit": 2.3497533798217773,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Modification Base, http://mirlab.sysu.edu.cn/rmbase",
            "probability": 0.0071030803981486325,
            "start_logit": 0.10522240400314331,
            "end_logit": 2.3497533798217773,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase (RNA Modification Base,",
            "probability": 0.004472453765200284,
            "start_logit": 3.3636369705200195,
            "end_logit": -1.3712525367736816,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "the MODOMICS databaseMODOMICS",
            "probability": 0.0032791737640174515,
            "start_logit": -0.925136387348175,
            "end_logit": 2.60717511177063,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "MODOMICS database",
            "probability": 0.0029089860129014487,
            "start_logit": 2.6676690578460693,
            "end_logit": -1.105417251586914,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "databaseMODOMICS",
            "probability": 0.0027701304980388506,
            "start_logit": -1.0938334465026855,
            "end_logit": 2.60717511177063,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "novel resource, RMBase",
            "probability": 0.002718075085961089,
            "start_logit": -2.01895809173584,
            "end_logit": 3.513329267501831,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "a novel resource, RMBase",
            "probability": 0.0024890485191944056,
            "start_logit": -2.1069815158843994,
            "end_logit": 3.513329267501831,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase (RNA Modification Base",
            "probability": 0.002195181331537718,
            "start_logit": 3.3636369705200195,
            "end_logit": -2.0829250812530518,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "mirlab.sysu.edu.cn/rmbase",
            "probability": 0.0014964108773451287,
            "start_logit": -1.4522366523742676,
            "end_logit": 2.3497533798217773,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "developed a novel resource, RMBase",
            "probability": 0.0014821389155759788,
            "start_logit": -2.6253957748413086,
            "end_logit": 3.513329267501831,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase: a resource for decoding the landscape of RNA modifications from high-throughput sequencing data.we developed a novel resource",
            "probability": 0.0014092175501284655,
            "start_logit": 2.297408103942871,
            "end_logit": -1.4599262475967407,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase (",
            "probability": 0.00135647469516364,
            "start_logit": 3.3636369705200195,
            "end_logit": -2.564300537109375,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA modification from the MODOMICS databaseMODOMICS",
            "probability": 0.0012888493501938155,
            "start_logit": -1.858978033065796,
            "end_logit": 2.60717511177063,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "rmbase/),",
            "probability": 0.001282304553877662,
            "start_logit": 1.5220249891281128,
            "end_logit": -0.7789188623428345,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "a resource for decoding the landscape of RNA modifications from high-throughput sequencing data.we developed a novel resource, RMBase",
            "probability": 0.0012720016483246002,
            "start_logit": -2.778290271759033,
            "end_logit": 3.513329267501831,
            "question_text": "List RNA modifications databases"
        }
    ],
    "58bc9a5002b8c60953000008": [
        {
            "text": "elevated liver enzymes",
            "probability": 0.2451231520825577,
            "start_logit": 5.60966157913208,
            "end_logit": 5.650413990020752,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis, elevated liver enzymes",
            "probability": 0.16181700509838173,
            "start_logit": 5.194366931915283,
            "end_logit": 5.650413990020752,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver enzymes, low platelets",
            "probability": 0.15852624118247113,
            "start_logit": 5.60966157913208,
            "end_logit": 5.214573383331299,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis, elevated liver enzymes, low platelets",
            "probability": 0.10465042310247188,
            "start_logit": 5.194366931915283,
            "end_logit": 5.214573383331299,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "low platelets",
            "probability": 0.08864823719035451,
            "start_logit": 5.028417587280273,
            "end_logit": 5.214573383331299,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis",
            "probability": 0.06428792525568626,
            "start_logit": 5.194366931915283,
            "end_logit": 4.727319717407227,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "liver enzymes",
            "probability": 0.03215654885488208,
            "start_logit": 4.411192417144775,
            "end_logit": 4.8177385330200195,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver enzymes, and low platelet count",
            "probability": 0.025167267434114734,
            "start_logit": 4.768139362335205,
            "end_logit": 4.215719699859619,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver enzymes, and low platelets",
            "probability": 0.019755766641317733,
            "start_logit": 4.693541049957275,
            "end_logit": 4.048219203948975,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis, elevated liver enzymes, and low platelet count",
            "probability": 0.018394600784673143,
            "start_logit": 4.454652309417725,
            "end_logit": 4.215719699859619,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis, elevated liver enzymes, and low platelets",
            "probability": 0.01520564284991525,
            "start_logit": 4.431762218475342,
            "end_logit": 4.048219203948975,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver enzymes and low platelets",
            "probability": 0.014728172261982036,
            "start_logit": 4.828024387359619,
            "end_logit": 3.6200525760650635,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "low platelet count",
            "probability": 0.014353285054802998,
            "start_logit": 4.206573963165283,
            "end_logit": 4.215719699859619,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "liver enzymes, low platelets",
            "probability": 0.014026177877491929,
            "start_logit": 3.184666872024536,
            "end_logit": 5.214573383331299,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "liver enzymes and low platelets",
            "probability": 0.009707804696486926,
            "start_logit": 4.411192417144775,
            "end_logit": 3.6200525760650635,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolytic anemia, elevated liver enzymes",
            "probability": 0.005632936042541186,
            "start_logit": 2.9892807006835938,
            "end_logit": 4.497664928436279,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "liver enzymes, and low platelet count",
            "probability": 0.00275609535264491,
            "start_logit": 2.556410074234009,
            "end_logit": 4.215719699859619,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver enzymes by intravascular breakdown of fibrin in hepatic sinusoids",
            "probability": 0.002679983245629096,
            "start_logit": 4.664546966552734,
            "end_logit": 2.079578399658203,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.0016355757489541808,
            "start_logit": 2.9892807006835938,
            "end_logit": 3.261029005050659,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "liver enzymes by intravascular breakdown of fibrin in hepatic sinusoids",
            "probability": 0.0007471592426401497,
            "start_logit": 3.3872594833374023,
            "end_logit": 2.079578399658203,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        }
    ],
    "58bbbe6822d300530900001a": [
        {
            "text": "Proteobacteria",
            "probability": 0.19748629358288758,
            "start_logit": 5.329341411590576,
            "end_logit": 5.467160224914551,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes, 43.7%; Proteobacteria",
            "probability": 0.12191802268442908,
            "start_logit": 4.847021102905273,
            "end_logit": 5.467160224914551,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bacteroidetes",
            "probability": 0.11944315697220965,
            "start_logit": 5.351618766784668,
            "end_logit": 4.942054271697998,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Proteobacteria, 28.7%; Bacteroidetes",
            "probability": 0.11681169912693125,
            "start_logit": 5.329341411590576,
            "end_logit": 4.942054271697998,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes",
            "probability": 0.09872511492422954,
            "start_logit": 4.847021102905273,
            "end_logit": 5.256150722503662,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bacteroidetes, 25.3%; Spirochea",
            "probability": 0.07665949283291448,
            "start_logit": 5.351618766784668,
            "end_logit": 4.498587131500244,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Proteobacteria, 28.7%; Bacteroidetes, 25.3%; Spirochea",
            "probability": 0.07497060391751877,
            "start_logit": 5.329341411590576,
            "end_logit": 4.498587131500244,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes, 43.7%; Proteobacteria, 28.7%; Bacteroidetes",
            "probability": 0.07211361925726043,
            "start_logit": 4.847021102905273,
            "end_logit": 4.942054271697998,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Spirochea",
            "probability": 0.04412286374418084,
            "start_logit": 4.79922342300415,
            "end_logit": 4.498587131500244,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bacteroidetes, 25.3%; Spirochea, 1.1%, and Synergistes",
            "probability": 0.03197257214147419,
            "start_logit": 5.351618766784668,
            "end_logit": 3.6240921020507812,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Spirochea, 1.1%, and Synergistes",
            "probability": 0.018402436436985546,
            "start_logit": 4.79922342300415,
            "end_logit": 3.6240921020507812,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Synergistes",
            "probability": 0.00821018048737639,
            "start_logit": 3.9921152591705322,
            "end_logit": 3.6240921020507812,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Synergistes, 1.1%) were recovered, alterations in the gut microbiota (increased Firmicutes",
            "probability": 0.007318638037257812,
            "start_logit": 3.9921152591705322,
            "end_logit": 3.509141445159912,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bacteroidetes and Proteobacteria",
            "probability": 0.004436452830213054,
            "start_logit": 3.365607738494873,
            "end_logit": 3.635079860687256,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Proteobacteria phyla. Specifically, intermittent hypoxia-exposed mice showed a higher abundance of Firmicutes",
            "probability": 0.003796803271045791,
            "start_logit": 3.5741195678710938,
            "end_logit": 3.2708723545074463,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes and a smaller abundance of Bacteroidetes and Proteobacteria",
            "probability": 0.0011762800365819562,
            "start_logit": 2.875239849090576,
            "end_logit": 2.7979495525360107,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Proteobacteria, 28.7%;",
            "probability": 0.0006676262772048794,
            "start_logit": 5.329341411590576,
            "end_logit": -0.22253568470478058,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes and a smaller abundance of Bacteroidetes",
            "probability": 0.0006000183610791638,
            "start_logit": 2.875239849090576,
            "end_logit": 2.1247975826263428,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bacteroidetes,",
            "probability": 0.000590567954389198,
            "start_logit": 5.351618766784668,
            "end_logit": -0.3674568831920624,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Proteobacteria, 28.7%; Bacteroidetes,",
            "probability": 0.0005775571238306165,
            "start_logit": 5.329341411590576,
            "end_logit": -0.3674568831920624,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        }
    ],
    "58b53bf722d3005309000004": [
        {
            "text": "orofacial edema, recurrent facial paralysis, and a fissured tongue",
            "probability": 0.137134050711248,
            "start_logit": 4.867236137390137,
            "end_logit": 5.533823490142822,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial paralysis, and a fissured tongue",
            "probability": 0.11245521848466929,
            "start_logit": 4.668832302093506,
            "end_logit": 5.533823490142822,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "orofacial edema, recurrent facial paralysis",
            "probability": 0.10807675852529489,
            "start_logit": 4.867236137390137,
            "end_logit": 5.295706272125244,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "fissured tongue",
            "probability": 0.10735792716798845,
            "start_logit": 4.622445583343506,
            "end_logit": 5.533823490142822,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial paralysis",
            "probability": 0.08862711653335563,
            "start_logit": 4.668832302093506,
            "end_logit": 5.295706272125244,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "orofacial edema",
            "probability": 0.08376894574116361,
            "start_logit": 4.867236137390137,
            "end_logit": 5.040926933288574,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial oedema",
            "probability": 0.06286710682651704,
            "start_logit": 4.656193733215332,
            "end_logit": 4.964930057525635,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "recurrent facial paralysis, and a fissured tongue",
            "probability": 0.0470792145306877,
            "start_logit": 3.7981088161468506,
            "end_logit": 5.533823490142822,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "recurrent facial paralysis",
            "probability": 0.037103614120663805,
            "start_logit": 3.7981088161468506,
            "end_logit": 5.295706272125244,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "lingua plicata and facial oedema",
            "probability": 0.033665423775009085,
            "start_logit": 4.031641960144043,
            "end_logit": 4.964930057525635,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "fissured tongue, and intermittent facial palsy",
            "probability": 0.03244395197522827,
            "start_logit": 4.392995357513428,
            "end_logit": 4.566619396209717,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial nerve palsy, lingua plicata and facial oedema",
            "probability": 0.030714819108219646,
            "start_logit": 3.939915895462036,
            "end_logit": 4.964930057525635,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial nerve palsy",
            "probability": 0.02153102432009851,
            "start_logit": 3.939915895462036,
            "end_logit": 4.609679698944092,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy",
            "probability": 0.02002546892724648,
            "start_logit": 3.9104862213134766,
            "end_logit": 4.566619396209717,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "a fissured tongue",
            "probability": 0.017039123549958544,
            "start_logit": 2.7817893028259277,
            "end_logit": 5.533823490142822,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "lingua plicata",
            "probability": 0.015733010277569955,
            "start_logit": 4.031641960144043,
            "end_logit": 4.204219818115234,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial nerve palsy, lingua plicata",
            "probability": 0.01435409124604704,
            "start_logit": 3.939915895462036,
            "end_logit": 4.204219818115234,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy, lingua plicata (fissured tongue), and orofacial edema",
            "probability": 0.011586564471940983,
            "start_logit": 3.8288426399230957,
            "end_logit": 4.101104259490967,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "face swelling, fissured tongue",
            "probability": 0.009597005937479924,
            "start_logit": 3.055778980255127,
            "end_logit": 4.685772895812988,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "furrowed tongue",
            "probability": 0.008839563769613267,
            "start_logit": 3.79581356048584,
            "end_logit": 3.8635246753692627,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        }
    ],
    "58850e50e56acf5176000013": [
        {
            "text": "Glasgow Coma Scale",
            "probability": 0.12513155958126876,
            "start_logit": 2.618046760559082,
            "end_logit": 2.2939910888671875,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Glasgow Coma Scale, ICH location, volume",
            "probability": 0.11592641140116582,
            "start_logit": 2.618046760559082,
            "end_logit": 2.217581033706665,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Age",
            "probability": 0.09817928639297269,
            "start_logit": 2.2702786922454834,
            "end_logit": 2.399188756942749,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Age, Glasgow Coma Scale",
            "probability": 0.08837574835885706,
            "start_logit": 2.2702786922454834,
            "end_logit": 2.2939910888671875,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Glasgow Coma Scale, ICH location",
            "probability": 0.08593511959718217,
            "start_logit": 2.618046760559082,
            "end_logit": 1.9182180166244507,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Age, Glasgow Coma Scale, ICH location, volume",
            "probability": 0.08187449590189859,
            "start_logit": 2.2702786922454834,
            "end_logit": 2.217581033706665,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "pre-ICH cognitive impairment",
            "probability": 0.061575157380505195,
            "start_logit": 2.170797824859619,
            "end_logit": 2.032132863998413,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Age, Glasgow Coma Scale, ICH location",
            "probability": 0.06069276631828785,
            "start_logit": 2.2702786922454834,
            "end_logit": 1.9182180166244507,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "volume",
            "probability": 0.0476938590427408,
            "start_logit": 1.7298938035964966,
            "end_logit": 2.217581033706665,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "volume (all P<0.0001), and pre-ICH cognitive impairment",
            "probability": 0.039620809737485656,
            "start_logit": 1.7298938035964966,
            "end_logit": 2.032132863998413,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "cognitive impairment",
            "probability": 0.029404000742216618,
            "start_logit": 1.431670069694519,
            "end_logit": 2.032132863998413,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Coma Scale",
            "probability": 0.028639405506274244,
            "start_logit": 1.1434646844863892,
            "end_logit": 2.2939910888671875,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Coma Scale, ICH location, volume",
            "probability": 0.026532583115843698,
            "start_logit": 1.1434646844863892,
            "end_logit": 2.217581033706665,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Coma Scale, ICH location, volume (all P<0.0001), and pre-ICH cognitive impairment",
            "probability": 0.02204146295930463,
            "start_logit": 1.1434646844863892,
            "end_logit": 2.032132863998413,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Coma Scale, ICH location",
            "probability": 0.01966834542468443,
            "start_logit": 1.1434646844863892,
            "end_logit": 1.9182180166244507,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "ICH location, volume",
            "probability": 0.019639537904238686,
            "start_logit": 0.8426359295845032,
            "end_logit": 2.217581033706665,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "ICH location, volume (all P<0.0001), and pre-ICH cognitive impairment",
            "probability": 0.01631519047218751,
            "start_logit": 0.8426359295845032,
            "end_logit": 2.032132863998413,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "ICH location",
            "probability": 0.014558598150629645,
            "start_logit": 0.8426359295845032,
            "end_logit": 1.9182180166244507,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Glasgow Coma",
            "probability": 0.010664045119456728,
            "start_logit": 2.618046760559082,
            "end_logit": -0.1684967577457428,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "Age, Glasgow Coma",
            "probability": 0.007531616892799298,
            "start_logit": 2.2702786922454834,
            "end_logit": -0.1684967577457428,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        }
    ],
    "589dee3778275d0c4a000050": [
        {
            "text": "ALK2",
            "probability": 0.29670832188471624,
            "start_logit": 5.066548824310303,
            "end_logit": 4.8011860847473145,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "ALK2 (ACVR1",
            "probability": 0.13016130498104564,
            "start_logit": 5.066548824310303,
            "end_logit": 3.9772109985351562,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP) receptor kinase ALK2",
            "probability": 0.12554324230269437,
            "start_logit": 4.206449508666992,
            "end_logit": 4.8011860847473145,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "ALK2 (ACVR1)",
            "probability": 0.06654035321444622,
            "start_logit": 5.066548824310303,
            "end_logit": 3.3062450885772705,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "bone morphogenetic protein (BMP) receptor kinase ALK2",
            "probability": 0.06634474697893475,
            "start_logit": 3.5686638355255127,
            "end_logit": 4.8011860847473145,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "ACVR1",
            "probability": 0.06359128200161514,
            "start_logit": 4.350250720977783,
            "end_logit": 3.9772109985351562,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP) receptor kinase ALK2 (ACVR1",
            "probability": 0.05507385888562786,
            "start_logit": 4.206449508666992,
            "end_logit": 3.9772109985351562,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP",
            "probability": 0.04338162901497355,
            "start_logit": 4.206449508666992,
            "end_logit": 3.738571882247925,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "ACVR1)",
            "probability": 0.0325087887399647,
            "start_logit": 4.350250720977783,
            "end_logit": 3.3062450885772705,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "bone morphogenetic protein (BMP) receptor kinase ALK2 (ACVR1",
            "probability": 0.02910440391614866,
            "start_logit": 3.5686638355255127,
            "end_logit": 3.9772109985351562,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP) receptor kinase ALK2 (ACVR1)",
            "probability": 0.028154558097476794,
            "start_logit": 4.206449508666992,
            "end_logit": 3.3062450885772705,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "bone morphogenetic protein (BMP",
            "probability": 0.022925512737619218,
            "start_logit": 3.5686638355255127,
            "end_logit": 3.738571882247925,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "bone morphogenetic protein (BMP) receptor kinase ALK2 (ACVR1)",
            "probability": 0.014878594809405591,
            "start_logit": 3.5686638355255127,
            "end_logit": 3.3062450885772705,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP)",
            "probability": 0.009361526282864446,
            "start_logit": 4.206449508666992,
            "end_logit": 2.205144166946411,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "bone morphogenetic protein (BMP)",
            "probability": 0.004947204494494401,
            "start_logit": 3.5686638355255127,
            "end_logit": 2.205144166946411,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "bone morphogenetic protein",
            "probability": 0.0029770075428197074,
            "start_logit": 3.5686638355255127,
            "end_logit": 1.6972401142120361,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "ACVR1,",
            "probability": 0.002757626969433254,
            "start_logit": 4.390161037445068,
            "end_logit": 0.7991948127746582,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "bone morphogenetic protein type I receptor. Small molecule inhibitors of the bone morphogenetic protein (BMP",
            "probability": 0.0022916634421308044,
            "start_logit": 1.2656913995742798,
            "end_logit": 3.738571882247925,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "ACVR1, the gene coding for a bone morphogenetic protein type I receptor",
            "probability": 0.0014693497484048752,
            "start_logit": 4.390161037445068,
            "end_logit": 0.16964425146579742,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "receptor kinase ALK2",
            "probability": 0.001279023955183803,
            "start_logit": -0.3801034986972809,
            "end_logit": 4.8011860847473145,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        }
    ],
    "58b52c8822d3005309000001": [
        {
            "text": "Ascher's syndrome",
            "probability": 0.9810496485186146,
            "start_logit": 5.657613754272461,
            "end_logit": 6.632853984832764,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's",
            "probability": 0.015686661822657225,
            "start_logit": 5.657613754272461,
            "end_logit": 2.497041702270508,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "syndrome",
            "probability": 0.0006996234962626609,
            "start_logit": -1.5882222652435303,
            "end_logit": 6.632853984832764,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher",
            "probability": 0.0006411806408744734,
            "start_logit": 5.657613754272461,
            "end_logit": -0.7002131342887878,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "cher's syndrome",
            "probability": 0.0005213761955613995,
            "start_logit": -1.8822927474975586,
            "end_logit": 6.632853984832764,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Waardenburg Syndrome",
            "probability": 0.0002281332629822384,
            "start_logit": 2.261244535446167,
            "end_logit": 1.6627748012542725,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "congenital Horner's syndrome",
            "probability": 0.0002081710141382708,
            "start_logit": 1.6080702543258667,
            "end_logit": 2.224379062652588,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome associated with iris coloboma",
            "probability": 0.00020122866578172616,
            "start_logit": 5.657613754272461,
            "end_logit": -1.8590824604034424,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Horner's syndrome",
            "probability": 0.0001434616175415754,
            "start_logit": 1.2357778549194336,
            "end_logit": 2.224379062652588,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome associated with iris coloboma,",
            "probability": 0.00011205751135183295,
            "start_logit": 5.657613754272461,
            "end_logit": -2.444512128829956,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "this is the first reported case of Ascher's syndrome",
            "probability": 7.133758765651884e-05,
            "start_logit": -3.8713412284851074,
            "end_logit": 6.632853984832764,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "As",
            "probability": 6.28960897362299e-05,
            "start_logit": 5.657613754272461,
            "end_logit": -3.022040367126465,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "s syndrome",
            "probability": 5.9932019339435755e-05,
            "start_logit": -4.045553684234619,
            "end_logit": 6.632853984832764,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome associated",
            "probability": 5.933475267229357e-05,
            "start_logit": 5.657613754272461,
            "end_logit": -3.080329179763794,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "'s syndrome",
            "probability": 5.613455954159063e-05,
            "start_logit": -4.111012935638428,
            "end_logit": 6.632853984832764,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Waardenburg syndrome",
            "probability": 5.159721866154348e-05,
            "start_logit": 1.909374713897705,
            "end_logit": 0.5281824469566345,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "first reported case of Ascher's syndrome",
            "probability": 4.947264305701012e-05,
            "start_logit": -4.237344741821289,
            "end_logit": 6.632853984832764,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome associated with",
            "probability": 4.8242975915491495e-05,
            "start_logit": 5.657613754272461,
            "end_logit": -3.287274122238159,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher'",
            "probability": 2.6850683654802178e-05,
            "start_logit": 5.657613754272461,
            "end_logit": -3.8732330799102783,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Waardenburg",
            "probability": 2.2658723999516208e-05,
            "start_logit": 2.261244535446167,
            "end_logit": -0.6466102004051208,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        }
    ],
    "58a8071760087bc10a000037": [
        {
            "text": "CID and HCD",
            "probability": 0.11057937226467675,
            "start_logit": 4.07350492477417,
            "end_logit": 3.437328338623047,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID-MS/MSECD",
            "probability": 0.07791273483899071,
            "start_logit": 3.90998911857605,
            "end_logit": 3.250699996948242,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD",
            "probability": 0.07727967395678687,
            "start_logit": 3.7152023315429688,
            "end_logit": 3.437328338623047,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD fragmentation techniquesBy integrating HCD-MS/MS, CID-MS/MSECD",
            "probability": 0.06412296892049724,
            "start_logit": 3.7152023315429688,
            "end_logit": 3.250699996948242,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID",
            "probability": 0.0617760428028489,
            "start_logit": 4.07350492477417,
            "end_logit": 2.8551104068756104,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation",
            "probability": 0.061412086623673416,
            "start_logit": 3.665712833404541,
            "end_logit": 3.256993532180786,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID-MS/MSECD and ETD",
            "probability": 0.05551894836880925,
            "start_logit": 3.90998911857605,
            "end_logit": 2.911834955215454,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "collision-induced dissociation (CID), electron transfer dissociation",
            "probability": 0.051801726797366256,
            "start_logit": 3.4955296516418457,
            "end_logit": 3.256993532180786,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD-MS/MS, CID-MS/MSECD",
            "probability": 0.04889016361295241,
            "start_logit": 3.4439759254455566,
            "end_logit": 3.250699996948242,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID and HCD fragmentation techniquesBy integrating HCD",
            "probability": 0.04427702228708946,
            "start_logit": 4.07350492477417,
            "end_logit": 2.5220606327056885,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD), and free-radical initiated peptide sequencing",
            "probability": 0.042983327546485324,
            "start_logit": 3.665712833404541,
            "end_logit": 2.9001991748809814,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "free-radical initiated peptide sequencing",
            "probability": 0.0421531506781824,
            "start_logit": 3.646209955215454,
            "end_logit": 2.9001991748809814,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID and HCD fragmentation techniquesBy integrating HCD-MS/MS",
            "probability": 0.038265599363382384,
            "start_logit": 4.07350492477417,
            "end_logit": 2.376146078109741,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "collision-induced dissociation",
            "probability": 0.03648045910815776,
            "start_logit": 3.4955296516418457,
            "end_logit": 2.9063467979431152,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "collision-induced dissociation (CID), electron transfer dissociation (ETD), and free-radical initiated peptide sequencing",
            "probability": 0.03625687894386601,
            "start_logit": 3.4955296516418457,
            "end_logit": 2.9001991748809814,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD-MS/MS, CID-MS/MSECD and ETD",
            "probability": 0.03483808487764416,
            "start_logit": 3.4439759254455566,
            "end_logit": 2.911834955215454,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD fragmentation techniquesBy integrating HCD",
            "probability": 0.030943509409093326,
            "start_logit": 3.7152023315429688,
            "end_logit": 2.5220606327056885,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID and HCD fragmentation techniquesBy integrating HCD-MS/MS, CID",
            "probability": 0.030357671324853643,
            "start_logit": 4.07350492477417,
            "end_logit": 2.144644021987915,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "photodissociation, ESI collision-induced dissociation (CID), electron transfer dissociation",
            "probability": 0.02740822134133524,
            "start_logit": 2.8589491844177246,
            "end_logit": 3.256993532180786,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD fragmentation techniquesBy integrating HCD-MS/MS",
            "probability": 0.026742356933308876,
            "start_logit": 3.7152023315429688,
            "end_logit": 2.376146078109741,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        }
    ],
    "588f220e3b87a8a73800000d": [
        {
            "text": "CIRCexplorer",
            "probability": 0.1454149454931703,
            "start_logit": 4.195153713226318,
            "end_logit": 3.707040309906006,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "CIRCexplorer, CIRI",
            "probability": 0.1322938046301535,
            "start_logit": 4.195153713226318,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer",
            "probability": 0.1259628560281418,
            "start_logit": 4.051549434661865,
            "end_logit": 3.707040309906006,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI",
            "probability": 0.11459692406119154,
            "start_logit": 4.051549434661865,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "CIRI",
            "probability": 0.11201747097594004,
            "start_logit": 4.028783321380615,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder, find_circ",
            "probability": 0.10659830384746521,
            "start_logit": 4.051549434661865,
            "end_logit": 3.540120840072632,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder",
            "probability": 0.07052941263307913,
            "start_logit": 4.051549434661865,
            "end_logit": 3.1270830631256104,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "find_circ, CIRCexplorer",
            "probability": 0.045886519318401084,
            "start_logit": 3.041733741760254,
            "end_logit": 3.707040309906006,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "find_circ, CIRCexplorer, CIRI",
            "probability": 0.04174606813129418,
            "start_logit": 3.041733741760254,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "find_circ",
            "probability": 0.038832281857063417,
            "start_logit": 3.041733741760254,
            "end_logit": 3.540120840072632,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA",
            "probability": 0.014475387685275093,
            "start_logit": 4.051549434661865,
            "end_logit": 1.5435030460357666,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.013046788122973404,
            "start_logit": 4.195153713226318,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.011301525358278632,
            "start_logit": 4.051549434661865,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "CIRI, and MapSplice",
            "probability": 0.011047140219303229,
            "start_logit": 4.028783321380615,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "find_circ, CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.004116988753924353,
            "start_logit": 3.041733741760254,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNAseq datasets to scrutinize and compare the output from five different algorithms; circRNA_finder",
            "probability": 0.003183816063286572,
            "start_logit": 0.9536001086235046,
            "end_logit": 3.1270830631256104,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circ, CIRCexplorer",
            "probability": 0.002686803236283502,
            "start_logit": 0.20391446352005005,
            "end_logit": 3.707040309906006,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circ, CIRCexplorer, CIRI",
            "probability": 0.002444366507273822,
            "start_logit": 0.20391446352005005,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circ",
            "probability": 0.002273754952775238,
            "start_logit": 0.20391446352005005,
            "end_logit": 3.540120840072632,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "MapSplice",
            "probability": 0.0015448421247258673,
            "start_logit": 2.0615334510803223,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        }
    ],
    "589a245878275d0c4a000025": [
        {
            "text": "Tokuhashi",
            "probability": 0.3169031181138408,
            "start_logit": 4.63160514831543,
            "end_logit": 4.171759605407715,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi scores were investigated.PURPOSE: To assess variability in the use of Tomita",
            "probability": 0.17520695329792998,
            "start_logit": 4.63160514831543,
            "end_logit": 3.5791313648223877,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tomita and Tokuhashi",
            "probability": 0.15083149300954643,
            "start_logit": 3.889172315597534,
            "end_logit": 4.171759605407715,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tomita",
            "probability": 0.1047666221256376,
            "start_logit": 3.889172315597534,
            "end_logit": 3.8073315620422363,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tomita and Tokuhashi scores were investigated.PURPOSE: To assess variability in the use of Tomita",
            "probability": 0.08339055326709473,
            "start_logit": 3.889172315597534,
            "end_logit": 3.5791313648223877,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi scores were investigated.PURPOSE: To assess variability in the use of Tomita and modified Bauer",
            "probability": 0.0711994413727076,
            "start_logit": 4.63160514831543,
            "end_logit": 2.6786484718322754,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tomita and Tokuhashi scores were investigated.PURPOSE: To assess variability in the use of Tomita and modified Bauer",
            "probability": 0.03388770078252545,
            "start_logit": 3.889172315597534,
            "end_logit": 2.6786484718322754,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tomita and modified Bauer",
            "probability": 0.022580873947004976,
            "start_logit": 3.4832234382629395,
            "end_logit": 2.6786484718322754,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Bauer",
            "probability": 0.011104820718628769,
            "start_logit": 2.7734994888305664,
            "end_logit": 2.6786484718322754,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tomita and modified Bauer scores in spine metastases.Only the Tomita",
            "probability": 0.009651051563940178,
            "start_logit": 3.4832234382629395,
            "end_logit": 1.8286120891571045,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "modified Bauer",
            "probability": 0.006939113343169953,
            "start_logit": 2.3032941818237305,
            "end_logit": 2.6786484718322754,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Bauer scores in spine metastases.Only the Tomita",
            "probability": 0.0047461935093974705,
            "start_logit": 2.7734994888305664,
            "end_logit": 1.8286120891571045,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "modified Bauer scores in spine metastases.Only the Tomita",
            "probability": 0.0029657727526458772,
            "start_logit": 2.3032941818237305,
            "end_logit": 1.8286120891571045,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi scores were investigated.PURPOSE: To assess variability in the use of Tomita and modified Bauer scores",
            "probability": 0.0019075173901947717,
            "start_logit": 4.63160514831543,
            "end_logit": -0.9410338997840881,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tomita scoring system was shown to be an independent prognostic factor for overall survival. .CONCLUSION: The Tomita",
            "probability": 0.0016165276820762889,
            "start_logit": 1.5515459775924683,
            "end_logit": 1.9735031127929688,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tomita and Tokuhashi scores were investigated.PURPOSE: To assess variability in the use of Tomita and modified Bauer scores",
            "probability": 0.0009078916535033773,
            "start_logit": 3.889172315597534,
            "end_logit": -0.9410338997840881,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tomita and modified Bauer scores",
            "probability": 0.0006049683664543341,
            "start_logit": 3.4832234382629395,
            "end_logit": -0.9410338997840881,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi scores",
            "probability": 0.0003059687320567124,
            "start_logit": 4.63160514831543,
            "end_logit": -2.771108865737915,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Bauer scores",
            "probability": 0.0002975113038442936,
            "start_logit": 2.7734994888305664,
            "end_logit": -0.9410338997840881,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "modified Bauer scores",
            "probability": 0.00018590706780043808,
            "start_logit": 2.3032941818237305,
            "end_logit": -0.9410338997840881,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        }
    ],
    "589c4c9078275d0c4a000040": [
        {
            "text": "gastrointestinal symptoms",
            "probability": 0.3132278626635055,
            "start_logit": 5.813793659210205,
            "end_logit": 5.696434020996094,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "gastrointestinal symptoms. Treatment Options for Statin-Associated Muscle Symptoms",
            "probability": 0.14343837661472006,
            "start_logit": 5.813793659210205,
            "end_logit": 4.915408611297607,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "muscle complaints and gastrointestinal symptoms",
            "probability": 0.1244252978530523,
            "start_logit": 4.890568256378174,
            "end_logit": 5.696434020996094,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "gastrointestinal symptoms. Treatment Options for Statin-Associated Muscle Symptoms.Muscle symptoms",
            "probability": 0.09110118776506272,
            "start_logit": 5.813793659210205,
            "end_logit": 4.4614739418029785,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "muscle complaints",
            "probability": 0.08132671323480928,
            "start_logit": 4.890568256378174,
            "end_logit": 5.27120304107666,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "muscle complaints and gastrointestinal symptoms. Treatment Options for Statin-Associated Muscle Symptoms",
            "probability": 0.05697884786519744,
            "start_logit": 4.890568256378174,
            "end_logit": 4.915408611297607,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "gastrointestinal",
            "probability": 0.050542638865552186,
            "start_logit": 5.813793659210205,
            "end_logit": 3.8723204135894775,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "muscle complaints and gastrointestinal symptoms. Treatment Options for Statin-Associated Muscle Symptoms.Muscle symptoms",
            "probability": 0.03618864658477734,
            "start_logit": 4.890568256378174,
            "end_logit": 4.4614739418029785,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "Muscle Symptoms",
            "probability": 0.021819379979571583,
            "start_logit": 3.9306867122650146,
            "end_logit": 4.915408611297607,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "Muscle symptoms",
            "probability": 0.02054964535436267,
            "start_logit": 4.324666500091553,
            "end_logit": 4.4614739418029785,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "muscle complaints and gastrointestinal",
            "probability": 0.020077341912208824,
            "start_logit": 4.890568256378174,
            "end_logit": 3.8723204135894775,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "Muscle Symptoms.Muscle symptoms",
            "probability": 0.013858016796825698,
            "start_logit": 3.9306867122650146,
            "end_logit": 4.4614739418029785,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "gastrointestinal symptoms. Treatment Options for Statin-Associated Muscle",
            "probability": 0.00852407362703405,
            "start_logit": 5.813793659210205,
            "end_logit": 2.092397451400757,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "muscle",
            "probability": 0.004384946358582454,
            "start_logit": 4.890568256378174,
            "end_logit": 2.3509058952331543,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "gastrointestinal symptoms. Treatment Options for Statin-Associated Muscle Symptoms.Muscle",
            "probability": 0.003773949192454639,
            "start_logit": 5.813793659210205,
            "end_logit": 1.2776250839233398,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "muscle complaints and gastrointestinal symptoms. Treatment Options for Statin-Associated Muscle",
            "probability": 0.0033860665872641484,
            "start_logit": 4.890568256378174,
            "end_logit": 2.092397451400757,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "muscle symptoms",
            "probability": 0.001963489938084211,
            "start_logit": 2.961244583129883,
            "end_logit": 3.476775646209717,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "gastrointestinal symptoms. Treatment Options for Statin-Associated Muscle Symptoms.",
            "probability": 0.0016377169595176014,
            "start_logit": 5.813793659210205,
            "end_logit": 0.44280627369880676,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "muscle complaints and gastrointestinal symptoms. Treatment Options for Statin-Associated Muscle Symptoms.Muscle",
            "probability": 0.0014991474524662881,
            "start_logit": 4.890568256378174,
            "end_logit": 1.2776250839233398,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "Muscle",
            "probability": 0.0012966543949509118,
            "start_logit": 3.9306867122650146,
            "end_logit": 2.092397451400757,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        }
    ],
    "58962ed178275d0c4a000006": [
        {
            "text": "sacubitril/valsartan",
            "probability": 0.36902736210851866,
            "start_logit": 5.8116583824157715,
            "end_logit": 5.415032863616943,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril",
            "probability": 0.33121920026691687,
            "start_logit": 5.8116583824157715,
            "end_logit": 5.306942462921143,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsartan",
            "probability": 0.2927270099430558,
            "start_logit": 5.580028057098389,
            "end_logit": 5.415032863616943,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "Sacubitril valsartan",
            "probability": 0.001755027882184733,
            "start_logit": 2.9534878730773926,
            "end_logit": 2.9248173236846924,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "Sacubitril",
            "probability": 0.0014411491963805339,
            "start_logit": 2.9534878730773926,
            "end_logit": 2.727773427963257,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril/valsartan (Entresto(\u00ae) ),",
            "probability": 0.0014230077215996945,
            "start_logit": 5.8116583824157715,
            "end_logit": -0.1430651843547821,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsartan (Entresto(\u00ae) ),",
            "probability": 0.0011287856626394674,
            "start_logit": 5.580028057098389,
            "end_logit": -0.1430651843547821,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril/valsart",
            "probability": 0.00032896724531711796,
            "start_logit": 5.8116583824157715,
            "end_logit": -1.6076350212097168,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsart",
            "probability": 0.00026094975055688624,
            "start_logit": 5.580028057098389,
            "end_logit": -1.6076350212097168,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril/valsartan (Entresto\u00ae, Novartis",
            "probability": 0.00011854659994593013,
            "start_logit": 5.346493721008301,
            "end_logit": -2.1631224155426025,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsartan (Entresto\u00ae, Novartis",
            "probability": 9.221062984308665e-05,
            "start_logit": 5.0952630043029785,
            "end_logit": -2.1631224155426025,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril/valsartan (",
            "probability": 7.986499303945678e-05,
            "start_logit": 5.8116583824157715,
            "end_logit": -3.0232555866241455,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril/v",
            "probability": 6.949655095580423e-05,
            "start_logit": 5.8116583824157715,
            "end_logit": -3.162316083908081,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsartan (",
            "probability": 6.335205193995417e-05,
            "start_logit": 5.580028057098389,
            "end_logit": -3.0232555866241455,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "v",
            "probability": 5.5127396099873586e-05,
            "start_logit": 5.580028057098389,
            "end_logit": -3.162316083908081,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "/valsartan",
            "probability": 5.352196840453792e-05,
            "start_logit": -3.0268754959106445,
            "end_logit": 5.415032863616943,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril/valsartan (Entresto\u00ae, Novartis),",
            "probability": 4.4148067913226697e-05,
            "start_logit": 5.346493721008301,
            "end_logit": -3.150879383087158,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "ril/valsartan",
            "probability": 4.1069721278692164e-05,
            "start_logit": -3.291696548461914,
            "end_logit": 5.415032863616943,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "ril",
            "probability": 3.686198269794798e-05,
            "start_logit": -3.291696548461914,
            "end_logit": 5.306942462921143,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsartan (Entresto\u00ae, Novartis),",
            "probability": 3.4340260711743494e-05,
            "start_logit": 5.0952630043029785,
            "end_logit": -3.150879383087158,
            "question_text": "Entresto is composed of which two drugs?"
        }
    ],
    "58ca746d02b8c6095300002d": [
        {
            "text": "adipocytes",
            "probability": 0.5222554516827351,
            "start_logit": 4.700494766235352,
            "end_logit": 3.945323944091797,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "white adipocytes",
            "probability": 0.3739267530036512,
            "start_logit": 4.366397857666016,
            "end_logit": 3.945323944091797,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "mature white adipocytes",
            "probability": 0.09905469708528171,
            "start_logit": 3.0380101203918457,
            "end_logit": 3.945323944091797,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "ad",
            "probability": 0.0009062951276604913,
            "start_logit": 4.700494766235352,
            "end_logit": -2.4112231731414795,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "white ad",
            "probability": 0.0006488931676197955,
            "start_logit": 4.366397857666016,
            "end_logit": -2.4112231731414795,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adip",
            "probability": 0.0005579220145270516,
            "start_logit": 4.700494766235352,
            "end_logit": -2.896368980407715,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "white",
            "probability": 0.00043980568452515724,
            "start_logit": 4.366397857666016,
            "end_logit": -2.8001582622528076,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "white adip",
            "probability": 0.00039946345538216055,
            "start_logit": 4.366397857666016,
            "end_logit": -2.896368980407715,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "FSP27, CIDEC in humans) is a lipid-coating protein highly expressed in mature white adipocytes",
            "probability": 0.00033219272230197684,
            "start_logit": -2.6597020626068115,
            "end_logit": 3.945323944091797,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "ipocytes",
            "probability": 0.00030768296396365617,
            "start_logit": -2.7363474369049072,
            "end_logit": 3.945323944091797,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "ocytes",
            "probability": 0.00029358606550052767,
            "start_logit": -2.7832465171813965,
            "end_logit": 3.945323944091797,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "mature white ad",
            "probability": 0.0001718944034974148,
            "start_logit": 3.0380101203918457,
            "end_logit": -2.4112231731414795,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "mature",
            "probability": 0.00013635684397165007,
            "start_logit": 3.0380101203918457,
            "end_logit": -2.6428282260894775,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "in mature white adipocytes",
            "probability": 0.00011694736503431276,
            "start_logit": -3.703693389892578,
            "end_logit": 3.945323944091797,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "mature white",
            "probability": 0.00011650629035521039,
            "start_logit": 3.0380101203918457,
            "end_logit": -2.8001582622528076,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "mature white adip",
            "probability": 0.00010581947199999753,
            "start_logit": 3.0380101203918457,
            "end_logit": -2.896368980407715,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose tissues",
            "probability": 8.675501620699043e-05,
            "start_logit": 1.078738808631897,
            "end_logit": -1.1357439756393433,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose tissues and promotes formation of fat droplets",
            "probability": 7.671695851403632e-05,
            "start_logit": 1.078738808631897,
            "end_logit": -1.25870943069458,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "fat droplets",
            "probability": 4.624030594221129e-05,
            "start_logit": 0.5724678635597229,
            "end_logit": -1.25870943069458,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose tissue",
            "probability": 2.002037132929141e-05,
            "start_logit": 0.8380310535430908,
            "end_logit": -2.3613741397857666,
            "question_text": "Which cells express CIDEC protein in humans?"
        }
    ],
    "588f952994c1512c50000007": [
        {
            "text": "optic nerve hypoplasia",
            "probability": 0.23666878883828457,
            "start_logit": 5.098770618438721,
            "end_logit": 5.131510257720947,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia.The triad consists of optic nerve hypoplasia",
            "probability": 0.13250182220902423,
            "start_logit": 5.098770618438721,
            "end_logit": 4.551445007324219,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "absent septum pellucidum with optic nerve hypoplasia",
            "probability": 0.12000220447222676,
            "start_logit": 4.419619083404541,
            "end_logit": 5.131510257720947,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia and pituitary endocrine dysfunction. Septo-optic dysplasia",
            "probability": 0.07599939563061707,
            "start_logit": 4.516799449920654,
            "end_logit": 4.577545166015625,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "absent septum pellucidum with optic nerve hypoplasia.The triad consists of optic nerve hypoplasia",
            "probability": 0.06718465429987373,
            "start_logit": 4.419619083404541,
            "end_logit": 4.551445007324219,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia.The triad consists of optic nerve hypoplasia, pituitary hormone abnormalities",
            "probability": 0.058848895352419786,
            "start_logit": 5.098770618438721,
            "end_logit": 3.739821672439575,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "Septo-optic dysplasia",
            "probability": 0.05027065644202117,
            "start_logit": 4.1034955978393555,
            "end_logit": 4.577545166015625,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia, pituitary hormone abnormalities, and midline brain defects",
            "probability": 0.04008416404329145,
            "start_logit": 4.657862663269043,
            "end_logit": 3.7967379093170166,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia, pituitary hormone abnormalities",
            "probability": 0.037866435308832894,
            "start_logit": 4.657862663269043,
            "end_logit": 3.739821672439575,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "absent septum pellucidum",
            "probability": 0.03358613667243974,
            "start_logit": 4.419619083404541,
            "end_logit": 3.8581135272979736,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia and pituitary endocrine dysfunction",
            "probability": 0.02805957808877802,
            "start_logit": 4.516799449920654,
            "end_logit": 3.5811498165130615,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pituitary endocrine dysfunction. Septo-optic dysplasia",
            "probability": 0.027715706330185,
            "start_logit": 3.508073329925537,
            "end_logit": 4.577545166015625,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "midline brain abnormalities, optic nerve hypoplasia",
            "probability": 0.013904829125176243,
            "start_logit": 3.063081741333008,
            "end_logit": 4.332773685455322,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia, absence of the septum pellucidum",
            "probability": 0.0129802420436241,
            "start_logit": 4.16528844833374,
            "end_logit": 3.1617591381073,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pituitary hormone abnormalities, and midline brain defects",
            "probability": 0.012941772857008765,
            "start_logit": 3.527341604232788,
            "end_logit": 3.7967379093170166,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pituitary hormone abnormalities",
            "probability": 0.012225745911583976,
            "start_logit": 3.527341604232788,
            "end_logit": 3.739821672439575,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pituitary endocrine dysfunction",
            "probability": 0.010232858032678422,
            "start_logit": 3.508073329925537,
            "end_logit": 3.5811498165130615,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "an absent septum pellucidum with optic nerve hypoplasia",
            "probability": 0.009702609327186645,
            "start_logit": 1.9045038223266602,
            "end_logit": 5.131510257720947,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "midline brain defect such as an absent septum pellucidum with optic nerve hypoplasia",
            "probability": 0.009686858263621295,
            "start_logit": 1.9028791189193726,
            "end_logit": 5.131510257720947,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pituitary hypoplasia.BACKGROUND: Septo-optic dysplasia",
            "probability": 0.0095366467511263,
            "start_logit": 2.8234310150146484,
            "end_logit": 4.1953301429748535,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        }
    ],
    "58a71f7460087bc10a00002e": [
        {
            "text": "H3",
            "probability": 0.15804467085069332,
            "start_logit": 4.700454235076904,
            "end_logit": 4.567570209503174,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3 localizes to centromeric DNA at all stages of the cell cycle.Our results favor a H3-Cse4",
            "probability": 0.10433107376947946,
            "start_logit": 4.700454235076904,
            "end_logit": 4.152261734008789,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3 localizes to centromeric DNA at all stages of the cell cycle.Our results favor a H3",
            "probability": 0.07844434488906536,
            "start_logit": 4.700454235076904,
            "end_logit": 3.867081880569458,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4",
            "probability": 0.07491465792571639,
            "start_logit": 4.296252250671387,
            "end_logit": 4.225244045257568,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Scm3 (HJURP in human) with the centromeric DNA. H3",
            "probability": 0.07250935234966764,
            "start_logit": 3.9212920665740967,
            "end_logit": 4.567570209503174,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3, as well as Cse4",
            "probability": 0.06237844505406462,
            "start_logit": 4.113122463226318,
            "end_logit": 4.225244045257568,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3-Cse4",
            "probability": 0.06117336601103436,
            "start_logit": 4.16659688949585,
            "end_logit": 4.152261734008789,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4, H4, H2A, and H2B, but not histone chaperone Scm3",
            "probability": 0.049908620665198127,
            "start_logit": 4.296252250671387,
            "end_logit": 3.8190882205963135,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4, H4",
            "probability": 0.03729207793554188,
            "start_logit": 4.296252250671387,
            "end_logit": 3.5276753902435303,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Scm3",
            "probability": 0.03430302568117938,
            "start_logit": 3.9212920665740967,
            "end_logit": 3.8190882205963135,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H2B, but not histone chaperone Scm3",
            "probability": 0.03350001750845139,
            "start_logit": 3.897604465484619,
            "end_logit": 3.8190882205963135,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H2A, and H2B, but not histone chaperone Scm3",
            "probability": 0.03179881708759976,
            "start_logit": 3.845487594604492,
            "end_logit": 3.8190882205963135,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3, as well as Cse4, H4",
            "probability": 0.031051624593423647,
            "start_logit": 4.113122463226318,
            "end_logit": 3.5276753902435303,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4, H4, H2A, and H2B",
            "probability": 0.03033275562669136,
            "start_logit": 4.296252250671387,
            "end_logit": 3.321122646331787,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H4, H2A, and H2B, but not histone chaperone Scm3",
            "probability": 0.028007107650316002,
            "start_logit": 3.7185168266296387,
            "end_logit": 3.8190882205963135,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3, as well as Cse4, H4, H2A, and H2B",
            "probability": 0.02525687472369037,
            "start_logit": 4.113122463226318,
            "end_logit": 3.321122646331787,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4, H4, H2A",
            "probability": 0.02480868677223427,
            "start_logit": 4.296252250671387,
            "end_logit": 3.1200883388519287,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H4",
            "probability": 0.020927110934424162,
            "start_logit": 3.7185168266296387,
            "end_logit": 3.5276753902435303,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3, as well as Cse4, H4, H2A",
            "probability": 0.02065720310996824,
            "start_logit": 4.113122463226318,
            "end_logit": 3.1200883388519287,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H2B",
            "probability": 0.02036016686156005,
            "start_logit": 3.897604465484619,
            "end_logit": 3.321122646331787,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        }
    ],
    "58c66a4b02b8c60953000025": [
        {
            "text": "kernicterus",
            "probability": 0.5153670974762964,
            "start_logit": 4.983829975128174,
            "end_logit": 4.469324588775635,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Bilirubin-induced neurologic dysfunction (BIND) and classical kernicterus",
            "probability": 0.13699693655326317,
            "start_logit": 3.6589090824127197,
            "end_logit": 4.469324588775635,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurologic dysfunction (BIND) and classical kernicterus",
            "probability": 0.11155532609736007,
            "start_logit": 3.4534711837768555,
            "end_logit": 4.469324588775635,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Bilirubin-induced neurologic dysfunction",
            "probability": 0.10537712052763175,
            "start_logit": 3.6589090824127197,
            "end_logit": 4.206911563873291,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurologic dysfunction",
            "probability": 0.0858076051875101,
            "start_logit": 3.4534711837768555,
            "end_logit": 4.206911563873291,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "classical kernicterus",
            "probability": 0.021698532088964752,
            "start_logit": 1.8161951303482056,
            "end_logit": 4.469324588775635,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "kernicterus in this model displays not only axonal damage",
            "probability": 0.004140965313914063,
            "start_logit": 2.819878578186035,
            "end_logit": 1.8093254566192627,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurologic dysfunction (BIND) and kernicterus",
            "probability": 0.0026774680730172686,
            "start_logit": 2.351550340652466,
            "end_logit": 1.8415963649749756,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "BIND) and classical kernicterus",
            "probability": 0.0020591378785595384,
            "start_logit": -0.538762092590332,
            "end_logit": 4.469324588775635,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Bilirubin-induced neurologic dysfunction (BIND) and kernicterus",
            "probability": 0.001899695414689223,
            "start_logit": 2.0083723068237305,
            "end_logit": 1.8415963649749756,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "kernicterus in this model displays not only axonal damage but also myelination deficits",
            "probability": 0.0018984579801993818,
            "start_logit": 2.819878578186035,
            "end_logit": 1.0294384956359863,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "seizures, leads to alterations in myelination and glia reactivity. Thus, kernicterus",
            "probability": 0.0017990361339705171,
            "start_logit": 1.1416047811508179,
            "end_logit": 2.653921365737915,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Bilirubin-induced neurologic dysfunction (BIND",
            "probability": 0.0015230104109066882,
            "start_logit": 3.6589090824127197,
            "end_logit": -0.029945066198706627,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "kernicterus in this model displays not only axonal damage but also myelination deficits and glial activation",
            "probability": 0.0013097254877331246,
            "start_logit": 2.819878578186035,
            "end_logit": 0.6582140922546387,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurologic dysfunction (BIND",
            "probability": 0.0012401731550567513,
            "start_logit": 3.4534711837768555,
            "end_logit": -0.029945066198706627,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Bilirubin-induced neurologic d",
            "probability": 0.001073095054437335,
            "start_logit": 3.6589090824127197,
            "end_logit": -0.3800869286060333,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Bilirubin-induced neurologic",
            "probability": 0.001035630294559126,
            "start_logit": 3.6589090824127197,
            "end_logit": -0.4156237542629242,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurologic d",
            "probability": 0.0008738112817922709,
            "start_logit": 3.4534711837768555,
            "end_logit": -0.3800869286060333,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurologic",
            "probability": 0.0008433040776859367,
            "start_logit": 3.4534711837768555,
            "end_logit": -0.4156237542629242,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Bilirubin-induced neurologic dysfunction (BIND)",
            "probability": 0.0008238715124526219,
            "start_logit": 3.6589090824127197,
            "end_logit": -0.644374668598175,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        }
    ],
    "58adb9919ef3c34033000004": [
        {
            "text": "HDAC2",
            "probability": 0.23415272385594676,
            "start_logit": 4.126209735870361,
            "end_logit": 3.4887349605560303,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "HDAC",
            "probability": 0.12532198523878743,
            "start_logit": 4.126209735870361,
            "end_logit": 2.863647699356079,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "MTA2, are also detectable in ATR immunoprecipitates.Sen1",
            "probability": 0.07039570228023419,
            "start_logit": 3.5921730995178223,
            "end_logit": 2.820930242538452,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "MTA1, and MTA2, are also detectable in ATR immunoprecipitates.Sen1",
            "probability": 0.06962148194499393,
            "start_logit": 3.5811140537261963,
            "end_logit": 2.820930242538452,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "Sen1",
            "probability": 0.06815149103274415,
            "start_logit": 3.5597739219665527,
            "end_logit": 2.820930242538452,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "MTA1",
            "probability": 0.05711283475929862,
            "start_logit": 3.5811140537261963,
            "end_logit": 2.6228859424591064,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD4",
            "probability": 0.05397016517036852,
            "start_logit": 3.20902681350708,
            "end_logit": 2.93837571144104,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "HDAC1",
            "probability": 0.05034829754376478,
            "start_logit": 3.372300148010254,
            "end_logit": 2.7056357860565186,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "HDAC1, MTA1",
            "probability": 0.046349706630735565,
            "start_logit": 3.372300148010254,
            "end_logit": 2.6228859424591064,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "MTA2",
            "probability": 0.03643198169133805,
            "start_logit": 3.5921730995178223,
            "end_logit": 2.162245035171509,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "MTA1, and MTA2",
            "probability": 0.036031298408625005,
            "start_logit": 3.5811140537261963,
            "end_logit": 2.162245035171509,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD3 and CHD4",
            "probability": 0.0330993317247054,
            "start_logit": 2.7201085090637207,
            "end_logit": 2.93837571144104,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "HDAC1, MTA1, and MTA2",
            "probability": 0.02924106495155814,
            "start_logit": 3.372300148010254,
            "end_logit": 2.162245035171509,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2",
            "probability": 0.021813098829655434,
            "start_logit": 1.752746820449829,
            "end_logit": 3.4887349605560303,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "ATR, CHD4",
            "probability": 0.01553113054942185,
            "start_logit": 2.483767509460449,
            "end_logit": 2.4180500507354736,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD3",
            "probability": 0.012532335567717922,
            "start_logit": 2.7201085090637207,
            "end_logit": 1.967174768447876,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC",
            "probability": 0.011674691647935163,
            "start_logit": 1.752746820449829,
            "end_logit": 2.863647699356079,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "HDAC2 coelute through two biochemical purification steps. Other members of the NRD complex, HDAC1",
            "probability": 0.010794651653488443,
            "start_logit": 1.8323861360549927,
            "end_logit": 2.7056357860565186,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD4, and HDAC2",
            "probability": 0.00996096832591555,
            "start_logit": 2.7749576568603516,
            "end_logit": 1.682687759399414,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD4, and HDAC",
            "probability": 0.007465058192764979,
            "start_logit": 2.7749576568603516,
            "end_logit": 1.3942466974258423,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        }
    ],
    "58bfcb8702b8c60953000016": [
        {
            "text": "lichen sclerosus",
            "probability": 0.5781072888966429,
            "start_logit": 5.718360900878906,
            "end_logit": 5.50119686126709,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Lichen sclerosus",
            "probability": 0.41302227982152684,
            "start_logit": 5.330520153045654,
            "end_logit": 5.552779674530029,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "vitiligo",
            "probability": 0.003480555987685036,
            "start_logit": 3.1360912322998047,
            "end_logit": 2.9708991050720215,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Vitiligo often develops following physical trauma, even if this is minor. The exact mechanism of the Koebner phenomenon in vitiligo",
            "probability": 0.0017442694754030276,
            "start_logit": 2.445235013961792,
            "end_logit": 2.9708991050720215,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen",
            "probability": 0.0009337508084711044,
            "start_logit": 5.718360900878906,
            "end_logit": -0.9271082878112793,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Vitiligo",
            "probability": 0.0006688752946182646,
            "start_logit": 2.445235013961792,
            "end_logit": 2.0124056339263916,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen scle",
            "probability": 0.00036857234674810924,
            "start_logit": 5.718360900878906,
            "end_logit": -1.8566808700561523,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma, injury, and sexual abuse",
            "probability": 0.0003647783438967254,
            "start_logit": 5.718360900878906,
            "end_logit": -1.867027997970581,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Lichen",
            "probability": 0.0002984170771868316,
            "start_logit": 5.330520153045654,
            "end_logit": -1.6799850463867188,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma",
            "probability": 0.0002617250809044142,
            "start_logit": 5.718360900878906,
            "end_logit": -2.1990232467651367,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen s",
            "probability": 0.00015599560905994137,
            "start_logit": 5.718360900878906,
            "end_logit": -2.7164900302886963,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Lichen scle",
            "probability": 0.00010340423648819837,
            "start_logit": 5.330520153045654,
            "end_logit": -2.7398312091827393,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen scleros",
            "probability": 8.93467110465055e-05,
            "start_logit": 5.718360900878906,
            "end_logit": -3.2737934589385986,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma, injury",
            "probability": 8.705292804718022e-05,
            "start_logit": 5.718360900878906,
            "end_logit": -3.2998015880584717,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "us",
            "probability": 7.683450856835487e-05,
            "start_logit": -3.259082794189453,
            "end_logit": 5.552779674530029,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Lichen s",
            "probability": 7.331343075261749e-05,
            "start_logit": 5.330520153045654,
            "end_logit": -3.083733320236206,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "ichen sclerosus",
            "probability": 5.5090010328628384e-05,
            "start_logit": -3.591768264770508,
            "end_logit": 5.552779674530029,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "sclerosus",
            "probability": 5.1731969811120235e-05,
            "start_logit": -3.654660701751709,
            "end_logit": 5.552779674530029,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Koebner phenomenon is known to occur (lichen sclerosus",
            "probability": 4.982695138938396e-05,
            "start_logit": -3.6405978202819824,
            "end_logit": 5.50119686126709,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "vitiligo is unclear.First described in 1877 as the appearance of psoriatic lesions in the uninvolved skin of psoriatic",
            "probability": 6.89051142472295e-06,
            "start_logit": 3.1360912322998047,
            "end_logit": -3.2539029121398926,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        }
    ],
    "58c6a6c502b8c60953000027": [
        {
            "text": "vertigo",
            "probability": 0.3751929965821393,
            "start_logit": 5.84524393081665,
            "end_logit": 5.704110622406006,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "tinnitus",
            "probability": 0.10864585653535322,
            "start_logit": 5.301976203918457,
            "end_logit": 5.008031368255615,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo, sensorineural hearing loss and tinnitus",
            "probability": 0.08657708381177402,
            "start_logit": 5.296980381011963,
            "end_logit": 4.785968780517578,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo, sensorineural hearing loss",
            "probability": 0.05710173614958358,
            "start_logit": 5.296980381011963,
            "end_logit": 4.369768142700195,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "tinnitus and dizziness",
            "probability": 0.05441301636973828,
            "start_logit": 5.002022743225098,
            "end_logit": 4.616494655609131,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "hypoacusia, tinnitus",
            "probability": 0.0425761823665037,
            "start_logit": 4.427631855010986,
            "end_logit": 4.945577144622803,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "dizziness",
            "probability": 0.03924438181759075,
            "start_logit": 4.675227642059326,
            "end_logit": 4.616494655609131,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo, hearing loss and tinnitus",
            "probability": 0.03865519253324677,
            "start_logit": 5.115614414215088,
            "end_logit": 4.160980701446533,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "sensorineural hearing loss and tinnitus",
            "probability": 0.0364070078489044,
            "start_logit": 4.43070650100708,
            "end_logit": 4.785968780517578,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "hypoacusia",
            "probability": 0.03398720720319147,
            "start_logit": 4.427631855010986,
            "end_logit": 4.720266342163086,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "hypoacusia, tinnitus and dizziness",
            "probability": 0.030637124989345173,
            "start_logit": 4.427631855010986,
            "end_logit": 4.616494655609131,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo, lasting between half an hour and a few hours and no more than 24 hours; the sensation of aural fullness",
            "probability": 0.025777274446080762,
            "start_logit": 5.84524393081665,
            "end_logit": 3.026163339614868,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "sensorineural hearing loss",
            "probability": 0.024012166553261036,
            "start_logit": 4.43070650100708,
            "end_logit": 4.369768142700195,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo, hearing loss",
            "probability": 0.011599342142060947,
            "start_logit": 5.115614414215088,
            "end_logit": 2.9572479724884033,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo,",
            "probability": 0.00825438047839764,
            "start_logit": 5.84524393081665,
            "end_logit": 1.8874140977859497,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "tinnitus accompanied by a fluctuating or permanent low-tone hearing loss",
            "probability": 0.007676282929067865,
            "start_logit": 5.301976203918457,
            "end_logit": 2.3580732345581055,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "hearing loss and tinnitus",
            "probability": 0.006630626019176817,
            "start_logit": 3.352632522583008,
            "end_logit": 4.160980701446533,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "attacks of vertigo",
            "probability": 0.005642385238957581,
            "start_logit": 1.648110270500183,
            "end_logit": 5.704110622406006,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "aural fullness; and tinnitus",
            "probability": 0.004272687402324816,
            "start_logit": 2.0661256313323975,
            "end_logit": 5.008031368255615,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "labyrinthic syndrome (hypoacusia, tinnitus",
            "probability": 0.0026970685833019306,
            "start_logit": 1.6685023307800293,
            "end_logit": 4.945577144622803,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        }
    ],
    "58ce5c7c1f5fb2b734000001": [
        {
            "text": "BB-3497",
            "probability": 0.9216265177870746,
            "start_logit": 2.7327308654785156,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "N-formyl-hydroxylamine derivative BB-3497",
            "probability": 0.04414485859936707,
            "start_logit": -0.3059327304363251,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "BB-3497 was identified as a potent inhibitor of Escherichia coli peptide deformylase",
            "probability": 0.00880446528156759,
            "start_logit": 2.7327308654785156,
            "end_logit": -2.4591026306152344,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "the N-formyl-hydroxylamine derivative BB-3497",
            "probability": 0.005141645203931863,
            "start_logit": -2.45603609085083,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "BB",
            "probability": 0.00450060163813024,
            "start_logit": 2.7327308654785156,
            "end_logit": -3.130150556564331,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "B",
            "probability": 0.0037698513212622072,
            "start_logit": 2.7327308654785156,
            "end_logit": -3.307326078414917,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "derivative BB-3497",
            "probability": 0.0024628028954258624,
            "start_logit": -3.1921091079711914,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "hydroxylamine derivative BB-3497",
            "probability": 0.001322009604373468,
            "start_logit": -3.814256191253662,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "BB-3497 was identified as a potent inhibitor of Escherichia coli",
            "probability": 0.0011907102219910872,
            "start_logit": 2.7327308654785156,
            "end_logit": -4.459811687469482,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "3497",
            "probability": 0.0011305458724677024,
            "start_logit": -3.9707086086273193,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "7",
            "probability": 0.001099562820887937,
            "start_logit": -3.9984965324401855,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "formyl-hydroxylamine derivative BB-3497",
            "probability": 0.0010253745176437795,
            "start_logit": -4.0683512687683105,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "N-formyl-hydroxylamine",
            "probability": 0.0007776752025146537,
            "start_logit": -0.3059327304363251,
            "end_logit": -1.847144365310669,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "library of metalloenzyme inhibitors, the N-formyl-hydroxylamine derivative BB-3497",
            "probability": 0.0007238731896054512,
            "start_logit": -4.416548252105713,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "BB-349",
            "probability": 0.0007102075716688356,
            "start_logit": 2.7327308654785156,
            "end_logit": -4.976559638977051,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "screening a library of metalloenzyme inhibitors, the N-formyl-hydroxylamine derivative BB-3497",
            "probability": 0.000705597441210118,
            "start_logit": -4.442119598388672,
            "end_logit": 2.1917784214019775,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "N-formyl-hydroxylamine derivative",
            "probability": 0.0003671005047454615,
            "start_logit": -0.3059327304363251,
            "end_logit": -2.5978176593780518,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "N-formyl-hydroxylamine derivative BB",
            "probability": 0.0002155736831492086,
            "start_logit": -0.3059327304363251,
            "end_logit": -3.130150556564331,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "N-formyl-hydroxylamine derivative B",
            "probability": 0.00018057157677857263,
            "start_logit": -0.3059327304363251,
            "end_logit": -3.307326078414917,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "N",
            "probability": 0.00010045506620433174,
            "start_logit": -0.3059327304363251,
            "end_logit": -3.893742799758911,
            "question_text": "List metalloenzyme inhibitors."
        }
    ],
    "58de71fa8acda3452900002c": [
        {
            "text": "INO80",
            "probability": 0.457997828591697,
            "start_logit": 6.06102991104126,
            "end_logit": 6.0147833824157715,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 promotes homologous recombinationBudding yeast INO80",
            "probability": 0.3976737527789465,
            "start_logit": 5.919797420501709,
            "end_logit": 6.0147833824157715,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 and ANP32E",
            "probability": 0.043358949955130996,
            "start_logit": 5.428609848022461,
            "end_logit": 4.289852142333984,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80.We also report that the histone chaperone ANP32E",
            "probability": 0.03589891538640119,
            "start_logit": 5.765848636627197,
            "end_logit": 3.7638072967529297,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "ANP32E",
            "probability": 0.027100895063299345,
            "start_logit": 4.958663463592529,
            "end_logit": 4.289852142333984,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 in these assays.H2A.Z removal from chromatin is the primary function of INO80",
            "probability": 0.026075019658406858,
            "start_logit": 4.0242838859558105,
            "end_logit": 5.185642719268799,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "DNA damage by INO80",
            "probability": 0.0029499136934024108,
            "start_logit": 1.43393874168396,
            "end_logit": 5.596786022186279,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 can remove H2A.Z/H2B",
            "probability": 0.0018678635064662452,
            "start_logit": 6.06102991104126,
            "end_logit": 0.5127142071723938,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 promotes homologous recombinationBudding yeast INO80 can remove H2A.Z/H2B",
            "probability": 0.0016218423842298975,
            "start_logit": 5.919797420501709,
            "end_logit": 0.5127142071723938,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO",
            "probability": 0.0015004153943858165,
            "start_logit": 6.06102991104126,
            "end_logit": 0.2936609387397766,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 promotes homologous recombinationBudding yeast INO",
            "probability": 0.0013027918111477436,
            "start_logit": 5.919797420501709,
            "end_logit": 0.2936609387397766,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80.We also report that the histone chaperone ANP32E,",
            "probability": 0.0008326866486633443,
            "start_logit": 5.765848636627197,
            "end_logit": 2.3341344785876572e-06,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "DNA damage by INO80.We also report that the histone chaperone ANP32E",
            "probability": 0.0004717987261536105,
            "start_logit": 1.43393874168396,
            "end_logit": 3.7638072967529297,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "HR and appears to work on the same pathway as INO80",
            "probability": 0.00023314330398799355,
            "start_logit": 0.012040523812174797,
            "end_logit": 4.480806350708008,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "ANP32E,",
            "probability": 0.00022683574104000927,
            "start_logit": 4.465417385101318,
            "end_logit": 2.3341344785876572e-06,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80.We also report that the histone chaperone AN",
            "probability": 0.00020934074818740732,
            "start_logit": 5.765848636627197,
            "end_logit": -1.3806917667388916,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "80",
            "probability": 0.0001911520976296995,
            "start_logit": -1.7205203771591187,
            "end_logit": 6.0147833824157715,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80.We also report that the histone chaperone ANP32",
            "probability": 0.00017746659196080802,
            "start_logit": 5.765848636627197,
            "end_logit": -1.545872688293457,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 and AN",
            "probability": 0.00017335835199780179,
            "start_logit": 5.428609848022461,
            "end_logit": -1.232055425643921,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 in these assays.H2A.Z removal from chromatin is the primary function of INO",
            "probability": 0.00013602956686519792,
            "start_logit": 4.0242838859558105,
            "end_logit": -0.0702180489897728,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        }
    ],
    "58ca6d3902b8c6095300002c": [
        {
            "text": "Waldmann's disease",
            "probability": 0.8854326709456698,
            "start_logit": 5.981611728668213,
            "end_logit": 6.088088512420654,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Hennekam syndrome",
            "probability": 0.047458494326660106,
            "start_logit": 4.671096324920654,
            "end_logit": 4.47238302230835,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Waldmann's disease treated with subcutaneous immunoglobulins.Octreotide in Hennekam syndrome",
            "probability": 0.043043642127357326,
            "start_logit": 4.573455333709717,
            "end_logit": 4.47238302230835,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Waldmann's",
            "probability": 0.017200831093965266,
            "start_logit": 5.981611728668213,
            "end_logit": 2.146969795227051,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Waldmann's disease,",
            "probability": 0.004200052776764715,
            "start_logit": 5.981611728668213,
            "end_logit": 0.7371091842651367,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Hennekam syndrome-associated intestinal lymphangiectasia",
            "probability": 0.0011525805098673099,
            "start_logit": 4.671096324920654,
            "end_logit": 0.7545308470726013,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Hennekam",
            "probability": 0.00026239887749630907,
            "start_logit": 4.671096324920654,
            "end_logit": -0.7253620028495789,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Hennekam syndrome (HS)",
            "probability": 0.0002573986129705177,
            "start_logit": 3.473541736602783,
            "end_logit": 0.45295271277427673,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Waldmann's disease treated with subcutaneous immunoglobulins.Octreotide in Hennekam",
            "probability": 0.0002379890794644656,
            "start_logit": 4.573455333709717,
            "end_logit": -0.7253620028495789,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Waldmann",
            "probability": 0.00020891053262454931,
            "start_logit": 5.981611728668213,
            "end_logit": -2.2638370990753174,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Waldmann's disease treated with subcutaneous immunoglobulins.Octreotide",
            "probability": 0.00016881344159725271,
            "start_logit": 4.573455333709717,
            "end_logit": -1.0687925815582275,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "disease",
            "probability": 0.0001484954531470478,
            "start_logit": -2.711665630340576,
            "end_logit": 6.088088512420654,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Octreotide in Hennekam syndrome",
            "probability": 9.691219362886091e-05,
            "start_logit": -1.5227091312408447,
            "end_logit": 4.47238302230835,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Wa",
            "probability": 4.124506841845008e-05,
            "start_logit": 5.981611728668213,
            "end_logit": -3.886211633682251,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Primary intestinal lymphangiectasia (PIL), also known as Waldmann's disease",
            "probability": 2.884098850230753e-05,
            "start_logit": -4.350422382354736,
            "end_logit": 6.088088512420654,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": ", also known as Waldmann's disease",
            "probability": 2.228346440912287e-05,
            "start_logit": -4.608375072479248,
            "end_logit": 6.088088512420654,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Hennekam syndrome-associated intestinal lymphangiectasia.Primary intestinal lymphangiectasia",
            "probability": 1.124052062702924e-05,
            "start_logit": 4.671096324920654,
            "end_logit": -3.8757026195526123,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "mann's disease",
            "probability": 9.71243244347187e-06,
            "start_logit": -5.438813209533691,
            "end_logit": 6.088088512420654,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "disease treated with subcutaneous immunoglobulins.Octreotide in Hennekam syndrome",
            "probability": 8.830767974770472e-06,
            "start_logit": -3.9182724952697754,
            "end_logit": 4.47238302230835,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "s disease",
            "probability": 8.656786411492099e-06,
            "start_logit": -5.5538763999938965,
            "end_logit": 6.088088512420654,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        }
    ],
    "58c99acf02b8c60953000028": [
        {
            "text": "arthroscopic debridement",
            "probability": 0.17585446446355987,
            "start_logit": 5.40474271774292,
            "end_logit": 5.678764820098877,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "double-layer double-row repair",
            "probability": 0.16458150940982777,
            "start_logit": 5.256557941436768,
            "end_logit": 5.7606987953186035,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "arthroscopic debridement (DB), partial (PR), and complete repair",
            "probability": 0.12324510817878016,
            "start_logit": 5.40474271774292,
            "end_logit": 5.3232831954956055,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "en masse repair and separate double-layer double-row repair",
            "probability": 0.09226869573045067,
            "start_logit": 4.677856922149658,
            "end_logit": 5.7606987953186035,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "conventional en masse repair and separate double-layer double-row repair",
            "probability": 0.08757186635744162,
            "start_logit": 4.625611782073975,
            "end_logit": 5.7606987953186035,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "complete repair",
            "probability": 0.0745089874202582,
            "start_logit": 4.901487350463867,
            "end_logit": 5.3232831954956055,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "en masse repair",
            "probability": 0.05075027664683353,
            "start_logit": 4.677856922149658,
            "end_logit": 5.1629109382629395,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "conventional en masse repair",
            "probability": 0.04816689353779369,
            "start_logit": 4.625611782073975,
            "end_logit": 5.1629109382629395,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "partial (PR), and complete repair",
            "probability": 0.03409741338821294,
            "start_logit": 4.119789123535156,
            "end_logit": 5.3232831954956055,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "debridement",
            "probability": 0.031179302056597444,
            "start_logit": 3.6748404502868652,
            "end_logit": 5.678764820098877,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "debridement (DB), partial (PR), and complete repair",
            "probability": 0.02185157179049321,
            "start_logit": 3.6748404502868652,
            "end_logit": 5.3232831954956055,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "double-layer double-row",
            "probability": 0.016214564541232695,
            "start_logit": 5.256557941436768,
            "end_logit": 3.4432027339935303,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "separate double-layer double-row repair",
            "probability": 0.01519322351363486,
            "start_logit": 2.8740015029907227,
            "end_logit": 5.7606987953186035,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "double-row repair",
            "probability": 0.012368579697234152,
            "start_logit": 2.668311357498169,
            "end_logit": 5.7606987953186035,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "arthroscopic",
            "probability": 0.011461484665421101,
            "start_logit": 5.40474271774292,
            "end_logit": 2.9481003284454346,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "arthroscopic debridement (DB)",
            "probability": 0.0106430237978973,
            "start_logit": 5.40474271774292,
            "end_logit": 2.8740127086639404,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "en masse repair and separate double-layer double-row",
            "probability": 0.00909030867089263,
            "start_logit": 4.677856922149658,
            "end_logit": 3.4432027339935303,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "conventional en masse repair and separate double-layer double-row",
            "probability": 0.008627577205608928,
            "start_logit": 4.625611782073975,
            "end_logit": 3.4432027339935303,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "arthroscopic debridement (DB), partial (PR), and complete repair (CR)",
            "probability": 0.007228062863639904,
            "start_logit": 5.40474271774292,
            "end_logit": 2.48707914352417,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "arthroscopic debridement (DB), partial (PR)",
            "probability": 0.005097086064189469,
            "start_logit": 5.40474271774292,
            "end_logit": 2.137777090072632,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        }
    ],
    "58948cb47d9090f353000008": [
        {
            "text": "Mcidas",
            "probability": 0.27811226090747826,
            "start_logit": 5.295207977294922,
            "end_logit": 4.615880012512207,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas and GemC1/Lynkeas",
            "probability": 0.19494486841554706,
            "start_logit": 5.295207977294922,
            "end_logit": 4.2605719566345215,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas and GemC1",
            "probability": 0.15497823481283654,
            "start_logit": 5.295207977294922,
            "end_logit": 4.031139850616455,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC1/Lynkeas",
            "probability": 0.14561433609154434,
            "start_logit": 5.003452777862549,
            "end_logit": 4.2605719566345215,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC1",
            "probability": 0.11576120445913167,
            "start_logit": 5.003452777862549,
            "end_logit": 4.031139850616455,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Lynkeas",
            "probability": 0.04193580701263861,
            "start_logit": 3.7586312294006348,
            "end_logit": 4.2605719566345215,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas and GemC",
            "probability": 0.023288623656626508,
            "start_logit": 5.295207977294922,
            "end_logit": 2.135820150375366,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC",
            "probability": 0.017395469292461024,
            "start_logit": 5.003452777862549,
            "end_logit": 2.135820150375366,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Lynkeas specify embryonic radial glial cells.Here we discuss recent findings suggesting that 2 novel molecules, Mcidas",
            "probability": 0.00644652686835911,
            "start_logit": 1.5307246446609497,
            "end_logit": 4.615880012512207,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "FoxJ1.Here we discuss recent findings suggesting that 2 novel molecules, Mcidas",
            "probability": 0.005654221734405474,
            "start_logit": 1.681848406791687,
            "end_logit": 4.333617210388184,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "c-Myb and FoxJ1.Here we discuss recent findings suggesting that 2 novel molecules, Mcidas",
            "probability": 0.005434562262487206,
            "start_logit": 1.642224907875061,
            "end_logit": 4.333617210388184,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "FoxJ1.Here we discuss recent findings suggesting that 2 novel molecules, Mcidas and GemC1/Lynkeas",
            "probability": 0.003875720079168511,
            "start_logit": 1.681848406791687,
            "end_logit": 3.955946207046509,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "FoxJ1.Here we discuss recent findings suggesting that 2 novel molecules, Mcidas and GemC1",
            "probability": 0.00261625582473135,
            "start_logit": 1.681848406791687,
            "end_logit": 3.5629589557647705,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "c-Myb and FoxJ1.Here we discuss recent findings suggesting that 2 novel molecules, Mcidas and GemC1",
            "probability": 0.0025146175445474187,
            "start_logit": 1.642224907875061,
            "end_logit": 3.5629589557647705,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "FoxJ1.Here we discuss recent findings suggesting that 2 novel molecules, Mcidas and GemC",
            "probability": 0.0007277822357123684,
            "start_logit": 1.681848406791687,
            "end_logit": 2.283461332321167,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "c-Myb and FoxJ1.Here we discuss recent findings suggesting that 2 novel molecules, Mcidas and GemC",
            "probability": 0.0006995088023244781,
            "start_logit": 1.642224907875061,
            "end_logit": 2.283461332321167,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        }
    ],
    "58cd59cb02b8c60953000039": [
        {
            "text": "attention deficit hyperactivity disorder",
            "probability": 0.7447879108494759,
            "start_logit": 5.694748401641846,
            "end_logit": 5.724254131317139,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "attention deficit hyperactivity disorder (ADHD)",
            "probability": 0.15784649590233396,
            "start_logit": 5.694748401641846,
            "end_logit": 4.1727776527404785,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "Attention Deficit Hyperactivity Disorder",
            "probability": 0.065601491879361,
            "start_logit": 4.3761420249938965,
            "end_logit": 4.613359451293945,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "neuropsychiatric diseases. Dopamine dysfunction may be involved with Attention Deficit Hyperactivity Disorder",
            "probability": 0.013855460755681006,
            "start_logit": 2.821223020553589,
            "end_logit": 4.613359451293945,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "attention deficit hyperactivity",
            "probability": 0.005773043305899063,
            "start_logit": 5.694748401641846,
            "end_logit": 0.8643540143966675,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "hyperactivity disorder",
            "probability": 0.002754562628841187,
            "start_logit": 0.09490758180618286,
            "end_logit": 5.724254131317139,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "Attention Deficit Hyperactivity Disorder (ADHD)",
            "probability": 0.0027387386520478373,
            "start_logit": 4.3761420249938965,
            "end_logit": 1.4372584819793701,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "neuropsychiatric diseases",
            "probability": 0.0019656170243501016,
            "start_logit": 2.821223020553589,
            "end_logit": 2.6604862213134766,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "neuropsychiatric",
            "probability": 0.0012239510877284651,
            "start_logit": 2.821223020553589,
            "end_logit": 2.1867642402648926,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "hyperactivity disorder (ADHD)",
            "probability": 0.0005837877500054869,
            "start_logit": 0.09490758180618286,
            "end_logit": 4.1727776527404785,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "neuropsychiatric diseases. Dopamine dysfunction may be involved with Attention Deficit Hyperactivity Disorder (ADHD)",
            "probability": 0.0005784393742645039,
            "start_logit": 2.821223020553589,
            "end_logit": 1.4372584819793701,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "disorder",
            "probability": 0.0004883966866801995,
            "start_logit": -1.6349784135818481,
            "end_logit": 5.724254131317139,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "attention",
            "probability": 0.0003979015791165165,
            "start_logit": 5.694748401641846,
            "end_logit": -1.8103959560394287,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "Attention Deficit Hyperactivity Disorder (ADHD) symptoms",
            "probability": 0.0003684716403307054,
            "start_logit": 4.3761420249938965,
            "end_logit": -0.5686305165290833,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "Attention Deficit Hyperactivity",
            "probability": 0.00031455519169510516,
            "start_logit": 4.3761420249938965,
            "end_logit": -0.7268347144126892,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "ivity disorder",
            "probability": 0.0002520820077444896,
            "start_logit": -2.296351909637451,
            "end_logit": 5.724254131317139,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "Hyperactivity Disorder",
            "probability": 0.0001435537538671187,
            "start_logit": -1.7485021352767944,
            "end_logit": 4.613359451293945,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "risk of attention deficit hyperactivity disorder",
            "probability": 0.0001145282119245386,
            "start_logit": -3.085285186767578,
            "end_logit": 5.724254131317139,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "diseases. Dopamine dysfunction may be involved with Attention Deficit Hyperactivity Disorder",
            "probability": 0.0001075034520984563,
            "start_logit": -2.037688732147217,
            "end_logit": 4.613359451293945,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "disorder (ADHD)",
            "probability": 0.00010350826655450381,
            "start_logit": -1.6349784135818481,
            "end_logit": 4.1727776527404785,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        }
    ],
    "58b548d722d3005309000005": [
        {
            "text": "Corynebacterium diphtheriae",
            "probability": 0.7136081502567866,
            "start_logit": 4.991751194000244,
            "end_logit": 4.803872585296631,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium ulcerans",
            "probability": 0.21573949602291462,
            "start_logit": 4.187331199645996,
            "end_logit": 4.412030220031738,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium diphtheriae. The zoonotic bacterium Corynebacterium ulcerans",
            "probability": 0.054033412791801565,
            "start_logit": 4.991751194000244,
            "end_logit": 2.2231411933898926,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium",
            "probability": 0.00752934073245891,
            "start_logit": 4.991751194000244,
            "end_logit": 0.25234606862068176,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae",
            "probability": 0.002473715698524288,
            "start_logit": -0.7198175191879272,
            "end_logit": 4.850828647613525,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "ulcerans",
            "probability": 0.0019081455580044497,
            "start_logit": -0.5406085848808289,
            "end_logit": 4.412030220031738,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium diphtheriae. The zoonotic bacterium Corynebacterium",
            "probability": 0.0014664087133839806,
            "start_logit": 4.991751194000244,
            "end_logit": -1.3836450576782227,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium diphtheriae,",
            "probability": 0.0014443810525949514,
            "start_logit": 4.271137237548828,
            "end_logit": -0.6781665682792664,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium ulcerans strains have been isolated mainly from cattle, dogs and cats.Corynebacterium",
            "probability": 0.0006764665053832015,
            "start_logit": 2.4787869453430176,
            "end_logit": 0.355630487203598,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Co",
            "probability": 0.000359709074527465,
            "start_logit": 4.991751194000244,
            "end_logit": -2.7889211177825928,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium diphtheriae, a pathogenic bacterium that causes diphtheria,",
            "probability": 0.00024144577946630692,
            "start_logit": 4.271137237548828,
            "end_logit": -2.4669578075408936,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae. The zoonotic bacterium Corynebacterium ulcerans",
            "probability": 0.00014016670699627478,
            "start_logit": -0.9627742171287537,
            "end_logit": 2.2231411933898926,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "iae",
            "probability": 0.00011597105916903806,
            "start_logit": -3.732997417449951,
            "end_logit": 4.803872585296631,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae NCTC 13129 prophage.Corynebacterium ulcerans",
            "probability": 0.00010530984518686604,
            "start_logit": -0.6804277896881104,
            "end_logit": 1.6548691987991333,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "ans",
            "probability": 5.462632376090094e-05,
            "start_logit": -4.093979835510254,
            "end_logit": 4.412030220031738,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Diphtheria toxin-positive Corynebacterium ulcerans",
            "probability": 4.598107838044427e-05,
            "start_logit": -1.407227635383606,
            "end_logit": 1.5529921054840088,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae, a pathogenic bacterium that causes diphtheria, has been performed. Corynebacterium ulcerans",
            "probability": 2.971354231640905e-05,
            "start_logit": -0.7198175191879272,
            "end_logit": 0.42895492911338806,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae,",
            "probability": 9.820592088983754e-06,
            "start_logit": -0.7198175191879272,
            "end_logit": -0.6781665682792664,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "NCTC 13129 prophage.Corynebacterium ulcerans",
            "probability": 8.957499574280038e-06,
            "start_logit": -3.144843578338623,
            "end_logit": 1.6548691987991333,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "iae. The zoonotic bacterium Corynebacterium ulcerans",
            "probability": 8.781166680520942e-06,
            "start_logit": -3.732997417449951,
            "end_logit": 2.2231411933898926,
            "question_text": "Which bacteria cause diphtheria?"
        }
    ],
    "589a245a78275d0c4a000026": [
        {
            "text": "topiramate",
            "probability": 0.32651183733398925,
            "start_logit": 4.974928379058838,
            "end_logit": 4.977818965911865,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "amitriptyline, topiramate",
            "probability": 0.30823231994074957,
            "start_logit": 4.91731595993042,
            "end_logit": 4.977818965911865,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "amitriptyline",
            "probability": 0.2479951933451302,
            "start_logit": 4.91731595993042,
            "end_logit": 4.760374546051025,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "amitriptyline and topiramate",
            "probability": 0.09276700578354874,
            "start_logit": 4.258145809173584,
            "end_logit": 4.4362263679504395,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "topiramate, and placebo",
            "probability": 0.010979377403268941,
            "start_logit": 4.974928379058838,
            "end_logit": 1.585371494293213,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "amitriptyline, topiramate, and placebo",
            "probability": 0.010364705292607595,
            "start_logit": 4.91731595993042,
            "end_logit": 1.585371494293213,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "amitriptyline and topiramate for the prevention of episodic and chronic migraine,",
            "probability": 0.0007616760499028869,
            "start_logit": 4.258145809173584,
            "end_logit": -0.3660986125469208,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "topiramate for the prevention of episodic and chronic migraine,",
            "probability": 0.000679194031379752,
            "start_logit": 4.143531322479248,
            "end_logit": -0.3660986125469208,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "topiramate. CONCLUSIONS: The goal of the CHAMP study is to obtain level 1 evidence for the effectiveness of amitriptyline",
            "probability": 0.0005437222575396767,
            "start_logit": 0.6568266153335571,
            "end_logit": 2.8981378078460693,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline",
            "probability": 0.00021097651184392887,
            "start_logit": -1.9199517965316772,
            "end_logit": 4.528224468231201,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine",
            "probability": 0.00012705694589522793,
            "start_logit": 4.755801677703857,
            "end_logit": -2.6546404361724854,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "topiramate, and placebo in the prevention of childhood and adolescent migraine",
            "probability": 0.00012484553847398014,
            "start_logit": 4.738243579864502,
            "end_logit": -2.6546404361724854,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "amitriptyline, topiramate,",
            "probability": 0.00012011698073190954,
            "start_logit": 4.755801677703857,
            "end_logit": -2.7108097076416016,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "am",
            "probability": 0.00011959398774143506,
            "start_logit": 4.91731595993042,
            "end_logit": -2.876687526702881,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "topiramate,",
            "probability": 0.00011802636238171353,
            "start_logit": 4.738243579864502,
            "end_logit": -2.7108097076416016,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "placebo",
            "probability": 9.961519419678508e-05,
            "start_logit": 0.27246907353401184,
            "end_logit": 1.585371494293213,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "amitriptyline and 2\u2009mg/kg of topiramate.",
            "probability": 8.451377298760677e-05,
            "start_logit": 0.69577956199646,
            "end_logit": 0.9976608157157898,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "topiramate for the prevention of episodic and chronic migraine, designed to mirror real-world practice,",
            "probability": 7.918258956133535e-05,
            "start_logit": 4.143531322479248,
            "end_logit": -2.515249013900757,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "mate",
            "probability": 7.567714714598261e-05,
            "start_logit": -3.3948168754577637,
            "end_logit": 4.977818965911865,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "amitriptyline: topiramate",
            "probability": 5.363530923468477e-06,
            "start_logit": -1.4877194166183472,
            "end_logit": 0.423867791891098,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        }
    ],
    "589a246178275d0c4a00002b": [
        {
            "text": "warfarin",
            "probability": 0.3509249420539657,
            "start_logit": 4.534765243530273,
            "end_logit": 3.9546914100646973,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban versus warfarin",
            "probability": 0.2501365604978555,
            "start_logit": 4.196199893951416,
            "end_logit": 3.9546914100646973,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban",
            "probability": 0.15746345426350297,
            "start_logit": 4.196199893951416,
            "end_logit": 3.491877794265747,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "Apixaban",
            "probability": 0.1446071480432857,
            "start_logit": 4.007043838500977,
            "end_logit": 3.5958611965179443,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban or warfarin",
            "probability": 0.03610455835980859,
            "start_logit": 3.1794421672821045,
            "end_logit": 3.0358612537384033,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "warfarin.Moreover, apixaban",
            "probability": 0.02463061652330371,
            "start_logit": 3.487166404724121,
            "end_logit": 2.345708131790161,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban or warfarin.Moreover, apixaban",
            "probability": 0.01810640975646593,
            "start_logit": 3.1794421672821045,
            "end_logit": 2.345708131790161,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "warfarin, apixaban",
            "probability": 0.011326350497003814,
            "start_logit": 2.7809667587280273,
            "end_logit": 2.2750494480133057,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "warfarin, apixaban (in the ARISTOTLE trial) and edoxaban",
            "probability": 0.0026226289047117162,
            "start_logit": 2.7809667587280273,
            "end_logit": 0.8120947480201721,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban (in the ARISTOTLE trial) and edoxaban",
            "probability": 0.002186614454867132,
            "start_logit": 2.5991439819335938,
            "end_logit": 0.8120947480201721,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "edoxaban",
            "probability": 0.0005032980057490348,
            "start_logit": 1.1302167177200317,
            "end_logit": 0.8120947480201721,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "warfari",
            "probability": 0.00036232723663840084,
            "start_logit": 4.534765243530273,
            "end_logit": -2.921088457107544,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban versus warfari",
            "probability": 0.0002582640271077818,
            "start_logit": 4.196199893951416,
            "end_logit": -2.921088457107544,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "warfarin, based on data from the Apixaban",
            "probability": 0.00025583319978931434,
            "start_logit": 0.8634034395217896,
            "end_logit": 0.4022512435913086,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "Apixaban for Reduction In Stroke and Other Thromboembolic Events in Atrial Fibrillation",
            "probability": 0.0001194355052226061,
            "start_logit": 4.007043838500977,
            "end_logit": -3.503138303756714,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban versus warfarin, based on data from the Apixaban",
            "probability": 0.00010815439495530819,
            "start_logit": 0.002437559887766838,
            "end_logit": 0.4022512435913086,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "warfarin on the risk of stroke",
            "probability": 8.405872148685476e-05,
            "start_logit": 4.534765243530273,
            "end_logit": -4.382120609283447,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "war",
            "probability": 7.037509378207709e-05,
            "start_logit": 4.534765243530273,
            "end_logit": -4.5597968101501465,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "ban versus warfarin",
            "probability": 6.905405971543833e-05,
            "start_logit": -3.9986727237701416,
            "end_logit": 3.9546914100646973,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban versus warfarin on the risk of stroke",
            "probability": 5.991640078218095e-05,
            "start_logit": 4.196199893951416,
            "end_logit": -4.382120609283447,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        }
    ],
    "58cea0768acda34529000001": [
        {
            "text": "Tay-Sachs disease",
            "probability": 0.633346390890728,
            "start_logit": 6.232934474945068,
            "end_logit": 6.019094467163086,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs",
            "probability": 0.2777432642651415,
            "start_logit": 6.232934474945068,
            "end_logit": 5.194774150848389,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD)",
            "probability": 0.04776707992818155,
            "start_logit": 6.232934474945068,
            "end_logit": 3.4344136714935303,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs patients.Tay-Sachs disease",
            "probability": 0.028223332783097122,
            "start_logit": 3.253358840942383,
            "end_logit": 5.887801647186279,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs patients.Tay-Sachs",
            "probability": 0.009686466019262914,
            "start_logit": 3.253358840942383,
            "end_logit": 4.818382263183594,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD",
            "probability": 0.001723475822259882,
            "start_logit": 6.232934474945068,
            "end_logit": 0.11242005228996277,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs patients.Tay-Sachs disease (TSD)",
            "probability": 0.0004722981941654868,
            "start_logit": 3.253358840942383,
            "end_logit": 1.797507882118225,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease",
            "probability": 0.0003310765787654653,
            "start_logit": -1.3234885931015015,
            "end_logit": 6.019094467163086,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "disease",
            "probability": 0.00016863678415143452,
            "start_logit": -1.9980911016464233,
            "end_logit": 6.019094467163086,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs",
            "probability": 0.00014518799038032342,
            "start_logit": -1.3234885931015015,
            "end_logit": 5.194774150848389,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD) is a recessively inherited neurodegenerative disorder",
            "probability": 0.000125889634435431,
            "start_logit": 6.092075824737549,
            "end_logit": -2.3634140491485596,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "ta",
            "probability": 9.144003756795335e-05,
            "start_logit": 6.232934474945068,
            "end_logit": -2.8239948749542236,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Ta",
            "probability": 6.58993755665814e-05,
            "start_logit": 6.092075824737549,
            "end_logit": -3.010690689086914,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "chs disease",
            "probability": 3.3749963261577834e-05,
            "start_logit": -3.606858968734741,
            "end_logit": 6.019094467163086,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease (TSD)",
            "probability": 2.496984529744858e-05,
            "start_logit": -1.3234885931015015,
            "end_logit": 3.4344136714935303,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "chs",
            "probability": 1.4800471116470777e-05,
            "start_logit": -3.606858968734741,
            "end_logit": 5.194774150848389,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "disease (TSD)",
            "probability": 1.2718611589566726e-05,
            "start_logit": -1.9980911016464233,
            "end_logit": 3.4344136714935303,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "TSD)",
            "probability": 1.0127040951107734e-05,
            "start_logit": -2.2259483337402344,
            "end_logit": 3.4344136714935303,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs patients.Tay-Sachs disease (TSD) is a recessively inherited neurodegenerative disorder",
            "probability": 7.364628608786613e-06,
            "start_logit": 3.253358840942383,
            "end_logit": -2.3634140491485596,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "(TSD)",
            "probability": 5.831135471360142e-06,
            "start_logit": -2.607125759124756,
            "end_logit": 3.2635936737060547,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        }
    ],
    "58c1b2f702b8c6095300001e": [
        {
            "text": "obesity",
            "probability": 0.9357758263336089,
            "start_logit": 4.313724040985107,
            "end_logit": 4.144439220428467,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "depression",
            "probability": 0.024620743496819576,
            "start_logit": 2.728652238845825,
            "end_logit": 2.091724395751953,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant",
            "probability": 0.015248366804627458,
            "start_logit": 2.511819839477539,
            "end_logit": 1.8294398784637451,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant or smoking cessation",
            "probability": 0.004864826877999287,
            "start_logit": 2.511819839477539,
            "end_logit": 0.6869986057281494,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant or smoking cessation therapy",
            "probability": 0.004118049064775248,
            "start_logit": 2.511819839477539,
            "end_logit": 0.520346999168396,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "obesity; a third, bupropion plus naltrexone",
            "probability": 0.002624921665720578,
            "start_logit": 4.0271992683410645,
            "end_logit": -1.4453608989715576,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking cessation",
            "probability": 0.002329730500505265,
            "start_logit": 1.7755413055419922,
            "end_logit": 0.6869986057281494,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepress",
            "probability": 0.0021166667282783197,
            "start_logit": 2.511819839477539,
            "end_logit": -0.14518997073173523,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking cessation therapy",
            "probability": 0.001972103992471299,
            "start_logit": 1.7755413055419922,
            "end_logit": 0.520346999168396,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "besity",
            "probability": 0.0012635039124026524,
            "start_logit": -2.2937631607055664,
            "end_logit": 4.144439220428467,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant or smoking",
            "probability": 0.0011741194547466912,
            "start_logit": 2.511819839477539,
            "end_logit": -0.734514057636261,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "obesity; a third, bupropion plus naltrexone,",
            "probability": 0.0006198644595738105,
            "start_logit": 4.0271992683410645,
            "end_logit": -2.8886663913726807,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking",
            "probability": 0.0005622773376233552,
            "start_logit": 1.7755413055419922,
            "end_logit": -0.734514057636261,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "o",
            "probability": 0.0005497091801921841,
            "start_logit": 4.313724040985107,
            "end_logit": -3.295302629470825,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "naltrexone are also noteworthy, the components of which have been previously approved, but not necessarily for obesity",
            "probability": 0.0004973110389877791,
            "start_logit": -3.226191520690918,
            "end_logit": 4.144439220428467,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "lorcaserin, have recently been approved by the US Food and Drug Administration for the indication of obesity",
            "probability": 0.00041780024937020533,
            "start_logit": -3.0050816535949707,
            "end_logit": 3.749117136001587,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "obesity;",
            "probability": 0.00037943472463664046,
            "start_logit": 4.0271992683410645,
            "end_logit": -3.3794846534729004,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "topiramate and lorcaserin, have recently been approved by the US Food and Drug Administration for the indication of obesity",
            "probability": 0.00035401836372442346,
            "start_logit": -3.170736312866211,
            "end_logit": 3.749117136001587,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "bupropion/naltrexone are also noteworthy, the components of which have been previously approved, but not necessarily for obesity",
            "probability": 0.0002884626415392713,
            "start_logit": -3.770841598510742,
            "end_logit": 4.144439220428467,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "pressant",
            "probability": 0.00022226317239741202,
            "start_logit": -1.7165457010269165,
            "end_logit": 1.8294398784637451,
            "question_text": "List 3 indications for Bupropion"
        }
    ],
    "587d2b7efe8a08052f000003": [
        {
            "text": "130",
            "probability": 0.25935730741244056,
            "start_logit": -0.7485320568084717,
            "end_logit": -2.2909445762634277,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130 transcription factor flexible models trained on ChIP-seq data for vertebrates,",
            "probability": 0.12247512373268088,
            "start_logit": -0.7485320568084717,
            "end_logit": -3.041243314743042,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130 transcription factor flexible models",
            "probability": 0.12080312483837444,
            "start_logit": -0.7485320568084717,
            "end_logit": -3.0549890995025635,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130 transcription factor flexible models trained on ChIP-seq data",
            "probability": 0.095022322451899,
            "start_logit": -0.7485320568084717,
            "end_logit": -3.295039415359497,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130 transcription factor flexible models trained on ChIP-seq data for vertebrates",
            "probability": 0.09281967213595534,
            "start_logit": -0.7485320568084717,
            "end_logit": -3.3184926509857178,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "59",
            "probability": 0.0926363630321296,
            "start_logit": -1.801209568977356,
            "end_logit": -2.267791986465454,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "59 profiles",
            "probability": 0.051144438529666575,
            "start_logit": -1.801209568977356,
            "end_logit": -2.8618199825286865,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130 transcription factor flexible models trained",
            "probability": 0.03581612982600289,
            "start_logit": -0.7485320568084717,
            "end_logit": -4.270752906799316,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "we introduced 130",
            "probability": 0.021637330640131628,
            "start_logit": -3.232318639755249,
            "end_logit": -2.2909445762634277,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "59 profiles (58 in vertebrates and 1 in fungi).",
            "probability": 0.016675713816872193,
            "start_logit": -1.801209568977356,
            "end_logit": -3.982520341873169,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "updated 59",
            "probability": 0.012754309698515076,
            "start_logit": -3.784022092819214,
            "end_logit": -2.267791986465454,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "we introduced 130 transcription factor flexible models trained on ChIP-seq data for vertebrates,",
            "probability": 0.010217698409325538,
            "start_logit": -3.232318639755249,
            "end_logit": -3.041243314743042,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "we introduced 130 transcription factor flexible models",
            "probability": 0.010078209018157114,
            "start_logit": -3.232318639755249,
            "end_logit": -3.0549890995025635,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "introduced 130",
            "probability": 0.009366728603891483,
            "start_logit": -4.06957483291626,
            "end_logit": -2.2909445762634277,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "164 in plants) and updated 59",
            "probability": 0.009337169781442346,
            "start_logit": -4.095888137817383,
            "end_logit": -2.267791986465454,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "494 new TF binding profiles",
            "probability": 0.009036850816070406,
            "start_logit": -3.106860876083374,
            "end_logit": -3.2895116806030273,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "JASPAR API",
            "probability": 0.008108823958392677,
            "start_logit": -2.9179654121398926,
            "end_logit": -3.5867650508880615,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "we introduced 130 transcription factor flexible models trained on ChIP-seq data",
            "probability": 0.007927401119318995,
            "start_logit": -3.232318639755249,
            "end_logit": -3.295039415359497,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "we introduced 130 transcription factor flexible models trained on ChIP-seq data for vertebrates",
            "probability": 0.007743641218176617,
            "start_logit": -3.232318639755249,
            "end_logit": -3.3184926509857178,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "updated 59 profiles",
            "probability": 0.0070416409605565935,
            "start_logit": -3.784022092819214,
            "end_logit": -2.8618199825286865,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        }
    ],
    "58add1d79ef3c34033000008": [
        {
            "text": "PIK3CA (n\u2009=\u20092), FGFR1",
            "probability": 0.32092890591705087,
            "start_logit": 3.2325897216796875,
            "end_logit": 1.8777680397033691,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "PIK3CA",
            "probability": 0.2494196741868878,
            "start_logit": 3.2325897216796875,
            "end_logit": 1.6256853342056274,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "FGFR1",
            "probability": 0.24524815853040483,
            "start_logit": 2.9636406898498535,
            "end_logit": 1.8777680397033691,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "PIK3",
            "probability": 0.11420542427537451,
            "start_logit": 3.2325897216796875,
            "end_logit": 0.8445472121238708,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "H3F3A",
            "probability": 0.012300118239784746,
            "start_logit": 1.086938500404358,
            "end_logit": 0.7618085145950317,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "HIST1H3B",
            "probability": 0.010071888328664208,
            "start_logit": 1.680415153503418,
            "end_logit": -0.03152880445122719,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "K27M mutations in H3F3A",
            "probability": 0.009787250938906296,
            "start_logit": 0.8584102392196655,
            "end_logit": 0.7618085145950317,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "PIK3CA (n\u2009=\u20092), FGFR1 (n\u2009=\u20092), and MET",
            "probability": 0.0072294977840497605,
            "start_logit": 3.2325897216796875,
            "end_logit": -1.9152820110321045,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "H3F3A (n\u2009=\u20094) or HIST1H3B",
            "probability": 0.0055637456320607745,
            "start_logit": 1.086938500404358,
            "end_logit": -0.03152880445122719,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "FGFR1 (n\u2009=\u20092), and MET",
            "probability": 0.005524653547711627,
            "start_logit": 2.9636406898498535,
            "end_logit": -1.9152820110321045,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "K27M mutations in H3F3A (n\u2009=\u20094) or HIST1H3B",
            "probability": 0.004427093593709679,
            "start_logit": 0.8584102392196655,
            "end_logit": -0.03152880445122719,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "K27M",
            "probability": 0.003953063460176773,
            "start_logit": 0.8584102392196655,
            "end_logit": -0.14478126168251038,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "PIK",
            "probability": 0.003120334038492882,
            "start_logit": 3.2325897216796875,
            "end_logit": -2.755511522293091,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "HIST1",
            "probability": 0.002076848130045435,
            "start_logit": 1.680415153503418,
            "end_logit": -1.610425591468811,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "PIK3CA (n\u2009=\u20092), FGFR1 (n\u2009=\u20092),",
            "probability": 0.0011853469208966336,
            "start_logit": 3.2325897216796875,
            "end_logit": -3.7234160900115967,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "PIK3CA (n\u2009=\u20092),",
            "probability": 0.0011075063897868912,
            "start_logit": 3.2325897216796875,
            "end_logit": -3.7913405895233154,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "DIPGsACVR1 (n\u2009=\u20092), PIK3CA (n\u2009=\u20092), FGFR1",
            "probability": 0.0010728550420581206,
            "start_logit": -2.468306541442871,
            "end_logit": 1.8777680397033691,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "FGFR",
            "probability": 0.0010380120485768722,
            "start_logit": 2.9636406898498535,
            "end_logit": -3.5871951580047607,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "FGFR1 (n\u2009=\u20092),",
            "probability": 0.0009058210220699842,
            "start_logit": 2.9636406898498535,
            "end_logit": -3.7234160900115967,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "DIPGsACVR1 (n\u2009=\u20092), PIK3CA",
            "probability": 0.0008338019732914287,
            "start_logit": -2.468306541442871,
            "end_logit": 1.6256853342056274,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        }
    ],
    "58dfd83a6fddd3e83e000003": [
        {
            "text": "ANGPTL3",
            "probability": 0.40701464639300905,
            "start_logit": 3.8618967533111572,
            "end_logit": 4.138418674468994,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene cause familial combined hypolipidemia. Mutations of the ANGPTL3",
            "probability": 0.22574724259681395,
            "start_logit": 3.8618967533111572,
            "end_logit": 3.548985481262207,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "APOB, and ANGPTL3",
            "probability": 0.08305420474446623,
            "start_logit": 2.9823648929595947,
            "end_logit": 3.4285948276519775,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 and ANGPTL4",
            "probability": 0.07209417151259544,
            "start_logit": 3.505643129348755,
            "end_logit": 2.763796329498291,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL4",
            "probability": 0.06891977073048695,
            "start_logit": 3.4606130123138428,
            "end_logit": 2.763796329498291,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "APOB, and ANGPTL3 and ANGPTL4",
            "probability": 0.042721186395495145,
            "start_logit": 2.9823648929595947,
            "end_logit": 2.763796329498291,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene mutations responsible for a combined hypolipidemia phenotype is about 10%, whereas mutations of APOB",
            "probability": 0.02721161676068003,
            "start_logit": 3.320124864578247,
            "end_logit": 1.9749853610992432,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "APOB",
            "probability": 0.02705333004404086,
            "start_logit": 2.9823648929595947,
            "end_logit": 2.3069114685058594,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene",
            "probability": 0.023718105286212834,
            "start_logit": 3.8618967533111572,
            "end_logit": 1.29580819606781,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene cause familial combined hypolipidemia. Mutations of the ANGPTL3 gene",
            "probability": 0.012963077786623547,
            "start_logit": 3.8618967533111572,
            "end_logit": 0.6916746497154236,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Mutations in the ANGPTL3",
            "probability": 0.0020491056689277564,
            "start_logit": -1.429548978805542,
            "end_logit": 4.138418674468994,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "apoB",
            "probability": 0.0018395854569680952,
            "start_logit": 1.7138882875442505,
            "end_logit": 0.8871182203292847,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "APOB gene",
            "probability": 0.0012333450810876685,
            "start_logit": 1.9950226545333862,
            "end_logit": 0.20617365837097168,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Mutations in the ANGPTL3 gene cause familial combined hypolipidemia. Mutations of the ANGPTL3",
            "probability": 0.001136519185855731,
            "start_logit": -1.429548978805542,
            "end_logit": 3.548985481262207,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Mutations of the ANGPTL3",
            "probability": 0.0007360572634311603,
            "start_logit": -1.8639665842056274,
            "end_logit": 3.548985481262207,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "the ANGPTL3",
            "probability": 0.000652961053083274,
            "start_logit": -2.573190212249756,
            "end_logit": 4.138418674468994,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "apoB, proprotein convertase subtilisin/kexin type 9 (PCSK9",
            "probability": 0.0005224256076160709,
            "start_logit": 1.7138882875442505,
            "end_logit": -0.3716947138309479,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "apoB, proprotein convertase subtilisin/kexin type 9 (PCSK9), and MTP",
            "probability": 0.000504697268405035,
            "start_logit": 1.7138882875442505,
            "end_logit": -0.4062185287475586,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "MTP",
            "probability": 0.0004657918203967823,
            "start_logit": 1.633668303489685,
            "end_logit": -0.4062185287475586,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "the ANGPTL3 gene cause familial combined hypolipidemia. Mutations of the ANGPTL3",
            "probability": 0.0003621593438048641,
            "start_logit": -2.573190212249756,
            "end_logit": 3.548985481262207,
            "question_text": "List genes associated with hypolipidemia."
        }
    ],
    "58c6665602b8c60953000024": [
        {
            "text": "acute hemolysis, chronic hemolysis",
            "probability": 0.14004444880946412,
            "start_logit": 5.311413288116455,
            "end_logit": 5.422919750213623,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "chronic hemolysis",
            "probability": 0.13909873541541234,
            "start_logit": 5.304637432098389,
            "end_logit": 5.422919750213623,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "acute hemolysis, chronic hemolysis, neonatal hyperbilirubinemia",
            "probability": 0.12429308086072394,
            "start_logit": 5.311413288116455,
            "end_logit": 5.30360221862793,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "chronic hemolysis, neonatal hyperbilirubinemia",
            "probability": 0.12345373569312024,
            "start_logit": 5.304637432098389,
            "end_logit": 5.30360221862793,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "acute hemolysis",
            "probability": 0.11935640710922703,
            "start_logit": 5.311413288116455,
            "end_logit": 5.263073921203613,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "neonatal hyperbilirubinemia",
            "probability": 0.11884397911893284,
            "start_logit": 5.266582489013672,
            "end_logit": 5.30360221862793,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolysis, chronic hemolysis",
            "probability": 0.06708681046029213,
            "start_logit": 4.575440883636475,
            "end_logit": 5.422919750213623,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolysis, chronic hemolysis, neonatal hyperbilirubinemia",
            "probability": 0.05954128441444974,
            "start_logit": 4.575440883636475,
            "end_logit": 5.30360221862793,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolysis",
            "probability": 0.05717642312157862,
            "start_logit": 4.575440883636475,
            "end_logit": 5.263073921203613,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hyperbilirubinemia",
            "probability": 0.02169819394528316,
            "start_logit": 3.565999984741211,
            "end_logit": 5.30360221862793,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolysis, neonatal hyperbilirubinemia",
            "probability": 0.015181745207069502,
            "start_logit": 3.208864688873291,
            "end_logit": 5.30360221862793,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.0042873218315021755,
            "start_logit": 3.682096481323242,
            "end_logit": 3.565938949584961,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "acute hemolysis, chronic hemolysis,",
            "probability": 0.0028709590569972396,
            "start_logit": 5.311413288116455,
            "end_logit": 1.535606026649475,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "chronic hemolysis,",
            "probability": 0.0028515716092472002,
            "start_logit": 5.304637432098389,
            "end_logit": 1.535606026649475,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "acute hemolysis,",
            "probability": 0.0014618386665469312,
            "start_logit": 5.311413288116455,
            "end_logit": 0.860654890537262,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolysis, chronic hemolysis,",
            "probability": 0.0013753025395392667,
            "start_logit": 4.575440883636475,
            "end_logit": 1.535606026649475,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolysis,",
            "probability": 0.0007002783357702976,
            "start_logit": 4.575440883636475,
            "end_logit": 0.860654890537262,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "acute hemolysis, chronic hemolysis, neonatal",
            "probability": 0.00022983737607190277,
            "start_logit": 5.311413288116455,
            "end_logit": -0.989423394203186,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "chronic hemolysis, neonatal",
            "probability": 0.000228285295380003,
            "start_logit": 5.304637432098389,
            "end_logit": -0.989423394203186,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "neonatal",
            "probability": 0.0002197611333912223,
            "start_logit": 5.266582489013672,
            "end_logit": -0.989423394203186,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        }
    ],
    "58d8e9bd8acda3452900000b": [
        {
            "text": "heart failure",
            "probability": 0.23444490168723092,
            "start_logit": 5.261900424957275,
            "end_logit": 4.803658962249756,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, systemic thromboembolic events, and fatal left ventricular arrhythmias",
            "probability": 0.10515546758719932,
            "start_logit": 5.261900424957275,
            "end_logit": 4.001878261566162,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, systemic thromboembolic events",
            "probability": 0.08318728092780049,
            "start_logit": 5.261900424957275,
            "end_logit": 3.7675328254699707,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "ventricular arrhythmias, thromboembolism, heart failure",
            "probability": 0.06497125850163137,
            "start_logit": 4.301069736480713,
            "end_logit": 4.4812140464782715,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, and sudden cardiac death",
            "probability": 0.06377715640009346,
            "start_logit": 4.758284091949463,
            "end_logit": 4.0054497718811035,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "ventricular arrhythmias",
            "probability": 0.052347111261719544,
            "start_logit": 4.301069736480713,
            "end_logit": 4.26516580581665,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "thromboembolism, heart failure",
            "probability": 0.049814716800967905,
            "start_logit": 4.035435199737549,
            "end_logit": 4.4812140464782715,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "ventricular arrhythmias, thromboembolism",
            "probability": 0.04501097137566408,
            "start_logit": 4.301069736480713,
            "end_logit": 4.114175319671631,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "ventricular arrhythmias, thromboembolism, heart failure, and sudden cardiac death",
            "probability": 0.040373786308138676,
            "start_logit": 4.301069736480713,
            "end_logit": 4.0054497718811035,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "thromboembolism",
            "probability": 0.034510779746691825,
            "start_logit": 4.035435199737549,
            "end_logit": 4.114175319671631,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "sudden cardiac death",
            "probability": 0.03419088547461334,
            "start_logit": 4.134848117828369,
            "end_logit": 4.0054497718811035,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "sudden cardiac death. The clinical presentations are variable ranging from asymptomatic patients to patients who develop ventricular arrhythmias",
            "probability": 0.0327196287581968,
            "start_logit": 3.831148147583008,
            "end_logit": 4.26516580581665,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "thromboembolism, heart failure, and sudden cardiac death",
            "probability": 0.03095536053179921,
            "start_logit": 4.035435199737549,
            "end_logit": 4.0054497718811035,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "left ventricular arrhythmias",
            "probability": 0.029393003260856768,
            "start_logit": 3.9872171878814697,
            "end_logit": 4.001878261566162,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "sudden cardiac death. The clinical presentation and the natural history of LVNC are highly variable, ranging from no symptoms to congestive heart failure",
            "probability": 0.02444471504408865,
            "start_logit": 4.134848117828369,
            "end_logit": 3.6699047088623047,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "systemic thromboembolic events, and fatal left ventricular arrhythmias",
            "probability": 0.023208606712721267,
            "start_logit": 3.750983715057373,
            "end_logit": 4.001878261566162,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "systemic thromboembolic events",
            "probability": 0.01836006182895811,
            "start_logit": 3.750983715057373,
            "end_logit": 3.7675328254699707,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, conduction defects",
            "probability": 0.012540834441729045,
            "start_logit": 4.582900524139404,
            "end_logit": 2.5544283390045166,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "thromboembolic events, and sudden cardiac death",
            "probability": 0.01033861883400386,
            "start_logit": 3.2369956970214844,
            "end_logit": 3.7072293758392334,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "ventricular arrhythmias, thromboembolic events, and sudden cardiac death",
            "probability": 0.01025485451589525,
            "start_logit": 3.22886061668396,
            "end_logit": 3.7072293758392334,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        }
    ],
    "58d8d8108acda34529000009": [
        {
            "text": "ADAMTSL4",
            "probability": 0.4766376696089394,
            "start_logit": 4.6083984375,
            "end_logit": 4.443641662597656,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "FBN1",
            "probability": 0.25070810632057,
            "start_logit": 4.555372714996338,
            "end_logit": 3.8542001247406006,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4. Here we report a novel founder mutation in ADAMTSL4",
            "probability": 0.20156978001723466,
            "start_logit": 4.152276039123535,
            "end_logit": 4.039143085479736,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "FBN1 gene",
            "probability": 0.047806915447438994,
            "start_logit": 4.458831310272217,
            "end_logit": 2.2936224937438965,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4 gene",
            "probability": 0.010029029599194286,
            "start_logit": 4.228423595428467,
            "end_logit": 0.9623437523841858,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4. Here we report a novel founder mutation in ADAMTSL4 gene",
            "probability": 0.009293695724016657,
            "start_logit": 4.152276039123535,
            "end_logit": 0.9623437523841858,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "FBN1 mutation",
            "probability": 0.0022337640530857086,
            "start_logit": 4.555372714996338,
            "end_logit": -0.8664011359214783,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "FBN1 mutation that has previously been reported only in Marfan syndrome",
            "probability": 0.00023501944884929648,
            "start_logit": 3.958705425262451,
            "end_logit": -2.5215089321136475,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "FBN1 mutation with non-penetrance.Isolated ectopia lentis is usually autosomal dominant",
            "probability": 0.00018721955809506305,
            "start_logit": 4.555372714996338,
            "end_logit": -3.34556245803833,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "mutations of FBN1",
            "probability": 0.0001653026351356213,
            "start_logit": -2.7261900901794434,
            "end_logit": 3.8114962577819824,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "FBN1 mutation with non-penetrance.",
            "probability": 0.00015519425778428444,
            "start_logit": 4.555372714996338,
            "end_logit": -3.5331668853759766,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "AD",
            "probability": 0.00013258390981549614,
            "start_logit": 4.6083984375,
            "end_logit": -3.743654489517212,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "FBN",
            "probability": 0.00012196422195948137,
            "start_logit": 4.458831310272217,
            "end_logit": -3.6775753498077393,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "4",
            "probability": 0.00011752308883197259,
            "start_logit": -3.6994786262512207,
            "end_logit": 4.443641662597656,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "F",
            "probability": 0.0001076902632774081,
            "start_logit": 4.555372714996338,
            "end_logit": -3.898585319519043,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4 gene in children of Bukharian Jewish origin presenting with early-onset bilateral EL.",
            "probability": 0.00010651199279303281,
            "start_logit": 4.228423595428467,
            "end_logit": -3.5826377868652344,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4.",
            "probability": 0.00010590373641901311,
            "start_logit": 4.152276039123535,
            "end_logit": -3.5122172832489014,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "A founder mutation in ADAMTSL4",
            "probability": 0.00010244711573771198,
            "start_logit": -3.8367667198181152,
            "end_logit": 4.443641662597656,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "FBN1 gene. In conclusion, we report on a case of early-onset autosomal dominant",
            "probability": 9.481184040255181e-05,
            "start_logit": 4.458831310272217,
            "end_logit": -3.9294087886810303,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "autosomal dominant and commonly due to the mutations of FBN1",
            "probability": 8.88671604188219e-05,
            "start_logit": -3.346825361251831,
            "end_logit": 3.8114962577819824,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        }
    ],
    "5880b2a6c872c95565000004": [
        {
            "text": "interleukin-13",
            "probability": 0.35322960387648095,
            "start_logit": 5.703707218170166,
            "end_logit": 5.17605447769165,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13",
            "probability": 0.322109112104069,
            "start_logit": 5.61147928237915,
            "end_logit": 5.17605447769165,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4",
            "probability": 0.20708608450164062,
            "start_logit": 5.61147928237915,
            "end_logit": 4.7342987060546875,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signalling, key drivers of type-2-mediated inflammation. Anti-IL-4 and IL-13",
            "probability": 0.026468020789093855,
            "start_logit": 5.703707218170166,
            "end_logit": 2.5848734378814697,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signalling, key drivers of type-2-mediated inflammation. Anti-IL-4",
            "probability": 0.025122955384102044,
            "start_logit": 5.703707218170166,
            "end_logit": 2.5327181816101074,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signalling, key drivers of type-2-mediated inflammation. Anti-IL-4",
            "probability": 0.022909554475034927,
            "start_logit": 5.61147928237915,
            "end_logit": 2.5327181816101074,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 receptor \u03b1 monoclonal antibody, inhibits interleukin-4",
            "probability": 0.012148699268013674,
            "start_logit": 2.775566816329956,
            "end_logit": 4.7342987060546875,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signalling,",
            "probability": 0.0068015800819334945,
            "start_logit": 5.703707218170166,
            "end_logit": 1.2260911464691162,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signalling,",
            "probability": 0.006202342320839071,
            "start_logit": 5.61147928237915,
            "end_logit": 1.2260911464691162,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signalling",
            "probability": 0.003786190551641378,
            "start_logit": 5.703707218170166,
            "end_logit": 0.6402965784072876,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signalling",
            "probability": 0.0034526168346650904,
            "start_logit": 5.61147928237915,
            "end_logit": 0.6402965784072876,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 and IL-13",
            "probability": 0.0015398090714840473,
            "start_logit": 2.8594284057617188,
            "end_logit": 2.5848734378814697,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signalling, key drivers of type-2-mediated inflammation",
            "probability": 0.0014939547588261831,
            "start_logit": 5.703707218170166,
            "end_logit": -0.2896369993686676,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-4",
            "probability": 0.001461558267283411,
            "start_logit": 2.8594284057617188,
            "end_logit": 2.5327181816101074,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-13",
            "probability": 0.0014032728624778295,
            "start_logit": 2.7665772438049316,
            "end_logit": 2.5848734378814697,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signalling, key drivers of type-2-mediated inflammation",
            "probability": 0.0013623332688089882,
            "start_logit": 5.61147928237915,
            "end_logit": -0.2896369993686676,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "type-2-mediated inflammation. Anti-IL-4 and IL-13",
            "probability": 0.0009662334984497769,
            "start_logit": 2.3934202194213867,
            "end_logit": 2.5848734378814697,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "type-2-mediated inflammation. Anti-IL-4",
            "probability": 0.0009171309508031268,
            "start_logit": 2.3934202194213867,
            "end_logit": 2.5327181816101074,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signalling, key drivers of type-2",
            "probability": 0.0008049319160754638,
            "start_logit": 5.703707218170166,
            "end_logit": -0.9080613851547241,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signalling, key drivers of type-2",
            "probability": 0.0007340152182770034,
            "start_logit": 5.61147928237915,
            "end_logit": -0.9080613851547241,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        }
    ],
    "58e0035f6fddd3e83e000009": [
        {
            "text": "actin filaments, microtubules, and intermediate filaments",
            "probability": 0.19820238995546116,
            "start_logit": 5.100541114807129,
            "end_logit": 5.123600006103516,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin filaments, microtubules",
            "probability": 0.175391977613633,
            "start_logit": 5.100541114807129,
            "end_logit": 5.0013346672058105,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin filaments",
            "probability": 0.16667703737770112,
            "start_logit": 5.100541114807129,
            "end_logit": 4.950369358062744,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "microtubules, and intermediate filaments",
            "probability": 0.16447774235293713,
            "start_logit": 4.914027690887451,
            "end_logit": 5.123600006103516,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "microtubules",
            "probability": 0.14554858047468455,
            "start_logit": 4.914027690887451,
            "end_logit": 5.0013346672058105,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "intermediate filaments",
            "probability": 0.11466037673006828,
            "start_logit": 4.553226947784424,
            "end_logit": 5.123600006103516,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "Fibrillar polymers-actin filaments, microtubules, and intermediate filaments",
            "probability": 0.00938958686172737,
            "start_logit": 2.050853729248047,
            "end_logit": 5.123600006103516,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "Fibrillar polymers-actin filaments, microtubules",
            "probability": 0.00830897250544467,
            "start_logit": 2.050853729248047,
            "end_logit": 5.0013346672058105,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "Fibrillar polymers-actin filaments",
            "probability": 0.007896113264148772,
            "start_logit": 2.050853729248047,
            "end_logit": 4.950369358062744,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "Fibrillar polymers",
            "probability": 0.001963758812845631,
            "start_logit": 2.050853729248047,
            "end_logit": 3.55885910987854,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin filaments,",
            "probability": 0.0012466053779604538,
            "start_logit": 5.100541114807129,
            "end_logit": 0.05473548546433449,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin filaments, microtubules,",
            "probability": 0.0009549990906385871,
            "start_logit": 5.100541114807129,
            "end_logit": -0.21173356473445892,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin",
            "probability": 0.0009040645056452545,
            "start_logit": 5.100541114807129,
            "end_logit": -0.2665432393550873,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "microtubules,",
            "probability": 0.0007925035334469981,
            "start_logit": 4.914027690887451,
            "end_logit": -0.21173356473445892,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "polymers-actin filaments, microtubules, and intermediate filaments",
            "probability": 0.0007643645651329259,
            "start_logit": -0.4574579894542694,
            "end_logit": 5.123600006103516,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "polymers-actin filaments, microtubules",
            "probability": 0.0006763965496408717,
            "start_logit": -0.4574579894542694,
            "end_logit": 5.0013346672058105,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "polymers-actin filaments",
            "probability": 0.0006427875124083013,
            "start_logit": -0.4574579894542694,
            "end_logit": 4.950369358062744,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "filaments, microtubules, and intermediate filaments",
            "probability": 0.0005509250210518357,
            "start_logit": -0.7849041223526001,
            "end_logit": 5.123600006103516,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "filaments, microtubules",
            "probability": 0.0004875210081009996,
            "start_logit": -0.7849041223526001,
            "end_logit": 5.0013346672058105,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "filaments",
            "probability": 0.0004632968873221069,
            "start_logit": -0.7849041223526001,
            "end_logit": 4.950369358062744,
            "question_text": "List the three main structures of the cytoskeleton."
        }
    ],
    "5880b583c872c95565000005": [
        {
            "text": "Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery",
            "probability": 0.26793102034785515,
            "start_logit": 4.142877101898193,
            "end_logit": 4.342947006225586,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Coronary Artery Bypass Surgery",
            "probability": 0.25261639673615716,
            "start_logit": 4.084019660949707,
            "end_logit": 4.342947006225586,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Everolimus-Eluting Stent",
            "probability": 0.13686257855747694,
            "start_logit": 4.142877101898193,
            "end_logit": 3.6711947917938232,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery",
            "probability": 0.08034249966779759,
            "start_logit": 3.638890266418457,
            "end_logit": 3.642503023147583,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Everolimus Eluting Stent",
            "probability": 0.05034422352181804,
            "start_logit": 3.638890266418457,
            "end_logit": 3.1750881671905518,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Everolimus",
            "probability": 0.04555963038462955,
            "start_logit": 4.142877101898193,
            "end_logit": 2.571239471435547,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization",
            "probability": 0.045117006597675466,
            "start_logit": 4.142877101898193,
            "end_logit": 2.561476707458496,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization",
            "probability": 0.04253817129285398,
            "start_logit": 4.084019660949707,
            "end_logit": 2.561476707458496,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery",
            "probability": 0.01844242990216856,
            "start_logit": 1.4668015241622925,
            "end_logit": 4.342947006225586,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Bypass Surgery",
            "probability": 0.015337148043370736,
            "start_logit": 1.2824254035949707,
            "end_logit": 4.342947006225586,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization",
            "probability": 0.013487471105628077,
            "start_logit": 3.638890266418457,
            "end_logit": 1.8579654693603516,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Xience Everolimus-Eluting Stent",
            "probability": 0.009420628145256535,
            "start_logit": 1.4668015241622925,
            "end_logit": 3.6711947917938232,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery",
            "probability": 0.005282149888439424,
            "start_logit": 0.9169247150421143,
            "end_logit": 3.642503023147583,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Xience Everolimus Eluting Stent",
            "probability": 0.0033099011825484356,
            "start_logit": 0.9169247150421143,
            "end_logit": 3.1750881671905518,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Xience Everolimus",
            "probability": 0.0031359948118227115,
            "start_logit": 1.4668015241622925,
            "end_logit": 2.571239471435547,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization",
            "probability": 0.003105527797763142,
            "start_logit": 1.4668015241622925,
            "end_logit": 2.561476707458496,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Left Main Revascularization",
            "probability": 0.0030729358991924438,
            "start_logit": 1.4562512636184692,
            "end_logit": 2.561476707458496,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Bypass Surgery for Effectiveness of Left Main Revascularization",
            "probability": 0.0025826282024526397,
            "start_logit": 1.2824254035949707,
            "end_logit": 2.561476707458496,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization",
            "probability": 0.0008867392014251511,
            "start_logit": 0.9169247150421143,
            "end_logit": 1.8579654693603516,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Everolimus-Eluting Stent Versus Coronary Artery Bypass",
            "probability": 0.0006249187136681404,
            "start_logit": 4.142877101898193,
            "end_logit": -1.7179162502288818,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        }
    ],
    "58add7699ef3c34033000009": [
        {
            "text": "Pap1",
            "probability": 0.2788882852696713,
            "start_logit": 4.992544651031494,
            "end_logit": 4.683281421661377,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ssu72",
            "probability": 0.2147051372783766,
            "start_logit": 4.950923919677734,
            "end_logit": 4.4633564949035645,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pap1 produces mRNA",
            "probability": 0.12990407988580835,
            "start_logit": 4.992544651031494,
            "end_logit": 3.91926646232605,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pap1 produces mRNA 3' ends, whereas those of nonpolyadenylated snoRNAs",
            "probability": 0.10427614169020297,
            "start_logit": 4.992544651031494,
            "end_logit": 3.6995127201080322,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pap",
            "probability": 0.09871287419523449,
            "start_logit": 4.992544651031494,
            "end_logit": 3.6446855068206787,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "snoRNAs",
            "probability": 0.04139492120414564,
            "start_logit": 4.068660259246826,
            "end_logit": 3.6995127201080322,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ssu72,",
            "probability": 0.02590976469167669,
            "start_logit": 4.950923919677734,
            "end_logit": 2.348710775375366,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "mRNA",
            "probability": 0.020411268609771077,
            "start_logit": 3.1418354511260986,
            "end_logit": 3.91926646232605,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "mRNA 3' ends, whereas those of nonpolyadenylated snoRNAs",
            "probability": 0.01638446105388106,
            "start_logit": 3.1418354511260986,
            "end_logit": 3.6995127201080322,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "polyadenosine polymerase (PAP",
            "probability": 0.01524799897986661,
            "start_logit": 3.370028495788574,
            "end_logit": 3.3994345664978027,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "PAP",
            "probability": 0.014781337590116028,
            "start_logit": 3.3389456272125244,
            "end_logit": 3.3994345664978027,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ssu",
            "probability": 0.008961592454583226,
            "start_logit": 4.950923919677734,
            "end_logit": 1.287038803100586,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "polyadenosine polymerase (PAP)",
            "probability": 0.005188147441509596,
            "start_logit": 3.370028495788574,
            "end_logit": 2.3213629722595215,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "poly(A) polymerase Pap1",
            "probability": 0.005099035193400431,
            "start_logit": 0.9907847046852112,
            "end_logit": 4.683281421661377,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "PAP)",
            "probability": 0.0050293654204403,
            "start_logit": 3.3389456272125244,
            "end_logit": 2.3213629722595215,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "polyadenosine polymerase (PAP), a key component of the mRNA",
            "probability": 0.0040306221189302955,
            "start_logit": 3.370028495788574,
            "end_logit": 2.0689070224761963,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "PAP), a key component of the mRNA",
            "probability": 0.003907265885626304,
            "start_logit": 3.3389456272125244,
            "end_logit": 2.0689070224761963,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "polyadenosine polymerase",
            "probability": 0.0028860827168653317,
            "start_logit": 3.370028495788574,
            "end_logit": 1.7348864078521729,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "poly(A) polymerase Pap1 produces mRNA",
            "probability": 0.0023750925015138,
            "start_logit": 0.9907847046852112,
            "end_logit": 3.91926646232605,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "poly(A) polymerase Pap1 produces mRNA 3' ends, whereas those of nonpolyadenylated snoRNAs",
            "probability": 0.00190652581838,
            "start_logit": 0.9907847046852112,
            "end_logit": 3.6995127201080322,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        }
    ],
    "587d30fb31b33e8760000001": [
        {
            "text": "EP-DNN",
            "probability": 0.4790599356835209,
            "start_logit": 3.8245744705200195,
            "end_logit": 3.66687273979187,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "EP-DNN: A Deep Neural Network-Based Global Enhancer Prediction AlgorithmWe present EP-DNN",
            "probability": 0.29750415816936754,
            "start_logit": 3.8245744705200195,
            "end_logit": 3.1904752254486084,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "Deep Neural Network-Based Global Enhancer Prediction AlgorithmWe present EP-DNN",
            "probability": 0.0931732453577698,
            "start_logit": 2.663606882095337,
            "end_logit": 3.1904752254486084,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "EP-DNN: A Deep Neural Network",
            "probability": 0.04179091448743193,
            "start_logit": 3.8245744705200195,
            "end_logit": 1.2277259826660156,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep neural network (DNN)-based architecture, called EP-DNN",
            "probability": 0.02737058276960577,
            "start_logit": 1.889868974685669,
            "end_logit": 2.7392213344573975,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "Deep Neural Network",
            "probability": 0.013088204054769391,
            "start_logit": 2.663606882095337,
            "end_logit": 1.2277259826660156,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "EP-DNN: A Deep",
            "probability": 0.011007721422945269,
            "start_logit": 3.8245744705200195,
            "end_logit": -0.10635600239038467,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "Deep Learning methods and develop a deep neural network (DNN)-based architecture, called EP-DNN",
            "probability": 0.010699116682686647,
            "start_logit": 0.9505613446235657,
            "end_logit": 2.7392213344573975,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "EP-DNN: A Deep Neural Network-Based Global Enhancer Prediction AlgorithmWe present EP-DNN,",
            "probability": 0.004809828530333372,
            "start_logit": 3.8245744705200195,
            "end_logit": -0.9342915415763855,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "Deep",
            "probability": 0.0034474312402254744,
            "start_logit": 2.663606882095337,
            "end_logit": -0.10635600239038467,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep neural network",
            "probability": 0.0033379018511169017,
            "start_logit": 1.889868974685669,
            "end_logit": 0.635094940662384,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "EP-DNN: A Deep Neural Network-Based Global Enhancer Prediction Algorithm",
            "probability": 0.0024207935026539854,
            "start_logit": 3.8245744705200195,
            "end_logit": -1.6208575963974,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "EP-DNN,",
            "probability": 0.0024079987075616813,
            "start_logit": 3.13270902633667,
            "end_logit": -0.9342915415763855,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DNN)-based architecture, called EP-DNN",
            "probability": 0.002268443046424934,
            "start_logit": -0.6005061268806458,
            "end_logit": 2.7392213344573975,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "EP-DNN: A Deep Neural Network-Based Global Enhancer Prediction",
            "probability": 0.00186074242870537,
            "start_logit": 3.8245744705200195,
            "end_logit": -1.8839774131774902,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "Deep Neural Network-Based Global Enhancer Prediction AlgorithmWe present EP-DNN,",
            "probability": 0.0015063565381510555,
            "start_logit": 2.663606882095337,
            "end_logit": -0.9342915415763855,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep neural network (DNN)",
            "probability": 0.0014195346130342352,
            "start_logit": 1.889868974685669,
            "end_logit": -0.2199184000492096,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "Deep Learning methods and develop a deep neural network",
            "probability": 0.0013047804528339558,
            "start_logit": 0.9505613446235657,
            "end_logit": 0.635094940662384,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "A Deep Neural Network-Based Global Enhancer Prediction AlgorithmWe present EP-DNN",
            "probability": 0.0007636174776325512,
            "start_logit": -2.1405420303344727,
            "end_logit": 3.1904752254486084,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep neural network (DNN)-based architecture, called EP-DNN,",
            "probability": 0.0007586929832291595,
            "start_logit": 1.889868974685669,
            "end_logit": -0.846405565738678,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        }
    ],
    "58a6c94860087bc10a00002a": [
        {
            "text": "H3F3A K27M",
            "probability": 0.6161249438931,
            "start_logit": 2.3134589195251465,
            "end_logit": 1.3584725856781006,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M",
            "probability": 0.1850206770536385,
            "start_logit": 1.1104767322540283,
            "end_logit": 1.3584725856781006,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3F3A",
            "probability": 0.1502352419737657,
            "start_logit": 2.3134589195251465,
            "end_logit": -0.05277484282851219,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3F3A K27M mutation",
            "probability": 0.02336744006787203,
            "start_logit": 2.3134589195251465,
            "end_logit": -1.9136335849761963,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M mutation",
            "probability": 0.007017179916543258,
            "start_logit": 1.1104767322540283,
            "end_logit": -1.9136335849761963,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3F3A gene (encoding histone H3 variant H3.3), replacing the lysine 27",
            "probability": 0.003569231053853496,
            "start_logit": 0.31582388281822205,
            "end_logit": -1.7949919700622559,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3F3A gene (encoding histone H3 variant H3.3",
            "probability": 0.0029861059149546964,
            "start_logit": 0.31582388281822205,
            "end_logit": -1.973371982574463,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "methionine (K27M",
            "probability": 0.0017816333966955114,
            "start_logit": -1.8711254596710205,
            "end_logit": -0.3028622269630432,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.3), replacing the lysine 27 with methionine (K27M",
            "probability": 0.0015832540775545245,
            "start_logit": -1.9891737699508667,
            "end_logit": -0.3028622269630432,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "lysine 27 with methionine (K27M",
            "probability": 0.0015147555543820735,
            "start_logit": -2.0334019660949707,
            "end_logit": -0.3028622269630432,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3F3A gene (encoding histone H3 variant H3.3), replacing the lysine 27 with methionine",
            "probability": 0.0013924321065734348,
            "start_logit": 0.31582388281822205,
            "end_logit": -2.736290216445923,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M)",
            "probability": 0.0013060856485075617,
            "start_logit": 0.5918372273445129,
            "end_logit": -3.0763208866119385,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3F3A K27M mutation in a newly obtained pediatric brainstem glioblastoma sample whose H3.3",
            "probability": 0.0008954813692536236,
            "start_logit": 1.004926085472107,
            "end_logit": -3.866838216781616,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M).In order to facilitate diagnosis of DIPG patients, a quick and reliable method to identify the H3F3A",
            "probability": 0.0007592878430037876,
            "start_logit": 0.5918372273445129,
            "end_logit": -3.618729829788208,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3F3A gene (encoding histone H3 variant H3.3),",
            "probability": 0.0005794828908116864,
            "start_logit": 0.31582388281822205,
            "end_logit": -3.6129612922668457,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "replacing the lysine 27 with methionine (K27M",
            "probability": 0.000517742598085959,
            "start_logit": -3.106933116912842,
            "end_logit": -0.3028622269630432,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.3), replacing the lysine 27",
            "probability": 0.0003560630449492806,
            "start_logit": -1.9891737699508667,
            "end_logit": -1.7949919700622559,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3 variant H3.3), replacing the lysine 27 with methionine (K27M",
            "probability": 0.0003544123583186078,
            "start_logit": -3.485950231552124,
            "end_logit": -0.3028622269630432,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "lysine 27",
            "probability": 0.00034065819421743595,
            "start_logit": -2.0334019660949707,
            "end_logit": -1.7949919700622559,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.3",
            "probability": 0.00029789104391880295,
            "start_logit": -1.9891737699508667,
            "end_logit": -1.973371982574463,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        }
    ],
    "58da5b588acda34529000015": [
        {
            "text": "headache",
            "probability": 0.09262068390739042,
            "start_logit": 4.738311290740967,
            "end_logit": 5.282566547393799,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "palpitations",
            "probability": 0.09135943023374982,
            "start_logit": 5.054396152496338,
            "end_logit": 4.952770709991455,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "palpitation",
            "probability": 0.09088404234794248,
            "start_logit": 4.963387966156006,
            "end_logit": 5.038561820983887,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "episodic headache",
            "probability": 0.07004216055766596,
            "start_logit": 4.458896160125732,
            "end_logit": 5.282566547393799,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, increased sweating, and palpitations",
            "probability": 0.06660080387289903,
            "start_logit": 4.738311290740967,
            "end_logit": 4.952770709991455,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "increased sweating, and palpitations",
            "probability": 0.058197244731329055,
            "start_logit": 4.603432655334473,
            "end_logit": 4.952770709991455,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, increased sweating",
            "probability": 0.05649674537578659,
            "start_logit": 4.738311290740967,
            "end_logit": 4.78823709487915,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "episodic headache, excessive sweating and palpitation",
            "probability": 0.05583204201601848,
            "start_logit": 4.476151466369629,
            "end_logit": 5.038561820983887,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, excessive sweating and palpitation",
            "probability": 0.051740010120899176,
            "start_logit": 4.4000349044799805,
            "end_logit": 5.038561820983887,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "excessive sweating and palpitation",
            "probability": 0.050423044886541896,
            "start_logit": 4.374251842498779,
            "end_logit": 5.038561820983887,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "episodic headache, increased sweating, and palpitations",
            "probability": 0.050365253217083995,
            "start_logit": 4.458896160125732,
            "end_logit": 4.952770709991455,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "increased sweating",
            "probability": 0.04936809656881872,
            "start_logit": 4.603432655334473,
            "end_logit": 4.78823709487915,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "episodic headache, increased sweating",
            "probability": 0.04272430243068704,
            "start_logit": 4.458896160125732,
            "end_logit": 4.78823709487915,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "episodic headache, excessive sweating",
            "probability": 0.029736322473636764,
            "start_logit": 4.476151466369629,
            "end_logit": 4.408583164215088,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, excessive sweating",
            "probability": 0.027556893321273625,
            "start_logit": 4.4000349044799805,
            "end_logit": 4.408583164215088,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "excessive sweating",
            "probability": 0.0268554734648374,
            "start_logit": 4.374251842498779,
            "end_logit": 4.408583164215088,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "palpitations. Among the presenting symptoms, episodes of palpitations, headache",
            "probability": 0.024823867491459355,
            "start_logit": 5.054396152496338,
            "end_logit": 3.6497747898101807,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "palpitations. Among the presenting symptoms, episodes of palpitations",
            "probability": 0.02316079708683106,
            "start_logit": 5.054396152496338,
            "end_logit": 3.580430269241333,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headaches, and profuse sweating are typical and constitute a classic triad.The classic triad of symptoms are episodic headache",
            "probability": 0.02291841212473155,
            "start_logit": 3.583299398422241,
            "end_logit": 5.041006565093994,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "profuse sweating are typical and constitute a classic triad.The classic triad of symptoms are episodic headache",
            "probability": 0.01829437377041744,
            "start_logit": 3.357952356338501,
            "end_logit": 5.041006565093994,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        }
    ],
    "58da5dc58acda34529000016": [
        {
            "text": "CRS type 4",
            "probability": 0.2720549522241547,
            "start_logit": 4.400595188140869,
            "end_logit": 4.190440654754639,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type 3",
            "probability": 0.2354955862445017,
            "start_logit": 4.3626017570495605,
            "end_logit": 4.084122180938721,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type 5",
            "probability": 0.23225496614919405,
            "start_logit": 4.4125285148620605,
            "end_logit": 4.020339012145996,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type 2",
            "probability": 0.14346460810977857,
            "start_logit": 4.213894844055176,
            "end_logit": 3.737225294113159,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type 1",
            "probability": 0.07444098731484709,
            "start_logit": 3.746434211730957,
            "end_logit": 3.5486042499542236,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type 4",
            "probability": 0.006024702590270154,
            "start_logit": 0.5904592275619507,
            "end_logit": 4.190440654754639,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type 3 = acute worsening of kidney function (acute kidney injury) leading to heart injury and/or dysfunction; CRS type 4",
            "probability": 0.005251895932917785,
            "start_logit": 0.4531802535057068,
            "end_logit": 4.190440654754639,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type 4 = chronic kidney disease (chronic kidney disease) leading to heart injury, disease and/or dysfunction; and CRS type 5",
            "probability": 0.005082313000062626,
            "start_logit": 0.5904592275619507,
            "end_logit": 4.020339012145996,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type 3",
            "probability": 0.004722180520845676,
            "start_logit": 0.4531802535057068,
            "end_logit": 4.084122180938721,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type 2",
            "probability": 0.004335236692118734,
            "start_logit": 0.7145826816558838,
            "end_logit": 3.737225294113159,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type 1",
            "probability": 0.0038362510908818027,
            "start_logit": 0.7809231281280518,
            "end_logit": 3.5486042499542236,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type 4 = chronic kidney disease",
            "probability": 0.003070244854300246,
            "start_logit": 4.400595188140869,
            "end_logit": -0.2938061058521271,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "chronic kidney disease (chronic kidney disease) leading to heart injury, disease and/or dysfunction; and CRS type 5",
            "probability": 0.002295783261778246,
            "start_logit": -0.20423316955566406,
            "end_logit": 4.020339012145996,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type 4 = chronic kidney disease (chronic kidney disease)",
            "probability": 0.001594444583783038,
            "start_logit": 4.400595188140869,
            "end_logit": -0.9490379691123962,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type 5",
            "probability": 0.0013441519995131457,
            "start_logit": -0.7395439147949219,
            "end_logit": 4.020339012145996,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "3 = acute worsening of kidney function (acute kidney injury) leading to heart injury and/or dysfunction; CRS type 4",
            "probability": 0.0010650499891911647,
            "start_logit": -1.1423871517181396,
            "end_logit": 4.190440654754639,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "4",
            "probability": 0.0010507580611631108,
            "start_logit": -1.1558970212936401,
            "end_logit": 4.190440654754639,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "3",
            "probability": 0.0009576271839589299,
            "start_logit": -1.1423871517181396,
            "end_logit": 4.084122180938721,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "4 = chronic kidney disease (chronic kidney disease) leading to heart injury, disease and/or dysfunction; and CRS type 5",
            "probability": 0.000886397506624541,
            "start_logit": -1.1558970212936401,
            "end_logit": 4.020339012145996,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type 1 = acute worsening of heart function (acute heart failure-acute coronary syndrome",
            "probability": 0.0007718626901148649,
            "start_logit": 3.746434211730957,
            "end_logit": -1.0203510522842407,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        }
    ],
    "58dcecf58acda34529000023": [
        {
            "text": "MCM",
            "probability": 0.07299253536268924,
            "start_logit": 4.756535053253174,
            "end_logit": 3.6299567222595215,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "MCM, ORC and Cdt1",
            "probability": 0.06447662459263492,
            "start_logit": 4.5793538093566895,
            "end_logit": 3.6830835342407227,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Sap1/Girdin",
            "probability": 0.06402436272931396,
            "start_logit": 4.478255748748779,
            "end_logit": 3.7771425247192383,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdt1",
            "probability": 0.0636836508302211,
            "start_logit": 4.566978931427002,
            "end_logit": 3.6830835342407227,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc6",
            "probability": 0.06263977479487919,
            "start_logit": 4.568807125091553,
            "end_logit": 3.6647279262542725,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc6 and the MCM",
            "probability": 0.06049914619468769,
            "start_logit": 4.568807125091553,
            "end_logit": 3.6299567222595215,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "MCM replicative helicase in conjunction with Cdt1",
            "probability": 0.060485214098739616,
            "start_logit": 4.756535053253174,
            "end_logit": 3.4419984817504883,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc6/Cdc18, MCM, ORC and Cdt1",
            "probability": 0.05516066779071896,
            "start_logit": 4.4233012199401855,
            "end_logit": 3.6830835342407227,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc6/Cdc18, MCM",
            "probability": 0.0524894337769711,
            "start_logit": 4.4233012199401855,
            "end_logit": 3.6334452629089355,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1",
            "probability": 0.05013257577907232,
            "start_logit": 4.568807125091553,
            "end_logit": 3.4419984817504883,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "MCM, ORC",
            "probability": 0.046562359805937814,
            "start_logit": 4.5793538093566895,
            "end_logit": 3.3575732707977295,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc6, and Cdt1",
            "probability": 0.045904326547612825,
            "start_logit": 4.431161880493164,
            "end_logit": 3.49153208732605,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc6/Cdc18",
            "probability": 0.043230182753653645,
            "start_logit": 4.4233012199401855,
            "end_logit": 3.4393723011016846,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc18, MCM, ORC and Cdt1",
            "probability": 0.04311291582244915,
            "start_logit": 4.176873683929443,
            "end_logit": 3.6830835342407227,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc18, MCM",
            "probability": 0.04102511138154368,
            "start_logit": 4.176873683929443,
            "end_logit": 3.6334452629089355,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc6/Cdc18, MCM, ORC",
            "probability": 0.03983475991546628,
            "start_logit": 4.4233012199401855,
            "end_logit": 3.3575732707977295,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Sap1",
            "probability": 0.03395624828338169,
            "start_logit": 4.478255748748779,
            "end_logit": 3.142951726913452,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdc18",
            "probability": 0.033788191925423934,
            "start_logit": 4.176873683929443,
            "end_logit": 3.4393723011016846,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2-7) complex onto DNA.ORC1",
            "probability": 0.033079005701511816,
            "start_logit": 4.466650485992432,
            "end_logit": 3.128382921218872,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "ORC and Cdt1",
            "probability": 0.032922911913091005,
            "start_logit": 3.907219886779785,
            "end_logit": 3.6830835342407227,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        }
    ],
    "58eb2887eda5a57672000003": [
        {
            "text": "BWA",
            "probability": 0.34753257345439764,
            "start_logit": 3.9138753414154053,
            "end_logit": 3.4641005992889404,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Burrows-Wheeler Aligner's Smith-Waterman Alignment (BWA-SW",
            "probability": 0.10179012234638388,
            "start_logit": 3.984804391860962,
            "end_logit": 2.1652262210845947,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Burrows-Wheeler Alignment tool (BWA",
            "probability": 0.10135279683181965,
            "start_logit": 2.681624412536621,
            "end_logit": 3.4641005992889404,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Burrows-Wheeler Aligner",
            "probability": 0.07463483496130242,
            "start_logit": 3.984804391860962,
            "end_logit": 1.854920506477356,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Burrows-Wheeler Aligner's Smith-Waterman",
            "probability": 0.06917476365478584,
            "start_logit": 3.984804391860962,
            "end_logit": 1.77894926071167,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Burrows-Wheeler Aligner's Smith-Waterman Alignment (BWA",
            "probability": 0.06252940167539536,
            "start_logit": 3.984804391860962,
            "end_logit": 1.6779500246047974,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "BWA-SW",
            "probability": 0.05764189866939968,
            "start_logit": 3.4161410331726074,
            "end_logit": 2.1652262210845947,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "BWA)",
            "probability": 0.04347436458882405,
            "start_logit": 3.9138753414154053,
            "end_logit": 1.385413646697998,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "(BWA",
            "probability": 0.022623054725470354,
            "start_logit": 1.1819864511489868,
            "end_logit": 3.4641005992889404,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Burrows-Wheeler Aligner's Smith-Waterman Alignment (BWA-SW)",
            "probability": 0.019512648678680973,
            "start_logit": 3.984804391860962,
            "end_logit": 0.5133760571479797,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Smith-Waterman Alignment (BWA-SW",
            "probability": 0.017514747765568217,
            "start_logit": 2.2249345779418945,
            "end_logit": 2.1652262210845947,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Burrows-Wheeler Alignment tool (BWA)",
            "probability": 0.012678663176134529,
            "start_logit": 2.681624412536621,
            "end_logit": 1.385413646697998,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "SOAP2",
            "probability": 0.012313353430272768,
            "start_logit": 2.2138917446136475,
            "end_logit": 1.823910117149353,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Smith-Waterman",
            "probability": 0.011902712259579196,
            "start_logit": 2.2249345779418945,
            "end_logit": 1.77894926071167,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "BWA-SW)",
            "probability": 0.011049658768271254,
            "start_logit": 3.4161410331726074,
            "end_logit": 0.5133760571479797,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Smith-Waterman Alignment (BWA",
            "probability": 0.010759263011293112,
            "start_logit": 2.2249345779418945,
            "end_logit": 1.6779500246047974,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "BWA), a new read alignment package that is based on backward search with Burrows-Wheeler Transform (BWT",
            "probability": 0.009999730457252064,
            "start_logit": 3.9138753414154053,
            "end_logit": -0.08419965952634811,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Burrows-Wheeler Aligner's Smith-Waterman Alignment",
            "probability": 0.0067694138184744655,
            "start_logit": 3.984804391860962,
            "end_logit": -0.5452723503112793,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Burrows-Wheeler Alignment tool",
            "probability": 0.0033885096721831647,
            "start_logit": 2.681624412536621,
            "end_logit": 0.0658833310008049,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "Smith-Waterman Alignment (BWA-SW)",
            "probability": 0.003357488054511473,
            "start_logit": 2.2249345779418945,
            "end_logit": 0.5133760571479797,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        }
    ],
    "58da14178acda34529000011": [
        {
            "text": "21",
            "probability": 0.22242239539710382,
            "start_logit": 2.8413925170898438,
            "end_logit": 3.0833027362823486,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13-15, 21",
            "probability": 0.15005546191926972,
            "start_logit": 2.447819232940674,
            "end_logit": 3.0833027362823486,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "21, and 22",
            "probability": 0.14731460167130941,
            "start_logit": 2.8413925170898438,
            "end_logit": 2.671294927597046,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13-15, 21, and 22",
            "probability": 0.09938459911725864,
            "start_logit": 2.447819232940674,
            "end_logit": 2.671294927597046,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13-15",
            "probability": 0.09144117390901883,
            "start_logit": 2.447819232940674,
            "end_logit": 2.587993621826172,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "22",
            "probability": 0.08591774688316257,
            "start_logit": 2.3022124767303467,
            "end_logit": 2.671294927597046,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13",
            "probability": 0.07575508990843507,
            "start_logit": 2.447819232940674,
            "end_logit": 2.399803400039673,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "15, 21",
            "probability": 0.024431076834322246,
            "start_logit": 0.6326702237129211,
            "end_logit": 3.0833027362823486,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "21, and 22. ROBs can be classified into two groups depending on their frequency of occurrence, common (rob(13",
            "probability": 0.019081193508763365,
            "start_logit": 2.8413925170898438,
            "end_logit": 0.6274276971817017,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "15, 21, and 22",
            "probability": 0.016181168923316974,
            "start_logit": 0.6326702237129211,
            "end_logit": 2.671294927597046,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "15",
            "probability": 0.014887870904651004,
            "start_logit": 0.6326702237129211,
            "end_logit": 2.587993621826172,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "22. ROBs can be classified into two groups depending on their frequency of occurrence, common (rob(13",
            "probability": 0.011128653477083413,
            "start_logit": 2.3022124767303467,
            "end_logit": 0.6274276971817017,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "14",
            "probability": 0.007341129911111518,
            "start_logit": 1.4395672082901,
            "end_logit": 1.074042558670044,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13q14q) and rob(14",
            "probability": 0.0065825956569173505,
            "start_logit": 1.3305035829544067,
            "end_logit": 1.074042558670044,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "21, and 22. ROBs can be classified into two groups depending on their frequency of occurrence, common (rob(13q14",
            "probability": 0.006239499501996601,
            "start_logit": 2.8413925170898438,
            "end_logit": -0.4903755486011505,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13q14q) and rob(14",
            "probability": 0.005844686151837013,
            "start_logit": 1.2116073369979858,
            "end_logit": 1.074042558670044,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(14",
            "probability": 0.005271810375450244,
            "start_logit": 1.1084482669830322,
            "end_logit": 1.074042558670044,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13",
            "probability": 0.004851486978778896,
            "start_logit": 1.2116073369979858,
            "end_logit": 0.8877949118614197,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "22. ROBs can be classified into two groups depending on their frequency of occurrence, common (rob(13q14",
            "probability": 0.00363904007347677,
            "start_logit": 2.3022124767303467,
            "end_logit": -0.4903755486011505,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "14;21",
            "probability": 0.002228718896736583,
            "start_logit": 0.5393915772438049,
            "end_logit": 0.7821523547172546,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        }
    ],
    "58ea59273e8b6dc87c000012": [
        {
            "text": "herpes simplex viral",
            "probability": 0.13980935343411702,
            "start_logit": 4.379748821258545,
            "end_logit": 3.588691473007202,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "herpes simplex",
            "probability": 0.1350062257401171,
            "start_logit": 4.379748821258545,
            "end_logit": 3.5537326335906982,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "herpes simplex viral vector",
            "probability": 0.10935196804687898,
            "start_logit": 4.379748821258545,
            "end_logit": 3.3429834842681885,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "herpes simplex viral vector (HSV) and adeno-associated viral vector (AAV",
            "probability": 0.10729143280400483,
            "start_logit": 4.379748821258545,
            "end_logit": 3.323960542678833,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adeno-associated viral vector (AAV",
            "probability": 0.07630129165216078,
            "start_logit": 4.0388898849487305,
            "end_logit": 3.323960542678833,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "herpes simplex viral vector (HSV) and adeno-associated viral",
            "probability": 0.06559719687241529,
            "start_logit": 4.379748821258545,
            "end_logit": 2.831944704055786,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "herpes simplex viral vector (HSV",
            "probability": 0.06259377499873808,
            "start_logit": 4.379748821258545,
            "end_logit": 2.7850775718688965,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "herpes simplex viral vector (HSV) and adeno-associated viral vector",
            "probability": 0.05925941605015757,
            "start_logit": 4.379748821258545,
            "end_logit": 2.7303364276885986,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "AAV",
            "probability": 0.049198508390516066,
            "start_logit": 3.547689437866211,
            "end_logit": 3.3763344287872314,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adeno-associated viral",
            "probability": 0.0466500513537698,
            "start_logit": 4.0388898849487305,
            "end_logit": 2.831944704055786,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adeno-associated viral vector",
            "probability": 0.04214288008847464,
            "start_logit": 4.0388898849487305,
            "end_logit": 2.7303364276885986,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "AAV (rAAV)",
            "probability": 0.01666958049138028,
            "start_logit": 3.547689437866211,
            "end_logit": 2.2940566539764404,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "herpes simplex viral vector (HSV) and adeno-associated",
            "probability": 0.01572325446443953,
            "start_logit": 4.379748821258545,
            "end_logit": 1.403552532196045,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "lentivirusesRecombinant AAV",
            "probability": 0.01276904679005219,
            "start_logit": 2.198850154876709,
            "end_logit": 3.3763344287872314,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "HSV) and adeno-associated viral vector (AAV",
            "probability": 0.011649273727528905,
            "start_logit": 2.1594438552856445,
            "end_logit": 3.323960542678833,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adeno-associated",
            "probability": 0.011181737378826006,
            "start_logit": 4.0388898849487305,
            "end_logit": 1.403552532196045,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "herpes simplex viral vector (HSV)",
            "probability": 0.010870890503978953,
            "start_logit": 4.379748821258545,
            "end_logit": 1.0345003604888916,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "AAV (rAAV",
            "probability": 0.0100678798576664,
            "start_logit": 3.547689437866211,
            "end_logit": 1.7898212671279907,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "herpes simplex viral vector (HSV) and adeno-associated viral vector (AAV)",
            "probability": 0.008997355115293412,
            "start_logit": 4.379748821258545,
            "end_logit": 0.8453423976898193,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adeno-associated viruses and lentivirusesRecombinant AAV",
            "probability": 0.008868882239483976,
            "start_logit": 1.8343749046325684,
            "end_logit": 3.3763344287872314,
            "question_text": "List viral vectors used in gene therapy."
        }
    ],
    "58dd07488acda34529000025": [
        {
            "text": "thrombocytopenia",
            "probability": 0.15659996025288714,
            "start_logit": 3.5881402492523193,
            "end_logit": 3.840822458267212,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, haemolysis, fever, coma",
            "probability": 0.09353510281092191,
            "start_logit": 3.5881402492523193,
            "end_logit": 3.3254647254943848,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, haemolysis",
            "probability": 0.08918179465935576,
            "start_logit": 3.5881402492523193,
            "end_logit": 3.2778048515319824,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, haemolysis, fever",
            "probability": 0.08705344670054299,
            "start_logit": 3.5881402492523193,
            "end_logit": 3.253650188446045,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "fever, coma",
            "probability": 0.07498447190940376,
            "start_logit": 3.367084503173828,
            "end_logit": 3.3254647254943848,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "coma",
            "probability": 0.07152121103856088,
            "start_logit": 3.3197975158691406,
            "end_logit": 3.3254647254943848,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "fever",
            "probability": 0.06978830976354497,
            "start_logit": 3.367084503173828,
            "end_logit": 3.253650188446045,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure",
            "probability": 0.06819079823538497,
            "start_logit": 3.5881402492523193,
            "end_logit": 3.0094375610351562,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "fever, coma and renal failure",
            "probability": 0.05466665285114734,
            "start_logit": 3.367084503173828,
            "end_logit": 3.0094375610351562,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "coma and renal failure",
            "probability": 0.0521417983721017,
            "start_logit": 3.3197975158691406,
            "end_logit": 3.0094375610351562,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "haemolysis, fever, coma",
            "probability": 0.03396514589815529,
            "start_logit": 2.5751383304595947,
            "end_logit": 3.3254647254943848,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "haemolysis",
            "probability": 0.032384341023150576,
            "start_logit": 2.5751383304595947,
            "end_logit": 3.2778048515319824,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "renal failure",
            "probability": 0.03203943178235249,
            "start_logit": 2.8327980041503906,
            "end_logit": 3.0094375610351562,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "haemolysis, fever",
            "probability": 0.03161147985370013,
            "start_logit": 2.5751383304595947,
            "end_logit": 3.253650188446045,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "haemolysis, fever, coma and renal failure",
            "probability": 0.02476193793958254,
            "start_logit": 2.5751383304595947,
            "end_logit": 3.0094375610351562,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, fever",
            "probability": 0.008629048500718953,
            "start_logit": 2.3941478729248047,
            "end_logit": 2.1362545490264893,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "fever, renal failure",
            "probability": 0.006935232345505424,
            "start_logit": 2.400228977203369,
            "end_logit": 1.911653757095337,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, fever, renal failure",
            "probability": 0.006893186446734556,
            "start_logit": 2.3941478729248047,
            "end_logit": 1.911653757095337,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "neurological symptoms, thrombocytopenia",
            "probability": 0.0028948213952785344,
            "start_logit": 0.8053316473960876,
            "end_logit": 2.632859945297241,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia,",
            "probability": 0.0022218282209703045,
            "start_logit": 3.5881402492523193,
            "end_logit": -0.41454169154167175,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        }
    ],
    "5895b7157d9090f353000009": [
        {
            "text": "microcephaly",
            "probability": 0.17376093130424147,
            "start_logit": 3.432245969772339,
            "end_logit": 3.779036283493042,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly, long narrow face",
            "probability": 0.12125228584645835,
            "start_logit": 3.432245969772339,
            "end_logit": 3.41922926902771,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly, long narrow face, ocular anomalies, and long thin hands and feet",
            "probability": 0.11514336857381699,
            "start_logit": 3.432245969772339,
            "end_logit": 3.3675339221954346,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "long narrow face",
            "probability": 0.07504655708265487,
            "start_logit": 2.952481269836426,
            "end_logit": 3.41922926902771,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "long narrow face, ocular anomalies, and long thin hands and feet",
            "probability": 0.07126557097081335,
            "start_logit": 2.952481269836426,
            "end_logit": 3.3675339221954346,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly, long narrow face, ocular anomalies",
            "probability": 0.07055602999463771,
            "start_logit": 3.432245969772339,
            "end_logit": 2.877763032913208,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "mental retardation, microcephaly",
            "probability": 0.045967795994979646,
            "start_logit": 2.102506637573242,
            "end_logit": 3.779036283493042,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "long narrow face, ocular anomalies",
            "probability": 0.043669173703027135,
            "start_logit": 2.952481269836426,
            "end_logit": 2.877763032913208,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "long thin hands and feet",
            "probability": 0.04287263186973816,
            "start_logit": 2.4443016052246094,
            "end_logit": 3.3675339221954346,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "ocular anomalies, and long thin hands and feet",
            "probability": 0.0409670352249584,
            "start_logit": 2.3988356590270996,
            "end_logit": 3.3675339221954346,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "mental retardation, microcephaly, long narrow face",
            "probability": 0.03207683279480041,
            "start_logit": 2.102506637573242,
            "end_logit": 3.41922926902771,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "mental retardation, microcephaly, long narrow face, ocular anomalies, and long thin hands and feet",
            "probability": 0.03046074187705951,
            "start_logit": 2.102506637573242,
            "end_logit": 3.3675339221954346,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "severe mental retardation, microcephaly",
            "probability": 0.027033322426598054,
            "start_logit": 1.5716358423233032,
            "end_logit": 3.779036283493042,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "ocular anomalies",
            "probability": 0.025103237832324658,
            "start_logit": 2.3988356590270996,
            "end_logit": 2.877763032913208,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "severe mental retardation, microcephaly, long narrow face",
            "probability": 0.018864149228747417,
            "start_logit": 1.5716358423233032,
            "end_logit": 3.41922926902771,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "mental retardation, microcephaly, long narrow face, ocular anomalies",
            "probability": 0.01866533039771986,
            "start_logit": 2.102506637573242,
            "end_logit": 2.877763032913208,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "severe mental retardation, microcephaly, long narrow face, ocular anomalies, and long thin hands and feet",
            "probability": 0.01791373805709242,
            "start_logit": 1.5716358423233032,
            "end_logit": 3.3675339221954346,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "mental retardation",
            "probability": 0.011588948261653608,
            "start_logit": 2.102506637573242,
            "end_logit": 2.4011471271514893,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "severe mental retardation, microcephaly, long narrow face, ocular anomalies",
            "probability": 0.010976943399584589,
            "start_logit": 1.5716358423233032,
            "end_logit": 2.877763032913208,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "severe mental retardation",
            "probability": 0.006815375159093132,
            "start_logit": 1.5716358423233032,
            "end_logit": 2.4011471271514893,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        }
    ],
    "58f4b73b70f9fc6f0f000014": [
        {
            "text": "mumps and rubella",
            "probability": 0.11316361019398025,
            "start_logit": 5.06550407409668,
            "end_logit": 5.034838676452637,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella",
            "probability": 0.11204202206923564,
            "start_logit": 5.055543422698975,
            "end_logit": 5.034838676452637,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps and rubella (MMR) vaccine Measles, mumps, rubella",
            "probability": 0.09117912571636844,
            "start_logit": 5.06550407409668,
            "end_logit": 4.8188300132751465,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella (MMR) vaccine Measles, mumps, rubella",
            "probability": 0.09027543039900647,
            "start_logit": 5.055543422698975,
            "end_logit": 4.8188300132751465,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps",
            "probability": 0.08338783751135671,
            "start_logit": 5.06550407409668,
            "end_logit": 4.729506492614746,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps and rubella (MMR) vaccine Measles, mumps",
            "probability": 0.058652713269106364,
            "start_logit": 5.06550407409668,
            "end_logit": 4.37763786315918,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "measles, mumps and rubella",
            "probability": 0.05838530932820079,
            "start_logit": 4.403733730316162,
            "end_logit": 5.034838676452637,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella (MMR) vaccine Measles, mumps",
            "probability": 0.058071394004248024,
            "start_logit": 5.055543422698975,
            "end_logit": 4.37763786315918,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps, rubella",
            "probability": 0.05711290723970128,
            "start_logit": 4.597708225250244,
            "end_logit": 4.8188300132751465,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "measles, mumps and rubella (MMR) vaccine Measles, mumps, rubella",
            "probability": 0.04704269729553276,
            "start_logit": 4.403733730316162,
            "end_logit": 4.8188300132751465,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "measles, mumps",
            "probability": 0.04302288234676074,
            "start_logit": 4.403733730316162,
            "end_logit": 4.729506492614746,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps and rubella (MMR) vaccine Measles",
            "probability": 0.03799369396901377,
            "start_logit": 5.06550407409668,
            "end_logit": 3.9434242248535156,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella (MMR) vaccine Measles",
            "probability": 0.03761713054992718,
            "start_logit": 5.055543422698975,
            "end_logit": 3.9434242248535156,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "measles",
            "probability": 0.03215743040148193,
            "start_logit": 4.403733730316162,
            "end_logit": 4.438417911529541,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "measles, mumps and rubella (MMR) vaccine Measles, mumps",
            "probability": 0.030261113102392045,
            "start_logit": 4.403733730316162,
            "end_logit": 4.37763786315918,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "measles, mumps and rubella (MMR) vaccine Measles",
            "probability": 0.01960235778179395,
            "start_logit": 4.403733730316162,
            "end_logit": 3.9434242248535156,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "Measles, mumps, rubella",
            "probability": 0.014264677685540763,
            "start_logit": 3.2104644775390625,
            "end_logit": 4.8188300132751465,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "Measles, mumps",
            "probability": 0.00917602624057674,
            "start_logit": 3.2104644775390625,
            "end_logit": 4.37763786315918,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "Measles",
            "probability": 0.005943989858347167,
            "start_logit": 3.2104644775390625,
            "end_logit": 3.9434242248535156,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella (MMR) vaccine is a live vaccine preparation containing attenuated strains of all 3 viruses.",
            "probability": 0.0006476510374291084,
            "start_logit": 4.6764302253723145,
            "end_logit": 0.2606746256351471,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        }
    ],
    "5895bfdc7d9090f35300000c": [
        {
            "text": "achalasia",
            "probability": 0.20979815538527405,
            "start_logit": 4.342015266418457,
            "end_logit": 4.591763973236084,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima, achalasia",
            "probability": 0.15659002788673673,
            "start_logit": 4.049500465393066,
            "end_logit": 4.591763973236084,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, adrenal failure",
            "probability": 0.1204386329742861,
            "start_logit": 4.342015266418457,
            "end_logit": 4.0367584228515625,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, alacrima",
            "probability": 0.11572715193910345,
            "start_logit": 4.0893731117248535,
            "end_logit": 4.249495506286621,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima",
            "probability": 0.104215393971134,
            "start_logit": 3.984597682952881,
            "end_logit": 4.249495506286621,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima, achalasia, adrenal failure",
            "probability": 0.08989349244491822,
            "start_logit": 4.049500465393066,
            "end_logit": 4.0367584228515625,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal failure",
            "probability": 0.06390583405696959,
            "start_logit": 3.7082855701446533,
            "end_logit": 4.0367584228515625,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, adrenal failure, progressive neurodegenerative disease",
            "probability": 0.022481604527767107,
            "start_logit": 4.342015266418457,
            "end_logit": 2.3583154678344727,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, alacrima, and adrenocorticotropic hormone (ACTH) insensitivity",
            "probability": 0.018513504871080232,
            "start_logit": 4.0893731117248535,
            "end_logit": 2.4167606830596924,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima achalasia",
            "probability": 0.018465204189399443,
            "start_logit": 3.0835180282592773,
            "end_logit": 3.4200034141540527,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima, achalasia, adrenal failure, progressive neurodegenerative disease",
            "probability": 0.016779914358526046,
            "start_logit": 4.049500465393066,
            "end_logit": 2.3583154678344727,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima, and adrenocorticotropic hormone (ACTH) insensitivity",
            "probability": 0.016671906044498495,
            "start_logit": 3.984597682952881,
            "end_logit": 2.4167606830596924,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal failure, progressive neurodegenerative disease",
            "probability": 0.011928943834763058,
            "start_logit": 3.7082855701446533,
            "end_logit": 2.3583154678344727,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and alacrimia",
            "probability": 0.007124840354067832,
            "start_logit": 3.0242209434509277,
            "end_logit": 2.5269997119903564,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia adrenal insufficiency",
            "probability": 0.006263037767804923,
            "start_logit": 3.499135971069336,
            "end_logit": 1.9231626987457275,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) insensitivity",
            "probability": 0.00584122639564062,
            "start_logit": 2.9358134269714355,
            "end_logit": 2.4167606830596924,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrimia",
            "probability": 0.004969724982129198,
            "start_logit": 2.6639981269836426,
            "end_logit": 2.5269997119903564,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima achalasia adrenal insufficiency",
            "probability": 0.00413318125871966,
            "start_logit": 3.0835180282592773,
            "end_logit": 1.9231626987457275,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, alacrima,",
            "probability": 0.003292888571839462,
            "start_logit": 4.0893731117248535,
            "end_logit": 0.6900253891944885,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima,",
            "probability": 0.002965334185342027,
            "start_logit": 3.984597682952881,
            "end_logit": 0.6900253891944885,
            "question_text": "List cardinal features of the Triple A syndrome."
        }
    ],
    "5895dd6a7d9090f35300000f": [
        {
            "text": "idiopathic retinal vasculitis, aneurysms, and neuroretinitis",
            "probability": 0.16509181788386112,
            "start_logit": 4.9579010009765625,
            "end_logit": 5.530171871185303,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "neuroretinitis",
            "probability": 0.15926534288259023,
            "start_logit": 4.921970844268799,
            "end_logit": 5.530171871185303,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "Idiopathic retinal vasculitis, aneurysms, and neuroretinitis",
            "probability": 0.13022830900604346,
            "start_logit": 4.720908164978027,
            "end_logit": 5.529952049255371,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "aneurysms, and neuroretinitis",
            "probability": 0.10333463099569527,
            "start_logit": 4.4893717765808105,
            "end_logit": 5.530171871185303,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic retinal vasculitis, aneurysms",
            "probability": 0.10268621062607258,
            "start_logit": 4.9579010009765625,
            "end_logit": 5.055347919464111,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic retinal vasculitis",
            "probability": 0.10231485071503744,
            "start_logit": 4.9579010009765625,
            "end_logit": 5.051724910736084,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "Idiopathic retinal vasculitis, aneurysms",
            "probability": 0.07218038555907581,
            "start_logit": 4.720908164978027,
            "end_logit": 4.939831256866455,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "aneurysms",
            "probability": 0.06427357708821228,
            "start_logit": 4.4893717765808105,
            "end_logit": 5.055347919464111,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "Idiopathic retinal vasculitis",
            "probability": 0.05700373439471331,
            "start_logit": 4.720908164978027,
            "end_logit": 4.703779697418213,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic vasculitis, aneurysms and neuroretinitis",
            "probability": 0.010775111266824679,
            "start_logit": 3.584415912628174,
            "end_logit": 4.174394130706787,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "aneurysms and neuroretinitis",
            "probability": 0.00790965726749179,
            "start_logit": 3.275261402130127,
            "end_logit": 4.174394130706787,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic vasculitis, aneurysms",
            "probability": 0.007725452148030764,
            "start_logit": 3.584415912628174,
            "end_logit": 3.8416755199432373,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic vasculitis",
            "probability": 0.007280971308075163,
            "start_logit": 3.584415912628174,
            "end_logit": 3.782419443130493,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "neuroretinitis (IRVAN) syndrome is a disease characterized by multiple retinal macroaneurysms",
            "probability": 0.002408866547275161,
            "start_logit": 4.553602695465088,
            "end_logit": 1.7071247100830078,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "retinal vasculitis, aneurysms, and neuroretinitis",
            "probability": 0.0017171555575225292,
            "start_logit": 0.39206838607788086,
            "end_logit": 5.530171871185303,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "vasculitis, aneurysms, and neuroretinitis",
            "probability": 0.001637864819463702,
            "start_logit": 0.3447926640510559,
            "end_logit": 5.530171871185303,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "retinal vasculitis, aneurysms",
            "probability": 0.001068061394669074,
            "start_logit": 0.39206838607788086,
            "end_logit": 5.055347919464111,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "retinal vasculitis",
            "probability": 0.0010641988002458686,
            "start_logit": 0.39206838607788086,
            "end_logit": 5.051724910736084,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "vasculitis, aneurysms",
            "probability": 0.0010187429878977994,
            "start_logit": 0.3447926640510559,
            "end_logit": 5.055347919464111,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "vasculitis",
            "probability": 0.0010150587512018808,
            "start_logit": 0.3447926640510559,
            "end_logit": 5.051724910736084,
            "question_text": "List 3 features of IRVAN syndrome."
        }
    ],
    "58dbb3f18acda34529000019": [
        {
            "text": "evolocumab",
            "probability": 0.22286545215239817,
            "start_logit": 6.110452651977539,
            "end_logit": 5.688163757324219,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "alirocumab",
            "probability": 0.19145990910415966,
            "start_logit": 6.000511646270752,
            "end_logit": 5.646214962005615,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Alirocumab and evolocumab",
            "probability": 0.14558731628456048,
            "start_logit": 5.6846604347229,
            "end_logit": 5.688163757324219,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Alirocumab",
            "probability": 0.13865163757383553,
            "start_logit": 5.6846604347229,
            "end_logit": 5.639352321624756,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Alirocumab (Praluent) and Evolocumab",
            "probability": 0.12248386319789345,
            "start_logit": 5.757826328277588,
            "end_logit": 5.442201137542725,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Evolocumab",
            "probability": 0.11302697523392824,
            "start_logit": 5.677473545074463,
            "end_logit": 5.442201137542725,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "evolocumab (Repatha) appears to be similar in efficacy and safety to alirocumab",
            "probability": 0.05398021581325767,
            "start_logit": 5.609276294708252,
            "end_logit": 4.771389484405518,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "alirocumab (Praluent)",
            "probability": 0.006068905388243323,
            "start_logit": 6.000511646270752,
            "end_logit": 2.1947147846221924,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "evolocumab (Repatha)",
            "probability": 0.00374046345666079,
            "start_logit": 5.609276294708252,
            "end_logit": 2.1019814014434814,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "evolocumab (Repatha) appears to be similar in efficacy and safety to alirocumab (Praluent)",
            "probability": 0.0006608818807039566,
            "start_logit": 5.609276294708252,
            "end_logit": 0.3685917258262634,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Alirocumab (Praluent) and Evolocumab (Repatha)",
            "probability": 0.0004971777455139394,
            "start_logit": 5.757826328277588,
            "end_logit": -0.06458583474159241,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Evolocumab (Repatha)",
            "probability": 0.0004587910216243962,
            "start_logit": 5.677473545074463,
            "end_logit": -0.06458583474159241,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Alirocumab (Praluent)",
            "probability": 0.00014666200577605106,
            "start_logit": 5.757826328277588,
            "end_logit": -1.285402774810791,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Alirocumab (Praluent) and Evolocumab (Repatha),",
            "probability": 0.00012117042521093934,
            "start_logit": 5.757826328277588,
            "end_logit": -1.4763354063034058,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Evolocumab (Repatha),",
            "probability": 0.00011181494681690396,
            "start_logit": 5.677473545074463,
            "end_logit": -1.4763354063034058,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "e",
            "probability": 3.411296374551195e-05,
            "start_logit": 6.110452651977539,
            "end_logit": -3.096482276916504,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Al",
            "probability": 3.0815511477053794e-05,
            "start_logit": 5.6846604347229,
            "end_logit": -2.7723493576049805,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "al",
            "probability": 2.712545504090946e-05,
            "start_logit": 6.000511646270752,
            "end_logit": -3.2157461643218994,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "evolocumab (Repatha) appears to be similar in efficacy and safety to alirocumab (Praluent),",
            "probability": 2.3554892702816876e-05,
            "start_logit": 5.609276294708252,
            "end_logit": -2.9656498432159424,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "evo",
            "probability": 2.3154946450250104e-05,
            "start_logit": 6.110452651977539,
            "end_logit": -3.4839513301849365,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        }
    ],
    "5895dfc97d9090f353000010": [
        {
            "text": "elvitegravir",
            "probability": 0.10205841049537423,
            "start_logit": 4.029441833496094,
            "end_logit": 3.7900819778442383,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "tenofovir",
            "probability": 0.09748756453829799,
            "start_logit": 4.248368263244629,
            "end_logit": 3.5253350734710693,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir, cobicistat, emtricitabine",
            "probability": 0.08524790940637501,
            "start_logit": 3.9224445819854736,
            "end_logit": 3.717097520828247,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir, cobicistat, emtricitabine, and tenofovir",
            "probability": 0.07037240032187188,
            "start_logit": 3.9224445819854736,
            "end_logit": 3.5253350734710693,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir, cobicistat",
            "probability": 0.06926735504517845,
            "start_logit": 4.029441833496094,
            "end_logit": 3.402510404586792,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir, cobicistat, emtricitabine and tenofovir",
            "probability": 0.06922390218898597,
            "start_logit": 4.029441833496094,
            "end_logit": 3.4018828868865967,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine",
            "probability": 0.06570433903385303,
            "start_logit": 3.662045955657959,
            "end_logit": 3.717097520828247,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "cobicistat, emtricitabine",
            "probability": 0.06125781063457683,
            "start_logit": 3.7053322792053223,
            "end_logit": 3.6037375926971436,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine, and tenofovir",
            "probability": 0.0542391254116611,
            "start_logit": 3.662045955657959,
            "end_logit": 3.5253350734710693,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine and tenofovir",
            "probability": 0.05074695159419553,
            "start_logit": 3.718947172164917,
            "end_logit": 3.4018828868865967,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "cobicistat",
            "probability": 0.0500921432155952,
            "start_logit": 3.7053322792053223,
            "end_logit": 3.402510404586792,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "cobicistat, emtricitabine and tenofovir",
            "probability": 0.05006071936962764,
            "start_logit": 3.7053322792053223,
            "end_logit": 3.4018828868865967,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "cobicistat, emtricitabine, and tenofovir",
            "probability": 0.042327185119497096,
            "start_logit": 3.4140729904174805,
            "end_logit": 3.5253350734710693,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine [FTC]).INTRODUCTION: Co-formulated elvitegravir",
            "probability": 0.02793043512213162,
            "start_logit": 2.7336134910583496,
            "end_logit": 3.7900819778442383,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine [FTC]).INTRODUCTION: Co-formulated elvitegravir, cobicistat, emtricitabine",
            "probability": 0.023181917895198936,
            "start_logit": 2.7336134910583496,
            "end_logit": 3.6037375926971436,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine [FTC]).INTRODUCTION: Co-formulated elvitegravir, cobicistat",
            "probability": 0.01895647165951797,
            "start_logit": 2.7336134910583496,
            "end_logit": 3.402510404586792,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir [EVG]/cobicistat [COBI]/tenofovir",
            "probability": 0.018881023272979434,
            "start_logit": 3.4283080101013184,
            "end_logit": 2.7038278579711914,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "tenofovir disoproxil fumarate [TDF]/emtricitabine",
            "probability": 0.017320926547262784,
            "start_logit": 3.361504316329956,
            "end_logit": 2.684389591217041,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir [EVG]/cobicistat",
            "probability": 0.012823627374490526,
            "start_logit": 3.4283080101013184,
            "end_logit": 2.316959857940674,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "Elvitegravir/cobicistat/emtricitabine",
            "probability": 0.012819781753328952,
            "start_logit": 2.970951557159424,
            "end_logit": 2.7740163803100586,
            "question_text": "List active ingredients of the Stribild polypill."
        }
    ],
    "5895e4637d9090f353000012": [
        {
            "text": "Metaphyseal dysplasia",
            "probability": 0.1384821670608259,
            "start_logit": 4.598667144775391,
            "end_logit": 5.052772045135498,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Metaphyseal dysplasia, Adrenal hypoplasia",
            "probability": 0.12747687459655274,
            "start_logit": 4.598667144775391,
            "end_logit": 4.96996545791626,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Adrenal hypoplasia",
            "probability": 0.12173903003356966,
            "start_logit": 4.552611827850342,
            "end_logit": 4.96996545791626,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Intrauterine Growth Restriction, Metaphyseal dysplasia",
            "probability": 0.10004128628313413,
            "start_logit": 4.273508548736572,
            "end_logit": 5.052772045135498,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Intrauterine Growth Restriction, Metaphyseal dysplasia, Adrenal hypoplasia",
            "probability": 0.09209092243907052,
            "start_logit": 4.273508548736572,
            "end_logit": 4.96996545791626,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Metaphyseal dysplasia, Adrenal hypoplasia, and Genital anomalies",
            "probability": 0.09114758733828536,
            "start_logit": 4.598667144775391,
            "end_logit": 4.634510517120361,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Adrenal hypoplasia, and Genital anomalies",
            "probability": 0.08704495546804848,
            "start_logit": 4.552611827850342,
            "end_logit": 4.634510517120361,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Genital anomalies",
            "probability": 0.05573459477672663,
            "start_logit": 4.106788158416748,
            "end_logit": 4.634510517120361,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Intrauterine Growth Restriction",
            "probability": 0.052039361839147084,
            "start_logit": 4.273508548736572,
            "end_logit": 4.399189472198486,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "metaphyseal dysplasia",
            "probability": 0.017595998193678106,
            "start_logit": 3.4913299083709717,
            "end_logit": 4.097039222717285,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "adrenal hypoplasia",
            "probability": 0.015056002434119512,
            "start_logit": 3.7812161445617676,
            "end_logit": 3.6512582302093506,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "adrenal hypoplasia congenita and genital abnormalities",
            "probability": 0.014073657160425824,
            "start_logit": 3.7812161445617676,
            "end_logit": 3.5837862491607666,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "intra-uterine growth restriction, metaphyseal dysplasia",
            "probability": 0.0132819346050672,
            "start_logit": 3.2100632190704346,
            "end_logit": 4.097039222717285,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "congenital adrenal hypoplasia",
            "probability": 0.012834470062101288,
            "start_logit": 3.538302183151245,
            "end_logit": 3.734529972076416,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "adrenal hypoplasia congenita",
            "probability": 0.011602319398804285,
            "start_logit": 3.7812161445617676,
            "end_logit": 3.390686511993408,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "metaphyseal dysplasia, adrenal hypoplasia",
            "probability": 0.01126713981466193,
            "start_logit": 3.4913299083709717,
            "end_logit": 3.6512582302093506,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "metaphyseal dysplasia, congenital adrenal hypoplasia",
            "probability": 0.01077237348073384,
            "start_logit": 3.363152503967285,
            "end_logit": 3.734529972076416,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "metaphyseal dysplasia, adrenal hypoplasia congenita and genital abnormalities",
            "probability": 0.010532003008367546,
            "start_logit": 3.4913299083709717,
            "end_logit": 3.5837862491607666,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "metaphyseal dysplasia, adrenal hypoplasia congenita",
            "probability": 0.008682580612795787,
            "start_logit": 3.4913299083709717,
            "end_logit": 3.390686511993408,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "intra-uterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia",
            "probability": 0.008504741393884366,
            "start_logit": 3.2100632190704346,
            "end_logit": 3.6512582302093506,
            "question_text": "List clinical features of the IMAGe syndrome."
        }
    ],
    "58e7a1393e8b6dc87c00000b": [
        {
            "text": "FCGR2A",
            "probability": 0.6944963010767462,
            "start_logit": 3.9472053050994873,
            "end_logit": 2.945448875427246,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "TLR5",
            "probability": 0.18519344165183957,
            "start_logit": 3.0610733032226562,
            "end_logit": 2.5097949504852295,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "TLR1",
            "probability": 0.0881632144157528,
            "start_logit": 2.694838285446167,
            "end_logit": 2.1338188648223877,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "NLRP3",
            "probability": 0.022856108048745157,
            "start_logit": 1.67196524143219,
            "end_logit": 1.806720495223999,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "FCGR2",
            "probability": 0.0015540419569984392,
            "start_logit": 3.9472053050994873,
            "end_logit": -3.156878709793091,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "Variation at FCGR2A",
            "probability": 0.0012363952604873291,
            "start_logit": -2.3837814331054688,
            "end_logit": 2.945448875427246,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "FCGR2A and functionally related genes is associated with the response",
            "probability": 0.001054756914353735,
            "start_logit": 3.9472053050994873,
            "end_logit": -3.5444276332855225,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "FCGR2A and functionally related genes",
            "probability": 0.001000686337249285,
            "start_logit": 3.9472053050994873,
            "end_logit": -3.5970518589019775,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "TLR5(rs5744174)",
            "probability": 0.0009815716255872629,
            "start_logit": 3.0610733032226562,
            "end_logit": -2.730206251144409,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "F",
            "probability": 0.0008683687226162851,
            "start_logit": 3.9472053050994873,
            "end_logit": -3.7388768196105957,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "TLR1(rs4833095)",
            "probability": 0.0006423749246624133,
            "start_logit": 2.694838285446167,
            "end_logit": -2.787954092025757,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "FCGR2A and functionally related genes is associated",
            "probability": 0.0005831314136563008,
            "start_logit": 3.9472053050994873,
            "end_logit": -4.137080669403076,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "FCGR2A polymorphism",
            "probability": 0.00046741899063032526,
            "start_logit": 1.8980048894882202,
            "end_logit": -2.3090667724609375,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": ". Variation at FCGR2A",
            "probability": 0.00039609799145035014,
            "start_logit": -3.5220751762390137,
            "end_logit": 2.945448875427246,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "FCGR2A polymorphism rs1081274",
            "probability": 0.00037139106702795154,
            "start_logit": 1.8980048894882202,
            "end_logit": -2.5390372276306152,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "NLRP3(rs10754558)",
            "probability": 7.289918627985411e-05,
            "start_logit": 1.67196524143219,
            "end_logit": -3.941175699234009,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "genotyped for FCGR2A",
            "probability": 4.495321292354577e-05,
            "start_logit": -3.4610862731933594,
            "end_logit": 0.7084205746650696,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "rs5744174)",
            "probability": 7.851133643070731e-06,
            "start_logit": -1.7674237489700317,
            "end_logit": -2.730206251144409,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "Variation",
            "probability": 5.191832387179712e-06,
            "start_logit": -2.3837814331054688,
            "end_logit": -2.5274198055267334,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "rs1081274",
            "probability": 3.8042369632042517e-06,
            "start_logit": -2.6831352710723877,
            "end_logit": -2.5390372276306152,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        }
    ],
    "5895e9977d9090f353000013": [
        {
            "text": "macular dystrophy",
            "probability": 0.1717076809295659,
            "start_logit": 5.683917045593262,
            "end_logit": 5.908493518829346,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia, ectrodactyly, macular dystrophy",
            "probability": 0.1342453045126738,
            "start_logit": 5.4377923011779785,
            "end_logit": 5.908493518829346,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectrodactyly, macular dystrophy",
            "probability": 0.10750619480991085,
            "start_logit": 5.215672016143799,
            "end_logit": 5.908493518829346,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia",
            "probability": 0.09843144348833192,
            "start_logit": 5.4377923011779785,
            "end_logit": 5.598185062408447,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia, ectrodactyly",
            "probability": 0.0910969505775707,
            "start_logit": 5.4377923011779785,
            "end_logit": 5.520749092102051,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectrodactyly",
            "probability": 0.07295217177936048,
            "start_logit": 5.215672016143799,
            "end_logit": 5.520749092102051,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "macular dystrophy (EEM syndrome).EEM syndrome is a rare condition characterised by ectodermal dysplasia",
            "probability": 0.07287665503485943,
            "start_logit": 5.683917045593262,
            "end_logit": 5.051468372344971,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia, ectrodactyly and macular dystrophy",
            "probability": 0.04015742123751867,
            "start_logit": 4.714702129364014,
            "end_logit": 5.424722194671631,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectrodactyly and macular dystrophy",
            "probability": 0.038145872742886534,
            "start_logit": 4.6633124351501465,
            "end_logit": 5.424722194671631,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "macular dystrophy. BACKGROUND: EEM syndrome is the rare association of ectodermal dysplasia",
            "probability": 0.03340904915840342,
            "start_logit": 5.020116806030273,
            "end_logit": 4.935327053070068,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectrodactyly, and macular dystrophy",
            "probability": 0.02882467719860895,
            "start_logit": 4.647709369659424,
            "end_logit": 5.160139560699463,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia, ectrodactyly, and macular dystrophy",
            "probability": 0.0279622779776175,
            "start_logit": 4.617333889007568,
            "end_logit": 5.160139560699463,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "hypotrichosis with juvenile macular dystrophy (HJMD) and ectodermal dysplasia",
            "probability": 0.02353500327471798,
            "start_logit": 4.00692081451416,
            "end_logit": 5.598185062408447,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "macular dystrophy (HJMD) and ectodermal dysplasia",
            "probability": 0.014952462613505753,
            "start_logit": 3.5533080101013184,
            "end_logit": 5.598185062408447,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "macular dystrophy (HJMD) and ectodermal dysplasia, ectrodactyly",
            "probability": 0.013838299017498138,
            "start_logit": 3.5533080101013184,
            "end_logit": 5.520749092102051,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "juvenile macular dystrophy (HJMD) and ectodermal dysplasia",
            "probability": 0.01087634822868797,
            "start_logit": 3.23502254486084,
            "end_logit": 5.598185062408447,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "juvenile macular dystrophy (HJMD) and ectodermal dysplasia, ectrodactyly",
            "probability": 0.010065911074144578,
            "start_logit": 3.23502254486084,
            "end_logit": 5.520749092102051,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "hypotrichosis with juvenile macular dystrophy",
            "probability": 0.004932042766234646,
            "start_logit": 4.00692081451416,
            "end_logit": 4.035449504852295,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "juvenile macular dystrophy",
            "probability": 0.0022792694769655734,
            "start_logit": 3.23502254486084,
            "end_logit": 4.035449504852295,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "hypotrichosis",
            "probability": 0.0022049641009374544,
            "start_logit": 4.00692081451416,
            "end_logit": 3.230407476425171,
            "question_text": "List clinical features of EEM syndrome."
        }
    ],
    "58e640573e8b6dc87c000003": [
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer",
            "probability": 0.09540929534887388,
            "start_logit": 5.3309102058410645,
            "end_logit": 4.887844562530518,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "CIRCexplorer",
            "probability": 0.09012647809643605,
            "start_logit": 5.2739481925964355,
            "end_logit": 4.887844562530518,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder, find_circ",
            "probability": 0.08646149086353465,
            "start_logit": 5.3309102058410645,
            "end_logit": 4.78936767578125,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI",
            "probability": 0.08243107402136368,
            "start_logit": 5.3309102058410645,
            "end_logit": 4.741631031036377,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "CIRCexplorer, CIRI",
            "probability": 0.07786686150533256,
            "start_logit": 5.2739481925964355,
            "end_logit": 4.741631031036377,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder",
            "probability": 0.07434970350517914,
            "start_logit": 5.3309102058410645,
            "end_logit": 4.638448238372803,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "CIRI",
            "probability": 0.07218167590521485,
            "start_logit": 5.198133945465088,
            "end_logit": 4.741631031036377,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "find_circ, CIRCexplorer",
            "probability": 0.055882113150158993,
            "start_logit": 4.795978546142578,
            "end_logit": 4.887844562530518,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.05326516952067594,
            "start_logit": 5.3309102058410645,
            "end_logit": 4.304951190948486,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "find_circ",
            "probability": 0.05064130070241117,
            "start_logit": 4.795978546142578,
            "end_logit": 4.78936767578125,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.0503158745335479,
            "start_logit": 5.2739481925964355,
            "end_logit": 4.304951190948486,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "find_circ, CIRCexplorer, CIRI",
            "probability": 0.048280648009264925,
            "start_logit": 4.795978546142578,
            "end_logit": 4.741631031036377,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "CIRI, and MapSplice",
            "probability": 0.04664223108850078,
            "start_logit": 5.198133945465088,
            "end_logit": 4.304951190948486,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "MapSplice",
            "probability": 0.04333674873578188,
            "start_logit": 5.12462854385376,
            "end_logit": 4.304951190948486,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "find_circ, CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.031197906024069022,
            "start_logit": 4.795978546142578,
            "end_logit": 4.304951190948486,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA",
            "probability": 0.029962180289553053,
            "start_logit": 5.3309102058410645,
            "end_logit": 3.729604482650757,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circ, CIRCexplorer",
            "probability": 0.003431412126849404,
            "start_logit": 2.0057060718536377,
            "end_logit": 4.887844562530518,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circ",
            "probability": 0.003109602761132997,
            "start_logit": 2.0057060718536377,
            "end_logit": 4.78936767578125,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circ, CIRCexplorer, CIRI",
            "probability": 0.0029646481088854075,
            "start_logit": 2.0057060718536377,
            "end_logit": 4.741631031036377,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapS",
            "probability": 0.002143585703233725,
            "start_logit": 5.3309102058410645,
            "end_logit": 1.0921485424041748,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        }
    ],
    "58adca6d9ef3c34033000007": [
        {
            "text": "Nab3",
            "probability": 0.2942980459804409,
            "start_logit": 5.337349891662598,
            "end_logit": 4.710750102996826,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "Nrd1 and Nab3",
            "probability": 0.26403371396068265,
            "start_logit": 5.2288336753845215,
            "end_logit": 4.710750102996826,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "Nrd1",
            "probability": 0.2091415288305559,
            "start_logit": 5.2288336753845215,
            "end_logit": 4.477684497833252,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA-binding proteins Nrd1 and Nab3",
            "probability": 0.06885021918839622,
            "start_logit": 3.884690284729004,
            "end_logit": 4.710750102996826,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA-binding proteins Nrd1",
            "probability": 0.054536369183233485,
            "start_logit": 3.884690284729004,
            "end_logit": 4.477684497833252,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "Nab",
            "probability": 0.030063857529789084,
            "start_logit": 5.337349891662598,
            "end_logit": 2.429480791091919,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "Nrd1 and Nab",
            "probability": 0.026972221079927243,
            "start_logit": 5.2288336753845215,
            "end_logit": 2.429480791091919,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "Nrd",
            "probability": 0.020665109107057843,
            "start_logit": 5.2288336753845215,
            "end_logit": 2.1631200313568115,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA-binding proteins Nrd1 and Nab",
            "probability": 0.007033356859978133,
            "start_logit": 3.884690284729004,
            "end_logit": 2.429480791091919,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA-binding proteins Nrd",
            "probability": 0.005388695520091515,
            "start_logit": 3.884690284729004,
            "end_logit": 2.1631200313568115,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA",
            "probability": 0.004755083082690902,
            "start_logit": 3.884690284729004,
            "end_logit": 2.0380308628082275,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA binding proteins Nrd1 and Nab3",
            "probability": 0.003105875342313086,
            "start_logit": 2.1148667335510254,
            "end_logit": 3.3819358348846436,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "NRD1 gene. These results suggest that transcription termination of CUTs directed by Nrd1 and Nab3",
            "probability": 0.00255873323567926,
            "start_logit": 2.334724187850952,
            "end_logit": 2.968295097351074,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA binding proteins Nrd1",
            "probability": 0.002160444080046658,
            "start_logit": 2.1148667335510254,
            "end_logit": 3.018954038619995,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "NRD1 gene. These results suggest that transcription termination of CUTs directed by Nrd1",
            "probability": 0.0017568574684520592,
            "start_logit": 2.334724187850952,
            "end_logit": 2.5923094749450684,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "Nab3 direct termination of sn/snoRNAs and recently have also been implicated in premature transcription termination of the NRD1",
            "probability": 0.0016310453845150312,
            "start_logit": 3.5653305053710938,
            "end_logit": 1.2873976230621338,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "Nab3These cryptic unstable transcripts (CUTs) are rapidly degraded by the nuclear exosome. Yeast RNA",
            "probability": 0.001247151788728575,
            "start_logit": 5.337349891662598,
            "end_logit": -0.7529805302619934,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA-binding proteins",
            "probability": 0.0011213823969741978,
            "start_logit": 3.884690284729004,
            "end_logit": 0.5933789014816284,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "NRD1",
            "probability": 0.000476453490060969,
            "start_logit": 2.334724187850952,
            "end_logit": 1.2873976230621338,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA binding proteins Nrd",
            "probability": 0.00020385649038586452,
            "start_logit": 2.1148667335510254,
            "end_logit": 0.6583012342453003,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        }
    ],
    "58eb6061eda5a57672000005": [
        {
            "text": "compression",
            "probability": 0.9735637531852873,
            "start_logit": 2.9227585792541504,
            "end_logit": 3.210407018661499,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "lossless compression",
            "probability": 0.016847688907942117,
            "start_logit": -1.1339912414550781,
            "end_logit": 3.210407018661499,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "compression via cascading Bloom filtersIn contrast to reference-based methods that first align reads to the genome",
            "probability": 0.002253921095923978,
            "start_logit": 2.9227585792541504,
            "end_logit": -2.8578848838806152,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "Fast lossless compression",
            "probability": 0.001973115125938807,
            "start_logit": -3.2785911560058594,
            "end_logit": 3.210407018661499,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "compression via cascading Bloom filtersIn contrast to reference-based methods",
            "probability": 0.0017448968585768519,
            "start_logit": 2.9227585792541504,
            "end_logit": -3.113860845565796,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "compression via cascading Bloom filters",
            "probability": 0.0008910148993061972,
            "start_logit": 2.9227585792541504,
            "end_logit": -3.7859504222869873,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "compression via cascading",
            "probability": 0.0007732015599879358,
            "start_logit": 2.9227585792541504,
            "end_logit": -3.927771806716919,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "one holding a sample of the input k-mers and the other holding k-mers likely to be correct.Fast lossless compression",
            "probability": 0.0005235017510825512,
            "start_logit": -4.605419635772705,
            "end_logit": 3.210407018661499,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "classification of sequences (FACSs), is introduced that can accurately and rapidly classify sequences as belonging or not belonging to a reference sequence. Classification",
            "probability": 0.00037044827962592116,
            "start_logit": -0.4862847626209259,
            "end_logit": -1.2545543909072876,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "classification",
            "probability": 0.00034031495075437246,
            "start_logit": -0.4862847626209259,
            "end_logit": -1.3393967151641846,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "Classification",
            "probability": 0.00019101111567009643,
            "start_logit": -1.1486669778823853,
            "end_logit": -1.2545543909072876,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "classify sequences as belonging or not belonging to a reference sequence. Classification",
            "probability": 0.0001230932448450049,
            "start_logit": -1.5880564451217651,
            "end_logit": -1.2545543909072876,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "accurate classification",
            "probability": 9.362339552646853e-05,
            "start_logit": -1.7768759727478027,
            "end_logit": -1.3393967151641846,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "decode by querying the same Bloom filters using read-length subsequences of the reference genome. Further compression",
            "probability": 8.364953516229905e-05,
            "start_logit": -4.367636203765869,
            "end_logit": 1.138719081878662,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "Classification of DNA sequences using Bloom filtersLighter is a fast, memory-efficient tool for correcting sequencing errors.",
            "probability": 5.628292624866481e-05,
            "start_logit": -1.1486669778823853,
            "end_logit": -2.476494789123535,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "Classification of DNA sequences using Bloom filtersLighter is a fast, memory-efficient tool for correcting sequencing errors",
            "probability": 5.1441473109693035e-05,
            "start_logit": -1.1486669778823853,
            "end_logit": -2.566441297531128,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "lossless compression via cascading Bloom filtersIn contrast to reference-based methods that first align reads to the genome",
            "probability": 3.900449387411418e-05,
            "start_logit": -1.1339912414550781,
            "end_logit": -2.8578848838806152,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "Classification of DNA sequences",
            "probability": 3.0309266613070753e-05,
            "start_logit": -1.1486669778823853,
            "end_logit": -3.0954325199127197,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "lossless compression via cascading Bloom filtersIn contrast to reference-based methods",
            "probability": 3.0195741525468837e-05,
            "start_logit": -1.1339912414550781,
            "end_logit": -3.113860845565796,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "classify sequences as belonging or not belonging to a reference sequence. Classification of DNA sequences",
            "probability": 1.953219299927545e-05,
            "start_logit": -1.5880564451217651,
            "end_logit": -3.0954325199127197,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        }
    ],
    "589a246c78275d0c4a000032": [
        {
            "text": "topiramate",
            "probability": 0.19012172337255226,
            "start_logit": 5.727567195892334,
            "end_logit": 5.378323554992676,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine/topiramate",
            "probability": 0.15535317784722474,
            "start_logit": 5.525603771209717,
            "end_logit": 5.378323554992676,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine",
            "probability": 0.12681878746402303,
            "start_logit": 5.525603771209717,
            "end_logit": 5.175381660461426,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine + topiramate",
            "probability": 0.0938675704461337,
            "start_logit": 5.1947150230407715,
            "end_logit": 5.2053961753845215,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "topiramate XR (Qsymia) and lorcaserin",
            "probability": 0.06491096832640925,
            "start_logit": 5.727567195892334,
            "end_logit": 4.303675651550293,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine-topiramate",
            "probability": 0.06260810657178716,
            "start_logit": 5.069921016693115,
            "end_logit": 4.92519998550415,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine/topiramate XR (Qsymia) and lorcaserin",
            "probability": 0.05304036291995902,
            "start_logit": 5.525603771209717,
            "end_logit": 4.303675651550293,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "bupropion + naltrexone (Contrave), phentermine + topiramate",
            "probability": 0.042903509798916696,
            "start_logit": 4.411783695220947,
            "end_logit": 5.2053961753845215,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine and topiramate",
            "probability": 0.04028085065946536,
            "start_logit": 4.66023063659668,
            "end_logit": 4.893871784210205,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "bupropion + naltrexone (Contrave), phentermine",
            "probability": 0.031305172766472544,
            "start_logit": 4.411783695220947,
            "end_logit": 4.890225887298584,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "topiramate XR",
            "probability": 0.027890709113894446,
            "start_logit": 5.727567195892334,
            "end_logit": 3.4589526653289795,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine/topiramate XR",
            "probability": 0.02279019049688246,
            "start_logit": 5.525603771209717,
            "end_logit": 3.4589526653289795,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "lorcaserin",
            "probability": 0.01762366732219222,
            "start_logit": 4.423793315887451,
            "end_logit": 4.303675651550293,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "bupropion",
            "probability": 0.01152970013607883,
            "start_logit": 4.411783695220947,
            "end_logit": 3.891368865966797,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "bupropion + naltrexone",
            "probability": 0.011502743050475193,
            "start_logit": 4.411783695220947,
            "end_logit": 3.8890280723571777,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "lorcaserin (Belviq) and phentermine-topiramate",
            "probability": 0.011482094369764233,
            "start_logit": 3.3738150596618652,
            "end_logit": 4.92519998550415,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "(phentermine 7.5\u00a0mg plus topiramate",
            "probability": 0.01137767483506082,
            "start_logit": 4.0519232749938965,
            "end_logit": 4.2379560470581055,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "naltrexone (Contrave), phentermine + topiramate",
            "probability": 0.010273996943598844,
            "start_logit": 2.9824461936950684,
            "end_logit": 5.2053961753845215,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "naltrexone (Contrave), phentermine",
            "probability": 0.007496571978120396,
            "start_logit": 2.9824461936950684,
            "end_logit": 4.890225887298584,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine + topiramate (Qsymia), higher doses of existing drugs licensed for other indications (liraglutide",
            "probability": 0.006822421580988819,
            "start_logit": 5.1947150230407715,
            "end_logit": 2.583725690841675,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        }
    ],
    "58da2a348acda34529000014": [
        {
            "text": "alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol",
            "probability": 0.18945527025851416,
            "start_logit": 5.07568883895874,
            "end_logit": 4.621119022369385,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "alpha-fetoprotein",
            "probability": 0.18296907333287332,
            "start_logit": 5.07568883895874,
            "end_logit": 4.586283206939697,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "alpha-fetoprotein, human chorionic gonadotropin",
            "probability": 0.1640001392558314,
            "start_logit": 5.07568883895874,
            "end_logit": 4.476833343505859,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "unconjugated estriol",
            "probability": 0.12726426176495495,
            "start_logit": 4.677801609039307,
            "end_logit": 4.621119022369385,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "human chorionic gonadotropin, and unconjugated estriol",
            "probability": 0.09923759720722242,
            "start_logit": 4.429052829742432,
            "end_logit": 4.621119022369385,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "human chorionic gonadotropin",
            "probability": 0.08590407508427272,
            "start_logit": 4.429052829742432,
            "end_logit": 4.476833343505859,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "\u03b1-fetoprotein",
            "probability": 0.05080258381715036,
            "start_logit": 4.524565696716309,
            "end_logit": 3.856036424636841,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "estriol",
            "probability": 0.02968254401788987,
            "start_logit": 3.222095012664795,
            "end_logit": 4.621119022369385,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "\u03b1-fetoprotein (AFP) and unconjugated oestriol",
            "probability": 0.02713997357340396,
            "start_logit": 4.524565696716309,
            "end_logit": 3.2290968894958496,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "Chorionic gonadotropin (CG), \u03b1-fetoprotein",
            "probability": 0.01397800079509507,
            "start_logit": 3.234103202819824,
            "end_logit": 3.856036424636841,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "Chorionic gonadotropin",
            "probability": 0.009391749762663373,
            "start_logit": 3.234103202819824,
            "end_logit": 3.458383321762085,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "unconjugated oestriol",
            "probability": 0.008915950157568235,
            "start_logit": 3.4113998413085938,
            "end_logit": 3.2290968894958496,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "oestriol",
            "probability": 0.005551490434563444,
            "start_logit": 2.937624454498291,
            "end_logit": 3.2290968894958496,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "alpha-fetoprotein, human chorionic gonadotropin,",
            "probability": 0.0016450246781713918,
            "start_logit": 5.07568883895874,
            "end_logit": -0.1252785474061966,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "\u03b1-fetoprotein (AFP)",
            "probability": 0.0009667314475091276,
            "start_logit": 4.524565696716309,
            "end_logit": -0.105745330452919,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "human chorionic gonadotropin,",
            "probability": 0.0008616719724162799,
            "start_logit": 4.429052829742432,
            "end_logit": -0.1252785474061966,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "gonadotropin, and unconjugated estriol",
            "probability": 0.0006288160660280945,
            "start_logit": -0.6323806047439575,
            "end_logit": 4.621119022369385,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "\u03b1-fetoprotein (AFP) and unconjugated oestriol (uE3)",
            "probability": 0.0005752266743778998,
            "start_logit": 4.524565696716309,
            "end_logit": -0.6249018907546997,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "gonadotropin",
            "probability": 0.0005443286019660204,
            "start_logit": -0.6323806047439575,
            "end_logit": 4.476833343505859,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "alpha-fetoprotein,",
            "probability": 0.00048549109752807985,
            "start_logit": 5.07568883895874,
            "end_logit": -1.345628261566162,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        }
    ],
    "5a6d0b2db750ff445500002d": [
        {
            "text": "CUL-2 and UBXN-3",
            "probability": 0.32088061297344317,
            "start_logit": 5.2895379066467285,
            "end_logit": 4.599802494049072,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "UBXN-3",
            "probability": 0.30239234108925206,
            "start_logit": 5.230194091796875,
            "end_logit": 4.599802494049072,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CUL-2",
            "probability": 0.22436568231961512,
            "start_logit": 5.2895379066467285,
            "end_logit": 4.242010593414307,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "UBXN-3, orthologous to the human tumour suppressor FAF1.CUL-2",
            "probability": 0.04706969327887984,
            "start_logit": 3.7278900146484375,
            "end_logit": 4.242010593414307,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "FAF1.CUL-2 and UBXN-3",
            "probability": 0.03992955213817458,
            "start_logit": 3.205585479736328,
            "end_logit": 4.599802494049072,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "FAF1.CUL-2",
            "probability": 0.027919484219321285,
            "start_logit": 3.205585479736328,
            "end_logit": 4.242010593414307,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "UBXN-3, orthologous to the human tumour suppressor FAF1",
            "probability": 0.00905300035100391,
            "start_logit": 3.7278900146484375,
            "end_logit": 2.593477487564087,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CUL-2LRR-1",
            "probability": 0.005614256776216508,
            "start_logit": 3.1169021129608154,
            "end_logit": 2.7266783714294434,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "FAF1",
            "probability": 0.00536980555492115,
            "start_logit": 3.205585479736328,
            "end_logit": 2.593477487564087,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC-48 cofactor UBXN-3",
            "probability": 0.004951994459867562,
            "start_logit": 2.229661226272583,
            "end_logit": 3.488400459289551,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CUL-2 and UBXN",
            "probability": 0.0024625972578837625,
            "start_logit": 5.2895379066467285,
            "end_logit": -0.270050048828125,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "UBXN",
            "probability": 0.0023207090732934818,
            "start_logit": 5.230194091796875,
            "end_logit": -0.270050048828125,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC-48 cofactor UBXN-3, orthologous to the human tumour suppressor FAF1",
            "probability": 0.002023578431481085,
            "start_logit": 2.229661226272583,
            "end_logit": 2.593477487564087,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "UFD-1",
            "probability": 0.0014424875534876126,
            "start_logit": 2.8657469749450684,
            "end_logit": 1.6188933849334717,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "UFD-1 and NPL-4",
            "probability": 0.0013475182743684236,
            "start_logit": 2.8657469749450684,
            "end_logit": 1.5507888793945312,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "NPL-4",
            "probability": 0.0011302232139420354,
            "start_logit": 2.6898975372314453,
            "end_logit": 1.5507888793945312,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "UBXN-3,",
            "probability": 0.000825296456861597,
            "start_logit": 3.7278900146484375,
            "end_logit": 0.198368638753891,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "FAF1.CUL-2 and UBXN",
            "probability": 0.00030643922265298566,
            "start_logit": 3.205585479736328,
            "end_logit": -0.270050048828125,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "UBXN-3, orthologous to the human tumour suppressor FAF",
            "probability": 0.00029951205943638305,
            "start_logit": 3.7278900146484375,
            "end_logit": -0.8152193427085876,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "UBXN-3, orthologous to the human tumour suppressor FAF1.",
            "probability": 0.00029521529589780375,
            "start_logit": 3.7278900146484375,
            "end_logit": -0.8296691179275513,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        }
    ],
    "5a7238d32dc08e987e000009": [
        {
            "text": "sodium-glucose cotransporters 1",
            "probability": 0.3109331451679157,
            "start_logit": 2.6928796768188477,
            "end_logit": 2.345468044281006,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "sodium-glucose cotransporters 1 and 2",
            "probability": 0.22666162143896035,
            "start_logit": 2.6928796768188477,
            "end_logit": 2.029348373413086,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "sodium-glucose",
            "probability": 0.17232679363314823,
            "start_logit": 2.6928796768188477,
            "end_logit": 1.7552827596664429,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "sodium",
            "probability": 0.07395494824911031,
            "start_logit": 2.6928796768188477,
            "end_logit": 0.9093462228775024,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "glucose cotransporters 1",
            "probability": 0.061973056522450866,
            "start_logit": 1.0800014734268188,
            "end_logit": 2.345468044281006,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "glucose cotransporters 1 and 2",
            "probability": 0.045176635862738866,
            "start_logit": 1.0800014734268188,
            "end_logit": 2.029348373413086,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "glucose",
            "probability": 0.034346991590080964,
            "start_logit": 1.0800014734268188,
            "end_logit": 1.7552827596664429,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "1",
            "probability": 0.023141084712466894,
            "start_logit": 0.0949113517999649,
            "end_logit": 2.345468044281006,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "1 and 2",
            "probability": 0.01686920762323836,
            "start_logit": 0.0949113517999649,
            "end_logit": 2.029348373413086,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "sodium-glucose cotransporters 1 and 2,",
            "probability": 0.008585990419336876,
            "start_logit": 2.6928796768188477,
            "end_logit": -1.2439780235290527,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "cotransporters 1",
            "probability": 0.007067262580670298,
            "start_logit": -1.091225028038025,
            "end_logit": 2.345468044281006,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "cotransporters 1 and 2",
            "probability": 0.0051518380094362284,
            "start_logit": -1.091225028038025,
            "end_logit": 2.029348373413086,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "sodium-glucose cotransporters",
            "probability": 0.004237584788251912,
            "start_logit": 2.6928796768188477,
            "end_logit": -1.9501163959503174,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "glucose cotransporters 1 and 2,",
            "probability": 0.001711300573219467,
            "start_logit": 1.0800014734268188,
            "end_logit": -1.2439780235290527,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT2 over SGLT1",
            "probability": 0.0014486634757687156,
            "start_logit": -0.43700677156448364,
            "end_logit": 0.10641796141862869,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "1 and 2, in combination with insulin treatment in patients with type 1 diabetes. Phase 2 studies with the SGLT2",
            "probability": 0.0014477701562616756,
            "start_logit": 0.0949113517999649,
            "end_logit": -0.4261170029640198,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "sodium-glucose cotransport",
            "probability": 0.001445768208923869,
            "start_logit": 2.6928796768188477,
            "end_logit": -3.0254690647125244,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT1",
            "probability": 0.0014052552673215746,
            "start_logit": -0.46742919087409973,
            "end_logit": 0.10641796141862869,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "2",
            "probability": 0.001059910317500067,
            "start_logit": -2.672394275665283,
            "end_logit": 2.029348373413086,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "sodium-glucose co",
            "probability": 0.001055171403198608,
            "start_logit": 2.6928796768188477,
            "end_logit": -3.340406656265259,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        }
    ],
    "5a894f6abc7bade53a000004": [
        {
            "text": "liver damage",
            "probability": 0.29090083496641367,
            "start_logit": 6.005609035491943,
            "end_logit": 5.988365650177002,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "barrier dysfunction, and liver damage",
            "probability": 0.13719485264749964,
            "start_logit": 5.254028797149658,
            "end_logit": 5.988365650177002,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "barrier dysfunction",
            "probability": 0.0819520132449781,
            "start_logit": 5.254028797149658,
            "end_logit": 5.473097324371338,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "disruption of intestinal epithelial tight junctions, barrier dysfunction, and liver damage",
            "probability": 0.07802048994446731,
            "start_logit": 4.689598083496094,
            "end_logit": 5.988365650177002,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhances EtOH-induced disruption of intestinal epithelial tight junctions, barrier dysfunction, and liver damage",
            "probability": 0.0745801666715848,
            "start_logit": 4.644501209259033,
            "end_logit": 5.988365650177002,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "disruption of intestinal epithelial tight junctions, barrier dysfunction",
            "probability": 0.04660478219060352,
            "start_logit": 4.689598083496094,
            "end_logit": 5.473097324371338,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhances EtOH-induced disruption of intestinal epithelial tight junctions, barrier dysfunction",
            "probability": 0.04454973848462224,
            "start_logit": 4.644501209259033,
            "end_logit": 5.473097324371338,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "disruption of intestinal epithelial tight junctions",
            "probability": 0.03552443218529117,
            "start_logit": 4.689598083496094,
            "end_logit": 5.201614856719971,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhances EtOH-induced disruption of intestinal epithelial tight junctions",
            "probability": 0.03395797790014143,
            "start_logit": 4.644501209259033,
            "end_logit": 5.201614856719971,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "intestinal epithelial tight junctions, barrier dysfunction, and liver damage",
            "probability": 0.032526555162831504,
            "start_logit": 3.814683437347412,
            "end_logit": 5.988365650177002,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "intestinal epithelial tight junctions, barrier dysfunction",
            "probability": 0.019429421935870706,
            "start_logit": 3.814683437347412,
            "end_logit": 5.473097324371338,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "tight junctions, barrier dysfunction, and liver damage",
            "probability": 0.019162851471990715,
            "start_logit": 3.285600185394287,
            "end_logit": 5.988365650177002,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "head and neck cancer and esophageal cancer",
            "probability": 0.015688567958147014,
            "start_logit": 4.635488033294678,
            "end_logit": 4.438436508178711,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "esophageal cancer",
            "probability": 0.01525317887270228,
            "start_logit": 4.607343673706055,
            "end_logit": 4.438436508178711,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "intestinal epithelial tight junctions",
            "probability": 0.01481005058960258,
            "start_logit": 3.814683437347412,
            "end_logit": 5.201614856719971,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "liver damage.",
            "probability": 0.014100545900440948,
            "start_logit": 6.005609035491943,
            "end_logit": 2.961596727371216,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "EtOH-induced disruption of intestinal epithelial tight junctions, barrier dysfunction, and liver damage",
            "probability": 0.013533499898781946,
            "start_logit": 2.9377946853637695,
            "end_logit": 5.988365650177002,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "head and neck cancer",
            "probability": 0.011935455071685705,
            "start_logit": 4.635488033294678,
            "end_logit": 4.165017604827881,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "tight junctions, barrier dysfunction",
            "probability": 0.011446743280370092,
            "start_logit": 3.285600185394287,
            "end_logit": 5.473097324371338,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "upper aerodigestive tract cancers, i.e., head and neck cancer and esophageal cancer",
            "probability": 0.008827841621974454,
            "start_logit": 4.060466289520264,
            "end_logit": 4.438436508178711,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        }
    ],
    "5a76196faacfb9cd4c000001": [
        {
            "text": "immune thrombocytopenia",
            "probability": 0.31319448269638994,
            "start_logit": 4.288349151611328,
            "end_logit": 4.500248432159424,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenia and autoimmune hemolytic anemia",
            "probability": 0.17453360926528586,
            "start_logit": 4.288349151611328,
            "end_logit": 3.915541410446167,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "autoimmune hemolytic anemia",
            "probability": 0.1406415592943212,
            "start_logit": 4.072446346282959,
            "end_logit": 3.915541410446167,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenia (platelet count<100,000/mm3) and AIHA.Thrombocytopenia",
            "probability": 0.10938775196635851,
            "start_logit": 4.097569465637207,
            "end_logit": 3.6391026973724365,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "thrombocytopenia",
            "probability": 0.07574106024207812,
            "start_logit": 2.8078091144561768,
            "end_logit": 4.56128454208374,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "Thrombocytopenia",
            "probability": 0.05456719542102227,
            "start_logit": 3.4021034240722656,
            "end_logit": 3.6391026973724365,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "AIHA.Thrombocytopenia",
            "probability": 0.03858692218276886,
            "start_logit": 3.055583953857422,
            "end_logit": 3.6391026973724365,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "thrombocytopenia (platelet count<100,000/mm3) and AIHA.Thrombocytopenia",
            "probability": 0.030118469134958276,
            "start_logit": 2.8078091144561768,
            "end_logit": 3.6391026973724365,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "Thrombocytopenia was only found in this cluster (36% of cases, manifested as Immune Thrombocytopenia",
            "probability": 0.022610841551085406,
            "start_logit": 3.4021034240722656,
            "end_logit": 2.758099317550659,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenia (platelet count<100,000/mm3)",
            "probability": 0.012470862291724954,
            "start_logit": 4.097569465637207,
            "end_logit": 1.4675986766815186,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "Immune Thrombocytopenia",
            "probability": 0.011564915133877465,
            "start_logit": 2.731649875640869,
            "end_logit": 2.758099317550659,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "thrombocytopenia and autoimmune hemolytic anemia",
            "probability": 0.005420541097624253,
            "start_logit": 0.81642746925354,
            "end_logit": 3.915541410446167,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "thrombocytopenia (platelet count<100,000/mm3)",
            "probability": 0.003433686809243026,
            "start_logit": 2.8078091144561768,
            "end_logit": 1.4675986766815186,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.0027339567126045132,
            "start_logit": 0.1319817304611206,
            "end_logit": 3.915541410446167,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenia (platelet count<100,000/mm3) and AIHA",
            "probability": 0.0010626066546196944,
            "start_logit": 4.097569465637207,
            "end_logit": -0.9950712323188782,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenia and autoimmune",
            "probability": 0.0009471366416735379,
            "start_logit": 4.288349151611328,
            "end_logit": -1.3008878231048584,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "(platelet count<100,000/mm3) and AIHA.Thrombocytopenia",
            "probability": 0.0009295252652459504,
            "start_logit": -0.6704107522964478,
            "end_logit": 3.6391026973724365,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "autoimmune",
            "probability": 0.0007632156047794944,
            "start_logit": 4.072446346282959,
            "end_logit": -1.3008878231048584,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "Immune Thrombocytopenia (ITP) or Evans syndrome).BACKGROUND: Autoimmune cytopenias",
            "probability": 0.0007570627986405999,
            "start_logit": 2.731649875640869,
            "end_logit": 0.03181428834795952,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenia and autoimmune hemolytic anemia.",
            "probability": 0.0005345992356981854,
            "start_logit": 4.288349151611328,
            "end_logit": -1.8728138208389282,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        }
    ],
    "5a82fc89faa1ab7d2e000028": [
        {
            "text": "H3K4me3",
            "probability": 0.43746924253495545,
            "start_logit": 4.743261814117432,
            "end_logit": 4.459299564361572,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K4me3 at promoters, while it was found with H3K27me3",
            "probability": 0.21601219225273488,
            "start_logit": 4.743261814117432,
            "end_logit": 3.7536280155181885,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K27me3",
            "probability": 0.10060700649765178,
            "start_logit": 3.9791488647460938,
            "end_logit": 3.7536280155181885,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K4me3 at promoters",
            "probability": 0.08784173214401071,
            "start_logit": 4.743261814117432,
            "end_logit": 2.853829860687256,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K4me3 at promoters, while it was found with H3K27me3 at enhancers",
            "probability": 0.03703135624606871,
            "start_logit": 4.743261814117432,
            "end_logit": 1.990058183670044,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "promoters, while it was found with H3K27me3",
            "probability": 0.031066576884982936,
            "start_logit": 2.8040595054626465,
            "end_logit": 3.7536280155181885,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K4me3 at promoter",
            "probability": 0.024403133807426362,
            "start_logit": 4.743261814117432,
            "end_logit": 1.5730047225952148,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K27me3 at enhancers",
            "probability": 0.017247238961892085,
            "start_logit": 3.9791488647460938,
            "end_logit": 1.990058183670044,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K4me3 at promoters,",
            "probability": 0.013926980985174385,
            "start_logit": 4.743261814117432,
            "end_logit": 1.0121212005615234,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "promoters",
            "probability": 0.012633277302093746,
            "start_logit": 2.8040595054626465,
            "end_logit": 2.853829860687256,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "promoters, while it was found with H3K27me3 at enhancers",
            "probability": 0.005325798807817624,
            "start_logit": 2.8040595054626465,
            "end_logit": 1.990058183670044,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "enhancers",
            "probability": 0.003989034913902338,
            "start_logit": 2.5150461196899414,
            "end_logit": 1.990058183670044,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "promoter",
            "probability": 0.0035096251964145285,
            "start_logit": 2.8040595054626465,
            "end_logit": 1.5730047225952148,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K4me3 at promoters, while it was found with H3K27me3 at enhancers,",
            "probability": 0.0024687850655601244,
            "start_logit": 4.743261814117432,
            "end_logit": -0.717980682849884,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "promoters,",
            "probability": 0.0020029592822492065,
            "start_logit": 2.8040595054626465,
            "end_logit": 1.0121212005615234,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K27me3 at enhancers,",
            "probability": 0.0011498289635499428,
            "start_logit": 3.9791488647460938,
            "end_logit": -0.717980682849884,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3",
            "probability": 0.0010519059826100126,
            "start_logit": 4.743261814117432,
            "end_logit": -1.5711030960083008,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H3K4me3 at promoters, while it was found with H3K27",
            "probability": 0.001029726683025012,
            "start_logit": 4.743261814117432,
            "end_logit": -1.5924134254455566,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "at\u00a0+1",
            "probability": 0.0006778886372267791,
            "start_logit": 1.821417212486267,
            "end_logit": 0.9113655090332031,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "at\u00a0+1 nucleosome\u00a0and maintaining high gene accessibility at -1",
            "probability": 0.0005557088506536748,
            "start_logit": 1.821417212486267,
            "end_logit": 0.7126269936561584,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        }
    ],
    "5a882b5761bb38fb24000013": [
        {
            "text": "Aicardi-Goutieres syndrome",
            "probability": 0.5262454615931837,
            "start_logit": 1.4358172416687012,
            "end_logit": 1.8105661869049072,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.41747466604830985,
            "start_logit": 1.4475890398025513,
            "end_logit": 1.5672504901885986,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Familial chilblain lupus",
            "probability": 0.01390045180880557,
            "start_logit": -0.24039652943611145,
            "end_logit": -0.14706645905971527,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Aicardi-Gouti\u00e8res syndrome.",
            "probability": 0.008260903363736258,
            "start_logit": 1.4475890398025513,
            "end_logit": -2.3554394245147705,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Aicardi-Goutieres",
            "probability": 0.007110693480487039,
            "start_logit": 1.4358172416687012,
            "end_logit": -2.4936017990112305,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Aicardi-Gouti\u00e8res",
            "probability": 0.005632783183986531,
            "start_logit": 1.4475890398025513,
            "end_logit": -2.7383697032928467,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathies such as Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.0052835170073222285,
            "start_logit": -2.9220428466796875,
            "end_logit": 1.5672504901885986,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "chilblain lupus",
            "probability": 0.005241369375620351,
            "start_logit": -1.2157350778579712,
            "end_logit": -0.14706645905971527,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "syndrome",
            "probability": 0.0032593049688663116,
            "start_logit": -3.6484365463256836,
            "end_logit": 1.8105661869049072,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Aicardi-Goutieres syndrome and ubiquitin specific peptidase 18 (USP18)-deficiency",
            "probability": 0.0027673156345519425,
            "start_logit": 1.4358172416687012,
            "end_logit": -3.437323808670044,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathies (Singleton-Merten syndrome",
            "probability": 0.0011308754939119042,
            "start_logit": -1.16167151927948,
            "end_logit": -1.7347207069396973,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathies",
            "probability": 0.0007340651144256417,
            "start_logit": -1.16167151927948,
            "end_logit": -2.166870355606079,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "acral ischaemia.interferonopathies such as Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.000666182170805823,
            "start_logit": -4.99282693862915,
            "end_logit": 1.5672504901885986,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "lupus",
            "probability": 0.0005134611893150967,
            "start_logit": -3.5388987064361572,
            "end_logit": -0.14706645905971527,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Familial chilblain lupus belongs to the group of type I interferonopathies",
            "probability": 0.00046566501956298934,
            "start_logit": -0.24039652943611145,
            "end_logit": -3.54327654838562,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "A",
            "probability": 0.0003900037888822048,
            "start_logit": 1.4475890398025513,
            "end_logit": -5.408572196960449,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Singleton-Merten syndrome",
            "probability": 0.00034836535032125904,
            "start_logit": -2.3391671180725098,
            "end_logit": -1.7347207069396973,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathies\" including Aicardi-Goutieres syndrome",
            "probability": 0.00029478042293534394,
            "start_logit": -6.0514750480651855,
            "end_logit": 1.8105661869049072,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "chilblain lupus belongs to the group of type I interferonopathies",
            "probability": 0.00017558583033171416,
            "start_logit": -1.2157350778579712,
            "end_logit": -3.54327654838562,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathies such as Aicardi-Gouti\u00e8res syndrome.",
            "probability": 0.000104549154638033,
            "start_logit": -2.9220428466796875,
            "end_logit": -2.3554394245147705,
            "question_text": "List the four most important interferonopathies"
        }
    ],
    "5a6d1143b750ff445500002e": [
        {
            "text": "Ufd1-Npl4",
            "probability": 0.4733533518430261,
            "start_logit": 5.692741870880127,
            "end_logit": 5.7613205909729,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1",
            "probability": 0.12745188007374303,
            "start_logit": 5.6343092918396,
            "end_logit": 4.507649898529053,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Npl4",
            "probability": 0.10541784656297533,
            "start_logit": 4.219540119171143,
            "end_logit": 5.732612133026123,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1-Npl4-Cdc48 to the CMG helicase, supporting a model whereby Ufd1",
            "probability": 0.044706080693987175,
            "start_logit": 4.670831203460693,
            "end_logit": 4.423498630523682,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1-Npl4 complex",
            "probability": 0.04417494798983481,
            "start_logit": 5.6343092918396,
            "end_logit": 3.448068857192993,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1-Npl4 complex recruits Cdc48 to ubiquitylated CMG.Mutation of K29",
            "probability": 0.043541144301902784,
            "start_logit": 5.6343092918396,
            "end_logit": 3.433617353439331,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "ubiquitin-binding Ufd1-Npl4",
            "probability": 0.043260622467450785,
            "start_logit": 3.3288509845733643,
            "end_logit": 5.732612133026123,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Npl4-Cdc48 to the CMG helicase, supporting a model whereby Ufd1-Npl4",
            "probability": 0.030088914780986003,
            "start_logit": 2.937056541442871,
            "end_logit": 5.7613205909729,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "K29 abrogates in\u00a0vitro recruitment of Ufd1-Npl4-Cdc48",
            "probability": 0.021072482662046334,
            "start_logit": 3.7607436180114746,
            "end_logit": 4.58144474029541,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "ubiquitin-binding Ufd1",
            "probability": 0.012708620909000455,
            "start_logit": 3.3288509845733643,
            "end_logit": 4.507649898529053,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Npl4 complex",
            "probability": 0.010733703685745655,
            "start_logit": 4.219540119171143,
            "end_logit": 3.448068857192993,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Npl4 complex recruits Cdc48 to ubiquitylated CMG.Mutation of K29",
            "probability": 0.010579700992120286,
            "start_logit": 4.219540119171143,
            "end_logit": 3.433617353439331,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Npl4-Cdc48 to the CMG helicase, supporting a model whereby Ufd1",
            "probability": 0.007895830724534562,
            "start_logit": 2.937056541442871,
            "end_logit": 4.423498630523682,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "K29",
            "probability": 0.006686834968113162,
            "start_logit": 3.7607436180114746,
            "end_logit": 3.433617353439331,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Cdc48 to the CMG helicase, supporting a model whereby Ufd1-Npl4",
            "probability": 0.005189027935481834,
            "start_logit": 1.655509352684021,
            "end_logit": 5.285257339477539,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "ubiquitin-binding Ufd1-Npl4 complex",
            "probability": 0.004404820606434346,
            "start_logit": 3.3288509845733643,
            "end_logit": 3.448068857192993,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "the ubiquitin-binding Ufd1-Npl4",
            "probability": 0.0034888662515896287,
            "start_logit": 0.8111850023269653,
            "end_logit": 5.732612133026123,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1-Npl4-Cdc48",
            "probability": 0.002922408485899303,
            "start_logit": 4.468146800994873,
            "end_logit": 1.8984816074371338,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Cdc48 to the CMG helicase, supporting a model whereby Ufd1",
            "probability": 0.001233559308341005,
            "start_logit": 1.655509352684021,
            "end_logit": 3.8486146926879883,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd",
            "probability": 0.0010893547567871877,
            "start_logit": 5.6343092918396,
            "end_logit": -0.25450342893600464,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        }
    ],
    "58f8a08370f9fc6f0f00001b": [
        {
            "text": "patella dislocations",
            "probability": 0.3160204279744434,
            "start_logit": 2.630035161972046,
            "end_logit": 3.4781906604766846,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "Skeletal manifestations in Ohdo syndrome: a case with bilateral patella dislocations",
            "probability": 0.25746381194960866,
            "start_logit": 2.425107479095459,
            "end_logit": 3.4781906604766846,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "bilateral patella dislocations",
            "probability": 0.0616390295801694,
            "start_logit": 0.9955235719680786,
            "end_logit": 3.4781906604766846,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "joint laxity",
            "probability": 0.06142518674191184,
            "start_logit": 2.3647000789642334,
            "end_logit": 2.105538845062256,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "joint laxity and skeletal deformities",
            "probability": 0.05959163955030574,
            "start_logit": 2.3647000789642334,
            "end_logit": 2.0752341747283936,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "Skeletal",
            "probability": 0.05291322854146284,
            "start_logit": 2.425107479095459,
            "end_logit": 1.8959648609161377,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "patella dislocations.We report a new case of Ohdo syndrome with bilateral patella dislocations",
            "probability": 0.04841203296025388,
            "start_logit": 2.630035161972046,
            "end_logit": 1.6021322011947632,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "skeletal deformities",
            "probability": 0.03200173392933174,
            "start_logit": 1.742974877357483,
            "end_logit": 2.0752341747283936,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "patella dislocation",
            "probability": 0.029891470338072053,
            "start_logit": 2.630035161972046,
            "end_logit": 1.1199569702148438,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "Skeletal manifestations in Ohdo syndrome: a case with bilateral patella dislocation",
            "probability": 0.024352767152891336,
            "start_logit": 2.425107479095459,
            "end_logit": 1.1199569702148438,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "Skeletal manifestations",
            "probability": 0.017483566130745285,
            "start_logit": 2.425107479095459,
            "end_logit": 0.7885728478431702,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "bilateral patella dislocations.We report a new case of Ohdo syndrome with bilateral patella dislocations",
            "probability": 0.009442651384278695,
            "start_logit": 0.9955235719680786,
            "end_logit": 1.6021322011947632,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "bilateral patella dislocation",
            "probability": 0.0058302598859595895,
            "start_logit": 0.9955235719680786,
            "end_logit": 1.1199569702148438,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "patella dislocations.We report a new case of Ohdo syndrome with bilateral patella dislocation",
            "probability": 0.005024962961479258,
            "start_logit": 2.630035161972046,
            "end_logit": -0.6631981134414673,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "skeletal manifestations reported in the literature on Ohdo syndrome reveals that joint laxity",
            "probability": 0.0040111288479297725,
            "start_logit": -0.36404716968536377,
            "end_logit": 2.105538845062256,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "skeletal manifestations reported in the literature on Ohdo syndrome reveals that joint laxity and skeletal deformities",
            "probability": 0.003891396301324854,
            "start_logit": -0.36404716968536377,
            "end_logit": 2.0752341747283936,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "patella",
            "probability": 0.003352843395207244,
            "start_logit": 2.630035161972046,
            "end_logit": -1.0678074359893799,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "Skeletal manifestations in Ohdo syndrome: a case with bilateral patella",
            "probability": 0.0027315824072927817,
            "start_logit": 2.425107479095459,
            "end_logit": -1.0678074359893799,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "joint laxity and skeletal",
            "probability": 0.002595327300101207,
            "start_logit": 2.3647000789642334,
            "end_logit": -1.0585684776306152,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "patella dislocations where surgical intervention has been indicated. A review of the skeletal",
            "probability": 0.0019249526672301697,
            "start_logit": 1.7766326665878296,
            "end_logit": -0.76931232213974,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        }
    ],
    "5a43b2d7966455904c00000c": [
        {
            "text": "CircTest DCC",
            "probability": 0.1938296282956493,
            "start_logit": 3.871840715408325,
            "end_logit": 2.9209189414978027,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "DCC",
            "probability": 0.17208510436419316,
            "start_logit": 3.526717185974121,
            "end_logit": 3.147052049636841,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "DCC and CircTest DCC",
            "probability": 0.13725713152099756,
            "start_logit": 3.526717185974121,
            "end_logit": 2.9209189414978027,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "CIRCexplorer",
            "probability": 0.0653688104631428,
            "start_logit": 3.1996231079101562,
            "end_logit": 2.506202220916748,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "CircTest",
            "probability": 0.0560487375908868,
            "start_logit": 3.871840715408325,
            "end_logit": 1.6801609992980957,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "CIRCexplorer, CIRI",
            "probability": 0.05344571244916849,
            "start_logit": 3.1996231079101562,
            "end_logit": 2.304823398590088,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "CIRI",
            "probability": 0.05018636938280842,
            "start_logit": 3.13670015335083,
            "end_logit": 2.304823398590088,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer",
            "probability": 0.0409128816137473,
            "start_logit": 2.731022834777832,
            "end_logit": 2.506202220916748,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "DCC and CircTest",
            "probability": 0.0396899535676967,
            "start_logit": 3.526717185974121,
            "end_logit": 1.6801609992980957,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI",
            "probability": 0.03345048029332127,
            "start_logit": 2.731022834777832,
            "end_logit": 2.304823398590088,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "circRNA_finder, find_circ",
            "probability": 0.03336027484411199,
            "start_logit": 2.731022834777832,
            "end_logit": 2.3021230697631836,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "find_circ, CIRCexplorer",
            "probability": 0.023073579077882583,
            "start_logit": 2.158266067504883,
            "end_logit": 2.506202220916748,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "circRNA_finder",
            "probability": 0.021354171430763246,
            "start_logit": 2.731022834777832,
            "end_logit": 1.8560043573379517,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "find_circ, CIRCexplorer, CIRI",
            "probability": 0.018865019323932395,
            "start_logit": 2.158266067504883,
            "end_logit": 2.304823398590088,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "find_circ",
            "probability": 0.01881414628630977,
            "start_logit": 2.158266067504883,
            "end_logit": 2.3021230697631836,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "UROBORUS",
            "probability": 0.010876278748260856,
            "start_logit": 2.243943691253662,
            "end_logit": 1.6684205532073975,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.009883545617518917,
            "start_logit": 3.1996231079101562,
            "end_logit": 0.6170282959938049,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "CIRI, and MapSplice",
            "probability": 0.009280805670696205,
            "start_logit": 3.13670015335083,
            "end_logit": 0.6170282959938049,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.0061858909303790545,
            "start_logit": 2.731022834777832,
            "end_logit": 0.6170282959938049,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "UROBORUS.In this work, we have developed a computational pipeline named UROBORUS",
            "probability": 0.006031478528533067,
            "start_logit": 2.243943691253662,
            "end_logit": 1.0788285732269287,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        }
    ],
    "5a68ff52b750ff445500001c": [
        {
            "text": "extensor pollicis brevis",
            "probability": 0.3187169741138331,
            "start_logit": 5.033741474151611,
            "end_logit": 4.731673717498779,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "abductor pollicis longus and extensor pollicis brevis",
            "probability": 0.24351429196879718,
            "start_logit": 4.744264125823975,
            "end_logit": 4.752023220062256,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "abductor pollicis longus",
            "probability": 0.19465125335289496,
            "start_logit": 4.7033562660217285,
            "end_logit": 4.568964958190918,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor pollicis brevis tendons",
            "probability": 0.08975144442598053,
            "start_logit": 4.947320461273193,
            "end_logit": 3.550835371017456,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "abductor pollicis longus and extensor pollicis brevis tendons",
            "probability": 0.07325802408150119,
            "start_logit": 4.744264125823975,
            "end_logit": 3.550835371017456,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor pollicis brevis tendons,",
            "probability": 0.017283991277541263,
            "start_logit": 5.033741474151611,
            "end_logit": 1.8171509504318237,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor pollicis",
            "probability": 0.013203202198578802,
            "start_logit": 4.947320461273193,
            "end_logit": 1.6342506408691406,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "abductor pollicis longus and extensor pollicis brevis tendons,",
            "probability": 0.012421085912907548,
            "start_logit": 4.7033562660217285,
            "end_logit": 1.8171509504318237,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "abductor pollicis longus and extensor pollicis",
            "probability": 0.010776879534391385,
            "start_logit": 4.744264125823975,
            "end_logit": 1.6342506408691406,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "the abductor pollicis longus and extensor pollicis brevis",
            "probability": 0.006449929871218729,
            "start_logit": 1.1131577491760254,
            "end_logit": 4.752023220062256,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "the abductor pollicis longus",
            "probability": 0.005023921875093361,
            "start_logit": 1.1131577491760254,
            "end_logit": 4.502164840698242,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "abductor pollicis",
            "probability": 0.003251867682346987,
            "start_logit": 4.744264125823975,
            "end_logit": 0.4360770881175995,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "brevis",
            "probability": 0.002147771042468479,
            "start_logit": 0.03386857360601425,
            "end_logit": 4.731673717498779,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "pollicis longus and extensor pollicis brevis",
            "probability": 0.0019889053064953643,
            "start_logit": -0.0633271187543869,
            "end_logit": 4.752023220062256,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "the abductor pollicis longus and extensor pollicis brevis tendons",
            "probability": 0.0019403753020388662,
            "start_logit": 1.1131577491760254,
            "end_logit": 3.550835371017456,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "pollicis longus",
            "probability": 0.0015491803905308657,
            "start_logit": -0.0633271187543869,
            "end_logit": 4.502164840698242,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "longus and extensor pollicis brevis",
            "probability": 0.0013026426818023911,
            "start_logit": -0.48651647567749023,
            "end_logit": 4.752023220062256,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "longus",
            "probability": 0.0010892128110983812,
            "start_logit": -0.48239800333976746,
            "end_logit": 4.568964958190918,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor",
            "probability": 0.0009179172581302238,
            "start_logit": 4.947320461273193,
            "end_logit": -1.0318567752838135,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "tendons",
            "probability": 0.000761128912350493,
            "start_logit": 0.17732380330562592,
            "end_logit": 3.550835371017456,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        }
    ],
    "590c740d70f9fc6f0f00001d": [
        {
            "text": "Osh7p, which have been implicated in regulating intracellular lipid and vesicular transportSterol metabolism and ERG2",
            "probability": 0.16532533864109622,
            "start_logit": 4.473327159881592,
            "end_logit": 3.848691701889038,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "ERG2",
            "probability": 0.15325013731862536,
            "start_logit": 4.3974833488464355,
            "end_logit": 3.848691701889038,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh1p",
            "probability": 0.11810250336660767,
            "start_logit": 4.733050346374512,
            "end_logit": 3.252606153488159,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh1",
            "probability": 0.11303750476474865,
            "start_logit": 4.733050346374512,
            "end_logit": 3.208772897720337,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh1p-Osh7p",
            "probability": 0.10993793780296202,
            "start_logit": 4.733050346374512,
            "end_logit": 3.18096923828125,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh7p",
            "probability": 0.08479128940884183,
            "start_logit": 4.473327159881592,
            "end_logit": 3.18096923828125,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh1p-Osh7",
            "probability": 0.08123199394937138,
            "start_logit": 4.733050346374512,
            "end_logit": 2.8783624172210693,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh7",
            "probability": 0.06265139810574892,
            "start_logit": 4.473327159881592,
            "end_logit": 2.8783624172210693,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Upc2p",
            "probability": 0.03542759141205203,
            "start_logit": 4.133434772491455,
            "end_logit": 2.6481597423553467,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Upc2",
            "probability": 0.019506706285958367,
            "start_logit": 4.133434772491455,
            "end_logit": 2.051427125930786,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh",
            "probability": 0.013548459032270194,
            "start_logit": 4.733050346374512,
            "end_logit": 1.0873260498046875,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh1p-Osh7p,",
            "probability": 0.008178139570867127,
            "start_logit": 4.733050346374512,
            "end_logit": 0.5825179219245911,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh7p,",
            "probability": 0.0063075132482666345,
            "start_logit": 4.473327159881592,
            "end_logit": 0.5825179219245911,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh7p, which have been implicated in regulating intracellular lipid and vesicular transportSterol metabolism and ERG",
            "probability": 0.005235318557573251,
            "start_logit": 4.473327159881592,
            "end_logit": 0.3962041139602661,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "ERG",
            "probability": 0.00485293600151992,
            "start_logit": 4.3974833488464355,
            "end_logit": 0.3962041139602661,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh1p-Osh",
            "probability": 0.004610414670415364,
            "start_logit": 4.733050346374512,
            "end_logit": 0.009371036663651466,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "oxysterol binding protein homologs, Osh1p",
            "probability": 0.0039165643349008215,
            "start_logit": 1.3267122507095337,
            "end_logit": 3.252606153488159,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "oxysterol binding protein homologs, Osh1",
            "probability": 0.0037485967447576617,
            "start_logit": 1.3267122507095337,
            "end_logit": 3.208772897720337,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "oxysterol binding protein homologs, Osh1p-Osh7p",
            "probability": 0.003645807616076052,
            "start_logit": 1.3267122507095337,
            "end_logit": 3.18096923828125,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "oxysterol binding protein homologs, Osh1p-Osh7",
            "probability": 0.0026938491673406915,
            "start_logit": 1.3267122507095337,
            "end_logit": 2.8783624172210693,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        }
    ],
    "5925227670f9fc6f0f000020": [
        {
            "text": "JBP1",
            "probability": 0.35896114608501967,
            "start_logit": 4.622109889984131,
            "end_logit": 3.7930409908294678,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP1 and JBP2",
            "probability": 0.29916267727405416,
            "start_logit": 4.622109889984131,
            "end_logit": 3.610814332962036,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP2",
            "probability": 0.2432246090875088,
            "start_logit": 4.415107727050781,
            "end_logit": 3.610814332962036,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylase",
            "probability": 0.026531118426278377,
            "start_logit": 3.226933002471924,
            "end_logit": 2.583322048187256,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP1 and JBP2 are two distinct thymidine hydroxylase",
            "probability": 0.022935382651768036,
            "start_logit": 4.622109889984131,
            "end_logit": 1.0425076484680176,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP2 are two distinct thymidine hydroxylase",
            "probability": 0.01864687644387691,
            "start_logit": 4.415107727050781,
            "end_logit": 1.0425076484680176,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP",
            "probability": 0.010142886612172192,
            "start_logit": 4.622109889984131,
            "end_logit": 0.22659946978092194,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP1 (J binding protein 1) and JBP2",
            "probability": 0.004514528595447402,
            "start_logit": 2.465299606323242,
            "end_logit": 1.5739378929138184,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP1 and JBP",
            "probability": 0.00367973262170001,
            "start_logit": 4.622109889984131,
            "end_logit": -0.787333071231842,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine residue in DNA is hydroxylated by a thymidine hydroxylase",
            "probability": 0.003365760567000905,
            "start_logit": 1.1622686386108398,
            "end_logit": 2.583322048187256,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP1 and JBP2 are two distinct thymidine hydroxylases",
            "probability": 0.003104529176216475,
            "start_logit": 4.622109889984131,
            "end_logit": -0.9573110938072205,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP2 are two distinct thymidine hydroxylases",
            "probability": 0.0025240377648923593,
            "start_logit": 4.415107727050781,
            "end_logit": -0.9573110938072205,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylases",
            "probability": 0.0008213043541188568,
            "start_logit": 3.292386293411255,
            "end_logit": -0.9573110938072205,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "a thymidine hydroxylase",
            "probability": 0.0005271044765740486,
            "start_logit": -0.6917418241500854,
            "end_logit": 2.583322048187256,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylase (TH",
            "probability": 0.0004999192604532074,
            "start_logit": 3.226933002471924,
            "end_logit": -1.3883049488067627,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylase (TH)",
            "probability": 0.0004939548608326635,
            "start_logit": 3.226933002471924,
            "end_logit": -1.4003074169158936,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "DNA is hydroxylated by a thymidine hydroxylase",
            "probability": 0.0002636891924562712,
            "start_logit": -1.3843694925308228,
            "end_logit": 2.583322048187256,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "hydroxylated by a thymidine hydroxylase",
            "probability": 0.0002241502848937815,
            "start_logit": -1.5468238592147827,
            "end_logit": 2.583322048187256,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP2,",
            "probability": 0.000197118876685048,
            "start_logit": 2.559079647064209,
            "end_logit": -1.65109121799469,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP1 (J binding protein 1) and JBP2,",
            "probability": 0.0001794733880507852,
            "start_logit": 2.465299606323242,
            "end_logit": -1.65109121799469,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        }
    ],
    "5a737b483b9d13c70800000b": [
        {
            "text": "Pembrolizumab versus ipilimumab",
            "probability": 0.14480574496825072,
            "start_logit": 4.982370853424072,
            "end_logit": 5.191597938537598,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pembrolizumab",
            "probability": 0.13417763222735665,
            "start_logit": 4.982370853424072,
            "end_logit": 5.1153693199157715,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "ipilimumab",
            "probability": 0.13301764757112752,
            "start_logit": 4.897459506988525,
            "end_logit": 5.191597938537598,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab and ipilimumab.Pembrolizumab versus ipilimumab",
            "probability": 0.11569118539826982,
            "start_logit": 4.757902145385742,
            "end_logit": 5.191597938537598,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab and ipilimumab.Pembrolizumab",
            "probability": 0.10719995487554382,
            "start_logit": 4.757902145385742,
            "end_logit": 5.1153693199157715,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "ipilimumab.Pembrolizumab versus ipilimumab",
            "probability": 0.09834078523030743,
            "start_logit": 4.59541654586792,
            "end_logit": 5.191597938537598,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "ipilimumab.Pembrolizumab",
            "probability": 0.0911229987213197,
            "start_logit": 4.59541654586792,
            "end_logit": 5.1153693199157715,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab",
            "probability": 0.07883331253425806,
            "start_logit": 4.757902145385742,
            "end_logit": 4.808009147644043,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab and ipilimumab",
            "probability": 0.07786306582976503,
            "start_logit": 4.757902145385742,
            "end_logit": 4.79562520980835,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab versus ipilimumab",
            "probability": 0.015802391019202288,
            "start_logit": 3.877758026123047,
            "end_logit": 4.080978870391846,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab versus ipilimumab in patients with ipilimumab",
            "probability": 0.0010013592911351855,
            "start_logit": 2.889871597290039,
            "end_logit": 2.3100624084472656,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "ipilimumab in patients with ipilimumab",
            "probability": 0.0005993113704529374,
            "start_logit": 2.3765392303466797,
            "end_logit": 2.3100624084472656,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pembrolizumab versus ipilimumab for advanced melanoma",
            "probability": 0.000495565160336268,
            "start_logit": 4.982370853424072,
            "end_logit": -0.4858516454696655,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "ipilimumab for advanced melanoma",
            "probability": 0.00045522304284676004,
            "start_logit": 4.897459506988525,
            "end_logit": -0.4858516454696655,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "ipilimumab.Pembrolizumab versus ipilimumab for advanced melanoma",
            "probability": 0.0003365492647473137,
            "start_logit": 4.59541654586792,
            "end_logit": -0.4858516454696655,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab and ipilimumab.",
            "probability": 6.311277539343796e-05,
            "start_logit": 4.757902145385742,
            "end_logit": -2.3221585750579834,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "ipilimumab.",
            "probability": 5.364764712962768e-05,
            "start_logit": 4.59541654586792,
            "end_logit": -2.3221585750579834,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "b versus ipilimumab",
            "probability": 4.8797431149234425e-05,
            "start_logit": -3.0130999088287354,
            "end_logit": 5.191597938537598,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "b",
            "probability": 4.781930825960335e-05,
            "start_logit": -3.0333480834960938,
            "end_logit": 5.191597938537598,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab continued to provide superior overall survival versus ipilimumab",
            "probability": 4.3896333148458386e-05,
            "start_logit": 0.9897506237030029,
            "end_logit": 1.0829005241394043,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        }
    ],
    "58ee2515eda5a57672000016": [
        {
            "text": "45-year-old patient",
            "probability": 0.6408955023990122,
            "start_logit": 0.1741509735584259,
            "end_logit": 0.4770423471927643,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "patient",
            "probability": 0.2225531071725856,
            "start_logit": -0.883549690246582,
            "end_logit": 0.4770423471927643,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "a 45-year-old patient",
            "probability": 0.04836851639157882,
            "start_logit": -2.4098663330078125,
            "end_logit": 0.4770423471927643,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "45",
            "probability": 0.038809993656358274,
            "start_logit": 0.1741509735584259,
            "end_logit": -2.327146291732788,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "45-year-old",
            "probability": 0.009020147715609354,
            "start_logit": 0.1741509735584259,
            "end_logit": -3.786363363265991,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "healthy human subjects",
            "probability": 0.008173871517951821,
            "start_logit": -1.5557852983474731,
            "end_logit": -2.154945135116577,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "stool samples from a 45-year-old patient",
            "probability": 0.005666269759512439,
            "start_logit": -4.554184436798096,
            "end_logit": 0.4770423471927643,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "healthy",
            "probability": 0.005600645443788543,
            "start_logit": -1.5557852983474731,
            "end_logit": -2.533005952835083,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "old patient",
            "probability": 0.005576427746733095,
            "start_logit": -4.570167064666748,
            "end_logit": 0.4770423471927643,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "a 45",
            "probability": 0.0029289982646124564,
            "start_logit": -2.4098663330078125,
            "end_logit": -2.327146291732788,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "subjects",
            "probability": 0.002257513519059958,
            "start_logit": -2.842463970184326,
            "end_logit": -2.154945135116577,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "45-year-old patient.",
            "probability": 0.002065927395049321,
            "start_logit": 0.1741509735584259,
            "end_logit": -5.260244846343994,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "samples from a 45-year-old patient",
            "probability": 0.0017051870333433339,
            "start_logit": -5.755040645599365,
            "end_logit": 0.4770423471927643,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "from stool samples from a 45-year-old patient",
            "probability": 0.0014213944571802074,
            "start_logit": -5.937077045440674,
            "end_logit": 0.4770423471927643,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "healthy human subjects where Prevotella appears to be a discriminatory taxon for residence in more agrarian societies",
            "probability": 0.0013989787813347605,
            "start_logit": -1.5557852983474731,
            "end_logit": -3.920145273208618,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "healthy human subjects where Prevotella",
            "probability": 0.001173615121509118,
            "start_logit": -1.5557852983474731,
            "end_logit": -4.095798969268799,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "patient.",
            "probability": 0.0007174001990030204,
            "start_logit": -0.883549690246582,
            "end_logit": -5.260244846343994,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "a 45-year-old",
            "probability": 0.000680752417521702,
            "start_logit": -2.4098663330078125,
            "end_logit": -3.786363363265991,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "human subjects",
            "probability": 0.0005345216038968037,
            "start_logit": -4.283111095428467,
            "end_logit": -2.154945135116577,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "healthy human subjects where Prevotella appears to be a discriminatory taxon for residence",
            "probability": 0.0004512294043591325,
            "start_logit": -1.5557852983474731,
            "end_logit": -5.051667213439941,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        }
    ],
    "5a67afb7b750ff445500000d": [
        {
            "text": "Polyneuropathy",
            "probability": 0.10344167435097844,
            "start_logit": 3.806757688522339,
            "end_logit": 3.9799721240997314,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "Polyneuropathy, Organomegaly",
            "probability": 0.09090643834149026,
            "start_logit": 3.806757688522339,
            "end_logit": 3.850795030593872,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly",
            "probability": 0.0768904430840721,
            "start_logit": 3.7246365547180176,
            "end_logit": 3.7654669284820557,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy",
            "probability": 0.07122561860483573,
            "start_logit": 3.7246365547180176,
            "end_logit": 3.6889379024505615,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "Organomegaly",
            "probability": 0.06718641088468816,
            "start_logit": 3.5043978691101074,
            "end_logit": 3.850795030593872,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "Organomegaly, Endocrinopathy, M protein, and Skin abnormalities.POEMS syndrome (polyneuropathy",
            "probability": 0.05714625621001938,
            "start_logit": 3.5043978691101074,
            "end_logit": 3.6889379024505615,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly",
            "probability": 0.05255883717817438,
            "start_logit": 3.3441882133483887,
            "end_logit": 3.7654669284820557,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 0.052461661475375565,
            "start_logit": 3.7246365547180176,
            "end_logit": 3.3831679821014404,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy",
            "probability": 0.05232189781618159,
            "start_logit": 3.806757688522339,
            "end_logit": 3.2983791828155518,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.04962441525850838,
            "start_logit": 3.7246365547180176,
            "end_logit": 3.327568292617798,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "Endocrinopathy, M protein, and Skin abnormalities.POEMS syndrome (polyneuropathy, organomegaly",
            "probability": 0.03950911596055963,
            "start_logit": 3.058786392211914,
            "end_logit": 3.7654669284820557,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "Organomegaly, Endocrinopathy",
            "probability": 0.038669654086978235,
            "start_logit": 3.5043978691101074,
            "end_logit": 3.2983791828155518,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.03812419910811743,
            "start_logit": 3.7246365547180176,
            "end_logit": 3.063934564590454,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "Endocrinopathy, M protein, and Skin abnormalities.POEMS syndrome (polyneuropathy",
            "probability": 0.036598322391563666,
            "start_logit": 3.058786392211914,
            "end_logit": 3.6889379024505615,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 0.03586042442967726,
            "start_logit": 3.3441882133483887,
            "end_logit": 3.3831679821014404,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly, endocrinopathy",
            "probability": 0.033921010947774666,
            "start_logit": 3.3441882133483887,
            "end_logit": 3.327568292617798,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.02624366060891366,
            "start_logit": 3.806757688522339,
            "end_logit": 2.608388662338257,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.026059982139534917,
            "start_logit": 3.3441882133483887,
            "end_logit": 3.063934564590454,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "endocrinopathy, monoclonal gammopathy",
            "probability": 0.026026806233277074,
            "start_logit": 3.0236809253692627,
            "end_logit": 3.3831679821014404,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "monoclonal gammopathy",
            "probability": 0.02522317088927957,
            "start_logit": 2.992316961288452,
            "end_logit": 3.3831679821014404,
            "question_text": "List main clinical features of the POEMS syndrome."
        }
    ],
    "5a678d63b750ff4455000003": [
        {
            "text": "redness, heat, swelling and pain",
            "probability": 0.13914172497392827,
            "start_logit": 5.046539783477783,
            "end_logit": 5.081570625305176,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, and swelling",
            "probability": 0.0972265707346616,
            "start_logit": 4.956059455871582,
            "end_logit": 4.813601970672607,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, heat, swelling",
            "probability": 0.0754385567361183,
            "start_logit": 5.046539783477783,
            "end_logit": 4.469396114349365,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness",
            "probability": 0.07532680293444602,
            "start_logit": 4.956059455871582,
            "end_logit": 4.558393955230713,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "pain",
            "probability": 0.06312255837476197,
            "start_logit": 4.256124973297119,
            "end_logit": 5.081570625305176,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "pain, heat, redness, and swelling",
            "probability": 0.05771965793178298,
            "start_logit": 4.434613227844238,
            "end_logit": 4.813601970672607,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "swelling and pain",
            "probability": 0.05436364371555501,
            "start_logit": 4.1067423820495605,
            "end_logit": 5.081570625305176,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, heat",
            "probability": 0.04729144756101944,
            "start_logit": 5.046539783477783,
            "end_logit": 4.002407073974609,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "pain, heat, redness",
            "probability": 0.04471861205859677,
            "start_logit": 4.434613227844238,
            "end_logit": 4.558393955230713,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "swelling",
            "probability": 0.043412967092932624,
            "start_logit": 4.149773597717285,
            "end_logit": 4.813601970672607,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat, swelling and pain",
            "probability": 0.04105510960994684,
            "start_logit": 3.8259620666503906,
            "end_logit": 5.081570625305176,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat, redness, and swelling",
            "probability": 0.04103976442264235,
            "start_logit": 4.093556880950928,
            "end_logit": 4.813601970672607,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "pain, heat",
            "probability": 0.03485795857110961,
            "start_logit": 4.434613227844238,
            "end_logit": 4.309285640716553,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat, redness",
            "probability": 0.03179577582322747,
            "start_logit": 4.093556880950928,
            "end_logit": 4.558393955230713,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "rubor, and dolor describe four cardinal signs of inflammation. Reference was paid to the cardinal signs of inflammation (pain, heat, redness",
            "probability": 0.028257702577616946,
            "start_logit": 3.9755895137786865,
            "end_logit": 4.558393955230713,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, heat, swelling and pain; inflammation gives rise to clinical cardinal signs: rubor, calor, dolor, tumor",
            "probability": 0.027279030004096302,
            "start_logit": 5.046539783477783,
            "end_logit": 3.452195882797241,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "dolor describe four cardinal signs of inflammation. Reference was paid to the cardinal signs of inflammation (pain, heat, redness, and swelling",
            "probability": 0.025753798997865944,
            "start_logit": 3.6275975704193115,
            "end_logit": 4.813601970672607,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "rubor, and dolor describe four cardinal signs of inflammation. Reference was paid to the cardinal signs of inflammation (pain",
            "probability": 0.02515477783803307,
            "start_logit": 3.9755895137786865,
            "end_logit": 4.442075729370117,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat",
            "probability": 0.024784665385635188,
            "start_logit": 4.093556880950928,
            "end_logit": 4.309285640716553,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat, swelling",
            "probability": 0.022258874656023258,
            "start_logit": 3.8259620666503906,
            "end_logit": 4.469396114349365,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        }
    ],
    "5a70dbe599e2c3af26000004": [
        {
            "text": "SMAD4",
            "probability": 0.7818747343960841,
            "start_logit": 4.945701599121094,
            "end_logit": 5.126871585845947,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene. Subsequent genetic screening revealed a novel mutation in SMAD4",
            "probability": 0.11981598564180387,
            "start_logit": 4.945701599121094,
            "end_logit": 3.251134157180786,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene",
            "probability": 0.05715160529888402,
            "start_logit": 4.945701599121094,
            "end_logit": 2.5108845233917236,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4, exon 5 (p.Ser144Stop). A SMAD4",
            "probability": 0.02998275498973362,
            "start_logit": 3.117819309234619,
            "end_logit": 3.6936817169189453,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD",
            "probability": 0.003340795821694191,
            "start_logit": 4.945701599121094,
            "end_logit": -0.32861390709877014,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "the SMAD4",
            "probability": 0.002136365700308364,
            "start_logit": -0.9568868279457092,
            "end_logit": 5.126871585845947,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene. Subsequent genetic screening revealed a novel mutation in SMAD4,",
            "probability": 0.0018486685342246154,
            "start_logit": 4.945701599121094,
            "end_logit": -0.9203572869300842,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 or BMPR1A",
            "probability": 0.0010881325017748035,
            "start_logit": 3.25858736038208,
            "end_logit": 0.23675420880317688,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "BMPR1A",
            "probability": 0.0005483757734225424,
            "start_logit": 2.5733299255371094,
            "end_logit": 0.23675420880317688,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene. Subsequent genetic screening revealed a novel mutation in SMAD",
            "probability": 0.0003680377959809365,
            "start_logit": 4.945701599121094,
            "end_logit": -2.5343925952911377,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "4",
            "probability": 0.00034885359084354785,
            "start_logit": -2.7690958976745605,
            "end_logit": 5.126871585845947,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "the SMAD4 gene. Subsequent genetic screening revealed a novel mutation in SMAD4",
            "probability": 0.0003273807821293775,
            "start_logit": -0.9568868279457092,
            "end_logit": 3.251134157180786,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene.",
            "probability": 0.0003059902074416913,
            "start_logit": 4.945701599121094,
            "end_logit": -2.719025135040283,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4,",
            "probability": 0.00029718019079297823,
            "start_logit": 3.117819309234619,
            "end_logit": -0.9203572869300842,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "the SMAD4 gene",
            "probability": 0.00015615893941425853,
            "start_logit": -0.9568868279457092,
            "end_logit": 2.5108845233917236,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "MAD4",
            "probability": 0.00012520216458886566,
            "start_logit": -3.793818473815918,
            "end_logit": 5.126871585845947,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4, exon 5 (p.Ser144Stop). A SMAD",
            "probability": 9.01595494524643e-05,
            "start_logit": 3.117819309234619,
            "end_logit": -2.113115072250366,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "mutation in the SMAD4",
            "probability": 7.606184066425815e-05,
            "start_logit": -4.292201519012451,
            "end_logit": 5.126871585845947,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 or BMPR1A genes",
            "probability": 5.915397838679255e-05,
            "start_logit": 3.25858736038208,
            "end_logit": -2.6753201484680176,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 or BMPR1",
            "probability": 5.8402302374887716e-05,
            "start_logit": 3.25858736038208,
            "end_logit": -2.6881086826324463,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        }
    ],
    "5a70ce4ab750ff4455000064": [
        {
            "text": "SERPINH1",
            "probability": 0.30203374814114764,
            "start_logit": 3.983560085296631,
            "end_logit": 3.19150710105896,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP, LEPRE1, PPIB, SERPINH1, FKBP10",
            "probability": 0.04367296414208556,
            "start_logit": 2.9243876934051514,
            "end_logit": 2.3168699741363525,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "SERPINF1",
            "probability": 0.04226094943357083,
            "start_logit": 2.9259755611419678,
            "end_logit": 2.282416343688965,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP, LEPRE1, PPIB, SERPINH1, FKBP10, SERPINF1",
            "probability": 0.04219389788402238,
            "start_logit": 2.9243876934051514,
            "end_logit": 2.282416343688965,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "SERPINH1, FKBP10",
            "probability": 0.04158050654254836,
            "start_logit": 2.8752899169921875,
            "end_logit": 2.3168699741363525,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "SERPINH1, are associated with autosomal recessive forms of OI.hese results expand the range of CRTAP",
            "probability": 0.040267573724601935,
            "start_logit": 3.983560085296631,
            "end_logit": 1.1765148639678955,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "SERPINH1, FKBP10, SERPINF1",
            "probability": 0.04017230525764876,
            "start_logit": 2.8752899169921875,
            "end_logit": 2.282416343688965,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP, LEPRE1, PPIB, SERPINH1",
            "probability": 0.04002218587867814,
            "start_logit": 2.9243876934051514,
            "end_logit": 2.229574680328369,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "FKBP10",
            "probability": 0.03897766527965186,
            "start_logit": 2.8106472492218018,
            "end_logit": 2.3168699741363525,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "FKBP10, SERPINF1",
            "probability": 0.03765761406110727,
            "start_logit": 2.8106472492218018,
            "end_logit": 2.282416343688965,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP",
            "probability": 0.03725611549081552,
            "start_logit": 2.9243876934051514,
            "end_logit": 2.157956838607788,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "SERPINF1, SP7, BMP1",
            "probability": 0.03622828145700688,
            "start_logit": 2.9259755611419678,
            "end_logit": 2.1283929347991943,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "BMP1",
            "probability": 0.034755185096946424,
            "start_logit": 2.8844642639160156,
            "end_logit": 2.1283929347991943,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "SERPINH1, FKBP10, SERPINF1, SP7, BMP1",
            "probability": 0.03443778715711463,
            "start_logit": 2.8752899169921875,
            "end_logit": 2.1283929347991943,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP, LEPRE1",
            "probability": 0.03340626376783805,
            "start_logit": 2.9243876934051514,
            "end_logit": 2.048884153366089,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP, LEPRE1, FKBP10, PP1B, SP7/Osterix",
            "probability": 0.03240505067002066,
            "start_logit": 2.8394436836242676,
            "end_logit": 2.1033990383148193,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "FKBP10, SERPINF1, SP7, BMP1",
            "probability": 0.03228206321653054,
            "start_logit": 2.8106472492218018,
            "end_logit": 2.1283929347991943,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "SERPINF1, SP7, BMP1, TMEM38B",
            "probability": 0.030895526099919066,
            "start_logit": 2.9259755611419678,
            "end_logit": 1.969164252281189,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "SERPINF1, SP7, BMP1, TMEM38B, and WNT1",
            "probability": 0.029855049113157617,
            "start_logit": 2.9259755611419678,
            "end_logit": 1.9349068403244019,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "BMP1, TMEM38B",
            "probability": 0.0296392675855881,
            "start_logit": 2.8844642639160156,
            "end_logit": 1.969164252281189,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        }
    ],
    "5a736efc3b9d13c708000006": [
        {
            "text": "11",
            "probability": 0.2663290717650089,
            "start_logit": 1.1183946132659912,
            "end_logit": 1.6532231569290161,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11 and 22",
            "probability": 0.16862779605748462,
            "start_logit": 1.1183946132659912,
            "end_logit": 1.1961843967437744,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22",
            "probability": 0.15784884261509788,
            "start_logit": 1.0523386001586914,
            "end_logit": 1.1961843967437744,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "chromosome 11",
            "probability": 0.053534750132967004,
            "start_logit": -0.48600706458091736,
            "end_logit": 1.6532231569290161,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11;22",
            "probability": 0.04209624059517228,
            "start_logit": 0.5228447318077087,
            "end_logit": 0.40399882197380066,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22)t(11;22",
            "probability": 0.037150708702917874,
            "start_logit": 0.39786913990974426,
            "end_logit": 0.40399882197380066,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22)t(11",
            "probability": 0.03520476036901326,
            "start_logit": 0.39786913990974426,
            "end_logit": 0.35019728541374207,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "chromosome 11 and 22",
            "probability": 0.03389583745996598,
            "start_logit": -0.48600706458091736,
            "end_logit": 1.1961843967437744,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "der(22)t(11;22",
            "probability": 0.03264473038282107,
            "start_logit": 0.2685697376728058,
            "end_logit": 0.40399882197380066,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "der(22)t(11",
            "probability": 0.030934804491307016,
            "start_logit": 0.2685697376728058,
            "end_logit": 0.35019728541374207,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22 and 11",
            "probability": 0.02905703906462462,
            "start_logit": 0.3914882242679596,
            "end_logit": 0.16465765237808228,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "der(22",
            "probability": 0.026884668607830887,
            "start_logit": 0.2685697376728058,
            "end_logit": 0.2098715603351593,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22 and 11 at 22q11.1\u2011q11.21 and 11",
            "probability": 0.017133041938555353,
            "start_logit": 0.3914882242679596,
            "end_logit": -0.3635942339897156,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11;22)(q23;q11.2)",
            "probability": 0.011227585800420409,
            "start_logit": 0.5228447318077087,
            "end_logit": -0.9175858497619629,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11 at 22q11.1\u2011q11.21 and 11",
            "probability": 0.01052394053358697,
            "start_logit": -0.09586793929338455,
            "end_logit": -0.3635942339897156,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22 and 11 at 22",
            "probability": 0.010163429695056151,
            "start_logit": 0.3914882242679596,
            "end_logit": -0.8858071565628052,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22)t(11;22)(q23;q11.2)",
            "probability": 0.009908551538359256,
            "start_logit": 0.39786913990974426,
            "end_logit": -0.9175858497619629,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11;22)",
            "probability": 0.00917779997203343,
            "start_logit": 0.5228447318077087,
            "end_logit": -1.1191720962524414,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22)(q23;q11.2)",
            "probability": 0.008949648650488988,
            "start_logit": 0.2960852384567261,
            "end_logit": -0.9175858497619629,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "der(22)t(11;22)(q23;q11.2)",
            "probability": 0.00870675162728779,
            "start_logit": 0.2685697376728058,
            "end_logit": -0.9175858497619629,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        }
    ],
    "5a8a9abdfcd1d6a10c000019": [
        {
            "text": "RIO3, TEX27",
            "probability": 0.07447379293483347,
            "start_logit": 4.401203632354736,
            "end_logit": 4.180050373077393,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "RIO3, TEX27, TTC3",
            "probability": 0.060592513804848216,
            "start_logit": 4.401203632354736,
            "end_logit": 3.9737744331359863,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "RIO3, TEX27, TTC3, UBFD1",
            "probability": 0.0585543524000756,
            "start_logit": 4.401203632354736,
            "end_logit": 3.939558506011963,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "RIO3",
            "probability": 0.05688464668542225,
            "start_logit": 4.401203632354736,
            "end_logit": 3.9106285572052,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "CALCOCO2, N4BP1, RIO3, TEX27",
            "probability": 0.05524519069948614,
            "start_logit": 4.102537631988525,
            "end_logit": 4.180050373077393,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TEX27",
            "probability": 0.05524392625188926,
            "start_logit": 4.102514743804932,
            "end_logit": 4.180050373077393,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "AWP1, CALCOCO2, N4BP1, RIO3, TEX27",
            "probability": 0.05489295394333697,
            "start_logit": 4.096141338348389,
            "end_logit": 4.180050373077393,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "N4BP1, RIO3, TEX27",
            "probability": 0.05149521123440928,
            "start_logit": 4.03224515914917,
            "end_logit": 4.180050373077393,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "UBFD1",
            "probability": 0.048767567201920596,
            "start_logit": 4.218313694000244,
            "end_logit": 3.939558506011963,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TTC3",
            "probability": 0.0481320220730603,
            "start_logit": 4.170979976654053,
            "end_logit": 3.9737744331359863,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TTC3, UBFD1",
            "probability": 0.04651299649443963,
            "start_logit": 4.170979976654053,
            "end_logit": 3.939558506011963,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "CALCOCO2, N4BP1, RIO3, TEX27, TTC3",
            "probability": 0.0449479588482782,
            "start_logit": 4.102537631988525,
            "end_logit": 3.9737744331359863,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TEX27, TTC3",
            "probability": 0.04494693008291725,
            "start_logit": 4.102514743804932,
            "end_logit": 3.9737744331359863,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "AWP1, CALCOCO2, N4BP1, RIO3, TEX27, TTC3",
            "probability": 0.04466137601600297,
            "start_logit": 4.096141338348389,
            "end_logit": 3.9737744331359863,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "CALCOCO2, N4BP1, RIO3, TEX27, TTC3, UBFD1",
            "probability": 0.043436036183327836,
            "start_logit": 4.102537631988525,
            "end_logit": 3.939558506011963,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TEX27, TTC3, UBFD1",
            "probability": 0.0434350420227344,
            "start_logit": 4.102514743804932,
            "end_logit": 3.939558506011963,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "CALCOCO2, N4BP1, RIO3",
            "probability": 0.042197436576903044,
            "start_logit": 4.102537631988525,
            "end_logit": 3.9106285572052,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "AWP1, CALCOCO2, N4BP1, RIO3",
            "probability": 0.041928390747040474,
            "start_logit": 4.096141338348389,
            "end_logit": 3.9106285572052,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "N4BP1, RIO3, TEX27, TTC3",
            "probability": 0.04189694353737023,
            "start_logit": 4.03224515914917,
            "end_logit": 3.9737744331359863,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "CALCOCO2, N4BP1",
            "probability": 0.04175471226170371,
            "start_logit": 4.102537631988525,
            "end_logit": 3.9000813961029053,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        }
    ],
    "5a7723b79e632bc06600000b": [
        {
            "text": "decline in growth rate",
            "probability": 0.3089330679202757,
            "start_logit": 5.9798808097839355,
            "end_logit": 5.392449378967285,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth rate in the prednisone-treated patients and excessive weight gain",
            "probability": 0.20199466357997883,
            "start_logit": 5.9798808097839355,
            "end_logit": 4.967566013336182,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "growth rate",
            "probability": 0.11706256971394502,
            "start_logit": 5.009464740753174,
            "end_logit": 5.392449378967285,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "excessive weight gain",
            "probability": 0.08773800278376369,
            "start_logit": 5.145994663238525,
            "end_logit": 4.967566013336182,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "a decline in growth rate",
            "probability": 0.07816770555406878,
            "start_logit": 4.605612754821777,
            "end_logit": 5.392449378967285,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "growth rate in the prednisone-treated patients and excessive weight gain",
            "probability": 0.07654089782735174,
            "start_logit": 5.009464740753174,
            "end_logit": 4.967566013336182,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "a decline in growth rate in the prednisone-treated patients and excessive weight gain",
            "probability": 0.05110964485772576,
            "start_logit": 4.605612754821777,
            "end_logit": 4.967566013336182,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "weight gain",
            "probability": 0.04731302776558008,
            "start_logit": 4.528425216674805,
            "end_logit": 4.967566013336182,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth rate in the prednisone-treated patients and excessive weight gain in one control and three treated patients.",
            "probability": 0.010557252918675408,
            "start_logit": 5.9798808097839355,
            "end_logit": 2.0161378383636475,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "excessive weight gain in one control and three treated patients.",
            "probability": 0.004585627508921231,
            "start_logit": 5.145994663238525,
            "end_logit": 2.0161378383636475,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "growth rate in the prednisone-treated patients and excessive weight gain in one control and three treated patients.",
            "probability": 0.004000410717117273,
            "start_logit": 5.009464740753174,
            "end_logit": 2.0161378383636475,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline",
            "probability": 0.003545686671099889,
            "start_logit": 5.9798808097839355,
            "end_logit": 0.9250565767288208,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "a decline in growth rate in the prednisone-treated patients and excessive weight gain in one control and three treated patients.",
            "probability": 0.002671246050681164,
            "start_logit": 4.605612754821777,
            "end_logit": 2.0161378383636475,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "weight gain in one control and three treated patients.",
            "probability": 0.002472815824026797,
            "start_logit": 4.528425216674805,
            "end_logit": 2.0161378383636475,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth",
            "probability": 0.0011553157535620817,
            "start_logit": 5.9798808097839355,
            "end_logit": -0.19630157947540283,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "a decline",
            "probability": 0.0008971464063699609,
            "start_logit": 4.605612754821777,
            "end_logit": 0.9250565767288208,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "growth",
            "probability": 0.0004377784218874287,
            "start_logit": 5.009464740753174,
            "end_logit": -0.19630157947540283,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth rate in the prednisone-treated patients and",
            "probability": 0.00032410241380574726,
            "start_logit": 5.9798808097839355,
            "end_logit": -1.4673709869384766,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "a decline in growth",
            "probability": 0.00029232345457341324,
            "start_logit": 4.605612754821777,
            "end_logit": -0.19630157947540283,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth rate in the prednisone-treated patients and excessive weight",
            "probability": 0.00020071385658988275,
            "start_logit": 5.9798808097839355,
            "end_logit": -1.9465502500534058,
            "question_text": "What are the prednisone side effects in DMD patients?"
        }
    ],
    "5a7727f39e632bc06600000d": [
        {
            "text": "growth failure and weight gain, facial fullness, blood pressure, bone health, cataracts",
            "probability": 0.09217901842477373,
            "start_logit": 6.091616153717041,
            "end_logit": 5.864264488220215,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "growth failure and weight gain, facial fullness, blood pressure, bone health, cataracts, gastrointestinal symptoms",
            "probability": 0.07616483885683885,
            "start_logit": 6.091616153717041,
            "end_logit": 5.673431873321533,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "growth failure and weight gain, facial fullness, blood pressure",
            "probability": 0.07282252056274573,
            "start_logit": 6.091616153717041,
            "end_logit": 5.628557205200195,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "growth failure and weight gain",
            "probability": 0.05635325086229017,
            "start_logit": 6.091616153717041,
            "end_logit": 5.372171878814697,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "growth failure",
            "probability": 0.05573359067486132,
            "start_logit": 6.091616153717041,
            "end_logit": 5.361114978790283,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "growth failure and weight gain, facial fullness",
            "probability": 0.055717381765657444,
            "start_logit": 6.091616153717041,
            "end_logit": 5.360824108123779,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "cataracts",
            "probability": 0.054447637840624355,
            "start_logit": 5.565123081207275,
            "end_logit": 5.864264488220215,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "gastrointestinal symptoms",
            "probability": 0.05158369891144879,
            "start_logit": 5.7019219398498535,
            "end_logit": 5.673431873321533,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "gastrointestinal symptoms, behavior, hypertrichosis",
            "probability": 0.047588454987056744,
            "start_logit": 5.7019219398498535,
            "end_logit": 5.592816352844238,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "cataracts, gastrointestinal symptoms",
            "probability": 0.04498849774204301,
            "start_logit": 5.565123081207275,
            "end_logit": 5.673431873321533,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "blood pressure, bone health, cataracts",
            "probability": 0.044844441462106054,
            "start_logit": 5.3710832595825195,
            "end_logit": 5.864264488220215,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "facial fullness, blood pressure, bone health, cataracts",
            "probability": 0.042889551648367816,
            "start_logit": 5.326511859893799,
            "end_logit": 5.864264488220215,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "weight gain, facial fullness, blood pressure, bone health, cataracts",
            "probability": 0.04186007204312354,
            "start_logit": 5.302216053009033,
            "end_logit": 5.864264488220215,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "cataracts, gastrointestinal symptoms, behavior, hypertrichosis",
            "probability": 0.04150406320042603,
            "start_logit": 5.565123081207275,
            "end_logit": 5.592816352844238,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "growth failure and weight gain, facial fullness, blood pressure, bone health",
            "probability": 0.039223951119215276,
            "start_logit": 6.091616153717041,
            "end_logit": 5.009819507598877,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "bone health, cataracts",
            "probability": 0.037605611195302466,
            "start_logit": 5.195036888122559,
            "end_logit": 5.864264488220215,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "blood pressure, bone health, cataracts, gastrointestinal symptoms",
            "probability": 0.037053656200230184,
            "start_logit": 5.3710832595825195,
            "end_logit": 5.673431873321533,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "hypertrichosis",
            "probability": 0.036573732878478496,
            "start_logit": 5.438662052154541,
            "end_logit": 5.592816352844238,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "facial fullness, blood pressure, bone health, cataracts, gastrointestinal symptoms",
            "probability": 0.0354383876695964,
            "start_logit": 5.326511859893799,
            "end_logit": 5.673431873321533,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "blood pressure",
            "probability": 0.03542764195481376,
            "start_logit": 5.3710832595825195,
            "end_logit": 5.628557205200195,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        }
    ],
    "5a86f074faa1ab7d2e00003a": [
        {
            "text": "Chordoma",
            "probability": 0.3592892907243457,
            "start_logit": 1.6786558628082275,
            "end_logit": 1.8967809677124023,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordoma",
            "probability": 0.35569895586227074,
            "start_logit": 1.6255145072937012,
            "end_logit": 1.9398791790008545,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordoma samples displaying copy loss at PTEN, and 3 of 4 chordoma",
            "probability": 0.10850389684908299,
            "start_logit": 0.8606644868850708,
            "end_logit": 1.5174305438995361,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordoma biology and to potentially identify therapeutic targetsGenotyping cancer-associated genes in chordoma",
            "probability": 0.07851983013952252,
            "start_logit": 0.1147809699177742,
            "end_logit": 1.9398791790008545,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordoma samples displaying copy loss at the locus for CDKN2A, 17 of 21 chordoma",
            "probability": 0.060076081473123384,
            "start_logit": 0.6344138979911804,
            "end_logit": 1.1525068283081055,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordoma pathogenesis.SMARCB1/INI1 Involvement in Pediatric Chordoma",
            "probability": 0.03220766537110526,
            "start_logit": -0.7332675457000732,
            "end_logit": 1.8967809677124023,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "Pediatric Chordoma",
            "probability": 0.0015656832787854108,
            "start_logit": -3.7571496963500977,
            "end_logit": 1.8967809677124023,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "ChordomaAll 8 cases were positive for brachyury,",
            "probability": 0.0009956106327821566,
            "start_logit": 1.6786558628082275,
            "end_logit": -3.991745948791504,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "ChordomaAll 8 cases were positive for brachyury",
            "probability": 0.0005026593499112617,
            "start_logit": 1.6786558628082275,
            "end_logit": -4.67518949508667,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "Chord",
            "probability": 0.00044790089625545586,
            "start_logit": 1.6786558628082275,
            "end_logit": -4.790530204772949,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "oma",
            "probability": 0.00036592767920494646,
            "start_logit": -5.21079158782959,
            "end_logit": 1.8967809677124023,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "3 of 4 chordoma",
            "probability": 0.00034637894791910497,
            "start_logit": -4.886343479156494,
            "end_logit": 1.5174305438995361,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordoma samples displaying deletion at the SMARCB1 locus,",
            "probability": 0.00033516883127683036,
            "start_logit": 1.0757085084915161,
            "end_logit": -4.47752046585083,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chord",
            "probability": 0.00030265036645725653,
            "start_logit": 1.6255145072937012,
            "end_logit": -5.129382610321045,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "17 of 21 chordoma samples displaying copy loss at PTEN, and 3 of 4 chordoma",
            "probability": 0.0002184022200472191,
            "start_logit": -5.347538471221924,
            "end_logit": 1.5174305438995361,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "17 of 21 chordoma",
            "probability": 0.00015162565593341448,
            "start_logit": -5.347538471221924,
            "end_logit": 1.1525068283081055,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordoma samples displaying deletion at the SMARCB1 locus, we can infer that a loss of heterozygosity",
            "probability": 0.00014227120313920508,
            "start_logit": 1.0757085084915161,
            "end_logit": -5.3344197273254395,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "18 of 21 chordoma samples displaying copy loss at the locus for CDKN2A, 17 of 21 chordoma",
            "probability": 0.00012307238612575092,
            "start_logit": -5.556180477142334,
            "end_logit": 1.1525068283081055,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "18 of 21 chordoma",
            "probability": 0.00010524285868807543,
            "start_logit": -5.556180477142334,
            "end_logit": 0.9960047602653503,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordoma samples displaying copy loss at PTEN, and 3",
            "probability": 0.00010168527402334853,
            "start_logit": 0.8606644868850708,
            "end_logit": -5.455228328704834,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        }
    ],
    "5a75fbf383b0d9ea6600000a": [
        {
            "text": "ulcerative colitis",
            "probability": 0.13164989581314926,
            "start_logit": -4.26237678527832,
            "end_logit": -4.637437343597412,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ulcerative colitis,",
            "probability": 0.10377848877726752,
            "start_logit": -4.26237678527832,
            "end_logit": -4.875324726104736,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "OCTAVE Induction 2",
            "probability": 0.08210716897460611,
            "start_logit": -4.407693386077881,
            "end_logit": -4.9642415046691895,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "OCTAVE Induction 1, OCTAVE Induction 2",
            "probability": 0.06185061683536694,
            "start_logit": -4.6909966468811035,
            "end_logit": -4.9642415046691895,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "OCTAVE Induction 1",
            "probability": 0.06013408137568888,
            "start_logit": -4.6909966468811035,
            "end_logit": -4.992386817932129,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "OCTAVE Sustain ClinicalTrials.gov numbers, NCT01465763 , NCT01458951",
            "probability": 0.059477696749966474,
            "start_logit": -4.235211372375488,
            "end_logit": -5.4591474533081055,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "OCTAVE Sustain trial",
            "probability": 0.05697929526329766,
            "start_logit": -4.341104984283447,
            "end_logit": -5.396167278289795,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ulcerative colitis, tofacitinib was more effective as induction and maintenance therapy than placebo.",
            "probability": 0.05521198183458483,
            "start_logit": -4.26237678527832,
            "end_logit": -5.50640344619751,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ulcerative",
            "probability": 0.05378501819867733,
            "start_logit": -4.26237678527832,
            "end_logit": -5.532588481903076,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "NCT01458574 , respectively.In patients with moderately to severely active ulcerative colitis",
            "probability": 0.044105455908761054,
            "start_logit": -5.3559393882751465,
            "end_logit": -4.637437343597412,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "moderately to severely active ulcerative colitis",
            "probability": 0.04205370363396287,
            "start_logit": -5.403575420379639,
            "end_logit": -4.637437343597412,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "NCT01458574 , respectively.In patients with moderately to severely active ulcerative colitis,",
            "probability": 0.03476795429857419,
            "start_logit": -5.3559393882751465,
            "end_logit": -4.875324726104736,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "moderately to severely active ulcerative colitis,",
            "probability": 0.03315057549923139,
            "start_logit": -5.403575420379639,
            "end_logit": -4.875324726104736,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "NCT01458574",
            "probability": 0.030026350874709874,
            "start_logit": -4.940378189086914,
            "end_logit": -5.437506675720215,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "NCT01458951 , and NCT01458574",
            "probability": 0.028868404788430144,
            "start_logit": -4.979705810546875,
            "end_logit": -5.437506675720215,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "NCT01458951",
            "probability": 0.02825038143344207,
            "start_logit": -4.979705810546875,
            "end_logit": -5.4591474533081055,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "NCT01465763 , NCT01458951 , and NCT01458574",
            "probability": 0.02519865187593319,
            "start_logit": -5.115663051605225,
            "end_logit": -5.437506675720215,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "NCT01465763 , NCT01458951",
            "probability": 0.024659191677571888,
            "start_logit": -5.115663051605225,
            "end_logit": -5.4591474533081055,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ClinicalTrials.gov numbers, NCT01465763 , NCT01458951",
            "probability": 0.02383920450538259,
            "start_logit": -5.149481296539307,
            "end_logit": -5.4591474533081055,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "We conducted three phase 3, randomized, double-blind, placebo-controlled trials of tofacitinib therapy",
            "probability": 0.02010588168139576,
            "start_logit": -5.101389408111572,
            "end_logit": -5.677558422088623,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        }
    ],
    "5a76155c83b0d9ea6600001e": [
        {
            "text": "RA-BUILD study",
            "probability": 0.3569402718420454,
            "start_logit": 1.0122147798538208,
            "end_logit": 0.6784504055976868,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "RA-BEAM",
            "probability": 0.16801629096633805,
            "start_logit": 1.0444215536117554,
            "end_logit": -0.10726388543844223,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "RA-BEAM study",
            "probability": 0.15300798032956825,
            "start_logit": 1.0444215536117554,
            "end_logit": -0.2008347511291504,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "RA-BUILD",
            "probability": 0.10130544887627747,
            "start_logit": 1.0122147798538208,
            "end_logit": -0.5809778571128845,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents",
            "probability": 0.038713065070742826,
            "start_logit": 0.49169033765792847,
            "end_logit": -1.0224164724349976,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "the RA-BUILD study",
            "probability": 0.03231874583076007,
            "start_logit": -1.3897062540054321,
            "end_logit": 0.6784504055976868,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "phase III study",
            "probability": 0.023565377355498834,
            "start_logit": 0.49169033765792847,
            "end_logit": -1.518815040588379,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "RA-BEACON)",
            "probability": 0.023292347014452573,
            "start_logit": 1.0696598291397095,
            "end_logit": -2.10843825340271,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "RA-BEACON",
            "probability": 0.019774901703004166,
            "start_logit": 1.0696598291397095,
            "end_logit": -2.2721495628356934,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents",
            "probability": 0.01697010762395639,
            "start_logit": -0.33303338289260864,
            "end_logit": -1.0224164724349976,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "randomised phase III study",
            "probability": 0.010330026547657356,
            "start_logit": -0.33303338289260864,
            "end_logit": -1.518815040588379,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "the RA-BUILD",
            "probability": 0.00917258519641718,
            "start_logit": -1.3897062540054321,
            "end_logit": -0.5809778571128845,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "RA-BUILD study.",
            "probability": 0.006596570341261505,
            "start_logit": 1.0122147798538208,
            "end_logit": -3.312568187713623,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "RA-BEACON)Baricitinib",
            "probability": 0.006343988263314317,
            "start_logit": 1.0696598291397095,
            "end_logit": -3.409055471420288,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "phase III",
            "probability": 0.006200512240432287,
            "start_logit": 0.49169033765792847,
            "end_logit": -2.853961706161499,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "BEAM",
            "probability": 0.006032028371252791,
            "start_logit": -2.2825560569763184,
            "end_logit": -0.10726388543844223,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "BEAM study",
            "probability": 0.005493208266101748,
            "start_logit": -2.2825560569763184,
            "end_logit": -0.2008347511291504,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study",
            "probability": 0.005410715249734072,
            "start_logit": -3.1769723892211914,
            "end_logit": 0.6784504055976868,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents",
            "probability": 0.005264028341109963,
            "start_logit": -1.5035902261734009,
            "end_logit": -1.0224164724349976,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "phase III study of baricitinib",
            "probability": 0.005251800570074896,
            "start_logit": 0.49169033765792847,
            "end_logit": -3.0200226306915283,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        }
    ],
    "5a67a207b750ff4455000008": [
        {
            "text": "prophylactic",
            "probability": 0.4384296043064094,
            "start_logit": 2.1415061950683594,
            "end_logit": 0.8906199336051941,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylactic agent approved for use for the treatment of RSV infection. Palivizumab prophylaxis",
            "probability": 0.1425067168015826,
            "start_logit": 2.1415061950683594,
            "end_logit": -0.23319019377231598,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylactic agent approved for use for the treatment of RSV infection",
            "probability": 0.1336301947100888,
            "start_logit": 2.1415061950683594,
            "end_logit": -0.2975030839443207,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylactic agent",
            "probability": 0.1332790547576532,
            "start_logit": 2.1415061950683594,
            "end_logit": -0.30013424158096313,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylactic agent approved",
            "probability": 0.056803004761124765,
            "start_logit": 2.1415061950683594,
            "end_logit": -1.1529901027679443,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylactic agent approved for use for the treatment",
            "probability": 0.01966310132003258,
            "start_logit": 2.1415061950683594,
            "end_logit": -2.2138354778289795,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "Palivizumab prophylaxis",
            "probability": 0.009609028301604577,
            "start_logit": -0.5551798343658447,
            "end_logit": -0.23319019377231598,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylaxis",
            "probability": 0.009447992894176324,
            "start_logit": -0.5720806121826172,
            "end_logit": -0.23319019377231598,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylactic agent approved for use for the treatment of RSV infection.",
            "probability": 0.008763546819775056,
            "start_logit": 2.1415061950683594,
            "end_logit": -3.0219786167144775,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "Palivizumab prophylaxis is recommended for infants with qualifying high risk conditions",
            "probability": 0.007380179214554827,
            "start_logit": -0.5551798343658447,
            "end_logit": -0.49709537625312805,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylaxis is recommended for infants with qualifying high risk conditions",
            "probability": 0.0072564965559751985,
            "start_logit": -0.5720806121826172,
            "end_logit": -0.49709537625312805,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylactic agent approved for use",
            "probability": 0.00642144570029027,
            "start_logit": 2.1415061950683594,
            "end_logit": -3.3329360485076904,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prop",
            "probability": 0.004785375290318102,
            "start_logit": 2.1415061950683594,
            "end_logit": -3.6270148754119873,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "treatment of RSV infection. Palivizumab prophylaxis",
            "probability": 0.0039056842819941606,
            "start_logit": -1.4554499387741089,
            "end_logit": -0.23319019377231598,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "treatment of RSV infection",
            "probability": 0.003662405273189318,
            "start_logit": -1.4554499387741089,
            "end_logit": -0.2975030839443207,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "only prophylactic",
            "probability": 0.00353828979620712,
            "start_logit": -2.6780495643615723,
            "end_logit": 0.8906199336051941,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "treatment of RSV infection. Palivizumab prophylaxis is recommended for infants with qualifying high risk conditions",
            "probability": 0.0029997465978712414,
            "start_logit": -1.4554499387741089,
            "end_logit": -0.49709537625312805,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "approved for use for the treatment of RSV infection. Palivizumab prophylaxis",
            "probability": 0.002834315052843093,
            "start_logit": -1.7760826349258423,
            "end_logit": -0.23319019377231598,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "approved for use for the treatment of RSV infection",
            "probability": 0.0026577699695973338,
            "start_logit": -1.7760826349258423,
            "end_logit": -0.2975030839443207,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "prophylactic agent approved for use for the treatment of RSV infection. Palivizumab",
            "probability": 0.002426047594711964,
            "start_logit": 2.1415061950683594,
            "end_logit": -4.306315898895264,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        }
    ],
    "5a89a20ffcd1d6a10c00000e": [
        {
            "text": "vascular endothelial growth factor",
            "probability": 0.4392578743805602,
            "start_logit": 4.414021968841553,
            "end_logit": 3.1726670265197754,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "VEGF-C",
            "probability": 0.1936980050349011,
            "start_logit": 3.676082134246826,
            "end_logit": 3.091820478439331,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "VEGF-C and -DVegfc",
            "probability": 0.07891622250493248,
            "start_logit": 3.676082134246826,
            "end_logit": 2.1939070224761963,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth factor (VEGF) signaling.ur results demonstrate that NHT",
            "probability": 0.04703163928330768,
            "start_logit": 4.414021968841553,
            "end_logit": 0.93840092420578,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vegfd",
            "probability": 0.04521996830672421,
            "start_logit": 3.248936653137207,
            "end_logit": 2.064204454421997,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth factor (VEGF)",
            "probability": 0.04085760495857529,
            "start_logit": 4.414021968841553,
            "end_logit": 0.7976733446121216,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "DVegfc",
            "probability": 0.03139714902913067,
            "start_logit": 2.7544124126434326,
            "end_logit": 2.1939070224761963,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "DVegfc is essential for secondary angiogenesis, giving rise to veins and lymphaticsvegfc",
            "probability": 0.027993275596675426,
            "start_logit": 2.7544124126434326,
            "end_logit": 2.0791542530059814,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "NHT stimulates lymphangiogenesis via upregulation of VEGF-C",
            "probability": 0.02451533424032928,
            "start_logit": 1.6090806722640991,
            "end_logit": 3.091820478439331,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth factor (VEGF",
            "probability": 0.022900703838852395,
            "start_logit": 4.414021968841553,
            "end_logit": 0.21874801814556122,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "NHT stimulates lymphangiogenesis via upregulation of VEGF-C and -DVegfc",
            "probability": 0.009988009795681804,
            "start_logit": 1.6090806722640991,
            "end_logit": 2.1939070224761963,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth",
            "probability": 0.009449959282761912,
            "start_logit": 4.414021968841553,
            "end_logit": -0.6664091944694519,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vegfc",
            "probability": 0.006065769254543938,
            "start_logit": 1.2251094579696655,
            "end_logit": 2.0791542530059814,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vegfc and vegfd",
            "probability": 0.0059757616996976215,
            "start_logit": 1.2251094579696655,
            "end_logit": 2.064204454421997,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "VEGF-C and its receptor VEGF-R3",
            "probability": 0.0036033116604970053,
            "start_logit": 3.1410531997680664,
            "end_logit": -0.3575975298881531,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth factor (VEGF) signaling.",
            "probability": 0.003508294433671276,
            "start_logit": 4.414021968841553,
            "end_logit": -1.6572896242141724,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "NHT",
            "probability": 0.0028458996951352495,
            "start_logit": 1.6090806722640991,
            "end_logit": 0.93840092420578,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "VEGF) signaling.ur results demonstrate that NHT",
            "probability": 0.0022950505885806585,
            "start_logit": 1.3939563035964966,
            "end_logit": 0.93840092420578,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth factor (VEGF) signaling.ur results demonstrate that NHT stimulates lymphangiogenesis",
            "probability": 0.0022539040890171926,
            "start_logit": 4.414021968841553,
            "end_logit": -2.0997557640075684,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "VEGF-R3",
            "probability": 0.0022262623264245316,
            "start_logit": 2.6595239639282227,
            "end_logit": -0.3575975298881531,
            "question_text": "List factors that promote lymphangiogenesis."
        }
    ],
    "5a86ebf2faa1ab7d2e000038": [
        {
            "text": "CLOCK",
            "probability": 0.5705882372567576,
            "start_logit": 3.703158140182495,
            "end_logit": 4.182128429412842,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "BMAL1",
            "probability": 0.24531586035547778,
            "start_logit": 4.150297164916992,
            "end_logit": 2.8908681869506836,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK and BMAL1",
            "probability": 0.11216850299188415,
            "start_logit": 3.703158140182495,
            "end_logit": 2.5554628372192383,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "BMAL1,",
            "probability": 0.01089871331404993,
            "start_logit": 4.068049907684326,
            "end_logit": -0.14078642427921295,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "BMAL1 proteins. Nuclear/cytoplasm distribution of CLOCK",
            "probability": 0.008497233531046562,
            "start_logit": 1.512595295906067,
            "end_logit": 2.165764093399048,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK and BMAL1,",
            "probability": 0.007566669196685256,
            "start_logit": 3.703158140182495,
            "end_logit": -0.14078642427921295,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK and BMAL1 proteins. Nuclear/cytoplasm distribution of CLOCK",
            "probability": 0.0071616448775929,
            "start_logit": 1.3415943384170532,
            "end_logit": 2.165764093399048,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK/BMAL1",
            "probability": 0.006069171577022746,
            "start_logit": 2.1454296112060547,
            "end_logit": 1.1964112520217896,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK was found to be under circadian regulation.Formation of CLOCK",
            "probability": 0.006064682463418155,
            "start_logit": 1.7036707401275635,
            "end_logit": 1.637430191040039,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "BMAL",
            "probability": 0.005422643706092063,
            "start_logit": 4.068049907684326,
            "end_logit": -0.8388476967811584,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "BMAL1 proteins. Nuclear/cytoplasm distribution of CLOCK was found to be under circadian regulation.Formation of CLOCK",
            "probability": 0.005009853841037971,
            "start_logit": 1.512595295906067,
            "end_logit": 1.637430191040039,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK and BMAL1 proteins. Nuclear/cytoplasm distribution of CLOCK was found to be under circadian regulation.Formation of CLOCK",
            "probability": 0.004222408854254437,
            "start_logit": 1.3415943384170532,
            "end_logit": 1.637430191040039,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK and BMAL",
            "probability": 0.00376478855009343,
            "start_logit": 3.703158140182495,
            "end_logit": -0.8388476967811584,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "Period-Arnt-Sim) domain-containing transcriptional activators, CLOCK",
            "probability": 0.003294449961004415,
            "start_logit": -1.4512704610824585,
            "end_logit": 4.182128429412842,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "Mammalian CLOCK",
            "probability": 0.0011660533368595555,
            "start_logit": -2.138699769973755,
            "end_logit": 3.8309433460235596,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK was found to be under circadian regulation.Formation of CLOCK/BMAL1",
            "probability": 0.0007065033671851757,
            "start_logit": 1.7036707401275635,
            "end_logit": -0.512479305267334,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "Period-Arnt-Sim) domain-containing transcriptional activators, CLOCK and BMAL1",
            "probability": 0.0006476360642907029,
            "start_logit": -1.4512704610824585,
            "end_logit": 2.5554628372192383,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "B",
            "probability": 0.0005906811310746379,
            "start_logit": 4.150297164916992,
            "end_logit": -3.138157367706299,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "Mammalian CLOCK and BMAL1",
            "probability": 0.0004554586577531292,
            "start_logit": -2.138699769973755,
            "end_logit": 2.8908681869506836,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcriptional activators, CLOCK",
            "probability": 0.0003888069664193155,
            "start_logit": -3.588181972503662,
            "end_logit": 4.182128429412842,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        }
    ],
    "5a7600b983b0d9ea6600000c": [
        {
            "text": "Psoriasis Trial (OPT) Compare Study (NCT01241591",
            "probability": 0.18468211343894522,
            "start_logit": -0.3261473476886749,
            "end_logit": 0.9331864714622498,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "NCT01241591",
            "probability": 0.1289102634208927,
            "start_logit": -0.6856668591499329,
            "end_logit": 0.9331864714622498,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis Trial",
            "probability": 0.07669894405828094,
            "start_logit": -0.3261473476886749,
            "end_logit": 0.05443837121129036,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis Trial (OPT) Compare Study (NCT01241591",
            "probability": 0.07303194351197759,
            "start_logit": -1.2538864612579346,
            "end_logit": 0.9331864714622498,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "OPT) Compare Study (NCT01241591",
            "probability": 0.06751751198173633,
            "start_logit": -1.332396388053894,
            "end_logit": 0.9331864714622498,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "non-inferiority, Oral-treatment Psoriasis Trial (OPT) Compare Study (NCT01241591",
            "probability": 0.06463756479037921,
            "start_logit": -1.3759876489639282,
            "end_logit": 0.9331864714622498,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis Trial (OPT) Compare Study",
            "probability": 0.05620034474308561,
            "start_logit": -0.3261473476886749,
            "end_logit": -0.2565266788005829,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "(OPT) Compare Study (NCT01241591",
            "probability": 0.050059155717681846,
            "start_logit": -1.631577968597412,
            "end_logit": 0.9331864714622498,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "01241591",
            "probability": 0.048015289028528516,
            "start_logit": -1.6732639074325562,
            "end_logit": 0.9331864714622498,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis Trial",
            "probability": 0.030330348974182138,
            "start_logit": -1.2538864612579346,
            "end_logit": 0.05443837121129036,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "(NCT01241591",
            "probability": 0.029571387003734347,
            "start_logit": -2.1579761505126953,
            "end_logit": 0.9331864714622498,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "non-inferiority, Oral-treatment Psoriasis Trial",
            "probability": 0.026844142475983563,
            "start_logit": -1.3759876489639282,
            "end_logit": 0.05443837121129036,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis",
            "probability": 0.025078183371032937,
            "start_logit": -0.3261473476886749,
            "end_logit": -1.0634512901306152,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "etanercept, in the Phase 3, randomized, placebo-controlled, non-inferiority, Oral-treatment Psoriasis Trial",
            "probability": 0.023179402232773743,
            "start_logit": -1.5227712392807007,
            "end_logit": 0.05443837121129036,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis Trial (OPT) Compare Study",
            "probability": 0.022224244276842713,
            "start_logit": -1.2538864612579346,
            "end_logit": -0.2565266788005829,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "OPT) Compare Study",
            "probability": 0.020546155655855845,
            "start_logit": -1.332396388053894,
            "end_logit": -0.2565266788005829,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "non-inferiority, Oral-treatment Psoriasis Trial (OPT) Compare Study",
            "probability": 0.019669763123940948,
            "start_logit": -1.3759876489639282,
            "end_logit": -0.2565266788005829,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Trial (OPT) Compare Study (NCT01241591",
            "probability": 0.019212652840561492,
            "start_logit": -2.589214324951172,
            "end_logit": 0.9331864714622498,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis Trial (OPT) Compare",
            "probability": 0.01762917255763222,
            "start_logit": -0.3261473476886749,
            "end_logit": -1.4158945083618164,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "A Phase 3 withdrawal/re-treatment study",
            "probability": 0.015961416795952043,
            "start_logit": -0.5416958332061768,
            "end_logit": -1.2997267246246338,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        }
    ],
    "5a7244aa2dc08e987e00000f": [
        {
            "text": "interleukin 12/23",
            "probability": 0.20947732631855992,
            "start_logit": 2.469564437866211,
            "end_logit": 3.664268732070923,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 12",
            "probability": 0.1431119777299372,
            "start_logit": 2.469564437866211,
            "end_logit": 3.283280611038208,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin (IL) 12",
            "probability": 0.11743958408681678,
            "start_logit": 2.9099442958831787,
            "end_logit": 2.6451973915100098,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 12/23 inhibitor (ustekinumab), the interleukin 17",
            "probability": 0.11657265062798028,
            "start_logit": 2.469564437866211,
            "end_logit": 3.0781679153442383,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "12/23",
            "probability": 0.08186907892877895,
            "start_logit": 1.5300703048706055,
            "end_logit": 3.664268732070923,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 17",
            "probability": 0.06582023052278796,
            "start_logit": 1.8979769945144653,
            "end_logit": 3.0781679153442383,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "12",
            "probability": 0.05593180897587098,
            "start_logit": 1.5300703048706055,
            "end_logit": 3.283280611038208,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin (IL) 12/23",
            "probability": 0.05503982668451044,
            "start_logit": 2.9099442958831787,
            "end_logit": 1.887330412864685,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "23",
            "probability": 0.04618539865693032,
            "start_logit": 0.9576126337051392,
            "end_logit": 3.664268732070923,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "12/23 inhibitor (ustekinumab), the interleukin 17",
            "probability": 0.04555956342829028,
            "start_logit": 1.5300703048706055,
            "end_logit": 3.0781679153442383,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "23 inhibitor (ustekinumab), the interleukin 17",
            "probability": 0.025701847719598776,
            "start_logit": 0.9576126337051392,
            "end_logit": 3.0781679153442383,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin (IL) 12/23 antibody ustekinumab; the IL-1",
            "probability": 0.013021369116396406,
            "start_logit": 2.9099442958831787,
            "end_logit": 0.4458651542663574,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 23",
            "probability": 0.0073123186492181835,
            "start_logit": 1.743114709854126,
            "end_logit": 1.035663366317749,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "17",
            "probability": 0.0055611824839470435,
            "start_logit": -0.573139488697052,
            "end_logit": 3.0781679153442383,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "12/23 antibody ustekinumab; the IL-1",
            "probability": 0.0035970085361657503,
            "start_logit": 1.6234550476074219,
            "end_logit": 0.4458651542663574,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 12/23 inhibitor",
            "probability": 0.002642067715008482,
            "start_logit": 2.469564437866211,
            "end_logit": -0.7087849378585815,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 23-helper T cell 17",
            "probability": 0.002113825051663751,
            "start_logit": 1.743114709854126,
            "end_logit": -0.20539791882038116,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "12/23 inhibitor",
            "probability": 0.0010325874121873558,
            "start_logit": 1.5300703048706055,
            "end_logit": -0.7087849378585815,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 23-helper T cell 17 (IL-23",
            "probability": 0.0010228485781182098,
            "start_logit": 1.743114709854126,
            "end_logit": -0.9313055872917175,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "23 antibody ustekinumab; the IL-1",
            "probability": 0.0009874987772330152,
            "start_logit": 0.3307724893093109,
            "end_logit": 0.4458651542663574,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        }
    ],
    "5a8842a261bb38fb24000015": [
        {
            "text": "S100A9",
            "probability": 0.6634040526964275,
            "start_logit": 4.611339092254639,
            "end_logit": 5.013592720031738,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1",
            "probability": 0.09559850909985998,
            "start_logit": 4.507485866546631,
            "end_logit": 3.1802189350128174,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1) and anti-programmed cell death protein ligand 1",
            "probability": 0.05885635832481447,
            "start_logit": 4.507485866546631,
            "end_logit": 2.6951615810394287,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein ligand 1",
            "probability": 0.0383315036684923,
            "start_logit": 4.078658103942871,
            "end_logit": 2.6951615810394287,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein 1",
            "probability": 0.022113999782343585,
            "start_logit": 3.043539524078369,
            "end_logit": 3.1802189350128174,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein ligand 1",
            "probability": 0.018206638003731134,
            "start_logit": 3.334172248840332,
            "end_logit": 2.6951615810394287,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1",
            "probability": 0.0181836788040462,
            "start_logit": 4.507485866546631,
            "end_logit": 1.5205861330032349,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein 1 (PD-1) and anti-programmed cell death protein ligand 1",
            "probability": 0.013614746793016561,
            "start_logit": 3.043539524078369,
            "end_logit": 2.6951615810394287,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1) and anti-programmed cell death protein ligand",
            "probability": 0.012289308072815867,
            "start_logit": 4.507485866546631,
            "end_logit": 1.128791332244873,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein ligand",
            "probability": 0.008003683389255266,
            "start_logit": 4.078658103942871,
            "end_logit": 1.128791332244873,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein",
            "probability": 0.0079997424402636,
            "start_logit": 4.507485866546631,
            "end_logit": 0.6994710564613342,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death",
            "probability": 0.007655921584144792,
            "start_logit": 4.507485866546631,
            "end_logit": 0.6555411219596863,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "S100A9-targeting agents with immune checkpoints inhibitors,Programmed cell death 1",
            "probability": 0.007159090657100367,
            "start_logit": 4.611339092254639,
            "end_logit": 0.48459145426750183,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "S100A9-targeting agents with immune checkpoints inhibitors,Programmed cell death",
            "probability": 0.007096295354168329,
            "start_logit": 4.611339092254639,
            "end_logit": 0.4757813513278961,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein 1 (PD-1",
            "probability": 0.004206277617727746,
            "start_logit": 3.043539524078369,
            "end_logit": 1.5205861330032349,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "PD-1) and anti-programmed cell death protein ligand 1",
            "probability": 0.00405980044376893,
            "start_logit": 1.8335198163986206,
            "end_logit": 2.6951615810394287,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein ligand",
            "probability": 0.0038015770898240423,
            "start_logit": 3.334172248840332,
            "end_logit": 1.128791332244873,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1) and anti-programmed cell death protein ligand 1 (PD-L1",
            "probability": 0.0033830073596752956,
            "start_logit": 4.507485866546631,
            "end_logit": -0.16117322444915771,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1) and anti-programmed cell death",
            "probability": 0.0031351966380405885,
            "start_logit": 4.507485866546631,
            "end_logit": -0.23724639415740967,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1)",
            "probability": 0.002900612180483467,
            "start_logit": 4.507485866546631,
            "end_logit": -0.3150164783000946,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        }
    ],
    "5a86c938faa1ab7d2e000034": [
        {
            "text": "IAA5 and IAA19",
            "probability": 0.3224096215598677,
            "start_logit": 4.554101467132568,
            "end_logit": 4.019718647003174,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "IAA19",
            "probability": 0.2899220648936572,
            "start_logit": 4.447890758514404,
            "end_logit": 4.019718647003174,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "IAA5",
            "probability": 0.2838396825978741,
            "start_logit": 4.554101467132568,
            "end_logit": 3.892305374145508,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "IAA",
            "probability": 0.04197873922273396,
            "start_logit": 4.554101467132568,
            "end_logit": 1.9810590744018555,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "IAA5 and IAA",
            "probability": 0.01639733397062065,
            "start_logit": 4.554101467132568,
            "end_logit": 1.041014552116394,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "IAA5 and IAA19 genes",
            "probability": 0.0102204391422677,
            "start_logit": 4.554101467132568,
            "end_logit": 0.568285346031189,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "IAA19 genes",
            "probability": 0.009190578140658845,
            "start_logit": 4.447890758514404,
            "end_logit": 0.568285346031189,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "DREB/CBF TFs directly promote transcription of the IAA5 and IAA19",
            "probability": 0.007512148343988592,
            "start_logit": 0.7948001027107239,
            "end_logit": 4.019718647003174,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "DREB/CBF TFs directly promote transcription of the IAA5",
            "probability": 0.006613468268315729,
            "start_logit": 0.7948001027107239,
            "end_logit": 3.892305374145508,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA4",
            "probability": 0.0031146289974960367,
            "start_logit": 2.087935209274292,
            "end_logit": 1.8461720943450928,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "CBF TFs directly promote transcription of the IAA5 and IAA19",
            "probability": 0.0026798515727612876,
            "start_logit": -0.2359599769115448,
            "end_logit": 4.019718647003174,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "CBF TFs directly promote transcription of the IAA5",
            "probability": 0.00235926029794596,
            "start_logit": -0.2359599769115448,
            "end_logit": 3.892305374145508,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "DREB/CBF TFs directly promote transcription of the IAA",
            "probability": 0.0009781051657486992,
            "start_logit": 0.7948001027107239,
            "end_logit": 1.9810590744018555,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "5 and IAA19",
            "probability": 0.00045393537828504124,
            "start_logit": -2.011521816253662,
            "end_logit": 4.019718647003174,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA",
            "probability": 0.0004153356882826974,
            "start_logit": 2.087935209274292,
            "end_logit": -0.16860614717006683,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "IAA19 degradation in vivo.We showed that EgrIAA4",
            "probability": 0.0004003781644185625,
            "start_logit": 0.0364793986082077,
            "end_logit": 1.8461720943450928,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "5",
            "probability": 0.000399630982068713,
            "start_logit": -2.011521816253662,
            "end_logit": 3.892305374145508,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "IAA6/IAA19 degradation in vivo.We showed that EgrIAA4",
            "probability": 0.00038381447912523965,
            "start_logit": -0.005770804360508919,
            "end_logit": 1.8461720943450928,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "DREB/CBF TFs directly promote transcription of the IAA5 and IAA",
            "probability": 0.00038205809317124503,
            "start_logit": 0.7948001027107239,
            "end_logit": 1.041014552116394,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "CBF TFs directly promote transcription of the IAA",
            "probability": 0.0003489250407115726,
            "start_logit": -0.2359599769115448,
            "end_logit": 1.9810590744018555,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        }
    ],
    "5a76018c83b0d9ea6600000e": [
        {
            "text": "MPygopagus",
            "probability": 0.34643731542882766,
            "start_logit": 2.8218002319335938,
            "end_logit": 2.9748620986938477,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Ischiopagus",
            "probability": 0.1812243466406145,
            "start_logit": 2.485036849975586,
            "end_logit": 2.6636593341827393,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Ischiopagus and diprosopus in India: two pairs of conjoined twinsDicephalus dipus dibrachius",
            "probability": 0.10877484890804769,
            "start_logit": 2.485036849975586,
            "end_logit": 2.1532037258148193,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Ischiopagus and diprosopus",
            "probability": 0.09987197292158276,
            "start_logit": 2.485036849975586,
            "end_logit": 2.06781268119812,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Thoracoomphalopagus",
            "probability": 0.08563586883754137,
            "start_logit": 1.8966187238693237,
            "end_logit": 2.502445936203003,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "diprosopus in India: two pairs of conjoined twinsDicephalus dipus dibrachius",
            "probability": 0.07622291502085832,
            "start_logit": 2.1294188499450684,
            "end_logit": 2.1532037258148193,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "diprosopus",
            "probability": 0.06998431145974274,
            "start_logit": 2.1294188499450684,
            "end_logit": 2.06781268119812,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Ischiopagus and diprosopus in India: two pairs of conjoined twinsDicephalus",
            "probability": 0.01044228785940427,
            "start_logit": 2.485036849975586,
            "end_logit": -0.19021271169185638,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "diprosopus in India: two pairs of conjoined twinsDicephalus",
            "probability": 0.007317331424689523,
            "start_logit": 2.1294188499450684,
            "end_logit": -0.19021271169185638,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "MPygopagus are one of the rare types of conjoined twins with only a handful of cases reported in the literature.",
            "probability": 0.00257534072928356,
            "start_logit": 2.8218002319335938,
            "end_logit": -1.9268579483032227,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Eight different types of conjoined twins have been described in the literature. MPygopagus",
            "probability": 0.0018172571292943318,
            "start_logit": -2.4285733699798584,
            "end_logit": 2.9748620986938477,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Thoracoomphalopagus Conjoined Twins. Eight different types of conjoined twins have been described in the literature.",
            "probability": 0.0016374426711702435,
            "start_logit": 1.8966187238693237,
            "end_logit": -1.4545226097106934,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Thoracoomphalopagus Conjoined Twins",
            "probability": 0.0016343879367166567,
            "start_logit": 1.8966187238693237,
            "end_logit": -1.4563899040222168,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Thoracoomphalopagus Conjoined Twins. Eight",
            "probability": 0.0013738947506063118,
            "start_logit": 1.8966187238693237,
            "end_logit": -1.6300086975097656,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Ischiopagus and diprosopus in India: two pairs of conjoined twinsDicephalus dipus",
            "probability": 0.0012119311417342618,
            "start_logit": 2.485036849975586,
            "end_logit": -2.3438613414764404,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "dipus dibrachius",
            "probability": 0.0010037349770727335,
            "start_logit": -2.2005152702331543,
            "end_logit": 2.1532037258148193,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "diprosopus in India: two pairs of conjoined twinsDicephalus dipus",
            "probability": 0.0008492489335069804,
            "start_logit": 2.1294188499450684,
            "end_logit": -2.3438613414764404,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Thoracoomphalopagus Conjoined Twins.",
            "probability": 0.0007802491269562424,
            "start_logit": 1.8966187238693237,
            "end_logit": -2.195800304412842,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Ischiopagus and diprosopus in India",
            "probability": 0.0006141208760899529,
            "start_logit": 2.485036849975586,
            "end_logit": -3.0236399173736572,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "Thoracoomphalopagus Conjoined Twins. Eight different types of conjoined twins have been described in the literature",
            "probability": 0.0005911932262598855,
            "start_logit": 1.8966187238693237,
            "end_logit": -2.4732706546783447,
            "question_text": "List the ten types of conjoined twins."
        }
    ],
    "5a6a2dcab750ff4455000023": [
        {
            "text": "developmental regulatory target genes",
            "probability": 0.29251229703041576,
            "start_logit": -2.5911107063293457,
            "end_logit": -3.3128411769866943,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "developmental regulatory target genes, and phylogenetically and functionally unrelated \"bystander\" genes",
            "probability": 0.1826543704422292,
            "start_logit": -2.5911107063293457,
            "end_logit": -3.783752202987671,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "developmental regulatory gene can extend into and beyond adjacent transcriptional units. We termed these chromosomal segments genomic regulatory blocks",
            "probability": 0.09080285154247637,
            "start_logit": -3.3446292877197266,
            "end_logit": -3.7291386127471924,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "developmental",
            "probability": 0.07472906406336213,
            "start_logit": -2.5911107063293457,
            "end_logit": -4.677478790283203,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "developmental regulatory gene",
            "probability": 0.052933968335790414,
            "start_logit": -3.3446292877197266,
            "end_logit": -4.268784046173096,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "transcriptional units. We termed these chromosomal segments genomic regulatory blocks",
            "probability": 0.04784378551972545,
            "start_logit": -3.9853787422180176,
            "end_logit": -3.7291386127471924,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "developmental regulatory gene can extend into and beyond adjacent transcriptional units",
            "probability": 0.04552279002061489,
            "start_logit": -3.3446292877197266,
            "end_logit": -4.419616222381592,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "transcriptional units",
            "probability": 0.02398583926614866,
            "start_logit": -3.9853787422180176,
            "end_logit": -4.419616222381592,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "target genes",
            "probability": 0.023975805100213753,
            "start_logit": -5.092572212219238,
            "end_logit": -3.3128411769866943,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "developmental regulatory gene can extend into and beyond adjacent transcriptional units.",
            "probability": 0.021055005192954494,
            "start_logit": -3.3446292877197266,
            "end_logit": -5.190690994262695,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "HCNEs), their developmental regulatory target genes",
            "probability": 0.018537051760376788,
            "start_logit": -5.349845886230469,
            "end_logit": -3.3128411769866943,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "regulatory domain of a developmental regulatory gene can extend into and beyond adjacent transcriptional units. We termed these chromosomal segments genomic regulatory blocks",
            "probability": 0.018093037912257966,
            "start_logit": -4.95779275894165,
            "end_logit": -3.7291386127471924,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "noncoding elements (HCNEs), their developmental regulatory target genes",
            "probability": 0.01709536610164482,
            "start_logit": -5.43080997467041,
            "end_logit": -3.3128411769866943,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "transcriptional units. We termed these chromosomal segments genomic regulatory blocks (GRBs).",
            "probability": 0.015882742366218797,
            "start_logit": -3.9853787422180176,
            "end_logit": -4.831846714019775,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "target genes, and phylogenetically and functionally unrelated \"bystander\" genes",
            "probability": 0.014971287124964075,
            "start_logit": -5.092572212219238,
            "end_logit": -3.783752202987671,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "bystander\" genes",
            "probability": 0.013363310644375136,
            "start_logit": -5.206193447113037,
            "end_logit": -3.783752202987671,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "chromosomal segments genomic regulatory blocks",
            "probability": 0.011837086365483408,
            "start_logit": -5.382082462310791,
            "end_logit": -3.7291386127471924,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "HCNEs), their developmental regulatory target genes, and phylogenetically and functionally unrelated \"bystander\" genes",
            "probability": 0.011575149330541039,
            "start_logit": -5.349845886230469,
            "end_logit": -3.783752202987671,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "developmental regulatory target genes, and phylogenetically and functionally unrelated \"bystander\" genes. Bystander genes",
            "probability": 0.011535364588921754,
            "start_logit": -3.788156032562256,
            "end_logit": -5.3488850593566895,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "transcriptional units.",
            "probability": 0.011093827291284952,
            "start_logit": -3.9853787422180176,
            "end_logit": -5.190690994262695,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        }
    ],
    "5a7636d39e632bc066000004": [
        {
            "text": "pmsignature",
            "probability": 0.559367730056916,
            "start_logit": 5.307441234588623,
            "end_logit": 4.639424800872803,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pmsignature (https://github.com/friend1ws/pmsignature",
            "probability": 0.22536790866427533,
            "start_logit": 5.307441234588623,
            "end_logit": 3.7303519248962402,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "SignatureEstimation",
            "probability": 0.14447106927289988,
            "start_logit": 4.16001558303833,
            "end_logit": 4.433122634887695,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pmsignature) and a web application available at https://friend1ws.shinyapps.io/pmsignature",
            "probability": 0.021431383386196427,
            "start_logit": 4.15671968460083,
            "end_logit": 2.52819561958313,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "signatureestimation",
            "probability": 0.013314706352715215,
            "start_logit": 2.900294065475464,
            "end_logit": 3.308634042739868,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "signeR",
            "probability": 0.012350031255286492,
            "start_logit": 3.431550979614258,
            "end_logit": 2.7021665573120117,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pm",
            "probability": 0.007373858109679114,
            "start_logit": 5.307441234588623,
            "end_logit": 0.3105587661266327,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "SignatureEstimation,",
            "probability": 0.00434609219153937,
            "start_logit": 4.16001558303833,
            "end_logit": 0.9293204545974731,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pmsignature (https://github.com/friend1ws/pm",
            "probability": 0.0024522988577289425,
            "start_logit": 5.307441234588623,
            "end_logit": -0.7903563976287842,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "Signature",
            "probability": 0.0024196896465729307,
            "start_logit": 4.16001558303833,
            "end_logit": 0.3436826467514038,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pmsignature (https://github.com/friend1ws/pmsignature)",
            "probability": 0.0016625349709413052,
            "start_logit": 5.307441234588623,
            "end_logit": -1.1790387630462646,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pmsignature (https://github.com/friend1ws",
            "probability": 0.0013635351712116856,
            "start_logit": 5.307441234588623,
            "end_logit": -1.377301573753357,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pmsignature_shiny/.SomaticSignature",
            "probability": 0.0013207330954908526,
            "start_logit": 3.4197635650634766,
            "end_logit": 0.47848233580589294,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pmsignature) and a web application available at https://friend1ws.shinyapps.io/pm",
            "probability": 0.0005866029221192299,
            "start_logit": 4.15671968460083,
            "end_logit": -1.0700678825378418,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pmsignature)",
            "probability": 0.0005260400010520175,
            "start_logit": 4.15671968460083,
            "end_logit": -1.1790387630462646,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "R package pmsignature",
            "probability": 0.00044958882498695864,
            "start_logit": -1.818787693977356,
            "end_logit": 4.639424800872803,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "pmsignature_shiny/.SomaticSignatures",
            "probability": 0.0004280630659677598,
            "start_logit": 3.4197635650634766,
            "end_logit": -0.6481893658638,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "friend1ws/pmsignature",
            "probability": 0.0003933790846710571,
            "start_logit": -1.0432745218276978,
            "end_logit": 3.7303519248962402,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "signature",
            "probability": 0.00019361681703715616,
            "start_logit": 2.900294065475464,
            "end_logit": -0.9221093654632568,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "R package pmsignature (https://github.com/friend1ws/pmsignature",
            "probability": 0.0001811382527122723,
            "start_logit": -1.818787693977356,
            "end_logit": 3.7303519248962402,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        }
    ],
    "5a981e66fcd1d6a10c00002f": [
        {
            "text": "dyslipidemia",
            "probability": 0.1548133942828745,
            "start_logit": 1.6929899454116821,
            "end_logit": 1.5588979721069336,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension, dyslipidemia",
            "probability": 0.15294887174904206,
            "start_logit": 1.680873155593872,
            "end_logit": 1.5588979721069336,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesity, hypertension, dyslipidemia",
            "probability": 0.09526283932952002,
            "start_logit": 1.2074092626571655,
            "end_logit": 1.5588979721069336,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension",
            "probability": 0.08259829329052049,
            "start_logit": 1.680873155593872,
            "end_logit": 0.9427832961082458,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "abdominal obesityMetabolic syndrome, defined as a cluster of obesity, hypertension, dyslipidemia",
            "probability": 0.07186006450195703,
            "start_logit": 0.925490140914917,
            "end_logit": 1.5588979721069336,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesity, hypertension",
            "probability": 0.05144560958604591,
            "start_logit": 1.2074092626571655,
            "end_logit": 0.9427832961082458,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "abdominal obesity",
            "probability": 0.04399550850241739,
            "start_logit": 0.925490140914917,
            "end_logit": 1.0682648420333862,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesityMetabolic syndrome, defined as a cluster of obesity, hypertension, dyslipidemia",
            "probability": 0.039841167672931325,
            "start_logit": 0.33567020297050476,
            "end_logit": 1.5588979721069336,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "elevated blood pressure, and abdominal obesity",
            "probability": 0.03955175431852664,
            "start_logit": 0.8190126419067383,
            "end_logit": 1.0682648420333862,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "abdominal obesityMetabolic syndrome, defined as a cluster of obesity, hypertension",
            "probability": 0.03880720802796992,
            "start_logit": 0.925490140914917,
            "end_logit": 0.9427832961082458,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "elevated blood pressure, and abdominal obesityMetabolic syndrome, defined as a cluster of obesity, hypertension",
            "probability": 0.034887496700393504,
            "start_logit": 0.8190126419067383,
            "end_logit": 0.9427832961082458,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dyslipidemia, and insulin resistance/glucose intolerance",
            "probability": 0.03071562833480679,
            "start_logit": 1.6929899454116821,
            "end_logit": -0.05855092033743858,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension, dyslipidemia, and insulin resistance/glucose intolerance",
            "probability": 0.030345699224755586,
            "start_logit": 1.680873155593872,
            "end_logit": -0.05855092033743858,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesity",
            "probability": 0.02439230250138379,
            "start_logit": 0.33567020297050476,
            "end_logit": 1.0682648420333862,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesityMetabolic syndrome, defined as a cluster of obesity, hypertension",
            "probability": 0.02151576807892469,
            "start_logit": 0.33567020297050476,
            "end_logit": 0.9427832961082458,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance, elevated blood pressure, and abdominal obesity",
            "probability": 0.01897767923419047,
            "start_logit": 0.08466610312461853,
            "end_logit": 1.0682648420333862,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesity, hypertension, dyslipidemia, and insulin resistance/glucose intolerance",
            "probability": 0.018900547853226896,
            "start_logit": 1.2074092626571655,
            "end_logit": -0.05855092033743858,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "abdominal obesityMetabolic syndrome, defined as a cluster of obesity",
            "probability": 0.017061746512679582,
            "start_logit": 0.925490140914917,
            "end_logit": 0.12101620435714722,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance, elevated blood pressure, and abdominal obesityMetabolic syndrome, defined as a cluster of obesity, hypertension",
            "probability": 0.016739680276427495,
            "start_logit": 0.08466610312461853,
            "end_logit": 0.9427832961082458,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "elevated blood pressure",
            "probability": 0.015338740021405894,
            "start_logit": 0.8190126419067383,
            "end_logit": 0.12103644758462906,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        }
    ],
    "5a8861eb8cb19eca6b000001": [
        {
            "text": "synaptophysin",
            "probability": 0.42108392534753203,
            "start_logit": 3.1697676181793213,
            "end_logit": 3.314256191253662,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD95 and the pre-synaptic marker synaptophysin",
            "probability": 0.34768053399219273,
            "start_logit": 2.978219509124756,
            "end_logit": 3.314256191253662,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD95",
            "probability": 0.1695787223104171,
            "start_logit": 2.978219509124756,
            "end_logit": 2.5962893962860107,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "synaptophysin, and the post-synaptic marker, PSD95",
            "probability": 0.028315623964946135,
            "start_logit": 1.9089587926864624,
            "end_logit": 1.8756465911865234,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "synaptophysin. post-synaptic density (PSD)-95",
            "probability": 0.0108794000228615,
            "start_logit": 3.1697676181793213,
            "end_logit": -0.3417048752307892,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "pre-synaptic marker synaptophysin",
            "probability": 0.005473700481996369,
            "start_logit": -1.1731096506118774,
            "end_logit": 3.314256191253662,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "synaptophysin. post-synaptic density (PSD)-95 protein",
            "probability": 0.005360477695685638,
            "start_logit": 3.1697676181793213,
            "end_logit": -1.049522876739502,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "postsynaptic density 95 (PSD-95) and synaptophysin",
            "probability": 0.004936013393815835,
            "start_logit": 0.5886754989624023,
            "end_logit": 1.449074149131775,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "postsynaptic density 95",
            "probability": 0.0019199808742368539,
            "start_logit": 0.5886754989624023,
            "end_logit": 0.5048313736915588,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "synaptophysin. post-synaptic density (PSD)-95 protein,",
            "probability": 0.0009554774438640283,
            "start_logit": 3.1697676181793213,
            "end_logit": -2.7741200923919678,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "post-synaptic marker PSD95 and the pre-synaptic marker synaptophysin",
            "probability": 0.0006293064832940633,
            "start_logit": -3.3362014293670654,
            "end_logit": 3.314256191253662,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD95 and the pre-synaptic marker",
            "probability": 0.0005121154641388784,
            "start_logit": 2.978219509124756,
            "end_logit": -3.206233024597168,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "synaptophysin,",
            "probability": 0.00047408201755734996,
            "start_logit": 1.9089587926864624,
            "end_logit": -2.214142084121704,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD95 and the pre",
            "probability": 0.00037737895933948225,
            "start_logit": 2.978219509124756,
            "end_logit": -3.511533260345459,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD95,",
            "probability": 0.00033852150888953895,
            "start_logit": 1.944961667060852,
            "end_logit": -2.586937665939331,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "synaptophysin. post-synaptic density",
            "probability": 0.00032812589335859936,
            "start_logit": 3.1697676181793213,
            "end_logit": -3.8429338932037354,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "synaptophysin, and the post-synaptic marker, PSD95,",
            "probability": 0.0003265505490556704,
            "start_logit": 1.9089587926864624,
            "end_logit": -2.586937665939331,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "post-synaptic marker PSD95",
            "probability": 0.0003069397879521937,
            "start_logit": -3.3362014293670654,
            "end_logit": 2.5962893962860107,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD95 and the pre-synaptic marker synaptophysin. post-synaptic density",
            "probability": 0.00027092695529858405,
            "start_logit": 2.978219509124756,
            "end_logit": -3.8429338932037354,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "the pre-synaptic marker synaptophysin",
            "probability": 0.00025219685356758044,
            "start_logit": -4.250609874725342,
            "end_logit": 3.314256191253662,
            "question_text": "List the two most important synaptic markers."
        }
    ],
    "5a68f965b750ff445500001a": [
        {
            "text": "Gardnerella",
            "probability": 0.5686951422188498,
            "start_logit": 5.456421375274658,
            "end_logit": 4.887240409851074,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Gardnerella vaginalis",
            "probability": 0.20913225635253857,
            "start_logit": 4.95649528503418,
            "end_logit": 4.386788845062256,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Trichomonas vaginalis, and clue cells (Gardnerella vaginalis",
            "probability": 0.06585968715841795,
            "start_logit": 3.8010549545288086,
            "end_logit": 4.386788845062256,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Trichomonas vaginalis, and clue cells (Gardnerella",
            "probability": 0.036857682273527884,
            "start_logit": 3.8010549545288086,
            "end_logit": 3.806326389312744,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Trichomonas vaginalis",
            "probability": 0.022577071111454055,
            "start_logit": 3.8010549545288086,
            "end_logit": 3.316197156906128,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Candida sp, Trichomonas vaginalis, and clue cells (Gardnerella vaginalis",
            "probability": 0.019365593091815674,
            "start_logit": 2.5770263671875,
            "end_logit": 4.386788845062256,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Gardnerella infection",
            "probability": 0.01606302546964617,
            "start_logit": 5.456421375274658,
            "end_logit": 1.32041597366333,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Trichomonas",
            "probability": 0.011179304218451694,
            "start_logit": 3.8010549545288086,
            "end_logit": 2.6133265495300293,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Candida sp, Trichomonas vaginalis, and clue cells (Gardnerella",
            "probability": 0.010837750800420208,
            "start_logit": 2.5770263671875,
            "end_logit": 3.806326389312744,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "T vaginalis",
            "probability": 0.0076227179987821215,
            "start_logit": 3.1032392978668213,
            "end_logit": 2.928210973739624,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Coccobacilli, Candida sp, Trichomonas vaginalis, and clue cells (Gardnerella",
            "probability": 0.007609903407385763,
            "start_logit": 2.2234413623809814,
            "end_logit": 3.806326389312744,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Candida sp, Trichomonas vaginalis",
            "probability": 0.00663863421181651,
            "start_logit": 2.5770263671875,
            "end_logit": 3.316197156906128,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Coccobacilli, Candida sp, Trichomonas vaginalis",
            "probability": 0.004661425238429674,
            "start_logit": 2.2234413623809814,
            "end_logit": 3.316197156906128,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Candida sp, Trichomonas",
            "probability": 0.003287198374073698,
            "start_logit": 2.5770263671875,
            "end_logit": 2.6133265495300293,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Coccobacilli",
            "probability": 0.0023105434421005857,
            "start_logit": 2.2234413623809814,
            "end_logit": 2.61435866355896,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Coccobacilli, Candida sp, Trichomonas",
            "probability": 0.0023081599280402785,
            "start_logit": 2.2234413623809814,
            "end_logit": 2.6133265495300293,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "T vaginalis), or direct visualization of T vaginalis",
            "probability": 0.0020205349212589914,
            "start_logit": 3.1032392978668213,
            "end_logit": 1.600440263748169,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Candida",
            "probability": 0.0013095385724061373,
            "start_logit": 2.5770263671875,
            "end_logit": 1.6929657459259033,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Coccobacilli, Candida",
            "probability": 0.0009195138574205052,
            "start_logit": 2.2234413623809814,
            "end_logit": 1.6929657459259033,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Candida sp",
            "probability": 0.0007443173531638487,
            "start_logit": 2.5770263671875,
            "end_logit": 1.1280031204223633,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        }
    ],
    "5a68fd01b750ff445500001b": [
        {
            "text": "p24",
            "probability": 0.4842780629128052,
            "start_logit": 4.008650779724121,
            "end_logit": 3.246253728866577,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 (p24",
            "probability": 0.24506362615088217,
            "start_logit": 3.3275094032287598,
            "end_logit": 3.246253728866577,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 antigen",
            "probability": 0.15465143826966202,
            "start_logit": 4.008650779724121,
            "end_logit": 2.1047682762145996,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 (p24 antigen",
            "probability": 0.07825967177587502,
            "start_logit": 3.3275094032287598,
            "end_logit": 2.1047682762145996,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "core protein p24",
            "probability": 0.010746072535693799,
            "start_logit": 0.17479243874549866,
            "end_logit": 3.2719931602478027,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "core protein p24 (p24",
            "probability": 0.010473004127720625,
            "start_logit": 0.17479243874549866,
            "end_logit": 3.246253728866577,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "(p24",
            "probability": 0.004211414608563767,
            "start_logit": -0.7362098693847656,
            "end_logit": 3.246253728866577,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "core protein p24 (p24 antigen",
            "probability": 0.003344494156134684,
            "start_logit": 0.17479243874549866,
            "end_logit": 2.1047682762145996,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "24",
            "probability": 0.00217737033134486,
            "start_logit": -1.3958905935287476,
            "end_logit": 3.246253728866577,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "(p24 antigen",
            "probability": 0.0013448912437760367,
            "start_logit": -0.7362098693847656,
            "end_logit": 2.1047682762145996,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 antigen)",
            "probability": 0.0011970588725180775,
            "start_logit": 4.008650779724121,
            "end_logit": -2.756537914276123,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "24 (p24",
            "probability": 0.0007900147964507497,
            "start_logit": -2.409712076187134,
            "end_logit": 3.246253728866577,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "24 antigen",
            "probability": 0.0006953308009923266,
            "start_logit": -1.3958905935287476,
            "end_logit": 2.1047682762145996,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 (p24 antigen)",
            "probability": 0.0006057585723600817,
            "start_logit": 3.3275094032287598,
            "end_logit": -2.756537914276123,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 antigen) detection,",
            "probability": 0.0006045222655862857,
            "start_logit": 4.008650779724121,
            "end_logit": -3.4397222995758057,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p",
            "probability": 0.0005228292553768025,
            "start_logit": 4.008650779724121,
            "end_logit": -3.5849058628082275,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 (p24 antigen) detection,",
            "probability": 0.0003059118920284353,
            "start_logit": 3.3275094032287598,
            "end_logit": -3.4397222995758057,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 (p",
            "probability": 0.00026457203617640256,
            "start_logit": 3.3275094032287598,
            "end_logit": -3.5849058628082275,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "24 (p24 antigen",
            "probability": 0.00025228672096059987,
            "start_logit": -2.409712076187134,
            "end_logit": 2.1047682762145996,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "HIV-1/2 Ag/Ab Combo POCT showed only 50% sensitivity for HIV core protein p24",
            "probability": 0.0002116686750922547,
            "start_logit": -3.752480983734131,
            "end_logit": 3.2719931602478027,
            "question_text": "What is included in the fourth generation HIV test?"
        }
    ],
    "5a6f7e6ab750ff4455000052": [
        {
            "text": "Beneficence, Respect for autonomy",
            "probability": 0.11068054294323355,
            "start_logit": 4.344048500061035,
            "end_logit": 3.726409435272217,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Beneficence",
            "probability": 0.10793641952128015,
            "start_logit": 4.344048500061035,
            "end_logit": 3.701303720474243,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Beneficence, Respect for autonomy, Non-maleficence, and Justice",
            "probability": 0.09145407220971481,
            "start_logit": 4.344048500061035,
            "end_logit": 3.5355982780456543,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Respect for autonomy",
            "probability": 0.08697653313679522,
            "start_logit": 4.103038787841797,
            "end_logit": 3.726409435272217,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Respect for autonomy, Non-maleficence, and Justice",
            "probability": 0.07186771884668834,
            "start_logit": 4.103038787841797,
            "end_logit": 3.5355982780456543,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Non-maleficence, and Justice",
            "probability": 0.059385006754283924,
            "start_logit": 3.9122533798217773,
            "end_logit": 3.5355982780456543,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Beneficence, Respect for autonomy, Non-maleficence",
            "probability": 0.055966165506665146,
            "start_logit": 4.344048500061035,
            "end_logit": 3.044508695602417,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Respect for autonomy, Non-maleficence",
            "probability": 0.043980115377880116,
            "start_logit": 4.103038787841797,
            "end_logit": 3.044508695602417,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, non-maleficence, respect for autonomy and justice",
            "probability": 0.04071564015571012,
            "start_logit": 3.6768076419830322,
            "end_logit": 3.3936145305633545,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "respect for autonomy and justice",
            "probability": 0.037542600795537714,
            "start_logit": 3.5956716537475586,
            "end_logit": 3.3936145305633545,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Respect for autonomy, Non-maleficence, and Justice.This paper argues that the four prima facie principles-beneficence",
            "probability": 0.03683688382274599,
            "start_logit": 4.103038787841797,
            "end_logit": 2.8672707080841064,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Non-maleficence",
            "probability": 0.03634120423859741,
            "start_logit": 3.9122533798217773,
            "end_logit": 3.044508695602417,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, non-maleficence, respect for autonomy",
            "probability": 0.036282031166718506,
            "start_logit": 3.6768076419830322,
            "end_logit": 3.278324842453003,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "respect for autonomy",
            "probability": 0.03345451052554165,
            "start_logit": 3.5956716537475586,
            "end_logit": 3.278324842453003,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Non-maleficence, and Justice.This paper argues that the four prima facie principles-beneficence",
            "probability": 0.03043868136801653,
            "start_logit": 3.9122533798217773,
            "end_logit": 2.8672707080841064,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "non-maleficence, respect for autonomy and justice",
            "probability": 0.029167565299905874,
            "start_logit": 3.343252658843994,
            "end_logit": 3.3936145305633545,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "non-maleficence, respect for autonomy",
            "probability": 0.025991449703881616,
            "start_logit": 3.343252658843994,
            "end_logit": 3.278324842453003,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence",
            "probability": 0.024053210374856124,
            "start_logit": 3.6768076419830322,
            "end_logit": 2.8672707080841064,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, non-maleficence",
            "probability": 0.023833012916840875,
            "start_logit": 3.6768076419830322,
            "end_logit": 2.8580739498138428,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "Justice",
            "probability": 0.017096635335106337,
            "start_logit": 2.667093276977539,
            "end_logit": 3.5355982780456543,
            "question_text": "List four principles of medical ethics."
        }
    ],
    "5a70d12899e2c3af26000001": [
        {
            "text": "facial nerve paralysis",
            "probability": 0.1561894111322354,
            "start_logit": 3.4427788257598877,
            "end_logit": 3.6996188163757324,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis",
            "probability": 0.09528403765467501,
            "start_logit": 3.1575098037719727,
            "end_logit": 3.490680694580078,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis and fever",
            "probability": 0.07808664370748022,
            "start_logit": 3.1575098037719727,
            "end_logit": 3.291637420654297,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial nerve paralysis.Heerfordt's syndrome is defined as a combination of facial palsy, parotid swelling",
            "probability": 0.06754391899199003,
            "start_logit": 3.4427788257598877,
            "end_logit": 2.8613274097442627,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid swelling, uveitis",
            "probability": 0.06719923165380932,
            "start_logit": 2.808309316635132,
            "end_logit": 3.490680694580078,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial nerve paralysis.Heerfordt's syndrome is defined as a combination of facial palsy",
            "probability": 0.06278891597247699,
            "start_logit": 3.4427788257598877,
            "end_logit": 2.788327932357788,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial palsy, parotid swelling, uveitis",
            "probability": 0.061716563153978374,
            "start_logit": 2.7231998443603516,
            "end_logit": 3.490680694580078,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever",
            "probability": 0.06147916304552279,
            "start_logit": 2.918389081954956,
            "end_logit": 3.291637420654297,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid swelling, uveitis and fever",
            "probability": 0.05507073995525607,
            "start_logit": 2.808309316635132,
            "end_logit": 3.291637420654297,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial palsy, parotid swelling, uveitis and fever",
            "probability": 0.05057761401044554,
            "start_logit": 2.7231998443603516,
            "end_logit": 3.291637420654297,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial palsy, anterior uveitis, and fever",
            "probability": 0.048868425499322216,
            "start_logit": 2.6772704124450684,
            "end_logit": 3.303189277648926,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid swelling",
            "probability": 0.035812913079152714,
            "start_logit": 2.808309316635132,
            "end_logit": 2.8613274097442627,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial palsy, parotid swelling",
            "probability": 0.03289099975374754,
            "start_logit": 2.7231998443603516,
            "end_logit": 2.8613274097442627,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial palsy",
            "probability": 0.030575516650636233,
            "start_logit": 2.7231998443603516,
            "end_logit": 2.788327932357788,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial palsy, anterior uveitis",
            "probability": 0.029379149135635847,
            "start_logit": 2.6772704124450684,
            "end_logit": 2.7943429946899414,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "anterior uveitis, and fever",
            "probability": 0.02795467567306877,
            "start_logit": 2.1187233924865723,
            "end_logit": 3.303189277648926,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "anterior uveitis",
            "probability": 0.016806037379878538,
            "start_logit": 2.1187233924865723,
            "end_logit": 2.7943429946899414,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis, and fever",
            "probability": 0.014984972804210461,
            "start_logit": 1.4951868057250977,
            "end_logit": 3.303189277648926,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid gland enlargement, facial palsy, anterior uveitis, and fever",
            "probability": 0.004241268005853568,
            "start_logit": 0.2330012023448944,
            "end_logit": 3.303189277648926,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid gland enlargement, facial palsy, anterior uveitis",
            "probability": 0.0025498027406244345,
            "start_logit": 0.2330012023448944,
            "end_logit": 2.7943429946899414,
            "question_text": "List symptoms of Heerfordt syndrome."
        }
    ],
    "5a8afbf2fcd1d6a10c00001c": [
        {
            "text": "tiger",
            "probability": 0.1756216303844152,
            "start_logit": 0.6179274916648865,
            "end_logit": 0.31515389680862427,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "menisci and ligaments of the normal tiger",
            "probability": 0.14538395170673252,
            "start_logit": 0.42897382378578186,
            "end_logit": 0.31515389680862427,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "menisci",
            "probability": 0.12793189403476354,
            "start_logit": 0.42897382378578186,
            "end_logit": 0.1872737556695938,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "patella",
            "probability": 0.10879519974777313,
            "start_logit": 0.7069382667541504,
            "end_logit": -0.25272151827812195,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "femur, tibia and patella",
            "probability": 0.04605429366025551,
            "start_logit": -0.15270794928073883,
            "end_logit": -0.25272151827812195,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "ligaments of the normal tiger",
            "probability": 0.04337851488206982,
            "start_logit": -0.780440092086792,
            "end_logit": 0.31515389680862427,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "menisci and ligaments",
            "probability": 0.0425618057462688,
            "start_logit": 0.42897382378578186,
            "end_logit": -0.9132670164108276,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tiger stifle. SE T1-weighted sequence provided excellent resolution of the subchondral bones of the femur, tibia",
            "probability": 0.03624037729433357,
            "start_logit": 0.6179274916648865,
            "end_logit": -1.2630040645599365,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "articular cartilage, menisci and ligaments of the normal tiger",
            "probability": 0.033097248072949406,
            "start_logit": -1.0509542226791382,
            "end_logit": 0.31515389680862427,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tiger stifle. SE T1-weighted sequence provided excellent resolution of the subchondral bones of the femur",
            "probability": 0.03014302575238869,
            "start_logit": 0.6179274916648865,
            "end_logit": -1.4472243785858154,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "articular cartilage, menisci",
            "probability": 0.02912421614355366,
            "start_logit": -1.0509542226791382,
            "end_logit": 0.1872737556695938,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tiger stifle.",
            "probability": 0.028601230856841426,
            "start_logit": 0.6179274916648865,
            "end_logit": -1.4997282028198242,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tibia and patella",
            "probability": 0.02812635948399317,
            "start_logit": -0.645821750164032,
            "end_logit": -0.25272151827812195,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tiger stifle",
            "probability": 0.02540414444543697,
            "start_logit": 0.6179274916648865,
            "end_logit": -1.6182656288146973,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "menisci and ligaments of the normal tiger stifle.",
            "probability": 0.023676809949562682,
            "start_logit": 0.42897382378578186,
            "end_logit": -1.4997282028198242,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "menisci and ligaments of the normal tiger stifle",
            "probability": 0.021030182336435117,
            "start_logit": 0.42897382378578186,
            "end_logit": -1.6182656288146973,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "femur, tibia",
            "probability": 0.01676910912297133,
            "start_logit": -0.15270794928073883,
            "end_logit": -1.2630040645599365,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "femur",
            "probability": 0.013947749054405538,
            "start_logit": -0.15270794928073883,
            "end_logit": -1.4472243785858154,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "ligaments",
            "probability": 0.012699255332504406,
            "start_logit": -0.780440092086792,
            "end_logit": -0.9132670164108276,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "cartilage, menisci and ligaments of the normal tiger",
            "probability": 0.011413001992345566,
            "start_logit": -2.1156511306762695,
            "end_logit": 0.31515389680862427,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        }
    ],
    "5a8dc6b4fcd1d6a10c000026": [
        {
            "text": "infliximab",
            "probability": 0.4874305769625286,
            "start_logit": 5.1962385177612305,
            "end_logit": 5.168426990509033,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "adalimumab",
            "probability": 0.22297519855138478,
            "start_logit": 4.791306495666504,
            "end_logit": 4.791271686553955,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab and adalimumab",
            "probability": 0.21577712478893488,
            "start_logit": 4.7584919929504395,
            "end_logit": 4.791271686553955,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Infliximab",
            "probability": 0.03730106271994774,
            "start_logit": 3.8271820545196533,
            "end_logit": 3.9673573970794678,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "corticosteroids",
            "probability": 0.010551963552895479,
            "start_logit": 2.890974998474121,
            "end_logit": 3.640854597091675,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "adalimumab.Infliximab",
            "probability": 0.007519293559541185,
            "start_logit": 2.455009937286377,
            "end_logit": 3.7379798889160156,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "corticosteroids and immunosuppressive drugs",
            "probability": 0.005252413865389498,
            "start_logit": 2.890974998474121,
            "end_logit": 2.943230390548706,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "certolizumab pegol and adalimumab.Infliximab",
            "probability": 0.003698770141528927,
            "start_logit": 1.7455381155014038,
            "end_logit": 3.7379798889160156,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab biosimilars",
            "probability": 0.002049365931538053,
            "start_logit": 5.1962385177612305,
            "end_logit": -0.3031904399394989,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "immunosuppressive drugs",
            "probability": 0.001692927268196976,
            "start_logit": 1.7587463855743408,
            "end_logit": 2.943230390548706,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "fliximab",
            "probability": 0.0014132513195135629,
            "start_logit": -0.6470164060592651,
            "end_logit": 5.168426990509033,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "certolizumab pegol and adalimumab",
            "probability": 0.0008961938019559132,
            "start_logit": 1.7455381155014038,
            "end_logit": 2.320380926132202,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "fliximab and adalimumab",
            "probability": 0.000875779202809684,
            "start_logit": -0.7483953237533569,
            "end_logit": 4.791271686553955,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "certolizumab",
            "probability": 0.0006232180248812971,
            "start_logit": 1.7455381155014038,
            "end_logit": 1.957120656967163,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "two infliximab",
            "probability": 0.0005987906703287626,
            "start_logit": -1.5057525634765625,
            "end_logit": 5.168426990509033,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "liximab and adalimumab",
            "probability": 0.000305696572605715,
            "start_logit": -1.800916314125061,
            "end_logit": 4.791271686553955,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "liximab",
            "probability": 0.00029789946762574326,
            "start_logit": -1.800916314125061,
            "end_logit": 4.765434741973877,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "adalimumab are the only biological agents that have been approved for this group of patients. In September 2013,",
            "probability": 0.0002746247517871718,
            "start_logit": 4.791306495666504,
            "end_logit": -1.9081385135650635,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "certolizumab pegol",
            "probability": 0.00026172087459382483,
            "start_logit": 1.7455381155014038,
            "end_logit": 1.0895028114318848,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "adalimumab are the only biological agents",
            "probability": 0.00020412797201202297,
            "start_logit": 4.791306495666504,
            "end_logit": -2.2047970294952393,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        }
    ],
    "5a75dff883b0d9ea66000003": [
        {
            "text": "Cistrome Data Browser",
            "probability": 0.2597321338150398,
            "start_logit": 4.178168773651123,
            "end_logit": 3.494499921798706,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome",
            "probability": 0.17062845350123218,
            "start_logit": 4.178168773651123,
            "end_logit": 3.0743374824523926,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "MGA",
            "probability": 0.1667111015156873,
            "start_logit": 3.6800479888916016,
            "end_logit": 3.549232244491577,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "MGA repository: a curated data resource for ChIP-seq and other genome annotated data.Cistrome Data Browser",
            "probability": 0.15783182392726103,
            "start_logit": 3.6800479888916016,
            "end_logit": 3.494499921798706,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "MGA repository: a curated data resource for ChIP-seq and other genome annotated data.Cistrome",
            "probability": 0.10368605391416497,
            "start_logit": 3.6800479888916016,
            "end_logit": 3.0743374824523926,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "MGA repository",
            "probability": 0.04186200123470979,
            "start_logit": 3.6800479888916016,
            "end_logit": 2.1673483848571777,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome DB (Cistrome",
            "probability": 0.018172083730006252,
            "start_logit": 2.923027992248535,
            "end_logit": 2.089876413345337,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome DB",
            "probability": 0.012895939427971015,
            "start_logit": 2.923027992248535,
            "end_logit": 1.746902346611023,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "CR Cistrome",
            "probability": 0.010759643953239067,
            "start_logit": 2.5539298057556152,
            "end_logit": 1.9348905086517334,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser), available online at http://cistrome",
            "probability": 0.009076400516471623,
            "start_logit": 2.923027992248535,
            "end_logit": 1.395667552947998,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome Data Browser), available online at http://cistrome",
            "probability": 0.007678653667073597,
            "start_logit": 2.7557945251464844,
            "end_logit": 1.395667552947998,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "CistromeMap",
            "probability": 0.0068422043673355476,
            "start_logit": 2.3354127407073975,
            "end_logit": 1.7007150650024414,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser",
            "probability": 0.006421556750822248,
            "start_logit": 2.923027992248535,
            "end_logit": 1.0496504306793213,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome database",
            "probability": 0.005666558428385504,
            "start_logit": 2.9622809886932373,
            "end_logit": 0.8853188157081604,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome Data",
            "probability": 0.005456850025717144,
            "start_logit": 4.178168773651123,
            "end_logit": -0.36827921867370605,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "cistrome",
            "probability": 0.004542467464068258,
            "start_logit": 2.230820655822754,
            "end_logit": 1.395667552947998,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "MGA repository: a curated data resource for ChIP-seq and other genome annotated data.",
            "probability": 0.00357614012709682,
            "start_logit": 3.6800479888916016,
            "end_logit": -0.29274609684944153,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "MGA repository: a curated data resource for ChIP-seq and other genome annotated data.Cistrome Data",
            "probability": 0.003315972420531458,
            "start_logit": 3.6800479888916016,
            "end_logit": -0.36827921867370605,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser), available online at http://cistrome.org/db",
            "probability": 0.002786541404200763,
            "start_logit": 2.923027992248535,
            "end_logit": 0.21479104459285736,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome Data Browser), available online at http://cistrome.org/db",
            "probability": 0.002357419808985739,
            "start_logit": 2.7557945251464844,
            "end_logit": 0.21479104459285736,
            "question_text": "Name curated data resources for ChIP-seq data"
        }
    ],
    "5a760e5583b0d9ea66000018": [
        {
            "text": "FANTOM CAGE",
            "probability": 0.4236775330451273,
            "start_logit": 2.8646936416625977,
            "end_logit": 2.0951125621795654,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "ChIP-Seq datasets from the Human Epigenome Atlas and FANTOM CAGE",
            "probability": 0.18444617000999342,
            "start_logit": 2.033078670501709,
            "end_logit": 2.0951125621795654,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "ChIP-Seq datasets from the Human Epigenome Atlas",
            "probability": 0.12030587012610418,
            "start_logit": 2.033078670501709,
            "end_logit": 1.6677923202514648,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "Epigenome Atlas and FANTOM CAGE",
            "probability": 0.07014783973205507,
            "start_logit": 1.0663260221481323,
            "end_logit": 2.0951125621795654,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "Epigenome Atlas",
            "probability": 0.04575425391578554,
            "start_logit": 1.0663260221481323,
            "end_logit": 1.6677923202514648,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "ChIP-Seq",
            "probability": 0.03946720281359346,
            "start_logit": 2.033078670501709,
            "end_logit": 0.5532249212265015,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "Human Epigenome Atlas and FANTOM CAGE",
            "probability": 0.018541951865811576,
            "start_logit": -0.26424315571784973,
            "end_logit": 2.0951125621795654,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "ChIP-Seq datasets",
            "probability": 0.013919884518210801,
            "start_logit": 2.033078670501709,
            "end_logit": -0.4889267385005951,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "Human Epigenome Atlas",
            "probability": 0.012094074129768819,
            "start_logit": -0.26424315571784973,
            "end_logit": 1.6677923202514648,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "datasets from the Human Epigenome Atlas and FANTOM CAGE",
            "probability": 0.011375225790363054,
            "start_logit": -0.7528411746025085,
            "end_logit": 2.0951125621795654,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "ChIP-Seq datasets from the Human Epigenome",
            "probability": 0.009752884227180608,
            "start_logit": 2.033078670501709,
            "end_logit": -0.8446820378303528,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "comparisons of ChIP-Seq datasets from the Human Epigenome Atlas and FANTOM CAGE",
            "probability": 0.00830717182516543,
            "start_logit": -1.0671597719192505,
            "end_logit": 2.0951125621795654,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "datasets from the Human Epigenome Atlas",
            "probability": 0.007419543797067631,
            "start_logit": -0.7528411746025085,
            "end_logit": 1.6677923202514648,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "ChIP",
            "probability": 0.007228911864900415,
            "start_logit": 2.033078670501709,
            "end_logit": -1.144156575202942,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "numerous comparisons of ChIP-Seq datasets from the Human Epigenome Atlas and FANTOM CAGE",
            "probability": 0.005801479960272407,
            "start_logit": -1.4261659383773804,
            "end_logit": 2.0951125621795654,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "comparisons of ChIP-Seq datasets from the Human Epigenome Atlas",
            "probability": 0.005418391364046409,
            "start_logit": -1.0671597719192505,
            "end_logit": 1.6677923202514648,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "FANTOM CAGE to demonstrate its wide applicability",
            "probability": 0.004618796738678801,
            "start_logit": 2.8646936416625977,
            "end_logit": -2.4237258434295654,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "Atlas and FANTOM CAGE",
            "probability": 0.004229593602014532,
            "start_logit": -1.7421730756759644,
            "end_logit": 2.0951125621795654,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "numerous comparisons of ChIP-Seq datasets from the Human Epigenome Atlas",
            "probability": 0.003784042220025022,
            "start_logit": -1.4261659383773804,
            "end_logit": 1.6677923202514648,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "Epigenome",
            "probability": 0.003709178453835531,
            "start_logit": 1.0663260221481323,
            "end_logit": -0.8446820378303528,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        }
    ],
    "5a75ee7e83b0d9ea66000005": [
        {
            "text": "jaundice",
            "probability": 0.19059474063318332,
            "start_logit": 2.807283401489258,
            "end_logit": 2.705756425857544,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "Hemolysis",
            "probability": 0.17872710074786521,
            "start_logit": 2.157205104827881,
            "end_logit": 3.2915453910827637,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "jaundice, hemolytic anemia and hyperlipoproteinemia",
            "probability": 0.14836241291500335,
            "start_logit": 2.807283401489258,
            "end_logit": 2.4552650451660156,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "Hemolysis in Acute Alcoholic Hepatitis",
            "probability": 0.10927757397573355,
            "start_logit": 2.157205104827881,
            "end_logit": 2.7995765209198,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipoproteinemia",
            "probability": 0.09983110128224033,
            "start_logit": 2.411105155944824,
            "end_logit": 2.4552650451660156,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "jaundice, hemolytic anemia",
            "probability": 0.07388213621257528,
            "start_logit": 2.807283401489258,
            "end_logit": 1.7580780982971191,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hemolytic anemia and hyperlipoproteinemia",
            "probability": 0.06225531866071773,
            "start_logit": 1.9388693571090698,
            "end_logit": 2.4552650451660156,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "Alcoholic Hepatitis",
            "probability": 0.04068859307046329,
            "start_logit": 1.1692616939544678,
            "end_logit": 2.7995765209198,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.031002164516450048,
            "start_logit": 1.9388693571090698,
            "end_logit": 1.7580780982971191,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "Hepatitis",
            "probability": 0.02048605771455954,
            "start_logit": 0.48305845260620117,
            "end_logit": 2.7995765209198,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "Acute Alcoholic Hepatitis",
            "probability": 0.01741062472877105,
            "start_logit": 0.3203945457935333,
            "end_logit": 2.7995765209198,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "jaundice, hemolytic anemia and hyperlipoproteinemia,",
            "probability": 0.006162757533439856,
            "start_logit": 2.807283401489258,
            "end_logit": -0.7258686423301697,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "jaundice,",
            "probability": 0.0060716958585661325,
            "start_logit": 2.807283401489258,
            "end_logit": -0.740755021572113,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipoproteinemia,",
            "probability": 0.004146837864191325,
            "start_logit": 2.411105155944824,
            "end_logit": -0.7258686423301697,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipidaemia associated with alcoholism.We report a case of recurrent Zieve's syndrome, consisting of jaundice",
            "probability": 0.0038519028588486987,
            "start_logit": -1.0942987203598022,
            "end_logit": 2.705756425857544,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hemolytic anemia and hyperlipoproteinemia,",
            "probability": 0.002585994838819708,
            "start_logit": 1.9388693571090698,
            "end_logit": -0.7258686423301697,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "Hemolysis in Acute Alcoholic Hepatitis: Zieve's Syndrome.Lab studies revealed hemolysis",
            "probability": 0.0020967097865932614,
            "start_logit": 2.157205104827881,
            "end_logit": -1.1539453268051147,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "jaundice, hyperlipidaemia and alcohol-induced liver disease",
            "probability": 0.0009603034744339393,
            "start_logit": 0.31330379843711853,
            "end_logit": -0.09091929346323013,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "jaundice, hyperlipidaemia",
            "probability": 0.0008252809293719926,
            "start_logit": 0.31330379843711853,
            "end_logit": -0.24244479835033417,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "Alcoholic Hepatitis: Zieve's Syndrome.Lab studies revealed hemolysis",
            "probability": 0.0007806923981721608,
            "start_logit": 1.1692616939544678,
            "end_logit": -1.1539453268051147,
            "question_text": "List symptoms of the Zieve's syndrome."
        }
    ],
    "5a75df9883b0d9ea66000002": [
        {
            "text": "gastric leiomyosarcoma",
            "probability": 0.24777180570475443,
            "start_logit": 4.742399215698242,
            "end_logit": 5.033578395843506,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric leiomyosarcoma, pulmonary chondroma, and extraadrenal paraganglioma",
            "probability": 0.16772627221890934,
            "start_logit": 4.742399215698242,
            "end_logit": 4.64340353012085,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric leiomyosarcoma, pulmonary chondroma",
            "probability": 0.15914441967012344,
            "start_logit": 4.742399215698242,
            "end_logit": 4.590882301330566,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "pulmonary chondroma, and extraadrenal paraganglioma",
            "probability": 0.09232223723473494,
            "start_logit": 4.145350933074951,
            "end_logit": 4.64340353012085,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "pulmonary chondroma",
            "probability": 0.08759849409991789,
            "start_logit": 4.145350933074951,
            "end_logit": 4.590882301330566,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "leiomyosarcoma",
            "probability": 0.05536009702681029,
            "start_logit": 3.2437500953674316,
            "end_logit": 5.033578395843506,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paraganglioma",
            "probability": 0.0516710386461547,
            "start_logit": 3.5649633407592773,
            "end_logit": 4.64340353012085,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "extraadrenal paraganglioma",
            "probability": 0.04908291874837232,
            "start_logit": 3.5135769844055176,
            "end_logit": 4.64340353012085,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "leiomyosarcoma, pulmonary chondroma, and extraadrenal paraganglioma",
            "probability": 0.03747538053239382,
            "start_logit": 3.2437500953674316,
            "end_logit": 4.64340353012085,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "leiomyosarcoma, pulmonary chondroma",
            "probability": 0.03555792189169323,
            "start_logit": 3.2437500953674316,
            "end_logit": 4.590882301330566,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric",
            "probability": 0.0033717100135279014,
            "start_logit": 4.742399215698242,
            "end_logit": 0.7364902496337891,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chondroma, and extraadrenal paraganglioma",
            "probability": 0.0031275348624695692,
            "start_logit": 0.7603110074996948,
            "end_logit": 4.64340353012085,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chondroma",
            "probability": 0.0029675119711489372,
            "start_logit": 0.7603110074996948,
            "end_logit": 4.590882301330566,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric leiomyosarcoma, pulmonary chondroma,",
            "probability": 0.0024311779882307434,
            "start_logit": 4.742399215698242,
            "end_logit": 0.409446120262146,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "pulmonary chondroma,",
            "probability": 0.0013382029423295069,
            "start_logit": 4.145350933074951,
            "end_logit": 0.409446120262146,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric leiomyosarcoma,",
            "probability": 0.0008981316718531032,
            "start_logit": 4.742399215698242,
            "end_logit": -0.5863683819770813,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric leiomyosarcoma, pulmonary chondroma, and extraadrenal paraganglioma)",
            "probability": 0.0007292670121767783,
            "start_logit": 4.742399215698242,
            "end_logit": -0.7946451306343079,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "leiomyosarcoma, pulmonary chondroma,",
            "probability": 0.0005432024395797377,
            "start_logit": 3.2437500953674316,
            "end_logit": 0.409446120262146,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric leiomyosarcoma, pulmonary chondroma, and extraadrenal",
            "probability": 0.0004812619909689076,
            "start_logit": 4.742399215698242,
            "end_logit": -1.210273265838623,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "pulmonary chondroma, and extraadrenal paraganglioma)",
            "probability": 0.0004014133338501539,
            "start_logit": 4.145350933074951,
            "end_logit": -0.7946451306343079,
            "question_text": "Which cancers compose Carney's triad?"
        }
    ],
    "5a981bcffcd1d6a10c00002d": [
        {
            "text": "ophthalmoplegia",
            "probability": 0.14609111230995517,
            "start_logit": 4.523898601531982,
            "end_logit": 4.461475849151611,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ophthalmoplegia, ataxia",
            "probability": 0.14463668969819504,
            "start_logit": 4.523898601531982,
            "end_logit": 4.451470375061035,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ataxia",
            "probability": 0.1337443652430044,
            "start_logit": 4.445603847503662,
            "end_logit": 4.451470375061035,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ophthalmoplegia, ataxia and acute confusion",
            "probability": 0.12872813472313455,
            "start_logit": 4.523898601531982,
            "end_logit": 4.3349480628967285,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ataxia and acute confusion",
            "probability": 0.1190338544347675,
            "start_logit": 4.445603847503662,
            "end_logit": 4.3349480628967285,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ataxia and acute confusion. entire triad of classic features of Wernicke-Korsakoff syndrome: confusion, ataxia",
            "probability": 0.05248016853867847,
            "start_logit": 4.445603847503662,
            "end_logit": 3.5159754753112793,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "acute confusion",
            "probability": 0.03878810718042063,
            "start_logit": 3.3243095874786377,
            "end_logit": 4.3349480628967285,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "confusion",
            "probability": 0.03316290419246693,
            "start_logit": 3.1676278114318848,
            "end_logit": 4.3349480628967285,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "cerebellar ataxia, ophthalmoplegia",
            "probability": 0.02828723181045915,
            "start_logit": 3.354011297225952,
            "end_logit": 3.9895431995391846,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ataxia and acute confusion. entire triad of classic features of Wernicke-Korsakoff syndrome: confusion",
            "probability": 0.023732236648293853,
            "start_logit": 4.445603847503662,
            "end_logit": 2.722374439239502,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "cerebellar ataxia",
            "probability": 0.020589896712979523,
            "start_logit": 3.354011297225952,
            "end_logit": 3.671933174133301,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ophthalmoplegia or nystagmus",
            "probability": 0.018450280235749114,
            "start_logit": 3.6489956378936768,
            "end_logit": 3.2672278881073,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "oculomotor dysfunction, and ataxia",
            "probability": 0.018235562734278506,
            "start_logit": 3.005023717880249,
            "end_logit": 3.899493932723999,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "acute confusion. entire triad of classic features of Wernicke-Korsakoff syndrome: confusion, ataxia",
            "probability": 0.017101071050676136,
            "start_logit": 3.3243095874786377,
            "end_logit": 3.5159754753112793,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ataxia, and ophthalmoplegia",
            "probability": 0.01644305761147108,
            "start_logit": 3.5316431522369385,
            "end_logit": 3.269404172897339,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ataxia, and ophthalmoplegia or nystagmus",
            "probability": 0.01640731174598952,
            "start_logit": 3.5316431522369385,
            "end_logit": 3.2672278881073,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "confusion. entire triad of classic features of Wernicke-Korsakoff syndrome: confusion, ataxia",
            "probability": 0.01462100685151279,
            "start_logit": 3.1676278114318848,
            "end_logit": 3.5159754753112793,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "nystagmus",
            "probability": 0.012383645606876829,
            "start_logit": 3.2502927780151367,
            "end_logit": 3.2672278881073,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "confusion, ataxia",
            "probability": 0.009350028796318228,
            "start_logit": 2.720547914505005,
            "end_logit": 3.5159754753112793,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "acute confusion. entire triad of classic features of Wernicke-Korsakoff syndrome: confusion",
            "probability": 0.0077333338747725185,
            "start_logit": 3.3243095874786377,
            "end_logit": 2.722374439239502,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        }
    ],
    "5a7486a90384be9551000003": [
        {
            "text": "VEGF",
            "probability": 0.0870275969534656,
            "start_logit": 5.078231334686279,
            "end_logit": 4.492125034332275,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGF and VEGF",
            "probability": 0.07854112052936833,
            "start_logit": 4.97562837600708,
            "end_logit": 4.492125034332275,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGFR",
            "probability": 0.0662123768218048,
            "start_logit": 4.890976905822754,
            "end_logit": 4.406021595001221,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGFR, PDGFR",
            "probability": 0.06556066495465268,
            "start_logit": 4.890976905822754,
            "end_logit": 4.396130084991455,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGFR, PDGFR, and KIT.Dovitinib, a suppressor of FGFR",
            "probability": 0.06459492003549269,
            "start_logit": 4.890976905822754,
            "end_logit": 4.381289958953857,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGF",
            "probability": 0.060811398464895854,
            "start_logit": 4.97562837600708,
            "end_logit": 4.2362799644470215,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "VEGFR, FGFR",
            "probability": 0.05733127992725424,
            "start_logit": 4.746955871582031,
            "end_logit": 4.406021595001221,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "VEGFR, FGFR, PDGFR",
            "probability": 0.056766982475915696,
            "start_logit": 4.746955871582031,
            "end_logit": 4.396130084991455,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "VEGFR",
            "probability": 0.05575827250786522,
            "start_logit": 4.746955871582031,
            "end_logit": 4.378201007843018,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGFR activity, may be active in ACC.We tested dovitinib, an inhibitor of both FGF",
            "probability": 0.05089449993896005,
            "start_logit": 4.797605991363525,
            "end_logit": 4.2362799644470215,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "PDGFR",
            "probability": 0.04794455852222435,
            "start_logit": 4.5780463218688965,
            "end_logit": 4.396130084991455,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "PDGFR, and KIT.Dovitinib, a suppressor of FGFR",
            "probability": 0.04723830861114988,
            "start_logit": 4.5780463218688965,
            "end_logit": 4.381289958953857,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "VEGF receptors",
            "probability": 0.040182535404562694,
            "start_logit": 5.078231334686279,
            "end_logit": 3.719332218170166,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "VEGF receptors, in patients progressing on anti-VEGF",
            "probability": 0.03971088197361346,
            "start_logit": 5.078231334686279,
            "end_logit": 3.7075250148773193,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGF and VEGF receptors",
            "probability": 0.036264144557190285,
            "start_logit": 4.97562837600708,
            "end_logit": 3.719332218170166,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGF and VEGF receptors, in patients progressing on anti-VEGF",
            "probability": 0.03583848430383315,
            "start_logit": 4.97562837600708,
            "end_logit": 3.7075250148773193,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGFR, PDGFR, and KIT",
            "probability": 0.032479002668569554,
            "start_logit": 4.890976905822754,
            "end_logit": 3.6937479972839355,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "VEGFR, FGFR, PDGFR, and KIT",
            "probability": 0.028122578936580198,
            "start_logit": 4.746955871582031,
            "end_logit": 3.6937479972839355,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "FGFRs",
            "probability": 0.024968475843972805,
            "start_logit": 4.342604637145996,
            "end_logit": 3.979140520095825,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "PDGFR, and KIT",
            "probability": 0.023751916568628455,
            "start_logit": 4.5780463218688965,
            "end_logit": 3.6937479972839355,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        }
    ],
    "5a7240aa2dc08e987e00000d": [
        {
            "text": "bezlotoxumab",
            "probability": 0.5756600685888542,
            "start_logit": 5.882401943206787,
            "end_logit": 6.306230545043945,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Actoxumab and bezlotoxumab",
            "probability": 0.2309843250122896,
            "start_logit": 4.969234466552734,
            "end_logit": 6.306230545043945,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Actoxumab",
            "probability": 0.16973553026407398,
            "start_logit": 4.969234466552734,
            "end_logit": 5.998122215270996,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotoxumab",
            "probability": 0.00834013087289979,
            "start_logit": 4.07936429977417,
            "end_logit": 3.8748297691345215,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Actoxumab-Bezlotoxumab",
            "probability": 0.0068278801313532995,
            "start_logit": 3.8792996406555176,
            "end_logit": 3.8748297691345215,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "actoxumab-bezlotoxumab",
            "probability": 0.002628836178782966,
            "start_logit": 3.3249077796936035,
            "end_logit": 3.4747486114501953,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "actoxumab",
            "probability": 0.0020788082536391506,
            "start_logit": 3.3249077796936035,
            "end_logit": 3.240002155303955,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "bezlotoxumab are human monoclonal antibodies against C. difficile toxins A and B",
            "probability": 0.0012458522437536785,
            "start_logit": 5.882401943206787,
            "end_logit": 0.17053304612636566,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "bezlotoxumab are human monoclonal antibodies against C. difficile toxins A",
            "probability": 0.0005298704289344136,
            "start_logit": 5.882401943206787,
            "end_logit": -0.6844095587730408,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "MK-3415A (actoxumab-bezlotoxumab",
            "probability": 0.00046082619784325286,
            "start_logit": 1.583632230758667,
            "end_logit": 3.4747486114501953,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "MK-3415A (actoxumab",
            "probability": 0.000364408140492497,
            "start_logit": 1.583632230758667,
            "end_logit": 3.240002155303955,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "bezlotoxumab to be approved by the Food and Drug Administration and the European Medicines Agency. Bezlotoxumab",
            "probability": 0.00025333243347347597,
            "start_logit": 0.4995376765727997,
            "end_logit": 3.960524797439575,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Actoxumab and bezlotoxumab are human monoclonal antibodies against C. difficile toxins A",
            "probability": 0.00021261117463195473,
            "start_logit": 4.969234466552734,
            "end_logit": -0.6844095587730408,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "bezlotoxumab are human monoclonal antibodies against C. difficile toxins A and B,",
            "probability": 0.00014468682070120406,
            "start_logit": 5.882401943206787,
            "end_logit": -1.9824705123901367,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "(Actoxumab-Bezlotoxumab",
            "probability": 0.00012130235407993146,
            "start_logit": -0.15118366479873657,
            "end_logit": 3.8748297691345215,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "(Actoxumab",
            "probability": 0.00011597731678296689,
            "start_logit": -0.15118366479873657,
            "end_logit": 3.8299381732940674,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "(actoxumab-bezlotoxumab",
            "probability": 7.97947173243129e-05,
            "start_logit": -0.16993142664432526,
            "end_logit": 3.4747486114501953,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "bezlotoxumab are human monoclonal antibodies against C. difficile toxins A and B, respectively.",
            "probability": 7.593865614805115e-05,
            "start_logit": 5.882401943206787,
            "end_logit": -2.6271162033081055,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "b and bezlotoxumab",
            "probability": 7.358521449609289e-05,
            "start_logit": -3.0824265480041504,
            "end_logit": 6.306230545043945,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "b",
            "probability": 6.623499944536724e-05,
            "start_logit": -3.187661647796631,
            "end_logit": 6.306230545043945,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        }
    ],
    "5aa80873d6d6b54f79000013": [
        {
            "text": "Nucleostemin",
            "probability": 0.6719286825094232,
            "start_logit": 5.658669948577881,
            "end_logit": 5.967090129852295,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Nucleostemin (NS)",
            "probability": 0.14726990616034935,
            "start_logit": 5.658669948577881,
            "end_logit": 4.449204921722412,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Nucleostemin (NS",
            "probability": 0.10021408346644166,
            "start_logit": 5.658669948577881,
            "end_logit": 4.064246654510498,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "NS)",
            "probability": 0.02942138647911076,
            "start_logit": 4.04812479019165,
            "end_logit": 4.449204921722412,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "NS",
            "probability": 0.02002063664728453,
            "start_logit": 4.04812479019165,
            "end_logit": 4.064246654510498,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "FGF13",
            "probability": 0.005405182670524459,
            "start_logit": 3.8425519466400146,
            "end_logit": 2.960414171218872,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 is an alternatively translated isoform of PTEN that regulates rDNA transcription.Nucleostemin",
            "probability": 0.0053264492556699935,
            "start_logit": 0.8212025761604309,
            "end_logit": 5.967090129852295,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "FGF13, miR-504, and p53",
            "probability": 0.0035355023527375564,
            "start_logit": 3.8425519466400146,
            "end_logit": 2.5359113216400146,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "FGF13, miR-504",
            "probability": 0.002100017359867175,
            "start_logit": 3.8425519466400146,
            "end_logit": 2.0150015354156494,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "(NS)",
            "probability": 0.0019070062834208679,
            "start_logit": 1.3119375705718994,
            "end_logit": 4.449204921722412,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Nucleostemin (NS) is a nucleolar protein",
            "probability": 0.0016937579131441705,
            "start_logit": 5.658669948577881,
            "end_logit": -0.016112400218844414,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "p53",
            "probability": 0.0015399250007104809,
            "start_logit": 3.011430263519287,
            "end_logit": 2.5359113216400146,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN that regulates rDNA transcription.Nucleostemin",
            "probability": 0.0015196838468446085,
            "start_logit": -0.432979941368103,
            "end_logit": 5.967090129852295,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "leostemin",
            "probability": 0.0015011751855697963,
            "start_logit": -0.4452340006828308,
            "end_logit": 5.967090129852295,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "ucleostemin",
            "probability": 0.0014124689840331727,
            "start_logit": -0.5061430335044861,
            "end_logit": 5.967090129852295,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "(NS",
            "probability": 0.001297677793382212,
            "start_logit": 1.3119375705718994,
            "end_logit": 4.064246654510498,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "miR-504, and p53",
            "probability": 0.001219981818686795,
            "start_logit": 2.7785325050354004,
            "end_logit": 2.5359113216400146,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 is an alternatively translated isoform of PTEN that regulates rDNA transcription.Nucleostemin (NS)",
            "probability": 0.0011674240175621343,
            "start_logit": 0.8212025761604309,
            "end_logit": 4.449204921722412,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 is an alternatively translated isoform of PTEN that regulates rDNA transcription.Nucleostemin (NS",
            "probability": 0.0007944075676215727,
            "start_logit": 0.8212025761604309,
            "end_logit": 4.064246654510498,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "miR-504",
            "probability": 0.0007246446876158466,
            "start_logit": 2.7785325050354004,
            "end_logit": 2.0150015354156494,
            "question_text": "List ribosomal biogenesis proteins."
        }
    ],
    "5aacdcf1fcf4565872000009": [
        {
            "text": "BRD4",
            "probability": 0.2863207152210363,
            "start_logit": 4.985360622406006,
            "end_logit": 4.964684963226318,
            "question_text": "List BET proteins."
        },
        {
            "text": "Brd4",
            "probability": 0.15384577302176297,
            "start_logit": 4.683770656585693,
            "end_logit": 4.645112991333008,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD4 inhibition of Brd4",
            "probability": 0.12346156038704421,
            "start_logit": 4.463749885559082,
            "end_logit": 4.645112991333008,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bdf1",
            "probability": 0.11611420874251273,
            "start_logit": 4.759846210479736,
            "end_logit": 4.287661075592041,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bdf1 has been explored in Saccharomyces cerevisiaeBET proteins BRD2, BRD3 and BRD4",
            "probability": 0.08393354083339391,
            "start_logit": 4.759846210479736,
            "end_logit": 3.9631121158599854,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD3 and BRD4 inhibition of Brd4",
            "probability": 0.050719720364390944,
            "start_logit": 3.5741348266601562,
            "end_logit": 4.645112991333008,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bdf1 has been explored in Saccharomyces cerevisiaeBET proteins BRD2, BRD3",
            "probability": 0.04354547623569219,
            "start_logit": 4.759846210479736,
            "end_logit": 3.3068926334381104,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bdf1 has been explored in Saccharomyces cerevisiaeBET proteins BRD2",
            "probability": 0.032539663140392895,
            "start_logit": 4.759846210479736,
            "end_logit": 3.0155465602874756,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD2, BRD3 and BRD4 inhibition of Brd4",
            "probability": 0.032315509320363575,
            "start_logit": 3.1233673095703125,
            "end_logit": 4.645112991333008,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD3 and BRD4",
            "probability": 0.025644110146226636,
            "start_logit": 3.5741348266601562,
            "end_logit": 3.9631121158599854,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD2, BRD3 and BRD4",
            "probability": 0.01633886138348327,
            "start_logit": 3.1233673095703125,
            "end_logit": 3.9631121158599854,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD3",
            "probability": 0.013304395094859376,
            "start_logit": 3.5741348266601562,
            "end_logit": 3.3068926334381104,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD2, BRD3",
            "probability": 0.0084767483061988,
            "start_logit": 3.1233673095703125,
            "end_logit": 3.3068926334381104,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD2",
            "probability": 0.006334309743603622,
            "start_logit": 3.1233673095703125,
            "end_logit": 3.0155465602874756,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain and extraterminal domain) family proteins the role of the BET protein Bdf1",
            "probability": 0.003204885976753684,
            "start_logit": 1.1699484586715698,
            "end_logit": 4.287661075592041,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD4 is a member of the BET (bromodomain and extraterminal domain",
            "probability": 0.0011736320158192985,
            "start_logit": 4.985360622406006,
            "end_logit": -0.5323243737220764,
            "question_text": "List BET proteins."
        },
        {
            "text": "Brd4,",
            "probability": 0.0008780211399815093,
            "start_logit": 4.683770656585693,
            "end_logit": -0.5209222435951233,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD4 inhibition of Brd4,",
            "probability": 0.0007046138341389076,
            "start_logit": 4.463749885559082,
            "end_logit": -0.5209222435951233,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bdf1 has been explored in Saccharomyces cerevisiaeBET proteins BRD",
            "probability": 0.0005805196543327089,
            "start_logit": 4.759846210479736,
            "end_logit": -1.0107448101043701,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bdf",
            "probability": 0.0005637354380122881,
            "start_logit": 4.759846210479736,
            "end_logit": -1.040083408355713,
            "question_text": "List BET proteins."
        }
    ],
    "5a9eb008d6d6b54f79000001": [
        {
            "text": "Europe, that in the Eastern United States of America",
            "probability": 0.23387450976225432,
            "start_logit": 3.38338041305542,
            "end_logit": 3.351191759109497,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Europe",
            "probability": 0.22322921836531068,
            "start_logit": 3.38338041305542,
            "end_logit": 3.3046061992645264,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "America",
            "probability": 0.1762210053842855,
            "start_logit": 3.100334644317627,
            "end_logit": 3.351191759109497,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "North America and Europe, that in the Eastern United States of America",
            "probability": 0.08998979827814331,
            "start_logit": 2.4282920360565186,
            "end_logit": 3.351191759109497,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "North America and Europe",
            "probability": 0.08589372288114155,
            "start_logit": 2.4282920360565186,
            "end_logit": 3.3046061992645264,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "America and Europe, that in the Eastern United States of America",
            "probability": 0.043326870849314095,
            "start_logit": 1.6973687410354614,
            "end_logit": 3.351191759109497,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "North America",
            "probability": 0.041597310207024486,
            "start_logit": 2.4282920360565186,
            "end_logit": 2.579530954360962,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "America and Europe",
            "probability": 0.04135475697517897,
            "start_logit": 1.6973687410354614,
            "end_logit": 3.3046061992645264,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Eastern United States of America",
            "probability": 0.019103598544527013,
            "start_logit": 0.8784724473953247,
            "end_logit": 3.351191759109497,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "East Asian species now established across North America and Europe, that in the Eastern United States of America",
            "probability": 0.010914462710526483,
            "start_logit": 0.31868448853492737,
            "end_logit": 3.351191759109497,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "East Asian species now established across North America and Europe",
            "probability": 0.010417667928945796,
            "start_logit": 0.31868448853492737,
            "end_logit": 3.3046061992645264,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Europe, that in the Eastern United States of America (US)",
            "probability": 0.005991607633807949,
            "start_logit": 3.38338041305542,
            "end_logit": -0.3132331669330597,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "East Asian species now established across North America",
            "probability": 0.005045152892881212,
            "start_logit": 0.31868448853492737,
            "end_logit": 2.579530954360962,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "America (US)",
            "probability": 0.004514588281429731,
            "start_logit": 3.100334644317627,
            "end_logit": -0.3132331669330597,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "North America and Europe, that in the Eastern United States of America (US)",
            "probability": 0.0023054396260467594,
            "start_logit": 2.4282920360565186,
            "end_logit": -0.3132331669330597,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Europe,",
            "probability": 0.0014478998754275001,
            "start_logit": 3.38338041305542,
            "end_logit": -1.7334787845611572,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "China",
            "probability": 0.0013899465091306725,
            "start_logit": 1.1415642499923706,
            "end_logit": 0.46748849749565125,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Europe, that in the Eastern",
            "probability": 0.0011634777923286417,
            "start_logit": 3.38338041305542,
            "end_logit": -1.9521793127059937,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "America and Europe, that in the Eastern United States of America (US)",
            "probability": 0.0011099867633871513,
            "start_logit": 1.6973687410354614,
            "end_logit": -0.3132331669330597,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "China, Japan",
            "probability": 0.0011089787389084538,
            "start_logit": 1.1415642499923706,
            "end_logit": 0.24166277050971985,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        }
    ],
    "5aa55b65d6d6b54f7900000e": [
        {
            "text": "erythema infectiosum",
            "probability": 0.6837103036285678,
            "start_logit": 5.245657444000244,
            "end_logit": 5.051359176635742,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "erythema infectiosum (fifth disease), and scarlet fever.The rash",
            "probability": 0.17811945066322413,
            "start_logit": 5.245657444000244,
            "end_logit": 3.7062792778015137,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "roseola, erythema infectiosum",
            "probability": 0.03938668712436032,
            "start_logit": 2.3915510177612305,
            "end_logit": 5.051359176635742,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "rash",
            "probability": 0.028442336110757842,
            "start_logit": 3.4110817909240723,
            "end_logit": 3.7062792778015137,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "erythema",
            "probability": 0.025514122236160574,
            "start_logit": 5.245657444000244,
            "end_logit": 1.763056993484497,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "roseola",
            "probability": 0.012037125593514393,
            "start_logit": 2.3915510177612305,
            "end_logit": 3.86592698097229,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "roseola, erythema infectiosum (fifth disease), and scarlet fever.The rash",
            "probability": 0.010260976084172924,
            "start_logit": 2.3915510177612305,
            "end_logit": 3.7062792778015137,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "fever is likely to occur with roseola, erythema infectiosum",
            "probability": 0.006227507690524853,
            "start_logit": 0.5470993518829346,
            "end_logit": 5.051359176635742,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "A fever is likely to occur with roseola, erythema infectiosum",
            "probability": 0.003988564449535301,
            "start_logit": 0.10155452787876129,
            "end_logit": 5.051359176635742,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "fever is likely to occur with roseola",
            "probability": 0.0019032139455836975,
            "start_logit": 0.5470993518829346,
            "end_logit": 3.86592698097229,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "fever is likely to occur with roseola, erythema infectiosum (fifth disease), and scarlet fever.The rash",
            "probability": 0.0016223834026639092,
            "start_logit": 0.5470993518829346,
            "end_logit": 3.7062792778015137,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "roseola, erythema",
            "probability": 0.0014697990427160093,
            "start_logit": 2.3915510177612305,
            "end_logit": 1.763056993484497,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "A fever is likely to occur with roseola",
            "probability": 0.0012189613984362937,
            "start_logit": 0.10155452787876129,
            "end_logit": 3.86592698097229,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "A fever is likely to occur with roseola, erythema infectiosum (fifth disease), and scarlet fever.The rash",
            "probability": 0.0010390963905555627,
            "start_logit": 0.10155452787876129,
            "end_logit": 3.7062792778015137,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "strawberry tongue in 86.3% and angular stomatitis",
            "probability": 0.0010179296564309325,
            "start_logit": 2.0827574729919434,
            "end_logit": 1.7044956684112549,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "strawberry tongue",
            "probability": 0.0009809425307356926,
            "start_logit": 2.0827574729919434,
            "end_logit": 1.6674834489822388,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "infectiosum",
            "probability": 0.0008804287902978901,
            "start_logit": -1.4092230796813965,
            "end_logit": 5.051359176635742,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "The rash",
            "probability": 0.0008361740704165313,
            "start_logit": -0.11571542173624039,
            "end_logit": 3.7062792778015137,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "erythema infectiosum (fifth disease)",
            "probability": 0.00074418568003357,
            "start_logit": 5.245657444000244,
            "end_logit": -1.7716398239135742,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "angular stomatitis",
            "probability": 0.0005998115113119462,
            "start_logit": 1.553846836090088,
            "end_logit": 1.7044956684112549,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        }
    ],
    "5a736f0c3b9d13c708000007": [
        {
            "text": "13",
            "probability": 0.43556761027399676,
            "start_logit": -1.1939135789871216,
            "end_logit": -0.12657126784324646,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV/RBC)<13",
            "probability": 0.2389616002043184,
            "start_logit": -1.7942607402801514,
            "end_logit": -0.12657126784324646,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV/RBC",
            "probability": 0.178175694542226,
            "start_logit": -0.706047534942627,
            "end_logit": -1.508317232131958,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "(MCV/RBC",
            "probability": 0.035588406087154904,
            "start_logit": -2.3167977333068848,
            "end_logit": -1.508317232131958,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "(MCV/RBC)<13",
            "probability": 0.03265570653966191,
            "start_logit": -3.784543991088867,
            "end_logit": -0.12657126784324646,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "RBC",
            "probability": 0.014969288428626269,
            "start_logit": -3.182816982269287,
            "end_logit": -1.508317232131958,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "RBC)<13",
            "probability": 0.013430099578714159,
            "start_logit": -4.673065185546875,
            "end_logit": -0.12657126784324646,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "RDWI",
            "probability": 0.011656983190429933,
            "start_logit": -1.9505571126937866,
            "end_logit": -2.9906723499298096,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "red distribution width index RDWI",
            "probability": 0.011157326414284359,
            "start_logit": -1.99436616897583,
            "end_logit": -2.9906723499298096,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "M",
            "probability": 0.006373192172068342,
            "start_logit": -0.706047534942627,
            "end_logit": -4.838986873626709,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "red",
            "probability": 0.00372719094582065,
            "start_logit": -1.99436616897583,
            "end_logit": -4.087113857269287,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV",
            "probability": 0.0035352098382864902,
            "start_logit": -0.706047534942627,
            "end_logit": -5.428314685821533,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV/RBC)",
            "probability": 0.003011421786264323,
            "start_logit": -0.706047534942627,
            "end_logit": -5.588675022125244,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "RBC), England and Fraser formula (MCV - RBC - 5 x Hb- 3.4",
            "probability": 0.002812629868969296,
            "start_logit": -3.182816982269287,
            "end_logit": -3.1801979541778564,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV/RBC), England and Fraser formula (MCV - RBC - 5",
            "probability": 0.0027182885748274254,
            "start_logit": -0.706047534942627,
            "end_logit": -5.691084861755371,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV/RBC), England and Fraser formula (MCV - RBC - 5 x Hb",
            "probability": 0.001706929597929143,
            "start_logit": -0.706047534942627,
            "end_logit": -6.156391143798828,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "(M",
            "probability": 0.0012729668413740494,
            "start_logit": -2.3167977333068848,
            "end_logit": -4.838986873626709,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "Green and King formula (MCV2 x RDW/Hb x 100), red distribution width index RDWI",
            "probability": 0.0010869201359728073,
            "start_logit": -4.323114395141602,
            "end_logit": -2.9906723499298096,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV2 x RDW/Hb x 100), red distribution width index RDWI",
            "probability": 0.0008864202441132853,
            "start_logit": -4.527026653289795,
            "end_logit": -2.9906723499298096,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "(MCV",
            "probability": 0.0007061147349613862,
            "start_logit": -2.3167977333068848,
            "end_logit": -5.428314685821533,
            "question_text": "What is included in the Mentzer index?"
        }
    ],
    "5a7339372dc08e987e000013": [
        {
            "text": "sofosbuvir/velpatasvir",
            "probability": 0.21857230997981936,
            "start_logit": 5.311785697937012,
            "end_logit": 4.889588356018066,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "sofosbuvir",
            "probability": 0.20266085497989106,
            "start_logit": 5.311785697937012,
            "end_logit": 4.814005374908447,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "sofosbuvir/velpatasvir/voxilaprevir",
            "probability": 0.19300761298763852,
            "start_logit": 5.311785697937012,
            "end_logit": 4.765201091766357,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "velpatasvir",
            "probability": 0.13727622706309373,
            "start_logit": 4.846663951873779,
            "end_logit": 4.889588356018066,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "voxilaprevir",
            "probability": 0.12483084724976753,
            "start_logit": 4.876015663146973,
            "end_logit": 4.765201091766357,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "velpatasvir/voxilaprevir",
            "probability": 0.12122009831823202,
            "start_logit": 4.846663951873779,
            "end_logit": 4.765201091766357,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX)",
            "probability": 0.0006647635699040636,
            "start_logit": 5.311785697937012,
            "end_logit": -0.9058523774147034,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "voxilaprevir (SOF/VEL/VOX)",
            "probability": 0.00042994676928738093,
            "start_logit": 4.876015663146973,
            "end_logit": -0.9058523774147034,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "velpatasvir/voxilaprevir (SOF/VEL/VOX)",
            "probability": 0.00041751050155369024,
            "start_logit": 4.846663951873779,
            "end_logit": -0.9058523774147034,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "vir",
            "probability": 0.00014285164827275738,
            "start_logit": -2.021279811859131,
            "end_logit": 4.889588356018066,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "vir/velpatasvir",
            "probability": 0.00013910505413714837,
            "start_logit": -2.0478570461273193,
            "end_logit": 4.889588356018066,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "vir/voxilaprevir",
            "probability": 0.0001261434060289717,
            "start_logit": -2.021279811859131,
            "end_logit": 4.765201091766357,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "vir/velpatasvir/voxilaprevir",
            "probability": 0.0001228350217646788,
            "start_logit": -2.0478570461273193,
            "end_logit": 4.765201091766357,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "/velpatasvir",
            "probability": 7.200315419884452e-05,
            "start_logit": -2.706376552581787,
            "end_logit": 4.889588356018066,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "/velpatasvir/voxilaprevir",
            "probability": 6.358150728600049e-05,
            "start_logit": -2.706376552581787,
            "end_logit": 4.765201091766357,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "so",
            "probability": 6.136762743215946e-05,
            "start_logit": 5.311785697937012,
            "end_logit": -3.2884013652801514,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "sofosbuvir/velpatasvir/v",
            "probability": 5.019837301903669e-05,
            "start_logit": 5.311785697937012,
            "end_logit": -3.4893012046813965,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "previr",
            "probability": 4.989308611899035e-05,
            "start_logit": -2.9488167762756348,
            "end_logit": 4.765201091766357,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "voxilaprevir (SOF/VEL/VOX) (Vosevi)",
            "probability": 4.659878938079822e-05,
            "start_logit": 4.876015663146973,
            "end_logit": -3.127939224243164,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "velpatasvir/voxilaprevir (SOF/VEL/VOX) (Vosevi)",
            "probability": 4.525091317331794e-05,
            "start_logit": 4.846663951873779,
            "end_logit": -3.127939224243164,
            "question_text": "List drugs that are included in the Vosevi polypill."
        }
    ],
    "5a76344e9e632bc066000003": [
        {
            "text": "SAMZIP",
            "probability": 0.956104847385649,
            "start_logit": 4.004048824310303,
            "end_logit": 3.728961229324341,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "GeneComp",
            "probability": 0.012710741635462519,
            "start_logit": 1.8276357650756836,
            "end_logit": 1.5849541425704956,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC",
            "probability": 0.010398694553689407,
            "start_logit": 1.5917357206344604,
            "end_logit": 1.6200870275497437,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAMZIP,",
            "probability": 0.0066084494008799444,
            "start_logit": 4.004048824310303,
            "end_logit": -1.2455573081970215,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAMZI",
            "probability": 0.002603530468313152,
            "start_logit": 4.004048824310303,
            "end_logit": -2.1770379543304443,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAM",
            "probability": 0.0018000609333815283,
            "start_logit": 4.004048824310303,
            "end_logit": -2.546085834503174,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "compressor GeneComp",
            "probability": 0.00170948710493838,
            "start_logit": -0.17861828207969666,
            "end_logit": 1.5849541425704956,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a tool for the compression of mapped short read data stored in the wide-spread SAM format. NGC",
            "probability": 0.0013417211847727955,
            "start_logit": 1.5917357206344604,
            "end_logit": -0.42763999104499817,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAMZIP, a specialized encoding scheme",
            "probability": 0.0012538106748828223,
            "start_logit": 4.004048824310303,
            "end_logit": -2.9077188968658447,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "QVZ",
            "probability": 0.0010924216594576514,
            "start_logit": 0.8274190425872803,
            "end_logit": 0.13112036883831024,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SA",
            "probability": 0.0010552215445040194,
            "start_logit": 4.004048824310303,
            "end_logit": -3.080155611038208,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAMZIP, a specialized encoding scheme,",
            "probability": 0.0007289423051261935,
            "start_logit": 4.004048824310303,
            "end_logit": -3.4500670433044434,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAMZIP, a specialized encoding scheme, for sequence alignment data in SAM (Sequence Alignment/Map) format,",
            "probability": 0.0006203817008907935,
            "start_logit": 4.004048824310303,
            "end_logit": -3.6113266944885254,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "ZIP",
            "probability": 0.000359233221597136,
            "start_logit": -3.8826022148132324,
            "end_logit": 3.728961229324341,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAMZIP, a specialized encoding scheme, for sequence alignment data in SAM (Sequence Alignment",
            "probability": 0.0003443373226836961,
            "start_logit": 4.004048824310303,
            "end_logit": -4.200039863586426,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAMZIP, a specialized encoding",
            "probability": 0.0002831669109853223,
            "start_logit": 4.004048824310303,
            "end_logit": -4.395625114440918,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "P",
            "probability": 0.0002589190191902142,
            "start_logit": -4.210058689117432,
            "end_logit": 3.728961229324341,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAMZIP, a specialized encoding scheme, for sequence alignment data in SAM (Sequence Alignment/Map",
            "probability": 0.00025256329173662203,
            "start_logit": 4.004048824310303,
            "end_logit": -4.509999752044678,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "SAMZIP, a specialized encoding scheme, for sequence alignment data in SAM",
            "probability": 0.00023917297789316492,
            "start_logit": 4.004048824310303,
            "end_logit": -4.564474582672119,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC,",
            "probability": 0.00023429670396559547,
            "start_logit": 1.5917357206344604,
            "end_logit": -2.172760248184204,
            "question_text": "Which algorithms are used for compression of SAM files?"
        }
    ],
    "5aa13fd3d6d6b54f79000003": [
        {
            "text": "methadone, buprenorphine",
            "probability": 0.15939589296963128,
            "start_logit": 3.2703604698181152,
            "end_logit": 3.0498244762420654,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine",
            "probability": 0.14680548177593453,
            "start_logit": 3.188077926635742,
            "end_logit": 3.0498244762420654,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine, and oral and injectable naltrexone",
            "probability": 0.13098812972837903,
            "start_logit": 3.2703604698181152,
            "end_logit": 2.8535401821136475,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine, and oral and injectable naltrexone",
            "probability": 0.12064159956346572,
            "start_logit": 3.188077926635742,
            "end_logit": 2.8535401821136475,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naltrexone",
            "probability": 0.11623036432762546,
            "start_logit": 3.1508278846740723,
            "end_logit": 2.8535401821136475,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone",
            "probability": 0.11023623416027721,
            "start_logit": 3.2703604698181152,
            "end_logit": 2.6810591220855713,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine/naloxone",
            "probability": 0.029973002497040702,
            "start_logit": 2.5865981578826904,
            "end_logit": 2.062492847442627,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine, or buprenorphine/naloxone",
            "probability": 0.029795612536846983,
            "start_logit": 2.580662250518799,
            "end_logit": 2.062492847442627,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine, or buprenorphine/naloxone",
            "probability": 0.029222657298797975,
            "start_logit": 2.5612454414367676,
            "end_logit": 2.062492847442627,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine, or buprenorphine",
            "probability": 0.022542431432261197,
            "start_logit": 2.580662250518799,
            "end_logit": 1.7835310697555542,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine, or buprenorphine",
            "probability": 0.022108951363626853,
            "start_logit": 2.5612454414367676,
            "end_logit": 1.7835310697555542,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine, LAAM), antagonist (e.g., naltrexone",
            "probability": 0.02095865922503168,
            "start_logit": 2.0254077911376953,
            "end_logit": 2.2659380435943604,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine, LAAM), antagonist (e.g., naltrexone",
            "probability": 0.018255580523100935,
            "start_logit": 1.887326717376709,
            "end_logit": 2.2659380435943604,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naloxone",
            "probability": 0.01621555070525514,
            "start_logit": 1.9722718000411987,
            "end_logit": 2.062492847442627,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "Methadone",
            "probability": 0.012863712363997462,
            "start_logit": 2.0021424293518066,
            "end_logit": 1.8010618686676025,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine-naloxone treatment, and methadone treatment.Methadone",
            "probability": 0.0046371306389829964,
            "start_logit": 0.9818278551101685,
            "end_logit": 1.8010618686676025,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone treatment.Methadone",
            "probability": 0.003327333063508774,
            "start_logit": 0.6499031782150269,
            "end_logit": 1.8010618686676025,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "LAAM), antagonist (e.g., naltrexone",
            "probability": 0.002417653949888902,
            "start_logit": -0.13434647023677826,
            "end_logit": 2.2659380435943604,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "injectable naltrexone",
            "probability": 0.001845394517738098,
            "start_logit": -0.9920531511306763,
            "end_logit": 2.8535401821136475,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine,",
            "probability": 0.0015386273586094096,
            "start_logit": 3.2703604698181152,
            "end_logit": -1.5906758308410645,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        }
    ],
    "5aa82388fcf4565872000001": [
        {
            "text": "glutathione S-transferase",
            "probability": 0.25323879407450073,
            "start_logit": 4.789208889007568,
            "end_logit": 3.4675943851470947,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "glutathione reductase, glutathione S-transferase",
            "probability": 0.20236558762408227,
            "start_logit": 4.5649518966674805,
            "end_logit": 3.4675943851470947,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "glutathione reductase",
            "probability": 0.1866192726831572,
            "start_logit": 4.5649518966674805,
            "end_logit": 3.3865890502929688,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "glutathione S-transferase, and NAD(P)H quinone oxidoreductase-1",
            "probability": 0.1507104576159007,
            "start_logit": 4.789208889007568,
            "end_logit": 2.948621988296509,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NLRP3",
            "probability": 0.041521256063812684,
            "start_logit": 3.4638161659240723,
            "end_logit": 2.9848597049713135,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NAD(P)H quinone oxidoreductase-1",
            "probability": 0.03782713647911609,
            "start_logit": 3.4068751335144043,
            "end_logit": 2.948621988296509,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NQO1",
            "probability": 0.026921045279597204,
            "start_logit": 3.661224842071533,
            "end_logit": 2.354153871536255,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NLRP3 Priming. Nrf2-regulated targets, including glutathione reductase",
            "probability": 0.021461967469729698,
            "start_logit": 2.4021637439727783,
            "end_logit": 3.3865890502929688,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NAD(P)H quinone oxidoreductase-1 (NQO1",
            "probability": 0.02087513263676905,
            "start_logit": 3.4068751335144043,
            "end_logit": 2.354153871536255,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NQO1)",
            "probability": 0.020538782504184443,
            "start_logit": 3.661224842071533,
            "end_logit": 2.0835604667663574,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NAD(P)H quinone oxidoreductase-1 (NQO1)",
            "probability": 0.015926194711969106,
            "start_logit": 3.4068751335144043,
            "end_logit": 2.0835604667663574,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3",
            "probability": 0.009456403051690602,
            "start_logit": 3.4638161659240723,
            "end_logit": 1.5053462982177734,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "quinone oxidoreductase-1",
            "probability": 0.0024194021074513475,
            "start_logit": 0.6573688387870789,
            "end_logit": 2.948621988296509,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "glutathione S-transferase,",
            "probability": 0.0023011680499152865,
            "start_logit": 4.789208889007568,
            "end_logit": -1.2333216667175293,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "glutathione reductase, glutathione S-transferase,",
            "probability": 0.0018388858087275209,
            "start_logit": 4.5649518966674805,
            "end_logit": -1.2333216667175293,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "glutathione S-transferase, and NAD(P)H quinone oxidoreductase",
            "probability": 0.0017260525994355113,
            "start_logit": 4.789208889007568,
            "end_logit": -1.5209014415740967,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "quinone oxidoreductase-1 (NQO1",
            "probability": 0.001335161595501918,
            "start_logit": 0.6573688387870789,
            "end_logit": 2.354153871536255,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NLRP3 Inflammasome",
            "probability": 0.00114400324051093,
            "start_logit": 3.4638161659240723,
            "end_logit": -0.606812059879303,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "quinone oxidoreductase-1 (NQO1)",
            "probability": 0.0010186303441470264,
            "start_logit": 0.6573688387870789,
            "end_logit": 2.0835604667663574,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NLRP3 Inflammasome Activity",
            "probability": 0.0007546660598005744,
            "start_logit": 3.4638161659240723,
            "end_logit": -1.0228257179260254,
            "question_text": "Which proteins are regulated by Nrf2?"
        }
    ],
    "5a9d96564e03427e73000001": [
        {
            "text": "hypertension",
            "probability": 0.6662088167643645,
            "start_logit": 5.677164554595947,
            "end_logit": 5.301346778869629,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertension",
            "probability": 0.08898647716185497,
            "start_logit": 4.493279457092285,
            "end_logit": 4.472113132476807,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "diabetes are major risk factors for cognitive decline and late onset Alzheimer's disease (AD)Cardiovascular risk factors, especially hypertension",
            "probability": 0.06468298854588182,
            "start_logit": 3.345059633255005,
            "end_logit": 5.301346778869629,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "type 2 diabetes",
            "probability": 0.05739673095431943,
            "start_logit": 4.3637824058532715,
            "end_logit": 4.163113117218018,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "hypertension, are also major risk factors for Alzheimer's disease (AD).Clusterin",
            "probability": 0.022533818139844047,
            "start_logit": 5.677164554595947,
            "end_logit": 1.9147608280181885,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "late onset Alzheimer's disease (AD)Cardiovascular risk factors, especially hypertension",
            "probability": 0.021414813335597218,
            "start_logit": 2.2396442890167236,
            "end_logit": 5.301346778869629,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "diabetes",
            "probability": 0.020723422391572006,
            "start_logit": 3.345059633255005,
            "end_logit": 4.163113117218018,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Apolipoprotein E4 (E4) and type 2 diabetes",
            "probability": 0.015280413301214086,
            "start_logit": 3.0403668880462646,
            "end_logit": 4.163113117218018,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Cardiovascular risk factors, especially hypertension",
            "probability": 0.014038831098407565,
            "start_logit": 1.8173885345458984,
            "end_logit": 5.301346778869629,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke",
            "probability": 0.008275642564160312,
            "start_logit": 4.493279457092285,
            "end_logit": 2.096945285797119,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Clusterin (Apo J) is one of the major risk factors for sporadic form of AD. Hypertension",
            "probability": 0.006306047024014972,
            "start_logit": 1.8463040590286255,
            "end_logit": 4.472113132476807,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Apolipoprotein E4",
            "probability": 0.0038756262963700557,
            "start_logit": 3.0403668880462646,
            "end_logit": 2.7912485599517822,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset Alzheimer's disease (AD)Cardiovascular risk factors",
            "probability": 0.0022707969714021135,
            "start_logit": 4.3637824058532715,
            "end_logit": 0.9332566261291504,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "hypertension,",
            "probability": 0.0017672967641064452,
            "start_logit": 5.677164554595947,
            "end_logit": -0.630805253982544,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Apolipoprotein E4 (E4)",
            "probability": 0.001589165738520682,
            "start_logit": 3.0403668880462646,
            "end_logit": 1.8997504711151123,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset Alzheimer's disease (AD)Cardiovascular",
            "probability": 0.0011441294762360537,
            "start_logit": 4.3637824058532715,
            "end_logit": 0.24776983261108398,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "stroke and Alzheimer's disease (AD).Major risk factors for AD are advancing age and diabetes",
            "probability": 0.0009649261156089413,
            "start_logit": 1.8163644075393677,
            "end_logit": 2.624840021133423,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "type 2 diabetes are major risk factors for cognitive decline",
            "probability": 0.0008710335081205193,
            "start_logit": 4.3637824058532715,
            "end_logit": -0.02494906447827816,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "advancing age and diabetes",
            "probability": 0.0008491394399818402,
            "start_logit": 1.688536286354065,
            "end_logit": 2.624840021133423,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "diabetes are major risk factors for cognitive decline and late onset Alzheimer's disease (AD)Cardiovascular risk factors",
            "probability": 0.0008198844084225152,
            "start_logit": 3.345059633255005,
            "end_logit": 0.9332566261291504,
            "question_text": "List major risk factors for Alzheimer's disease. "
        }
    ],
    "5a9d2dd21d1251d03b00001a": [
        {
            "text": "V1V2 glycan site",
            "probability": 0.14620967384570238,
            "start_logit": 2.194573163986206,
            "end_logit": 0.7949769496917725,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER), and the V1V2 glycan site",
            "probability": 0.11663415084974495,
            "start_logit": 1.9685735702514648,
            "end_logit": 0.7949769496917725,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region",
            "probability": 0.08006202111886189,
            "start_logit": 1.9685735702514648,
            "end_logit": 0.41873642802238464,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER)",
            "probability": 0.07945619870916666,
            "start_logit": 1.9685735702514648,
            "end_logit": 0.4111407399177551,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the V1V2 glycan site",
            "probability": 0.06963017437730806,
            "start_logit": 1.4527294635772705,
            "end_logit": 0.7949769496917725,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V1V2",
            "probability": 0.06165931905472325,
            "start_logit": 2.194573163986206,
            "end_logit": -0.06844038516283035,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER), and the V1V2",
            "probability": 0.04918677492920576,
            "start_logit": 1.9685735702514648,
            "end_logit": -0.06844038516283035,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V1V2 glycan",
            "probability": 0.045184059157873865,
            "start_logit": 2.194573163986206,
            "end_logit": -0.3793204128742218,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the CD4 binding site",
            "probability": 0.044412304189646014,
            "start_logit": 0.6821520924568176,
            "end_logit": 1.115872859954834,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the membrane-proximal external region (MPER), and the V1V2 glycan site",
            "probability": 0.04412348973165666,
            "start_logit": 0.9965237379074097,
            "end_logit": 0.7949769496917725,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER), and the V1V2 glycan",
            "probability": 0.03604415654045427,
            "start_logit": 1.9685735702514648,
            "end_logit": -0.3793204128742218,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the CD4 binding site, the membrane-proximal external region (MPER), and the V1V2 glycan site",
            "probability": 0.032221071797557024,
            "start_logit": 0.6821520924568176,
            "end_logit": 0.7949769496917725,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the membrane-proximal external region",
            "probability": 0.030288005193990795,
            "start_logit": 0.9965237379074097,
            "end_logit": 0.41873642802238464,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the membrane-proximal external region (MPER)",
            "probability": 0.03005881847055993,
            "start_logit": 0.9965237379074097,
            "end_logit": 0.4111407399177551,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the V1V2",
            "probability": 0.029364330176246064,
            "start_logit": 1.4527294635772705,
            "end_logit": -0.06844038516283035,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the CD4 binding site, the membrane-proximal external region",
            "probability": 0.02211774263313048,
            "start_logit": 0.6821520924568176,
            "end_logit": 0.41873642802238464,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the CD4 binding site, the membrane-proximal external region (MPER)",
            "probability": 0.021950379581938847,
            "start_logit": 0.6821520924568176,
            "end_logit": 0.4111407399177551,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the V1V2 glycan",
            "probability": 0.02151823361262383,
            "start_logit": 1.4527294635772705,
            "end_logit": -0.3793204128742218,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "MPER), and the V1V2 glycan site",
            "probability": 0.02013562822869735,
            "start_logit": 0.21202224493026733,
            "end_logit": 0.7949769496917725,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER",
            "probability": 0.01974346780091164,
            "start_logit": 1.9685735702514648,
            "end_logit": -0.9812424778938293,
            "question_text": "What do the trispecific HIV antibodies target?"
        }
    ],
    "5ac7185f0340b9f058000004": [
        {
            "text": "autophagy",
            "probability": 0.6198623648373467,
            "start_logit": 4.895050048828125,
            "end_logit": 5.062017917633057,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "cardiomyocyte apoptosis",
            "probability": 0.1846103952645176,
            "start_logit": 4.2035908699035645,
            "end_logit": 4.542227268218994,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "cardiomyocyte apoptosis and improved left ventricular structure and function",
            "probability": 0.04829700850676201,
            "start_logit": 4.2035908699035645,
            "end_logit": 3.2013492584228516,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "apoptosis",
            "probability": 0.03844604129247736,
            "start_logit": 2.634598970413208,
            "end_logit": 4.542227268218994,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "autophagy activation in cardiomyocytes exposed to high glucose. In conclusion, our study suggested that H19 could inhibit autophagy",
            "probability": 0.03230105146588519,
            "start_logit": 3.8744139671325684,
            "end_logit": 3.128256320953369,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "cardiomyocyte apoptosis and improved left ventricular structure",
            "probability": 0.01762197679613147,
            "start_logit": 4.2035908699035645,
            "end_logit": 2.1931264400482178,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "autophagy by epigenetically silencing of DIRAS3",
            "probability": 0.017334980258412697,
            "start_logit": 4.895050048828125,
            "end_logit": 1.4852468967437744,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "apoptosis and improved left ventricular structure and function",
            "probability": 0.01005809440304572,
            "start_logit": 2.634598970413208,
            "end_logit": 3.2013492584228516,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy",
            "probability": 0.008307202661021893,
            "start_logit": 4.895050048828125,
            "end_logit": 0.7496433854103088,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "left ventricular structure and function",
            "probability": 0.0037042070113935716,
            "start_logit": 1.635690450668335,
            "end_logit": 3.2013492584228516,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "apoptosis and improved left ventricular structure",
            "probability": 0.0036698651047705334,
            "start_logit": 2.634598970413208,
            "end_logit": 2.1931264400482178,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "improved left ventricular structure and function",
            "probability": 0.0027011554434351803,
            "start_logit": 1.3199008703231812,
            "end_logit": 3.2013492584228516,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "cardiomyocyte",
            "probability": 0.0024409690317994015,
            "start_logit": 4.2035908699035645,
            "end_logit": 0.2163747400045395,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "cardiomyopathy.LncRNA H19 inhibits autophagy",
            "probability": 0.002367692253350413,
            "start_logit": -0.6725316643714905,
            "end_logit": 5.062017917633057,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "autophagy in cardiomyocytes",
            "probability": 0.0020216767863379904,
            "start_logit": 3.1838860511779785,
            "end_logit": 1.0476117134094238,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "structure and function",
            "probability": 0.0015836155867342036,
            "start_logit": 0.7859318256378174,
            "end_logit": 3.2013492584228516,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy.",
            "probability": 0.0013591020007756413,
            "start_logit": 4.895050048828125,
            "end_logit": -1.0606553554534912,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "left ventricular structure",
            "probability": 0.0013515423008798957,
            "start_logit": 1.635690450668335,
            "end_logit": 2.1931264400482178,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "improved left ventricular structure",
            "probability": 0.0009855620465663952,
            "start_logit": 1.3199008703231812,
            "end_logit": 2.1931264400482178,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "cardiomyocyte apoptosis in dilated cardiomyopathy",
            "probability": 0.0009754969483559366,
            "start_logit": 2.664966106414795,
            "end_logit": 0.837796151638031,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        }
    ],
    "5ac721230340b9f058000005": [
        {
            "text": "circ-ABCB10",
            "probability": 0.713303451199181,
            "start_logit": 4.688385486602783,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "ABCB10",
            "probability": 0.1936718042329237,
            "start_logit": 3.3846435546875,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271",
            "probability": 0.05569087871995946,
            "start_logit": 4.688385486602783,
            "end_logit": 2.6424944400787354,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271",
            "probability": 0.015120847856377045,
            "start_logit": 3.3846435546875,
            "end_logit": 2.6424944400787354,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circ-ABCB",
            "probability": 0.005270265037290509,
            "start_logit": 4.688385486602783,
            "end_logit": 0.28475871682167053,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "miR-1271",
            "probability": 0.004327764607566823,
            "start_logit": 2.133620262145996,
            "end_logit": 2.6424944400787354,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "irc-ABCB10",
            "probability": 0.0020944136739489802,
            "start_logit": -1.1422477960586548,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271.",
            "probability": 0.0020646122231634902,
            "start_logit": 4.688385486602783,
            "end_logit": -0.6523795127868652,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "RNA circ-ABCB10",
            "probability": 0.001746542130074968,
            "start_logit": -1.3238835334777832,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circ",
            "probability": 0.00155837675782821,
            "start_logit": 4.688385486602783,
            "end_logit": -0.9336771965026855,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "ABCB",
            "probability": 0.0014309502314082197,
            "start_logit": 3.3846435546875,
            "end_logit": 0.28475871682167053,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "10",
            "probability": 0.000845003007931581,
            "start_logit": -2.049936532974243,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "BCB10",
            "probability": 0.0005729714673615005,
            "start_logit": -2.4384407997131348,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271.",
            "probability": 0.0005605709233976015,
            "start_logit": 3.3846435546875,
            "end_logit": -0.6523795127868652,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "c",
            "probability": 0.00036355866104512114,
            "start_logit": 4.688385486602783,
            "end_logit": -2.389136552810669,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "c-ABCB10",
            "probability": 0.0002978092600431556,
            "start_logit": -3.0928235054016113,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "B10",
            "probability": 0.0002862785751852089,
            "start_logit": -3.1323113441467285,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "Circular RNA circ-ABCB10",
            "probability": 0.0002723909669686505,
            "start_logit": -3.1820383071899414,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "CB10",
            "probability": 0.0002672437362376902,
            "start_logit": -3.201115608215332,
            "end_logit": 5.192584991455078,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circ-ABCB10 promotes breast cancer",
            "probability": 0.0002542667321074234,
            "start_logit": 4.688385486602783,
            "end_logit": -2.7466933727264404,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        }
    ],
    "5abcf755fcf4565872000028": [
        {
            "text": "herpes zoster",
            "probability": 0.6589530942600251,
            "start_logit": 4.641292095184326,
            "end_logit": 4.558395862579346,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "post-herpetic neuralgia",
            "probability": 0.07821506634505652,
            "start_logit": 3.476497173309326,
            "end_logit": 3.592000722885132,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpetic neuralgia",
            "probability": 0.04750427040314986,
            "start_logit": 2.9778544902801514,
            "end_logit": 3.592000722885132,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes labialis",
            "probability": 0.047441012100295235,
            "start_logit": 3.309885025024414,
            "end_logit": 3.2586376667022705,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes labialis. n herpes zoster",
            "probability": 0.04093029361030785,
            "start_logit": 3.309885025024414,
            "end_logit": 3.111021041870117,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex virus infection and for the treatment of herpes labialis",
            "probability": 0.02680151402452472,
            "start_logit": 2.738856315612793,
            "end_logit": 3.2586376667022705,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex virus infection and for the treatment of herpes labialis. n herpes zoster",
            "probability": 0.02312332283100161,
            "start_logit": 2.738856315612793,
            "end_logit": 3.111021041870117,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "zoster-associated pain and post-herpetic neuralgia",
            "probability": 0.021536668989648337,
            "start_logit": 2.1867918968200684,
            "end_logit": 3.592000722885132,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes",
            "probability": 0.013403131873053765,
            "start_logit": 4.641292095184326,
            "end_logit": 0.6632319092750549,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "neuralgia",
            "probability": 0.008660477659293035,
            "start_logit": 1.2758047580718994,
            "end_logit": 3.592000722885132,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes zoster-associated pain and postherpetic neuralgia",
            "probability": 0.006056981826540517,
            "start_logit": 2.550039291381836,
            "end_logit": 1.9602079391479492,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex",
            "probability": 0.005758167745203039,
            "start_logit": 2.738856315612793,
            "end_logit": 1.7207986116409302,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex virus",
            "probability": 0.0054949896894994354,
            "start_logit": 2.738856315612793,
            "end_logit": 1.674015998840332,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "zoster",
            "probability": 0.004620858695652935,
            "start_logit": 2.1867918968200684,
            "end_logit": 2.0528242588043213,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpesvirus therapieIn controlled clinical trials in herpes zoster",
            "probability": 0.00372769614472602,
            "start_logit": -0.533569872379303,
            "end_logit": 4.558395862579346,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "postherpetic neuralgia",
            "probability": 0.0027700008215216067,
            "start_logit": 1.7676752805709839,
            "end_logit": 1.9602079391479492,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex virus infection",
            "probability": 0.0025891778927138727,
            "start_logit": 2.738856315612793,
            "end_logit": 0.9215196967124939,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "genital herpes.valacyclovir is also indicated in the reduction of the sexual transmission of herpes simplex",
            "probability": 0.0008652429363558204,
            "start_logit": 0.8434920310974121,
            "end_logit": 1.7207986116409302,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "genital herpes.valacyclovir is also indicated in the reduction of the sexual transmission of herpes simplex virus",
            "probability": 0.0008256968578500138,
            "start_logit": 0.8434920310974121,
            "end_logit": 1.674015998840332,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "genital herpes",
            "probability": 0.0007223352935806796,
            "start_logit": 0.8434920310974121,
            "end_logit": 1.5402777194976807,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        }
    ],
    "5ace20fa0340b9f05800000c": [
        {
            "text": "EPAS1, EGLN1, and PPARA",
            "probability": 0.14674717008190308,
            "start_logit": 4.757696628570557,
            "end_logit": 4.236990451812744,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "PPARA",
            "probability": 0.14185753955182043,
            "start_logit": 4.723808765411377,
            "end_logit": 4.236990451812744,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1, and PPARA",
            "probability": 0.14127457620524797,
            "start_logit": 4.719690799713135,
            "end_logit": 4.236990451812744,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, EGLN1",
            "probability": 0.13483194981425642,
            "start_logit": 4.757696628570557,
            "end_logit": 4.152308464050293,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1",
            "probability": 0.12980370632227536,
            "start_logit": 4.719690799713135,
            "end_logit": 4.152308464050293,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1",
            "probability": 0.1249765660313045,
            "start_logit": 4.757696628570557,
            "end_logit": 4.0764055252075195,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1 and EGLN1",
            "probability": 0.026404931836926958,
            "start_logit": 4.104992389678955,
            "end_logit": 3.174534320831299,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, EGLN1 and PPARA",
            "probability": 0.02344301965259059,
            "start_logit": 3.8156979084014893,
            "end_logit": 3.344850778579712,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1 and EGLN1. Three of these genes, EPAS1, EGLN1 and PPARA",
            "probability": 0.020955150050290035,
            "start_logit": 3.703509569168091,
            "end_logit": 3.344850778579712,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1. Three of these genes, EPAS1, EGLN1 and PPARA",
            "probability": 0.01962771962173091,
            "start_logit": 3.6380679607391357,
            "end_logit": 3.344850778579712,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1 and EGLN1. Three of these genes, EPAS1, EGLN1",
            "probability": 0.017274044776279602,
            "start_logit": 3.703509569168091,
            "end_logit": 3.1516714096069336,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1 and PPARA",
            "probability": 0.017167942902162673,
            "start_logit": 3.50416898727417,
            "end_logit": 3.344850778579712,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1 and EGLN1. Three of these genes, EPAS1",
            "probability": 0.01679385072703094,
            "start_logit": 3.703509569168091,
            "end_logit": 3.123479127883911,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1. Three of these genes, EPAS1, EGLN1",
            "probability": 0.016179798607423895,
            "start_logit": 3.6380679607391357,
            "end_logit": 3.1516714096069336,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1. Three of these genes, EPAS1",
            "probability": 0.015730023056303662,
            "start_logit": 3.6380679607391357,
            "end_logit": 3.123479127883911,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, EGLN1,",
            "probability": 0.001915324940300489,
            "start_logit": 4.757696628570557,
            "end_logit": -0.10183343291282654,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1,",
            "probability": 0.0018438973581928195,
            "start_logit": 4.719690799713135,
            "end_logit": -0.10183343291282654,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1 (or HIFPH2, MIM 606425) and EPAS1",
            "probability": 0.00154975235726199,
            "start_logit": 2.386333465576172,
            "end_logit": 2.0577375888824463,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, EGLN1, and PPARA)",
            "probability": 0.000825267043981836,
            "start_logit": 4.757696628570557,
            "end_logit": -0.9437689781188965,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "PPARA)",
            "probability": 0.0007977690627160135,
            "start_logit": 4.723808765411377,
            "end_logit": -0.9437689781188965,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        }
    ],
    "5a99566e1d1251d03b00000f": [
        {
            "text": "antisocial personality disorder",
            "probability": 0.2909736161312444,
            "start_logit": 2.9256739616394043,
            "end_logit": 2.0813424587249756,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial personality",
            "probability": 0.1685371264718694,
            "start_logit": 2.9256739616394043,
            "end_logit": 1.5352659225463867,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial personality disorder and high psychopathic traits",
            "probability": 0.13939402810702,
            "start_logit": 2.9256739616394043,
            "end_logit": 1.3454145193099976,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial",
            "probability": 0.0914954310540116,
            "start_logit": 2.9256739616394043,
            "end_logit": 0.9243988990783691,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "psychopathic traits",
            "probability": 0.03889623330028354,
            "start_logit": 1.6492667198181152,
            "end_logit": 1.3454145193099976,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "Borderline Personality Disorder",
            "probability": 0.0386456740150687,
            "start_logit": 1.8292416334152222,
            "end_logit": 1.1589770317077637,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "Impulsiveness in Borderline Personality Disorder",
            "probability": 0.0324121601954174,
            "start_logit": 1.653340458869934,
            "end_logit": 1.1589770317077637,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial personality disorder and high psychopathic",
            "probability": 0.031171370005526996,
            "start_logit": 2.9256739616394043,
            "end_logit": -0.15239009261131287,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "Impulsiveness",
            "probability": 0.027262169603434996,
            "start_logit": 1.653340458869934,
            "end_logit": 0.9859433770179749,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "aggression",
            "probability": 0.026464379885167862,
            "start_logit": 1.1927794218063354,
            "end_logit": 1.4168040752410889,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "Borderline Personality",
            "probability": 0.01917385740237912,
            "start_logit": 1.8292416334152222,
            "end_logit": 0.4580899477005005,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "Borderline Personality Disorder. These preliminary results suggest that MAOA-L may modulate the impact of childhood abuse on impulsivity",
            "probability": 0.018799203043859233,
            "start_logit": 1.8292416334152222,
            "end_logit": 0.4383566677570343,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "aggression in clinical and non-clinical populationsMonoamine Oxidase-A Genetic Variants and Childhood Abuse Predict Impulsiveness",
            "probability": 0.017200508981088724,
            "start_logit": 1.1927794218063354,
            "end_logit": 0.9859433770179749,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "Impulsiveness in Borderline Personality",
            "probability": 0.016081130774111482,
            "start_logit": 1.653340458869934,
            "end_logit": 0.4580899477005005,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality",
            "probability": 0.010666694814420034,
            "start_logit": 1.5274412631988525,
            "end_logit": 0.17346881330013275,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "psychopathic",
            "probability": 0.008697997299379132,
            "start_logit": 1.6492667198181152,
            "end_logit": -0.15239009261131287,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "Borderline",
            "probability": 0.007269266806833091,
            "start_logit": 1.8292416334152222,
            "end_logit": -0.5118023753166199,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "impulsivity",
            "probability": 0.006342547956371551,
            "start_logit": 0.7427077293395996,
            "end_logit": 0.4383566677570343,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "Impulsiveness in Borderline",
            "probability": 0.006096740353252331,
            "start_logit": 1.653340458869934,
            "end_logit": -0.5118023753166199,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "high psychopathic traits",
            "probability": 0.004419863799260477,
            "start_logit": -0.5255218148231506,
            "end_logit": 1.3454145193099976,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        }
    ],
    "5abd2ce0fcf456587200002a": [
        {
            "text": "Bacteroidetes and Firmicutes",
            "probability": 0.38311574600540554,
            "start_logit": 5.921727180480957,
            "end_logit": 5.854565143585205,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes",
            "probability": 0.29214603510317033,
            "start_logit": 5.650643825531006,
            "end_logit": 5.854565143585205,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes",
            "probability": 0.25609952957467164,
            "start_logit": 5.921727180480957,
            "end_logit": 5.451794147491455,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes and Firmicutesthe prevalence of some representative viable bacteria from the four dominant phyla (Firmicutes",
            "probability": 0.027011895929211,
            "start_logit": 5.921727180480957,
            "end_logit": 3.202505350112915,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutesthe prevalence of some representative viable bacteria from the four dominant phyla (Firmicutes",
            "probability": 0.02059800041793928,
            "start_logit": 5.650643825531006,
            "end_logit": 3.202505350112915,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutesthe prevalence of some representative viable bacteria from the four dominant phyla (Firmicutes, Bacteroidetes",
            "probability": 0.009609536061142678,
            "start_logit": 5.650643825531006,
            "end_logit": 2.4400672912597656,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "the Bacteroidetes and Firmicutes",
            "probability": 0.002570028200899557,
            "start_logit": 0.9173069000244141,
            "end_logit": 5.854565143585205,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "the Bacteroidetes",
            "probability": 0.0017179743200498203,
            "start_logit": 0.9173069000244141,
            "end_logit": 5.451794147491455,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes, Proteobacteria",
            "probability": 0.001381146840462505,
            "start_logit": 3.472831964492798,
            "end_logit": 2.678037405014038,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes, Bacteroidetes, Proteobacteria",
            "probability": 0.0010565110400733379,
            "start_logit": 3.2048897743225098,
            "end_logit": 2.678037405014038,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes, Proteobacteria, Actinobacteria",
            "probability": 0.0009325304536631935,
            "start_logit": 3.472831964492798,
            "end_logit": 2.2852697372436523,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes, Bacteroidetes",
            "probability": 0.0008327697329450504,
            "start_logit": 3.2048897743225098,
            "end_logit": 2.4400672912597656,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Actinobacteria",
            "probability": 0.0008011234920120329,
            "start_logit": 3.3209452629089355,
            "end_logit": 2.2852697372436523,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria",
            "probability": 0.0007133410370542777,
            "start_logit": 3.2048897743225098,
            "end_logit": 2.2852697372436523,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Proteobacteria",
            "probability": 0.0006498086097462961,
            "start_logit": 2.7188403606414795,
            "end_logit": 2.678037405014038,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Proteobacteria, Actinobacteria",
            "probability": 0.0004387414139383199,
            "start_logit": 2.7188403606414795,
            "end_logit": 2.2852697372436523,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "the Bacteroidetes and Firmicutesthe prevalence of some representative viable bacteria from the four dominant phyla (Firmicutes",
            "probability": 0.0001812019866624243,
            "start_logit": 0.9173069000244141,
            "end_logit": 3.202505350112915,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "B",
            "probability": 8.72829006418302e-05,
            "start_logit": 5.921727180480957,
            "end_logit": -2.5323727130889893,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes and Firm",
            "probability": 2.9046407043465817e-05,
            "start_logit": 5.921727180480957,
            "end_logit": -3.6326324939727783,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "tes and Firmicutes",
            "probability": 2.7750473267491776e-05,
            "start_logit": -3.611112356185913,
            "end_logit": 5.854565143585205,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        }
    ],
    "5aac5469fcf4565872000005": [
        {
            "text": "loss of appetite, and nausea or vomiting.The illness was characterized by fever, headache, myalgia",
            "probability": 0.08226636169673826,
            "start_logit": 4.703427791595459,
            "end_logit": 4.581434726715088,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "myalgia",
            "probability": 0.07812635936312397,
            "start_logit": 4.651793003082275,
            "end_logit": 4.581434726715088,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache",
            "probability": 0.06666540611357501,
            "start_logit": 4.441651344299316,
            "end_logit": 4.632935047149658,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache, shivers, loss of appetite, and nausea or vomiting.The illness was characterized by fever, headache, myalgia",
            "probability": 0.06331902576327782,
            "start_logit": 4.441651344299316,
            "end_logit": 4.581434726715088,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "loss of appetite, and nausea or vomiting.The illness was characterized by fever, headache",
            "probability": 0.06198882938880819,
            "start_logit": 4.703427791595459,
            "end_logit": 4.298426628112793,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "shivers, loss of appetite, and nausea or vomiting.The illness was characterized by fever, headache, myalgia",
            "probability": 0.06009510022193744,
            "start_logit": 4.3893938064575195,
            "end_logit": 4.581434726715088,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "vomiting.The illness was characterized by fever, headache, myalgia",
            "probability": 0.05175684464834314,
            "start_logit": 4.2400221824646,
            "end_logit": 4.581434726715088,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache, shivers, loss of appetite, and nausea or vomiting.The illness was characterized by fever, headache",
            "probability": 0.04771175246055645,
            "start_logit": 4.441651344299316,
            "end_logit": 4.298426628112793,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache, myalgia",
            "probability": 0.04549974419804758,
            "start_logit": 4.111172199249268,
            "end_logit": 4.581434726715088,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "shivers, loss of appetite, and nausea or vomiting.The illness was characterized by fever, headache",
            "probability": 0.04528248044435772,
            "start_logit": 4.3893938064575195,
            "end_logit": 4.298426628112793,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "muscle pain with prominent backache, headache",
            "probability": 0.04194083010079024,
            "start_logit": 3.978224992752075,
            "end_logit": 4.632935047149658,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "loss of appetite, and nausea or vomiting.The illness was characterized by fever",
            "probability": 0.04171958738982965,
            "start_logit": 4.703427791595459,
            "end_logit": 3.9024431705474854,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache, shivers",
            "probability": 0.04082179936349757,
            "start_logit": 4.441651344299316,
            "end_logit": 4.142465114593506,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "loss of appetite, and nausea or vomiting.The illness was characterized by fever, headache, myalgia, gastrointestinal symptoms",
            "probability": 0.04019298849014479,
            "start_logit": 4.703427791595459,
            "end_logit": 3.8651649951934814,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "nausea or vomiting.The illness was characterized by fever, headache, myalgia",
            "probability": 0.03964041849455594,
            "start_logit": 3.9733147621154785,
            "end_logit": 4.581434726715088,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "backache, headache",
            "probability": 0.03905025476362027,
            "start_logit": 3.9068145751953125,
            "end_logit": 4.632935047149658,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "vomiting.The illness was characterized by fever, headache",
            "probability": 0.038999490757063576,
            "start_logit": 4.2400221824646,
            "end_logit": 4.298426628112793,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "shivers",
            "probability": 0.03874333337282565,
            "start_logit": 4.3893938064575195,
            "end_logit": 4.142465114593506,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "myalgia, gastrointestinal symptoms",
            "probability": 0.03817030190583302,
            "start_logit": 4.651793003082275,
            "end_logit": 3.8651649951934814,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "loss of appetite",
            "probability": 0.03800909106307374,
            "start_logit": 4.703427791595459,
            "end_logit": 3.809297800064087,
            "question_text": "What are 7 symptoms of yellow fever?"
        }
    ],
    "5a7d5580faa1ab7d2e00001a": [
        {
            "text": "[(18)F]THK523, [(18)F]THK5117",
            "probability": 0.09075744610728174,
            "start_logit": 3.4606313705444336,
            "end_logit": 3.687060594558716,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5117, [(18)F]THK5105",
            "probability": 0.08965480536396342,
            "start_logit": 3.3395237922668457,
            "end_logit": 3.7959444522857666,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK523",
            "probability": 0.0844515583554595,
            "start_logit": 3.4606313705444336,
            "end_logit": 3.6150481700897217,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5117",
            "probability": 0.08040552898336856,
            "start_logit": 3.3395237922668457,
            "end_logit": 3.687060594558716,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK523, [(18)F]THK5117, [(18)F]THK5105",
            "probability": 0.05959300080524654,
            "start_logit": 2.9310951232910156,
            "end_logit": 3.7959444522857666,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5105",
            "probability": 0.0565160577808829,
            "start_logit": 2.878081798553467,
            "end_logit": 3.7959444522857666,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5105",
            "probability": 0.05540692538921972,
            "start_logit": 2.8582615852355957,
            "end_logit": 3.7959444522857666,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK523, [(18)F]THK5117",
            "probability": 0.053445063362751274,
            "start_logit": 2.9310951232910156,
            "end_logit": 3.687060594558716,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5117, [(18)F]THK5105",
            "probability": 0.05235124677068457,
            "start_logit": 2.801532745361328,
            "end_logit": 3.7959444522857666,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK523",
            "probability": 0.04973166479426184,
            "start_logit": 2.9310951232910156,
            "end_logit": 3.6150481700897217,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5105 and [(18)F]THK5351",
            "probability": 0.04871647220632498,
            "start_logit": 2.878081798553467,
            "end_logit": 3.6474368572235107,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5105 and [(18)F]THK5351",
            "probability": 0.04776040733815805,
            "start_logit": 2.8582615852355957,
            "end_logit": 3.6474368572235107,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5117",
            "probability": 0.04695040798368283,
            "start_logit": 2.801532745361328,
            "end_logit": 3.687060594558716,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5117, [(18)F]THK5105 and [(18)F]THK5351",
            "probability": 0.045126432352349984,
            "start_logit": 2.801532745361328,
            "end_logit": 3.6474368572235107,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "18F-RO6958948",
            "probability": 0.036112714842275684,
            "start_logit": 3.064143657684326,
            "end_logit": 3.1620028018951416,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5351",
            "probability": 0.03398579662834218,
            "start_logit": 2.518007278442383,
            "end_logit": 3.6474368572235107,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5351",
            "probability": 0.03171085989641614,
            "start_logit": 2.448723793029785,
            "end_logit": 3.6474368572235107,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "18F-T807 (18F-AV-1451), and 18F-RO6958948",
            "probability": 0.017352064553532262,
            "start_logit": 2.331210136413574,
            "end_logit": 3.1620028018951416,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5105 and [(18)F]THK5351, [(18)F]AV1451",
            "probability": 0.011037614085493024,
            "start_logit": 2.8582615852355957,
            "end_logit": 2.182548761367798,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "18F-THK-5351",
            "probability": 0.008933932400304613,
            "start_logit": 2.629638671875,
            "end_logit": 2.1997194290161133,
            "question_text": "What in vivo tau tracers are being used?"
        }
    ],
    "5ac2776195d0062724000006": [
        {
            "text": "Dentatorubral-pallidoluysian atrophy",
            "probability": 0.5930259994833439,
            "start_logit": 4.615481376647949,
            "end_logit": 4.298887252807617,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Dentatorubral-pallidoluysian atrophy (DRPLA)",
            "probability": 0.29364090847159324,
            "start_logit": 4.615481376647949,
            "end_logit": 3.5960066318511963,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Huntington's Disease",
            "probability": 0.054910637818244276,
            "start_logit": 3.1165051460266113,
            "end_logit": 3.41833233833313,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy",
            "probability": 0.021297161357592152,
            "start_logit": 2.9174892902374268,
            "end_logit": 2.670214891433716,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Dentatorubral-pallidoluysian atrophy (DRPLA",
            "probability": 0.012579791273212255,
            "start_logit": 4.615481376647949,
            "end_logit": 0.445740669965744,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Huntington's Disease (HD)",
            "probability": 0.0051830308218548185,
            "start_logit": 3.1165051460266113,
            "end_logit": 1.05801522731781,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "DRPLA)",
            "probability": 0.004850235436122232,
            "start_logit": 0.5121510028839111,
            "end_logit": 3.5960066318511963,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "pallidoluysian atrophy",
            "probability": 0.004418137390739584,
            "start_logit": -0.2840386629104614,
            "end_logit": 4.298887252807617,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy (DRPLA)",
            "probability": 0.002694619063097186,
            "start_logit": 2.9174892902374268,
            "end_logit": 0.6028979420661926,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "pallidoluysian atrophy (DRPLA)",
            "probability": 0.0021876711616343287,
            "start_logit": -0.2840386629104614,
            "end_logit": 3.5960066318511963,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Huntington's disease",
            "probability": 0.0017256136450589019,
            "start_logit": 1.1223071813583374,
            "end_logit": 1.9524059295654297,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "atrophy",
            "probability": 0.0014099533161398565,
            "start_logit": -1.426200270652771,
            "end_logit": 4.298887252807617,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "atrophy (DRPLA)",
            "probability": 0.0006981480963980422,
            "start_logit": -1.426200270652771,
            "end_logit": 3.5960066318511963,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Huntington's",
            "probability": 0.00048658820863263193,
            "start_logit": 3.1165051460266113,
            "end_logit": -1.3077118396759033,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Dentatorubral-pallidoluysian",
            "probability": 0.00031373217047969606,
            "start_logit": 4.615481376647949,
            "end_logit": -3.2455666065216064,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "DRPLA",
            "probability": 0.00020778763330334086,
            "start_logit": 0.5121510028839111,
            "end_logit": 0.445740669965744,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Huntington's Disease (HD) is a fatally inherited neurodegenerative disorder",
            "probability": 0.00015803591501080145,
            "start_logit": 3.1165051460266113,
            "end_logit": -2.432307720184326,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "pallidoluysian atrophy (DRPLA",
            "probability": 9.372143251779909e-05,
            "start_logit": -0.2840386629104614,
            "end_logit": 0.445740669965744,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy (DRPLA",
            "probability": 7.292472412388443e-05,
            "start_logit": 2.9174892902374268,
            "end_logit": -3.0066864490509033,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Disease",
            "probability": 4.53025809012046e-05,
            "start_logit": -3.983593225479126,
            "end_logit": 3.41833233833313,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        }
    ],
    "5abd44b1fcf4565872000030": [
        {
            "text": "HEATR1",
            "probability": 0.40624190501835783,
            "start_logit": 3.568831443786621,
            "end_logit": 2.513237237930298,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEAT repeat-containing protein 1 (HEATR1",
            "probability": 0.24248485096255168,
            "start_logit": 3.0528218746185303,
            "end_logit": 2.513237237930298,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEAT repeat-containing protein 1",
            "probability": 0.14838663765372354,
            "start_logit": 3.0528218746185303,
            "end_logit": 2.0221192836761475,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEATR1)",
            "probability": 0.0523437615491647,
            "start_logit": 3.568831443786621,
            "end_logit": 0.4641211926937103,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "(HEATR1",
            "probability": 0.047576377916998404,
            "start_logit": 1.424219012260437,
            "end_logit": 2.513237237930298,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEAT repeat-containing protein 1 (HEATR1)",
            "probability": 0.031243869874760896,
            "start_logit": 3.0528218746185303,
            "end_logit": 0.4641211926937103,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEATR",
            "probability": 0.021782825551717296,
            "start_logit": 3.568831443786621,
            "end_logit": -0.4125897288322449,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEAT repeat-containing protein 1 (HEATR",
            "probability": 0.013002118053805257,
            "start_logit": 3.0528218746185303,
            "end_logit": -0.4125897288322449,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "(HEATR1)",
            "probability": 0.006130156811242241,
            "start_logit": 1.424219012260437,
            "end_logit": 0.4641211926937103,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEAT repeat-containing protein",
            "probability": 0.006083552511979555,
            "start_logit": 3.0528218746185303,
            "end_logit": -1.1721131801605225,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEAT repeat",
            "probability": 0.004946896767294322,
            "start_logit": 3.0528218746185303,
            "end_logit": -1.378941535949707,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEATR1) The first 1,300 residues of Tor form a HEAT repeat",
            "probability": 0.0036422076706527245,
            "start_logit": 3.568831443786621,
            "end_logit": -2.2011215686798096,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEAT",
            "probability": 0.002960482907474546,
            "start_logit": 3.0528218746185303,
            "end_logit": -1.8923496007919312,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "(HEATR",
            "probability": 0.00255106114791806,
            "start_logit": 1.424219012260437,
            "end_logit": -0.4125897288322449,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEATR1) The first 1,300 residues of Tor form a HEAT repeat-containing \u03b1-solenoid",
            "probability": 0.0024115613327701417,
            "start_logit": 3.568831443786621,
            "end_logit": -2.6134371757507324,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "HEAT repeat-containing protein 1 (HEATR1) The first 1,300 residues of Tor form a HEAT repeat",
            "probability": 0.0021740253117240034,
            "start_logit": 3.0528218746185303,
            "end_logit": -2.2011215686798096,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "protein 1 (HEATR1",
            "probability": 0.0019668130041902423,
            "start_logit": -1.7617028951644897,
            "end_logit": 2.513237237930298,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "1 (HEATR1",
            "probability": 0.0017787990433548804,
            "start_logit": -1.862178921699524,
            "end_logit": 2.513237237930298,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "protein 1",
            "probability": 0.0012035752642975657,
            "start_logit": -1.7617028951644897,
            "end_logit": 2.0221192836761475,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "1",
            "probability": 0.0010885216460217303,
            "start_logit": -1.862178921699524,
            "end_logit": 2.0221192836761475,
            "question_text": "List proteins with HEAT repeats"
        }
    ],
    "5ac0f7b919833b0d7b000006": [
        {
            "text": "ciraparantag",
            "probability": 0.2320068428339777,
            "start_logit": 4.490352153778076,
            "end_logit": 3.9922592639923096,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "ciraparantag) are at various stages of clinical development. Idarucizumab",
            "probability": 0.12279615063722492,
            "start_logit": 4.490352153778076,
            "end_logit": 3.35601806640625,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "andexanet alfa and ciraparantag",
            "probability": 0.09299478661367604,
            "start_logit": 3.5761287212371826,
            "end_logit": 3.9922592639923096,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "Idarucizumab",
            "probability": 0.0923832712098018,
            "start_logit": 3.9430503845214844,
            "end_logit": 3.6187400817871094,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "dabigatran, was approved by FDA in October 2015.Idarucizumab",
            "probability": 0.05099254778074296,
            "start_logit": 3.3487839698791504,
            "end_logit": 3.6187400817871094,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "andexanet alfa and ciraparantag) are at various stages of clinical development. Idarucizumab",
            "probability": 0.04922010784682408,
            "start_logit": 3.5761287212371826,
            "end_logit": 3.35601806640625,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "andexanet alfa have been reported to produce anticoagulation reversal effects within minutes of administration. Idarucizumab",
            "probability": 0.04490596729313524,
            "start_logit": 3.3491110801696777,
            "end_logit": 3.4913041591644287,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "Idarucizumab has recently been approved in United States for dabigatran reversal, whereas andexanet alfa",
            "probability": 0.04366912723064176,
            "start_logit": 3.775869846343994,
            "end_logit": 3.036616086959839,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "andexanet alfa",
            "probability": 0.04331408754657547,
            "start_logit": 3.5761287212371826,
            "end_logit": 3.228193759918213,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "andexanet alfa is expected to get approved in the near future for reversal of oral factor Xa inhibitors.. Aripazine",
            "probability": 0.04250809798796416,
            "start_logit": 3.6919803619384766,
            "end_logit": 3.0935587882995605,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "Idarucizumab, a reversal agent for the oral direct thrombin inhibitor dabigatran",
            "probability": 0.034581612120935766,
            "start_logit": 3.856463670730591,
            "end_logit": 2.722702980041504,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "Idarucizumab and andexanet alfa",
            "probability": 0.031548564389124054,
            "start_logit": 3.9430503845214844,
            "end_logit": 2.5443222522735596,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "Aripazine",
            "probability": 0.024745111444140624,
            "start_logit": 3.150913715362549,
            "end_logit": 3.0935587882995605,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "Idarucizumab has recently been approved in United States for dabigatran",
            "probability": 0.024363756790616153,
            "start_logit": 3.775869846343994,
            "end_logit": 2.453071355819702,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "dabigatran",
            "probability": 0.020814344706421996,
            "start_logit": 3.3487839698791504,
            "end_logit": 2.722702980041504,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "dabigatran reversal, whereas andexanet alfa",
            "probability": 0.020419858370122917,
            "start_logit": 3.0157363414764404,
            "end_logit": 3.036616086959839,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "dabigatran, was approved by FDA in October 2015.Idarucizumab and andexanet alfa",
            "probability": 0.017413776931245618,
            "start_logit": 3.3487839698791504,
            "end_logit": 2.5443222522735596,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "Aripazine has shown promising results to reverse the effects of LMWH, fondaparinux",
            "probability": 0.007235745270397185,
            "start_logit": 3.150913715362549,
            "end_logit": 1.8639642000198364,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "fondaparinux",
            "probability": 0.0025183871761136384,
            "start_logit": 2.095499038696289,
            "end_logit": 1.8639642000198364,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "andexanet",
            "probability": 0.001567855820318048,
            "start_logit": 3.5761287212371826,
            "end_logit": -0.0905752032995224,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        }
    ],
    "5ace34eb0340b9f058000010": [
        {
            "text": "Keratin 14",
            "probability": 0.9133893024292117,
            "start_logit": 3.9849605560302734,
            "end_logit": 4.357717990875244,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Keratin 14 gene",
            "probability": 0.0334490660392095,
            "start_logit": 3.9849605560302734,
            "end_logit": 1.0505796670913696,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "14",
            "probability": 0.03258992978000328,
            "start_logit": 0.6518017053604126,
            "end_logit": 4.357717990875244,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratin 14",
            "probability": 0.010397896751847917,
            "start_logit": 1.7464112043380737,
            "end_logit": 2.120708703994751,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "14, for mutations in patients from 49 apparently independent kindreds using single-strand conformation polymorphism analysis. Keratin 14",
            "probability": 0.001983937332744706,
            "start_logit": -1.3726967573165894,
            "end_logit": 3.583296537399292,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratin 14In the first family, linkage was found to chromosome 17 markers flanking the keratin 14",
            "probability": 0.0019506864434778416,
            "start_logit": 1.3437384366989136,
            "end_logit": 0.8499592542648315,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "14 gene",
            "probability": 0.0011934699810095641,
            "start_logit": 0.6518017053604126,
            "end_logit": 1.0505796670913696,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Keratin 14 gene mutations",
            "probability": 0.0009795706294766261,
            "start_logit": 3.9849605560302734,
            "end_logit": -2.4800851345062256,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Keratin 14 gene point mutation in the K\u00f6bner and Dowling-Meara",
            "probability": 0.0009557477781912664,
            "start_logit": 2.880545139312744,
            "end_logit": -1.4002900123596191,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratin 14,",
            "probability": 0.000575156757892961,
            "start_logit": 1.7464112043380737,
            "end_logit": -0.7740074992179871,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "14 gene (D17S74: Z less than -2.0, theta = 0.14). Keratin 14",
            "probability": 0.0005745147058588353,
            "start_logit": -3.3864312171936035,
            "end_logit": 4.357717990875244,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Keratin 14 gene point mutation in the K\u00f6bner",
            "probability": 0.0005365476381115246,
            "start_logit": 2.880545139312744,
            "end_logit": -1.9776287078857422,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "K",
            "probability": 0.0004490962170462835,
            "start_logit": 3.9849605560302734,
            "end_logit": -3.259962320327759,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Keratin",
            "probability": 0.00039265250274499847,
            "start_logit": 3.9849605560302734,
            "end_logit": -3.3942744731903076,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "14In the first family, linkage was found to chromosome 17 markers flanking the keratin 14",
            "probability": 0.0002643796339685768,
            "start_logit": -0.6548120975494385,
            "end_logit": 0.8499592542648315,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Keratin 14 gene point mutation",
            "probability": 0.00013133660950611836,
            "start_logit": 2.880545139312744,
            "end_logit": -3.3850204944610596,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "14 gene point mutation in the K\u00f6bner and Dowling-Meara",
            "probability": 6.939829843963972e-05,
            "start_logit": 0.2579134404659271,
            "end_logit": -1.4002900123596191,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Dowling-Meara",
            "probability": 4.2668724952052875e-05,
            "start_logit": -0.2284826934337616,
            "end_logit": -1.4002900123596191,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "14 gene point mutation in the K\u00f6bner",
            "probability": 3.895953929101967e-05,
            "start_logit": 0.2579134404659271,
            "end_logit": -1.9776287078857422,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Dowling-Meara types of epidermolysis bullosa simplex as detected by the PASA",
            "probability": 3.568220701556505e-05,
            "start_logit": -0.2284826934337616,
            "end_logit": -1.5791040658950806,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        }
    ],
    "5aae6a86fcf456587200000e": [
        {
            "text": "UV-B",
            "probability": 0.10442045475070329,
            "start_logit": 4.7888054847717285,
            "end_logit": 3.9063186645507812,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-A",
            "probability": 0.09704106905919693,
            "start_logit": 4.8359761238098145,
            "end_logit": 3.7858567237854004,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-B, and UV-A",
            "probability": 0.09256986365779982,
            "start_logit": 4.7888054847717285,
            "end_logit": 3.7858567237854004,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "short-wave UVC",
            "probability": 0.0836164249313391,
            "start_logit": 4.503561019897461,
            "end_logit": 3.9693775177001953,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-C, UV-B",
            "probability": 0.08042866080311124,
            "start_logit": 4.527750492095947,
            "end_logit": 3.9063186645507812,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-C",
            "probability": 0.07517437345770499,
            "start_logit": 4.527750492095947,
            "end_logit": 3.8387584686279297,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-C, UV-B, and UV-A",
            "probability": 0.07130087857305842,
            "start_logit": 4.527750492095947,
            "end_logit": 3.7858567237854004,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "long-wave UVA (320-400 nm). short-wave UVC",
            "probability": 0.04900761259708557,
            "start_logit": 3.96929669380188,
            "end_logit": 3.9693775177001953,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "mid-wave UVB (280-320 nm), and long-wave UVA",
            "probability": 0.04153522080936164,
            "start_logit": 4.310335636138916,
            "end_logit": 3.462904691696167,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "short-wave UVC (200-280 nm), mid-wave UVB",
            "probability": 0.03702722934694927,
            "start_logit": 4.503561019897461,
            "end_logit": 3.1547911167144775,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "long-wave UVA",
            "probability": 0.03623581805343058,
            "start_logit": 4.173841953277588,
            "end_logit": 3.462904691696167,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "mid-wave UVB",
            "probability": 0.030521403345003386,
            "start_logit": 4.310335636138916,
            "end_logit": 3.1547911167144775,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "short-wave UVC (200-280 nm), mid-wave UVB (280-320 nm)",
            "probability": 0.029967010770987887,
            "start_logit": 4.503561019897461,
            "end_logit": 2.94323468208313,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "short-wave",
            "probability": 0.02908830775547092,
            "start_logit": 4.503561019897461,
            "end_logit": 2.9134738445281982,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "short-wave UVC (200-280 nm)",
            "probability": 0.028933387315996734,
            "start_logit": 4.503561019897461,
            "end_logit": 2.9081337451934814,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "mid-wave UVB (280-320 nm)",
            "probability": 0.024701692211835467,
            "start_logit": 4.310335636138916,
            "end_logit": 2.94323468208313,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "long-wave UVA (320-400 nm)",
            "probability": 0.023294276075753507,
            "start_logit": 3.96929669380188,
            "end_logit": 3.225609540939331,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "medium-wave UVB (280-320 nm), and long-wave UVA",
            "probability": 0.02211228805196487,
            "start_logit": 3.905200958251953,
            "end_logit": 3.23763108253479,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "medium-wave UVB (280-320 nm), and long-wave UVA (320-400 nm)",
            "probability": 0.021848055683755,
            "start_logit": 3.905200958251953,
            "end_logit": 3.225609540939331,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "mid-wave UVB (280-320 nm), and long-wave UVA (320- 400 nm)",
            "probability": 0.02117597274949118,
            "start_logit": 4.310335636138916,
            "end_logit": 2.7892301082611084,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        }
    ],
    "5aaef38dfcf456587200000f": [
        {
            "text": "heart failure, diabetes",
            "probability": 0.12877156851951488,
            "start_logit": 5.6401777267456055,
            "end_logit": 5.986551761627197,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "hypertension, heart failure, diabetes",
            "probability": 0.12033695822075811,
            "start_logit": 5.5724334716796875,
            "end_logit": 5.986551761627197,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "heart failure, diabetes, sleep apnoea, and obesity",
            "probability": 0.09545391190091022,
            "start_logit": 5.6401777267456055,
            "end_logit": 5.687155246734619,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "hypertension, heart failure, diabetes, sleep apnoea, and obesity",
            "probability": 0.08920162688464106,
            "start_logit": 5.5724334716796875,
            "end_logit": 5.687155246734619,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obesity",
            "probability": 0.0863995666082772,
            "start_logit": 5.5405168533325195,
            "end_logit": 5.687155246734619,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "sleep apnoea, and obesity",
            "probability": 0.07867591610306815,
            "start_logit": 5.446871280670166,
            "end_logit": 5.687155246734619,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "diabetes",
            "probability": 0.0713739931017657,
            "start_logit": 5.0500712394714355,
            "end_logit": 5.986551761627197,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "heart failure",
            "probability": 0.05404705222446514,
            "start_logit": 5.6401777267456055,
            "end_logit": 5.118366718292236,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "diabetes, sleep apnoea, and obesity",
            "probability": 0.05290707357128792,
            "start_logit": 5.0500712394714355,
            "end_logit": 5.687155246734619,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "hypertension, heart failure",
            "probability": 0.050506939849109284,
            "start_logit": 5.5724334716796875,
            "end_logit": 5.118366718292236,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "hypertension",
            "probability": 0.043927058625639066,
            "start_logit": 5.5724334716796875,
            "end_logit": 4.978786468505859,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "heart failure, diabetes, sleep apnoea",
            "probability": 0.0363525825654463,
            "start_logit": 5.6401777267456055,
            "end_logit": 4.721776962280273,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "hypertension, heart failure, diabetes, sleep apnoea",
            "probability": 0.0339714679233081,
            "start_logit": 5.5724334716796875,
            "end_logit": 4.721776962280273,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "sleep apnoea",
            "probability": 0.02996286562899512,
            "start_logit": 5.446871280670166,
            "end_logit": 4.721776962280273,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "diabetes, sleep apnoea",
            "probability": 0.020149082651457536,
            "start_logit": 5.0500712394714355,
            "end_logit": 4.721776962280273,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "heart failure, diabetes, sleep apnoea,",
            "probability": 0.0017922673671397211,
            "start_logit": 5.6401777267456055,
            "end_logit": 1.7119932174682617,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "hypertension, heart failure, diabetes, sleep apnoea,",
            "probability": 0.0016748728446779446,
            "start_logit": 5.5724334716796875,
            "end_logit": 1.7119932174682617,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "heart failure, diabetes,",
            "probability": 0.0015600707754706183,
            "start_logit": 5.6401777267456055,
            "end_logit": 1.5732429027557373,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "sleep apnoea,",
            "probability": 0.0014772393734657084,
            "start_logit": 5.446871280670166,
            "end_logit": 1.7119932174682617,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "hypertension, heart failure, diabetes,",
            "probability": 0.0014578852606022502,
            "start_logit": 5.5724334716796875,
            "end_logit": 1.5732429027557373,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        }
    ],
    "5abce6acfcf4565872000022": [
        {
            "text": "fluorouracil",
            "probability": 0.10691719149647932,
            "start_logit": 5.126193523406982,
            "end_logit": 4.561770915985107,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "amiodarone",
            "probability": 0.10399821647539685,
            "start_logit": 5.037182331085205,
            "end_logit": 4.623101234436035,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "amiodarone, and fluorouracil",
            "probability": 0.09781162463426332,
            "start_logit": 5.037182331085205,
            "end_logit": 4.561770915985107,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "omeprazole, lipid-lowering agents, amiodarone",
            "probability": 0.08390293987625128,
            "start_logit": 4.822469234466553,
            "end_logit": 4.623101234436035,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "omeprazole, lipid-lowering agents, amiodarone, and fluorouracil",
            "probability": 0.078911765403482,
            "start_logit": 4.822469234466553,
            "end_logit": 4.561770915985107,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "omeprazole",
            "probability": 0.07271446726438172,
            "start_logit": 4.822469234466553,
            "end_logit": 4.479980945587158,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "quinolones",
            "probability": 0.052977615200566555,
            "start_logit": 4.433422088623047,
            "end_logit": 4.552357196807861,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "macrolides, quinolones",
            "probability": 0.051978333989873386,
            "start_logit": 4.414379596710205,
            "end_logit": 4.552357196807861,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "macrolides",
            "probability": 0.04644786968549965,
            "start_logit": 4.414379596710205,
            "end_logit": 4.439860820770264,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "quinolones, nonsteroidal anti-inflammatory drugs, including selective cyclooxygenase-2 inhibitors",
            "probability": 0.0368009770807228,
            "start_logit": 4.433422088623047,
            "end_logit": 4.18801212310791,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "azole antibiotics, macrolides, quinolones",
            "probability": 0.03485067317881182,
            "start_logit": 4.014625072479248,
            "end_logit": 4.552357196807861,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "selective serotonin reuptake inhibitors, omeprazole, lipid-lowering agents, amiodarone",
            "probability": 0.03396549585214008,
            "start_logit": 3.918153762817383,
            "end_logit": 4.623101234436035,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "azole antibiotics, macrolides",
            "probability": 0.03114258195687377,
            "start_logit": 4.014625072479248,
            "end_logit": 4.439860820770264,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "selective serotonin reuptake inhibitors, omeprazole",
            "probability": 0.029436190673433185,
            "start_logit": 3.918153762817383,
            "end_logit": 4.479980945587158,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "omeprazole, lipid-lowering agents",
            "probability": 0.027553676576048704,
            "start_logit": 4.822469234466553,
            "end_logit": 3.5095765590667725,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "azole antibiotics",
            "probability": 0.024138375959476845,
            "start_logit": 4.014625072479248,
            "end_logit": 4.18508768081665,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "quinolones, nonsteroidal anti-inflammatory drugs",
            "probability": 0.023775031648182454,
            "start_logit": 4.433422088623047,
            "end_logit": 3.7511236667633057,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "macrolides, quinolones, nonsteroidal anti-inflammatory drugs",
            "probability": 0.02332657917783777,
            "start_logit": 4.414379596710205,
            "end_logit": 3.7511236667633057,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "selective serotonin reuptake inhibitors",
            "probability": 0.02286030537184871,
            "start_logit": 3.918153762817383,
            "end_logit": 4.227158069610596,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "nonsteroidal anti-inflammatory drugs, including selective cyclooxygenase-2 inhibitors",
            "probability": 0.016490088498429388,
            "start_logit": 3.630657196044922,
            "end_logit": 4.18801212310791,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        }
    ],
    "5ad303970340b9f05800001a": [
        {
            "text": "inflammatory",
            "probability": 0.7549704755174751,
            "start_logit": 5.0928826332092285,
            "end_logit": 4.699967861175537,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "inflammatory states",
            "probability": 0.19934485286632986,
            "start_logit": 5.0928826332092285,
            "end_logit": 3.3683254718780518,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "during inflammatory",
            "probability": 0.015637375075854776,
            "start_logit": 1.2158678770065308,
            "end_logit": 4.699967861175537,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "inflammation",
            "probability": 0.015580186167309435,
            "start_logit": 2.9743194580078125,
            "end_logit": 2.937852382659912,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "during inflammatory states",
            "probability": 0.0041289432299657265,
            "start_logit": 1.2158678770065308,
            "end_logit": 3.3683254718780518,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "inflammation, oxidative stress",
            "probability": 0.0026449817752357105,
            "start_logit": 2.9743194580078125,
            "end_logit": 1.164516568183899,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "inflammation, oxidative stress, hypoxia",
            "probability": 0.002553782303951645,
            "start_logit": 2.9743194580078125,
            "end_logit": 1.1294279098510742,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "hypoxia",
            "probability": 0.0010018878471171426,
            "start_logit": 2.0386300086975098,
            "end_logit": 1.1294279098510742,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "oxidative stress",
            "probability": 0.0006650907836614686,
            "start_logit": 1.5938235521316528,
            "end_logit": 1.164516568183899,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion",
            "probability": 0.0006578758435805984,
            "start_logit": 2.9743194580078125,
            "end_logit": -0.22688665986061096,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "oxidative stress, hypoxia",
            "probability": 0.0006421583277958985,
            "start_logit": 1.5938235521316528,
            "end_logit": 1.1294279098510742,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "inflammatory states.",
            "probability": 0.0005953014814576155,
            "start_logit": 5.0928826332092285,
            "end_logit": -2.4453980922698975,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "states",
            "probability": 0.0003307792278461561,
            "start_logit": -1.3084577322006226,
            "end_logit": 3.3683254718780518,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene activation",
            "probability": 0.0002718274444023437,
            "start_logit": 2.9743194580078125,
            "end_logit": -1.1107354164123535,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "hypoxia, telomere erosion",
            "probability": 0.00025809475285949035,
            "start_logit": 2.0386300086975098,
            "end_logit": -0.22688665986061096,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "anorexia",
            "probability": 0.0002007669209061702,
            "start_logit": 1.2201956510543823,
            "end_logit": 0.34036555886268616,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "increases during inflammatory",
            "probability": 0.0001752009237574456,
            "start_logit": -3.275617837905884,
            "end_logit": 4.699967861175537,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "oxidative stress, hypoxia, telomere erosion",
            "probability": 0.00016542539705022258,
            "start_logit": 1.5938235521316528,
            "end_logit": -0.22688665986061096,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "hypoxia, telomere erosion, and oncogene activation",
            "probability": 0.0001066420628877439,
            "start_logit": 2.0386300086975098,
            "end_logit": -1.1107354164123535,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "oxidative stress, hypoxia, telomere erosion, and oncogene activation",
            "probability": 6.835205055510742e-05,
            "start_logit": 1.5938235521316528,
            "end_logit": -1.1107354164123535,
            "question_text": "In what states are GDF15 expression increased?"
        }
    ],
    "5c34ad63da8336e21a000007": [
        {
            "text": "noncoding DNA",
            "probability": 0.40697123031119087,
            "start_logit": 1.5590896606445312,
            "end_logit": 1.6057676076889038,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "DNA",
            "probability": 0.4023069341510809,
            "start_logit": 1.5475624799728394,
            "end_logit": 1.6057676076889038,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916 has a marked preference for insertion into noncoding DNA",
            "probability": 0.13701235980430743,
            "start_logit": 0.4704183042049408,
            "end_logit": 1.6057676076889038,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916",
            "probability": 0.011712978334316325,
            "start_logit": 0.4704183042049408,
            "end_logit": -0.8536060452461243,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding",
            "probability": 0.005490233504208037,
            "start_logit": 1.5590896606445312,
            "end_logit": -2.7000041007995605,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding DNA for H. influenzae",
            "probability": 0.004588533931120042,
            "start_logit": 1.5590896606445312,
            "end_logit": -2.8794143199920654,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "DNA for H. influenzae",
            "probability": 0.004535944756256029,
            "start_logit": 1.5475624799728394,
            "end_logit": -2.8794143199920654,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertion into noncoding DNA",
            "probability": 0.004513181235313437,
            "start_logit": -2.942650556564331,
            "end_logit": 1.6057676076889038,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "DNA for H. influenzae, suggesting that this mobile element has evolved to minimize disruption of host cell function on integration.Preferential integration",
            "probability": 0.0035209347970720263,
            "start_logit": 1.5475624799728394,
            "end_logit": -3.132721185684204,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "non",
            "probability": 0.003418552907121539,
            "start_logit": 1.5590896606445312,
            "end_logit": -3.173757553100586,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding DNA for H. influenzae,",
            "probability": 0.002925546688921308,
            "start_logit": 1.5590896606445312,
            "end_logit": -3.329493522644043,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "DNA for H. influenzae,",
            "probability": 0.0028920170063024063,
            "start_logit": 1.5475624799728394,
            "end_logit": -3.329493522644043,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916 has a marked preference for insertion into noncoding",
            "probability": 0.0018483612409482164,
            "start_logit": 0.4704183042049408,
            "end_logit": -2.7000041007995605,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916 has a marked preference for insertion into noncoding DNA for H. influenzae",
            "probability": 0.001544791904489581,
            "start_logit": 0.4704183042049408,
            "end_logit": -2.8794143199920654,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "NA",
            "probability": 0.0011922956845834866,
            "start_logit": -4.273772239685059,
            "end_logit": 1.6057676076889038,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding D",
            "probability": 0.0011776226825301066,
            "start_logit": 1.5590896606445312,
            "end_logit": -4.239477157592773,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "D",
            "probability": 0.0011641259521789622,
            "start_logit": 1.5475624799728394,
            "end_logit": -4.239477157592773,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916 has a marked preference for insertion into non",
            "probability": 0.0011509019951175595,
            "start_logit": 0.4704183042049408,
            "end_logit": -3.173757553100586,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "These data support the hypothesis that Tn916 has a marked preference for insertion into noncoding DNA",
            "probability": 0.0010423490727000267,
            "start_logit": -4.408175945281982,
            "end_logit": 1.6057676076889038,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "DNA for H. influenzae, suggesting that this mobile element has evolved to minimize disruption of host cell function on integration.Preferential integration points",
            "probability": 0.0009911040402415556,
            "start_logit": 1.5475624799728394,
            "end_logit": -4.400383472442627,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        }
    ],
    "5c55de1607647bbc4b00000a": [
        {
            "text": "myelokathexis",
            "probability": 0.3189322844656135,
            "start_logit": 5.235040187835693,
            "end_logit": 5.24077844619751,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia, infections, and myelokathexis",
            "probability": 0.16460826080312346,
            "start_logit": 4.573629856109619,
            "end_logit": 5.24077844619751,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "warts, hypogammaglobulinemia, infections, and myelokathexis",
            "probability": 0.1277328146852826,
            "start_logit": 4.32000207901001,
            "end_logit": 5.24077844619751,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia",
            "probability": 0.08092687949015633,
            "start_logit": 4.573629856109619,
            "end_logit": 4.530755996704102,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "infections, and myelokathexis",
            "probability": 0.08018589266194799,
            "start_logit": 3.8544089794158936,
            "end_logit": 5.24077844619751,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "warts, hypogammaglobulinemia",
            "probability": 0.06279768737328272,
            "start_logit": 4.32000207901001,
            "end_logit": 4.530755996704102,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia, infections",
            "probability": 0.05773837044811635,
            "start_logit": 4.573629856109619,
            "end_logit": 4.193131923675537,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "warts, hypogammaglobulinemia, infections",
            "probability": 0.044803854537411515,
            "start_logit": 4.32000207901001,
            "end_logit": 4.193131923675537,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "warts",
            "probability": 0.03103157847868354,
            "start_logit": 4.32000207901001,
            "end_logit": 3.825843095779419,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "infections",
            "probability": 0.028126187304571743,
            "start_logit": 3.8544089794158936,
            "end_logit": 4.193131923675537,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia,",
            "probability": 0.0006568907689712319,
            "start_logit": 4.573629856109619,
            "end_logit": -0.2830275595188141,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia, infections,",
            "probability": 0.0006336033398179837,
            "start_logit": 4.573629856109619,
            "end_logit": -0.31912219524383545,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "warts, hypogammaglobulinemia,",
            "probability": 0.0005097344838715591,
            "start_logit": 4.32000207901001,
            "end_logit": -0.2830275595188141,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "warts, hypogammaglobulinemia, infections,",
            "probability": 0.0004916638909498213,
            "start_logit": 4.32000207901001,
            "end_logit": -0.31912219524383545,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "infections,",
            "probability": 0.0003086482364190834,
            "start_logit": 3.8544089794158936,
            "end_logit": -0.31912219524383545,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "warts,",
            "probability": 0.0002664281781713819,
            "start_logit": 4.32000207901001,
            "end_logit": -0.9318128228187561,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Myelokathexis",
            "probability": 7.956520259672518e-05,
            "start_logit": 1.189381718635559,
            "end_logit": 0.9902796745300293,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts, Hypogammaglobulinemia, Infections, Myelokathexis",
            "probability": 6.553200775314265e-05,
            "start_logit": 0.9953435659408569,
            "end_logit": 0.9902796745300293,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "myelokathexis, which refers to abnormal accumulation of mature neutrophils in the bone marrow.The Warts",
            "probability": 6.495049136577822e-05,
            "start_logit": 1.7734413146972656,
            "end_logit": 0.20326854288578033,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts, Hypogammaglobulinemia, Infections",
            "probability": 3.917315189343966e-05,
            "start_logit": 0.9953435659408569,
            "end_logit": 0.47573259472846985,
            "question_text": "List four features of the WHIM syndrome."
        }
    ],
    "5be47df8133db5eb78000019": [
        {
            "text": "Oscillospira and/or Ruminococcus",
            "probability": 0.32027569282798035,
            "start_logit": 6.310572147369385,
            "end_logit": 6.092548370361328,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Oscillospira",
            "probability": 0.30968247623316897,
            "start_logit": 6.310572147369385,
            "end_logit": 6.058913707733154,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Ruminococcus",
            "probability": 0.2677157345923469,
            "start_logit": 6.1313157081604,
            "end_logit": 6.092548370361328,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Ruminococcus and Oscillospira",
            "probability": 0.09781266087609236,
            "start_logit": 5.621845722198486,
            "end_logit": 5.595146656036377,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Oscillospira,",
            "probability": 0.0011015159156965145,
            "start_logit": 5.867697238922119,
            "end_logit": 0.8629284501075745,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Ruminococcus and Oscillospira,",
            "probability": 0.0008614276736999874,
            "start_logit": 5.621845722198486,
            "end_logit": 0.8629284501075745,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Oscillospira and/or Ruminococc",
            "probability": 0.000853655745044956,
            "start_logit": 6.310572147369385,
            "end_logit": 0.16513893008232117,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Ruminococc",
            "probability": 0.0007135635953379533,
            "start_logit": 6.1313157081604,
            "end_logit": 0.16513893008232117,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Oscillosp",
            "probability": 0.0001865335460876051,
            "start_logit": 6.310572147369385,
            "end_logit": -1.3557779788970947,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Oscillospira, which have been negatively associated with childhood atopy and obesity.",
            "probability": 0.00014980272898960359,
            "start_logit": 5.867697238922119,
            "end_logit": -1.1321948766708374,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Ruminococcus and Oscillospira, which have been negatively associated with childhood atopy and obesity.",
            "probability": 0.0001171514768952078,
            "start_logit": 5.621845722198486,
            "end_logit": -1.1321948766708374,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "O",
            "probability": 0.00011679031319015012,
            "start_logit": 6.310572147369385,
            "end_logit": -1.8240089416503906,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "uminococcus",
            "probability": 8.440524880477938e-05,
            "start_logit": -1.93073570728302,
            "end_logit": 6.092548370361328,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Oscillospira and/or R",
            "probability": 6.379312798681756e-05,
            "start_logit": 6.310572147369385,
            "end_logit": -2.428743600845337,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "R",
            "probability": 5.3324134498421846e-05,
            "start_logit": 6.1313157081604,
            "end_logit": -2.428743600845337,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Oscillospira and/or Ruminococcus (P\u2009<\u20090.05)",
            "probability": 5.262157910804251e-05,
            "start_logit": 6.310572147369385,
            "end_logit": -2.621262788772583,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Ruminococcus and Oscillosp",
            "probability": 4.440765364527378e-05,
            "start_logit": 5.621845722198486,
            "end_logit": -2.102250814437866,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Ruminococcus (P\u2009<\u20090.05)",
            "probability": 4.3985931563920885e-05,
            "start_logit": 6.1313157081604,
            "end_logit": -2.621262788772583,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Ruminococcus and O",
            "probability": 4.005159440155339e-05,
            "start_logit": 5.621845722198486,
            "end_logit": -2.2054941654205322,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "scillospira and/or Ruminococcus",
            "probability": 3.0405205460762445e-05,
            "start_logit": -2.951751470565796,
            "end_logit": 6.092548370361328,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        }
    ],
    "5ad4eddf133db5eb78000009": [
        {
            "text": "Protein-Protein Interaction Database",
            "probability": 0.13959732091538476,
            "start_logit": 1.9010964632034302,
            "end_logit": 0.8272334933280945,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "Protein-Protein Interaction Database for Maize.",
            "probability": 0.12909648996708187,
            "start_logit": 1.9010964632034302,
            "end_logit": 0.7490316033363342,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "PPIM: A Protein-Protein Interaction Database",
            "probability": 0.09021456402962306,
            "start_logit": 1.4645253419876099,
            "end_logit": 0.8272334933280945,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "PPIM",
            "probability": 0.08911591614928063,
            "start_logit": 1.4645253419876099,
            "end_logit": 0.8149805665016174,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "PPIM: A Protein-Protein Interaction Database for Maize.",
            "probability": 0.0834284174206625,
            "start_logit": 1.4645253419876099,
            "end_logit": 0.7490316033363342,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "Protein-Protein Interaction Database for Maize",
            "probability": 0.0726694150295396,
            "start_logit": 1.9010964632034302,
            "end_logit": 0.17439208924770355,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "Protein-Protein Interaction",
            "probability": 0.05275847999766873,
            "start_logit": 1.9010964632034302,
            "end_logit": -0.14580398797988892,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "PPIM: A Protein-Protein Interaction Database for Maize",
            "probability": 0.046962502949117454,
            "start_logit": 1.4645253419876099,
            "end_logit": 0.17439208924770355,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "Protein-Protein Interaction Database for Maize. experimentally validated human protein-protein interaction database, HPRD",
            "probability": 0.03449598499104566,
            "start_logit": 1.9010964632034302,
            "end_logit": -0.5706855654716492,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "PPIM: A Protein-Protein Interaction",
            "probability": 0.034095090368820455,
            "start_logit": 1.4645253419876099,
            "end_logit": -0.14580398797988892,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "HPRD (interactome) STRING Protein-Protein interaction database",
            "probability": 0.030491854036539767,
            "start_logit": 1.0715875625610352,
            "end_logit": 0.13543996214866638,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "Protein-Protein Interaction Database for Maize. experimentally validated human protein-protein interaction database",
            "probability": 0.02946445265595307,
            "start_logit": 1.9010964632034302,
            "end_logit": -0.7283439636230469,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "Protein-Protein Interaction Database for Maize. experimentally validated human protein-protein interaction database, HPRD (interactome)",
            "probability": 0.028440683265698583,
            "start_logit": 1.9010964632034302,
            "end_logit": -0.7637078762054443,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "HPRD (interactome) STRING Protein-Protein interaction databasehuman protein-protein interaction database HPRD DAPID",
            "probability": 0.024466990905172608,
            "start_logit": 1.0715875625610352,
            "end_logit": -0.08469470590353012,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "PPIM: A Protein-Protein Interaction Database for Maize. experimentally validated human protein-protein interaction database, HPRD",
            "probability": 0.022292979738672284,
            "start_logit": 1.4645253419876099,
            "end_logit": -0.5706855654716492,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "HPRD DAPID",
            "probability": 0.020271889460843195,
            "start_logit": 0.8834978342056274,
            "end_logit": -0.08469470590353012,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "PPIM: A Protein-Protein Interaction Database for Maize. experimentally validated human protein-protein interaction database",
            "probability": 0.019041359341985264,
            "start_logit": 1.4645253419876099,
            "end_logit": -0.7283439636230469,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "PPIM: A Protein-Protein Interaction Database for Maize. experimentally validated human protein-protein interaction database, HPRD (interactome)",
            "probability": 0.018379749874102534,
            "start_logit": 1.4645253419876099,
            "end_logit": -0.7637078762054443,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "Maize.",
            "probability": 0.01776059539545667,
            "start_logit": -0.08248138427734375,
            "end_logit": 0.7490316033363342,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "Protein-Protein Interaction Database for Maize. experimentally validated human protein-protein interaction database, HPRD (interactome",
            "probability": 0.016955263507351114,
            "start_logit": 1.9010964632034302,
            "end_logit": -1.2809501886367798,
            "question_text": "List the main PPI databases."
        }
    ],
    "5c5f03371a4c55d80b000009": [
        {
            "text": "Pcp1",
            "probability": 0.507312196623439,
            "start_logit": 3.645296573638916,
            "end_logit": 2.8671329021453857,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "PARL The newly identified Pcp1",
            "probability": 0.24349991790055792,
            "start_logit": 2.9112865924835205,
            "end_logit": 2.8671329021453857,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "PARL",
            "probability": 0.11795024126240605,
            "start_logit": 2.9112865924835205,
            "end_logit": 2.1422791481018066,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the rhomboid-GlpG",
            "probability": 0.04901423854692374,
            "start_logit": 3.645296573638916,
            "end_logit": 0.5301171541213989,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "PARL The newly identified Pcp1 protein belongs to the rhomboid-GlpG",
            "probability": 0.023525874484333003,
            "start_logit": 2.9112865924835205,
            "end_logit": 0.5301171541213989,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein",
            "probability": 0.018748506416802847,
            "start_logit": 3.645296573638916,
            "end_logit": -0.4308795928955078,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp",
            "probability": 0.01001130072741192,
            "start_logit": 3.645296573638916,
            "end_logit": -1.0582791566848755,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "PARL The newly identified Pcp1 protein",
            "probability": 0.008998915862135711,
            "start_logit": 2.9112865924835205,
            "end_logit": -0.4308795928955078,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "PARL The newly identified Pcp",
            "probability": 0.0048052282626511724,
            "start_logit": 2.9112865924835205,
            "end_logit": -1.0582791566848755,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "rhomboid protease PARL The newly identified Pcp1",
            "probability": 0.003522636259937549,
            "start_logit": -1.3246203660964966,
            "end_logit": 2.8671329021453857,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the rhomboid-GlpG superfamily",
            "probability": 0.0028599046847133107,
            "start_logit": 3.645296573638916,
            "end_logit": -2.3112053871154785,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "GlpG",
            "probability": 0.002035467879735506,
            "start_logit": 0.4639114439487457,
            "end_logit": 0.5301171541213989,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "rhomboid protease PARL",
            "probability": 0.001706348816548745,
            "start_logit": -1.3246203660964966,
            "end_logit": 2.1422791481018066,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "PARL The newly identified Pcp1 protein belongs to the rhomboid-GlpG superfamily",
            "probability": 0.0013726982330921893,
            "start_logit": 2.9112865924835205,
            "end_logit": -2.3112053871154785,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the rhomboid",
            "probability": 0.0009476035632450767,
            "start_logit": 3.645296573638916,
            "end_logit": -3.4158127307891846,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "P",
            "probability": 0.0008814105335776746,
            "start_logit": 3.645296573638916,
            "end_logit": -3.4882254600524902,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the rhomboid-G",
            "probability": 0.0007899846843563473,
            "start_logit": 3.645296573638916,
            "end_logit": -3.5977354049682617,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "1",
            "probability": 0.0007558808136904252,
            "start_logit": -2.863701581954956,
            "end_logit": 2.8671329021453857,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "PAR",
            "probability": 0.0006621308334671671,
            "start_logit": 2.9112865924835205,
            "end_logit": -3.040275812149048,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "cp1",
            "probability": 0.0005995136109747409,
            "start_logit": -3.0954666137695312,
            "end_logit": 2.8671329021453857,
            "question_text": "List intramembrane rhomboid peptidases"
        }
    ],
    "5c34a029da8336e21a000003": [
        {
            "text": "brain and kidney",
            "probability": 0.2057925921058587,
            "start_logit": 4.202753067016602,
            "end_logit": 4.393444061279297,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "kidney",
            "probability": 0.18617653822122998,
            "start_logit": 4.102579593658447,
            "end_logit": 4.393444061279297,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "brain and kidney are the most frequently affected organs. The heart",
            "probability": 0.11464486560633101,
            "start_logit": 4.202753067016602,
            "end_logit": 3.8084144592285156,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "kidney are the most frequently affected organs. The heart",
            "probability": 0.10371697049447494,
            "start_logit": 4.102579593658447,
            "end_logit": 3.8084144592285156,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "brain",
            "probability": 0.08073290506109462,
            "start_logit": 4.202753067016602,
            "end_logit": 3.457721471786499,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "heart",
            "probability": 0.060609922974689714,
            "start_logit": 3.5653724670410156,
            "end_logit": 3.8084144592285156,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "The heart",
            "probability": 0.05165524892506288,
            "start_logit": 3.405505657196045,
            "end_logit": 3.8084144592285156,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "brain and kidney are the most frequently affected organs. The heart is one of the most frequently affected organs in SLE. Any part of the heart",
            "probability": 0.04050485292804864,
            "start_logit": 4.202753067016602,
            "end_logit": 2.7679970264434814,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "kidney are the most frequently affected organs. The heart is one of the most frequently affected organs in SLE. Any part of the heart",
            "probability": 0.03664394924101575,
            "start_logit": 4.102579593658447,
            "end_logit": 2.7679970264434814,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "heart is one of the most frequently affected organs in SLE. Any part of the heart",
            "probability": 0.021413920310222694,
            "start_logit": 3.5653724670410156,
            "end_logit": 2.7679970264434814,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "The heart is one of the most frequently affected organs in SLE. Any part of the heart",
            "probability": 0.018250169770846435,
            "start_logit": 3.405505657196045,
            "end_logit": 2.7679970264434814,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "heart is one of the most frequently affected organs in SLE. Any part of the heart can be affected, including the pericardium",
            "probability": 0.012828162500501603,
            "start_logit": 3.5653724670410156,
            "end_logit": 2.255598783493042,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "The heart is one of the most frequently affected organs in SLE. Any part of the heart can be affected, including the pericardium",
            "probability": 0.010932895055670706,
            "start_logit": 3.405505657196045,
            "end_logit": 2.255598783493042,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "myocardium",
            "probability": 0.010343123320333164,
            "start_logit": 3.1754302978515625,
            "end_logit": 2.430219888687134,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "myocardium, coronary arteries",
            "probability": 0.010070959240236937,
            "start_logit": 3.1754302978515625,
            "end_logit": 2.4035539627075195,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "pericardium, myocardium",
            "probability": 0.008416409183759101,
            "start_logit": 2.9692916870117188,
            "end_logit": 2.430219888687134,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "pericardium, myocardium, coronary arteries",
            "probability": 0.008194943752837658,
            "start_logit": 2.9692916870117188,
            "end_logit": 2.4035539627075195,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "pericardium",
            "probability": 0.0070678912589861,
            "start_logit": 2.9692916870117188,
            "end_logit": 2.255598783493042,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "coronary arteries",
            "probability": 0.006586500779514907,
            "start_logit": 2.7507965564727783,
            "end_logit": 2.4035539627075195,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "myocardium, coronary arteries, valves",
            "probability": 0.005417179269284428,
            "start_logit": 3.1754302978515625,
            "end_logit": 1.783473253250122,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        }
    ],
    "5be94f3d133db5eb78000022": [
        {
            "text": "bladder cancer",
            "probability": 0.9289809962441314,
            "start_logit": 4.731545925140381,
            "end_logit": 4.775472164154053,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "Liver Cancer",
            "probability": 0.04223934496080593,
            "start_logit": 2.9599661827087402,
            "end_logit": 3.456315755844116,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast cancer",
            "probability": 0.022138910711912475,
            "start_logit": 2.8683745861053467,
            "end_logit": 2.9018919467926025,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "cancer",
            "probability": 0.0028582753541226452,
            "start_logit": -1.0523239374160767,
            "end_logit": 4.775472164154053,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "bladder",
            "probability": 0.0008763100621290341,
            "start_logit": 4.731545925140381,
            "end_logit": -2.1906514167785645,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast cancer.",
            "probability": 0.0006733698210435805,
            "start_logit": 2.8683745861053467,
            "end_logit": -0.5909053683280945,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "bladder cancer with intravesically delivered small activating RNA (saRNA) in an orthotopic xenograft mouse bladder tumor",
            "probability": 0.0006416881048640688,
            "start_logit": 4.731545925140381,
            "end_logit": -2.5022690296173096,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "bladder tumor model. Treatment of Liver Cancer",
            "probability": 0.0005016573431994312,
            "start_logit": -1.4732239246368408,
            "end_logit": 3.456315755844116,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "Liver Cancer by C/EBPA saRNA.In preclinical models of liver disease",
            "probability": 0.00040511462040152945,
            "start_logit": 2.9599661827087402,
            "end_logit": -1.1906216144561768,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "Cancer",
            "probability": 0.0003141013379259257,
            "start_logit": -1.9414255619049072,
            "end_logit": 3.456315755844116,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "Treatment of Liver Cancer",
            "probability": 7.311635892465181e-05,
            "start_logit": -3.3990890979766846,
            "end_logit": 3.456315755844116,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "Liver Cancer by C/EBPA saRNA.In preclinical models of liver disease,",
            "probability": 4.880705837073547e-05,
            "start_logit": 2.9599661827087402,
            "end_logit": -3.3069167137145996,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "Liver",
            "probability": 4.5384434573087955e-05,
            "start_logit": 2.9599661827087402,
            "end_logit": -3.379622459411621,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "Liver Cancer by C/EBPA saRNA.",
            "probability": 4.3833190997210905e-05,
            "start_logit": 2.9599661827087402,
            "end_logit": -3.414400339126587,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "advanced HCC",
            "probability": 3.18198541288187e-05,
            "start_logit": -1.5555012226104736,
            "end_logit": 0.7807661890983582,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast cancer.Upon saRNA treatment,",
            "probability": 3.1667680426008126e-05,
            "start_logit": 2.8683745861053467,
            "end_logit": -3.6479034423828125,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "Liver Cancer by C/EBPA saRNA",
            "probability": 2.7728195500398645e-05,
            "start_logit": 2.9599661827087402,
            "end_logit": -3.8723418712615967,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "HCC",
            "probability": 2.4210393932560953e-05,
            "start_logit": -1.8288096189498901,
            "end_logit": 0.7807661890983582,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast",
            "probability": 2.3731391108098826e-05,
            "start_logit": 2.8683745861053467,
            "end_logit": -3.9364013671875,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": ". Treatment of Liver Cancer",
            "probability": 1.9932881502306274e-05,
            "start_logit": -4.698770523071289,
            "end_logit": 3.456315755844116,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        }
    ],
    "5c34a761da8336e21a000005": [
        {
            "text": "estrogen",
            "probability": 0.3218447255393155,
            "start_logit": 2.5960144996643066,
            "end_logit": 1.087935447692871,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen metabolism",
            "probability": 0.23798798823833467,
            "start_logit": 2.5960144996643066,
            "end_logit": 0.7860864400863647,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen receptor beta (ESR2), and aromatase",
            "probability": 0.09317765046588777,
            "start_logit": 2.017432451248169,
            "end_logit": 0.4269561767578125,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen receptor alpha (ESR1), estrogen receptor beta (ESR2), and aromatase",
            "probability": 0.06284322545994211,
            "start_logit": 1.6235677003860474,
            "end_logit": 0.4269561767578125,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen receptor beta",
            "probability": 0.055622932670787585,
            "start_logit": 2.017432451248169,
            "end_logit": -0.08895613998174667,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "aromatase",
            "probability": 0.05140753646963384,
            "start_logit": 1.422709345817566,
            "end_logit": 0.4269561767578125,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen receptor alpha (ESR1), estrogen receptor beta",
            "probability": 0.03751462374395448,
            "start_logit": 1.6235677003860474,
            "end_logit": -0.08895613998174667,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen metabolic pathway genes, including estrogen receptor alpha (ESR1), estrogen receptor beta",
            "probability": 0.026883689357665067,
            "start_logit": 1.2903566360473633,
            "end_logit": -0.08895613998174667,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "xenobiotic metabolic pathway involved in estrogen",
            "probability": 0.023977120213649686,
            "start_logit": -0.0009546595392748713,
            "end_logit": 1.087935447692871,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 0.017729874534476844,
            "start_logit": -0.0009546595392748713,
            "end_logit": 0.7860864400863647,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen receptor alpha",
            "probability": 0.012250936464664191,
            "start_logit": 1.6235677003860474,
            "end_logit": -1.2080845832824707,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "est",
            "probability": 0.010287508297900849,
            "start_logit": 2.5960144996643066,
            "end_logit": -2.35520339012146,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen metabolic pathway genes, including estrogen receptor alpha",
            "probability": 0.008779252925590087,
            "start_logit": 1.2903566360473633,
            "end_logit": -1.2080845832824707,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "unsaturated fatty acid",
            "probability": 0.007708595519428888,
            "start_logit": 0.45323365926742554,
            "end_logit": -0.5010169148445129,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "unsaturated fatty acid and amino acid",
            "probability": 0.006917377695760483,
            "start_logit": 0.45323365926742554,
            "end_logit": -0.6093161702156067,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "amino acid",
            "probability": 0.0058005517268212,
            "start_logit": 0.2771499454975128,
            "end_logit": -0.6093161702156067,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "glycosphingolipid metabolismgenetic polymorphisms of the xenobiotic metabolic pathway involved in estrogen",
            "probability": 0.005751449419949212,
            "start_logit": -1.4286028146743774,
            "end_logit": 1.087935447692871,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen receptor",
            "probability": 0.005531416188626557,
            "start_logit": 2.017432451248169,
            "end_logit": -2.3971078395843506,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "glycosphingolipid metabolismgenetic polymorphisms of the xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 0.004252907592674048,
            "start_logit": -1.4286028146743774,
            "end_logit": 0.7860864400863647,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "estrogen receptor alpha (ESR1), estrogen receptor",
            "probability": 0.003730637474937113,
            "start_logit": 1.6235677003860474,
            "end_logit": -2.3971078395843506,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        }
    ],
    "5be44d8b133db5eb78000015": [
        {
            "text": "Pseudomonas",
            "probability": 0.1795254316740543,
            "start_logit": 6.015446186065674,
            "end_logit": 5.786624431610107,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus",
            "probability": 0.17454548968480446,
            "start_logit": 5.823745250701904,
            "end_logit": 5.950193881988525,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus",
            "probability": 0.16577993751533618,
            "start_logit": 5.772221088409424,
            "end_logit": 5.950193881988525,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, and Pseudomonas",
            "probability": 0.1482078889407531,
            "start_logit": 5.823745250701904,
            "end_logit": 5.786624431610107,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus, and Pseudomonas",
            "probability": 0.14076499262310604,
            "start_logit": 5.772221088409424,
            "end_logit": 5.786624431610107,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus",
            "probability": 0.13781360603165752,
            "start_logit": 5.772221088409424,
            "end_logit": 5.765434741973877,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Pseudomonas genera.",
            "probability": 0.013079287401278882,
            "start_logit": 6.015446186065674,
            "end_logit": 3.167337417602539,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, and Pseudomonas genera.",
            "probability": 0.010797654441028617,
            "start_logit": 5.823745250701904,
            "end_logit": 3.167337417602539,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus, and Pseudomonas genera.",
            "probability": 0.010255403802059703,
            "start_logit": 5.772221088409424,
            "end_logit": 3.167337417602539,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Pseudomonas genera",
            "probability": 0.004588704225024868,
            "start_logit": 6.015446186065674,
            "end_logit": 2.1199052333831787,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, and Pseudomonas genera",
            "probability": 0.003788221868193053,
            "start_logit": 5.823745250701904,
            "end_logit": 2.1199052333831787,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus, and Pseudomonas genera",
            "probability": 0.0035979800207804947,
            "start_logit": 5.772221088409424,
            "end_logit": 2.1199052333831787,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Pseudomona",
            "probability": 0.0012276272896752183,
            "start_logit": 6.015446186065674,
            "end_logit": 0.8013908267021179,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococ",
            "probability": 0.0010393981388993302,
            "start_logit": 5.823745250701904,
            "end_logit": 0.8266503214836121,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, and Pseudomona",
            "probability": 0.0010134722825184982,
            "start_logit": 5.823745250701904,
            "end_logit": 0.8013908267021179,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococ",
            "probability": 0.000987200292780116,
            "start_logit": 5.772221088409424,
            "end_logit": 0.8266503214836121,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus, and Pseudomona",
            "probability": 0.0009625764147377371,
            "start_logit": 5.772221088409424,
            "end_logit": 0.8013908267021179,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococ",
            "probability": 0.0007785502186465343,
            "start_logit": 5.772221088409424,
            "end_logit": 0.5892108678817749,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus,",
            "probability": 0.0006393422266156392,
            "start_logit": 5.823745250701904,
            "end_logit": 0.34069308638572693,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus,",
            "probability": 0.0006072349080497829,
            "start_logit": 5.772221088409424,
            "end_logit": 0.34069308638572693,
            "question_text": "What are the 3 main bacteria found in human milk?"
        }
    ],
    "5be2a070133db5eb78000013": [
        {
            "text": "adipose",
            "probability": 0.4837942827049184,
            "start_logit": 5.208754062652588,
            "end_logit": 3.46100115776062,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "adipose tissue",
            "probability": 0.39252091144094176,
            "start_logit": 5.208754062652588,
            "end_logit": 3.2519311904907227,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "female adipose",
            "probability": 0.04169503461693921,
            "start_logit": 2.757476329803467,
            "end_logit": 3.46100115776062,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "female adipose tissue",
            "probability": 0.033828785447604905,
            "start_logit": 2.757476329803467,
            "end_logit": 3.2519311904907227,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "XX femalesX-chromosome inactive specific transcript (Xist) was expressed only in female adipose",
            "probability": 0.0067218066568402145,
            "start_logit": 0.9324512481689453,
            "end_logit": 3.46100115776062,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "kidney and brain",
            "probability": 0.005933481382060973,
            "start_logit": 2.2560606002807617,
            "end_logit": 2.012645959854126,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "XX femalesX-chromosome inactive specific transcript (Xist) was expressed only in female adipose tissue",
            "probability": 0.0054536603052045265,
            "start_logit": 0.9324512481689453,
            "end_logit": 3.2519311904907227,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "liver, kidney and brain",
            "probability": 0.005417799400697513,
            "start_logit": 2.1651391983032227,
            "end_logit": 2.012645959854126,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "brain",
            "probability": 0.005209398398102544,
            "start_logit": 2.1259138584136963,
            "end_logit": 2.012645959854126,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "kidney",
            "probability": 0.004674150076222501,
            "start_logit": 2.2560606002807617,
            "end_logit": 1.7740821838378906,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "liver, kidney",
            "probability": 0.004267917239664859,
            "start_logit": 2.1651391983032227,
            "end_logit": 1.7740821838378906,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "liver",
            "probability": 0.0030627810275997026,
            "start_logit": 2.1651391983032227,
            "end_logit": 1.442279577255249,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "female",
            "probability": 0.0016833657617398494,
            "start_logit": 2.757476329803467,
            "end_logit": 0.25141432881355286,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "only in female adipose",
            "probability": 0.001655870286857713,
            "start_logit": -0.4685789942741394,
            "end_logit": 3.46100115776062,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "only in female adipose tissue",
            "probability": 0.0013434712592951348,
            "start_logit": -0.4685789942741394,
            "end_logit": 3.2519311904907227,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "ad",
            "probability": 0.0010245294390858143,
            "start_logit": 5.208754062652588,
            "end_logit": -2.696425199508667,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "kidney and brain tissue",
            "probability": 0.0004603422674981053,
            "start_logit": 2.2560606002807617,
            "end_logit": -0.5437501668930054,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "duodenum",
            "probability": 0.0004279134798747964,
            "start_logit": 1.069730520248413,
            "end_logit": 0.5695306658744812,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "liver, kidney and brain tissue",
            "probability": 0.00042033367939896905,
            "start_logit": 2.1651391983032227,
            "end_logit": -0.5437501668930054,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "brain tissue",
            "probability": 0.00040416512945230635,
            "start_logit": 2.1259138584136963,
            "end_logit": -0.5437501668930054,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        }
    ],
    "5c0e82b2133db5eb7800002d": [
        {
            "text": "CLEC11A",
            "probability": 0.6274396823152627,
            "start_logit": 5.028304576873779,
            "end_logit": 4.104373455047607,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CCL2, TNF, CCL27 and other pro-inflammatory factors including a novel SASP component CLEC11A",
            "probability": 0.09355579715035074,
            "start_logit": 3.1252150535583496,
            "end_logit": 4.104373455047607,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CCL27 and other pro-inflammatory factors including a novel SASP component CLEC11A",
            "probability": 0.0668437324397825,
            "start_logit": 2.7890145778656006,
            "end_logit": 4.104373455047607,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "TNF, CCL27 and other pro-inflammatory factors including a novel SASP component CLEC11A",
            "probability": 0.03059190318584123,
            "start_logit": 2.007392406463623,
            "end_logit": 4.104373455047607,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CXCL8, CCL2",
            "probability": 0.02029552760315875,
            "start_logit": 3.1860647201538086,
            "end_logit": 2.515366315841675,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CXCL8, CCL2, TNF, CCL27",
            "probability": 0.01948825872880454,
            "start_logit": 3.1860647201538086,
            "end_logit": 2.474777936935425,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CCL2",
            "probability": 0.01909737479014646,
            "start_logit": 3.1252150535583496,
            "end_logit": 2.515366315841675,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CCL2, TNF, CCL27",
            "probability": 0.018337763286005882,
            "start_logit": 3.1252150535583496,
            "end_logit": 2.474777936935425,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CXCL8",
            "probability": 0.017407384384151875,
            "start_logit": 3.1860647201538086,
            "end_logit": 2.3618602752685547,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CCL27",
            "probability": 0.01310196246485885,
            "start_logit": 2.7890145778656006,
            "end_logit": 2.474777936935425,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "IL1B, CXCL8, CCL2",
            "probability": 0.010294268948247408,
            "start_logit": 2.507251501083374,
            "end_logit": 2.515366315841675,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "IL1B, CXCL8, CCL2, TNF, CCL27",
            "probability": 0.00988480716589602,
            "start_logit": 2.507251501083374,
            "end_logit": 2.474777936935425,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CXCL8, CCL2, TNF",
            "probability": 0.009109707337466293,
            "start_logit": 3.1860647201538086,
            "end_logit": 1.714306354522705,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "IL1B, CXCL8",
            "probability": 0.008829349009290688,
            "start_logit": 2.507251501083374,
            "end_logit": 2.3618602752685547,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CCL2, TNF",
            "probability": 0.008571912918640482,
            "start_logit": 3.1252150535583496,
            "end_logit": 1.714306354522705,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CLEC11A.Senescent cells secrete cytokines",
            "probability": 0.008562952389844747,
            "start_logit": 5.028304576873779,
            "end_logit": -0.1898290514945984,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "TNF, CCL27",
            "probability": 0.00599628346054088,
            "start_logit": 2.007392406463623,
            "end_logit": 2.474777936935425,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "IL1B, CXCL8, CCL2, TNF",
            "probability": 0.004620612935290506,
            "start_logit": 2.507251501083374,
            "end_logit": 1.714306354522705,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "IL1B",
            "probability": 0.004213577573075502,
            "start_logit": 2.507251501083374,
            "end_logit": 1.6220910549163818,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "SASP component CLEC11A",
            "probability": 0.0037571419133437004,
            "start_logit": -0.08968442678451538,
            "end_logit": 4.104373455047607,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        }
    ],
    "5c61cdd7e842deac67000004": [
        {
            "text": "rilpivirine",
            "probability": 0.4969085692469474,
            "start_logit": 5.333297252655029,
            "end_logit": 5.399384021759033,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "Dolutegravir/rilpivirine",
            "probability": 0.2481486953974051,
            "start_logit": 4.638919353485107,
            "end_logit": 5.399384021759033,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "Dolutegravir",
            "probability": 0.24675636325247563,
            "start_logit": 4.638919353485107,
            "end_logit": 5.393757343292236,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "virine",
            "probability": 0.0018122788810074123,
            "start_logit": -0.2805236876010895,
            "end_logit": 5.399384021759033,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "rilpivir",
            "probability": 0.0012858696920738197,
            "start_logit": 5.333297252655029,
            "end_logit": -0.5575867295265198,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "vir/rilpivirine",
            "probability": 0.0010685121909386227,
            "start_logit": -0.8088415861129761,
            "end_logit": 5.399384021759033,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "vir",
            "probability": 0.0010625168990096834,
            "start_logit": -0.8088415861129761,
            "end_logit": 5.393757343292236,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "/rilpivirine",
            "probability": 0.0006595105505896386,
            "start_logit": -1.2913661003112793,
            "end_logit": 5.399384021759033,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "Dolutegravir/rilpivir",
            "probability": 0.000642144060873713,
            "start_logit": 4.638919353485107,
            "end_logit": -0.5575867295265198,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "ine",
            "probability": 0.00028499714086752717,
            "start_logit": -2.130384922027588,
            "end_logit": 5.399384021759033,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "rilpivirine (Juluca\u00ae) is the first two-drug single-tablet",
            "probability": 0.0002566763658658478,
            "start_logit": 5.333297252655029,
            "end_logit": -2.1689612865448,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "rilpivirine (Juluca\u00ae)",
            "probability": 0.00023901674871308395,
            "start_logit": 5.333297252655029,
            "end_logit": -2.240243673324585,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "r",
            "probability": 0.00013325144111497802,
            "start_logit": 5.333297252655029,
            "end_logit": -2.8245394229888916,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "rilpivirine (Juluca\u00ae",
            "probability": 0.00012838249654125111,
            "start_logit": 5.333297252655029,
            "end_logit": -2.8617632389068604,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "Dolutegravir/rilpivirine (Juluca\u00ae) is the first two-drug single-tablet",
            "probability": 0.00012818033189784537,
            "start_logit": 4.638919353485107,
            "end_logit": -2.1689612865448,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "Dolutegravir/rilpivirine (Juluca\u00ae)",
            "probability": 0.00011936138364682782,
            "start_logit": 4.638919353485107,
            "end_logit": -2.240243673324585,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "egravir/rilpivirine",
            "probability": 9.977143150154626e-05,
            "start_logit": -3.1799821853637695,
            "end_logit": 5.399384021759033,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "egravir",
            "probability": 9.921162613564353e-05,
            "start_logit": -3.1799821853637695,
            "end_logit": 5.393757343292236,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "rilpivirine (Juluca\u00ae) is the first two-drug single-tablet regimen",
            "probability": 9.084718900424209e-05,
            "start_logit": 5.333297252655029,
            "end_logit": -3.2075984477996826,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "Do",
            "probability": 7.584367339034344e-05,
            "start_logit": 4.638919353485107,
            "end_logit": -2.693725109100342,
            "question_text": "List two medication included in the Juluca pill."
        }
    ],
    "5c61f379e842deac67000006": [
        {
            "text": "c.1482delinsGCCAGG",
            "probability": 0.32751122747614714,
            "start_logit": 1.3799669742584229,
            "end_logit": 0.2395782470703125,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23)",
            "probability": 0.2184725147728382,
            "start_logit": 1.3799669742584229,
            "end_logit": -0.16528387367725372,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.12203285083391154,
            "start_logit": 0.39273491501808167,
            "end_logit": 0.2395782470703125,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG",
            "probability": 0.10482321006279102,
            "start_logit": 0.24071985483169556,
            "end_logit": 0.2395782470703125,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG (p.Ile494MetfsTer23)",
            "probability": 0.0699242907959463,
            "start_logit": 0.24071985483169556,
            "end_logit": -0.16528387367725372,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter)",
            "probability": 0.02660991995290963,
            "start_logit": 0.39273491501808167,
            "end_logit": -1.2834279537200928,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.026071136099976525,
            "start_logit": -1.150726556777954,
            "end_logit": 0.2395782470703125,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T",
            "probability": 0.02418586156596367,
            "start_logit": 0.39273491501808167,
            "end_logit": -1.3789438009262085,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1516C>T (p.Arg506Ter)",
            "probability": 0.016914885027715126,
            "start_logit": -0.25991150736808777,
            "end_logit": -1.083871603012085,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1516C>T",
            "probability": 0.010041274287867052,
            "start_logit": -0.25991150736808777,
            "end_logit": -1.6053615808486938,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23",
            "probability": 0.008649908461284841,
            "start_logit": 1.3799669742584229,
            "end_logit": -3.394395351409912,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1516C>T (p.Arg506Ter)",
            "probability": 0.006321312494344189,
            "start_logit": -1.2441786527633667,
            "end_logit": -1.083871603012085,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23).",
            "probability": 0.0057740304646884885,
            "start_logit": 1.3799669742584229,
            "end_logit": -3.7985737323760986,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1558C>T (p.Gln520Ter)",
            "probability": 0.005684951551660402,
            "start_logit": -1.150726556777954,
            "end_logit": -1.2834279537200928,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482",
            "probability": 0.005204551767398295,
            "start_logit": 1.3799669742584229,
            "end_logit": -3.9024105072021484,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1558C>T",
            "probability": 0.005167074966064848,
            "start_logit": -1.150726556777954,
            "end_logit": -1.3789438009262085,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1516C>T (p.Arg506Ter), which occurs in three unrelated individuals, c.1558C>T",
            "probability": 0.0047060770450702075,
            "start_logit": -1.2441786527633667,
            "end_logit": -1.3789438009262085,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1516C>T (p.Arg506Ter),",
            "probability": 0.004429977925131783,
            "start_logit": -0.25991150736808777,
            "end_logit": -2.423671007156372,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1516C>T",
            "probability": 0.003752554777110724,
            "start_logit": -1.2441786527633667,
            "end_logit": -1.6053615808486938,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter),",
            "probability": 0.0037223896711798977,
            "start_logit": 0.39273491501808167,
            "end_logit": -3.2503461837768555,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        }
    ],
    "5c72d4c77c78d6947100007c": [
        {
            "text": "Nup60",
            "probability": 0.3592431964006649,
            "start_logit": 4.671620845794678,
            "end_logit": 4.542113780975342,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup1 and Nup60",
            "probability": 0.35823838510076267,
            "start_logit": 4.668819904327393,
            "end_logit": 4.542113780975342,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup1",
            "probability": 0.19095795274889973,
            "start_logit": 4.668819904327393,
            "end_logit": 3.912968397140503,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "NPC basket proteins Nup1 and Nup60",
            "probability": 0.03625178685323938,
            "start_logit": 2.378109931945801,
            "end_logit": 4.542113780975342,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "NPC basket proteins Nup1",
            "probability": 0.0193239119226069,
            "start_logit": 2.378109931945801,
            "end_logit": 3.912968397140503,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup153",
            "probability": 0.017786770025696712,
            "start_logit": 3.368903160095215,
            "end_logit": 2.8392868041992188,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup",
            "probability": 0.0047047156168288475,
            "start_logit": 4.668819904327393,
            "end_logit": 0.20948046445846558,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup133",
            "probability": 0.002595120809681057,
            "start_logit": 2.4919261932373047,
            "end_logit": 1.7914419174194336,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "nucleoporin Nup153",
            "probability": 0.002348121488570409,
            "start_logit": 1.3440638780593872,
            "end_logit": 2.8392868041992188,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "NUP153",
            "probability": 0.0018456483762842586,
            "start_logit": 2.4003021717071533,
            "end_logit": 1.5422635078430176,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup60 and Mlp1",
            "probability": 0.001087398900356561,
            "start_logit": 2.3313021659851074,
            "end_logit": 1.0822213888168335,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Ulp1 and nuclear basket components Nup60",
            "probability": 0.0009295014753006079,
            "start_logit": 1.3218461275100708,
            "end_logit": 1.9347820281982422,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "NUP153 and TPR, but is independent of transcription. In esc1Delta cells, Ulp1",
            "probability": 0.0008571100713454578,
            "start_logit": 2.4003021717071533,
            "end_logit": 0.7752439379692078,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "NPC",
            "probability": 0.0007878988050166344,
            "start_logit": 2.378109931945801,
            "end_logit": 0.7132394909858704,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "NUP153 and TPR",
            "probability": 0.0006551876333961604,
            "start_logit": 2.4003021717071533,
            "end_logit": 0.5065992474555969,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Mlp1",
            "probability": 0.000566948390702097,
            "start_logit": 1.680026650428772,
            "end_logit": 1.0822213888168335,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "TPR, but is independent of transcription. In esc1Delta cells, Ulp1 and nuclear basket components Nup60",
            "probability": 0.0004921021834803217,
            "start_logit": 0.6858841180801392,
            "end_logit": 1.9347820281982422,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "NPC basket proteins Nup",
            "probability": 0.00047609177251738046,
            "start_logit": 2.378109931945801,
            "end_logit": 0.20948046445846558,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup1 and Nup",
            "probability": 0.0004558846114904246,
            "start_logit": 4.668819904327393,
            "end_logit": -2.124600410461426,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Ulp1 and nuclear basket components Nup60 and Mlp1",
            "probability": 0.0003962668131591564,
            "start_logit": 1.3218461275100708,
            "end_logit": 1.0822213888168335,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        }
    ],
    "5c641179e842deac67000012": [
        {
            "text": "increases nuclear height and impairs nuclear re-orientation",
            "probability": 0.14104089912452505,
            "start_logit": 5.823235511779785,
            "end_logit": 6.061136722564697,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "increases nuclear height and impairs nuclear re-orientation.Finally, STEF depletion decreases nuclear stiffness",
            "probability": 0.12131348180761786,
            "start_logit": 5.823235511779785,
            "end_logit": 5.910464763641357,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "increases nuclear height",
            "probability": 0.1062809607109538,
            "start_logit": 5.823235511779785,
            "end_logit": 5.778172969818115,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "decreases nuclear stiffness",
            "probability": 0.09478149535956486,
            "start_logit": 5.576431751251221,
            "end_logit": 5.910464763641357,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "impairs nuclear re-orientation",
            "probability": 0.07408622571480492,
            "start_logit": 5.179415225982666,
            "end_logit": 6.061136722564697,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "impairs nuclear re-orientation.Finally, STEF depletion decreases nuclear stiffness",
            "probability": 0.06372377126944469,
            "start_logit": 5.179415225982666,
            "end_logit": 5.910464763641357,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "decreases nuclear stiffness and reduces expression of TAZ-regulated genes",
            "probability": 0.04963164910560416,
            "start_logit": 5.576431751251221,
            "end_logit": 5.263519287109375,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "reduces apical perinuclear actin cables",
            "probability": 0.043978417359904085,
            "start_logit": 4.998410701751709,
            "end_logit": 5.720610618591309,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "nuclear stiffness",
            "probability": 0.040663516457934215,
            "start_logit": 4.730188846588135,
            "end_logit": 5.910464763641357,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "drastically reduced dbcAMP-induced neurite outgrowth",
            "probability": 0.039736001504490255,
            "start_logit": 4.845952987670898,
            "end_logit": 5.771626949310303,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "impairs nuclear re-orientation.Finally, STEF depletion decreases nuclear stiffness and reduces expression of TAZ-regulated genes",
            "probability": 0.033368495014060716,
            "start_logit": 5.179415225982666,
            "end_logit": 5.263519287109375,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "neurite outgrowth",
            "probability": 0.02686395099210009,
            "start_logit": 4.4544806480407715,
            "end_logit": 5.771626949310303,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "reduces expression of TAZ-regulated genes",
            "probability": 0.02677233865180652,
            "start_logit": 4.880740642547607,
            "end_logit": 5.3419508934021,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "nuclear height and impairs nuclear re-orientation",
            "probability": 0.024645682377892456,
            "start_logit": 4.1624369621276855,
            "end_logit": 5.977487087249756,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "reduced dbcAMP-induced neurite outgrowth",
            "probability": 0.022007659968098055,
            "start_logit": 4.2550859451293945,
            "end_logit": 5.771626949310303,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "nuclear stiffness and reduces expression of TAZ-regulated genes",
            "probability": 0.021293158253980687,
            "start_logit": 4.730188846588135,
            "end_logit": 5.263519287109375,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "nuclear height",
            "probability": 0.01856222707142431,
            "start_logit": 4.1624369621276855,
            "end_logit": 5.694014072418213,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "nuclear height and impairs nuclear re-orientation.Finally, STEF depletion decreases nuclear stiffness",
            "probability": 0.018001854127590252,
            "start_logit": 3.915332317352295,
            "end_logit": 5.910464763641357,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "nuclear re-orientation",
            "probability": 0.017817039742975216,
            "start_logit": 3.8379905223846436,
            "end_logit": 5.977487087249756,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "disruption of the actin cap.STEF depletion drastically reduced dbcAMP-induced neurite outgrowth",
            "probability": 0.015431175385227572,
            "start_logit": 3.900085210800171,
            "end_logit": 5.771626949310303,
            "question_text": "What are the effects of STEF depletion?"
        }
    ],
    "5c53131e7e3cb0e231000012": [
        {
            "text": "Coryza",
            "probability": 0.161099521610772,
            "start_logit": 3.1933388710021973,
            "end_logit": 3.280472755432129,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Coryza, conjunctivitis",
            "probability": 0.09838907620658974,
            "start_logit": 3.1933388710021973,
            "end_logit": 2.7873802185058594,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "conjunctivitis",
            "probability": 0.0913454151129603,
            "start_logit": 3.1190571784973145,
            "end_logit": 2.7873802185058594,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Coryza, conjunctivitis, or cough",
            "probability": 0.08274887981367442,
            "start_logit": 3.1933388710021973,
            "end_logit": 2.6142609119415283,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "conjunctivitis, or cough",
            "probability": 0.07682489833364543,
            "start_logit": 3.1190571784973145,
            "end_logit": 2.6142609119415283,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "conjunctivitis, or cough.Measles is a highly contagious viral infection associated with clinical symptoms such as fever, cough",
            "probability": 0.06229918620686963,
            "start_logit": 3.1190571784973145,
            "end_logit": 2.4046804904937744,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "Coryza, conjunctivitis, or cough.Measles is a highly contagious viral infection associated with clinical symptoms such as fever",
            "probability": 0.06094360961537346,
            "start_logit": 3.1933388710021973,
            "end_logit": 2.3083994388580322,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "conjunctivitis, or cough.Measles is a highly contagious viral infection associated with clinical symptoms such as fever",
            "probability": 0.056580664576111106,
            "start_logit": 3.1190571784973145,
            "end_logit": 2.3083994388580322,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough",
            "probability": 0.04008402766536719,
            "start_logit": 2.468506336212158,
            "end_logit": 2.6142609119415283,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "coryza",
            "probability": 0.032764978773078955,
            "start_logit": 2.4798808097839355,
            "end_logit": 2.401268720626831,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough.Measles is a highly contagious viral infection associated with clinical symptoms such as fever, cough",
            "probability": 0.032505116929681326,
            "start_logit": 2.468506336212158,
            "end_logit": 2.4046804904937744,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough.Measles is a highly contagious viral infection associated with clinical symptoms such as fever",
            "probability": 0.02952143085623112,
            "start_logit": 2.468506336212158,
            "end_logit": 2.3083994388580322,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "maculopapular rash, plus \u22651 of the following symptoms: Coryza",
            "probability": 0.028130066091619804,
            "start_logit": 1.4481555223464966,
            "end_logit": 3.280472755432129,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever, cough",
            "probability": 0.023762548280870006,
            "start_logit": 2.155219554901123,
            "end_logit": 2.4046804904937744,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough, conjunctivitis, coryza",
            "probability": 0.0228541318181062,
            "start_logit": 2.2774646282196045,
            "end_logit": 2.2434566020965576,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough.Measles is a highly contagious viral infection associated with clinical symptoms such as fever, cough, conjunctivitis",
            "probability": 0.021759892471436934,
            "start_logit": 2.468506336212158,
            "end_logit": 2.0033514499664307,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever",
            "probability": 0.0215813537160666,
            "start_logit": 2.155219554901123,
            "end_logit": 2.3083994388580322,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever, cough, conjunctivitis, coryza",
            "probability": 0.020224340438719283,
            "start_logit": 2.155219554901123,
            "end_logit": 2.2434566020965576,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever, rash, cough and coryza",
            "probability": 0.018605054947947005,
            "start_logit": 1.9139539003372192,
            "end_logit": 2.401268720626831,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough, conjunctivitis",
            "probability": 0.017975806534879585,
            "start_logit": 2.2774646282196045,
            "end_logit": 2.0033514499664307,
            "question_text": "Please list symptoms of measles."
        }
    ],
    "5c641c60e842deac67000013": [
        {
            "text": "GeneMatcher, PhenomeCentral, DECIPHER, MyGene2, matchbox",
            "probability": 0.0819869076757964,
            "start_logit": 2.43939471244812,
            "end_logit": 1.855058193206787,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "MyGene2, matchbox",
            "probability": 0.08062878566161276,
            "start_logit": 2.285101890563965,
            "end_logit": 1.9926471710205078,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher, PhenomeCentral, DECIPHER, MyGene2",
            "probability": 0.06712355108224875,
            "start_logit": 2.43939471244812,
            "end_logit": 1.6550335884094238,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "MyGene2",
            "probability": 0.0639830495339112,
            "start_logit": 2.285101890563965,
            "end_logit": 1.7614096403121948,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "MyGene2, matchbox, Australian Genomics Health Alliance Patient Archive, and Monarch Initiative",
            "probability": 0.05965563315552914,
            "start_logit": 2.304638147354126,
            "end_logit": 1.6718437671661377,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher",
            "probability": 0.05849874122192517,
            "start_logit": 2.43939471244812,
            "end_logit": 1.5175038576126099,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "matchbox",
            "probability": 0.056589843722094614,
            "start_logit": 1.9310756921768188,
            "end_logit": 1.9926471710205078,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher, PhenomeCentral, DECIPHER",
            "probability": 0.04846321231037981,
            "start_logit": 2.319763660430908,
            "end_logit": 1.4489346742630005,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "MyGene",
            "probability": 0.04630934164030959,
            "start_logit": 2.285101890563965,
            "end_logit": 1.4381351470947266,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "MyGene2, matchbox, Australian Genomics Health Alliance Patient Archive",
            "probability": 0.045708927305893106,
            "start_logit": 2.304638147354126,
            "end_logit": 1.4055488109588623,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "DECIPHER, MyGene2, matchbox",
            "probability": 0.042081286779111236,
            "start_logit": 1.6348493099212646,
            "end_logit": 1.9926471710205078,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher, PhenomeCentral, DECIPHER, MyGene",
            "probability": 0.0418293637682228,
            "start_logit": 2.43939471244812,
            "end_logit": 1.1820971965789795,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "matchbox, Australian Genomics Health Alliance Patient Archive, and Monarch Initiative",
            "probability": 0.041799296321041894,
            "start_logit": 1.9489290714263916,
            "end_logit": 1.6718437671661377,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "DECIPHER, MyGene2, matchbox, Australian Genomics Health Alliance Patient Archive, and Monarch Initiative",
            "probability": 0.04070712916890191,
            "start_logit": 1.7884019613265991,
            "end_logit": 1.8058946132659912,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "PhenomeCentral, DECIPHER, MyGene2, matchbox",
            "probability": 0.039837140545119595,
            "start_logit": 1.5800458192825317,
            "end_logit": 1.9926471710205078,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher, PhenomeCentral",
            "probability": 0.03960194264047411,
            "start_logit": 2.319763660430908,
            "end_logit": 1.2470078468322754,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "Monarch Initiative",
            "probability": 0.038780960055701516,
            "start_logit": 1.739928126335144,
            "end_logit": 1.8058946132659912,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "Monarch Initiative; the latter included for model organism matching).To date, seven databases can exchange data using the API (GeneMatcher",
            "probability": 0.03633335644650786,
            "start_logit": 1.739928126335144,
            "end_logit": 1.74070143699646,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "Australian Genomics Health Alliance Patient Archive, and Monarch Initiative",
            "probability": 0.03569694537707333,
            "start_logit": 1.7911146879196167,
            "end_logit": 1.6718437671661377,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "DECIPHER, MyGene2",
            "probability": 0.03438458558814529,
            "start_logit": 1.7884019613265991,
            "end_logit": 1.6370997428894043,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        }
    ],
    "5c5315727e3cb0e231000014": [
        {
            "text": "Axl, and Mer",
            "probability": 0.10627725704522208,
            "start_logit": 5.388679027557373,
            "end_logit": 4.752430438995361,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Axl",
            "probability": 0.10194728365958278,
            "start_logit": 5.388679027557373,
            "end_logit": 4.710834980010986,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Tyro-3, Axl, and Mer",
            "probability": 0.08495331577447517,
            "start_logit": 5.164729595184326,
            "end_logit": 4.752430438995361,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Tyro-3, Axl",
            "probability": 0.08149212749626465,
            "start_logit": 5.164729595184326,
            "end_logit": 4.710834980010986,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Axl/Mer",
            "probability": 0.0664344688134696,
            "start_logit": 5.036625385284424,
            "end_logit": 4.63464879989624,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Mer",
            "probability": 0.062141171748597915,
            "start_logit": 4.852036476135254,
            "end_logit": 4.752430438995361,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Mer (TAM) family of receptor tyrosine kinases (RTKs)Tyro-3, Axl",
            "probability": 0.05415337288950884,
            "start_logit": 4.756043434143066,
            "end_logit": 4.710834980010986,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL or TYRO3 receptors of the Tyro3/Axl/Mer",
            "probability": 0.04500864799161152,
            "start_logit": 4.647264003753662,
            "end_logit": 4.63464879989624,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Tyro3/Axl/Mer",
            "probability": 0.04159246519446362,
            "start_logit": 4.568328380584717,
            "end_logit": 4.63464879989624,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3 receptors of the Tyro3/Axl/Mer",
            "probability": 0.03932097529087333,
            "start_logit": 4.512167453765869,
            "end_logit": 4.63464879989624,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTKTAM family members AXL or TYRO3 receptors of the Tyro3/Axl/Mer",
            "probability": 0.03621141737667553,
            "start_logit": 4.429783821105957,
            "end_logit": 4.63464879989624,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL, and MERTKTAM family members AXL or TYRO3 receptors of the Tyro3/Axl",
            "probability": 0.03527513988509422,
            "start_logit": 4.677735805511475,
            "end_logit": 4.360500812530518,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL or TYRO3 receptors of the Tyro3/Axl",
            "probability": 0.03421645475445192,
            "start_logit": 4.647264003753662,
            "end_logit": 4.360500812530518,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Tyro-3",
            "probability": 0.03371535325652391,
            "start_logit": 5.164729595184326,
            "end_logit": 3.828281879425049,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Tyro3/Axl",
            "probability": 0.03161940575770504,
            "start_logit": 4.568328380584717,
            "end_logit": 4.360500812530518,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL",
            "probability": 0.031396118936231815,
            "start_logit": 4.677735805511475,
            "end_logit": 4.244006633758545,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3 receptors of the Tyro3/Axl",
            "probability": 0.0298925746934643,
            "start_logit": 4.512167453765869,
            "end_logit": 4.360500812530518,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "Axl/Mer (TAM) family of receptor tyrosine kinases (RTKs)Tyro-3",
            "probability": 0.029661476311267573,
            "start_logit": 5.036625385284424,
            "end_logit": 3.828281879425049,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTKTAM family members AXL or TYRO3 receptors of the Tyro3/Axl",
            "probability": 0.027528627931559187,
            "start_logit": 4.429783821105957,
            "end_logit": 4.360500812530518,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL, and MERTKTAM family members AXL",
            "probability": 0.027162345192957155,
            "start_logit": 4.677735805511475,
            "end_logit": 4.099153995513916,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        }
    ],
    "5c645313e842deac67000019": [
        {
            "text": "loss of self-avoidance",
            "probability": 0.41327779478332316,
            "start_logit": 6.189533710479736,
            "end_logit": 6.3921027183532715,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "axonal arborization defect and loss of self-avoidance",
            "probability": 0.14895569271638165,
            "start_logit": 5.169062614440918,
            "end_logit": 6.3921027183532715,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "severe axonal arborization defect and loss of self-avoidance",
            "probability": 0.12967395681695879,
            "start_logit": 5.084484577178955,
            "end_logit": 6.33805513381958,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "axonal arborization defect",
            "probability": 0.11304464913478895,
            "start_logit": 5.169062614440918,
            "end_logit": 6.116236686706543,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "severe axonal arborization defect",
            "probability": 0.09213733937611318,
            "start_logit": 5.084484577178955,
            "end_logit": 5.996312141418457,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "self-avoidance",
            "probability": 0.045556613229980815,
            "start_logit": 3.9843695163726807,
            "end_logit": 6.3921027183532715,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "a severe axonal arborization defect and loss of self-avoidance",
            "probability": 0.015926650339032025,
            "start_logit": 2.987455129623413,
            "end_logit": 6.33805513381958,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "a severe axonal arborization defect",
            "probability": 0.011316375496148737,
            "start_logit": 2.987455129623413,
            "end_logit": 5.996312141418457,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "arborization defect and loss of self-avoidance",
            "probability": 0.005280088998449465,
            "start_logit": 1.8293566703796387,
            "end_logit": 6.3921027183532715,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "led to a severe axonal arborization defect and loss of self-avoidance",
            "probability": 0.00496117865299335,
            "start_logit": 1.7670570611953735,
            "end_logit": 6.3921027183532715,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "axonal arborization",
            "probability": 0.00469008668531415,
            "start_logit": 5.169062614440918,
            "end_logit": 2.9339048862457275,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "arborization defect",
            "probability": 0.004007136601127938,
            "start_logit": 1.8293566703796387,
            "end_logit": 6.116236686706543,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "led to a severe axonal arborization defect",
            "probability": 0.0037651108856275317,
            "start_logit": 1.7670570611953735,
            "end_logit": 6.116236686706543,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "severe axonal arborization",
            "probability": 0.0036127698541238156,
            "start_logit": 4.90808629989624,
            "end_logit": 2.9339048862457275,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "loss of self-avoidance.",
            "probability": 0.001629743422424947,
            "start_logit": 6.189533710479736,
            "end_logit": 0.8564053177833557,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "axonal arborization defect and loss of self-avoidance.",
            "probability": 0.0005874004446925356,
            "start_logit": 5.169062614440918,
            "end_logit": 0.8564053177833557,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "loss of self-avoidance.Although deletion of individual Pcdh clusters had subtle phenotypic consequences",
            "probability": 0.0005061706767323246,
            "start_logit": 6.189533710479736,
            "end_logit": -0.3128986358642578,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "severe axonal arborization defect and loss of self-avoidance.",
            "probability": 0.0004524740716475631,
            "start_logit": 4.90808629989624,
            "end_logit": 0.8564053177833557,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "a severe axonal arborization",
            "probability": 0.0004156478416014497,
            "start_logit": 2.987455129623413,
            "end_logit": 2.6921443939208984,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "loss of self-avoidance.Although deletion of individual Pcdh clusters had subtle phenotypic consequences,",
            "probability": 0.00020311997253792734,
            "start_logit": 6.189533710479736,
            "end_logit": -1.225975751876831,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        }
    ],
    "5c6ffdd47c78d69471000058": [
        {
            "text": "miR-423-5p",
            "probability": 0.48619643432955223,
            "start_logit": 4.7893242835998535,
            "end_logit": 4.2879414558410645,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "c-miRNAs such as miR-423-5p",
            "probability": 0.210649833676417,
            "start_logit": 3.952908754348755,
            "end_logit": 4.2879414558410645,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "c-miRNAs",
            "probability": 0.16371619350202132,
            "start_logit": 3.952908754348755,
            "end_logit": 4.035878658294678,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs such as miR-423-5p",
            "probability": 0.057159787614298845,
            "start_logit": 2.64856219291687,
            "end_logit": 4.2879414558410645,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs",
            "probability": 0.04442435432430466,
            "start_logit": 2.64856219291687,
            "end_logit": 4.035878658294678,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-423",
            "probability": 0.01342876914709062,
            "start_logit": 4.7893242835998535,
            "end_logit": 0.698728084564209,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-214",
            "probability": 0.007724620805938526,
            "start_logit": 2.521399974822998,
            "end_logit": 2.413665771484375,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "c-miRNAs such as miR-423",
            "probability": 0.005818158644487819,
            "start_logit": 3.952908754348755,
            "end_logit": 0.698728084564209,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "c-miRNA",
            "probability": 0.0017466792818611426,
            "start_logit": 3.952908754348755,
            "end_logit": -0.5045393109321594,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "423-5p",
            "probability": 0.0016668561426679894,
            "start_logit": -0.8863491415977478,
            "end_logit": 4.2879414558410645,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs such as miR-423",
            "probability": 0.0015787561120797244,
            "start_logit": 2.64856219291687,
            "end_logit": 0.698728084564209,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-423-5",
            "probability": 0.0012778394413492237,
            "start_logit": 4.7893242835998535,
            "end_logit": -1.6535005569458008,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "mi",
            "probability": 0.0009897081099898251,
            "start_logit": 4.7893242835998535,
            "end_logit": -1.909016489982605,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR",
            "probability": 0.0008600815198927814,
            "start_logit": 4.7893242835998535,
            "end_logit": -2.0493993759155273,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "c-miRNAs such as miR-423-5",
            "probability": 0.0005536376797097756,
            "start_logit": 3.952908754348755,
            "end_logit": -1.6535005569458008,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "c",
            "probability": 0.000538596628320723,
            "start_logit": 3.952908754348755,
            "end_logit": -1.681044101715088,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNA",
            "probability": 0.00047396105204072786,
            "start_logit": 2.64856219291687,
            "end_logit": -0.5045393109321594,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "c-miRNAs such as mi",
            "probability": 0.00042880168186557516,
            "start_logit": 3.952908754348755,
            "end_logit": -1.909016489982605,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "5p",
            "probability": 0.0003881476284902358,
            "start_logit": -2.343657970428467,
            "end_logit": 4.2879414558410645,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "serum levels of c-miRNAs such as miR-423-5p",
            "probability": 0.0003787826776215296,
            "start_logit": -2.3680810928344727,
            "end_logit": 4.2879414558410645,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        }
    ],
    "5c5f11c31a4c55d80b000015": [
        {
            "text": "Larp7",
            "probability": 0.7798800813253621,
            "start_logit": 5.647951126098633,
            "end_logit": 5.107081413269043,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "PIPKI\u03b1 interaction and directs specificity toward mRNA targets., we show that Larp7",
            "probability": 0.09146958619211959,
            "start_logit": 3.504817485809326,
            "end_logit": 5.107081413269043,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "PIPKIalpha",
            "probability": 0.047526067570826766,
            "start_logit": 4.589158058166504,
            "end_logit": 3.3680126667022705,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "Larp7 interacts with a poly(A) polymerase Star-PAP",
            "probability": 0.04166802299135528,
            "start_logit": 5.647951126098633,
            "end_logit": 2.177675247192383,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "PIPKIalpha function together in a complexPhosphorylation regulates the Star-PAP-PIPKI",
            "probability": 0.012451131984760453,
            "start_logit": 4.589158058166504,
            "end_logit": 2.02854585647583,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "PIPKIalpha function together in a complexPhosphorylation regulates the Star-PAP-PIPKI\u03b1",
            "probability": 0.007470875933905108,
            "start_logit": 4.589158058166504,
            "end_logit": 1.5177465677261353,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "PIPKI",
            "probability": 0.004607568335130013,
            "start_logit": 4.589158058166504,
            "end_logit": 1.0344345569610596,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "PIPKIalpha function together in a complexPhosphorylation regulates the Star-PAP",
            "probability": 0.004195818128998687,
            "start_logit": 4.589158058166504,
            "end_logit": 0.9408226609230042,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "Larp",
            "probability": 0.002874596059075435,
            "start_logit": 5.647951126098633,
            "end_logit": -0.4961465895175934,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "PIPKI\u03b1",
            "probability": 0.0025260875431111535,
            "start_logit": 3.504817485809326,
            "end_logit": 1.5177465677261353,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "Larp7 interacts with a poly(A) polymerase Star-PAP to maintain Lin28 mRNA stability.",
            "probability": 0.002294085256258669,
            "start_logit": 5.647951126098633,
            "end_logit": -0.7217245697975159,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "Larp7 interacts with a poly(A) polymerase Star-PAP to maintain Lin28",
            "probability": 0.0009396720644763892,
            "start_logit": 5.647951126098633,
            "end_logit": -1.6142830848693848,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "mRNA targets., we show that Larp7",
            "probability": 0.00044838090844200837,
            "start_logit": -1.8133012056350708,
            "end_logit": 5.107081413269043,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "Star-PAP-PIPKI\u03b1 interaction and directs specificity toward mRNA targets., we show that Larp7",
            "probability": 0.00034867150346403446,
            "start_logit": -2.0648140907287598,
            "end_logit": 5.107081413269043,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "PIPKI\u03b1 interaction and directs specificity toward mRNA targets., we show that Larp",
            "probability": 0.0003371519779634317,
            "start_logit": 3.504817485809326,
            "end_logit": -0.4961465895175934,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "we show that Larp7",
            "probability": 0.000301666377757324,
            "start_logit": -2.209622621536255,
            "end_logit": 5.107081413269043,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF) 160",
            "probability": 0.0002476278682200455,
            "start_logit": 1.2327021360397339,
            "end_logit": 1.4673620462417603,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "poly(A) polymerase Star-PAP",
            "probability": 0.00016064150317478563,
            "start_logit": 0.08963704109191895,
            "end_logit": 2.177675247192383,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "polyadenylation specificity factor (CPSF) 160",
            "probability": 0.0001594548758407155,
            "start_logit": 0.7925360202789307,
            "end_logit": 1.4673620462417603,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF",
            "probability": 9.281159975787576e-05,
            "start_logit": 1.2327021360397339,
            "end_logit": 0.48600658774375916,
            "question_text": "List proteins interacting with Star-PAP"
        }
    ],
    "5c654b3de842deac67000024": [
        {
            "text": "Multiple Myeloma",
            "probability": 0.25627456045622976,
            "start_logit": 5.963089942932129,
            "end_logit": 5.614834785461426,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "chronic lymphatic leukemia (CLL), Multiple Myeloma",
            "probability": 0.175631552428479,
            "start_logit": 5.58522891998291,
            "end_logit": 5.614834785461426,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Multiple Myeloma (MM), and non-Hodgkin's lymphoma",
            "probability": 0.15788760694489343,
            "start_logit": 5.963089942932129,
            "end_logit": 5.130468845367432,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "chronic lymphatic leukemia",
            "probability": 0.12757066731779046,
            "start_logit": 5.58522891998291,
            "end_logit": 5.295116901397705,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "non-Hodgkin's lymphoma",
            "probability": 0.10876306198584268,
            "start_logit": 5.590378284454346,
            "end_logit": 5.130468845367432,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Multiple Myeloma (MM)",
            "probability": 0.0420171296526815,
            "start_logit": 5.963089942932129,
            "end_logit": 3.8066627979278564,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Multiple Myeloma (MM), and non-Hodgkin's lymphoma (NHL)",
            "probability": 0.03873580053233037,
            "start_logit": 5.963089942932129,
            "end_logit": 3.7253496646881104,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "chronic lymphatic leukemia (CLL), Multiple Myeloma (MM)",
            "probability": 0.0287954204129813,
            "start_logit": 5.58522891998291,
            "end_logit": 3.8066627979278564,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "non-Hodgkin's lymphoma (NHL)",
            "probability": 0.026683692000218435,
            "start_logit": 5.590378284454346,
            "end_logit": 3.7253496646881104,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "chronic lymphatic leukemia (CLL)",
            "probability": 0.026352880306511665,
            "start_logit": 5.58522891998291,
            "end_logit": 3.7180240154266357,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Myeloma",
            "probability": 0.002600786725111047,
            "start_logit": 1.3726545572280884,
            "end_logit": 5.614834785461426,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Myeloma (MM), and non-Hodgkin's lymphoma",
            "probability": 0.0016023127362731857,
            "start_logit": 1.3726545572280884,
            "end_logit": 5.130468845367432,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "leukemia (CLL), Multiple Myeloma",
            "probability": 0.0015089396031642715,
            "start_logit": 0.8282477259635925,
            "end_logit": 5.614834785461426,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "(CLL), Multiple Myeloma",
            "probability": 0.001119578965637536,
            "start_logit": 0.5297932624816895,
            "end_logit": 5.614834785461426,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "leukemia",
            "probability": 0.0010960242021222056,
            "start_logit": 0.8282477259635925,
            "end_logit": 5.295116901397705,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "leukemia (CLL), Multiple Myeloma (MM), and non-Hodgkin's lymphoma",
            "probability": 0.0009296391438301753,
            "start_logit": 0.8282477259635925,
            "end_logit": 5.130468845367432,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "(CLL), Multiple Myeloma (MM), and non-Hodgkin's lymphoma",
            "probability": 0.0006897588405016131,
            "start_logit": 0.5297932624816895,
            "end_logit": 5.130468845367432,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "lymphatic leukemia (CLL), Multiple Myeloma",
            "probability": 0.0006582148032393693,
            "start_logit": -0.0013833808479830623,
            "end_logit": 5.614834785461426,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Multiple Myeloma (MM),",
            "probability": 0.0005763887018687569,
            "start_logit": 5.963089942932129,
            "end_logit": -0.48238760232925415,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Multiple Myeloma (MM), and non-Hodgkin's lymphoma (NHL).",
            "probability": 0.0005059842402931403,
            "start_logit": 5.963089942932129,
            "end_logit": -0.6126643419265747,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        }
    ],
    "5c658a8f7c78d69471000007": [
        {
            "text": "diarrhea",
            "probability": 0.33407532876596835,
            "start_logit": 3.7218782901763916,
            "end_logit": 3.7624452114105225,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "diarrhea, differentiation syndrome",
            "probability": 0.13124121856208779,
            "start_logit": 3.7218782901763916,
            "end_logit": 2.828115701675415,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "elevated bilirubin level, diarrhea",
            "probability": 0.12801369775361376,
            "start_logit": 2.7626490592956543,
            "end_logit": 3.7624452114105225,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "bilirubin level, diarrhea",
            "probability": 0.06960662747110559,
            "start_logit": 2.153371572494507,
            "end_logit": 3.7624452114105225,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "elevated bilirubin level, diarrhea, differentiation syndrome",
            "probability": 0.050290076037289605,
            "start_logit": 2.7626490592956543,
            "end_logit": 2.828115701675415,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "diarrhea, differentiation syndrome, decreased potassium and calcium levels",
            "probability": 0.04016687696238348,
            "start_logit": 3.7218782901763916,
            "end_logit": 1.6441214084625244,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "differentiation syndrome",
            "probability": 0.03363684634980263,
            "start_logit": 2.3604633808135986,
            "end_logit": 2.828115701675415,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "elevated bilirubin",
            "probability": 0.03142575336197863,
            "start_logit": 2.7626490592956543,
            "end_logit": 2.357935667037964,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "bilirubin level, diarrhea, differentiation syndrome",
            "probability": 0.02734490644086073,
            "start_logit": 2.153371572494507,
            "end_logit": 2.828115701675415,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "diarrhea, differentiation syndrome, decreased potassium",
            "probability": 0.02648460416113144,
            "start_logit": 3.7218782901763916,
            "end_logit": 1.227642297744751,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "diarrhea, differentiation syndrome, decreased potassium and calcium",
            "probability": 0.01826121984088924,
            "start_logit": 3.7218782901763916,
            "end_logit": 0.8558583855628967,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "bilirubin",
            "probability": 0.017087551923359232,
            "start_logit": 2.153371572494507,
            "end_logit": 2.357935667037964,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "elevated bilirubin level",
            "probability": 0.017045499069831188,
            "start_logit": 2.7626490592956543,
            "end_logit": 1.7461941242218018,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "elevated bilirubin level, diarrhea, differentiation syndrome, decreased potassium and calcium levels",
            "probability": 0.015391470139871485,
            "start_logit": 2.7626490592956543,
            "end_logit": 1.6441214084625244,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "decreased potassium and calcium levels",
            "probability": 0.011845952386732304,
            "start_logit": 2.500821828842163,
            "end_logit": 1.6441214084625244,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "differentiation syndrome, decreased potassium and calcium levels",
            "probability": 0.010294685492393124,
            "start_logit": 2.3604633808135986,
            "end_logit": 1.6441214084625244,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "elevated bilirubin level, diarrhea, differentiation syndrome, decreased potassium",
            "probability": 0.010148585723857123,
            "start_logit": 2.7626490592956543,
            "end_logit": 1.227642297744751,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "diarrhea, differentiation syndrome,",
            "probability": 0.01000170549908397,
            "start_logit": 3.7218782901763916,
            "end_logit": 0.2538343369960785,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "bilirubin level",
            "probability": 0.009268380842309685,
            "start_logit": 2.153371572494507,
            "end_logit": 1.7461941242218018,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "bilirubin level, diarrhea, differentiation syndrome, decreased potassium and calcium levels",
            "probability": 0.008369013215450503,
            "start_logit": 2.153371572494507,
            "end_logit": 1.6441214084625244,
            "question_text": "Name 4 side effects of enasidenib"
        }
    ],
    "5c76c1457c78d694710000a6": [
        {
            "text": "birdshot chorioretinopathy, Beh\u00e7et's disease",
            "probability": 0.10605317458676639,
            "start_logit": 4.734605312347412,
            "end_logit": 4.9886860847473145,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "birdshot chorioretinopathy",
            "probability": 0.10039237140699887,
            "start_logit": 4.734605312347412,
            "end_logit": 4.933831691741943,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "Beh\u00e7et's disease",
            "probability": 0.09718139460540275,
            "start_logit": 4.647243976593018,
            "end_logit": 4.9886860847473145,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, birdshot chorioretinopathy, Beh\u00e7et's disease",
            "probability": 0.0865627837894405,
            "start_logit": 4.531534671783447,
            "end_logit": 4.9886860847473145,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "psoriasis",
            "probability": 0.08464102269272729,
            "start_logit": 4.779379367828369,
            "end_logit": 4.718390464782715,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, birdshot chorioretinopathy",
            "probability": 0.08194231972851895,
            "start_logit": 4.531534671783447,
            "end_logit": 4.933831691741943,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "birdshot chorioretinopathy, Beh\u00e7et's disease and psoriasis",
            "probability": 0.08093488928291347,
            "start_logit": 4.734605312347412,
            "end_logit": 4.718390464782715,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "Beh\u00e7et's disease and psoriasis",
            "probability": 0.0741643561675037,
            "start_logit": 4.647243976593018,
            "end_logit": 4.718390464782715,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis",
            "probability": 0.07406790970189848,
            "start_logit": 4.531534671783447,
            "end_logit": 4.832798480987549,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, birdshot chorioretinopathy, Beh\u00e7et's disease and psoriasis",
            "probability": 0.06606072236232112,
            "start_logit": 4.531534671783447,
            "end_logit": 4.718390464782715,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "psoriasis, and Beh\u00e7et's disease",
            "probability": 0.04925322015238053,
            "start_logit": 4.354934215545654,
            "end_logit": 4.601391315460205,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, psoriasis, and Beh\u00e7et's disease",
            "probability": 0.044668792663938715,
            "start_logit": 4.257234573364258,
            "end_logit": 4.601391315460205,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, psoriasis",
            "probability": 0.0344835112922388,
            "start_logit": 4.257234573364258,
            "end_logit": 4.342597484588623,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "psoriasis.Birdshot chorioretinopathy",
            "probability": 0.006258141354446205,
            "start_logit": 4.779379367828369,
            "end_logit": 2.1138546466827393,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "birdshot chorioretinopathy, Beh\u00e7et's disease and psoriasis.Birdshot chorioretinopathy",
            "probability": 0.005984119302027838,
            "start_logit": 4.734605312347412,
            "end_logit": 2.1138546466827393,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "Beh\u00e7et's disease and psoriasis.Birdshot chorioretinopathy",
            "probability": 0.005483523350641326,
            "start_logit": 4.647243976593018,
            "end_logit": 2.1138546466827393,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "psoriasis.",
            "probability": 0.0004992836957072415,
            "start_logit": 4.779379367828369,
            "end_logit": -0.4146094024181366,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "birdshot chorioretinopathy, Beh\u00e7et's disease and psoriasis.",
            "probability": 0.00047742181447320335,
            "start_logit": 4.734605312347412,
            "end_logit": -0.4146094024181366,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "chorioretinopathy, Beh\u00e7et's disease",
            "probability": 0.00045355851437754637,
            "start_logit": -0.7199662923812866,
            "end_logit": 4.9886860847473145,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "Beh\u00e7et's disease and psoriasis.",
            "probability": 0.0004374835352768143,
            "start_logit": 4.647243976593018,
            "end_logit": -0.4146094024181366,
            "question_text": "List MHC-I-associated inflammatory disorders."
        }
    ],
    "5c6e146a7c78d6947100004c": [
        {
            "text": "glecaprevir/pibrentasvir",
            "probability": 0.3064111720213173,
            "start_logit": 6.5129075050354,
            "end_logit": 6.465219974517822,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "pibrentasvir",
            "probability": 0.2467731710315564,
            "start_logit": 6.296449184417725,
            "end_logit": 6.465219974517822,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir",
            "probability": 0.19519540206595573,
            "start_logit": 6.5129075050354,
            "end_logit": 6.014293193817139,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "delafloxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir/pibrentasvir",
            "probability": 0.12522074279139367,
            "start_logit": 5.618057727813721,
            "end_logit": 6.465219974517822,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "delafloxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir",
            "probability": 0.07977030692099968,
            "start_logit": 5.618057727813721,
            "end_logit": 6.014293193817139,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "delafloxacin",
            "probability": 0.04548715673583422,
            "start_logit": 5.618057727813721,
            "end_logit": 5.452571868896484,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "/pibrentasvir",
            "probability": 0.0001839850271476444,
            "start_logit": -0.904921293258667,
            "end_logit": 6.465219974517822,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir",
            "probability": 0.0001514497004451775,
            "start_logit": 2.6727969646453857,
            "end_logit": 2.6929008960723877,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "pibrentasvir [glecaprevir",
            "probability": 8.986877237194227e-05,
            "start_logit": 2.7627370357513428,
            "end_logit": 2.0810577869415283,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir/pibrentas",
            "probability": 8.463021310331328e-05,
            "start_logit": 6.5129075050354,
            "end_logit": -1.729171872138977,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir",
            "probability": 8.21387959924646e-05,
            "start_logit": 2.6727969646453857,
            "end_logit": 2.0810577869415283,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "vir/pibrentasvir",
            "probability": 7.55854285595878e-05,
            "start_logit": -1.794512152671814,
            "end_logit": 6.465219974517822,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "pibrentas",
            "probability": 6.815830478638045e-05,
            "start_logit": 6.296449184417725,
            "end_logit": -1.729171872138977,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "vir",
            "probability": 6.714709871006227e-05,
            "start_logit": -1.9128899574279785,
            "end_logit": 6.465219974517822,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "pibrentasvir [glecaprevir/pibrentasvir",
            "probability": 6.674788616568593e-05,
            "start_logit": 2.7627370357513428,
            "end_logit": 1.7836298942565918,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir/pib",
            "probability": 6.427807786669695e-05,
            "start_logit": 6.5129075050354,
            "end_logit": -2.004244565963745,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "ibrentasvir",
            "probability": 5.709525582425931e-05,
            "start_logit": -2.07505464553833,
            "end_logit": 6.465219974517822,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "pib",
            "probability": 5.1767384976010496e-05,
            "start_logit": 6.296449184417725,
            "end_logit": -2.004244565963745,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir/pibrentasvir (Mavyret) for chronic HCV infection.",
            "probability": 5.072611442835725e-05,
            "start_logit": 6.5129075050354,
            "end_logit": -2.2410223484039307,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "lecaprevir/pibrentasvir",
            "probability": 4.8470372565602394e-05,
            "start_logit": -2.2388229370117188,
            "end_logit": 6.465219974517822,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        }
    ],
    "5c61bd04e842deac67000002": [
        {
            "text": "valsartan-sacubitril",
            "probability": 0.31912424863154176,
            "start_logit": 5.6142449378967285,
            "end_logit": 4.970973491668701,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan",
            "probability": 0.31088176141919066,
            "start_logit": 5.6142449378967285,
            "end_logit": 4.94480562210083,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril",
            "probability": 0.1648847735247194,
            "start_logit": 4.953911304473877,
            "end_logit": 4.970973491668701,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril/valsartan",
            "probability": 0.0686330649199716,
            "start_logit": 4.794895648956299,
            "end_logit": 4.253516674041748,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan-sacubitril co-crystal (Entresto, Novartis",
            "probability": 0.06108749477446951,
            "start_logit": 5.6142449378967285,
            "end_logit": 3.317700147628784,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril co-crystal (Entresto, Novartis",
            "probability": 0.031562621092796964,
            "start_logit": 4.953911304473877,
            "end_logit": 3.317700147628784,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril-valsartan",
            "probability": 0.024390854598682413,
            "start_logit": 4.105748653411865,
            "end_logit": 3.908097505569458,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "Novartis",
            "probability": 0.01254631700677771,
            "start_logit": 4.031364917755127,
            "end_logit": 3.317700147628784,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan (Entresto; Novartis",
            "probability": 0.0031859351960392985,
            "start_logit": 4.88610315322876,
            "end_logit": 1.092280626296997,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril/valsartan (Entresto; Novartis",
            "probability": 0.00290821173078659,
            "start_logit": 4.794895648956299,
            "end_logit": 1.092280626296997,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "v",
            "probability": 0.0001860530391316135,
            "start_logit": 5.6142449378967285,
            "end_logit": -2.476330518722534,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan-sacubitril co-crystal",
            "probability": 0.0001550352551950882,
            "start_logit": 5.6142449378967285,
            "end_logit": -2.658709764480591,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril co-crystal",
            "probability": 8.010344889430186e-05,
            "start_logit": 4.953911304473877,
            "end_logit": -2.658709764480591,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan-sacubitril co-crystal (Entresto, Novartis)",
            "probability": 6.27481846751855e-05,
            "start_logit": 5.6142449378967285,
            "end_logit": -3.563232660293579,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan-sa",
            "probability": 6.13884290157005e-05,
            "start_logit": 5.6142449378967285,
            "end_logit": -3.5851409435272217,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan (Entresto; Novartis, Cambridge",
            "probability": 5.618863025787075e-05,
            "start_logit": 4.88610315322876,
            "end_logit": -2.9455060958862305,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan could improve the outcome of SDB in CHF patients.This positive change in regulatory perspective coupled with successful commercialization of v",
            "probability": 5.2100577388895565e-05,
            "start_logit": 4.341389179229736,
            "end_logit": -2.476330518722534,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan-sacubitril co-crystal (Entresto",
            "probability": 5.149773707938122e-05,
            "start_logit": 5.6142449378967285,
            "end_logit": -3.76082444190979,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril/valsartan (Entresto; Novartis, Cambridge",
            "probability": 5.129057045978736e-05,
            "start_logit": 4.794895648956299,
            "end_logit": -2.9455060958862305,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "artan-sacubitril",
            "probability": 3.831123292633626e-05,
            "start_logit": -3.4133477210998535,
            "end_logit": 4.970973491668701,
            "question_text": "Which two drugs are included in the Entresto pill?"
        }
    ],
    "5c6585287c78d69471000004": [
        {
            "text": "acute myeloid leukemia",
            "probability": 0.5439793713452808,
            "start_logit": 5.7549238204956055,
            "end_logit": 5.549990177154541,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Acute Myeloid Leukemia",
            "probability": 0.07352253202472962,
            "start_logit": 4.7918219566345215,
            "end_logit": 4.511772632598877,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Acute Myeloid Leukemia and Systemic Mastocytosis",
            "probability": 0.06309395352310856,
            "start_logit": 4.7918219566345215,
            "end_logit": 4.3588056564331055,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "systemic mastocytosis",
            "probability": 0.05735625061385595,
            "start_logit": 4.314774036407471,
            "end_logit": 4.7405104637146,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy",
            "probability": 0.046830143728308654,
            "start_logit": 5.7549238204956055,
            "end_logit": 3.0976059436798096,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Systemic Mastocytosis",
            "probability": 0.041083004609748994,
            "start_logit": 4.362791538238525,
            "end_logit": 4.3588056564331055,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "mastocytosis",
            "probability": 0.02569451547426073,
            "start_logit": 3.5117697715759277,
            "end_logit": 4.7405104637146,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "systemic mastocytosis with associated hematological neoplasm (SM-AHN) or mast cell leukemia",
            "probability": 0.023832900312656988,
            "start_logit": 4.071353435516357,
            "end_logit": 4.105716228485107,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Mastocytosis",
            "probability": 0.02075781860406456,
            "start_logit": 3.6801199913024902,
            "end_logit": 4.3588056564331055,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.01968720667426429,
            "start_logit": 2.435981512069702,
            "end_logit": 5.549990177154541,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "mast cell leukemia",
            "probability": 0.01204028506541042,
            "start_logit": 3.3885445594787598,
            "end_logit": 4.105716228485107,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm",
            "probability": 0.011923671563859598,
            "start_logit": 4.314774036407471,
            "end_logit": 3.1697542667388916,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "systemic mastocytosis (ASM), systemic mastocytosis",
            "probability": 0.011164115919200438,
            "start_logit": 4.314774036407471,
            "end_logit": 3.103933334350586,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "acute myeloid leukemia with activating FLT3 mutations",
            "probability": 0.009720672386258497,
            "start_logit": 5.7549238204956055,
            "end_logit": 1.5253336429595947,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "systemic mastocytosis with associated hematological neoplasm",
            "probability": 0.009347463568673432,
            "start_logit": 4.071353435516357,
            "end_logit": 3.1697542667388916,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis",
            "probability": 0.008762570552334578,
            "start_logit": 2.435981512069702,
            "end_logit": 4.7405104637146,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "aggressive systemic mastocytosis",
            "probability": 0.005859047253214064,
            "start_logit": 2.0334792137145996,
            "end_logit": 4.7405104637146,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm",
            "probability": 0.00534157934363967,
            "start_logit": 3.5117697715759277,
            "end_logit": 3.1697542667388916,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "systemic mastocytosis (ASM)",
            "probability": 0.005001584656530968,
            "start_logit": 4.314774036407471,
            "end_logit": 2.300983428955078,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "mastocytosis (ASM), systemic mastocytosis",
            "probability": 0.005001312780599336,
            "start_logit": 3.5117697715759277,
            "end_logit": 3.103933334350586,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        }
    ],
    "5c73ad087c78d69471000091": [
        {
            "text": "ivacaftor",
            "probability": 0.2395914510555027,
            "start_logit": 5.618992328643799,
            "end_logit": 5.240555286407471,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor",
            "probability": 0.21734021749628268,
            "start_logit": 5.47299337387085,
            "end_logit": 5.289083003997803,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor or VX-809) and a potentiator of channel activity (ivacaftor",
            "probability": 0.2070450144557357,
            "start_logit": 5.47299337387085,
            "end_logit": 5.240555286407471,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor combined with ivacaftor",
            "probability": 0.09427319354363618,
            "start_logit": 5.125503063201904,
            "end_logit": 4.801306247711182,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor/ivacaftor",
            "probability": 0.07380509631811467,
            "start_logit": 4.979789733886719,
            "end_logit": 4.7022504806518555,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "ivacaftor (Kalydeco) and lumacaftor",
            "probability": 0.04351269072059829,
            "start_logit": 4.642946720123291,
            "end_logit": 4.51071834564209,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "ivacaftor (Kalydeco) and lumacaftor/ivacaftor",
            "probability": 0.04188575185545176,
            "start_logit": 4.642946720123291,
            "end_logit": 4.472611427307129,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "VX-809) and a potentiator of channel activity (ivacaftor",
            "probability": 0.030582493673172333,
            "start_logit": 3.5604848861694336,
            "end_logit": 5.240555286407471,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "ivacaftor or VX-770",
            "probability": 0.017803621044273216,
            "start_logit": 5.618992328643799,
            "end_logit": 2.641021966934204,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor or VX-809",
            "probability": 0.008421014722763161,
            "start_logit": 5.47299337387085,
            "end_logit": 2.0383493900299072,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor in combination with ivacaftor",
            "probability": 0.006325533775548202,
            "start_logit": 3.8059561252593994,
            "end_logit": 3.419250726699829,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor alone and lumacaftor",
            "probability": 0.0051368790408882195,
            "start_logit": 3.5627593994140625,
            "end_logit": 3.454298734664917,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor alone and lumacaftor in combination with ivacaftor",
            "probability": 0.004959960101234399,
            "start_logit": 3.5627593994140625,
            "end_logit": 3.419250726699829,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "VX-770",
            "probability": 0.0037587120466808822,
            "start_logit": 4.063666820526123,
            "end_logit": 2.641021966934204,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "VX-809) and a potentiator of channel activity (ivacaftor or VX-770",
            "probability": 0.0022725315346076845,
            "start_logit": 3.5604848861694336,
            "end_logit": 2.641021966934204,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "VX-809",
            "probability": 0.0012438629838906563,
            "start_logit": 3.5604848861694336,
            "end_logit": 2.0383493900299072,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "(lumacaftor",
            "probability": 0.0005585137971642673,
            "start_logit": -0.49094653129577637,
            "end_logit": 5.289083003997803,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "(lumacaftor or VX-809) and a potentiator of channel activity (ivacaftor",
            "probability": 0.0005320575204153433,
            "start_logit": -0.49094653129577637,
            "end_logit": 5.240555286407471,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "ivacaft",
            "probability": 0.000482655522841178,
            "start_logit": 5.618992328643799,
            "end_logit": -0.9668319821357727,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "ivacaftor or VX-770),",
            "probability": 0.00046874879119775223,
            "start_logit": 5.618992328643799,
            "end_logit": -0.9960681796073914,
            "question_text": "Which drugs are included in the Orkambi pill?"
        }
    ],
    "5c6c46677c78d69471000035": [
        {
            "text": "NanoStringNormCNV",
            "probability": 0.7017131191056282,
            "start_logit": 3.536292791366577,
            "end_logit": 3.32492995262146,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm",
            "probability": 0.24496737121050124,
            "start_logit": 2.9760913848876953,
            "end_logit": 2.8327317237854004,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm in the R statistical language.NanoStringNormCNV",
            "probability": 0.02773017733299149,
            "start_logit": 1.3116365671157837,
            "end_logit": 2.318582773208618,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNormCNV,",
            "probability": 0.017004299385249937,
            "start_logit": 3.536292791366577,
            "end_logit": -0.3951284885406494,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm:",
            "probability": 0.0012535753616892047,
            "start_logit": 2.9760913848876953,
            "end_logit": -2.4423935413360596,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNormCNV, an R package for pre-processing and copy number variant calling",
            "probability": 0.0010593616034693778,
            "start_logit": 3.536292791366577,
            "end_logit": -3.1709282398223877,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA",
            "probability": 0.000834458578320893,
            "start_logit": 2.9760913848876953,
            "end_logit": -2.849365472793579,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNormCNV, an R package for pre-processing and copy number variant calling from NanoString data",
            "probability": 0.0007686159267188916,
            "start_logit": 3.536292791366577,
            "end_logit": -3.4917585849761963,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNormCNV: pre-processing of NanoString CNV data",
            "probability": 0.000724096396324825,
            "start_logit": 2.775635242462158,
            "end_logit": -2.7907679080963135,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA",
            "probability": 0.0007015159983830374,
            "start_logit": 2.9760913848876953,
            "end_logit": -3.022904872894287,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data",
            "probability": 0.0006613730657184192,
            "start_logit": 2.9760913848876953,
            "end_logit": -3.0818305015563965,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "Na",
            "probability": 0.000526292074940844,
            "start_logit": 3.536292791366577,
            "end_logit": -3.8704936504364014,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNormCNV, an R package",
            "probability": 0.0005036977311495538,
            "start_logit": 3.536292791366577,
            "end_logit": -3.9143736362457275,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNormCNV: pre-processing",
            "probability": 0.000418086051569451,
            "start_logit": 2.775635242462158,
            "end_logit": -3.3400051593780518,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "created NanoStringNormCNV",
            "probability": 0.000321085627973513,
            "start_logit": -4.1532793045043945,
            "end_logit": 3.32492995262146,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm: an extensible R package for the pre-processing",
            "probability": 0.0003184133293076122,
            "start_logit": 2.9760913848876953,
            "end_logit": -3.812798261642456,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "R statistical language.NanoStringNormCNV",
            "probability": 0.0002825894435401253,
            "start_logit": -3.2746448516845703,
            "end_logit": 2.318582773208618,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm in the R statistical language.NanoStringNormCNV: pre-processing",
            "probability": 9.670727197131948e-05,
            "start_logit": 1.3116365671157837,
            "end_logit": -3.3400051593780518,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm in the R statistical language.Na",
            "probability": 6.0334668388429905e-05,
            "start_logit": 1.3116365671157837,
            "end_logit": -3.8117868900299072,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoStringNorm in the R",
            "probability": 5.4829836163745394e-05,
            "start_logit": 1.3116365671157837,
            "end_logit": -3.907459259033203,
            "question_text": "List available R packages for processing NanoString data"
        }
    ],
    "5c76e6d27c78d694710000ac": [
        {
            "text": "early endosome antigen 1",
            "probability": 0.2738669133698525,
            "start_logit": 4.549646854400635,
            "end_logit": 4.288418292999268,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "mannose-6-phosphate receptor",
            "probability": 0.06869264510453534,
            "start_logit": 3.922919750213623,
            "end_logit": 3.5321452617645264,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7",
            "probability": 0.06549118177407849,
            "start_logit": 3.923537254333496,
            "end_logit": 3.4838011264801025,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "mannose-6-phosphate receptor (M6PR) and Rab7",
            "probability": 0.06545075318321301,
            "start_logit": 3.922919750213623,
            "end_logit": 3.4838011264801025,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7, Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9",
            "probability": 0.04992819447995272,
            "start_logit": 3.805286169052124,
            "end_logit": 3.3307225704193115,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "CD63 and Rab7 late phagosomal markers mannose-6-phosphate receptor",
            "probability": 0.04674586627018134,
            "start_logit": 3.538003444671631,
            "end_logit": 3.5321452617645264,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9",
            "probability": 0.04174043524004685,
            "start_logit": 3.6261706352233887,
            "end_logit": 3.3307225704193115,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab9",
            "probability": 0.03741026474921304,
            "start_logit": 3.5166454315185547,
            "end_logit": 3.3307225704193115,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7, Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9, and V-ATPase",
            "probability": 0.03528590871185808,
            "start_logit": 3.805286169052124,
            "end_logit": 2.9836204051971436,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7 late phagosomal markers mannose-6-phosphate receptor",
            "probability": 0.03232383962020952,
            "start_logit": 3.1690826416015625,
            "end_logit": 3.5321452617645264,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7, Lysosomal Associated Membrane Protein 1, Cathepsin D",
            "probability": 0.031008720058253125,
            "start_logit": 3.805286169052124,
            "end_logit": 2.854405164718628,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7 late phagosomal markers mannose-6-phosphate receptor (M6PR) and Rab7",
            "probability": 0.030798343049631874,
            "start_logit": 3.1690826416015625,
            "end_logit": 3.4838011264801025,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Cathepsin D, Rab9",
            "probability": 0.029884146455586787,
            "start_logit": 3.2920284271240234,
            "end_logit": 3.3307225704193115,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9, and V-ATPase",
            "probability": 0.029499348070054863,
            "start_logit": 3.6261706352233887,
            "end_logit": 2.9836204051971436,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Transferrin receptor",
            "probability": 0.029235677537804015,
            "start_logit": 3.4859700202941895,
            "end_logit": 3.114842653274536,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7, Lysosomal Associated Membrane Protein 1",
            "probability": 0.028532347353538746,
            "start_logit": 3.805286169052124,
            "end_logit": 2.7711751461029053,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "CD63",
            "probability": 0.027704469223760863,
            "start_logit": 3.538003444671631,
            "end_logit": 3.0090131759643555,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab9, and V-ATPase",
            "probability": 0.026439073164506378,
            "start_logit": 3.5166454315185547,
            "end_logit": 2.9836204051971436,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Lysosomal Associated Membrane Protein 1, Cathepsin D",
            "probability": 0.025923578550150726,
            "start_logit": 3.6261706352233887,
            "end_logit": 2.854405164718628,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "mannose-6-phosphate receptor (M6PR",
            "probability": 0.02403829403357153,
            "start_logit": 3.922919750213623,
            "end_logit": 2.4821512699127197,
            "question_text": "List phagosomal markers."
        }
    ],
    "5c0119f3133db5eb7800002b": [
        {
            "text": "Klebsiella pneumonia",
            "probability": 0.2416859793669906,
            "start_logit": 1.3371741771697998,
            "end_logit": 0.4275670647621155,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumoniae",
            "probability": 0.17286444831508418,
            "start_logit": 0.7781839370727539,
            "end_logit": 0.6514257788658142,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumoniae, and Klebsiella pneumonia",
            "probability": 0.1381926930319391,
            "start_logit": 0.7781839370727539,
            "end_logit": 0.4275670647621155,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Klebsiella pneumoniae",
            "probability": 0.07963645876517988,
            "start_logit": 1.3371741771697998,
            "end_logit": -0.682600200176239,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumonia",
            "probability": 0.05035105685594452,
            "start_logit": 1.255557894706726,
            "end_logit": -1.059436321258545,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumoniae, and Klebsiella pneumoniae",
            "probability": 0.0455350232939092,
            "start_logit": 0.7781839370727539,
            "end_logit": -0.682600200176239,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus",
            "probability": 0.04537448844414903,
            "start_logit": 1.255557894706726,
            "end_logit": -1.1635059118270874,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Staphylococcus aureus, Streptococcus pneumoniae",
            "probability": 0.044709657258265166,
            "start_logit": -0.5741342902183533,
            "end_logit": 0.6514257788658142,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumonia",
            "probability": 0.03574215520471195,
            "start_logit": -0.5741342902183533,
            "end_logit": 0.4275670647621155,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Klebsiella",
            "probability": 0.03358037816786309,
            "start_logit": 1.3371741771697998,
            "end_logit": -1.5461302995681763,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Staphylococcus aureus",
            "probability": 0.024750926588995394,
            "start_logit": -0.5741342902183533,
            "end_logit": 0.06009918078780174,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumoniae, and Klebsiella",
            "probability": 0.01920079478421635,
            "start_logit": 0.7781839370727539,
            "end_logit": -1.5461302995681763,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Moraxella catarrhalis",
            "probability": 0.018183789070294127,
            "start_logit": -0.43055179715156555,
            "end_logit": -0.39181575179100037,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae",
            "probability": 0.011777177462233293,
            "start_logit": -0.5741342902183533,
            "end_logit": -0.682600200176239,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Haemophilus influenzae, and 100 Moraxella catarrhalis",
            "probability": 0.011775505126782226,
            "start_logit": -0.8650607466697693,
            "end_logit": -0.39181575179100037,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Haemophilus influenzae",
            "probability": 0.00832653430796219,
            "start_logit": -0.8650607466697693,
            "end_logit": -0.7383899688720703,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumoniae (plus 30 levofloxacin-resistant isolates), 200 Haemophilus",
            "probability": 0.0056257388511923665,
            "start_logit": 1.255557894706726,
            "end_logit": -3.251103639602661,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella",
            "probability": 0.004966093157130037,
            "start_logit": -0.5741342902183533,
            "end_logit": -1.5461302995681763,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Klebsiel",
            "probability": 0.004912310749394748,
            "start_logit": 1.3371741771697998,
            "end_logit": -3.468327760696411,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumoniae, and Klebsiel",
            "probability": 0.002808791197762461,
            "start_logit": 0.7781839370727539,
            "end_logit": -3.468327760696411,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        }
    ],
    "5c7036127c78d69471000064": [
        {
            "text": "Robotic Cystectomy",
            "probability": 0.41609893556167643,
            "start_logit": 5.291118144989014,
            "end_logit": 5.642940044403076,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "Open versus Robotic Cystectomy",
            "probability": 0.11481055703983267,
            "start_logit": 4.003478527069092,
            "end_logit": 5.642940044403076,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic cystectomy",
            "probability": 0.0902950321117461,
            "start_logit": 4.547184467315674,
            "end_logit": 4.859033107757568,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "Robot-assisted radical cystectomy",
            "probability": 0.08572732043218759,
            "start_logit": 4.471309185028076,
            "end_logit": 4.882997512817383,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "Robot-assisted radical cystectomy versus open radical cystectomy",
            "probability": 0.08429877622644975,
            "start_logit": 4.471309185028076,
            "end_logit": 4.8661932945251465,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open radical cystectomy",
            "probability": 0.058693932976509745,
            "start_logit": 4.109278202056885,
            "end_logit": 4.8661932945251465,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic cystectomy) study is to compare open radical cystectomy",
            "probability": 0.03346105895990746,
            "start_logit": 3.959409713745117,
            "end_logit": 4.454107761383057,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "Robotic",
            "probability": 0.027008923283456745,
            "start_logit": 5.291118144989014,
            "end_logit": 2.908184289932251,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "Cystectomy",
            "probability": 0.022259673886766543,
            "start_logit": 2.362971782684326,
            "end_logit": 5.642940044403076,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open vs robotic cystectomy",
            "probability": 0.009897937281964572,
            "start_logit": 2.33642840385437,
            "end_logit": 4.859033107757568,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "Open versus Robotic",
            "probability": 0.007452337081886481,
            "start_logit": 4.003478527069092,
            "end_logit": 2.908184289932251,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "radical cystectomy",
            "probability": 0.007108257589693148,
            "start_logit": 2.4102845191955566,
            "end_logit": 4.454107761383057,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic cystectomy) study is to compare open radical cystectomy (ORC) vs robot-assisted",
            "probability": 0.006443306290210992,
            "start_logit": 3.959409713745117,
            "end_logit": 2.806767225265503,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robot-assisted",
            "probability": 0.0062043730249759215,
            "start_logit": 3.9216222763061523,
            "end_logit": 2.806767225265503,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "Open",
            "probability": 0.005824296156346407,
            "start_logit": 4.003478527069092,
            "end_logit": 2.6616947650909424,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robot-assisted RC (RARC), pelvic lymph node dissection",
            "probability": 0.005606898760527298,
            "start_logit": 3.9216222763061523,
            "end_logit": 2.7055106163024902,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open radical cystectomy (ORC) vs robot-assisted",
            "probability": 0.005442287625127516,
            "start_logit": 3.790567398071289,
            "end_logit": 2.806767225265503,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open vs robotic cystectomy) study is to compare open radical cystectomy",
            "probability": 0.004514508730810707,
            "start_logit": 1.9563237428665161,
            "end_logit": 4.454107761383057,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic",
            "probability": 0.004508952304513675,
            "start_logit": 4.547184467315674,
            "end_logit": 1.8620154857635498,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic cystectomy) trial: study design and trial update.The purpose of the RAZOR (randomized open",
            "probability": 0.004342634675410148,
            "start_logit": 4.547184467315674,
            "end_logit": 1.8244318962097168,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        }
    ],
    "5c5214207e3cb0e231000003": [
        {
            "text": "development of drugs against disease-associated genes",
            "probability": 0.2073359295856521,
            "start_logit": 0.96193927526474,
            "end_logit": 1.0820932388305664,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "drugs against disease-associated genes",
            "probability": 0.1418485934714415,
            "start_logit": 0.5823591947555542,
            "end_logit": 1.0820932388305664,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "development of drugs",
            "probability": 0.10939753221795595,
            "start_logit": 0.96193927526474,
            "end_logit": 0.4427412450313568,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "the development of drugs against disease-associated genes",
            "probability": 0.10450674991602141,
            "start_logit": 0.2768506109714508,
            "end_logit": 1.0820932388305664,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "disease-associated genes",
            "probability": 0.10333494397179376,
            "start_logit": 0.26557454466819763,
            "end_logit": 1.0820932388305664,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "drugs",
            "probability": 0.07484417247592001,
            "start_logit": 0.5823591947555542,
            "end_logit": 0.4427412450313568,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "the development of drugs",
            "probability": 0.05514133784616836,
            "start_logit": 0.2768506109714508,
            "end_logit": 0.4427412450313568,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "levels of funding awarded by the National Institutes of Health (NIH), and the development of drugs against disease-associated genes",
            "probability": 0.033202145266966764,
            "start_logit": -0.8697865605354309,
            "end_logit": 1.0820932388305664,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "funding awarded by the National Institutes of Health (NIH), and the development of drugs against disease-associated genes",
            "probability": 0.03309497160424911,
            "start_logit": -0.8730196952819824,
            "end_logit": 1.0820932388305664,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "the levels of funding awarded by the National Institutes of Health (NIH), and the development of drugs against disease-associated genes",
            "probability": 0.01862153974349325,
            "start_logit": -1.4480820894241333,
            "end_logit": 1.0820932388305664,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "National Institutes of Health (NIH), and the development of drugs against disease-associated genes",
            "probability": 0.018418406441679927,
            "start_logit": -1.4590505361557007,
            "end_logit": 1.0820932388305664,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "levels of funding awarded by the National Institutes of Health (NIH), and the development of drugs",
            "probability": 0.017518588137651975,
            "start_logit": -0.8697865605354309,
            "end_logit": 0.4427412450313568,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "funding awarded by the National Institutes of Health (NIH), and the development of drugs",
            "probability": 0.017462039645340485,
            "start_logit": -0.8730196952819824,
            "end_logit": 0.4427412450313568,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "development of drugs against disease",
            "probability": 0.011894161235745217,
            "start_logit": 0.96193927526474,
            "end_logit": -1.776199460029602,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "the levels of funding awarded by the National Institutes of Health (NIH), and the development of drugs",
            "probability": 0.009825361663595248,
            "start_logit": -1.4480820894241333,
            "end_logit": 0.4427412450313568,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "National Institutes of Health (NIH), and the development of drugs",
            "probability": 0.009718181581618754,
            "start_logit": -1.4590505361557007,
            "end_logit": 0.4427412450313568,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "levels of funding awarded by the National Institutes of Health",
            "probability": 0.008743922471663357,
            "start_logit": -0.8697865605354309,
            "end_logit": -0.252162367105484,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "funding awarded by the National Institutes of Health",
            "probability": 0.008715697843698139,
            "start_logit": -0.8730196952819824,
            "end_logit": -0.252162367105484,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "development of drugs against disease-associated",
            "probability": 0.008238350690583552,
            "start_logit": 0.96193927526474,
            "end_logit": -2.143446922302246,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "drugs against disease",
            "probability": 0.008137374188760746,
            "start_logit": 0.5823591947555542,
            "end_logit": -1.776199460029602,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        }
    ],
    "5c7ab080d774d0424000000b": [
        {
            "text": "dimethylxanthenone-4-acetic acid",
            "probability": 0.4827674537791088,
            "start_logit": 3.7387163639068604,
            "end_logit": 3.2816920280456543,
            "question_text": "List STING agonists."
        },
        {
            "text": "dimethylxanthenone",
            "probability": 0.1286985159154094,
            "start_logit": 3.7387163639068604,
            "end_logit": 1.9596295356750488,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP) STING agonist, dimethylxanthenone-4-acetic acid",
            "probability": 0.1257112234840895,
            "start_logit": 2.3931686878204346,
            "end_logit": 3.2816920280456543,
            "question_text": "List STING agonists."
        },
        {
            "text": "dimethylxanthenone-4-acetic acid (DMXAA",
            "probability": 0.045772653277688695,
            "start_logit": 3.7387163639068604,
            "end_logit": 0.9258437752723694,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP",
            "probability": 0.04037659230908736,
            "start_logit": 2.3931686878204346,
            "end_logit": 2.1459548473358154,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP) STING agonist, dimethylxanthenone",
            "probability": 0.03351271459926407,
            "start_logit": 2.3931686878204346,
            "end_logit": 1.9596295356750488,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP (cGAMP) STING agonist, dimethylxanthenone-4-acetic acid",
            "probability": 0.02948804619811909,
            "start_logit": 0.9431662559509277,
            "end_logit": 3.2816920280456543,
            "question_text": "List STING agonists."
        },
        {
            "text": "3'3'-cGAMP (cGAMP) STING agonist, dimethylxanthenone-4-acetic acid",
            "probability": 0.018429276305832083,
            "start_logit": 0.4731217920780182,
            "end_logit": 3.2816920280456543,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP) STING agonist, dimethylxanthenone-4-acetic acid (DMXAA",
            "probability": 0.011919064138661015,
            "start_logit": 2.3931686878204346,
            "end_logit": 0.9258437752723694,
            "question_text": "List STING agonists."
        },
        {
            "text": "CDN 3'3'-cGAMP",
            "probability": 0.00969404902830466,
            "start_logit": 0.5362403392791748,
            "end_logit": 2.5761451721191406,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP (cGAMP",
            "probability": 0.009471125857618262,
            "start_logit": 0.9431662559509277,
            "end_logit": 2.1459548473358154,
            "question_text": "List STING agonists."
        },
        {
            "text": "(cGAMP) STING agonist, dimethylxanthenone-4-acetic acid",
            "probability": 0.009288735202038075,
            "start_logit": -0.21201631426811218,
            "end_logit": 3.2816920280456543,
            "question_text": "List STING agonists."
        },
        {
            "text": "3'3'-cGAMP",
            "probability": 0.009101085096630152,
            "start_logit": 0.4731217920780182,
            "end_logit": 2.5761451721191406,
            "question_text": "List STING agonists."
        },
        {
            "text": "dimethylxanthenone-4-acetic acid (DMXAA)",
            "probability": 0.008696386417241055,
            "start_logit": 3.7387163639068604,
            "end_logit": -0.734935462474823,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP (cGAMP) STING agonist, dimethylxanthenone",
            "probability": 0.007861068001239781,
            "start_logit": 0.9431662559509277,
            "end_logit": 1.9596295356750488,
            "question_text": "List STING agonists."
        },
        {
            "text": "CDN 3'3'-cGAMP (cGAMP",
            "probability": 0.006304866970966275,
            "start_logit": 0.5362403392791748,
            "end_logit": 2.1459548473358154,
            "question_text": "List STING agonists."
        },
        {
            "text": "3'3'-cGAMP (cGAMP",
            "probability": 0.005919211947263271,
            "start_logit": 0.4731217920780182,
            "end_logit": 2.1459548473358154,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP)",
            "probability": 0.005910591699412903,
            "start_logit": 2.3931686878204346,
            "end_logit": 0.22445057332515717,
            "question_text": "List STING agonists."
        },
        {
            "text": "dimethylxanthenone-4-acetic acid (DMXAA) various cyclic dinucleotide",
            "probability": 0.005844277859151618,
            "start_logit": 3.7387163639068604,
            "end_logit": -1.1323800086975098,
            "question_text": "List STING agonists."
        },
        {
            "text": "CDN 3'3'-cGAMP (cGAMP) STING agonist, dimethylxanthenone",
            "probability": 0.005233061912873826,
            "start_logit": 0.5362403392791748,
            "end_logit": 1.9596295356750488,
            "question_text": "List STING agonists."
        }
    ],
    "5c6dfdf27c78d69471000047": [
        {
            "text": "nivolumab plus ipilimumab",
            "probability": 0.197310293154965,
            "start_logit": 4.924731731414795,
            "end_logit": 4.83879280090332,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "ipilimumab",
            "probability": 0.16160967877969992,
            "start_logit": 4.725138187408447,
            "end_logit": 4.83879280090332,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "nivolumab",
            "probability": 0.1343531934749412,
            "start_logit": 4.924731731414795,
            "end_logit": 4.454487323760986,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "nivolumab plus ipilimumab resulted in greater objective response rate and prolonged progression-free survival when compared with sunitinib",
            "probability": 0.13135867190281844,
            "start_logit": 4.924731731414795,
            "end_logit": 4.431946754455566,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "sunitinib",
            "probability": 0.10861866513241865,
            "start_logit": 4.734643459320068,
            "end_logit": 4.431946754455566,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "ipilimumab resulted in greater objective response rate and prolonged progression-free survival when compared with sunitinib",
            "probability": 0.1075911065342629,
            "start_logit": 4.725138187408447,
            "end_logit": 4.431946754455566,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "sunitinib in intermediate- and poor-risk patients with previously untreated aRCCNivolumab plus Ipilimumab",
            "probability": 0.04709120466260496,
            "start_logit": 4.734643459320068,
            "end_logit": 3.5961897373199463,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "sunitinib in intermediate- and poor-risk patients with previously untreated aRCCNivolumab",
            "probability": 0.026188127908345578,
            "start_logit": 4.734643459320068,
            "end_logit": 3.0094096660614014,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Sunitinib",
            "probability": 0.020074419292222423,
            "start_logit": 3.6512184143066406,
            "end_logit": 3.826974868774414,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Ipilimumab versus Sunitinib",
            "probability": 0.016966686436555502,
            "start_logit": 3.4830238819122314,
            "end_logit": 3.826974868774414,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Nivolumab plus Ipilimumab versus Sunitinib",
            "probability": 0.015029418524106384,
            "start_logit": 3.361781597137451,
            "end_logit": 3.826974868774414,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Ipilimumab",
            "probability": 0.013470022605781505,
            "start_logit": 3.4830238819122314,
            "end_logit": 3.5961897373199463,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Nivolumab plus Ipilimumab",
            "probability": 0.01193200617153411,
            "start_logit": 3.361781597137451,
            "end_logit": 3.5961897373199463,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Nivolumab",
            "probability": 0.0066355682778156105,
            "start_logit": 3.361781597137451,
            "end_logit": 3.0094096660614014,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Sunitinib in Advanced Renal-Cell Carcinoma.BACKGROUND: Nivolumab plus ipilimumab",
            "probability": 0.0007694492712915769,
            "start_logit": 3.6512184143066406,
            "end_logit": 0.5654482841491699,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Sunitinib in Advanced Renal-Cell Carcinoma.BACKGROUND: Nivolumab",
            "probability": 0.0003087936581680336,
            "start_logit": 3.6512184143066406,
            "end_logit": -0.34755346179008484,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.BACKGROUND: Nivolumab",
            "probability": 0.00026098912728019955,
            "start_logit": 3.4830238819122314,
            "end_logit": -0.34755346179008484,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "combined immunotherapy with nivolumab plus ipilimumab",
            "probability": 0.00016698269803807958,
            "start_logit": -2.1499109268188477,
            "end_logit": 4.83879280090332,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "in 2017, the phase III study CheckMate 214 showed that combined immunotherapy with nivolumab",
            "probability": 0.0001510199625182766,
            "start_logit": -1.8660836219787598,
            "end_logit": 4.454487323760986,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "combined immunotherapy with nivolumab",
            "probability": 0.00011370242463153146,
            "start_logit": -2.1499109268188477,
            "end_logit": 4.454487323760986,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        }
    ],
    "5c6e01af7c78d69471000048": [
        {
            "text": "cytomegalovirus infection and disease after stem cell transplant",
            "probability": 0.27098208148095515,
            "start_logit": 5.3454132080078125,
            "end_logit": 4.843627452850342,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus",
            "probability": 0.21682101541303814,
            "start_logit": 5.3454132080078125,
            "end_logit": 4.620646953582764,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus infection",
            "probability": 0.2140755956220325,
            "start_logit": 5.3454132080078125,
            "end_logit": 4.607903957366943,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "asthma",
            "probability": 0.04992300606406257,
            "start_logit": 4.36570405960083,
            "end_logit": 4.131765842437744,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prophylaxis of cytomegalovirus infection and disease after stem cell transplant",
            "probability": 0.04705469930860749,
            "start_logit": 3.5946712493896484,
            "end_logit": 4.843627452850342,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prophylaxis of cytomegalovirus",
            "probability": 0.03764989783933184,
            "start_logit": 3.5946712493896484,
            "end_logit": 4.620646953582764,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prophylaxis of cytomegalovirus infection",
            "probability": 0.03717316925995251,
            "start_logit": 3.5946712493896484,
            "end_logit": 4.607903957366943,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "stem cell transplant",
            "probability": 0.03417160269489808,
            "start_logit": 3.2747554779052734,
            "end_logit": 4.843627452850342,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus infection and disease",
            "probability": 0.026286998152025648,
            "start_logit": 5.3454132080078125,
            "end_logit": 2.5106492042541504,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "stem cell transplant; benralizumab (Fasenra) for the add-on maintenance treatment of severe asthma",
            "probability": 0.016769023718377005,
            "start_logit": 3.2747554779052734,
            "end_logit": 4.131765842437744,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "reduction of intraocular pressure; letermovir (Prevymis) for prophylaxis of cytomegalovirus",
            "probability": 0.008927786245491717,
            "start_logit": 2.1555094718933105,
            "end_logit": 4.620646953582764,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "intraocular pressure; letermovir (Prevymis) for prophylaxis of cytomegalovirus",
            "probability": 0.007141276984672259,
            "start_logit": 1.9322326183319092,
            "end_logit": 4.620646953582764,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "intraocular pressure; letermovir (Prevymis) for prophylaxis of cytomegalovirus infection",
            "probability": 0.007050853078440551,
            "start_logit": 1.9322326183319092,
            "end_logit": 4.607903957366943,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus infection treatment and prophylaxis",
            "probability": 0.006772567030389854,
            "start_logit": 4.246214866638184,
            "end_logit": 2.2536532878875732,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "severe asthma",
            "probability": 0.00527796880185279,
            "start_logit": 2.1187634468078613,
            "end_logit": 4.131765842437744,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prophylaxis of cytomegalovirus infection and disease",
            "probability": 0.004564607323884697,
            "start_logit": 3.5946712493896484,
            "end_logit": 2.5106492042541504,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus infection treatment",
            "probability": 0.0038507191995851785,
            "start_logit": 4.246214866638184,
            "end_logit": 1.689033031463623,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "for prophylaxis of cytomegalovirus infection and disease after stem cell transplant",
            "probability": 0.0021018704403417987,
            "start_logit": 0.486188143491745,
            "end_logit": 4.843627452850342,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus infection and disease after stem cell transplant;",
            "probability": 0.0017234907960115104,
            "start_logit": 5.3454132080078125,
            "end_logit": -0.21407347917556763,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "for prophylaxis of cytomegalovirus",
            "probability": 0.0016817705460484013,
            "start_logit": 0.486188143491745,
            "end_logit": 4.620646953582764,
            "question_text": "List two indications of Letermovir?"
        }
    ],
    "5c544c1707647bbc4b000003": [
        {
            "text": "AsCNAR",
            "probability": 0.842496538846812,
            "start_logit": 4.596693515777588,
            "end_logit": 4.519615650177002,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\"",
            "probability": 0.0778997449970382,
            "start_logit": 4.596693515777588,
            "end_logit": 2.1386687755584717,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "UPDtool",
            "probability": 0.0522583574163471,
            "start_logit": 2.8481950759887695,
            "end_logit": 3.4879443645477295,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "\"AsCNAR",
            "probability": 0.014409070284480737,
            "start_logit": 0.5281818509101868,
            "end_logit": 4.519615650177002,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis using anonymous references)",
            "probability": 0.0035144084822484795,
            "start_logit": 4.596693515777588,
            "end_logit": -0.9598826766014099,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis using anonymous references),",
            "probability": 0.002045513693758537,
            "start_logit": 4.596693515777588,
            "end_logit": -1.5011049509048462,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis",
            "probability": 0.001760991537783546,
            "start_logit": 4.596693515777588,
            "end_logit": -1.6508768796920776,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis using anonymous references",
            "probability": 0.0016783917413428675,
            "start_logit": 4.596693515777588,
            "end_logit": -1.6989178657531738,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "\"AsCNAR\"",
            "probability": 0.0013323056523672475,
            "start_logit": 0.5281818509101868,
            "end_logit": 2.1386687755584717,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "trio SNP-microarray experiments.The performance of the new algorithm, called \"AsCNAR",
            "probability": 0.0006380129703968353,
            "start_logit": -2.5890727043151855,
            "end_logit": 4.519615650177002,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "As",
            "probability": 0.0005491850909895386,
            "start_logit": 4.596693515777588,
            "end_logit": -2.8160736560821533,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "microarray experiments.The performance of the new algorithm, called \"AsCNAR",
            "probability": 0.000511214279710265,
            "start_logit": -2.8106424808502197,
            "end_logit": 4.519615650177002,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (all",
            "probability": 0.00043554360442131095,
            "start_logit": 4.596693515777588,
            "end_logit": -3.0479142665863037,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "UPDtool is a computational tool for detection and classification",
            "probability": 7.827193015387373e-05,
            "start_logit": 2.8481950759887695,
            "end_logit": -3.015821695327759,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "UPDtool is a computational tool for detection and classification of uniparental disomy",
            "probability": 7.21608811978051e-05,
            "start_logit": 2.8481950759887695,
            "end_logit": -3.0971126556396484,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "UPDtool is a computational",
            "probability": 7.140545673744611e-05,
            "start_logit": 2.8481950759887695,
            "end_logit": -3.1076364517211914,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "UPDtool is a computational tool",
            "probability": 6.95592235263514e-05,
            "start_logit": 2.8481950759887695,
            "end_logit": -3.1338322162628174,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "allele-specific copy-number analysis using anonymous references)",
            "probability": 6.022501603228754e-05,
            "start_logit": 0.530154824256897,
            "end_logit": -0.9598826766014099,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "\"AsCNAR\" (allele-specific copy-number analysis using anonymous references)",
            "probability": 6.010631082046638e-05,
            "start_logit": 0.5281818509101868,
            "end_logit": -0.9598826766014099,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "trio SNP-microarray experiments.The performance of the new algorithm, called \"AsCNAR\"",
            "probability": 5.899258383511686e-05,
            "start_logit": -2.5890727043151855,
            "end_logit": 2.1386687755584717,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        }
    ],
    "5c6b7daa7c78d6947100002b": [
        {
            "text": "telangiectasias",
            "probability": 0.16167192445999168,
            "start_logit": 4.642078876495361,
            "end_logit": 5.338984966278076,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis",
            "probability": 0.09971856664880561,
            "start_logit": 4.642078876495361,
            "end_logit": 4.855767726898193,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis, monoclonal gammopathy",
            "probability": 0.0891952493466063,
            "start_logit": 4.52493953704834,
            "end_logit": 4.861382961273193,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis",
            "probability": 0.08869580068935924,
            "start_logit": 4.52493953704834,
            "end_logit": 4.855767726898193,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy",
            "probability": 0.08127715964196737,
            "start_logit": 4.431976795196533,
            "end_logit": 4.861382961273193,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis, monoclonal gammopathy, perinephric fluid collections",
            "probability": 0.06293410053655404,
            "start_logit": 4.52493953704834,
            "end_logit": 4.512643337249756,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy, perinephric fluid collections",
            "probability": 0.05734727996954412,
            "start_logit": 4.431976795196533,
            "end_logit": 4.512643337249756,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting",
            "probability": 0.04355739710845468,
            "start_logit": 4.431976795196533,
            "end_logit": 4.237597465515137,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis with elevated erythropoietin, monoclonal gammopathy",
            "probability": 0.038662135716162616,
            "start_logit": 4.203813552856445,
            "end_logit": 4.346541881561279,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "perinephric fluid collections",
            "probability": 0.03449648021026162,
            "start_logit": 3.92370867729187,
            "end_logit": 4.512643337249756,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin",
            "probability": 0.03378478964296796,
            "start_logit": 4.534408092498779,
            "end_logit": 3.8810973167419434,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, erythrocytosis",
            "probability": 0.031610957853551946,
            "start_logit": 4.534408092498779,
            "end_logit": 3.8145904541015625,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "perinephric fluid collections, and intrapulmonary shunting",
            "probability": 0.02620136278756899,
            "start_logit": 3.92370867729187,
            "end_logit": 4.237597465515137,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, elevated erythropoietin",
            "probability": 0.024704471568675657,
            "start_logit": 4.642078876495361,
            "end_logit": 3.460400104522705,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis with elevated erythropoietin",
            "probability": 0.02427425080789182,
            "start_logit": 4.203813552856445,
            "end_logit": 3.8810973167419434,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin level and erythrocytosis, monoclonal gammopathy",
            "probability": 0.024004045981682418,
            "start_logit": 3.212334156036377,
            "end_logit": 4.861382961273193,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin level and erythrocytosis",
            "probability": 0.02386963536427991,
            "start_logit": 3.212334156036377,
            "end_logit": 4.855767726898193,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "intrapulmonary shunting",
            "probability": 0.020222158049067414,
            "start_logit": 3.6646761894226074,
            "end_logit": 4.237597465515137,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting",
            "probability": 0.0177906291320086,
            "start_logit": 3.91396164894104,
            "end_logit": 3.8602049350738525,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythropoietin, monoclonal gammopathy",
            "probability": 0.01598160448459787,
            "start_logit": 3.3203911781311035,
            "end_logit": 4.346541881561279,
            "question_text": "List major features of TEMPI Syndrome."
        }
    ],
    "5c561da707647bbc4b00000f": [
        {
            "text": "tmvar",
            "probability": 0.16687604037905562,
            "start_logit": -2.8930552005767822,
            "end_logit": -2.952960252761841,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmVar",
            "probability": 0.15118399015133593,
            "start_logit": -2.6634864807128906,
            "end_logit": -3.281282663345337,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmvar/RESULTS Here, we report tmVar",
            "probability": 0.12017257720662694,
            "start_logit": -2.8930552005767822,
            "end_logit": -3.281282663345337,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmVar, a text-mining approach based on conditional random field (CRF)",
            "probability": 0.06950927457368485,
            "start_logit": -2.6634864807128906,
            "end_logit": -4.058320045471191,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmvar/RESULTS Here, we report tmVar, a text-mining approach based on conditional random field (CRF)",
            "probability": 0.05525127797540778,
            "start_logit": -2.8930552005767822,
            "end_logit": -4.058320045471191,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmVar, a text-mining approach based on conditional random field",
            "probability": 0.054814970332463304,
            "start_logit": -2.6634864807128906,
            "end_logit": -4.295816898345947,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmVar,",
            "probability": 0.05098396999874152,
            "start_logit": -2.6634864807128906,
            "end_logit": -4.368268966674805,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmvar/RESULTS Here, we report tmVar, a text-mining approach based on conditional random field",
            "probability": 0.04357112315770364,
            "start_logit": -2.8930552005767822,
            "end_logit": -4.295816898345947,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "conditional random field (CRF)",
            "probability": 0.04283759546595621,
            "start_logit": -3.1475305557250977,
            "end_logit": -4.058320045471191,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmvar/RESULTS Here,",
            "probability": 0.04085081250535996,
            "start_logit": -2.8930552005767822,
            "end_logit": -4.360284805297852,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmvar/RESULTS Here, we report tmVar,",
            "probability": 0.04052595162253017,
            "start_logit": -2.8930552005767822,
            "end_logit": -4.368268966674805,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "conditional random field",
            "probability": 0.033781700916634586,
            "start_logit": -3.1475305557250977,
            "end_logit": -4.295816898345947,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmVar 2.0",
            "probability": 0.03337851746044559,
            "start_logit": -2.709686279296875,
            "end_logit": -4.745667934417725,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "we report tmVar",
            "probability": 0.02245205425250842,
            "start_logit": -4.570601940155029,
            "end_logit": -3.281282663345337,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "text-mining approach based on conditional random field (CRF)",
            "probability": 0.0170505174865765,
            "start_logit": -4.068766117095947,
            "end_logit": -4.058320045471191,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "text-mining approach based on conditional random field",
            "probability": 0.013446027395798373,
            "start_logit": -4.068766117095947,
            "end_logit": -4.295816898345947,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "CRF)",
            "probability": 0.011255128802751462,
            "start_logit": -4.4841227531433105,
            "end_logit": -4.058320045471191,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "a text-mining approach based on conditional random field (CRF)",
            "probability": 0.011230280858645155,
            "start_logit": -4.486332893371582,
            "end_logit": -4.058320045471191,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature.tmVar",
            "probability": 0.010505495882755414,
            "start_logit": -4.767709255218506,
            "end_logit": -3.843658924102783,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "we report tmVar, a text-mining approach based on conditional random field (CRF)",
            "probability": 0.010322693575018638,
            "start_logit": -4.570601940155029,
            "end_logit": -4.058320045471191,
            "question_text": "List the releases of tmVar"
        }
    ],
    "5c57041807647bbc4b000015": [
        {
            "text": "inflammation and metabolism",
            "probability": 0.3604612432396376,
            "start_logit": 5.01413106918335,
            "end_logit": 5.352770805358887,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "inflammation",
            "probability": 0.21686806606604256,
            "start_logit": 5.01413106918335,
            "end_logit": 4.844675540924072,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "metabolism",
            "probability": 0.1926561899452446,
            "start_logit": 4.387653827667236,
            "end_logit": 5.352770805358887,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "insulin resistance",
            "probability": 0.1308624130763849,
            "start_logit": 4.872356414794922,
            "end_logit": 4.481307506561279,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "inflammation and insulin resistance",
            "probability": 0.04207519398177964,
            "start_logit": 3.73766827583313,
            "end_logit": 4.481307506561279,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipose inflammation and insulin resistance",
            "probability": 0.014550761471003803,
            "start_logit": 2.6758532524108887,
            "end_logit": 4.481307506561279,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipose inflammation",
            "probability": 0.012851341826020712,
            "start_logit": 2.6758532524108887,
            "end_logit": 4.357112407684326,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "insulin resistance in mice.Recently, we found that Stamp2 has a critical role in the integration of inflammatory",
            "probability": 0.006137261587278637,
            "start_logit": 4.872356414794922,
            "end_logit": 1.4215396642684937,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "insulin resistance in mice.Recently, we found that Stamp2 has a critical role in the integration of inflammatory and metabolic",
            "probability": 0.005661912968068431,
            "start_logit": 4.872356414794922,
            "end_logit": 1.3409228324890137,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "inflammation and metabolism in adipocytes.",
            "probability": 0.004793610554613594,
            "start_logit": 5.01413106918335,
            "end_logit": 1.032670259475708,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "metabolism in adipocytes.",
            "probability": 0.002562047273745886,
            "start_logit": 4.387653827667236,
            "end_logit": 1.032670259475708,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "inflammation and insulin resistance in mice.Recently, we found that Stamp2 has a critical role in the integration of inflammatory",
            "probability": 0.0019732669276925656,
            "start_logit": 3.73766827583313,
            "end_logit": 1.4215396642684937,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "inflammation and insulin resistance in mice.Recently, we found that Stamp2 has a critical role in the integration of inflammatory and metabolic",
            "probability": 0.0018204317102144482,
            "start_logit": 3.73766827583313,
            "end_logit": 1.3409228324890137,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "insulin",
            "probability": 0.0015175027106144854,
            "start_logit": 4.872356414794922,
            "end_logit": 0.024227047339081764,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "metabolic",
            "probability": 0.0012067627254312592,
            "start_logit": 2.412546157836914,
            "end_logit": 2.2549126148223877,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "inflammatory and metabolic",
            "probability": 0.001187721959300789,
            "start_logit": 2.396641969680786,
            "end_logit": 2.2549126148223877,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "inflammatory",
            "probability": 0.0010143953745507964,
            "start_logit": 2.396641969680786,
            "end_logit": 2.097168207168579,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipose inflammation and insulin resistance in mice.Recently, we found that Stamp2 has a critical role in the integration of inflammatory",
            "probability": 0.000682410077441563,
            "start_logit": 2.6758532524108887,
            "end_logit": 1.4215396642684937,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipose inflammation and insulin resistance in mice.Recently, we found that Stamp2 has a critical role in the integration of inflammatory and metabolic",
            "probability": 0.0006295554478264006,
            "start_logit": 2.6758532524108887,
            "end_logit": 1.3409228324890137,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "inflammation and insulin",
            "probability": 0.0004879110771074644,
            "start_logit": 3.73766827583313,
            "end_logit": 0.024227047339081764,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        }
    ],
    "5c56bbb107647bbc4b000011": [
        {
            "text": "tmVar",
            "probability": 0.6309993437566034,
            "start_logit": 4.543153285980225,
            "end_logit": 4.346629619598389,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar: a text mining approach for extracting sequence variants in biomedical literature.Here, we report tmVar",
            "probability": 0.18942016256068006,
            "start_logit": 3.8187310695648193,
            "end_logit": 3.8677146434783936,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "nala",
            "probability": 0.08513841442633553,
            "start_logit": 3.674039602279663,
            "end_logit": 3.212716817855835,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "nala substantially outperformed the state-of-the-art.RESULTS Here, we report tmVar",
            "probability": 0.042159400243496264,
            "start_logit": 1.8373061418533325,
            "end_logit": 4.346629619598389,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar,",
            "probability": 0.010993617900970138,
            "start_logit": 4.543153285980225,
            "end_logit": 0.29663971066474915,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar, a text-mining approach based on conditional random field",
            "probability": 0.006687539685696578,
            "start_logit": 4.543153285980225,
            "end_logit": -0.20042915642261505,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar, a text-mining",
            "probability": 0.006032693859886826,
            "start_logit": 4.543153285980225,
            "end_logit": -0.3034815490245819,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "text mining approach for extracting sequence variants in biomedical literature.Here, we report tmVar",
            "probability": 0.005269336622854648,
            "start_logit": 0.2366679161787033,
            "end_logit": 3.8677146434783936,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar, a text-mining approach based on conditional random field (CRF)",
            "probability": 0.0047277492840448075,
            "start_logit": 4.543153285980225,
            "end_logit": -0.5472259521484375,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar, a text-mining approach",
            "probability": 0.003828178658626542,
            "start_logit": 4.543153285980225,
            "end_logit": -0.7582860589027405,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar: a text mining",
            "probability": 0.0031255713792638726,
            "start_logit": 3.8187310695648193,
            "end_logit": -0.23663587868213654,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar: a text mining approach for extracting sequence variants in biomedical literature.Here, we report tmVar, a text-mining",
            "probability": 0.0027873126303421284,
            "start_logit": 3.8187310695648193,
            "end_logit": -0.35117506980895996,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar: a text mining approach",
            "probability": 0.0021345793162575754,
            "start_logit": 3.8187310695648193,
            "end_logit": -0.6179834008216858,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature.nala",
            "probability": 0.0018477064058621073,
            "start_logit": 2.968047857284546,
            "end_logit": 0.08837531507015228,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0012812198173348783,
            "start_logit": 4.543153285980225,
            "end_logit": -1.8528625965118408,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar: a text mining approach for extracting sequence variants in biomedical literature.Here, we report tmVar,",
            "probability": 0.00122162936773305,
            "start_logit": 3.8187310695648193,
            "end_logit": -1.1760674715042114,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "nala substantially outperformed the state-of-the-art.RESULTS Here, we report tmVar,",
            "probability": 0.0007345242777143778,
            "start_logit": 1.8373061418533325,
            "end_logit": 0.29663971066474915,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "tmVar, a text",
            "probability": 0.0006214569744303857,
            "start_logit": 4.543153285980225,
            "end_logit": -2.5763638019561768,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "a text mining approach for extracting sequence variants in biomedical literature.Here, we report tmVar",
            "probability": 0.0005425130808620896,
            "start_logit": -2.0367796421051025,
            "end_logit": 3.8677146434783936,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "conditional random field",
            "probability": 0.00044704975100456586,
            "start_logit": 1.5549989938735962,
            "end_logit": 0.08239369839429855,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        }
    ],
    "5c6f107c7c78d69471000051": [
        {
            "text": "FAK",
            "probability": 0.38048262586833276,
            "start_logit": 4.80933141708374,
            "end_logit": 3.985724449157715,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitor in mice plasma and its application to a pharmacokinetic study in mice.Effect of FAK",
            "probability": 0.30144643766158064,
            "start_logit": 4.576483249664307,
            "end_logit": 3.985724449157715,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "Fak",
            "probability": 0.19524412105612754,
            "start_logit": 4.526777744293213,
            "end_logit": 3.601088285446167,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "Fak activation as well as Fak",
            "probability": 0.08647402199389666,
            "start_logit": 4.134914398193359,
            "end_logit": 3.1785449981689453,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer.Focal Adhesion Kinase",
            "probability": 0.015570843866693355,
            "start_logit": 4.80933141708374,
            "end_logit": 0.7896841168403625,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitor",
            "probability": 0.006380164392963812,
            "start_logit": 4.80933141708374,
            "end_logit": -0.10252220183610916,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitor in mice plasma and its application to a pharmacokinetic study in mice.Effect of FAK inhibitor",
            "probability": 0.005054837454311931,
            "start_logit": 4.576483249664307,
            "end_logit": -0.10252220183610916,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "Fak degrader, PROTAC-3,",
            "probability": 0.002331773495779087,
            "start_logit": 4.526777744293213,
            "end_logit": -0.8265332579612732,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer.",
            "probability": 0.001430493547794623,
            "start_logit": 4.80933141708374,
            "end_logit": -1.5976965427398682,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "Focal Adhesion Kinase (FAK",
            "probability": 0.0011671138599855173,
            "start_logit": 1.8416441679000854,
            "end_logit": 1.1665050983428955,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "Fak degrader, PROTAC-3, which outperforms a clinical candidate, defactinib,",
            "probability": 0.0010780211127989832,
            "start_logit": 4.526777744293213,
            "end_logit": -1.5980353355407715,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitor VS-6063",
            "probability": 0.0009637717116303007,
            "start_logit": 4.80933141708374,
            "end_logit": -1.992616891860962,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "Focal Adhesion Kinase",
            "probability": 0.0008006854813134364,
            "start_logit": 1.8416441679000854,
            "end_logit": 0.7896841168403625,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitor VS-6063 (defactinib) on docetaxel",
            "probability": 0.0006113002314447391,
            "start_logit": 4.80933141708374,
            "end_logit": -2.447883129119873,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "Fak-mediated cell migration and invasion. Prompted by our observation of a correlation between PTEN loss and FAK",
            "probability": 0.0002898764071050546,
            "start_logit": 4.341930866241455,
            "end_logit": -2.726616144180298,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "Fak activation as well as Fak-mediated cell migration and invasion. Prompted by our observation of a correlation between PTEN loss and FAK",
            "probability": 0.0002356713339653868,
            "start_logit": 4.134914398193359,
            "end_logit": -2.726616144180298,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK)",
            "probability": 0.0001418504061343742,
            "start_logit": 2.009859323501587,
            "end_logit": -1.1092262268066406,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "Focal Adhesion Kinase (FAK)",
            "probability": 0.00011988798743009879,
            "start_logit": 1.8416441679000854,
            "end_logit": -1.1092262268066406,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "AK inhibitor in mice plasma and its application to a pharmacokinetic study in mice.Effect of FAK",
            "probability": 9.939979164720343e-05,
            "start_logit": -3.4407143592834473,
            "end_logit": 3.985724449157715,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "PROTAC-3, which outperforms a clinical candidate, defactinib, with respect to Fak",
            "probability": 7.710233906466494e-05,
            "start_logit": -3.0566346645355225,
            "end_logit": 3.347628355026245,
            "question_text": "Which molecules are targeted by defactinib?"
        }
    ],
    "5c6ffa257c78d69471000056": [
        {
            "text": "NAGLU",
            "probability": 0.25489909724289084,
            "start_logit": 3.005310535430908,
            "end_logit": 2.147446870803833,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "MPS IIIB, HGSNAT",
            "probability": 0.1695472193636705,
            "start_logit": 2.623164415359497,
            "end_logit": 2.121856689453125,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "HGSNAT",
            "probability": 0.15949158616190345,
            "start_logit": 2.5620241165161133,
            "end_logit": 2.121856689453125,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "SGSH (coding for heparan N-sulfatase) - causing MPS IIIA, NAGLU",
            "probability": 0.12716087132237114,
            "start_logit": 2.3098957538604736,
            "end_logit": 2.147446870803833,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "SGSH",
            "probability": 0.07167858907676575,
            "start_logit": 2.3098957538604736,
            "end_logit": 1.5741859674453735,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "NAGLU (coding for alpha-N-acetylglucosaminidase) - causing MPS IIIB",
            "probability": 0.04524452861691871,
            "start_logit": 3.005310535430908,
            "end_logit": 0.41866084933280945,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "GNS",
            "probability": 0.04334079382824006,
            "start_logit": 2.4875030517578125,
            "end_logit": 0.8934808969497681,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "MPS IIIB",
            "probability": 0.030874655229210242,
            "start_logit": 2.623164415359497,
            "end_logit": 0.41866084933280945,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "MPS IIIA, NAGLU",
            "probability": 0.02143645047578122,
            "start_logit": 0.5295355319976807,
            "end_logit": 2.147446870803833,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "MPS IIIC), and GNS",
            "probability": 0.013037478127798409,
            "start_logit": 1.2862368822097778,
            "end_logit": 0.8934808969497681,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "SGSH (coding for heparan N-sulfatase",
            "probability": 0.011393362931102498,
            "start_logit": 2.3098957538604736,
            "end_logit": -0.2649751305580139,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "\u03b1-N-acetylglucosaminidase (NAGLU",
            "probability": 0.009272379884061856,
            "start_logit": 0.8186226487159729,
            "end_logit": 1.0203070640563965,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "sulfamidase (SGSH), \u03b1-N-acetylglucosaminidase (NAGLU",
            "probability": 0.00805423512675117,
            "start_logit": 0.6777806282043457,
            "end_logit": 1.0203070640563965,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "HGSNAT (coding for acetyl CoA alpha-glucosaminide acetyltransferase",
            "probability": 0.0060784686104576975,
            "start_logit": 2.5620241165161133,
            "end_logit": -1.1453816890716553,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "HGSNAT), and N-acetylglucosamine-6-sulfatase (GNS",
            "probability": 0.0060198161837463305,
            "start_logit": 1.2275952100753784,
            "end_logit": 0.17935115098953247,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "heparan N-sulfatase) - causing MPS IIIA, NAGLU",
            "probability": 0.0055573584832984005,
            "start_logit": -0.8204343318939209,
            "end_logit": 2.147446870803833,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "GNS (coding for N-acetylglucosamine-6-sulfatase) - causing MPS IIID",
            "probability": 0.005214550976634678,
            "start_logit": 2.4875030517578125,
            "end_logit": -1.2241604328155518,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "GNS (coding for N-acetylglucosamine-6-sulfatase",
            "probability": 0.005071953122102762,
            "start_logit": 2.4875030517578125,
            "end_logit": -1.2518874406814575,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "SGSH (coding for heparan N-sulfatase) - causing MPS IIIA",
            "probability": 0.00355460728365351,
            "start_logit": 2.3098957538604736,
            "end_logit": -1.429761528968811,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "\u03b1-N-acetylglucosaminidase",
            "probability": 0.003071997952640571,
            "start_logit": 0.8186226487159729,
            "end_logit": -0.08440486341714859,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        }
    ],
    "5c580fe107647bbc4b00001b": [
        {
            "text": "esophageal squamous cell carcinoma",
            "probability": 0.43487021346155114,
            "start_logit": 2.7496981620788574,
            "end_logit": 3.1081368923187256,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "gynecological cancer",
            "probability": 0.16960898557858933,
            "start_logit": 2.360182762145996,
            "end_logit": 2.556100368499756,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "gynecological cancers",
            "probability": 0.10138283235540257,
            "start_logit": 2.360182762145996,
            "end_logit": 2.041508436203003,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancer",
            "probability": 0.056382831571367975,
            "start_logit": 1.2588517665863037,
            "end_logit": 2.556100368499756,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "squamous cell carcinoma",
            "probability": 0.041776443647160155,
            "start_logit": 0.4069831669330597,
            "end_logit": 3.1081368923187256,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers remains undefined and the clinical significance of uc.189 in gynecological cancer",
            "probability": 0.036665367430097316,
            "start_logit": 0.9978681802749634,
            "end_logit": 2.386751890182495,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers",
            "probability": 0.03370252549664735,
            "start_logit": 1.2588517665863037,
            "end_logit": 2.041508436203003,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "gynecological cancers.Until now, the role of uc.189 in human cancer",
            "probability": 0.027828128224840362,
            "start_logit": 2.360182762145996,
            "end_logit": 0.7486519813537598,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "gynecological cancers.Until now, the role of uc.189 in human cancers",
            "probability": 0.02195850543949002,
            "start_logit": 2.360182762145996,
            "end_logit": 0.5117592215538025,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "esophageal cancer",
            "probability": 0.01991164803614258,
            "start_logit": 1.0743408203125,
            "end_logit": 1.6997514963150024,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers remains undefined and the clinical significance of uc.189 in gynecological cancers",
            "probability": 0.013461312006118236,
            "start_logit": 0.9978681802749634,
            "end_logit": 1.3847390413284302,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers.Until now, the role of uc.189 in human cancer",
            "probability": 0.009250858150558223,
            "start_logit": 1.2588517665863037,
            "end_logit": 0.7486519813537598,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers.Until now, the role of uc.189 in human cancers",
            "probability": 0.007299629259206083,
            "start_logit": 1.2588517665863037,
            "end_logit": 0.5117592215538025,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "gynecological cancers.",
            "probability": 0.005914549603324437,
            "start_logit": 2.360182762145996,
            "end_logit": -0.7999799847602844,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers remains undefined and the clinical significance of uc.189 in esophageal cancer",
            "probability": 0.005223947910887917,
            "start_logit": -0.2637106478214264,
            "end_logit": 1.6997514963150024,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "gynecological tumors.Upregulation of uc.189 in patients with esophageal squamous cell carcinoma",
            "probability": 0.003872471974135835,
            "start_logit": -1.9714564085006714,
            "end_logit": 3.1081368923187256,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "endometrial adenocarcinoma",
            "probability": 0.0029963250472277063,
            "start_logit": 0.40182748436927795,
            "end_logit": 0.47834649682044983,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "esophageal cancers",
            "probability": 0.002804305204553219,
            "start_logit": 1.0743408203125,
            "end_logit": -0.2603975832462311,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "endometrial adenocarcinomas (EACs), 29 ovarian cystoadenocarcinoma",
            "probability": 0.0026581299556115096,
            "start_logit": 0.40182748436927795,
            "end_logit": 0.3585827946662903,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancer biology. Until now, the role of the UCE uc.189 in human cancer",
            "probability": 0.0024309896470881896,
            "start_logit": 0.9454067349433899,
            "end_logit": -0.2743208706378937,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        }
    ],
    "5c58282e07647bbc4b00001e": [
        {
            "text": "mmquant",
            "probability": 0.3168209430339614,
            "start_logit": 3.974612236022949,
            "end_logit": 4.0801215171813965,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "htseq-count",
            "probability": 0.22234057155057313,
            "start_logit": 3.886308431625366,
            "end_logit": 3.8142988681793213,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "mmquant is a drop-in replacement of the widely used tools htseq-count",
            "probability": 0.11984149434112966,
            "start_logit": 3.26826810836792,
            "end_logit": 3.8142988681793213,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "htseq",
            "probability": 0.10264477147313006,
            "start_logit": 3.886308431625366,
            "end_logit": 3.041362762451172,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "htseq-count and featureCounts",
            "probability": 0.0788135145448856,
            "start_logit": 3.886308431625366,
            "end_logit": 2.7771730422973633,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "mmquant is a drop-in replacement of the widely used tools htseq",
            "probability": 0.05532549778862865,
            "start_logit": 3.26826810836792,
            "end_logit": 3.041362762451172,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "mmquant is a drop-in replacement of the widely used tools htseq-count and featureCounts",
            "probability": 0.042480458206374076,
            "start_logit": 3.26826810836792,
            "end_logit": 2.7771730422973633,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "featureCounts",
            "probability": 0.03495396228202696,
            "start_logit": 3.073255777359009,
            "end_logit": 2.7771730422973633,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "mmquant,",
            "probability": 0.012876997943730551,
            "start_logit": 3.974612236022949,
            "end_logit": 0.8772273659706116,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "mmquant: how to count multi-mapping reads?mmquant",
            "probability": 0.0052422568013226365,
            "start_logit": 2.2331929206848145,
            "end_logit": 1.7199561595916748,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "mm",
            "probability": 0.003387547060260481,
            "start_logit": 3.974612236022949,
            "end_logit": -0.45810917019844055,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "mmquant: how to count multi-mapping reads?RNA-Seq",
            "probability": 0.002390532801720181,
            "start_logit": 2.9688782691955566,
            "end_logit": 0.19903498888015747,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "count",
            "probability": 0.0006046246780601291,
            "start_logit": -2.0210492610931396,
            "end_logit": 3.8142988681793213,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "htseq-count and feature",
            "probability": 0.00042097686066633707,
            "start_logit": 3.886308431625366,
            "end_logit": -2.4550888538360596,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "htseq-count and featureCounts that handles multi-mapping reads in an unabiased way.CONCLUSION mmquant",
            "probability": 0.0003802217702729545,
            "start_logit": 0.4145687520503998,
            "end_logit": 0.9148276448249817,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "htseq-count and featureCounts that handles multi-mapping reads",
            "probability": 0.0003744670655478377,
            "start_logit": 3.886308431625366,
            "end_logit": -2.5721628665924072,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "mmquant: how to count multi-mapping reads?mmquant is a drop-in replacement of the widely used tools htseq",
            "probability": 0.00037288176177344,
            "start_logit": 2.2331929206848145,
            "end_logit": -0.9232898354530334,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "h",
            "probability": 0.0002741399562748486,
            "start_logit": 3.886308431625366,
            "end_logit": -2.8840279579162598,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "RNA-Seq",
            "probability": 0.0002272336913512303,
            "start_logit": 0.6155856847763062,
            "end_logit": 0.19903498888015747,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "mmquant is a drop-in replacement of the widely used tools htseq-count and feature",
            "probability": 0.00022690638830986362,
            "start_logit": 3.26826810836792,
            "end_logit": -2.4550888538360596,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        }
    ],
    "5c596ad686df2b9174000015": [
        {
            "text": "ITGA4",
            "probability": 0.2501117326592223,
            "start_logit": 4.684956073760986,
            "end_logit": 4.1842875480651855,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8",
            "probability": 0.20973557044527358,
            "start_logit": 4.684956073760986,
            "end_logit": 4.008227348327637,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB8",
            "probability": 0.18430135687349566,
            "start_logit": 4.555680751800537,
            "end_logit": 4.008227348327637,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8) and at previously implicated loci (ITGAL",
            "probability": 0.05699754916147457,
            "start_logit": 4.684956073760986,
            "end_logit": 2.705388069152832,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM1",
            "probability": 0.05682296389143942,
            "start_logit": 4.684956073760986,
            "end_logit": 2.7023203372955322,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB8) and at previously implicated loci (ITGAL",
            "probability": 0.05008557025697529,
            "start_logit": 4.555680751800537,
            "end_logit": 2.705388069152832,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB8) and at previously implicated loci (ITGAL and ICAM1",
            "probability": 0.04993215659381223,
            "start_logit": 4.555680751800537,
            "end_logit": 2.7023203372955322,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGAL",
            "probability": 0.026279501736562887,
            "start_logit": 3.9107370376586914,
            "end_logit": 2.705388069152832,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGAL and ICAM1",
            "probability": 0.02619900680345499,
            "start_logit": 3.9107370376586914,
            "end_logit": 2.7023203372955322,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM",
            "probability": 0.019161429882537603,
            "start_logit": 4.684956073760986,
            "end_logit": 1.615279197692871,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ICAM1",
            "probability": 0.017965995709181212,
            "start_logit": 3.533496379852295,
            "end_logit": 2.7023203372955322,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB8) and at previously implicated loci (ITGAL and ICAM",
            "probability": 0.01683776156562579,
            "start_logit": 4.555680751800537,
            "end_logit": 1.615279197692871,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGAL and ICAM",
            "probability": 0.008834640037707679,
            "start_logit": 3.9107370376586914,
            "end_logit": 1.615279197692871,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB",
            "probability": 0.00859357632765957,
            "start_logit": 4.684956073760986,
            "end_logit": 0.8133947849273682,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB",
            "probability": 0.007551450496552155,
            "start_logit": 4.555680751800537,
            "end_logit": 0.8133947849273682,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ICAM",
            "probability": 0.006058363441040257,
            "start_logit": 3.533496379852295,
            "end_logit": 1.615279197692871,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA",
            "probability": 0.00317549748524756,
            "start_logit": 4.684956073760986,
            "end_logit": -0.18215589225292206,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "PLCG2",
            "probability": 0.0006073044100398967,
            "start_logit": 1.605345606803894,
            "end_logit": 1.243265151977539,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8)",
            "probability": 0.0003984454533620445,
            "start_logit": 4.684956073760986,
            "end_logit": -2.2578048706054688,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB8)",
            "probability": 0.0003501267693353004,
            "start_logit": 4.555680751800537,
            "end_logit": -2.2578048706054688,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        }
    ],
    "5c72a9147c78d6947100006e": [
        {
            "text": "Trifluridine",
            "probability": 0.2072410905675367,
            "start_logit": 4.887683391571045,
            "end_logit": 4.996598720550537,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine",
            "probability": 0.2043072312412131,
            "start_logit": 5.0049052238464355,
            "end_logit": 4.865118980407715,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine/tipiracil",
            "probability": 0.2035708874379452,
            "start_logit": 5.0049052238464355,
            "end_logit": 4.861508369445801,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "Trifluridine/tipiracil",
            "probability": 0.1756330622978187,
            "start_logit": 4.887683391571045,
            "end_logit": 4.831112861633301,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "tipiracil",
            "probability": 0.17440293939195795,
            "start_logit": 4.880654811859131,
            "end_logit": 4.831112861633301,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine and tipiracil",
            "probability": 0.030077025890683187,
            "start_logit": 3.9750866889953613,
            "end_logit": 3.979074239730835,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine, FTD) with a thymidine phosphorylase inhibitor (tipiracil",
            "probability": 0.0028558113241503326,
            "start_logit": 3.282715320587158,
            "end_logit": 2.317039966583252,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 0.00038109769813667835,
            "start_logit": 5.0049052238464355,
            "end_logit": -1.4192054271697998,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "Trifluridine/tipiracil (FTD/TPI; TAS-102, Lonsurf\u00ae),",
            "probability": 0.00024858815092168243,
            "start_logit": 4.887683391571045,
            "end_logit": -1.7292418479919434,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "tipiracil (FTD/TPI; TAS-102, Lonsurf\u00ae),",
            "probability": 0.00024684705517026974,
            "start_logit": 4.880654811859131,
            "end_logit": -1.7292418479919434,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "Trifluridine/tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 0.00023704136863672028,
            "start_logit": 4.706213474273682,
            "end_logit": -1.595334768295288,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 0.00017588073822946161,
            "start_logit": 4.231655597686768,
            "end_logit": -1.4192054271697998,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "Triflurid",
            "probability": 0.00010981369023536116,
            "start_logit": 4.887683391571045,
            "end_logit": -2.5462541580200195,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "triflurid",
            "probability": 0.00010051273808093135,
            "start_logit": 5.0049052238464355,
            "end_logit": -2.751976728439331,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine/tipiraci",
            "probability": 9.006497323262884e-05,
            "start_logit": 5.0049052238464355,
            "end_logit": -2.861729860305786,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "Trifluridine/tipiraci",
            "probability": 8.156690407371242e-05,
            "start_logit": 4.887683391571045,
            "end_logit": -2.843615770339966,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "tipiraci",
            "probability": 8.099561461517597e-05,
            "start_logit": 4.880654811859131,
            "end_logit": -2.843615770339966,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102",
            "probability": 7.7335769933267e-05,
            "start_logit": 5.0049052238464355,
            "end_logit": -3.0141046047210693,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "ine",
            "probability": 4.117777814095085e-05,
            "start_logit": -3.5045762062072754,
            "end_logit": 4.865118980407715,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "ine/tipiracil",
            "probability": 4.102936928835066e-05,
            "start_logit": -3.5045762062072754,
            "end_logit": 4.861508369445801,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        }
    ],
    "5c72b6be7c78d69471000072": [
        {
            "text": "phosphoinositide 3-kinase-\u03b4",
            "probability": 0.31649583482020327,
            "start_logit": 4.698276042938232,
            "end_logit": 4.058342456817627,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "phosphoinositide 3-kinase-\u03b4 (PI3K-\u03b4) and PI3K-\u03b3",
            "probability": 0.3016983039353422,
            "start_logit": 4.698276042938232,
            "end_logit": 4.010459899902344,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b3",
            "probability": 0.2310302011143062,
            "start_logit": 4.431396961212158,
            "end_logit": 4.010459899902344,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "phosphoinositide 3-kinase-\u03b4 (PI3K-\u03b4)",
            "probability": 0.044907494584616604,
            "start_logit": 4.698276042938232,
            "end_logit": 2.1056370735168457,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "phosphoinositide 3-kinase-\u03b4 (PI3K-\u03b4",
            "probability": 0.03819266116317993,
            "start_logit": 4.698276042938232,
            "end_logit": 1.9436757564544678,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4) and PI3K-\u03b3",
            "probability": 0.02257179358699664,
            "start_logit": 2.1055495738983154,
            "end_logit": 4.010459899902344,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4",
            "probability": 0.010328912880581943,
            "start_logit": 3.1893787384033203,
            "end_logit": 2.144876718521118,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "phosphoinositide 3-kinase",
            "probability": 0.008795293388653987,
            "start_logit": 4.698276042938232,
            "end_logit": 0.47524911165237427,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "phosphoinositide 3-kinase-\u03b4 (PI3K-\u03b4) and PI3K",
            "probability": 0.00763158126513839,
            "start_logit": 4.698276042938232,
            "end_logit": 0.33332744240760803,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K",
            "probability": 0.0058440028714346155,
            "start_logit": 4.431396961212158,
            "end_logit": 0.33332744240760803,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4,\u03b3",
            "probability": 0.0037242181433244344,
            "start_logit": 3.1893787384033203,
            "end_logit": 1.124786615371704,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4)",
            "probability": 0.0033597891836023444,
            "start_logit": 2.1055495738983154,
            "end_logit": 2.1056370735168457,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "(PI3K-\u03b4) and PI3K-\u03b3",
            "probability": 0.0018460722694050614,
            "start_logit": -0.398091197013855,
            "end_logit": 4.010459899902344,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4) and PI3K",
            "probability": 0.00057096269621725,
            "start_logit": 2.1055495738983154,
            "end_logit": 0.33332744240760803,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4,\u03b3,",
            "probability": 0.0005592854849097184,
            "start_logit": 3.1893787384033203,
            "end_logit": -0.7711655497550964,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "3-kinase-\u03b4",
            "probability": 0.0005219603137990318,
            "start_logit": -1.709197759628296,
            "end_logit": 4.058342456817627,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "3-kinase-\u03b4 (PI3K-\u03b4) and PI3K-\u03b3",
            "probability": 0.0004975564417275378,
            "start_logit": -1.709197759628296,
            "end_logit": 4.010459899902344,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K\u03b3",
            "probability": 0.0004944305536841347,
            "start_logit": 1.3480228185653687,
            "end_logit": 0.9469370245933533,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "phosphatidylinositol 3-kinase (PI3K)-\u03b4/\u03b3 isoforms",
            "probability": 0.00048827435908455714,
            "start_logit": 2.2613205909729004,
            "end_logit": 0.021110007539391518,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "\u03b4",
            "probability": 0.00044137094379228094,
            "start_logit": -1.8769036531448364,
            "end_logit": 4.058342456817627,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        }
    ],
    "5c78174b7c78d694710000b1": [
        {
            "text": "MyriMatch",
            "probability": 0.11070075937881682,
            "start_logit": 3.900265693664551,
            "end_logit": 4.031867504119873,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MS Amanda, MyriMatch",
            "probability": 0.10174045777586116,
            "start_logit": 3.8158600330352783,
            "end_logit": 4.031867504119873,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MS-GF[Formula: see text], MS Amanda, MyriMatch",
            "probability": 0.09715739479411376,
            "start_logit": 3.7697672843933105,
            "end_logit": 4.031867504119873,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "OMSSA",
            "probability": 0.08941223074853574,
            "start_logit": 4.241384029388428,
            "end_logit": 3.4771759510040283,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MyriMatch, Comet, Tide, Andromeda",
            "probability": 0.07490007683254307,
            "start_logit": 3.900265693664551,
            "end_logit": 3.6411917209625244,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MS Amanda, MyriMatch, Comet, Tide, Andromeda",
            "probability": 0.06883754137867552,
            "start_logit": 3.8158600330352783,
            "end_logit": 3.6411917209625244,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MS-GF[Formula: see text], MS Amanda, MyriMatch, Comet, Tide, Andromeda",
            "probability": 0.06573664332352676,
            "start_logit": 3.7697672843933105,
            "end_logit": 3.6411917209625244,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MyriMatch, Comet, Tide, Andromeda, and OMSSA",
            "probability": 0.06356984014819002,
            "start_logit": 3.900265693664551,
            "end_logit": 3.4771759510040283,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MS Amanda, MyriMatch, Comet, Tide, Andromeda, and OMSSA",
            "probability": 0.058424392693486656,
            "start_logit": 3.8158600330352783,
            "end_logit": 3.4771759510040283,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MS Amanda",
            "probability": 0.039730876354600035,
            "start_logit": 3.8158600330352783,
            "end_logit": 3.091571092605591,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MS-GF[Formula: see text], MS Amanda",
            "probability": 0.037941134961315744,
            "start_logit": 3.7697672843933105,
            "end_logit": 3.091571092605591,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "X!Tandem, MS-GF[Formula: see text], MS Amanda, MyriMatch",
            "probability": 0.03240061060787984,
            "start_logit": 2.67161226272583,
            "end_logit": 4.031867504119873,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MyriMatch, Comet",
            "probability": 0.0276951039096338,
            "start_logit": 3.900265693664551,
            "end_logit": 2.6462924480438232,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MS Amanda, MyriMatch, Comet",
            "probability": 0.025453416631714357,
            "start_logit": 3.8158600330352783,
            "end_logit": 2.6462924480438232,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "MS-GF[Formula: see text], MS Amanda, MyriMatch, Comet",
            "probability": 0.024306826434717214,
            "start_logit": 3.7697672843933105,
            "end_logit": 2.6462924480438232,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Comet, Tide, Andromeda",
            "probability": 0.022539409917518665,
            "start_logit": 2.699376106262207,
            "end_logit": 3.6411917209625244,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Comet, Tide, Andromeda, and OMSSA",
            "probability": 0.019129842666177965,
            "start_logit": 2.699376106262207,
            "end_logit": 3.4771759510040283,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Andromeda",
            "probability": 0.014967373522367036,
            "start_logit": 2.2899835109710693,
            "end_logit": 3.6411917209625244,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Andromeda, and OMSSA",
            "probability": 0.012703238534486011,
            "start_logit": 2.2899835109710693,
            "end_logit": 3.4771759510040283,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "X!Tandem, MS-GF[Formula: see text], MS Amanda",
            "probability": 0.012652829385839864,
            "start_logit": 2.67161226272583,
            "end_logit": 3.091571092605591,
            "question_text": "List search engines used in proteomics."
        }
    ],
    "5c62a276e842deac6700000a": [
        {
            "text": "PRKCD, and C1QTNF4",
            "probability": 0.35553477778358167,
            "start_logit": 1.0850363969802856,
            "end_logit": 0.12486357986927032,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "C1QTNF4",
            "probability": 0.2558872965679315,
            "start_logit": 0.7561504244804382,
            "end_logit": 0.12486357986927032,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "DNMT3A, PRKCD, and C1QTNF4",
            "probability": 0.13028444524348187,
            "start_logit": 0.08113342523574829,
            "end_logit": 0.12486357986927032,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "PRKCD",
            "probability": 0.11567473404302359,
            "start_logit": 1.0850363969802856,
            "end_logit": -0.9979772567749023,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "DNMT3A",
            "probability": 0.06370253642091599,
            "start_logit": 0.08113342523574829,
            "end_logit": -0.5906321406364441,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "DNMT3A, PRKCD",
            "probability": 0.042388591764309216,
            "start_logit": 0.08113342523574829,
            "end_logit": -0.9979772567749023,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "PRKCD associated with SLE risk (P\u2009=\u20090.0028), and across DNMT3A",
            "probability": 0.01513628201285507,
            "start_logit": -0.8021146059036255,
            "end_logit": -1.1445138454437256,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "DNMT3",
            "probability": 0.010633078204312287,
            "start_logit": 0.08113342523574829,
            "end_logit": -2.3808867931365967,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "PRKCD, and C1QTNF4. We identify a burden of rare variants across PRKCD",
            "probability": 0.005473057567008831,
            "start_logit": 1.0850363969802856,
            "end_logit": -4.048922061920166,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "C1QTNF4. We identify a burden of rare variants across PRKCD",
            "probability": 0.003939096798105763,
            "start_logit": 0.7561504244804382,
            "end_logit": -4.048922061920166,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "C1QTNF4 on NF-\u03baB activation and apoptosis,",
            "probability": 0.0005486156734340937,
            "start_logit": -0.8420082926750183,
            "end_logit": -4.422071933746338,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "PRKCD associated with SLE risk (P\u2009=\u20090.0028),",
            "probability": 0.0005103278833180349,
            "start_logit": -0.8021146059036255,
            "end_logit": -4.534310340881348,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "implicate novel genes",
            "probability": 4.4724976775709674e-05,
            "start_logit": -3.6406514644622803,
            "end_logit": -4.1302947998046875,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "implicate novel genes in systemic lupus erythematosus",
            "probability": 4.025785405238836e-05,
            "start_logit": -3.6406514644622803,
            "end_logit": -4.2355217933654785,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "implicate novel genes in systemic lupus erythematosus.",
            "probability": 3.8881234850367434e-05,
            "start_logit": -3.6406514644622803,
            "end_logit": -4.270315170288086,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "results identify three novel genes in SLE susceptibility",
            "probability": 3.519657779925061e-05,
            "start_logit": -4.347691059112549,
            "end_logit": -3.6628384590148926,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "14",
            "probability": 3.4547494896035834e-05,
            "start_logit": -3.965339183807373,
            "end_logit": -4.0638041496276855,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "three novel genes in SLE susceptibility",
            "probability": 3.406336846858024e-05,
            "start_logit": -4.380417346954346,
            "end_logit": -3.6628384590148926,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "Our results identify three novel genes in SLE susceptibility",
            "probability": 3.0549672623925655e-05,
            "start_logit": -4.489285945892334,
            "end_logit": -3.6628384590148926,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "14 genes with missense de novo mutations (DNM),",
            "probability": 2.8938858255901366e-05,
            "start_logit": -3.965339183807373,
            "end_logit": -4.2409539222717285,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        }
    ],
    "5c7034ae7c78d69471000063": [
        {
            "text": "dolutegravir",
            "probability": 0.16726084619355763,
            "start_logit": 5.9766459465026855,
            "end_logit": 6.096595287322998,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir (DTG)/lamivudine (3TC)/abacavir",
            "probability": 0.15391578324622113,
            "start_logit": 5.9766459465026855,
            "end_logit": 6.01344633102417,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir (DTG)/lamivudine",
            "probability": 0.14800969288737645,
            "start_logit": 5.9766459465026855,
            "end_logit": 5.974318504333496,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "abacavir",
            "probability": 0.11198690100602014,
            "start_logit": 5.6586222648620605,
            "end_logit": 6.01344633102417,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "lamivudine (3TC)/abacavir",
            "probability": 0.10786048779027901,
            "start_logit": 5.621078968048096,
            "end_logit": 6.01344633102417,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "lamivudine",
            "probability": 0.10372164137958063,
            "start_logit": 5.621078968048096,
            "end_logit": 5.974318504333496,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir (Triumeq).Newer STRs include dolutegravir",
            "probability": 0.06334641081445497,
            "start_logit": 5.005709648132324,
            "end_logit": 6.096595287322998,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir/abacavir/lamivudine",
            "probability": 0.037255862801763476,
            "start_logit": 5.377599239349365,
            "end_logit": 5.193896770477295,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir/abacavir",
            "probability": 0.03219915042953653,
            "start_logit": 5.377599239349365,
            "end_logit": 5.048027515411377,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "abacavir/lamivudine",
            "probability": 0.017624775977035937,
            "start_logit": 4.629095554351807,
            "end_logit": 5.193896770477295,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir, abacavir and lamivudine",
            "probability": 0.016440737955602067,
            "start_logit": 4.861672878265381,
            "end_logit": 4.891776084899902,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir, abacavir",
            "probability": 0.012812371810356955,
            "start_logit": 4.861672878265381,
            "end_logit": 4.642425060272217,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "abacavir and lamivudine",
            "probability": 0.012471899311967424,
            "start_logit": 4.585388660430908,
            "end_logit": 4.891776084899902,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "rilpivirine",
            "probability": 0.005749558814221818,
            "start_logit": 4.2606682777404785,
            "end_logit": 4.442141532897949,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "rilpivirine (RPV)/emtricitabine",
            "probability": 0.0029038036175095734,
            "start_logit": 4.2606682777404785,
            "end_logit": 3.759039878845215,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "rilpivirine (RPV)/emtricitabine (FTC)/tenofovir",
            "probability": 0.001986003548217847,
            "start_logit": 4.2606682777404785,
            "end_logit": 3.3791427612304688,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "rilpivirine (RPV)/emtricitabine (FTC)/tenofovir alafenamide",
            "probability": 0.0015278853537197253,
            "start_logit": 4.2606682777404785,
            "end_logit": 3.116903066635132,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "tenofovir",
            "probability": 0.0012927436542366365,
            "start_logit": 3.792564868927002,
            "end_logit": 3.417888641357422,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "emtricitabine",
            "probability": 0.0008228404247763585,
            "start_logit": 2.9996538162231445,
            "end_logit": 3.759039878845215,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "tenofovir alafenamide",
            "probability": 0.0008106029835656391,
            "start_logit": 3.6268067359924316,
            "end_logit": 3.116903066635132,
            "question_text": "List drugs included in the TRIUMEQ pill."
        }
    ],
    "5c928958ecadf2e73f000017": [
        {
            "text": "single-reaction multiplexing",
            "probability": 0.23841579962479892,
            "start_logit": 1.2199457883834839,
            "end_logit": 0.8781284689903259,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four-channel single-reaction multiplexing",
            "probability": 0.18712473377687752,
            "start_logit": 0.9777050018310547,
            "end_logit": 0.8781284689903259,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes",
            "probability": 0.17686197698565317,
            "start_logit": 1.2199457883834839,
            "end_logit": 0.5794818997383118,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four-channel single-reaction multiplexing with orthogonal CRISPR enzymes",
            "probability": 0.13881315924018223,
            "start_logit": 0.9777050018310547,
            "end_logit": 0.5794818997383118,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar",
            "probability": 0.04754822317822083,
            "start_logit": 1.2199457883834839,
            "end_logit": -0.7341433167457581,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "CRISPR enzymes",
            "probability": 0.042901505471614934,
            "start_logit": -0.19651693105697632,
            "end_logit": 0.5794818997383118,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "lateral-flow readout",
            "probability": 0.030167845959472358,
            "start_logit": 0.3233332931995392,
            "end_logit": -0.2924985885620117,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "(i) four-channel single-reaction multiplexing",
            "probability": 0.019914831409440753,
            "start_logit": -1.2626056671142578,
            "end_logit": 0.8781284689903259,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "quantitative measurement of input as low as 2 attomolar",
            "probability": 0.017792320139430023,
            "start_logit": 0.2369682788848877,
            "end_logit": -0.7341433167457581,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "(i) four-channel single-reaction multiplexing with orthogonal CRISPR enzymes",
            "probability": 0.014773251017560973,
            "start_logit": -1.2626056671142578,
            "end_logit": 0.5794818997383118,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement",
            "probability": 0.012320037095385398,
            "start_logit": 1.2199457883834839,
            "end_logit": -2.084660768508911,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes;",
            "probability": 0.012198076051679775,
            "start_logit": 1.2199457883834839,
            "end_logit": -2.094609498977661,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar",
            "probability": 0.01153379822849929,
            "start_logit": -0.19651693105697632,
            "end_logit": -0.7341433167457581,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four-channel single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement",
            "probability": 0.009669592641189424,
            "start_logit": 0.9777050018310547,
            "end_logit": -2.084660768508911,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four-channel single-reaction multiplexing with orthogonal CRISPR enzymes;",
            "probability": 0.009573869422046731,
            "start_logit": 0.9777050018310547,
            "end_logit": -2.094609498977661,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar;",
            "probability": 0.009527693668857085,
            "start_logit": 1.2199457883834839,
            "end_logit": -2.3416850566864014,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "quantitative measurement of input as low as 2 attomolar; (iii) 3.5-fold increase in signal sensitivity",
            "probability": 0.006345155526751504,
            "start_logit": 0.2369682788848877,
            "end_logit": -1.7652186155319214,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "multiplexing",
            "probability": 0.005303806352707252,
            "start_logit": -2.5856456756591797,
            "end_logit": 0.8781284689903259,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "quantitative measurement",
            "probability": 0.0046100995889822175,
            "start_logit": 0.2369682788848877,
            "end_logit": -2.084660768508911,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "Csm6, an auxiliary CRISPR-associated enzyme; and (iv) lateral-flow readout",
            "probability": 0.004604224620649328,
            "start_logit": -1.5564690828323364,
            "end_logit": -0.2924985885620117,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        }
    ],
    "5c63286ae842deac6700000e": [
        {
            "text": "amegakaryocytic thrombocytopenia",
            "probability": 0.781450089601967,
            "start_logit": 3.7219491004943848,
            "end_logit": 4.082531929016113,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "bone marrow failure syndrome with amegakaryocytic thrombocytopenia",
            "probability": 0.16016467501530401,
            "start_logit": 2.137000322341919,
            "end_logit": 4.082531929016113,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "thrombocytopenia",
            "probability": 0.026950068434570117,
            "start_logit": 0.35478365421295166,
            "end_logit": 4.082531929016113,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "bone marrow failure",
            "probability": 0.008017183602185939,
            "start_logit": 2.137000322341919,
            "end_logit": 1.087916612625122,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "congenital amegakaryocytic thrombocytopenia",
            "probability": 0.006666894804713999,
            "start_logit": 1.3276005983352661,
            "end_logit": 1.7128833532333374,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "hypomegakaryocytic thrombocytopenia",
            "probability": 0.005672202988021621,
            "start_logit": 1.3223024606704712,
            "end_logit": 1.5566048622131348,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "congenital hypomegakaryocytic thrombocytopenia",
            "probability": 0.0026955385113231504,
            "start_logit": 0.5783228874206543,
            "end_logit": 1.5566048622131348,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "amegakaryocytic thrombocytopenia and radioulnar synostosis",
            "probability": 0.0026923515661279283,
            "start_logit": 1.674993634223938,
            "end_logit": 0.4587511122226715,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "congenital amegakaryocytic thrombocytopenia and radioulnar synostosis",
            "probability": 0.001902220644556713,
            "start_logit": 1.3276005983352661,
            "end_logit": 0.4587511122226715,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "enia",
            "probability": 0.0007546311328254229,
            "start_logit": -3.2207283973693848,
            "end_logit": 4.082531929016113,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia",
            "probability": 0.0006672884971137032,
            "start_logit": -3.3437349796295166,
            "end_logit": 4.082531929016113,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "amegakaryocytic",
            "probability": 0.0006373970086092347,
            "start_logit": 3.7219491004943848,
            "end_logit": -3.028981924057007,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "am",
            "probability": 0.0004529209766353746,
            "start_logit": 3.7219491004943848,
            "end_logit": -3.370656967163086,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "radioulnar synostosis",
            "probability": 0.00039943627326665966,
            "start_logit": -0.23312240839004517,
            "end_logit": 0.4587511122226715,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "amegakaryocytic thrombocytopenia.",
            "probability": 0.00038838951122531105,
            "start_logit": 3.7219491004943848,
            "end_logit": -3.5243659019470215,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "bone marrow failure syndrome with amegakaryocytic",
            "probability": 0.00013063980169433973,
            "start_logit": 2.137000322341919,
            "end_logit": -3.028981924057007,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "bone marrow failure syndrome with",
            "probability": 0.00010341101337950282,
            "start_logit": 2.137000322341919,
            "end_logit": -3.262714385986328,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "bone marrow failure syndrome with am",
            "probability": 9.282990941541544e-05,
            "start_logit": 2.137000322341919,
            "end_logit": -3.370656967163086,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "bone",
            "probability": 8.222705652735358e-05,
            "start_logit": 2.137000322341919,
            "end_logit": -3.491941452026367,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "bone marrow failure syndrome with amegakaryocytic thrombocytopenia.",
            "probability": 7.960365053696466e-05,
            "start_logit": 2.137000322341919,
            "end_logit": -3.5243659019470215,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        }
    ],
    "5c72fb4a7c78d69471000082": [
        {
            "text": "achalasia",
            "probability": 0.23378892971247284,
            "start_logit": 4.404507637023926,
            "end_logit": 4.30222749710083,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "alacrima, achalasia",
            "probability": 0.16411742244094554,
            "start_logit": 4.050671100616455,
            "end_logit": 4.30222749710083,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "alacrima",
            "probability": 0.13863806456053474,
            "start_logit": 4.050671100616455,
            "end_logit": 4.133512020111084,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and neurological and dermatological abnormalities. Background Triple A syndrome is characterized by achalasia",
            "probability": 0.12404089105241581,
            "start_logit": 4.404507637023926,
            "end_logit": 3.6684200763702393,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, alacrima, achalasia",
            "probability": 0.055246505904015995,
            "start_logit": 2.9618940353393555,
            "end_logit": 4.30222749710083,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "achalasia, alacrima",
            "probability": 0.04934372794021549,
            "start_logit": 3.4221301078796387,
            "end_logit": 3.728996992111206,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, alacrima",
            "probability": 0.04666944275840655,
            "start_logit": 2.9618940353393555,
            "end_logit": 4.133512020111084,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and neurological and dermatological abnormalities",
            "probability": 0.03286861417115146,
            "start_logit": 4.404507637023926,
            "end_logit": 2.340327024459839,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "achalasia, alacrima and adrenal insufficiency",
            "probability": 0.025618971227013235,
            "start_logit": 3.4221301078796387,
            "end_logit": 3.073519468307495,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.025163391880407178,
            "start_logit": 3.4041872024536133,
            "end_logit": 3.073519468307495,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "alacrima, achalasia, and neurological and dermatological abnormalities",
            "probability": 0.02307342885571849,
            "start_logit": 4.050671100616455,
            "end_logit": 2.340327024459839,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "alacrima and adrenal insufficiency",
            "probability": 0.01935317196808726,
            "start_logit": 3.141653299331665,
            "end_logit": 3.073519468307495,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "neurological and dermatological abnormalities. Background Triple A syndrome is characterized by achalasia, alacrima",
            "probability": 0.0106460164180122,
            "start_logit": 1.888505220413208,
            "end_logit": 3.728996992111206,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "neurological and dermatological abnormalities. Background Triple A syndrome is characterized by achalasia",
            "probability": 0.010020258173919567,
            "start_logit": 1.888505220413208,
            "end_logit": 3.6684200763702393,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima, achalasia",
            "probability": 0.00974101587518674,
            "start_logit": 1.226434350013733,
            "end_logit": 4.30222749710083,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima",
            "probability": 0.00822871556050227,
            "start_logit": 1.226434350013733,
            "end_logit": 4.133512020111084,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, alacrima, achalasia, and neurological and dermatological abnormalities",
            "probability": 0.007767160271859803,
            "start_logit": 2.9618940353393555,
            "end_logit": 2.340327024459839,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, and alacrima",
            "probability": 0.00750152072746762,
            "start_logit": 2.675827741622925,
            "end_logit": 2.5915944576263428,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "achalasia, adrenal insufficiency, and alacrima",
            "probability": 0.004633641759362986,
            "start_logit": 2.1940650939941406,
            "end_logit": 2.5915944576263428,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone-resistant adrenal insufficiency",
            "probability": 0.0035391087423043235,
            "start_logit": 1.226434350013733,
            "end_logit": 3.289757013320923,
            "question_text": "List features of the Triple A syndrome."
        }
    ],
    "5c8d00980101eac870000006": [
        {
            "text": "nicotinamide",
            "probability": 0.8705490018862978,
            "start_logit": 5.673662185668945,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "BZD9L1) Sirtuin inhibitor nicotinamide",
            "probability": 0.09115908455643015,
            "start_logit": 3.417144298553467,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "BZD9L1",
            "probability": 0.00981329320564638,
            "start_logit": 3.417144298553467,
            "end_logit": 2.898371934890747,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "nicotinamide (NAM)of a novel sirtuin inhibitor (BZD9L1",
            "probability": 0.009572913647366118,
            "start_logit": 3.3923439979553223,
            "end_logit": 2.898371934890747,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Sirtinol",
            "probability": 0.009174346194548093,
            "start_logit": 2.4682178497314453,
            "end_logit": 3.7799715995788574,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "(BZD9L1) Sirtuin inhibitor nicotinamide",
            "probability": 0.0035937492337692416,
            "start_logit": 0.18373414874076843,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Sirtuin inhibitor nicotinamide",
            "probability": 0.0026173504898221282,
            "start_logit": -0.133299320936203,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "NAM)of a novel sirtuin inhibitor (BZD9L1) Sirtuin inhibitor nicotinamide",
            "probability": 0.000909074966566943,
            "start_logit": -1.1907895803451538,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "(BZD9L1",
            "probability": 0.00038686780489456945,
            "start_logit": 0.18373414874076843,
            "end_logit": 2.898371934890747,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "ni",
            "probability": 0.0003466301694933301,
            "start_logit": 5.673662185668945,
            "end_logit": -2.701380729675293,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "nicotinamide (NAM",
            "probability": 0.0002772529108677237,
            "start_logit": 3.3923439979553223,
            "end_logit": -0.6433908343315125,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "novel sirtuin inhibitor (BZD9L1) Sirtuin inhibitor nicotinamide",
            "probability": 0.00026184444724905204,
            "start_logit": -2.4354665279388428,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "nicotinamide.",
            "probability": 0.00022812596304427318,
            "start_logit": 5.673662185668945,
            "end_logit": -3.119741201400757,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "(NAM)of a novel sirtuin inhibitor (BZD9L1) Sirtuin inhibitor nicotinamide",
            "probability": 0.00021277527611154827,
            "start_logit": -2.6429805755615234,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "a novel sirtuin inhibitor (BZD9L1) Sirtuin inhibitor nicotinamide",
            "probability": 0.00018264519416186272,
            "start_logit": -2.7956717014312744,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "1) Sirtuin inhibitor nicotinamide",
            "probability": 0.00018163624329951245,
            "start_logit": -2.80121111869812,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "de",
            "probability": 0.00018160580211578695,
            "start_logit": -2.8013787269592285,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "inhibitor nicotinamide",
            "probability": 0.00012201163509164192,
            "start_logit": -3.1991007328033447,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "mide",
            "probability": 0.00011565456837922296,
            "start_logit": -3.2526092529296875,
            "end_logit": 5.127240180969238,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "nicotinamide (NAM)",
            "probability": 0.00011413580484483275,
            "start_logit": 3.3923439979553223,
            "end_logit": -1.5309319496154785,
            "question_text": "List sirtuin inhibitors."
        }
    ],
    "5c8d0a980101eac870000008": [
        {
            "text": "p16INK4a",
            "probability": 0.4610462960756127,
            "start_logit": 4.740172863006592,
            "end_logit": 4.367379665374756,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16",
            "probability": 0.16569400448946073,
            "start_logit": 4.740172863006592,
            "end_logit": 3.3440239429473877,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a (p16",
            "probability": 0.1644652518296686,
            "start_logit": 4.740172863006592,
            "end_logit": 3.336580514907837,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a (p16)",
            "probability": 0.088457949220277,
            "start_logit": 4.740172863006592,
            "end_logit": 2.7164084911346436,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16)",
            "probability": 0.04001360446129428,
            "start_logit": 3.9468650817871094,
            "end_logit": 2.7164084911346436,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16(INK4a",
            "probability": 0.027660164973443972,
            "start_logit": 3.912292242050171,
            "end_logit": 2.3817551136016846,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16 INK4a",
            "probability": 0.019257228379254344,
            "start_logit": 3.103358030319214,
            "end_logit": 2.828582525253296,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16(INK4a)",
            "probability": 0.011815129705196254,
            "start_logit": 3.912292242050171,
            "end_logit": 1.5311427116394043,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a (p16) tumor-suppressor protein",
            "probability": 0.009947736872080882,
            "start_logit": 4.740172863006592,
            "end_logit": 0.5312262773513794,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16) tumor-suppressor protein",
            "probability": 0.004499819541297192,
            "start_logit": 3.9468650817871094,
            "end_logit": 0.5312262773513794,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "(p16",
            "probability": 0.002460199150285453,
            "start_logit": 0.5377158522605896,
            "end_logit": 3.336580514907837,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "(p16)",
            "probability": 0.0013232228029122263,
            "start_logit": 0.5377158522605896,
            "end_logit": 2.7164084911346436,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "INK4a",
            "probability": 0.0006821128941422243,
            "start_logit": -1.7758857011795044,
            "end_logit": 4.367379665374756,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a (p16) tumor-suppressor",
            "probability": 0.0005352152511006702,
            "start_logit": 4.740172863006592,
            "end_logit": -2.391205072402954,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "16INK4a",
            "probability": 0.0005218232475018438,
            "start_logit": -2.0437519550323486,
            "end_logit": 4.367379665374756,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "16",
            "probability": 0.0004924230742617314,
            "start_logit": -1.61074960231781,
            "end_logit": 3.8763866424560547,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a (p16) tumor-suppressor protein is a biomarker of human papillomavirus",
            "probability": 0.0004077090364037068,
            "start_logit": 4.740172863006592,
            "end_logit": -2.663320302963257,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "INK4a (p16",
            "probability": 0.00024332452047931983,
            "start_logit": -1.7758857011795044,
            "end_logit": 3.336580514907837,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16) tumor-suppressor",
            "probability": 0.00024210250800484767,
            "start_logit": 3.9468650817871094,
            "end_logit": -2.391205072402954,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "16)",
            "probability": 0.00023468196732198755,
            "start_logit": -1.1918784379959106,
            "end_logit": 2.7164084911346436,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        }
    ],
    "5c73acf57c78d6947100008c": [
        {
            "text": "Trouble",
            "probability": 0.10662276846042612,
            "start_logit": 2.696474075317383,
            "end_logit": 2.5823957920074463,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Forget",
            "probability": 0.0818380340364233,
            "start_logit": 2.33860182762146,
            "end_logit": 2.675713062286377,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Forget, Friends, Trouble",
            "probability": 0.07566538157079404,
            "start_logit": 2.207284450531006,
            "end_logit": 2.728609085083008,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Forget, Family/Friends, Trouble",
            "probability": 0.07454662950872096,
            "start_logit": 2.33860182762146,
            "end_logit": 2.5823957920074463,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Relax, Alone, Forget",
            "probability": 0.0720404822021604,
            "start_logit": 2.211087942123413,
            "end_logit": 2.675713062286377,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Relax",
            "probability": 0.06743361216916319,
            "start_logit": 2.211087942123413,
            "end_logit": 2.609628438949585,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Relax, Alone, Forget, Family/Friends, Trouble",
            "probability": 0.06562199592873758,
            "start_logit": 2.211087942123413,
            "end_logit": 2.5823957920074463,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Family/Friends, Trouble",
            "probability": 0.05341558420488626,
            "start_logit": 2.005279541015625,
            "end_logit": 2.5823957920074463,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Relax, Alone, Forget, Friends, Trouble",
            "probability": 0.05283718885852324,
            "start_logit": 1.8481789827346802,
            "end_logit": 2.728609085083008,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car, Relax, Alone, Forget",
            "probability": 0.0465267173323309,
            "start_logit": 1.7738864421844482,
            "end_logit": 2.675713062286377,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car, Relax",
            "probability": 0.04355141048734673,
            "start_logit": 1.7738864421844482,
            "end_logit": 2.609628438949585,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car, Relax, Alone, Forget, Family/Friends, Trouble",
            "probability": 0.042381393933370724,
            "start_logit": 1.7738864421844482,
            "end_logit": 2.5823957920074463,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car, Relax, Alone, Forget, Friends, Trouble",
            "probability": 0.0411100469515379,
            "start_logit": 1.597216248512268,
            "end_logit": 2.728609085083008,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Forget, Family/Friends",
            "probability": 0.030432104343339147,
            "start_logit": 2.33860182762146,
            "end_logit": 1.6864690780639648,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Friends, Trouble",
            "probability": 0.028098259702045655,
            "start_logit": 1.216671347618103,
            "end_logit": 2.728609085083008,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Alone, Forget",
            "probability": 0.027203069141522703,
            "start_logit": 1.237189531326294,
            "end_logit": 2.675713062286377,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Relax, Alone, Forget, Family/Friends",
            "probability": 0.0267888091048824,
            "start_logit": 2.211087942123413,
            "end_logit": 1.6864690780639648,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Alone, Forget, Family/Friends, Trouble",
            "probability": 0.02477939677645073,
            "start_logit": 1.237189531326294,
            "end_logit": 2.5823957920074463,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Family/Friends",
            "probability": 0.021805796490012335,
            "start_logit": 2.005279541015625,
            "end_logit": 1.6864690780639648,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car, Relax, Alone, Forget, Family/Friends",
            "probability": 0.017301318797325566,
            "start_logit": 1.7738864421844482,
            "end_logit": 1.6864690780639648,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        }
    ],
    "5c5f0f581a4c55d80b000012": [
        {
            "text": "Th17 cells",
            "probability": 0.10134183431938251,
            "start_logit": 2.2881360054016113,
            "end_logit": 1.5986756086349487,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Th17 cells, regulatory Treg-cells, CD4+ T-cells, CD8+ T-cells",
            "probability": 0.08776072224163957,
            "start_logit": 2.2881360054016113,
            "end_logit": 1.4547903537750244,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Th17 cells, regulatory Treg-cells, CD4+ T-cells",
            "probability": 0.08773350461658046,
            "start_logit": 2.2881360054016113,
            "end_logit": 1.4544801712036133,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD8+ T-cells",
            "probability": 0.08468809171130104,
            "start_logit": 2.2524969577789307,
            "end_logit": 1.4547903537750244,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Th17 cells, regulatory Treg-cells",
            "probability": 0.07336344552322346,
            "start_logit": 2.2881360054016113,
            "end_logit": 1.275602102279663,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4+ T-cells, CD8+ T-cells",
            "probability": 0.07200222786531037,
            "start_logit": 2.090219020843506,
            "end_logit": 1.4547903537750244,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4+ T-cells",
            "probability": 0.07197989749254904,
            "start_logit": 2.090219020843506,
            "end_logit": 1.4544801712036133,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Th17",
            "probability": 0.048392237491866184,
            "start_logit": 2.2881360054016113,
            "end_logit": 0.8595157265663147,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD8+ T-cells, and CD3+ T-cells",
            "probability": 0.0415304759092762,
            "start_logit": 2.2524969577789307,
            "end_logit": 0.7422428727149963,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Th17 cells, regulatory Treg-cells, CD4",
            "probability": 0.04029542277093379,
            "start_logit": 2.2881360054016113,
            "end_logit": 0.6764141917228699,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4+ T-cells, CD8+ T-cells, and CD3+ T-cells",
            "probability": 0.03530941280349401,
            "start_logit": 2.090219020843506,
            "end_logit": 0.7422428727149963,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "Th17 cells, regulatory Treg-cells, CD4+ T-cells, CD8",
            "probability": 0.0343680760729295,
            "start_logit": 2.2881360054016113,
            "end_logit": 0.5173044204711914,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD8",
            "probability": 0.03316479974254651,
            "start_logit": 2.2524969577789307,
            "end_logit": 0.5173044204711914,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4",
            "probability": 0.03305989442854872,
            "start_logit": 2.090219020843506,
            "end_logit": 0.6764141917228699,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD3+ T-cells",
            "probability": 0.031795531222203556,
            "start_logit": 1.9853951930999756,
            "end_logit": 0.7422428727149963,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD8 T cells",
            "probability": 0.029126520250983456,
            "start_logit": 1.6987391710281372,
            "end_logit": 0.9412222504615784,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4+ T-cells, CD8",
            "probability": 0.028196874199393096,
            "start_logit": 2.090219020843506,
            "end_logit": 0.5173044204711914,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD8 T cells and NK cells",
            "probability": 0.02525723342629036,
            "start_logit": 1.6987391710281372,
            "end_logit": 0.7986857295036316,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4 and CD8 T cells",
            "probability": 0.021762402513963403,
            "start_logit": 1.4072738885879517,
            "end_logit": 0.9412222504615784,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4 and CD8 T cells and NK cells",
            "probability": 0.01887139539758453,
            "start_logit": 1.4072738885879517,
            "end_logit": 0.7986857295036316,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        }
    ],
    "5c73ad057c78d6947100008f": [
        {
            "text": "palonosetron",
            "probability": 0.11767665059670501,
            "start_logit": 4.891139507293701,
            "end_logit": 5.369659423828125,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "dulaglutide",
            "probability": 0.1124359348948348,
            "start_logit": 5.1588239669799805,
            "end_logit": 5.056417942047119,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "dulaglutide (Trulicity) for glycemic control in type-2 diabetes; netupitant/palonosetron",
            "probability": 0.10032172961610418,
            "start_logit": 5.1588239669799805,
            "end_logit": 4.942416667938232,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "dulaglutide (Trulicity) for glycemic control in type-2 diabetes; netupitant",
            "probability": 0.09763750845340473,
            "start_logit": 5.1588239669799805,
            "end_logit": 4.9152960777282715,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "netupitant/palonosetron",
            "probability": 0.08843058388734461,
            "start_logit": 5.032659530639648,
            "end_logit": 4.942416667938232,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "netupitant",
            "probability": 0.0860645237565175,
            "start_logit": 5.032659530639648,
            "end_logit": 4.9152960777282715,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "netupitant and the 5-hydroxytryptamine-3 RA palonosetron",
            "probability": 0.07519513779441293,
            "start_logit": 4.4432854652404785,
            "end_logit": 5.369659423828125,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "palonosetron (Akynzeo\u00ae).An oral fixed combination of netupitant/palonosetron",
            "probability": 0.07203318256322427,
            "start_logit": 4.891139507293701,
            "end_logit": 4.878845691680908,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "palonosetron (Akynzeo\u00ae).An oral fixed combination of netupitant",
            "probability": 0.05774036273146581,
            "start_logit": 4.891139507293701,
            "end_logit": 4.657675266265869,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "palonosetron (Akynzeo) for prevention of nausea and vomiting related to chemotherapy; and naloxegol",
            "probability": 0.05498307081793554,
            "start_logit": 4.721503257751465,
            "end_logit": 4.778380393981934,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "5-hydroxytryptamine-3 RA palonosetron",
            "probability": 0.0528952881244994,
            "start_logit": 4.091513156890869,
            "end_logit": 5.369659423828125,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "naloxegol",
            "probability": 0.01649968029328838,
            "start_logit": 3.865607738494873,
            "end_logit": 4.430591583251953,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "Ledipasvir",
            "probability": 0.010588007489498327,
            "start_logit": 3.6394202709198,
            "end_logit": 4.213160037994385,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "NEPA, a fixed combination antiemetic composed of the neurokinin-1 receptor antagonist (RA) netupitant",
            "probability": 0.009894923462852152,
            "start_logit": 3.149691581726074,
            "end_logit": 4.635188579559326,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "Ledipasvir/sofosbuvir",
            "probability": 0.00984986077332366,
            "start_logit": 3.6394202709198,
            "end_logit": 4.140895366668701,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "netupitant/palonosetron (NEPA",
            "probability": 0.008858861638782637,
            "start_logit": 5.030385494232178,
            "end_logit": 2.6438910961151123,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "palonosetron (Akynzeo\u00ae).An oral fixed combination of netupitant/palonosetron (NEPA",
            "probability": 0.007707333561712729,
            "start_logit": 4.891139507293701,
            "end_logit": 2.6438910961151123,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "palonosetron (NEPA",
            "probability": 0.00748693935368406,
            "start_logit": 4.862127304077148,
            "end_logit": 2.6438910961151123,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "netupitant and the 5-hydroxytryptamine",
            "probability": 0.007071092288921416,
            "start_logit": 4.4432854652404785,
            "end_logit": 3.0055878162384033,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "sofosbuvir (Harvoni) for hepatitis C virus genotype 1 infection; dulaglutide",
            "probability": 0.006629327901487902,
            "start_logit": 2.327943801879883,
            "end_logit": 5.056417942047119,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        }
    ],
    "5c5f2dc21a4c55d80b000024": [
        {
            "text": "serotonin",
            "probability": 0.3660701464810045,
            "start_logit": 5.909299850463867,
            "end_logit": 5.695613384246826,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "serotonin and gamma-aminobutyric acid",
            "probability": 0.32030979385654257,
            "start_logit": 5.909299850463867,
            "end_logit": 5.562077045440674,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "gamma-aminobutyric acid",
            "probability": 0.2857803369217763,
            "start_logit": 5.795234680175781,
            "end_logit": 5.562077045440674,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "aminobutyric acid",
            "probability": 0.008570162332990868,
            "start_logit": 2.2882978916168213,
            "end_logit": 5.562077045440674,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "serotonin and gamma-aminobutyric acid,",
            "probability": 0.006145809583509419,
            "start_logit": 5.909299850463867,
            "end_logit": 1.6085588932037354,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "gamma-aminobutyric acid,",
            "probability": 0.0054832901369822684,
            "start_logit": 5.795234680175781,
            "end_logit": 1.6085588932037354,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "neuroactive substances such as serotonin",
            "probability": 0.0011847199525726669,
            "start_logit": 0.1759812980890274,
            "end_logit": 5.695613384246826,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "rotonin",
            "probability": 0.001090838991644008,
            "start_logit": 0.09342199563980103,
            "end_logit": 5.695613384246826,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "neuroactive substances such as serotonin and gamma-aminobutyric acid",
            "probability": 0.0010366248311537063,
            "start_logit": 0.1759812980890274,
            "end_logit": 5.562077045440674,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "rotonin and gamma-aminobutyric acid",
            "probability": 0.0009544793966483737,
            "start_logit": 0.09342199563980103,
            "end_logit": 5.562077045440674,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "butyric acid",
            "probability": 0.0005737685579044053,
            "start_logit": -0.4155179560184479,
            "end_logit": 5.562077045440674,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "serotonin and gamma-aminobutyric",
            "probability": 0.0004888169034587256,
            "start_logit": 5.909299850463867,
            "end_logit": -0.9229788780212402,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "onin",
            "probability": 0.0004438360981467833,
            "start_logit": -0.8058250546455383,
            "end_logit": 5.695613384246826,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "gamma-aminobutyric",
            "probability": 0.0004361223479356331,
            "start_logit": 5.795234680175781,
            "end_logit": -0.9229788780212402,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "onin and gamma-aminobutyric acid",
            "probability": 0.0003883546650009751,
            "start_logit": -0.8058250546455383,
            "end_logit": 5.562077045440674,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "yric acid",
            "probability": 0.0002500807699329751,
            "start_logit": -1.2459601163864136,
            "end_logit": 5.562077045440674,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "serotonin and gamma",
            "probability": 0.00021581377260722104,
            "start_logit": 5.909299850463867,
            "end_logit": -1.7405509948730469,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "se",
            "probability": 0.0002100529527235763,
            "start_logit": 5.909299850463867,
            "end_logit": -1.7676072120666504,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "gamma",
            "probability": 0.00019254900671464894,
            "start_logit": 5.795234680175781,
            "end_logit": -1.7405509948730469,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "serotonin and gamma-aminobutyric acid, which act on the gut-brain axis",
            "probability": 0.00017440244075010386,
            "start_logit": 5.909299850463867,
            "end_logit": -1.953601360321045,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        }
    ],
    "5c851a8175a4a5d219000005": [
        {
            "text": "toxin B",
            "probability": 0.3834050656352289,
            "start_logit": 4.258345603942871,
            "end_logit": 3.974069833755493,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A, toxin B",
            "probability": 0.29596225570713625,
            "start_logit": 3.999485492706299,
            "end_logit": 3.974069833755493,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA) and toxin B",
            "probability": 0.10111652197475153,
            "start_logit": 3.229186534881592,
            "end_logit": 3.670410394668579,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A",
            "probability": 0.0670570752738424,
            "start_logit": 3.999485492706299,
            "end_logit": 2.489382028579712,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A and toxin B",
            "probability": 0.06164388424306027,
            "start_logit": 3.1501576900482178,
            "end_logit": 3.254539728164673,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin B, and binary toxin",
            "probability": 0.022825967759768667,
            "start_logit": 4.258345603942871,
            "end_logit": 1.152876615524292,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A, toxin B, and binary toxin",
            "probability": 0.017620072117948474,
            "start_logit": 3.999485492706299,
            "end_logit": 1.152876615524292,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin B (TcdB)",
            "probability": 0.014204202646709562,
            "start_logit": 3.896512508392334,
            "end_logit": 1.040348768234253,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA) and toxin B (TcdB)",
            "probability": 0.0072878742713280405,
            "start_logit": 3.229186534881592,
            "end_logit": 1.040348768234253,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "exotoxins toxin A (TcdA) and toxin B",
            "probability": 0.004098583932580561,
            "start_logit": 0.02355453185737133,
            "end_logit": 3.670410394668579,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA)",
            "probability": 0.004052586561905936,
            "start_logit": 3.229186534881592,
            "end_logit": 0.4534921944141388,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "A, toxin B",
            "probability": 0.003935763502125553,
            "start_logit": -0.32064154744148254,
            "end_logit": 3.974069833755493,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin",
            "probability": 0.0036634479456694544,
            "start_logit": 4.258345603942871,
            "end_logit": -0.676617443561554,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A, toxin",
            "probability": 0.0028279290360173613,
            "start_logit": 3.999485492706299,
            "end_logit": -0.676617443561554,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin B (TcdB",
            "probability": 0.0021603071106397202,
            "start_logit": 3.896512508392334,
            "end_logit": -0.8429387211799622,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "binary toxin",
            "probability": 0.002112644401190673,
            "start_logit": 1.878387212753296,
            "end_logit": 1.152876615524292,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin B,",
            "probability": 0.0018559891934912113,
            "start_logit": 3.6990272998809814,
            "end_logit": -0.7972860932350159,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "exotoxins toxin A",
            "probability": 0.001646506313918642,
            "start_logit": 0.02355453185737133,
            "end_logit": 2.7584245204925537,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "B",
            "probability": 0.0014149147414109868,
            "start_logit": -1.3436771631240845,
            "end_logit": 3.974069833755493,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA) and toxin B (TcdB",
            "probability": 0.00110840763127562,
            "start_logit": 3.229186534881592,
            "end_logit": -0.8429387211799622,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        }
    ],
    "5c7d520ed774d0424000000f": [
        {
            "text": "leptin",
            "probability": 0.3988672714663769,
            "start_logit": 4.440079212188721,
            "end_logit": 4.045596599578857,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and leptin",
            "probability": 0.34231026122192615,
            "start_logit": 4.287168025970459,
            "end_logit": 4.045596599578857,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin",
            "probability": 0.21559008205455288,
            "start_logit": 4.287168025970459,
            "end_logit": 3.5832579135894775,
            "question_text": "List adipokines."
        },
        {
            "text": "leptin) number of adipokines, like Resistin",
            "probability": 0.016917172471852253,
            "start_logit": 4.440079212188721,
            "end_logit": 0.8852971196174622,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and leptin) number of adipokines, like Resistin",
            "probability": 0.014518417885445075,
            "start_logit": 4.287168025970459,
            "end_logit": 0.8852971196174622,
            "question_text": "List adipokines."
        },
        {
            "text": "(adiponectin and leptin",
            "probability": 0.0033245861447357135,
            "start_logit": -0.3472042977809906,
            "end_logit": 4.045596599578857,
            "question_text": "List adipokines."
        },
        {
            "text": "(adiponectin",
            "probability": 0.0020938542630374764,
            "start_logit": -0.3472042977809906,
            "end_logit": 3.5832579135894775,
            "question_text": "List adipokines."
        },
        {
            "text": "leptin)",
            "probability": 0.0015498564136972974,
            "start_logit": 4.440079212188721,
            "end_logit": -1.504869818687439,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and leptin)",
            "probability": 0.0013300959787419448,
            "start_logit": 4.287168025970459,
            "end_logit": -1.504869818687439,
            "question_text": "List adipokines."
        },
        {
            "text": "Resistin",
            "probability": 0.0006136433956669388,
            "start_logit": 1.1234086751937866,
            "end_logit": 0.8852971196174622,
            "question_text": "List adipokines."
        },
        {
            "text": "lept",
            "probability": 0.0004954904275455176,
            "start_logit": 4.440079212188721,
            "end_logit": -2.6452393531799316,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and lept",
            "probability": 0.000425232827608338,
            "start_logit": 4.287168025970459,
            "end_logit": -2.6452393531799316,
            "question_text": "List adipokines."
        },
        {
            "text": "leptin) number of adipokines, like Resistin (RETN)",
            "probability": 0.00039033467976661875,
            "start_logit": 4.440079212188721,
            "end_logit": -2.8837828636169434,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponect",
            "probability": 0.0003581554560712066,
            "start_logit": 4.287168025970459,
            "end_logit": -2.816909074783325,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and leptin) number of adipokines, like Resistin (RETN)",
            "probability": 0.00033498754035062885,
            "start_logit": 4.287168025970459,
            "end_logit": -2.8837828636169434,
            "question_text": "List adipokines."
        },
        {
            "text": "ad",
            "probability": 0.0002885816363284712,
            "start_logit": 4.287168025970459,
            "end_logit": -3.032898187637329,
            "question_text": "List adipokines."
        },
        {
            "text": "le",
            "probability": 0.0001875881938038159,
            "start_logit": 4.440079212188721,
            "end_logit": -3.6165382862091064,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and le",
            "probability": 0.0001609893019977862,
            "start_logit": 4.287168025970459,
            "end_logit": -3.6165382862091064,
            "question_text": "List adipokines."
        },
        {
            "text": "(adiponectin and leptin) number of adipokines, like Resistin",
            "probability": 0.00014100579624208521,
            "start_logit": -0.3472042977809906,
            "end_logit": 0.8852971196174622,
            "question_text": "List adipokines."
        },
        {
            "text": "leptin) number of adipokines, like Resist",
            "probability": 0.00010239284425269571,
            "start_logit": 4.440079212188721,
            "end_logit": -4.221970558166504,
            "question_text": "List adipokines."
        }
    ],
    "5c73ace67c78d69471000083": [
        {
            "text": "osteodystrophy",
            "probability": 0.16402585684056178,
            "start_logit": 4.683004379272461,
            "end_logit": 4.567540168762207,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy",
            "probability": 0.1174200754613979,
            "start_logit": 4.348738193511963,
            "end_logit": 4.567540168762207,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "osteodystrophy, mental retardation",
            "probability": 0.10897043547395456,
            "start_logit": 4.683004379272461,
            "end_logit": 4.158592700958252,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onychodystrophy",
            "probability": 0.08459225395864048,
            "start_logit": 4.279860019683838,
            "end_logit": 4.308503150939941,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy, mental retardation",
            "probability": 0.07800792510933553,
            "start_logit": 4.348738193511963,
            "end_logit": 4.158592700958252,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "osteodystrophy, and mental retardation",
            "probability": 0.060411426251588476,
            "start_logit": 4.495075225830078,
            "end_logit": 3.7566235065460205,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "deafness, onychodystrophy, osteodystrophy",
            "probability": 0.057134743325475884,
            "start_logit": 3.6283926963806152,
            "end_logit": 4.567540168762207,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "mental retardation",
            "probability": 0.05058847541784276,
            "start_logit": 3.915651559829712,
            "end_logit": 4.158592700958252,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 0.04871383408748047,
            "start_logit": 4.279860019683838,
            "end_logit": 3.7566235065460205,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "mental retardation) is a rarely described disorder with less than 35 reports in the literature. [DOOR (deafness, onychodystrophy",
            "probability": 0.04206125528155665,
            "start_logit": 3.6756606101989746,
            "end_logit": 4.213986873626709,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "deafness, onychodystrophy",
            "probability": 0.04011936361909859,
            "start_logit": 3.6283926963806152,
            "end_logit": 4.213986873626709,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation",
            "probability": 0.037957417085292766,
            "start_logit": 3.6283926963806152,
            "end_logit": 4.158592700958252,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "mental retardation) is a rarely described disorder with less than 35 reports in the literature. [DOOR (deafness",
            "probability": 0.024303555640093618,
            "start_logit": 3.6756606101989746,
            "end_logit": 3.665482521057129,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "deafness",
            "probability": 0.02318150467538364,
            "start_logit": 3.6283926963806152,
            "end_logit": 3.665482521057129,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 0.020475646041680114,
            "start_logit": 3.413133144378662,
            "end_logit": 3.7566235065460205,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "deafness (sensorineural), onychodystrophy",
            "probability": 0.015425939283276022,
            "start_logit": 2.549267292022705,
            "end_logit": 4.337303638458252,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy",
            "probability": 0.015162628954587315,
            "start_logit": 2.549267292022705,
            "end_logit": 4.32008695602417,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 0.009079812926173195,
            "start_logit": 2.549267292022705,
            "end_logit": 3.8073067665100098,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "osteodystrophy,",
            "probability": 0.001318917753937837,
            "start_logit": 4.418521404266357,
            "end_logit": 0.008810581639409065,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy,",
            "probability": 0.0010489328126423462,
            "start_logit": 4.189483165740967,
            "end_logit": 0.008810581639409065,
            "question_text": "List features of the DOOR syndrome."
        }
    ],
    "5c6d6b377c78d69471000039": [
        {
            "text": "pedigreejs",
            "probability": 0.5930438616230658,
            "start_logit": 4.0616679191589355,
            "end_logit": 4.295530796051025,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "Pedigreejs",
            "probability": 0.39223822843737566,
            "start_logit": 3.889723539352417,
            "end_logit": 4.054076194763184,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigreejs'",
            "probability": 0.004335483534300243,
            "start_logit": 3.8453240394592285,
            "end_logit": -0.4065605401992798,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigreejs:",
            "probability": 0.00433091742248712,
            "start_logit": 4.0616679191589355,
            "end_logit": -0.623958170413971,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "'pedigreejs",
            "probability": 0.0011298069081578659,
            "start_logit": -1.6347492933273315,
            "end_logit": 3.728726387023926,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigreejs',",
            "probability": 0.0011268951734069337,
            "start_logit": 3.8453240394592285,
            "end_logit": -1.75392746925354,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigreejs: a web-based graphical pedigree editor",
            "probability": 0.0007473934449782234,
            "start_logit": 4.0616679191589355,
            "end_logit": -2.3809010982513428,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigreejs', an interactive graphical pedigree editor written in JavaScript,",
            "probability": 0.000529362396640338,
            "start_logit": 3.8453240394592285,
            "end_logit": -2.5094757080078125,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "Madeline 2.0 PDE",
            "probability": 0.0003794873907673762,
            "start_logit": 1.3587065935134888,
            "end_logit": -0.35571014881134033,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "P",
            "probability": 0.0003575952422054573,
            "start_logit": 3.889723539352417,
            "end_logit": -2.9461467266082764,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "p",
            "probability": 0.00032813962522453883,
            "start_logit": 4.0616679191589355,
            "end_logit": -3.2040536403656006,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "Madeline",
            "probability": 0.00023422920264182538,
            "start_logit": 1.3587065935134888,
            "end_logit": -0.8382313847541809,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "madeline",
            "probability": 0.00019557780690230807,
            "start_logit": 0.3333412706851959,
            "end_logit": 0.00679209316149354,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigree nomenclature. Pedigreejs",
            "probability": 0.00018381068512551596,
            "start_logit": -3.7759947776794434,
            "end_logit": 4.054076194763184,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigreejs: a web-based graphical",
            "probability": 0.0001813386996936394,
            "start_logit": 4.0616679191589355,
            "end_logit": -3.797126293182373,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigreejs', an interactive graphical pedigree editor",
            "probability": 0.00015463797321567735,
            "start_logit": 3.8453240394592285,
            "end_logit": -3.7400622367858887,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigreej",
            "probability": 0.00014924628852026848,
            "start_logit": 3.8453240394592285,
            "end_logit": -3.7755510807037354,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "graphical pedigree editor written in JavaScript, which uses standard pedigree nomenclature. Pedigreejs",
            "probability": 0.00012787952099847918,
            "start_logit": -4.13881254196167,
            "end_logit": 4.054076194763184,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "s",
            "probability": 0.00012315159285989507,
            "start_logit": -4.41793966293335,
            "end_logit": 4.295530796051025,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "JavaScript, which uses standard pedigree nomenclature. Pedigreejs",
            "probability": 0.00010295703143278277,
            "start_logit": -4.355589389801025,
            "end_logit": 4.054076194763184,
            "question_text": "Which web-based pedigree editors are available?"
        }
    ],
    "5c6d783e7c78d6947100003a": [
        {
            "text": "ArachnoServer",
            "probability": 0.545513359073836,
            "start_logit": 4.968525409698486,
            "end_logit": 4.883965015411377,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer: a database of protein toxins from spiders.We have developed ArachnoServer",
            "probability": 0.19084889886402523,
            "start_logit": 4.0803656578063965,
            "end_logit": 4.721879482269287,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver",
            "probability": 0.10689755506451437,
            "start_logit": 4.814174175262451,
            "end_logit": 3.4084599018096924,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer 2.0, an updated online resource for spider toxin sequences and structures.ArachnoServer",
            "probability": 0.040946270135148004,
            "start_logit": 2.880980968475342,
            "end_logit": 4.38204288482666,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver",
            "probability": 0.028638147726045823,
            "start_logit": 3.4970428943634033,
            "end_logit": 3.4084599018096924,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org)",
            "probability": 0.027004920143689895,
            "start_logit": 4.814174175262451,
            "end_logit": 2.0326080322265625,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer,",
            "probability": 0.016145871319534374,
            "start_logit": 4.908349990844727,
            "end_logit": 1.4240775108337402,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver.org.ArachnoServer",
            "probability": 0.011698710433386442,
            "start_logit": 2.875112533569336,
            "end_logit": 3.13512921333313,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer is available online at http://www.arachnoserver",
            "probability": 0.01157481707384682,
            "start_logit": 3.279629707336426,
            "end_logit": 2.7199652194976807,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver.org)",
            "probability": 0.007234692055756749,
            "start_logit": 3.4970428943634033,
            "end_logit": 2.0326080322265625,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer: a database of protein toxins from spiders.We have developed ArachnoServer,",
            "probability": 0.007054601070736167,
            "start_logit": 4.0803656578063965,
            "end_logit": 1.4240775108337402,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org",
            "probability": 0.0011873113929704218,
            "start_logit": 4.814174175262451,
            "end_logit": -1.091719627380371,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer, a manually curated database",
            "probability": 0.0008535447875481871,
            "start_logit": 4.908349990844727,
            "end_logit": -1.5159441232681274,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer is a manually curated database",
            "probability": 0.0007747458993914311,
            "start_logit": 4.968525409698486,
            "end_logit": -1.6729824542999268,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (",
            "probability": 0.0007531313038271317,
            "start_logit": 4.814174175262451,
            "end_logit": -1.546926736831665,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org) is a manually curated database",
            "probability": 0.0007155309767387461,
            "start_logit": 4.814174175262451,
            "end_logit": -1.5981414318084717,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer is a manually",
            "probability": 0.000598432202253314,
            "start_logit": 4.968525409698486,
            "end_logit": -1.9312043190002441,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer:",
            "probability": 0.0005542699768042382,
            "start_logit": 4.0803656578063965,
            "end_logit": -1.1197059154510498,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "A",
            "probability": 0.0005098061866386645,
            "start_logit": 4.968525409698486,
            "end_logit": -2.091486930847168,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org) is a manually",
            "probability": 0.0004953843133081627,
            "start_logit": 4.814174175262451,
            "end_logit": -1.9658324718475342,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        }
    ],
    "5c851c2675a4a5d219000006": [
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxumab",
            "probability": 0.24189620582742488,
            "start_logit": 6.456461429595947,
            "end_logit": 6.560763835906982,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bezlotoxumab",
            "probability": 0.2344051038597674,
            "start_logit": 6.425003528594971,
            "end_logit": 6.560763835906982,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab",
            "probability": 0.19519606025768468,
            "start_logit": 6.456461429595947,
            "end_logit": 6.346259593963623,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab",
            "probability": 0.15342373959580086,
            "start_logit": 6.215660572052002,
            "end_logit": 6.346259593963623,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab",
            "probability": 0.1330604276650424,
            "start_logit": 6.215660572052002,
            "end_logit": 6.203859329223633,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Actoxumab-Bezlotoxumab",
            "probability": 0.021701464240914473,
            "start_logit": 5.340400218963623,
            "end_logit": 5.265696048736572,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Actoxumab",
            "probability": 0.018998432443437067,
            "start_logit": 5.340400218963623,
            "end_logit": 5.1326727867126465,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotox",
            "probability": 0.00020248038390681186,
            "start_logit": 6.456461429595947,
            "end_logit": -0.5248571634292603,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "(Actoxumab-Bezlotoxumab",
            "probability": 0.00018893909875574946,
            "start_logit": 0.5966899394989014,
            "end_logit": 5.265696048736572,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "(Actoxumab",
            "probability": 0.0001654057377781681,
            "start_logit": 0.5966899394989014,
            "end_logit": 5.1326727867126465,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotox",
            "probability": 0.00015914920440897312,
            "start_logit": 6.215660572052002,
            "end_logit": -0.5248571634292603,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxuma",
            "probability": 9.58802745794055e-05,
            "start_logit": 6.456461429595947,
            "end_logit": -1.27239990234375,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotox",
            "probability": 8.060023031518887e-05,
            "start_logit": 6.456461429595947,
            "end_logit": -1.4459986686706543,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bezlotox",
            "probability": 7.810418230218897e-05,
            "start_logit": 6.425003528594971,
            "end_logit": -1.4459986686706543,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxuma",
            "probability": 7.536171713724671e-05,
            "start_logit": 6.215660572052002,
            "end_logit": -1.27239990234375,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bez",
            "probability": 6.026666531545035e-05,
            "start_logit": 6.456461429595947,
            "end_logit": -1.7367210388183594,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bez",
            "probability": 5.840031220923086e-05,
            "start_logit": 6.425003528594971,
            "end_logit": -1.7367210388183594,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxuma",
            "probability": 5.414276156189317e-05,
            "start_logit": 6.456461429595947,
            "end_logit": -1.8438758850097656,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bezlotoxuma",
            "probability": 5.246605503281241e-05,
            "start_logit": 6.425003528594971,
            "end_logit": -1.8438758850097656,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bez",
            "probability": 4.736948662518367e-05,
            "start_logit": 6.215660572052002,
            "end_logit": -1.7367210388183594,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        }
    ],
    "5c8bfe25d558e5f23200000f": [
        {
            "text": "modulates the host immune-inflammatory response and bone metabolism",
            "probability": 0.21161513827011855,
            "start_logit": 4.305832386016846,
            "end_logit": 5.6141180992126465,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "immune-inflammatory response and bone metabolism",
            "probability": 0.20189578835245203,
            "start_logit": 4.258814811706543,
            "end_logit": 5.6141180992126465,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "bone metabolism",
            "probability": 0.19395271147749232,
            "start_logit": 4.218677520751953,
            "end_logit": 5.6141180992126465,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "modulates the host immune-inflammatory response",
            "probability": 0.08131939756503258,
            "start_logit": 4.305832386016846,
            "end_logit": 4.65773344039917,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "immune-inflammatory response",
            "probability": 0.07758444889127793,
            "start_logit": 4.258814811706543,
            "end_logit": 4.65773344039917,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "host immune-inflammatory response and bone metabolism",
            "probability": 0.04497312512887863,
            "start_logit": 2.7571282386779785,
            "end_logit": 5.6141180992126465,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "tumor suppressor",
            "probability": 0.03543561271045633,
            "start_logit": 4.5758137702941895,
            "end_logit": 3.557084798812866,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "modulates the host immune-inflammatory response and bone metabolism, and might be involved in dental implant osseointegration",
            "probability": 0.0243995359465846,
            "start_logit": 4.305832386016846,
            "end_logit": 3.4539129734039307,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "immune-inflammatory response and bone metabolism, and might be involved in dental implant osseointegration",
            "probability": 0.02327888063982281,
            "start_logit": 4.258814811706543,
            "end_logit": 3.4539129734039307,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "bone metabolism, and might be involved in dental implant osseointegration",
            "probability": 0.022363032221220182,
            "start_logit": 4.218677520751953,
            "end_logit": 3.4539129734039307,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "modulation of immune responses",
            "probability": 0.017482470149900876,
            "start_logit": 3.6460976600646973,
            "end_logit": 3.7802822589874268,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "host immune-inflammatory response",
            "probability": 0.017282258121954303,
            "start_logit": 2.7571282386779785,
            "end_logit": 4.65773344039917,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "regulation of iron absorption and modulation of immune responses",
            "probability": 0.008518691137452333,
            "start_logit": 2.927161693572998,
            "end_logit": 3.7802822589874268,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "tumor suppressor function",
            "probability": 0.006114828712406583,
            "start_logit": 4.5758137702941895,
            "end_logit": 1.8000842332839966,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "anti-microbial, anti-viral, antioxidant, anti-cancer, and anti-inflammatory activities.The tumor suppressor",
            "probability": 0.005947162238830108,
            "start_logit": 2.791010618209839,
            "end_logit": 3.557084798812866,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "the host immune-inflammatory response and bone metabolism",
            "probability": 0.005792763402438388,
            "start_logit": 0.7076725959777832,
            "end_logit": 5.6141180992126465,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "regulation of iron absorption",
            "probability": 0.005774995203897839,
            "start_logit": 2.927161693572998,
            "end_logit": 3.391556978225708,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "antioxidant, anti-cancer, and anti-inflammatory activities.The tumor suppressor",
            "probability": 0.005456133552427197,
            "start_logit": 2.704836845397949,
            "end_logit": 3.557084798812866,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "anti-viral, antioxidant, anti-cancer, and anti-inflammatory activities.The tumor suppressor",
            "probability": 0.005435175689479315,
            "start_logit": 2.700988292694092,
            "end_logit": 3.557084798812866,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "modulates the host immune-inflammatory",
            "probability": 0.005377850587877205,
            "start_logit": 4.305832386016846,
            "end_logit": 1.941637635231018,
            "question_text": "List the functions of the protein lactotransferrin."
        }
    ],
    "5c900983ecadf2e73f000002": [
        {
            "text": "patisiran",
            "probability": 0.5637747920906945,
            "start_logit": 5.267494201660156,
            "end_logit": 4.902049541473389,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1007, and patisiran",
            "probability": 0.09588869914208925,
            "start_logit": 3.4960274696350098,
            "end_logit": 4.902049541473389,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1002, QPI-1007, and patisiran",
            "probability": 0.09581648354343072,
            "start_logit": 3.495274066925049,
            "end_logit": 4.902049541473389,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siG12D-LODER (phase 2), QPI-1002, QPI-1007, and patisiran",
            "probability": 0.05831487641757268,
            "start_logit": 2.9986965656280518,
            "end_logit": 4.902049541473389,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL1001, siG12D-LODER (phase 2), QPI-1002, QPI-1007",
            "probability": 0.029742875609392146,
            "start_logit": 3.690100908279419,
            "end_logit": 3.5373775959014893,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1007",
            "probability": 0.02449615556083691,
            "start_logit": 3.4960274696350098,
            "end_logit": 3.5373775959014893,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1002, QPI-1007",
            "probability": 0.024477707041308694,
            "start_logit": 3.495274066925049,
            "end_logit": 3.5373775959014893,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL1001",
            "probability": 0.022508501695618962,
            "start_logit": 3.690100908279419,
            "end_logit": 3.258681058883667,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL1001, siG12D-LODER (phase 2), QPI-1002",
            "probability": 0.01493682774598818,
            "start_logit": 3.690100908279419,
            "end_logit": 2.8486177921295166,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siG12D-LODER (phase 2), QPI-1002, QPI-1007",
            "probability": 0.014897378909261065,
            "start_logit": 2.9986965656280518,
            "end_logit": 3.5373775959014893,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1002",
            "probability": 0.012292667948264403,
            "start_logit": 3.495274066925049,
            "end_logit": 2.8486177921295166,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL1001, siG12D-LODER",
            "probability": 0.009291365279606324,
            "start_logit": 3.690100908279419,
            "end_logit": 2.373873472213745,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL040012, SYL1001",
            "probability": 0.008092509376154383,
            "start_logit": 2.667146682739258,
            "end_logit": 3.258681058883667,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siG12D-LODER (phase 2), QPI-1002",
            "probability": 0.0074814414569949325,
            "start_logit": 2.9986965656280518,
            "end_logit": 2.8486177921295166,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL040012, SYL1001, siG12D-LODER (phase 2), QPI-1002",
            "probability": 0.005370256102294878,
            "start_logit": 2.667146682739258,
            "end_logit": 2.8486177921295166,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siG12D-LODER",
            "probability": 0.0046537863713130255,
            "start_logit": 2.9986965656280518,
            "end_logit": 2.373873472213745,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL040012, SYL1001, siG12D-LODER",
            "probability": 0.0033405360187579477,
            "start_logit": 2.667146682739258,
            "end_logit": 2.373873472213745,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL040012",
            "probability": 0.0024804084501454334,
            "start_logit": 2.667146682739258,
            "end_logit": 2.0761654376983643,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "Atu027, SYL040012, SYL1001",
            "probability": 0.0013552269156082506,
            "start_logit": 0.8801767230033875,
            "end_logit": 3.258681058883667,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "TKM-080301, Atu027, SYL040012, SYL1001",
            "probability": 0.0007875043246671922,
            "start_logit": 0.337321400642395,
            "end_logit": 3.258681058883667,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        }
    ],
    "5c6b15467c78d69471000024": [
        {
            "text": "IntMAP",
            "probability": 0.5456027610026343,
            "start_logit": 3.0210063457489014,
            "end_logit": 2.8161003589630127,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "TAPAS",
            "probability": 0.23053321616845154,
            "start_logit": 2.399313449859619,
            "end_logit": 2.5762970447540283,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "TAPAS: tool for alternative polyadenylation site analysis.We propose a new tool, called TAPAS",
            "probability": 0.198042149343523,
            "start_logit": 2.2473983764648438,
            "end_logit": 2.5762970447540283,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "IntMAP,",
            "probability": 0.004493484258484442,
            "start_logit": 3.0210063457489014,
            "end_logit": -1.9831624031066895,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "bioinformatics algorithm, IntMAP",
            "probability": 0.00328784349954375,
            "start_logit": -2.0906529426574707,
            "end_logit": 2.8161003589630127,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "a novel bioinformatics algorithm, IntMAP",
            "probability": 0.0021282704621452047,
            "start_logit": -2.5255751609802246,
            "end_logit": 2.8161003589630127,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "IntMAP, which integrates RNA-Seq and PolyA Site (PAS)-Seq",
            "probability": 0.0019191987110559344,
            "start_logit": 3.0210063457489014,
            "end_logit": -2.833883047103882,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "novel bioinformatics algorithm, IntMAP",
            "probability": 0.0016534171953057242,
            "start_logit": -2.778040647506714,
            "end_logit": 2.8161003589630127,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "In",
            "probability": 0.0015856649701665895,
            "start_logit": 3.0210063457489014,
            "end_logit": -3.024786949157715,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "TAPAS: tool for alternative polyadenylation site analysis",
            "probability": 0.0014218126962201882,
            "start_logit": 2.2473983764648438,
            "end_logit": -2.360250234603882,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "IntMAP, which integrates RNA-Seq and PolyA Site (PAS)-Seq data for a comprehensive characterization",
            "probability": 0.001368985324587475,
            "start_logit": 3.0210063457489014,
            "end_logit": -3.1717209815979004,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "IntMAP, which integrates RNA-Seq",
            "probability": 0.0013482834389023151,
            "start_logit": 3.0210063457489014,
            "end_logit": -3.1869585514068604,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "TAPAS outperforms the existing tools for APA site detection or shortening/lengthening analysis significantly.PlantAPA",
            "probability": 0.0012209819750153487,
            "start_logit": 0.5077409744262695,
            "end_logit": -0.7728700041770935,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "IntMAP as a new bioinformatics algorithm for APA analysis",
            "probability": 0.0010622504423780648,
            "start_logit": 1.588726282119751,
            "end_logit": -1.9931210279464722,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "TAPAS,",
            "probability": 0.001021654790945385,
            "start_logit": 2.399313449859619,
            "end_logit": -2.8426742553710938,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "TAPAS: tool for alternative polyadenylation site analysis.We propose a new tool, called TAPAS,",
            "probability": 0.0008776640262463864,
            "start_logit": 2.2473983764648438,
            "end_logit": -2.8426742553710938,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "algorithm, IntMAP",
            "probability": 0.0007599816790992707,
            "start_logit": -3.5553457736968994,
            "end_logit": 2.8161003589630127,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "IntMAP toolbox is available at http://compbio.cs.umn.edu/IntMAP",
            "probability": 0.0006527993961430768,
            "start_logit": -0.4318659007549286,
            "end_logit": -0.45940396189689636,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "developed a novel bioinformatics algorithm, IntMAP",
            "probability": 0.0005164464423683047,
            "start_logit": -3.9416685104370117,
            "end_logit": 2.8161003589630127,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "IntMAP as a new bioinformatics",
            "probability": 0.0005031341767837322,
            "start_logit": 1.588726282119751,
            "end_logit": -2.7404091358184814,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        }
    ],
    "5c6bda9d7c78d69471000031": [
        {
            "text": "MGA",
            "probability": 0.28396904632218073,
            "start_logit": 4.276517391204834,
            "end_logit": 4.09672737121582,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome",
            "probability": 0.11490356337024728,
            "start_logit": 4.164419651031494,
            "end_logit": 3.3040530681610107,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB",
            "probability": 0.08899184354733394,
            "start_logit": 3.8469676971435547,
            "end_logit": 3.3659565448760986,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "CR Cistrome",
            "probability": 0.08529562303989408,
            "start_logit": 3.7157318592071533,
            "end_logit": 3.454770803451538,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome Data Browser",
            "probability": 0.07669359952212208,
            "start_logit": 4.164419651031494,
            "end_logit": 2.899778127670288,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "MGA repository",
            "probability": 0.0566973308690313,
            "start_logit": 4.276517391204834,
            "end_logit": 2.4855892658233643,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome",
            "probability": 0.05196479903376548,
            "start_logit": 3.8469676971435547,
            "end_logit": 2.8279783725738525,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser), available online at http://cistrome",
            "probability": 0.03353685635095565,
            "start_logit": 3.8469676971435547,
            "end_logit": 2.390056848526001,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome database",
            "probability": 0.03222636845318824,
            "start_logit": 3.9057841300964355,
            "end_logit": 2.2913804054260254,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser), available online at http://cistrome.org/db",
            "probability": 0.031627936080528087,
            "start_logit": 3.8469676971435547,
            "end_logit": 2.3314526081085205,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser",
            "probability": 0.027998633963444555,
            "start_logit": 3.8469676971435547,
            "end_logit": 2.2095675468444824,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome Data Browser), available online at http://cistrome",
            "probability": 0.020807219833726767,
            "start_logit": 3.3696227073669434,
            "end_logit": 2.390056848526001,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome Data Browser), available online at http://cistrome.org/db",
            "probability": 0.01962287138746246,
            "start_logit": 3.3696227073669434,
            "end_logit": 2.3314526081085205,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "cistrome",
            "probability": 0.018432861019408248,
            "start_logit": 3.248457670211792,
            "end_logit": 2.390056848526001,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "cistrome.org/db",
            "probability": 0.01738366124726205,
            "start_logit": 3.248457670211792,
            "end_logit": 2.3314526081085205,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome database, a collection of ChIP-seq and chromatin accessibility data (DNase-seq",
            "probability": 0.01547952869244974,
            "start_logit": 3.9057841300964355,
            "end_logit": 1.5581138134002686,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser)",
            "probability": 0.006894846779012054,
            "start_logit": 3.8469676971435547,
            "end_logit": 0.8081861138343811,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "db, is expected to become a valuable resource for transcriptional and epigenetic regulation studies.CR Cistrome",
            "probability": 0.0061672842567084924,
            "start_logit": 1.0888673067092896,
            "end_logit": 3.454770803451538,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "ATAC-seq",
            "probability": 0.0058034914158950155,
            "start_logit": 2.739792823791504,
            "end_logit": 1.7430464029312134,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "DNase-seq and ATAC-seq",
            "probability": 0.005502634815383796,
            "start_logit": 2.6865601539611816,
            "end_logit": 1.7430464029312134,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        }
    ],
    "5c73ad0f7c78d69471000096": [
        {
            "text": "ocular hypertension and open-angle glaucoma",
            "probability": 0.28798624686039315,
            "start_logit": 4.964682102203369,
            "end_logit": 4.965989112854004,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle glaucoma",
            "probability": 0.2275507496045769,
            "start_logit": 4.729142665863037,
            "end_logit": 4.965989112854004,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ocular hypertension",
            "probability": 0.22377062294485534,
            "start_logit": 4.964682102203369,
            "end_logit": 4.713697910308838,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle glaucoma or ocular hypertension",
            "probability": 0.11430643837114589,
            "start_logit": 4.514589786529541,
            "end_logit": 4.492051601409912,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle glaucoma and ocular hypertension",
            "probability": 0.075816438618465,
            "start_logit": 4.239828586578369,
            "end_logit": 4.356245040893555,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "glaucoma",
            "probability": 0.046700177806089614,
            "start_logit": 3.145517349243164,
            "end_logit": 4.965989112854004,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "glaucoma or ocular hypertension",
            "probability": 0.0072818316900876,
            "start_logit": 1.7610893249511719,
            "end_logit": 4.492051601409912,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "glaucoma and ocular hypertension",
            "probability": 0.00564519263995567,
            "start_logit": 1.642317771911621,
            "end_logit": 4.356245040893555,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "hypertension and open-angle glaucoma",
            "probability": 0.0051781954332751415,
            "start_logit": 0.9462260007858276,
            "end_logit": 4.965989112854004,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "hypertension",
            "probability": 0.004023553313627158,
            "start_logit": 0.9462260007858276,
            "end_logit": 4.713697910308838,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ocular hypertension and open-angle g",
            "probability": 0.0003525829855487341,
            "start_logit": 4.964682102203369,
            "end_logit": -1.739392876625061,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle g",
            "probability": 0.0002785915075254529,
            "start_logit": 4.729142665863037,
            "end_logit": -1.739392876625061,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ocular hypertension and open-angle",
            "probability": 0.0002707594752772352,
            "start_logit": 4.964682102203369,
            "end_logit": -2.003448009490967,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle",
            "probability": 0.00021393911075116078,
            "start_logit": 4.729142665863037,
            "end_logit": -2.003448009490967,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ocular hypertension and open-angle glaucoma.",
            "probability": 0.0001923224547539297,
            "start_logit": 4.964682102203369,
            "end_logit": -2.345505475997925,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle glaucoma.",
            "probability": 0.00015196253023243864,
            "start_logit": 4.729142665863037,
            "end_logit": -2.345505475997925,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ocular hypertension and open-angle glaucom",
            "probability": 7.997414530005426e-05,
            "start_logit": 4.964682102203369,
            "end_logit": -3.222975492477417,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ocular h",
            "probability": 6.953927107740675e-05,
            "start_logit": 4.964682102203369,
            "end_logit": -3.3627872467041016,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "o",
            "probability": 6.704749199917496e-05,
            "start_logit": 4.964682102203369,
            "end_logit": -3.399277687072754,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ion and open-angle glaucoma",
            "probability": 6.383374506326305e-05,
            "start_logit": -3.4497039318084717,
            "end_logit": 4.965989112854004,
            "question_text": "Which diseases are treated with netarsudil?"
        }
    ],
    "5c6c497d7c78d69471000036": [
        {
            "text": "FlatNJ",
            "probability": 0.14998763983583413,
            "start_logit": 4.381563663482666,
            "end_logit": 3.669424295425415,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "QNet and FlatNJ",
            "probability": 0.09863930087291853,
            "start_logit": 3.9624805450439453,
            "end_logit": 3.669424295425415,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet, QNet and FlatNJ",
            "probability": 0.09308304901027326,
            "start_logit": 3.9045028686523438,
            "end_logit": 3.669424295425415,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree",
            "probability": 0.0823108290032788,
            "start_logit": 4.381563663482666,
            "end_logit": 3.0693740844726562,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "QNet",
            "probability": 0.07098527048683259,
            "start_logit": 3.9624805450439453,
            "end_logit": 3.3404269218444824,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet, QNet",
            "probability": 0.06698674213279468,
            "start_logit": 3.9045028686523438,
            "end_logit": 3.3404269218444824,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition, NeighborNet, QNet and FlatNJ",
            "probability": 0.0635966298363061,
            "start_logit": 3.523571252822876,
            "end_logit": 3.669424295425415,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet",
            "probability": 0.06324689880349693,
            "start_logit": 3.9045028686523438,
            "end_logit": 3.2829782962799072,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "QNet and FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree",
            "probability": 0.05413167802387143,
            "start_logit": 3.9624805450439453,
            "end_logit": 3.0693740844726562,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet, QNet and FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree",
            "probability": 0.051082495454788296,
            "start_logit": 3.9045028686523438,
            "end_logit": 3.0693740844726562,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition, NeighborNet, QNet",
            "probability": 0.045766990753485705,
            "start_logit": 3.523571252822876,
            "end_logit": 3.3404269218444824,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition, NeighborNet",
            "probability": 0.04321183775422288,
            "start_logit": 3.523571252822876,
            "end_logit": 3.2829782962799072,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "SplitsTree",
            "probability": 0.0371079520687194,
            "start_logit": 3.5848922729492188,
            "end_logit": 3.0693740844726562,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition, NeighborNet, QNet and FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree",
            "probability": 0.03490081802320866,
            "start_logit": 3.523571252822876,
            "end_logit": 3.0693740844726562,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "SPECTRE",
            "probability": 0.03100061167853261,
            "start_logit": 3.117271900177002,
            "end_logit": 3.3571701049804688,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition",
            "probability": 0.008527988071504298,
            "start_logit": 3.523571252822876,
            "end_logit": 1.66021728515625,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree software",
            "probability": 0.00199087800721411,
            "start_logit": 4.381563663482666,
            "end_logit": -0.6525528430938721,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "QNet and FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree software",
            "probability": 0.001309299986117599,
            "start_logit": 3.9624805450439453,
            "end_logit": -0.6525528430938721,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet, QNet and FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree software",
            "probability": 0.001235548444670648,
            "start_logit": 3.9045028686523438,
            "end_logit": -0.6525528430938721,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "SplitsTree software",
            "probability": 0.0008975417519294568,
            "start_logit": 3.5848922729492188,
            "end_logit": -0.6525528430938721,
            "question_text": "Which tools have been developed for computing split-networks?"
        }
    ],
    "5c88550075a4a5d219000008": [
        {
            "text": "COG133",
            "probability": 0.5058447578095459,
            "start_logit": 1.4864476919174194,
            "end_logit": 0.26222819089889526,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "COG112",
            "probability": 0.27238505772480714,
            "start_logit": 1.608146071434021,
            "end_logit": -0.47848328948020935,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH(2)",
            "probability": 0.12446363237579362,
            "start_logit": 1.3656255006790161,
            "end_logit": -1.0191658735275269,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A",
            "probability": 0.04447642527551198,
            "start_logit": 1.3656255006790161,
            "end_logit": -2.048220157623291,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "COG",
            "probability": 0.007658969457981362,
            "start_logit": 1.4864476919174194,
            "end_logit": -3.928124189376831,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH(2). ApoE mimetics such as Ac-hE18A",
            "probability": 0.007101759631979879,
            "start_logit": -0.4689911901950836,
            "end_logit": -2.048220157623291,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "COG133,",
            "probability": 0.00642220609977777,
            "start_logit": 1.4864476919174194,
            "end_logit": -4.1042399406433105,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18",
            "probability": 0.005501874359534793,
            "start_logit": 1.3656255006790161,
            "end_logit": -4.13809061050415,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE",
            "probability": 0.005412899010040144,
            "start_logit": 1.3656255006790161,
            "end_logit": -4.154394626617432,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH(2",
            "probability": 0.004314325412205965,
            "start_logit": 1.3656255006790161,
            "end_logit": -4.3812384605407715,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "COG112,",
            "probability": 0.004030397802877266,
            "start_logit": 1.608146071434021,
            "end_logit": -4.691834926605225,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "CO",
            "probability": 0.002845296114156578,
            "start_logit": 1.608146071434021,
            "end_logit": -5.040032863616943,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "COG133 to a protein transduction domain creates COG112",
            "probability": 0.002694052138787741,
            "start_logit": -3.008024215698242,
            "end_logit": -0.47848328948020935,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac",
            "probability": 0.002013919836422613,
            "start_logit": 1.3656255006790161,
            "end_logit": -5.143096446990967,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE18A-NH(2)",
            "probability": 0.001390457695806464,
            "start_logit": -3.1287550926208496,
            "end_logit": -1.0191658735275269,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "133",
            "probability": 0.0008827113587282972,
            "start_logit": -4.86453914642334,
            "end_logit": 0.26222819089889526,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH(2). ApoE mimetics such as Ac-hE18",
            "probability": 0.0008785101092259389,
            "start_logit": -0.4689911901950836,
            "end_logit": -4.13809061050415,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH(2). ApoE mimetics such as Ac-hE",
            "probability": 0.0008643029974500224,
            "start_logit": -0.4689911901950836,
            "end_logit": -4.154394626617432,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE18A",
            "probability": 0.0004968727541196545,
            "start_logit": -3.1287550926208496,
            "end_logit": -2.048220157623291,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH(2). ApoE mimetics such as Ac",
            "probability": 0.00032157203524682315,
            "start_logit": -0.4689911901950836,
            "end_logit": -5.143096446990967,
            "question_text": "List 3 apoE mimetics."
        }
    ],
    "5ca60a77ecadf2e73f00004d": [
        {
            "text": "enhancers",
            "probability": 0.11689193856416245,
            "start_logit": -2.4778881072998047,
            "end_logit": -2.6211841106414795,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "activated by stimulation in differentiated cells",
            "probability": 0.10988317065642766,
            "start_logit": -2.4499571323394775,
            "end_logit": -2.710947275161743,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "enhancers activated by stimulation in differentiated cells",
            "probability": 0.10685649237262104,
            "start_logit": -2.4778881072998047,
            "end_logit": -2.710947275161743,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "Latent enhancers",
            "probability": 0.09665489508865321,
            "start_logit": -2.6679911613464355,
            "end_logit": -2.6211841106414795,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "Latent enhancers activated by stimulation in differentiated cells",
            "probability": 0.08835684638892327,
            "start_logit": -2.6679911613464355,
            "end_logit": -2.710947275161743,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "activated by stimulation in differentiated cells.",
            "probability": 0.0857796565359038,
            "start_logit": -2.4499571323394775,
            "end_logit": -2.958583116531372,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "enhancers activated by stimulation in differentiated cells.",
            "probability": 0.08341689777968453,
            "start_logit": -2.4778881072998047,
            "end_logit": -2.958583116531372,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "Latent enhancers activated by stimulation in differentiated cells.",
            "probability": 0.0689752569985029,
            "start_logit": -2.6679911613464355,
            "end_logit": -2.958583116531372,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "we describe latent enhancers,",
            "probability": 0.02766409165043635,
            "start_logit": -3.7505829334259033,
            "end_logit": -2.7896039485931396,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "activated by stimulation",
            "probability": 0.02430268725086507,
            "start_logit": -2.4499571323394775,
            "end_logit": -4.219778060913086,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "enhancers activated by stimulation",
            "probability": 0.023633281596651408,
            "start_logit": -2.4778881072998047,
            "end_logit": -4.219778060913086,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "we describe latent enhancers",
            "probability": 0.023171564634603233,
            "start_logit": -3.7505829334259033,
            "end_logit": -2.966813325881958,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "enhancers,",
            "probability": 0.021538350125077085,
            "start_logit": -4.000883102416992,
            "end_logit": -2.7896039485931396,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "Latent enhancers activated by stimulation",
            "probability": 0.019541744121824915,
            "start_logit": -2.6679911613464355,
            "end_logit": -4.219778060913086,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "stimulation in differentiated cells",
            "probability": 0.01944021180216186,
            "start_logit": -4.182031154632568,
            "end_logit": -2.710947275161743,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "Here, we describe latent enhancers,",
            "probability": 0.017584722890269633,
            "start_logit": -4.182066440582275,
            "end_logit": -2.811225175857544,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "TFs and lack the histone marks characteristic of enhancers but acquire these features in response to stimulation. Here, we describe latent enhancers,",
            "probability": 0.017404751134400667,
            "start_logit": -4.213974952697754,
            "end_logit": -2.7896039485931396,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "activated",
            "probability": 0.017099271748238568,
            "start_logit": -2.4499571323394775,
            "end_logit": -4.571329116821289,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "enhancers activated",
            "probability": 0.01662828065688099,
            "start_logit": -2.4778881072998047,
            "end_logit": -4.571329116821289,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "stimulation in differentiated cells.",
            "probability": 0.015175888003711533,
            "start_logit": -4.182031154632568,
            "end_logit": -2.958583116531372,
            "question_text": "Which enhancers are characterized as latent?"
        }
    ],
    "5c8c095e0101eac870000002": [
        {
            "text": "macrophages",
            "probability": 0.3434313449720665,
            "start_logit": 5.301271915435791,
            "end_logit": 4.855803966522217,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, macrophages",
            "probability": 0.2671709163643306,
            "start_logit": 5.050173282623291,
            "end_logit": 4.855803966522217,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils",
            "probability": 0.23853391358097342,
            "start_logit": 5.050173282623291,
            "end_logit": 4.742426872253418,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "macrophages and distinct subtypes of dendritic cells",
            "probability": 0.04414118309339881,
            "start_logit": 5.301271915435791,
            "end_logit": 2.8042099475860596,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, macrophages and distinct subtypes of dendritic cells",
            "probability": 0.03433944079107945,
            "start_logit": 5.050173282623291,
            "end_logit": 2.8042099475860596,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "dendritic cells",
            "probability": 0.0171146682829043,
            "start_logit": 4.353814601898193,
            "end_logit": 2.8042099475860596,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "macrophages and distinct subtypes of dendritic cells.",
            "probability": 0.008729940276487757,
            "start_logit": 5.301271915435791,
            "end_logit": 1.1835752725601196,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "macrophages and distinct subtypes of dendritic",
            "probability": 0.007962744921573712,
            "start_logit": 5.301271915435791,
            "end_logit": 1.0915905237197876,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "macrophage",
            "probability": 0.0070674320535667485,
            "start_logit": 5.301271915435791,
            "end_logit": 0.9723139405250549,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, macrophages and distinct subtypes of dendritic cells.",
            "probability": 0.006791418947693373,
            "start_logit": 5.050173282623291,
            "end_logit": 1.1835752725601196,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, macrophages and distinct subtypes of dendritic",
            "probability": 0.006194582668758162,
            "start_logit": 5.050173282623291,
            "end_logit": 1.0915905237197876,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, macrophage",
            "probability": 0.005498077929513544,
            "start_logit": 5.050173282623291,
            "end_logit": 0.9723139405250549,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophil",
            "probability": 0.005114667107137882,
            "start_logit": 5.050173282623291,
            "end_logit": 0.9000276923179626,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "dendritic cells.",
            "probability": 0.0033848216448008534,
            "start_logit": 4.353814601898193,
            "end_logit": 1.1835752725601196,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "dendritic",
            "probability": 0.0030873603379809535,
            "start_logit": 4.353814601898193,
            "end_logit": 1.0915905237197876,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "mac",
            "probability": 0.00039214981164719477,
            "start_logit": 5.301271915435791,
            "end_logit": -1.9192945957183838,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "ne",
            "probability": 0.00034971369537279264,
            "start_logit": 5.050173282623291,
            "end_logit": -1.7827250957489014,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, mac",
            "probability": 0.00030507123494625214,
            "start_logit": 5.050173282623291,
            "end_logit": -1.9192945957183838,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "We conclude that lactotransferrin represents a late stage differentiation marker of neutrophils, macrophages",
            "probability": 0.00020417332477516549,
            "start_logit": -2.1265013217926025,
            "end_logit": 4.855803966522217,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "lactotransferrin represents a late stage differentiation marker of neutrophils, macrophages",
            "probability": 0.0001863789609925395,
            "start_logit": -2.21768856048584,
            "end_logit": 4.855803966522217,
            "question_text": "Which cells secrete lactotransferrin?"
        }
    ],
    "5c9d18f1ecadf2e73f000033": [
        {
            "text": "OPRM1",
            "probability": 0.4203173167143716,
            "start_logit": 2.433156967163086,
            "end_logit": 1.8528902530670166,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "OPRM1, PTGS2) Morphine is the current gold standard analgesic acting at MOP receptors",
            "probability": 0.19136559637897246,
            "start_logit": 2.433156967163086,
            "end_logit": 1.066066026687622,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "OPRM1, PTGS2",
            "probability": 0.15363125689450252,
            "start_logit": 2.433156967163086,
            "end_logit": 0.8464356064796448,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "MOP receptors",
            "probability": 0.10876424807553657,
            "start_logit": 1.8681539297103882,
            "end_logit": 1.066066026687622,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "PTGS2) Morphine is the current gold standard analgesic acting at MOP receptors",
            "probability": 0.031185736187771734,
            "start_logit": 0.6189320683479309,
            "end_logit": 1.066066026687622,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "PTGS2",
            "probability": 0.025036390753433235,
            "start_logit": 0.6189320683479309,
            "end_logit": 0.8464356064796448,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "OPRM",
            "probability": 0.022268365771994057,
            "start_logit": 2.433156967163086,
            "end_logit": -1.0849525928497314,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "(OPRM1",
            "probability": 0.008993054322874946,
            "start_logit": -1.4114004373550415,
            "end_logit": 1.8528902530670166,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "OPRM1, PTGS2) Morphine",
            "probability": 0.008292387188566074,
            "start_logit": 2.433156967163086,
            "end_logit": -2.072781801223755,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Morphine is the current gold standard analgesic acting at MOP receptors",
            "probability": 0.004130528862624603,
            "start_logit": -1.4026232957839966,
            "end_logit": 1.066066026687622,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "(OPRM1, PTGS2) Morphine is the current gold standard analgesic acting at MOP receptors",
            "probability": 0.00409443326584364,
            "start_logit": -1.4114004373550415,
            "end_logit": 1.066066026687622,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "OPRM1, PTGS2) Morphine is the current gold standard analgesic acting at M",
            "probability": 0.0034184298201204687,
            "start_logit": 2.433156967163086,
            "end_logit": -2.9589383602142334,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "OPRM1,",
            "probability": 0.003310818927765333,
            "start_logit": 2.433156967163086,
            "end_logit": -2.990924119949341,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "(OPRM1, PTGS2",
            "probability": 0.003287074274607389,
            "start_logit": -1.4114004373550415,
            "end_logit": 0.8464356064796448,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "OPRM1, PTGS2) Morphine is the current gold standard analgesic acting at MOP",
            "probability": 0.0029361028766247067,
            "start_logit": 2.433156967163086,
            "end_logit": -3.111036539077759,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "OPRM1, PTGS",
            "probability": 0.0022572527242808098,
            "start_logit": 2.433156967163086,
            "end_logit": -3.3739712238311768,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "M",
            "probability": 0.0019428933727883427,
            "start_logit": 1.8681539297103882,
            "end_logit": -2.9589383602142334,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "1",
            "probability": 0.0017479927724314715,
            "start_logit": -3.049384832382202,
            "end_logit": 1.8528902530670166,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "MOP",
            "probability": 0.0016687587930700588,
            "start_logit": 1.8681539297103882,
            "end_logit": -3.111036539077759,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "PTGS2) Morphine",
            "probability": 0.0013513620218200077,
            "start_logit": 0.6189320683479309,
            "end_logit": -2.072781801223755,
            "question_text": "List targets of classical analgesics."
        }
    ],
    "5c961603ecadf2e73f000022": [
        {
            "text": "tocilizumab",
            "probability": 0.96147081213377,
            "start_logit": 5.048341274261475,
            "end_logit": 5.102461338043213,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "rituximab (RIX) was administered, while 1\u00a0patient was given tocilizumab",
            "probability": 0.011145181606603247,
            "start_logit": 0.5908843278884888,
            "end_logit": 5.102461338043213,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.006299869642256981,
            "start_logit": 2.596754550933838,
            "end_logit": 2.5261127948760986,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "systemic lupus erythematosus (SLE) and lupus nephritis",
            "probability": 0.004544370841007118,
            "start_logit": 2.596754550933838,
            "end_logit": 2.1994731426239014,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "(RIX) was administered, while 1\u00a0patient was given tocilizumab",
            "probability": 0.003471420630120718,
            "start_logit": -0.5755590200424194,
            "end_logit": 5.102461338043213,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "1\u00a0patient was given tocilizumab",
            "probability": 0.0029504970520975947,
            "start_logit": -0.7381492853164673,
            "end_logit": 5.102461338043213,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "tocilizumab as off-label therapyOff-label use of rituximab to treat MS patients",
            "probability": 0.002702605960787575,
            "start_logit": 5.048341274261475,
            "end_logit": -0.7717863917350769,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "tocilizumab as off-label therapyOff-label use of rituximab to treat MS patients in Sweden",
            "probability": 0.0023328732248384587,
            "start_logit": 5.048341274261475,
            "end_logit": -0.9189022183418274,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "lupus nephritis",
            "probability": 0.002309700281062092,
            "start_logit": 1.9199830293655396,
            "end_logit": 2.1994731426239014,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "tocilizumab as off-label therapyOff-label use of rituximab",
            "probability": 0.0007914074836987452,
            "start_logit": 5.048341274261475,
            "end_logit": -1.9999451637268066,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "tocilizumab as off-label therapyOff-label use",
            "probability": 0.00041340787047681863,
            "start_logit": 5.048341274261475,
            "end_logit": -2.6493234634399414,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "autoimmune disease",
            "probability": 0.0004106096858573273,
            "start_logit": 1.5321130752563477,
            "end_logit": 0.8601131439208984,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "autoimmune disease in the Top End of the Northern Territory, 2008-2016.immune thrombocytopenia",
            "probability": 0.00032580766267397066,
            "start_logit": 1.5321130752563477,
            "end_logit": 0.628777265548706,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "rituximab) Conventional treatment of systemic lupus erythematosus",
            "probability": 0.00027731089355438246,
            "start_logit": -0.5263904333114624,
            "end_logit": 2.5261127948760986,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "rituximab) Conventional treatment of systemic lupus erythematosus (SLE) and lupus nephritis",
            "probability": 0.0002000364468034748,
            "start_logit": -0.5263904333114624,
            "end_logit": 2.1994731426239014,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "thrombocytopenia",
            "probability": 9.945747773564983e-05,
            "start_logit": 0.3455360531806946,
            "end_logit": 0.628777265548706,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "to treat MS patients in Sweden is highOff-label use of rituximab in autoimmune disease",
            "probability": 8.728377766380135e-05,
            "start_logit": -0.016365395858883858,
            "end_logit": 0.8601131439208984,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "systemic lupus",
            "probability": 6.344178802859902e-05,
            "start_logit": 2.596754550933838,
            "end_logit": -2.0720486640930176,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "treat MS patients in Sweden is highOff-label use of rituximab in autoimmune disease",
            "probability": 5.4257492573118753e-05,
            "start_logit": -0.49178892374038696,
            "end_logit": 0.8601131439208984,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "systemic lupus erythematosus (SLE) and lupus",
            "probability": 4.964804839005453e-05,
            "start_logit": 2.596754550933838,
            "end_logit": -2.3172123432159424,
            "question_text": "List off label uses for Rituximab."
        }
    ],
    "5c890ff475a4a5d219000010": [
        {
            "text": "bronchitis and bronchial asthma",
            "probability": 0.1405189527937667,
            "start_logit": 5.150325298309326,
            "end_logit": 5.555872440338135,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchial asthma",
            "probability": 0.12343005212549438,
            "start_logit": 5.020657539367676,
            "end_logit": 5.555872440338135,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchitis",
            "probability": 0.10783012641426822,
            "start_logit": 5.150325298309326,
            "end_logit": 5.2910871505737305,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchitis and bronchial asthma; against the common cold and lung emphysema",
            "probability": 0.1058543811153439,
            "start_logit": 5.150325298309326,
            "end_logit": 5.272594451904297,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchial asthma; against the common cold and lung emphysema",
            "probability": 0.09298113541989352,
            "start_logit": 5.020657539367676,
            "end_logit": 5.272594451904297,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchitis and bronchial asthma; against the common cold",
            "probability": 0.05705815619232227,
            "start_logit": 5.150325298309326,
            "end_logit": 4.654601097106934,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "lung emphysema",
            "probability": 0.054247856835464424,
            "start_logit": 4.4818243980407715,
            "end_logit": 5.272594451904297,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchial asthma; against the common cold",
            "probability": 0.05011915512449896,
            "start_logit": 5.020657539367676,
            "end_logit": 4.654601097106934,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "asthma",
            "probability": 0.03394669675065162,
            "start_logit": 3.7297744750976562,
            "end_logit": 5.555872440338135,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "common cold and lung emphysema",
            "probability": 0.02608572255510582,
            "start_logit": 3.7496490478515625,
            "end_logit": 5.272594451904297,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "asthma; against the common cold and lung emphysema",
            "probability": 0.025572397915065333,
            "start_logit": 3.7297744750976562,
            "end_logit": 5.272594451904297,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "loosening agent in bronchitis and bronchial asthma",
            "probability": 0.025559969286302334,
            "start_logit": 3.4460103511810303,
            "end_logit": 5.555872440338135,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "against the common cold and lung emphysema",
            "probability": 0.024803801777684424,
            "start_logit": 3.6992578506469727,
            "end_logit": 5.272594451904297,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "lung emphysema; in the treatment of inflammation, gastrointestinal disorders",
            "probability": 0.02398309966515813,
            "start_logit": 4.4818243980407715,
            "end_logit": 4.456380367279053,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "lung emphysema; in the treatment of inflammation, gastrointestinal disorders and coughs",
            "probability": 0.020546931028478616,
            "start_logit": 4.4818243980407715,
            "end_logit": 4.3017425537109375,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "loosening agent in bronchitis",
            "probability": 0.019613971385994088,
            "start_logit": 3.4460103511810303,
            "end_logit": 5.2910871505737305,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "loosening agent in bronchitis and bronchial asthma; against the common cold and lung emphysema",
            "probability": 0.019254589337138528,
            "start_logit": 3.4460103511810303,
            "end_logit": 5.272594451904297,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "emphysema",
            "probability": 0.018180328410032302,
            "start_logit": 3.388601064682007,
            "end_logit": 5.272594451904297,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "gastrointestinal disorders",
            "probability": 0.015882533756045605,
            "start_logit": 4.069694995880127,
            "end_logit": 4.456380367279053,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchitis and bronchial asthma; against the common cold and lung emphysema; in the treatment of inflammation",
            "probability": 0.014530142111290967,
            "start_logit": 5.150325298309326,
            "end_logit": 3.286755323410034,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        }
    ],
    "5c979ffcecadf2e73f000028": [
        {
            "text": "Toxocara canis",
            "probability": 0.4812960093484797,
            "start_logit": 6.103977203369141,
            "end_logit": 6.09234094619751,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara catiHuman toxocariasis which is caused mainly by the larvae of Toxocara canis",
            "probability": 0.1759263093346938,
            "start_logit": 6.234344482421875,
            "end_logit": 4.955556392669678,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara cat",
            "probability": 0.07307414616742598,
            "start_logit": 6.234344482421875,
            "end_logit": 4.076965808868408,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara canis and Toxocara cat",
            "probability": 0.06414251134048632,
            "start_logit": 6.103977203369141,
            "end_logit": 4.076965808868408,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara cati",
            "probability": 0.05301733889822567,
            "start_logit": 5.449472904205322,
            "end_logit": 4.540981769561768,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara canis and Toxocara cati",
            "probability": 0.03538941390314867,
            "start_logit": 5.045266628265381,
            "end_logit": 4.540981769561768,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara canis and, less frequently, T. cati",
            "probability": 0.020687168799566575,
            "start_logit": 4.668028354644775,
            "end_logit": 4.381320953369141,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara cani",
            "probability": 0.020270932890467934,
            "start_logit": 4.599025726318359,
            "end_logit": 4.42999792098999,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara cani and T. cati",
            "probability": 0.020033575239239213,
            "start_logit": 4.599025726318359,
            "end_logit": 4.418219566345215,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "roundworms Toxocara cani",
            "probability": 0.011971313367515916,
            "start_logit": 4.072350978851318,
            "end_logit": 4.42999792098999,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "roundworms Toxocara cani and T. cati",
            "probability": 0.011831138130471314,
            "start_logit": 4.072350978851318,
            "end_logit": 4.418219566345215,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "T. cati",
            "probability": 0.01044699354161398,
            "start_logit": 3.947930335998535,
            "end_logit": 4.418219566345215,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "canis",
            "probability": 0.007003457993064763,
            "start_logit": 1.8738987445831299,
            "end_logit": 6.09234094619751,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "nematodes of dogs and cats, namely Toxocara canis",
            "probability": 0.003593121876744021,
            "start_logit": 1.206516146659851,
            "end_logit": 6.09234094619751,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara",
            "probability": 0.002624331853569173,
            "start_logit": 6.234344482421875,
            "end_logit": 0.7503175139427185,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara canis and Toxocara",
            "probability": 0.002303567602323852,
            "start_logit": 6.103977203369141,
            "end_logit": 0.7503175139427185,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "canis and Toxocara catiHuman toxocariasis which is caused mainly by the larvae of Toxocara canis",
            "probability": 0.002247052758732749,
            "start_logit": 1.8738987445831299,
            "end_logit": 4.955556392669678,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "roundworm",
            "probability": 0.001669863040746417,
            "start_logit": 4.072350978851318,
            "end_logit": 2.46022629737854,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "ascarid nematode Toxocara canis",
            "probability": 0.00123732607442333,
            "start_logit": 1.2983129024505615,
            "end_logit": 4.934475421905518,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "T. cati.Toxocariasis is a preventable parasitic disease that is caused by the dog and cat roundworm",
            "probability": 0.0012344278390604283,
            "start_logit": 3.770216941833496,
            "end_logit": 2.46022629737854,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        }
    ],
    "5c97f579ecadf2e73f00002a": [
        {
            "text": "retina",
            "probability": 0.31425765084821944,
            "start_logit": 5.249517440795898,
            "end_logit": 5.9404401779174805,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "the human retina",
            "probability": 0.13377862734728346,
            "start_logit": 4.395490646362305,
            "end_logit": 5.9404401779174805,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "retina, and the main source is the retinal pigment epithelium",
            "probability": 0.10197549524171955,
            "start_logit": 5.249517440795898,
            "end_logit": 4.814959526062012,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "retinal pigment epithelium",
            "probability": 0.08109933431145766,
            "start_logit": 5.0204596519470215,
            "end_logit": 4.814959526062012,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "human retina",
            "probability": 0.06411957638883031,
            "start_logit": 3.6600539684295654,
            "end_logit": 5.9404401779174805,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "retina, and the main source is the retinal pigment epithelium (RPE)",
            "probability": 0.06064769353505351,
            "start_logit": 5.249517440795898,
            "end_logit": 4.295308589935303,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "retinal pigment epithelium (RPE)",
            "probability": 0.04823205380429389,
            "start_logit": 5.0204596519470215,
            "end_logit": 4.295308589935303,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "the human retina, and the main source is the retinal pigment epithelium",
            "probability": 0.043410691003623575,
            "start_logit": 4.395490646362305,
            "end_logit": 4.814959526062012,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "olfactory bulb",
            "probability": 0.037632811986935084,
            "start_logit": 4.474876403808594,
            "end_logit": 4.59274435043335,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "the human retina, and the main source is the retinal pigment epithelium (RPE)",
            "probability": 0.02581755820741109,
            "start_logit": 4.395490646362305,
            "end_logit": 4.295308589935303,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "human retina, and the main source is the retinal pigment epithelium",
            "probability": 0.020806575557640993,
            "start_logit": 3.6600539684295654,
            "end_logit": 4.814959526062012,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "human retina, and the main source is the retinal pigment epithelium (RPE)",
            "probability": 0.012374255353628306,
            "start_logit": 3.6600539684295654,
            "end_logit": 4.295308589935303,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "olfactory bulb (OB)The production of somatostatin interneurons in the olfactory bulb",
            "probability": 0.011559974706146997,
            "start_logit": 4.474876403808594,
            "end_logit": 3.412416696548462,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "central nervous system (CNS)Somatostatin (SST) is abundantly produced by the human retina",
            "probability": 0.011477537062555039,
            "start_logit": 1.9396960735321045,
            "end_logit": 5.9404401779174805,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "retina,",
            "probability": 0.00822491732534156,
            "start_logit": 5.249517440795898,
            "end_logit": 2.2973952293395996,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "pigment epithelium",
            "probability": 0.006254948301166264,
            "start_logit": 2.458157777786255,
            "end_logit": 4.814959526062012,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "the retinal pigment epithelium",
            "probability": 0.005420005891819057,
            "start_logit": 2.3148818016052246,
            "end_logit": 4.814959526062012,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "retina, and the main source is the retina",
            "probability": 0.004844817209353316,
            "start_logit": 5.249517440795898,
            "end_logit": 1.7681365013122559,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "the olfactory bulb",
            "probability": 0.004345482337224478,
            "start_logit": 2.3161368370056152,
            "end_logit": 4.59274435043335,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "pigment epithelium (RPE)",
            "probability": 0.003719993580296325,
            "start_logit": 2.458157777786255,
            "end_logit": 4.295308589935303,
            "question_text": "List places in the body where somatostatin is produced."
        }
    ],
    "5c9f79c3ecadf2e73f00003d": [
        {
            "text": "IgA, and IgG",
            "probability": 0.2922687214554582,
            "start_logit": 5.170220375061035,
            "end_logit": 4.5757527351379395,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgG",
            "probability": 0.2700744073204766,
            "start_logit": 5.091244220733643,
            "end_logit": 4.5757527351379395,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgA",
            "probability": 0.2454141451520985,
            "start_logit": 5.170220375061035,
            "end_logit": 4.401026248931885,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgA, and IgG subclasses",
            "probability": 0.037515548072121485,
            "start_logit": 5.170220375061035,
            "end_logit": 2.522834539413452,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgM, IgA, and IgG",
            "probability": 0.03593213349765252,
            "start_logit": 3.074178695678711,
            "end_logit": 4.5757527351379395,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgG subclasses",
            "probability": 0.03466669084678353,
            "start_logit": 5.091244220733643,
            "end_logit": 2.522834539413452,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgM, IgA",
            "probability": 0.030171732992513814,
            "start_logit": 3.074178695678711,
            "end_logit": 4.401026248931885,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgM",
            "probability": 0.021834112137372432,
            "start_logit": 3.074178695678711,
            "end_logit": 4.07759428024292,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgA, and IgG subclass",
            "probability": 0.005130706232105478,
            "start_logit": 5.170220375061035,
            "end_logit": 0.5333223938941956,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgG subclass",
            "probability": 0.004741090452207487,
            "start_logit": 5.091244220733643,
            "end_logit": 0.5333223938941956,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "IgM, IgA, and IgG subclasses",
            "probability": 0.00461224066281245,
            "start_logit": 3.074178695678711,
            "end_logit": 2.522834539413452,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "(IgM, IgA, and IgG",
            "probability": 0.004125404631483867,
            "start_logit": 0.9097108244895935,
            "end_logit": 4.5757527351379395,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "(IgM, IgA",
            "probability": 0.0034640472165490214,
            "start_logit": 0.9097108244895935,
            "end_logit": 4.401026248931885,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "(IgM",
            "probability": 0.0025067965235556914,
            "start_logit": 0.9097108244895935,
            "end_logit": 4.07759428024292,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "specific antibodies (IgM, IgA, and IgG",
            "probability": 0.001606140582262697,
            "start_logit": -0.03361913561820984,
            "end_logit": 4.5757527351379395,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "total and specific antibodies (IgM, IgA, and IgG",
            "probability": 0.0014327663569347658,
            "start_logit": -0.14784619212150574,
            "end_logit": 4.5757527351379395,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "specific antibodies (IgM, IgA",
            "probability": 0.0013486548133757963,
            "start_logit": -0.03361913561820984,
            "end_logit": 4.401026248931885,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "total and specific antibodies (IgM, IgA",
            "probability": 0.0012030747900042364,
            "start_logit": -0.14784619212150574,
            "end_logit": 4.401026248931885,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "specific antibodies (IgM",
            "probability": 0.0009759691442702516,
            "start_logit": -0.03361913561820984,
            "end_logit": 4.07759428024292,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "M, IgA, and IgG",
            "probability": 0.0009756171199613271,
            "start_logit": -0.5321383476257324,
            "end_logit": 4.5757527351379395,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        }
    ],
    "5c9fb583ecadf2e73f000042": [
        {
            "text": "Why we build models of human performance",
            "probability": 0.3612902709025946,
            "start_logit": 4.504601955413818,
            "end_logit": 4.292141437530518,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "Why we build models of human performance; 2) What the expectations of a good human performance model",
            "probability": 0.08269308578270175,
            "start_logit": 4.398136138916016,
            "end_logit": 2.9240615367889404,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "Why we build models of human performance; 2) What the expectations of a good human performance model are",
            "probability": 0.06402888532978479,
            "start_logit": 4.398136138916016,
            "end_logit": 2.668259859085083,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What are the prevalence and predictors of screening",
            "probability": 0.04511501874297415,
            "start_logit": 3.284867763519287,
            "end_logit": 3.4314091205596924,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "1) Why we build models of human performance",
            "probability": 0.04414593065760835,
            "start_logit": 2.402420997619629,
            "end_logit": 4.292141437530518,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "How we integrate a human performance model with system design",
            "probability": 0.042895320044686554,
            "start_logit": 3.246154308319092,
            "end_logit": 3.4196701049804688,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "Why we build models of human performance; 2) What the expectations",
            "probability": 0.04190711598469924,
            "start_logit": 4.398136138916016,
            "end_logit": 2.2443811893463135,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What the expectations of a good human performance model",
            "probability": 0.03712653170569362,
            "start_logit": 3.597332000732422,
            "end_logit": 2.9240615367889404,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "How well do screening tools detect depression; 4) Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.03187550672581691,
            "start_logit": 3.0624706745147705,
            "end_logit": 3.306428909301758,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What are the prevalence and predictors of screening; 3) How well do screening tools detect depression",
            "probability": 0.02941912161147496,
            "start_logit": 3.284867763519287,
            "end_logit": 3.0038387775421143,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What the expectations of a good human performance model are",
            "probability": 0.02874690693636864,
            "start_logit": 3.597332000732422,
            "end_logit": 2.668259859085083,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What the expectations of a good human performance model are; 3) What the procedures and requirements in building and verifying a human performance model",
            "probability": 0.027420263667651323,
            "start_logit": 3.597332000732422,
            "end_logit": 2.621011972427368,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What are the current national clinical practice recommendations and guidelines for depression screening",
            "probability": 0.024617897031802023,
            "start_logit": 2.492500066757202,
            "end_logit": 3.618035316467285,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What the expectations of a good human performance model are; 3) What the procedures and requirements in building and verifying a human performance model are",
            "probability": 0.023803493644548732,
            "start_logit": 3.597332000732422,
            "end_logit": 2.4795620441436768,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "How well do screening tools detect depression",
            "probability": 0.023552872060189783,
            "start_logit": 3.0624706745147705,
            "end_logit": 3.0038387775421143,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What the procedures and requirements in building and verifying a human performance model are; 4) How we integrate a human performance model with system design",
            "probability": 0.02345281585351853,
            "start_logit": 2.6423821449279785,
            "end_logit": 3.4196701049804688,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What are the current national clinical practice recommendations and guidelines for depression screening; 2) What are the prevalence and predictors of screening",
            "probability": 0.020426794688523254,
            "start_logit": 2.492500066757202,
            "end_logit": 3.4314091205596924,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What the expectations",
            "probability": 0.018814945113894657,
            "start_logit": 3.597332000732422,
            "end_logit": 2.2443811893463135,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.01737934925858776,
            "start_logit": 2.4559154510498047,
            "end_logit": 3.306428909301758,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "1) Why we build models of human performance; 2) What the expectations of a good human performance model",
            "probability": 0.01128787425688037,
            "start_logit": 2.406729221343994,
            "end_logit": 2.9240615367889404,
            "question_text": "What are 5 key questions in human performance modeling?"
        }
    ],
    "5ca9f932ecadf2e73f000054": [
        {
            "text": "bacterial gene expression",
            "probability": 0.4900837879989406,
            "start_logit": 3.052008628845215,
            "end_logit": 2.4798057079315186,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "gene expression",
            "probability": 0.1263408189933531,
            "start_logit": 1.6964154243469238,
            "end_logit": 2.4798057079315186,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter genes, which are genetic constructs that allow bacterial gene expression",
            "probability": 0.06586416549906547,
            "start_logit": 1.0450267791748047,
            "end_logit": 2.4798057079315186,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene",
            "probability": 0.05962341099375501,
            "start_logit": 3.052008628845215,
            "end_logit": 0.3732776343822479,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial",
            "probability": 0.05166104807251496,
            "start_logit": 3.052008628845215,
            "end_logit": 0.22993341088294983,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene expression to be visualized in vivo using ultrasound,",
            "probability": 0.03419172678871714,
            "start_logit": 3.052008628845215,
            "end_logit": -0.1827869564294815,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene expression to be visualized in vivo",
            "probability": 0.029455015370253655,
            "start_logit": 3.052008628845215,
            "end_logit": -0.3319064676761627,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene expression to be visualized in vivo using ultrasound",
            "probability": 0.0278999158313766,
            "start_logit": 3.052008628845215,
            "end_logit": -0.38614699244499207,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "expression",
            "probability": 0.02486410751332311,
            "start_logit": 0.07085755467414856,
            "end_logit": 2.4798057079315186,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "gene",
            "probability": 0.015370576951516262,
            "start_logit": 1.6964154243469238,
            "end_logit": 0.3732776343822479,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter genes",
            "probability": 0.01152360589574343,
            "start_logit": 1.0450267791748047,
            "end_logit": 0.7366088032722473,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter",
            "probability": 0.009307645902125843,
            "start_logit": 1.0450267791748047,
            "end_logit": 0.5230473875999451,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "gene expression to be visualized in vivo using ultrasound,",
            "probability": 0.008814433105248591,
            "start_logit": 1.6964154243469238,
            "end_logit": -0.1827869564294815,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter genes, which are genetic constructs that allow bacterial gene",
            "probability": 0.008013009827046082,
            "start_logit": 1.0450267791748047,
            "end_logit": 0.3732776343822479,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "gene expression to be visualized in vivo",
            "probability": 0.007593335785569169,
            "start_logit": 1.6964154243469238,
            "end_logit": -0.3319064676761627,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "gene expression to be visualized in vivo using ultrasound",
            "probability": 0.00719243995067504,
            "start_logit": 1.6964154243469238,
            "end_logit": -0.38614699244499207,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter genes, which are genetic constructs that allow bacterial",
            "probability": 0.006942918544595193,
            "start_logit": 1.0450267791748047,
            "end_logit": 0.22993341088294983,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "acoustic reporter genes, which are genetic constructs that allow bacterial gene expression",
            "probability": 0.006672553460156683,
            "start_logit": -1.2445651292800903,
            "end_logit": 2.4798057079315186,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter genes, which are genetic constructs that allow bacterial gene expression to be visualized in vivo using ultrasound,",
            "probability": 0.0045951521087977,
            "start_logit": 1.0450267791748047,
            "end_logit": -0.1827869564294815,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene expression to be visualized",
            "probability": 0.003990331407226331,
            "start_logit": 3.052008628845215,
            "end_logit": -2.3308963775634766,
            "question_text": "What are acoustic reported genes used to detect?"
        }
    ],
    "5ca64b5becadf2e73f000051": [
        {
            "text": "moesin (ERM proteins)Ezrin/radixin/moesin",
            "probability": 0.10962278632591893,
            "start_logit": 5.763452053070068,
            "end_logit": 5.661355495452881,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "Ezrin/radixin/moesin",
            "probability": 0.09952828387132719,
            "start_logit": 5.666848659515381,
            "end_logit": 5.661355495452881,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin",
            "probability": 0.09888050053477829,
            "start_logit": 5.763452053070068,
            "end_logit": 5.55822229385376,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin",
            "probability": 0.07892923268532022,
            "start_logit": 5.434958457946777,
            "end_logit": 5.661355495452881,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM proteins)Ezrin/radixin",
            "probability": 0.0757478930167661,
            "start_logit": 5.763452053070068,
            "end_logit": 5.291720867156982,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "Ezrin/radixin",
            "probability": 0.06877272555737897,
            "start_logit": 5.666848659515381,
            "end_logit": 5.291720867156982,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM proteins)Ezrin",
            "probability": 0.059410425612675725,
            "start_logit": 5.763452053070068,
            "end_logit": 5.0487799644470215,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin and moesin (ERM proteins)Ezrin/radixin/moesin",
            "probability": 0.05645438074755334,
            "start_logit": 5.099839687347412,
            "end_logit": 5.661355495452881,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin",
            "probability": 0.054539054093806404,
            "start_logit": 5.434958457946777,
            "end_logit": 5.291720867156982,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "Ezrin",
            "probability": 0.05393967717363793,
            "start_logit": 5.666848659515381,
            "end_logit": 5.0487799644470215,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin and moesin",
            "probability": 0.05092223626849353,
            "start_logit": 5.099839687347412,
            "end_logit": 5.55822229385376,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin and moesin (ERM proteins)Ezrin/radixin",
            "probability": 0.03900922916226198,
            "start_logit": 5.099839687347412,
            "end_logit": 5.291720867156982,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin and moesin (ERM proteins)Ezrin",
            "probability": 0.03059563527185392,
            "start_logit": 5.099839687347412,
            "end_logit": 5.0487799644470215,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/moesin (ERM) proteinsezrin, radixin and moesin",
            "probability": 0.023230282832714107,
            "start_logit": 4.314996719360352,
            "end_logit": 5.55822229385376,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM) proteinsezrin, radixin and moesin",
            "probability": 0.02146650727082599,
            "start_logit": 4.236033916473389,
            "end_logit": 5.55822229385376,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM) proteinsezrin, radixin and moesin (ERM proteins)Ezrin/radixin",
            "probability": 0.016444523312483094,
            "start_logit": 4.236033916473389,
            "end_logit": 5.291720867156982,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/moesin (ERM) proteinsezrin, radixin",
            "probability": 0.01613009507508894,
            "start_logit": 4.314996719360352,
            "end_logit": 5.19345235824585,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin (ERM) proteinsezrin, radixin and moesin",
            "probability": 0.015747991677768965,
            "start_logit": 3.926252841949463,
            "end_logit": 5.55822229385376,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin, radixin and moesin (ERM proteins)Ezrin/radixin/moesin",
            "probability": 0.015723133247099112,
            "start_logit": 3.821539878845215,
            "end_logit": 5.661355495452881,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM) proteinsezrin, radixin",
            "probability": 0.01490540626224723,
            "start_logit": 4.236033916473389,
            "end_logit": 5.19345235824585,
            "question_text": "List the ERM proteins."
        }
    ],
    "5c9007460101eac870000012": [
        {
            "text": "Cfl2",
            "probability": 0.9140424305722364,
            "start_logit": 1.4037762880325317,
            "end_logit": 1.002349853515625,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "(Cfl2",
            "probability": 0.02345925092296479,
            "start_logit": -2.258835792541504,
            "end_logit": 1.002349853515625,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Cfl2)",
            "probability": 0.018158830773468117,
            "start_logit": 1.4037762880325317,
            "end_logit": -2.916370153427124,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Cofilin-2 (Cfl2",
            "probability": 0.017083504798234898,
            "start_logit": -2.5759873390197754,
            "end_logit": 1.002349853515625,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Cfl",
            "probability": 0.007405958972935494,
            "start_logit": 1.4037762880325317,
            "end_logit": -3.813242197036743,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "C",
            "probability": 0.005465979020260018,
            "start_logit": 1.4037762880325317,
            "end_logit": -4.116983890533447,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "2",
            "probability": 0.004696187834975337,
            "start_logit": -3.867349624633789,
            "end_logit": 1.002349853515625,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Cfl2) was identified as one of the potential targets of miR-301a",
            "probability": 0.0028622725080535974,
            "start_logit": 1.4037762880325317,
            "end_logit": -4.763911247253418,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Cfl2) was identified as one of the potential targets of miR-301a using prediction databases,",
            "probability": 0.0020501722596776716,
            "start_logit": 1.4037762880325317,
            "end_logit": -5.0976033210754395,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Cfl2) was",
            "probability": 0.001325392203176301,
            "start_logit": 1.4037762880325317,
            "end_logit": -5.53381872177124,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "l2",
            "probability": 0.0012071492247716922,
            "start_logit": -5.225839138031006,
            "end_logit": 1.002349853515625,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "2 (Cfl2",
            "probability": 0.0006961771761441023,
            "start_logit": -5.776251792907715,
            "end_logit": 1.002349853515625,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "(Cfl2)",
            "probability": 0.00046605338366595373,
            "start_logit": -2.258835792541504,
            "end_logit": -2.916370153427124,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Cofilin-2 (Cfl2)",
            "probability": 0.0003393895756618946,
            "start_logit": -2.5759873390197754,
            "end_logit": -2.916370153427124,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "(Cfl",
            "probability": 0.0001900767886262211,
            "start_logit": -2.258835792541504,
            "end_logit": -3.813242197036743,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "(C",
            "probability": 0.00014028645617213193,
            "start_logit": -2.258835792541504,
            "end_logit": -4.116983890533447,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Cofilin-2 (Cfl",
            "probability": 0.00013841779267343926,
            "start_logit": -2.5759873390197754,
            "end_logit": -3.813242197036743,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Cofilin-2 (C",
            "probability": 0.00010215945747858108,
            "start_logit": -2.5759873390197754,
            "end_logit": -4.116983890533447,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "2)",
            "probability": 9.329685069690792e-05,
            "start_logit": -3.867349624633789,
            "end_logit": -2.916370153427124,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "actin filaments",
            "probability": 7.701342812637714e-05,
            "start_logit": -2.966348171234131,
            "end_logit": -4.009178161621094,
            "question_text": "Name three binding partners of cofilin 2."
        }
    ],
    "5c990afbecadf2e73f000030": [
        {
            "text": "TRAF6",
            "probability": 0.44579079115574294,
            "start_logit": 3.2822604179382324,
            "end_logit": 2.0119550228118896,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RF1",
            "probability": 0.24188317983227295,
            "start_logit": 2.2329769134521484,
            "end_logit": 2.449843645095825,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RING1",
            "probability": 0.14705866035978402,
            "start_logit": 2.90334415435791,
            "end_logit": 1.2818530797958374,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1",
            "probability": 0.11621209572645058,
            "start_logit": 1.49993896484375,
            "end_logit": 2.449843645095825,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RING",
            "probability": 0.009077429514936662,
            "start_logit": 2.90334415435791,
            "end_logit": -1.5031874179840088,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "TRAF6 RING dimer promotes ubiquitin transfer was unknown. RING ubiquitin E3 ligases",
            "probability": 0.008329733857160045,
            "start_logit": 3.2822604179382324,
            "end_logit": -1.968063235282898,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "ubiquitin E3 ligases enclose a RING domain for ubiquitin ligase activity UHRF1",
            "probability": 0.005831823254225369,
            "start_logit": -1.4921482801437378,
            "end_logit": 2.449843645095825,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RF1 RING domain",
            "probability": 0.005369006629219314,
            "start_logit": 2.2329769134521484,
            "end_logit": -1.3579683303833008,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RING ubiquitin E3 ligases enclose a RING domain for ubiquitin ligase activity UHRF1",
            "probability": 0.0026647950733048507,
            "start_logit": -2.27535080909729,
            "end_logit": 2.449843645095825,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 RING domain",
            "probability": 0.002579524185118778,
            "start_logit": 1.49993896484375,
            "end_logit": -1.3579683303833008,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RF1 RING",
            "probability": 0.002325349210623856,
            "start_logit": 2.2329769134521484,
            "end_logit": -2.1947410106658936,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RING1 was required for its E3 Ub ligase activity",
            "probability": 0.0020956263686794457,
            "start_logit": 2.90334415435791,
            "end_logit": -2.969125986099243,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RING1 was required for its E3 Ub ligase activity.",
            "probability": 0.001922572122382026,
            "start_logit": 2.90334415435791,
            "end_logit": -3.055314540863037,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "TRAF6 RING dimer promotes ubiquitin transfer was unknown. RING",
            "probability": 0.0016453062490615305,
            "start_logit": 3.2822604179382324,
            "end_logit": -3.589968204498291,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RF",
            "probability": 0.0016082081475097148,
            "start_logit": 2.2329769134521484,
            "end_logit": -2.563490629196167,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "TRAF6 RING",
            "probability": 0.0014028485586088304,
            "start_logit": 3.2822604179382324,
            "end_logit": -3.749389886856079,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "TRAF",
            "probability": 0.001156899051920259,
            "start_logit": 3.2822604179382324,
            "end_logit": -3.9421515464782715,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 RING",
            "probability": 0.0011172075100460966,
            "start_logit": 1.49993896484375,
            "end_logit": -2.1947410106658936,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "RING domain of RING1",
            "probability": 0.00097964282795424,
            "start_logit": -2.1080546379089355,
            "end_logit": 1.2818530797958374,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "coiled coil domainthe detailed mechanism by which the TRAF6",
            "probability": 0.000949300364998024,
            "start_logit": -2.869619369506836,
            "end_logit": 2.0119550228118896,
            "question_text": "List proteins with RING domain."
        }
    ],
    "5c9d170cecadf2e73f000032": [
        {
            "text": "obesity",
            "probability": 0.24723780740053647,
            "start_logit": 5.655539035797119,
            "end_logit": 5.866247177124023,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "obesity.Human FAAH gene mutations are associated with increased body weight and obesity.whereas mutations in FAAH are associated with obesity",
            "probability": 0.21621826125041074,
            "start_logit": 5.655539035797119,
            "end_logit": 5.732184886932373,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "obesity.Human FAAH gene mutations are associated with increased body weight and obesity",
            "probability": 0.16482213681051394,
            "start_logit": 5.655539035797119,
            "end_logit": 5.460763454437256,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "obesity.whereas mutations in FAAH are associated with obesity",
            "probability": 0.1515484607812749,
            "start_logit": 5.300156116485596,
            "end_logit": 5.732184886932373,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "increased body weight and obesity",
            "probability": 0.06258204252476839,
            "start_logit": 4.2816667556762695,
            "end_logit": 5.866247177124023,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "increased body weight and obesity.Human FAAH gene mutations are associated with increased body weight and obesity",
            "probability": 0.041720585064840665,
            "start_logit": 4.2816667556762695,
            "end_logit": 5.460763454437256,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "obesity.Human FAAH gene mutations are associated with increased body weight",
            "probability": 0.03930571710498084,
            "start_logit": 5.655539035797119,
            "end_logit": 4.027266502380371,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "increased body weight and obesity.whereas mutations in FAAH are associated with obesity",
            "probability": 0.028885193390224828,
            "start_logit": 3.6425797939300537,
            "end_logit": 5.732184886932373,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "increased body weight",
            "probability": 0.019170377169611053,
            "start_logit": 4.2816667556762695,
            "end_logit": 4.683135032653809,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "increased body weight and obesity.Human FAAH gene mutations are associated with increased body weight",
            "probability": 0.009949255274479065,
            "start_logit": 4.2816667556762695,
            "end_logit": 4.027266502380371,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "body weight and obesity",
            "probability": 0.006193233422076713,
            "start_logit": 1.968645691871643,
            "end_logit": 5.866247177124023,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "body weight and obesity.Human FAAH gene mutations are associated with increased body weight and obesity",
            "probability": 0.004128745425812899,
            "start_logit": 1.968645691871643,
            "end_logit": 5.460763454437256,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "body weight",
            "probability": 0.0018971355969032587,
            "start_logit": 1.968645691871643,
            "end_logit": 4.683135032653809,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "body weight and obesity.whereas mutations in FAAH are associated with obesity",
            "probability": 0.0015262227676364104,
            "start_logit": 0.7020465731620789,
            "end_logit": 5.732184886932373,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "obesity.",
            "probability": 0.0014525039676222499,
            "start_logit": 5.655539035797119,
            "end_logit": 0.7291854619979858,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "obesity.Human FAAH gene mutations are associated with increased body weight and obesity.",
            "probability": 0.0014296365025374684,
            "start_logit": 5.655539035797119,
            "end_logit": 0.7133167386054993,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "body weight and obesity.Human FAAH gene mutations are associated with increased body weight",
            "probability": 0.0009845965041216083,
            "start_logit": 1.968645691871643,
            "end_logit": 4.027266502380371,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "increased body weight and obesity.",
            "probability": 0.000367664905399631,
            "start_logit": 4.2816667556762695,
            "end_logit": 0.7291854619979858,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "increased body weight and obesity.Human FAAH gene mutations are associated with increased body weight and obesity.",
            "probability": 0.00036187658084111795,
            "start_logit": 4.2816667556762695,
            "end_logit": 0.7133167386054993,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "besity",
            "probability": 0.00021854755540743302,
            "start_logit": -1.3755632638931274,
            "end_logit": 5.866247177124023,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        }
    ],
    "5c961281ecadf2e73f000021": [
        {
            "text": "interstitial lung disease",
            "probability": 0.36088702776403364,
            "start_logit": 6.024080276489258,
            "end_logit": 5.195491790771484,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "antisynthetase syndrome",
            "probability": 0.352859238727176,
            "start_logit": 5.516048908233643,
            "end_logit": 5.681027412414551,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "antisynthetase syndrome (AS) and interstitial lung disease",
            "probability": 0.21713810911292955,
            "start_logit": 5.516048908233643,
            "end_logit": 5.195491790771484,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "juvenile idiopathic arthritis",
            "probability": 0.038635732824912734,
            "start_logit": 4.918018817901611,
            "end_logit": 4.067165851593018,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "juvenile idiopathic arthritischronic lymphocytic leukemia",
            "probability": 0.01252256830620013,
            "start_logit": 4.918018817901611,
            "end_logit": 2.940520763397217,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "idiopathic arthritis",
            "probability": 0.0025393733357149508,
            "start_logit": 2.195758581161499,
            "end_logit": 4.067165851593018,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "poly- and dermatomyositis",
            "probability": 0.002126417294311159,
            "start_logit": 2.940633773803711,
            "end_logit": 3.1448118686676025,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "lung disease",
            "probability": 0.0020304490642832785,
            "start_logit": 0.843772292137146,
            "end_logit": 5.195491790771484,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "dermatomyositis",
            "probability": 0.0016138052857721532,
            "start_logit": 2.664790153503418,
            "end_logit": 3.1448118686676025,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "arthritis",
            "probability": 0.0014513836893758757,
            "start_logit": 1.636358618736267,
            "end_logit": 4.067165851593018,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "JIA, although it is not licensed for this indication rituximab in children and young people with juvenile idiopathic arthritis",
            "probability": 0.0012574962756899289,
            "start_logit": 1.4929639101028442,
            "end_logit": 4.067165851593018,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "syndrome",
            "probability": 0.0010941102702790074,
            "start_logit": -0.2600788176059723,
            "end_logit": 5.681027412414551,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "ronic lymphocytic leukemia",
            "probability": 0.0010202270052421007,
            "start_logit": 2.4105114936828613,
            "end_logit": 2.940520763397217,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "interstitial lung",
            "probability": 0.0009814296705329306,
            "start_logit": 6.024080276489258,
            "end_logit": -0.7118180990219116,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "idiopathic arthritischronic lymphocytic leukemia",
            "probability": 0.0008230587004921285,
            "start_logit": 2.195758581161499,
            "end_logit": 2.940520763397217,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "antisynthetase",
            "probability": 0.000796031524967388,
            "start_logit": 5.516048908233643,
            "end_logit": -0.4131582975387573,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "syndrome (AS) and interstitial lung disease",
            "probability": 0.0006732799064759839,
            "start_logit": -0.2600788176059723,
            "end_logit": 5.195491790771484,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "antisynthetase syndrome (AS) and interstitial lung",
            "probability": 0.0005905055224821919,
            "start_logit": 5.516048908233643,
            "end_logit": -0.7118180990219116,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "the antisynthetase syndrome",
            "probability": 0.0004893349438564136,
            "start_logit": -1.0647283792495728,
            "end_logit": 5.681027412414551,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "arthritischronic lymphocytic leukemia",
            "probability": 0.0004704207752724361,
            "start_logit": 1.636358618736267,
            "end_logit": 2.940520763397217,
            "question_text": "List 3 indications for rituximab."
        }
    ]
}
